Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" AADAT "KAT2, KATII, KYAT2" ENSG00000109576 "Aminoadipate aminotransferase" Q8N5Z0 4 170060222-170091699 "Enzymes, Predicted intracellular proteins" "Aminotransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "liver: 56.5" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 60.6;Hepatocytes: 22.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA037502 Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA037502: AB_10671759" "unprognostic (1.90e-1)" "unprognostic (1.82e-2)" "prognostic favorable (5.59e-4)" "unprognostic (4.21e-2)" "unprognostic (1.30e-1)" "unprognostic (1.06e-1)" "unprognostic (7.41e-2)" "unprognostic (1.03e-2)" "unprognostic (2.97e-2)" "unprognostic (3.38e-2)" "unprognostic (1.23e-2)" "unprognostic (3.55e-1)" "unprognostic (1.35e-1)" "unprognostic (1.23e-2)" "unprognostic (1.39e-1)" "unprognostic (7.28e-3)" "unprognostic (1.17e-2)" 3.0 3.1 9.2 2.2 9.0 0.9 4.7 0.8 10.8 8.3 4.7 10.3 2.9 1.9 9.7 5.8 2.8 5.7 3.9 2.8 7.2 6.4 6.3 56.5 4.7 1.1 8.2 8.0 4.7 4.6 7.6 8.9 2.2 6.0 13.3 5.0 6.6 1.7 5.4 3.6 1.8 2.0 7.0 7.0 2.0 3.2 7.2 9.2 0.9 7.0 1.2 1.3 5.5 4.9 0.4 0.4 0.0 0.7 0.0 0.7 0.0 2.2 5.5 16.7 0.0 3.3 13.0 6.0 5.7 2.8 3.3 3.3 5.3 0.6 0.0 0.9 6.3 4.3 1.9 7.4 2.7 2.3 0.0 6.4 0.0 6.2 8.9 2.7 0.0 2.4 5.3 1.6 2.7 3.5 9.1 3.1 7.5 0.9 0.1 12.6 5.6 2.7 0.1 12.6 6.2 5.0 0.0 5.2 0.0 2.9 10.0 13.5 15.7 4.5 1.1 5.4 5.6 0.0 1.1 2.1 8.4 9.0 9.5 8.8 0.0 0.0 0.0 8.4 0.0 9.8 0.0 0.7 0.0 0.0 0.1 0.2 0.0 0.3 0.3 0.4 0.4 0.3 0.0 0.0 0.0 0.2 0.0 0.7 0.0 9.2 9.0 0.8 10.8 7.2 6.4 8.2 8.0 6.0 9.2 0.0 5.1 0.0 2.6 0.8 5.1 1.1 2.5 14.7 3.4 0.0 2.0 1.4 0.0 1.3 0.4 0.5 0.0 0.0 1.9 60.6 2.4 3.6 0.0 22.9 1.4 0.0 6.4 0.0 0.3 0.6 1.1 0.6 1.7 0.0 1.3 3.2 0.9 0.0 2.1 6.5 8.2 6.5 2.2 2.4 12.5 0.4 4.7 0.0 2.3 1.4 ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949577-16143074 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport "Hydrolase, Translocase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.5;eosinophil: 3.1;T-reg: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 7.5;T-cells: 2.1" "Cell line enhanced" "Detected in many" "EFO-21: 39.0" "Low region specificity" "Detected in all" "HPA002380, HPA076011" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA002380: AB_1844432, HPA076011: " "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavorable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavorable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 8.9 8.2 2.4 8.3 3.1 8.4 9.6 4.4 5.0 8.3 10.7 2.6 15.5 3.5 10.5 12.7 14.7 5.6 9.6 8.0 2.1 2.4 4.5 1.6 10.9 12.2 3.0 2.1 6.8 5.8 18.4 4.2 5.2 4.1 9.6 4.1 12.0 16.9 10.9 20.8 6.6 8.2 16.4 4.0 9.2 10.9 15.1 2.3 26.8 15.7 12.6 15.6 15.3 11.8 0.7 0.5 7.5 0.5 0.4 2.1 0.2 2.3 24.7 0.1 6.5 5.7 3.5 1.3 7.3 8.9 6.3 6.6 3.9 17.8 6.7 39.0 14.0 5.9 6.7 2.0 7.1 4.8 11.8 2.3 8.3 14.4 14.3 17.1 3.0 21.5 7.5 4.8 1.8 1.0 5.4 6.9 12.9 8.4 3.4 1.9 4.6 5.3 2.8 3.9 3.3 3.6 18.9 3.7 3.3 2.3 8.3 3.6 5.9 9.2 10.0 2.4 6.6 3.5 1.6 0.7 0.4 1.5 5.2 5.8 6.4 3.2 2.3 3.3 3.1 0.7 7.5 0.1 3.1 0.6 0.4 0.6 0.7 0.5 0.6 0.5 0.3 0.6 0.6 0.0 0.4 0.5 0.3 2.1 0.2 2.4 3.1 4.4 5.0 2.1 2.4 3.0 2.1 4.1 2.3 23.8 6.4 10.4 6.8 7.8 3.1 5.3 5.1 2.7 12.5 5.2 21.6 0.6 3.3 8.7 7.2 6.2 1.1 0.0 5.5 2.2 3.3 13.8 20.9 0.2 7.2 4.8 17.9 8.6 15.5 11.0 6.9 10.2 3.3 6.4 7.2 1.2 8.5 3.5 6.3 1.4 8.3 0.0 3.1 2.4 5.9 4.4 0.5 9.6 3.1 8.4 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell type enhanced" "Detected in many" 14 "Distal tubular cells: 38.1;Hepatocytes: 56.7;Proximal tubular cells: 117.8" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Cell line enriched" "Detected in some" 8 "Hep G2: 38.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038105: AB_2675835" "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favorable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.6 0.9 3.8 1.5 0.0 0.5 0.0 0.1 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 38.6 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.4 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.1 0.5 0.1 0.2 4.9 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 26.8 26.9 3.6 0.7 0.1 0.3 2.4 20.4 18.7 9.1 8.7 0.0 0.0 38.1 1.6 0.2 0.6 19.1 0.0 7.1 0.0 1.0 1.6 1.1 56.7 1.1 0.0 2.9 1.8 4.1 0.4 1.4 1.5 1.7 1.0 13.4 1.3 2.9 3.5 5.3 117.8 0.7 0.0 0.5 0.1 0.2 0.6 0.0 0.0 13.3 0.4 ABCG2 "ABCP, BCRP, CD338, EST157481, MXR" ENSG00000118777 "ATP binding cassette subfamily G member 2 (Junior blood group)" Q9UNQ0 4 88090264-88231322 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" Transport Translocase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0" "Cell type enhanced" "Detected in many" 15 "Enterocytes: 135.7;Extravillous trophoblasts: 47.1;Hofbauer cells: 105.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 18.8;BEWO: 32.9;OE19: 25.5;RPMI-8226: 16.5;SuSa: 12.7" "CAB037299, HPA054719" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB037299: AB_476804, HPA054719: " "unprognostic (5.04e-1)" "unprognostic (3.05e-2)" "unprognostic (2.01e-1)" "unprognostic (1.10e-1)" "unprognostic (1.01e-3)" "unprognostic (9.19e-2)" "unprognostic (1.09e-1)" "unprognostic (1.30e-1)" "unprognostic (9.14e-2)" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (4.52e-2)" "unprognostic (1.67e-3)" "unprognostic (8.82e-3)" "unprognostic (7.04e-2)" "unprognostic (1.30e-1)" "unprognostic (1.92e-1)" 2.8 2.5 11.6 0.8 14.8 1.2 2.4 4.3 9.7 13.6 12.5 8.4 49.6 24.9 14.4 4.2 1.5 6.1 3.3 2.0 16.0 12.2 2.3 19.7 3.0 0.8 17.6 5.6 5.6 0.6 3.2 7.0 12.3 17.0 5.5 8.1 6.9 2.9 61.0 0.4 0.6 56.6 11.8 15.7 0.9 1.2 1.9 5.5 0.0 3.8 0.8 1.3 2.0 3.1 1.2 0.5 0.0 0.2 2.4 5.7 0.7 0.6 18.8 5.6 0.0 0.2 0.0 32.9 0.7 0.6 1.0 1.6 4.1 0.2 0.0 0.2 0.1 2.4 5.5 0.1 0.5 1.4 5.3 0.8 0.2 0.1 5.6 0.0 0.2 0.0 0.1 2.3 2.2 0.1 0.5 1.7 0.4 0.4 0.0 0.6 10.9 2.6 0.0 1.9 25.5 0.0 1.2 0.0 16.5 0.0 4.0 0.0 0.2 3.9 0.4 0.5 12.7 0.1 0.0 0.0 0.7 0.7 0.2 0.0 5.2 1.9 0.0 1.4 0.0 0.8 0.0 0.0 0.0 1.9 0.0 5.7 0.1 0.7 0.6 0.0 1.2 0.7 0.3 0.0 2.4 0.2 0.5 1.7 0.7 11.6 14.8 4.3 9.7 16.0 12.2 17.6 5.6 17.0 5.5 3.0 1.4 0.5 0.2 3.4 0.0 1.1 0.0 1.4 0.0 0.0 0.0 14.3 1.7 0.0 2.6 9.0 135.7 0.0 0.2 47.1 2.1 0.2 5.7 25.0 105.8 0.0 2.9 13.5 1.0 0.4 1.1 1.1 5.0 0.0 2.9 0.9 0.1 35.1 0.4 4.5 0.2 0.0 1.4 0.9 3.4 0.4 31.5 0.8 0.8 0.1 AC005324.3 ENSG00000251537 17 15571491-15651653 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 23.3;tongue: 21.1;vagina: 17.9" "Group enriched" "Detected in some" 11 "Club cells: 1.2;Pancreatic endocrine cells: 2.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 3.5;CAPAN-2: 3.1;HaCaT: 6.6;HeLa: 3.1;OE19: 2.2" "HPA023623, HPA066431" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (3.45e-2)" "unprognostic (1.41e-1)" "unprognostic (1.93e-1)" "unprognostic (2.48e-1)" "unprognostic (1.24e-2)" "unprognostic (3.52e-2)" "unprognostic (2.87e-3)" "unprognostic (1.93e-1)" "unprognostic (2.98e-2)" "unprognostic (4.39e-2)" "unprognostic (4.81e-3)" "unprognostic (6.35e-3)" "unprognostic (1.80e-11)" "unprognostic (1.95e-1)" "unprognostic (1.36e-1)" "unprognostic (5.30e-2)" "unprognostic (3.09e-1)" 7.5 2.8 0.9 1.5 1.0 1.0 7.7 0.9 1.0 5.3 2.2 1.3 0.0 2.1 0.7 1.5 23.3 0.8 4.0 2.6 0.8 0.9 0.9 1.0 2.1 1.6 3.7 0.0 0.7 1.0 0.8 0.7 12.4 2.7 1.4 0.9 0.2 2.4 1.1 2.9 4.4 1.6 2.1 1.5 1.0 2.8 1.8 1.0 1.6 1.8 21.1 17.5 3.2 17.9 0.6 0.6 0.0 0.1 0.0 0.5 0.0 0.6 3.5 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.1 0.1 3.1 0.1 0.1 1.0 0.0 6.6 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.4 1.0 0.0 0.0 0.6 0.4 0.1 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.3 0.9 0.0 0.2 0.0 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.6 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.9 1.0 0.8 0.9 3.7 0.0 2.7 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AC008403.1 ENSG00000268465 19 48465837-48472431 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "endometrium 1: 2.7;intestine: 3.6;testis: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.8;U-698: 5.0" HPA060662 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA060662: AB_2732652" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.6 0.5 0.1 3.6 0.0 2.7 0.0 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.5 0.2 0.3 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.3 0.1 1.6 0.0 0.2 0.1 0.5 4.7 0.1 0.0 0.0 0.0 1.0 0.5 0.7 0.4 0.0 1.0 0.0 0.0 0.0 0.0 2.9 2.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.7 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.6 2.3 1.3 0.0 2.2 0.0 0.0 1.2 0.0 0.0 0.0 1.9 0.3 0.0 3.6 0.0 0.0 3.8 1.9 1.7 0.0 0.0 0.0 0.0 0.0 0.3 1.5 0.2 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.9 1.9 0.0 0.0 0.9 0.9 5.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 0.3 0.2 1.0 0.3 0.4 0.3 0.0 0.6 0.1 0.0 0.0 0.4 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ACKR3 "CMKOR1, CXCR7, GPR159, RDC1" ENSG00000144476 "Atypical chemokine receptor 3" P25106 2 236567787-236582358 "Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Basal keratinocytes: 19.6;Club cells: 21.6;Endothelial cells: 44.5;Fibroblasts: 27.8;Ito cells: 17.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "NK-cells: 6.1;T-cells: 6.1" "Cell line enhanced" "Detected in some" "HeLa: 23.4;MCF7: 17.2;RT4: 68.3;SiHa: 20.9;U-2197: 71.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA032003, HPA049718" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA032003: AB_2674107, HPA049718: AB_2680859" "unprognostic (1.65e-2)" "prognostic unfavorable (4.64e-4)" "unprognostic (2.50e-1)" "unprognostic (1.92e-3)" "unprognostic (2.10e-1)" "unprognostic (1.23e-1)" "unprognostic (7.34e-3)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "unprognostic (1.35e-1)" "unprognostic (9.70e-3)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.76e-6)" "prognostic unfavorable (2.01e-4)" "unprognostic (9.71e-2)" "unprognostic (8.57e-3)" "prognostic unfavorable (2.93e-4)" 56.1 2.9 5.4 6.9 5.6 1.7 28.5 2.2 6.4 10.7 15.2 8.9 9.1 5.7 9.9 20.4 23.6 14.6 15.3 30.2 8.4 3.0 3.8 29.6 10.9 7.2 3.8 6.5 19.3 25.7 2.2 10.7 59.6 8.4 14.2 12.8 25.2 8.9 8.9 36.4 16.0 15.7 32.6 7.2 70.9 12.6 9.4 5.5 0.2 34.3 22.3 8.6 59.2 17.8 1.0 0.2 0.1 0.5 6.1 6.1 0.6 0.0 0.0 1.4 0.0 2.4 0.0 10.0 0.5 0.3 0.5 1.0 0.1 0.0 0.0 1.1 0.0 3.8 14.7 0.0 5.2 0.0 0.0 0.0 0.0 23.4 0.0 0.0 0.0 0.0 0.6 13.4 0.0 0.0 3.3 2.4 0.0 0.2 0.0 0.0 17.2 0.0 0.0 2.3 0.0 0.1 0.0 1.6 0.1 0.0 68.3 0.0 0.0 20.9 0.1 0.0 5.5 0.0 0.0 0.0 0.1 5.4 71.8 0.0 0.3 0.0 0.0 0.2 1.4 0.1 0.0 0.1 0.0 4.1 0.3 6.1 0.6 2.1 5.0 0.2 1.0 1.8 2.3 0.1 6.1 0.5 0.0 3.1 0.6 5.4 5.6 2.2 6.4 8.4 3.0 3.8 6.5 8.4 5.5 8.9 4.5 0.5 0.1 19.6 1.3 6.9 0.0 6.7 21.6 0.0 0.0 0.0 0.0 0.2 1.0 44.5 0.7 0.0 9.3 0.2 27.8 0.2 5.8 0.9 0.8 0.0 0.0 17.8 2.5 0.2 1.4 4.0 1.7 1.0 0.0 0.0 0.9 0.8 1.1 0.6 0.0 0.0 15.0 0.3 0.4 13.9 0.2 0.0 0.0 0.9 ACTR6 "ARP6, FLJ13433" ENSG00000075089 "ARP6 actin related protein 6 homolog" Q9GZN1 12 100199122-100241865 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038587, HPA038588" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA038587: AB_10670781, HPA038588: AB_10672719" "unprognostic (1.24e-2)" "unprognostic (8.43e-3)" "unprognostic (1.81e-1)" "unprognostic (1.14e-1)" "unprognostic (1.70e-1)" "unprognostic (1.24e-2)" "prognostic unfavorable (7.70e-9)" "unprognostic (4.11e-2)" "unprognostic (1.09e-1)" "unprognostic (1.05e-1)" "unprognostic (6.98e-2)" "unprognostic (3.99e-1)" "unprognostic (5.32e-2)" "unprognostic (4.30e-2)" "unprognostic (3.22e-1)" "unprognostic (6.67e-3)" "unprognostic (3.40e-2)" 7.6 8.0 12.6 6.6 13.8 5.6 20.5 14.8 20.2 10.3 9.9 10.2 6.9 7.5 8.6 7.2 10.4 9.6 5.9 8.1 15.2 15.7 12.3 12.5 8.2 11.6 13.8 15.4 9.9 5.9 15.8 14.0 11.6 21.2 11.0 10.6 6.7 7.7 12.2 8.3 6.8 9.2 8.3 12.8 9.6 7.3 13.9 14.6 13.4 9.6 5.8 11.9 11.6 8.6 6.1 6.1 4.6 5.8 7.9 10.9 6.6 18.0 7.1 9.0 11.0 9.0 11.1 18.5 5.1 8.9 8.5 5.8 5.1 5.3 9.5 7.1 8.0 8.0 5.9 13.2 8.3 15.5 9.0 11.9 5.8 7.2 5.4 9.8 8.9 6.0 6.6 10.1 7.2 9.3 13.0 11.5 13.9 10.1 3.8 11.8 3.9 11.9 10.0 8.8 7.0 8.9 7.3 8.8 11.1 11.5 10.4 7.9 13.8 9.3 19.8 9.1 9.6 12.9 8.5 5.8 5.2 3.8 6.9 5.4 6.4 16.2 12.2 3.6 5.9 7.5 3.8 2.8 4.6 8.0 5.8 9.9 6.0 8.8 7.5 4.1 6.1 10.9 10.0 2.1 7.9 4.5 6.1 7.7 6.6 12.6 13.8 14.8 20.2 15.2 15.7 13.8 15.4 21.2 14.6 14.9 15.3 10.1 32.9 20.4 31.8 31.3 5.1 32.1 14.8 22.7 17.7 49.3 39.7 17.9 95.8 19.5 8.9 23.3 10.5 57.0 22.6 20.7 32.3 13.7 20.8 31.8 12.0 14.7 19.9 23.7 18.7 18.5 30.4 19.8 9.8 24.1 12.4 10.7 21.2 53.1 29.9 32.3 25.4 36.4 22.6 17.2 80.3 33.8 11.3 26.9 ADA ENSG00000196839 "Adenosine deaminase" P00813 20 44619522-44652233 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Nucleotide metabolism" Hydrolase "Disease mutation, FDA approved drug targets, Hereditary hemolytic anemia, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0" "Cell type enhanced" "Detected in many" 10 "Extravillous trophoblasts: 90.2;Leydig cells: 39.1;monocytes: 49.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 64.0" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in many" 5 "JURKAT: 61.5;MOLT-4: 198.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001399, CAB004307, HPA023884" Enhanced Supported "Plasma membrane,Cytosol" No No 650000 "Plasma membrane" Cytosol "CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573" "unprognostic (4.30e-2)" "unprognostic (6.89e-2)" "unprognostic (3.96e-2)" "prognostic unfavorable (1.23e-7)" "unprognostic (9.33e-2)" "unprognostic (9.07e-3)" "prognostic unfavorable (6.77e-5)" "prognostic unfavorable (2.20e-4)" "unprognostic (1.59e-1)" "unprognostic (2.16e-1)" "unprognostic (3.66e-2)" "unprognostic (3.48e-1)" "prognostic unfavorable (2.94e-14)" "unprognostic (2.29e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-1)" "unprognostic (1.82e-1)" 8.1 3.2 2.5 5.4 6.5 5.3 5.1 0.9 5.0 2.8 7.4 5.0 1.8 142.2 1.7 3.4 4.6 2.4 3.0 9.2 2.7 0.8 1.3 2.1 2.8 8.9 3.6 2.3 1.2 2.4 0.8 0.3 1.8 3.9 1.8 1.5 0.7 2.6 1.3 2.0 2.8 5.0 2.1 1.3 9.5 19.7 1.6 6.1 99.0 2.8 2.1 7.6 3.6 2.6 1.3 41.6 0.5 64.0 16.9 10.3 9.6 1.4 4.0 2.0 1.4 3.9 5.5 3.3 1.4 0.8 1.4 1.0 1.8 1.5 4.0 1.7 1.9 2.7 0.2 1.4 5.9 0.8 0.3 1.8 0.8 0.7 1.4 1.6 0.6 2.2 26.2 2.5 0.5 0.9 1.3 5.4 61.5 2.0 3.3 0.6 3.4 198.0 2.9 0.5 1.8 1.4 10.7 2.8 9.9 0.2 0.0 0.0 0.9 2.1 0.4 2.5 2.7 0.4 1.9 1.7 1.0 2.0 2.2 0.2 4.3 2.7 8.3 0.3 3.3 0.9 0.0 1.8 0.2 8.7 30.7 5.7 1.3 7.3 10.3 6.8 1.0 5.7 8.1 0.5 16.9 64.0 41.6 5.3 9.6 2.5 6.5 0.9 5.0 2.7 0.8 3.6 2.3 3.9 6.1 0.0 3.4 12.7 3.0 11.4 0.0 1.9 0.0 2.7 0.0 1.8 0.0 2.3 0.0 3.7 0.1 16.2 0.5 0.0 17.9 90.2 16.7 0.9 0.0 2.9 27.6 0.0 0.0 6.7 13.4 1.5 39.1 14.4 8.5 49.5 1.4 2.9 8.2 0.0 2.5 2.1 0.0 12.9 16.1 0.4 1.3 12.2 3.1 30.5 3.3 2.4 ADAM28 "ADAM23, eMDCII, MDC-Lm, MDC-Ls" ENSG00000042980 "ADAM metallopeptidase domain 28" Q9UKQ2 8 24294040-24359018 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 133.1" "Cell type enhanced" "Detected in many" 15 "B-cells: 115.5;Club cells: 62.6;Macrophages: 32.1;Pancreatic endocrine cells: 32.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "memory B-cell: 24.9;naive B-cell: 32.2" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "CAPAN-2: 24.8;OE19: 7.6" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA074034 Enhanced Approved "Plasma membrane,Mitochondria" "Secreted to blood" NA NA "Plasma membrane" Mitochondria "HPA074034: AB_2686654" "unprognostic (4.23e-2)" "unprognostic (1.01e-2)" "unprognostic (2.06e-2)" "prognostic favorable (3.17e-4)" "unprognostic (2.89e-1)" "unprognostic (2.55e-2)" "unprognostic (5.59e-2)" "unprognostic (1.53e-1)" "unprognostic (4.71e-1)" "unprognostic (1.35e-2)" "unprognostic (3.77e-3)" "unprognostic (7.77e-2)" "unprognostic (3.97e-3)" "unprognostic (1.71e-2)" "unprognostic (1.30e-1)" "unprognostic (2.60e-1)" "unprognostic (1.62e-1)" 2.0 1.7 7.7 17.4 8.8 3.5 2.1 0.9 5.8 6.7 5.8 12.7 2.0 3.7 3.1 133.1 2.7 5.1 16.7 1.1 8.9 5.0 3.1 1.1 3.1 10.1 12.4 3.7 1.8 2.7 1.0 22.5 1.9 10.8 3.3 5.0 1.9 12.6 5.1 0.7 1.8 17.9 1.7 26.0 15.5 38.7 0.9 12.1 0.8 1.8 0.4 19.9 7.4 1.6 32.2 7.5 12.5 0.9 0.9 0.0 0.9 0.0 0.4 0.1 0.0 0.0 0.4 0.1 0.1 0.2 0.0 0.0 1.0 24.8 0.2 0.8 0.0 0.8 0.1 0.0 0.8 0.1 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.2 3.2 0.6 7.6 0.1 0.1 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.5 0.3 0.1 0.1 1.1 2.1 0.1 1.9 0.9 0.2 12.5 0.9 6.4 0.0 0.2 0.0 24.9 0.0 0.0 7.5 32.2 0.0 0.0 1.6 0.9 0.0 0.4 0.0 0.9 7.7 8.8 0.9 5.8 8.9 5.0 12.4 3.7 10.8 12.1 3.0 5.9 115.5 2.2 0.8 0.0 0.9 25.5 17.4 62.6 3.5 0.0 0.3 0.0 7.1 0.9 0.7 0.5 0.0 3.1 8.1 1.1 2.0 2.3 0.0 9.0 0.0 0.0 0.0 12.3 1.8 0.6 32.1 5.0 5.4 0.1 0.0 32.8 0.0 0.4 3.6 0.0 6.5 0.3 0.2 0.1 0.5 0.5 6.9 0.9 6.3 ADAM33 "C20orf153, dJ964F7.1, DKFZp434K0521" ENSG00000149451 "ADAM metallopeptidase domain 33" Q9BZ11 20 3667965-3682246 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" Asthma "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 55.7;smooth muscle: 58.0" "Cell type enhanced" "Detected in some" 12 "Fibroblasts: 23.2;Leydig cells: 21.0;Peritubular cells: 9.6;Smooth muscle cells: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.2" "Lineage enriched" "Detected in single" 12 "dendritic cells: 1.2" "Cell line enhanced" "Detected in some" "ASC diff: 31.3;ASC TERT1: 40.6;BJ: 13.8;BJ hTERT+: 23.7;fHDF/TERT166: 14.1;U-2197: 18.9" "Region enhanced" "Detected in single" "cerebral cortex: 1.0" "Low region specificity" "Detected in all" "HPA067152, HPA071758" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA067152: AB_2685791, HPA071758: " "unprognostic (1.10e-1)" "unprognostic (3.02e-2)" "unprognostic (2.24e-2)" "unprognostic (3.35e-3)" "unprognostic (4.39e-3)" "unprognostic (7.43e-4)" "unprognostic (7.14e-3)" "unprognostic (1.67e-1)" "unprognostic (1.78e-3)" "unprognostic (1.28e-1)" "unprognostic (1.26e-1)" "unprognostic (3.56e-1)" "unprognostic (2.75e-11)" "unprognostic (1.05e-2)" "unprognostic (1.92e-1)" "unprognostic (3.21e-5)" "unprognostic (3.10e-3)" 10.0 1.5 4.6 9.2 2.6 0.0 20.2 2.8 2.7 55.7 29.5 2.2 20.9 4.7 44.3 12.3 17.0 16.9 17.5 5.3 5.0 0.9 0.9 0.5 3.6 2.2 4.9 3.0 11.8 1.6 0.0 1.6 5.4 7.0 22.8 5.5 3.7 4.2 27.1 3.5 4.8 9.1 58.0 3.3 1.9 9.9 5.4 3.5 0.1 4.0 10.1 2.0 24.9 36.7 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.3 40.6 0.1 13.8 23.7 4.1 8.0 0.0 0.0 0.0 0.0 14.1 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 6.9 0.0 1.5 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 4.6 2.6 2.8 2.7 5.0 0.9 4.9 3.0 7.0 3.5 0.0 0.0 0.0 0.1 4.8 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.8 0.0 0.0 0.0 0.2 23.2 0.2 0.0 0.0 0.5 0.0 0.0 3.1 0.0 0.0 21.0 0.6 3.3 0.0 0.0 3.3 0.0 0.0 9.6 0.0 0.0 6.5 15.1 0.6 0.5 2.8 0.5 0.0 0.0 0.0 ADAMTS2 "ADAM-TS2, ADAMTS-3, hPCPNI, NPI, PCINP" ENSG00000087116 "ADAM metallopeptidase with thrombospondin type 1 motif 2" O95450 5 179110851-179345430 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Ehlers-Danlos syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 16 "Ito cells: 28.8;Kupffer cells: 58.6;Sertoli cells: 25.8;Smooth muscle cells: 16.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 14.0;ASC TERT1: 14.0;BJ: 12.3;fHDF/TERT166: 14.5;HHSteC: 45.5;HSkMC: 36.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA028363, HPA028444" Uncertain Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA028363: , HPA028444: AB_10601964" "unprognostic (6.78e-2)" "unprognostic (7.83e-2)" "unprognostic (1.13e-1)" "unprognostic (5.50e-2)" "unprognostic (8.85e-3)" "unprognostic (4.80e-2)" "unprognostic (1.09e-1)" "unprognostic (2.22e-2)" "unprognostic (1.58e-1)" "unprognostic (1.91e-2)" "unprognostic (2.08e-1)" "unprognostic (2.45e-1)" "prognostic unfavorable (1.71e-8)" "unprognostic (1.32e-3)" "unprognostic (1.03e-2)" "unprognostic (7.16e-3)" "unprognostic (1.48e-2)" 24.2 4.3 0.9 5.8 0.7 0.7 29.1 0.9 2.3 16.3 10.1 0.4 3.9 2.7 12.0 9.5 6.0 7.2 9.5 10.1 0.7 1.2 4.2 7.4 13.1 25.9 1.0 1.3 6.3 2.7 1.0 8.7 15.1 2.4 6.0 2.6 3.8 2.5 3.8 3.8 4.6 4.6 13.8 0.7 16.5 4.2 4.3 0.5 0.8 3.2 5.9 1.2 8.8 14.7 1.4 1.3 2.1 0.3 0.8 0.6 0.1 0.0 0.0 0.0 0.3 14.0 14.0 0.0 12.3 2.1 4.7 5.0 0.0 0.0 0.0 0.1 14.5 0.3 0.0 0.7 0.0 2.0 0.0 0.7 0.0 0.0 0.9 45.5 0.0 0.0 36.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.9 0.5 0.0 0.0 0.1 0.8 0.0 4.0 0.0 7.9 1.2 10.3 0.0 0.1 0.0 0.0 0.3 0.1 0.0 1.5 0.3 0.4 0.6 0.2 0.3 0.6 0.5 0.4 1.3 1.4 0.5 0.5 2.1 0.8 0.1 0.8 0.5 0.1 0.9 0.7 0.9 2.3 0.7 1.2 1.0 1.3 2.4 0.5 0.0 0.6 0.0 0.3 1.9 0.0 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 1.4 0.0 0.0 0.0 0.1 13.5 0.2 1.1 0.5 3.9 0.0 0.0 28.8 58.6 2.1 4.6 2.9 0.0 0.0 0.0 0.0 0.8 0.0 12.0 0.0 0.0 25.8 16.1 0.5 2.6 2.4 0.0 0.0 0.0 0.1 ADAMTSL4 "DKFZP434K1772, TSRC1" ENSG00000143382 "ADAMTS like 4" Q6UY14 1 150549369-150560937 "Disease related genes, Predicted secreted proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "placenta: 157.1" "Cell type enhanced" "Detected in many" 13 "Cytotrophoblasts: 113.3;Extravillous trophoblasts: 39.4;Syncytiotrophoblasts: 83.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "classical monocyte: 1.6;intermediate monocyte: 1.8;neutrophil: 2.3;non-classical monocyte: 3.5" "Group enriched" "Detected in many" 5 "granulocytes: 2.3;monocytes: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 30.2;BEWO: 63.6;HSkMC: 14.2;K-562: 20.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006279 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 47000000 "Plasma membrane, Cytosol" "HPA006279: AB_1078102" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "prognostic unfavorable (1.86e-4)" "unprognostic (8.09e-4)" "prognostic unfavorable (2.43e-4)" "unprognostic (1.09e-1)" "unprognostic (1.65e-1)" "unprognostic (7.52e-2)" "unprognostic (3.56e-2)" "unprognostic (1.68e-2)" "unprognostic (1.28e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (4.35e-7)" "unprognostic (1.90e-1)" "unprognostic (5.23e-2)" "unprognostic (1.44e-2)" "unprognostic (7.40e-3)" 14.4 2.4 0.8 8.9 1.4 2.2 13.2 0.7 1.1 11.0 8.2 1.5 3.9 2.2 9.7 8.1 19.7 11.1 6.6 10.7 1.0 0.2 3.4 14.9 13.3 2.3 1.4 0.4 14.5 1.8 0.2 1.3 157.1 3.4 9.4 2.4 19.1 5.7 2.3 21.1 5.4 6.0 17.4 2.2 3.9 8.9 3.3 1.1 0.8 3.8 15.5 4.8 19.1 15.9 0.0 0.5 2.3 3.5 0.0 0.1 0.6 6.7 0.1 0.1 1.2 6.2 30.2 63.6 6.5 5.7 3.9 2.2 0.5 2.6 0.0 1.3 4.4 0.0 3.4 0.2 0.9 1.6 0.5 0.1 1.9 0.7 2.7 5.0 0.0 0.9 14.2 0.2 0.9 2.2 3.3 0.0 0.0 20.3 0.2 0.6 0.1 0.0 0.3 1.1 0.1 0.2 0.0 0.0 0.0 0.6 0.2 0.0 0.2 2.0 5.0 0.0 3.3 1.4 3.5 1.2 0.2 1.8 2.7 0.1 0.6 0.1 1.4 0.2 1.2 0.1 0.0 1.6 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 3.5 0.0 0.0 0.6 0.8 1.4 0.7 1.1 1.0 0.2 1.4 0.4 3.4 1.1 0.0 1.0 0.8 2.1 2.2 1.0 2.0 7.6 1.4 0.0 0.0 0.0 113.3 0.0 1.1 0.4 3.5 0.0 0.0 0.5 39.4 15.5 1.3 2.3 9.2 28.7 0.0 0.0 1.3 22.6 0.0 27.9 16.5 3.3 25.2 0.0 2.4 7.4 0.0 3.2 0.0 2.4 0.0 1.4 0.0 0.9 2.5 83.2 0.0 0.1 1.7 ADAP1 "CENTA1, GCS1L" ENSG00000105963 "ArfGAP with dual PH domains 1" O75689 7 897901-955407 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.8;intestine: 30.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 56.4;Mucus-secreting cells: 30.1;Paneth cells: 34.3;Undifferentiated cells: 26.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 31.2;CAPAN-2: 22.5;HMC-1: 21.6;OE19: 57.2;THP-1: 36.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007033, HPA012049" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007033: AB_1846529, HPA012049: AB_1846527" "unprognostic (2.45e-1)" "unprognostic (7.15e-2)" "prognostic unfavorable (5.25e-4)" "unprognostic (4.41e-2)" "unprognostic (1.97e-1)" "prognostic unfavorable (9.13e-4)" "unprognostic (3.06e-1)" "unprognostic (9.10e-3)" "unprognostic (1.70e-2)" "unprognostic (1.38e-1)" "unprognostic (5.74e-2)" "unprognostic (1.69e-1)" "prognostic favorable (4.13e-5)" "unprognostic (5.88e-2)" "unprognostic (1.58e-1)" "unprognostic (1.41e-1)" "unprognostic (1.79e-2)" 3.0 2.1 32.9 8.9 25.9 8.1 1.2 13.8 41.8 3.6 30.8 30.3 1.7 16.7 2.6 1.3 4.5 4.2 6.2 3.9 36.1 17.7 6.5 1.6 5.8 3.3 28.0 20.1 0.7 5.4 3.7 1.3 3.0 19.3 1.9 20.6 0.9 3.0 3.1 0.8 2.0 22.8 7.7 36.1 7.4 16.3 1.1 19.3 0.0 4.8 0.4 2.3 5.1 1.0 1.3 5.5 3.4 11.7 1.6 6.8 3.7 31.2 1.1 0.0 1.1 0.4 0.0 0.3 1.0 0.0 0.3 0.1 12.4 22.5 0.0 3.1 0.1 0.0 14.3 1.7 2.4 0.1 0.1 1.3 0.0 1.9 7.0 0.5 0.2 21.6 0.5 6.7 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 10.0 0.0 8.4 1.0 57.2 0.0 4.2 0.0 0.1 1.7 7.6 0.9 0.3 0.9 0.4 0.1 0.1 8.1 36.7 0.1 0.2 0.9 0.0 0.1 0.0 0.0 0.0 0.0 6.5 1.1 1.1 7.6 3.4 6.8 8.1 3.3 1.3 2.0 6.1 5.5 1.1 0.6 3.1 3.4 1.6 11.7 0.4 0.9 3.7 32.9 25.9 13.8 33.4 36.1 17.7 28.0 20.1 19.3 19.3 0.0 13.0 3.2 2.5 0.9 4.2 7.7 7.6 8.1 2.3 7.0 0.0 0.1 8.3 3.7 0.0 0.5 56.4 0.0 4.0 0.4 1.4 2.0 6.9 0.4 11.1 0.0 15.5 0.0 21.6 0.0 0.0 13.7 10.1 0.0 30.1 1.2 12.4 34.3 0.0 5.9 0.6 0.0 1.0 0.3 0.9 1.1 0.6 4.4 26.9 3.3 ADCK5 FLJ35454 ENSG00000173137 "AarF domain containing kinase 5" Q3MIX3 8 144373101-144393242 "Enzymes, Predicted membrane proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 43.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025692, HPA028679" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA025692: AB_10599486, HPA028679: AB_10600226" "unprognostic (6.76e-2)" "unprognostic (1.66e-1)" "unprognostic (1.68e-2)" "unprognostic (8.96e-2)" "unprognostic (1.68e-2)" "unprognostic (1.00e-1)" "unprognostic (2.31e-3)" "unprognostic (6.45e-2)" "unprognostic (2.70e-1)" "unprognostic (4.25e-2)" "unprognostic (6.60e-2)" "unprognostic (2.03e-2)" "unprognostic (1.33e-3)" "unprognostic (1.39e-2)" "unprognostic (1.20e-1)" "unprognostic (3.47e-1)" "unprognostic (2.90e-2)" 4.1 10.0 4.8 8.9 4.5 4.5 4.3 11.5 9.1 4.6 18.3 2.8 7.6 19.1 5.8 4.2 7.2 4.2 6.3 3.8 3.9 4.1 4.8 6.9 3.7 5.0 3.4 8.4 5.5 5.6 4.7 4.1 3.7 4.5 4.7 4.0 4.6 7.4 4.7 5.6 8.3 17.0 2.7 2.4 6.7 5.6 7.7 3.8 6.8 4.1 4.9 6.1 5.1 5.0 4.7 6.3 2.5 5.4 1.8 4.1 2.8 3.9 4.9 1.1 3.4 0.9 0.8 5.7 3.3 1.9 2.7 0.9 5.3 4.2 1.7 2.4 0.7 0.9 5.2 0.2 3.6 0.2 4.4 1.6 4.5 3.6 5.9 2.7 1.0 3.5 1.4 2.1 0.9 0.8 1.5 1.8 3.1 2.9 3.1 1.5 10.3 3.2 4.4 0.7 3.4 3.7 4.3 1.7 3.1 1.8 3.7 0.7 1.8 4.9 3.9 2.8 0.9 3.4 3.0 1.3 1.4 5.2 3.5 2.2 1.4 0.4 1.6 3.2 3.9 2.0 1.8 4.2 2.5 2.3 5.4 3.0 1.8 2.8 1.8 6.3 4.7 2.9 1.5 0.7 1.8 5.0 4.0 4.1 2.8 4.8 4.5 11.5 9.1 3.9 4.1 3.4 8.4 4.5 3.8 3.0 1.7 2.2 3.4 3.7 9.2 2.0 7.6 6.7 1.2 5.2 15.7 3.5 3.3 7.7 6.5 4.1 43.3 0.0 6.3 9.4 3.9 2.3 9.2 6.7 7.0 3.2 8.1 3.7 3.8 8.6 5.5 5.2 3.3 11.8 26.0 5.8 9.0 14.0 6.7 5.1 15.2 12.9 3.3 13.4 10.4 4.4 2.1 5.7 20.0 2.2 ADD1 ENSG00000087274 "Adducin 1" P35611 4 2843857-2930076 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 379.0;Rod photoreceptor cells: 557.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009794, HPA035873, HPA035874" Enhanced Enhanced "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "CAB009794: AB_633663, HPA035873: AB_2674836, HPA035874: AB_2674837" "unprognostic (1.79e-1)" "unprognostic (1.37e-1)" "unprognostic (1.66e-2)" "unprognostic (5.40e-3)" "unprognostic (1.90e-1)" "unprognostic (2.66e-2)" "unprognostic (5.07e-3)" "unprognostic (1.68e-2)" "unprognostic (3.52e-1)" "unprognostic (2.50e-1)" "prognostic favorable (3.94e-4)" "unprognostic (5.22e-2)" "prognostic favorable (1.29e-7)" "unprognostic (2.61e-2)" "unprognostic (1.12e-1)" "unprognostic (7.38e-2)" "unprognostic (4.03e-3)" 44.0 31.7 43.1 27.9 52.1 26.7 35.6 46.3 66.6 37.5 43.3 47.2 27.3 30.8 47.9 29.2 35.1 43.0 33.1 41.1 39.5 34.1 36.8 23.4 38.0 27.9 40.5 46.7 65.3 25.0 31.3 28.4 31.2 44.7 43.1 30.7 36.3 26.2 54.9 69.5 25.5 33.6 58.1 33.8 34.9 32.6 25.2 37.0 25.5 27.9 19.6 28.5 45.3 34.9 21.3 16.2 21.5 6.5 16.4 12.9 9.1 18.5 15.6 37.1 19.1 55.0 41.2 13.9 31.5 37.9 32.9 27.9 22.9 23.6 9.7 16.6 54.0 38.6 11.9 27.7 26.5 27.6 12.4 12.7 27.5 13.5 22.0 26.9 16.3 19.6 40.6 24.9 28.9 11.6 34.3 40.9 18.5 28.5 23.6 37.5 10.9 50.2 22.8 20.8 17.1 22.2 22.3 20.6 11.4 24.1 41.3 22.2 28.9 22.8 9.3 19.5 29.4 21.8 15.5 49.4 27.0 13.9 22.1 26.0 19.0 15.4 12.4 26.0 20.3 26.0 11.0 4.8 21.5 12.9 4.5 11.8 16.1 7.2 10.8 7.5 21.3 6.8 8.1 6.7 16.4 6.5 16.2 9.2 9.1 43.1 52.1 46.3 66.6 39.5 34.1 40.5 46.7 44.7 37.0 65.5 42.1 48.2 25.8 23.9 91.0 71.2 40.8 34.8 51.2 57.6 379.0 29.9 13.3 33.6 44.3 61.8 38.1 0.0 39.8 26.5 52.3 36.5 35.9 41.0 35.3 104.9 55.5 59.5 43.4 29.2 71.9 38.1 33.7 57.7 42.6 228.9 44.9 31.6 114.5 36.3 557.2 97.0 52.0 40.7 36.8 32.0 30.6 55.8 35.2 27.7 ADGRD1 "DKFZp434B1272, GPR133, PGR25" ENSG00000111452 "Adhesion G protein-coupled receptor D1" Q6QNK2 12 130953907-131141469 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 66.1" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 20.8;Alveolar cells type 2: 29.1;Cardiomyocytes: 39.1;Fibroblasts: 20.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 4.1;intermediate monocyte: 4.9;myeloid DC: 2.4;non-classical monocyte: 3.6" "Group enriched" "Detected in many" 6 "dendritic cells: 2.4;monocytes: 4.9" "Cell line enhanced" "Detected in some" "BJ: 5.1;fHDF/TERT166: 5.8;HeLa: 10.5;HHSteC: 6.7;HMC-1: 14.5;U-2 OS: 7.1" "Region enhanced" "Detected in some" "basal ganglia: 5.3" "Low region specificity" "Detected in all" "HPA042395, HPA076279" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA 600000 "Plasma membrane" Nucleoplasm "HPA042395: AB_10796906, HPA076279: " "unprognostic (3.21e-1)" "unprognostic (1.49e-4)" "unprognostic (1.32e-2)" "unprognostic (1.63e-1)" "unprognostic (4.40e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (9.27e-4)" "unprognostic (2.55e-3)" "unprognostic (1.63e-2)" "unprognostic (6.94e-2)" "unprognostic (1.11e-2)" "unprognostic (3.98e-2)" "unprognostic (4.79e-5)" "unprognostic (1.31e-3)" "unprognostic (4.58e-1)" "unprognostic (2.15e-2)" "unprognostic (1.77e-3)" 12.7 2.1 2.0 3.2 3.1 0.5 8.9 1.1 3.9 11.2 5.5 2.2 3.9 2.2 13.3 14.0 6.8 8.8 45.6 34.8 1.9 1.5 1.6 5.2 18.6 0.6 4.2 2.2 12.5 11.8 0.3 3.5 26.6 2.4 13.3 2.4 13.0 1.6 2.3 11.6 3.8 6.4 66.1 6.4 1.9 10.2 3.8 2.6 0.0 6.3 7.1 2.1 29.5 30.8 0.2 2.4 0.0 4.9 0.5 0.0 1.2 0.0 0.7 0.0 2.6 0.1 0.0 0.1 5.1 0.0 0.0 0.4 0.0 0.0 0.3 0.0 5.8 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 10.5 0.0 6.7 0.0 14.5 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.9 0.0 0.1 0.2 2.2 0.5 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.4 0.0 0.5 7.1 1.9 0.1 0.1 1.8 0.9 0.1 0.0 0.0 0.0 4.1 0.0 0.0 4.9 0.0 0.0 0.0 0.0 2.4 0.2 0.0 0.0 0.0 0.5 3.6 0.0 0.0 1.2 2.0 3.1 1.1 3.9 1.9 1.5 4.2 2.2 2.4 2.6 20.8 29.1 0.0 0.0 0.0 0.0 39.1 0.0 4.0 9.1 1.8 0.0 0.9 0.0 0.0 14.7 1.0 0.0 0.0 0.3 0.6 20.1 0.1 1.1 2.6 2.3 0.0 0.0 3.1 2.4 14.7 12.7 0.7 0.0 1.8 0.0 0.0 0.5 0.0 14.9 0.0 0.7 6.5 0.9 2.6 5.7 0.0 0.8 0.0 0.0 0.3 ADGRG2 "EDDM6, GPR64, HE6, TM7LN2" ENSG00000173698 "Adhesion G protein-coupled receptor G2" Q8IZP9 X 18989309-19122637 "Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "epididymis: 202.4" "Cell type enhanced" "Detected in some" 9 "Cholangiocytes: 5.1;Ciliated cells: 4.0;Glandular cells: 3.0;Horizontal cells: 3.2;Muller glia cells: 4.5" "Cancer enhanced" "Detected in many" "ovarian cancer: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 6.3;BEWO: 7.9;HeLa: 6.5;NTERA-2: 6.8;SH-SY5Y: 7.1;U-2197: 15.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA001478, HPA050029" Enhanced Approved "Plasma membrane,Cytosol" NA NA 7900000 "Plasma membrane, Cytosol" "HPA001478: AB_1078923, HPA050029: AB_2680996" "unprognostic (3.33e-2)" "unprognostic (3.20e-1)" "unprognostic (2.40e-1)" "unprognostic (2.55e-2)" "unprognostic (1.58e-1)" "unprognostic (4.43e-3)" "unprognostic (2.63e-4)" "unprognostic (2.66e-1)" "unprognostic (1.27e-3)" "unprognostic (1.12e-1)" "unprognostic (1.78e-2)" "unprognostic (1.07e-1)" "unprognostic (3.54e-7)" "unprognostic (6.37e-2)" "unprognostic (3.19e-1)" "unprognostic (2.83e-1)" "unprognostic (1.35e-1)" 4.4 0.3 0.4 0.9 0.2 0.2 2.8 0.1 0.2 0.8 1.0 0.1 6.6 0.2 0.5 202.4 0.9 6.9 1.4 1.8 0.6 0.6 0.7 0.9 1.7 3.1 0.2 0.2 0.9 0.9 24.8 1.9 0.6 0.3 3.2 0.2 1.6 9.6 0.8 0.6 0.3 1.4 0.6 0.2 1.2 3.5 4.7 0.2 2.7 1.8 0.6 1.9 1.1 1.5 0.1 0.2 0.9 0.6 0.0 0.2 0.0 0.2 6.3 0.0 0.0 0.1 1.0 7.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 2.5 0.0 6.5 0.3 0.9 0.0 0.0 0.1 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 2.3 6.8 0.0 2.1 0.0 0.1 4.5 0.0 1.3 2.4 7.1 1.6 0.1 0.0 1.2 0.1 0.1 0.1 0.2 0.4 15.7 2.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.4 0.9 0.1 0.4 0.0 0.0 0.1 0.0 0.2 0.1 0.2 0.0 0.7 0.0 0.6 0.1 0.0 0.0 0.4 0.2 0.1 0.2 0.6 0.6 0.2 0.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.4 0.8 5.1 4.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 3.0 0.0 0.4 0.0 3.2 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 1.8 0.0 1.4 0.0 0.7 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 ADGRL2 "KIAA0786, LEC1, LPHH1, LPHN2" ENSG00000117114 "Adhesion G protein-coupled receptor L2" O95490 1 81306160-81992436 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 51.9;Cardiomyocytes: 43.9;Hepatocytes: 33.8;Horizontal cells: 31.8;Ito cells: 40.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 63.8;hTEC/SVTERT24-B: 31.7;NTERA-2: 26.8;SH-SY5Y: 42.7;U-2197: 29.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043447 Approved "Plasma membrane,Cell Junctions" NA NA 280000 "Plasma membrane, Cell Junctions" "HPA043447: AB_2678486" "unprognostic (2.54e-2)" "unprognostic (6.29e-3)" "unprognostic (2.57e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (3.22e-1)" "unprognostic (1.61e-1)" "prognostic unfavorable (9.92e-4)" "unprognostic (3.55e-2)" "unprognostic (9.84e-2)" "unprognostic (2.42e-1)" "unprognostic (7.81e-2)" "unprognostic (8.01e-2)" "unprognostic (1.61e-1)" "prognostic unfavorable (3.00e-4)" "unprognostic (2.76e-1)" "unprognostic (3.38e-3)" "unprognostic (1.41e-2)" 8.9 10.5 21.1 3.6 20.9 0.0 8.8 1.5 45.8 7.5 7.0 1.4 1.2 2.7 6.1 8.6 12.0 12.0 11.5 17.6 12.2 6.6 10.9 18.7 32.7 3.5 3.5 22.8 18.8 4.9 20.3 11.8 24.4 6.2 15.6 5.4 9.4 19.1 10.1 2.0 6.3 6.1 6.0 3.2 10.0 7.6 2.0 3.3 0.6 22.4 15.0 5.0 6.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 2.4 63.8 0.0 7.9 9.1 0.8 1.5 3.5 0.6 0.7 0.0 0.0 0.0 17.5 8.1 1.8 2.5 5.0 6.7 0.5 0.1 10.4 0.0 1.8 4.4 3.0 0.0 0.1 7.7 0.4 31.7 3.2 4.4 10.4 0.0 0.0 0.0 0.8 0.0 0.0 0.0 26.8 0.0 1.9 0.0 8.8 0.0 14.5 0.9 3.2 42.7 0.0 1.8 0.0 18.9 0.1 18.8 6.8 6.5 7.4 29.2 2.2 0.0 0.0 0.0 3.7 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.1 20.9 1.5 45.8 12.2 6.6 3.5 22.8 6.2 3.3 3.0 2.1 0.0 6.5 0.0 51.9 43.9 10.2 0.0 5.7 5.2 5.9 0.3 0.0 3.7 1.0 27.2 0.0 0.0 1.5 0.2 9.1 8.9 0.0 33.8 0.7 31.8 0.0 40.5 6.0 1.3 21.6 0.9 0.0 0.0 1.1 20.6 1.0 0.0 16.6 7.0 2.4 19.4 3.7 0.5 3.0 0.0 0.3 0.0 0.7 2.4 ADH1A ADH1 ENSG00000187758 "Alcohol dehydrogenase 1A (class I), alpha polypeptide" P07327 4 99276367-99291028 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 322 "liver: 250.3" "Cell type enriched" "Detected in some" 10 "Hepatocytes: 212.0" "Cancer enriched" "Detected in some" 251 "liver cancer: 165.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "ASC diff: 11.2" "CAB009562, HPA047814, HPA060902" Enhanced Approved "Plasma membrane,Cytosol" NA NA 12000000 "Plasma membrane, Cytosol" "CAB009562: AB_2257984, HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.89e-2)" "unprognostic (6.16e-2)" "unprognostic (1.20e-1)" "unprognostic (2.07e-1)" "unprognostic (4.40e-1)" "prognostic favorable (2.38e-4)" "unprognostic (2.78e-3)" "unprognostic (4.25e-1)" "unprognostic (4.79e-3)" "unprognostic (6.21e-2)" "unprognostic (9.36e-2)" "unprognostic (3.25e-2)" "unprognostic (1.40e-1)" "unprognostic (2.86e-2)" 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 250.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 11.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 1.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 20.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 212.0 0.0 0.0 0.0 7.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 ADH1B ADH2 ENSG00000196616 "Alcohol dehydrogenase 1B (class I), beta polypeptide" P00325 4 99304964-99352760 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adipose tissue: 253.5;liver: 466.3" "Cell type enriched" "Detected in many" 38 "Hepatocytes: 3603.2" "Cancer enriched" "Detected in many" 31 "liver cancer: 223.1" "Group enriched" "Detected in some" 5 "midbrain: 2.3;pons and medulla: 1.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 7 "ASC diff: 394.3" "HPA047814, HPA060902" Supported Approved "Plasma membrane,Cytosol" NA NA 16000000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (5.13e-2)" "unprognostic (9.80e-3)" "unprognostic (6.59e-2)" "unprognostic (5.56e-2)" "unprognostic (9.49e-2)" "unprognostic (5.53e-2)" "unprognostic (1.54e-3)" "unprognostic (1.04e-2)" "unprognostic (6.51e-2)" "unprognostic (2.73e-2)" "unprognostic (7.47e-3)" "unprognostic (7.79e-2)" "prognostic unfavorable (7.87e-4)" "unprognostic (4.60e-3)" "unprognostic (2.33e-1)" "unprognostic (2.58e-1)" "unprognostic (1.60e-2)" 253.5 12.3 0.2 21.8 0.0 0.4 78.7 0.2 0.4 18.3 60.0 0.4 5.7 3.5 12.8 14.4 33.5 22.3 31.9 24.2 0.3 0.0 9.2 466.3 43.8 17.5 2.3 0.1 18.0 8.7 0.8 5.3 0.9 1.6 30.7 10.1 2.3 11.2 3.9 20.5 11.9 25.4 30.8 2.4 5.9 10.9 18.0 0.2 0.2 16.1 9.7 2.0 42.3 76.0 0.6 0.2 1.2 0.3 0.8 0.4 0.0 0.0 0.0 0.0 0.0 394.3 57.8 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.3 0.2 0.1 0.1 0.2 0.4 0.1 0.0 0.6 0.3 0.4 1.2 0.8 0.1 0.2 0.1 0.0 0.2 0.0 0.2 0.0 0.3 0.0 2.3 0.1 1.6 0.2 0.0 4.3 14.0 0.4 19.8 0.0 8.9 66.2 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.4 9.2 0.0 46.7 0.0 0.0 81.0 0.3 1.1 3603.2 0.1 0.0 0.0 93.9 77.5 0.0 51.2 1.0 27.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 6.5 43.7 0.0 0.0 11.4 0.1 12.5 0.0 0.1 ADH1C ADH3 ENSG00000248144 "Alcohol dehydrogenase 1C (class I), gamma polypeptide" P00326 4 99336492-99353027 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Oxidoreductase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 47.1;liver: 149.4;stomach 1: 43.1" "Cell type enhanced" "Detected in many" 15 "Exocrine glandular cells: 606.8;Hepatocytes: 378.8;Undifferentiated cells: 355.3" "Cancer enriched" "Detected in many" 7 "liver cancer: 238.2" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "ASC TERT1: 5.2;HSkMC: 15.4" "HPA047814, HPA060902" Supported Supported "Plasma membrane,Cytosol" NA NA 9700000 "Plasma membrane, Cytosol" "HPA047814: AB_2680163, HPA060902: AB_2684384" "unprognostic (3.98e-2)" "unprognostic (9.88e-3)" "unprognostic (7.04e-2)" "unprognostic (1.90e-1)" "unprognostic (5.14e-1)" "unprognostic (1.57e-1)" "prognostic favorable (4.55e-4)" "prognostic favorable (2.99e-4)" "unprognostic (8.25e-2)" "unprognostic (8.89e-3)" "unprognostic (7.95e-2)" "unprognostic (2.04e-1)" "unprognostic (1.12e-1)" "unprognostic (1.21e-1)" "unprognostic (1.53e-1)" "unprognostic (1.70e-1)" "unprognostic (9.37e-2)" 4.7 0.0 0.0 18.5 0.0 0.0 1.1 0.0 0.0 1.1 37.9 0.0 1.1 43.4 0.3 1.2 1.7 0.0 12.0 2.0 0.0 8.3 149.4 1.1 0.0 0.2 0.0 1.1 11.4 0.0 0.0 0.0 0.0 2.5 13.6 0.0 1.1 0.8 6.0 0.0 47.1 0.9 0.5 0.0 43.1 1.6 0.0 0.0 0.5 2.0 0.2 1.3 0.7 0.2 0.2 0.3 0.1 0.1 0.3 0.1 0.0 2.3 0.0 0.1 1.8 5.2 1.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.6 0.3 0.1 0.5 1.4 0.3 15.4 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.4 1.0 0.4 0.0 0.1 0.1 0.9 2.2 0.9 0.0 0.4 1.6 0.7 0.8 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.3 0.2 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.1 0.3 0.1 0.0 0.2 0.0 0.1 3.0 5.3 1.5 3.6 0.0 0.0 0.8 50.9 80.3 45.5 27.9 0.0 0.0 0.0 141.2 2.4 0.0 51.2 23.3 606.8 0.0 0.0 1.2 0.0 378.8 0.0 0.0 20.7 12.9 12.9 0.6 9.8 0.0 0.0 3.6 36.7 0.0 99.5 63.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 355.3 2.0 ADH7 ADH-4 ENSG00000196344 "Alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide" P40394 4 99412261-99435737 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "esophagus: 75.0;lymphoid tissue: 30.7;tongue: 68.7" "Group enriched" "Detected in some" 15 "Ciliated cells: 8.1;Club cells: 10.3" "Group enriched" "Detected in some" 17 "cervical cancer: 18.4;head and neck cancer: 18.9;lung cancer: 22.4;urothelial cancer: 5.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "ASC TERT1: 4.0;HaCaT: 4.5" "Not detected" "Not detected" HPA039695 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039695: AB_10795681" "unprognostic (1.02e-2)" "unprognostic (8.64e-2)" "unprognostic (4.86e-2)" "unprognostic (5.66e-3)" "unprognostic (4.50e-2)" "unprognostic (1.66e-1)" "unprognostic (2.02e-1)" "unprognostic (1.88e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 75.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.2 0.0 0.1 0.0 0.0 9.4 0.0 0.0 0.1 0.0 68.7 30.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 8.1 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 ADSS ENSG00000035687 "Adenylosuccinate synthase" P30520 1 244408494-244452134 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024400 Supported Supported "Plasma membrane,Cytosol" NA NA 620000 Cytosol "Plasma membrane" "HPA024400: AB_1844623" "unprognostic (4.24e-3)" "unprognostic (2.63e-1)" "unprognostic (3.95e-2)" "unprognostic (8.68e-2)" "unprognostic (6.91e-2)" "unprognostic (2.04e-1)" "unprognostic (1.62e-2)" "unprognostic (2.58e-1)" "unprognostic (1.12e-1)" "unprognostic (1.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.10e-1)" "unprognostic (1.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.86e-1)" "unprognostic (2.04e-1)" "unprognostic (1.18e-2)" 19.4 17.8 23.2 23.8 31.2 29.2 26.3 18.3 26.3 20.9 20.9 35.9 27.1 21.1 18.9 23.3 27.7 18.3 15.8 9.8 24.9 23.4 25.1 19.3 19.2 21.2 42.5 16.6 20.9 21.2 26.6 17.7 21.0 34.9 19.8 22.7 13.1 25.0 21.7 11.0 26.5 23.2 22.9 29.3 24.9 24.7 48.9 36.7 26.7 26.3 17.9 24.8 26.5 21.8 10.9 13.6 24.6 21.3 15.5 16.0 11.9 25.7 14.2 12.4 10.9 14.6 20.9 22.9 26.0 21.9 18.7 14.2 18.7 24.9 23.0 17.3 20.0 8.0 19.5 13.5 17.0 21.0 17.0 24.0 15.3 14.2 14.1 17.5 36.2 19.8 14.3 20.6 17.4 17.6 21.8 66.6 12.7 26.5 17.1 18.5 6.1 23.2 24.3 33.0 24.6 15.7 21.5 11.8 24.8 31.0 16.0 16.9 14.8 22.1 20.6 26.0 13.8 14.3 19.3 29.1 17.3 9.5 20.0 27.0 20.8 27.2 17.4 14.3 42.5 25.5 24.6 15.8 13.0 15.0 20.5 16.0 10.9 13.7 12.8 13.6 8.6 11.8 13.3 11.9 15.5 21.3 5.5 14.7 11.9 23.2 31.2 18.3 26.3 24.9 23.4 42.5 16.6 34.9 36.7 44.7 30.5 40.0 44.7 90.9 12.4 5.8 35.7 127.2 85.3 57.6 5.9 47.0 74.6 41.2 102.9 33.7 30.0 0.0 44.0 83.0 35.8 40.9 28.9 29.6 33.8 9.5 17.3 37.4 38.1 103.8 17.5 51.2 40.5 37.9 29.4 34.0 38.5 21.0 15.9 57.5 7.2 12.9 34.0 104.8 68.7 86.1 45.2 60.6 38.1 62.8 AFAP1L2 "Em:AC005383.4, FLJ14564, KIAA1914, XB130" ENSG00000169129 "Actin filament associated protein 1 like 2" Q8N4X5 10 114294824-114404756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 47.9" "Cell type enhanced" "Detected in many" 10 "Collecting duct cells: 38.4;Sertoli cells: 19.4;Smooth muscle cells: 17.6" "Cancer enhanced" "Detected in all" "thyroid cancer: 39.0" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "B-cells: 4.0;T-cells: 4.0" "Cell line enhanced" "Detected in some" "A-431: 26.4;CAPAN-2: 28.5;EFO-21: 21.2;HaCaT: 36.3;RPMI-8226: 18.6;RPTEC TERT1: 22.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 5 "cerebellum: 169.5;olfactory region: 48.1" HPA037843 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037843: AB_10669990" "unprognostic (2.31e-3)" "unprognostic (1.30e-1)" "unprognostic (2.02e-1)" "unprognostic (5.06e-3)" "unprognostic (4.14e-2)" "unprognostic (9.80e-2)" "unprognostic (9.88e-2)" "unprognostic (1.08e-1)" "unprognostic (1.36e-1)" "unprognostic (1.32e-1)" "prognostic unfavorable (3.76e-4)" "unprognostic (2.08e-1)" "prognostic unfavorable (1.55e-5)" "unprognostic (1.11e-1)" "unprognostic (3.88e-2)" "unprognostic (1.72e-1)" "unprognostic (1.86e-1)" 4.5 1.7 9.0 5.9 6.3 0.3 7.1 24.7 8.8 12.9 7.1 5.3 30.5 2.4 22.3 9.7 5.9 13.8 3.6 2.9 7.8 7.1 9.1 1.2 3.2 2.4 8.0 6.7 9.3 8.2 35.1 1.8 10.6 5.5 7.9 3.2 8.1 4.2 28.4 1.8 5.7 4.0 11.1 5.7 39.9 4.1 1.5 6.5 3.4 47.9 7.5 4.3 3.7 14.0 4.0 0.3 0.4 0.0 0.8 4.0 1.4 26.4 3.9 3.7 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 28.5 0.0 21.2 0.2 0.4 36.3 0.1 9.9 0.0 0.5 0.0 0.0 0.2 0.0 1.1 0.0 1.0 0.0 10.8 3.0 2.7 0.1 0.1 1.0 0.0 0.0 0.0 1.1 0.6 0.0 0.2 0.7 0.2 0.3 0.3 18.6 22.4 0.2 0.1 0.1 0.8 0.6 1.0 6.3 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 2.6 3.8 2.7 2.8 0.0 4.0 0.9 2.2 0.4 0.8 0.0 0.3 4.0 1.4 9.0 6.3 24.7 8.5 7.8 7.1 8.0 6.7 5.5 6.5 0.0 0.0 0.5 8.2 11.0 0.8 1.2 0.0 0.0 2.3 38.4 0.0 0.6 0.0 0.6 1.0 9.5 2.5 0.0 12.8 0.9 5.8 3.2 0.0 0.0 0.4 1.6 0.0 4.9 0.0 2.1 2.8 0.0 5.0 1.0 1.3 2.8 14.6 1.7 1.8 0.3 0.5 19.4 17.6 0.0 0.8 5.9 0.2 3.2 1.7 3.0 AFG1L "AFG1, LACE1" ENSG00000135537 "AFG1 like ATPase" Q8WV93 6 108294894-108526796 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 10.7;Club cells: 9.1;Distal tubular cells: 8.3;Proximal tubular cells: 6.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030154, HPA030155, HPA030659" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415" "unprognostic (9.76e-5)" "unprognostic (1.72e-1)" "unprognostic (1.68e-1)" "unprognostic (3.76e-2)" "unprognostic (1.62e-1)" "unprognostic (7.04e-2)" "unprognostic (2.57e-1)" "unprognostic (5.53e-2)" "unprognostic (2.35e-3)" "unprognostic (1.48e-1)" "unprognostic (2.73e-2)" "unprognostic (9.61e-2)" "unprognostic (8.40e-8)" "unprognostic (2.03e-2)" "unprognostic (2.03e-1)" "unprognostic (1.41e-1)" "unprognostic (1.23e-1)" 4.9 7.3 7.6 6.5 6.6 4.3 5.7 6.2 7.3 4.1 5.7 7.3 6.9 8.9 3.7 4.9 5.5 5.1 4.8 9.4 6.3 4.9 11.0 7.6 9.1 4.8 7.3 7.4 4.1 5.2 11.6 6.9 4.7 6.1 3.9 7.0 5.5 4.7 5.4 9.0 4.2 6.3 4.0 5.6 4.4 6.0 25.4 6.5 5.6 6.6 4.1 4.5 4.8 4.3 5.7 3.0 5.1 7.2 4.2 4.4 1.7 3.5 1.9 4.7 8.2 4.8 7.1 4.6 3.9 5.9 6.6 6.5 7.4 4.4 6.3 5.3 6.1 7.8 2.0 5.9 5.9 7.4 3.6 3.5 7.5 2.4 8.6 4.8 6.6 3.7 6.6 4.9 4.9 8.0 4.2 3.5 4.8 7.5 3.0 6.1 3.3 1.2 6.2 3.0 6.0 3.7 4.4 6.3 3.6 8.2 3.9 5.1 4.5 3.3 4.7 8.7 6.5 3.8 13.0 4.3 4.0 1.0 3.5 4.5 2.1 3.2 4.9 5.0 7.9 6.1 0.0 3.1 5.1 2.0 2.2 2.6 4.8 3.2 3.8 2.7 5.7 4.4 2.9 0.8 4.2 7.2 3.0 4.1 1.7 7.6 6.6 6.2 7.3 6.3 4.9 7.3 7.4 6.1 6.5 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 10.7 9.1 3.5 0.0 5.1 8.3 2.7 0.0 0.0 0.0 0.0 3.3 4.1 0.0 0.0 2.3 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.9 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 AGRN AGRIN ENSG00000188157 Agrin O00468 1 1020123-1056118 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Differentiation "Developmental protein" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cholangiocytes: 79.0;Collecting duct cells: 148.3;Ductal cells: 85.5;Pancreatic endocrine cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "CAPAN-2: 46.4;EFO-21: 54.1;HaCaT: 47.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040090 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 15000000 Cytosol "Plasma membrane" "HPA040090: AB_10805603" "unprognostic (8.04e-2)" "unprognostic (8.25e-3)" "unprognostic (1.42e-3)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (2.41e-2)" "prognostic unfavorable (4.62e-4)" "unprognostic (2.82e-3)" "unprognostic (1.32e-1)" "unprognostic (3.33e-2)" "unprognostic (9.49e-3)" "unprognostic (1.06e-1)" "unprognostic (8.46e-2)" "unprognostic (8.49e-2)" "unprognostic (2.07e-2)" "unprognostic (4.08e-1)" "unprognostic (1.31e-2)" 10.2 2.8 13.0 5.3 12.4 2.9 8.3 2.3 24.0 11.3 8.5 20.5 8.9 9.8 8.2 14.5 8.8 11.4 37.2 8.1 10.9 8.3 36.0 9.3 18.1 2.3 9.3 7.0 7.6 25.2 5.7 5.0 11.0 12.7 8.7 2.5 13.6 26.5 10.8 4.7 18.6 11.2 3.9 7.7 7.2 14.1 7.5 8.1 6.4 27.0 9.5 7.6 13.7 6.2 0.0 0.1 0.0 0.5 0.0 1.1 0.1 27.0 16.8 3.3 10.9 0.5 0.7 29.4 13.7 4.4 9.2 5.6 14.1 46.4 0.5 54.1 2.1 4.5 47.1 1.1 16.9 1.1 1.0 6.4 0.0 22.0 14.8 3.9 0.3 5.5 2.4 7.3 2.9 6.4 12.8 1.6 0.4 5.6 0.1 0.7 22.2 0.2 3.8 7.0 8.7 12.3 4.3 6.4 4.0 16.1 12.1 0.8 6.5 27.8 30.1 26.5 3.3 26.5 2.1 23.9 11.3 40.0 1.5 11.0 0.3 0.2 1.0 7.1 2.5 3.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.1 0.1 13.0 12.4 2.3 22.0 10.9 8.3 9.3 7.0 12.7 8.1 23.8 9.1 2.4 7.5 13.4 0.8 2.2 79.0 5.3 14.8 148.3 7.9 1.1 1.7 85.5 0.1 17.9 18.6 0.0 14.5 4.6 5.6 15.4 2.3 8.9 3.9 4.8 6.4 13.5 2.1 0.8 5.2 3.1 23.6 27.1 10.4 10.0 62.9 14.0 2.5 11.3 5.4 6.5 8.5 0.5 9.6 5.3 1.0 1.0 18.4 13.7 AHNAK MGC5395 ENSG00000124942 "AHNAK nucleoprotein" Q09666 11 62433542-62556235 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 86.5;fHDF/TERT166: 80.4;TIME: 84.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019010, HPA019070, HPA026643" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA 950000 "Plasma membrane, Cytosol" "HPA019010: AB_1844657, HPA019070: AB_1844656, HPA026643: AB_10670426" "unprognostic (1.39e-1)" "unprognostic (7.84e-2)" "unprognostic (3.46e-1)" "unprognostic (3.19e-1)" "unprognostic (1.96e-2)" "unprognostic (5.99e-2)" "unprognostic (2.53e-1)" "unprognostic (1.63e-2)" "unprognostic (4.84e-2)" "unprognostic (1.98e-3)" "prognostic unfavorable (2.42e-4)" "unprognostic (4.30e-1)" "unprognostic (4.49e-3)" "unprognostic (5.42e-2)" "unprognostic (1.18e-1)" "unprognostic (2.61e-1)" "prognostic unfavorable (3.47e-6)" 85.2 8.2 15.3 35.3 9.3 10.0 91.1 9.3 10.8 69.7 66.3 16.8 36.4 13.0 52.2 47.4 96.9 39.4 59.2 55.8 20.9 6.0 18.4 16.0 54.9 16.6 16.2 13.4 40.2 8.9 8.0 5.3 39.8 15.9 42.6 26.8 29.6 35.5 36.8 64.8 88.4 38.2 101.5 16.1 16.9 38.3 16.9 16.2 5.8 18.4 72.9 44.0 54.3 86.1 8.2 28.9 15.3 30.1 11.1 16.7 12.2 26.5 15.7 1.4 6.5 64.4 86.5 10.4 24.1 29.6 15.4 8.6 13.5 9.5 0.0 9.2 80.4 11.9 35.4 6.0 29.7 19.7 21.5 1.0 3.2 23.3 4.0 12.3 4.4 21.2 31.2 34.9 30.2 27.7 19.7 31.7 0.4 3.0 20.5 31.2 10.3 0.0 8.6 0.4 8.5 23.8 0.0 6.6 15.9 34.2 17.4 0.0 1.3 24.3 10.3 10.3 31.1 19.7 4.1 84.1 27.5 17.9 34.1 10.6 3.6 0.7 0.0 20.9 1.4 8.9 15.3 30.1 0.1 16.7 17.5 11.0 8.2 10.7 13.1 28.9 5.2 1.4 7.6 0.4 11.1 14.0 7.9 7.9 12.2 15.3 9.3 9.3 10.8 20.9 6.0 16.2 13.4 15.9 16.2 408.0 109.1 70.5 114.1 425.8 1.3 166.6 206.4 97.7 178.6 183.2 0.0 83.1 11.6 83.1 9.2 245.0 291.2 0.0 57.2 123.8 177.9 136.3 226.0 73.3 79.4 1.6 45.8 165.7 304.6 18.1 418.0 252.7 301.9 91.0 140.5 27.9 164.5 142.7 438.1 5.4 1.0 174.6 271.5 1.7 7.6 533.5 85.5 86.3 79.4 166.3 AHNAK2 C14orf78 ENSG00000185567 "AHNAK nucleoprotein 2" Q8IVF2 14 104937244-104978357 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 131.1" "Cell type enhanced" "Detected in many" 13 "Basal keratinocytes: 101.5;Horizontal cells: 57.2;Suprabasal keratinocytes: 143.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "ASC diff: 28.6;ASC TERT1: 32.5;HBEC3-KT: 28.6;hTCEpi: 72.0;hTERT-HME1: 30.7;TIME: 32.3" "HPA000878, HPA002940, HPA004145, HPA020111" Enhanced Enhanced "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA000878: AB_2666127, HPA002940: AB_1859547, HPA004145: AB_1859546, HPA020111: AB_2670371" "unprognostic (3.56e-1)" "unprognostic (6.04e-2)" "unprognostic (6.19e-3)" "unprognostic (1.31e-3)" "unprognostic (9.55e-4)" "unprognostic (1.76e-1)" "unprognostic (1.36e-1)" "prognostic unfavorable (2.79e-5)" "unprognostic (3.43e-1)" "unprognostic (3.06e-3)" "prognostic unfavorable (4.05e-6)" "unprognostic (1.48e-1)" "unprognostic (1.17e-2)" "unprognostic (1.39e-2)" "unprognostic (6.97e-2)" "unprognostic (2.05e-1)" "prognostic unfavorable (2.23e-5)" 6.9 1.8 2.9 2.0 5.6 1.0 8.5 3.0 13.7 17.2 23.0 2.9 5.7 1.7 16.3 2.9 25.8 7.1 3.2 1.5 2.4 3.1 1.1 10.8 2.3 1.0 2.7 11.6 1.8 1.2 1.2 0.7 1.8 23.3 5.7 5.1 10.1 6.0 14.6 1.6 131.1 4.8 19.9 4.8 1.1 7.1 3.2 0.8 0.0 1.2 14.4 3.0 10.0 19.5 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.6 20.0 0.0 1.4 28.6 32.5 0.0 2.4 5.1 0.9 0.4 0.0 8.9 0.0 3.4 18.8 20.0 14.5 0.0 28.6 0.4 0.0 0.1 0.0 13.3 0.1 2.6 0.0 0.9 4.1 72.0 2.8 30.7 12.3 12.5 0.0 0.0 0.0 14.4 1.6 0.0 0.0 0.0 2.1 9.9 0.0 1.3 0.0 19.6 0.0 0.1 0.1 10.6 0.0 0.5 0.6 1.3 0.0 32.3 6.9 4.3 7.9 2.2 0.0 0.0 0.0 21.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.9 5.6 3.0 13.7 2.4 3.1 2.7 11.6 23.3 0.8 11.9 1.4 0.0 4.0 101.5 4.7 1.0 0.0 25.4 18.2 1.8 2.0 0.0 0.0 10.2 20.6 16.7 0.0 0.0 7.7 0.2 11.4 1.9 16.2 0.5 1.0 57.2 0.0 1.8 0.3 1.6 0.6 0.7 30.4 0.0 0.0 3.0 41.0 0.0 0.4 0.3 10.5 0.0 7.2 0.4 3.8 143.9 0.1 0.7 0.0 4.9 AKAP10 "D-AKAP2, MGC9414, PRKA10" ENSG00000108599 "A-kinase anchoring protein 10" O43572 17 19904302-19978343 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028901 Approved Supported "Plasma membrane,Cytosol" Yes No "Plasma membrane, Cytosol" "HPA028901: AB_10602227" "unprognostic (2.17e-2)" "unprognostic (3.48e-2)" "unprognostic (5.33e-1)" "unprognostic (1.40e-1)" "unprognostic (1.50e-1)" "unprognostic (5.51e-2)" "unprognostic (1.59e-3)" "unprognostic (3.88e-1)" "unprognostic (7.69e-3)" "unprognostic (1.89e-1)" "unprognostic (3.59e-2)" "unprognostic (3.21e-2)" "unprognostic (3.21e-2)" "unprognostic (2.49e-2)" "unprognostic (7.15e-2)" "unprognostic (2.16e-2)" "unprognostic (5.20e-2)" 20.5 24.2 22.5 19.4 25.5 16.1 21.2 22.8 27.9 21.2 19.4 17.4 13.4 16.1 22.3 15.9 18.5 19.2 18.4 14.4 20.1 17.9 22.7 14.9 18.5 24.3 22.4 23.2 24.3 16.2 28.0 20.3 20.3 19.2 19.5 20.3 16.1 17.8 21.3 13.7 17.5 18.5 22.9 19.0 28.6 20.2 22.9 24.2 25.9 26.0 9.1 20.5 22.2 22.7 7.3 6.1 24.4 10.3 5.1 7.9 3.0 8.7 10.5 7.0 4.9 9.3 11.8 13.0 10.2 11.0 11.4 13.7 11.4 5.3 7.5 6.9 8.1 9.9 9.3 9.0 8.5 15.6 6.2 7.7 6.4 10.3 5.5 8.8 4.6 10.6 9.9 10.7 10.4 12.9 12.8 9.1 9.2 4.1 3.8 11.8 6.3 8.6 6.9 4.6 12.2 3.6 5.7 23.0 3.9 9.5 5.6 2.4 7.2 11.7 5.5 9.7 45.2 13.4 5.2 8.0 8.8 7.3 7.5 9.4 4.7 5.0 9.2 11.7 5.6 8.5 3.6 7.3 8.8 6.7 10.3 6.1 6.0 6.5 7.2 6.1 7.3 7.9 7.0 24.4 5.1 9.3 4.6 4.9 3.0 22.5 25.5 22.8 27.9 20.1 17.9 22.4 23.2 19.2 24.2 3.0 10.5 23.8 8.2 6.3 24.2 7.7 10.2 18.7 13.6 5.2 15.7 11.8 1.7 8.1 10.1 10.0 11.8 0.0 6.2 9.3 8.2 12.9 9.3 11.1 14.2 31.8 6.9 16.0 28.9 8.5 14.1 22.0 5.0 21.6 10.6 10.9 7.0 14.8 13.1 4.5 23.0 19.4 9.9 15.1 25.3 6.8 11.7 17.3 10.3 9.8 AKAP12 "AKAP250, SSeCKS" ENSG00000131016 "A-kinase anchoring protein 12" Q02952 6 151239999-151358557 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Ito cells: 255.3;Muller glia cells: 521.2;Spermatocytes: 222.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 184 "basophil: 20.4" "Lineage enriched" "Detected in single" 184 "granulocytes: 20.4" "Cell line enhanced" "Detected in many" "GAMG: 37.5;REH: 42.9;TIME: 42.7;U-251 MG: 45.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006344, CAB026379, HPA056230" Enhanced Enhanced "Plasma membrane,Cytosol" No No 6400000 "Plasma membrane, Cytosol" "CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073" "unprognostic (6.66e-2)" "unprognostic (1.51e-1)" "unprognostic (9.90e-3)" "prognostic unfavorable (7.08e-4)" "unprognostic (2.61e-2)" "unprognostic (8.88e-2)" "unprognostic (5.05e-2)" "prognostic unfavorable (6.34e-5)" "unprognostic (1.34e-1)" "unprognostic (8.26e-3)" "unprognostic (2.59e-1)" "unprognostic (4.72e-2)" "unprognostic (4.51e-3)" "unprognostic (1.10e-3)" "unprognostic (3.51e-1)" "unprognostic (7.03e-3)" "unprognostic (2.34e-2)" 52.5 11.2 11.5 11.0 18.1 2.0 38.5 31.3 21.2 11.5 23.4 1.9 5.9 6.1 20.5 13.6 12.8 15.6 32.3 22.8 9.8 17.4 14.9 20.6 18.2 6.9 11.4 9.9 49.0 7.6 2.0 11.1 24.1 28.7 13.5 9.4 26.6 3.3 14.7 11.3 4.1 10.6 27.9 14.1 8.1 12.4 62.0 6.6 0.3 11.4 6.6 2.8 34.5 24.7 0.0 0.0 20.4 0.0 0.0 0.1 0.0 1.7 8.5 12.3 0.0 23.3 35.0 4.3 10.0 5.4 4.5 4.5 0.2 32.4 0.0 4.0 7.5 37.5 0.2 23.4 7.4 4.0 11.1 8.6 0.1 9.5 7.9 2.6 0.0 2.2 24.7 0.0 19.0 1.0 5.9 29.3 0.1 2.1 0.2 16.2 0.1 0.0 0.0 7.7 0.0 10.1 42.9 0.5 0.0 26.0 1.4 8.8 5.1 3.2 0.1 5.6 18.2 0.6 0.1 42.7 0.6 8.0 25.5 45.7 0.0 0.0 0.0 14.8 0.0 8.5 20.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 18.1 31.3 19.1 9.8 17.4 11.4 9.9 28.7 6.6 11.9 21.0 12.7 21.4 17.4 9.5 7.8 7.6 8.1 23.9 48.8 2.0 1.6 1.7 120.3 57.8 105.1 0.0 0.0 5.7 5.5 80.8 45.7 64.5 3.9 20.4 0.0 1.7 255.3 23.1 93.7 36.8 11.7 55.6 1.0 0.0 521.2 193.7 0.0 104.0 64.3 24.1 97.0 171.6 222.6 34.3 9.9 8.4 7.2 0.0 129.4 AKR1B10 "AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI" ENSG00000198074 "Aldo-keto reductase family 1 member B10" O60218 7 134527592-134541408 "Predicted intracellular proteins, Predicted secreted proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 41.5;intestine: 99.7;stomach 1: 68.6" "Group enriched" "Detected in many" 5 "Cholangiocytes: 275.2;Enterocytes: 221.4;Pancreatic endocrine cells: 89.4" "Cancer enhanced" "Detected in many" "liver cancer: 353.4" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 99 "A549: 217.4;Hep G2: 60.3;OE19: 227.4" "HPA020280, CAB070163, HPA073633" Enhanced Supported "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 68000000 Cytosol "Plasma membrane" "CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (1.29e-2)" "unprognostic (1.50e-1)" "prognostic favorable (1.91e-4)" "unprognostic (6.03e-2)" "unprognostic (4.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.16e-3)" "unprognostic (1.01e-1)" "unprognostic (1.47e-1)" "unprognostic (3.18e-2)" "unprognostic (4.65e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (4.80e-9)" "unprognostic (2.12e-1)" "unprognostic (2.12e-1)" "unprognostic (1.43e-2)" "unprognostic (1.25e-1)" 0.6 0.8 0.6 2.2 0.6 0.0 0.6 0.6 0.6 13.1 11.5 0.6 0.6 99.7 0.6 0.9 41.5 0.0 28.9 0.6 0.6 0.0 4.0 6.3 2.0 0.6 0.6 0.6 0.6 0.6 0.0 2.5 0.6 0.6 2.0 7.3 1.3 6.1 0.6 0.6 1.0 54.1 7.1 0.6 0.6 68.6 0.8 0.6 0.9 0.7 28.6 3.6 16.3 22.9 0.4 0.1 1.8 0.2 0.4 0.2 0.1 0.0 217.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.3 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.1 60.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 227.4 0.1 0.0 0.0 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.2 1.8 0.4 0.1 0.1 0.1 0.1 0.6 0.6 0.6 0.6 0.6 0.0 0.6 0.6 0.6 0.6 0.0 0.0 0.5 1.9 2.5 0.0 0.4 275.2 5.3 1.2 0.0 0.0 0.2 0.0 21.5 0.3 0.0 221.4 23.3 23.1 0.1 0.1 0.3 0.0 31.6 0.0 0.0 3.4 3.7 1.6 0.4 3.1 0.0 0.0 1.0 11.7 0.0 89.4 24.6 1.8 1.4 0.0 0.0 0.9 0.0 0.0 9.2 0.2 0.0 41.3 5.2 AKR1B15 ENSG00000227471 "Aldo-keto reductase family 1 member B15" C9JRZ8 7 134549136-134579875 "Enzymes, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 61.7;placenta: 31.8" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 2.3;Late spermatids: 2.7;Syncytiotrophoblasts: 8.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 1.8" "Lineage enhanced" "Detected in single" "granulocytes: 1.8" "Cell line enhanced" "Detected in some" "A549: 15.5;HDLM-2: 12.3;Hep G2: 10.8;SK-BR-3: 5.2;U-87 MG: 6.6" "HPA020280, HPA073633" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA020280: AB_10602228, HPA073633: AB_2686620" "unprognostic (2.35e-1)" "unprognostic (3.85e-2)" "unprognostic (9.74e-3)" "unprognostic (2.74e-2)" "unprognostic (2.08e-1)" "prognostic favorable (8.36e-4)" "prognostic unfavorable (1.80e-5)" "unprognostic (5.04e-2)" "unprognostic (2.39e-1)" "unprognostic (2.75e-1)" "unprognostic (2.14e-3)" "unprognostic (1.24e-1)" "unprognostic (1.22e-7)" "unprognostic (6.88e-2)" "unprognostic (4.29e-1)" "unprognostic (2.99e-3)" "prognostic unfavorable (1.90e-5)" 2.7 0.1 0.1 0.1 0.1 0.0 61.7 0.1 0.2 1.6 0.6 0.2 0.1 5.6 0.1 1.5 3.8 0.0 2.2 0.1 0.1 0.0 0.1 0.8 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.1 31.8 0.2 0.8 0.2 0.5 2.9 0.1 11.6 1.9 1.7 0.8 0.4 0.1 5.0 0.6 0.1 0.3 0.4 16.1 1.8 1.5 3.0 0.1 0.0 1.8 0.1 0.4 0.0 0.3 0.0 15.5 0.2 0.0 0.6 0.5 1.0 0.0 0.4 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.7 0.1 0.0 0.1 0.0 12.3 0.1 0.1 0.2 10.8 0.0 0.2 0.5 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.6 0.0 0.0 0.2 0.2 3.2 0.3 0.0 0.1 0.2 0.3 0.1 0.1 0.1 0.1 0.6 5.2 0.0 0.1 0.1 0.3 0.0 0.1 0.7 0.4 0.0 0.2 0.2 0.2 6.6 0.2 0.2 1.8 0.0 0.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.4 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 8.7 0.0 0.0 0.1 AL132780.3 ENSG00000259132 14 22946270-22982258 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "Alveolar cells type 1: 3.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 28.1" HPA029803 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA029803: AB_10601428" 4.8 6.2 4.5 4.7 5.5 6.6 5.3 3.5 2.4 16.1 7.1 2.3 7.1 5.5 12.4 9.2 16.2 6.6 11.2 6.0 4.6 3.8 20.4 24.5 10.5 7.9 5.3 1.9 11.8 13.8 0.0 3.5 18.1 3.8 13.1 6.1 10.4 5.7 16.0 6.2 8.8 4.5 3.5 4.5 11.3 4.5 6.0 1.9 10.3 22.1 7.7 9.6 5.0 7.9 3.3 5.7 10.2 5.9 1.1 4.1 2.8 4.1 8.9 6.2 2.0 6.1 7.2 4.0 0.7 5.8 3.7 3.8 3.0 3.1 0.0 2.4 6.8 2.1 1.6 2.9 3.1 2.6 0.0 0.7 1.3 6.8 28.1 4.0 3.2 2.6 3.2 8.2 2.9 7.0 8.1 5.1 7.4 0.0 6.1 4.0 16.8 7.0 12.0 3.0 6.9 1.9 3.4 4.4 3.8 10.3 8.4 3.5 2.0 2.8 3.6 1.7 4.5 5.5 7.1 1.0 4.7 3.4 1.9 3.5 6.0 7.3 6.3 1.6 3.2 2.9 0.5 5.9 2.1 2.5 4.2 1.2 2.7 1.8 2.1 5.7 3.3 3.4 1.7 10.2 1.1 2.9 2.6 4.1 2.8 4.5 5.5 3.5 2.4 4.6 3.8 5.3 1.9 3.8 1.9 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALOX15B 15-LOX-2 ENSG00000179593 "Arachidonate 15-lipoxygenase, type B" O15296 17 8039017-8049134 "Enzymes, Predicted intracellular proteins" "Lipid metabolism" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "breast: 57.4;esophagus: 30.6;lung: 44.0;prostate: 35.9" "Cell type enhanced" "Detected in many" 26 "Alveolar cells type 2: 58.0;Kupffer cells: 33.3;monocytes: 149.7" "Cancer enhanced" "Detected in all" "prostate cancer: 91.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 9 "classical monocyte: 6.1;myeloid DC: 6.8" "Group enriched" "Detected in many" 9 "dendritic cells: 6.8;monocytes: 6.1" "Cell line enhanced" "Detected in some" "HHSteC: 6.1;HSkMC: 13.0;hTCEpi: 26.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA010562 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA010562: AB_2668305" "unprognostic (1.76e-2)" "unprognostic (6.47e-2)" "unprognostic (2.56e-1)" "unprognostic (2.28e-3)" "unprognostic (1.67e-2)" "unprognostic (1.52e-1)" "unprognostic (1.34e-1)" "unprognostic (1.52e-1)" "unprognostic (2.28e-1)" "unprognostic (1.85e-1)" "unprognostic (1.44e-2)" "unprognostic (4.59e-1)" "unprognostic (1.59e-2)" "unprognostic (9.37e-2)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" "unprognostic (9.49e-2)" 8.9 0.6 0.4 0.7 0.6 0.3 57.4 0.1 0.4 7.6 4.6 0.1 0.0 0.2 0.3 0.7 30.6 0.8 0.5 0.2 1.3 0.0 2.9 0.7 44.0 7.1 1.8 0.3 0.8 0.8 0.2 0.9 0.7 1.3 35.9 0.3 0.1 3.6 0.2 0.3 15.4 1.9 0.2 4.1 3.1 1.6 1.0 2.0 0.5 0.8 6.6 4.1 1.1 12.9 0.0 6.8 0.2 6.1 0.7 0.0 1.7 0.0 0.0 0.0 0.0 0.4 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 13.0 26.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.2 0.7 0.0 0.2 0.0 1.7 0.4 0.6 0.1 0.4 1.3 0.0 1.8 0.3 1.3 2.0 0.0 58.0 0.0 0.5 2.7 0.0 0.3 2.5 2.7 2.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.3 0.0 0.1 16.8 1.1 0.0 4.1 0.0 0.0 1.3 33.3 0.0 0.0 1.9 5.0 149.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.7 1.0 0.7 0.0 0.0 1.8 ALOXE3 "E-LOX, eLOX3" ENSG00000179148 "Arachidonate lipoxygenase 3" Q9BYJ1 17 8095900-8119047 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism" "Dioxygenase, Isomerase, Lyase, Oxidoreductase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "skin 1: 30.2" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 1.6;Glandular cells: 2.0;Pancreatic endocrine cells: 3.6;Spermatogonia: 1.5;Suprabasal keratinocytes: 1.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 3.9" "Group enriched" "Detected in many" 8 "basal ganglia: 1.1;cerebellum: 1.4;cerebral cortex: 2.3;pons and medulla: 1.1" "Group enriched" "Detected in some" 5 "gdT-cell: 1.0;naive CD4 T-cell: 2.7" "Lineage enriched" "Detected in single" 28 "T-cells: 2.7" "Cell line enhanced" "Detected in some" "A-431: 6.6;HBEC3-KT: 10.8;hTCEpi: 8.0;hTERT-HME1: 15.1;T-47d: 4.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA023120, HPA078597" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023120: AB_10959300, HPA078597: AB_2732385" "unprognostic (2.40e-1)" "unprognostic (3.01e-2)" "unprognostic (1.87e-3)" "unprognostic (2.09e-4)" "unprognostic (1.07e-2)" "unprognostic (4.06e-2)" "unprognostic (3.56e-4)" "unprognostic (3.60e-1)" "unprognostic (4.65e-2)" "unprognostic (3.82e-2)" "unprognostic (3.72e-1)" "unprognostic (3.66e-5)" "unprognostic (9.81e-2)" "unprognostic (2.55e-1)" "unprognostic (1.08e-2)" "unprognostic (2.88e-2)" 0.1 0.0 0.1 0.1 1.1 0.0 1.6 1.4 2.3 1.2 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.1 0.1 0.0 0.1 0.1 0.1 0.1 30.2 0.1 0.1 0.1 0.1 0.0 0.4 0.1 0.1 0.1 0.1 1.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 2.7 0.2 6.6 0.8 0.0 0.0 0.0 0.0 0.0 0.5 0.5 0.1 0.4 0.1 0.5 0.2 0.2 0.1 3.2 0.5 0.9 10.8 0.1 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 8.0 0.2 15.1 0.0 0.0 1.0 0.0 0.1 0.0 2.4 0.0 0.0 0.0 0.2 2.2 0.0 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.7 0.0 0.0 4.8 0.0 0.1 0.0 2.3 0.0 0.3 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 2.7 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.1 1.4 2.3 0.1 0.1 0.1 0.1 1.1 0.1 0.0 0.0 0.0 1.6 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.8 0.9 0.0 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 1.6 0.9 0.0 0.0 0.7 ALS2CR12 ENSG00000155749 "Amyotrophic lateral sclerosis 2 chromosome region 12" Q96Q35 2 201288271-201357398 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.3;epididymis: 14.4;testis: 29.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 99.0;Early spermatids: 82.1" "Not detected" "Not detected" "Region enhanced" "Detected in many" "pons and medulla: 14.3" "Cell type enhanced" "Detected in many" "neutrophil: 7.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-MEL-30: 7.0;U-2197: 9.6" "Low region specificity" "Detected in many" HPA035793 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035793: AB_10602429" "unprognostic (1.45e-1)" "unprognostic (1.91e-1)" "unprognostic (9.72e-2)" "unprognostic (2.95e-2)" "unprognostic (1.53e-1)" "unprognostic (8.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.40e-3)" "unprognostic (1.40e-5)" "unprognostic (1.37e-1)" "unprognostic (3.62e-2)" "unprognostic (1.14e-1)" "unprognostic (6.23e-2)" "unprognostic (1.13e-1)" "unprognostic (2.73e-2)" "unprognostic (2.23e-1)" "unprognostic (8.25e-2)" 0.8 0.9 1.5 0.7 3.6 4.3 0.5 0.7 1.1 0.9 0.6 7.6 0.4 0.3 0.7 14.4 1.1 9.9 0.9 4.7 2.1 2.6 1.3 0.7 3.7 1.4 1.0 1.3 5.3 0.7 1.2 1.3 0.9 14.3 0.4 0.9 0.5 0.7 0.7 1.4 1.1 0.9 0.9 0.9 0.8 0.5 29.9 1.3 0.4 1.7 0.4 0.5 0.6 0.4 1.8 0.5 7.3 1.1 2.8 1.5 0.4 0.3 0.4 2.1 1.5 5.7 2.2 0.1 1.5 0.5 1.3 0.9 0.0 0.5 0.7 1.2 2.2 1.0 2.0 0.8 0.2 0.6 1.2 0.2 0.3 2.5 0.7 1.1 2.1 1.9 1.1 0.6 1.3 0.3 1.7 0.2 2.5 1.0 2.9 1.3 0.0 1.1 1.8 0.6 0.8 1.2 0.5 1.0 1.3 0.8 0.5 0.5 1.3 1.6 0.0 7.0 2.2 1.5 2.5 1.6 2.9 1.7 9.6 1.0 1.6 3.1 1.0 2.8 1.0 1.3 5.4 1.1 1.0 1.5 0.5 0.7 0.6 1.0 0.9 0.5 1.8 1.2 1.4 7.3 2.8 0.6 0.4 0.6 0.4 1.5 3.6 0.7 1.0 2.1 2.6 1.0 1.3 14.3 1.3 0.0 0.3 0.0 0.0 0.5 5.4 5.7 0.0 99.0 9.1 0.0 9.8 0.0 3.3 0.0 82.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 1.1 0.0 0.3 1.6 0.0 0.0 0.0 16.0 0.6 0.0 0.0 1.0 0.0 0.8 0.1 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.5 0.0 0.0 0.0 0.0 0.1 AMACR "P504S, RACE" ENSG00000242110 "Alpha-methylacyl-CoA racemase" Q9UHK6 5 33986178-34008108 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Isomerase "Disease mutation, Intrahepatic cholestasis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 68.0;liver: 63.6" "Cell type enhanced" "Detected in many" 10 "Hepatocytes: 17.8;Late spermatids: 18.9;Proximal tubular cells: 33.2" "Cancer enhanced" "Detected in all" "prostate cancer: 34.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 59.8;U-266/84: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001809, HPA019527, HPA020912" Enhanced Supported "Vesicles,Plasma membrane" NA NA 65000 "Vesicles, Plasma membrane" "CAB001809: AB_2305454, HPA019527: AB_10669651, HPA020912: AB_10670034" "unprognostic (8.96e-2)" "unprognostic (5.20e-3)" "prognostic favorable (7.11e-4)" "unprognostic (9.55e-2)" "unprognostic (1.39e-1)" "unprognostic (9.12e-3)" "unprognostic (1.68e-1)" "unprognostic (5.41e-2)" "unprognostic (1.50e-1)" "unprognostic (1.60e-1)" "unprognostic (5.59e-5)" "unprognostic (1.95e-2)" "unprognostic (5.52e-3)" "unprognostic (6.32e-2)" "unprognostic (3.41e-1)" "unprognostic (2.18e-1)" "unprognostic (1.50e-1)" 2.8 8.3 5.2 2.7 8.2 0.9 2.8 4.7 7.8 4.4 14.1 4.3 6.5 6.2 4.0 3.6 8.2 2.3 11.0 3.5 4.5 6.8 68.0 63.6 3.3 2.0 4.5 4.5 2.9 5.1 5.4 4.3 3.2 7.0 13.9 15.5 5.5 25.4 5.4 6.0 2.6 7.4 3.7 3.8 2.9 15.9 2.1 2.1 3.8 3.3 3.4 3.3 5.7 4.5 7.8 10.2 11.2 14.2 9.9 10.0 6.8 4.1 6.6 3.7 4.8 2.6 4.1 6.4 5.5 4.1 2.5 1.9 21.6 5.0 1.3 2.9 7.8 9.7 1.9 0.9 4.0 2.6 4.1 3.5 3.1 4.8 6.2 1.8 1.9 1.0 6.2 2.0 3.3 1.2 3.6 2.8 2.7 1.2 4.9 7.5 3.0 1.6 2.4 3.3 3.0 10.8 1.9 6.3 2.1 11.3 20.7 2.1 2.9 9.1 6.5 5.5 3.2 5.0 1.9 5.2 8.4 1.9 2.1 4.4 59.8 31.1 2.4 2.4 3.9 6.2 0.3 7.1 10.2 10.0 8.8 8.4 7.8 8.7 7.8 10.2 7.0 8.1 6.1 11.2 9.9 14.2 5.3 8.9 6.8 5.2 8.2 4.7 7.8 4.5 6.8 4.5 4.5 7.0 2.1 3.0 2.6 0.0 0.4 0.3 3.3 0.9 7.6 4.0 5.7 1.8 0.0 0.9 5.0 0.7 8.1 0.8 5.0 0.0 3.3 0.9 1.1 0.6 0.0 17.8 0.9 4.8 4.1 1.3 1.2 18.9 0.6 0.8 0.0 1.8 4.5 10.6 2.4 3.5 2.1 33.2 0.8 0.0 0.5 0.7 0.7 0.5 0.2 0.8 4.0 0.3 AMPH ENSG00000078053 Amphiphysin P49418 7 38383704-38631567 "Cancer-related genes, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 57.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 53.7;Cone photoreceptor cells: 82.5;Rod photoreceptor cells: 54.5" "Cancer enhanced" "Detected in many" "glioma: 3.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 31.2;ASC TERT1: 18.5;BJ hTERT+ SV40 Large T+: 12.1;BJ hTERT+ SV40 Large T+ RasG12V: 14.4;GAMG: 21.3;HBF TERT88: 11.1;U-138 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008559, HPA019828, HPA019829" Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB008559: AB_1611845, HPA019828: AB_1844801, HPA019829: AB_1844802" "unprognostic (1.76e-2)" "unprognostic (1.59e-1)" "unprognostic (5.94e-2)" "unprognostic (7.36e-2)" "unprognostic (3.24e-3)" "unprognostic (2.92e-1)" "unprognostic (4.90e-2)" "unprognostic (2.55e-2)" "unprognostic (4.37e-1)" "unprognostic (1.08e-1)" "prognostic favorable (9.96e-4)" "unprognostic (5.06e-2)" "unprognostic (5.81e-5)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (8.03e-2)" "unprognostic (1.68e-3)" 3.8 2.4 17.4 2.5 17.7 1.0 2.8 29.7 57.2 7.7 2.2 1.8 0.0 1.4 5.1 4.7 4.5 5.7 4.2 6.5 13.5 16.0 3.7 1.4 1.6 1.3 10.4 20.4 1.7 2.9 1.2 12.6 1.0 26.5 2.4 2.5 4.8 1.5 4.2 2.9 1.3 1.9 5.0 4.9 1.9 2.0 3.5 1.5 0.0 1.2 0.2 1.1 2.9 1.7 0.2 1.6 0.0 0.8 0.7 2.9 0.2 0.0 0.0 7.9 0.0 31.2 18.5 0.0 1.1 0.0 12.1 14.4 0.0 0.0 0.0 0.0 2.2 21.3 0.0 0.0 0.0 11.1 0.0 0.9 0.1 0.0 0.0 0.0 0.1 0.0 10.8 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.2 0.0 0.1 0.0 0.1 4.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 11.8 8.4 4.1 4.5 0.0 0.1 0.0 8.0 0.1 10.6 0.0 0.8 0.0 2.9 0.2 1.7 0.0 1.0 1.5 0.2 0.2 0.4 2.0 0.0 0.7 0.2 1.6 0.2 0.2 17.4 17.7 29.7 32.9 13.5 16.0 10.4 20.4 26.5 1.5 0.0 0.0 0.5 0.1 0.2 53.7 6.3 0.0 0.0 0.0 0.0 82.5 0.0 1.7 0.1 7.7 0.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 1.6 0.0 5.5 14.2 10.2 2.6 0.0 0.0 0.0 0.0 4.7 0.1 0.0 4.6 0.0 54.5 6.5 3.0 0.4 3.0 0.3 0.0 0.0 0.0 0.0 ANKFN1 FLJ38335 ENSG00000153930 "Ankyrin repeat and fibronectin type III domain containing 1" Q8N957 17 55882301-56511659 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 11.8;cervix, uterine: 19.9;fallopian tube: 10.9" "Cell type enhanced" "Detected in some" 22 "Ciliated cells: 34.8;Early spermatids: 13.6;Late spermatids: 7.4;Sertoli cells: 6.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HeLa: 8.1;MOLT-4: 16.8;T-47d: 5.8;U-2197: 5.6" "Low region specificity" "Detected in many" "HPA021566, HPA022538, HPA048953" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021566: AB_1844828, HPA022538: AB_1844829, HPA048953: " "unprognostic (6.64e-2)" "unprognostic (1.29e-1)" "unprognostic (3.52e-2)" "unprognostic (9.38e-5)" "unprognostic (2.39e-1)" "unprognostic (2.31e-3)" "unprognostic (3.84e-2)" "unprognostic (1.68e-1)" "unprognostic (3.31e-1)" "unprognostic (1.21e-1)" "unprognostic (1.24e-2)" "unprognostic (6.81e-3)" "unprognostic (3.44e-8)" "unprognostic (1.24e-1)" "unprognostic (1.69e-1)" "unprognostic (4.93e-2)" "unprognostic (9.51e-2)" 3.9 1.0 5.5 0.5 10.2 0.5 1.2 2.6 4.7 19.9 0.7 11.4 0.5 0.7 0.8 3.4 0.7 10.9 0.9 0.5 6.8 4.6 0.7 0.6 2.0 0.6 6.3 3.7 0.5 0.5 0.5 1.0 2.1 11.8 0.9 0.8 0.0 0.7 0.8 0.6 5.2 0.8 0.5 7.5 0.6 1.1 3.6 10.0 0.0 0.6 0.0 0.5 3.2 5.3 0.2 0.5 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.1 0.0 1.3 0.2 0.3 0.0 2.9 0.2 0.3 0.0 0.1 0.3 0.2 0.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 8.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 2.2 0.1 0.4 16.8 0.0 0.0 0.9 0.7 0.1 0.0 0.1 0.0 0.1 1.5 0.0 1.7 0.0 0.3 0.1 5.8 0.0 0.0 0.0 0.4 5.6 0.1 1.5 0.3 0.0 0.8 0.0 0.4 0.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.2 0.0 0.3 0.1 0.3 0.1 0.5 0.0 0.0 5.5 10.2 2.6 4.7 6.8 4.6 6.3 3.7 11.8 10.0 0.0 0.6 0.0 0.1 0.5 0.0 0.6 0.0 34.8 0.0 0.0 0.0 0.3 0.0 0.0 13.6 0.0 0.0 0.0 0.0 0.7 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.6 0.0 1.7 0.0 1.3 0.2 0.0 0.0 0.0 0.0 0.0 6.5 0.3 5.9 2.1 0.4 2.4 0.0 0.0 0.9 ANKIB1 "DKFZP434A0225, KIAA1386" ENSG00000001629 "Ankyrin repeat and IBR domain containing 1" Q9P2G1 7 92246234-92401384 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019358, HPA021780" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019358: AB_1844831, HPA021780: AB_2670819" "unprognostic (1.77e-1)" "unprognostic (5.96e-3)" "unprognostic (1.23e-1)" "unprognostic (4.97e-3)" "unprognostic (2.75e-1)" "unprognostic (7.67e-2)" "unprognostic (4.88e-3)" "unprognostic (2.14e-1)" "unprognostic (4.24e-2)" "unprognostic (1.87e-2)" "unprognostic (1.52e-3)" "unprognostic (1.48e-1)" "unprognostic (1.06e-3)" "unprognostic (4.05e-2)" "unprognostic (3.00e-1)" "unprognostic (3.00e-2)" "unprognostic (3.20e-1)" 11.9 11.8 21.4 9.2 29.2 5.8 12.3 15.0 25.5 13.6 12.1 34.9 16.0 10.7 12.6 16.4 11.8 10.0 14.7 9.7 22.7 20.0 25.3 10.1 10.6 11.5 31.1 18.4 13.1 12.7 28.5 10.9 12.2 23.4 10.2 12.6 8.4 12.7 18.4 8.6 14.0 11.3 13.4 23.8 11.4 10.9 19.4 35.0 11.5 17.1 4.5 11.1 13.1 13.3 4.8 4.5 3.1 2.0 3.2 4.9 1.1 16.8 10.3 9.1 13.8 16.9 18.0 9.7 13.2 15.1 12.8 16.8 7.5 26.1 9.7 11.6 19.5 33.1 8.1 8.4 13.8 19.6 16.4 6.9 6.1 11.9 6.0 11.5 8.7 13.6 12.2 11.7 15.1 20.0 18.0 14.5 8.8 7.8 21.0 15.1 13.6 18.5 8.2 9.9 11.8 11.6 7.0 11.2 10.4 13.6 14.6 12.7 14.9 18.9 21.3 11.1 18.9 8.8 5.0 12.9 24.8 20.1 28.0 13.4 13.2 23.5 12.2 14.4 10.6 28.3 2.8 1.3 3.1 2.7 2.0 2.2 3.9 2.6 3.8 1.1 4.8 2.2 2.8 0.8 3.2 1.6 4.5 4.9 1.1 21.4 29.2 15.0 25.5 22.7 20.0 31.1 18.4 23.4 35.0 23.8 25.4 15.9 15.3 16.6 20.1 32.3 17.8 14.7 23.9 26.2 17.7 11.3 1.7 18.0 40.4 15.7 15.3 0.0 16.6 22.9 19.1 16.9 26.5 12.9 11.8 28.6 40.3 28.3 21.1 45.0 30.8 16.4 16.9 6.4 23.5 26.9 26.0 7.0 38.2 30.1 15.7 19.4 18.1 58.5 57.5 19.8 11.7 17.5 19.2 21.8 ANKLE2 "KIAA0692, Lem4, LEMD7" ENSG00000176915 "Ankyrin repeat and LEM domain containing 2" Q86XL3 12 132725503-132761888 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Mitosis" "Disease mutation, Primary microcephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Urothelial cells: 154.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003602, HPA074838" Uncertain Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA003602: AB_1858349, HPA074838: " "unprognostic (4.43e-2)" "unprognostic (6.92e-2)" "unprognostic (7.97e-2)" "unprognostic (9.84e-3)" "unprognostic (1.97e-2)" "unprognostic (5.81e-2)" "prognostic unfavorable (3.97e-6)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (4.76e-2)" "unprognostic (6.10e-2)" "prognostic unfavorable (1.90e-8)" "unprognostic (1.42e-1)" "unprognostic (1.42e-1)" "unprognostic (6.92e-3)" "unprognostic (2.09e-1)" 20.1 26.4 14.9 21.3 17.6 27.2 21.8 23.3 20.4 15.6 15.4 19.6 15.1 14.6 18.9 16.8 23.7 18.6 17.0 16.5 12.4 10.7 16.3 16.3 21.6 24.1 16.0 11.3 20.7 18.1 17.2 22.3 18.3 15.2 17.2 13.9 16.7 19.1 15.7 19.9 27.3 22.8 18.5 13.4 27.4 16.8 43.7 14.1 31.4 17.4 15.8 27.9 16.4 28.6 4.8 3.3 7.7 2.2 4.7 5.5 1.4 19.7 18.5 19.4 12.0 11.3 17.8 24.3 24.2 18.1 24.3 18.7 21.1 13.6 15.6 12.7 21.2 16.3 23.9 16.9 22.1 23.3 6.6 21.0 19.8 31.1 9.9 12.6 21.2 14.0 16.5 22.6 23.1 17.2 45.1 17.3 12.9 17.8 6.1 24.8 14.2 19.8 35.2 16.4 9.8 17.8 22.8 12.7 6.5 17.5 25.9 23.9 14.7 31.2 13.2 10.6 19.0 23.2 15.4 24.7 29.3 21.1 15.5 26.9 11.5 11.3 19.1 22.7 14.2 16.4 1.4 2.2 7.7 3.6 2.1 4.8 4.8 5.3 5.5 3.3 4.3 5.0 4.1 1.3 4.7 2.2 3.2 4.7 1.4 14.9 17.6 23.3 20.4 12.4 10.7 16.0 11.3 15.2 14.1 68.5 24.5 25.4 82.7 59.8 30.8 22.9 28.1 20.1 55.7 29.6 43.2 25.0 1.7 29.1 63.9 32.7 20.2 0.0 28.1 29.6 26.8 92.4 18.4 12.1 17.7 30.2 20.0 19.0 15.1 14.0 23.3 33.1 32.1 42.3 16.9 24.7 66.6 20.9 26.5 6.4 38.7 25.8 34.8 131.6 52.4 63.7 30.6 37.3 18.6 154.8 ANKRD35 FLJ25124 ENSG00000198483 "Ankyrin repeat domain 35" Q8N283 1 145866560-145885866 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 42.4" "Cell type enhanced" "Detected in many" 9 "Leydig cells: 33.6;Muller glia cells: 39.3;Peritubular cells: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "classical monocyte: 5.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC TERT1: 11.0;THP-1: 7.4;TIME: 9.4;U-87 MG: 9.4;U-937: 8.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035453 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA035453: AB_10672864" "prognostic favorable (9.35e-4)" "prognostic favorable (2.90e-4)" "unprognostic (2.07e-1)" "unprognostic (7.39e-3)" "unprognostic (1.77e-2)" "unprognostic (1.02e-2)" "unprognostic (3.27e-1)" "unprognostic (3.58e-2)" "unprognostic (3.03e-1)" "unprognostic (1.79e-1)" "unprognostic (2.98e-1)" "unprognostic (5.86e-2)" "unprognostic (9.29e-10)" "unprognostic (8.80e-3)" "unprognostic (2.18e-1)" "unprognostic (5.92e-2)" "unprognostic (8.69e-3)" 2.1 1.2 3.3 1.0 3.7 0.4 3.6 12.1 7.4 16.1 1.7 0.8 0.3 0.5 2.1 1.3 11.4 2.5 1.1 0.8 3.4 3.6 0.4 1.4 0.8 0.5 3.7 3.4 2.8 0.5 0.2 0.3 0.3 8.0 2.5 0.8 0.3 4.2 2.3 5.2 42.4 0.7 1.8 2.0 0.4 1.2 0.8 0.3 0.7 0.3 14.9 13.6 2.3 7.7 0.0 1.3 0.3 5.5 1.5 2.9 1.9 0.1 0.0 0.0 0.0 2.5 11.0 0.3 1.6 4.0 0.5 1.3 0.4 0.0 0.0 0.3 1.3 0.0 0.2 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 1.3 3.1 0.1 3.8 0.5 0.3 0.1 0.1 0.5 0.0 0.0 0.0 2.4 0.0 0.0 4.2 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 1.2 0.0 0.0 0.0 0.0 0.0 0.0 7.4 9.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 8.2 0.0 0.0 5.5 0.0 2.0 2.0 0.3 0.0 0.8 2.9 0.7 0.0 0.6 1.9 0.3 1.5 0.4 1.3 1.5 1.9 3.3 3.7 12.1 7.4 3.4 3.6 3.7 3.4 8.0 0.3 0.0 0.0 0.0 14.7 4.0 1.5 1.2 2.5 4.0 1.2 1.8 0.0 0.1 0.0 0.0 3.6 1.0 0.0 0.0 0.4 0.1 20.2 8.0 19.5 8.6 8.7 0.0 0.0 1.8 1.6 4.7 33.6 1.1 5.0 0.0 0.0 39.3 0.1 0.0 47.7 0.0 1.4 0.0 5.2 0.0 0.9 10.8 0.2 7.5 0.0 12.9 ANO1 "DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A" ENSG00000131620 "Anoctamin 1" Q5XXA6 11 70078302-70189528 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Developmental protein, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "ductus deferens: 142.4;epididymis: 38.5;salivary gland: 122.9;seminal vesicle: 93.6" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 56.2;Hepatocytes: 117.3;Late spermatids: 50.1;Sertoli cells: 45.3;Smooth muscle cells: 42.3;Suprabasal keratinocytes: 40.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "A-431: 32.9;CAPAN-2: 50.5;HaCaT: 61.6;OE19: 43.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA032148, HPA057356" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA032148: AB_2674180, HPA057356: AB_2732610" "unprognostic (2.73e-1)" "unprognostic (7.91e-2)" "unprognostic (3.66e-2)" "prognostic favorable (4.58e-6)" "unprognostic (1.90e-1)" "prognostic unfavorable (7.28e-5)" "unprognostic (1.16e-3)" "prognostic unfavorable (2.40e-4)" "unprognostic (2.13e-2)" "unprognostic (3.51e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.21e-1)" "prognostic unfavorable (4.09e-6)" "unprognostic (1.56e-1)" "unprognostic (1.06e-1)" "unprognostic (8.85e-3)" "unprognostic (1.81e-1)" 6.9 0.4 1.1 2.1 1.1 0.0 17.2 1.6 1.4 9.7 5.3 1.1 142.4 0.2 14.2 38.5 3.6 11.7 10.6 6.9 1.1 0.2 2.6 24.4 4.4 1.5 1.0 1.0 3.9 4.5 0.5 2.0 6.2 1.5 7.2 1.7 1.7 122.9 93.6 3.4 19.1 1.8 5.7 1.0 1.1 9.5 7.6 0.9 1.1 8.9 8.1 3.8 4.5 5.9 0.0 0.0 0.0 0.0 0.0 0.3 0.0 32.9 1.3 0.0 1.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 50.5 0.0 0.6 0.0 0.0 61.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.2 43.3 4.8 0.0 0.0 0.1 0.0 0.0 1.8 0.0 0.0 10.5 0.2 0.3 3.9 0.1 0.1 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.1 1.6 1.4 1.1 0.2 1.0 1.0 1.5 0.9 0.0 0.0 0.0 18.1 15.8 0.0 2.8 25.5 0.0 1.2 0.0 0.0 1.1 0.0 2.9 56.2 2.2 0.0 0.0 0.0 0.6 3.5 9.1 4.6 117.3 0.2 0.0 0.0 4.9 1.6 50.1 1.7 0.9 5.0 0.0 11.4 1.0 0.6 0.0 1.4 0.4 0.3 45.3 42.3 1.4 1.5 40.8 3.4 0.0 0.2 17.8 ANO10 "FLJ10375, MGC47890, SCAR10, TMEM16K" ENSG00000160746 "Anoctamin 10" Q9NW15 3 43354859-43691594 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.4" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016624, HPA051569" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA016624: , HPA051569: AB_2681537" "unprognostic (1.51e-3)" "unprognostic (1.38e-2)" "prognostic favorable (6.70e-4)" "prognostic favorable (1.11e-4)" "unprognostic (4.23e-1)" "unprognostic (2.69e-2)" "prognostic unfavorable (3.19e-4)" "unprognostic (7.99e-3)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (1.05e-1)" "unprognostic (1.33e-1)" "prognostic favorable (6.41e-6)" "unprognostic (9.83e-3)" "unprognostic (1.22e-1)" "unprognostic (5.19e-3)" "unprognostic (5.71e-2)" 21.6 12.7 11.8 12.6 13.2 20.6 22.0 18.2 14.1 17.5 27.4 14.3 13.2 42.0 17.9 12.4 19.8 10.4 16.7 10.5 12.3 15.2 22.2 10.5 13.6 10.7 17.3 12.3 12.7 14.4 18.6 14.4 17.5 19.4 10.7 24.4 18.6 23.1 19.5 11.3 24.6 52.9 19.9 23.6 9.4 11.1 9.1 8.8 5.5 17.7 15.8 13.9 13.7 17.0 2.0 8.5 22.4 12.5 6.3 4.6 4.3 9.0 7.2 8.0 8.4 32.6 17.6 9.8 26.5 44.2 13.6 17.3 4.8 8.4 1.0 8.5 34.9 13.4 4.9 6.3 14.5 16.5 10.0 4.5 11.8 9.7 5.2 14.3 2.1 9.6 16.3 11.6 16.7 22.8 24.9 31.7 5.7 8.8 7.7 30.0 6.4 2.3 1.5 9.6 7.0 8.4 1.8 5.7 3.1 26.7 9.5 2.0 5.9 10.5 8.6 6.1 14.8 18.4 4.3 25.8 20.7 7.7 21.7 12.1 5.0 6.5 0.3 18.9 4.5 13.6 4.4 12.5 0.9 4.6 7.1 2.7 1.9 3.2 3.1 8.5 2.0 2.8 4.3 22.4 6.3 7.7 1.5 3.5 4.3 11.8 13.2 18.2 14.1 12.3 15.2 17.3 12.3 19.4 8.8 6.0 2.7 2.2 5.2 4.9 7.1 4.5 10.2 4.0 7.9 14.0 0.0 12.0 104.5 19.0 2.7 14.0 47.9 23.3 15.4 15.5 7.8 5.5 2.3 6.8 10.4 9.5 9.2 19.0 9.2 3.1 5.2 8.2 13.5 1.8 19.1 20.3 11.8 16.5 9.6 14.9 3.6 6.5 12.3 14.7 22.6 5.4 14.3 3.9 24.3 4.6 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ANO6 "DKFZp313M0720, TMEM16F" ENSG00000177119 "Anoctamin 6" Q4KMQ2 12 45215987-45440404 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Lipid transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 81.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038958 Approved Approved "Plasma membrane,Cytosol" NA NA 1500000 "Plasma membrane, Cytosol" "HPA038958: AB_10672835" "prognostic unfavorable (7.56e-5)" "prognostic unfavorable (3.82e-4)" "unprognostic (2.16e-1)" "unprognostic (1.75e-2)" "unprognostic (1.29e-1)" "unprognostic (9.82e-3)" "unprognostic (7.43e-2)" "unprognostic (3.01e-3)" "unprognostic (7.55e-2)" "unprognostic (2.84e-3)" "unprognostic (1.41e-3)" "unprognostic (3.02e-1)" "unprognostic (2.68e-2)" "unprognostic (1.26e-3)" "unprognostic (1.26e-1)" "unprognostic (4.20e-2)" "unprognostic (1.28e-1)" 40.7 15.3 6.4 17.3 7.0 3.8 42.8 2.5 7.3 22.2 29.7 6.1 34.8 16.5 33.2 16.0 21.2 18.5 20.2 20.7 6.7 5.4 21.6 25.4 25.6 11.7 7.6 4.2 27.4 12.7 20.1 7.1 23.3 8.8 21.6 6.9 14.2 16.8 39.3 40.3 10.0 41.3 42.8 14.6 12.5 13.5 10.4 5.8 21.6 11.2 14.7 9.6 37.6 38.1 2.1 7.1 4.4 9.3 3.1 4.0 5.0 13.6 15.7 8.8 12.0 40.6 21.1 33.7 19.2 24.2 13.3 12.3 23.6 20.7 7.1 18.0 30.0 11.8 18.1 8.0 10.6 15.5 10.4 5.7 8.2 6.4 19.9 12.9 12.7 6.6 17.6 10.6 11.1 16.4 31.7 17.4 14.9 6.2 11.5 14.1 3.6 13.5 4.1 9.8 0.0 5.9 7.8 11.5 7.8 12.2 21.7 4.0 13.7 20.1 12.5 9.2 23.9 14.7 20.1 23.8 14.2 9.1 14.3 9.7 6.1 7.0 8.6 12.8 40.8 11.3 4.4 7.7 1.9 3.3 9.3 3.4 2.1 3.2 2.8 7.1 1.7 2.9 2.0 0.9 3.1 8.6 3.6 4.0 5.0 6.4 7.0 2.5 7.3 6.7 5.4 7.6 4.2 8.8 5.8 56.6 10.2 3.7 20.1 27.1 0.4 20.3 30.6 6.7 13.6 17.4 0.0 29.4 3.3 35.0 1.0 34.4 4.9 0.0 32.0 21.1 32.3 17.2 12.7 81.6 17.8 0.0 8.1 54.0 49.8 1.3 47.5 21.3 16.9 8.2 11.4 9.8 55.0 10.2 38.2 18.0 0.2 38.8 31.6 2.4 4.2 19.3 20.6 6.4 10.7 25.1 ANXA13 ANX13 ENSG00000104537 "Annexin A13" P27216 8 123680794-123737407 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6" "Cell type enhanced" "Detected in some" 20 "Cholangiocytes: 180.9;Intestinal endocrine cells: 43.0;Mucus-secreting cells: 139.9" "Group enriched" "Detected in many" 13 "colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3" "Region enhanced" "Detected in single" "midbrain: 3.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "A549: 23.8;HDLM-2: 12.3" "Low region specificity" "Detected in all" "HPA018535, HPA019569, HPA019650, CAB025135" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856" "unprognostic (6.47e-3)" "unprognostic (1.95e-1)" "unprognostic (3.50e-2)" "unprognostic (1.83e-1)" "unprognostic (5.66e-2)" "unprognostic (4.05e-2)" "unprognostic (5.48e-2)" "unprognostic (2.86e-3)" "unprognostic (2.06e-1)" "unprognostic (9.11e-2)" "unprognostic (2.48e-2)" "unprognostic (2.01e-1)" "unprognostic (1.57e-2)" "unprognostic (1.49e-1)" "unprognostic (1.03e-1)" "unprognostic (5.79e-2)" "unprognostic (4.79e-2)" 0.2 0.1 0.3 0.7 0.5 0.0 0.4 0.1 0.4 0.2 30.3 0.4 41.9 66.5 1.1 2.6 0.2 13.3 38.7 0.1 0.5 0.6 2.1 4.3 0.1 0.1 3.0 0.1 0.9 0.3 0.0 0.1 0.1 0.7 1.1 8.1 0.2 0.2 20.7 0.1 0.1 108.6 0.4 8.0 0.1 0.7 2.3 0.3 0.1 0.1 0.1 0.1 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.5 0.0 0.0 0.0 1.4 1.4 0.0 0.1 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.1 0.4 0.5 0.6 3.0 0.1 0.7 0.3 0.0 0.0 0.0 0.2 0.9 0.0 0.3 180.9 5.3 0.0 0.0 0.0 0.0 3.3 0.0 0.9 0.0 11.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 43.0 0.0 0.0 1.0 1.1 0.0 0.0 0.0 139.9 0.0 0.1 18.7 0.0 18.5 9.5 0.0 0.0 0.0 0.1 0.5 0.0 0.0 20.0 0.0 ANXA2 "ANX2, ANX2L4, CAL1H, LIP2, LPC2D" ENSG00000182718 "Annexin A2" P07355 15 60347134-60402883 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters" "Host-virus interaction" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB004311, HPA046964, HPA061798" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 16000000 "Plasma membrane" Cytosol "CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671" "unprognostic (1.61e-1)" "unprognostic (1.31e-3)" "unprognostic (1.84e-1)" "prognostic favorable (6.88e-5)" "unprognostic (4.06e-3)" "unprognostic (5.42e-3)" "prognostic unfavorable (2.54e-5)" "prognostic unfavorable (7.51e-4)" "unprognostic (2.94e-1)" "unprognostic (4.10e-3)" "prognostic unfavorable (8.47e-6)" "unprognostic (5.16e-2)" "prognostic unfavorable (2.11e-6)" "unprognostic (7.74e-2)" "unprognostic (2.55e-1)" "unprognostic (7.41e-2)" "prognostic unfavorable (6.59e-5)" 91.7 29.8 4.9 23.5 7.1 6.6 50.1 4.5 5.6 65.1 39.1 8.6 38.2 26.4 38.3 40.3 158.8 26.2 54.9 29.9 4.7 5.5 36.7 28.5 62.0 46.6 10.8 5.7 23.3 94.3 29.7 12.8 84.1 25.7 29.5 35.2 31.7 74.7 27.9 22.7 77.3 71.9 37.1 15.1 32.6 25.6 18.7 7.1 14.6 31.0 122.7 81.4 34.0 87.4 35.5 209.6 183.3 138.0 15.2 83.9 150.8 144.7 161.6 8.5 3.8 116.8 187.4 37.1 173.0 111.6 109.9 96.5 76.6 69.9 0.3 142.5 223.8 82.7 154.9 38.0 324.9 120.6 30.8 4.0 2.9 77.8 29.7 70.4 0.1 2.1 91.5 88.7 78.1 168.4 132.2 204.9 2.1 11.5 16.9 234.8 16.8 0.6 8.5 18.5 123.9 125.9 1.7 46.9 8.1 194.9 88.2 11.2 6.3 68.4 15.6 67.9 92.0 33.4 6.0 233.6 93.8 127.8 314.4 169.8 6.3 20.7 2.8 88.3 1.6 186.5 183.3 138.0 17.7 33.4 122.6 36.5 35.5 38.5 38.5 209.6 16.9 4.5 18.1 3.9 15.2 129.1 32.0 83.9 150.8 4.9 7.1 4.5 5.6 4.7 5.5 10.8 5.7 25.7 7.1 1989.1 372.8 135.8 2699.6 2231.6 2.1 19.9 922.3 1675.6 1452.5 532.1 0.0 1604.6 11.6 3597.2 77.7 904.5 724.0 23.3 2130.9 2200.2 1229.1 3363.5 101.8 70.0 1517.4 0.0 99.2 465.3 432.0 90.7 714.0 1131.8 1344.5 1757.5 521.7 18.0 3399.7 582.2 600.4 22.4 6.8 181.1 774.1 7.0 17.7 2032.4 961.8 162.4 580.5 3656.9 APBB1IP "INAG1, RIAM" ENSG00000077420 "Amyloid beta precursor protein binding family B member 1 interacting protein" Q7Z5R6 10 26438203-26567803 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 54.2;lymphoid tissue: 100.5" "Cell type enhanced" "Detected in many" 12 "B-cells: 48.4;Hofbauer cells: 56.0;Kupffer cells: 108.6;Macrophages: 52.4;T-cells: 69.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 54.2" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 25.7;MOLT-4: 22.0;REH: 49.7;U-698: 52.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017009, HPA063903" Enhanced Enhanced "Plasma membrane,Cytosol" No NA "Plasma membrane, Cytosol" "HPA017009: AB_2669505, HPA063903: AB_2685147" "unprognostic (1.31e-2)" "unprognostic (3.26e-2)" "unprognostic (2.79e-3)" "prognostic favorable (7.48e-4)" "unprognostic (3.06e-1)" "unprognostic (1.07e-2)" "unprognostic (3.83e-2)" "unprognostic (3.05e-1)" "unprognostic (1.62e-2)" "unprognostic (3.74e-1)" "unprognostic (5.72e-2)" "unprognostic (9.75e-2)" "unprognostic (1.71e-1)" "unprognostic (7.77e-3)" "unprognostic (2.68e-2)" "unprognostic (6.00e-2)" "unprognostic (2.38e-2)" 18.3 3.9 7.9 27.7 14.2 25.8 10.1 1.2 7.3 2.6 3.9 16.6 0.0 4.5 2.0 1.5 2.9 4.9 7.5 4.8 7.3 4.9 4.8 25.4 11.1 28.2 14.5 3.2 1.5 3.0 1.3 2.7 5.5 11.1 2.5 4.5 1.6 4.0 1.6 1.5 2.8 12.0 4.7 21.9 41.5 5.4 1.3 12.1 100.5 3.0 0.7 26.2 8.0 3.9 11.0 14.8 54.2 10.3 5.3 9.5 3.5 0.0 0.4 0.0 0.0 3.4 5.7 3.0 9.6 1.8 5.5 5.3 0.0 0.0 25.7 0.1 6.4 5.9 0.0 0.0 0.0 7.6 0.0 0.0 18.6 0.0 0.0 0.0 3.5 0.0 8.2 0.0 0.2 0.0 0.6 0.0 10.6 0.0 16.4 0.0 0.0 22.0 4.9 0.0 2.0 0.0 49.7 0.0 18.2 1.5 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 12.1 0.0 0.0 0.1 1.8 0.0 4.5 0.0 52.9 4.5 18.2 0.0 19.0 7.1 16.1 9.5 6.9 7.7 9.5 8.1 7.9 4.4 11.0 9.3 9.0 54.2 5.3 10.3 14.8 7.6 3.5 7.9 14.2 1.2 7.3 7.3 4.9 14.5 3.2 11.1 12.1 0.0 25.9 48.4 0.0 1.0 0.0 0.9 5.1 6.7 4.5 3.5 0.0 2.0 0.0 4.1 0.3 1.7 0.0 0.0 0.0 14.9 4.1 0.1 22.0 21.5 56.0 0.0 0.0 8.6 108.6 0.0 0.0 52.4 3.3 8.2 0.0 0.0 0.1 0.0 0.0 2.7 0.1 0.0 1.0 0.0 0.9 0.1 1.1 69.3 0.0 0.0 APOLD1 "DKFZP434F0318, FLJ25138" ENSG00000178878 "Apolipoprotein L domain containing 1" Q96LR9 12 12725917-12829975 "Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adipose tissue: 109.5" "Cell type enhanced" "Detected in many" 9 "Endothelial cells: 140.0;Erythroid cells: 70.0;Ito cells: 65.7;Muller glia cells: 64.4;Sertoli cells: 109.9;Smooth muscle cells: 101.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 26.2;HDLM-2: 13.2;hTERT-RPE1: 10.9" "Group enriched" "Detected in many" 5 "basal ganglia: 5.8;olfactory region: 24.7" "Low region specificity" "Detected in all" "HPA052462, HPA058882" Approved Approved "Nucleoplasm,Plasma membrane" No No "Nucleoplasm, Plasma membrane" "HPA052462: AB_2681841, HPA058882: AB_2683844" "unprognostic (1.98e-1)" "unprognostic (8.36e-3)" "unprognostic (5.28e-2)" "unprognostic (1.28e-3)" "unprognostic (1.37e-1)" "unprognostic (1.16e-2)" "unprognostic (5.58e-3)" "unprognostic (8.07e-2)" "unprognostic (3.46e-1)" "unprognostic (4.23e-2)" "unprognostic (1.35e-1)" "unprognostic (3.23e-2)" "unprognostic (4.30e-3)" "unprognostic (3.42e-3)" "unprognostic (1.81e-1)" "unprognostic (6.18e-2)" "unprognostic (1.15e-2)" 109.5 8.8 11.2 9.2 17.7 0.6 34.4 9.8 17.5 25.5 9.0 7.7 2.9 2.5 7.1 7.0 18.8 14.0 18.7 22.3 13.0 11.8 7.4 9.3 7.1 3.4 16.6 3.3 10.0 12.8 17.2 4.7 44.8 16.7 7.2 7.1 8.1 4.4 3.7 16.6 7.4 6.0 28.0 13.9 4.7 5.3 5.4 12.4 5.7 34.4 9.9 3.3 10.9 7.1 2.3 1.7 4.8 0.9 0.8 2.7 0.3 4.3 0.1 26.2 0.8 0.8 1.5 0.2 4.2 7.0 4.3 6.3 1.7 4.6 1.3 0.4 1.6 1.5 1.4 1.0 0.2 7.3 13.2 1.0 0.4 1.3 0.0 1.6 0.6 0.4 1.0 1.2 1.5 3.4 10.9 3.2 2.4 0.4 1.8 2.2 0.9 0.7 0.7 0.1 1.0 0.8 2.0 0.5 0.6 0.5 0.4 2.3 2.4 4.0 0.4 9.6 0.4 0.1 2.1 3.9 1.0 1.4 5.8 3.8 1.3 0.6 1.0 1.5 2.8 4.9 4.8 0.9 0.7 0.9 0.4 1.1 2.2 2.0 1.3 0.6 2.3 1.6 1.0 4.4 0.8 0.6 1.7 2.7 0.3 11.2 17.7 9.8 17.5 13.0 11.8 16.6 3.3 16.7 12.4 6.0 4.0 21.4 2.2 16.1 4.2 7.0 7.6 8.1 9.1 0.0 3.9 1.5 0.0 0.9 1.6 140.0 1.1 70.0 0.4 1.1 8.4 3.7 7.0 1.6 5.1 3.2 3.5 65.7 14.5 1.1 4.0 5.7 27.0 3.6 4.7 64.4 0.8 0.0 0.4 0.3 3.3 109.9 101.3 3.2 0.7 13.6 0.8 20.8 6.3 2.8 AQP10 ENSG00000143595 "Aquaporin 10" Q96PS8 1 154321090-154325325 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "intestine: 59.9" "Group enriched" "Detected in some" 7 "Cholangiocytes: 2.5;granulocytes: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 16.0;HMC-1: 6.7;K-562: 18.3;SH-SY5Y: 4.4" "Low region specificity" "Detected in many" "HPA062621, HPA065947" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA062621: , HPA065947: AB_2685584" "unprognostic (6.84e-2)" "unprognostic (4.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.87e-1)" "unprognostic (1.09e-1)" "unprognostic (8.45e-4)" "unprognostic (1.63e-1)" "unprognostic (3.07e-1)" "unprognostic (4.08e-2)" "unprognostic (3.99e-1)" "unprognostic (1.22e-1)" "unprognostic (1.43e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-1)" "unprognostic (7.64e-3)" 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 36.0 0.0 0.0 37.2 0.2 0.3 0.1 4.3 0.5 0.7 0.4 0.0 0.0 0.1 2.2 0.4 0.1 0.0 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 59.9 0.0 0.0 2.7 0.3 1.3 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.9 0.1 0.0 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 6.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 7.6 0.0 0.2 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.0 AQP3 GIL ENSG00000165272 "Aquaporin 3 (Gill blood group)" Q92482 9 33441154-33447633 "Blood group antigen proteins, Plasma proteins, Predicted membrane proteins" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 179.6;lymphoid tissue: 156.1;salivary gland: 194.2;tongue: 132.4" "Group enriched" "Detected in many" 6 "Basal glandular cells: 608.6;Basal keratinocytes: 1708.5;Collecting duct cells: 1526.7;Glandular cells: 959.6;Suprabasal keratinocytes: 2172.4;Urothelial cells: 2008.6" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in some" 5 "hippocampal formation: 2.1;pons and medulla: 6.7" "Group enriched" "Detected in many" 6 "MAIT T-cell: 41.1;memory CD4 T-cell: 39.2;memory CD8 T-cell: 12.0;naive CD4 T-cell: 22.7;naive CD8 T-cell: 10.8;T-reg: 42.1" "Lineage enriched" "Detected in many" 16 "T-cells: 42.1" "Cell line enhanced" "Detected in many" "HaCaT: 28.1;HeLa: 51.2;JURKAT: 28.8;RT4: 47.6;SK-BR-3: 32.9;U-266/70: 34.1;U-266/84: 44.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA014924 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014924: AB_2669120" "unprognostic (4.29e-2)" "prognostic favorable (5.31e-4)" "unprognostic (1.15e-1)" "unprognostic (3.26e-2)" "unprognostic (1.84e-2)" "unprognostic (1.11e-2)" "unprognostic (9.95e-2)" "unprognostic (1.64e-1)" "unprognostic (3.46e-1)" "unprognostic (9.06e-2)" "unprognostic (4.87e-2)" "unprognostic (1.25e-1)" "unprognostic (1.54e-2)" "unprognostic (1.16e-2)" "unprognostic (2.59e-1)" "unprognostic (3.73e-2)" "unprognostic (4.51e-2)" 1.3 0.4 0.4 2.7 0.2 1.9 5.2 0.9 0.3 29.7 26.7 0.1 1.7 9.9 5.5 3.2 179.6 3.3 2.0 6.0 2.1 0.4 23.9 44.0 16.5 5.7 0.5 0.3 3.6 5.7 0.0 0.7 5.3 6.7 15.5 1.2 0.4 194.2 5.5 0.9 65.2 33.2 5.1 0.3 17.2 3.9 1.2 0.0 70.6 0.6 132.4 156.1 37.6 60.2 2.6 2.4 0.5 0.1 0.5 42.1 10.3 0.1 8.4 0.4 0.0 15.6 2.8 0.2 0.0 0.2 0.2 0.2 4.4 2.6 0.1 2.0 0.0 0.1 28.1 1.3 0.1 0.0 13.4 1.3 0.9 51.2 0.4 0.0 0.2 0.3 0.4 1.4 0.1 0.0 0.0 0.1 28.8 14.3 13.0 1.5 6.2 12.8 5.0 1.1 19.2 0.1 0.2 21.3 2.3 0.2 47.6 0.4 1.1 7.1 32.9 0.0 1.9 0.2 2.2 0.2 0.0 0.2 0.0 0.0 34.1 44.2 3.2 0.1 0.0 0.0 0.3 0.1 0.0 4.5 0.0 41.1 2.6 39.2 12.0 0.0 0.5 22.7 10.8 0.5 0.5 0.1 2.4 42.1 10.3 0.4 0.2 0.9 0.3 2.1 0.4 0.5 0.3 6.7 0.0 35.7 265.4 2.2 608.6 1708.5 1.4 2.1 104.4 136.5 215.0 1526.7 2.0 0.6 0.0 27.2 1.3 40.5 4.2 93.5 41.7 1.3 46.3 959.6 19.7 111.7 2.2 0.0 7.9 16.0 3.8 0.0 30.8 32.1 150.1 1.0 63.7 0.3 32.0 2.9 1.1 28.8 0.4 0.0 42.2 0.0 1.0 2172.4 42.0 43.3 3.5 2008.6 AQP4 MIWC ENSG00000171885 "Aquaporin 4" P55087 18 26852038-26865818 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 185.1;lung: 53.5" "Cell type enriched" "Detected in some" 4 "Alveolar cells type 1: 1024.3" "Cancer enriched" "Detected in some" 22 "glioma: 223.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 6.9;Karpas-707: 2.0;RPTEC TERT1: 3.9;SCLC-21H: 1.3;U-87 MG: 1.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005079, HPA014784, CAB058689" Enhanced Supported Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967" "unprognostic (7.23e-5)" "unprognostic (1.55e-1)" "unprognostic (3.19e-8)" "unprognostic (3.68e-1)" "unprognostic (1.96e-1)" "unprognostic (2.69e-2)" "unprognostic (1.74e-1)" "unprognostic (2.34e-1)" "unprognostic (5.38e-3)" "unprognostic (1.64e-3)" "unprognostic (8.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.14e-2)" "unprognostic (1.35e-1)" "unprognostic (4.10e-2)" 1.7 1.7 60.7 1.6 57.1 1.6 1.8 21.8 185.1 1.9 1.6 41.3 0.0 1.6 1.6 2.0 1.9 2.1 1.6 2.7 64.3 27.1 2.7 2.0 53.5 1.7 39.8 36.4 2.8 1.7 2.9 0.8 1.6 39.1 1.8 1.6 0.0 1.8 1.7 25.4 1.6 1.6 1.6 67.2 1.8 6.1 1.7 42.2 0.0 8.4 0.1 1.6 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.5 0.2 0.9 0.0 0.0 0.0 0.0 0.0 3.9 0.0 1.3 0.3 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.7 57.1 21.8 31.7 64.3 27.1 39.8 36.4 39.1 42.2 1024.3 245.1 0.0 0.6 0.0 2.1 8.5 0.0 37.5 138.8 3.5 5.9 0.0 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 3.5 0.5 0.0 1.6 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 224.7 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.6 ARF1 ENSG00000143761 "ADP ribosylation factor 1" P84077 1 228082660-228099212 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB007742 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB007742: AB_562043" "unprognostic (9.54e-2)" "unprognostic (1.35e-2)" "unprognostic (2.30e-2)" "unprognostic (2.50e-3)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.55e-4)" "unprognostic (4.65e-2)" "unprognostic (1.78e-1)" "unprognostic (3.73e-1)" "unprognostic (8.95e-3)" "unprognostic (6.74e-2)" "unprognostic (2.96e-2)" "unprognostic (5.85e-2)" "unprognostic (2.69e-2)" "unprognostic (1.56e-1)" "unprognostic (8.57e-2)" "unprognostic (1.94e-1)" 72.0 70.1 64.8 51.0 82.5 111.1 59.3 50.0 116.9 76.0 76.7 53.5 63.6 73.6 71.1 63.3 81.1 66.8 58.5 101.1 70.3 65.9 81.7 135.9 77.4 55.6 52.7 56.5 73.5 109.2 64.9 79.7 129.6 61.4 70.1 55.7 67.8 106.7 68.6 96.5 57.5 91.6 54.7 45.9 81.5 66.0 73.0 33.8 75.6 102.9 60.5 76.5 72.6 57.6 37.4 73.3 111.7 70.0 41.5 64.7 110.7 64.1 44.4 36.5 36.2 42.2 53.4 60.7 56.9 61.0 63.3 55.6 52.5 61.8 32.7 61.2 60.6 29.5 41.6 44.7 55.7 31.8 48.1 71.3 31.8 31.3 52.2 81.7 45.9 47.5 51.0 68.0 58.3 61.5 54.0 62.4 37.4 60.9 75.1 60.9 46.2 46.6 68.0 46.8 90.7 90.9 37.8 32.3 101.9 44.7 33.3 51.6 45.6 36.7 111.5 63.4 13.2 76.6 93.4 55.8 46.6 37.0 67.7 85.3 71.0 39.6 44.9 64.1 39.2 93.9 104.5 70.0 77.2 53.1 66.5 64.7 37.4 45.7 49.1 54.5 34.9 36.2 39.4 111.7 41.5 63.0 73.3 51.8 110.7 64.8 82.5 50.0 116.9 70.3 65.9 52.7 56.5 61.4 33.8 160.8 159.4 184.0 242.8 233.2 114.0 114.2 104.4 214.2 168.4 109.9 43.2 328.6 195.6 344.6 194.6 176.5 349.6 46.7 355.5 480.3 217.0 287.7 192.9 110.7 362.5 149.4 220.8 138.7 177.0 322.5 212.3 230.8 285.1 408.4 315.0 144.2 328.8 293.4 213.6 122.7 61.1 226.4 208.9 174.2 166.0 249.9 565.9 208.8 250.8 292.8 ARHGAP24 "DKFZP564B1162, FilGAP, FLJ33877" ENSG00000138639 "Rho GTPase activating protein 24" Q8N264 4 85475114-86002670 "Predicted intracellular proteins" "Angiogenesis, Differentiation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 62.5" "Cell type enhanced" "Detected in many" 7 "B-cells: 105.7;Distal tubular cells: 192.3;Proximal tubular cells: 165.1;Syncytiotrophoblasts: 194.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 8.0;memory B-cell: 23.1;naive B-cell: 18.4;plasmacytoid DC: 6.5" "Group enriched" "Detected in many" 4 "B-cells: 23.1;dendritic cells: 6.5;monocytes: 8.0" "Cell line enhanced" "Detected in many" "ASC diff: 36.4;ASC TERT1: 22.1;HHSteC: 21.3;HUVEC TERT2: 39.2;RPTEC TERT1: 22.0;TIME: 27.6;U-138 MG: 19.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014288 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014288: AB_1844994" "unprognostic (2.19e-1)" "unprognostic (1.30e-1)" "unprognostic (1.14e-1)" "unprognostic (2.95e-2)" "unprognostic (2.81e-1)" "unprognostic (9.22e-2)" "unprognostic (5.75e-3)" "unprognostic (4.28e-3)" "unprognostic (3.66e-1)" "unprognostic (1.33e-1)" "unprognostic (5.91e-2)" "unprognostic (6.45e-2)" "prognostic favorable (1.67e-11)" "unprognostic (1.75e-2)" "unprognostic (6.86e-2)" "unprognostic (2.50e-2)" "unprognostic (8.75e-4)" 21.3 1.9 5.3 16.4 7.9 10.7 17.6 1.8 9.4 5.8 6.2 8.4 2.4 4.8 9.2 7.3 7.7 3.9 7.1 16.8 6.3 7.3 62.5 6.0 9.9 23.8 11.0 3.3 4.1 21.5 6.9 8.2 13.9 9.0 6.7 4.3 8.7 9.0 5.8 7.6 6.2 8.7 13.2 19.8 33.6 15.9 2.8 6.7 2.1 17.8 6.5 24.2 13.0 5.2 23.1 6.5 2.8 8.0 0.0 0.0 1.4 0.9 1.9 1.4 0.0 36.4 22.1 1.5 6.9 9.2 1.7 2.7 0.0 0.0 0.9 2.4 15.4 2.1 0.0 0.0 2.9 3.6 0.0 0.3 1.1 0.2 0.0 21.3 0.1 0.0 16.1 0.3 3.3 1.5 7.8 39.2 0.0 2.0 0.1 14.9 0.0 0.0 0.0 0.1 0.4 3.6 0.1 7.3 3.6 22.0 0.0 0.7 0.7 0.7 1.1 2.4 1.6 0.1 0.0 27.6 19.7 0.4 1.4 0.1 0.1 0.0 1.2 3.3 0.7 6.4 0.0 8.0 0.0 0.0 1.5 0.0 23.1 0.0 0.0 1.9 18.4 0.0 0.0 2.8 0.0 1.1 6.5 0.0 1.4 5.3 7.9 1.8 9.4 6.3 7.3 11.0 3.3 9.0 6.7 53.6 24.5 105.7 2.4 7.2 3.7 22.1 43.3 25.4 10.3 43.6 5.9 36.9 192.3 7.0 17.7 4.9 0.0 0.0 10.3 22.3 17.9 2.2 1.1 6.6 10.1 104.9 2.4 5.5 24.7 6.8 15.5 12.9 18.6 0.0 2.5 40.3 7.3 2.9 11.7 165.1 6.2 6.5 14.0 5.2 4.1 5.5 194.7 0.9 3.0 1.7 ARHGAP9 "10C, MGC1295" ENSG00000123329 "Rho GTPase activating protein 9" Q9BRR9 12 57472255-57488814 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 76.9;bone marrow: 48.1;lymphoid tissue: 50.4" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 56.4;Hofbauer cells: 36.3;Kupffer cells: 39.0;Macrophages: 34.2;T-cells: 110.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in all" "neutrophil: 76.9" "Lineage enriched" "Detected in all" 4 "granulocytes: 76.9" "Cell line enhanced" "Detected in some" "HEL: 11.2;HMC-1: 50.1;THP-1: 14.4;U-937: 11.4" "Low region specificity" "Detected in some" HPA078822 Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA078822: " "unprognostic (1.02e-2)" "unprognostic (4.01e-3)" "unprognostic (1.91e-2)" "prognostic favorable (6.61e-5)" "unprognostic (1.24e-1)" "unprognostic (2.38e-3)" "unprognostic (4.79e-2)" "unprognostic (5.56e-3)" "unprognostic (1.28e-2)" "unprognostic (2.80e-1)" "unprognostic (3.05e-2)" "unprognostic (3.64e-1)" "prognostic unfavorable (7.90e-9)" "unprognostic (1.60e-1)" "unprognostic (6.32e-2)" "unprognostic (9.13e-2)" "unprognostic (6.91e-2)" 5.1 2.5 5.1 33.0 8.0 48.1 4.4 3.7 4.8 1.8 5.4 2.5 0.5 3.6 1.6 1.7 2.7 4.4 4.8 2.4 4.2 1.8 3.5 3.8 11.2 24.1 8.1 0.6 1.2 2.2 0.3 1.5 2.3 5.8 2.5 5.1 2.4 6.0 1.3 0.9 1.4 18.6 2.6 8.5 50.4 3.9 8.8 6.4 19.0 2.6 3.2 28.5 4.7 2.2 8.9 18.9 76.9 17.0 13.1 13.3 11.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 5.9 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.3 0.0 11.2 0.0 0.0 0.4 6.5 50.1 0.3 0.0 0.0 0.1 0.0 0.0 5.9 0.2 3.3 0.0 0.0 8.9 8.9 0.4 0.0 0.0 3.7 4.3 1.8 0.0 0.0 1.6 1.4 0.0 0.0 0.1 0.2 0.0 14.4 0.3 0.0 0.1 0.0 0.0 4.0 2.7 5.4 0.1 11.4 0.2 8.4 16.6 45.1 9.0 17.0 6.2 7.1 9.9 8.1 13.9 8.9 13.3 9.6 76.9 13.1 12.8 18.9 12.1 11.8 5.1 8.0 3.7 4.8 4.2 1.8 8.1 0.6 5.8 6.4 0.0 23.5 22.6 0.0 1.3 0.0 1.2 0.0 4.0 2.3 0.0 2.0 0.3 0.0 0.0 56.4 1.8 0.0 0.0 0.0 0.4 1.3 0.2 11.5 1.1 36.3 0.0 0.0 4.3 39.0 28.4 1.7 34.2 0.0 10.0 0.0 0.0 0.2 0.0 0.0 0.3 0.7 0.0 0.5 28.8 8.5 1.3 0.2 110.8 0.1 0.1 ARHGDIG RHOGDI-3 ENSG00000242173 "Rho GDP dissociation inhibitor gamma" Q99819 16 268727-283010 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 60.4;intestine: 31.7;pancreas: 45.3" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 3.3;Exocrine glandular cells: 9.9;Pancreatic endocrine cells: 6.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 5.2;HEK 293: 18.8;MCF7: 24.2;SCLC-21H: 8.5;SH-SY5Y: 10.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA078260 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA078260: AB_2732375" "unprognostic (1.11e-2)" "unprognostic (5.69e-2)" "unprognostic (7.98e-2)" "unprognostic (2.66e-2)" "unprognostic (9.04e-2)" "unprognostic (2.13e-2)" "unprognostic (1.49e-1)" "unprognostic (2.75e-1)" "unprognostic (1.22e-1)" "unprognostic (1.44e-2)" "unprognostic (3.18e-1)" "unprognostic (2.94e-1)" "unprognostic (5.86e-6)" "unprognostic (2.81e-2)" "unprognostic (4.34e-1)" "unprognostic (2.15e-1)" "unprognostic (6.32e-2)" 3.7 3.1 37.3 1.8 15.6 1.0 1.1 43.3 60.4 1.0 1.8 3.7 0.0 31.7 1.1 2.3 1.1 1.0 0.9 3.6 29.0 27.4 1.0 0.9 1.0 1.0 21.2 21.4 1.0 45.3 0.9 1.7 2.4 12.7 1.1 1.2 0.6 1.3 1.3 2.0 0.9 12.0 1.3 8.6 1.0 9.3 2.0 2.0 0.0 0.9 0.0 1.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 2.0 0.0 0.6 0.1 0.3 0.0 0.3 0.0 0.3 0.1 0.0 0.7 0.4 0.0 0.1 5.2 0.0 0.0 0.0 18.8 0.0 0.3 0.1 0.5 0.0 0.1 0.2 0.0 0.0 0.0 0.9 0.2 0.0 1.2 0.2 0.0 24.2 0.0 0.3 2.6 1.3 0.0 0.0 0.0 0.4 0.0 0.0 8.5 10.5 0.1 0.1 0.0 0.3 1.8 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 37.3 15.6 43.3 43.8 29.0 27.4 21.2 21.4 12.7 2.0 0.0 0.0 0.0 0.0 0.3 3.3 0.8 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.1 0.4 0.0 1.3 0.0 9.9 0.2 0.4 0.0 0.0 0.0 0.4 0.0 1.2 1.3 0.0 0.2 0.3 0.0 0.0 0.0 0.3 0.9 6.4 0.3 0.0 0.0 2.7 0.0 0.2 0.2 2.5 0.0 0.3 0.0 0.9 0.0 ARHGEF1 "LBCL2, P115-RHOGEF, SUB1.5" ENSG00000076928 "Rho guanine nucleotide exchange factor 1" Q92888 19 41883161-41930150 "Plasma proteins, Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 61.0" "Cell type enhanced" "Detected in many" 8 "T-cells: 145.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009502, HPA012924, HPA060784" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009502: AB_667785, HPA012924: AB_1845000, HPA060784: AB_2684363" "prognostic favorable (5.92e-4)" "unprognostic (2.09e-1)" "unprognostic (8.29e-3)" "unprognostic (8.10e-3)" "unprognostic (7.63e-2)" "unprognostic (7.59e-3)" "unprognostic (4.99e-2)" "unprognostic (7.28e-2)" "unprognostic (5.88e-2)" "unprognostic (1.84e-2)" "unprognostic (6.59e-2)" "unprognostic (3.29e-3)" "prognostic unfavorable (3.36e-8)" "unprognostic (3.54e-1)" "unprognostic (1.95e-1)" "unprognostic (8.00e-2)" "unprognostic (4.65e-2)" 15.5 8.4 10.7 40.1 16.5 50.0 13.8 8.7 13.8 11.7 14.1 23.3 9.7 13.7 12.7 9.6 12.2 13.0 14.1 9.3 10.6 6.2 12.4 10.4 23.7 57.8 18.1 8.5 12.5 10.8 7.0 11.8 9.6 11.8 11.4 5.8 12.1 13.1 9.2 5.2 12.9 29.3 9.0 12.2 61.0 17.0 3.7 15.6 43.6 13.4 8.6 40.8 12.4 11.7 11.1 10.8 13.7 26.9 15.4 26.3 14.3 20.0 24.4 5.6 7.0 8.0 8.4 6.6 10.6 16.3 13.5 11.9 7.4 17.3 26.9 19.6 9.7 7.1 11.8 7.2 16.4 4.3 25.2 8.3 21.7 10.5 9.7 11.7 23.1 35.9 10.2 10.9 13.0 8.5 7.2 12.8 24.0 8.5 16.6 7.7 13.8 16.2 18.0 6.4 16.0 19.0 24.5 10.5 15.9 8.3 11.1 3.7 15.7 14.8 6.6 12.1 3.0 7.8 39.6 17.3 17.9 12.1 9.5 16.4 22.6 14.3 23.2 14.6 36.9 28.3 5.1 9.4 13.7 25.1 19.8 20.3 10.8 19.1 26.3 10.8 11.1 20.0 20.4 13.7 15.4 26.9 5.8 19.4 14.3 10.7 16.5 8.7 13.8 10.6 6.2 18.1 8.5 11.8 15.6 6.0 19.5 51.4 11.9 12.9 17.4 2.8 7.6 1.4 2.3 7.0 25.5 11.4 3.3 21.3 1.1 20.3 9.5 0.0 21.5 19.5 14.6 12.3 31.1 9.5 33.0 11.1 20.8 18.4 49.7 0.0 17.8 29.5 18.6 25.2 27.7 10.8 38.4 20.1 15.6 5.8 20.1 25.8 9.8 4.8 8.6 12.9 8.5 145.4 26.3 10.1 ARHGEF11 "GTRAP48, KIAA0380, PDZ-RHOGEF" ENSG00000132694 "Rho guanine nucleotide exchange factor 11" O15085 1 156934840-157045370 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Bipolar cells: 47.5;Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 54.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 3.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "WM-115: 37.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011026, HPA012037, HPA014658" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA011026: AB_1850426, HPA012037: AB_1850430, HPA014658: AB_1850428" "unprognostic (2.19e-1)" "unprognostic (9.10e-2)" "unprognostic (1.91e-1)" "unprognostic (2.17e-1)" "unprognostic (2.00e-1)" "unprognostic (4.94e-3)" "unprognostic (3.30e-2)" "unprognostic (9.40e-2)" "unprognostic (1.21e-1)" "unprognostic (1.58e-1)" "prognostic favorable (1.72e-4)" "unprognostic (3.38e-1)" "unprognostic (2.41e-2)" "unprognostic (5.11e-2)" "unprognostic (1.58e-1)" "unprognostic (1.08e-1)" "unprognostic (4.73e-2)" 11.9 13.0 17.5 11.6 13.4 4.3 12.3 28.8 22.4 12.3 13.2 9.2 22.0 14.4 14.7 11.9 13.1 12.2 14.3 13.2 13.6 16.0 10.9 7.6 12.7 8.0 13.9 13.7 15.6 11.0 31.7 15.4 12.3 13.1 11.4 12.9 14.5 9.3 25.1 14.7 11.2 23.3 15.2 9.1 9.8 11.9 20.9 9.9 1.0 14.9 5.3 6.3 13.2 12.6 0.4 0.9 3.3 2.8 0.0 1.0 0.7 7.0 14.0 12.0 9.1 16.0 8.3 13.7 7.0 10.5 11.0 8.1 9.4 7.5 0.9 12.3 12.3 8.4 7.7 8.1 7.3 6.1 10.1 5.0 3.5 8.3 6.1 9.3 7.1 12.5 12.7 8.0 10.1 7.9 8.3 7.9 3.1 5.7 0.6 7.3 9.2 1.8 3.9 14.9 11.2 8.6 0.2 5.9 3.9 5.4 11.6 2.3 13.7 15.1 12.2 12.8 10.9 10.9 16.2 11.8 11.3 7.2 9.9 7.2 10.1 6.2 0.7 7.2 0.9 37.4 0.0 1.4 0.0 0.0 2.8 0.0 0.4 0.6 0.0 0.9 0.0 0.6 1.0 3.3 0.0 1.5 0.0 0.3 0.7 17.5 13.4 28.8 22.4 13.6 16.0 13.9 13.7 13.1 9.9 3.0 3.4 0.8 2.3 1.0 47.5 11.8 0.0 1.4 2.3 1.8 88.4 1.5 1.7 1.0 5.3 3.5 14.6 0.0 1.4 0.5 3.0 3.2 9.2 4.9 3.6 20.6 5.2 2.5 7.5 6.7 4.4 4.0 1.7 0.0 4.0 12.3 1.1 5.1 4.2 0.8 54.7 0.0 4.1 3.0 4.8 1.8 1.3 0.0 3.9 2.2 ARHGEF40 "FLJ10357, solo" ENSG00000165801 "Rho guanine nucleotide exchange factor 40" Q8TER5 14 21070270-21090240 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 58.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 2.8;neutrophil: 9.2" "Lineage enriched" "Detected in many" 7 "granulocytes: 9.2" "Cell line enhanced" "Detected in many" "AF22: 17.4;ASC TERT1: 22.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030745, HPA030746, HPA030757" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA030745: , HPA030746: AB_10599613, HPA030757: AB_10600203" "unprognostic (6.30e-2)" "unprognostic (1.94e-1)" "unprognostic (2.36e-1)" "unprognostic (5.91e-2)" "unprognostic (2.55e-1)" "unprognostic (8.16e-3)" "unprognostic (1.27e-2)" "unprognostic (9.84e-3)" "unprognostic (1.33e-1)" "unprognostic (8.80e-2)" "unprognostic (1.64e-2)" "unprognostic (2.53e-1)" "unprognostic (6.01e-3)" "unprognostic (1.14e-2)" "unprognostic (1.38e-2)" "unprognostic (2.33e-1)" "unprognostic (8.95e-2)" 15.7 32.9 9.3 7.4 9.2 1.7 12.4 16.5 8.2 16.2 8.2 11.4 30.9 3.5 13.6 12.6 5.9 9.3 20.2 7.8 10.2 4.6 7.2 16.9 9.3 4.2 12.6 4.5 15.7 16.6 17.7 6.6 6.3 9.1 9.8 6.3 10.3 20.1 30.0 6.5 4.9 5.2 11.2 10.5 19.5 6.4 4.7 10.8 1.3 11.0 4.9 2.5 8.6 9.6 0.0 1.0 9.2 1.3 0.1 0.0 0.5 1.6 1.5 17.4 3.1 14.8 22.3 0.6 5.8 15.7 6.8 5.3 0.7 4.1 0.0 0.9 11.5 6.9 2.5 1.5 2.0 2.6 3.2 0.6 2.3 1.7 4.7 2.0 1.5 8.6 9.0 1.4 5.9 1.8 13.4 0.0 0.0 0.7 0.7 5.5 0.2 0.0 4.8 3.9 0.3 0.3 0.5 11.5 0.7 4.4 2.1 0.4 6.0 3.2 0.3 4.7 3.6 1.5 5.1 2.8 14.1 9.2 6.2 2.7 1.4 0.0 0.0 4.8 2.1 3.8 0.0 1.3 2.8 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 9.2 0.1 0.0 0.0 0.0 0.5 9.3 9.2 16.5 8.2 10.2 4.6 12.6 4.5 9.1 10.8 6.0 5.3 0.9 6.7 4.2 8.1 10.6 58.6 0.0 2.3 14.0 0.0 0.9 16.6 18.1 0.8 9.0 1.7 0.0 8.9 0.7 16.6 2.0 36.9 26.9 12.7 4.8 7.5 6.7 26.9 2.0 22.5 16.1 21.9 3.6 8.7 33.2 12.1 0.0 22.6 6.0 6.8 25.8 24.2 2.6 2.5 3.9 1.0 1.9 20.0 4.9 ARID2 "BAF200, DKFZp686G052, FLJ30619, KIAA1557" ENSG00000189079 "AT-rich interaction domain 2" Q68CP9 12 45729665-45908040 "Cancer-related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "Early spermatids: 522.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063044 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA063044: AB_2684929" "unprognostic (8.41e-2)" "unprognostic (1.03e-1)" "unprognostic (4.02e-2)" "unprognostic (3.94e-2)" "unprognostic (4.15e-2)" "prognostic favorable (5.75e-4)" "unprognostic (1.26e-2)" "unprognostic (9.71e-2)" "unprognostic (9.04e-2)" "unprognostic (5.57e-2)" "unprognostic (1.34e-1)" "unprognostic (2.47e-1)" "unprognostic (1.12e-2)" "unprognostic (9.21e-2)" "unprognostic (3.02e-1)" "unprognostic (2.00e-1)" "unprognostic (6.53e-2)" 9.0 7.9 7.1 14.6 7.2 14.0 11.8 15.7 8.8 10.2 11.4 8.2 17.9 6.4 12.2 10.7 11.5 8.8 10.6 8.2 7.4 5.8 8.7 6.9 10.2 13.0 9.6 3.8 12.2 10.7 18.4 15.1 10.3 7.5 9.9 8.1 10.1 9.7 20.6 8.6 13.5 12.6 12.5 7.3 10.2 9.0 30.9 11.0 33.3 11.5 8.2 11.2 10.0 10.0 2.1 5.3 10.5 4.9 3.1 4.4 1.3 5.4 7.8 14.0 6.1 6.0 4.2 7.6 3.8 5.4 5.3 5.0 11.1 5.6 10.5 7.1 5.2 3.9 6.6 11.3 6.5 7.7 4.6 5.4 13.9 8.6 5.4 4.1 10.9 6.4 3.4 4.9 6.7 10.8 7.5 5.4 15.9 11.7 10.9 4.7 7.1 15.6 7.8 8.4 0.0 4.2 12.1 10.0 10.1 5.1 9.1 7.6 9.7 6.2 7.2 6.0 8.4 11.0 21.9 6.4 5.7 6.9 3.8 4.9 7.3 6.1 29.4 4.4 28.8 4.0 10.5 1.7 4.2 4.1 2.2 4.3 1.7 3.7 4.4 2.4 2.1 3.6 3.3 2.4 3.1 4.9 5.3 3.1 1.3 7.1 7.2 15.7 8.8 7.4 5.8 9.6 3.8 7.5 11.0 26.8 27.9 10.2 11.5 30.0 49.0 12.6 5.1 9.4 12.5 27.9 64.8 11.9 6.6 11.2 522.0 21.5 15.0 0.0 8.7 8.9 17.5 17.9 20.9 13.1 9.9 30.2 20.2 16.5 27.5 122.6 23.0 20.0 13.5 12.6 19.9 19.7 15.6 24.6 21.2 6.9 67.9 25.8 22.7 61.7 16.5 36.1 19.6 24.5 16.0 16.5 ARL4C "ARL7, LAK" ENSG00000188042 "ADP ribosylation factor like GTPase 4C" P56559 2 234493041-234497053 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.7" "Cell type enhanced" "Detected in many" 6 "Bipolar cells: 168.9;Kupffer cells: 128.2;T-cells: 193.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 38.6;RPTEC TERT1: 72.9;U-2197: 39.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028927 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA028927: AB_10602387" "unprognostic (1.93e-1)" "unprognostic (1.14e-1)" "unprognostic (3.20e-3)" "prognostic unfavorable (2.90e-7)" "unprognostic (8.01e-3)" "unprognostic (3.35e-2)" "unprognostic (9.26e-2)" "unprognostic (2.68e-2)" "unprognostic (2.10e-1)" "unprognostic (4.34e-2)" "unprognostic (3.17e-3)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.69e-8)" "unprognostic (8.57e-2)" "unprognostic (4.64e-2)" "unprognostic (1.20e-1)" "prognostic unfavorable (6.99e-5)" 9.3 6.8 11.1 17.7 9.6 30.3 12.8 19.2 21.2 6.4 6.2 4.9 3.1 3.9 3.6 9.4 13.9 7.6 19.2 3.6 9.1 16.5 8.5 7.9 9.9 28.9 9.4 11.8 2.6 3.6 0.8 5.4 16.8 23.9 6.7 7.4 5.9 14.2 3.6 1.7 15.1 8.1 3.6 5.3 28.0 7.9 1.9 1.8 44.7 2.5 4.4 20.1 14.0 10.8 5.9 17.8 18.7 0.5 18.2 29.7 8.7 7.2 22.5 2.9 0.3 2.6 0.8 7.5 0.7 3.4 0.9 1.6 10.4 14.3 0.0 1.9 1.9 27.4 5.5 2.9 15.6 1.0 6.7 1.0 0.0 0.1 0.1 2.7 0.0 0.6 1.6 10.4 8.8 5.4 38.6 1.5 19.2 0.0 24.2 4.1 1.0 21.0 0.0 3.0 5.4 5.1 0.0 13.0 4.1 72.9 8.1 10.6 1.9 0.2 1.7 1.1 4.8 0.2 0.4 3.3 14.6 5.6 39.9 14.0 12.1 4.4 0.3 25.1 0.0 7.6 18.7 0.4 8.4 29.7 0.5 29.2 5.9 20.7 23.5 3.2 5.7 18.7 20.9 0.7 18.2 0.2 17.8 25.8 8.7 11.1 9.6 19.2 21.2 9.1 16.5 9.4 11.8 23.9 1.8 68.5 22.3 38.9 97.5 110.8 168.9 8.1 50.9 6.7 44.3 14.0 7.9 25.6 0.0 15.7 7.5 16.9 0.2 0.0 4.9 3.3 28.8 51.3 25.6 3.0 29.0 101.7 1.7 9.8 128.2 4.2 0.3 83.9 40.5 43.3 0.0 30.9 11.5 0.0 0.0 1.0 10.8 0.0 16.0 0.4 0.8 37.5 12.2 193.9 0.4 46.5 ARMC12 "C6orf81, FLJ25390" ENSG00000157343 "Armadillo repeat containing 12" Q5T9G4 6 35737032-35749079 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 60.2" "Group enriched" "Detected in some" 65 "Early spermatids: 374.1;Late spermatids: 785.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2;plasmacytoid DC: 2.9" "Group enriched" "Detected in many" 11 "dendritic cells: 2.9;monocytes: 1.0;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC diff: 7.3;HSkMC: 9.7;MOLT-4: 6.6;U-698: 7.2" "Not detected" "Not detected" "HPA030895, HPA075457, HPA075777" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA030895: AB_10602114, HPA075457: , HPA075777: " "unprognostic (1.94e-4)" "unprognostic (2.21e-1)" "unprognostic (3.24e-1)" "unprognostic (1.32e-2)" "unprognostic (2.34e-1)" "unprognostic (1.19e-1)" "unprognostic (2.52e-1)" "unprognostic (2.12e-1)" "unprognostic (4.48e-1)" "unprognostic (3.52e-2)" "unprognostic (6.36e-4)" "unprognostic (8.99e-2)" "unprognostic (1.17e-12)" "unprognostic (6.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.49e-1)" "unprognostic (2.09e-1)" 0.5 0.4 0.9 0.5 1.2 0.7 0.7 0.5 0.9 0.6 0.5 0.5 0.5 0.0 0.5 5.8 0.5 0.6 0.8 0.5 0.7 0.9 0.5 1.4 0.5 1.1 0.7 0.5 1.0 0.5 0.1 4.8 0.5 0.5 1.1 0.3 0.6 0.5 1.0 0.5 0.5 0.5 0.6 0.5 0.8 0.1 60.2 0.5 0.5 0.7 0.5 0.6 0.5 0.5 0.1 2.9 0.0 1.0 0.2 3.2 0.4 0.0 0.5 3.2 3.8 7.3 3.4 0.0 0.1 0.2 0.3 0.4 0.1 0.2 0.7 0.1 0.1 1.1 0.1 1.1 0.2 0.2 1.6 0.9 0.4 0.1 0.1 3.8 0.0 0.0 9.7 2.3 0.1 1.3 3.7 0.7 2.8 0.1 4.5 1.1 0.4 6.6 0.8 0.5 0.0 0.2 3.0 0.0 0.0 0.8 0.0 0.9 3.2 0.0 0.0 0.5 1.5 2.0 0.3 0.0 0.6 0.3 0.1 0.0 1.0 0.3 7.2 0.3 4.0 0.3 0.0 1.0 0.0 0.1 0.0 1.2 0.0 1.2 0.5 0.7 0.1 0.7 3.2 0.0 0.2 0.1 2.9 0.0 0.4 0.9 1.2 0.5 0.6 0.7 0.9 0.7 0.5 0.5 0.5 0.0 0.0 0.0 1.7 0.8 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 374.1 0.6 0.0 0.0 0.0 0.0 0.4 0.5 0.0 2.4 0.0 0.0 0.0 0.0 1.6 785.6 7.8 0.0 0.0 0.0 0.1 0.8 0.0 0.0 3.9 0.1 0.1 0.0 0.5 8.9 5.4 0.1 0.0 0.0 0.0 0.3 ARRDC4 FLJ36045 ENSG00000140450 "Arrestin domain containing 4" Q8NCT1 15 97960698-97973838 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 67.3" "Cell type enhanced" "Detected in many" 4 "Paneth cells: 45.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basophil: 2.3;classical monocyte: 5.1;eosinophil: 3.1;intermediate monocyte: 3.6;myeloid DC: 2.4;neutrophil: 3.0" "Group enriched" "Detected in many" 7 "dendritic cells: 2.4;granulocytes: 3.1;monocytes: 5.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 19.1;BJ: 39.3;HSkMC: 22.2;hTCEpi: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039934, HPA042109" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA039934: , HPA042109: AB_10795606" "unprognostic (2.13e-1)" "unprognostic (1.10e-1)" "unprognostic (2.32e-1)" "unprognostic (5.60e-3)" "unprognostic (4.49e-3)" "unprognostic (8.23e-2)" "unprognostic (1.16e-2)" "unprognostic (2.78e-1)" "unprognostic (7.65e-2)" "unprognostic (1.10e-1)" "unprognostic (1.01e-2)" "unprognostic (1.42e-2)" "unprognostic (2.02e-3)" "unprognostic (2.90e-2)" "unprognostic (1.65e-1)" "unprognostic (3.04e-2)" "unprognostic (6.77e-2)" 9.2 9.3 11.4 11.5 18.4 6.7 14.8 3.3 16.3 9.4 27.4 67.3 11.6 11.2 10.7 11.9 11.8 10.8 14.7 9.7 18.7 9.2 14.1 21.8 14.1 6.4 18.1 15.2 7.4 25.0 3.7 6.5 13.0 29.4 8.3 17.0 4.6 6.5 13.5 10.1 25.3 15.3 14.0 48.7 5.9 18.1 10.2 41.9 1.9 14.9 4.5 3.5 11.7 12.4 0.5 2.4 3.1 5.1 0.1 0.1 0.8 2.1 0.0 0.3 5.8 2.6 19.1 0.0 39.3 17.6 5.2 2.3 2.3 1.4 0.0 5.5 1.8 0.5 2.3 1.4 13.7 8.5 0.0 3.6 3.7 0.7 1.5 1.0 2.5 5.9 22.2 33.9 6.0 7.0 7.4 0.2 1.1 5.3 0.0 1.8 7.1 0.4 2.1 1.1 6.5 0.8 0.0 0.3 0.0 10.2 4.8 1.9 3.4 5.9 2.2 10.6 1.2 0.8 3.9 0.0 1.6 1.1 8.2 1.8 0.0 0.0 0.0 3.4 0.4 4.0 2.3 5.1 3.1 0.1 3.6 0.0 0.5 0.0 0.0 2.4 0.4 0.1 0.0 3.0 0.1 0.6 0.6 0.0 0.8 11.4 18.4 3.3 16.3 18.7 9.2 18.1 15.2 29.4 41.9 3.0 7.2 3.2 2.6 22.6 1.6 12.6 15.3 9.4 3.4 21.0 5.9 0.2 6.6 2.4 3.3 5.0 36.0 0.0 7.2 0.1 13.0 10.0 23.1 14.1 18.0 0.0 36.8 6.2 31.5 6.7 4.6 17.3 23.6 0.0 21.7 0.5 8.8 45.6 7.8 1.3 3.1 0.0 16.4 1.4 5.9 27.1 0.6 1.3 20.3 5.9 ARVCF ENSG00000099889 "ARVCF, delta catenin family member" O00192 22 19969896-20016808 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 30.8" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 21.6;Muller glia cells: 18.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "K-562: 15.7;SCLC-21H: 15.0;SH-SY5Y: 11.5;U-2 OS: 13.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016162, HPA055264, HPA063675" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB016162: AB_2058690, HPA055264: AB_2682766, HPA063675: AB_2685085" "unprognostic (1.66e-1)" "unprognostic (1.48e-2)" "unprognostic (4.00e-2)" "unprognostic (4.28e-2)" "unprognostic (3.35e-1)" "unprognostic (3.18e-2)" "unprognostic (4.79e-3)" "unprognostic (1.67e-2)" "unprognostic (2.06e-2)" "unprognostic (1.71e-2)" "unprognostic (2.09e-3)" "unprognostic (5.77e-2)" "unprognostic (4.00e-3)" "unprognostic (9.84e-2)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "prognostic favorable (5.76e-6)" 3.4 6.6 9.0 1.8 6.1 6.0 3.2 30.8 11.1 3.4 3.2 7.7 3.5 2.7 4.2 14.6 3.1 2.6 8.0 6.2 8.1 8.1 5.0 4.9 3.9 1.4 3.8 6.8 2.9 8.7 4.9 7.3 2.7 5.9 6.1 1.1 6.4 8.7 4.6 13.4 5.3 3.7 3.6 4.0 13.4 5.2 5.2 2.8 0.5 12.1 1.6 1.5 2.8 1.8 0.0 0.6 0.0 0.2 0.7 1.2 0.8 3.3 0.3 4.5 5.9 0.0 0.0 4.7 0.8 0.3 0.2 0.5 0.9 0.7 1.4 3.7 0.4 0.4 3.1 0.7 1.4 0.0 0.4 5.6 0.4 0.3 3.5 1.3 0.5 1.1 0.1 0.6 0.2 0.2 0.3 3.7 1.0 15.7 0.4 0.0 3.0 0.2 2.1 4.6 1.0 1.8 8.3 0.2 0.4 0.8 0.7 15.0 11.5 0.9 1.4 2.2 0.8 1.2 0.4 1.3 0.1 13.1 0.5 0.3 1.8 0.5 0.4 0.2 0.2 0.2 0.0 0.2 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.4 1.2 0.0 0.7 0.0 0.6 0.0 0.8 9.0 6.1 30.8 8.9 8.1 8.1 3.8 6.8 5.9 2.8 3.0 1.6 0.0 2.6 1.8 8.5 5.0 5.1 1.4 0.0 1.8 21.6 3.8 0.0 7.0 2.1 1.6 1.2 0.0 4.6 1.7 1.9 4.2 0.0 3.2 1.2 4.8 8.6 4.3 1.0 1.3 3.7 0.9 3.3 0.0 6.2 18.8 9.7 0.0 3.2 5.0 7.6 0.0 3.1 2.2 9.2 1.6 3.7 0.0 1.8 0.9 ASGR2 CLEC4H2 ENSG00000161944 "Asialoglycoprotein receptor 2" P07307 17 7101322-7115700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "liver: 154.1" "Cell type enriched" "Detected in some" 4 "Hepatocytes: 660.0" "Cancer enriched" "Detected in many" 66 "liver cancer: 214.2" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "classical monocyte: 36.9;myeloid DC: 21.7" "Group enriched" "Detected in many" 52 "dendritic cells: 21.7;monocytes: 36.9" "Cell line enriched" "Detected in some" 8 "Hep G2: 107.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014899, HPA015998" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA 4700000 "Endoplasmic reticulum, Plasma membrane" "HPA014899: AB_1845085, HPA015998: AB_1845084" "unprognostic (6.76e-2)" "unprognostic (7.45e-7)" "unprognostic (1.61e-1)" "unprognostic (2.55e-2)" "unprognostic (1.03e-2)" "unprognostic (4.99e-2)" "unprognostic (1.16e-3)" "unprognostic (1.32e-1)" "unprognostic (1.81e-1)" "unprognostic (9.74e-2)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (9.35e-4)" "unprognostic (1.54e-3)" "unprognostic (6.95e-2)" "unprognostic (1.86e-1)" "unprognostic (7.31e-2)" 0.2 0.0 0.3 1.4 0.1 1.0 0.1 0.1 0.2 0.1 0.1 0.0 0.0 0.0 0.1 0.5 0.1 0.1 3.4 0.2 0.2 0.0 0.2 154.1 0.5 4.1 0.1 0.1 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.2 0.9 0.1 0.1 0.1 1.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.2 0.0 21.7 0.5 36.9 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 107.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 36.9 0.2 0.0 3.8 0.0 0.0 0.0 0.0 21.7 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.1 9.5 0.3 0.1 0.1 0.2 0.2 0.0 0.1 0.1 0.2 0.1 0.0 9.0 14.0 0.0 0.0 0.0 0.0 152.8 0.0 0.0 0.0 0.0 0.1 1.7 0.0 0.3 0.0 0.0 23.3 0.0 0.1 0.0 0.1 2.3 660.0 6.9 0.0 6.8 16.0 35.5 0.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.3 0.3 1.5 0.0 0.0 ASH2L "ASH2, ASH2L1, ASH2L2, Bre2" ENSG00000129691 "ASH2 like histone lysine methyltransferase complex subunit" Q9UBL3 8 38105242-38144076 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 65.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042289 Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "HPA042289: AB_10795608" "unprognostic (9.39e-2)" "unprognostic (5.58e-3)" "unprognostic (2.67e-3)" "unprognostic (5.40e-3)" "unprognostic (2.87e-1)" "unprognostic (2.66e-2)" "unprognostic (4.04e-1)" "unprognostic (9.15e-2)" "unprognostic (1.30e-1)" "unprognostic (1.12e-1)" "unprognostic (5.10e-2)" "unprognostic (9.73e-3)" "prognostic favorable (4.25e-4)" "unprognostic (9.95e-2)" "unprognostic (1.27e-1)" "unprognostic (7.69e-3)" "unprognostic (2.54e-1)" 22.3 17.0 24.2 16.7 26.7 24.0 19.7 26.1 28.2 20.9 20.0 21.9 14.7 14.5 20.8 16.1 21.6 18.2 19.6 20.6 21.0 23.4 21.0 20.6 16.0 21.4 20.3 26.8 24.1 30.1 28.3 13.9 24.3 23.1 19.4 20.9 16.0 18.1 20.0 31.8 18.8 23.0 21.8 20.1 20.3 18.8 41.7 16.0 36.2 19.5 15.3 24.1 20.1 17.4 12.6 17.0 33.9 16.6 16.6 13.2 11.4 14.1 7.5 12.6 12.6 9.1 11.4 16.2 14.4 15.2 18.2 16.1 8.0 6.4 16.0 12.3 12.1 9.1 8.5 16.2 8.1 17.3 6.2 7.3 65.0 8.0 16.9 13.2 10.5 13.2 9.8 7.7 8.4 9.4 9.2 14.2 15.0 43.5 12.4 17.7 8.2 27.7 13.1 16.4 12.6 4.8 11.5 14.0 6.9 9.4 10.7 5.8 10.4 10.7 7.0 11.6 13.1 8.5 12.3 11.1 11.3 11.4 16.0 11.4 11.8 14.8 14.2 11.5 13.7 15.5 18.2 13.9 33.9 11.1 16.6 11.8 12.5 12.5 13.1 17.0 12.6 13.2 12.1 11.8 16.6 15.0 9.7 13.0 11.4 24.2 26.7 26.1 28.2 21.0 23.4 20.3 26.8 23.1 16.0 11.9 18.6 12.7 7.9 6.2 12.1 15.3 10.2 25.4 17.0 12.2 9.8 31.2 6.6 17.1 6.6 11.3 10.6 0.0 25.1 31.4 12.7 5.3 18.5 10.2 20.4 6.4 10.4 13.5 18.9 11.2 21.6 14.8 21.9 29.7 10.5 14.8 16.9 7.0 19.4 13.2 14.9 12.9 9.5 30.1 32.2 5.9 25.9 15.0 11.4 6.5 ASIC1 "ACCN2, BNaC2, hBNaC2" ENSG00000110881 "Acid sensing ion channel subunit 1" P78348 12 50057548-50083611 "FDA approved drug targets, Predicted membrane proteins" "Calcium transport, Ion transport, Sodium transport, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 43.7" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 3.1;Ciliated cells: 6.7;Club cells: 2.3;Horizontal cells: 3.2" "Cancer enhanced" "Detected in many" "glioma: 12.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 23.0;SH-SY5Y: 17.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA058870 Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA058870: AB_2683841" "unprognostic (5.32e-3)" "unprognostic (1.70e-1)" "unprognostic (4.00e-2)" "unprognostic (3.56e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-3)" "unprognostic (2.92e-3)" "unprognostic (3.00e-2)" "unprognostic (1.72e-1)" "unprognostic (9.37e-2)" "unprognostic (2.34e-2)" "unprognostic (2.86e-3)" "unprognostic (6.97e-7)" "unprognostic (7.19e-2)" "unprognostic (3.73e-1)" "unprognostic (2.78e-3)" "unprognostic (8.27e-5)" 2.5 1.7 13.9 1.8 20.3 0.8 2.9 20.1 43.7 5.3 3.1 12.8 0.3 2.3 2.5 1.2 3.4 3.6 4.0 2.2 12.3 14.3 1.6 0.9 1.3 1.3 12.9 8.5 1.4 1.4 5.2 0.5 1.5 10.2 4.5 2.5 1.8 5.6 3.4 1.3 1.5 2.5 3.6 5.4 1.1 4.3 1.4 11.0 0.4 1.1 0.0 1.0 2.6 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 1.9 4.3 5.7 12.9 1.7 2.7 3.2 1.4 3.7 2.5 2.5 3.0 1.5 1.2 3.0 0.8 1.5 2.0 5.6 4.7 1.4 1.2 15.4 3.9 6.1 1.8 2.5 5.7 14.5 6.8 2.3 0.4 0.6 23.0 0.4 15.2 2.5 0.1 2.0 2.4 5.5 11.3 2.4 4.4 7.6 5.6 5.4 2.6 1.2 0.2 8.5 17.9 3.2 1.1 2.0 1.0 7.0 3.8 0.4 2.5 8.4 1.7 0.7 0.0 0.0 0.0 3.2 5.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.3 13.9 20.3 20.1 18.3 12.3 14.3 12.9 8.5 10.2 11.0 0.0 0.0 0.0 0.2 0.0 3.1 0.9 0.0 6.7 2.3 1.8 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.6 0.0 0.0 0.3 3.2 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 1.4 0.1 0.0 1.1 0.8 0.5 0.0 0.2 0.0 0.7 0.0 0.2 0.0 0.0 0.1 ASPM "ASP, Calmbp1, FLJ10517, FLJ10549, MCPH5" ENSG00000066279 "Abnormal spindle microtubule assembly" Q8IZT6 1 197084128-197146694 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Calmodulin-binding "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 62.8" "Cell type enhanced" "Detected in many" 16 "Erythroid cells: 70.0;Spermatocytes: 32.6;Spermatogonia: 30.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "plasmacytoid DC: 1.5;T-reg: 2.4" "Group enriched" "Detected in many" 5 "dendritic cells: 1.5;T-cells: 2.4" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" CAB017816 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "CAB017816: " "unprognostic (3.24e-1)" "unprognostic (1.56e-1)" "unprognostic (2.81e-2)" "prognostic unfavorable (1.97e-4)" "unprognostic (3.67e-1)" "unprognostic (3.47e-2)" "prognostic unfavorable (1.25e-4)" "prognostic unfavorable (2.41e-4)" "unprognostic (4.67e-3)" "unprognostic (9.29e-2)" "prognostic unfavorable (2.40e-4)" "unprognostic (1.03e-1)" "unprognostic (0.00e+0)" "unprognostic (7.31e-3)" "unprognostic (1.23e-1)" "unprognostic (4.94e-2)" "unprognostic (3.66e-2)" 0.7 0.7 0.2 12.4 0.4 13.8 1.5 0.2 0.4 1.2 2.8 0.2 0.2 2.8 0.3 1.5 8.7 0.2 0.4 0.6 0.2 0.2 0.5 1.3 1.9 7.0 0.3 0.2 0.5 0.3 0.0 0.2 1.8 0.5 0.4 2.8 0.3 1.5 0.2 0.5 4.6 3.1 0.8 0.5 4.3 1.7 6.3 0.2 62.8 0.3 5.0 6.9 1.2 2.3 0.0 1.5 0.0 0.0 0.3 2.4 0.0 20.1 11.3 18.3 11.2 1.1 2.5 6.9 16.1 11.3 16.0 12.7 7.8 15.7 20.5 5.7 12.6 7.0 20.3 15.7 6.4 20.0 18.5 11.9 14.4 26.5 7.5 0.2 21.5 10.3 0.2 0.6 12.8 9.0 4.1 16.8 16.6 18.0 24.4 16.4 7.9 17.2 10.0 8.3 16.2 3.1 13.2 25.2 15.1 5.8 5.5 9.6 13.7 22.9 11.8 5.1 11.8 13.2 8.9 12.8 9.9 9.7 17.0 29.2 7.0 9.5 11.9 7.8 5.9 20.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.5 2.4 0.0 0.2 0.4 0.2 0.4 0.2 0.2 0.3 0.2 0.5 0.2 0.0 0.6 3.7 0.6 5.5 0.0 1.0 0.0 0.0 1.2 1.8 0.0 6.4 0.0 0.3 2.9 0.3 0.3 70.0 0.0 13.2 1.3 0.7 1.1 1.0 9.3 0.0 0.0 1.8 4.0 3.3 0.6 3.1 0.0 1.0 1.5 0.5 0.4 0.0 1.4 0.0 0.3 0.0 0.0 32.6 30.2 3.0 3.1 4.9 4.9 1.7 ATG3 "APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96" ENSG00000144848 "Autophagy related 3" Q9NT62 3 112532509-112562046 "Predicted intracellular proteins, Transporters" "Autophagy, Protein transport, Transport, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Early spermatids: 501.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037260, HPA040471" Enhanced Supported "Plasma membrane,Cytosol" NA NA 26000 "Plasma membrane, Cytosol" "CAB037260: AB_1078236, HPA040471: AB_2677000" "unprognostic (2.77e-2)" "prognostic favorable (6.82e-4)" "unprognostic (4.90e-3)" "unprognostic (1.30e-1)" "unprognostic (2.63e-1)" "unprognostic (1.44e-1)" "prognostic unfavorable (9.35e-6)" "unprognostic (6.79e-2)" "unprognostic (6.67e-2)" "unprognostic (6.99e-2)" "unprognostic (2.56e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.52e-3)" "unprognostic (4.66e-2)" "unprognostic (6.02e-2)" "unprognostic (3.48e-2)" "unprognostic (5.25e-2)" 24.2 27.7 30.8 30.3 34.2 51.6 23.1 19.5 26.8 20.0 24.3 29.9 16.6 24.5 18.0 17.0 23.6 15.7 17.4 20.9 31.4 27.1 32.2 36.2 23.2 31.0 38.9 17.9 21.1 29.0 24.5 27.7 24.5 33.3 18.5 26.9 13.1 20.3 22.3 18.7 19.6 27.9 19.6 53.3 40.1 23.5 51.7 34.8 33.8 28.2 23.4 28.6 21.6 19.7 12.3 34.5 35.6 61.9 9.7 15.0 24.0 31.2 17.1 16.1 16.4 21.2 17.6 18.1 27.7 20.2 27.4 25.1 23.9 18.7 39.4 21.1 23.8 33.6 22.8 26.3 24.0 38.5 6.7 12.7 24.8 17.0 15.3 33.1 43.3 21.1 16.2 18.4 26.8 41.4 18.0 25.4 25.1 21.2 33.9 28.9 27.4 25.5 20.4 17.6 41.1 34.1 22.4 14.4 33.2 22.7 17.1 27.8 10.9 23.0 22.0 32.3 15.9 24.8 32.5 20.5 29.3 23.9 12.3 24.2 22.1 21.1 61.0 26.8 40.4 21.5 10.8 34.3 23.9 8.6 51.6 10.7 12.3 10.6 10.6 34.5 11.5 10.4 10.2 35.6 9.7 61.9 7.4 15.0 24.0 30.8 34.2 19.5 26.8 31.4 27.1 38.9 17.9 33.3 34.8 44.7 36.6 54.6 35.3 65.8 20.1 77.1 38.2 29.4 29.6 24.4 11.8 64.1 99.5 58.2 501.6 54.0 48.5 93.5 75.2 69.9 44.7 31.1 38.2 35.8 111.6 17.5 30.0 36.2 92.5 97.9 39.4 118.7 65.8 143.3 50.3 40.1 56.9 45.6 40.7 62.4 18.1 58.2 69.0 227.9 110.0 61.7 102.3 47.9 67.3 39.9 ATIC "AICARFT, IMPCHASE, PURH" ENSG00000138363 "5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase" P31939 2 215311817-215349773 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Purine biosynthesis" "Hydrolase, Multifunctional enzyme, Transferase" "Cancer-related genes, Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cytotrophoblasts: 144.4;Extravillous trophoblasts: 132.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013462, HPA021012" Supported Approved "Plasma membrane,Cytosol" NA NA 3400000 Cytosol "Plasma membrane" "CAB013462: , HPA021012: AB_1845169" "unprognostic (1.41e-2)" "unprognostic (2.18e-1)" "unprognostic (1.13e-2)" "unprognostic (8.46e-2)" "unprognostic (2.90e-1)" "unprognostic (3.81e-2)" "prognostic unfavorable (1.99e-7)" "unprognostic (1.86e-2)" "unprognostic (5.07e-2)" "unprognostic (1.83e-1)" "unprognostic (6.31e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (8.77e-4)" "unprognostic (1.00e-1)" "unprognostic (1.30e-1)" "unprognostic (4.18e-2)" "unprognostic (4.39e-3)" 19.4 27.4 21.1 23.0 28.4 16.9 24.8 12.1 32.3 20.6 26.7 29.1 18.1 23.4 27.9 15.6 19.1 21.9 19.1 18.2 20.3 21.1 23.1 35.6 17.3 36.1 29.7 19.9 23.4 32.9 25.1 21.1 31.1 24.4 21.9 35.9 19.5 14.4 29.4 35.5 17.0 20.6 26.7 21.7 29.0 20.4 15.0 28.0 46.3 16.1 13.5 35.3 27.6 18.0 21.7 13.4 2.9 8.9 19.6 22.8 10.0 20.5 31.1 17.4 29.5 23.4 23.7 8.7 21.0 18.3 24.0 27.6 60.0 32.2 29.9 26.0 21.9 33.8 21.6 38.2 31.7 34.5 22.3 36.9 36.4 26.7 53.7 30.3 45.6 18.7 20.0 24.3 32.1 38.8 16.6 16.0 29.0 47.0 25.0 33.0 30.3 39.7 22.2 66.8 32.9 17.5 36.9 25.0 26.8 25.5 33.2 27.3 18.9 16.9 20.8 23.7 40.4 34.1 16.2 14.1 20.4 21.1 26.3 13.2 31.6 41.2 62.1 17.7 25.4 29.4 2.9 6.0 0.1 13.2 8.9 22.8 21.7 18.6 20.0 13.4 13.2 18.9 17.5 0.7 19.6 7.4 11.7 17.7 10.0 21.1 28.4 12.1 32.3 20.3 21.1 29.7 19.9 24.4 28.0 11.9 17.1 19.3 23.5 13.4 9.6 18.5 25.5 26.8 19.4 22.7 3.9 144.4 23.2 32.2 0.8 6.3 13.5 0.0 42.8 132.7 23.3 16.1 24.3 18.7 46.4 9.5 18.5 4.3 15.0 0.0 22.2 18.7 28.7 32.5 29.9 20.6 30.0 21.0 32.2 44.0 12.8 25.8 19.8 3.2 40.3 7.4 79.8 21.5 52.7 17.4 ATOX1 HAH1 ENSG00000177556 "Antioxidant 1 copper chaperone" O00244 5 151742316-151772532 "Predicted intracellular proteins" "Copper transport, Ion transport, Transport" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 744.7;Proximal tubular cells: 898.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055036 Approved "Nucleoplasm,Plasma membrane" NA NA 27000 Nucleoplasm "Plasma membrane" "HPA055036: " "unprognostic (5.55e-2)" "unprognostic (1.60e-1)" "unprognostic (3.84e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (3.34e-2)" "unprognostic (2.33e-1)" "unprognostic (8.60e-2)" "unprognostic (3.58e-2)" "unprognostic (2.53e-2)" "prognostic favorable (9.57e-4)" "unprognostic (2.72e-1)" "unprognostic (7.15e-2)" "unprognostic (8.18e-2)" "unprognostic (2.57e-2)" "unprognostic (1.87e-1)" "unprognostic (2.22e-1)" 27.0 37.2 43.1 25.6 40.4 23.4 39.1 22.8 38.5 29.0 23.9 29.7 32.3 30.2 21.4 37.6 28.4 24.5 33.4 27.7 37.5 45.7 50.5 96.1 21.3 48.9 54.3 37.0 16.2 29.0 31.5 23.0 25.6 35.2 25.7 24.4 25.0 34.7 29.8 12.8 26.3 31.6 28.1 46.5 34.1 21.0 28.7 33.8 24.5 36.3 29.7 44.8 27.2 22.1 22.5 49.9 43.3 54.8 20.1 22.8 24.2 14.1 23.3 13.7 9.5 36.6 30.0 18.1 25.6 29.0 25.8 35.2 31.5 30.6 28.5 31.2 43.8 57.9 13.2 16.6 64.1 21.2 18.3 28.4 12.5 15.1 32.0 34.1 17.2 14.3 38.7 13.5 32.3 21.3 19.1 37.7 17.9 10.3 84.2 39.0 34.7 12.7 38.2 7.8 31.7 48.9 7.8 15.8 44.0 24.7 12.3 18.0 10.6 21.9 62.6 95.4 16.2 30.6 21.1 42.2 26.8 21.3 32.6 44.3 69.6 61.1 17.0 36.3 11.7 110.2 27.5 48.7 43.3 18.3 54.8 16.7 22.5 16.6 15.8 39.1 16.2 13.2 14.3 36.4 20.1 37.4 49.9 22.8 24.2 43.1 40.4 22.8 38.5 37.5 45.7 54.3 37.0 35.2 33.8 53.6 54.1 119.1 60.7 60.1 20.6 93.1 175.8 60.2 37.5 200.7 13.7 132.7 459.3 179.7 119.0 146.1 314.3 70.0 138.4 184.0 143.5 107.5 72.6 744.7 575.7 23.8 144.8 249.2 183.4 241.2 76.8 138.6 226.0 621.2 138.5 98.0 246.1 221.7 97.2 898.1 22.2 90.5 140.1 71.6 147.1 93.1 99.3 57.9 140.1 99.5 ATP10D "ATPVD, KIAA1487" ENSG00000145246 "ATPase phospholipid transporting 10D (putative)" Q9P241 4 47485288-47593486 "Enzymes, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 55.7" "Cell type enhanced" "Detected in many" 11 "Leydig cells: 57.5;Syncytiotrophoblasts: 147.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 9 "basophil: 31.5" "Lineage enriched" "Detected in many" 9 "granulocytes: 31.5" "Cell line enhanced" "Detected in many" "HAP1: 24.4" HPA050808 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA050808: AB_2681242" "unprognostic (1.62e-1)" "unprognostic (2.97e-1)" "unprognostic (4.93e-2)" "unprognostic (1.47e-2)" "unprognostic (1.16e-1)" "unprognostic (4.23e-2)" "unprognostic (1.65e-2)" "unprognostic (8.05e-2)" "unprognostic (3.48e-2)" "unprognostic (3.54e-2)" "unprognostic (3.04e-1)" "unprognostic (2.43e-1)" "prognostic favorable (5.00e-8)" "unprognostic (3.97e-2)" "unprognostic (4.47e-3)" "unprognostic (1.11e-2)" "unprognostic (3.37e-2)" 8.1 9.7 7.6 6.8 8.0 1.4 6.9 3.9 7.5 10.2 7.4 5.2 10.4 4.5 12.9 10.1 15.2 6.7 8.6 7.4 7.3 4.0 14.5 5.8 9.4 6.7 7.0 4.8 10.0 6.2 16.9 18.6 55.7 8.1 8.1 4.5 7.7 7.5 11.5 2.8 14.8 6.0 11.4 8.9 12.7 7.6 3.9 7.3 3.6 10.7 5.4 9.2 9.9 13.1 3.6 1.8 31.5 2.9 1.0 0.9 0.6 1.4 1.0 2.3 1.6 6.7 7.3 0.4 10.4 12.6 5.0 9.0 5.4 9.0 4.6 3.9 16.8 8.5 2.7 24.4 8.7 7.7 1.8 1.9 3.7 1.7 0.3 6.0 1.1 2.3 6.3 6.7 9.8 6.5 16.5 8.4 2.3 0.0 2.5 13.6 0.5 2.4 0.7 0.8 0.0 1.3 2.8 5.3 0.0 9.1 1.8 1.5 2.9 4.8 1.2 3.1 5.4 2.2 1.2 12.7 12.4 2.5 1.1 4.5 1.1 0.8 0.0 6.1 6.9 3.9 31.5 1.4 0.1 0.6 2.3 0.9 1.3 0.2 0.3 1.8 3.6 0.0 0.4 0.7 1.0 2.9 1.1 0.3 0.6 7.6 8.0 3.9 7.5 7.3 4.0 7.0 4.8 8.1 7.3 8.9 6.9 15.0 7.9 17.1 10.9 3.6 0.0 2.7 2.3 15.7 29.5 27.1 1.7 4.3 1.6 14.0 1.6 0.0 4.1 7.4 11.8 5.8 2.3 4.9 11.7 12.7 9.2 17.8 16.1 0.6 57.5 9.1 6.8 7.2 4.3 28.8 2.7 2.5 23.7 9.1 8.9 25.8 9.8 0.4 2.7 23.6 147.8 11.5 3.7 6.5 ATP2C2 "KIAA0703, SPCA2" ENSG00000064270 "ATPase secretory pathway Ca2+ transporting 2" O75185 16 84368527-84464187 "Enzymes, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Translocase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 23.0;salivary gland: 35.8" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 42.2;Ciliated cells: 72.3;Mucus-secreting cells: 62.9;Undifferentiated cells: 69.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "neutrophil: 2.7" "Lineage enriched" "Detected in single" 24 "granulocytes: 2.7" "Cell line enhanced" "Detected in some" "MCF7: 14.5;OE19: 26.0;RT4: 11.4;SK-BR-3: 20.2;T-47d: 6.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA052262, HPA075812" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA052262: AB_2681776, HPA075812: AB_2686765" "unprognostic (2.28e-2)" "unprognostic (6.13e-2)" "unprognostic (3.34e-2)" "prognostic favorable (6.20e-6)" "unprognostic (2.04e-1)" "unprognostic (2.41e-2)" "unprognostic (8.36e-2)" "unprognostic (1.72e-1)" "unprognostic (9.92e-2)" "unprognostic (1.89e-2)" "unprognostic (5.08e-2)" "unprognostic (2.16e-1)" "unprognostic (8.37e-3)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (4.32e-4)" "unprognostic (1.39e-1)" 0.3 0.0 2.1 8.0 1.5 6.1 2.5 0.2 2.0 3.5 23.0 0.5 1.9 16.3 1.8 1.9 2.7 4.0 18.8 0.4 1.8 1.9 2.6 0.2 21.9 0.2 1.3 0.7 1.3 0.5 0.0 2.9 4.8 0.7 7.9 21.9 1.0 35.8 0.2 0.9 15.2 14.5 0.5 0.6 0.2 3.4 0.4 0.4 0.3 8.2 2.2 8.1 4.8 7.8 0.0 0.0 2.7 0.0 0.0 0.1 0.0 3.6 0.2 0.4 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 3.4 3.2 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 0.0 0.0 0.0 26.0 0.1 0.0 0.0 0.1 0.0 11.4 2.9 0.0 0.0 20.2 0.1 0.5 6.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 2.1 1.5 0.2 2.0 1.8 1.9 1.3 0.7 0.7 0.4 29.8 42.2 0.0 12.3 0.6 1.4 0.6 2.5 72.3 29.6 0.0 0.0 1.9 0.0 7.2 3.0 0.6 15.4 0.0 2.3 2.2 0.3 21.6 9.2 0.0 0.2 0.0 32.8 0.0 0.0 1.1 0.0 0.7 1.7 0.0 62.9 1.3 3.1 17.3 0.0 1.9 5.6 0.0 0.5 0.7 0.6 1.0 20.1 0.0 69.5 9.5 ATP6V0A2 "a2, ATP6a2, ATP6N1D, J6B7, Stv1, TJ6, TJ6M, TJ6s, Vph1" ENSG00000185344 "ATPase H+ transporting V0 subunit a2" Q9Y487 12 123712318-123761755 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrogen ion transport, Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "granulocytes: 71.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 13.1" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HMC-1: 37.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044279 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044279: AB_10961274" "unprognostic (2.60e-1)" "unprognostic (8.79e-3)" "unprognostic (3.60e-2)" "unprognostic (1.50e-1)" "unprognostic (2.70e-1)" "unprognostic (2.29e-2)" "unprognostic (2.06e-4)" "unprognostic (1.40e-1)" "unprognostic (3.77e-2)" "unprognostic (1.75e-1)" "unprognostic (8.85e-3)" "unprognostic (1.63e-1)" "unprognostic (1.26e-1)" "unprognostic (7.48e-2)" "unprognostic (1.12e-1)" "unprognostic (3.47e-1)" "unprognostic (1.58e-1)" 13.5 9.4 7.2 13.0 9.9 15.5 11.5 16.2 9.8 8.9 13.1 13.0 9.0 16.0 13.4 8.8 9.1 10.4 10.4 13.6 8.0 7.9 8.9 13.7 13.1 16.6 12.8 6.9 9.7 18.1 8.1 10.4 10.2 9.1 9.8 12.0 9.8 24.5 10.0 13.0 20.5 15.8 12.3 9.4 13.1 15.9 15.9 10.8 24.0 10.3 8.6 17.5 11.0 10.3 2.3 3.4 13.1 1.5 2.1 2.7 0.9 3.3 8.4 8.8 11.8 5.2 5.0 5.4 4.0 4.7 5.2 5.7 6.2 2.7 12.8 2.8 5.4 5.5 7.1 11.4 4.2 3.9 8.7 6.4 18.4 6.7 3.6 8.2 11.7 37.8 4.5 3.7 6.1 6.6 5.2 4.5 10.1 11.1 2.3 5.7 9.2 11.0 14.3 9.2 5.0 5.6 10.6 7.6 4.1 5.0 8.3 5.3 9.0 6.8 4.7 6.0 4.7 4.9 8.5 6.5 6.6 2.5 8.1 6.7 7.6 8.4 11.9 5.5 7.1 5.6 6.4 0.9 13.1 2.1 0.9 1.5 1.3 2.1 1.8 1.1 2.3 1.9 2.7 2.4 2.1 1.5 3.4 1.4 0.9 7.2 9.9 16.2 9.8 8.0 7.9 12.8 6.9 9.1 10.8 6.0 14.1 16.0 6.8 9.0 18.1 7.9 17.8 8.1 9.1 8.7 11.8 4.7 0.0 7.4 7.9 8.9 10.5 0.0 9.5 4.6 8.0 12.1 71.8 9.5 7.4 11.1 12.7 14.1 10.8 3.1 8.1 11.7 1.7 10.0 10.1 12.2 6.7 8.0 8.9 3.7 27.6 6.5 8.9 19.5 11.5 12.4 5.7 13.1 9.9 10.6 ATP8A2 "ATPIB, ML-1" ENSG00000132932 "ATPase phospholipid transporting 8A2" Q9NTI2 13 25372071-26025851 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Lipid transport, Transport" Translocase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 34.9;pituitary gland: 37.0;testis: 10.4" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 90.3;Early spermatids: 29.4;Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3;naive CD8 T-cell: 3.3" "Lineage enriched" "Detected in single" 12 "T-cells: 3.3" "Group enriched" "Detected in some" 4 "HMC-1: 21.6;JURKAT: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039926, HPA040033" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA039926: AB_10794205, HPA040033: AB_2676809" "unprognostic (3.79e-2)" "unprognostic (4.28e-2)" "unprognostic (3.32e-2)" "unprognostic (1.95e-4)" "unprognostic (3.57e-2)" "unprognostic (1.89e-1)" "unprognostic (1.31e-2)" "unprognostic (2.97e-3)" "unprognostic (2.77e-1)" "unprognostic (3.66e-1)" "unprognostic (4.96e-4)" "unprognostic (1.24e-1)" "unprognostic (1.18e-2)" "unprognostic (4.20e-5)" "unprognostic (9.10e-2)" "unprognostic (2.95e-1)" "unprognostic (7.22e-2)" 1.1 4.9 11.2 1.4 11.4 0.8 2.2 34.9 30.2 1.1 1.3 1.3 0.0 1.4 2.1 4.8 0.9 0.9 1.0 1.0 9.4 11.8 1.3 0.8 2.3 1.9 6.7 10.4 1.2 1.9 0.9 37.0 1.2 19.8 1.1 1.3 3.1 1.0 1.0 1.3 0.9 1.5 1.0 3.5 1.3 1.8 10.4 1.4 0.0 1.0 0.0 1.2 1.2 0.3 0.0 0.0 0.2 0.0 0.2 3.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.0 0.0 0.0 0.6 1.4 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 21.6 0.2 0.0 0.0 0.0 0.6 0.5 9.6 0.0 0.0 1.7 0.3 3.7 0.0 2.0 0.0 0.7 0.0 2.7 1.0 0.2 0.1 3.3 0.0 0.1 0.3 0.1 0.4 0.0 0.4 0.2 0.1 1.1 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.8 0.6 0.0 0.0 2.3 3.3 0.2 0.2 0.0 0.0 0.7 0.6 11.2 11.4 34.9 18.4 9.4 11.8 6.7 10.4 19.8 1.4 0.0 9.8 0.9 0.1 0.9 20.0 2.2 2.5 0.0 0.0 0.0 90.3 1.2 0.0 0.3 29.4 1.5 0.0 0.0 0.0 0.3 0.4 0.2 4.7 0.0 2.4 20.6 0.0 0.0 0.0 24.5 0.9 0.0 0.0 0.0 0.0 4.5 0.0 0.0 1.1 0.6 86.2 12.9 0.0 12.9 9.9 0.4 0.9 0.5 0.0 0.0 ATXN10 "E46L, FLJ37990, SCA10" ENSG00000130638 "Ataxin 10" Q9UBB4 22 45671798-45845307 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049531 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA049531: AB_2680806" "unprognostic (5.73e-2)" "unprognostic (1.97e-1)" "unprognostic (1.27e-2)" "unprognostic (5.76e-2)" "unprognostic (3.01e-2)" "unprognostic (7.50e-2)" "unprognostic (1.19e-3)" "unprognostic (3.18e-1)" "unprognostic (2.15e-2)" "unprognostic (5.07e-2)" "unprognostic (8.38e-2)" "unprognostic (3.51e-1)" "unprognostic (1.23e-2)" "unprognostic (1.18e-1)" "unprognostic (6.22e-2)" "unprognostic (7.48e-2)" "unprognostic (6.98e-2)" 18.1 33.3 40.2 20.6 40.5 20.9 38.5 31.7 75.3 28.5 20.6 20.9 22.0 13.8 28.8 23.9 27.5 33.6 23.3 42.3 44.5 42.4 32.0 37.0 30.5 38.8 35.6 41.2 35.4 33.5 39.7 32.6 28.1 38.1 28.3 21.8 18.0 22.6 30.1 47.5 18.3 13.6 29.7 38.3 18.3 18.5 31.5 22.3 34.0 37.2 21.8 28.7 26.8 21.8 23.3 52.2 28.1 40.4 25.2 31.0 33.3 41.3 21.4 41.6 25.1 19.1 28.8 22.4 47.3 50.5 33.8 37.2 10.7 27.8 42.7 19.6 47.3 17.4 24.7 30.0 31.5 36.6 7.8 31.0 20.0 41.3 20.5 27.6 53.4 15.0 29.6 22.0 17.6 27.7 41.4 24.7 19.8 14.6 23.7 51.2 17.6 29.0 24.0 27.5 23.4 16.6 42.0 16.0 34.6 43.1 39.6 23.1 36.2 29.4 17.7 32.0 32.9 26.7 28.6 22.5 34.3 12.8 12.2 15.5 23.4 14.1 34.4 21.3 22.5 36.3 19.0 31.7 28.1 23.4 37.6 31.0 23.3 23.3 28.3 52.2 22.6 25.7 24.8 1.5 25.2 40.4 18.5 21.9 33.3 40.2 40.5 31.7 75.3 44.5 42.4 35.6 41.2 38.1 22.3 32.8 25.7 30.5 107.7 44.9 67.9 77.5 68.8 58.9 42.1 55.8 19.6 90.0 58.0 72.1 42.5 42.6 15.9 46.7 60.7 89.4 55.5 67.5 38.2 48.6 63.4 66.7 57.9 33.2 52.7 30.9 53.2 45.5 23.6 62.3 32.0 70.5 50.1 24.6 71.1 51.6 43.1 45.3 38.1 108.0 105.2 36.3 43.7 34.8 46.1 79.0 ATXN7L3 DKFZp761G2113 ENSG00000087152 "Ataxin 7 like 3" Q14CW9 17 44191805-44200113 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064316 Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA064316: AB_2685243" "unprognostic (2.37e-2)" "unprognostic (8.87e-3)" "unprognostic (1.10e-1)" "unprognostic (3.74e-2)" "unprognostic (3.75e-2)" "unprognostic (1.23e-1)" "prognostic unfavorable (4.03e-4)" "unprognostic (2.86e-3)" "unprognostic (6.74e-3)" "unprognostic (1.09e-1)" "unprognostic (1.50e-1)" "unprognostic (1.00e-1)" "prognostic unfavorable (2.87e-4)" "unprognostic (1.21e-3)" "unprognostic (9.05e-2)" "unprognostic (3.75e-2)" "unprognostic (1.40e-1)" 14.0 12.9 36.7 18.9 25.1 23.8 11.9 23.0 53.1 13.2 16.1 11.3 16.7 19.1 14.3 16.9 22.3 14.2 14.9 12.4 30.7 24.8 12.4 12.6 14.3 20.8 22.7 32.1 13.2 13.7 16.3 17.1 18.8 23.6 13.0 15.3 7.9 16.9 18.5 11.3 19.0 16.5 16.1 15.1 17.6 15.5 17.0 14.1 13.9 14.3 11.3 21.3 16.7 22.4 5.1 4.4 6.7 3.2 1.3 4.8 2.6 16.9 28.7 31.8 20.6 22.2 22.1 17.3 20.9 23.3 26.7 25.3 21.9 19.3 29.8 16.8 23.4 24.7 18.7 24.7 19.6 22.5 34.7 24.6 20.2 23.7 24.3 21.9 31.5 41.1 24.9 30.0 22.4 23.7 28.4 25.8 23.1 27.0 18.7 17.5 12.8 37.7 24.0 23.8 15.3 22.6 26.1 30.7 22.3 21.5 24.4 20.2 25.7 12.3 10.9 21.3 46.2 26.7 28.1 22.1 27.0 28.3 14.0 19.4 22.7 29.4 36.1 17.8 13.7 15.7 1.4 3.2 3.7 4.8 2.2 2.9 3.6 3.8 3.0 2.7 5.1 2.9 3.6 6.7 1.3 2.3 4.4 2.0 2.6 36.7 25.1 23.0 53.1 30.7 24.8 22.7 32.1 23.6 14.1 3.0 3.0 4.8 4.4 6.4 16.5 5.3 5.1 4.0 4.5 17.4 15.7 5.1 3.3 6.5 12.7 8.0 14.8 0.0 11.2 6.0 6.2 6.9 2.3 7.3 7.3 27.0 13.8 12.3 10.8 25.8 8.3 7.6 5.0 10.8 11.9 7.6 11.5 11.5 5.3 3.6 13.1 6.5 6.2 6.4 8.9 9.3 11.4 5.4 9.3 7.5 AVPI1 "PP5395, VIP32, VIT32" ENSG00000119986 "Arginine vasopressin induced 1" Q5T686 10 97677424-97687323 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 211.2;Syncytiotrophoblasts: 162.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HeLa: 29.0;HHSteC: 30.0;hTCEpi: 56.5;SK-MEL-30: 45.6;U-2197: 33.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037649 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037649: AB_10671879" "unprognostic (4.57e-2)" "unprognostic (3.28e-2)" "unprognostic (3.04e-2)" "unprognostic (4.79e-2)" "unprognostic (2.73e-1)" "unprognostic (1.25e-1)" "unprognostic (4.37e-3)" "unprognostic (4.60e-2)" "unprognostic (7.34e-3)" "unprognostic (8.56e-3)" "unprognostic (2.29e-3)" "unprognostic (1.23e-1)" "unprognostic (3.91e-3)" "unprognostic (4.04e-1)" "unprognostic (2.03e-1)" "unprognostic (8.66e-2)" "unprognostic (3.83e-3)" 21.5 27.4 5.1 4.7 8.5 3.3 11.0 6.3 17.7 13.0 18.6 3.6 4.8 10.7 5.8 8.2 16.3 6.5 19.9 8.5 5.5 5.8 5.6 29.9 17.1 1.7 7.3 5.6 43.3 10.8 4.1 7.2 19.3 8.0 15.3 15.0 13.6 10.7 13.8 8.3 35.5 15.3 8.5 12.6 11.9 12.7 8.4 2.5 1.3 8.2 9.7 7.6 22.0 16.6 3.5 12.4 2.3 7.1 2.0 5.0 3.0 9.0 23.9 0.1 3.5 5.0 2.3 4.9 4.4 24.4 6.1 9.3 4.4 11.4 0.2 3.2 2.5 4.4 9.6 1.8 7.7 2.3 0.2 2.1 0.6 29.0 12.3 30.0 0.6 0.7 3.6 56.5 4.6 12.1 5.6 0.8 0.8 1.3 0.5 3.3 7.8 0.4 0.7 0.8 2.5 2.2 0.3 2.7 0.3 6.0 5.0 0.4 1.0 15.4 5.5 45.6 0.8 4.2 0.7 1.3 1.5 2.9 33.0 1.1 1.1 0.7 0.1 5.5 1.9 0.9 0.0 7.1 2.3 5.0 6.1 2.3 3.5 3.3 3.7 12.4 2.2 3.6 4.4 0.7 2.0 0.5 2.4 2.9 3.0 5.1 8.5 6.3 17.7 5.5 5.8 7.3 5.6 8.0 2.5 17.9 14.7 1.4 58.4 85.3 9.6 6.7 30.6 13.4 17.0 36.6 5.9 126.4 36.5 16.0 51.3 6.0 96.5 0.0 21.5 57.2 30.8 25.7 5.8 38.1 39.2 12.7 30.5 22.7 16.7 211.2 9.5 40.5 79.2 9.0 38.3 125.0 29.4 66.6 13.8 9.1 12.7 6.5 29.8 2.7 1.6 94.7 162.8 9.6 58.7 83.6 BAG3 ENSG00000151929 "BCL2 associated athanogene 3" O95817 10 119651370-119677819 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis Chaperone "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 115.2;vagina: 160.1" "Group enriched" "Detected in many" 5 "Basal glandular cells: 723.0;Cardiomyocytes: 186.4;Glandular cells: 269.5;Urothelial cells: 305.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 7.6" "Lineage enriched" "Detected in many" 7 "T-cells: 7.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018493, HPA020586" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 890000 "Plasma membrane, Cytosol" "HPA018493: AB_1845257, HPA020586: AB_1845258" "unprognostic (1.18e-1)" "unprognostic (1.68e-1)" "unprognostic (2.12e-2)" "unprognostic (1.17e-1)" "unprognostic (2.82e-2)" "unprognostic (5.31e-3)" "unprognostic (4.51e-3)" "unprognostic (3.32e-2)" "unprognostic (1.98e-2)" "unprognostic (1.46e-2)" "unprognostic (1.30e-2)" "unprognostic (1.49e-1)" "unprognostic (2.18e-3)" "unprognostic (4.21e-2)" "unprognostic (1.34e-1)" "unprognostic (8.46e-2)" "unprognostic (3.03e-2)" 17.8 14.1 18.8 7.7 25.7 2.7 38.3 18.4 20.7 11.7 14.1 7.3 6.5 6.3 10.1 10.6 23.3 8.7 17.0 38.2 20.6 14.3 16.8 10.1 14.3 5.9 20.9 4.5 7.3 9.3 27.6 8.8 16.5 27.4 14.4 6.7 5.5 14.6 12.9 115.2 18.5 5.6 20.4 35.8 4.4 15.1 8.1 20.6 1.3 11.1 32.7 12.8 14.0 160.1 0.3 0.8 0.4 1.1 0.2 7.6 1.0 26.5 30.2 8.5 10.9 21.9 15.4 15.8 24.3 20.6 18.6 16.0 12.8 13.0 1.0 11.6 20.8 24.2 39.6 8.6 42.8 12.9 13.0 14.2 1.4 8.1 15.9 18.6 0.0 6.1 15.5 24.8 13.5 21.4 19.8 20.7 4.7 11.3 6.6 18.4 38.0 1.4 5.9 3.3 8.9 34.6 0.1 12.0 4.6 14.0 6.0 1.5 1.4 9.6 17.1 12.5 9.6 10.7 3.5 25.8 9.8 8.5 13.2 34.6 6.1 3.6 0.6 18.3 0.4 7.4 0.0 1.0 0.0 1.2 1.1 2.0 0.3 4.4 1.5 0.8 0.0 7.6 2.7 0.4 0.2 0.5 0.2 3.0 1.0 18.8 25.7 18.4 20.7 20.6 14.3 20.9 4.5 27.4 20.6 20.8 36.3 0.9 723.0 70.5 2.3 186.4 10.2 29.4 46.6 7.0 17.7 35.8 23.2 16.0 20.3 50.1 18.0 0.0 22.4 39.6 80.3 269.5 24.1 13.7 29.0 1.6 36.8 27.6 7.2 25.2 20.8 15.4 52.3 5.4 12.1 30.3 26.4 8.2 22.6 33.1 1.0 19.4 68.0 17.1 15.1 66.6 61.4 5.7 10.6 305.7 BAIAP2 "BAP2, IRSp53" ENSG00000175866 "BAI1 associated protein 2" Q9UQB8 17 81035122-81117432 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 172.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 15.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023310, HPA027421" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023310: AB_1845264, HPA027421: AB_10602392" "unprognostic (2.20e-1)" "unprognostic (1.84e-3)" "unprognostic (5.81e-2)" "unprognostic (2.28e-2)" "unprognostic (1.73e-1)" "unprognostic (6.97e-3)" "unprognostic (3.73e-3)" "unprognostic (1.53e-1)" "unprognostic (6.77e-2)" "unprognostic (1.45e-2)" "unprognostic (4.23e-2)" "unprognostic (2.94e-1)" "unprognostic (7.04e-2)" "unprognostic (6.77e-2)" "unprognostic (7.15e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (7.58e-6)" 10.1 10.9 29.0 4.1 37.4 1.7 11.5 19.6 45.3 14.6 11.8 11.4 18.0 4.3 10.1 26.0 45.9 20.6 17.6 8.7 22.1 10.6 20.6 26.3 20.0 3.6 7.3 24.3 5.1 7.6 8.4 19.2 17.0 9.8 25.7 7.1 11.8 17.0 17.1 3.9 52.6 4.9 10.8 5.4 6.2 20.1 9.2 12.3 2.1 10.2 20.1 20.2 11.1 20.5 0.1 15.4 4.8 7.8 1.3 2.7 2.3 30.1 13.9 8.9 11.6 7.1 9.6 10.4 12.4 8.2 11.3 5.0 18.9 15.3 0.1 9.0 11.0 23.4 29.4 8.1 14.3 4.3 0.1 10.2 6.1 12.3 14.0 6.7 0.0 9.0 4.0 16.9 9.3 4.9 10.5 6.0 0.3 7.9 0.2 6.5 16.0 1.2 6.8 3.7 20.0 12.3 1.8 2.2 24.8 34.6 10.6 11.7 12.8 19.9 28.9 33.6 7.7 25.4 7.0 7.3 26.4 25.1 4.3 13.1 0.4 0.1 0.4 23.0 1.0 5.7 0.0 5.9 0.4 2.7 7.8 0.9 0.1 1.0 0.9 8.3 0.1 1.2 1.5 4.8 1.3 7.2 15.4 0.4 2.3 29.0 37.4 19.6 45.3 22.1 10.6 7.3 24.3 9.8 12.3 71.5 36.6 4.8 115.9 56.6 35.5 15.3 17.8 83.0 31.8 21.0 74.6 60.3 6.6 9.5 8.4 26.9 4.7 0.0 4.5 5.5 34.7 89.9 13.8 62.5 35.9 11.1 47.1 47.3 18.5 20.9 6.4 27.1 38.8 25.2 20.7 17.7 9.1 6.2 3.5 23.1 18.0 0.0 19.4 7.4 20.0 65.7 84.4 7.2 12.4 172.9 BAIAP2L1 IRTKS ENSG00000006453 "BAI1 associated protein 2 like 1" Q9UHR4 7 98291651-98401068 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Glandular cells: 91.6;Urothelial cells: 132.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 27.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA019484, HPA021257, HPA023874, HPA029503" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA019484: AB_1845265, HPA021257: AB_1845266, HPA023874: AB_1845267, HPA029503: AB_10602330" "unprognostic (1.75e-1)" "unprognostic (1.86e-3)" "unprognostic (1.21e-1)" "unprognostic (1.22e-1)" "unprognostic (3.39e-2)" "unprognostic (1.71e-1)" "unprognostic (1.42e-2)" "unprognostic (1.00e-1)" "unprognostic (2.95e-1)" "unprognostic (2.80e-2)" "unprognostic (8.31e-3)" "unprognostic (4.56e-2)" "unprognostic (1.34e-2)" "unprognostic (9.09e-2)" "unprognostic (2.79e-1)" "unprognostic (1.46e-1)" "unprognostic (1.44e-1)" 4.7 11.2 1.3 16.9 1.1 0.0 10.3 0.3 0.9 6.1 27.3 1.1 10.8 16.2 3.6 4.7 17.9 6.8 29.6 2.1 0.7 0.6 8.9 31.0 15.4 0.9 0.8 0.2 2.6 47.4 4.7 16.9 17.0 1.2 15.2 12.5 6.5 14.7 12.3 3.3 11.3 34.0 3.4 0.7 1.4 33.0 11.6 0.4 2.1 18.0 11.2 14.1 18.9 12.9 1.3 2.7 0.1 0.2 0.0 0.9 0.1 15.8 12.6 0.3 0.3 0.0 0.5 21.2 4.1 2.7 2.1 1.6 17.5 23.8 0.6 6.2 1.5 18.3 14.1 5.9 17.4 1.9 0.0 7.6 0.0 5.4 9.9 2.6 0.0 5.7 0.6 23.5 1.2 17.3 4.8 0.0 0.0 9.4 0.0 1.8 13.3 0.0 0.0 10.0 22.9 6.8 0.0 0.2 2.5 13.5 14.0 9.1 1.8 9.5 27.7 4.8 14.3 7.7 0.3 0.5 3.2 15.4 0.6 1.8 0.3 4.7 8.0 0.3 2.0 4.9 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.4 0.3 0.0 1.3 0.9 0.2 0.1 0.0 0.2 2.7 0.1 0.1 1.3 1.1 0.3 0.9 0.7 0.6 0.8 0.2 1.2 0.4 11.9 19.3 0.0 43.5 14.8 0.6 1.9 28.1 37.5 28.4 21.0 3.9 10.1 8.3 49.7 27.7 7.5 49.7 0.0 67.4 67.3 2.9 91.6 0.0 13.0 2.2 1.6 30.9 0.0 0.8 35.9 0.9 1.5 8.5 4.6 43.9 1.3 82.9 31.7 0.7 0.8 0.8 0.0 4.3 29.0 49.5 16.9 10.2 0.0 28.5 132.5 BCAR1 "CAS, CASS1, Crkas, P130Cas" ENSG00000050820 "BCAR1, Cas family scaffolding protein" P56945 16 75228187-75268053 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000443, HPA042282" Approved Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB000443: , HPA042282: AB_2677929" "unprognostic (5.44e-2)" "unprognostic (2.96e-1)" "unprognostic (1.61e-2)" "unprognostic (1.67e-2)" "unprognostic (2.17e-1)" "unprognostic (5.43e-3)" "prognostic unfavorable (9.11e-5)" "prognostic unfavorable (1.24e-4)" "unprognostic (2.15e-1)" "unprognostic (3.49e-2)" "unprognostic (5.18e-2)" "unprognostic (1.77e-2)" "prognostic favorable (4.55e-8)" "unprognostic (3.38e-1)" "unprognostic (3.60e-2)" "unprognostic (8.20e-2)" "unprognostic (2.20e-1)" 16.6 12.3 14.3 8.4 19.5 1.8 11.5 29.1 26.7 16.7 22.7 31.5 9.1 28.6 17.5 11.0 9.6 10.8 20.4 17.8 14.2 9.4 21.3 17.3 15.9 4.9 18.9 13.5 11.3 31.0 9.2 13.2 28.1 13.9 10.9 7.9 14.6 25.7 12.5 37.4 7.2 25.7 8.6 10.4 28.9 28.7 17.3 20.1 0.2 11.8 9.7 6.3 13.3 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.2 16.4 8.0 2.6 3.1 2.8 15.4 13.0 7.5 9.5 7.5 21.0 14.1 0.8 17.2 14.4 10.6 8.1 2.7 14.9 2.7 0.0 9.2 0.0 10.0 17.5 7.8 0.0 6.7 8.7 7.4 11.3 5.6 5.6 25.7 0.0 8.3 0.4 5.6 22.4 0.0 0.6 10.6 7.1 10.9 0.3 3.6 3.4 8.7 12.1 9.8 14.1 12.4 2.9 5.0 4.0 6.7 2.2 23.2 16.0 13.9 3.9 19.1 3.5 1.9 0.2 10.1 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 19.5 29.1 26.7 14.2 9.4 18.9 13.5 13.9 20.1 20.8 5.8 2.2 51.8 24.8 13.4 20.7 25.5 4.0 13.6 21.0 5.9 38.1 23.2 45.7 13.5 54.0 56.1 0.0 53.7 20.9 26.0 47.8 9.2 17.9 5.5 12.7 33.5 42.4 1.2 18.0 15.3 2.5 30.4 1.0 35.4 12.3 55.9 52.6 31.5 30.0 4.7 19.4 67.4 14.0 14.7 15.4 30.2 0.0 22.6 54.5 BCL2L12 ENSG00000126453 "BCL2 like 12" Q9HB09 19 49665142-49673916 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Extravillous trophoblasts: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020856 Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020856: AB_1845320" "unprognostic (2.59e-1)" "unprognostic (3.96e-2)" "unprognostic (2.24e-1)" "unprognostic (5.72e-2)" "unprognostic (3.64e-1)" "unprognostic (3.68e-2)" "unprognostic (6.80e-3)" "unprognostic (3.87e-3)" "unprognostic (6.12e-2)" "unprognostic (8.90e-2)" "unprognostic (1.60e-2)" "unprognostic (2.33e-2)" "prognostic unfavorable (8.75e-5)" "unprognostic (8.67e-2)" "unprognostic (3.62e-2)" "unprognostic (2.37e-1)" "unprognostic (2.56e-1)" 6.7 6.5 2.8 15.3 3.3 12.6 7.9 1.2 3.2 8.8 11.8 2.9 9.3 8.3 8.2 9.1 14.0 7.2 11.3 9.5 3.3 1.8 8.1 15.3 12.0 15.5 3.7 2.2 9.2 18.0 3.2 2.6 21.5 3.8 9.0 5.8 6.3 10.6 9.4 12.5 6.5 9.0 8.1 3.4 14.8 8.9 10.0 3.8 29.8 6.6 18.1 15.1 8.4 7.0 13.9 22.4 13.4 9.8 12.0 13.6 5.6 33.1 20.2 16.4 30.6 4.2 4.1 19.1 18.9 7.6 19.0 20.3 28.1 18.2 18.7 9.1 6.3 10.6 16.5 14.9 12.4 10.4 23.4 32.6 17.3 13.8 19.5 3.8 17.7 21.1 5.0 6.0 21.2 6.1 3.8 12.6 24.6 44.0 24.2 10.0 18.8 21.3 30.7 21.0 19.7 26.2 27.6 17.4 20.2 8.2 16.3 0.3 9.6 19.3 26.1 13.4 12.2 10.9 22.8 7.6 21.4 25.5 15.0 30.9 20.4 31.4 35.7 9.1 25.2 21.2 9.6 6.8 13.4 11.4 9.8 13.6 13.9 12.3 11.0 6.0 11.6 11.9 11.6 9.2 12.0 7.1 22.4 12.4 5.6 2.8 3.3 1.2 3.2 3.3 1.8 3.7 2.2 3.8 3.8 8.9 13.3 13.7 29.2 28.6 0.8 4.5 12.7 6.7 12.5 5.2 0.0 53.9 6.6 22.6 5.5 10.2 6.1 46.7 22.6 106.1 23.2 19.8 9.2 12.4 31.8 0.0 6.4 6.7 8.8 2.7 6.1 15.4 25.3 28.9 12.9 3.3 26.4 8.7 5.6 8.2 1.1 12.9 10.8 10.4 18.7 16.9 46.6 12.9 19.6 19.6 BCORL1 "CXorf10, FLJ11362" ENSG00000085185 "BCL6 corepressor like 1" Q5H9F3 X 129981107-130058083 "Cancer-related genes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Autism spectrum disorder, Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "Syncytiotrophoblasts: 78.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 20.4;HAP1: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031775, HPA031777, HPA068568" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA031775: AB_10602332, HPA031777: AB_10671578, HPA068568: AB_2686007" "unprognostic (8.07e-2)" "unprognostic (2.78e-2)" "unprognostic (7.09e-2)" "prognostic unfavorable (2.20e-5)" "unprognostic (4.58e-1)" "unprognostic (1.68e-3)" "unprognostic (1.96e-3)" "unprognostic (5.56e-3)" "unprognostic (2.39e-1)" "unprognostic (8.02e-2)" "unprognostic (4.46e-2)" "unprognostic (2.04e-1)" "prognostic unfavorable (5.00e-4)" "unprognostic (9.18e-2)" "unprognostic (2.60e-2)" "unprognostic (3.09e-1)" "unprognostic (1.41e-2)" 7.5 7.9 7.7 5.2 9.1 9.8 9.1 19.8 10.5 8.7 8.3 10.7 8.1 5.4 9.2 5.4 5.8 9.3 4.2 6.9 8.4 4.5 7.5 4.7 6.7 5.3 7.6 5.9 11.4 8.9 13.4 15.0 28.9 7.5 8.1 4.5 6.0 6.5 8.4 6.0 6.5 6.0 8.8 5.3 7.7 6.6 26.1 8.1 6.8 10.3 2.2 5.1 6.7 8.5 1.2 1.6 3.5 1.3 0.8 1.3 0.7 2.2 5.5 12.9 20.4 7.6 5.5 3.6 3.0 3.5 3.9 4.5 6.6 1.4 1.0 6.7 6.0 3.7 1.3 30.8 1.2 3.7 2.2 4.5 10.6 2.7 2.2 3.8 2.6 3.1 3.4 2.5 7.7 0.4 5.8 4.7 3.5 5.1 10.8 2.5 1.3 3.9 8.0 3.5 1.8 3.9 8.3 5.2 1.4 2.2 0.3 2.1 7.3 1.6 0.4 2.0 7.2 4.5 4.0 3.9 3.2 4.1 3.8 2.9 3.5 6.3 1.6 2.1 5.4 1.5 0.1 1.3 2.8 1.3 0.2 1.0 1.2 0.9 0.8 1.6 1.0 0.6 0.7 3.5 0.8 0.5 0.7 0.2 0.7 7.7 9.1 19.8 10.5 8.4 4.5 7.6 5.9 7.5 8.1 0.0 3.2 0.0 2.3 10.5 1.8 6.4 5.1 2.7 1.2 7.0 0.0 10.7 0.0 3.2 0.4 7.1 2.7 0.0 0.9 4.2 5.8 2.9 6.9 3.0 2.8 7.9 11.5 3.1 2.6 1.0 4.4 1.8 6.8 1.0 1.7 3.1 2.3 0.0 3.5 2.2 1.0 6.5 4.5 3.5 5.3 10.0 78.1 1.5 2.8 2.5 BEND6 "bA203B9.1, C6orf65, FLJ30162" ENSG00000151917 "BEN domain containing 6" Q5SZJ8 6 56955126-57027342 "Predicted intracellular proteins" "Neurogenesis, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 33.0" "Group enriched" "Detected in many" 8 "Bipolar cells: 68.2;Horizontal cells: 39.7" "Cancer enriched" "Detected in many" 6 "glioma: 4.1" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 11.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 11.1" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.2;fHDF/TERT166: 18.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031605, HPA052973" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA031605: AB_10602395, HPA052973: AB_2682002" "unprognostic (4.27e-1)" "unprognostic (7.05e-2)" "unprognostic (4.42e-2)" "unprognostic (1.18e-6)" "unprognostic (2.44e-1)" "unprognostic (2.10e-1)" "unprognostic (1.17e-1)" "unprognostic (1.77e-2)" "unprognostic (9.41e-3)" "unprognostic (1.57e-1)" "unprognostic (8.82e-2)" "unprognostic (1.94e-2)" "unprognostic (9.84e-6)" "unprognostic (9.27e-3)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.98e-3)" 1.5 3.1 12.0 2.0 10.7 1.0 1.1 29.2 29.7 5.8 1.7 2.5 0.6 0.8 3.2 1.3 1.8 1.1 5.2 3.1 11.2 10.0 1.0 0.5 1.0 1.2 11.3 8.6 2.9 0.8 2.8 1.1 2.7 33.0 3.4 2.2 0.2 1.0 3.4 4.3 1.5 1.2 4.8 7.2 1.2 1.3 1.5 4.1 0.0 1.3 0.0 1.3 3.9 1.6 0.0 11.1 0.0 0.0 2.1 0.0 0.1 3.4 1.5 0.8 0.4 12.1 20.2 3.3 10.4 10.1 4.7 5.4 0.1 1.6 0.0 3.4 18.4 6.5 0.4 1.2 0.5 5.9 1.5 0.6 2.2 4.9 0.2 3.2 6.3 0.1 8.7 2.9 6.4 2.9 8.0 3.1 8.7 2.8 6.0 9.4 3.5 3.8 1.6 2.9 0.1 0.8 0.0 0.1 1.6 1.7 3.4 4.1 4.1 6.9 0.9 0.8 4.2 0.2 3.8 3.9 14.2 0.4 9.6 2.2 8.3 9.1 2.7 8.3 4.4 12.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 2.1 0.0 11.1 0.0 0.1 12.0 10.7 29.2 20.8 11.2 10.0 11.3 8.6 33.0 4.1 0.0 0.0 0.0 0.2 0.8 68.2 3.6 0.0 0.0 1.2 0.0 3.9 0.4 0.0 0.2 0.4 0.0 0.0 0.0 0.3 1.2 6.9 0.6 0.0 0.0 0.1 39.7 0.0 1.8 0.0 0.6 1.7 2.1 3.3 0.0 0.0 3.7 0.3 0.0 2.8 0.3 4.1 0.0 1.9 0.5 4.1 0.9 0.0 0.0 0.0 0.0 BFSP1 "CP115, CP94, filensin, LIFL-H" ENSG00000125864 "Beaded filament structural protein 1" Q12934 20 17493905-17569220 "Disease related genes, Predicted intracellular proteins" "Eye lens protein" Cataract "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 6 "Ito cells: 3.7;Late spermatids: 4.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 6.1" "Group enriched" "Detected in many" 5 "NK-cells: 1.5;T-cells: 6.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 10.0;RPTEC TERT1: 18.2;SK-BR-3: 9.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040748, HPA042038" Enhanced Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA040748: AB_10963786, HPA042038: AB_10964054" "unprognostic (2.24e-3)" "unprognostic (1.99e-1)" "unprognostic (1.63e-1)" "prognostic favorable (1.39e-4)" "unprognostic (1.07e-2)" "unprognostic (2.21e-1)" "unprognostic (1.22e-6)" "unprognostic (5.11e-2)" "unprognostic (5.53e-1)" "unprognostic (2.10e-4)" "unprognostic (1.75e-1)" "unprognostic (8.81e-2)" "unprognostic (3.35e-4)" "unprognostic (4.45e-2)" "unprognostic (2.73e-2)" "unprognostic (1.78e-2)" "unprognostic (7.50e-2)" 2.5 1.8 3.5 2.5 5.6 0.8 2.6 2.8 4.4 3.5 1.8 0.9 5.5 0.8 10.7 5.4 5.1 2.2 4.8 2.4 3.2 3.7 6.1 1.1 4.1 0.6 3.3 1.7 5.3 2.7 4.8 1.3 4.5 3.0 3.3 1.2 2.3 2.0 4.0 3.0 1.8 0.9 2.7 6.9 0.8 1.1 8.0 0.7 0.6 5.3 2.3 1.5 5.1 1.1 0.0 0.0 0.7 0.0 1.5 6.1 0.5 0.7 7.4 2.4 0.3 0.6 2.5 0.4 1.8 8.7 1.2 1.1 3.3 6.4 0.0 1.5 1.0 4.7 1.1 2.6 1.4 1.0 1.6 2.0 0.5 1.0 1.0 1.4 0.4 0.8 2.9 4.6 0.7 2.1 10.0 5.2 0.5 0.2 0.4 3.9 1.4 0.0 1.0 5.6 4.7 2.0 0.0 1.7 0.4 18.2 1.3 2.5 0.3 2.1 9.8 3.8 1.2 4.7 1.6 5.9 0.3 0.6 0.6 1.7 0.0 0.1 0.0 1.3 0.0 1.5 0.1 0.0 0.0 6.1 0.0 0.2 0.0 1.7 1.0 0.0 0.0 0.1 0.5 0.7 1.5 0.0 0.0 0.0 0.5 3.5 5.6 2.8 4.4 3.2 3.7 3.3 1.7 3.0 0.7 3.0 1.7 0.0 0.4 0.8 0.2 1.1 2.5 1.4 0.0 0.0 0.0 0.8 1.7 0.7 0.7 2.1 0.0 0.0 0.8 1.5 0.6 0.3 0.0 0.0 0.4 0.0 0.0 3.7 0.0 4.7 1.7 0.0 1.7 0.0 0.0 1.0 0.7 0.0 0.0 0.2 0.0 0.0 0.9 0.7 1.6 0.6 0.3 0.0 0.2 0.5 BFSP2 "CP47, CP49, LIFL-L, phakinin" ENSG00000170819 "Beaded filament structural protein 2" Q13515 3 133399995-133475222 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Eye lens protein" "Cataract, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "blood: 12.7" "Group enriched" "Detected in some" 4 "B-cells: 10.7;Melanocytes: 5.0" "Cancer enriched" "Detected in single" 7 "testis cancer: 1.7" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 7 "T-reg: 12.7" "Lineage enriched" "Detected in single" 48 "T-cells: 12.7" "Group enriched" "Detected in some" 7 "Daudi: 5.7;U-698: 6.6" "Low region specificity" "Detected in some" "Not detected" "Not detected" "HPA038464, HPA062959" Enhanced Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038464: AB_10672746, HPA062959: AB_2684912" "unprognostic (1.58e-3)" "unprognostic (7.47e-4)" "unprognostic (1.04e-2)" "unprognostic (2.32e-1)" "unprognostic (9.59e-2)" "unprognostic (4.04e-5)" "unprognostic (8.13e-2)" "unprognostic (5.57e-2)" "unprognostic (6.71e-2)" "unprognostic (1.91e-3)" "unprognostic (1.74e-2)" "unprognostic (4.70e-2)" "unprognostic (1.68e-5)" "unprognostic (2.11e-2)" "unprognostic (1.63e-1)" "unprognostic (8.23e-2)" "unprognostic (2.21e-2)" 0.0 0.0 0.1 0.1 0.0 0.1 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.3 0.0 0.0 0.1 0.3 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.1 0.0 0.0 0.1 0.2 0.0 0.0 12.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.6 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 1.7 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 12.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.7 0.0 0.9 0.0 0.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 BLNK "BASH, bca, BLNK-s, Ly57, SLP-65, SLP65" ENSG00000095585 "B cell linker" Q8WV28 10 96191702-96271587 "Disease related genes, Predicted intracellular proteins" "B-cell activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 50.7;lymphoid tissue: 47.1" "Cell type enhanced" "Detected in many" 5 "B-cells: 42.3;Collecting duct cells: 38.4;Syncytiotrophoblasts: 34.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "memory B-cell: 35.9;naive B-cell: 31.0;plasmacytoid DC: 50.7" "Group enriched" "Detected in many" 117 "B-cells: 35.9;dendritic cells: 50.7" "Group enriched" "Detected in some" 6 "Daudi: 18.3;REH: 44.3;RPMI-8226: 24.4;U-698: 66.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009333, CAB016291, HPA038309, HPA038310" Enhanced Supported "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "CAB009333: AB_2290422, CAB016291: AB_626752, HPA038309: AB_2675945, HPA038310: AB_2675946" "unprognostic (4.86e-2)" "unprognostic (6.05e-3)" "unprognostic (1.00e-2)" "unprognostic (2.73e-2)" "unprognostic (2.29e-1)" "unprognostic (1.63e-3)" "unprognostic (1.08e-2)" "unprognostic (5.19e-2)" "unprognostic (2.97e-1)" "unprognostic (1.02e-1)" "unprognostic (8.94e-2)" "unprognostic (3.73e-1)" "unprognostic (1.84e-2)" "unprognostic (5.23e-2)" "unprognostic (9.76e-2)" "unprognostic (1.46e-3)" "prognostic favorable (2.67e-6)" 2.3 2.0 6.9 22.1 8.9 4.2 3.0 1.3 4.8 6.2 15.0 13.7 9.8 17.7 1.9 15.3 31.1 2.7 9.9 1.5 6.4 3.6 18.9 29.5 3.2 24.4 8.9 4.4 1.4 10.4 9.3 2.4 5.0 9.2 5.4 8.5 2.4 9.5 11.5 1.2 6.3 20.6 1.2 16.7 41.7 13.3 1.4 8.7 3.6 6.4 12.8 47.1 6.8 11.8 35.9 50.7 0.2 0.3 0.3 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 18.3 0.1 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.2 0.0 1.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 44.3 0.0 24.4 0.2 3.4 0.0 0.0 0.0 4.2 0.0 0.0 6.2 0.3 0.0 0.0 0.1 0.0 0.0 1.5 0.0 66.8 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.2 0.0 35.9 0.0 0.0 4.4 31.0 0.0 0.0 0.2 0.3 0.0 50.7 0.0 1.8 6.9 8.9 1.3 4.8 6.4 3.6 8.9 4.4 9.2 8.7 6.0 7.7 42.3 18.6 1.0 0.0 0.7 28.1 1.4 2.3 38.4 0.0 16.5 23.2 7.3 2.1 0.0 10.2 0.0 12.2 11.6 0.3 4.4 1.1 22.1 20.5 0.0 4.7 3.7 6.9 1.1 0.3 9.7 1.7 3.6 16.7 0.0 5.5 20.4 0.0 1.8 0.0 6.5 0.2 0.2 0.1 1.3 34.7 0.5 20.1 24.2 BMPR2 "BMPR-II, BMPR3, BRK-3, PPH1, T-ALK" ENSG00000204217 "Bone morphogenetic protein receptor type 2" Q13873 2 202376936-202567751 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017385, HPA049014" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA017385: AB_1845397, HPA049014: AB_2680599" "unprognostic (2.17e-1)" "unprognostic (9.00e-2)" "unprognostic (2.35e-1)" "unprognostic (2.73e-1)" "unprognostic (1.67e-1)" "unprognostic (2.55e-1)" "unprognostic (4.30e-2)" "unprognostic (1.11e-1)" "unprognostic (3.18e-2)" "unprognostic (1.10e-2)" "unprognostic (2.13e-2)" "unprognostic (1.97e-1)" "unprognostic (1.29e-2)" "unprognostic (1.21e-3)" "unprognostic (9.20e-2)" "unprognostic (1.18e-1)" "unprognostic (3.40e-1)" 18.1 15.0 12.1 9.8 14.2 1.1 10.2 9.5 17.1 15.7 11.7 8.2 6.5 5.5 12.9 10.2 10.6 10.3 13.2 14.6 10.8 13.5 10.7 11.5 24.9 4.4 10.4 14.5 12.0 7.0 15.5 6.1 21.7 10.8 11.0 7.7 11.4 7.1 9.1 10.6 7.2 8.1 15.3 7.5 8.9 7.2 12.9 3.8 3.9 11.6 5.2 5.4 11.1 8.9 1.6 2.6 0.9 2.7 1.1 3.6 0.9 5.7 5.4 5.6 8.8 14.0 13.6 10.8 12.0 12.1 10.5 10.5 4.7 8.7 2.0 14.0 24.2 9.0 10.9 7.3 9.3 16.5 6.0 5.0 6.1 5.8 7.3 9.7 1.7 4.8 9.9 8.8 7.7 10.3 16.2 30.2 2.5 3.9 10.0 12.9 10.8 1.4 1.6 3.1 2.8 5.0 3.9 11.0 3.0 8.9 12.3 5.7 5.7 12.8 7.6 14.1 14.3 5.9 4.0 33.3 21.4 11.4 7.3 7.2 1.4 1.7 0.6 5.1 3.9 6.2 0.5 2.0 0.9 3.4 1.8 2.5 1.5 1.3 2.2 2.3 1.6 2.7 1.4 0.6 1.1 2.7 2.6 3.6 0.9 12.1 14.2 9.5 17.1 10.8 13.5 10.4 14.5 10.8 3.8 98.3 38.9 17.1 16.1 29.8 51.7 46.4 12.7 21.4 39.8 19.2 76.6 14.0 1.7 27.3 2.4 119.4 12.7 0.0 24.7 19.4 40.9 19.9 23.1 15.5 16.2 33.4 24.1 109.2 20.0 2.3 31.4 17.4 40.5 15.4 16.3 38.7 36.3 20.9 40.3 10.7 29.9 64.7 45.7 17.7 11.1 31.5 16.7 13.8 13.4 22.7 BMX "ETK, PSCTK3" ENSG00000102010 "BMX non-receptor tyrosine kinase" P51813 X 15464246-15556529 "Enzymes, Predicted intracellular proteins" "Apoptosis, Cell adhesion, Stress response" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "epididymis: 57.1" "Group enriched" "Detected in some" 9 "Endothelial cells: 18.5;Ito cells: 51.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 17 "neutrophil: 10.5" "Lineage enriched" "Detected in single" 105 "granulocytes: 10.5" "Cell line enriched" "Detected in single" 121 "HUVEC TERT2: 90.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001048, CAB032495" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB032495: AB_2290760, HPA001048: AB_1078289" "unprognostic (7.80e-2)" "unprognostic (4.92e-3)" "unprognostic (1.16e-2)" "unprognostic (4.07e-3)" "unprognostic (2.69e-1)" "unprognostic (2.14e-1)" "unprognostic (1.06e-3)" "unprognostic (2.36e-1)" "unprognostic (1.87e-1)" "unprognostic (1.21e-1)" "unprognostic (1.78e-1)" "unprognostic (1.06e-1)" "unprognostic (1.26e-2)" "unprognostic (1.84e-2)" "unprognostic (3.64e-2)" "unprognostic (1.26e-1)" "unprognostic (2.81e-2)" 8.2 0.3 0.1 1.0 0.7 3.6 5.4 0.1 0.3 2.2 5.5 0.1 4.6 2.4 2.6 57.1 1.5 2.5 2.6 10.5 0.5 0.0 0.2 0.9 3.7 6.5 0.4 0.0 1.4 0.9 0.2 0.6 2.6 0.7 2.2 1.4 0.5 1.5 0.6 4.2 1.6 5.5 2.2 0.4 2.4 1.5 1.9 0.1 0.2 2.2 1.1 0.8 2.8 2.4 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 90.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.1 0.3 0.5 0.0 0.4 0.0 0.7 0.1 0.0 1.4 0.0 0.5 0.3 0.0 1.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 18.5 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.1 0.0 4.1 51.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 BORCS5 "LOH12CR1, LOH1CR12" ENSG00000165714 "BLOC-1 related complex subunit 5" Q969J3 12 12357079-12469694 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039509, HPA043627" Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA039509: AB_2676550, HPA043627: AB_2678588" "unprognostic (1.82e-1)" "unprognostic (2.87e-1)" "unprognostic (2.81e-1)" "unprognostic (2.41e-1)" "unprognostic (8.00e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.47e-4)" "unprognostic (6.78e-2)" "unprognostic (6.16e-2)" "unprognostic (2.79e-2)" "unprognostic (6.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-3)" "unprognostic (1.50e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-1)" "unprognostic (9.51e-2)" 8.9 11.9 13.6 8.3 19.4 17.7 13.7 10.8 20.8 9.5 8.6 20.4 4.8 5.9 8.4 19.7 11.1 7.5 8.4 10.9 12.9 14.9 8.6 11.5 9.1 9.4 16.1 18.2 8.1 13.5 14.5 9.9 8.8 16.6 9.1 7.9 10.0 7.7 7.3 10.7 10.7 6.7 10.1 16.0 8.7 8.9 11.3 15.0 9.0 8.5 4.4 12.2 8.8 8.9 8.3 7.8 9.7 10.5 12.9 14.4 6.7 4.2 4.4 3.3 3.3 7.6 10.2 3.9 3.9 4.6 4.7 5.8 11.0 4.4 5.3 2.3 6.1 3.4 3.2 5.6 5.5 5.2 15.2 5.0 3.0 4.4 6.2 7.3 3.0 4.4 5.8 4.0 6.4 7.5 7.5 5.5 7.0 4.1 7.5 6.0 9.0 4.5 3.2 10.1 4.5 2.8 3.8 4.7 5.7 5.9 2.8 4.1 4.7 4.2 3.4 8.3 11.6 2.6 3.5 4.6 3.1 7.3 4.0 3.6 3.8 3.4 12.1 6.7 4.9 5.3 2.5 6.5 9.7 11.3 10.5 13.3 8.3 12.8 12.3 7.8 6.5 8.7 8.8 7.1 12.9 6.7 5.3 14.4 6.7 13.6 19.4 10.8 20.8 12.9 14.9 16.1 18.2 16.6 15.0 8.9 2.9 6.2 10.4 0.0 14.8 0.0 10.2 5.3 4.5 7.0 11.8 7.5 8.3 8.3 4.2 2.9 3.4 0.0 10.9 10.2 3.1 7.6 2.3 4.7 13.1 12.7 4.7 5.5 10.0 3.1 4.9 8.3 0.0 25.2 4.6 14.1 8.2 2.6 6.7 8.6 15.7 25.8 0.0 11.9 5.1 0.0 12.1 12.5 4.7 7.6 BRPF1 BR140 ENSG00000156983 "Bromodomain and PHD finger containing 1" P55201 3 9731729-9748018 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003359 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003359: AB_1078217" "unprognostic (4.18e-2)" "unprognostic (2.21e-2)" "unprognostic (6.47e-2)" "unprognostic (9.10e-2)" "unprognostic (3.42e-1)" "unprognostic (2.33e-2)" "prognostic unfavorable (3.20e-5)" "unprognostic (3.00e-1)" "unprognostic (3.72e-1)" "unprognostic (3.26e-3)" "unprognostic (4.27e-2)" "prognostic unfavorable (5.28e-4)" "unprognostic (1.51e-3)" "unprognostic (4.86e-2)" "unprognostic (3.55e-1)" "unprognostic (6.87e-2)" "unprognostic (9.67e-3)" 10.5 7.7 6.2 10.4 8.1 29.2 10.7 16.5 13.1 10.7 9.5 10.4 5.0 6.8 14.4 8.9 10.7 12.9 10.7 7.0 5.4 4.2 8.2 5.3 10.7 12.3 8.3 7.0 12.5 9.2 11.3 9.5 9.9 7.5 9.0 6.3 9.6 12.1 8.5 11.1 14.2 10.5 8.3 5.1 12.2 9.2 23.7 11.4 24.3 12.0 7.8 11.4 11.5 9.4 1.2 3.5 2.3 1.8 9.3 4.2 1.3 5.4 8.5 8.4 4.1 5.3 4.5 43.2 6.7 4.5 7.9 5.9 7.5 4.6 9.4 3.1 6.7 7.8 4.6 8.5 6.8 5.7 9.9 9.1 12.1 16.9 5.0 6.2 17.1 11.3 5.7 5.7 11.7 7.0 4.4 6.1 9.8 12.8 9.5 4.9 13.1 10.7 14.1 10.7 4.0 8.0 14.4 5.9 6.5 4.2 8.6 5.0 7.8 7.3 5.2 6.2 5.5 5.3 16.7 7.7 9.4 8.0 8.0 12.4 7.7 8.6 17.4 7.3 14.1 8.0 2.2 1.8 2.3 2.7 1.6 4.2 1.1 2.1 2.5 1.5 1.2 2.5 2.9 1.3 9.3 1.5 3.5 1.3 1.3 6.2 8.1 16.5 13.1 5.4 4.2 8.3 7.0 7.5 11.4 14.9 10.6 4.5 4.7 12.6 4.4 3.5 0.0 4.0 7.9 7.0 5.9 3.6 0.0 3.6 1.6 7.5 4.4 0.0 4.7 4.6 4.1 4.4 8.1 2.4 5.5 7.9 9.8 8.6 4.8 0.4 6.1 5.2 1.7 1.0 5.0 4.5 4.3 2.9 5.6 1.8 3.8 6.5 4.7 15.8 11.7 16.2 3.1 7.5 5.8 5.5 BSDC1 "FLJ10276, RP4-811H24.7" ENSG00000160058 "BSD domain containing 1" Q9NW68 1 32365103-32394731 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 36.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 36.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031358, HPA031360" Approved Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA031358: AB_2673841, HPA031360: AB_10601120" "unprognostic (1.42e-1)" "unprognostic (8.97e-2)" "unprognostic (2.91e-2)" "unprognostic (3.86e-2)" "unprognostic (2.48e-1)" "prognostic favorable (8.82e-5)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (1.61e-1)" "unprognostic (1.04e-1)" "unprognostic (9.56e-3)" "unprognostic (5.92e-2)" "unprognostic (1.95e-3)" "unprognostic (1.92e-3)" "unprognostic (2.68e-1)" "unprognostic (2.37e-1)" "unprognostic (2.07e-1)" 21.9 34.7 30.5 16.8 33.9 45.6 22.8 44.0 41.2 20.7 20.5 34.4 30.8 20.7 25.9 36.8 19.9 22.5 23.4 19.6 27.7 27.1 20.1 41.4 19.6 16.6 27.8 27.2 32.0 37.1 44.5 26.4 28.1 32.5 24.8 24.3 22.2 30.4 21.2 19.0 25.1 23.9 22.8 28.9 20.1 21.4 40.4 27.3 16.2 23.9 16.1 20.3 19.5 19.8 8.4 6.8 36.4 5.8 5.2 6.8 5.4 17.5 9.5 19.6 18.2 28.0 23.5 15.9 20.1 27.4 25.6 25.8 13.9 16.2 12.7 23.1 29.1 18.7 16.2 15.4 15.1 20.5 24.2 19.5 10.2 17.9 15.8 26.1 12.8 17.6 23.7 33.8 23.3 16.2 31.3 22.0 17.4 27.4 21.9 18.4 9.2 14.9 11.5 17.2 13.2 15.4 12.3 14.8 17.1 18.7 13.6 28.7 15.8 18.8 19.6 19.2 30.9 15.8 11.3 21.9 16.1 13.6 22.3 16.9 24.8 29.4 9.3 20.7 14.0 12.0 36.4 4.9 17.2 6.5 5.8 6.8 5.9 5.8 5.4 4.6 8.4 6.8 5.9 8.1 5.2 5.1 6.8 6.1 5.4 30.5 33.9 44.0 41.2 27.7 27.1 27.8 27.2 32.5 27.3 29.8 15.2 36.9 49.2 25.2 48.7 17.1 35.7 14.7 10.3 24.4 78.5 42.9 16.6 31.5 87.7 26.6 52.4 70.0 38.4 26.0 26.1 51.5 20.7 49.0 18.0 81.0 38.5 52.8 18.7 78.5 50.6 15.3 30.4 26.2 43.0 35.7 38.9 31.6 44.6 22.6 66.5 38.8 25.9 28.6 41.1 22.6 80.7 37.0 35.7 42.7 BTK "AGMX1, ATK, IMD1, PSCTK1, XLA" ENSG00000010671 "Bruton tyrosine kinase" Q06187 X 101349447-101390796 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Apoptosis, Immunity, Innate immunity, Transcription, Transcription regulation" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 77.5;lymphoid tissue: 37.0" "Cell type enhanced" "Detected in some" 19 "B-cells: 86.8;granulocytes: 203.6;Hofbauer cells: 50.3;Kupffer cells: 53.4;Macrophages: 53.0;monocytes: 52.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 77.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 29.5;HEL: 40.9;HMC-1: 147.5;U-937: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001198, HPA002028, CAB016689" Enhanced Supported "Plasma membrane,Cytosol" NA NA 610000 "Plasma membrane, Cytosol" "CAB016689: AB_1611894, HPA001198: AB_1078305, HPA002028: AB_1078306" "unprognostic (3.19e-2)" "unprognostic (2.51e-3)" "unprognostic (1.06e-2)" "unprognostic (3.66e-2)" "unprognostic (5.69e-2)" "unprognostic (3.76e-3)" "unprognostic (6.55e-2)" "unprognostic (3.58e-3)" "unprognostic (6.02e-2)" "unprognostic (3.12e-1)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (2.08e-3)" "unprognostic (7.80e-2)" "unprognostic (1.29e-2)" "unprognostic (1.56e-2)" "unprognostic (8.14e-2)" 7.3 2.4 3.3 23.5 5.6 14.0 2.6 0.8 3.6 2.3 3.0 4.7 0.3 2.2 1.9 2.6 2.4 2.0 3.7 3.3 3.3 2.5 2.2 2.5 10.7 25.1 5.4 1.2 1.2 1.5 0.2 1.4 3.2 4.1 2.5 4.5 1.5 3.2 1.0 1.0 2.5 12.9 3.3 10.8 37.0 3.1 1.3 6.3 4.0 1.7 1.8 36.7 5.8 2.0 13.7 13.2 77.5 20.7 0.0 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.9 0.0 0.0 0.0 16.4 147.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 0.3 0.0 0.0 0.0 11.5 0.2 0.0 0.0 12.3 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.3 0.2 14.0 0.0 21.4 0.0 77.5 11.3 19.3 0.0 18.1 0.0 13.7 0.0 0.0 13.2 13.7 0.0 0.0 4.5 0.0 20.7 6.0 0.0 6.1 3.3 5.6 0.8 3.6 3.3 2.5 5.4 1.2 4.1 6.3 3.0 12.8 86.8 0.1 0.9 0.0 0.4 0.0 0.0 1.2 0.0 0.0 1.1 0.0 0.0 0.2 0.6 0.0 23.3 0.0 0.4 0.5 0.0 203.6 0.0 50.3 0.0 0.0 1.3 53.4 0.0 0.3 53.0 3.3 52.3 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.3 0.4 1.6 0.3 1.6 0.8 0.0 0.1 BVES "HBVES, POP1, POPDC1" ENSG00000112276 "Blood vessel epicardial substance" Q8NE79 6 105096822-105137174 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Developmental protein" "Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 29.3;skeletal muscle: 37.1" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 31.1;Early spermatids: 24.1;Late spermatids: 42.6;Sertoli cells: 12.9;Spermatocytes: 12.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.9" "Group enriched" "Detected in many" 4 "dendritic cells: 1.2;granulocytes: 2.9" "Cell line enhanced" "Detected in many" "RH-30: 18.7;WM-115: 18.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA014788, HPA018176" Enhanced Supported "Plasma membrane,Cell Junctions" Yes NA "Plasma membrane, Cell Junctions" "HPA014788: AB_1845504, HPA018176: AB_1845503" "unprognostic (2.91e-1)" "unprognostic (2.45e-1)" "unprognostic (2.79e-2)" "unprognostic (1.73e-2)" "unprognostic (5.46e-2)" "unprognostic (3.66e-2)" "unprognostic (5.21e-2)" "unprognostic (2.22e-2)" "unprognostic (8.37e-2)" "unprognostic (4.49e-2)" "unprognostic (2.29e-2)" "unprognostic (8.92e-2)" "unprognostic (5.84e-3)" "unprognostic (3.77e-2)" "unprognostic (1.78e-1)" "unprognostic (2.02e-2)" "unprognostic (3.24e-4)" 2.9 1.0 2.3 2.4 7.6 0.6 8.9 0.7 4.1 2.6 11.5 6.7 6.7 1.7 5.3 2.8 5.3 2.5 2.1 29.3 2.8 2.5 1.5 0.7 2.3 0.9 10.4 1.3 1.2 1.0 0.8 3.5 3.5 6.1 5.4 3.5 3.6 1.6 10.0 37.1 0.8 2.7 19.4 10.7 0.7 5.9 10.0 6.3 0.0 1.6 8.6 0.8 10.3 8.6 0.5 1.2 2.9 0.3 0.4 0.4 0.1 0.8 1.2 4.8 0.8 7.0 9.7 2.1 3.6 2.5 5.6 7.4 0.3 0.0 0.0 0.0 6.7 9.3 0.0 2.0 1.2 5.2 0.0 1.7 0.0 0.6 0.2 1.5 0.0 0.4 5.6 4.3 8.6 0.7 4.2 2.4 2.0 0.1 12.1 12.2 0.1 0.1 0.6 1.0 0.0 0.0 3.4 18.7 0.0 0.0 0.0 6.2 10.8 2.3 0.0 4.8 3.6 0.0 12.2 5.5 8.9 0.0 0.0 9.3 1.1 0.5 0.0 5.3 0.0 18.8 2.9 0.3 0.3 0.2 0.1 0.2 0.3 0.2 0.4 0.0 0.5 0.3 0.3 1.7 0.4 0.1 1.2 0.1 0.1 2.3 7.6 0.7 4.1 2.8 2.5 10.4 1.3 6.1 6.3 0.0 0.0 0.0 0.2 0.2 0.0 31.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 1.9 0.0 0.0 0.0 0.1 1.5 0.6 0.0 0.0 1.7 0.0 0.0 2.5 0.0 42.6 1.1 0.5 0.0 1.8 0.0 0.0 0.2 0.0 3.2 0.0 0.0 12.9 3.9 12.5 5.1 0.6 0.1 0.0 0.0 0.1 C12orf76 FLJ40142 ENSG00000174456 "Chromosome 12 open reading frame 76" Q8N812 12 110027028-110073686 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "brain: 47.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA039713, HPA042013" Uncertain Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA039713: AB_2676640, HPA042013: AB_2677797" "unprognostic (9.20e-2)" "unprognostic (3.31e-2)" "unprognostic (2.35e-3)" "unprognostic (9.54e-2)" "unprognostic (3.50e-2)" "unprognostic (1.14e-1)" "unprognostic (1.75e-2)" "prognostic favorable (6.44e-5)" "unprognostic (1.39e-1)" "unprognostic (1.47e-1)" "unprognostic (8.86e-3)" "unprognostic (1.75e-1)" "prognostic unfavorable (5.74e-5)" "unprognostic (2.09e-1)" "unprognostic (7.85e-2)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" 5.7 8.8 34.6 8.4 26.1 11.6 9.4 19.7 47.6 6.6 6.1 32.6 2.5 7.6 8.1 14.0 5.9 12.0 6.7 5.3 36.1 33.5 8.5 7.9 9.7 11.4 36.2 21.2 11.9 8.4 5.1 7.5 9.4 26.1 7.5 6.4 5.9 7.7 7.9 8.3 14.6 7.4 5.3 38.7 11.1 9.2 9.8 27.4 4.8 11.1 1.8 7.9 6.3 5.0 14.0 12.8 31.3 9.4 14.3 16.3 11.1 6.3 9.4 11.4 10.3 8.2 16.9 12.6 5.6 3.2 5.4 4.1 7.7 6.2 7.8 6.7 2.5 4.2 12.6 4.7 4.6 4.1 11.6 10.0 7.8 14.3 15.5 7.8 12.7 15.3 13.5 15.4 4.7 8.7 19.7 8.5 12.7 11.6 20.5 5.6 6.8 6.4 20.9 8.9 4.0 8.6 12.2 7.0 12.6 9.8 6.2 22.9 12.4 7.0 5.2 12.5 12.0 11.4 6.6 10.8 8.3 6.0 6.3 3.3 9.4 10.8 6.4 9.1 7.3 4.7 31.3 9.4 11.2 8.3 6.2 9.2 14.0 13.1 9.3 8.8 11.8 16.3 10.6 12.8 14.3 6.1 12.8 12.6 11.1 34.6 26.1 19.7 35.1 36.1 33.5 36.2 21.2 26.1 27.4 29.8 14.2 10.7 13.8 7.0 23.3 6.3 20.4 36.1 10.3 15.7 2.0 24.1 29.9 10.0 16.2 13.1 6.3 0.0 13.2 8.0 13.6 10.2 4.7 17.3 22.8 30.2 5.8 16.5 19.2 9.0 24.2 16.1 18.6 15.4 11.0 32.3 9.6 7.0 31.8 32.3 20.5 6.5 14.4 26.2 10.1 7.4 10.1 20.8 10.7 5.8 C14orf93 "FLJ12154, RTFC" ENSG00000100802 "Chromosome 14 open reading frame 93" Q9H972 14 22985908-23010166 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Intestinal endocrine cells: 15.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002569 Approved Approved "Nucleoplasm,Plasma membrane" "Secreted - unknown location" NA NA "Nucleoplasm, Plasma membrane" "HPA002569: AB_1078334" "prognostic favorable (5.05e-4)" "unprognostic (1.31e-2)" "unprognostic (2.97e-2)" "unprognostic (2.23e-3)" "unprognostic (2.30e-2)" "unprognostic (1.30e-1)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (1.88e-1)" "unprognostic (1.29e-1)" "unprognostic (4.86e-3)" "unprognostic (7.45e-2)" "unprognostic (2.01e-3)" "unprognostic (1.10e-1)" "unprognostic (2.49e-1)" "unprognostic (2.14e-1)" "unprognostic (7.11e-2)" 10.4 6.1 10.2 11.8 7.3 12.4 9.8 14.3 7.9 12.0 12.2 8.3 16.7 8.1 10.8 13.5 10.3 11.1 10.3 7.2 9.6 4.6 10.3 9.7 8.7 10.3 6.8 5.9 12.2 15.9 12.9 18.9 5.4 7.4 11.0 10.9 9.1 9.8 10.2 7.3 20.3 9.4 8.4 11.0 12.9 9.5 5.8 9.0 22.7 16.3 7.8 14.6 11.6 9.5 9.7 8.8 21.3 11.3 8.8 12.4 6.6 3.9 7.4 6.3 8.8 10.2 22.9 8.8 4.6 7.2 3.7 4.9 4.6 11.7 11.1 4.4 4.2 5.2 8.4 3.8 11.7 3.5 4.3 2.7 7.0 9.0 10.5 8.9 5.0 6.0 16.5 9.2 5.5 7.0 13.5 6.8 7.2 7.5 2.4 3.8 11.1 6.4 9.4 2.1 8.5 5.2 10.4 6.0 6.7 4.8 6.0 23.0 10.0 6.2 6.0 6.3 7.1 9.3 8.9 3.8 7.0 9.3 3.1 4.6 8.6 2.3 7.6 4.8 6.3 7.1 11.7 7.5 21.3 8.3 6.9 7.3 9.7 6.8 8.6 8.8 9.4 10.2 9.8 10.7 8.8 11.3 6.2 12.4 6.6 10.2 7.3 14.3 7.9 9.6 4.6 6.8 5.9 7.4 9.0 8.9 0.6 4.7 4.8 2.7 1.2 2.8 2.5 5.3 1.2 0.0 3.9 3.0 6.6 2.8 0.5 2.9 2.9 0.0 2.6 4.3 2.4 2.0 6.9 1.1 3.3 0.0 15.1 1.3 2.7 1.0 4.0 3.4 5.0 0.0 5.2 2.9 3.4 7.0 3.9 3.0 1.9 6.5 3.1 1.5 7.9 1.4 2.5 4.3 4.9 1.4 C16orf74 MGC17624 ENSG00000154102 "Chromosome 16 open reading frame 74" Q96GX8 16 85690084-85751129 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 44.6" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 47.6;Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 69.6;Syncytiotrophoblasts: 62.1;Urothelial cells: 43.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 26.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 34.3;hTCEpi: 29.3;T-47d: 30.5" "Low region specificity" "Detected in all" HPA049367 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA049367: AB_2680730" "unprognostic (1.16e-1)" "unprognostic (2.21e-2)" "unprognostic (6.74e-3)" "unprognostic (2.15e-3)" "unprognostic (3.65e-2)" "prognostic unfavorable (1.71e-4)" "unprognostic (1.08e-3)" "unprognostic (4.22e-3)" "prognostic unfavorable (4.08e-4)" "unprognostic (5.06e-2)" "prognostic unfavorable (1.54e-5)" "unprognostic (3.40e-1)" "unprognostic (1.76e-3)" "unprognostic (2.51e-1)" "unprognostic (3.55e-1)" "unprognostic (2.15e-2)" "unprognostic (9.07e-3)" 2.7 0.7 6.3 5.6 3.9 9.3 6.8 0.6 3.3 4.7 3.0 1.4 10.8 1.5 2.1 3.7 6.8 1.5 2.4 1.8 9.2 1.7 2.0 0.8 2.0 11.7 2.0 2.1 0.9 2.1 3.9 1.0 44.6 1.6 7.1 1.3 18.8 4.5 9.5 1.5 6.3 4.2 3.9 1.5 12.9 3.0 1.4 1.5 0.4 4.7 6.2 10.3 18.9 10.0 26.3 8.8 10.3 8.2 3.3 8.3 5.4 12.2 4.1 0.1 1.7 1.9 2.1 5.1 1.5 2.0 4.8 1.3 3.1 11.5 0.1 17.4 1.2 2.0 17.7 0.7 34.3 2.7 0.0 2.7 0.0 1.8 0.3 5.2 0.3 0.0 4.5 29.3 4.6 20.1 3.6 15.6 2.1 0.0 0.0 0.1 10.3 0.0 18.7 1.1 13.2 11.8 0.5 0.0 1.0 0.0 14.0 3.9 1.0 6.2 3.2 3.1 1.4 30.5 5.2 15.9 3.1 8.0 1.3 4.4 4.3 3.1 13.5 0.0 4.4 0.6 0.0 8.2 10.3 0.6 2.7 2.2 20.4 4.5 3.6 8.8 26.3 7.6 4.7 3.2 3.3 0.8 0.1 8.3 5.4 6.3 3.9 0.6 3.3 9.2 1.7 2.0 2.1 1.6 1.5 3.0 0.6 38.4 47.6 8.2 17.9 1.2 0.0 1.4 3.4 1.8 55.0 38.4 3.3 2.8 1.3 2.1 0.0 0.0 1.0 13.5 4.8 4.1 0.0 0.0 4.3 14.3 0.0 1.3 0.8 0.0 3.1 1.6 18.6 0.0 0.0 8.8 2.2 0.0 3.2 1.7 69.6 0.0 3.4 0.9 6.4 6.0 62.1 0.9 0.0 43.2 C17orf58 ENSG00000186665 "Chromosome 17 open reading frame 58" Q2M2W7 17 67991101-67996431 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-BR-3: 31.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 110.1" HPA023036 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023036: AB_10601144" "unprognostic (1.41e-1)" "unprognostic (1.22e-1)" "unprognostic (6.66e-2)" "unprognostic (1.35e-1)" "unprognostic (1.00e-1)" "unprognostic (7.65e-3)" "prognostic unfavorable (8.99e-4)" "unprognostic (7.45e-2)" "unprognostic (2.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.22e-2)" "unprognostic (6.69e-2)" "prognostic unfavorable (1.31e-10)" "unprognostic (1.16e-2)" "unprognostic (1.04e-1)" "unprognostic (5.00e-2)" "unprognostic (1.01e-1)" 11.1 6.8 10.7 6.2 9.3 3.5 17.3 8.8 11.5 29.0 8.3 5.7 8.3 4.1 15.4 8.1 6.5 8.1 6.6 8.9 7.7 6.3 6.3 9.1 6.2 3.1 7.4 5.0 6.3 10.4 5.2 3.6 33.3 5.2 7.8 7.5 5.7 5.3 4.0 6.9 3.7 6.1 11.8 5.5 5.1 6.6 4.8 4.4 1.1 6.9 4.5 6.8 11.0 11.7 3.6 5.2 9.5 6.3 3.2 3.0 2.2 5.3 5.3 5.3 6.5 3.8 9.8 4.2 2.2 6.4 3.9 6.4 3.1 7.0 7.1 5.1 1.8 7.0 2.8 12.0 4.8 9.6 12.8 12.1 4.6 2.0 9.7 6.1 3.9 8.5 5.3 5.8 3.8 8.9 4.4 18.4 6.3 9.8 11.1 3.8 7.1 0.7 5.2 6.0 13.0 5.6 1.7 5.8 9.5 4.9 3.6 3.9 7.2 3.4 31.5 11.5 6.8 8.9 4.6 3.4 3.4 3.5 2.4 4.6 22.3 16.3 6.3 8.5 6.9 5.9 9.5 3.8 6.3 3.0 3.6 1.0 3.6 1.1 2.4 5.2 0.8 0.5 1.2 1.5 3.2 6.3 0.2 0.5 2.2 10.7 9.3 8.8 11.5 7.7 6.3 7.4 5.0 5.2 4.4 0.0 1.7 3.7 5.6 4.2 8.6 4.4 5.1 18.7 2.3 10.4 9.8 23.3 19.9 9.6 0.6 13.6 8.0 0.0 8.1 18.2 27.4 13.3 12.7 13.1 15.0 4.8 3.5 11.1 7.5 1.4 3.4 8.9 8.5 27.9 13.0 29.6 8.9 10.5 4.9 15.0 13.6 6.5 10.3 6.0 3.6 7.3 12.8 4.6 9.5 6.0 C17orf62 "FLJ90469, MGC4368" ENSG00000178927 "Chromosome 17 open reading frame 62" Q9BQA9 17 82442589-82450829 "Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "B-cells: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045696 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA045696: AB_2679421" "unprognostic (1.87e-2)" "unprognostic (6.92e-3)" "unprognostic (2.25e-1)" "unprognostic (2.15e-3)" "unprognostic (5.75e-2)" "unprognostic (2.05e-3)" "unprognostic (3.81e-3)" "unprognostic (4.86e-2)" "unprognostic (1.66e-1)" "unprognostic (1.44e-1)" "unprognostic (3.49e-3)" "unprognostic (7.99e-2)" "prognostic unfavorable (6.83e-11)" "unprognostic (1.47e-1)" "unprognostic (5.51e-2)" "unprognostic (7.78e-2)" "unprognostic (9.14e-3)" 19.9 17.3 16.8 35.8 25.2 16.4 20.0 8.6 20.4 16.2 16.2 20.8 10.5 12.1 16.5 13.1 17.1 16.0 22.9 12.1 15.2 12.1 17.5 29.1 20.2 48.3 26.8 12.4 17.6 21.3 12.9 15.7 14.9 20.6 19.5 13.6 12.2 14.7 12.7 6.5 13.9 21.1 20.2 19.0 53.7 16.4 8.3 20.9 26.0 13.8 8.2 42.3 29.2 13.3 30.6 33.0 74.9 44.2 24.2 25.9 34.6 14.2 20.9 11.5 19.0 18.2 19.2 11.2 12.9 15.7 19.0 22.7 7.8 14.5 36.4 11.9 18.3 23.9 14.5 7.9 9.7 13.1 25.9 6.4 9.9 6.9 9.0 18.9 11.1 29.2 22.1 14.1 16.3 9.2 18.4 24.6 28.2 8.3 27.3 16.0 15.9 46.1 9.3 8.7 19.8 11.2 35.2 6.9 27.9 14.0 18.2 9.9 18.7 23.3 27.2 16.6 21.7 28.0 44.7 8.4 14.8 14.5 24.3 13.7 49.9 16.6 26.7 19.4 18.1 13.1 43.8 34.1 44.0 25.9 44.2 20.0 30.2 23.9 25.0 31.4 30.6 20.2 19.6 74.9 24.2 39.6 33.0 24.8 34.6 16.8 25.2 8.6 20.4 15.2 12.1 26.8 12.4 20.6 20.9 29.8 24.8 93.2 8.2 9.8 16.7 0.0 17.8 9.4 13.6 0.0 9.8 23.8 0.0 0.0 1.1 17.6 29.5 23.3 0.0 27.8 22.4 13.1 32.4 21.3 69.8 25.4 24.9 19.0 53.5 1.5 24.7 43.5 18.6 0.0 20.3 22.1 0.0 28.1 17.0 0.0 12.0 0.0 11.4 10.4 7.3 7.8 23.1 58.6 15.2 7.1 C18orf21 "HsT3108, PNAS-124, PNAS-131" ENSG00000141428 "Chromosome 18 open reading frame 21" Q32NC0 18 35972083-35979286 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 94.7;Spermatocytes: 73.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065505, HPA067322" Uncertain Approved "Nucleoli,Plasma membrane" NA NA "Nucleoli, Plasma membrane" "HPA065505: AB_2685498, HPA067322: AB_2685822" "unprognostic (7.31e-2)" "unprognostic (2.14e-3)" "unprognostic (9.88e-2)" "unprognostic (8.66e-3)" "unprognostic (2.04e-1)" "unprognostic (1.77e-1)" "prognostic unfavorable (1.38e-6)" "unprognostic (2.53e-3)" "unprognostic (1.83e-2)" "prognostic favorable (1.81e-6)" "unprognostic (2.88e-2)" "unprognostic (1.24e-1)" "unprognostic (1.16e-1)" "unprognostic (1.21e-2)" "unprognostic (5.15e-3)" "unprognostic (2.35e-3)" "unprognostic (5.97e-2)" 14.1 16.1 13.4 16.7 12.5 53.0 18.4 23.1 25.8 13.0 12.8 7.9 17.6 15.2 15.0 17.7 15.0 12.9 11.7 15.2 12.4 12.5 14.0 14.5 11.3 17.1 11.7 14.7 16.4 22.0 12.9 16.9 14.8 13.0 13.4 12.3 8.1 16.5 17.8 28.7 13.6 14.1 15.8 10.6 17.2 16.7 28.7 11.7 22.9 14.8 21.4 15.7 17.8 14.8 18.5 15.1 40.6 16.5 16.5 21.7 10.6 13.3 9.1 19.8 13.6 12.7 19.4 13.3 18.4 17.5 22.1 22.5 7.7 9.1 10.7 19.7 13.5 15.3 13.7 13.8 14.1 24.6 16.2 14.1 11.2 10.8 17.3 18.4 34.0 14.0 18.7 23.0 19.5 19.8 20.6 18.0 17.2 18.1 17.4 14.5 14.9 22.4 23.6 16.6 6.2 10.0 15.2 16.9 20.8 14.9 14.7 12.7 19.0 12.3 9.9 29.4 18.9 14.4 15.3 12.8 21.8 10.4 8.0 16.2 24.4 21.7 23.5 11.1 17.7 11.4 40.6 16.5 18.3 14.6 16.5 14.6 18.5 15.9 13.7 15.1 16.1 12.3 16.0 14.9 16.5 15.3 14.6 21.7 10.6 13.4 12.5 23.1 25.8 12.4 12.5 11.7 14.7 13.0 11.7 17.9 6.7 15.9 8.2 10.5 9.1 10.8 5.1 2.7 11.4 1.8 5.9 15.8 10.0 17.5 94.7 8.7 9.3 0.0 24.9 24.6 8.9 7.3 13.9 9.4 18.9 7.9 6.9 8.6 16.8 46.0 20.8 13.1 11.8 10.8 13.0 8.4 18.6 11.5 15.9 17.0 11.1 0.0 8.6 73.2 36.1 10.8 11.0 12.8 16.6 7.1 C1orf116 "FLJ36507, MGC2742, MGC4309, SARG" ENSG00000182795 "Chromosome 1 open reading frame 116" Q9BW04 1 207018521-207032756 "Predicted intracellular proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 49.4;lung: 42.8;lymphoid tissue: 37.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 163.8;Alveolar cells type 2: 71.9;Club cells: 78.5;Urothelial cells: 120.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 18.2;CAPAN-2: 32.4;HaCaT: 40.0;HBEC3-KT: 38.4;hTCEpi: 20.4;RPTEC TERT1: 18.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "HPA011888, HPA011889" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 7900 "Plasma membrane, Cytosol" "HPA011888: AB_1853872, HPA011889: AB_1853873" "unprognostic (1.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.95e-2)" "unprognostic (1.68e-1)" "unprognostic (2.35e-1)" "unprognostic (5.78e-2)" "unprognostic (3.27e-1)" "unprognostic (5.19e-2)" "unprognostic (8.07e-2)" "unprognostic (4.18e-2)" "unprognostic (2.87e-3)" "unprognostic (7.09e-3)" "prognostic favorable (1.01e-5)" "unprognostic (5.17e-1)" "unprognostic (2.48e-1)" "unprognostic (7.57e-3)" "unprognostic (1.19e-1)" 0.2 0.3 0.2 1.6 0.2 0.0 4.1 0.2 0.4 7.1 8.3 0.3 0.2 8.4 1.0 1.1 49.4 0.6 14.0 0.2 0.3 0.1 4.3 1.1 42.8 0.2 0.2 0.2 0.5 7.0 0.0 0.9 1.4 0.4 18.8 2.7 0.3 12.5 1.9 0.3 14.4 16.5 0.6 0.2 0.4 20.3 0.4 0.2 0.4 6.8 16.0 37.1 6.1 12.3 0.0 0.0 0.7 0.0 0.1 0.0 1.8 18.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 32.4 0.0 2.1 0.0 0.0 40.0 0.0 38.4 0.0 0.0 0.0 3.3 0.3 0.5 0.0 0.0 0.2 0.0 20.4 0.0 11.4 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 11.8 1.0 0.0 0.0 0.0 18.7 4.8 0.0 0.1 0.3 3.6 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 1.8 0.2 0.2 0.2 0.4 0.3 0.1 0.2 0.2 0.4 0.2 163.8 71.9 0.0 39.9 18.4 0.0 42.3 28.1 41.5 78.5 10.4 0.0 0.0 13.3 21.7 4.8 0.0 31.1 0.0 21.6 0.0 0.5 57.3 5.8 0.0 0.2 0.0 10.3 0.0 0.0 3.3 0.3 0.6 0.0 0.0 16.3 0.0 41.6 7.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 20.5 0.0 0.0 7.4 120.4 C1orf68 "LEP7, XP32" ENSG00000198854 "Chromosome 1 open reading frame 68" Q5T750 1 152719522-152720470 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "skin 1: 123.1" "Cell type enriched" "Detected in some" 14 "Suprabasal keratinocytes: 68.4" "Group enriched" "Detected in some" 13 "head and neck cancer: 2.4;melanoma: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "HaCaT: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA057942 Approved "Plasma membrane,Cytosol" NA NA 61000 "Plasma membrane" Cytosol "HPA057942: " "unprognostic (1.73e-1)" "unprognostic (7.46e-2)" "unprognostic (9.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 123.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 68.4 0.0 0.0 0.0 0.0 C1orf74 "FLJ25078, URLC4" ENSG00000162757 "Chromosome 1 open reading frame 74" Q96LT6 1 209779208-209784559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 11.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028496 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028496: AB_10602698" "unprognostic (3.25e-1)" "prognostic unfavorable (8.52e-6)" "unprognostic (8.41e-3)" "unprognostic (9.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" "unprognostic (1.75e-2)" "unprognostic (9.98e-2)" "unprognostic (3.82e-2)" "unprognostic (1.39e-2)" "unprognostic (4.95e-1)" "unprognostic (2.81e-1)" "unprognostic (6.31e-2)" "unprognostic (1.10e-1)" "unprognostic (2.67e-2)" "unprognostic (1.07e-1)" "unprognostic (5.40e-2)" 2.5 3.9 5.7 5.5 8.5 2.3 5.8 10.4 8.9 2.7 3.8 5.8 4.0 3.3 2.3 5.2 10.4 2.8 2.3 4.1 3.7 2.9 4.9 4.1 2.2 9.8 5.1 4.6 2.5 4.5 4.5 6.5 3.4 4.8 4.6 5.2 3.9 5.1 2.7 2.3 15.0 4.1 2.4 4.9 4.9 3.9 3.9 5.0 4.9 3.2 0.0 5.7 3.9 4.7 6.3 5.5 5.9 1.9 2.8 2.9 1.9 5.6 3.0 1.9 1.1 2.6 3.0 4.4 3.2 4.2 4.0 4.1 6.0 4.4 6.0 1.9 2.1 2.4 11.5 1.2 9.4 4.7 5.9 3.9 4.0 2.2 0.5 3.6 5.5 1.8 1.8 8.3 4.9 8.1 3.3 2.3 8.2 7.8 4.4 3.4 2.9 4.6 5.7 8.0 4.0 5.1 4.9 9.1 8.4 3.4 4.9 7.7 8.2 4.4 3.4 4.9 4.6 5.3 2.9 2.2 3.4 3.9 3.5 5.2 4.0 4.1 6.6 3.0 4.6 4.7 5.9 1.6 1.4 2.9 1.9 2.1 3.8 1.4 2.3 3.2 6.3 2.4 2.8 1.1 2.8 1.0 5.5 1.2 1.9 5.7 8.5 10.4 8.9 3.7 2.9 5.1 4.6 4.8 5.0 3.0 2.1 1.4 6.1 1.9 1.4 2.0 0.0 1.4 1.2 0.0 0.0 3.1 6.6 1.7 0.0 0.6 2.0 0.0 1.8 5.7 0.6 4.8 1.1 2.0 2.3 1.6 3.5 1.3 0.3 0.2 2.3 0.8 0.0 1.8 4.4 2.3 2.7 2.6 0.0 4.8 1.2 0.0 0.4 3.7 3.6 4.3 3.3 0.0 2.9 11.4 C1QBP "gC1Q-R, gC1qR, HABP1, p32, SF2p32" ENSG00000108561 "Complement C1q binding protein" Q07021 17 5432777-5448830 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation" "Cancer-related genes, Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026483 Supported Approved "Plasma membrane,Mitochondria" "Intracellular and membrane" NA NA 930000 "Plasma membrane" Mitochondria "HPA026483: AB_1847108" "unprognostic (2.18e-1)" "unprognostic (1.74e-1)" "unprognostic (3.80e-2)" "unprognostic (6.40e-2)" "unprognostic (2.60e-1)" "unprognostic (6.76e-2)" "unprognostic (7.47e-2)" "unprognostic (4.62e-2)" "unprognostic (2.40e-3)" "unprognostic (6.03e-2)" "unprognostic (4.60e-3)" "unprognostic (3.08e-2)" "unprognostic (7.80e-3)" "unprognostic (1.20e-1)" "unprognostic (3.13e-1)" "unprognostic (3.28e-1)" "unprognostic (3.97e-1)" 24.1 51.6 34.0 51.0 31.4 36.3 42.3 25.8 46.2 22.0 48.8 21.1 22.5 33.9 25.8 25.7 51.1 27.1 33.0 47.1 34.8 35.4 48.4 69.0 26.6 81.1 35.4 25.1 25.2 51.9 32.7 31.2 26.7 36.6 23.8 52.2 24.9 25.1 28.0 55.0 27.3 30.0 29.2 27.8 43.8 26.4 21.3 17.2 55.4 28.1 71.9 46.0 25.5 25.4 59.5 68.1 9.9 35.8 39.0 55.6 65.7 49.5 77.1 27.3 44.0 20.4 25.2 36.9 38.0 31.1 88.6 54.6 73.7 16.6 106.5 37.7 28.7 32.0 44.4 87.6 51.6 82.0 24.3 150.8 49.0 40.0 85.6 32.5 59.7 39.0 27.7 47.5 48.7 70.4 21.4 45.1 63.3 58.2 27.3 34.4 34.6 84.7 43.2 61.5 56.3 46.1 67.6 38.6 58.1 51.1 37.6 21.9 41.1 31.2 40.2 53.0 28.6 25.4 30.3 26.5 28.5 26.0 32.3 82.6 14.3 21.8 46.8 27.2 57.5 43.6 9.9 34.7 8.3 40.1 35.8 52.5 59.5 45.0 39.9 68.1 49.4 55.6 46.3 2.8 39.0 26.9 56.9 34.3 65.7 34.0 31.4 25.8 46.2 34.8 35.4 35.4 25.1 36.6 17.2 26.8 23.3 138.5 155.3 215.9 60.0 72.6 68.8 16.0 27.3 78.5 25.5 269.8 265.2 184.9 64.3 105.7 64.2 23.3 178.3 380.4 101.4 99.0 62.2 125.2 179.0 57.2 76.1 74.3 73.1 64.4 110.7 119.7 148.5 174.1 146.5 91.7 174.3 77.2 92.6 338.8 60.8 84.1 121.5 45.2 160.8 223.2 149.7 85.6 301.5 214.0 C2orf72 LOC257407 ENSG00000204128 "Chromosome 2 open reading frame 72" A6NCS6 2 231037490-231049719 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 22.5;placenta: 23.9" "Cell type enhanced" "Detected in many" 16 "Cholangiocytes: 33.1;Hepatocytes: 111.5;Paneth cells: 62.8" "Cancer enhanced" "Detected in many" "liver cancer: 40.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 13.1;CACO-2: 3.0;EFO-21: 4.9;OE19: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044962 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA044962: AB_10960863" "unprognostic (4.90e-2)" "unprognostic (7.03e-2)" "unprognostic (2.15e-1)" "unprognostic (7.44e-3)" "unprognostic (2.88e-2)" "unprognostic (6.41e-2)" "unprognostic (3.38e-1)" "unprognostic (6.51e-2)" "unprognostic (6.25e-3)" "unprognostic (1.84e-1)" "prognostic favorable (5.27e-4)" "unprognostic (2.65e-1)" "prognostic unfavorable (4.74e-4)" "unprognostic (2.78e-1)" "unprognostic (7.23e-3)" "unprognostic (2.70e-2)" "unprognostic (5.19e-2)" 1.0 0.9 6.5 0.9 8.4 0.8 1.6 1.7 10.1 0.8 7.8 9.9 0.0 2.3 0.8 1.1 0.9 0.9 1.8 0.8 7.7 4.7 1.4 22.5 1.2 0.8 5.1 7.9 0.8 6.1 1.7 1.7 23.9 8.2 2.0 2.5 0.8 1.0 0.9 0.8 0.8 2.6 1.0 2.2 0.8 4.2 0.9 5.9 0.0 0.8 0.0 0.8 0.8 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.0 0.0 13.1 0.0 0.0 0.1 0.0 3.0 0.0 0.0 4.9 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.0 5.6 0.1 0.0 0.0 0.3 0.0 0.0 0.1 2.2 0.1 1.5 0.8 0.8 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 8.4 1.7 10.1 7.7 4.7 5.1 7.9 8.2 5.9 0.0 0.0 1.9 0.0 0.1 0.6 0.3 33.1 0.0 0.0 0.0 0.0 1.4 1.7 2.0 7.3 0.0 15.3 0.0 1.8 9.0 0.0 0.9 0.0 111.5 0.5 0.0 4.7 3.7 2.5 25.8 0.3 0.0 1.7 0.0 13.2 9.7 1.0 62.8 3.9 1.4 0.3 0.0 0.1 0.5 0.9 0.0 4.3 0.0 24.3 0.1 C3orf14 HT021 ENSG00000114405 "Chromosome 3 open reading frame 14" Q9HBI5 3 62318973-62336213 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Early spermatids: 111.9;Spermatocytes: 148.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 21.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 106.9" "Low region specificity" "Detected in all" HPA048286 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA048286: AB_2680340" "unprognostic (8.00e-2)" "unprognostic (1.32e-1)" "unprognostic (7.81e-2)" "unprognostic (3.69e-3)" "unprognostic (6.91e-2)" "unprognostic (9.19e-2)" "unprognostic (5.76e-5)" "unprognostic (1.57e-3)" "unprognostic (2.67e-1)" "unprognostic (9.61e-2)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "prognostic favorable (4.33e-5)" "unprognostic (8.19e-2)" "unprognostic (1.73e-2)" "unprognostic (1.01e-1)" "unprognostic (1.59e-1)" 3.8 14.7 28.2 5.6 23.6 1.0 35.0 16.4 31.2 5.0 3.9 7.7 2.5 3.3 5.5 6.8 11.0 4.1 6.8 4.6 20.9 22.0 9.6 2.9 6.4 5.0 19.9 20.5 8.2 6.3 2.3 19.0 4.8 25.9 17.8 4.1 4.1 5.0 5.6 1.0 12.0 2.7 6.8 15.2 3.0 6.1 20.9 8.1 1.2 9.2 3.8 8.2 13.5 3.4 3.7 6.7 5.2 21.0 0.7 6.1 2.1 0.0 5.8 7.0 0.0 5.1 7.4 5.4 9.5 5.7 12.0 11.9 0.0 8.5 0.0 0.0 6.4 24.7 1.5 0.0 6.0 9.2 0.0 4.0 5.1 0.0 0.0 3.4 0.0 11.2 3.3 8.1 13.5 11.1 0.2 5.8 0.0 0.6 0.1 11.8 106.9 0.0 0.0 8.8 8.4 12.0 0.0 0.0 2.9 9.8 16.3 12.3 10.4 6.3 22.6 8.7 6.1 9.2 5.8 0.1 5.9 0.0 27.4 9.4 5.8 0.0 0.0 5.7 0.0 20.5 5.2 4.3 0.4 0.2 14.3 0.1 3.7 3.6 2.8 4.6 1.1 1.0 0.7 0.3 0.7 21.0 6.7 6.1 2.1 28.2 23.6 16.4 31.2 20.9 22.0 19.9 20.5 25.9 8.1 20.8 10.2 2.7 19.7 32.6 31.2 4.5 7.6 4.0 19.4 21.0 3.9 16.3 51.4 31.3 111.9 11.7 2.6 0.0 47.7 18.9 20.3 22.1 1.1 3.0 27.0 35.0 84.0 4.9 7.8 44.2 13.0 19.5 43.9 83.8 2.6 27.9 29.7 0.0 9.9 34.8 23.1 0.0 15.5 148.6 37.5 25.1 8.2 4.4 3.8 17.0 C3orf20 DKFZP434N1817 ENSG00000131379 "Chromosome 3 open reading frame 20" Q8ND61 3 14675099-14773034 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 25 "testis: 30.9" "Group enriched" "Detected in some" 27 "Early spermatids: 16.4;Late spermatids: 27.1" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 4 "Daudi: 5.7;HEL: 12.2;U-698: 9.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA039584 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039584: AB_10795152" "unprognostic (1.23e-1)" "unprognostic (2.82e-1)" "unprognostic (5.88e-3)" "unprognostic (2.04e-1)" "unprognostic (3.51e-2)" "unprognostic (5.76e-3)" "unprognostic (1.81e-1)" "unprognostic (7.82e-2)" "unprognostic (1.63e-1)" "unprognostic (1.18e-1)" "unprognostic (9.08e-2)" "unprognostic (4.74e-2)" "unprognostic (3.24e-1)" "unprognostic (1.26e-1)" "unprognostic (1.97e-1)" "unprognostic (1.44e-1)" "unprognostic (1.39e-4)" 0.0 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 30.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.3 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.1 0.0 0.2 0.0 0.0 5.7 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.0 0.1 12.2 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.4 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 2.0 0.0 0.5 0.8 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.1 1.2 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 C4orf22 ENSG00000197826 "Chromosome 4 open reading frame 22" Q6V702 4 80335720-80963756 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 22.0;fallopian tube: 19.8;testis: 34.8" "Cell type enhanced" "Detected in some" 25 "Ciliated cells: 163.3;Early spermatids: 74.5;Spermatocytes: 40.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basal ganglia: 8.4;pons and medulla: 22.0" "Cell type enhanced" "Detected in some" "memory B-cell: 1.2;naive B-cell: 2.1" "Lineage enhanced" "Detected in single" "B-cells: 2.1" "Cell line enhanced" "Detected in some" "A-431: 3.2;BJ: 4.0;hTERT-RPE1: 6.3;LHCN-M2: 2.4;SCLC-21H: 2.7;U-251 MG: 2.6" "Low region specificity" "Detected in many" HPA043383 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043383: AB_10797140" "unprognostic (4.77e-4)" "unprognostic (1.52e-1)" "unprognostic (4.06e-2)" "unprognostic (1.45e-2)" "unprognostic (7.24e-2)" "unprognostic (3.27e-1)" "unprognostic (6.93e-2)" "unprognostic (5.90e-2)" "unprognostic (2.67e-3)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.79e-2)" "unprognostic (4.61e-2)" 0.1 0.1 1.4 0.1 8.4 0.1 0.3 0.6 0.2 0.9 0.1 5.1 0.1 0.3 0.4 7.8 0.2 19.8 0.3 0.1 2.8 2.5 0.4 0.1 5.9 0.3 0.1 0.1 3.5 0.1 0.1 1.2 0.1 22.0 0.2 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.2 0.4 0.1 0.1 34.8 2.4 2.9 0.7 0.0 0.2 0.1 0.0 2.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.3 1.9 0.0 4.0 0.7 0.1 0.1 0.0 0.0 1.1 0.0 1.4 0.2 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 2.6 0.0 0.0 1.0 1.9 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 2.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.4 8.4 0.6 0.2 2.8 2.5 0.1 0.1 22.0 2.4 0.0 1.0 0.0 0.1 0.0 0.6 0.0 0.0 163.3 23.9 0.0 0.0 0.0 0.0 0.0 74.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.0 1.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 1.5 0.0 0.0 40.9 2.3 0.0 0.0 0.0 0.0 0.0 C8orf33 FLJ20989 ENSG00000182307 "Chromosome 8 open reading frame 33" Q9H7E9 8 145052378-145056030 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024812, HPA026104" Approved Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA024812: AB_10599490, HPA026104: AB_10600875" "prognostic unfavorable (2.77e-4)" "unprognostic (6.51e-3)" "unprognostic (1.85e-1)" "unprognostic (5.06e-2)" "unprognostic (1.12e-1)" "unprognostic (9.56e-3)" "prognostic unfavorable (8.95e-4)" "unprognostic (4.75e-2)" "unprognostic (3.51e-1)" "unprognostic (2.45e-2)" "unprognostic (5.17e-2)" "unprognostic (2.71e-1)" "unprognostic (1.05e-1)" "unprognostic (5.29e-2)" "unprognostic (1.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.37e-1)" 14.3 41.8 14.4 8.8 13.5 5.5 23.2 10.7 17.3 25.3 19.3 13.4 11.3 11.3 11.9 15.0 12.1 14.4 13.1 15.0 15.3 12.1 15.5 11.8 9.4 12.4 14.3 12.0 24.3 13.5 32.4 8.5 12.9 18.1 13.9 24.9 11.9 12.5 24.4 21.7 11.5 7.6 9.5 21.8 9.3 10.2 9.3 13.5 9.1 16.6 10.5 8.5 10.1 9.4 8.7 13.7 4.9 12.0 17.9 13.0 11.3 8.3 8.6 3.0 1.4 17.7 6.2 5.8 5.8 12.1 11.2 8.1 1.7 0.7 9.8 19.3 6.8 1.6 2.8 12.2 12.9 8.1 4.4 22.1 12.8 5.2 2.7 16.8 6.6 2.8 13.3 21.8 6.2 11.5 5.5 8.7 12.5 24.2 2.1 5.3 12.1 13.8 3.7 7.2 7.3 22.8 8.6 3.8 11.6 7.5 2.9 7.0 10.7 16.5 1.8 7.5 5.3 1.9 2.6 4.5 2.9 8.6 4.3 7.4 7.0 4.8 20.7 9.5 15.3 5.0 0.3 10.0 4.9 10.3 12.0 13.0 8.7 10.9 11.5 13.7 8.6 12.9 10.3 0.6 17.9 9.4 12.6 7.8 11.3 14.4 13.5 10.7 17.3 15.3 12.1 14.3 12.0 18.1 13.5 26.8 22.7 32.8 25.8 39.4 43.0 15.7 50.9 28.1 38.7 24.4 29.5 32.9 53.0 60.8 2.6 44.6 31.5 0.0 56.0 33.0 30.5 21.9 20.8 57.2 25.9 47.7 33.9 37.4 16.7 3.7 35.1 22.8 15.1 28.9 32.5 47.3 45.2 34.5 36.4 31.4 50.3 25.8 34.4 22.4 38.2 37.5 20.8 24.2 44.8 23.5 CACNG4 "MGC11138, MGC24983" ENSG00000075461 "Calcium voltage-gated channel auxiliary subunit gamma 4" Q9UBN1 17 66964910-67033398 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.8;prostate: 16.5" "Cell type enhanced" "Detected in some" 13 "Alveolar cells type 1: 3.0;Glandular cells: 3.0;Intestinal endocrine cells: 7.5;Muller glia cells: 3.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 97.2" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "basal ganglia: 159.8" "HPA005803, HPA065370" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005803: AB_2667439, HPA065370: AB_2685480" "unprognostic (1.27e-1)" "unprognostic (3.16e-1)" "unprognostic (8.87e-2)" "unprognostic (1.05e-2)" "unprognostic (6.42e-2)" "unprognostic (8.64e-3)" "unprognostic (2.91e-1)" "unprognostic (7.08e-2)" "unprognostic (3.37e-2)" "unprognostic (3.85e-2)" "unprognostic (6.03e-2)" "unprognostic (3.87e-2)" "unprognostic (2.38e-10)" "unprognostic (8.57e-3)" "unprognostic (1.23e-1)" "unprognostic (8.71e-2)" "unprognostic (4.28e-1)" 0.7 1.8 16.0 0.8 32.3 0.7 8.1 3.5 37.8 1.2 0.9 11.4 0.2 1.0 1.2 0.8 0.8 6.2 1.2 0.7 9.6 12.9 0.8 0.7 8.0 0.7 7.5 7.1 0.7 1.2 4.9 0.1 1.6 6.8 16.5 0.8 0.1 0.9 2.4 0.8 0.9 0.9 2.0 4.2 0.7 1.7 0.9 10.3 0.0 0.7 0.0 0.7 1.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 1.0 3.9 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 1.1 0.0 0.0 0.0 0.0 10.3 15.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 3.9 1.7 0.0 0.0 0.1 2.1 0.0 2.7 3.9 97.2 0.9 2.5 0.0 10.0 9.5 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 32.3 3.5 13.0 9.6 12.9 7.5 7.1 6.8 10.3 3.0 2.2 0.0 1.1 0.0 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 2.1 0.0 0.0 0.0 0.2 0.1 0.2 3.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.5 CALD1 "CDM, H-CAD, L-CAD" ENSG00000122786 "Caldesmon 1" Q05682 7 134744252-134970728 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Muscle protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 224.5" "Cell type enhanced" "Detected in many" 8 "Leydig cells: 1615.7;Peritubular cells: 1885.2;Sertoli cells: 2257.2;Smooth muscle cells: 2337.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 9 "neutrophil: 4.3" "Lineage enriched" "Detected in single" 9 "granulocytes: 4.3" "Cell line enhanced" "Detected in many" "BJ hTERT+: 79.3;fHDF/TERT166: 128.9;U-138 MG: 82.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000006, HPA008066, HPA017330" Enhanced Enhanced "Plasma membrane,Actin filaments" Yes No 110000000 "Plasma membrane, Actin filaments" "CAB000006: AB_2065456, HPA008066: AB_1078378, HPA017330: AB_1845917" "unprognostic (2.16e-2)" "unprognostic (1.19e-2)" "unprognostic (2.80e-3)" "unprognostic (3.05e-2)" "unprognostic (4.51e-2)" "unprognostic (1.51e-1)" "unprognostic (2.58e-1)" "unprognostic (1.22e-2)" "prognostic unfavorable (3.73e-4)" "unprognostic (2.07e-1)" "unprognostic (1.27e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (1.84e-5)" "unprognostic (6.52e-3)" "unprognostic (1.14e-2)" "unprognostic (1.19e-1)" "unprognostic (1.18e-3)" 38.6 17.4 6.7 33.4 11.1 0.0 26.6 11.9 9.1 83.1 141.0 6.0 111.4 12.6 82.3 59.8 122.8 45.8 46.3 20.1 7.7 5.0 33.5 39.6 26.1 12.9 8.7 8.5 76.3 6.9 4.1 17.8 57.4 8.9 87.8 25.1 10.9 12.4 133.3 15.3 12.9 39.2 224.5 8.5 35.9 64.5 29.7 9.7 2.1 20.3 14.1 5.3 205.3 70.4 0.1 0.2 4.3 0.2 0.4 0.2 5.9 12.1 8.0 18.1 15.9 62.7 50.9 17.9 71.6 79.3 24.6 27.3 14.5 0.3 0.0 17.1 128.9 16.4 2.9 11.5 21.3 33.5 0.1 3.9 0.4 9.5 9.8 41.3 0.0 0.0 39.0 15.9 27.5 15.6 37.8 20.7 0.0 0.0 0.1 36.7 0.0 0.0 0.2 21.6 0.0 2.8 0.1 16.1 0.0 5.0 3.3 3.1 7.9 25.1 3.3 9.6 57.0 0.7 0.1 55.2 82.7 14.5 15.7 24.3 0.0 0.0 0.0 28.7 0.0 61.7 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.2 0.0 4.3 0.4 0.0 0.0 0.0 5.9 6.7 11.1 11.9 9.1 7.7 5.0 8.7 8.5 8.9 9.7 20.8 21.2 22.4 285.3 373.4 156.1 350.6 211.5 9.4 25.0 41.8 5.9 146.5 19.9 303.7 58.2 355.4 0.0 23.3 20.1 802.8 618.3 367.0 4.7 529.8 38.7 87.4 3.5 505.2 24.5 42.4 1615.7 35.2 318.9 11.8 0.9 180.9 118.9 0.0 1885.2 249.0 13.7 2257.2 2337.7 6.8 10.3 150.2 231.4 15.0 0.2 28.3 CALML5 CLSP ENSG00000178372 "Calmodulin like 5" Q9NZT1 10 5498697-5499555 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "salivary gland: 129.5;skin 1: 212.5" "Cell type enriched" "Detected in some" 6 "Suprabasal keratinocytes: 341.5" "Group enriched" "Detected in many" 6 "breast cancer: 97.6;cervical cancer: 189.1;head and neck cancer: 206.0;melanoma: 222.1;urothelial cancer: 82.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 21 "A-431: 95.2" "Not detected" "Not detected" HPA040725 Enhanced Approved "Plasma membrane,Cytosol" NA NA 75000000 "Plasma membrane, Cytosol" "HPA040725: AB_10793863" "unprognostic (7.68e-3)" "unprognostic (5.06e-3)" "unprognostic (5.64e-2)" "prognostic favorable (2.59e-5)" "unprognostic (4.82e-2)" "unprognostic (2.67e-1)" "unprognostic (1.37e-1)" "unprognostic (8.27e-2)" "unprognostic (1.14e-1)" "unprognostic (2.79e-1)" "unprognostic (1.71e-1)" "unprognostic (4.99e-2)" 0.2 0.0 0.2 0.2 0.2 0.0 8.0 0.3 0.2 6.7 0.2 0.2 0.2 0.0 1.0 0.2 4.8 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.2 129.5 0.2 1.8 212.5 0.2 0.2 0.2 0.2 0.0 0.2 0.2 3.1 0.2 10.9 8.2 0.2 19.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 95.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.2 24.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 341.5 0.0 0.0 0.0 1.4 CALN1 CABP8 ENSG00000183166 "Calneuron 1" Q9BXU9 7 71779491-72447151 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.0;brain: 48.5;lymphoid tissue: 20.0" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 4.8;Early spermatids: 5.1;Spermatocytes: 6.9;Spermatogonia: 11.4;Suprabasal keratinocytes: 8.5" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 6 "Karpas-707: 31.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA036278, HPA036708" Approved Uncertain "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA036278: AB_10673125, HPA036708: " "unprognostic (6.38e-2)" "unprognostic (1.11e-1)" "unprognostic (2.87e-1)" "unprognostic (1.32e-2)" "unprognostic (2.02e-1)" "unprognostic (1.13e-2)" "unprognostic (3.67e-4)" "unprognostic (3.16e-1)" "unprognostic (1.29e-1)" "unprognostic (1.57e-2)" "unprognostic (1.41e-1)" "unprognostic (2.43e-1)" "unprognostic (1.83e-2)" "unprognostic (3.53e-2)" "unprognostic (1.23e-2)" "unprognostic (7.72e-4)" "unprognostic (2.99e-1)" 0.8 16.0 10.8 0.8 17.7 1.5 1.0 48.5 39.1 2.3 0.9 5.1 0.0 0.9 1.4 0.8 0.8 1.0 1.3 0.8 9.5 4.4 0.8 1.0 0.9 0.8 6.8 7.3 1.0 1.9 0.8 0.3 0.8 18.6 1.0 0.9 0.0 0.8 2.4 0.9 4.2 0.8 0.9 8.4 0.8 0.8 11.3 3.3 20.0 0.9 0.0 0.8 0.9 1.9 0.3 1.3 0.6 0.4 0.3 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.4 0.0 0.0 0.0 0.0 4.2 0.0 0.0 4.8 0.0 0.5 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 0.0 0.0 5.0 4.8 0.0 0.2 0.0 0.0 0.6 0.4 0.3 0.2 0.1 0.1 0.2 0.2 0.2 1.3 0.3 0.2 0.2 0.5 0.3 0.1 0.4 0.1 0.1 10.8 17.7 48.5 11.6 9.5 4.4 6.8 7.3 18.6 3.3 0.0 0.0 0.0 0.2 2.1 0.1 4.8 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.0 1.8 0.3 3.2 0.0 0.0 0.0 0.0 1.3 0.2 0.0 0.0 0.7 0.0 0.6 0.0 0.0 6.9 11.4 8.5 0.1 0.0 0.0 0.1 CASP4 "ICE(rel)II, ICH-2, TX" ENSG00000196954 "Caspase 4" P49662 11 104942866-104969436 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Immunity, Inflammatory response, Innate immunity, Necrosis" "Hydrolase, Protease, Thiol protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "blood: 82.8" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "HPA027588, CAB037167" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "CAB037167: AB_258864, HPA027588: AB_10603781" "unprognostic (1.19e-2)" "unprognostic (3.73e-1)" "unprognostic (3.44e-1)" "unprognostic (1.99e-2)" "unprognostic (7.19e-3)" "unprognostic (2.63e-2)" "unprognostic (1.26e-2)" "unprognostic (1.56e-2)" "unprognostic (5.31e-2)" "unprognostic (2.71e-1)" "unprognostic (2.38e-3)" "unprognostic (8.39e-3)" "prognostic unfavorable (3.27e-11)" "unprognostic (6.75e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-2)" "unprognostic (4.08e-3)" 10.6 6.3 0.5 9.7 0.5 6.1 9.4 0.0 0.0 4.7 3.5 8.9 3.5 5.9 14.1 5.8 7.3 4.9 0.5 0.5 6.7 16.5 14.0 10.5 1.0 7.5 16.8 0.0 3.0 10.7 5.8 4.0 11.2 1.9 1.6 10.4 8.8 4.3 2.0 19.0 8.2 0.2 4.2 11.3 8.2 8.0 20.5 29.3 82.8 43.2 29.6 35.7 46.8 6.4 2.1 0.0 2.8 13.7 31.4 5.3 11.0 21.6 17.8 25.0 5.3 29.1 3.3 23.8 14.3 21.5 10.7 0.0 19.1 17.0 3.8 0.1 8.6 1.6 13.9 33.8 8.7 4.2 28.5 28.6 21.2 29.7 21.3 30.9 0.1 0.2 0.0 13.5 0.6 5.0 10.2 0.0 14.4 6.3 3.8 4.1 2.9 14.9 10.2 0.1 0.0 10.2 7.2 10.1 0.2 2.9 12.7 16.0 18.8 6.5 16.5 7.7 0.0 0.0 0.0 9.6 19.8 13.1 14.9 39.1 7.0 31.5 43.2 34.6 20.5 24.2 30.1 29.3 20.0 14.8 22.0 82.8 29.6 33.5 4.9 35.7 46.8 56.6 57.5 87.2 53.6 49.6 0.0 3.6 40.8 72.3 54.6 21.0 0.0 113.8 13.3 118.8 0.5 68.8 12.0 0.0 164.0 65.7 45.5 29.4 33.5 26.8 101.8 0.0 20.1 65.1 148.5 1.3 27.0 95.5 28.7 63.1 28.2 1.9 153.2 9.9 19.4 30.9 0.1 6.5 22.7 0.2 0.6 40.1 96.9 117.6 17.5 68.0 CAV3 "LGMD1C, LQT9, VIP-21, VIP21" ENSG00000182533 "Caveolin 3" P56539 3 8733800-8841808 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cardiomyopathy, Disease mutation, Limb-girdle muscular dystrophy, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "skeletal muscle: 65.8;tongue: 44.6" "Cell type enhanced" "Detected in some" 28 "Cardiomyocytes: 18.9;Early spermatids: 4.4;Sertoli cells: 6.5" "Cancer enhanced" "Detected in single" "head and neck cancer: 0.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "RH-30: 46.2" "Low region specificity" "Detected in single" "Not detected" "Not detected" "CAB017518, CAB018557, HPA054488" Enhanced Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.40e-2)" "unprognostic (6.43e-2)" "unprognostic (8.79e-2)" "unprognostic (3.05e-3)" "unprognostic (8.38e-3)" "unprognostic (9.79e-2)" "unprognostic (1.36e-1)" 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 6.3 2.3 0.0 0.3 10.0 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.7 1.3 0.1 65.8 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.0 0.1 44.6 1.5 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 1.4 0.0 0.1 0.3 0.0 0.0 0.0 0.0 CAVIN1 "cavin-1, CGL4, PTRF" ENSG00000177469 "Caveolae associated protein 1" Q6NZI2 17 42402452-42423517 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation, Transcription termination" "RNA-binding, rRNA-binding" "Congenital generalized lipodystrophy, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 399.0;Alveolar cells type 2: 119.0;Club cells: 93.3;Cytotrophoblasts: 122.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 112.6;fHDF/TERT166: 80.4;TIME: 93.4;U-138 MG: 95.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049838, HPA074213" Supported Supported "Vesicles,Plasma membrane" NA NA 29000 "Plasma membrane" Vesicles "HPA049838: AB_2680907, HPA074213: AB_2686674" "unprognostic (1.59e-1)" "unprognostic (4.46e-2)" "prognostic unfavorable (6.36e-4)" "unprognostic (1.56e-1)" "unprognostic (1.76e-3)" "unprognostic (6.33e-3)" "unprognostic (1.72e-1)" "unprognostic (1.04e-1)" "unprognostic (1.43e-1)" "prognostic unfavorable (5.92e-4)" "unprognostic (7.18e-3)" "unprognostic (2.36e-1)" "unprognostic (3.44e-3)" "unprognostic (4.24e-3)" "unprognostic (3.21e-2)" "unprognostic (2.07e-3)" "prognostic unfavorable (5.87e-4)" 105.6 12.7 4.7 26.4 5.4 0.7 111.2 4.5 7.6 68.6 52.0 15.3 31.9 7.1 65.6 45.6 60.3 37.1 74.0 37.3 6.4 4.6 12.1 6.6 47.0 15.6 7.7 6.1 57.8 6.8 7.5 6.9 47.7 13.6 51.8 12.4 34.0 17.4 53.8 45.4 28.6 18.6 115.4 14.7 23.9 27.0 24.3 5.2 3.3 30.4 47.9 12.6 80.6 57.9 0.9 0.6 2.7 0.5 0.7 1.2 0.2 31.2 26.8 0.5 7.1 36.3 43.8 0.7 112.6 49.0 45.0 35.7 13.5 2.0 0.0 22.6 80.4 18.5 51.8 4.8 33.7 36.9 0.1 0.9 13.7 16.4 6.5 23.0 0.0 0.1 30.0 12.5 35.4 12.1 24.1 60.7 0.0 9.3 0.1 19.2 0.5 0.7 0.1 2.6 4.8 0.1 0.0 18.0 0.0 19.2 0.1 0.0 0.2 37.8 0.6 9.0 15.8 3.1 0.2 93.4 95.7 45.0 34.2 40.8 0.0 0.0 0.1 28.4 0.0 10.7 2.7 0.5 0.3 0.5 0.4 0.3 0.3 1.2 0.3 0.2 0.9 0.6 0.3 2.3 0.7 0.4 0.6 0.3 0.2 4.7 5.4 4.5 7.6 6.4 4.6 7.7 6.1 13.6 5.2 399.0 119.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 93.3 22.7 0.0 122.7 3.3 43.9 0.0 0.0 0.0 0.0 3.9 8.9 0.0 0.0 58.1 0.0 14.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 65.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 64.5 0.0 0.0 0.0 CAVIN2 "cavin-2, PS-p68, SDPR, SDR" ENSG00000168497 "Caveolae associated protein 2" O95810 2 191834302-191847255 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 23 "Alveolar cells type 1: 384.1;Alveolar cells type 2: 70.0;Club cells: 150.2;granulocytes: 170.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "basophil: 9.9;neutrophil: 8.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 9.9" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 28.2;HEL: 20.6;HUVEC TERT2: 64.0;LHCN-M2: 99.1;TIME: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "HPA039325, HPA062122" Enhanced Enhanced "Plasma membrane,Cytosol" Yes No 160000000 "Plasma membrane" Cytosol "HPA039325: AB_10805473, HPA062122: AB_2684688" "unprognostic (6.85e-3)" "unprognostic (1.37e-1)" "unprognostic (1.24e-1)" "unprognostic (4.47e-2)" "unprognostic (2.83e-1)" "unprognostic (1.46e-1)" "unprognostic (3.19e-2)" "unprognostic (6.14e-2)" "unprognostic (8.50e-2)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (2.90e-1)" "prognostic favorable (8.45e-5)" "prognostic unfavorable (3.69e-4)" "unprognostic (1.03e-1)" "unprognostic (1.33e-1)" "unprognostic (4.39e-3)" 60.3 8.9 4.9 10.1 8.3 1.8 37.8 2.8 6.1 26.1 32.6 2.8 14.5 3.9 23.9 17.4 18.2 19.5 45.3 46.5 7.1 5.3 15.9 10.4 57.9 20.1 8.9 5.6 20.4 7.6 3.2 4.3 11.6 5.8 19.3 8.9 9.8 6.9 11.2 35.7 3.8 10.6 39.3 7.1 52.9 8.8 7.2 4.4 0.3 34.5 20.1 2.8 33.2 34.5 0.1 1.0 9.9 0.8 0.4 0.1 39.0 0.0 3.5 1.2 0.0 0.1 0.6 0.0 0.7 0.6 0.1 0.2 0.0 0.0 0.0 4.5 28.2 0.0 0.6 0.0 5.5 0.4 0.0 0.0 20.6 0.2 7.8 8.0 0.0 0.0 1.5 3.6 0.6 1.7 0.4 64.0 0.0 7.4 0.0 99.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.8 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 26.0 0.0 2.2 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 9.9 0.8 0.3 0.0 0.2 0.1 0.0 0.0 0.0 0.7 0.1 0.0 0.0 8.9 0.4 0.4 1.0 0.1 39.0 4.9 8.3 2.8 6.1 7.1 5.3 8.9 5.6 5.8 4.4 384.1 70.0 0.0 0.0 0.0 0.0 0.0 0.0 53.5 150.2 0.0 0.0 0.1 5.0 1.5 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 170.9 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 CCBE1 "FLJ30681, KIAA1983" ENSG00000183287 "Collagen and calcium binding EGF domains 1" Q6UXH8 18 59430940-59697380 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" Angiogenesis "Developmental protein" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 28.0" "Cell type enhanced" "Detected in many" 15 "Horizontal cells: 14.3;Ito cells: 12.3;Rod photoreceptor cells: 42.0" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 4 "hippocampal formation: 10.0" "Group enriched" "Detected in some" 7 "basophil: 9.6;neutrophil: 2.7" "Lineage enriched" "Detected in single" 11 "granulocytes: 9.6" "Cell line enhanced" "Detected in many" "BJ: 26.8;BJ hTERT+: 27.5;BJ hTERT+ SV40 Large T+ RasG12V: 25.7;HBF TERT88: 30.8;hTERT-HME1: 41.8;LHCN-M2: 46.9;TIME: 25.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA041361, HPA041374" Uncertain Supported "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA041361: AB_10796667, HPA041374: AB_10794515" "unprognostic (3.09e-1)" "unprognostic (5.01e-2)" "unprognostic (9.54e-5)" "unprognostic (1.66e-2)" "unprognostic (2.40e-2)" "unprognostic (5.68e-5)" "unprognostic (2.31e-2)" "unprognostic (2.03e-1)" "unprognostic (4.54e-2)" "unprognostic (1.21e-1)" "unprognostic (7.39e-2)" "unprognostic (2.17e-2)" "unprognostic (3.62e-3)" "unprognostic (4.04e-3)" "unprognostic (1.64e-1)" "unprognostic (7.45e-2)" "unprognostic (2.02e-2)" 10.0 12.6 2.4 3.8 1.1 0.4 3.5 0.4 2.0 16.8 15.8 0.6 8.2 0.8 12.1 2.8 2.3 6.9 6.9 2.1 10.0 0.5 3.1 4.3 16.5 3.6 0.4 2.1 28.0 0.8 0.4 2.6 0.3 1.7 3.0 2.3 9.1 1.0 3.5 10.6 3.3 3.0 4.9 0.3 0.3 1.7 2.1 1.3 0.2 1.0 0.0 0.7 2.9 5.1 0.8 0.4 9.6 0.3 0.8 0.3 0.2 5.2 0.4 0.0 0.0 4.2 13.1 8.2 26.8 27.5 19.5 25.7 0.0 0.1 0.1 0.0 10.6 4.6 0.5 0.0 17.3 30.8 0.1 0.1 0.0 0.1 0.1 9.7 0.1 0.0 8.8 0.7 15.2 41.8 8.4 0.9 0.0 0.0 0.1 46.9 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.5 0.1 0.2 0.0 0.0 0.2 2.0 0.0 0.1 25.2 0.0 2.7 3.9 0.0 0.1 0.0 0.0 1.3 0.1 0.6 9.6 0.3 0.8 0.3 0.2 0.2 0.4 0.2 0.2 0.1 0.8 0.3 0.3 2.7 0.8 0.2 0.4 0.2 0.2 2.4 1.1 0.4 2.0 10.0 0.5 0.4 2.1 1.7 1.3 3.0 2.2 0.0 1.1 4.0 7.2 0.8 2.5 1.4 3.4 0.0 7.9 0.6 0.0 0.1 0.5 0.7 0.0 0.0 0.2 0.6 3.1 1.1 1.1 0.0 0.3 14.3 0.0 12.3 1.5 0.2 8.9 0.5 6.8 0.0 0.0 1.1 0.5 0.0 0.4 0.0 42.0 0.0 4.1 0.0 0.7 3.8 0.7 0.0 0.0 0.7 CCDC115 "ccp1, FLJ30131, MGC12981" ENSG00000136710 "Coiled-coil domain containing 115" Q96NT0 2 130338241-130342349 "Disease related genes, Predicted intracellular proteins" "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA034598 Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA034598: AB_10601697" "prognostic favorable (7.59e-4)" "unprognostic (1.28e-2)" "unprognostic (1.10e-3)" "unprognostic (6.80e-3)" "unprognostic (3.23e-1)" "unprognostic (1.08e-1)" "unprognostic (4.20e-2)" "unprognostic (8.13e-3)" "unprognostic (2.63e-1)" "unprognostic (4.29e-1)" "unprognostic (2.87e-1)" "unprognostic (1.91e-2)" "unprognostic (1.19e-2)" "unprognostic (1.07e-1)" "unprognostic (7.83e-2)" "unprognostic (2.16e-1)" "unprognostic (3.16e-2)" 18.7 18.4 25.1 14.7 25.9 17.2 21.5 23.4 39.8 27.1 22.3 24.6 17.9 18.1 22.3 28.9 24.2 25.6 19.9 15.0 25.2 24.1 24.9 14.9 21.8 22.6 26.1 22.5 36.1 24.0 25.3 17.1 23.2 28.1 21.3 17.2 19.1 23.8 25.4 9.4 26.5 19.1 17.7 24.1 19.5 16.9 13.0 16.8 17.1 25.3 14.2 28.4 20.3 20.1 34.0 32.8 51.5 56.2 26.7 34.4 38.7 12.7 6.8 8.3 5.3 16.9 17.9 10.5 6.6 16.1 13.3 15.4 15.0 28.4 16.8 22.7 10.2 7.7 13.4 7.0 11.0 10.5 20.1 12.7 12.2 3.8 18.6 14.3 13.9 24.3 15.3 26.1 8.3 4.8 13.7 13.7 14.9 12.0 14.1 15.9 12.2 21.3 23.0 11.4 7.2 17.3 17.1 9.4 14.1 11.6 12.3 9.4 14.5 8.6 15.2 14.7 6.3 15.1 15.0 11.0 7.5 8.1 12.0 5.0 7.7 8.1 15.9 13.9 13.5 8.8 36.8 33.1 51.5 29.7 45.3 26.6 33.8 32.1 31.7 32.8 34.0 30.9 28.8 11.4 26.7 56.2 25.8 34.4 38.7 25.1 25.9 23.4 39.8 25.2 24.1 26.1 22.5 28.1 16.8 17.9 21.2 46.9 40.9 46.0 24.7 9.8 25.5 21.4 25.0 73.3 9.8 63.5 89.5 38.6 1.0 26.9 31.9 0.0 37.4 30.0 32.8 14.5 53.0 17.4 55.9 22.3 26.6 25.8 41.5 3.0 39.4 47.9 50.6 125.4 31.4 38.4 24.8 48.7 49.1 53.6 21.3 45.3 33.9 5.8 20.6 61.2 22.1 52.4 39.6 21.0 CCDC124 ENSG00000007080 "Coiled-coil domain containing 124" Q96CT7 19 17933016-17943991 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041708, HPA046765" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041708: AB_2677628, HPA046765: AB_2679793" "unprognostic (9.39e-2)" "unprognostic (1.36e-1)" "unprognostic (2.51e-1)" "unprognostic (1.70e-1)" "unprognostic (2.16e-1)" "unprognostic (1.97e-1)" "prognostic unfavorable (1.68e-4)" "unprognostic (4.32e-2)" "unprognostic (1.02e-1)" "unprognostic (3.20e-2)" "unprognostic (1.34e-1)" "unprognostic (2.04e-2)" "unprognostic (1.10e-1)" "unprognostic (2.50e-1)" "unprognostic (2.19e-1)" "unprognostic (3.71e-2)" "unprognostic (3.22e-1)" 32.2 21.8 28.8 23.1 25.7 28.1 16.3 16.8 34.4 15.0 22.3 16.8 16.5 20.0 29.0 17.8 22.0 13.6 20.0 34.8 26.5 22.3 18.1 24.4 15.5 16.2 26.4 23.8 15.5 29.4 14.0 12.3 16.3 18.5 17.6 7.6 16.1 34.7 19.9 96.8 20.6 21.2 20.5 20.2 20.7 26.7 14.0 13.3 13.6 19.1 29.0 14.1 17.0 33.2 30.2 39.1 31.9 42.4 32.4 42.2 28.7 48.4 34.5 11.8 23.3 7.9 6.1 38.8 24.3 8.0 13.0 11.0 25.9 20.3 37.1 35.3 10.2 8.5 18.6 13.0 23.3 3.8 38.9 71.4 30.7 27.0 30.0 15.4 34.4 21.2 9.7 15.5 13.2 12.6 7.4 13.6 24.7 39.3 15.7 6.7 47.8 33.7 43.8 26.7 16.7 59.2 33.3 21.5 40.5 10.6 17.6 23.6 33.9 17.0 19.7 24.2 5.0 18.0 12.9 28.8 22.1 27.5 42.3 37.6 22.2 23.4 35.7 27.4 41.8 27.7 27.4 39.0 31.9 42.2 42.4 33.5 28.2 32.8 38.8 39.1 30.2 26.1 31.6 9.5 32.4 30.2 34.5 36.9 28.7 28.8 25.7 16.8 30.4 26.5 22.3 26.4 23.8 18.5 13.3 17.9 4.5 43.2 45.5 80.4 21.8 12.6 28.1 6.7 9.1 69.8 2.0 86.3 116.0 142.5 25.0 54.0 90.6 0.0 172.9 115.7 72.5 52.7 27.6 49.5 97.5 9.5 58.6 41.1 56.9 74.0 30.2 52.2 91.1 104.6 46.2 32.1 165.3 48.0 38.9 105.4 17.4 19.4 59.2 31.6 40.5 96.0 69.2 45.4 56.2 62.5 CCDC144NL MGC87631 ENSG00000205212 "Coiled-coil domain containing 144 family, N-terminal like" Q6NUI1 17 20836447-20896140 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 13.1;testis: 10.6" "Group enriched" "Detected in some" 4 "Early spermatids: 7.2;Rod photoreceptor cells: 7.5;Spermatocytes: 25.8;Spermatogonia: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.2" "Lineage enriched" "Detected in single" 5 "T-cells: 1.2" "Cell line enriched" "Detected in some" 5 "U-2 OS: 26.7" HPA023457 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA023457: AB_2671217" "unprognostic (1.29e-1)" "unprognostic (6.71e-2)" "unprognostic (1.21e-1)" "unprognostic (3.53e-1)" "unprognostic (7.53e-2)" "unprognostic (5.17e-2)" "unprognostic (6.33e-2)" "unprognostic (1.08e-1)" "unprognostic (1.22e-1)" "unprognostic (2.28e-1)" 0.3 0.9 0.9 0.2 13.1 0.5 1.0 2.4 6.6 0.3 0.4 1.4 0.0 0.5 1.5 0.3 0.3 0.9 0.2 0.5 1.2 1.1 0.3 0.6 0.5 0.5 1.7 1.4 1.3 0.4 0.2 1.2 0.8 4.5 1.6 0.5 0.6 0.3 1.8 0.8 0.3 0.2 1.2 4.5 0.4 0.5 10.6 0.0 0.4 0.4 0.0 0.7 0.9 0.2 0.0 0.1 0.0 0.2 0.0 1.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 2.4 0.0 0.0 26.7 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.0 1.2 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.9 13.1 2.4 6.6 1.2 1.1 1.7 1.4 4.5 0.0 0.0 0.3 0.0 0.6 0.2 1.7 0.4 0.0 0.0 0.0 0.0 2.0 0.5 0.0 0.0 7.2 0.7 0.0 0.0 0.0 1.6 0.9 0.5 0.0 0.0 0.4 1.6 1.2 0.0 0.0 1.3 2.8 0.3 1.7 0.0 0.0 1.4 0.1 0.0 1.1 0.3 7.5 0.0 0.9 25.8 7.3 0.3 0.1 0.0 0.0 0.4 CCDC15 FLJ13215 ENSG00000149548 "Coiled-coil domain containing 15" Q0P6D6 11 124954121-125041489 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.2;testis: 19.4" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 34.8;Erythroid cells: 23.3;Spermatocytes: 93.6;Spermatogonia: 24.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA040450, HPA041738" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA040450: AB_10794031, HPA041738: AB_10794675" "unprognostic (2.38e-1)" "unprognostic (3.93e-2)" "unprognostic (8.81e-2)" "unprognostic (1.85e-1)" "unprognostic (2.50e-1)" "unprognostic (4.59e-4)" "unprognostic (2.12e-3)" "unprognostic (1.43e-1)" "unprognostic (1.46e-2)" "unprognostic (2.04e-2)" "unprognostic (9.05e-3)" "unprognostic (3.25e-2)" "unprognostic (9.38e-3)" "unprognostic (1.33e-2)" "unprognostic (3.14e-1)" "unprognostic (5.04e-2)" "unprognostic (1.66e-1)" 1.9 1.3 2.2 2.5 3.9 3.2 5.2 1.2 2.4 1.6 2.2 2.2 0.3 1.3 2.2 2.9 2.4 2.1 1.5 0.9 1.9 1.2 1.2 2.4 2.6 2.0 1.6 0.8 1.7 2.3 1.7 3.8 1.6 1.6 3.0 1.6 1.5 7.7 2.2 0.8 3.7 1.8 1.2 3.3 2.5 1.5 19.4 2.3 16.2 1.3 2.6 2.9 2.6 2.2 1.5 1.1 6.7 1.7 2.3 3.9 1.3 4.7 0.9 6.4 0.0 0.5 1.8 0.0 5.2 6.4 4.9 6.1 0.1 4.0 5.6 4.6 1.8 9.8 3.8 2.7 3.5 8.9 4.7 1.1 6.9 0.8 1.5 0.2 2.0 4.0 0.4 2.5 10.2 5.1 0.9 3.7 7.2 4.6 5.8 10.3 1.0 4.2 2.3 1.5 4.1 5.9 5.3 11.7 1.8 0.7 2.0 3.6 3.2 3.0 0.3 1.3 3.2 7.3 1.8 2.6 10.1 2.3 4.4 6.4 1.4 1.5 4.9 1.4 11.3 6.7 6.7 1.3 1.7 2.4 1.7 2.5 0.8 2.2 3.9 0.4 1.5 3.1 3.4 0.8 2.3 1.7 1.1 3.7 1.3 2.2 3.9 1.2 2.4 1.9 1.2 1.6 0.8 1.6 2.3 3.0 1.4 0.9 1.3 4.4 4.7 0.6 0.0 4.0 3.4 0.0 0.0 0.4 0.0 2.0 34.8 3.0 0.0 23.3 2.9 0.2 1.7 1.4 9.2 1.0 2.8 3.2 1.2 0.6 3.3 21.2 4.0 2.6 3.3 0.0 1.2 3.4 1.3 0.0 2.1 0.7 2.5 6.5 2.0 93.6 24.9 3.3 0.1 2.2 0.6 0.3 CCDC154 "C16orf29, LOC645811" ENSG00000197599 "Coiled-coil domain containing 154" A6NI56 16 1434383-1444556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 10.8" "Cell type enhanced" "Detected in many" 19 "Cone photoreceptor cells: 7.9;Early spermatids: 36.6;Spermatocytes: 12.0" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 7.5;SCLC-21H: 26.6;U-266/70: 4.8" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "cerebellum: 5.4" "HPA041158, HPA043535, HPA048237" Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA041158: , HPA043535: AB_2678536, HPA048237: AB_2680323" "unprognostic (2.40e-1)" "unprognostic (1.42e-2)" "unprognostic (5.97e-4)" "unprognostic (3.28e-2)" "unprognostic (1.97e-1)" "unprognostic (5.76e-3)" "unprognostic (7.96e-2)" "unprognostic (3.01e-3)" "unprognostic (1.67e-1)" "unprognostic (5.34e-2)" "unprognostic (4.19e-5)" "unprognostic (2.35e-2)" "unprognostic (8.02e-6)" "unprognostic (9.33e-2)" "unprognostic (1.43e-1)" "unprognostic (2.33e-1)" "unprognostic (9.35e-5)" 0.6 1.5 0.6 1.5 1.1 1.6 0.5 4.5 1.4 1.0 0.7 2.6 1.3 0.4 0.0 1.5 0.7 0.2 0.7 0.9 1.2 0.4 0.4 2.5 0.5 1.3 1.1 0.0 3.9 0.6 2.9 0.0 1.2 0.8 1.2 2.9 1.2 0.2 0.7 3.4 3.7 10.8 2.8 0.6 0.2 0.6 0.7 0.0 0.8 0.1 0.0 1.1 0.0 7.5 0.3 0.2 0.5 0.3 0.1 0.4 0.1 0.0 0.0 0.0 0.2 0.6 0.1 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.2 0.3 0.3 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.9 0.4 0.0 0.5 0.0 3.8 0.2 0.0 0.1 2.2 0.1 0.1 0.0 0.1 26.6 0.4 0.1 0.1 1.1 0.1 0.8 1.9 0.0 0.4 0.1 0.3 0.0 4.8 1.2 0.0 0.0 3.8 0.2 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.7 0.2 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 3.3 0.5 2.5 1.4 0.0 3.5 7.9 0.0 0.0 0.0 36.6 0.0 0.0 0.0 0.3 0.0 0.2 0.1 1.1 0.0 0.7 6.4 0.0 0.0 0.8 4.4 1.4 0.5 1.7 0.0 0.0 3.2 0.0 0.0 0.4 0.2 3.9 0.0 1.0 12.0 1.3 0.4 0.0 0.0 0.0 0.1 CCDC28A "C6orf80, CCRL1AP, DKFZp586D0623" ENSG00000024862 "Coiled-coil domain containing 28A" Q8IWP9 6 138773509-138793319 "Disease related genes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 140.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA055125 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055125: AB_2682705" "unprognostic (1.51e-1)" "unprognostic (6.88e-3)" "unprognostic (2.70e-1)" "unprognostic (6.67e-2)" "unprognostic (7.96e-2)" "unprognostic (9.66e-3)" "unprognostic (1.16e-1)" "unprognostic (2.58e-3)" "unprognostic (3.80e-1)" "unprognostic (8.34e-3)" "unprognostic (4.29e-3)" "unprognostic (1.02e-1)" "prognostic favorable (1.11e-5)" "unprognostic (1.63e-1)" "unprognostic (1.06e-1)" "unprognostic (2.28e-2)" "unprognostic (2.37e-2)" 12.9 30.8 25.4 19.8 28.7 20.9 17.9 22.6 27.9 15.6 17.4 13.3 18.7 18.5 11.5 24.8 12.4 22.6 16.8 11.0 31.4 32.2 36.5 40.5 17.4 19.2 22.2 21.7 14.2 22.2 25.5 19.2 19.3 28.3 16.1 15.4 16.4 31.6 20.8 17.4 11.0 21.3 13.9 16.1 18.3 16.5 15.0 13.4 18.2 33.9 9.3 19.8 19.3 12.5 30.0 29.3 73.5 27.3 30.6 44.5 24.5 3.4 6.2 4.7 8.6 8.9 12.5 9.6 5.7 10.0 7.5 12.4 5.3 6.8 14.8 11.1 5.6 10.7 6.0 7.7 7.9 12.3 17.1 17.2 12.0 7.7 10.6 14.1 20.8 12.7 8.0 10.1 5.4 16.2 15.6 12.3 21.1 12.1 20.8 8.5 7.6 17.0 27.4 4.3 13.9 6.5 10.3 4.7 13.7 9.0 5.1 5.9 9.1 7.5 6.9 16.4 9.8 3.3 23.0 9.4 5.9 6.8 11.0 8.6 27.9 24.6 10.9 6.4 12.9 5.2 33.2 27.3 33.7 26.0 27.0 23.2 30.0 27.6 28.3 29.3 29.7 32.1 29.5 73.5 30.6 22.9 25.8 44.5 24.5 25.4 28.7 22.6 27.9 31.4 32.2 22.2 21.7 28.3 13.4 29.8 34.4 36.3 23.6 11.8 15.2 9.4 15.3 60.2 20.5 34.9 17.7 69.7 104.5 12.9 140.9 19.6 31.3 0.0 27.6 36.9 20.0 38.9 41.6 41.9 35.0 9.5 23.7 28.3 38.3 64.6 15.5 34.4 30.4 35.1 32.2 20.5 17.7 32.0 14.2 100.3 12.5 12.9 12.2 40.2 30.3 13.0 91.1 37.6 22.2 27.7 CCDC62 "CT109, ERAP75, FLJ40344, TSP-NY" ENSG00000130783 "Coiled-coil domain containing 62" Q6P9F0 12 122774327-122827528 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 18 "testis: 44.3" "Group enriched" "Detected in some" 7 "Early spermatids: 148.4;Late spermatids: 50.4;Spermatocytes: 78.8" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "U-2 OS: 7.7" "Low region specificity" "Detected in all" "HPA039021, HPA058741" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039021: AB_10673604, HPA058741: AB_2683805" "unprognostic (3.39e-2)" "unprognostic (4.16e-2)" "unprognostic (1.46e-2)" "unprognostic (7.48e-2)" "unprognostic (1.58e-2)" "unprognostic (9.37e-2)" "unprognostic (1.65e-1)" "unprognostic (7.09e-2)" "unprognostic (1.97e-1)" "unprognostic (1.48e-1)" "unprognostic (2.21e-4)" "unprognostic (5.23e-1)" "unprognostic (6.39e-6)" "unprognostic (2.78e-2)" "unprognostic (6.18e-2)" "unprognostic (7.27e-2)" "unprognostic (3.25e-4)" 0.2 0.2 0.3 0.1 0.3 0.1 0.1 0.3 0.7 0.2 0.1 0.1 0.1 0.0 0.1 0.8 0.1 0.0 0.1 0.1 0.7 0.2 0.1 0.3 0.1 0.6 0.1 0.2 0.1 0.1 0.1 0.4 0.1 0.2 0.1 0.0 0.1 0.1 0.5 0.3 0.2 0.1 0.1 0.2 0.3 0.0 44.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 1.0 1.1 2.4 0.6 0.8 1.9 0.4 0.4 0.5 0.3 1.0 0.1 0.7 0.9 0.2 0.3 0.8 0.3 0.3 0.7 1.6 0.2 0.0 0.4 0.3 0.5 0.2 0.4 0.7 0.7 2.6 0.3 0.2 0.0 1.7 2.1 0.3 1.0 1.1 0.4 0.2 0.1 1.8 0.9 0.8 1.1 0.3 0.2 3.4 0.4 0.1 1.9 2.0 0.8 0.3 0.6 0.3 1.5 0.0 0.3 0.9 1.2 0.6 0.1 1.7 0.4 0.9 7.7 0.4 0.4 1.0 0.7 0.7 0.0 0.7 0.5 1.5 0.6 0.4 0.5 0.3 0.9 0.3 0.3 0.4 0.2 1.0 0.8 0.7 2.4 0.8 0.3 1.1 1.9 0.4 0.3 0.3 0.3 0.7 0.7 0.2 0.1 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.5 1.2 0.8 0.0 0.0 0.0 0.0 3.9 0.1 0.0 0.1 148.4 0.2 0.0 0.0 0.2 0.4 0.3 0.5 0.0 0.0 0.1 1.6 0.0 0.0 0.3 50.4 2.8 0.0 1.7 0.0 0.0 0.8 0.1 0.0 2.5 0.0 1.1 12.9 0.0 78.8 3.0 0.6 0.0 0.0 0.1 0.1 CCDC93 FLJ10996 ENSG00000125633 "Coiled-coil domain containing 93" Q567U6 2 117915478-118014133 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054183 Approved Enhanced "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA054183: AB_2682408" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" "unprognostic (8.29e-2)" "unprognostic (1.02e-2)" "unprognostic (3.32e-2)" "unprognostic (2.47e-3)" "prognostic unfavorable (2.97e-6)" "unprognostic (2.51e-1)" "unprognostic (8.12e-2)" "unprognostic (8.99e-2)" "unprognostic (1.52e-3)" "unprognostic (8.56e-2)" "unprognostic (4.87e-1)" "unprognostic (1.79e-2)" "unprognostic (2.67e-1)" "prognostic unfavorable (9.66e-4)" "unprognostic (2.40e-2)" 23.0 20.6 12.9 21.9 14.3 27.2 14.5 23.9 15.6 12.3 18.1 12.8 16.0 17.3 16.8 16.9 10.9 12.3 14.9 23.4 13.1 13.0 14.6 11.0 15.9 16.0 11.8 11.5 20.3 18.0 24.0 26.8 18.6 13.3 11.4 16.0 14.6 13.6 24.9 20.6 16.0 18.1 17.2 15.1 17.1 12.1 15.9 12.0 17.4 17.1 10.2 20.4 11.9 19.2 4.2 3.0 6.3 5.5 3.9 5.7 2.3 13.5 6.0 16.7 14.6 24.2 16.7 14.1 16.2 10.6 10.6 11.0 13.0 8.8 11.7 11.1 12.6 19.1 11.8 9.6 8.4 13.9 15.1 9.8 14.7 10.6 17.4 10.7 15.9 16.8 11.4 8.8 16.7 19.9 14.8 11.2 14.2 8.0 8.3 11.9 5.9 10.0 17.3 7.5 9.8 9.8 12.8 13.1 7.8 8.8 14.5 13.3 7.9 10.5 8.0 11.4 15.6 6.7 9.9 15.7 18.4 15.5 15.5 11.2 10.9 11.3 18.4 10.6 11.9 10.7 6.3 4.2 4.5 5.7 5.5 5.6 4.2 4.1 4.7 3.0 4.1 5.6 4.8 4.4 3.9 3.4 1.5 1.8 2.3 12.9 14.3 23.9 15.6 13.1 13.0 11.8 11.5 13.3 12.0 17.9 26.2 5.1 10.4 15.7 30.5 38.3 5.1 18.7 21.6 1.8 45.2 11.0 8.3 21.2 3.9 12.7 16.0 0.0 14.4 6.6 12.2 10.2 14.0 5.0 13.7 19.1 16.0 12.3 17.1 6.2 12.7 14.1 3.3 20.8 10.3 13.5 23.0 10.4 13.4 7.8 37.9 6.5 12.7 37.0 27.8 14.1 10.8 11.4 11.7 14.5 CCT3 "Cctg, TRIC5" ENSG00000163468 "Chaperonin containing TCP1 subunit 3" P49368 1 156308968-156367873 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006543 Approved Approved "Plasma membrane,Cytosol" NA NA 4000000 "Plasma membrane, Cytosol" "HPA006543: AB_1078426" "unprognostic (2.14e-2)" "unprognostic (3.20e-3)" "unprognostic (1.66e-1)" "unprognostic (6.00e-3)" "unprognostic (8.39e-3)" "unprognostic (3.14e-3)" "prognostic unfavorable (3.87e-7)" "unprognostic (4.43e-3)" "unprognostic (2.78e-1)" "unprognostic (1.16e-1)" "unprognostic (5.44e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (6.34e-4)" "unprognostic (7.16e-2)" "unprognostic (5.76e-2)" "unprognostic (5.67e-2)" "unprognostic (1.10e-1)" 38.8 68.8 37.6 41.8 43.2 26.9 51.2 54.5 51.4 35.1 42.1 46.2 33.8 37.9 50.4 34.8 56.1 52.2 29.2 41.5 36.7 41.6 60.8 61.9 30.9 48.1 43.5 32.8 53.0 59.0 56.7 55.9 39.2 43.0 38.1 50.0 35.3 34.4 41.4 66.4 38.2 39.5 59.7 41.2 41.6 41.9 49.8 47.6 62.1 60.0 49.9 60.7 44.8 82.4 34.8 39.3 14.2 30.5 30.8 45.1 43.9 50.4 57.6 39.3 37.7 43.7 32.5 51.3 47.2 37.5 74.7 46.0 57.0 46.8 83.4 55.0 39.5 47.6 47.6 124.4 61.4 63.9 44.7 78.3 52.9 46.8 45.0 32.2 65.4 44.5 41.2 36.8 67.1 62.5 36.7 63.2 50.4 90.7 30.2 44.3 46.9 86.0 40.1 79.6 99.6 83.5 69.2 39.8 90.3 54.8 32.0 53.3 55.0 43.5 76.7 42.1 66.0 67.8 80.1 43.6 30.4 45.4 31.8 84.1 56.1 99.6 124.1 35.4 41.7 49.3 14.2 25.3 11.2 31.2 30.5 41.6 34.1 34.7 34.2 39.3 34.8 45.1 37.8 3.6 30.8 30.2 25.5 35.5 43.9 37.6 43.2 54.5 51.4 36.7 41.6 43.5 32.8 43.0 47.6 50.6 46.8 129.4 183.9 128.7 109.7 102.4 58.6 127.2 85.3 85.5 100.1 202.7 96.2 186.6 88.8 105.6 80.4 23.3 158.9 172.8 109.3 142.8 72.6 72.7 143.2 69.9 120.2 69.3 70.6 169.9 77.3 80.0 106.3 208.2 75.5 134.0 167.6 87.7 82.7 157.7 195.7 116.4 117.4 367.9 233.1 139.6 154.4 96.5 112.5 146.5 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 36.9;Endothelial cells: 28.0;Hofbauer cells: 36.5;Suprabasal keratinocytes: 38.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 62.8;BJ hTERT+: 38.5" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane,Cytosol" NA NA 120000000 "Plasma membrane" Cytosol "HPA008992: , HPA015723: AB_2732415" "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavorable (2.65e-4)" "prognostic unfavorable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.4 8.5 0.5 0.0 12.9 62.8 0.0 8.6 38.5 2.8 6.2 0.0 5.5 0.0 5.3 17.7 6.2 26.6 0.9 17.2 3.8 2.6 1.5 3.3 6.9 1.4 2.7 0.0 0.0 17.3 13.7 5.3 21.5 9.9 20.3 1.0 0.0 0.0 12.9 0.2 0.2 0.0 0.6 0.0 5.5 0.7 2.4 11.6 1.2 1.1 0.0 0.0 19.5 0.1 8.4 0.4 0.2 1.5 18.8 26.9 3.7 4.8 7.4 0.1 5.3 0.0 10.8 0.0 23.8 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 3.0 1.7 0.8 6.2 36.9 0.3 11.1 0.0 2.7 12.5 0.0 0.0 0.3 1.7 0.1 18.2 28.0 0.0 0.0 0.0 0.4 7.8 5.8 2.3 0.4 36.5 0.0 0.0 19.0 2.8 17.2 0.6 15.3 21.9 4.6 0.0 0.0 0.3 0.0 0.0 15.9 0.1 0.0 14.6 0.7 3.2 38.1 1.1 2.2 0.0 6.4 CD164L2 ENSG00000174950 "CD164 molecule like 2" Q6UWJ8 1 27379176-27383380 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 26.8" "Cell type enriched" "Detected in some" 8 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HaCaT: 3.6;HBEC3-KT: 3.9;hTCEpi: 5.4;SK-BR-3: 4.9;T-47d: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062915 Enhanced Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA062915: AB_2684903" "unprognostic (8.97e-3)" "unprognostic (2.15e-2)" "unprognostic (3.56e-2)" "unprognostic (1.36e-2)" "unprognostic (1.04e-1)" "prognostic favorable (1.64e-5)" "unprognostic (7.81e-3)" "unprognostic (4.47e-2)" "unprognostic (1.39e-1)" "unprognostic (1.65e-2)" "unprognostic (4.07e-2)" "unprognostic (5.91e-6)" "unprognostic (1.33e-2)" "unprognostic (6.42e-2)" "unprognostic (1.34e-2)" "unprognostic (2.71e-2)" 0.1 0.1 0.2 0.1 0.5 0.0 2.3 0.1 0.4 3.2 0.4 0.7 1.2 0.0 0.4 12.6 13.4 26.8 0.1 0.1 0.4 0.4 0.4 0.3 7.4 0.1 0.1 0.6 3.3 0.3 0.4 5.8 0.1 1.1 2.4 0.2 1.0 12.9 0.3 0.1 8.1 0.1 0.1 0.1 0.1 0.2 1.0 0.4 0.1 0.9 5.9 6.0 0.1 5.5 0.0 0.0 0.0 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.6 0.0 0.0 0.0 0.0 3.6 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 5.4 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.7 2.0 0.1 0.0 0.0 0.1 1.0 0.0 1.0 0.0 0.0 4.9 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 0.4 0.4 0.4 0.1 0.6 1.1 0.4 0.0 3.0 0.0 8.0 2.6 0.0 0.6 0.0 62.9 4.5 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 3.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.3 0.0 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 2.5 0.0 0.0 0.0 3.1 CD248 "CD164L1, TEM1" ENSG00000174807 "CD248 molecule" Q9HCU0 11 66314487-66317044 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 71.0" "Cell type enhanced" "Detected in many" 14 "Fibroblasts: 70.0;Leydig cells: 69.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 6 "naive CD8 T-cell: 17.8" "Lineage enriched" "Detected in single" 122 "T-cells: 17.8" "Cell line enhanced" "Detected in some" "ASC diff: 68.1;ASC TERT1: 67.2;BJ: 29.4;BJ hTERT+: 44.3;fHDF/TERT166: 59.3;HSkMC: 71.6;U-2197: 107.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" HPA051856 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 27000000 "Plasma membrane" Nucleoplasm "HPA051856: AB_2681640" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.95e-2)" "unprognostic (2.77e-2)" "unprognostic (1.14e-2)" "unprognostic (2.61e-1)" "unprognostic (7.21e-3)" "unprognostic (1.36e-2)" "unprognostic (1.01e-1)" "unprognostic (2.82e-2)" "unprognostic (6.31e-2)" "unprognostic (4.77e-2)" "prognostic unfavorable (2.69e-7)" "unprognostic (1.90e-2)" "unprognostic (2.92e-2)" "unprognostic (1.25e-1)" "unprognostic (1.30e-2)" 59.2 3.5 0.8 14.4 2.5 0.0 55.2 0.6 2.2 21.2 7.6 1.9 6.3 2.7 14.1 22.9 14.8 17.7 12.3 18.2 1.2 0.5 5.3 1.7 9.3 16.2 1.3 1.6 15.6 4.9 1.4 2.3 71.0 2.1 10.6 2.7 11.5 4.6 8.0 6.7 13.3 7.5 27.6 1.2 1.9 7.5 8.0 0.7 4.1 9.4 6.6 4.5 19.5 17.6 0.1 0.0 0.0 0.0 0.0 17.8 1.9 0.0 0.0 0.6 0.0 68.1 67.2 0.0 29.4 44.3 2.2 2.0 0.0 0.0 0.0 0.7 59.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 13.5 0.0 0.0 71.6 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.3 0.0 0.1 1.2 0.0 0.0 0.0 0.0 0.3 1.0 0.0 0.1 0.0 1.9 0.0 0.0 0.0 0.0 0.1 107.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 2.3 0.0 0.1 2.8 17.8 0.0 0.0 0.0 0.0 0.0 1.9 0.8 2.5 0.6 2.2 1.2 0.5 1.3 1.6 2.1 0.7 0.0 0.0 0.0 0.0 11.1 0.0 2.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.2 0.3 2.5 0.0 0.0 0.0 2.5 70.0 0.0 0.0 0.0 5.5 0.0 0.0 4.3 0.0 0.4 69.3 0.0 11.8 1.0 0.0 3.6 0.4 0.0 19.1 0.0 0.0 32.3 12.2 0.1 0.0 7.2 3.7 0.0 0.0 0.0 CD33 "FLJ00391, p67, SIGLEC-3, SIGLEC3" ENSG00000105383 "CD33 molecule" P20138 19 51225064-51243860 "CD markers, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 49.3;lymphoid tissue: 45.4" "Group enriched" "Detected in many" 7 "granulocytes: 73.9;Hofbauer cells: 67.4;Kupffer cells: 119.1;Macrophages: 56.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "classical monocyte: 37.6;intermediate monocyte: 27.3;myeloid DC: 49.3;non-classical monocyte: 12.6" "Group enriched" "Detected in many" 9 "dendritic cells: 49.3;monocytes: 37.6" "Cell line enhanced" "Detected in some" "HEL: 28.5;HL-60: 37.9;HMC-1: 28.4;NB-4: 18.1;RPMI-8226: 20.5;THP-1: 22.2;U-937: 28.0" "CAB011442, HPA035832, HPA064807" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB011442: , HPA035832: AB_2674808, HPA064807: AB_2685356" "unprognostic (1.18e-2)" "unprognostic (1.45e-2)" "unprognostic (2.80e-2)" "unprognostic (7.14e-2)" "unprognostic (3.71e-1)" "unprognostic (9.43e-2)" "unprognostic (2.59e-1)" "unprognostic (5.90e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-1)" "unprognostic (2.53e-1)" "unprognostic (6.28e-2)" "unprognostic (6.88e-4)" "unprognostic (7.79e-2)" "unprognostic (3.35e-2)" "unprognostic (6.49e-2)" "unprognostic (1.67e-1)" 10.2 4.3 3.6 8.4 6.0 23.0 6.5 0.8 3.5 2.6 2.7 4.4 0.3 2.5 2.3 5.2 1.7 3.9 5.3 7.5 3.1 2.5 4.1 6.4 11.6 45.4 6.4 1.8 1.9 1.9 0.5 1.7 5.4 5.2 2.6 3.4 2.6 2.9 2.1 1.2 2.5 4.0 5.6 9.9 31.6 2.8 1.5 5.8 2.5 1.7 0.2 2.7 4.7 2.3 0.1 49.3 4.6 37.6 3.3 0.2 14.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 28.5 0.1 0.0 0.0 37.9 28.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.2 7.2 0.0 0.0 0.0 18.1 0.0 0.0 8.7 0.0 1.5 20.5 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 22.2 0.2 4.9 0.4 0.6 0.0 0.1 2.4 0.0 3.3 28.0 0.1 3.3 37.6 2.3 0.0 27.3 0.1 0.0 0.0 0.1 49.3 0.1 0.0 0.0 4.6 3.3 12.6 1.4 0.2 14.7 3.6 6.0 0.8 3.5 3.1 2.5 6.4 1.8 5.2 5.8 0.0 10.7 1.4 0.5 1.5 0.1 0.6 0.0 1.4 1.2 0.0 0.0 0.7 0.0 0.0 0.4 1.5 0.0 0.0 0.0 0.4 1.5 0.3 73.9 0.8 67.4 0.0 0.0 8.6 119.1 1.3 0.3 56.4 1.7 2.8 0.0 0.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.7 0.5 0.9 0.7 1.7 0.0 0.3 CD37 TSPAN26 ENSG00000104894 "CD37 molecule" P11049 19 49335171-49343335 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 163.4;lymphoid tissue: 109.6" "Cell type enhanced" "Detected in many" 18 "B-cells: 979.0;granulocytes: 262.7;Hofbauer cells: 303.3;Kupffer cells: 224.9;Macrophages: 253.6;T-cells: 359.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 67.2;HMC-1: 66.6;RPMI-8226: 23.9;THP-1: 23.9;U-698: 14.8;U-937: 17.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002492, HPA032120, HPA032121" Enhanced Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "CAB002492: AB_563554, HPA032120: AB_2674162, HPA032121: AB_2674163" "unprognostic (4.30e-3)" "unprognostic (2.39e-3)" "unprognostic (8.85e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.46e-2)" "unprognostic (4.59e-3)" "unprognostic (1.76e-1)" "unprognostic (6.23e-2)" "unprognostic (5.34e-2)" "unprognostic (2.23e-1)" "unprognostic (1.22e-1)" "unprognostic (3.06e-1)" "unprognostic (2.45e-3)" "unprognostic (7.12e-2)" "unprognostic (3.35e-2)" "unprognostic (7.22e-2)" "unprognostic (7.71e-2)" 7.3 3.1 3.4 62.9 4.8 48.7 3.7 1.0 3.1 1.9 4.2 8.5 0.0 3.2 2.0 2.2 5.9 2.9 5.2 10.4 3.8 3.8 4.3 2.7 25.3 109.6 6.9 1.7 2.5 1.6 0.5 1.9 5.4 4.7 3.5 1.7 2.7 10.7 1.4 1.1 2.0 39.3 1.7 14.5 88.1 5.1 2.9 5.0 47.9 3.4 1.7 86.8 10.2 2.4 163.4 53.7 84.4 62.8 27.9 43.5 58.8 0.0 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 67.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 10.7 0.0 11.8 0.0 0.1 0.0 2.0 66.6 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.6 3.7 0.0 0.0 0.1 1.2 0.0 0.0 0.0 0.6 0.0 23.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 23.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 14.8 0.0 17.8 0.0 42.8 58.2 71.7 34.3 53.4 34.7 137.2 41.8 36.4 41.1 163.4 43.5 36.3 84.4 27.9 62.8 53.7 40.9 58.8 3.4 4.8 1.0 3.1 3.8 3.8 6.9 1.7 4.7 5.0 8.9 20.5 979.0 1.1 10.4 12.4 1.2 2.5 1.4 4.5 1.8 5.9 1.6 0.0 0.3 98.9 4.3 0.4 0.0 0.0 1.5 5.4 0.5 262.7 2.5 303.3 0.0 1.2 14.1 224.9 158.6 2.6 253.6 27.0 43.3 0.5 1.1 0.0 5.3 0.7 2.5 5.2 0.0 0.5 1.1 0.9 10.3 2.4 359.8 0.4 0.9 CD3E ENSG00000198851 "CD3e molecule" P07766 11 118304545-118316175 "CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 294.2" "Cell type enriched" "Detected in some" 31 "T-cells: 377.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 36 "gdT-cell: 59.5;MAIT T-cell: 50.2;memory CD4 T-cell: 50.7;memory CD8 T-cell: 55.7;naive CD4 T-cell: 61.3;naive CD8 T-cell: 62.0;NK-cell: 21.8;T-reg: 46.8" "Group enriched" "Detected in many" 29 "NK-cells: 21.8;T-cells: 62.0" "Group enriched" "Detected in some" 67 "JURKAT: 80.1;MOLT-4: 108.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "CAB000010, HPA040957, HPA043955, CAB072863, CAB072864" Enhanced Supported "Endoplasmic reticulum,Plasma membrane" NA NA "Endoplasmic reticulum, Plasma membrane" "CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747" "prognostic favorable (1.72e-4)" "prognostic favorable (1.62e-4)" "unprognostic (1.51e-2)" "prognostic favorable (2.30e-6)" "unprognostic (4.31e-2)" "prognostic favorable (1.32e-4)" "unprognostic (3.60e-3)" "unprognostic (3.85e-2)" "prognostic favorable (1.18e-4)" "unprognostic (6.11e-3)" "unprognostic (1.59e-1)" "unprognostic (3.59e-1)" "prognostic unfavorable (1.12e-5)" "unprognostic (5.46e-2)" "unprognostic (9.28e-2)" "unprognostic (3.13e-2)" "unprognostic (1.12e-2)" 3.9 1.0 0.5 16.7 0.7 6.8 1.9 0.5 0.7 2.1 4.7 0.9 0.7 4.4 2.0 1.4 3.3 3.0 4.0 1.4 0.5 0.5 3.3 2.6 7.3 40.9 1.3 0.6 1.5 1.3 0.0 0.9 1.2 0.9 2.6 3.9 1.9 6.4 1.1 0.8 1.3 21.1 1.1 1.9 34.5 4.6 1.2 0.5 294.2 3.4 2.1 37.8 6.3 3.0 0.2 0.9 1.4 0.2 21.8 62.0 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.1 0.1 0.3 0.0 0.0 108.8 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.1 1.4 0.0 0.1 0.0 1.3 0.2 0.2 59.5 0.1 50.2 0.1 50.7 55.7 0.1 0.2 61.3 62.0 1.4 21.8 0.2 0.9 46.8 32.9 0.5 0.7 0.5 0.7 0.5 0.5 1.3 0.6 0.9 0.5 0.0 11.3 4.5 0.3 4.6 0.0 0.2 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 6.5 0.2 0.0 0.0 0.0 0.0 1.0 0.1 7.0 0.8 0.3 0.0 0.0 12.3 7.3 0.0 0.0 2.5 11.8 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.5 0.0 0.0 4.6 0.2 377.3 0.2 0.3 CD3G ENSG00000160654 "CD3g molecule" P09693 11 118344344-118355161 "CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 187.6" "Cell type enriched" "Detected in some" 18 "T-cells: 153.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in many" 30 "gdT-cell: 43.5;MAIT T-cell: 25.6;memory CD4 T-cell: 36.1;memory CD8 T-cell: 37.1;naive CD4 T-cell: 37.6;naive CD8 T-cell: 46.7;T-reg: 34.2" "Lineage enriched" "Detected in many" 37 "T-cells: 46.7" "Group enriched" "Detected in some" 53 "JURKAT: 24.1;MOLT-4: 64.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB017520, HPA038494" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB017520: AB_831094, HPA038494: AB_2676044" "prognostic favorable (6.33e-4)" "prognostic favorable (2.61e-4)" "unprognostic (4.58e-3)" "unprognostic (3.12e-5)" "unprognostic (6.30e-2)" "prognostic favorable (3.00e-4)" "unprognostic (1.98e-2)" "unprognostic (1.54e-2)" "unprognostic (8.25e-3)" "unprognostic (1.08e-3)" "unprognostic (1.54e-2)" "unprognostic (2.19e-1)" "prognostic unfavorable (9.33e-5)" "unprognostic (1.60e-1)" "unprognostic (2.37e-2)" "unprognostic (4.13e-2)" "unprognostic (2.10e-3)" 1.1 0.6 0.4 7.1 0.4 0.5 0.8 0.3 0.3 0.7 2.3 0.4 0.4 2.0 0.9 0.6 1.5 1.1 1.9 0.6 0.4 0.4 1.2 0.9 2.4 17.2 0.5 0.2 0.7 0.7 0.0 0.5 0.4 0.3 1.0 1.6 0.9 2.9 0.3 5.9 0.6 8.1 0.2 0.8 11.5 2.4 0.5 0.2 187.6 1.4 1.7 19.2 2.5 1.1 0.1 0.2 1.2 0.2 0.2 46.7 14.1 0.0 0.1 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 24.1 0.8 0.2 0.0 0.2 64.5 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.2 0.1 0.1 0.1 0.0 0.6 0.2 0.2 43.5 0.1 25.6 0.1 36.1 37.1 0.1 0.1 37.6 46.7 1.2 0.2 0.1 0.2 34.2 14.1 0.4 0.4 0.3 0.3 0.4 0.4 0.5 0.2 0.3 0.2 3.0 8.6 0.8 0.0 2.1 0.1 0.4 0.0 1.4 3.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 5.8 1.3 0.1 0.0 0.0 6.2 2.8 0.4 0.0 2.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.0 0.3 0.2 0.0 2.0 0.2 153.8 0.0 0.0 CD44 "CD44R, CSPG8, HCELL, IN, MC56, MDU2, MDU3, MIC4, Pgp1" ENSG00000026508 "CD44 molecule (Indian blood group)" P16070 11 35138870-35232402 "Blood group antigen proteins, Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Blood group antigen, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 888.0;Ductal cells: 858.7;Suprabasal keratinocytes: 895.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 139.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB000112, CAB000316, HPA005785" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 2400000000 "Plasma membrane" "Golgi apparatus" "CAB000112: , CAB000316: AB_2076596, HPA005785: AB_1078467" "unprognostic (5.33e-2)" "unprognostic (1.85e-1)" "unprognostic (4.97e-2)" "unprognostic (9.90e-3)" "unprognostic (3.50e-3)" "unprognostic (1.46e-2)" "unprognostic (1.56e-2)" "unprognostic (8.12e-2)" "unprognostic (1.57e-1)" "unprognostic (4.18e-2)" "unprognostic (1.51e-3)" "unprognostic (4.63e-2)" "prognostic unfavorable (1.78e-8)" "unprognostic (6.41e-2)" "unprognostic (4.14e-2)" "unprognostic (3.93e-2)" "unprognostic (7.98e-2)" 45.5 9.0 10.5 42.5 21.7 53.0 35.6 4.7 13.4 43.2 19.5 26.3 8.3 10.6 80.5 20.3 66.5 18.6 48.0 11.7 14.9 9.3 12.4 9.1 43.4 48.4 31.5 6.1 12.8 83.9 0.8 3.8 19.4 40.7 30.1 24.5 30.2 148.2 22.4 15.9 107.7 18.9 44.5 100.5 30.9 19.9 7.2 20.3 17.9 20.6 53.9 53.7 55.0 54.2 22.7 41.0 19.1 65.2 54.6 53.1 59.9 39.7 35.9 0.3 0.0 21.7 60.0 0.1 77.9 60.9 43.4 24.2 2.4 12.5 0.0 10.4 110.3 89.3 68.5 0.8 84.7 59.6 8.5 0.4 1.4 17.7 0.0 21.4 20.2 93.5 27.0 66.8 58.3 47.4 139.4 15.1 0.0 0.3 13.0 41.6 0.2 1.8 13.3 0.7 0.7 10.6 0.1 7.4 0.6 63.6 11.5 0.1 0.1 14.7 0.4 35.2 3.4 2.1 1.2 43.5 54.1 9.8 66.3 80.0 22.5 24.3 0.2 82.1 11.4 78.6 19.1 65.2 6.0 26.2 45.7 37.0 22.7 39.8 34.9 41.0 16.2 34.5 28.7 16.4 54.6 59.3 14.2 53.1 59.9 10.5 21.7 4.7 13.4 14.9 9.3 31.5 6.1 40.7 20.3 89.3 339.9 168.9 263.7 888.0 0.0 4.0 25.5 18.7 135.4 19.2 2.0 4.0 1.7 858.7 30.1 53.0 5.0 23.3 741.5 3.7 143.9 293.1 733.4 2.5 234.7 0.0 96.2 20.3 427.0 13.8 20.8 611.7 573.6 514.0 84.8 26.6 787.6 8.6 0.4 0.6 1.6 155.2 254.2 0.4 0.4 895.8 15.0 244.8 66.1 304.0 CD47 "IAP, MER6, OA3" ENSG00000196776 "CD47 molecule" Q08722 3 108043094-108091862 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016055, HPA044659" Approved Supported "Vesicles,Plasma membrane" NA NA 2000000 "Plasma membrane" Vesicles "CAB016055: AB_627086, HPA044659: AB_2679040" "unprognostic (3.54e-2)" "unprognostic (4.74e-2)" "unprognostic (3.19e-2)" "prognostic unfavorable (2.44e-4)" "unprognostic (4.49e-2)" "unprognostic (2.14e-1)" "unprognostic (2.05e-3)" "unprognostic (8.77e-3)" "unprognostic (7.35e-2)" "unprognostic (1.53e-1)" "unprognostic (1.69e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (1.69e-4)" "unprognostic (7.37e-2)" "unprognostic (3.78e-1)" "prognostic favorable (7.29e-5)" "unprognostic (1.83e-1)" 16.2 24.3 23.0 28.8 46.5 58.0 29.0 44.0 55.5 20.5 25.7 42.5 13.4 19.8 16.2 30.4 46.7 31.7 26.0 26.7 24.1 24.4 19.1 22.1 49.6 35.1 27.4 28.8 16.2 25.7 11.5 34.8 23.3 43.6 40.2 29.0 15.7 43.8 18.9 18.1 19.3 21.2 21.0 37.7 29.0 33.4 20.6 25.0 34.4 30.1 22.0 42.5 25.1 29.1 40.1 35.6 44.1 64.4 45.1 65.3 51.7 45.7 8.2 16.6 9.4 23.8 25.6 21.9 17.3 27.1 13.5 23.1 0.4 25.9 21.0 28.1 16.6 31.0 31.4 9.2 17.5 17.6 12.4 6.3 53.5 7.7 0.7 13.8 38.1 72.3 16.4 10.7 12.9 10.4 21.0 13.3 21.8 12.6 50.0 20.0 23.5 46.3 14.3 6.9 42.7 21.0 24.6 12.2 29.7 34.2 18.3 12.6 7.8 10.3 20.5 17.5 8.8 37.1 12.5 12.8 35.0 6.4 19.6 11.7 19.4 13.1 29.5 25.5 19.1 9.6 31.7 24.7 44.1 40.2 48.1 35.0 40.1 47.0 42.0 35.6 39.2 35.4 38.3 30.1 45.1 64.4 27.7 65.3 51.7 23.0 46.5 44.0 55.5 24.1 24.4 27.4 28.8 43.6 25.0 342.4 135.6 141.2 259.6 146.8 90.6 37.8 109.5 58.9 102.4 89.0 90.3 137.8 13.3 418.5 33.5 71.3 35.8 23.3 357.7 75.9 79.2 245.6 56.6 30.2 163.7 116.0 61.4 82.9 78.2 40.6 31.7 105.3 111.3 90.2 60.0 47.2 337.0 107.2 45.6 11.9 214.8 64.7 72.9 25.2 13.2 122.5 101.4 137.1 79.7 264.1 CD84 "hCD84, mCD84, SLAMF5" ENSG00000066294 "CD84 molecule" Q9UIB8 1 160541095-160579516 "CD markers, Predicted membrane proteins" "Adaptive immunity, Autophagy, Cell adhesion, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.0" "Cell type enhanced" "Detected in many" 14 "granulocytes: 177.3;Hofbauer cells: 84.2;Kupffer cells: 123.8;Macrophages: 52.0;monocytes: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.6;HEL: 24.3;HL-60: 6.8;HMC-1: 27.7;MOLT-4: 6.7;U-698: 17.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA063316, HPA068020, HPA070502" Enhanced Enhanced "Vesicles,Plasma membrane" NA NA 36000000 "Plasma membrane" Vesicles "HPA063316: , HPA068020: , HPA070502: AB_2686274" "unprognostic (4.38e-2)" "unprognostic (6.16e-3)" "unprognostic (1.00e-2)" "unprognostic (8.16e-2)" "unprognostic (2.35e-1)" "unprognostic (2.00e-2)" "unprognostic (3.84e-1)" "unprognostic (2.54e-2)" "unprognostic (8.60e-2)" "unprognostic (1.80e-1)" "unprognostic (8.26e-2)" "unprognostic (1.57e-1)" "unprognostic (1.30e-2)" "unprognostic (2.15e-1)" "unprognostic (4.14e-2)" "unprognostic (1.24e-1)" "unprognostic (1.08e-1)" 15.9 4.8 3.8 18.5 4.5 6.7 3.7 1.3 3.4 3.3 3.2 7.9 7.7 2.5 2.5 4.3 2.7 3.1 6.4 5.0 3.8 3.0 3.1 5.1 9.2 26.0 6.0 2.2 1.8 4.3 0.9 1.9 7.1 5.3 3.7 4.7 2.4 4.3 9.8 1.6 2.7 9.6 4.1 11.1 25.6 3.5 2.8 5.9 13.8 2.9 2.3 16.3 5.8 2.7 5.1 5.4 21.0 7.3 1.0 8.2 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 6.8 27.7 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.1 0.0 0.0 6.7 5.1 0.0 0.0 0.0 0.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.1 0.0 1.5 0.0 21.0 7.3 11.0 6.9 6.3 5.2 5.1 5.9 8.2 5.4 4.7 3.5 6.3 1.0 1.0 2.4 3.2 7.9 6.1 3.8 4.5 1.3 3.4 3.8 3.0 6.0 2.2 5.3 5.9 0.0 8.3 23.1 0.7 2.2 0.2 1.2 5.1 1.4 2.3 0.0 0.0 0.4 0.0 0.0 0.6 2.6 0.0 0.0 0.2 0.3 0.8 0.6 177.3 0.9 84.2 0.0 0.0 5.5 123.8 0.5 0.6 52.0 5.0 78.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 2.0 0.8 42.4 0.0 0.7 CD93 "C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4" ENSG00000125810 "CD93 molecule" Q9NPY3 20 23079349-23086340 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 6 "Endothelial cells: 232.0;Ito cells: 170.6;Kupffer cells: 149.3;Macrophages: 59.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 14.4;neutrophil: 17.4" "Group enriched" "Detected in many" 40 "dendritic cells: 5.5;granulocytes: 17.4;monocytes: 14.4" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 58.4;TIME: 73.9;U-937: 98.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA009300, HPA012368" Enhanced Approved "Vesicles,Plasma membrane" NA NA 440000000 "Vesicles, Plasma membrane" "HPA009300: AB_1846342, HPA012368: AB_1846341" "unprognostic (2.05e-1)" "unprognostic (2.85e-1)" "unprognostic (1.07e-1)" "unprognostic (4.83e-2)" "unprognostic (2.31e-1)" "unprognostic (2.66e-2)" "unprognostic (6.45e-2)" "unprognostic (2.77e-1)" "unprognostic (4.51e-1)" "unprognostic (3.74e-2)" "unprognostic (2.61e-1)" "unprognostic (1.81e-1)" "prognostic unfavorable (2.74e-4)" "unprognostic (8.81e-3)" "unprognostic (6.13e-2)" "unprognostic (4.49e-2)" "unprognostic (3.11e-2)" 50.5 6.1 2.4 15.0 3.4 4.7 31.4 1.0 3.0 13.6 8.1 1.7 3.9 3.2 14.3 12.5 10.0 13.6 14.2 33.3 2.4 2.2 10.8 10.9 34.8 25.3 4.1 1.2 11.6 5.9 5.1 4.3 48.9 5.3 9.7 4.3 4.9 5.9 3.9 16.2 6.8 7.7 15.4 4.3 17.5 7.5 6.9 3.3 6.9 12.3 9.3 4.5 15.6 12.2 0.0 5.5 17.4 14.4 0.0 0.3 4.7 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.4 0.0 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.1 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.4 73.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.9 0.0 0.0 14.4 0.2 0.2 10.3 0.0 0.0 0.1 0.0 5.5 0.0 0.0 0.0 17.4 0.0 4.2 0.7 0.3 4.7 2.4 3.4 1.0 3.0 2.4 2.2 4.1 1.2 5.3 3.3 3.0 11.9 3.7 0.6 13.4 0.0 7.3 10.2 5.3 6.8 0.0 0.0 0.2 0.0 0.2 0.4 232.0 0.0 0.0 0.0 0.4 6.5 2.9 4.7 1.3 16.2 0.0 0.0 170.6 149.3 0.2 1.7 59.8 8.5 0.0 0.0 0.1 0.1 0.0 26.2 0.2 0.0 19.4 15.3 0.0 0.2 8.8 0.3 2.9 0.0 0.9 CDAN1 "CDA-I, CDAI" ENSG00000140326 "Codanin 1" Q8IWY9 15 42723544-42737128 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Congenital dyserythropoietic anemia, Disease mutation, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Sertoli cells: 19.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.7" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039404, HPA040787" Supported Enhanced "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039404: AB_10673530, HPA040787: AB_2677137" "unprognostic (1.11e-1)" "unprognostic (1.24e-1)" "unprognostic (5.79e-3)" "unprognostic (1.24e-1)" "unprognostic (2.10e-1)" "unprognostic (7.71e-2)" "prognostic unfavorable (1.07e-4)" "unprognostic (7.17e-2)" "unprognostic (9.82e-2)" "unprognostic (1.24e-1)" "unprognostic (2.95e-2)" "unprognostic (1.26e-1)" "unprognostic (4.35e-3)" "unprognostic (2.05e-1)" "unprognostic (1.16e-1)" "unprognostic (9.20e-3)" "unprognostic (2.04e-1)" 6.5 9.0 8.4 9.8 8.1 14.4 9.8 16.2 9.7 11.8 6.8 8.7 9.4 6.0 11.0 9.6 7.1 9.1 7.2 5.2 6.4 4.4 6.3 6.7 6.6 8.0 8.3 7.4 21.7 9.6 9.1 9.5 6.7 5.8 11.4 5.5 9.3 10.6 10.1 6.6 10.1 6.9 9.3 5.1 8.1 8.0 14.7 8.6 14.7 9.0 3.3 8.2 10.2 12.2 0.3 0.8 3.7 0.3 0.0 0.6 0.1 6.9 4.7 6.5 9.3 5.8 5.0 7.8 9.2 3.9 9.0 6.5 11.8 3.7 3.3 10.2 5.1 8.8 13.7 6.9 4.1 2.6 8.5 6.4 12.6 8.5 4.6 4.3 9.2 11.9 6.8 4.7 5.6 4.1 5.5 6.8 11.5 16.0 5.1 7.3 3.8 7.1 12.2 3.2 6.7 7.6 10.3 8.1 2.9 2.8 6.9 5.3 6.1 7.2 10.1 1.5 4.3 7.7 13.8 4.9 9.5 8.5 7.7 10.5 10.1 10.6 7.5 4.9 13.8 7.7 3.7 0.3 1.7 0.5 0.1 0.6 0.1 0.4 0.5 0.0 0.3 0.4 0.3 0.4 0.0 0.0 0.8 0.1 0.1 8.4 8.1 16.2 9.7 6.4 4.4 8.3 7.4 5.8 8.6 0.0 3.0 0.8 1.7 1.6 3.1 2.2 5.1 1.4 1.2 7.0 3.9 2.6 0.0 1.4 0.3 2.2 1.6 0.0 1.5 1.2 1.9 1.8 1.1 2.4 1.8 1.6 4.6 4.9 4.4 0.9 4.0 1.3 0.0 1.0 2.0 4.8 1.5 0.0 4.6 1.1 4.1 19.4 1.0 4.2 1.9 1.1 1.8 2.5 2.7 1.4 CDC42EP3 "BORG2, CEP3, UB1" ENSG00000163171 "CDC42 effector protein 3" Q9UKI2 2 37641882-37738468 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 60.2" "Cell type enhanced" "Detected in many" 5 "Melanocytes: 190.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "LHCN-M2: 107.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034986, HPA061792" Approved Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA034986: AB_10602207, HPA061792: AB_2732670" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (3.92e-2)" "unprognostic (4.11e-3)" "unprognostic (2.38e-2)" "unprognostic (2.72e-3)" "unprognostic (1.41e-1)" "unprognostic (5.76e-2)" "unprognostic (2.68e-1)" "unprognostic (1.72e-1)" "unprognostic (1.84e-1)" "unprognostic (3.81e-1)" "unprognostic (3.14e-3)" "unprognostic (7.30e-3)" "unprognostic (1.97e-1)" "unprognostic (2.97e-1)" "unprognostic (4.53e-2)" 19.7 2.1 5.1 5.7 5.8 18.9 14.0 2.4 6.6 13.6 14.4 2.9 1.8 0.9 33.3 6.6 5.0 8.6 4.9 14.3 2.6 1.8 8.4 3.0 10.6 5.7 3.2 2.3 7.7 7.4 1.1 5.5 6.0 3.8 24.9 4.9 7.9 5.8 28.5 27.8 5.3 6.3 25.4 3.2 6.9 5.4 60.2 2.7 14.8 6.4 3.5 5.2 14.9 8.2 7.2 8.4 51.9 30.3 10.1 21.8 13.8 16.9 6.5 3.8 0.2 14.7 7.8 5.8 14.6 39.0 22.9 16.7 12.1 6.8 3.1 11.6 34.6 7.0 8.1 4.7 17.4 23.4 11.3 1.3 5.4 6.7 0.0 28.6 1.2 0.3 23.4 16.3 19.7 43.9 37.3 13.3 1.2 0.8 2.4 107.3 0.1 0.7 9.5 7.6 0.2 4.0 0.4 28.3 1.6 16.5 8.2 4.1 11.5 7.1 5.2 8.8 7.0 1.7 10.1 9.8 27.4 7.1 7.1 14.9 4.5 6.0 1.0 11.3 8.2 37.9 11.0 21.8 1.7 20.2 15.3 21.8 7.2 13.1 17.3 8.4 2.9 4.4 11.1 51.9 10.1 30.3 0.2 9.4 13.8 5.1 5.8 2.4 6.6 2.6 1.8 3.2 2.3 3.8 2.7 6.0 37.0 25.9 93.8 33.0 7.6 91.1 12.7 83.0 18.2 29.6 33.4 23.8 8.3 19.5 42.0 51.9 2.6 0.0 14.1 58.6 26.9 25.1 130.1 1.3 10.6 95.3 39.5 55.3 42.4 92.4 14.1 52.8 190.6 1.8 36.9 27.1 17.9 3.5 119.2 3.7 11.7 0.0 18.7 64.4 13.2 11.8 10.1 74.3 5.8 35.2 CDH15 "CDH14, CDH3" ENSG00000129910 "Cadherin 15" P55291 16 89171767-89195492 "Disease related genes, Predicted membrane proteins" "Cell adhesion" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "brain: 44.2;skeletal muscle: 60.3" "Cell type enhanced" "Detected in some" 14 "Alveolar cells type 2: 1.3;Ito cells: 1.3;Melanocytes: 1.7;Muller glia cells: 1.5;Spermatocytes: 1.6;Spermatogonia: 4.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in some" 24 "cerebellum: 44.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RH-30: 57.9" "Region enriched" "Detected in some" 7 "cerebellum: 17.6" "Region enriched" "Detected in all" 6 "cerebellum: 17.9" "HPA009139, HPA070961" Enhanced Supported Enhanced "Golgi apparatus,Plasma membrane" NA NA 390000 "Golgi apparatus, Plasma membrane" "HPA009139: AB_1078372, HPA070961: AB_2686328" "unprognostic (1.26e-1)" "unprognostic (7.70e-3)" "unprognostic (6.64e-3)" "unprognostic (2.81e-1)" "unprognostic (7.79e-3)" "unprognostic (2.70e-3)" "unprognostic (2.84e-3)" "unprognostic (4.37e-2)" "unprognostic (2.30e-3)" "unprognostic (7.66e-2)" "unprognostic (4.05e-2)" "unprognostic (1.73e-1)" "unprognostic (1.14e-7)" "unprognostic (3.09e-2)" "unprognostic (3.13e-1)" "unprognostic (5.50e-2)" "unprognostic (2.64e-2)" 0.8 0.2 0.0 0.1 0.0 0.1 0.1 44.2 0.2 0.7 0.1 0.0 0.0 0.2 0.1 2.8 0.6 0.1 0.1 0.1 0.0 0.0 0.2 0.8 0.2 0.1 0.0 0.0 0.1 0.9 0.1 0.0 0.8 1.8 0.5 0.1 0.0 0.3 0.2 60.3 0.1 0.1 0.1 0.3 0.6 0.1 0.3 0.0 0.0 0.1 6.5 0.3 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 57.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 44.2 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 1.3 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.2 0.2 0.0 0.6 0.3 0.0 0.0 1.3 0.0 0.4 0.0 0.0 1.7 0.0 0.0 1.5 0.2 0.0 0.0 0.0 0.0 0.0 0.3 1.6 4.3 0.0 0.1 0.0 0.0 0.0 CDH2 "CD325, CDHN, NCAD" ENSG00000170558 "Cadherin 2" P19022 18 27950966-28177446 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 77.6;parathyroid gland: 35.4" "Cell type enhanced" "Detected in many" 15 "Cardiomyocytes: 330.4;Cone photoreceptor cells: 141.4;Hepatocytes: 98.3;Muller glia cells: 175.2;Rod photoreceptor cells: 92.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "basophil: 4.4;neutrophil: 4.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.4" "Cell line enhanced" "Detected in many" "AF22: 56.7;BJ: 40.9;fHDF/TERT166: 84.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000141, CAB018580, HPA058574, CAB078686" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 160000000 "Plasma membrane, Cell Junctions" "CAB000141: , CAB018580: AB_626778, CAB078686: AB_2665849, HPA058574: AB_2683760" "unprognostic (9.42e-2)" "unprognostic (2.69e-3)" "unprognostic (9.07e-3)" "unprognostic (5.45e-2)" "unprognostic (1.14e-1)" "unprognostic (9.30e-2)" "unprognostic (3.97e-2)" "unprognostic (2.53e-3)" "unprognostic (6.70e-3)" "unprognostic (1.00e-2)" "unprognostic (7.53e-2)" "unprognostic (3.51e-2)" "unprognostic (3.02e-2)" "unprognostic (1.93e-3)" "unprognostic (6.69e-2)" "unprognostic (1.33e-1)" "unprognostic (2.59e-3)" 0.6 29.6 9.8 1.5 9.4 0.5 0.5 5.7 16.1 3.2 2.0 8.0 0.2 0.8 3.1 1.9 0.6 4.7 1.7 77.6 9.9 9.6 9.2 23.3 0.7 1.1 6.0 9.1 3.4 0.7 35.4 5.4 0.5 5.9 1.4 0.8 6.8 0.5 4.6 0.4 0.5 0.9 3.2 6.7 5.9 2.5 19.6 7.4 0.9 2.8 0.0 1.0 1.0 1.3 0.0 0.0 4.4 0.0 0.7 0.9 0.0 0.0 4.5 56.7 0.0 9.0 1.8 0.0 40.9 12.4 16.7 15.3 0.0 0.0 0.0 22.0 84.6 8.0 6.0 9.3 0.0 23.7 0.1 5.9 0.0 15.3 14.0 8.6 0.0 0.0 0.8 0.1 38.3 6.7 38.6 14.6 2.5 0.0 0.0 13.0 0.0 10.3 0.0 7.6 0.0 4.9 0.0 6.7 7.8 0.0 1.8 14.8 25.6 0.0 0.0 4.5 23.2 0.0 0.0 2.3 36.2 11.5 0.5 29.6 0.0 0.0 0.0 6.9 0.0 27.8 4.4 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.7 0.0 0.0 0.0 0.0 9.8 9.4 5.7 10.1 9.9 9.6 6.0 9.1 5.9 7.4 0.0 1.1 5.0 0.0 0.2 23.9 330.4 58.6 2.7 1.2 10.4 141.4 0.2 0.0 5.6 31.9 3.6 0.0 0.0 0.3 0.0 1.2 0.0 0.0 98.3 0.3 3.2 0.0 18.4 1.9 11.0 2.0 0.4 3.3 0.0 0.0 175.2 12.4 0.0 12.0 40.6 92.8 6.5 5.3 3.3 28.8 0.0 0.2 0.0 0.0 0.1 CDH26 VR20 ENSG00000124215 "Cadherin 26" Q8IXH8 20 59958427-60034011 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 16.1;prostate: 15.3" "Cell type enhanced" "Detected in some" 19 "Ciliated cells: 45.5;Club cells: 18.2;Glandular cells: 12.1;Syncytiotrophoblasts: 12.5" "Group enriched" "Detected in some" 6 "cervical cancer: 1.5;head and neck cancer: 0.9;lung cancer: 2.3;prostate cancer: 3.6;urothelial cancer: 3.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "classical monocyte: 1.4;eosinophil: 1.6" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 6 "RT4: 34.7" "Low region specificity" "Detected in single" "HPA015722, HPA047578" Uncertain Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane" Microtubules "HPA015722: AB_2077659, HPA047578: AB_2680091" "unprognostic (2.42e-1)" "prognostic favorable (7.62e-4)" "unprognostic (4.71e-4)" "unprognostic (8.17e-2)" "unprognostic (9.40e-2)" "unprognostic (9.95e-3)" "unprognostic (6.65e-2)" "prognostic favorable (3.75e-4)" "unprognostic (1.37e-1)" "unprognostic (1.69e-1)" "unprognostic (3.26e-4)" "unprognostic (8.24e-3)" "unprognostic (9.96e-7)" "unprognostic (1.85e-2)" "unprognostic (2.73e-1)" "unprognostic (2.54e-2)" "unprognostic (1.04e-1)" 0.8 0.5 0.8 0.7 1.2 1.3 0.8 2.0 1.1 3.8 0.7 0.7 0.7 0.5 1.3 0.7 3.8 2.5 0.7 0.7 1.2 1.0 0.7 0.7 2.9 0.7 1.3 0.7 2.0 0.7 0.7 1.9 0.7 1.4 15.3 0.4 1.4 2.8 0.7 1.0 0.4 0.7 0.7 1.6 0.7 1.9 0.7 0.7 4.2 0.7 0.7 16.1 6.2 1.3 0.0 0.9 1.6 1.4 0.0 0.2 0.4 0.0 0.5 0.1 0.0 0.4 0.2 0.3 0.1 0.0 0.1 0.0 0.6 0.6 0.0 0.4 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 5.3 0.0 0.1 0.0 0.2 0.2 0.1 1.0 0.1 0.0 0.0 0.0 0.4 0.0 0.3 0.2 0.2 0.2 0.4 0.4 0.0 0.1 0.0 0.0 0.6 0.0 34.7 0.7 0.1 0.3 0.2 0.1 0.4 0.2 0.4 0.1 0.0 0.0 0.8 0.0 0.2 0.1 0.0 0.0 0.8 0.0 0.0 1.4 1.6 0.2 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.8 1.2 2.0 1.1 1.2 1.0 1.3 0.7 1.4 0.7 6.0 6.7 0.0 0.9 0.1 0.7 0.6 0.0 45.5 18.2 0.0 0.0 1.4 0.0 0.0 2.7 2.1 0.0 0.0 0.0 0.0 0.2 12.1 1.1 0.0 0.5 0.0 0.0 0.0 1.5 1.1 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 0.2 0.0 12.5 0.0 0.0 6.7 CDH3 "CDHP, PCAD" ENSG00000062038 "Cadherin 3" P22223 16 68636189-68722616 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Ectodermal dysplasia, Hypotrichosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 44.0;retina: 40.5" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 49.5;Basal keratinocytes: 54.0;Melanocytes: 57.3;Pancreatic endocrine cells: 60.0;Urothelial cells: 48.9" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 10 "pons and medulla: 16.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A-431: 24.9;HaCaT: 69.1;HBEC3-KT: 33.3;hTCEpi: 26.6;hTERT-HME1: 20.3;RPTEC TERT1: 29.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA001767, CAB002487" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "CAB002487: AB_563446, HPA001767: AB_1078376" "unprognostic (1.55e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-1)" "unprognostic (4.38e-3)" "unprognostic (6.73e-2)" "unprognostic (1.55e-2)" "unprognostic (1.85e-2)" "prognostic unfavorable (8.53e-4)" "unprognostic (1.22e-1)" "unprognostic (3.45e-2)" "prognostic unfavorable (8.43e-4)" "unprognostic (4.30e-2)" "unprognostic (2.41e-5)" "unprognostic (2.11e-1)" "unprognostic (1.09e-1)" "unprognostic (1.33e-3)" "unprognostic (8.56e-2)" 2.2 0.1 1.0 2.5 1.2 0.0 8.7 1.5 1.1 10.5 1.0 2.2 3.0 0.3 9.4 10.3 23.5 8.9 1.4 0.4 1.1 0.8 8.3 0.2 3.6 2.1 0.6 0.4 32.6 0.4 0.5 3.6 6.4 16.0 11.7 0.5 40.5 9.3 4.4 0.1 21.2 0.4 4.1 1.5 10.0 0.7 2.2 0.1 44.0 2.0 26.1 20.1 2.5 6.7 0.9 0.6 1.4 0.5 0.6 0.8 0.2 24.9 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 14.9 9.3 0.0 0.1 0.0 0.0 69.1 0.6 33.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 26.6 0.0 20.3 0.0 0.0 0.0 0.0 0.0 0.0 13.0 0.0 0.0 1.3 0.2 2.1 0.0 0.0 0.0 29.9 11.3 0.1 0.0 0.2 0.0 11.8 12.0 7.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.5 0.2 0.4 0.2 0.3 0.6 0.5 0.4 0.1 0.9 0.6 0.8 1.4 0.6 0.2 0.6 0.2 0.2 1.0 1.2 1.5 1.1 1.1 0.8 0.6 0.4 16.0 0.1 14.9 2.9 0.0 49.5 54.0 0.8 1.2 0.0 4.0 13.6 14.0 2.0 21.3 0.0 31.6 0.2 0.5 0.0 0.0 28.5 1.2 3.3 13.1 1.1 0.0 2.5 0.0 1.2 0.0 0.0 0.0 0.6 1.2 57.3 1.8 1.4 0.2 60.0 0.0 8.9 0.0 0.4 0.0 1.9 0.2 0.7 26.8 5.3 0.0 0.4 48.9 CDH6 ENSG00000113361 "Cadherin 6" P55285 5 31193750-31329146 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 73.8" "Cell type enhanced" "Detected in some" 14 "Ductal cells: 30.0;Pancreatic endocrine cells: 38.4;Proximal tubular cells: 100.9;Sertoli cells: 45.3;Smooth muscle cells: 69.4" "Group enriched" "Detected in many" 5 "ovarian cancer: 15.0;renal cancer: 28.6" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "EFO-21: 106.5" "Low region specificity" "Detected in many" "HPA007047, HPA007403, HPA007456, CAB025274" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 1200000 "Plasma membrane, Cell Junctions" "CAB025274: , HPA007047: AB_1078374, HPA007403: , HPA007456: AB_1078373" "unprognostic (3.87e-2)" "unprognostic (4.69e-2)" "unprognostic (1.35e-1)" "unprognostic (1.92e-3)" "unprognostic (1.58e-2)" "unprognostic (7.61e-3)" "unprognostic (9.04e-2)" "unprognostic (2.68e-1)" "unprognostic (2.74e-2)" "unprognostic (5.22e-2)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (8.29e-3)" "unprognostic (1.22e-3)" "unprognostic (2.67e-1)" "unprognostic (6.22e-2)" "unprognostic (2.09e-2)" 6.7 1.9 3.4 2.2 7.5 0.6 3.9 1.1 8.4 7.0 2.1 2.4 1.0 2.1 4.5 8.4 3.8 10.0 13.4 3.0 3.3 4.3 73.8 1.4 6.5 1.1 5.0 4.8 3.5 1.3 2.5 2.1 5.3 5.6 2.4 1.7 20.4 1.4 2.9 1.9 1.8 2.0 4.0 6.3 1.4 1.8 0.9 5.5 0.0 3.5 3.3 1.3 4.4 3.4 0.6 0.5 1.7 0.5 0.7 0.4 0.3 0.0 0.4 13.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 106.5 0.0 0.0 0.0 10.6 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 2.4 0.0 3.1 0.0 0.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.4 1.3 0.3 0.0 0.0 0.2 0.0 0.0 0.3 1.5 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.3 0.2 0.6 0.3 0.4 1.7 0.7 0.5 0.5 0.3 0.3 3.4 7.5 1.1 6.7 3.3 4.3 5.0 4.8 5.6 5.5 0.0 0.3 0.0 0.0 0.8 7.9 1.7 25.5 0.0 3.4 10.4 0.0 0.0 23.2 30.0 0.2 1.4 0.0 0.0 2.5 0.0 0.9 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 1.8 0.0 0.3 38.4 0.0 0.4 100.9 0.7 45.3 69.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 CELSR1 "ADGRC1, CDHF9, FMI2, HFMI2, ME2" ENSG00000075275 "Cadherin EGF LAG seven-pass G-type receptor 1" Q9NYQ6 22 46360834-46537170 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 38.7;Ciliated cells: 33.5;Club cells: 27.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "memory B-cell: 3.0;naive B-cell: 3.0" "Lineage enriched" "Detected in single" 4 "B-cells: 3.0" "Cell line enhanced" "Detected in many" "A549: 24.1;HaCaT: 15.2;T-47d: 17.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052976, HPA060521" Enhanced "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052976: AB_2682004, HPA060521: AB_2684303" "unprognostic (5.62e-2)" "unprognostic (4.93e-2)" "unprognostic (4.22e-2)" "unprognostic (1.54e-3)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.66e-1)" "unprognostic (3.36e-1)" "unprognostic (5.31e-2)" "unprognostic (1.05e-2)" "unprognostic (1.18e-2)" "unprognostic (8.59e-2)" "unprognostic (2.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.67e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" 3.4 0.5 0.6 5.0 1.4 0.3 4.1 0.4 0.3 8.7 1.3 0.9 3.6 0.3 5.7 7.5 14.2 11.1 5.3 4.6 0.7 0.7 16.2 0.8 19.3 4.2 0.4 0.0 6.0 2.6 7.5 3.8 3.4 2.2 7.2 0.4 3.8 22.6 3.0 0.3 13.9 2.3 3.1 0.4 1.8 3.6 2.8 0.0 1.8 5.7 12.7 12.8 3.1 5.0 3.0 0.2 0.0 0.0 0.7 0.1 0.0 8.7 24.1 4.6 3.9 0.0 0.0 2.2 0.7 1.5 1.4 0.3 5.7 6.8 0.0 11.9 0.1 9.3 15.2 3.8 11.5 0.5 0.0 4.6 0.0 9.7 0.2 0.2 1.5 0.6 0.0 10.8 0.0 9.6 9.1 0.0 0.6 0.0 0.0 0.0 10.9 0.0 1.7 1.7 2.8 3.8 0.0 0.0 2.8 6.4 5.4 0.2 0.3 7.5 6.0 1.2 1.9 17.3 5.1 0.3 0.0 0.1 0.0 0.1 4.6 0.2 2.4 6.0 0.0 5.2 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.6 1.4 0.4 0.3 0.7 0.7 0.4 0.0 2.2 0.0 38.7 16.8 1.3 3.3 15.1 0.0 10.2 0.0 33.5 27.3 5.2 0.0 1.0 0.0 1.4 1.2 5.5 0.0 0.0 0.6 1.7 1.7 3.6 0.0 1.6 2.4 0.0 1.2 1.3 0.0 5.0 0.0 1.3 5.0 1.8 2.0 1.3 2.6 0.0 0.0 11.0 0.3 0.0 1.0 0.2 0.2 13.7 0.7 0.0 1.5 4.7 CEP295 KIAA1731 ENSG00000166004 "Centrosomal protein 295" Q9C0D2 11 93661639-93730358 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 78.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038595, HPA038596, HPA038597" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038595: AB_2676104, HPA038596: AB_10672720, HPA038597: AB_2676106" "unprognostic (1.35e-2)" "unprognostic (3.08e-1)" "unprognostic (7.66e-2)" "unprognostic (5.56e-2)" "unprognostic (5.73e-2)" "unprognostic (4.08e-3)" "unprognostic (6.03e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (3.73e-2)" "unprognostic (4.99e-4)" "unprognostic (1.34e-1)" "unprognostic (5.29e-3)" "unprognostic (1.46e-2)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (2.18e-2)" 8.4 7.4 15.8 12.1 15.4 19.6 11.7 30.6 20.5 10.0 10.0 6.1 9.4 8.6 10.5 11.2 8.4 7.7 7.6 6.5 12.1 8.1 7.6 6.3 8.6 14.1 10.7 14.7 12.2 8.1 8.5 24.5 8.5 12.1 10.6 9.8 5.1 7.9 9.4 13.4 12.5 9.2 7.8 13.8 11.7 8.0 15.5 15.0 11.6 12.3 5.2 9.9 10.7 8.9 6.3 3.0 9.1 3.1 2.7 3.0 0.6 7.2 6.7 17.2 14.8 8.1 7.9 8.5 9.4 6.9 9.0 10.5 12.3 14.0 2.2 14.0 5.9 12.4 13.6 8.7 6.9 9.1 10.4 6.8 13.2 19.4 6.1 4.9 11.9 13.0 5.7 4.1 8.4 7.5 8.5 7.4 12.2 14.9 14.0 11.3 6.2 6.1 19.6 5.8 13.7 6.9 12.3 16.4 8.9 7.3 12.8 10.3 9.7 14.8 10.0 2.7 11.7 16.4 6.5 7.5 8.4 11.0 15.1 7.2 5.2 11.3 14.7 5.0 14.0 11.5 4.1 3.1 5.7 2.8 1.5 2.2 5.0 2.5 1.9 1.3 6.3 3.0 2.5 9.1 2.7 2.0 3.0 1.7 0.6 15.8 15.4 30.6 20.5 12.1 8.1 10.7 14.7 12.1 15.0 8.9 14.7 0.0 2.0 0.0 27.0 7.8 2.5 9.4 10.3 5.2 25.5 9.3 3.3 6.5 78.2 6.3 2.6 23.3 6.8 9.1 4.6 3.6 15.1 3.2 6.9 17.5 3.5 5.5 8.6 15.5 11.8 4.8 0.0 4.6 7.0 7.8 5.0 4.3 13.4 3.0 37.3 6.5 1.4 39.0 17.0 0.0 5.5 6.4 6.4 2.2 CEP57L1 "bA487F23.2, C6orf182, MGC21731" ENSG00000183137 "Centrosomal protein 57 like 1" Q8IYX8 6 109095110-109163932 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Spermatocytes: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040378 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040378: AB_10794028" "unprognostic (5.93e-3)" "unprognostic (4.95e-2)" "unprognostic (1.40e-2)" "unprognostic (2.13e-2)" "unprognostic (1.11e-1)" "unprognostic (3.41e-2)" "unprognostic (4.69e-3)" "unprognostic (3.63e-2)" "unprognostic (7.25e-2)" "unprognostic (1.27e-1)" "unprognostic (2.33e-1)" "unprognostic (9.97e-2)" "unprognostic (2.42e-5)" "unprognostic (2.37e-1)" "unprognostic (2.00e-1)" "unprognostic (8.48e-2)" "unprognostic (1.72e-1)" 11.9 9.3 10.6 7.3 13.5 8.9 11.4 13.9 16.1 11.3 8.8 8.1 8.6 8.4 9.6 10.9 8.0 7.1 9.3 10.4 8.9 6.9 8.1 11.8 8.4 8.1 10.2 10.5 9.3 7.5 18.5 13.5 9.7 13.5 7.1 11.1 7.0 7.4 7.3 7.8 6.8 7.6 10.7 12.8 7.2 7.8 24.6 11.8 6.3 8.7 6.1 6.9 7.6 9.1 7.4 6.9 14.6 10.3 13.4 8.2 5.2 8.3 3.6 11.0 11.2 10.5 17.4 8.9 19.3 10.5 17.1 19.6 5.5 7.3 7.4 8.9 9.8 15.0 4.4 7.6 7.1 27.1 9.4 7.4 15.9 8.7 5.7 9.7 13.0 7.0 10.0 5.5 14.6 14.6 9.5 14.9 25.1 28.8 25.8 15.7 5.6 14.5 11.3 3.6 6.8 7.1 12.0 8.3 7.4 8.1 3.5 8.5 6.9 9.4 7.1 6.3 7.6 8.9 20.8 7.2 11.3 6.8 11.9 20.1 7.5 8.5 11.8 10.7 20.1 9.1 14.6 6.3 7.4 6.1 7.1 6.2 4.0 6.0 8.2 6.7 7.4 5.8 8.2 3.6 13.4 10.3 6.9 8.0 5.2 10.6 13.5 13.9 16.1 8.9 6.9 10.2 10.5 13.5 11.8 6.0 4.0 2.2 6.5 3.0 6.0 8.1 2.5 12.0 7.9 5.2 19.6 7.0 6.6 6.5 36.0 8.7 4.2 23.3 4.7 11.0 11.8 3.3 4.7 4.9 8.4 4.8 5.2 6.7 4.4 26.1 16.1 5.9 8.5 8.2 2.6 9.4 5.0 5.5 11.7 10.4 12.0 12.9 12.8 72.6 5.0 3.9 7.1 6.9 4.5 3.0 CEP89 "CCDC123, FLJ14640" ENSG00000121289 "Centrosomal protein 89" Q96ST8 19 32875925-32971991 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 62.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039382, HPA040056" Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA039382: AB_2676479, HPA040056: AB_10671048" "unprognostic (4.23e-2)" "unprognostic (7.50e-3)" "unprognostic (1.97e-1)" "unprognostic (1.53e-3)" "unprognostic (1.30e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (8.78e-5)" "unprognostic (1.12e-1)" "unprognostic (4.55e-2)" "unprognostic (3.04e-2)" "unprognostic (1.80e-2)" "unprognostic (4.00e-2)" "unprognostic (1.74e-1)" "unprognostic (4.48e-2)" "unprognostic (6.53e-2)" "unprognostic (3.03e-1)" "unprognostic (2.47e-2)" 10.1 9.5 8.5 8.3 12.1 6.8 11.6 16.4 14.4 12.9 10.5 12.5 9.7 6.4 17.0 11.3 10.1 14.8 8.3 8.8 8.1 6.4 9.8 5.6 9.4 8.9 7.9 8.4 17.1 9.0 11.3 20.2 8.8 9.1 15.0 7.4 10.2 10.3 10.2 10.5 10.7 7.4 11.4 6.6 7.7 8.1 8.4 8.4 10.1 11.8 5.0 7.6 10.2 11.4 7.7 5.1 12.7 6.1 2.8 6.9 2.1 13.4 18.5 12.9 11.0 7.0 8.2 7.4 10.9 7.3 19.3 14.8 6.6 8.4 5.6 5.9 11.1 10.9 7.8 12.6 8.8 13.4 14.5 7.7 4.3 12.9 6.4 5.6 5.9 4.3 9.8 12.2 18.2 11.9 7.9 14.4 7.7 6.5 8.2 8.9 10.2 6.7 4.6 5.5 7.5 6.0 7.5 7.0 4.8 8.8 7.6 18.2 13.4 11.1 7.7 6.3 8.2 5.9 4.9 9.2 14.0 12.4 11.9 11.0 4.1 6.3 5.0 12.0 5.6 10.5 12.7 4.4 2.1 4.0 6.1 6.9 4.7 4.2 3.4 2.4 7.7 4.1 4.7 5.3 2.8 3.0 5.1 4.4 2.1 8.5 12.1 16.4 14.4 8.1 6.4 7.9 8.4 9.1 8.4 26.8 13.6 12.6 9.2 4.5 15.3 15.3 12.7 62.9 25.0 19.2 17.7 8.4 10.0 16.5 11.6 11.7 6.4 23.3 14.2 9.1 9.9 6.2 16.2 5.3 10.2 19.1 9.4 14.1 5.7 5.9 15.0 9.9 5.0 12.6 9.6 10.1 12.8 2.9 12.0 12.2 38.5 0.0 11.3 21.5 13.2 4.0 3.5 7.1 7.7 4.3 CFAP157 C9orf117 ENSG00000160401 "Cilia and flagella associated protein 157" Q5JU67 9 127706989-127716002 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 30.2;epididymis: 24.0;fallopian tube: 44.8;testis: 11.5" "Cell type enriched" "Detected in some" 6 "Ciliated cells: 348.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 19.8;pons and medulla: 30.2" "Cell type enriched" "Detected in single" 11 "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 12 "T-cells: 1.2" "Cell line enhanced" "Detected in many" "A549: 9.3;HeLa: 7.6;MCF7: 6.6;SCLC-21H: 6.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA021474, HPA021786" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021474: AB_1845801, HPA021786: AB_1845802" "unprognostic (1.69e-1)" "unprognostic (2.80e-2)" "unprognostic (2.41e-2)" "prognostic favorable (1.45e-4)" "unprognostic (3.02e-1)" "unprognostic (1.58e-1)" "unprognostic (4.71e-3)" "unprognostic (1.49e-1)" "unprognostic (3.14e-4)" "unprognostic (7.72e-2)" "unprognostic (4.93e-4)" "unprognostic (9.32e-3)" "unprognostic (4.95e-3)" "unprognostic (5.71e-4)" "unprognostic (4.34e-2)" "unprognostic (7.38e-2)" "unprognostic (1.28e-1)" 0.4 0.4 3.1 0.3 19.8 0.3 0.3 0.1 0.4 5.3 0.3 7.0 1.6 0.2 1.0 24.0 0.8 44.8 0.6 0.4 4.6 5.8 0.4 0.3 6.1 0.4 0.0 0.0 4.4 0.9 0.2 4.4 0.3 30.2 0.4 0.2 0.0 0.5 1.3 0.4 0.6 0.3 0.2 0.5 0.4 0.4 11.5 3.5 0.0 0.4 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 1.5 9.3 0.9 1.2 0.0 0.0 1.2 1.2 0.0 0.0 0.0 0.9 1.3 1.4 1.4 0.0 2.3 4.6 0.0 0.0 0.0 3.4 1.1 0.9 7.6 2.3 0.0 0.7 2.1 0.0 0.0 0.0 0.0 0.5 0.0 2.8 3.1 0.7 0.0 6.6 1.3 0.5 0.9 1.7 4.9 2.0 0.9 1.5 0.0 0.4 6.4 1.1 1.9 3.6 0.7 0.2 3.2 0.3 1.7 1.9 1.5 5.0 0.8 1.0 2.6 1.2 0.8 0.7 1.2 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 19.8 0.1 0.3 4.6 5.8 0.0 0.0 30.2 3.5 8.9 10.9 0.0 0.2 0.0 0.6 0.0 0.0 348.0 51.2 0.0 0.0 0.0 1.7 0.3 44.7 0.0 0.0 0.0 0.0 0.1 0.0 0.3 2.3 0.2 0.2 0.0 0.0 0.0 0.3 61.4 0.3 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.7 0.3 0.2 0.0 0.0 11.4 1.1 0.0 0.0 0.0 0.2 0.1 CFAP65 "CCDC108, DKFZp434O0527, MGC35338" ENSG00000181378 "Cilia and flagella associated protein 65" Q6ZU64 2 219002846-219041527 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 16.3;fallopian tube: 29.2;testis: 20.4" "Group enriched" "Detected in many" 4 "Ciliated cells: 53.5;Early spermatids: 163.7;Late spermatids: 138.9" "Cancer enhanced" "Detected in single" "endometrial cancer: 1.1" "Region enhanced" "Detected in many" "pons and medulla: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "OE19: 2.4;SCLC-21H: 1.5;SH-SY5Y: 4.0;U-87 MG: 2.0" "Low region specificity" "Detected in many" "Region enhanced" "Detected in many" "midbrain: 13.1" "HPA055156, HPA063406" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA055156: AB_2682720, HPA063406: " "unprognostic (3.95e-2)" "unprognostic (1.80e-1)" "unprognostic (9.88e-3)" "prognostic favorable (6.08e-5)" "unprognostic (2.18e-2)" "unprognostic (1.04e-2)" "unprognostic (2.20e-1)" "unprognostic (3.76e-3)" "unprognostic (3.71e-1)" "unprognostic (3.03e-1)" "unprognostic (5.58e-3)" "unprognostic (1.43e-1)" "unprognostic (6.62e-3)" "unprognostic (8.04e-2)" "unprognostic (2.81e-2)" "unprognostic (9.60e-2)" "unprognostic (6.60e-2)" 0.2 0.4 1.8 0.3 6.4 0.3 0.3 0.0 2.1 2.2 0.4 5.4 0.3 0.3 0.9 6.0 0.2 29.2 0.6 0.2 2.9 3.2 0.5 0.2 3.6 0.3 0.4 1.2 4.2 0.6 0.3 6.1 0.2 16.3 0.3 0.5 2.8 0.4 0.4 0.2 0.2 0.7 0.2 0.6 0.3 0.6 20.4 2.5 0.0 1.3 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.0 0.5 0.5 0.0 1.1 0.2 0.0 0.0 0.0 1.4 0.2 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.1 0.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.5 0.0 0.1 0.0 0.0 0.1 2.4 0.1 0.0 0.0 0.0 1.2 0.0 1.5 4.0 0.0 0.1 0.7 0.6 1.1 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.8 6.4 0.0 2.1 2.9 3.2 0.4 1.2 16.3 2.5 0.0 3.4 0.0 0.1 0.0 0.7 0.0 7.6 53.5 12.5 0.0 11.8 0.0 0.0 0.4 163.7 0.0 0.5 0.0 1.3 0.0 0.0 1.4 0.0 0.0 0.1 0.0 28.1 0.0 0.0 138.9 0.6 0.0 0.0 0.0 25.9 0.8 1.4 0.0 0.7 0.9 20.7 0.0 0.0 15.4 4.1 0.0 0.0 0.0 3.4 0.0 CGN KIAA1319 ENSG00000143375 Cingulin Q9P2M7 1 151510510-151538692 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 44.1" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 1: 110.2;Ciliated cells: 50.9;Enterocytes: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 36.9;CAPAN-2: 24.3;OE19: 23.6;RT4: 17.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB017193, HPA027586, HPA027587, HPA027657" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 24000000 "Plasma membrane, Cell Junctions" "CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527" "unprognostic (1.57e-1)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (8.74e-3)" "unprognostic (1.02e-1)" "unprognostic (3.01e-1)" "unprognostic (1.98e-1)" "unprognostic (8.38e-2)" "unprognostic (4.61e-1)" "unprognostic (2.11e-2)" "unprognostic (2.96e-3)" "unprognostic (7.10e-2)" "prognostic favorable (5.84e-10)" "unprognostic (2.66e-1)" "unprognostic (3.00e-1)" "unprognostic (8.28e-2)" "unprognostic (2.10e-2)" 3.9 0.3 2.1 8.5 5.1 0.0 4.1 11.9 3.5 2.2 18.0 3.7 15.5 23.9 1.0 3.5 5.9 6.1 11.9 0.5 1.4 1.4 10.7 15.0 12.4 0.2 5.0 1.0 1.4 25.3 22.1 4.7 1.9 4.8 4.6 11.6 1.8 19.8 14.4 0.2 11.6 44.1 1.8 1.9 0.2 13.6 6.4 4.3 0.9 3.6 2.3 4.3 6.9 3.8 1.2 0.9 2.6 1.0 1.6 2.4 0.1 11.5 1.3 1.1 1.9 0.0 0.0 14.8 0.0 0.0 0.3 0.4 36.9 24.3 0.5 4.0 0.0 2.0 11.1 3.6 2.0 0.2 6.9 2.4 1.0 0.5 0.7 0.0 0.2 1.6 0.0 0.4 0.5 0.3 0.0 0.1 3.3 0.5 3.5 0.0 10.7 2.0 0.2 9.5 23.6 1.0 2.2 1.2 1.7 7.8 17.9 3.7 1.9 0.7 11.3 0.4 4.5 13.9 0.1 0.2 0.1 3.6 0.2 0.5 3.3 3.2 2.0 0.1 1.3 0.9 1.1 1.0 0.4 2.4 0.4 0.7 0.7 0.7 0.5 0.1 1.2 0.8 1.4 2.6 1.6 0.5 0.9 0.7 0.1 2.1 5.1 11.9 3.5 1.4 1.4 5.0 1.0 4.8 4.3 110.2 25.7 0.0 3.7 0.2 2.7 0.4 15.3 50.9 26.1 3.5 0.0 2.1 0.0 19.2 0.0 0.0 85.9 0.0 22.2 0.2 0.3 9.6 0.0 25.2 0.2 0.0 9.9 0.0 0.0 0.5 0.6 0.7 3.3 3.6 26.7 16.6 34.9 40.1 0.7 2.6 1.4 0.0 0.3 0.7 7.1 1.6 0.3 0.0 21.4 13.9 CHIC2 BTL ENSG00000109220 "Cysteine rich hydrophobic domain 2" Q9UKJ5 4 54009789-54064690 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Basal keratinocytes: 309.8;Suprabasal keratinocytes: 326.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026782, HPA026784, HPA076603" Uncertain Enhanced "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA026782: AB_1846654, HPA026784: AB_2732433, HPA076603: AB_2732317" "unprognostic (4.56e-2)" "unprognostic (2.24e-3)" "unprognostic (3.47e-3)" "unprognostic (9.58e-2)" "unprognostic (1.49e-1)" "unprognostic (2.25e-2)" "unprognostic (7.87e-2)" "unprognostic (1.22e-1)" "unprognostic (3.65e-2)" "unprognostic (7.81e-3)" "unprognostic (2.94e-2)" "unprognostic (5.63e-2)" "prognostic unfavorable (1.56e-4)" "unprognostic (2.89e-1)" "unprognostic (1.77e-1)" "unprognostic (4.56e-2)" "unprognostic (9.40e-2)" 17.0 17.5 9.5 14.6 9.7 23.7 17.1 17.9 12.0 12.8 14.2 7.1 11.9 13.0 16.8 14.9 25.3 11.0 22.1 14.3 7.3 7.9 12.3 20.2 17.7 13.5 6.6 10.0 13.2 9.9 5.5 16.7 18.5 9.9 12.3 9.6 15.9 15.3 9.9 10.9 24.7 20.6 10.8 8.1 18.5 12.9 50.1 8.3 32.3 11.8 11.6 20.5 12.9 16.3 8.4 10.9 63.8 15.9 13.6 15.6 13.6 11.6 2.1 6.5 5.7 10.8 8.3 6.3 16.2 17.2 9.7 9.7 8.3 10.4 9.9 14.5 10.4 8.8 3.5 8.7 11.8 10.5 5.4 4.4 5.4 2.0 6.3 32.4 8.7 11.2 11.2 9.7 14.6 22.4 19.6 14.2 10.8 5.8 7.5 19.3 3.2 10.2 14.1 4.3 5.4 8.0 6.7 3.5 3.8 11.1 3.9 9.4 8.9 3.8 5.7 11.8 9.7 3.0 13.1 24.1 12.5 9.7 17.8 10.4 8.9 4.2 8.1 9.2 8.8 8.9 56.0 15.9 32.2 12.6 12.4 12.1 8.4 12.8 14.2 10.9 8.2 11.8 12.7 63.8 13.6 12.5 9.1 15.6 13.6 9.5 9.7 17.9 12.0 7.3 7.9 6.6 10.0 9.9 8.3 6.0 8.2 16.1 80.5 309.8 7.1 4.0 12.7 29.4 7.9 7.0 7.9 24.6 14.9 37.6 40.4 37.2 22.7 23.3 24.6 33.5 50.4 75.8 36.8 21.5 22.8 12.7 24.8 38.6 38.9 11.4 15.8 40.6 64.1 23.4 21.3 8.2 45.8 24.6 23.0 22.8 7.0 19.4 37.6 152.1 82.4 326.7 39.9 39.9 18.0 124.8 CHRNA5 ENSG00000169684 "Cholinergic receptor nicotinic alpha 5 subunit" P30532 15 78565520-78595269 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "vagina: 33.9" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 9.6;Spermatogonia: 32.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA054381 Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Focal adhesion sites" "Plasma membrane" "HPA054381: AB_2682468" "unprognostic (2.66e-1)" "unprognostic (1.76e-1)" "unprognostic (2.32e-2)" "unprognostic (3.20e-3)" "unprognostic (6.66e-2)" "unprognostic (1.29e-3)" "unprognostic (7.03e-5)" "prognostic unfavorable (3.64e-5)" "unprognostic (1.34e-2)" "unprognostic (1.31e-2)" "unprognostic (4.52e-2)" "unprognostic (8.97e-2)" "unprognostic (6.50e-11)" "unprognostic (4.37e-1)" "unprognostic (5.39e-1)" "unprognostic (5.44e-2)" "unprognostic (2.22e-1)" 2.9 3.3 1.7 4.4 1.7 0.6 4.9 1.8 1.7 2.7 6.4 0.4 1.6 7.8 4.7 1.9 4.0 1.1 16.3 2.4 1.7 1.8 0.9 1.8 1.4 2.0 1.9 0.3 1.7 11.8 0.0 0.7 2.1 1.2 3.6 7.1 3.5 1.7 0.7 5.8 1.0 6.8 6.1 1.3 1.9 5.3 9.8 0.6 4.5 1.6 2.9 4.4 5.7 33.9 0.9 1.1 3.4 1.6 1.6 1.4 0.7 6.7 17.4 9.5 5.2 1.1 0.8 3.8 4.9 2.4 5.5 10.0 6.6 32.1 4.0 12.2 1.0 14.8 6.0 18.1 7.3 5.6 8.1 21.7 7.4 13.6 6.6 0.6 5.0 10.5 0.3 1.3 1.5 2.0 2.0 10.2 5.6 7.2 5.2 3.5 14.7 6.3 1.7 7.7 13.3 4.8 8.1 10.9 4.0 6.6 16.1 16.0 23.5 11.9 11.6 5.5 5.6 25.8 1.3 2.2 7.5 9.0 5.5 15.5 6.1 25.0 4.5 4.5 8.1 6.9 3.0 1.6 2.5 0.8 1.6 0.4 0.3 0.8 0.5 0.9 0.9 1.4 1.4 3.4 1.6 1.3 1.1 0.3 0.7 1.7 1.7 1.8 1.7 1.7 1.8 1.9 0.3 1.2 0.6 0.0 0.0 0.0 7.8 2.9 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.3 1.0 1.0 0.0 0.0 1.8 9.6 0.4 5.2 0.0 0.0 0.9 4.8 3.4 0.0 0.0 1.2 0.3 0.8 1.7 0.0 6.3 0.2 0.7 0.0 0.4 0.2 0.5 0.0 2.1 3.2 32.1 1.4 0.8 1.3 1.5 2.7 CIB1 "CIB, KIP, SIP2-28" ENSG00000185043 "Calcium and integrin binding 1" Q99828 15 90229975-90234047 "Predicted intracellular proteins" "Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 1100.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB012991, HPA042413, HPA048825" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533" "unprognostic (1.20e-1)" "unprognostic (1.59e-1)" "unprognostic (1.73e-2)" "prognostic favorable (2.26e-5)" "unprognostic (7.56e-2)" "unprognostic (5.51e-2)" "unprognostic (1.21e-2)" "unprognostic (8.29e-3)" "unprognostic (1.77e-1)" "unprognostic (4.09e-2)" "unprognostic (5.25e-3)" "unprognostic (2.44e-1)" "unprognostic (1.29e-3)" "unprognostic (1.85e-1)" "unprognostic (6.31e-2)" "unprognostic (1.39e-1)" "unprognostic (2.68e-2)" 16.5 40.1 15.0 31.1 14.7 42.5 21.8 4.1 13.8 24.1 51.6 15.4 31.0 31.6 12.2 37.2 39.9 37.2 43.3 47.7 14.8 14.0 49.8 74.5 27.9 27.6 17.5 13.8 17.8 67.8 20.2 24.0 20.6 18.3 30.3 34.0 16.7 40.4 44.5 21.2 10.0 67.5 13.9 13.6 29.3 23.8 25.7 11.0 21.5 37.8 27.8 44.3 38.0 16.3 87.9 43.0 49.4 45.4 35.9 55.2 64.9 24.5 55.6 4.9 17.8 21.8 22.9 8.2 26.1 22.8 21.6 19.3 21.8 43.9 7.1 28.2 30.6 27.9 25.6 10.5 30.1 11.7 16.9 23.9 15.9 38.3 36.1 21.5 31.9 15.6 16.2 18.1 20.1 13.9 24.3 27.5 17.8 21.4 11.3 16.4 48.2 24.0 37.2 7.9 47.2 28.6 13.7 13.5 28.9 55.0 42.0 4.1 4.9 35.6 28.9 27.8 9.3 22.5 19.3 17.3 23.9 17.0 28.8 31.9 15.4 24.1 8.3 38.5 36.5 10.2 25.3 39.3 49.4 46.0 45.4 37.7 87.9 55.2 50.2 43.0 70.7 46.0 45.5 22.8 35.9 41.0 28.5 44.3 64.9 15.0 14.7 4.1 13.8 14.8 14.0 17.5 13.8 18.3 11.0 83.4 104.1 147.3 209.7 76.1 10.0 74.5 152.8 653.1 152.4 174.5 9.8 90.9 384.7 302.9 295.2 73.0 544.4 0.0 585.6 97.5 113.1 427.5 136.2 209.7 199.6 3.2 93.2 65.1 107.8 1100.8 97.5 194.3 121.4 222.8 293.7 96.5 506.2 613.7 87.0 538.0 22.1 38.8 86.5 141.6 49.6 58.8 55.3 173.0 242.6 478.0 CIB3 KIP3 ENSG00000141977 "Calcium and integrin binding family member 3" Q96Q77 19 16161368-16173525 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 5.4;bone marrow: 4.8;testis: 3.8" "Group enriched" "Detected in some" 8 "Cardiomyocytes: 22.7;Late spermatids: 6.6" "Cancer enriched" "Detected in single" 7 "breast cancer: 0.9" "Cell type enhanced" "Detected in some" "eosinophil: 5.4" "Lineage enriched" "Detected in single" 9 "granulocytes: 5.4" "Cell line enhanced" "Detected in some" "HMC-1: 9.2;MCF7: 4.4;NB-4: 2.8;THP-1: 2.6;U-937: 4.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA043553, HPA043995" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043553: AB_10964566, HPA043995: " "unprognostic (8.43e-2)" "unprognostic (7.26e-5)" "unprognostic (3.18e-2)" "unprognostic (2.62e-1)" "unprognostic (5.32e-2)" "unprognostic (1.95e-2)" "unprognostic (1.25e-1)" "unprognostic (3.14e-1)" "unprognostic (2.93e-2)" "unprognostic (3.05e-1)" "unprognostic (5.68e-2)" "unprognostic (3.42e-1)" "unprognostic (1.54e-2)" 0.0 0.0 0.0 0.8 0.0 4.8 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 3.8 0.0 0.7 0.1 0.0 0.1 0.6 5.4 0.5 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 9.2 0.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 4.4 0.0 2.8 0.4 0.0 0.3 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 4.1 0.0 1.9 0.1 5.4 0.0 0.5 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.1 0.4 0.0 0.1 0.0 0.0 1.5 0.0 0.0 0.0 22.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 1.1 0.0 0.0 0.0 0.0 0.0 CIP2A KIAA1524 ENSG00000163507 "Cell proliferation regulating inhibitor of protein phosphatase 2A" Q8TCG1 3 108549869-108589644 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.5" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 8.9;Exocrine glandular cells: 6.4;Extravillous trophoblasts: 10.7;Hofbauer cells: 6.7;monocytes: 5.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039570 Approved Supported "Plasma membrane,Cytosol" NA Yes Cytosol "Plasma membrane" "HPA039570: AB_10796329" "unprognostic (2.02e-1)" "unprognostic (1.54e-2)" "unprognostic (2.31e-3)" "prognostic unfavorable (6.24e-5)" "unprognostic (3.10e-2)" "unprognostic (1.07e-2)" "unprognostic (1.91e-7)" "unprognostic (2.80e-3)" "unprognostic (2.53e-3)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.18e-4)" "unprognostic (6.85e-2)" "prognostic unfavorable (1.42e-4)" "unprognostic (9.11e-3)" "unprognostic (3.73e-1)" "unprognostic (2.11e-1)" "unprognostic (1.25e-1)" 2.1 2.3 2.5 8.5 6.3 10.4 3.6 6.3 6.2 3.2 3.1 2.6 0.8 2.0 3.2 1.8 4.0 1.8 2.0 2.7 2.9 2.1 2.2 1.6 2.2 10.2 2.0 3.2 3.8 1.8 1.8 3.0 3.3 2.4 3.0 4.4 2.2 2.3 1.4 2.0 1.9 2.7 2.5 2.4 5.5 2.0 8.5 1.5 21.5 1.9 1.5 8.0 4.0 2.7 1.9 0.3 0.7 1.1 0.0 1.6 0.6 18.9 5.6 15.9 10.2 0.7 1.5 6.5 14.4 6.8 17.1 20.1 6.8 8.5 12.8 5.0 5.2 13.0 9.7 5.4 5.1 31.2 4.0 5.3 15.3 7.8 5.1 0.2 9.8 11.0 0.6 1.0 13.3 5.5 2.8 7.6 5.9 9.4 20.7 16.7 3.9 11.8 8.8 16.4 7.1 9.8 13.6 14.8 7.0 5.2 5.3 7.7 10.2 10.6 4.2 5.9 9.7 7.1 7.0 5.5 17.6 19.9 5.3 17.3 4.8 5.3 21.2 7.8 10.7 17.9 0.6 0.3 0.7 0.0 0.5 1.3 1.2 0.7 0.3 0.0 1.9 0.7 1.6 0.0 0.0 1.1 0.3 0.8 0.6 2.5 6.3 6.3 6.2 2.9 2.1 2.0 3.2 2.4 1.5 8.9 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 4.5 3.5 0.0 2.5 1.7 2.4 0.0 0.0 0.0 0.0 6.4 10.7 0.0 0.0 3.5 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 5.4 0.0 0.0 3.2 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 CLCN6 "CLC-6, KIAA0046" ENSG00000011021 "Chloride voltage-gated channel 6" P51797 1 11806096-11843144 "Plasma proteins, Predicted membrane proteins" "Antiport, Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032097 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA032097: AB_10670827" "unprognostic (3.14e-2)" "unprognostic (1.14e-1)" "unprognostic (2.46e-1)" "unprognostic (8.83e-2)" "unprognostic (2.08e-1)" "unprognostic (3.84e-3)" "unprognostic (1.51e-3)" "unprognostic (6.49e-2)" "unprognostic (7.76e-2)" "unprognostic (6.61e-3)" "unprognostic (1.71e-3)" "unprognostic (3.44e-1)" "unprognostic (2.13e-2)" "unprognostic (6.91e-2)" "unprognostic (1.45e-1)" "unprognostic (1.69e-1)" "unprognostic (3.65e-2)" 11.2 14.6 18.9 11.5 18.7 12.2 8.6 18.0 27.9 9.2 8.7 22.4 8.6 9.6 12.8 14.2 6.3 10.7 8.1 15.7 15.0 20.6 10.0 9.1 10.6 11.1 16.4 17.8 21.4 6.6 8.4 14.8 9.6 32.4 11.3 7.8 13.1 6.7 8.7 11.2 10.0 9.1 10.8 15.9 10.6 8.5 16.1 14.5 4.3 10.7 5.0 9.5 7.7 8.2 10.1 3.2 4.2 4.6 2.0 3.2 1.1 5.6 5.3 12.0 10.1 12.9 13.4 3.7 4.7 9.2 6.6 10.3 8.1 13.8 8.1 3.9 4.4 16.4 8.4 7.9 8.8 5.9 3.6 4.2 8.4 10.5 10.7 16.7 4.7 7.9 9.2 5.2 12.4 7.0 8.0 5.9 8.4 10.6 11.7 6.7 3.1 4.8 12.7 8.0 2.7 4.2 6.1 6.6 7.4 8.7 4.7 5.2 8.3 3.2 5.1 11.0 8.8 4.5 8.4 7.1 6.2 7.0 10.5 3.3 7.0 4.3 20.8 7.6 9.4 4.5 4.2 4.6 1.5 2.6 3.7 1.5 8.0 2.1 3.2 2.7 10.1 2.3 2.1 3.9 2.0 4.6 3.2 1.4 1.1 18.9 18.7 18.0 27.9 15.0 20.6 16.4 17.8 32.4 14.5 17.9 20.5 11.3 3.3 3.1 18.5 21.8 10.2 8.1 6.8 3.5 13.7 3.2 0.0 3.6 12.5 5.6 5.4 0.0 3.9 2.2 5.2 4.1 2.3 5.5 6.5 25.4 6.3 8.0 8.2 7.4 6.9 10.1 1.7 5.4 2.9 7.8 4.2 3.5 6.7 3.0 16.0 0.0 4.2 9.7 9.4 2.8 3.4 2.5 3.0 3.5 CLDN23 CLDNL ENSG00000253958 "Claudin 23" Q96B33 8 8701938-8704106 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Enterocytes: 128.5;Paneth cells: 76.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4;plasmacytoid DC: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 9.8;Daudi: 7.8;RT4: 8.3;SK-BR-3: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" HPA070578 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA070578: " "unprognostic (1.86e-1)" "unprognostic (1.53e-1)" "prognostic favorable (3.46e-4)" "unprognostic (2.97e-1)" "unprognostic (8.32e-2)" "unprognostic (3.04e-1)" "unprognostic (3.44e-1)" "unprognostic (2.05e-2)" "unprognostic (2.14e-1)" "unprognostic (1.14e-1)" "unprognostic (1.97e-2)" "unprognostic (8.25e-3)" "prognostic favorable (9.65e-8)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (9.59e-2)" "unprognostic (1.33e-3)" 9.1 1.0 0.3 7.1 1.4 0.3 6.1 0.4 0.6 2.6 14.8 0.5 3.8 5.5 1.0 6.3 2.8 1.4 10.6 1.4 0.9 0.2 6.5 13.3 8.7 3.1 1.1 0.3 2.6 3.2 1.5 0.7 15.7 1.7 3.3 8.8 2.8 6.0 2.5 0.9 10.0 20.0 0.5 0.3 2.4 18.0 1.5 0.5 0.4 8.8 4.3 3.0 6.0 5.3 0.5 3.9 0.8 2.4 0.0 0.0 0.6 0.2 3.2 0.0 0.2 1.0 0.1 9.8 2.4 1.9 2.6 4.0 1.9 5.2 7.8 0.0 0.1 1.0 3.1 0.0 0.1 0.2 1.5 0.0 0.0 1.0 0.1 4.6 0.0 0.1 1.3 1.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.3 4.0 0.1 0.2 2.5 0.4 1.6 0.0 0.0 0.0 1.2 8.3 0.4 1.2 3.2 8.5 0.1 1.0 1.2 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.8 0.0 2.4 0.0 0.5 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 0.6 0.3 1.4 0.4 0.6 0.9 0.2 1.1 0.3 1.7 0.5 8.9 1.9 1.3 6.7 0.1 0.0 0.5 20.4 6.7 1.2 1.8 0.0 15.9 6.6 19.6 0.0 1.0 128.5 0.0 9.5 15.2 3.5 2.8 4.6 6.8 15.3 0.0 7.5 8.0 1.9 0.0 0.3 2.9 3.3 1.0 23.5 0.2 20.1 76.4 0.4 3.8 1.1 6.5 2.1 0.0 0.0 0.5 7.9 0.0 18.9 10.5 CLEC4F "CLECSF13, FLJ39110, KCLR" ENSG00000152672 "C-type lectin domain family 4 member F" Q8N1N0 2 70808643-70820600 "Predicted membrane proteins" Endocytosis Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 17 "Cone photoreceptor cells: 9.8;Horizontal cells: 4.8;Rod photoreceptor cells: 7.0" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in single" "Group enriched" "Detected in some" 9 "intermediate monocyte: 7.9;non-classical monocyte: 5.8" "Lineage enriched" "Detected in single" 11 "monocytes: 7.9" "Cell line enhanced" "Detected in some" "AN3-CA: 6.0;BEWO: 2.1;HAP1: 1.7;SH-SY5Y: 1.4;T-47d: 3.1" "Not detected" "Not detected" HPA056101 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA056101: " "unprognostic (8.14e-3)" "unprognostic (3.73e-2)" "unprognostic (2.07e-2)" "unprognostic (2.46e-1)" "unprognostic (4.91e-2)" "unprognostic (5.41e-2)" "unprognostic (3.66e-2)" "unprognostic (2.07e-2)" "unprognostic (9.29e-2)" "unprognostic (3.45e-1)" "unprognostic (2.68e-4)" "unprognostic (2.62e-1)" "unprognostic (1.93e-1)" "unprognostic (1.91e-1)" "unprognostic (2.44e-2)" "unprognostic (9.59e-2)" "unprognostic (2.44e-1)" 3.1 0.0 0.5 3.2 0.5 0.0 2.1 0.7 0.7 1.8 4.2 0.5 6.8 2.5 2.9 1.4 1.5 1.5 7.0 1.5 0.5 0.1 1.2 2.4 9.0 1.8 1.2 0.5 1.3 0.5 0.0 1.4 0.5 0.5 2.9 1.3 0.8 3.3 2.7 1.4 2.3 7.6 2.0 0.5 6.8 0.7 2.0 0.5 0.9 0.6 0.5 2.0 1.5 2.5 0.0 0.7 0.0 7.9 0.0 0.0 0.6 0.0 0.1 0.1 6.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.3 3.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.6 0.5 0.5 0.7 0.5 0.5 0.1 1.2 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.2 0.4 0.3 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.8 0.0 0.0 0.3 0.7 0.0 1.7 0.0 1.8 0.0 0.7 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 CLEC5A "CLECSF5, MDL-1" ENSG00000258227 "C-type lectin domain containing 5A" Q9NY25 7 141927357-141947007 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 35.8" "Group enriched" "Detected in some" 4 "Hofbauer cells: 18.6;Macrophages: 57.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "classical monocyte: 11.5" "Lineage enriched" "Detected in many" 8 "monocytes: 11.5" "Group enriched" "Detected in some" 23 "HL-60: 15.2;U-937: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA054137 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054137: AB_2732582" "unprognostic (6.89e-2)" "unprognostic (1.07e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" "unprognostic (1.69e-2)" "unprognostic (4.56e-2)" "unprognostic (1.33e-5)" "unprognostic (4.57e-1)" "unprognostic (2.59e-1)" "prognostic unfavorable (2.21e-4)" "unprognostic (6.58e-3)" "unprognostic (1.06e-1)" "unprognostic (1.73e-2)" "unprognostic (3.00e-2)" "unprognostic (2.82e-1)" "unprognostic (7.23e-2)" "unprognostic (1.64e-1)" 1.4 3.2 1.8 7.3 2.4 35.8 0.8 0.8 2.5 1.7 0.4 1.9 0.6 0.4 0.8 0.5 1.4 1.2 2.0 3.8 7.6 3.1 2.9 2.1 13.9 0.3 2.4 0.5 2.7 2.6 1.4 1.1 2.7 8.2 0.9 0.5 0.8 2.7 0.8 0.3 2.7 0.3 1.5 4.8 2.1 0.4 0.9 4.8 1.1 1.4 4.9 1.4 1.9 1.1 0.0 0.5 1.4 11.5 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.7 0.0 0.0 11.5 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.4 0.0 0.0 0.3 0.0 1.9 1.8 2.4 0.8 2.5 7.6 3.1 2.4 0.5 8.2 4.8 0.0 7.4 0.0 0.0 1.6 0.0 0.3 2.5 5.3 9.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.6 0.0 2.3 0.0 18.6 0.0 0.0 0.0 3.8 0.2 0.0 57.4 1.7 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.3 0.2 0.0 0.0 0.0 CLECL1 DCAL1 ENSG00000184293 "C-type lectin like 1" Q8IZS7 12 9715860-9733299 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 9 "blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6" "Group enriched" "Detected in some" 4 "B-cells: 69.2;Hofbauer cells: 21.8;Kupffer cells: 84.7;Macrophages: 31.4;monocytes: 69.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "memory B-cell: 42.4" "Lineage enriched" "Detected in many" 5 "B-cells: 42.4" "Group enriched" "Detected in some" 5 "HEL: 16.0;Karpas-707: 22.2;U-698: 56.8;U-937: 31.2" HPA063928 Supported "Plasma membrane,Centriolar satellite" NA NA "Plasma membrane, Centriolar satellite" "HPA063928: " "unprognostic (2.18e-2)" "unprognostic (2.35e-3)" "unprognostic (2.20e-3)" "unprognostic (1.90e-3)" "unprognostic (3.66e-1)" "unprognostic (1.90e-3)" "unprognostic (2.83e-1)" "unprognostic (7.55e-4)" "unprognostic (5.10e-2)" "unprognostic (2.82e-1)" "unprognostic (1.09e-1)" "unprognostic (2.20e-1)" "unprognostic (3.91e-5)" "unprognostic (3.31e-1)" "unprognostic (2.45e-1)" "unprognostic (6.10e-2)" "unprognostic (7.39e-2)" 2.7 1.0 0.8 9.8 1.1 0.9 1.1 0.3 0.9 0.6 1.7 1.3 0.1 1.6 0.7 1.3 2.6 0.9 1.5 2.7 1.0 0.9 1.6 1.4 1.9 15.5 1.3 0.7 0.5 1.7 0.0 0.9 0.5 0.9 0.8 2.8 0.8 1.5 0.1 0.5 0.5 11.5 0.9 2.5 20.5 2.6 0.6 0.3 2.2 0.9 0.5 20.6 2.8 2.4 42.4 8.6 0.7 4.6 0.0 3.5 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.3 56.8 0.0 31.2 0.0 0.7 2.6 0.1 1.7 4.6 0.0 42.4 1.4 3.5 6.1 14.5 0.0 0.5 0.1 0.0 4.6 8.6 0.1 2.1 0.8 1.1 0.3 0.9 1.0 0.9 1.3 0.7 0.9 0.3 0.0 0.0 69.2 0.1 1.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.1 0.4 0.0 4.7 0.2 21.8 0.0 0.0 0.6 84.7 1.1 0.3 31.4 11.8 69.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.5 0.2 0.0 0.0 1.6 0.2 12.5 0.0 0.1 CLIC5 DFNB102 ENSG00000112782 "Chloride intracellular channel 5" Q9NZA1 6 45880827-46080348 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters" "Hearing, Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel, Voltage-gated channel" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9" "Cell type enhanced" "Detected in many" 20 "Alveolar cells type 1: 473.4;Cardiomyocytes: 276.0;Enterocytes: 100.0" "Cancer enhanced" "Detected in many" "ovarian cancer: 11.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "MAIT T-cell: 8.8" "Lineage enriched" "Detected in single" 23 "T-cells: 8.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.6;EFO-21: 9.6;HDLM-2: 5.0;REH: 11.7;U-266/70: 12.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA074371 Supported "Nuclear speckles,Plasma membrane" NA NA 1000000 "Plasma membrane" "Nuclear speckles" "HPA074371: " "unprognostic (4.95e-2)" "unprognostic (1.59e-2)" "unprognostic (8.84e-2)" "unprognostic (5.05e-2)" "unprognostic (2.44e-1)" "unprognostic (6.73e-2)" "unprognostic (3.37e-1)" "unprognostic (1.26e-1)" "unprognostic (1.79e-1)" "unprognostic (6.46e-2)" "unprognostic (5.50e-2)" "unprognostic (3.65e-1)" "unprognostic (6.77e-3)" "unprognostic (1.22e-1)" "unprognostic (1.99e-1)" "unprognostic (8.26e-2)" "unprognostic (1.01e-1)" 7.4 0.6 0.8 3.2 1.5 0.0 2.3 0.6 1.1 6.0 10.2 0.3 0.4 5.6 0.8 2.5 2.2 1.2 2.1 65.6 0.9 1.2 17.5 0.5 32.8 0.4 1.1 1.4 0.7 0.7 0.4 1.3 22.0 0.8 0.9 7.5 7.8 2.0 0.4 99.9 0.7 46.2 1.4 0.9 16.1 0.9 1.0 0.0 0.2 4.8 18.8 1.5 1.0 4.3 0.3 0.0 0.0 0.0 0.3 8.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 13.6 0.0 9.6 0.0 0.0 0.3 0.0 0.1 0.0 5.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.8 0.0 0.0 0.0 0.1 0.3 1.5 0.0 11.7 0.3 0.1 0.1 0.5 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.4 0.1 0.0 12.9 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 2.6 0.0 8.8 0.3 3.6 2.2 0.0 0.0 0.6 0.5 0.0 0.3 0.0 0.0 1.6 0.8 0.8 1.5 0.6 1.1 0.9 1.2 1.1 1.4 0.8 0.0 473.4 23.0 0.5 0.0 0.1 0.1 276.0 0.0 20.1 48.9 14.0 0.0 0.1 0.0 1.4 38.1 3.8 100.0 0.0 0.2 0.0 0.2 1.5 1.1 0.0 0.0 0.0 12.5 0.6 0.0 75.0 0.9 0.0 0.0 1.0 16.3 47.6 1.9 24.6 0.7 2.1 1.1 0.0 2.1 0.6 0.1 0.1 1.8 2.9 9.8 0.8 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 CNKSR2 "CNK2, KIAA0902, KSR2" ENSG00000149970 "Connector enhancer of kinase suppressor of Ras 2" Q8WXI2 X 21372801-21654695 "Predicted intracellular proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 38.4" "Cell type enhanced" "Detected in many" 21 "Cone photoreceptor cells: 19.6;Horizontal cells: 22.3;Rod photoreceptor cells: 86.9" "Cancer enhanced" "Detected in some" "glioma: 2.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.9;naive CD4 T-cell: 3.0" "Group enriched" "Detected in many" 5 "B-cells: 2.9;T-cells: 3.0" "Cell line enhanced" "Detected in some" "A549: 6.8;AF22: 4.8;NTERA-2: 11.1;PC-3: 5.7;RH-30: 10.3;U-251 MG: 6.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA001502 Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA001502: AB_1078542" "unprognostic (1.33e-2)" "unprognostic (1.00e-3)" "unprognostic (5.35e-2)" "unprognostic (4.90e-4)" "unprognostic (1.26e-1)" "unprognostic (5.40e-2)" "unprognostic (4.35e-3)" "unprognostic (2.58e-2)" "unprognostic (3.47e-1)" "unprognostic (7.16e-2)" "unprognostic (1.35e-2)" "unprognostic (2.01e-1)" "unprognostic (1.78e-2)" "unprognostic (2.72e-2)" "unprognostic (3.93e-2)" "unprognostic (2.27e-2)" "unprognostic (4.13e-2)" 2.0 5.2 23.5 1.4 29.6 1.3 2.1 31.3 38.4 1.4 1.2 1.7 0.0 1.1 1.4 1.8 1.1 2.3 1.2 1.7 26.4 4.4 1.0 2.0 2.8 2.4 3.1 20.8 1.9 4.9 1.0 1.0 1.1 1.8 2.2 1.1 3.5 1.7 1.2 7.4 1.1 1.2 1.2 1.7 1.8 1.3 1.8 5.0 0.6 1.2 0.0 2.6 1.3 0.7 2.9 0.1 0.6 0.0 0.0 3.0 0.3 0.0 6.8 4.8 0.0 0.5 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.7 0.0 0.0 1.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 2.0 0.1 11.1 0.0 5.7 0.0 10.3 0.0 0.0 0.0 4.7 1.9 0.0 0.1 0.2 2.9 0.0 0.6 0.0 0.1 2.2 0.0 6.8 3.6 0.0 3.6 1.0 0.0 2.7 0.1 0.0 0.6 0.1 0.0 0.4 1.1 0.6 0.0 0.0 2.9 3.0 1.0 0.0 0.0 0.0 0.1 0.8 0.3 23.5 29.6 31.3 24.4 26.4 4.4 3.1 20.8 1.8 5.0 14.9 2.2 0.5 0.5 1.1 11.3 5.6 0.0 0.0 10.3 0.0 19.6 0.0 0.0 0.4 0.2 0.0 0.4 0.0 1.9 0.0 1.4 2.1 1.1 2.4 0.1 22.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.3 12.8 0.8 0.0 1.4 0.0 86.9 0.0 0.8 0.9 8.7 1.6 0.0 0.0 0.1 0.0 CNNM1 ACDP1 ENSG00000119946 "Cyclin and CBS domain divalent metal cation transport mediator 1" Q9NRU3 10 99329099-99394330 "Predicted membrane proteins" "Ion transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.5;testis: 16.8" "Group enriched" "Detected in many" 4 "Bipolar cells: 30.2;Early spermatids: 76.6;Horizontal cells: 47.7;Late spermatids: 66.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 6 "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 6 "T-cells: 1.3" "Cell line enhanced" "Detected in some" "A549: 17.4;BJ hTERT+: 6.6;BJ hTERT+ SV40 Large T+: 6.1;BJ hTERT+ SV40 Large T+ RasG12V: 10.4;HAP1: 7.8;OE19: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040408 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040408: AB_10793963" "unprognostic (9.04e-4)" "unprognostic (2.93e-1)" "unprognostic (1.70e-1)" "unprognostic (7.60e-4)" "unprognostic (4.08e-3)" "unprognostic (9.51e-2)" "unprognostic (6.01e-2)" "unprognostic (2.27e-2)" "unprognostic (6.03e-2)" "unprognostic (1.94e-1)" "unprognostic (3.09e-2)" "unprognostic (2.45e-1)" "unprognostic (8.94e-2)" "unprognostic (1.50e-1)" "unprognostic (4.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.03e-1)" 0.6 2.5 3.4 0.7 15.5 0.5 1.3 8.1 12.7 2.0 1.0 0.3 1.1 1.2 2.1 3.7 1.4 2.4 1.0 0.5 2.8 5.0 2.4 0.8 0.6 0.5 2.1 7.1 5.4 1.7 0.4 4.2 0.5 4.8 3.6 1.2 0.7 1.0 2.1 0.5 2.5 1.2 1.5 1.0 0.5 1.6 16.8 2.3 0.0 0.5 0.2 0.6 2.2 1.2 0.1 0.1 0.2 0.0 0.1 1.3 0.0 0.0 17.4 0.0 0.0 0.0 0.0 0.0 2.5 6.6 6.1 10.4 0.0 4.0 0.0 0.0 1.2 0.1 1.6 7.8 0.0 4.4 0.0 0.8 1.7 2.6 3.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.1 0.0 0.0 0.3 2.3 0.2 0.0 0.8 6.7 0.7 0.0 0.0 0.0 0.8 0.0 2.0 5.6 1.8 0.4 0.8 0.5 0.0 0.0 0.0 0.6 0.1 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 1.3 0.1 0.2 0.1 0.0 0.1 0.0 0.0 3.4 15.5 8.1 12.4 2.8 5.0 2.1 7.1 4.8 2.3 0.0 0.0 0.0 3.4 2.1 30.2 1.1 0.0 0.0 0.0 1.8 13.7 0.0 0.0 0.4 76.6 0.7 0.0 0.0 1.3 0.0 0.5 2.4 0.0 0.0 0.0 47.7 0.0 2.5 0.0 66.1 2.0 0.0 1.7 0.0 0.0 0.8 1.8 0.0 2.5 0.5 3.3 0.0 0.3 1.1 1.4 0.9 0.0 0.0 0.0 2.2 CNNM4 "ACDP4, KIAA1592" ENSG00000158158 "Cyclin and CBS domain divalent metal cation transport mediator 4" Q6P4Q7 2 96760902-96811891 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Biomineralization, Ion transport, Sensory transduction, Transport, Vision" "Amelogenesis imperfecta, Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 106.0;Enterocytes: 53.8;Rod photoreceptor cells: 46.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SK-BR-3: 29.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA017732 Enhanced Uncertain "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA017732: AB_1847395" "unprognostic (1.98e-3)" "unprognostic (8.95e-3)" "unprognostic (1.11e-1)" "prognostic unfavorable (9.14e-4)" "unprognostic (3.42e-2)" "unprognostic (5.28e-2)" "unprognostic (1.54e-3)" "unprognostic (3.36e-2)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.75e-4)" "unprognostic (4.75e-3)" "unprognostic (3.72e-1)" "unprognostic (8.14e-2)" "unprognostic (3.13e-1)" "unprognostic (3.44e-2)" "unprognostic (1.15e-2)" "unprognostic (1.06e-1)" 3.7 4.0 4.8 17.0 9.6 4.5 7.4 24.1 11.1 6.8 31.2 11.3 8.3 6.3 10.4 5.2 7.7 10.8 7.3 11.5 5.4 5.0 5.9 4.9 8.1 4.3 6.0 6.6 6.1 11.4 9.0 10.6 17.1 5.5 7.4 33.5 13.9 10.8 11.3 21.3 7.4 11.1 5.7 5.2 6.1 12.6 11.8 6.1 4.6 9.7 6.1 9.3 6.5 7.4 3.7 2.2 2.8 2.3 0.8 3.2 1.1 6.9 4.6 3.7 6.8 3.9 2.6 10.2 3.0 4.3 4.5 6.1 8.3 7.5 5.0 8.8 3.1 6.2 9.0 9.5 5.2 4.2 10.1 7.5 4.0 3.1 4.5 5.4 1.9 4.0 2.5 6.5 7.2 4.4 3.0 2.4 5.1 2.0 14.4 2.3 9.8 4.0 2.8 4.9 12.9 6.3 6.0 1.7 5.8 4.5 5.4 17.4 5.2 5.8 29.6 4.3 10.8 14.4 3.3 2.2 2.6 5.9 5.7 3.4 5.0 4.0 2.6 3.8 3.8 4.6 2.8 1.6 0.5 3.2 1.8 1.1 3.7 1.7 1.7 2.2 2.1 1.1 2.1 0.7 0.8 2.3 1.7 0.8 1.1 4.8 9.6 24.1 11.1 5.4 5.0 6.0 6.6 5.5 6.1 35.7 7.7 4.7 3.8 5.0 38.8 11.8 7.6 5.3 14.8 7.0 106.0 4.7 0.0 2.6 4.1 2.9 53.8 0.0 3.6 1.4 2.8 3.4 1.1 3.0 3.0 31.8 9.7 3.1 5.4 1.0 0.9 2.4 0.0 0.0 26.3 7.7 3.8 20.9 1.1 1.2 46.8 0.0 4.7 5.5 2.0 3.6 5.6 2.9 21.7 4.9 CNR1 "CANN6, CB-R, CB1, CB1A, CB1K5, CNR" ENSG00000118432 "Cannabinoid receptor 1" P21554 6 88139864-88166359 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.5" "Cell type enriched" "Detected in some" 14 "Sertoli cells: 97.0" "Cancer enriched" "Detected in many" 13 "glioma: 12.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 2.9;naive B-cell: 2.1" "Lineage enriched" "Detected in single" 6 "B-cells: 2.9" "Group enriched" "Detected in some" 7 "ASC diff: 40.3;HSkMC: 26.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042256, HPA069945" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA042256: AB_2677917, HPA069945: " "unprognostic (1.28e-1)" "unprognostic (7.04e-2)" "unprognostic (4.61e-2)" "unprognostic (4.08e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-3)" "unprognostic (1.37e-1)" "unprognostic (2.07e-2)" "unprognostic (2.49e-1)" "unprognostic (1.16e-2)" "unprognostic (2.74e-2)" "unprognostic (2.68e-1)" "unprognostic (1.70e-1)" "unprognostic (5.59e-3)" "unprognostic (2.68e-3)" "unprognostic (5.88e-2)" "unprognostic (7.00e-2)" 19.4 6.4 18.0 5.2 15.8 1.5 14.9 13.8 30.5 3.9 5.5 0.8 0.8 2.3 3.1 4.7 3.7 5.5 3.6 1.4 17.6 7.7 0.9 0.7 6.4 6.5 2.3 14.7 4.1 1.8 1.3 18.3 5.2 4.2 1.5 5.1 0.0 4.3 4.0 1.7 2.4 4.2 5.8 3.2 2.3 2.3 2.7 2.8 0.0 2.6 0.0 9.9 2.7 3.1 2.9 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 1.8 0.0 40.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.1 0.9 1.4 0.0 2.6 0.0 0.0 26.6 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.0 3.3 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.7 3.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 18.0 15.8 13.8 21.4 17.6 7.7 2.3 14.7 4.2 2.8 0.0 7.2 2.7 0.4 0.6 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 97.0 2.3 0.0 0.1 0.1 0.1 0.0 0.0 0.7 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 68.7" "Cell type enhanced" "Detected in many" 7 "Muller glia cells: 114.1;Rod photoreceptor cells: 71.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 46 "plasmacytoid DC: 4.6" "Lineage enriched" "Detected in single" 46 "dendritic cells: 4.6" "Cell line enhanced" "Detected in many" "BEWO: 15.1;HeLa: 27.0;OE19: 23.9;RPMI-8226: 20.7;SuSa: 16.0;U-266/84: 15.3" "Low region specificity" "Detected in many" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 1.8 1.3 27.5 1.8 26.1 0.7 9.5 12.5 23.8 3.9 11.6 27.9 2.2 11.6 2.0 4.4 9.5 12.7 5.8 32.8 27.7 14.5 8.3 12.3 8.8 0.7 23.8 13.8 2.6 11.4 24.7 5.2 3.4 10.8 9.4 7.3 2.8 26.9 3.7 68.7 10.7 20.7 2.2 25.0 0.8 7.4 2.5 16.8 0.0 5.5 12.2 3.1 1.0 2.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 5.5 4.1 0.0 0.1 0.0 0.0 15.1 0.0 0.0 0.0 0.0 9.9 8.9 0.0 0.4 0.0 0.6 10.4 5.7 0.0 0.0 0.0 4.4 0.0 27.0 2.1 0.0 0.0 0.0 0.7 1.3 0.0 0.0 0.0 0.0 0.8 2.8 0.1 0.0 3.5 0.0 0.0 4.0 23.9 3.4 0.0 0.2 20.7 8.1 0.0 5.4 0.1 1.9 12.1 1.7 16.0 8.7 0.0 0.0 0.0 4.9 0.1 0.4 0.0 15.3 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 27.5 26.1 12.5 19.0 27.7 14.5 23.8 13.8 10.8 16.8 35.7 15.8 2.2 2.5 15.9 1.6 66.3 17.8 37.5 19.4 8.7 55.0 16.7 0.0 19.8 2.6 1.4 61.6 0.0 8.3 8.0 1.8 28.8 9.3 24.7 1.8 0.0 17.9 0.6 0.6 2.7 0.6 1.8 15.1 1.8 27.0 114.1 19.3 28.1 0.4 14.7 71.8 0.0 1.0 0.5 5.5 31.1 33.6 1.3 11.7 6.4 COL16A1 ENSG00000084636 "Collagen type XVI alpha 1 chain" Q07092 1 31652247-31704319 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Fibroblasts: 46.4;Leydig cells: 40.6;Muller glia cells: 43.8;Peritubular cells: 85.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 38.8;ASC TERT1: 30.0;BJ hTERT+: 32.9;fHDF/TERT166: 30.0;HSkMC: 28.4;U-2197: 27.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA027237 Uncertain "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 530000 Cytosol "Plasma membrane" "HPA027237: AB_10600699" "unprognostic (2.25e-2)" "unprognostic (9.88e-2)" "unprognostic (5.64e-2)" "unprognostic (8.43e-2)" "prognostic unfavorable (8.08e-4)" "unprognostic (1.00e-1)" "unprognostic (3.99e-2)" "unprognostic (2.04e-1)" "unprognostic (4.48e-3)" "unprognostic (1.66e-3)" "unprognostic (1.44e-1)" "unprognostic (2.43e-1)" "prognostic unfavorable (4.00e-9)" "unprognostic (9.62e-2)" "unprognostic (6.13e-2)" "unprognostic (4.60e-2)" "unprognostic (2.15e-2)" 18.0 7.3 7.0 12.7 9.0 0.2 10.8 2.8 8.2 63.1 17.3 10.2 12.5 6.1 31.0 15.2 9.3 8.3 15.9 9.1 9.6 6.2 3.4 1.0 7.2 3.1 9.9 10.2 62.6 2.6 1.3 7.3 8.2 8.8 29.3 4.6 12.5 15.3 38.1 4.2 26.9 8.6 45.2 15.7 3.9 10.5 10.0 10.3 1.5 11.8 7.9 5.0 26.1 28.3 0.2 0.0 0.7 0.1 0.1 0.4 0.0 0.0 0.5 0.0 0.0 38.8 30.0 4.1 17.8 32.9 4.3 4.5 0.1 3.1 0.0 0.5 30.0 0.6 13.9 0.0 18.3 1.0 0.0 0.0 0.0 2.0 6.0 12.9 0.0 0.1 28.4 12.6 12.3 6.7 1.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.4 0.1 0.0 0.1 0.4 0.7 2.1 0.3 2.6 0.1 0.3 0.0 0.0 16.0 16.0 27.5 0.3 0.0 0.0 0.0 10.9 0.0 1.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.4 0.1 0.7 0.1 0.1 0.0 0.0 0.0 7.0 9.0 2.8 7.1 9.6 6.2 9.9 10.2 8.8 10.3 8.9 3.8 0.0 13.1 27.2 2.6 7.0 0.0 8.1 4.5 17.4 2.0 1.4 0.0 4.5 10.5 2.2 4.5 0.0 0.6 3.1 46.4 3.8 6.9 0.0 1.1 0.0 26.6 6.7 0.8 17.8 40.6 1.5 13.5 0.0 14.2 43.8 1.2 2.5 85.9 0.8 1.9 0.0 25.8 8.8 1.8 18.4 1.8 0.0 4.5 10.6 COL17A1 "BP180, BPAG2" ENSG00000065618 "Collagen type XVII alpha 1 chain" Q9UMD9 10 104031286-104086002 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 85.8;skin 1: 123.2;tongue: 64.0" "Cell type enriched" "Detected in many" 4 "Basal keratinocytes: 520.3" "Cancer enhanced" "Detected in many" "head and neck cancer: 227.4" "Region enriched" "Detected in single" 4 "basal ganglia: 1.2" "Cell type enriched" "Detected in single" 15 "neutrophil: 3.7" "Lineage enriched" "Detected in single" 15 "granulocytes: 3.7" "Cell line enhanced" "Detected in some" "CAPAN-2: 24.8;HaCaT: 56.6;HBEC3-KT: 90.6;hTCEpi: 117.8;hTERT-HME1: 100.3" "Region enriched" "Detected in single" 4 "cerebellum: 1.1" "Not detected" "Not detected" "HPA043673, HPA052963" Enhanced Supported "Golgi apparatus,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" "Golgi apparatus" "HPA043673: AB_10960893, HPA052963: AB_2681999" "prognostic favorable (1.38e-4)" "unprognostic (1.33e-1)" "unprognostic (4.01e-1)" "unprognostic (1.01e-1)" "unprognostic (9.65e-2)" "unprognostic (3.75e-1)" "unprognostic (2.13e-1)" "unprognostic (6.82e-3)" "unprognostic (1.63e-1)" "unprognostic (7.85e-3)" "prognostic unfavorable (1.86e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (1.14e-1)" "unprognostic (1.23e-1)" "unprognostic (3.75e-2)" "unprognostic (8.35e-2)" 0.2 0.0 0.2 4.4 1.2 7.5 8.1 0.2 0.2 15.2 9.3 0.2 0.9 2.0 0.6 2.6 31.5 0.1 1.2 0.2 0.2 0.1 0.4 0.2 0.7 0.2 0.2 0.2 0.2 0.2 0.0 0.6 85.8 0.2 5.0 5.4 0.2 15.5 7.3 0.5 123.2 23.2 0.8 0.2 0.3 3.9 4.0 0.2 18.1 2.0 64.0 24.7 3.0 17.3 0.0 0.0 3.7 0.2 0.0 0.0 0.8 3.1 0.0 0.1 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 24.8 0.0 0.7 0.0 0.5 56.6 0.1 90.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 117.8 0.0 100.3 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 5.1 3.1 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.2 0.0 0.6 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 0.0 0.8 0.2 1.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.0 0.6 0.0 12.4 520.3 0.6 0.8 0.0 2.7 20.5 0.0 0.0 3.5 0.0 0.7 8.5 1.0 105.8 0.0 0.8 8.3 2.1 0.6 0.0 0.0 1.2 0.0 2.4 0.0 0.0 2.6 0.3 1.0 32.1 0.0 5.9 0.4 45.8 16.1 0.7 0.0 0.4 0.0 1.7 8.3 1.1 121.8 4.7 0.0 14.5 8.0 COL4A5 "ASLN, ATS" ENSG00000188153 "Collagen type IV alpha 5 chain" P29400 X 108439844-108697545 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Alport syndrome, Cancer-related genes, Deafness, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.2" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 25.8;Basal keratinocytes: 23.9;Peritubular cells: 34.6;Urothelial cells: 22.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 28.5;HHSteC: 32.8;HUVEC TERT2: 30.8;TIME: 29.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA077177 Approved "Vesicles,Plasma membrane" "Secreted to extracellular matrix" NA NA "Plasma membrane" Vesicles "HPA077177: " "unprognostic (2.58e-2)" "unprognostic (2.57e-2)" "unprognostic (3.64e-2)" "unprognostic (3.98e-2)" "unprognostic (1.11e-1)" "unprognostic (1.61e-1)" "unprognostic (1.97e-2)" "unprognostic (7.27e-2)" "unprognostic (2.70e-1)" "unprognostic (2.20e-1)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "prognostic unfavorable (2.41e-5)" "unprognostic (2.10e-3)" "unprognostic (1.70e-1)" "unprognostic (2.61e-2)" "unprognostic (1.06e-1)" 3.3 2.7 13.1 1.7 27.7 0.3 5.8 1.8 16.1 16.9 3.7 47.2 9.5 2.7 31.4 18.2 6.9 19.3 12.6 5.9 13.9 6.2 5.9 1.7 5.9 0.9 46.6 15.7 11.5 2.8 22.3 10.2 9.7 19.5 18.0 4.1 5.8 3.7 23.9 4.8 17.5 3.1 32.8 20.5 2.8 17.7 2.8 40.5 0.0 5.4 0.9 0.9 23.9 11.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 8.8 15.8 5.0 6.2 3.6 0.1 0.9 3.9 4.8 7.9 7.9 0.6 1.3 0.0 0.6 2.9 7.1 4.4 14.9 6.1 2.1 3.8 1.1 28.5 0.9 32.8 0.0 4.5 17.0 18.1 5.9 12.7 15.4 30.8 0.0 0.0 0.0 4.6 0.6 0.0 0.1 4.7 0.0 5.3 0.0 0.0 0.0 12.0 8.8 0.0 0.0 23.0 0.7 1.9 23.3 4.3 0.0 29.1 3.2 1.0 2.1 1.3 0.6 0.0 0.0 2.8 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.1 27.7 1.8 16.1 13.9 6.2 46.6 15.7 19.5 40.5 6.0 5.3 0.0 25.8 23.9 0.3 8.9 0.0 4.0 11.4 19.2 0.0 0.6 0.0 0.2 0.1 2.9 0.0 0.0 0.8 0.3 8.5 8.2 1.1 0.4 0.4 0.0 0.0 4.9 0.3 1.2 18.7 0.8 1.7 0.0 0.0 13.0 0.5 0.0 34.6 0.0 0.4 6.5 18.6 0.3 0.7 13.9 0.6 0.0 0.0 22.6 COL6A2 ENSG00000142173 "Collagen type VI alpha 2 chain" P12110 21 46098097-46132849 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Congenital muscular dystrophy, Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 19 "Fibroblasts: 1607.7;Leydig cells: 560.6;Peritubular cells: 443.7;Smooth muscle cells: 512.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 7.6;MAIT T-cell: 5.1;memory CD8 T-cell: 3.8;naive CD8 T-cell: 2.1" "Lineage enriched" "Detected in single" 14 "T-cells: 7.6" "Cell line enhanced" "Detected in many" "ASC diff: 95.7;ASC TERT1: 177.1;BJ: 85.2;BJ hTERT+: 79.3;HHSteC: 93.9;HSkMC: 126.5;U-138 MG: 92.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA007029, HPA030920, HPA038799" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 8900000 Cytosol "Plasma membrane" "HPA007029: AB_1078549, HPA030920: AB_2673659, HPA038799: AB_2676214" "unprognostic (3.53e-1)" "unprognostic (3.76e-2)" "unprognostic (3.20e-2)" "unprognostic (4.87e-2)" "unprognostic (2.92e-2)" "unprognostic (1.38e-1)" "unprognostic (2.39e-1)" "unprognostic (5.28e-3)" "unprognostic (2.11e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-1)" "unprognostic (2.01e-1)" "prognostic unfavorable (8.72e-14)" "unprognostic (2.13e-2)" "unprognostic (7.61e-2)" "unprognostic (2.31e-2)" "unprognostic (2.22e-3)" 81.2 8.7 1.5 65.0 2.7 0.2 116.7 1.8 2.7 103.5 112.6 4.7 75.0 15.3 127.2 160.3 55.5 66.5 179.8 90.6 2.1 1.3 9.6 9.1 38.7 38.3 3.2 3.8 76.1 14.8 2.7 11.8 52.6 8.8 81.0 9.8 23.5 33.4 81.4 30.6 37.8 38.1 231.3 5.8 23.6 49.0 33.2 1.8 9.8 19.9 58.5 17.2 107.2 76.1 0.0 0.0 0.0 0.0 0.5 7.6 0.7 0.7 0.9 2.8 2.5 95.7 177.1 0.8 85.2 79.3 21.6 9.9 0.1 3.3 0.0 6.4 61.1 13.9 0.0 0.6 0.0 1.7 0.0 0.9 0.0 0.0 0.0 93.9 0.0 0.3 126.5 0.0 40.8 0.8 0.0 0.0 0.0 0.0 0.0 8.6 0.4 0.0 0.1 1.5 0.0 10.4 0.0 5.4 0.1 0.0 0.0 0.0 4.4 3.3 0.0 0.0 1.6 0.1 0.5 0.0 92.4 10.8 34.0 21.0 0.0 0.0 0.0 47.2 0.0 13.1 0.0 0.0 0.0 7.6 0.0 5.1 0.0 0.7 3.8 0.0 0.0 0.8 2.1 0.0 0.5 0.0 0.0 0.1 0.7 1.5 2.7 1.8 2.7 2.1 1.3 3.2 3.8 8.8 1.8 3.0 1.1 0.0 4.5 146.1 0.1 6.7 0.0 0.0 1.2 7.0 0.0 14.3 0.0 14.0 3.2 42.2 0.0 0.0 0.3 22.5 1607.7 10.7 0.0 0.9 32.2 0.0 0.0 166.3 6.8 7.6 560.6 4.3 172.1 3.6 0.0 3.9 6.9 0.0 443.7 0.2 0.4 291.1 512.9 2.7 10.7 122.7 33.8 8.7 0.2 2.5 COLQ EAD ENSG00000206561 "Collagen like tail subunit of asymmetric acetylcholinesterase" Q9Y215 3 15450133-15521751 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Neurotransmitter degradation" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 31.8;lymphoid tissue: 19.6" "Cell type enhanced" "Detected in some" 11 "Ciliated cells: 6.7;Early spermatids: 4.2;Horizontal cells: 6.4;Late spermatids: 11.3;Peritubular cells: 4.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 5 "cerebellum: 11.4" "Cell type enriched" "Detected in some" 6 "MAIT T-cell: 31.8" "Lineage enriched" "Detected in single" 35 "T-cells: 31.8" "Group enriched" "Detected in some" 5 "BEWO: 17.3;HDLM-2: 5.6;U-937: 8.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA045876 Approved "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA "Plasma membrane" "Cell Junctions" "HPA045876: AB_2679479" "unprognostic (4.08e-3)" "unprognostic (2.61e-2)" "unprognostic (2.13e-3)" "unprognostic (2.37e-1)" "unprognostic (2.11e-1)" "unprognostic (4.62e-2)" "unprognostic (1.27e-2)" "unprognostic (1.15e-1)" "unprognostic (1.52e-1)" "unprognostic (1.99e-1)" "unprognostic (1.28e-3)" "unprognostic (4.68e-1)" "unprognostic (7.00e-5)" "unprognostic (6.58e-2)" "unprognostic (1.97e-1)" "unprognostic (1.05e-1)" "unprognostic (1.30e-4)" 2.7 0.7 0.9 0.7 1.1 1.3 0.9 11.4 2.1 2.4 2.3 0.4 0.2 0.8 3.2 2.7 1.3 8.8 1.8 15.9 1.5 1.2 0.5 0.9 2.1 19.6 0.9 1.1 2.3 0.6 10.0 1.1 0.5 2.1 2.0 0.5 2.0 1.1 1.4 14.3 0.9 1.4 1.1 1.5 3.8 1.5 2.0 0.4 3.8 1.0 0.6 3.3 1.3 1.4 0.0 0.2 0.0 0.4 0.9 31.8 1.7 0.1 0.5 2.0 1.2 1.5 1.0 17.3 0.3 0.5 0.4 0.6 0.0 0.3 0.1 0.7 0.3 0.1 0.2 0.3 0.4 0.5 5.6 1.2 0.6 0.7 0.2 0.2 0.4 1.2 0.8 0.4 0.8 0.3 0.8 0.3 1.5 0.0 0.6 0.8 0.3 0.6 1.8 0.2 0.0 0.6 0.8 0.2 0.4 0.4 0.4 0.6 1.8 0.2 0.1 0.4 1.9 1.2 0.8 0.1 0.2 1.1 1.9 0.6 1.7 1.5 0.1 0.1 8.7 0.1 0.0 0.4 0.0 5.5 0.0 31.8 0.0 2.7 3.9 0.0 0.0 0.3 0.3 0.0 0.9 0.0 0.2 0.1 1.7 0.9 1.1 11.4 2.1 1.5 1.2 0.9 1.1 2.1 0.4 0.0 1.1 0.0 0.1 0.2 0.3 0.7 0.0 6.7 2.3 0.0 0.0 0.2 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.1 0.4 0.2 0.0 0.8 0.2 6.4 1.2 2.5 0.0 11.3 1.7 0.0 0.0 0.0 0.0 0.4 0.2 0.0 4.2 0.0 0.6 0.0 0.2 0.7 0.2 0.1 1.9 1.3 0.0 0.0 COQ7 "CAT5, CLK-1" ENSG00000167186 "Coenzyme Q7, hydroxylase" Q99807 16 19067599-19080095 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Ubiquinone biosynthesis" "Monooxygenase, Oxidoreductase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "neutrophil: 45.2" "Lineage enriched" "Detected in all" 8 "granulocytes: 45.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA067252, HPA071922" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067252: AB_2685813, HPA071922: AB_2686473" "unprognostic (1.37e-1)" "unprognostic (6.89e-3)" "unprognostic (1.59e-2)" "unprognostic (6.08e-2)" "unprognostic (2.44e-2)" "unprognostic (9.03e-2)" "unprognostic (1.31e-1)" "unprognostic (4.42e-2)" "unprognostic (1.15e-1)" "unprognostic (7.27e-3)" "unprognostic (2.15e-1)" "unprognostic (8.32e-2)" "prognostic favorable (8.23e-12)" "unprognostic (2.19e-1)" "unprognostic (2.76e-1)" "unprognostic (3.14e-2)" "unprognostic (5.27e-2)" 9.1 14.2 13.5 7.8 12.9 4.0 12.6 11.3 18.5 11.2 12.8 12.8 15.2 11.4 14.7 17.4 11.9 15.0 13.9 21.1 12.1 13.0 13.5 11.4 14.6 11.1 12.2 12.0 19.4 12.2 23.7 15.1 9.4 12.9 17.1 12.5 16.5 11.3 14.7 37.3 7.5 12.1 11.1 12.4 8.7 11.8 34.7 10.7 9.4 15.3 24.7 7.6 12.1 10.0 5.1 5.3 45.2 4.0 4.1 4.4 1.8 12.6 13.6 11.8 6.9 6.7 7.1 9.9 7.4 6.1 10.2 10.5 8.6 10.6 9.6 36.1 5.7 11.0 13.4 16.4 9.3 7.4 8.2 16.6 5.1 12.5 26.4 8.3 12.2 11.3 5.9 8.2 9.4 6.9 8.4 8.2 11.6 14.0 9.0 7.1 22.7 12.7 9.9 9.0 4.9 7.3 15.6 13.1 12.3 8.8 8.5 17.2 9.8 6.9 15.3 8.6 6.0 14.1 16.6 8.9 10.8 6.3 7.9 10.6 8.4 13.6 10.5 11.6 7.1 6.9 10.8 4.0 5.8 3.5 3.5 3.3 5.1 3.2 3.1 4.3 5.0 4.4 3.9 45.2 4.1 3.9 5.3 2.0 1.8 13.5 12.9 11.3 18.5 12.1 13.0 12.2 12.0 12.9 10.7 14.9 9.3 38.9 25.6 9.7 30.8 19.0 22.9 21.4 9.1 15.7 37.3 18.0 38.1 20.5 10.9 11.3 47.3 0.0 15.9 14.6 13.0 14.3 25.3 8.9 20.1 19.1 23.1 13.5 18.7 6.2 17.3 15.3 10.1 9.0 30.7 39.8 11.7 24.3 13.1 19.5 53.8 19.4 15.1 77.6 54.5 10.8 26.9 33.1 29.9 22.2 CORO1B coronin-2 ENSG00000172725 "Coronin 1B" Q9BR76 11 67435510-67443821 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 281.3;Paneth cells: 280.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017616, HPA040113, HPA070456" Enhanced Supported "Plasma membrane,Cytosol" NA NA 200000000 "Plasma membrane, Cytosol" "CAB017616: AB_2087018, HPA040113: AB_2676850, HPA070456: AB_2686268" "unprognostic (1.94e-1)" "unprognostic (2.40e-1)" "unprognostic (3.21e-1)" "prognostic favorable (1.65e-4)" "unprognostic (1.02e-1)" "unprognostic (8.23e-3)" "unprognostic (1.49e-3)" "unprognostic (7.22e-2)" "unprognostic (1.86e-1)" "unprognostic (4.86e-2)" "unprognostic (1.48e-1)" "unprognostic (3.88e-2)" "unprognostic (8.58e-3)" "unprognostic (1.85e-1)" "unprognostic (1.04e-1)" "unprognostic (1.21e-2)" "unprognostic (6.64e-3)" 26.0 24.0 12.6 20.6 16.1 9.7 21.6 9.7 19.0 25.8 37.0 20.3 23.1 35.0 28.7 34.0 31.2 25.6 35.3 15.2 12.6 11.0 27.5 36.4 21.6 23.3 15.9 10.7 21.2 24.2 15.4 16.1 29.2 14.3 31.4 19.1 20.5 42.5 27.4 9.2 16.7 44.7 20.5 14.8 34.7 29.8 13.9 16.5 16.1 31.6 23.3 20.0 25.8 20.8 4.2 17.5 10.9 47.1 2.4 12.3 11.7 18.7 18.5 8.9 18.2 23.2 20.3 13.4 13.3 28.3 22.9 17.4 30.9 28.0 0.6 28.0 18.9 23.3 16.3 10.0 17.7 4.1 4.2 8.7 13.2 12.1 13.2 37.1 0.2 28.5 27.4 15.9 19.3 9.0 14.5 29.0 11.6 9.7 2.0 13.0 53.7 2.9 1.5 11.5 46.2 17.5 2.6 9.4 3.3 15.4 23.5 10.2 12.6 12.6 34.4 41.4 6.6 43.1 15.1 22.8 15.7 11.3 21.2 8.3 0.3 0.6 3.0 25.2 1.8 15.8 10.9 22.9 1.7 1.9 47.1 1.4 4.2 9.3 3.0 17.5 1.4 5.3 2.3 10.9 2.4 45.8 13.5 12.3 11.7 12.6 16.1 9.7 19.0 12.6 11.0 15.9 10.7 14.3 16.5 3.0 2.1 39.3 50.5 24.7 11.1 1.4 28.1 0.0 3.4 45.4 7.9 80.7 51.4 101.4 6.0 45.0 241.3 0.0 92.1 190.3 39.9 57.7 28.7 19.5 220.1 14.3 95.0 41.7 89.7 3.0 36.5 74.8 67.4 281.3 138.0 26.4 112.4 280.5 32.5 63.3 12.8 51.8 44.5 6.9 5.9 27.0 125.9 76.7 99.3 62.6 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192640 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 27.7;intestine: 36.1" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 38.2;Enterocytes: 69.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1" "Cell line enhanced" "Detected in many" "BEWO: 32.3;OE19: 26.3;SK-BR-3: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.6 0.8 1.2 6.9 1.8 8.1 2.9 9.3 2.4 3.9 22.0 0.7 1.3 20.8 2.0 2.2 13.6 2.7 27.7 1.5 1.3 3.0 1.4 2.9 7.5 1.6 2.6 1.3 1.5 1.4 2.8 5.2 3.5 3.3 9.0 7.9 1.2 5.4 1.9 0.9 6.3 36.1 1.9 0.6 3.8 6.6 11.4 0.6 5.6 1.1 3.6 6.6 7.7 6.2 0.6 0.7 10.9 7.0 1.5 11.1 1.4 3.9 1.4 0.3 0.9 0.6 0.6 32.3 0.3 0.3 1.0 1.6 8.9 0.6 0.0 4.5 0.6 1.5 11.0 3.7 6.0 0.6 3.2 0.8 0.1 5.6 7.9 1.3 3.6 0.3 0.2 7.4 0.5 9.1 0.3 0.3 4.7 3.1 1.8 0.1 2.9 0.7 3.6 4.1 26.3 1.0 2.8 0.0 0.1 0.6 11.1 0.8 1.1 2.0 21.8 0.7 7.6 2.5 6.0 0.3 0.1 4.8 0.1 1.1 0.3 1.8 0.3 0.2 1.2 1.3 7.7 1.5 10.9 2.4 3.0 5.5 0.6 4.1 3.8 0.5 0.6 2.7 3.5 1.1 1.5 7.0 0.7 11.1 1.4 1.2 1.8 9.3 2.4 1.3 3.0 2.6 1.3 3.3 0.6 11.9 23.8 0.9 17.5 6.0 1.5 1.2 38.2 20.1 35.2 0.0 3.9 8.5 0.0 3.0 2.2 1.9 69.1 0.0 4.5 31.7 3.1 14.5 0.0 3.2 5.8 1.6 6.9 1.3 11.0 3.0 0.0 4.9 0.0 0.0 14.0 0.5 13.8 17.3 0.4 1.4 1.5 0.0 1.9 0.5 3.2 8.7 13.3 8.7 25.7 26.0 CORO2B "ClipinC, KIAA0925" ENSG00000103647 "Coronin 2B" Q9UQ03 15 68578969-68727806 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.5;fallopian tube: 27.4" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 32.6;Ciliated cells: 14.7;Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 20.9" "Group enriched" "Detected in many" 8 "glioma: 34.7;melanoma: 21.5" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.2;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 21 "B-cells: 4.5" "Cell line enhanced" "Detected in many" "ASC diff: 12.9;ASC TERT1: 27.8;HSkMC: 20.0;hTEC/SVTERT24-B: 16.3;U-87 MG: 27.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017960 Enhanced Supported Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA017960: AB_1847167" "unprognostic (1.35e-1)" "unprognostic (2.63e-2)" "unprognostic (2.81e-3)" "unprognostic (4.71e-3)" "unprognostic (3.28e-1)" "unprognostic (8.11e-5)" "unprognostic (4.77e-2)" "unprognostic (1.24e-1)" "unprognostic (3.68e-2)" "unprognostic (1.81e-1)" "unprognostic (1.33e-3)" "unprognostic (4.12e-2)" "unprognostic (1.26e-1)" "unprognostic (1.10e-2)" "unprognostic (5.83e-2)" "unprognostic (3.59e-2)" "unprognostic (1.87e-2)" 10.9 4.4 15.7 3.2 30.1 1.9 4.8 33.7 53.5 6.5 3.4 27.3 0.8 2.4 7.5 3.9 2.7 27.4 6.3 7.2 23.0 15.1 5.5 2.0 5.8 3.5 20.9 18.8 18.4 2.9 1.6 1.5 4.7 23.6 3.2 2.9 11.8 3.4 6.9 3.8 5.6 3.3 8.4 35.0 3.6 2.0 2.2 17.5 0.0 4.6 0.6 1.9 3.0 1.6 4.5 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 12.3 1.0 12.9 27.8 0.0 6.2 6.9 1.1 1.5 0.1 1.4 1.5 0.7 1.0 1.7 0.0 0.4 0.1 4.5 0.0 0.5 0.0 0.0 0.6 4.7 0.0 0.1 20.0 0.1 16.3 1.0 9.7 0.4 0.0 0.0 0.0 11.4 0.0 0.0 0.0 3.0 0.0 0.0 1.0 0.0 0.5 1.7 0.0 7.1 0.1 0.1 0.0 3.6 2.4 0.0 1.4 0.1 3.7 4.1 0.7 8.2 0.0 0.0 1.5 27.8 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.2 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.7 30.1 33.7 29.3 23.0 15.1 20.9 18.8 23.6 17.5 0.0 0.0 0.0 0.3 0.9 32.6 1.1 0.0 14.7 0.0 7.0 35.3 0.0 0.0 3.8 0.2 1.5 0.0 0.0 0.5 0.0 2.6 0.1 0.0 0.0 0.2 0.0 3.5 5.5 0.3 0.0 7.2 0.0 6.8 0.0 0.0 9.5 0.4 0.0 0.4 0.0 20.9 6.5 2.3 0.2 0.4 0.6 0.0 0.0 0.0 0.1 CPPED1 "CSTP1, FLJ11151" ENSG00000103381 "Calcineurin like phosphoesterase domain containing 1" Q9BRF8 16 12659799-12804017 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.6" "Cell type enhanced" "Detected in many" 6 "Cytotrophoblasts: 85.5;Syncytiotrophoblasts: 110.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 93.6" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 45.3;HMC-1: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040938, HPA041970" Uncertain Supported "Plasma membrane,Cytosol" No No 380000 Cytosol "Plasma membrane" "HPA040938: AB_10673443, HPA041970: AB_2677774" "prognostic unfavorable (9.72e-4)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (1.05e-2)" "unprognostic (1.13e-3)" "unprognostic (3.86e-2)" "unprognostic (1.35e-1)" "unprognostic (8.67e-2)" "unprognostic (1.23e-1)" "unprognostic (3.26e-2)" "unprognostic (6.26e-2)" "unprognostic (3.64e-1)" "prognostic favorable (1.62e-9)" "unprognostic (5.05e-2)" "unprognostic (1.25e-1)" "unprognostic (2.48e-3)" "unprognostic (2.40e-2)" 10.9 11.5 8.3 14.3 14.3 9.5 8.5 2.7 11.8 9.2 13.8 20.8 7.4 16.3 8.2 6.2 23.1 7.2 8.9 10.7 11.2 9.5 26.2 31.4 10.4 21.2 20.7 7.7 6.4 4.1 4.3 6.5 36.6 17.6 9.1 11.9 10.2 15.1 7.3 6.4 6.8 20.5 10.0 22.1 27.4 8.1 18.2 13.1 5.8 11.1 8.4 16.9 9.8 9.6 1.5 23.1 93.6 43.7 1.9 1.8 14.6 1.5 9.5 1.0 2.5 4.0 8.5 0.1 17.4 4.7 9.3 7.6 4.6 4.9 2.3 18.0 12.6 4.1 0.1 0.0 4.3 9.7 5.3 2.6 19.7 1.4 45.3 2.5 0.0 42.8 8.5 0.9 0.8 6.7 0.0 13.9 3.2 6.8 1.4 22.8 1.9 1.7 9.1 2.8 0.7 1.3 3.7 6.1 4.9 14.1 3.0 5.0 3.3 0.0 15.8 6.2 5.2 3.4 4.3 20.8 13.5 2.8 0.0 0.0 0.0 0.3 3.6 3.0 10.0 2.8 6.1 30.6 19.3 1.3 43.7 1.1 1.5 1.1 1.4 23.1 1.0 0.3 0.8 93.6 1.9 40.6 5.6 1.8 14.6 8.3 14.3 2.7 11.8 11.2 9.5 20.7 7.7 17.6 13.1 8.9 18.4 13.0 2.9 4.0 3.6 8.2 7.6 10.7 6.8 14.0 7.9 85.5 51.4 33.8 2.3 11.3 13.5 0.0 10.9 10.0 9.3 3.3 52.1 38.5 44.3 9.5 5.8 7.4 74.6 2.3 14.4 42.4 6.8 27.9 7.5 12.5 30.7 13.6 22.6 51.8 5.5 25.8 4.2 1.6 11.5 4.0 110.3 7.4 10.6 1.4 CRLF3 "CREME9, CYTOR4" ENSG00000176390 "Cytokine receptor like factor 3" Q8IUI8 17 30769388-30824776 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 43.6" "Cell type enhanced" "Detected in many" 4 "T-cells: 45.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007596 Enhanced Approved "Plasma membrane,Cytosol" NA NA 830000 "Plasma membrane, Cytosol" "HPA007596: AB_1847241" "unprognostic (1.02e-1)" "unprognostic (9.79e-2)" "unprognostic (7.12e-2)" "unprognostic (9.65e-2)" "unprognostic (2.28e-1)" "unprognostic (1.55e-1)" "unprognostic (2.52e-2)" "unprognostic (9.22e-2)" "unprognostic (1.00e-2)" "unprognostic (3.10e-2)" "unprognostic (5.81e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.31e-7)" "unprognostic (3.35e-1)" "unprognostic (2.40e-2)" "unprognostic (1.84e-1)" "unprognostic (6.51e-2)" 8.7 4.8 8.8 22.7 8.3 16.7 7.3 12.4 9.4 6.9 7.0 5.9 3.9 5.5 6.3 3.6 15.4 6.1 7.0 5.8 7.5 6.6 5.3 5.4 9.7 28.6 6.6 9.3 5.8 5.5 5.1 6.9 12.3 7.3 6.6 7.4 4.4 7.5 3.9 3.8 10.7 11.3 6.1 8.7 22.0 5.9 9.6 6.7 26.7 5.7 4.5 27.8 10.3 9.3 15.9 13.9 43.6 21.8 12.9 35.7 25.2 6.2 6.9 4.3 9.0 7.9 6.2 6.5 5.9 5.8 11.5 12.1 9.2 4.3 20.9 8.9 7.3 11.2 11.0 7.3 4.9 13.9 9.8 13.4 8.8 6.1 6.0 4.4 11.5 6.5 3.7 6.9 9.3 7.9 4.5 11.2 18.8 22.1 22.2 7.2 3.8 25.5 12.7 8.6 10.5 4.6 11.3 14.0 12.3 7.6 5.3 3.1 7.3 6.3 9.5 6.5 9.5 7.2 5.8 5.9 6.7 8.3 10.8 14.4 9.3 7.7 14.0 6.4 9.5 7.4 15.5 18.8 43.6 13.0 19.2 13.7 15.9 18.3 14.6 13.9 14.9 35.7 26.4 38.3 12.9 21.8 7.2 20.1 25.2 8.8 8.3 12.4 9.4 7.5 6.6 6.6 9.3 7.3 6.7 0.0 8.4 28.2 5.7 20.0 17.5 3.7 2.5 9.4 3.4 7.0 13.7 16.5 5.0 4.9 13.2 9.0 6.3 0.0 4.6 15.0 7.1 4.7 22.0 3.0 15.6 6.4 3.5 6.2 19.7 16.0 6.1 21.7 5.0 16.2 2.9 3.5 6.7 3.5 3.9 3.7 22.3 12.9 8.2 10.9 22.3 24.3 38.3 45.7 3.5 7.0 CROCC "ROLT, rootletin" ENSG00000058453 "Ciliary rootlet coiled-coil, rootletin" Q5TZA2 1 16740273-16972979 "Predicted intracellular proteins" "Cell cycle, Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "salivary gland: 135.2" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 111.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021191, HPA021762" Enhanced Supported "Plasma membrane,Centrosome" NA NA "Plasma membrane, Centrosome" "HPA021191: AB_1856395, HPA021762: AB_1856396" "unprognostic (9.07e-3)" "unprognostic (9.03e-2)" "unprognostic (6.04e-2)" "prognostic favorable (8.34e-5)" "unprognostic (3.27e-1)" "unprognostic (1.25e-3)" "unprognostic (1.42e-3)" "prognostic favorable (7.92e-4)" "unprognostic (2.05e-1)" "unprognostic (7.75e-2)" "unprognostic (3.36e-3)" "unprognostic (5.75e-2)" "prognostic unfavorable (7.97e-4)" "unprognostic (1.58e-1)" "unprognostic (9.83e-2)" "unprognostic (6.05e-2)" "unprognostic (1.76e-3)" 5.0 3.8 3.2 3.2 7.0 2.1 2.5 12.9 3.0 3.9 2.8 5.4 2.2 2.4 5.1 2.4 3.2 9.9 2.3 2.1 4.6 3.5 2.4 1.8 3.9 3.2 2.1 2.5 5.0 4.2 3.0 3.6 2.2 11.3 3.3 0.6 30.6 135.2 2.9 8.2 14.4 3.1 1.8 2.3 6.4 3.5 1.9 4.3 2.1 2.5 2.3 1.8 2.9 3.8 1.1 0.6 1.7 0.8 1.3 2.8 0.6 4.1 1.7 3.2 3.2 2.3 2.1 1.3 3.0 1.0 1.0 1.1 0.2 1.9 10.9 2.8 1.2 0.3 5.0 0.8 2.2 0.1 0.9 5.8 5.0 5.3 0.8 3.9 0.3 5.1 1.8 5.2 0.9 0.9 1.7 1.6 7.9 0.7 2.8 0.3 3.5 3.3 1.2 11.6 0.9 2.7 3.1 4.2 3.7 0.7 1.2 9.9 10.6 3.2 2.1 9.7 1.0 4.2 1.4 4.4 2.8 3.7 7.0 2.3 5.0 3.6 2.2 2.8 0.7 3.3 0.0 0.4 1.7 1.6 0.8 2.8 0.7 1.3 1.3 0.2 1.1 1.1 0.9 0.1 1.3 0.3 0.6 1.3 0.6 3.2 7.0 12.9 3.0 4.6 3.5 2.1 2.5 11.3 4.3 0.0 5.8 0.5 4.2 5.6 20.9 3.2 2.5 14.7 3.4 5.2 25.5 1.1 0.0 4.8 3.5 6.8 0.7 0.0 2.0 5.8 4.5 2.1 1.1 2.4 2.0 3.2 3.5 6.7 2.2 1.9 17.8 2.2 5.0 2.8 3.7 11.9 3.2 2.3 12.0 1.3 111.2 0.0 9.2 1.4 13.2 4.4 0.9 3.8 2.5 1.4 CRYAB "CRYA2, HSPB5" ENSG00000109846 "Crystallin alpha B" P02511 11 111908565-111923722 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Chaperone, Eye lens protein" "Cancer-related genes, Cardiomyopathy, Cataract, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 743.1;skeletal muscle: 581.1" "Cell type enhanced" "Detected in many" 16 "Basal glandular cells: 1730.9;Cardiomyocytes: 6792.5;Proximal tubular cells: 5845.1" "Group enriched" "Detected in all" 6 "glioma: 426.4;renal cancer: 575.9" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "ASC diff: 235.7;fHDF/TERT166: 76.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002053, CAB040560, HPA057100" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 12000 "Plasma membrane, Cytosol" "CAB002053: AB_442024, CAB040560: , HPA057100: AB_2683337" "unprognostic (1.06e-2)" "unprognostic (2.26e-1)" "prognostic unfavorable (4.90e-5)" "unprognostic (2.46e-2)" "unprognostic (3.02e-2)" "unprognostic (8.41e-3)" "unprognostic (9.29e-3)" "unprognostic (7.35e-2)" "unprognostic (8.91e-2)" "unprognostic (1.55e-2)" "unprognostic (6.68e-2)" "unprognostic (7.02e-2)" "unprognostic (3.68e-2)" "unprognostic (7.92e-2)" "unprognostic (8.83e-2)" "unprognostic (1.18e-1)" "prognostic unfavorable (1.70e-5)" 107.4 11.5 47.8 16.7 82.3 2.1 69.5 24.8 153.7 22.4 23.6 132.9 7.2 5.5 14.8 25.9 41.9 13.5 14.0 743.1 65.9 44.0 151.8 3.8 8.4 3.9 139.2 29.7 8.8 6.6 3.3 8.6 16.1 80.7 30.3 12.9 23.3 30.6 75.1 581.1 18.1 6.2 45.2 168.0 5.5 11.6 3.9 101.8 0.0 40.7 94.1 9.2 16.2 53.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.4 235.7 10.3 1.6 6.5 0.2 0.1 0.2 0.1 0.0 0.0 3.9 76.9 0.0 0.2 0.2 0.2 0.1 0.0 0.0 0.0 1.2 0.6 2.0 0.0 0.0 8.2 1.0 0.0 0.5 5.1 0.0 0.0 0.5 0.2 18.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.4 0.8 3.5 5.8 0.5 0.0 0.1 30.5 10.9 0.8 0.3 0.1 0.0 0.0 0.6 0.1 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.8 82.3 24.8 48.5 65.9 44.0 139.2 29.7 80.7 101.8 77.4 5.5 0.9 1730.9 155.3 11.4 6792.5 86.6 2.7 1.2 1270.1 17.7 2.9 573.6 165.7 20.3 23.3 0.0 0.0 10.0 5.8 309.0 1331.1 0.0 0.8 5.4 9.5 6.8 56.4 0.3 11.1 211.7 26.8 458.9 6.4 0.0 1097.1 19.7 0.0 176.4 5845.1 41.9 135.8 899.5 10.0 0.7 135.6 27.9 0.5 0.0 203.0 CSDE1 "D1S155E, UNR" ENSG00000009307 "Cold shock domain containing E1" O75534 1 114716913-114758676 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 266.5" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "MCF7: 226.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018846, HPA052221" Supported Enhanced "Plasma membrane,Cytosol" NA NA 13000 "Plasma membrane, Cytosol" "HPA018846: AB_1847266, HPA052221: AB_2681767" "unprognostic (2.84e-1)" "unprognostic (9.18e-3)" "unprognostic (4.86e-3)" "unprognostic (3.30e-3)" "unprognostic (2.83e-2)" "unprognostic (4.51e-2)" "unprognostic (5.32e-3)" "unprognostic (5.16e-2)" "unprognostic (1.78e-1)" "unprognostic (5.19e-2)" "unprognostic (3.24e-2)" "unprognostic (2.40e-1)" "unprognostic (4.69e-2)" "unprognostic (4.67e-2)" "unprognostic (1.18e-1)" "unprognostic (5.17e-3)" "unprognostic (2.54e-2)" 71.2 31.4 33.5 25.8 33.2 37.9 42.1 29.6 35.4 39.0 64.7 29.6 35.9 29.5 46.4 38.9 58.8 30.3 29.4 64.2 33.2 31.7 37.4 39.5 34.2 31.4 41.6 31.4 43.9 37.2 50.3 38.4 38.8 44.4 52.6 32.9 32.0 43.2 42.0 266.5 33.8 46.5 88.3 42.4 32.2 39.9 41.5 35.1 39.6 55.7 73.9 31.9 75.4 45.5 43.9 59.0 57.9 65.2 48.1 62.3 80.5 61.7 21.8 38.8 38.7 44.3 57.6 54.3 54.6 40.8 36.8 29.9 31.9 18.7 48.7 46.1 52.0 21.5 26.3 43.0 42.4 53.7 59.5 29.4 47.8 39.7 28.2 39.2 35.5 28.5 41.8 46.2 44.0 58.1 50.0 42.0 41.2 48.4 32.0 44.9 226.5 47.5 22.7 73.9 26.0 29.4 35.6 120.2 22.9 29.2 48.7 48.0 31.8 53.4 44.6 41.3 42.8 22.9 56.7 50.6 43.5 60.0 57.0 59.9 48.9 53.2 54.6 56.2 40.3 132.6 46.4 57.7 57.9 40.9 60.8 55.5 43.9 52.2 49.7 59.0 34.7 62.3 52.3 40.9 48.1 65.2 23.0 56.7 80.5 33.5 33.2 29.6 35.4 33.2 31.7 41.6 31.4 44.4 35.1 184.6 166.5 131.5 180.2 192.1 123.0 534.2 132.5 139.2 159.3 122.1 55.0 150.1 192.3 174.5 301.0 172.2 163.0 93.5 175.1 175.9 149.1 211.7 211.6 144.5 141.9 93.8 210.9 124.6 242.4 459.7 149.8 180.0 209.2 170.5 206.0 141.9 193.9 122.8 212.2 179.3 91.0 161.7 255.2 219.6 163.8 204.6 228.3 138.0 172.8 220.6 CSF1 "M-CSF, MCSF, MGC31930" ENSG00000184371 "Colony stimulating factor 1" P09603 1 109910242-109930992 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Cytokine, Growth factor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 47.6;granulocytes: 111.9;Ito cells: 54.0;Sertoli cells: 58.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 11 "basophil: 7.0;eosinophil: 16.5" "Lineage enriched" "Detected in many" 16 "granulocytes: 16.5" "Cell line enhanced" "Detected in many" "ASC diff: 46.5;ASC TERT1: 29.2;BJ hTERT+: 30.6;GAMG: 29.0;HHSteC: 70.7;HSkMC: 45.2;hTERT-RPE1: 32.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076624 Supported "Nuclear bodies,Plasma membrane" "Secreted to blood" NA NA 270000 17000000 "Plasma membrane" "Nuclear bodies" "HPA076624: AB_2686810" "unprognostic (2.35e-3)" "unprognostic (2.14e-1)" "unprognostic (7.36e-2)" "unprognostic (4.19e-1)" "unprognostic (3.60e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (4.25e-5)" "unprognostic (1.04e-1)" "unprognostic (1.75e-2)" "unprognostic (2.18e-1)" "unprognostic (1.72e-1)" "unprognostic (5.10e-2)" "prognostic unfavorable (1.00e-11)" "unprognostic (2.03e-1)" "unprognostic (1.88e-2)" "unprognostic (4.01e-1)" "unprognostic (3.16e-2)" 38.1 21.4 11.5 14.6 16.7 10.1 36.5 4.3 14.6 13.8 12.8 28.2 3.6 8.5 12.0 10.1 11.3 15.7 20.6 16.0 11.4 5.8 10.7 10.3 23.5 16.9 24.3 5.4 16.9 11.3 6.7 5.2 26.0 19.2 16.3 11.0 12.2 12.4 11.6 12.7 10.4 12.7 16.0 21.9 25.8 11.9 7.5 20.3 2.9 12.4 7.8 11.0 20.6 29.2 0.0 0.0 16.5 0.0 0.0 1.0 0.1 1.5 5.7 2.9 1.1 46.5 29.2 1.0 6.6 30.6 5.3 4.9 0.2 0.8 0.0 8.4 16.3 29.0 1.2 1.2 2.2 2.0 18.5 0.9 2.0 3.3 1.9 70.7 0.0 2.6 45.2 0.6 11.6 7.0 32.5 1.0 0.5 0.4 1.1 6.3 0.1 0.0 0.3 0.9 0.4 0.5 0.2 1.5 0.1 2.1 1.5 0.1 0.3 1.9 0.5 2.3 3.7 0.4 0.2 3.5 5.5 1.9 24.4 3.7 0.5 0.2 0.0 14.0 0.0 20.6 7.0 0.0 16.5 0.2 0.0 0.5 0.0 0.7 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 1.0 0.1 11.5 16.7 4.3 14.6 11.4 5.8 24.3 5.4 19.2 20.3 8.9 47.6 2.4 5.4 6.5 0.2 2.4 22.9 0.0 5.7 3.5 0.0 0.5 0.0 23.8 0.3 19.0 0.6 0.0 2.0 0.4 28.2 4.8 111.9 2.5 9.2 0.0 7.5 54.0 3.5 0.0 23.3 11.7 10.1 2.8 0.8 1.9 8.1 0.9 8.1 1.1 0.1 58.2 25.9 0.6 0.6 4.8 0.7 8.5 0.6 1.8 CSF1R "C-FMS, CD115, CSFR, FMS" ENSG00000182578 "Colony stimulating factor 1 receptor" P07333 5 150053291-150113372 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Immunity, Inflammatory response, Innate immunity" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Neurodegeneration, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 82.5;lymphoid tissue: 82.6" "Group enriched" "Detected in many" 8 "Extravillous trophoblasts: 97.9;Hofbauer cells: 277.3;Kupffer cells: 200.7;Macrophages: 125.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 60.7;non-classical monocyte: 82.5" "Lineage enriched" "Detected in many" 4 "monocytes: 82.5" "Group enriched" "Detected in some" 5 "BEWO: 51.8;SK-BR-3: 19.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB008970, HPA012323" Uncertain Supported "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1500000000 "Vesicles, Plasma membrane" "CAB008970: , HPA012323: AB_1848977" "unprognostic (3.82e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-3)" "unprognostic (9.83e-2)" "unprognostic (1.20e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (1.45e-1)" "unprognostic (9.37e-2)" "unprognostic (1.11e-2)" "unprognostic (2.49e-1)" "unprognostic (1.65e-1)" "prognostic unfavorable (1.08e-4)" "unprognostic (3.67e-2)" "prognostic unfavorable (4.92e-4)" "unprognostic (1.72e-2)" "unprognostic (4.61e-2)" 20.9 12.4 18.2 28.1 18.9 1.8 7.7 2.8 13.5 9.3 8.3 25.4 1.1 9.2 5.9 13.1 8.4 7.9 16.1 8.7 16.4 13.7 7.8 15.1 13.7 25.4 21.3 6.0 5.3 5.2 5.9 6.4 52.1 17.1 8.5 8.4 16.8 8.0 8.7 3.0 5.8 14.5 16.2 25.8 82.6 9.0 4.9 23.0 3.1 4.2 2.9 8.2 16.4 4.7 0.0 19.1 2.9 82.5 0.0 0.1 13.9 1.7 0.0 0.0 0.0 0.8 0.2 51.8 0.1 0.0 0.0 0.0 1.5 0.0 2.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 1.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.1 0.0 19.8 0.0 0.8 0.0 7.4 0.0 0.3 0.0 0.0 1.3 0.0 0.1 0.0 2.6 0.9 0.0 0.4 18.1 0.5 0.1 60.7 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 2.9 0.0 82.5 1.4 0.0 13.9 18.2 18.9 2.8 13.4 16.4 13.7 21.3 6.0 17.1 23.0 0.0 6.7 0.5 0.0 2.5 0.0 2.8 5.1 1.4 0.0 0.0 0.0 2.9 0.0 0.0 3.7 2.2 0.0 0.0 0.0 97.9 3.3 0.0 2.3 0.8 277.3 0.0 0.0 4.9 200.7 3.5 1.7 125.7 3.3 1.8 0.0 0.0 0.1 0.0 0.0 0.0 0.4 12.9 1.3 0.5 0.2 1.1 22.1 2.2 0.0 0.0 CSPG4 "HMW-MAA, MCSP, MCSPG, MEL-CSPG, MSK16, NG2" ENSG00000173546 "Chondroitin sulfate proteoglycan 4" Q6UVK1 15 75674322-75712848 "Predicted membrane proteins" "Angiogenesis, Differentiation, Tissue remodeling" "Developmental protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 6 "Sertoli cells: 116.4;Smooth muscle cells: 29.5" "Cancer enhanced" "Detected in all" "melanoma: 74.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 1.9" "Lineage enriched" "Detected in single" 11 "NK-cells: 1.9" "Cell line enhanced" "Detected in many" "BJ: 20.1;SK-MEL-30: 45.8;U-138 MG: 29.6;WM-115: 43.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA001933, HPA002951, CAB016189, HPA042785, HPA050008" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA 28000000 "Plasma membrane" Nucleoplasm "CAB016189: AB_784821, HPA001933: , HPA002951: AB_1854449, HPA042785: AB_10964270, HPA050008: AB_2680991" "unprognostic (5.21e-2)" "unprognostic (2.17e-3)" "unprognostic (3.55e-2)" "unprognostic (1.01e-2)" "unprognostic (3.56e-2)" "unprognostic (3.58e-1)" "unprognostic (1.09e-2)" "unprognostic (2.11e-2)" "unprognostic (1.07e-1)" "unprognostic (5.00e-2)" "unprognostic (1.63e-1)" "unprognostic (3.14e-1)" "prognostic unfavorable (7.60e-6)" "unprognostic (1.23e-2)" "unprognostic (2.04e-2)" "unprognostic (3.21e-2)" "prognostic unfavorable (4.93e-5)" 36.1 3.1 8.3 10.0 7.9 1.0 19.5 1.6 7.8 15.3 29.2 7.2 6.9 4.6 21.3 14.9 19.9 9.4 18.2 9.2 6.5 5.2 3.5 1.5 10.9 1.4 6.6 5.2 7.0 3.8 3.0 1.6 20.9 6.6 11.4 3.9 10.0 3.4 16.7 25.7 8.0 9.1 37.9 5.4 3.8 14.0 2.5 6.3 0.0 4.7 6.0 1.3 30.3 10.9 0.0 0.1 0.0 0.0 1.9 0.0 0.0 3.6 0.0 0.3 2.2 0.5 3.2 0.0 20.1 9.0 14.1 9.2 0.0 14.0 0.0 0.5 14.0 1.9 0.2 0.0 0.1 4.3 0.1 0.0 0.0 5.9 0.0 3.2 0.0 0.0 1.5 0.0 4.2 0.5 5.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 45.8 0.4 0.3 0.3 0.0 29.6 5.8 1.1 0.2 0.0 0.0 0.0 6.5 0.1 43.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 8.3 7.9 1.6 5.9 6.5 5.2 6.6 5.2 6.6 6.3 0.0 0.0 0.0 0.6 2.5 0.0 9.8 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.6 2.8 0.0 0.0 0.0 0.2 6.5 0.6 0.0 0.0 1.1 0.0 0.0 1.3 0.0 0.0 0.3 0.8 11.8 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 116.4 29.5 0.0 1.3 1.6 0.2 0.0 0.0 0.3 CST6 ENSG00000175315 "Cystatin E/M" Q15828 11 66011841-66013505 "Cancer-related genes, Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Thiol protease inhibitor" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skin 1: 124.5" "Cell type enhanced" "Detected in many" 16 "Alveolar cells type 1: 86.4;Ciliated cells: 56.2;Collecting duct cells: 55.8;Pancreatic endocrine cells: 216.2" "Cancer enhanced" "Detected in many" "thyroid cancer: 171.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 6 "A-431: 26.8;CAPAN-2: 74.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB019316, HPA044963" Enhanced Approved "Plasma membrane,Cytosol" "Secreted in other tissues" NA NA 110000000 "Plasma membrane" Cytosol "CAB019316: , HPA044963: AB_2679158" "unprognostic (3.01e-2)" "unprognostic (5.10e-2)" "unprognostic (1.14e-1)" "unprognostic (3.59e-2)" "unprognostic (5.00e-2)" "unprognostic (2.60e-1)" "unprognostic (1.65e-1)" "unprognostic (8.38e-2)" "unprognostic (5.02e-1)" "unprognostic (8.89e-3)" "unprognostic (1.29e-3)" "unprognostic (1.46e-1)" "unprognostic (1.74e-3)" "unprognostic (5.89e-3)" "unprognostic (1.83e-1)" "unprognostic (1.64e-2)" "unprognostic (2.59e-2)" 0.6 0.2 0.1 1.5 0.1 0.2 8.7 0.4 0.2 5.5 0.2 0.0 1.4 0.1 0.3 0.8 11.3 4.3 0.7 2.4 0.1 0.2 1.0 0.1 27.2 1.2 0.1 0.0 1.3 0.2 0.5 0.4 26.5 0.2 0.9 0.1 1.1 1.3 26.5 0.7 124.5 0.2 0.2 0.2 0.2 0.2 1.0 0.0 2.8 14.6 13.6 4.4 0.5 3.7 0.4 0.9 0.0 1.6 0.0 0.2 0.7 26.8 0.0 0.0 0.1 0.0 0.0 8.0 0.2 0.0 0.0 0.0 0.1 74.8 0.0 0.4 0.9 0.0 0.9 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.0 0.0 7.5 0.1 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.4 0.0 0.2 0.0 0.0 0.6 0.0 0.0 0.7 0.1 0.1 0.4 0.1 0.1 0.2 0.1 0.0 0.2 0.0 86.4 6.7 0.0 1.2 1.0 0.0 1.0 0.0 56.2 26.1 55.8 0.0 5.9 0.0 14.5 0.1 0.1 0.0 0.0 19.3 11.2 1.9 1.4 21.8 0.0 43.3 0.0 0.0 0.0 0.3 0.5 0.0 6.5 5.0 1.8 0.0 0.8 216.2 0.0 0.4 0.2 0.0 0.0 0.4 1.4 16.7 24.1 53.7 0.0 0.0 5.4 CTNNA1 CAP102 ENSG00000044115 "Catenin alpha 1" P35221 5 138610967-138935034 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021089, HPA046119, HPA063535" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA 5400 "Plasma membrane, Cell Junctions" "CAB021089: AB_10123543, HPA046119: AB_2679547, HPA063535: AB_2685033" "unprognostic (2.25e-3)" "unprognostic (3.32e-2)" "unprognostic (2.82e-3)" "unprognostic (1.80e-1)" "unprognostic (8.40e-2)" "unprognostic (2.35e-1)" "unprognostic (1.66e-3)" "unprognostic (4.83e-2)" "unprognostic (2.28e-1)" "unprognostic (2.48e-1)" "prognostic unfavorable (8.02e-4)" "unprognostic (6.18e-2)" "prognostic favorable (7.34e-7)" "unprognostic (1.54e-1)" "unprognostic (2.31e-1)" "unprognostic (7.62e-2)" "unprognostic (1.04e-1)" 55.9 54.0 39.6 24.4 50.2 10.9 55.1 16.5 39.5 43.4 58.9 68.5 33.9 44.2 53.0 47.5 76.9 45.8 41.1 68.6 38.8 32.3 62.2 37.7 49.8 27.0 57.3 29.3 42.7 38.1 55.5 25.6 54.0 45.5 39.4 49.0 35.6 48.8 43.5 30.5 49.8 53.9 59.6 49.7 30.9 48.2 18.7 56.6 8.1 51.2 46.4 44.1 48.4 45.1 3.8 15.2 9.8 21.8 0.3 5.0 7.1 32.2 23.5 35.7 52.8 31.1 34.2 54.4 32.7 41.2 31.3 39.7 49.0 43.9 0.1 27.7 48.8 34.4 24.7 24.5 53.8 36.5 18.5 21.3 13.6 38.8 29.7 37.5 0.2 13.3 21.5 43.1 37.4 41.1 34.9 59.0 9.8 7.4 14.0 33.7 28.5 0.3 4.1 14.3 34.4 0.5 12.7 20.8 19.4 66.1 43.2 14.3 18.8 60.4 84.9 49.4 79.5 30.0 9.3 50.0 33.0 17.9 20.4 22.6 5.1 9.5 1.9 31.4 5.9 42.5 2.2 17.1 1.5 2.9 21.8 1.9 3.8 2.1 2.1 15.2 3.2 0.1 1.1 9.8 0.3 20.2 3.7 5.0 7.1 39.6 50.2 16.5 39.5 38.8 32.3 57.3 29.3 45.5 56.6 241.2 121.7 23.1 99.7 69.7 8.7 202.9 84.1 172.6 201.3 115.1 19.6 101.5 58.0 167.3 13.9 111.5 204.4 23.3 152.7 117.7 74.1 118.0 39.3 51.3 79.8 3.2 49.0 92.7 73.9 18.8 72.2 73.0 74.2 212.8 129.6 45.5 232.1 131.5 79.5 116.5 23.0 97.0 108.1 17.0 21.1 67.5 158.8 17.0 92.7 143.6 CUTA "ACHAP, C6orf82" ENSG00000112514 "CutA divalent cation tolerance homolog" O60888 6 33416442-33418317 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016787, HPA064369" Uncertain Approved "Plasma membrane,Focal adhesion sites" "Secreted to blood" NA NA 35000000 "Plasma membrane, Focal adhesion sites" "CAB016787: , HPA064369: AB_2685248" "unprognostic (7.03e-2)" "unprognostic (5.44e-2)" "unprognostic (4.56e-2)" "unprognostic (8.91e-2)" "unprognostic (1.86e-1)" "unprognostic (1.03e-1)" "unprognostic (1.98e-2)" "prognostic favorable (8.50e-4)" "unprognostic (1.87e-1)" "unprognostic (2.78e-2)" "unprognostic (1.27e-3)" "unprognostic (1.91e-1)" "unprognostic (5.55e-2)" "unprognostic (9.90e-2)" "unprognostic (1.54e-1)" "unprognostic (7.94e-2)" "unprognostic (2.74e-1)" 26.6 65.6 47.9 28.3 60.1 33.5 47.6 37.7 73.7 47.7 37.9 36.8 53.9 42.1 40.1 78.5 30.5 46.0 48.8 49.6 45.2 44.9 46.3 61.6 39.0 77.4 46.5 37.8 57.7 66.6 43.8 86.1 45.7 39.8 38.8 28.9 34.2 74.3 69.7 34.6 32.7 37.2 32.4 47.0 36.0 38.7 27.3 31.6 52.2 69.7 30.3 31.3 42.6 28.9 56.5 31.4 27.1 32.0 49.9 69.8 60.8 43.8 26.3 42.1 53.3 31.7 31.2 20.4 40.1 75.1 77.6 82.7 26.2 27.4 31.0 31.2 45.9 56.4 26.8 27.3 40.8 43.8 26.2 60.5 32.3 43.6 68.6 41.3 25.1 24.6 41.3 34.5 37.3 31.5 54.0 20.8 32.9 39.6 63.1 56.7 34.1 38.0 53.5 37.7 38.0 34.7 41.8 25.1 81.9 53.4 19.1 82.4 42.0 24.0 41.8 72.8 25.2 30.7 52.8 22.9 42.0 35.7 29.8 41.8 62.0 61.6 33.9 36.3 55.6 34.1 27.1 32.0 16.5 45.7 22.9 63.2 56.5 67.6 52.7 31.4 44.2 68.5 53.2 4.6 49.9 16.8 27.1 69.8 60.8 47.9 60.1 37.7 73.7 45.2 44.9 46.5 37.8 39.8 31.6 122.1 105.5 178.5 242.5 204.8 84.5 113.4 239.5 131.2 121.7 300.1 64.8 309.8 240.4 162.1 64.8 93.9 157.7 23.3 122.9 203.5 204.8 237.5 167.3 299.7 277.3 73.1 280.4 131.3 162.9 285.6 185.2 150.2 300.3 80.2 266.0 150.8 114.3 196.4 180.0 440.5 69.0 90.5 220.1 100.6 65.6 201.4 203.1 245.2 291.8 203.9 CXADR CAR ENSG00000154639 "CXADR, Ig-like cell adhesion molecule" P78310 21 17512382-17593579 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.4" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 287.2;Suprabasal keratinocytes: 300.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 32.2;Hep G2: 20.8;NTERA-2: 37.3;RT4: 36.0" "HPA003342, CAB005103, HPA030411, HPA030412" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA 11000 "Plasma membrane, Cell Junctions" "CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992" "unprognostic (3.75e-1)" "unprognostic (1.03e-1)" "unprognostic (6.45e-3)" "unprognostic (2.10e-1)" "unprognostic (1.56e-1)" "prognostic favorable (3.50e-4)" "unprognostic (1.32e-1)" "unprognostic (2.52e-1)" "unprognostic (1.94e-1)" "unprognostic (2.15e-1)" "unprognostic (3.48e-3)" "unprognostic (1.04e-1)" "unprognostic (9.35e-2)" "unprognostic (3.89e-3)" "unprognostic (2.20e-1)" "unprognostic (8.27e-2)" "unprognostic (5.71e-3)" 4.0 3.1 6.4 3.2 9.4 1.3 5.8 2.0 15.4 6.3 27.1 12.5 9.0 24.9 3.3 9.3 15.0 6.5 17.2 10.8 7.9 5.5 5.1 28.6 9.9 4.2 9.2 5.6 1.1 12.0 5.2 11.1 0.3 11.6 9.2 15.4 3.7 16.3 15.8 0.6 30.0 41.4 2.1 13.0 1.4 17.6 8.5 6.9 0.9 13.1 4.9 3.8 14.7 10.0 0.8 0.4 2.6 0.5 0.9 2.7 0.9 5.6 3.1 15.4 0.0 0.0 0.0 9.3 0.0 0.0 0.2 0.9 32.2 4.9 2.0 6.9 0.0 4.6 9.8 7.8 2.0 0.3 3.1 6.6 0.0 9.2 20.8 1.0 0.6 0.0 0.0 8.5 0.4 0.1 3.7 3.0 1.9 0.1 0.1 0.0 0.3 1.2 0.0 37.3 5.0 0.0 0.0 5.2 4.0 12.9 36.0 6.2 4.2 3.6 4.1 2.1 16.5 8.6 0.1 0.1 0.0 9.3 0.1 2.2 1.5 2.5 0.1 1.2 0.0 0.2 2.6 0.5 0.4 0.5 0.2 1.0 0.3 2.6 0.6 0.1 0.8 2.7 0.8 1.4 0.9 0.2 0.4 0.5 0.9 6.4 9.4 2.0 15.4 7.9 5.5 9.2 5.6 11.6 6.9 131.0 63.6 1.5 156.7 287.2 15.2 27.4 137.6 50.9 55.7 97.7 25.5 1.0 5.0 109.2 4.3 2.0 199.0 0.0 81.3 0.2 6.8 133.1 5.7 114.1 0.6 0.0 77.6 70.6 23.6 4.0 2.0 5.3 21.9 1.0 96.0 11.6 81.7 112.0 0.0 4.4 10.0 6.5 3.8 4.2 22.3 300.5 0.6 3.8 81.0 165.3 CYB5D2 MGC32124 ENSG00000167740 "Cytochrome b5 domain containing 2" Q8WUJ1 17 4143168-4187310 "Predicted intracellular proteins, Predicted secreted proteins" Neurogenesis "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 40.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011032, HPA042299" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted - unknown location" NA NA "Endoplasmic reticulum, Plasma membrane" "HPA011032: , HPA042299: AB_10793879" "unprognostic (2.57e-2)" "unprognostic (2.89e-2)" "unprognostic (4.16e-2)" "prognostic favorable (6.19e-4)" "unprognostic (1.88e-2)" "unprognostic (1.75e-2)" "prognostic favorable (4.98e-6)" "unprognostic (1.57e-1)" "unprognostic (2.47e-1)" "unprognostic (9.71e-3)" "prognostic favorable (7.76e-5)" "unprognostic (2.04e-1)" "prognostic favorable (2.03e-10)" "unprognostic (2.01e-3)" "unprognostic (8.73e-2)" "unprognostic (1.82e-1)" "unprognostic (2.97e-1)" 13.1 17.3 18.7 5.1 26.4 3.6 15.0 20.6 27.5 15.0 8.1 21.8 14.6 13.3 13.9 27.1 9.8 17.4 14.5 10.3 17.8 21.6 22.9 25.3 8.6 7.4 19.7 26.1 19.5 17.0 28.5 18.5 9.9 19.1 12.0 6.8 17.3 17.5 16.8 12.2 11.7 10.3 7.8 21.7 7.9 12.3 54.1 17.1 4.8 20.6 7.1 6.8 12.0 8.6 9.4 13.0 14.7 12.7 5.9 12.5 9.0 7.9 10.7 6.2 6.5 40.1 11.8 2.6 7.7 16.7 5.7 5.8 3.1 5.3 2.6 7.0 8.9 4.8 11.3 2.6 3.6 2.3 8.5 12.9 2.4 6.7 5.3 7.3 1.0 4.9 15.4 8.6 3.1 6.2 11.9 10.2 5.8 2.5 15.8 4.3 9.8 3.7 1.6 2.2 6.8 5.8 4.5 5.5 6.3 13.1 4.2 5.0 4.2 8.7 5.1 11.4 7.2 13.5 1.6 13.7 8.3 2.1 7.6 4.0 3.0 2.3 2.0 10.2 2.2 3.2 0.6 12.7 14.7 7.2 10.4 8.1 9.4 11.4 8.8 12.0 9.4 10.8 9.7 11.7 5.9 9.4 13.0 12.5 9.0 18.7 26.4 20.6 27.5 17.8 21.6 19.7 26.1 19.1 17.1 11.9 9.3 19.5 18.9 47.7 26.3 8.5 56.0 45.5 11.4 29.6 55.0 44.7 44.7 26.6 19.7 31.6 18.6 0.0 23.9 24.3 20.3 8.4 10.5 31.1 17.8 38.1 13.3 29.4 21.3 23.3 26.7 17.5 13.5 14.4 13.8 34.2 24.3 17.3 26.9 34.9 30.0 0.0 21.2 83.1 23.6 37.5 32.3 15.2 15.8 7.8 DAAM1 KIAA0666 ENSG00000100592 "Dishevelled associated activator of morphogenesis 1" Q9Y4D1 14 59188646-59371405 "Plasma proteins, Predicted intracellular proteins" "Wnt signaling pathway" Actin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Basal keratinocytes: 415.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 18.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HaCaT: 27.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026605, HPA064789" Uncertain Approved "Plasma membrane,Cytosol" NA NA 450000 "Plasma membrane, Cytosol" "HPA026605: AB_1847464, HPA064789: AB_2685352" "unprognostic (2.81e-1)" "unprognostic (9.70e-2)" "unprognostic (3.85e-2)" "unprognostic (2.74e-1)" "unprognostic (2.32e-1)" "unprognostic (1.84e-1)" "unprognostic (1.76e-2)" "unprognostic (2.48e-1)" "unprognostic (2.02e-1)" "unprognostic (6.40e-2)" "unprognostic (1.98e-1)" "unprognostic (4.64e-2)" "prognostic favorable (3.77e-4)" "unprognostic (5.01e-2)" "unprognostic (3.29e-1)" "unprognostic (1.39e-1)" "unprognostic (3.15e-2)" 13.8 8.0 13.8 9.4 9.3 3.7 9.3 17.3 13.3 14.6 11.4 6.3 7.4 4.5 16.9 7.0 19.2 8.4 6.0 17.3 10.2 6.7 6.0 10.7 9.7 8.8 5.6 13.6 8.6 8.2 25.6 9.6 12.4 8.7 10.9 7.8 16.9 12.0 10.5 6.0 25.6 7.7 19.5 10.0 10.2 9.1 5.8 7.2 4.1 7.1 14.1 13.8 15.3 13.1 10.7 18.3 4.9 3.1 6.9 3.8 1.9 13.1 1.3 9.1 2.3 6.0 4.2 11.8 1.7 1.7 3.5 3.7 6.8 10.9 13.6 3.5 4.1 7.2 27.2 8.5 6.6 2.9 6.0 3.0 5.1 3.4 8.1 3.7 5.7 2.7 2.8 6.7 3.0 2.9 7.0 7.7 6.7 8.3 6.7 2.1 11.3 4.8 2.8 4.9 8.1 3.9 4.5 7.7 1.3 4.5 10.3 14.1 3.1 11.5 16.8 10.2 6.1 22.3 1.2 7.7 2.7 5.3 6.1 1.5 1.5 1.7 15.9 3.6 1.0 6.5 4.9 2.1 2.5 2.6 2.4 3.1 10.7 3.3 2.4 2.4 4.7 2.7 2.7 2.6 6.9 3.1 18.3 3.8 1.9 13.8 9.3 17.3 13.3 10.2 6.7 5.6 13.6 8.7 7.2 32.8 24.8 21.7 108.9 415.1 111.0 118.9 30.6 65.6 52.4 27.9 290.6 30.5 19.9 42.3 28.7 59.1 37.1 186.9 81.9 21.8 46.3 89.2 25.4 41.2 26.6 184.3 84.3 111.7 17.1 11.1 55.8 14.9 86.0 24.4 50.3 117.4 130.6 38.6 69.6 11.3 180.1 32.3 49.5 32.1 44.8 290.2 28.6 20.2 36.8 75.2 DAGLB "DAGLBETA, KCCR13L" ENSG00000164535 "Diacylglycerol lipase beta" Q8NCG7 7 6409126-6484190 "Predicted membrane proteins" "Lipid degradation, Lipid metabolism" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA069377 Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA069377: AB_2686132" "unprognostic (2.39e-1)" "unprognostic (4.61e-2)" "unprognostic (2.13e-3)" "unprognostic (1.42e-1)" "unprognostic (9.04e-3)" "unprognostic (3.68e-2)" "unprognostic (1.78e-3)" "unprognostic (2.36e-1)" "unprognostic (2.22e-1)" "prognostic unfavorable (7.18e-5)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (1.54e-4)" "unprognostic (2.18e-1)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.81e-2)" 20.1 28.2 12.6 12.7 20.3 25.8 29.8 18.4 26.1 19.1 18.0 11.4 19.4 15.1 14.3 17.5 16.2 12.5 26.6 18.9 12.4 13.8 24.0 88.0 18.4 25.2 11.6 5.8 22.5 47.0 14.2 19.0 45.7 7.5 14.6 10.6 14.6 34.1 22.3 22.0 22.1 31.3 16.0 13.2 15.1 14.0 27.1 7.9 7.2 23.1 15.1 16.8 15.6 20.8 5.6 18.9 13.6 14.7 2.4 8.4 7.5 10.9 12.5 5.4 7.0 8.2 6.4 4.3 15.4 10.5 13.3 14.4 6.6 12.0 5.9 6.7 7.4 32.5 16.2 8.8 8.1 7.6 2.7 6.1 3.1 14.3 4.5 8.8 8.9 5.0 5.7 13.5 8.9 8.8 5.3 5.7 7.6 8.9 2.9 7.8 7.7 3.1 12.6 19.7 5.4 9.5 27.4 6.2 12.7 8.4 4.0 7.0 4.2 8.7 13.4 2.5 9.0 9.3 16.7 7.0 11.5 21.9 14.4 7.1 3.1 5.6 5.0 5.7 14.0 13.9 6.2 14.7 13.6 4.4 13.9 3.9 5.6 3.5 2.9 18.9 3.6 8.4 4.8 7.3 2.4 12.2 3.2 2.9 7.5 12.6 20.3 18.4 23.4 12.4 13.8 11.6 5.8 7.5 7.9 8.9 13.0 3.9 2.8 14.9 4.2 2.4 2.5 2.7 3.4 5.2 2.0 4.4 0.0 6.2 0.4 6.7 10.9 0.0 5.3 7.7 4.6 4.6 3.5 6.2 14.7 0.0 2.4 8.0 15.4 0.9 5.8 15.3 5.0 11.8 4.7 0.9 9.2 5.8 2.1 1.8 4.5 0.0 5.7 7.2 6.8 11.7 10.4 5.3 6.3 3.2 DBN1 D0S117E ENSG00000113758 "Drebrin 1" Q16643 5 177456608-177474401 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Alzheimer disease, Amyloidosis, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 78.5;Pancreatic endocrine cells: 52.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 12.7" "Group enriched" "Detected in many" 8 "dendritic cells: 5.1;granulocytes: 6.0;T-cells: 12.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA051452, HPA056940" Enhanced Supported Supported "Plasma membrane,Actin filaments" NA NA 17000000 "Plasma membrane, Actin filaments" "HPA051452: AB_2681489, HPA056940: AB_2683279" "unprognostic (3.81e-2)" "unprognostic (6.60e-3)" "unprognostic (2.88e-2)" "unprognostic (7.57e-3)" "unprognostic (9.32e-2)" "unprognostic (5.68e-2)" "unprognostic (2.01e-3)" "unprognostic (4.29e-2)" "unprognostic (1.73e-2)" "unprognostic (7.92e-2)" "unprognostic (2.94e-2)" "unprognostic (3.64e-1)" "prognostic favorable (8.28e-4)" "unprognostic (1.53e-1)" "unprognostic (4.56e-2)" "unprognostic (1.05e-1)" "unprognostic (1.76e-3)" 21.4 9.0 21.7 15.0 42.4 5.4 13.5 12.0 46.0 25.7 21.7 8.8 8.7 8.6 37.4 15.0 19.2 16.2 21.5 13.9 24.2 20.9 15.1 2.7 12.1 7.3 11.9 22.1 20.2 13.2 9.1 17.1 6.7 20.3 14.9 5.8 9.3 24.8 23.0 21.3 12.7 10.0 29.5 8.6 7.8 17.0 14.4 9.4 19.8 20.0 11.0 4.4 20.6 12.0 0.2 5.1 6.0 0.9 0.1 12.7 1.5 3.0 10.3 34.3 59.8 8.2 12.9 10.6 36.6 9.4 21.5 18.0 35.4 10.8 0.0 26.2 28.4 7.3 4.8 15.1 26.6 10.2 0.8 13.1 19.9 13.4 14.7 28.9 7.5 3.7 16.8 7.0 24.0 7.2 21.6 35.4 24.5 9.1 4.8 15.7 4.3 20.4 11.4 49.6 1.0 23.1 61.2 37.1 6.0 16.1 4.3 40.4 54.9 12.0 5.3 20.4 11.6 14.6 7.7 54.7 24.1 32.7 5.3 17.0 1.1 0.5 32.0 10.1 7.0 14.7 6.0 0.9 0.7 9.2 0.5 12.7 0.1 0.2 6.6 1.4 0.2 0.3 4.5 2.5 0.1 0.4 5.1 0.0 1.5 21.7 42.4 12.0 40.8 24.2 20.9 11.9 22.1 20.3 9.4 3.0 1.0 0.5 10.4 9.2 7.6 3.4 5.1 6.7 3.4 8.7 3.9 0.8 1.7 78.5 15.9 26.1 0.8 0.0 37.0 2.4 27.1 6.4 10.4 0.0 1.4 39.7 39.0 20.3 3.2 27.6 46.3 4.1 8.5 2.8 1.6 12.7 52.8 0.0 38.5 2.6 3.7 19.4 17.6 6.1 15.6 6.4 0.7 7.5 3.6 7.2 DCAF16 "C4orf30, FLJ20280" ENSG00000163257 "DDB1 and CUL4 associated factor 16" Q9NXF7 4 17800655-17810758 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042487 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042487: AB_10795505" "unprognostic (2.23e-3)" "unprognostic (1.05e-1)" "unprognostic (1.19e-1)" "unprognostic (3.97e-1)" "unprognostic (8.02e-2)" "unprognostic (2.14e-1)" "prognostic unfavorable (6.40e-4)" "prognostic favorable (5.78e-4)" "unprognostic (5.31e-2)" "unprognostic (3.30e-1)" "unprognostic (1.45e-2)" "unprognostic (3.19e-2)" "unprognostic (1.78e-1)" "unprognostic (8.72e-2)" "unprognostic (1.68e-1)" "unprognostic (2.23e-3)" "prognostic favorable (7.67e-4)" 13.0 13.1 12.7 12.1 20.5 23.3 19.8 19.4 19.7 18.5 13.1 22.5 9.9 12.0 26.9 16.5 11.5 16.1 11.3 11.8 13.9 15.7 11.3 6.8 12.6 16.7 14.4 16.2 29.6 16.0 17.8 25.8 14.8 19.0 16.9 14.8 17.1 15.2 13.0 16.2 22.4 14.0 17.2 16.0 13.3 13.6 19.2 16.3 30.6 15.7 7.0 18.3 16.3 14.6 4.8 3.0 9.7 2.8 3.6 6.3 2.2 12.2 2.6 14.3 15.0 4.1 7.2 7.9 8.0 9.5 9.6 11.4 7.5 10.0 13.9 6.4 7.4 7.8 6.2 8.4 8.5 14.3 4.7 7.7 19.4 8.8 12.2 9.9 17.0 7.9 9.4 7.0 12.2 12.1 6.5 6.6 13.7 20.8 23.1 5.5 4.6 18.7 16.4 11.8 3.6 7.7 19.8 16.4 8.9 4.1 9.7 21.4 17.2 8.5 2.3 9.2 7.6 8.4 4.7 8.3 11.2 8.8 12.3 10.1 10.3 4.1 17.3 9.2 11.9 7.5 9.7 2.4 3.4 4.5 2.8 5.9 3.7 5.0 4.9 1.5 4.8 6.3 5.9 1.8 3.6 1.9 3.0 3.4 2.2 12.7 20.5 19.4 19.7 13.9 15.7 14.4 16.2 19.0 16.3 17.9 19.0 9.0 15.5 22.6 11.8 14.8 15.3 21.4 17.0 8.7 5.9 14.1 11.6 8.6 14.8 12.1 7.1 23.3 6.7 7.7 16.1 12.3 16.2 5.7 6.4 14.3 16.8 11.6 9.7 9.1 19.5 9.6 10.1 5.4 16.5 23.4 8.7 5.8 20.8 5.0 13.6 12.9 13.2 24.2 17.2 18.4 10.3 15.2 13.0 14.3 DCHS2 "CDH27, CDHJ, CDHR7, FLJ20047, PCDH23, PCDHJ" ENSG00000197410 "Dachsous cadherin-related 2" 4 154231742-154495570 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "endometrium 1: 8.6" "Group enriched" "Detected in some" 7 "Early spermatids: 20.6;Horizontal cells: 23.8;Intestinal endocrine cells: 6.4;Late spermatids: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "U-2 OS: 8.0" "Low region specificity" "Detected in many" HPA064159 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA064159: AB_2685201" "unprognostic (1.38e-2)" "unprognostic (1.51e-1)" "unprognostic (5.74e-3)" "unprognostic (5.93e-2)" "unprognostic (7.43e-3)" "unprognostic (1.29e-1)" "unprognostic (2.27e-4)" "unprognostic (1.18e-1)" "unprognostic (4.00e-1)" "unprognostic (1.61e-1)" "unprognostic (2.53e-3)" "unprognostic (1.62e-1)" "unprognostic (1.06e-3)" "unprognostic (3.13e-1)" "unprognostic (2.62e-1)" "unprognostic (1.49e-1)" "unprognostic (1.68e-3)" 0.9 1.6 3.4 1.3 7.0 1.1 1.0 0.6 4.8 2.6 4.0 1.9 1.1 1.3 8.6 1.5 1.0 2.0 1.6 0.8 3.5 2.6 0.9 0.7 1.1 0.8 3.0 2.3 1.9 0.6 1.1 1.7 0.8 4.6 1.6 1.5 2.7 0.8 3.6 1.0 2.1 1.0 3.0 7.0 0.8 4.9 2.6 2.9 0.0 1.0 0.0 0.9 2.3 1.2 0.3 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.2 0.0 0.0 0.0 0.0 1.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 8.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.4 7.0 0.6 4.8 3.5 2.6 3.0 2.3 4.6 2.9 0.0 0.0 0.0 0.2 0.3 0.0 1.7 0.0 1.4 2.3 0.0 0.0 0.0 0.0 0.0 20.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 23.8 6.4 0.0 0.0 14.1 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.3 0.0 0.0 0.0 0.0 DCT TYRP2 ENSG00000080166 "Dopachrome tautomerase" P40126 13 94436808-94479682 "Enzymes, Predicted membrane proteins" "Melanin biosynthesis" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 58 "retina: 151.5;skin 1: 54.2" "Cell type enriched" "Detected in some" 25 "Melanocytes: 3369.1" "Cancer enriched" "Detected in some" 215 "melanoma: 155.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 259 "SK-MEL-30: 76.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA010742, HPA010743, HPA010800, CAB017634" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB017634: AB_1130818, HPA010742: , HPA010743: AB_1847519, HPA010800: AB_1847520" "unprognostic (5.99e-2)" "unprognostic (1.67e-2)" "unprognostic (1.54e-2)" "unprognostic (3.17e-2)" "unprognostic (2.45e-2)" "unprognostic (3.35e-2)" "unprognostic (2.15e-2)" "unprognostic (2.81e-2)" "unprognostic (6.07e-2)" "unprognostic (1.81e-1)" "unprognostic (3.64e-3)" "unprognostic (1.06e-2)" "unprognostic (6.18e-5)" "unprognostic (6.97e-2)" "unprognostic (9.87e-2)" "unprognostic (1.22e-3)" "unprognostic (2.42e-1)" 0.2 0.2 0.5 0.1 1.5 0.1 1.7 0.2 0.6 0.2 0.1 0.3 0.1 0.0 0.2 0.5 0.1 0.8 0.1 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.1 0.1 1.4 0.1 0.3 0.2 0.0 151.5 1.4 0.2 0.2 54.2 0.2 0.1 0.8 0.1 0.0 0.3 0.4 0.1 0.1 0.3 0.2 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 76.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 1.5 0.2 0.6 0.4 0.5 0.3 0.1 0.3 0.4 0.0 0.0 0.0 0.1 135.3 0.7 0.8 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 12.6 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.9 0.0 3369.1 0.0 0.0 2.4 0.0 0.0 0.7 0.0 0.2 0.0 0.9 0.5 0.2 29.2 0.0 0.0 0.0 0.0 DCUN1D2 "C13orf17, FLJ10704, FLJ20092" ENSG00000150401 "Defective in cullin neddylation 1 domain containing 2" Q6PH85 13 113455819-113490952 "Predicted intracellular proteins" "Ubl conjugation pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 24.0;heart muscle: 59.1;skeletal muscle: 65.6" "Cell type enhanced" "Detected in many" 11 "Cardiomyocytes: 67.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SCLC-21H: 32.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039349 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039349: AB_10673240" "unprognostic (3.09e-1)" "unprognostic (1.35e-1)" "unprognostic (1.78e-1)" "unprognostic (4.69e-2)" "unprognostic (7.43e-2)" "unprognostic (7.68e-2)" "unprognostic (4.33e-2)" "unprognostic (1.15e-1)" "unprognostic (1.40e-1)" "unprognostic (2.02e-2)" "prognostic favorable (5.65e-5)" "unprognostic (1.21e-2)" "unprognostic (7.20e-2)" "unprognostic (3.57e-2)" "unprognostic (1.28e-1)" "unprognostic (3.69e-2)" "unprognostic (1.25e-2)" 4.9 4.5 6.2 6.0 7.0 7.8 4.6 24.0 13.3 4.1 4.3 6.5 3.4 3.1 6.2 6.6 4.7 4.0 4.9 59.1 5.9 7.2 4.3 4.0 3.8 4.6 7.2 5.9 5.5 4.5 3.5 7.1 5.2 9.7 3.9 4.5 6.2 4.5 4.5 65.6 9.1 5.4 5.2 8.5 4.9 4.3 5.6 6.1 5.3 3.3 7.5 4.9 3.8 3.7 3.5 2.7 10.9 2.2 2.8 4.1 1.8 6.9 4.3 7.2 5.5 5.3 4.7 5.6 5.4 6.6 5.1 5.8 15.3 4.2 5.0 1.7 6.2 8.0 10.0 7.8 4.1 7.3 3.2 13.1 8.4 19.6 4.1 2.8 12.9 6.3 6.9 6.8 5.7 4.6 3.5 4.3 6.9 4.7 4.8 4.9 4.9 8.7 21.2 4.6 5.0 6.8 9.2 12.0 6.6 3.8 4.5 32.2 7.2 4.1 14.5 4.0 5.3 8.3 6.1 7.1 6.7 9.1 5.1 7.7 14.2 6.0 10.0 15.3 5.7 4.5 10.9 1.9 3.6 3.1 1.7 4.1 3.5 2.8 1.9 2.7 1.9 3.0 1.6 1.5 2.8 2.2 0.3 2.9 1.8 6.2 7.0 24.0 13.3 5.9 7.2 7.2 5.9 9.7 6.1 14.9 17.0 2.7 1.7 5.3 7.7 67.8 0.0 5.3 13.6 3.5 15.7 2.0 1.7 1.6 5.2 4.6 3.6 0.0 1.2 1.1 4.5 2.6 4.7 3.9 1.2 17.5 6.3 6.2 4.0 4.5 6.6 3.5 5.0 0.0 4.3 4.4 1.8 0.0 5.3 2.1 9.9 0.0 3.3 3.4 4.8 6.5 2.2 2.6 3.7 2.5 DDIAS "C11orf82, FLJ25416, FLJ38838, noxin" ENSG00000165490 "DNA damage induced apoptosis suppressor" Q8IXT1 11 82899975-82958277 "Predicted intracellular proteins" "Apoptosis, Cell cycle, Growth arrest" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 17.6;testis: 16.3" "Cell type enhanced" "Detected in some" 12 "Kupffer cells: 5.3;Spermatocytes: 12.0;Spermatogonia: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038540, HPA038541" Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA038540: AB_10672648, HPA038541: AB_2676071" "unprognostic (2.53e-1)" "unprognostic (2.27e-1)" "unprognostic (5.04e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (5.32e-2)" "unprognostic (3.86e-6)" "unprognostic (4.65e-3)" "unprognostic (1.01e-3)" "unprognostic (8.24e-3)" "unprognostic (2.04e-4)" "unprognostic (4.72e-2)" "unprognostic (1.11e-16)" "unprognostic (7.17e-3)" "unprognostic (9.59e-2)" "unprognostic (1.89e-1)" "unprognostic (9.13e-2)" 1.3 1.0 0.8 6.1 0.8 7.0 1.7 0.8 1.2 1.9 2.3 1.2 0.2 1.3 1.5 2.6 5.5 1.0 0.4 2.6 0.9 0.7 1.0 2.3 3.1 5.0 0.8 0.6 1.3 0.9 0.0 0.5 2.5 1.0 0.9 2.0 0.2 2.1 0.2 10.1 2.3 1.9 1.5 0.9 5.5 1.1 16.3 0.9 17.6 0.8 9.5 5.9 1.8 1.8 2.0 4.5 5.8 10.7 1.9 0.7 3.2 6.0 9.6 9.9 7.2 1.0 1.5 7.3 11.5 4.9 12.8 14.9 9.4 7.6 7.4 17.3 2.6 10.1 11.6 16.7 7.2 17.7 13.4 9.0 10.5 4.9 4.2 0.1 12.9 9.3 0.3 0.7 16.1 7.4 1.1 6.0 9.2 10.6 12.8 11.3 8.8 12.1 10.5 11.8 16.7 11.0 9.0 19.2 9.5 2.7 10.1 7.4 10.0 7.1 7.2 2.7 10.1 7.8 5.4 2.8 12.8 17.4 33.7 14.0 7.3 19.1 25.7 4.0 9.3 12.1 0.6 10.7 3.9 0.5 8.3 0.3 1.1 0.3 0.7 4.5 2.0 0.7 0.4 5.8 1.9 7.8 1.4 0.5 3.2 0.8 0.8 0.8 1.2 0.9 0.7 0.8 0.6 1.0 0.9 0.0 0.0 4.6 0.8 0.0 0.0 0.8 2.5 0.0 0.0 0.0 0.0 1.4 0.0 0.5 2.7 0.0 0.0 0.0 0.5 4.3 0.0 0.3 0.0 0.5 2.2 0.0 0.0 1.3 5.3 1.6 0.3 1.6 0.0 0.0 0.2 0.0 0.3 0.0 0.7 0.2 0.0 0.0 0.3 12.0 15.1 0.0 0.2 0.0 0.6 0.9 DDR2 "NTRKR3, TKT, TYRO10" ENSG00000162733 "Discoidin domain receptor tyrosine kinase 2" Q16832 1 162631373-162787400 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Osteogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Dwarfism, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 84.7;Leydig cells: 58.4;Peritubular cells: 83.1;Smooth muscle cells: 68.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.1;MAIT T-cell: 1.3" "Lineage enriched" "Detected in single" 5 "T-cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 61.7;ASC TERT1: 61.0;BJ hTERT+: 45.1;fHDF/TERT166: 32.3;HSkMC: 43.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA070112 Supported "Plasma membrane,Actin filaments" Yes No 850000 "Plasma membrane, Actin filaments" "HPA070112: AB_2686229" "unprognostic (4.12e-2)" "unprognostic (2.73e-1)" "unprognostic (6.97e-3)" "unprognostic (4.52e-2)" "unprognostic (1.17e-1)" "unprognostic (8.16e-2)" "unprognostic (1.81e-1)" "unprognostic (1.19e-1)" "unprognostic (6.62e-2)" "unprognostic (2.24e-2)" "unprognostic (1.00e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.73e-7)" "unprognostic (1.56e-3)" "unprognostic (8.26e-3)" "unprognostic (7.57e-2)" "unprognostic (4.10e-3)" 42.1 43.5 4.7 10.9 6.9 0.2 15.6 7.9 7.1 30.3 30.4 9.0 18.6 3.3 24.2 17.7 25.0 13.4 16.6 15.4 7.9 4.7 4.0 3.3 8.9 5.1 12.9 3.4 26.4 2.2 2.1 4.0 6.6 12.7 21.8 9.1 30.7 6.4 19.3 5.2 6.1 10.1 34.3 19.7 3.4 14.1 8.3 7.5 0.0 8.6 12.8 4.1 29.0 18.3 0.1 0.2 0.0 0.0 0.2 1.3 0.0 0.1 0.0 0.0 16.3 61.7 61.0 0.2 24.0 45.1 10.5 15.1 0.0 0.0 0.0 0.0 32.3 2.1 0.0 0.0 0.1 14.4 12.9 0.1 0.0 0.1 0.0 26.8 0.0 0.0 43.3 0.1 18.5 0.5 17.0 12.1 0.1 0.1 5.1 9.6 0.0 0.0 0.0 0.1 0.0 0.1 0.0 6.9 0.1 0.0 0.0 0.0 9.9 0.0 0.0 0.8 0.9 0.0 0.0 0.6 16.8 3.7 8.5 3.3 0.7 1.3 0.0 15.2 0.0 17.0 0.0 0.0 0.0 1.1 0.0 1.3 0.0 0.8 0.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 4.7 6.9 7.9 7.1 7.9 4.7 12.9 3.4 12.7 7.5 3.0 2.9 0.0 2.4 11.2 3.1 23.3 2.5 4.0 1.2 0.0 0.0 0.5 0.0 0.5 6.9 21.3 2.0 0.0 1.5 0.4 84.7 4.1 1.1 3.0 1.1 0.0 1.2 24.5 2.1 4.0 58.4 1.5 21.9 0.0 0.7 19.0 1.5 1.7 83.1 0.9 2.9 38.8 68.4 0.9 0.9 7.5 0.8 1.3 0.6 3.3 DDX58 "DKFZp434J1111, FLJ13599, RIG-I" ENSG00000107201 "DExD/H-box helicase 58" O95786 9 32455705-32526324 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Antiviral defense, Host-virus interaction, Immunity, Innate immunity" "Helicase, Hydrolase, RNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 45.5;BJ hTERT+ SV40 Large T+ RasG12V: 47.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB012643, HPA047193" Uncertain Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB012643: , HPA047193: AB_2679978" "unprognostic (1.10e-1)" "unprognostic (4.65e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (5.46e-4)" "unprognostic (2.45e-1)" "unprognostic (2.37e-1)" "unprognostic (8.15e-2)" "unprognostic (4.57e-2)" "unprognostic (2.82e-1)" "unprognostic (6.48e-3)" "unprognostic (1.00e-2)" "unprognostic (3.35e-1)" "prognostic unfavorable (4.66e-4)" "unprognostic (2.22e-2)" "unprognostic (3.68e-2)" "unprognostic (1.05e-2)" "unprognostic (1.26e-1)" 27.7 8.2 5.7 14.5 7.9 5.6 11.3 4.2 5.7 9.9 9.5 5.2 9.1 7.2 12.7 11.7 10.8 7.6 10.3 7.1 6.0 5.1 14.7 8.5 13.7 14.3 6.3 4.5 9.2 7.7 6.6 10.2 14.8 7.5 12.1 8.1 5.5 12.4 5.8 8.3 10.7 16.1 10.8 7.7 13.8 8.0 4.5 6.4 35.4 13.0 7.4 9.7 9.9 9.4 4.9 2.0 24.8 5.7 6.1 6.5 3.0 2.9 1.1 1.6 0.9 3.9 4.1 2.5 1.8 8.9 45.5 47.6 1.2 2.6 0.8 3.2 1.6 14.7 2.4 1.8 2.0 6.4 7.3 0.6 2.8 2.5 2.0 3.2 1.8 2.2 2.8 0.7 5.2 1.6 3.5 8.3 2.2 0.6 0.6 6.0 0.4 2.6 4.7 1.3 0.6 1.3 2.4 1.2 0.3 6.9 1.6 1.2 0.8 2.6 1.1 5.0 1.1 1.9 1.6 9.4 1.4 1.3 1.1 0.9 0.1 0.5 0.6 2.0 0.8 0.9 8.5 3.8 10.3 6.2 5.7 5.5 4.8 5.6 5.6 2.0 4.9 5.1 5.6 24.8 6.1 3.9 0.1 6.5 3.0 5.7 7.9 4.2 5.7 6.0 5.1 6.3 4.5 7.5 6.4 20.8 9.1 5.4 4.4 3.8 3.7 4.4 2.5 8.1 6.8 1.8 2.0 4.5 0.0 17.2 2.0 14.5 14.6 0.0 10.6 6.7 5.1 4.6 4.7 6.4 5.0 6.4 2.9 8.6 6.9 0.0 6.1 6.7 0.0 2.8 2.9 9.4 12.8 5.8 5.6 6.5 2.7 6.5 6.6 0.5 1.5 4.6 2.1 9.2 1.9 4.3 DDX60L FLJ31033 ENSG00000181381 "DExD/H-box 60 like" Q5H9U9 4 168356735-168537786 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase, RNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 22.5" "Group enriched" "Detected in all" 4 "granulocytes: 22.5;monocytes: 7.8" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 23.3" "HPA043211, HPA055501" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043211: AB_10794390, HPA055501: AB_2682838" "unprognostic (8.86e-2)" "unprognostic (2.77e-1)" "unprognostic (1.16e-1)" "unprognostic (2.45e-1)" "unprognostic (2.38e-1)" "unprognostic (3.20e-2)" "unprognostic (1.05e-1)" "unprognostic (7.94e-2)" "unprognostic (1.78e-1)" "unprognostic (4.19e-2)" "prognostic unfavorable (3.04e-5)" "unprognostic (1.70e-1)" "prognostic unfavorable (2.94e-4)" "unprognostic (1.13e-1)" "unprognostic (8.80e-2)" "unprognostic (8.93e-2)" "unprognostic (1.69e-1)" 12.7 5.0 2.8 13.1 3.1 33.0 9.9 1.4 3.2 7.2 8.4 3.2 2.7 6.0 9.2 7.9 3.8 6.9 6.7 6.0 2.4 2.4 4.5 6.0 25.8 17.7 3.8 1.4 7.3 5.1 4.4 5.2 32.6 3.4 5.0 6.5 6.8 7.0 5.7 3.3 4.3 14.0 5.3 4.2 11.9 9.5 2.7 3.1 25.3 5.8 3.5 8.1 4.9 6.8 1.6 2.4 22.5 7.8 1.7 3.7 1.6 6.1 3.6 1.4 0.6 3.7 10.8 7.0 6.2 13.1 23.3 16.2 0.0 14.5 0.1 0.3 6.3 12.7 2.4 0.6 3.7 6.8 3.5 0.5 13.6 4.0 0.3 4.5 5.5 3.4 3.0 1.1 8.4 0.7 4.9 16.4 3.1 0.2 0.1 14.9 0.1 4.9 3.5 0.3 0.6 3.1 2.7 3.2 0.0 2.2 3.6 0.2 1.9 11.0 1.3 6.2 0.2 1.0 7.8 17.5 1.2 8.2 2.9 2.1 5.9 0.9 0.0 4.1 16.5 1.8 1.6 4.0 3.5 2.7 6.3 3.7 0.9 2.7 2.7 2.4 1.6 2.2 2.3 22.5 1.7 7.8 0.0 3.6 1.6 2.8 3.1 1.4 3.2 2.4 2.4 3.8 1.4 3.4 3.1 8.9 7.9 0.0 2.1 0.9 1.3 8.1 5.1 12.0 3.4 3.5 21.6 4.5 0.0 6.8 10.7 13.1 11.6 0.0 8.7 29.4 7.0 2.6 8.1 5.4 22.5 0.0 0.0 9.2 23.2 3.6 3.1 29.7 0.0 26.2 13.2 3.2 17.0 14.0 3.9 3.3 16.8 6.5 3.3 0.5 1.3 2.0 5.9 8.7 3.8 1.4 DFFA "DFF-45, DFF1, DFF45, ICAD" ENSG00000160049 "DNA fragmentation factor subunit alpha" O00273 1 10456522-10472526 "Plasma proteins, Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002679, HPA018859, HPA019938, HPA025230" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB002679: , HPA018859: AB_1847622, HPA019938: AB_1847625, HPA025230: AB_1847623" "unprognostic (1.23e-1)" "unprognostic (2.63e-1)" "unprognostic (1.06e-1)" "unprognostic (3.59e-2)" "unprognostic (1.57e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (9.46e-4)" "unprognostic (1.55e-1)" "unprognostic (9.24e-3)" "unprognostic (3.57e-2)" "unprognostic (1.50e-1)" "unprognostic (1.91e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.21e-2)" "unprognostic (3.46e-2)" "unprognostic (3.89e-2)" "unprognostic (1.88e-1)" 17.8 19.9 22.9 15.6 23.0 7.9 20.9 20.4 20.7 16.6 15.1 22.5 19.1 16.5 18.4 14.4 24.2 18.6 15.3 17.2 20.7 19.9 23.7 18.9 15.5 15.6 26.4 18.9 22.5 19.8 25.7 17.2 27.2 26.1 17.0 17.3 15.0 16.3 18.4 16.8 14.8 14.7 22.4 24.1 14.8 16.8 13.4 21.9 16.7 18.0 13.0 21.4 18.7 26.1 14.1 10.7 7.2 9.9 14.1 14.4 8.9 14.6 14.6 12.6 14.3 10.7 10.2 6.1 20.9 13.5 21.8 16.3 34.9 19.4 31.3 13.5 17.6 12.2 12.1 24.3 24.8 22.1 12.4 16.8 15.6 15.2 13.9 17.5 19.0 10.4 12.7 12.5 34.4 27.8 12.0 16.6 15.7 27.8 7.1 15.4 18.6 18.7 8.6 11.0 11.1 17.1 16.1 15.1 15.8 19.6 11.3 14.9 14.5 19.5 17.0 23.0 11.4 10.9 6.6 17.3 10.3 14.0 18.8 13.8 8.8 12.3 45.6 10.9 18.1 15.5 1.3 9.9 7.2 14.4 8.0 10.9 14.1 9.7 12.4 9.2 13.7 10.2 12.3 1.5 14.1 9.7 10.7 13.5 8.9 22.9 23.0 20.4 20.7 20.7 19.9 26.4 18.9 26.1 21.9 41.7 29.3 39.4 29.8 30.6 18.3 22.1 28.1 32.1 35.2 17.4 102.1 83.5 31.5 40.0 25.0 27.1 15.1 0.0 33.8 52.0 19.4 20.0 24.3 27.7 36.5 19.1 32.8 30.7 19.8 58.1 27.9 18.5 10.1 44.1 12.4 21.1 39.9 7.0 30.4 45.1 30.9 19.4 20.0 31.2 30.4 35.5 55.5 24.9 25.7 31.2 DGKG DAGK3 ENSG00000058866 "Diacylglycerol kinase gamma" P49619 3 186105668-186362237 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 53.4" "Group enriched" "Detected in many" 6 "Cardiomyocytes: 16.2;Ito cells: 27.6;Muller glia cells: 7.5;Sertoli cells: 12.9;Smooth muscle cells: 16.7" "Cancer enhanced" "Detected in some" "glioma: 2.8" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 4.2;eosinophil: 2.4;intermediate monocyte: 2.4;myeloid DC: 2.9;neutrophil: 5.3;non-classical monocyte: 2.8" "Group enriched" "Detected in many" 6 "dendritic cells: 2.9;granulocytes: 5.3;monocytes: 4.2" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HL-60: 6.4;U-266/84: 7.7;U-87 MG: 12.8;U-937: 6.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036577 Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036577: AB_10672358" "unprognostic (2.23e-1)" "unprognostic (1.97e-1)" "unprognostic (1.56e-2)" "unprognostic (3.24e-5)" "unprognostic (2.70e-1)" "unprognostic (6.09e-4)" "unprognostic (1.21e-3)" "unprognostic (3.80e-2)" "unprognostic (5.88e-2)" "unprognostic (1.50e-1)" "unprognostic (1.94e-1)" "unprognostic (5.09e-2)" "unprognostic (8.05e-7)" "unprognostic (3.47e-3)" "unprognostic (7.19e-2)" "unprognostic (1.41e-1)" "unprognostic (9.16e-3)" 3.1 6.9 13.4 3.1 7.1 14.5 1.9 53.4 23.1 2.7 3.5 6.2 1.1 3.0 1.9 14.6 8.5 7.7 2.2 15.0 15.3 7.4 3.1 2.1 4.3 2.1 7.4 11.3 2.0 1.6 4.7 7.5 13.5 25.2 3.1 2.1 7.8 1.9 4.0 2.4 1.4 2.7 5.3 5.6 2.0 3.3 1.2 7.1 0.0 2.5 0.0 2.1 4.8 2.4 0.6 2.9 5.3 4.2 0.0 0.0 1.3 2.7 4.2 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.4 0.0 2.9 0.2 0.0 0.0 0.0 20.2 0.0 2.7 0.0 2.9 0.0 6.4 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.4 0.3 0.1 0.1 2.2 0.4 0.0 1.2 1.4 0.0 2.3 0.0 0.0 0.5 0.0 0.8 0.0 1.7 0.0 0.1 4.2 0.0 0.0 0.7 2.1 2.4 0.0 7.7 0.0 12.8 6.0 2.3 0.0 4.2 2.4 0.0 2.4 0.0 0.6 0.0 0.0 2.9 0.3 0.0 0.0 5.3 0.0 2.8 0.5 0.0 1.3 13.4 7.1 53.4 14.7 15.3 7.4 7.4 11.3 25.2 7.1 0.0 1.7 1.5 0.1 0.3 0.0 16.2 0.0 0.0 0.0 1.8 0.0 0.0 0.0 1.2 2.4 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.0 0.0 1.9 1.6 0.0 27.6 2.7 2.0 1.7 2.3 0.0 1.0 0.0 7.5 0.7 0.0 0.4 0.8 0.0 12.9 16.7 0.0 0.0 0.4 0.1 0.0 0.0 0.4 DGKH DGKeta ENSG00000102780 "Diacylglycerol kinase eta" Q86XP1 13 42040036-42256578 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Urothelial cells: 105.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA039533, HPA040355, HPA061538" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA039533: AB_10795145, HPA040355: AB_10796452, HPA061538: " "unprognostic (2.80e-1)" "unprognostic (7.03e-2)" "unprognostic (1.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.55e-3)" "unprognostic (7.62e-2)" "unprognostic (1.04e-2)" "unprognostic (9.60e-2)" "unprognostic (7.00e-3)" "unprognostic (4.37e-2)" "unprognostic (1.86e-1)" "unprognostic (2.41e-1)" "unprognostic (3.43e-3)" "unprognostic (1.03e-1)" "unprognostic (1.67e-1)" "unprognostic (4.93e-2)" "unprognostic (1.43e-2)" 4.9 2.8 3.3 4.9 12.7 2.3 8.3 9.6 6.2 5.2 6.4 3.4 7.9 3.1 9.4 14.0 5.2 5.9 6.8 10.2 9.0 2.7 6.0 6.8 9.5 4.0 3.5 4.0 4.3 4.2 1.4 3.5 8.9 3.6 4.6 6.9 5.5 7.7 4.8 5.8 6.2 5.1 8.3 3.5 6.1 4.0 7.0 4.3 2.2 4.3 2.0 2.9 8.1 6.0 1.4 1.5 4.3 1.3 0.7 1.7 0.2 4.9 5.8 4.8 3.7 1.8 4.1 0.5 3.2 2.5 2.1 2.6 0.5 4.3 3.9 3.9 3.3 7.4 11.0 4.1 7.1 3.2 3.3 11.5 7.0 3.1 0.4 2.3 2.9 2.0 1.5 7.2 4.0 16.4 3.1 9.4 5.1 2.8 2.7 3.6 4.7 3.0 1.6 1.9 4.8 4.0 4.7 3.9 2.7 7.0 15.0 2.7 2.5 2.9 3.7 2.7 1.9 3.4 8.2 9.1 4.0 3.6 4.3 4.3 1.4 1.3 4.5 2.2 2.7 2.8 2.4 1.3 0.6 1.1 0.9 1.2 0.8 1.7 1.7 0.3 1.4 1.0 1.6 4.3 0.7 0.7 1.5 1.1 0.2 3.3 12.7 9.6 6.2 9.0 2.7 3.5 4.0 3.6 4.3 20.8 28.6 1.9 54.1 54.8 48.5 7.1 25.5 69.6 39.8 10.4 3.9 3.3 1.7 10.6 21.9 28.0 13.6 0.0 6.3 1.8 13.3 64.9 7.0 2.6 5.8 1.6 45.5 27.0 7.5 14.9 3.1 16.5 8.5 9.0 22.6 15.5 17.7 14.4 8.5 7.3 2.2 25.8 35.8 2.3 2.6 29.0 2.4 5.1 18.0 105.9 DIAPH3 "AN, AUNA1, DRF3, FLJ34705, NSDAN" ENSG00000139734 "Diaphanous related formin 3" Q9NSV4 13 59665583-60163987 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Deafness, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 35.2;testis: 19.6" "Cell type enriched" "Detected in many" 6 "Early spermatids: 290.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 4 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 4 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HBF TERT88: 39.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA032151 Supported "Plasma membrane,Microtubules" NA Yes "Plasma membrane, Microtubules" "HPA032151: AB_2674181" "unprognostic (3.78e-2)" "unprognostic (1.28e-2)" "prognostic favorable (9.04e-4)" "prognostic unfavorable (4.18e-4)" "unprognostic (2.78e-1)" "unprognostic (4.69e-2)" "unprognostic (1.27e-4)" "prognostic unfavorable (3.72e-4)" "unprognostic (1.74e-2)" "unprognostic (2.19e-1)" "unprognostic (5.22e-5)" "unprognostic (3.59e-3)" "unprognostic (5.31e-5)" "unprognostic (4.30e-2)" "unprognostic (2.37e-1)" "unprognostic (4.07e-1)" "unprognostic (2.74e-3)" 1.8 0.4 1.7 11.5 1.8 6.7 1.6 0.1 1.4 0.9 4.7 0.2 0.4 2.0 1.4 1.1 7.1 0.3 2.5 1.1 1.0 1.6 1.7 0.4 4.1 2.9 1.0 0.0 0.4 0.4 0.5 0.2 9.4 0.2 0.4 2.3 0.0 1.6 0.0 0.1 1.8 4.3 2.7 0.3 2.5 3.1 19.6 0.0 35.2 0.2 5.3 5.9 0.8 1.5 0.4 2.0 0.4 0.2 0.0 0.5 0.2 18.3 6.1 6.4 3.6 1.1 2.9 10.8 25.7 11.4 26.0 22.7 16.2 12.5 6.1 2.1 13.1 6.8 12.6 10.3 10.1 39.7 6.9 7.1 8.8 15.7 3.6 1.7 11.9 7.0 1.1 0.2 15.8 10.7 6.6 11.6 5.6 6.7 8.8 24.7 2.6 10.6 5.1 5.9 8.7 3.5 7.2 15.7 5.0 8.5 3.8 3.3 5.8 13.1 9.1 3.9 14.3 6.6 6.5 11.5 16.5 10.6 5.5 21.2 5.9 6.5 9.6 4.4 5.9 12.4 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 2.0 0.5 0.2 1.7 1.8 0.1 1.4 1.0 1.6 1.0 0.0 0.2 0.0 50.6 4.3 0.8 0.3 3.3 0.0 0.4 2.5 0.0 2.3 0.0 0.0 8.7 5.0 0.6 290.3 0.7 1.3 23.3 3.7 26.7 3.3 0.3 0.0 0.4 5.2 0.0 0.0 2.5 0.6 34.3 0.6 1.2 0.0 0.0 1.1 2.3 1.3 0.0 0.0 3.1 0.0 0.0 0.0 34.2 17.3 1.0 6.1 0.9 1.7 0.6 DLG1 "dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97" ENSG00000075711 "Discs large MAGUK scaffold protein 1" Q12959 3 197042560-197299300 "Predicted intracellular proteins, Transporters" "Host-virus interaction" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016307, HPA069593" Supported Uncertain "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "CAB016307: AB_2092015, HPA069593: " "unprognostic (2.04e-2)" "unprognostic (1.37e-1)" "unprognostic (7.79e-2)" "unprognostic (4.56e-3)" "unprognostic (3.54e-2)" "unprognostic (8.56e-2)" "unprognostic (8.90e-3)" "unprognostic (2.97e-1)" "unprognostic (5.98e-2)" "unprognostic (2.33e-1)" "unprognostic (2.41e-2)" "unprognostic (3.40e-2)" "unprognostic (1.70e-3)" "unprognostic (3.56e-1)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (3.07e-1)" 12.3 12.6 30.0 10.2 34.5 9.6 14.2 42.1 37.7 19.9 17.8 32.3 17.0 16.1 15.4 8.8 30.2 12.7 12.9 13.8 26.9 19.2 21.0 18.6 12.9 10.6 32.9 27.3 18.7 11.9 28.2 19.8 15.1 29.1 12.1 20.2 10.4 16.5 14.7 18.7 13.7 18.4 15.3 32.2 8.8 16.7 11.1 39.4 14.7 34.6 13.9 14.8 13.8 15.7 3.7 2.9 2.9 1.0 1.4 3.9 1.5 45.1 7.1 14.2 25.8 11.7 11.0 14.5 16.1 14.8 16.2 19.1 20.9 19.5 13.1 46.3 16.0 32.9 29.7 13.0 25.1 31.3 3.5 8.6 11.5 11.0 15.2 11.7 11.4 11.5 9.9 13.7 14.9 32.7 54.8 20.3 10.9 9.3 16.1 39.0 17.5 17.0 4.4 11.1 25.5 13.8 9.1 17.2 9.5 16.9 19.1 7.0 11.8 25.3 16.8 18.4 16.5 38.4 8.8 19.3 44.0 11.6 12.1 27.2 25.4 18.3 17.1 16.2 17.5 13.8 0.0 0.9 2.9 1.5 1.0 3.9 3.7 2.9 2.7 2.2 2.0 3.0 3.1 1.1 1.4 0.4 2.9 2.9 1.5 30.0 34.5 42.1 37.7 26.9 19.2 32.9 27.3 29.1 39.4 23.8 18.8 19.3 47.6 47.4 27.5 25.2 22.9 28.1 18.2 47.1 90.3 41.8 5.0 19.0 10.7 25.6 44.1 0.0 17.6 17.3 28.1 48.9 11.5 47.8 12.9 35.0 27.7 28.3 20.6 14.9 26.4 15.8 35.4 9.0 32.3 90.6 23.3 43.2 24.1 15.4 91.0 12.9 20.8 28.6 35.1 61.9 20.9 24.5 33.3 110.2 DLG2 "chapsyn-110, PPP1R58, PSD-93, PSD93" ENSG00000150672 "Discs large MAGUK scaffold protein 2" Q15700 11 83455012-85627922 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 223.8;Cone photoreceptor cells: 259.2" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 7.5;CACO-2: 4.7;NTERA-2: 5.2;SCLC-21H: 5.2;SH-SY5Y: 7.8;SK-BR-3: 4.7;SuSa: 6.6;T-47d: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA021307, HPA023896, CAB072341" Enhanced Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB072341: , HPA021307: AB_1846625, HPA023896: AB_2671353" "unprognostic (2.61e-3)" "unprognostic (2.81e-2)" "unprognostic (4.05e-2)" "unprognostic (9.03e-2)" "unprognostic (3.25e-1)" "unprognostic (1.09e-1)" "unprognostic (9.44e-3)" "unprognostic (7.78e-2)" "unprognostic (4.32e-1)" "unprognostic (4.61e-2)" "unprognostic (9.28e-3)" "unprognostic (4.84e-1)" "unprognostic (7.66e-6)" "unprognostic (2.92e-2)" "unprognostic (2.41e-1)" "unprognostic (6.52e-2)" "unprognostic (8.89e-2)" 1.4 11.0 20.0 1.4 30.7 0.7 2.5 9.3 44.7 2.4 1.7 39.5 0.6 1.5 3.3 4.4 7.8 6.0 2.3 2.8 19.9 9.9 3.7 2.8 1.9 1.3 28.7 21.2 6.2 3.3 14.6 7.9 2.7 25.7 4.3 1.5 2.9 3.1 5.4 1.2 19.5 1.5 2.6 19.7 2.6 1.5 6.6 37.3 0.0 15.6 0.0 2.9 1.5 2.1 1.3 0.5 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.1 7.5 0.0 0.0 0.0 0.0 4.7 0.1 0.0 0.1 0.0 0.1 0.2 1.4 0.0 0.0 0.0 0.1 0.0 4.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.4 0.0 0.1 5.2 0.0 0.0 0.0 0.7 0.4 0.0 0.0 5.2 7.8 0.0 4.7 0.0 6.6 19.3 0.0 0.0 0.3 0.9 0.2 0.0 0.0 0.0 3.6 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.2 0.3 0.0 0.0 0.0 0.5 0.0 0.2 20.0 30.7 9.3 34.9 19.9 9.9 28.7 21.2 25.7 37.3 3.0 7.2 0.0 3.1 3.0 223.8 7.2 0.0 1.4 3.4 7.0 259.2 6.2 8.3 0.7 16.5 2.8 0.9 0.0 0.4 0.4 3.3 2.5 0.0 3.8 3.0 22.3 4.1 0.6 0.3 12.1 7.2 0.0 1.7 1.0 0.1 17.1 0.3 0.0 6.0 2.3 52.8 6.5 1.9 8.1 3.3 7.4 1.7 1.0 0.4 0.9 DLL3 SCDO1 ENSG00000090932 "Delta like canonical Notch ligand 3" Q9NYJ7 19 39498895-39508481 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway" "Developmental protein" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "brain: 38.5" "Cell type enriched" "Detected in some" 6 "Spermatogonia: 37.2" "Group enriched" "Detected in many" 11 "glioma: 29.2;melanoma: 15.5;testis cancer: 8.0" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 5.4;naive CD8 T-cell: 3.3" "Group enriched" "Detected in many" 13 "B-cells: 5.4;T-cells: 3.3" "Cell line enriched" "Detected in some" 5 "SK-MEL-30: 42.1" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA056533 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056533: " "unprognostic (2.52e-1)" "unprognostic (3.81e-1)" "unprognostic (3.13e-2)" "prognostic unfavorable (2.94e-4)" "unprognostic (9.85e-2)" "unprognostic (1.41e-2)" "unprognostic (1.65e-3)" "unprognostic (1.85e-1)" "unprognostic (4.82e-2)" "unprognostic (6.58e-2)" "unprognostic (1.06e-2)" "unprognostic (4.20e-2)" "unprognostic (3.82e-4)" "unprognostic (4.94e-2)" "unprognostic (5.13e-2)" "unprognostic (4.15e-2)" "unprognostic (2.97e-1)" 0.6 0.6 8.9 0.7 10.1 0.6 0.6 1.4 38.5 0.5 0.6 10.3 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.6 6.5 6.8 0.5 0.6 0.6 0.7 4.5 1.9 0.6 0.5 0.6 3.2 0.5 4.3 0.6 0.5 0.0 0.6 0.5 0.5 0.6 0.6 0.5 3.6 0.6 0.6 1.2 2.3 0.0 0.7 0.0 0.6 0.6 0.0 5.4 0.3 0.0 0.0 0.0 3.3 0.4 0.0 2.0 0.4 1.0 0.0 0.0 0.3 0.5 0.0 0.3 0.1 0.3 0.4 0.0 2.0 0.0 0.8 0.0 1.2 0.5 0.1 0.6 3.1 0.1 0.0 0.2 0.1 0.5 2.4 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.5 0.0 0.2 0.0 0.1 0.0 0.4 0.0 3.2 0.3 0.1 0.1 0.1 0.1 7.4 7.6 1.5 0.0 42.1 0.1 0.0 0.1 0.0 0.0 1.4 0.1 0.5 0.7 0.0 0.4 0.0 0.2 1.2 0.0 0.0 0.0 0.9 0.0 0.4 5.4 0.2 1.3 0.3 1.2 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.4 8.9 10.1 1.4 4.8 6.5 6.8 4.5 1.9 4.3 2.3 0.0 0.0 0.0 0.2 0.2 0.2 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 0.0 0.0 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.2 0.0 2.9 0.0 0.0 1.6 1.1 0.0 1.7 0.0 0.0 0.5 0.2 0.0 1.4 0.0 0.6 6.5 0.0 5.4 37.2 0.1 0.2 0.0 0.0 0.0 DMWD "D19S593E, DMR-N9, gene59" ENSG00000185800 "DM1 locus, WD repeat containing" Q09019 19 45782947-45792802 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA068172, HPA069843" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA068172: AB_2685964, HPA069843: AB_2686212" "unprognostic (6.49e-2)" "unprognostic (3.35e-1)" "unprognostic (1.03e-2)" "unprognostic (1.65e-3)" "unprognostic (3.10e-2)" "unprognostic (2.39e-1)" "prognostic unfavorable (1.47e-4)" "unprognostic (5.11e-3)" "unprognostic (7.61e-2)" "unprognostic (7.26e-3)" "unprognostic (1.31e-2)" "unprognostic (2.16e-1)" "unprognostic (1.81e-1)" "unprognostic (1.85e-1)" "unprognostic (1.97e-1)" "unprognostic (1.18e-2)" "unprognostic (4.59e-2)" 20.1 15.5 24.2 12.9 29.4 7.3 11.0 17.1 34.2 12.1 17.7 19.2 6.6 10.8 21.7 9.0 13.2 14.5 16.6 29.0 20.2 16.2 9.6 5.8 13.6 11.5 17.8 19.1 17.0 13.4 13.7 20.3 16.7 18.8 14.7 8.7 14.8 13.6 14.9 31.8 13.1 10.4 16.9 9.9 15.0 13.1 17.8 16.7 11.2 11.8 6.7 8.5 14.6 11.8 4.3 0.7 1.8 1.9 4.8 3.8 0.9 17.0 19.1 17.3 12.0 10.6 13.5 13.3 15.1 10.6 13.4 12.2 11.3 9.6 7.2 8.8 16.9 16.4 13.0 9.0 7.4 7.0 21.2 16.9 6.2 19.0 9.8 13.2 0.7 10.1 12.6 9.2 12.5 17.9 15.4 11.5 4.6 15.1 16.4 10.5 14.1 8.6 4.9 7.8 11.3 12.5 8.9 6.2 7.9 8.3 16.4 17.3 19.3 16.1 12.6 10.7 8.0 10.9 4.2 24.1 15.5 15.4 10.3 22.3 23.6 14.5 8.2 16.2 1.1 18.0 1.3 0.7 0.5 3.8 1.6 3.0 1.7 3.2 3.0 0.7 4.3 1.2 2.4 1.8 4.8 1.9 0.6 1.9 0.9 24.2 29.4 17.1 34.2 20.2 16.2 17.8 19.1 18.8 16.7 6.0 6.6 1.5 12.2 7.4 31.0 23.8 10.2 4.0 3.4 8.7 56.9 6.0 5.0 6.2 15.1 13.0 8.6 23.3 9.1 8.1 11.8 9.7 11.5 5.4 1.6 49.3 25.2 17.8 4.3 46.1 15.8 1.5 5.0 0.0 8.7 25.5 10.8 5.8 15.9 6.2 37.8 12.9 12.3 8.6 12.3 6.0 4.6 5.0 6.9 9.5 DNAAF4 "CILD25, DYX1C1, EKN1, FLJ37882" ENSG00000256061 "Dynein axonemal assembly factor 4" Q8WXU2 15 55410525-55508234 "Disease related genes, Predicted intracellular proteins" Neurogenesis "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 26.6" "Cell type enriched" "Detected in some" 7 "Ciliated cells: 187.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 17.1" "Low region specificity" "Detected in all" HPA051048 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051048: AB_2681325" "unprognostic (5.97e-4)" "unprognostic (3.60e-2)" "unprognostic (1.69e-1)" "unprognostic (7.45e-4)" "unprognostic (1.74e-1)" "unprognostic (5.30e-3)" "unprognostic (4.05e-2)" "unprognostic (3.08e-2)" "unprognostic (8.24e-2)" "unprognostic (2.91e-1)" "unprognostic (9.47e-2)" "unprognostic (1.75e-1)" "unprognostic (5.29e-2)" "unprognostic (3.85e-2)" "unprognostic (3.06e-2)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" 1.8 3.0 11.4 1.8 14.7 1.6 4.9 1.8 8.0 4.3 2.1 3.2 5.9 1.1 7.0 15.3 1.8 15.7 3.4 1.6 9.2 7.8 7.2 1.0 6.2 1.5 4.2 8.9 4.8 3.5 13.6 26.6 1.2 9.1 3.2 1.5 6.9 2.4 3.2 1.3 2.4 1.3 3.1 3.7 2.0 1.7 14.6 4.5 0.1 14.3 0.9 1.3 2.8 2.0 2.9 4.2 4.3 1.8 0.7 1.1 0.4 6.5 4.4 4.7 10.1 1.9 3.3 1.5 0.9 2.4 3.1 3.6 0.9 2.6 0.5 4.2 2.0 5.0 1.8 1.8 2.6 3.7 2.0 2.1 2.3 2.8 1.5 1.8 5.0 4.1 2.0 5.5 7.5 2.8 4.9 7.0 2.1 0.7 0.3 4.6 2.3 0.9 4.3 2.6 10.1 3.6 0.8 2.3 0.8 17.1 2.3 4.8 10.5 4.3 1.1 5.8 4.4 6.0 1.2 2.3 5.0 2.5 4.1 4.8 1.8 4.8 1.4 8.2 1.0 1.1 0.0 1.8 1.3 0.6 1.2 0.4 2.9 0.9 0.7 1.2 2.6 1.1 0.8 4.3 0.7 1.2 4.2 0.9 0.4 11.4 14.7 1.8 8.0 9.2 7.8 4.2 8.9 9.1 4.5 11.9 15.9 0.0 0.0 0.0 0.0 0.0 0.0 187.4 28.4 12.2 0.0 1.6 5.0 11.3 0.0 0.0 0.0 0.0 4.4 1.1 0.0 0.0 2.3 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 3.9 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 DNAJA4 PRO1472 ENSG00000140403 "DnaJ heat shock protein family (Hsp40) member A4" Q8WW22 15 78264086-78282196 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 63.2;skeletal muscle: 69.0" "Group enriched" "Detected in many" 5 "Early spermatids: 661.6;Late spermatids: 1220.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 17.7;HeLa: 18.6;RT4: 34.6;SCLC-21H: 22.3;SiHa: 17.4;THP-1: 16.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004646, HPA041790" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004646: AB_426011, HPA041790: AB_2677674" "unprognostic (8.41e-2)" "unprognostic (2.48e-1)" "unprognostic (3.00e-2)" "unprognostic (8.20e-3)" "unprognostic (1.14e-3)" "unprognostic (1.99e-1)" "unprognostic (2.28e-2)" "unprognostic (2.46e-1)" "unprognostic (5.86e-2)" "unprognostic (7.78e-2)" "unprognostic (2.31e-2)" "unprognostic (1.28e-1)" "prognostic favorable (1.08e-7)" "unprognostic (1.89e-1)" "unprognostic (2.84e-1)" "unprognostic (9.01e-2)" "unprognostic (2.93e-2)" 7.3 10.1 29.6 7.6 33.7 28.6 7.6 20.1 25.8 8.6 8.7 10.5 10.4 7.8 5.1 25.3 9.1 21.7 6.6 63.2 22.3 33.8 7.7 1.9 7.0 6.0 26.0 28.1 3.6 3.2 9.5 11.9 5.5 29.2 15.4 10.6 7.2 6.8 9.6 69.0 15.5 9.0 10.7 16.0 5.1 10.8 26.8 14.9 2.0 6.3 15.2 6.9 12.6 62.3 1.9 1.1 2.7 1.0 0.4 4.7 1.6 13.3 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.5 0.2 0.0 17.7 0.0 0.1 1.3 0.0 12.8 0.0 0.0 0.0 0.0 0.0 7.9 18.6 0.0 4.0 0.0 8.6 1.5 1.7 1.0 0.0 0.0 2.7 0.0 0.0 0.0 0.1 13.4 0.0 0.0 0.0 5.8 0.1 0.0 0.0 0.0 0.0 34.6 22.3 0.0 17.4 3.5 1.5 1.0 13.4 16.0 0.2 0.0 3.7 1.6 0.1 0.2 0.9 0.0 0.0 1.7 0.0 0.0 0.8 2.7 1.8 0.9 2.6 1.9 2.5 2.5 1.1 0.4 4.7 3.9 0.0 0.4 1.0 0.6 1.4 1.6 29.6 33.7 20.1 25.8 22.3 33.8 26.0 28.1 29.2 14.9 6.0 4.5 10.8 119.2 25.5 16.8 36.3 2.5 131.2 36.4 7.0 76.6 1.2 1.7 1.2 661.6 9.0 34.2 93.5 2.1 3.7 10.3 173.0 37.9 0.2 13.8 6.4 96.0 7.4 7.3 1220.8 9.5 17.6 49.0 1.8 23.3 9.8 3.7 22.8 10.6 5.0 21.2 6.5 7.7 27.5 21.6 40.8 5.7 8.5 16.9 141.9 DNAJC9 "JDD1, SB73" ENSG00000213551 "DnaJ heat shock protein family (Hsp40) member C9" Q8WXX5 10 73183362-73248862 "Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 24.2" "Cell type enhanced" "Detected in all" 5 "Erythroid cells: 140.2" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035215, HPA035216" Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA035215: AB_10603663, HPA035216: AB_2674522" "unprognostic (4.18e-2)" "unprognostic (1.61e-2)" "unprognostic (7.63e-2)" "unprognostic (2.67e-3)" "unprognostic (3.45e-1)" "unprognostic (6.83e-3)" "unprognostic (2.43e-3)" "prognostic unfavorable (3.26e-4)" "unprognostic (6.20e-2)" "unprognostic (1.66e-1)" "unprognostic (3.91e-1)" "prognostic unfavorable (7.07e-5)" "unprognostic (5.61e-2)" "unprognostic (3.08e-3)" "unprognostic (6.49e-2)" "unprognostic (3.38e-1)" "unprognostic (1.56e-1)" 3.1 4.0 4.0 5.0 4.3 24.2 4.6 12.9 5.8 3.0 4.6 4.2 4.0 3.9 6.8 2.9 1.7 2.7 4.2 5.2 2.8 3.5 2.9 7.7 3.5 5.2 2.6 3.6 4.3 5.4 3.6 5.8 3.6 3.9 3.4 5.3 4.1 3.8 3.1 5.9 3.4 4.3 2.9 9.9 3.1 4.4 15.6 9.4 13.2 4.9 10.6 16.5 8.8 26.5 16.4 21.3 17.6 5.1 5.0 9.4 21.6 12.8 21.7 22.7 28.1 18.7 18.4 7.1 9.5 9.3 18.1 21.3 14.3 24.6 21.3 14.7 39.1 16.8 18.6 3.5 34.3 15.8 4.0 7.9 22.8 20.0 10.6 14.3 23.4 34.9 21.4 17.1 24.6 33.2 26.0 7.8 12.6 46.0 24.7 18.6 10.1 10.8 12.9 10.2 17.2 15.8 26.0 11.3 10.2 13.6 16.1 10.4 14.5 25.7 15.5 32.9 10.0 15.1 29.6 14.6 34.2 9.3 7.3 1.8 13.2 13.0 4.9 14.4 15.6 15.9 14.1 3.0 12.7 15.6 13.8 2.1 10.6 4.7 9.4 16.5 8.8 8.9 10.5 40.2 29.5 42.4 24.8 2.4 25.5 29.4 27.3 8.7 7.9 69.3 18.3 29.2 74.3 18.0 13.1 140.2 27.2 89.2 17.4 20.5 39.5 8.2 51.9 14.3 11.5 9.8 11.3 30.7 13.0 16.8 30.4 31.5 17.2 26.4 30.7 17.3 19.1 11.3 38.3 25.8 22.7 21.1 59.5 38.0 48.5 45.3 32.2 33.3 DPYSL2 "CRMP2, DHPRP2, DRP-2, DRP2" ENSG00000092964 "Dihydropyrimidinase like 2" Q16555 8 26514022-26658178 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 137.0" "Cell type enhanced" "Detected in many" 5 "Ito cells: 240.0" "Cancer enhanced" "Detected in all" "glioma: 89.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 24.0;intermediate monocyte: 26.7;myeloid DC: 25.5;non-classical monocyte: 16.2;plasmacytoid DC: 15.1" "Group enriched" "Detected in many" 6 "dendritic cells: 25.5;monocytes: 26.7" "Cell line enhanced" "Detected in many" "ASC diff: 61.4;Karpas-707: 63.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002381, CAB018719" Supported Supported "Plasma membrane,Cytosol" NA NA 3900000 Cytosol "Plasma membrane" "CAB018719: AB_2085366, HPA002381: AB_1847244" "unprognostic (2.88e-2)" "unprognostic (1.01e-2)" "unprognostic (9.51e-2)" "unprognostic (3.16e-3)" "unprognostic (8.23e-2)" "unprognostic (1.68e-2)" "unprognostic (1.51e-1)" "unprognostic (9.95e-3)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" "unprognostic (1.79e-2)" "unprognostic (4.13e-2)" "unprognostic (5.58e-2)" "unprognostic (9.32e-3)" "unprognostic (1.23e-1)" "unprognostic (3.27e-2)" "prognostic unfavorable (5.41e-5)" 31.6 21.7 53.5 13.4 48.1 3.0 21.3 51.8 137.0 14.6 12.2 54.7 3.9 7.1 14.2 8.1 12.0 14.7 18.0 27.2 52.9 48.6 12.1 11.2 45.3 9.9 56.5 45.4 25.8 7.5 5.1 7.2 25.6 46.9 9.8 12.4 8.2 6.5 10.3 10.9 10.2 9.7 19.9 70.1 19.0 8.5 7.5 44.9 5.8 7.7 5.2 12.3 14.0 13.1 3.2 25.5 0.6 26.7 4.0 4.6 8.8 4.7 23.1 22.8 12.1 61.4 28.3 2.2 9.3 21.8 8.9 11.6 9.0 6.9 7.1 6.8 29.2 18.0 4.6 23.9 9.3 8.5 16.1 2.0 8.1 8.8 12.6 39.4 1.7 3.3 35.1 13.5 24.4 14.2 28.8 17.9 5.6 0.2 63.2 8.9 3.0 13.7 1.7 17.8 15.3 4.5 18.3 9.1 4.7 15.0 5.5 10.4 21.9 11.3 0.1 6.1 15.7 1.7 3.2 32.2 20.3 8.2 16.8 4.0 8.9 9.1 5.6 29.4 10.6 10.3 0.4 24.0 0.2 3.5 26.7 1.2 3.2 3.1 2.3 25.5 1.7 1.6 2.1 0.6 4.0 16.2 15.1 4.6 8.8 53.5 48.1 51.8 68.4 52.9 48.6 56.5 45.4 46.9 44.9 122.1 67.9 17.3 0.8 35.8 104.6 86.8 104.4 17.4 31.8 21.0 29.5 12.9 3.3 17.3 2.6 134.9 3.1 0.0 1.6 9.2 59.6 1.1 19.7 13.4 46.2 133.5 58.3 240.0 207.1 6.4 100.9 92.1 114.7 101.8 73.9 141.1 9.7 3.6 84.1 17.3 36.8 135.8 60.8 3.1 8.5 29.5 3.8 8.7 6.6 1.1 DQX1 FLJ23757 ENSG00000144045 "DEAQ-box RNA dependent ATPase 1" Q8TE96 2 74518131-74526336 "Enzymes, Predicted intracellular proteins" "Helicase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "intestine: 41.0" "Cell type enhanced" "Detected in some" 15 "Enterocytes: 21.9;Mucus-secreting cells: 12.7;Paneth cells: 11.8;Undifferentiated cells: 10.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HBEC3-KT: 5.9;Hep G2: 16.6;hTCEpi: 6.1;OE19: 14.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA039158 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039158: AB_10960125" "unprognostic (2.17e-1)" "unprognostic (1.43e-1)" "unprognostic (1.20e-2)" "unprognostic (9.95e-2)" "unprognostic (2.20e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-2)" "unprognostic (3.93e-1)" "unprognostic (4.54e-2)" "unprognostic (1.68e-1)" "unprognostic (7.67e-2)" "unprognostic (2.21e-2)" "unprognostic (0.00e+0)" "unprognostic (1.13e-2)" "unprognostic (1.36e-1)" "unprognostic (1.29e-1)" "unprognostic (6.16e-3)" 0.1 0.0 0.1 2.1 0.2 0.0 0.1 0.1 0.1 0.8 13.3 0.2 0.1 14.7 0.1 0.1 3.7 0.2 3.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 1.0 0.1 0.2 5.1 0.1 0.6 0.1 0.1 1.5 41.0 0.3 0.1 0.2 2.9 0.1 0.1 0.2 0.1 0.7 1.5 1.1 1.4 0.7 1.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.5 0.0 0.3 0.0 0.0 0.0 0.6 0.1 5.9 0.0 0.0 0.3 0.4 0.1 16.6 0.0 0.2 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.2 0.0 0.1 0.3 14.1 0.0 0.1 0.1 0.1 0.0 1.1 0.0 0.1 0.0 2.3 0.0 1.1 0.6 0.0 0.0 0.7 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.3 0.0 5.3 1.2 0.0 2.0 1.2 0.0 0.0 0.0 0.0 21.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.7 0.5 0.1 11.8 0.0 0.0 0.8 0.0 0.0 0.1 0.2 0.0 0.9 0.0 10.6 0.2 DRD1 ENSG00000184845 "Dopamine receptor D1" P21728 5 175440039-175444208 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "brain: 34.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 40.8;Horizontal cells: 31.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 5 "basal ganglia: 34.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "RT4: 24.2" "Region enriched" "Detected in many" 9 "basal ganglia: 147.4" "Region enriched" "Detected in many" 13 "basal ganglia: 95.6" "HPA013393, HPA017304" Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA013393: AB_1847833, HPA017304: " "unprognostic (2.74e-2)" "unprognostic (6.36e-3)" "unprognostic (2.02e-1)" "unprognostic (1.07e-1)" "unprognostic (7.63e-3)" "unprognostic (1.28e-1)" "unprognostic (1.15e-6)" "unprognostic (6.69e-2)" "unprognostic (1.05e-1)" "unprognostic (1.24e-1)" "unprognostic (1.49e-1)" "unprognostic (2.74e-2)" "unprognostic (8.60e-4)" "unprognostic (5.86e-2)" "unprognostic (5.43e-1)" "unprognostic (6.00e-3)" "unprognostic (1.10e-2)" 0.7 1.5 1.9 0.2 34.5 0.0 0.1 0.1 12.0 0.7 0.7 0.4 0.0 0.5 0.4 0.7 0.7 0.6 1.1 0.3 1.0 0.6 0.7 2.6 1.8 0.1 0.5 1.6 0.3 0.0 0.0 0.1 2.5 0.3 2.7 0.9 2.1 0.1 1.2 0.1 0.1 0.3 0.4 0.1 0.4 0.4 0.1 6.8 0.1 0.1 0.0 0.4 1.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 24.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 34.5 0.1 5.3 1.0 0.6 0.5 1.6 0.3 6.8 0.0 0.0 0.0 0.0 0.1 40.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 31.8 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.2 0.0 0.0 0.0 2.9 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DRP2 ENSG00000102385 "Dystrophin related protein 2" Q13474 X 101219769-101264497 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 20.3" "Cell type enhanced" "Detected in some" 15 "Bipolar cells: 2.3;Intestinal endocrine cells: 1.7;Peritubular cells: 2.1" "Cancer enhanced" "Detected in single" "glioma: 1.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "RH-30: 11.3;TIME: 19.0;U-87 MG: 4.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002949 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "HPA002949: AB_1078706" "unprognostic (8.47e-4)" "unprognostic (3.56e-3)" "unprognostic (1.01e-2)" "unprognostic (5.58e-4)" "unprognostic (1.74e-2)" "unprognostic (2.47e-2)" "unprognostic (7.93e-3)" "unprognostic (2.94e-3)" "unprognostic (1.27e-2)" "unprognostic (5.46e-3)" "unprognostic (1.42e-1)" "unprognostic (4.61e-2)" "unprognostic (4.44e-16)" "unprognostic (3.71e-4)" "unprognostic (4.22e-1)" "unprognostic (9.03e-2)" "unprognostic (1.25e-1)" 1.1 1.5 9.3 1.2 17.2 1.1 0.8 0.4 20.3 1.7 2.8 1.2 0.0 1.1 2.5 2.7 1.3 1.0 1.3 0.9 5.8 4.2 0.7 0.6 0.8 0.8 4.6 10.1 4.4 0.6 0.6 2.4 0.7 2.6 4.1 1.8 0.5 0.7 3.1 0.7 0.8 1.2 2.2 3.1 0.7 0.7 1.6 2.2 0.9 0.6 0.0 0.8 1.1 1.1 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.7 2.4 0.1 0.1 0.2 0.1 0.5 0.1 0.4 1.0 0.0 0.4 0.3 0.3 0.1 0.7 0.0 0.3 0.0 0.8 0.1 0.2 0.2 0.5 0.0 0.2 0.1 0.5 1.5 0.0 0.8 0.0 0.1 1.4 0.5 0.0 1.0 1.6 0.0 1.3 0.5 0.1 0.1 0.1 0.3 11.3 0.0 0.0 0.0 0.0 0.5 0.1 0.2 0.0 0.5 0.0 0.1 19.0 0.2 0.7 0.2 0.4 0.0 0.1 0.0 4.6 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.9 0.0 9.3 17.2 0.4 20.3 5.8 4.2 4.6 10.1 2.6 2.2 0.0 0.0 0.0 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.1 0.0 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 DSC3 "CDHF3, DSC, DSC1, DSC2, DSC4" ENSG00000134762 "Desmocollin 3" Q14574 18 30990008-31042815 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" Hypotrichosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 73.2;lymphoid tissue: 28.4;skin 1: 99.1;tongue: 92.4" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 444.8;Suprabasal keratinocytes: 602.1" "Cancer enhanced" "Detected in many" "cervical cancer: 78.6;head and neck cancer: 107.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 71.0;HBEC3-KT: 16.3;hTCEpi: 42.0;hTERT-HME1: 30.9;REH: 11.9" "Group enriched" "Detected in some" 4 "basal ganglia: 1.3;hippocampal formation: 3.6" "Low region specificity" "Detected in some" "CAB037328, HPA049265, HPA073937" Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 2700000 "Plasma membrane, Cell Junctions" "CAB037328: , HPA049265: AB_2680695, HPA073937: AB_2686645" "unprognostic (4.44e-3)" "unprognostic (6.28e-2)" "unprognostic (1.46e-1)" "unprognostic (3.02e-3)" "unprognostic (2.38e-1)" "unprognostic (1.32e-2)" "unprognostic (6.38e-2)" "unprognostic (1.84e-2)" "unprognostic (2.41e-1)" "unprognostic (3.48e-2)" "unprognostic (3.92e-3)" "unprognostic (3.13e-1)" "unprognostic (4.13e-4)" "unprognostic (1.22e-2)" "unprognostic (7.85e-2)" "unprognostic (3.47e-1)" "prognostic unfavorable (1.04e-5)" 1.5 0.0 0.0 0.6 0.0 0.0 10.4 0.0 0.0 11.9 1.0 0.0 0.4 0.1 2.1 1.4 73.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.0 2.4 0.1 16.0 0.1 4.5 0.0 0.0 7.2 0.3 0.2 99.1 0.2 0.1 0.0 0.0 0.0 0.5 0.0 2.2 0.0 92.4 28.4 1.0 14.4 0.7 0.2 1.0 0.5 0.4 0.4 0.1 4.5 0.5 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 71.0 0.0 16.3 0.0 0.0 3.9 0.2 1.4 0.1 2.7 0.0 0.0 2.8 42.0 0.0 30.9 5.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 5.8 11.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.2 0.3 0.2 0.2 0.4 0.3 0.2 0.0 0.7 0.3 0.4 1.0 0.4 0.5 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.0 1.4 0.0 43.5 444.8 0.0 1.2 0.0 2.7 19.4 0.0 0.0 62.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 10.1 7.5 19.6 0.0 0.0 4.6 0.0 2.4 0.0 0.0 0.0 0.0 0.6 37.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 602.1 20.9 0.0 0.0 96.7 DSEL "C18orf4, DE-epi2, FLJ11477, NCAG1" ENSG00000171451 "Dermatan sulfate epimerase-like" Q8IZU8 18 67506582-67516980 "Predicted membrane proteins" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 43.3;Extravillous trophoblasts: 69.4;Fibroblasts: 40.8" "Cancer enhanced" "Detected in many" "glioma: 6.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.2" "Lineage enriched" "Detected in single" 5 "T-cells: 3.2" "Cell line enhanced" "Detected in many" "BJ: 19.9;BJ hTERT+: 11.5;LHCN-M2: 24.9;U-138 MG: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060942 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060942: AB_2684392" "unprognostic (2.49e-1)" "unprognostic (5.00e-1)" "unprognostic (1.67e-1)" "unprognostic (1.19e-5)" "unprognostic (1.56e-1)" "unprognostic (2.71e-1)" "unprognostic (2.40e-3)" "unprognostic (7.11e-2)" "unprognostic (4.91e-1)" "unprognostic (2.83e-1)" "unprognostic (2.19e-2)" "unprognostic (2.47e-1)" "unprognostic (7.95e-3)" "unprognostic (3.25e-2)" "unprognostic (1.24e-1)" "unprognostic (9.70e-3)" "unprognostic (1.16e-4)" 10.2 3.4 8.8 3.2 15.5 1.6 9.4 7.9 12.8 10.9 4.5 15.7 2.5 2.2 5.7 4.0 3.1 7.1 8.3 5.1 8.6 8.4 9.0 7.1 6.0 1.9 13.2 4.5 7.6 3.6 3.6 1.3 11.5 9.7 4.8 3.5 2.4 2.3 4.9 1.9 3.2 2.7 7.4 11.1 4.5 3.1 3.4 10.9 0.0 2.8 1.1 1.6 3.6 8.4 0.2 0.1 0.6 0.1 0.3 3.2 0.3 0.0 0.0 2.4 0.0 4.7 7.0 0.3 19.9 11.5 5.1 2.2 0.0 0.0 0.0 0.0 10.1 1.3 0.1 0.4 0.9 4.9 0.0 0.0 0.0 2.2 0.0 4.0 0.0 0.0 7.0 1.3 3.1 7.4 1.9 1.0 0.0 0.0 0.2 24.9 0.0 0.0 0.0 0.3 0.0 2.1 0.2 5.3 0.0 2.3 0.0 0.9 1.1 1.8 0.0 0.0 1.1 0.0 0.0 1.7 25.9 0.8 1.8 2.2 0.1 0.0 0.0 5.4 0.0 2.2 0.6 0.1 0.2 0.2 0.0 1.7 0.1 0.8 1.2 0.0 0.2 0.5 3.2 0.5 0.3 0.1 0.1 0.2 0.3 8.8 15.5 7.9 9.9 8.6 8.4 13.2 4.5 9.7 10.9 6.0 14.4 2.0 8.0 10.3 9.4 14.3 43.3 0.0 2.3 10.4 3.9 2.4 0.0 7.9 1.1 11.3 0.5 0.0 2.0 69.4 40.8 6.6 4.6 12.9 2.2 3.2 6.3 16.0 2.1 1.4 22.7 2.9 6.8 0.0 0.1 14.3 5.4 0.0 34.6 18.8 4.2 12.9 12.3 13.1 11.7 11.5 7.4 2.5 0.6 5.4 DUSP15 "bA243J16.5, bA243J16.6, C20orf57, FLJ20645, VHY" ENSG00000149599 "Dual specificity phosphatase 15" Q9H1R2 20 31847637-31870747 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 75.1" "Group enriched" "Detected in many" 5 "Distal tubular cells: 232.1;Early spermatids: 237.5;Late spermatids: 743.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 14 "naive B-cell: 1.6" "Lineage enriched" "Detected in single" 14 "B-cells: 1.6" "Cell line enhanced" "Detected in some" "CACO-2: 5.4;REH: 17.7;SH-SY5Y: 5.1;SK-MEL-30: 4.4;U-2 OS: 4.3" "Low region specificity" "Detected in all" HPA076649 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076649: AB_2686811" "unprognostic (3.84e-2)" "unprognostic (2.30e-1)" "unprognostic (2.28e-1)" "unprognostic (9.01e-3)" "unprognostic (3.88e-2)" "unprognostic (2.36e-1)" "unprognostic (1.47e-2)" "unprognostic (2.24e-2)" "unprognostic (1.43e-1)" "unprognostic (1.76e-1)" "unprognostic (1.48e-5)" "unprognostic (7.31e-2)" "prognostic favorable (5.40e-7)" "unprognostic (2.79e-2)" "unprognostic (1.93e-1)" "unprognostic (3.11e-3)" "unprognostic (2.55e-1)" 1.1 2.1 2.8 0.6 4.0 0.5 1.3 1.2 3.7 1.6 0.8 4.2 6.9 0.9 1.4 10.4 0.6 0.7 1.1 2.7 2.8 3.1 15.4 0.6 0.8 1.0 4.9 2.3 2.1 1.8 10.6 2.7 1.1 5.9 1.9 0.5 5.3 2.1 9.3 2.4 0.7 1.0 2.3 5.2 1.0 1.1 75.1 1.4 0.0 3.5 0.1 0.6 0.7 0.8 1.6 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.2 0.2 1.6 0.0 0.3 0.0 0.0 0.0 0.9 0.0 5.4 0.1 1.1 2.2 0.3 3.0 0.0 0.4 0.0 0.0 0.0 0.6 0.5 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 3.8 0.7 0.0 0.0 17.7 2.1 0.1 0.0 0.0 2.5 5.1 2.9 0.0 4.4 0.2 1.3 1.1 0.0 0.0 4.3 0.0 0.0 1.9 0.0 0.0 0.0 0.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.0 1.2 3.7 2.8 3.1 4.9 2.3 5.9 1.4 0.0 0.0 0.0 1.0 0.6 0.5 2.0 2.5 0.0 0.0 17.4 3.9 0.0 232.1 1.7 237.5 0.7 0.0 0.0 0.9 0.1 2.4 0.7 0.0 0.0 0.5 6.4 1.7 3.1 0.0 743.6 8.1 0.8 6.8 1.0 0.0 2.7 0.9 0.0 10.3 33.5 0.2 0.0 1.0 85.0 5.2 0.1 0.1 0.0 0.0 0.1 DYSF "FER1L1, LGMD2B" ENSG00000135636 Dysferlin O75923 2 71453722-71686768 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease mutation, Limb-girdle muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 39.9;skeletal muscle: 53.3" "Cell type enhanced" "Detected in many" 12 "Cardiomyocytes: 20.1;Endothelial cells: 22.1;Ito cells: 34.4;Kupffer cells: 20.6;Syncytiotrophoblasts: 55.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "neutrophil: 19.9" "Lineage enriched" "Detected in many" 8 "granulocytes: 19.9" "Group enriched" "Detected in some" 5 "hTERT-RPE1: 12.8;HUVEC TERT2: 32.9;LHCN-M2: 29.9;RH-30: 31.6;TIME: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002510, HPA017071, HPA021945" Enhanced Supported "Plasma membrane,Centriolar satellite" Yes No "Plasma membrane, Centriolar satellite" "CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928" "unprognostic (1.04e-1)" "unprognostic (7.66e-3)" "unprognostic (5.43e-3)" "unprognostic (1.66e-2)" "unprognostic (1.65e-1)" "unprognostic (2.42e-1)" "unprognostic (4.43e-2)" "unprognostic (1.14e-1)" "unprognostic (2.70e-1)" "unprognostic (3.21e-1)" "unprognostic (2.93e-1)" "unprognostic (6.43e-2)" "unprognostic (4.88e-3)" "unprognostic (1.22e-2)" "unprognostic (3.18e-2)" "unprognostic (1.36e-1)" "unprognostic (5.97e-3)" 6.6 2.1 1.1 7.2 1.3 18.6 7.9 1.2 2.0 1.9 6.4 0.0 3.9 1.6 4.2 4.9 5.1 3.6 3.3 20.8 1.2 2.0 4.7 13.4 9.1 17.8 2.1 0.7 4.1 1.4 2.0 2.1 39.9 7.0 4.8 1.9 3.3 1.9 3.6 53.3 1.7 3.3 12.1 1.4 26.5 3.2 1.5 0.3 0.8 4.9 8.3 1.0 8.7 11.9 0.0 0.0 19.9 2.6 0.3 0.3 0.7 0.4 0.0 1.3 1.1 0.0 0.0 2.4 0.0 0.3 0.9 0.6 0.1 0.3 0.0 4.9 0.0 1.3 1.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.9 4.2 12.8 32.9 0.0 3.1 0.0 29.9 0.0 0.0 2.2 3.2 0.0 0.3 0.0 31.6 0.0 1.0 0.0 0.0 0.0 1.5 0.2 0.0 3.3 0.1 0.3 21.5 0.1 1.5 0.1 0.4 0.0 0.0 0.0 0.0 5.2 0.0 0.0 2.6 0.0 0.3 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.2 19.9 0.3 0.1 0.0 0.0 0.7 1.1 1.3 1.2 2.0 1.2 2.0 2.1 0.7 7.0 0.3 3.0 13.8 0.5 0.0 2.2 0.8 20.1 0.0 1.4 2.3 0.0 0.0 5.4 0.0 0.4 4.4 22.1 0.0 0.0 0.2 2.8 1.4 0.2 2.3 9.9 11.0 0.0 0.0 34.4 20.6 4.1 0.6 2.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 1.7 0.1 6.5 3.1 0.5 0.0 1.4 55.4 0.9 0.0 0.0 EDNRA ENSG00000151617 "Endothelin receptor type A" P25101 4 147480917-147544954 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "cervix, uterine: 62.6;seminal vesicle: 52.3" "Cell type enhanced" "Detected in some" 14 "Leydig cells: 40.6;Peritubular cells: 64.0;Sertoli cells: 51.8;Smooth muscle cells: 84.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 7.3;ASC TERT1: 14.5;HHSteC: 7.4;LHCN-M2: 17.2;SH-SY5Y: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA013774, CAB018957" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB018957: AB_2039838, HPA013774: AB_1847994" "unprognostic (3.08e-2)" "unprognostic (6.28e-2)" "unprognostic (1.78e-1)" "unprognostic (3.42e-1)" "unprognostic (1.07e-2)" "unprognostic (1.39e-1)" "unprognostic (3.20e-2)" "unprognostic (7.20e-2)" "unprognostic (2.75e-3)" "unprognostic (1.47e-2)" "unprognostic (1.34e-3)" "unprognostic (2.88e-1)" "prognostic unfavorable (1.50e-7)" "prognostic unfavorable (3.93e-4)" "unprognostic (6.20e-3)" "unprognostic (3.11e-2)" "unprognostic (2.53e-3)" 7.6 2.6 1.3 1.4 1.8 0.0 7.2 0.6 2.4 62.6 2.6 1.0 21.7 1.5 37.3 14.2 4.7 13.3 7.3 15.1 1.3 1.3 3.1 1.4 12.7 2.0 1.8 1.0 23.5 0.9 1.9 2.2 5.9 2.7 21.5 1.5 10.3 4.1 52.3 4.8 3.2 1.8 19.4 1.6 11.5 4.4 9.1 1.4 2.9 5.0 6.0 2.6 14.7 18.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 4.2 0.0 7.3 14.5 0.0 2.2 2.9 0.4 0.1 0.2 0.0 0.0 0.0 0.7 0.5 0.0 0.3 0.6 0.2 0.0 1.5 0.0 2.5 0.0 7.4 0.0 0.0 5.6 0.5 0.4 0.0 2.7 0.0 0.0 0.0 1.1 17.2 0.2 0.0 0.1 1.2 0.0 0.9 0.0 0.7 0.1 1.1 0.8 0.0 13.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.9 0.6 0.0 0.0 1.1 0.3 0.0 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.8 0.6 2.4 1.3 1.3 1.8 1.0 2.7 1.4 3.0 4.0 0.0 0.6 2.7 0.0 17.1 0.0 0.0 7.9 0.0 0.0 0.2 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.1 11.8 1.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.1 40.6 0.3 3.3 0.0 0.0 0.0 0.2 0.0 64.0 0.0 0.0 51.8 84.6 0.6 0.6 2.4 0.1 0.0 0.0 0.2 EDNRB "ETB, HSCR, HSCR2" ENSG00000136160 "Endothelin receptor type B" P24530 13 77895481-77975529 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Hirschsprung disease, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 67.5" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 97.7;Ito cells: 106.8;Melanocytes: 104.6;Muller glia cells: 142.7;Sertoli cells: 213.4;Smooth muscle cells: 110.2" "Group enriched" "Detected in all" 7 "glioma: 41.1;melanoma: 127.7;renal cancer: 28.2" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 21 "classical monocyte: 2.0;intermediate monocyte: 2.1" "Lineage enriched" "Detected in single" 21 "monocytes: 2.1" "Cell line enhanced" "Detected in some" "AF22: 25.2;ASC diff: 19.2;SK-MEL-30: 23.1;U-266/70: 15.1;WM-115: 48.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017842, HPA027546" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB017842: , HPA027546: AB_2672327" "unprognostic (7.75e-2)" "unprognostic (6.73e-2)" "unprognostic (1.41e-3)" "unprognostic (2.59e-2)" "unprognostic (8.37e-2)" "unprognostic (2.45e-3)" "unprognostic (4.17e-3)" "unprognostic (5.43e-2)" "unprognostic (1.02e-1)" "unprognostic (1.38e-2)" "unprognostic (3.40e-2)" "unprognostic (3.01e-2)" "prognostic favorable (7.20e-5)" "unprognostic (1.59e-2)" "unprognostic (3.86e-2)" "unprognostic (4.58e-2)" "unprognostic (6.77e-3)" 25.4 23.2 22.2 10.3 29.8 0.8 23.1 10.3 30.7 8.1 7.2 13.6 2.3 10.9 7.7 3.6 4.9 6.0 8.5 23.7 16.7 16.4 22.3 26.5 28.4 15.6 24.2 8.1 4.9 6.4 7.7 6.3 67.5 33.2 14.9 7.7 51.0 13.4 4.4 6.7 5.1 11.9 7.4 33.4 16.0 5.8 3.1 12.4 0.0 17.6 2.0 2.9 10.9 8.2 0.0 0.0 0.0 2.1 0.0 0.0 0.4 2.0 0.0 25.2 0.0 19.2 0.7 0.3 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 1.3 0.0 0.0 5.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 23.1 3.4 0.0 0.1 0.1 0.2 0.0 0.0 0.1 15.1 8.5 0.0 0.4 0.0 48.1 0.0 2.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 22.2 29.8 10.3 11.9 16.7 16.4 24.2 8.1 33.2 12.4 11.9 38.2 0.0 1.0 13.2 3.2 7.3 0.0 2.7 4.5 0.0 5.9 14.3 0.0 0.0 2.4 97.7 0.0 0.0 0.0 10.2 27.8 2.5 5.8 0.5 10.9 0.0 0.0 106.8 21.3 1.8 73.9 9.2 104.6 0.0 0.0 142.7 0.1 0.0 2.5 0.0 3.4 213.4 110.2 0.3 1.4 6.4 4.8 0.0 0.0 1.4 EEF1AKMT1 N6AMT2 ENSG00000150456 "EEF1A lysine methyltransferase 1" Q8WVE0 13 20728731-20773958 "Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 20.8;Cytotrophoblasts: 17.3;Distal tubular cells: 23.2;Proximal tubular cells: 28.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA040417, HPA042543" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA040417: AB_2676973, HPA042543: AB_2678045" "unprognostic (4.14e-1)" "unprognostic (5.11e-2)" "unprognostic (8.57e-2)" "prognostic favorable (1.82e-4)" "unprognostic (9.14e-2)" "unprognostic (3.44e-1)" "unprognostic (2.24e-1)" "unprognostic (1.65e-1)" "unprognostic (1.11e-1)" "unprognostic (1.41e-1)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (2.39e-3)" "unprognostic (3.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.81e-2)" "unprognostic (4.31e-2)" 12.1 14.1 15.2 8.9 13.8 3.9 13.4 20.9 14.1 12.2 9.4 9.5 8.6 5.9 14.8 19.9 8.0 15.2 8.4 12.4 12.2 14.7 11.5 17.3 7.8 8.1 14.3 14.7 14.5 10.3 9.1 19.1 8.5 11.7 14.1 8.1 10.6 12.8 12.7 15.5 7.2 5.9 12.5 16.2 8.1 8.1 8.2 14.0 11.3 12.9 8.2 8.6 8.9 8.6 10.7 8.8 0.7 4.4 13.1 11.2 5.7 5.8 4.5 3.8 6.2 16.0 16.6 9.3 7.8 5.9 6.8 3.6 6.3 6.6 9.5 5.8 8.4 3.1 4.8 5.1 6.6 7.1 6.1 4.5 12.2 2.1 12.0 8.8 24.1 2.5 11.3 5.9 5.1 11.4 7.7 12.2 8.3 7.1 1.3 19.3 16.2 8.0 21.5 6.5 10.7 3.4 10.1 4.1 1.8 9.7 6.8 8.7 5.2 6.6 3.3 8.6 3.3 3.5 22.3 7.1 4.7 0.0 10.5 3.4 1.8 3.4 10.3 4.0 16.7 3.3 0.0 4.4 0.7 7.7 3.3 8.1 10.7 9.0 7.6 7.2 4.9 11.2 9.8 0.6 13.1 3.4 8.8 9.5 5.7 15.2 13.8 20.9 14.1 12.2 14.7 14.3 14.7 11.7 14.0 20.8 8.6 0.0 0.0 0.0 0.0 0.0 0.0 13.4 14.8 7.0 0.0 17.3 23.2 10.0 0.0 0.0 0.0 0.0 9.0 11.0 0.0 0.0 3.5 0.0 15.6 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 6.4 0.0 0.0 7.5 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.0 0.0 EEF2 "EEF-2, EF2" ENSG00000167658 "Eukaryotic translation elongation factor 2" P13639 19 3976056-3985469 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Elongation factor" "Cancer-related genes, Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007795, HPA040534, HPA057351" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 9700000 "Plasma membrane, Cytosol" "CAB007795: AB_598149, HPA040534: AB_2677024, HPA057351: AB_2683417" "unprognostic (5.47e-2)" "unprognostic (9.59e-2)" "unprognostic (3.75e-1)" "prognostic favorable (1.81e-6)" "unprognostic (2.06e-2)" "unprognostic (3.26e-1)" "unprognostic (1.53e-2)" "unprognostic (2.11e-1)" "unprognostic (1.83e-1)" "unprognostic (1.77e-2)" "unprognostic (1.25e-2)" "unprognostic (1.42e-1)" "prognostic favorable (1.25e-5)" "unprognostic (4.46e-2)" "unprognostic (5.60e-2)" "unprognostic (6.82e-2)" "unprognostic (9.86e-2)" 104.2 84.9 64.0 66.7 57.1 92.7 77.5 55.7 96.2 93.4 91.3 55.8 80.8 95.4 100.1 75.1 115.1 83.4 88.6 104.1 51.6 44.4 65.5 161.0 67.7 108.9 51.4 38.3 167.1 395.7 45.1 72.3 63.7 47.5 105.6 41.3 67.7 191.3 64.4 260.8 87.2 100.9 112.3 46.8 85.4 98.5 70.9 32.4 123.4 127.1 112.5 108.3 111.8 94.7 84.9 60.0 10.0 58.4 48.3 76.3 83.7 95.2 68.4 39.8 105.1 106.7 192.3 57.3 74.9 101.4 71.7 70.6 107.8 44.2 199.0 44.6 69.1 31.9 72.3 62.8 116.0 38.0 49.6 104.2 50.8 65.7 110.7 156.0 109.1 88.4 248.2 122.7 63.1 97.7 104.2 74.2 97.5 99.1 146.7 43.6 138.2 97.9 83.7 105.3 34.4 69.2 109.1 59.2 126.5 59.0 85.2 109.0 101.3 47.1 94.3 135.0 39.5 91.9 132.7 88.9 51.4 53.7 104.4 115.2 157.4 105.6 99.0 76.6 137.2 67.0 10.0 58.4 8.3 38.6 45.8 68.7 84.9 67.7 50.8 60.0 70.7 76.3 59.4 6.1 48.3 43.8 50.5 58.4 83.7 64.0 57.1 55.7 96.2 51.6 44.4 51.4 38.3 47.5 32.4 205.4 339.7 970.0 885.9 1173.5 200.3 547.0 484.1 158.0 288.9 242.5 72.6 782.8 835.6 627.1 628.8 571.1 713.7 186.9 1561.0 1076.2 818.7 720.7 366.9 607.5 546.3 192.3 715.0 498.4 743.9 1007.5 933.7 543.3 612.4 762.0 931.2 218.1 963.4 716.9 782.8 713.6 97.3 575.6 971.3 259.8 261.2 1177.5 1039.5 756.1 908.5 772.4 EFCAB1 FLJ11767 ENSG00000034239 "EF-hand calcium binding domain 1" Q9HAE3 8 48710789-48735311 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 61.9" "Group enriched" "Detected in many" 21 "Ciliated cells: 342.6;Early spermatids: 456.6;Late spermatids: 332.2" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.9" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 4.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.1;ASC diff: 4.0;ASC TERT1: 9.3;CAPAN-2: 4.5;hTEC/SVTERT24-B: 3.8;SCLC-21H: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA023527, HPA069955" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA023527: AB_2231065, HPA069955: AB_2686220" "unprognostic (5.29e-3)" "unprognostic (7.39e-3)" "unprognostic (1.05e-1)" "unprognostic (2.67e-3)" "unprognostic (4.67e-2)" "unprognostic (2.77e-1)" "unprognostic (9.81e-2)" "unprognostic (1.62e-1)" "unprognostic (2.52e-2)" "unprognostic (1.85e-1)" "unprognostic (5.94e-3)" "unprognostic (7.81e-2)" "unprognostic (4.87e-3)" "unprognostic (4.81e-2)" "unprognostic (1.99e-1)" "unprognostic (2.51e-1)" "unprognostic (3.47e-3)" 0.6 1.5 5.4 0.5 9.5 0.9 2.5 0.2 4.1 8.1 0.8 14.0 10.3 0.9 8.6 19.0 0.9 61.9 0.9 0.6 9.1 8.4 0.6 0.9 16.5 0.5 2.7 3.9 13.7 1.8 0.4 2.0 0.8 23.9 4.2 0.7 1.9 1.8 4.6 0.5 3.5 1.1 2.7 1.4 0.6 0.8 19.7 3.0 0.0 0.5 0.3 0.6 1.4 2.1 1.0 0.0 4.1 0.0 1.1 1.1 0.3 9.1 0.0 1.2 0.0 4.0 9.3 0.0 0.1 0.9 0.0 0.3 0.0 4.5 0.0 0.0 0.2 0.0 2.5 0.0 1.1 0.3 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.1 3.3 0.3 3.8 1.6 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.1 0.5 0.0 0.3 0.1 0.0 0.0 0.0 2.1 7.2 0.5 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.5 0.5 0.0 1.1 1.0 0.7 0.8 0.0 0.8 0.5 0.3 4.1 1.1 0.0 0.0 0.7 0.3 5.4 9.5 0.2 4.1 9.1 8.4 2.7 3.9 23.9 3.0 0.0 5.1 0.0 6.6 6.1 0.0 0.4 0.0 342.6 18.2 0.0 0.0 0.3 0.0 0.1 456.6 0.1 0.0 0.0 1.3 0.1 1.9 2.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 332.2 4.4 1.2 1.7 0.0 0.0 0.0 2.0 0.0 5.3 0.0 0.0 0.0 0.8 5.7 4.4 1.6 0.2 0.0 0.0 1.8 EFCAB2 "CFAP200, DRC8, MGC12458" ENSG00000203666 "EF-hand calcium binding domain 2" Q5VUJ9 1 244969705-245127164 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 161.9;Early spermatids: 83.3;Late spermatids: 104.3;Spermatocytes: 117.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 10.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 34.8;THP-1: 30.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031206, HPA031207" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA031206: AB_10599710, HPA031207: AB_10599946" "unprognostic (1.36e-2)" "unprognostic (9.04e-2)" "unprognostic (1.09e-1)" "unprognostic (2.84e-2)" "unprognostic (3.13e-2)" "unprognostic (1.21e-1)" "unprognostic (4.47e-2)" "unprognostic (9.86e-2)" "unprognostic (2.85e-2)" "unprognostic (3.02e-1)" "unprognostic (4.34e-3)" "unprognostic (8.41e-2)" "unprognostic (1.48e-2)" "unprognostic (2.25e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (6.51e-4)" "unprognostic (4.88e-2)" 11.0 12.5 16.7 5.6 18.6 10.8 14.7 20.1 15.5 11.6 7.3 23.6 13.9 3.0 18.7 19.5 9.6 32.1 13.1 13.7 18.0 14.3 12.5 6.5 11.2 7.8 22.3 12.3 10.6 12.1 14.6 20.6 14.7 16.3 9.2 11.3 11.8 7.4 16.0 15.5 6.1 6.5 13.2 20.9 6.4 10.5 24.4 21.9 5.4 23.7 13.5 9.1 11.5 16.0 3.6 10.8 4.9 1.8 2.9 0.8 1.2 3.1 4.0 9.1 2.3 3.3 7.8 11.1 4.0 4.3 5.2 4.8 10.2 8.6 11.0 8.7 5.0 5.5 2.5 3.6 2.3 3.2 1.1 2.2 5.3 15.9 4.5 7.0 5.4 34.8 6.7 4.9 7.0 6.6 6.2 7.9 0.3 20.3 9.0 4.4 3.3 1.1 14.9 11.6 4.5 3.0 20.8 1.4 2.9 13.2 5.4 7.2 9.7 7.0 2.7 5.8 10.7 2.6 30.7 1.2 6.4 2.4 3.5 14.5 3.1 5.1 7.3 5.1 15.6 5.1 1.2 1.7 2.8 0.5 1.8 0.8 3.6 0.7 0.4 5.5 3.3 0.6 0.6 4.9 2.9 1.3 10.8 0.8 1.2 16.7 18.6 20.1 15.5 18.0 14.3 22.3 12.3 16.3 21.9 3.0 12.6 4.7 9.1 4.5 12.5 54.7 0.0 161.9 21.6 22.7 13.7 12.8 43.1 5.7 83.3 11.4 2.6 0.0 9.5 40.1 10.4 6.8 0.0 6.8 9.8 4.8 18.1 8.0 14.2 104.3 8.3 9.8 6.8 6.4 6.3 12.5 5.9 5.8 6.0 14.4 20.0 6.5 11.8 117.5 31.9 2.6 28.6 6.2 6.0 8.8 EFR3A KIAA0143 ENSG00000132294 "EFR3 homolog A" Q14156 8 131904088-132013642 "Predicted intracellular proteins" "Autism, Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 326.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022859, HPA023092, HPA023402" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022859: AB_1848029, HPA023092: AB_2293240, HPA023402: AB_1848031" "unprognostic (4.79e-2)" "unprognostic (6.54e-2)" "unprognostic (6.42e-2)" "unprognostic (4.37e-3)" "unprognostic (2.77e-1)" "unprognostic (3.44e-2)" "unprognostic (3.04e-1)" "unprognostic (3.02e-1)" "unprognostic (1.51e-1)" "unprognostic (8.11e-2)" "unprognostic (5.89e-3)" "unprognostic (5.22e-2)" "unprognostic (3.46e-1)" "unprognostic (3.00e-1)" "unprognostic (3.29e-2)" "unprognostic (1.29e-1)" "unprognostic (2.21e-3)" 14.7 16.0 21.6 13.6 21.4 8.0 46.8 48.6 52.2 20.4 19.2 7.1 15.0 15.0 18.0 26.5 18.6 16.5 14.6 22.7 28.2 18.5 20.2 28.9 18.8 22.4 20.7 24.4 13.6 13.8 29.2 12.9 13.3 63.3 18.7 12.5 13.9 14.6 20.8 37.1 13.8 15.2 28.1 11.9 14.5 14.8 13.8 7.6 18.7 25.4 9.8 17.7 18.1 14.1 9.5 12.0 11.8 25.8 10.0 12.1 9.5 21.1 19.2 6.0 4.9 24.6 28.5 12.0 15.2 21.3 12.7 16.8 4.2 15.9 13.0 14.4 34.2 16.9 7.0 9.5 20.8 15.6 30.0 5.2 13.0 9.5 8.5 23.7 4.9 13.7 24.0 11.9 12.5 19.9 21.1 15.9 6.5 7.1 17.7 22.4 13.9 13.8 4.5 3.4 18.3 12.1 5.6 11.8 6.1 15.3 13.3 4.0 14.0 30.2 4.3 11.7 16.5 13.7 8.5 22.1 22.6 20.8 11.0 15.8 12.6 10.8 8.2 16.7 12.1 11.5 5.4 11.7 11.8 12.1 16.4 10.8 9.5 9.8 9.8 12.0 8.3 9.0 9.1 7.2 10.0 25.8 2.8 7.7 9.5 21.6 21.4 48.6 52.2 28.2 18.5 20.7 24.4 63.3 7.6 38.7 39.7 28.4 22.3 18.8 326.9 47.0 20.4 14.7 37.5 48.8 86.4 19.7 18.3 23.5 2.9 20.4 30.0 0.0 26.8 17.3 31.0 39.8 24.4 65.5 40.6 25.4 10.9 26.4 46.6 6.5 18.4 36.1 8.5 35.1 17.5 38.4 22.9 31.7 41.8 40.4 105.3 19.4 32.3 32.9 29.7 27.5 31.0 18.4 14.7 27.8 EGFR "ERBB, ERBB1" ENSG00000146648 "Epidermal growth factor receptor" P00533 7 55019021-55211628 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Host-virus interaction" "Developmental protein, Host cell receptor for virus entry, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 102.3" "Cell type enhanced" "Detected in many" 8 "Cytotrophoblasts: 207.2;Syncytiotrophoblasts: 315.1" "Cancer enhanced" "Detected in all" "glioma: 136.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 12 "A-431: 345.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB000035, HPA001200, HPA018530, CAB068186, CAB073534" Enhanced Enhanced "Plasma membrane,Cell Junctions" "Secreted to blood" NA NA 4740000 93000000 "Plasma membrane, Cell Junctions" "CAB000035: , CAB068186: AB_2665679, CAB073534: , HPA001200: AB_1078723, HPA018530: AB_1848044" "unprognostic (2.62e-2)" "unprognostic (9.56e-3)" "unprognostic (1.59e-1)" "unprognostic (7.51e-2)" "unprognostic (1.08e-1)" "unprognostic (1.27e-2)" "unprognostic (6.11e-2)" "unprognostic (4.88e-2)" "unprognostic (2.85e-2)" "unprognostic (3.30e-3)" "unprognostic (1.78e-3)" "unprognostic (1.04e-1)" "unprognostic (1.93e-3)" "unprognostic (6.98e-3)" "unprognostic (1.72e-1)" "unprognostic (6.62e-2)" "prognostic unfavorable (2.04e-5)" 16.2 8.4 4.9 7.5 6.8 0.1 39.8 5.1 8.5 13.8 7.8 3.3 10.7 3.6 8.2 11.7 15.6 8.8 8.5 4.8 6.8 2.7 7.6 23.5 14.2 2.3 4.1 3.9 10.4 10.1 1.8 2.1 102.3 5.6 10.9 6.7 9.2 15.4 12.9 10.7 32.5 6.3 15.5 3.5 3.3 7.8 5.5 5.9 3.2 12.8 15.5 8.0 10.2 28.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 345.9 4.4 1.1 1.5 7.1 4.4 1.2 3.4 4.6 2.1 1.6 0.8 3.7 0.2 0.8 2.9 9.0 13.9 0.0 15.3 2.5 0.1 0.2 0.0 1.9 0.2 1.8 0.0 0.0 2.1 14.0 5.3 28.6 3.1 0.2 0.0 0.0 0.0 4.5 0.2 0.0 0.0 0.3 1.3 2.2 0.0 0.6 0.0 2.6 3.7 0.0 1.3 2.9 3.5 0.7 1.2 0.3 0.8 1.0 1.9 0.5 14.9 3.2 0.0 0.3 0.2 2.6 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 6.8 5.1 6.6 6.8 2.7 4.1 3.9 5.6 5.9 89.3 37.5 4.2 67.7 76.2 1.5 7.3 53.5 16.0 59.1 21.0 5.9 207.2 0.0 30.6 4.6 10.9 15.9 23.3 21.0 36.6 45.3 37.8 0.0 77.4 24.2 0.0 4.1 6.7 7.0 2.2 118.8 1.3 16.9 2.8 25.3 106.1 41.7 17.3 125.5 14.0 2.3 77.6 23.1 1.6 2.7 78.5 315.1 0.0 20.0 46.4 EHBP1 "KIAA0903, NACSIN" ENSG00000115504 "EH domain binding protein 1" Q8NDI1 2 62673851-63046487 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Early spermatids: 215.6;Late spermatids: 370.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035468, HPA035469" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035468: AB_10671513, HPA035469: AB_10601365" "unprognostic (5.39e-2)" "unprognostic (1.63e-3)" "unprognostic (8.78e-2)" "unprognostic (3.83e-3)" "unprognostic (1.43e-1)" "unprognostic (1.57e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (9.03e-4)" "unprognostic (1.78e-1)" "unprognostic (1.95e-1)" "unprognostic (3.33e-2)" "unprognostic (3.14e-1)" "unprognostic (3.13e-3)" "unprognostic (1.15e-2)" "unprognostic (1.29e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (1.95e-8)" 19.6 12.6 19.8 10.2 15.4 4.0 12.0 27.5 22.5 22.5 22.3 8.0 7.5 6.8 22.3 6.0 20.9 12.7 18.2 7.8 16.0 15.9 12.3 36.9 8.1 5.7 17.1 13.0 35.1 10.9 9.7 14.5 8.2 12.8 12.6 10.4 8.6 10.2 14.0 5.4 7.4 8.5 21.4 9.3 5.4 11.1 24.1 9.8 5.4 10.4 7.5 7.0 12.3 12.7 8.4 5.4 3.5 3.6 4.7 6.8 2.8 18.7 25.9 10.7 6.3 18.6 35.9 10.7 16.7 16.4 12.3 10.2 30.9 14.1 13.0 6.2 30.7 18.9 11.5 13.7 11.9 20.5 13.8 6.4 11.2 9.2 36.4 12.8 6.5 8.6 16.5 21.4 12.5 24.6 12.5 7.9 10.4 7.6 7.4 19.9 7.3 7.5 4.1 10.3 15.6 10.1 6.7 13.2 5.5 8.2 6.1 11.6 9.4 13.8 10.2 16.6 11.8 4.9 6.4 5.8 13.3 13.8 21.9 8.7 8.6 5.9 12.4 13.3 10.1 26.6 0.2 3.4 3.5 6.3 3.6 6.3 8.4 6.8 6.0 5.4 7.3 6.7 5.7 1.3 4.7 1.9 3.5 3.7 2.8 19.8 15.4 27.5 22.5 16.0 15.9 17.1 13.0 12.8 9.8 35.7 13.1 9.0 11.0 13.9 30.3 13.3 25.5 14.7 22.7 14.0 3.9 8.5 13.3 18.7 215.6 17.4 5.8 0.0 35.1 26.0 18.6 8.4 2.3 57.0 4.3 17.5 15.5 26.4 9.8 370.2 54.1 8.3 10.1 3.6 5.8 22.2 35.4 5.8 37.8 12.2 17.8 6.5 18.6 46.0 20.9 12.4 2.4 8.4 8.7 11.3 EIF5 ENSG00000100664 "Eukaryotic translation initiation factor 5" P55010 14 103333544-103345025 "Predicted intracellular proteins" "Protein biosynthesis" "Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/84: 125.8" "Low region specificity" "Detected in all" "HPA000867, CAB004226" Supported Enhanced "Plasma membrane,Cytosol" NA NA 21000 Cytosol "Plasma membrane" "CAB004226: AB_627507, HPA000867: AB_1078731" "unprognostic (1.39e-1)" "unprognostic (3.13e-1)" "unprognostic (4.02e-2)" "unprognostic (6.47e-3)" "unprognostic (6.33e-2)" "unprognostic (3.02e-1)" "unprognostic (2.01e-1)" "unprognostic (5.59e-2)" "unprognostic (7.82e-2)" "unprognostic (3.92e-3)" "unprognostic (1.08e-1)" "unprognostic (2.70e-2)" "prognostic favorable (5.67e-7)" "unprognostic (2.76e-1)" "unprognostic (8.41e-2)" "unprognostic (5.43e-3)" "unprognostic (3.14e-2)" 35.7 31.9 36.5 20.8 41.1 67.7 34.4 31.5 47.2 21.3 32.5 25.5 18.8 31.7 27.6 23.5 34.0 27.6 26.2 34.1 37.9 34.2 37.9 78.4 27.3 37.2 37.1 33.3 24.7 32.1 30.1 26.7 31.9 39.3 23.4 32.5 19.2 28.5 32.8 59.4 22.7 31.5 39.5 36.9 31.1 28.2 39.1 27.0 29.6 40.1 30.5 31.1 29.1 37.9 96.7 96.6 90.1 74.3 86.8 90.5 102.2 21.9 25.7 29.9 13.5 26.0 23.1 31.7 32.3 35.1 33.4 25.4 37.8 23.4 22.8 20.5 29.0 28.7 29.4 37.6 32.7 57.0 18.5 15.0 20.2 13.6 19.9 27.1 36.5 17.4 24.7 22.0 29.5 40.4 27.9 33.5 16.7 41.9 21.8 27.5 31.4 24.8 12.1 15.6 41.9 49.1 21.1 38.9 14.2 19.7 71.4 26.7 18.7 32.4 24.3 26.2 29.2 23.2 16.8 25.4 26.8 18.2 34.0 33.7 65.4 125.8 47.8 26.3 25.7 31.1 83.4 74.3 90.1 74.1 73.2 82.6 95.9 76.0 69.3 70.7 96.7 90.5 76.1 80.3 86.8 73.8 96.6 62.3 102.2 36.5 41.1 31.5 47.2 37.9 34.2 37.1 33.3 39.3 27.0 134.0 134.2 172.4 275.5 302.0 187.9 268.9 94.3 211.5 160.3 69.8 174.7 201.6 182.4 188.8 177.9 189.8 216.8 116.8 244.5 166.6 191.4 206.1 270.4 218.5 155.2 166.8 191.4 125.2 135.3 526.7 118.5 188.0 145.1 271.5 121.6 154.4 191.1 147.3 163.4 197.4 198.0 116.4 294.0 384.8 335.3 231.9 412.9 139.6 161.2 208.2 EIF5B "DKFZp434I036, FLJ10524, IF2, KIAA0741" ENSG00000158417 "Eukaryotic translation initiation factor 5B" O60841 2 99337353-99401326 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Protein biosynthesis" "Hydrolase, Initiation factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034648, HPA040095" Approved Approved "Plasma membrane,Cytosol" NA NA 11000 Cytosol "Plasma membrane" "HPA034648: AB_10601902, HPA040095: AB_2676843" "unprognostic (1.23e-1)" "unprognostic (6.94e-2)" "unprognostic (2.01e-1)" "unprognostic (5.03e-2)" "unprognostic (4.65e-2)" "unprognostic (5.88e-3)" "prognostic unfavorable (7.15e-10)" "unprognostic (6.80e-2)" "unprognostic (9.84e-3)" "prognostic favorable (8.99e-4)" "unprognostic (1.68e-2)" "unprognostic (2.36e-1)" "prognostic unfavorable (1.42e-6)" "unprognostic (6.89e-2)" "unprognostic (3.24e-2)" "unprognostic (1.43e-1)" "unprognostic (7.93e-3)" 24.5 16.0 25.2 22.4 32.6 11.5 22.6 27.7 26.0 23.7 25.1 10.5 19.9 14.8 19.4 28.7 30.8 14.5 15.0 61.7 26.0 22.3 28.8 32.1 17.9 19.2 26.9 23.0 22.3 24.6 26.8 27.5 26.4 28.5 26.0 20.3 7.1 22.3 29.1 105.8 25.3 19.3 31.5 37.6 27.0 20.7 22.6 33.8 17.8 18.2 29.2 22.8 40.1 31.9 15.9 20.2 11.6 12.1 14.1 14.9 4.5 34.1 17.1 19.5 25.4 23.7 28.1 32.4 30.2 19.0 20.1 20.1 39.3 24.4 39.2 26.2 22.4 23.9 19.6 34.1 29.2 35.6 23.6 20.4 47.1 17.5 51.7 18.8 46.0 29.1 18.9 20.6 27.9 28.6 17.3 29.2 24.1 51.9 19.6 28.9 27.7 29.1 42.7 30.4 22.5 25.2 25.5 29.1 31.9 41.2 28.7 16.6 15.7 16.4 37.8 24.3 38.8 15.3 30.4 32.0 31.3 30.7 16.3 26.8 14.6 20.6 32.0 22.7 51.1 23.0 11.6 8.8 9.8 12.7 9.5 14.9 15.3 13.4 12.5 6.4 15.9 13.2 14.0 2.3 14.1 12.1 20.2 9.0 4.5 25.2 32.6 27.7 26.0 26.0 22.3 26.9 23.0 28.5 33.8 101.3 209.4 134.1 138.3 285.5 99.2 532.6 145.2 179.3 205.9 326.2 47.1 126.1 122.7 191.6 558.1 145.8 91.2 116.8 202.2 178.1 139.3 179.5 165.5 428.2 118.4 73.1 151.6 136.2 112.7 88.6 115.3 122.6 135.0 171.3 133.7 81.8 227.8 86.3 165.2 160.8 108.6 271.7 161.7 293.6 551.3 283.8 151.7 127.0 125.6 200.5 ELMO3 "CED-12, CED12, ELMO-3, FLJ13824" ENSG00000102890 "Engulfment and cell motility 3" Q96BJ8 16 67199111-67204029 "Predicted intracellular proteins" "Apoptosis, Phagocytosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 67.1;Paneth cells: 44.1;Undifferentiated cells: 45.7" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in many" "cerebellum: 6.7" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 17.0;CAPAN-2: 24.9;HaCaT: 23.6;T-47d: 23.3" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA021484 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA021484: AB_1848129" "unprognostic (4.49e-3)" "unprognostic (2.04e-1)" "unprognostic (1.10e-2)" "unprognostic (8.08e-2)" "unprognostic (1.39e-1)" "unprognostic (6.16e-3)" "unprognostic (3.14e-1)" "unprognostic (8.17e-3)" "unprognostic (1.73e-1)" "unprognostic (8.06e-2)" "unprognostic (3.40e-2)" "unprognostic (6.95e-3)" "prognostic favorable (2.77e-5)" "unprognostic (3.47e-1)" "unprognostic (2.66e-1)" "unprognostic (1.84e-1)" "unprognostic (1.97e-2)" 1.1 0.8 0.6 7.8 1.8 2.5 4.6 6.7 1.4 2.8 30.3 0.5 32.0 18.9 2.6 9.8 13.1 4.8 16.0 0.9 0.7 0.8 13.3 3.9 6.9 1.4 0.5 0.5 1.2 26.6 6.5 28.7 13.7 1.0 13.2 5.1 0.9 25.1 28.8 0.5 19.1 37.7 1.7 0.5 2.8 12.8 8.7 0.6 1.1 18.2 9.7 9.2 6.8 6.0 1.2 0.8 2.1 0.4 0.4 1.0 0.1 10.8 1.2 1.2 1.5 0.2 0.3 17.0 0.6 0.3 0.8 0.7 7.1 24.9 1.5 0.8 0.3 0.3 23.6 1.1 10.9 0.2 0.7 1.4 1.5 2.0 2.3 0.5 0.9 3.9 0.2 8.0 0.6 0.6 0.8 0.8 1.3 1.5 0.8 0.4 9.0 0.9 4.5 1.6 10.2 1.0 2.2 1.2 2.4 1.0 1.5 8.3 1.9 1.6 7.4 0.7 0.7 23.3 1.7 1.4 1.9 2.3 1.2 1.1 2.5 0.8 2.8 1.0 2.1 0.9 0.0 0.4 1.0 1.0 0.0 0.1 1.2 0.8 0.1 0.5 1.1 0.6 0.2 2.1 0.4 0.1 0.8 0.5 0.1 0.6 1.8 6.7 1.4 0.7 0.8 0.5 0.5 1.0 0.6 0.0 12.5 2.4 11.4 7.8 0.8 1.1 12.7 1.4 2.3 19.2 0.0 26.3 14.9 16.5 19.0 1.4 67.1 0.0 20.8 12.4 1.0 6.3 4.6 3.9 3.1 0.0 12.6 1.3 1.3 26.2 0.9 1.4 3.3 2.8 31.8 0.4 23.9 44.1 0.7 23.7 1.3 0.0 0.4 7.9 2.5 11.8 14.1 0.0 45.7 8.1 EMP3 YMP ENSG00000142227 "Epithelial membrane protein 3" P54852 19 48321509-48330553 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 165.9" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 530.6;Hofbauer cells: 548.3;Kupffer cells: 540.8;Macrophages: 782.1;Melanocytes: 1059.5" "Cancer enhanced" "Detected in all" "melanoma: 195.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 116.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA062030 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA062030: " "unprognostic (5.06e-3)" "unprognostic (4.41e-1)" "unprognostic (1.83e-1)" "unprognostic (9.28e-3)" "unprognostic (1.33e-2)" "unprognostic (4.83e-3)" "unprognostic (1.49e-2)" "unprognostic (1.02e-1)" "unprognostic (9.31e-2)" "unprognostic (4.72e-2)" "unprognostic (3.41e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (2.31e-7)" "prognostic unfavorable (3.13e-4)" "unprognostic (1.16e-1)" "unprognostic (2.41e-1)" "unprognostic (2.90e-3)" 27.6 23.4 10.4 26.5 12.6 66.2 28.7 7.2 8.4 50.6 40.3 9.2 14.6 8.4 45.9 22.6 26.9 26.1 21.1 37.9 10.8 6.9 15.6 7.0 36.1 48.0 15.2 6.7 41.4 6.4 2.2 6.1 29.9 12.7 30.7 15.4 24.7 11.3 23.1 13.2 16.3 20.8 46.7 19.1 27.8 19.2 18.2 8.2 16.2 11.6 13.4 25.6 36.8 30.6 44.9 54.8 165.9 91.0 59.7 119.1 124.8 5.6 63.2 3.5 10.1 56.2 87.8 0.1 39.0 71.1 51.7 45.8 6.1 20.4 0.7 8.8 86.6 26.7 1.0 3.7 4.2 31.8 18.6 1.6 27.0 16.6 3.7 47.2 13.3 28.3 47.6 0.8 53.0 36.6 38.4 22.1 6.1 17.8 46.4 79.0 0.9 2.0 116.0 4.7 1.2 16.0 1.6 12.2 27.4 44.3 0.0 0.1 0.2 17.7 0.1 10.1 6.8 0.2 20.4 36.4 46.8 20.3 36.9 30.6 24.5 30.4 1.7 27.7 17.6 31.7 165.9 77.2 105.6 109.2 91.0 90.4 44.9 114.8 106.6 54.8 35.4 65.7 78.2 85.7 59.7 86.6 40.8 119.1 124.8 10.4 12.6 7.2 8.4 10.8 6.9 15.2 6.7 12.7 8.2 0.0 5.0 254.5 67.7 246.9 2.2 3.9 15.3 5.3 11.4 31.4 0.0 10.5 5.0 62.4 5.0 137.6 1.3 0.0 9.8 19.7 530.6 38.3 254.8 4.7 548.3 0.0 5.8 114.8 540.8 9.1 310.7 782.1 1059.5 206.4 2.9 65.0 72.6 17.3 204.0 6.5 3.3 103.5 237.6 9.8 4.5 166.0 16.9 200.3 2.6 22.6 ENG "CD105, END, HHT1, ORW, ORW1" ENSG00000106991 Endoglin P17813 9 127815012-127854756 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Cell adhesion" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Endothelial cells: 336.5;Ito cells: 724.3;Leydig cells: 451.1;Peritubular cells: 1336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.2;intermediate monocyte: 17.7;myeloid DC: 6.4;NK-cell: 4.6;non-classical monocyte: 13.0" "Group enriched" "Detected in many" 4 "dendritic cells: 6.4;monocytes: 17.7;NK-cells: 4.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 36.6;HUVEC TERT2: 68.4;TIME: 139.4;U-138 MG: 34.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000096, HPA011862, HPA067440, CAB072873" Enhanced Supported "Nuclear bodies,Plasma membrane" NA NA 260000000 "Plasma membrane" "Nuclear bodies" "CAB000096: AB_563482, CAB072873: AB_2665725, HPA011862: AB_1846217, HPA067440: AB_2685840" "unprognostic (2.28e-1)" "unprognostic (1.13e-1)" "unprognostic (3.87e-2)" "unprognostic (2.96e-2)" "unprognostic (1.77e-1)" "prognostic favorable (6.61e-4)" "prognostic favorable (5.62e-6)" "unprognostic (2.15e-1)" "unprognostic (4.06e-1)" "unprognostic (3.87e-2)" "unprognostic (2.20e-2)" "unprognostic (8.98e-2)" "prognostic unfavorable (4.26e-4)" "unprognostic (3.33e-3)" "unprognostic (7.35e-2)" "unprognostic (2.84e-1)" "unprognostic (1.27e-1)" 40.3 19.3 6.4 26.6 10.5 5.5 52.7 3.9 8.6 26.3 14.0 7.6 18.5 11.2 27.0 25.2 17.2 23.2 28.3 105.4 8.0 5.0 40.8 26.8 66.7 44.1 10.6 7.0 66.4 9.6 8.6 12.5 60.2 10.1 23.1 6.4 35.5 9.9 51.7 24.1 10.1 14.5 23.1 8.7 52.4 11.6 37.2 7.7 6.7 35.4 19.3 11.0 20.3 44.8 1.1 6.4 0.3 17.7 4.6 2.3 4.6 0.1 0.1 1.0 0.0 17.2 11.8 30.3 19.9 14.3 10.6 6.2 0.0 0.1 0.1 9.7 36.6 8.0 0.3 0.0 3.2 3.5 0.0 0.0 5.6 11.3 0.6 13.3 2.6 0.0 20.1 0.7 13.8 5.0 0.1 68.4 0.1 0.0 0.1 12.4 0.1 0.0 0.2 0.2 0.0 0.5 8.8 1.7 0.1 0.0 0.0 0.1 0.2 10.5 9.2 2.7 0.7 1.8 4.0 139.4 34.9 1.9 22.7 0.0 0.7 0.1 0.1 9.4 7.0 11.4 0.0 12.2 0.3 1.3 17.7 0.4 0.4 2.1 2.3 6.4 1.1 1.3 2.0 0.3 4.6 13.0 2.4 0.8 4.6 6.4 10.5 3.9 8.6 8.0 5.0 10.6 7.0 10.1 7.7 3.0 23.1 25.1 2.3 10.6 2.5 16.5 22.9 8.1 3.4 3.5 3.9 24.4 0.0 8.3 7.0 336.5 0.0 23.3 1.0 249.8 36.6 1.4 15.0 5.1 119.5 0.0 2.4 724.3 66.8 29.3 451.1 50.7 23.6 46.9 1.1 3.1 2.0 0.0 1336.5 0.0 4.1 71.1 20.8 3.7 4.9 7.3 314.8 5.7 0.2 1.1 ENO1 "ENO1L1, MBP-1, MPB1, PPH" ENSG00000074800 "Enolase 1" P06733 1 8861000-8879250 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" "Glycolysis, Plasminogen activation, Transcription, Transcription regulation" "DNA-binding, Lyase, Repressor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "monocytes: 2408.5;Muller glia cells: 2654.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018614, HPA068284, HPA068721, CAB069394" Supported Enhanced "Plasma membrane,Cytosol" NA NA 490000000 "Plasma membrane, Cytosol" "CAB018614: AB_2099061, CAB069394: , HPA068284: , HPA068721: AB_2732119" "unprognostic (6.51e-3)" "unprognostic (9.50e-3)" "unprognostic (3.56e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (2.71e-4)" "unprognostic (1.82e-2)" "prognostic unfavorable (1.30e-8)" "unprognostic (2.37e-2)" "unprognostic (5.58e-2)" "unprognostic (9.72e-2)" "unprognostic (1.67e-2)" "unprognostic (1.46e-1)" "unprognostic (7.53e-2)" "unprognostic (6.20e-2)" "unprognostic (1.97e-1)" "unprognostic (2.22e-1)" "unprognostic (1.36e-3)" 68.6 57.7 92.7 94.9 109.6 121.8 73.4 46.6 119.4 47.3 63.8 74.6 21.7 71.3 44.9 24.2 138.2 52.2 55.0 45.2 79.1 70.7 180.4 165.4 64.8 80.3 74.9 62.7 58.2 31.6 52.7 35.5 70.5 88.6 38.6 66.4 62.6 106.1 69.1 45.0 74.6 70.3 84.0 56.4 80.0 44.3 31.7 48.8 98.8 55.4 91.0 119.3 73.5 62.9 38.7 114.1 22.1 105.4 55.5 63.7 159.3 182.3 159.4 76.9 65.8 64.4 71.9 69.7 99.1 109.9 213.7 200.9 102.1 105.9 131.5 132.4 119.3 87.5 90.0 130.6 264.6 218.0 89.7 138.0 111.0 161.9 126.7 96.7 221.2 68.4 74.2 80.3 169.2 257.3 161.8 136.8 67.1 121.6 51.4 138.5 90.3 83.4 118.4 83.9 65.5 160.0 86.4 114.6 214.7 252.9 43.5 104.0 64.2 116.3 169.4 122.3 96.7 84.8 66.3 125.1 148.0 131.1 126.2 168.6 146.8 104.1 199.5 229.8 181.4 124.2 13.9 105.4 20.8 52.3 75.8 59.1 38.7 55.8 53.8 114.1 32.7 45.6 47.8 22.1 55.5 72.4 31.2 63.7 159.3 92.7 109.6 46.6 119.4 79.1 70.7 74.9 62.7 88.6 48.8 259.1 414.8 250.1 443.8 370.0 168.1 63.1 310.8 202.1 440.2 575.7 66.8 1020.4 784.2 1640.5 217.6 199.3 508.9 23.3 1210.7 1855.9 354.5 232.4 289.9 288.6 1045.8 456.1 181.6 141.8 389.1 532.9 158.8 475.7 425.1 2408.5 221.4 2654.1 1226.2 336.6 126.9 717.5 187.6 148.8 217.3 150.6 148.2 305.6 837.7 297.2 410.6 403.0 ENO2 ENSG00000111674 "Enolase 2" P09104 12 6913745-6923698 "Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Glycolysis Lyase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 119.2" "Group enriched" "Detected in many" 4 "Bipolar cells: 242.1;Cone photoreceptor cells: 294.5;Horizontal cells: 405.2;Rod photoreceptor cells: 613.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "gdT-cell: 8.2;MAIT T-cell: 9.7;memory B-cell: 5.6;memory CD4 T-cell: 10.8;memory CD8 T-cell: 9.6;naive B-cell: 3.3;naive CD4 T-cell: 7.1;naive CD8 T-cell: 7.4;neutrophil: 6.2;T-reg: 5.5" "Group enriched" "Detected in many" 7 "B-cells: 5.6;granulocytes: 6.2;T-cells: 10.8" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 94.8;U-87 MG: 70.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000063, HPA068284, HPA068721, CAB073539, CAB079023" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 89000000 "Plasma membrane, Cytosol" "CAB000063: AB_2099322, CAB073539: , CAB079023: , HPA068284: , HPA068721: AB_2732119" "unprognostic (8.96e-2)" "unprognostic (8.28e-2)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.28e-1)" "unprognostic (7.95e-3)" "unprognostic (1.39e-2)" "prognostic unfavorable (5.15e-4)" "unprognostic (1.48e-1)" "unprognostic (9.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.98e-1)" "unprognostic (2.02e-2)" "prognostic unfavorable (7.89e-11)" "unprognostic (7.61e-2)" "unprognostic (3.06e-1)" "unprognostic (8.10e-3)" "unprognostic (1.24e-1)" 4.2 20.7 31.2 8.3 48.0 4.0 4.9 115.2 119.2 7.6 7.9 10.9 2.6 4.9 11.7 6.3 5.9 9.4 8.0 10.3 30.2 39.2 3.5 2.0 10.1 10.5 29.6 47.4 3.7 4.1 19.1 15.5 4.8 47.7 8.0 7.4 28.6 3.1 15.3 2.1 5.8 6.0 15.2 15.7 5.8 6.4 3.2 13.3 1.7 14.2 0.3 10.3 7.1 5.0 5.6 1.0 6.2 0.2 0.4 10.8 4.5 12.2 7.7 2.8 0.1 4.2 4.5 0.2 9.5 6.1 14.1 21.7 1.4 1.0 17.2 1.5 4.1 18.6 1.8 29.3 2.6 21.4 34.4 2.7 23.8 7.9 10.3 3.0 1.3 28.6 2.3 0.1 10.4 2.1 94.8 2.9 22.5 1.5 0.2 9.4 1.6 11.1 1.5 14.9 5.3 4.4 12.4 2.3 3.8 6.9 1.6 22.5 15.8 2.5 0.1 16.2 14.3 0.7 0.7 3.7 12.3 13.0 16.6 12.2 12.6 12.6 2.5 70.7 0.0 2.5 1.3 0.0 0.1 8.2 0.0 9.7 5.6 10.8 9.6 0.0 3.3 7.1 7.4 6.2 0.4 0.2 1.0 5.5 4.5 31.2 48.0 115.2 91.3 30.2 39.2 29.6 47.4 47.7 13.3 32.8 30.1 5.4 2.3 5.6 242.1 12.0 0.0 21.4 10.3 12.2 294.5 0.2 0.0 16.0 0.3 7.1 0.0 0.0 1.5 0.3 6.6 1.7 65.8 0.0 1.7 405.2 23.0 6.2 0.0 0.0 5.2 2.5 11.8 5.4 0.0 91.6 10.4 0.2 9.2 0.0 613.6 12.9 21.7 1.8 1.3 1.9 0.2 11.4 0.4 1.6 ENO3 ENSG00000108515 "Enolase 3" P13929 17 4948092-4957131 "Candidate cardiovascular disease genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Glycolysis Lyase "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 12 "skeletal muscle: 638.2;tongue: 320.3" "Group enriched" "Detected in many" 8 "Cardiomyocytes: 511.6;monocytes: 134.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 4 "HDLM-2: 71.7;HeLa: 30.7;HMC-1: 30.3;RH-30: 49.3;RPMI-8226: 25.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA000793, HPA068284, HPA068721" Enhanced Supported "Plasma membrane,Cytosol" Yes No 100000000 "Plasma membrane, Cytosol" "HPA000793: AB_1078742, HPA068284: , HPA068721: AB_2732119" "unprognostic (7.35e-2)" "unprognostic (5.25e-2)" "prognostic unfavorable (7.33e-4)" "unprognostic (1.57e-1)" "unprognostic (1.29e-1)" "unprognostic (5.86e-2)" "unprognostic (5.68e-2)" "unprognostic (2.08e-2)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (6.04e-3)" "unprognostic (2.21e-2)" "unprognostic (4.63e-2)" "unprognostic (5.34e-2)" "unprognostic (3.48e-1)" "unprognostic (2.15e-1)" "unprognostic (4.50e-2)" 7.6 0.3 0.2 0.6 0.2 0.7 0.5 0.6 0.2 0.2 0.4 0.0 0.1 0.8 0.4 8.5 8.6 0.4 0.1 38.3 0.2 0.1 0.5 5.0 0.4 0.5 0.2 0.0 0.4 0.3 0.3 0.5 0.2 0.1 2.1 0.1 1.2 11.8 0.1 638.2 0.3 0.7 0.4 0.2 0.8 0.4 0.5 0.0 0.6 4.8 320.3 10.5 0.3 0.3 13.3 21.0 27.1 24.8 18.5 23.3 36.0 2.9 6.3 2.9 2.7 2.5 0.7 6.9 5.1 0.7 0.3 0.3 3.0 2.0 5.4 7.0 0.4 0.9 3.7 1.0 0.4 0.3 71.7 5.8 5.2 30.7 4.5 0.9 1.6 30.3 4.2 1.0 0.5 1.0 2.6 0.3 6.2 2.4 9.9 1.5 1.6 1.9 6.3 3.7 0.8 2.6 8.5 49.3 25.8 0.7 1.9 1.8 6.9 3.3 2.8 3.7 2.0 2.6 1.7 1.6 3.0 5.7 1.3 3.8 7.0 3.9 4.4 1.7 5.1 3.0 13.5 15.6 27.1 21.8 22.5 14.7 13.3 18.7 20.3 21.0 11.1 12.3 19.7 19.7 18.5 24.8 16.6 23.3 36.0 0.2 0.2 0.6 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.0 2.6 2.9 1.0 1.8 3.2 511.6 0.0 0.0 2.3 5.2 3.9 4.3 0.0 1.4 1.3 2.2 4.3 0.0 0.7 3.1 3.6 1.0 8.1 38.1 4.4 3.2 0.0 3.1 3.8 2.7 0.3 4.5 1.7 134.3 2.3 1.5 1.3 1.7 0.4 5.4 2.4 6.5 0.9 8.6 3.9 1.6 2.7 4.3 2.1 0.6 ENOX2 "APK1, COVA1, tNOX" ENSG00000165675 "Ecto-NOX disulfide-thiol exchanger 2" Q16206 X 130623369-130903317 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Growth regulation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000514, HPA003027" Uncertain Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA000514: AB_1078558, HPA003027: " "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (6.07e-2)" "unprognostic (6.27e-3)" "unprognostic (5.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.44e-1)" "prognostic favorable (1.09e-5)" "unprognostic (6.42e-2)" "unprognostic (4.60e-2)" "unprognostic (3.02e-1)" "unprognostic (1.38e-1)" 13.1 14.6 13.5 14.8 17.6 4.7 11.4 7.6 11.0 13.2 11.6 13.9 10.7 8.0 15.6 12.9 13.3 13.2 11.2 18.9 14.6 13.1 10.4 23.6 8.8 16.0 14.7 8.8 14.6 7.4 12.5 12.3 11.7 12.2 12.9 9.3 8.5 10.3 15.1 11.2 8.6 11.1 14.5 13.4 17.7 9.2 9.7 17.7 17.4 11.0 11.7 15.9 14.2 9.7 12.8 11.9 15.0 16.7 11.3 13.3 9.7 12.3 9.1 14.0 5.8 12.0 11.4 5.6 10.5 12.1 7.1 4.4 4.3 10.7 8.7 25.4 8.8 9.5 8.7 9.1 9.7 8.8 11.5 10.0 20.2 6.2 5.7 9.3 14.7 14.3 9.0 16.6 7.7 9.6 3.0 10.6 7.8 12.4 7.1 5.5 17.2 9.2 3.2 7.3 17.3 12.7 6.6 8.7 9.6 8.2 8.7 4.2 8.5 9.1 6.0 14.7 5.2 3.9 8.1 8.6 6.8 4.1 10.9 21.3 7.4 3.6 5.7 19.9 15.4 11.5 8.0 12.0 15.0 10.4 16.7 11.1 12.8 12.2 10.8 11.9 11.6 13.3 11.7 2.1 11.3 7.8 5.7 13.2 9.7 13.5 17.6 7.6 11.0 14.6 13.1 14.7 8.8 12.2 17.7 3.0 6.1 1.5 5.8 3.8 4.3 10.1 5.1 20.1 10.3 3.5 0.0 4.9 6.6 7.0 0.8 7.1 4.0 0.0 8.2 4.4 5.6 5.8 5.8 10.6 6.0 3.2 4.6 6.2 17.7 0.9 5.2 14.4 8.5 19.0 4.2 4.9 8.9 3.5 6.0 6.7 6.4 6.5 8.4 6.5 10.6 4.3 6.1 8.2 5.0 4.7 EPB41L3 "4.1B, DAL1, KIAA0987" ENSG00000082397 "Erythrocyte membrane protein band 4.1 like 3" Q9Y2J2 18 5392381-5630700 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 46.8" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 163.9;Late spermatids: 207.6;Syncytiotrophoblasts: 179.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 7.7;non-classical monocyte: 11.6" "Lineage enriched" "Detected in many" 4 "monocytes: 11.6" "Cell line enhanced" "Detected in many" "ASC TERT1: 20.9;HUVEC TERT2: 18.9;SCLC-21H: 21.2;TIME: 51.8;U-2 OS: 18.9;U-2197: 18.4;U-251 MG: 22.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA028605 Enhanced Enhanced "Plasma membrane,Cell Junctions" NA NA 140000 "Plasma membrane, Cell Junctions" "HPA028605: AB_10611963" "unprognostic (3.58e-3)" "unprognostic (1.17e-2)" "unprognostic (3.61e-1)" "unprognostic (7.97e-2)" "unprognostic (1.88e-1)" "unprognostic (1.44e-2)" "unprognostic (2.60e-1)" "unprognostic (9.73e-2)" "unprognostic (3.40e-1)" "unprognostic (3.63e-3)" "unprognostic (1.07e-3)" "unprognostic (5.81e-2)" "unprognostic (5.96e-2)" "unprognostic (5.65e-3)" "unprognostic (8.99e-2)" "unprognostic (2.72e-2)" "unprognostic (6.59e-3)" 17.1 19.4 12.0 16.4 32.1 2.5 8.9 35.9 36.3 5.1 10.6 36.2 1.4 29.8 5.8 7.1 6.8 8.8 6.0 6.0 11.3 16.6 21.0 3.1 8.8 8.8 46.4 15.9 7.8 4.4 14.7 9.0 12.7 46.8 4.0 8.4 3.8 3.6 5.0 4.6 3.5 27.9 8.3 27.2 10.5 3.2 35.9 36.6 0.9 4.0 1.5 2.6 5.6 5.8 0.0 2.5 0.7 11.6 0.0 0.6 0.7 0.1 0.3 1.2 0.0 17.9 20.9 14.1 4.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 12.4 7.5 0.0 12.2 0.0 0.0 0.0 10.9 0.0 0.1 0.0 0.0 0.0 1.4 10.9 0.0 3.9 0.0 5.2 18.9 0.0 0.1 0.1 0.0 0.0 0.1 0.2 2.5 0.0 4.0 0.0 0.0 0.0 0.1 1.5 21.2 0.1 0.0 0.1 8.3 10.5 0.2 1.5 51.8 0.1 18.9 18.4 22.2 0.0 0.0 0.0 0.0 1.7 2.1 0.0 4.5 0.0 0.0 7.7 0.0 0.0 0.0 0.0 2.5 0.0 0.6 0.0 0.7 0.0 11.6 0.0 0.0 0.7 12.0 32.1 35.9 27.7 11.3 16.6 46.4 15.9 46.8 36.6 17.9 8.3 0.0 3.7 14.2 75.0 2.0 5.1 2.7 3.4 7.0 72.6 84.0 13.3 0.3 163.9 11.1 47.9 0.0 0.6 44.2 10.4 3.0 0.0 0.5 50.4 3.2 8.7 3.7 66.5 207.6 20.8 56.6 10.1 55.9 6.1 2.9 1.2 7.0 7.4 56.6 13.2 0.0 5.0 1.9 3.0 7.3 179.0 2.2 7.2 1.3 EPB41L4A NBL4 ENSG00000129595 "Erythrocyte membrane protein band 4.1 like 4A" Q9HCS5 5 112142441-112419316 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Cholangiocytes: 68.8;Ciliated cells: 42.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "EFO-21: 20.0;HeLa: 22.6;RT4: 13.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA036580 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036580: AB_10669908" "unprognostic (1.40e-1)" "unprognostic (1.90e-1)" "unprognostic (1.92e-3)" "unprognostic (3.64e-2)" "unprognostic (4.73e-2)" "unprognostic (5.59e-3)" "unprognostic (4.40e-2)" "unprognostic (8.38e-2)" "unprognostic (1.90e-1)" "unprognostic (3.97e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-3)" "prognostic favorable (3.65e-5)" "unprognostic (1.68e-1)" "unprognostic (3.35e-2)" "unprognostic (2.73e-1)" "unprognostic (1.92e-1)" 21.4 3.7 3.5 5.0 4.0 2.1 19.0 2.1 6.1 7.3 3.0 1.7 22.1 1.9 6.1 11.3 13.6 6.2 11.7 9.3 4.0 3.1 10.0 4.8 21.9 6.9 3.7 2.0 4.9 4.2 14.3 4.3 8.9 3.7 5.3 3.8 10.5 7.7 22.0 6.8 7.2 3.2 5.9 4.3 6.7 4.3 4.8 1.9 2.1 15.7 8.2 6.9 5.5 12.2 3.6 0.5 1.3 1.2 0.4 4.8 0.9 0.5 3.5 9.2 0.9 0.0 0.0 1.9 1.3 0.0 0.0 0.0 1.9 7.8 3.8 20.0 0.0 0.5 4.7 0.6 4.3 0.0 0.6 3.2 6.1 22.6 1.2 0.1 1.6 2.0 0.0 1.9 0.0 0.0 1.0 5.8 1.1 1.2 3.6 0.0 1.1 2.8 2.1 1.7 0.7 0.7 1.4 7.0 0.8 5.4 13.6 7.7 4.0 6.8 3.4 2.7 6.7 10.2 0.8 10.0 0.4 1.6 1.2 2.7 3.6 0.7 2.9 0.9 3.2 0.5 1.3 0.4 0.2 4.8 0.6 2.7 3.6 1.5 1.4 0.5 3.3 2.4 4.7 0.5 0.4 1.2 0.3 1.4 0.9 3.5 4.0 2.1 3.9 4.0 3.1 3.7 2.0 3.7 1.9 26.8 7.7 4.2 14.0 5.4 4.0 7.6 68.8 42.8 27.3 14.0 3.9 6.0 10.0 12.3 16.7 18.0 2.6 0.0 6.8 0.9 6.7 12.1 8.1 1.7 2.1 1.6 1.2 30.1 5.6 14.1 1.7 1.3 3.3 4.6 6.3 7.7 10.4 10.5 1.8 20.3 31.5 0.0 4.7 1.6 6.1 7.0 2.1 1.7 4.5 16.3 EPB41L4B EHM2 ENSG00000095203 "Erythrocyte membrane protein band 4.1 like 4B" Q9H329 9 109171975-109320964 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 28.1;pancreas: 59.8" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 67.5;Hepatocytes: 107.1;Intestinal endocrine cells: 49.7;Mucus-secreting cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 16.0;hTCEpi: 25.1;OE19: 30.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042862 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042862: AB_10794534" "prognostic unfavorable (1.02e-4)" "unprognostic (6.58e-2)" "unprognostic (2.33e-2)" "unprognostic (1.20e-1)" "unprognostic (2.31e-2)" "unprognostic (1.74e-1)" "unprognostic (2.40e-2)" "unprognostic (6.19e-2)" "unprognostic (2.72e-2)" "unprognostic (1.40e-1)" "unprognostic (3.60e-1)" "unprognostic (6.20e-2)" "unprognostic (8.82e-4)" "unprognostic (1.46e-3)" "unprognostic (1.43e-1)" "unprognostic (4.65e-2)" "unprognostic (1.29e-1)" 6.5 4.2 7.3 1.2 14.6 0.0 4.8 4.9 11.4 1.1 18.4 1.5 7.1 15.1 0.7 5.9 0.7 3.2 1.8 3.5 2.9 3.5 1.9 28.1 1.7 0.2 1.6 6.8 4.7 59.8 3.3 0.9 1.1 2.7 2.2 18.7 2.4 8.0 3.5 2.2 5.6 16.1 0.3 2.2 0.2 9.4 2.7 1.3 0.4 14.6 1.3 1.2 1.2 1.3 0.8 0.0 0.1 0.0 0.0 0.0 0.0 4.2 5.3 0.3 0.4 0.4 0.0 16.0 0.5 0.2 1.8 0.9 9.0 4.2 0.0 1.1 0.5 4.5 6.9 10.6 5.6 2.0 4.4 2.5 0.0 1.7 12.8 1.1 0.2 0.0 0.1 25.1 0.7 8.6 0.5 0.1 3.9 0.1 0.0 2.6 10.7 0.1 0.1 6.9 30.4 7.8 0.0 0.0 0.2 6.4 6.4 6.6 0.7 1.7 11.1 0.0 3.3 2.6 0.0 0.2 3.8 3.9 1.2 1.5 0.0 0.0 0.0 2.8 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 14.6 4.9 11.4 2.9 3.5 1.6 6.8 2.7 1.3 6.0 3.2 0.8 4.6 10.2 8.3 14.9 22.9 16.0 5.7 7.0 0.0 3.3 0.0 3.2 8.7 0.7 67.5 0.0 18.0 1.6 2.2 9.9 0.0 107.1 0.5 36.5 49.7 4.3 1.6 1.5 12.4 0.2 1.7 0.0 52.8 1.8 12.8 37.4 2.5 0.6 1.0 0.0 0.4 1.4 14.8 21.0 1.6 0.0 34.5 5.7 EPHB2 "DRT, EPHT3, ERK, Hek5, Tyro5" ENSG00000133216 "EPH receptor B2" P29323 1 22710839-22921500 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Neurogenesis "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.0" "Cell type enhanced" "Detected in many" 11 "Ductal cells: 42.3;Intestinal endocrine cells: 46.8;Mucus-secreting cells: 53.6;Pancreatic endocrine cells: 38.4;Undifferentiated cells: 82.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.5;intermediate monocyte: 2.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "GAMG: 34.4;HUVEC TERT2: 29.7;TIME: 29.4;U-251 MG: 25.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB013647, HPA071200" Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" No No 290000 "Plasma membrane" Nucleoplasm "CAB013647: , HPA071200: AB_2686360" "unprognostic (2.47e-2)" "unprognostic (2.43e-2)" "prognostic favorable (4.98e-4)" "prognostic unfavorable (1.05e-5)" "unprognostic (3.99e-2)" "unprognostic (8.91e-3)" "unprognostic (1.23e-1)" "unprognostic (2.33e-3)" "unprognostic (1.56e-1)" "unprognostic (7.73e-2)" "unprognostic (1.23e-2)" "unprognostic (2.15e-2)" "unprognostic (2.16e-4)" "unprognostic (1.45e-1)" "unprognostic (8.07e-2)" "unprognostic (2.58e-1)" "unprognostic (3.46e-2)" 3.7 2.9 3.4 15.4 5.4 0.9 2.5 1.9 8.2 3.8 23.9 16.2 4.6 21.6 2.5 3.2 1.1 5.4 4.4 5.4 5.6 6.5 3.5 1.1 3.0 5.5 12.7 3.8 17.9 5.4 6.1 5.4 12.0 8.2 3.3 25.0 2.2 6.6 4.0 0.7 1.8 22.6 4.0 12.1 3.3 2.3 2.9 9.3 0.1 8.4 1.0 2.1 5.3 3.3 0.1 0.6 0.3 2.5 0.1 0.1 0.4 15.9 6.7 6.5 10.4 0.6 0.6 0.0 3.7 0.2 11.3 2.4 2.3 6.4 0.2 8.0 1.6 34.4 15.1 4.4 21.7 3.0 0.0 1.6 0.0 0.7 0.0 6.8 0.0 1.6 2.2 7.0 20.2 0.1 10.0 29.7 0.9 0.6 0.0 2.2 2.3 0.3 0.1 1.5 17.8 4.4 1.9 6.7 0.3 5.5 1.5 7.1 7.4 6.5 0.2 0.0 0.6 0.4 0.2 29.4 4.5 11.8 11.4 25.5 0.0 0.1 0.0 8.4 0.3 0.1 0.3 2.5 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.6 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.4 3.4 5.4 1.9 8.2 5.6 6.5 12.7 3.8 8.2 9.3 3.0 0.0 0.0 1.5 0.7 11.6 1.2 12.7 1.4 3.4 0.0 0.0 0.4 0.0 42.3 2.3 0.5 6.8 0.0 6.8 2.2 1.5 1.4 0.0 0.5 9.1 6.4 46.8 0.6 7.5 0.4 0.9 3.7 0.0 0.0 53.6 20.9 38.4 3.5 0.7 0.0 1.7 0.0 1.7 0.5 2.6 0.4 0.9 0.0 82.9 1.0 EPOR ENSG00000187266 "Erythropoietin receptor" P19235 19 11377205-11384342 "Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted membrane proteins" Receptor "Cancer-related genes, Congenital erythrocytosis, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 70.0;Ito cells: 78.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA077654 Supported "Nuclear speckles,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077654: " "unprognostic (9.13e-2)" "unprognostic (7.14e-2)" "unprognostic (1.45e-2)" "unprognostic (1.04e-1)" "unprognostic (1.88e-1)" "unprognostic (1.11e-1)" "unprognostic (3.70e-1)" "unprognostic (1.50e-2)" "unprognostic (5.60e-2)" "unprognostic (9.00e-2)" "prognostic favorable (3.17e-5)" "unprognostic (6.37e-3)" "unprognostic (1.59e-2)" "unprognostic (2.08e-1)" "unprognostic (2.00e-1)" "unprognostic (7.48e-2)" "unprognostic (1.01e-3)" 5.5 8.6 2.1 1.1 2.9 14.7 2.6 1.3 1.7 3.9 3.3 2.8 13.3 1.0 3.6 11.6 2.4 3.2 1.8 11.2 1.9 1.4 12.1 8.4 8.5 6.9 1.9 1.6 1.9 9.2 28.1 5.2 12.7 2.3 3.1 1.4 3.3 8.7 18.3 2.0 1.1 1.7 1.5 4.0 8.0 3.7 2.2 1.0 1.6 21.5 1.0 1.5 1.9 2.1 2.6 2.5 12.2 7.7 0.9 4.8 2.9 3.5 1.2 3.5 4.1 5.4 3.4 2.1 2.2 6.8 3.6 4.6 1.2 1.3 2.4 3.9 4.0 5.0 0.9 2.7 1.4 4.2 2.0 1.6 13.1 1.1 2.0 3.8 2.7 5.5 2.5 0.5 4.8 3.3 8.4 8.3 5.1 11.6 11.7 4.0 3.1 2.5 3.3 1.9 1.9 9.4 6.7 6.0 5.3 3.3 1.8 1.4 11.0 1.4 2.0 6.1 3.9 3.6 4.7 3.4 1.9 2.7 6.5 2.0 6.0 4.3 2.6 10.5 2.7 2.0 8.1 4.2 3.3 2.1 5.1 4.5 2.6 4.2 3.1 2.5 1.6 4.8 2.8 12.2 0.9 7.7 0.1 3.7 2.9 2.1 2.9 1.3 1.7 1.9 1.4 1.9 1.6 2.3 1.0 17.9 16.8 5.3 3.5 2.1 2.5 5.1 7.6 2.7 4.5 19.2 0.0 1.8 3.3 2.0 0.7 6.5 0.3 70.0 2.9 11.5 7.6 2.4 26.5 1.9 32.5 1.6 8.1 78.5 15.6 0.0 2.6 3.1 8.5 1.0 2.3 11.1 3.8 0.0 3.9 0.8 2.2 19.4 20.8 3.3 6.4 0.9 2.5 8.7 1.4 1.1 EPS8L2 "FLJ21935, FLJ22171, MGC3088" ENSG00000177106 "EPS8 like 2" Q9H6S3 11 694438-727727 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 73.3" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 1: 131.0;Enterocytes: 200.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 6.4" "Lineage enriched" "Detected in single" 8 "dendritic cells: 6.4" "Cell line enhanced" "Detected in many" "A-431: 46.7;BEWO: 46.2;CAPAN-2: 44.0;SK-BR-3: 54.0" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 10 "cerebellum: 13.6" HPA041143 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041143: AB_10794985" "unprognostic (1.39e-2)" "unprognostic (1.07e-1)" "unprognostic (7.58e-2)" "unprognostic (3.40e-2)" "prognostic unfavorable (2.31e-4)" "unprognostic (6.87e-2)" "unprognostic (3.27e-2)" "unprognostic (1.33e-1)" "unprognostic (4.82e-2)" "unprognostic (4.26e-2)" "unprognostic (2.54e-1)" "unprognostic (1.92e-1)" "unprognostic (3.25e-2)" "unprognostic (2.51e-2)" "unprognostic (4.19e-1)" "unprognostic (2.79e-1)" "unprognostic (5.03e-2)" 1.7 3.0 2.0 6.4 3.3 0.0 12.4 6.9 2.5 11.6 31.5 1.2 23.9 38.7 4.6 10.1 53.3 5.3 21.7 1.0 1.3 1.6 30.4 38.3 18.0 0.4 1.7 0.5 3.9 11.6 1.8 4.3 39.6 3.6 8.4 6.0 2.7 26.2 17.6 0.7 22.8 73.3 2.4 2.4 0.5 18.0 7.2 1.5 0.9 29.5 29.4 33.7 6.9 19.2 0.2 6.4 0.7 0.1 0.1 0.1 0.1 46.7 14.3 0.0 0.3 0.5 3.2 46.2 4.1 4.2 6.1 2.6 10.7 44.0 0.1 17.1 4.3 1.1 24.8 0.1 24.8 1.4 0.1 0.9 0.0 5.3 19.2 3.5 0.0 0.0 1.7 16.6 1.8 4.3 2.5 0.0 0.0 0.3 0.2 0.7 15.0 0.1 0.2 0.5 14.6 4.6 0.1 0.1 0.3 21.7 11.7 0.1 0.1 14.6 54.0 0.1 3.2 20.4 0.0 0.3 2.5 5.8 1.5 0.3 0.1 0.2 0.1 1.3 0.1 0.1 0.0 0.0 0.7 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 0.0 6.4 0.0 0.1 2.0 3.3 6.9 2.5 1.3 1.6 1.7 0.5 3.6 1.5 131.0 60.0 7.3 23.9 17.5 0.8 3.6 53.5 33.5 51.2 85.5 0.0 43.8 23.2 45.5 1.0 3.0 200.0 0.0 70.5 25.8 7.1 28.6 6.9 55.5 4.3 0.0 42.1 0.6 1.3 1.7 16.7 3.2 13.5 3.6 61.8 8.9 66.1 98.2 11.0 84.7 0.7 0.0 5.1 0.7 4.1 21.3 77.3 21.0 62.0 26.8 ERBB2 "CD340, HER-2, HER2, NEU, NGL" ENSG00000141736 "Erb-b2 receptor tyrosine kinase 2" P04626 17 39687914-39730426 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Transcription, Transcription regulation" "Activator, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Collecting duct cells: 129.1;Enterocytes: 93.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "gdT-cell: 8.8" "Lineage enriched" "Detected in many" 4 "T-cells: 8.8" "Group enriched" "Detected in many" 41 "OE19: 366.2;SK-BR-3: 179.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB000043, HPA001060, HPA001338, HPA001383, CAB020416, CAB062555" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 430000 "Plasma membrane" Cytosol "CAB000043: AB_2335701, CAB020416: AB_442047, CAB062555: AB_2665610, HPA001060: AB_2666185, HPA001338: AB_2666279, HPA001383: AB_1078500" "unprognostic (1.97e-1)" "unprognostic (6.60e-3)" "unprognostic (6.21e-2)" "prognostic unfavorable (8.99e-8)" "unprognostic (2.96e-2)" "unprognostic (1.40e-2)" "unprognostic (1.97e-2)" "unprognostic (9.04e-2)" "unprognostic (1.79e-2)" "unprognostic (1.20e-3)" "prognostic unfavorable (9.17e-4)" "unprognostic (3.92e-1)" "prognostic favorable (2.41e-14)" "unprognostic (9.29e-2)" "unprognostic (1.40e-1)" "unprognostic (3.75e-2)" "unprognostic (1.96e-1)" 5.8 2.4 5.2 10.4 7.0 0.1 20.1 4.2 7.0 19.1 46.5 9.1 55.2 21.6 14.9 18.7 40.9 22.7 26.6 24.8 6.3 3.1 37.5 21.5 17.6 3.7 5.1 5.6 19.3 16.2 27.7 8.1 60.8 7.5 23.6 16.6 15.9 28.7 58.1 8.9 35.3 47.2 10.9 4.5 4.0 17.1 6.5 3.7 2.8 35.7 20.8 22.9 19.7 20.3 1.3 0.3 2.1 0.4 0.9 8.8 2.2 2.1 2.5 2.9 1.8 3.5 2.4 3.9 1.5 2.5 3.3 2.8 1.9 5.8 0.1 3.1 3.5 1.8 6.7 0.1 3.4 1.5 0.2 2.2 0.1 2.0 3.1 2.0 0.0 0.0 2.4 3.2 2.0 1.2 3.2 1.3 0.1 0.3 0.1 2.4 3.3 0.3 0.1 5.2 366.2 0.6 0.2 1.1 0.3 3.4 6.7 0.5 0.1 2.9 179.8 0.9 3.7 5.0 0.1 0.1 1.7 2.2 2.1 0.9 0.3 0.1 0.1 0.1 0.0 5.6 1.6 0.4 0.8 8.8 0.3 0.7 0.9 0.5 2.5 0.3 1.3 1.0 2.5 2.1 0.9 0.2 0.2 0.4 2.2 5.2 7.0 4.2 7.0 6.3 3.1 5.1 5.6 7.5 3.7 38.7 34.4 1.3 21.0 12.5 4.3 13.5 30.6 10.7 15.9 129.1 11.8 9.7 6.6 27.1 0.3 4.6 93.2 0.0 22.3 75.4 11.0 33.4 0.0 10.4 3.5 6.4 15.0 12.3 2.4 0.7 17.0 1.8 10.1 1.0 56.6 30.9 26.2 42.1 21.5 20.7 5.9 0.0 10.3 7.1 5.3 16.6 19.0 2.2 63.0 28.1 ERBB3 "HER3, LCCS2" ENSG00000065361 "Erb-b2 receptor tyrosine kinase 3" P21860 12 56076799-56103505 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Cholangiocytes: 180.9;Enterocytes: 163.1;Paneth cells: 165.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.3" "Lineage enriched" "Detected in many" 4 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "Hep G2: 30.9;MCF7: 20.2;OE19: 31.8;RT4: 24.2;SK-BR-3: 28.4;SK-MEL-30: 37.9;T-47d: 31.5;WM-115: 40.2" "Low region specificity" "Detected in many" "CAB025331, HPA045396" Uncertain Supported "Plasma membrane,Actin filaments" "Secreted - unknown location" NA NA 420000 "Plasma membrane" "Actin filaments" "CAB025331: , HPA045396: AB_2679312" "unprognostic (2.97e-1)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (8.97e-2)" "unprognostic (1.63e-1)" "unprognostic (1.07e-3)" "unprognostic (2.31e-3)" "unprognostic (2.66e-2)" "unprognostic (9.89e-2)" "unprognostic (4.30e-2)" "unprognostic (4.76e-3)" "unprognostic (5.77e-2)" "unprognostic (1.06e-2)" "unprognostic (4.56e-2)" "unprognostic (1.57e-1)" "unprognostic (6.72e-3)" "unprognostic (2.07e-2)" 1.1 1.4 11.6 12.6 16.5 0.6 26.8 2.0 16.7 6.8 40.5 40.3 12.0 37.7 2.8 7.5 29.4 5.7 22.9 3.4 18.6 9.0 16.5 33.9 13.4 0.5 23.5 9.3 0.9 21.5 11.4 1.0 15.4 14.9 16.8 29.7 5.5 36.8 22.3 1.1 30.7 41.3 3.2 27.4 0.5 32.9 1.2 23.8 0.0 4.5 7.4 8.5 11.8 14.4 0.9 0.7 5.3 0.6 1.2 1.2 0.2 10.0 0.6 0.8 0.3 0.0 0.0 16.4 0.8 1.9 1.1 1.1 5.5 18.2 0.0 0.2 0.2 0.1 8.6 1.2 1.9 0.6 0.2 0.8 0.0 0.3 30.9 0.0 0.0 0.1 0.4 2.5 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.1 20.2 0.1 0.3 2.8 31.8 0.4 0.1 1.9 0.5 2.1 24.2 0.9 0.3 0.7 28.4 37.9 2.7 31.5 0.1 0.0 0.1 1.1 0.6 0.1 0.2 0.1 0.1 0.1 0.0 40.2 5.3 0.4 0.8 0.9 0.4 0.4 0.4 0.7 0.3 0.3 0.9 0.6 1.2 3.3 1.2 0.6 0.7 0.8 0.2 11.6 16.5 2.0 16.7 18.6 9.0 23.5 9.3 14.9 23.8 110.2 61.2 1.3 13.0 16.3 1.5 1.4 180.9 21.4 61.4 33.2 2.0 44.4 1.7 41.9 0.9 2.2 163.1 0.0 77.1 73.6 2.7 83.4 1.1 83.9 5.5 0.0 89.5 6.7 1.9 0.0 1.4 1.7 52.3 2.8 134.3 11.3 75.9 165.5 0.0 31.8 1.1 6.5 1.7 2.4 2.3 32.2 84.1 1.5 124.3 62.5 ERBIN "ERBB2IP, LAP2" ENSG00000112851 "Erbb2 interacting protein" Q96RT1 5 65926475-66082549 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 65.5;Alveolar cells type 2: 48.1;Ciliated cells: 44.2;Club cells: 58.0;Collecting duct cells: 50.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048606, HPA059863" Approved Supported "Nuclear speckles,Plasma membrane" NA NA 250000 "Nuclear speckles, Plasma membrane" "HPA048606: AB_2680461, HPA059863: AB_2684146" "unprognostic (4.34e-1)" "unprognostic (5.56e-2)" "unprognostic (9.88e-2)" "unprognostic (2.15e-2)" "unprognostic (2.04e-1)" "unprognostic (4.23e-3)" "unprognostic (1.74e-1)" "unprognostic (1.01e-1)" "unprognostic (1.46e-2)" "unprognostic (6.52e-2)" "unprognostic (5.45e-3)" "unprognostic (7.98e-2)" "unprognostic (5.62e-3)" "unprognostic (7.21e-3)" "unprognostic (3.08e-1)" "unprognostic (6.86e-2)" "unprognostic (7.81e-2)" 20.1 8.7 33.2 28.5 32.7 13.3 13.0 5.4 15.9 16.1 21.1 10.6 16.3 12.1 14.5 22.1 17.2 10.5 17.2 12.6 29.5 22.5 15.8 24.1 20.1 21.1 32.5 7.4 11.1 13.7 15.4 6.9 10.4 16.0 18.2 13.8 11.1 17.3 26.0 16.4 16.9 37.4 15.3 31.0 27.6 20.3 13.3 17.6 40.2 19.6 16.3 19.6 20.7 14.9 6.2 4.5 13.5 7.6 5.0 7.1 3.6 30.6 10.3 13.5 16.1 10.1 12.3 10.3 19.7 20.3 28.2 31.5 9.8 36.6 25.9 19.3 30.5 22.2 10.3 8.6 14.4 49.9 11.3 3.9 9.0 13.1 7.7 13.3 6.8 8.7 13.3 9.6 15.4 22.5 16.6 10.4 11.9 9.0 17.8 19.0 10.4 18.1 7.9 3.3 3.0 3.0 16.7 10.9 14.2 16.5 20.9 6.6 6.1 21.0 7.0 14.9 10.6 12.2 16.9 9.5 16.0 28.5 9.6 25.3 15.4 9.6 22.2 10.5 11.4 9.1 13.5 5.2 6.7 7.1 7.6 6.5 6.2 5.5 6.3 4.5 4.9 6.5 6.7 11.9 5.0 6.0 2.9 4.8 3.6 33.2 32.7 5.4 15.3 29.5 22.5 32.5 7.4 16.0 17.6 65.5 48.1 0.0 0.0 0.0 0.0 0.0 0.0 44.2 58.0 50.6 0.0 5.1 10.0 23.8 0.0 0.0 0.0 0.0 21.5 8.9 0.0 0.0 25.6 0.0 34.1 0.0 0.0 0.0 0.0 0.0 0.0 17.6 0.0 10.0 0.0 0.0 35.0 0.0 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 ERMN "ERMIN, JN, KIAA1189" ENSG00000136541 Ermin Q8TAM6 2 157318625-157327713 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 106.7" "Cell type enhanced" "Detected in some" 12 "Alveolar cells type 2: 2.2;Early spermatids: 1.2;Kupffer cells: 1.2;Macrophages: 1.1;T-cells: 1.9" "Group enriched" "Detected in some" 12 "endometrial cancer: 2.2;glioma: 9.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in some" 6 "HAP1: 21.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038295, HPA038296" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038295: AB_10805353, HPA038296: AB_10796217" "unprognostic (7.89e-2)" "unprognostic (9.06e-3)" "unprognostic (2.71e-2)" "prognostic favorable (6.93e-6)" "unprognostic (1.06e-1)" "unprognostic (2.02e-2)" "unprognostic (9.14e-2)" "unprognostic (1.79e-1)" "unprognostic (4.57e-2)" "unprognostic (4.40e-2)" "unprognostic (1.07e-1)" "unprognostic (5.49e-2)" "unprognostic (1.46e-3)" "unprognostic (2.84e-2)" "unprognostic (7.96e-2)" "unprognostic (9.97e-3)" "unprognostic (5.76e-2)" 1.6 1.4 29.1 2.9 50.5 9.7 1.6 2.7 106.7 1.4 1.8 52.4 0.0 1.8 1.6 1.5 1.7 1.4 1.9 1.6 40.9 21.4 1.5 1.5 2.0 3.1 75.1 18.4 1.5 1.6 1.4 0.1 1.4 54.5 1.5 1.9 4.3 2.4 1.5 1.7 1.9 1.9 1.6 100.9 2.5 2.2 1.7 69.5 0.0 1.6 0.0 2.7 1.7 0.1 1.7 1.3 3.9 1.6 2.4 2.1 0.7 0.1 0.3 0.3 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.1 0.2 1.2 0.0 2.0 0.0 0.3 21.3 0.0 0.0 0.0 0.0 0.2 0.2 0.4 0.0 0.7 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 2.8 0.4 0.2 0.8 2.3 0.3 0.1 0.5 0.0 0.4 0.5 0.0 1.0 0.4 0.6 0.0 0.1 0.0 0.3 0.7 1.3 0.0 0.2 0.1 0.2 0.6 3.5 2.0 0.6 1.8 1.0 1.0 2.6 1.6 1.1 2.1 1.2 1.0 0.7 0.8 0.6 0.6 1.7 1.5 1.6 3.9 2.4 1.0 1.3 0.9 0.7 29.1 50.5 2.7 27.9 40.9 21.4 75.1 18.4 54.5 69.5 0.0 2.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.6 1.2 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 EVA1A "FAM176A, FLJ13391, TMEM166" ENSG00000115363 "Eva-1 homolog A, regulator of programmed cell death" Q9H8M9 2 75469302-75569722 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Apoptosis, Autophagy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 69.4;pancreas: 32.3" "Cell type enhanced" "Detected in many" 9 "Hepatocytes: 71.0;Proximal tubular cells: 53.7;Syncytiotrophoblasts: 104.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.1;naive CD8 T-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.2;U-138 MG: 36.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008055 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA008055: AB_1080308" "unprognostic (2.72e-1)" "unprognostic (2.61e-2)" "unprognostic (4.14e-3)" "unprognostic (1.01e-1)" "unprognostic (1.36e-2)" "unprognostic (3.60e-2)" "unprognostic (5.02e-2)" "unprognostic (1.77e-2)" "unprognostic (1.77e-1)" "prognostic favorable (5.67e-4)" "unprognostic (7.33e-2)" "unprognostic (1.22e-1)" "prognostic favorable (5.80e-4)" "unprognostic (8.19e-2)" "unprognostic (4.37e-2)" "unprognostic (2.43e-2)" "unprognostic (9.07e-2)" 0.6 0.3 0.3 0.7 0.5 0.0 1.2 0.3 0.2 3.7 0.6 0.1 11.4 0.5 1.6 5.1 0.5 1.3 0.4 0.6 0.3 0.3 23.6 69.4 15.2 0.1 0.8 0.0 0.8 32.3 0.8 0.8 26.6 0.5 0.6 0.2 5.7 14.3 13.5 0.9 1.5 1.1 0.7 0.4 5.9 0.4 2.2 0.3 3.3 1.2 0.8 0.8 0.3 0.6 0.8 0.0 0.0 0.0 0.0 1.1 0.7 0.3 4.6 0.5 0.1 1.0 7.1 0.5 21.7 14.6 19.4 9.9 0.1 0.4 0.0 2.0 27.2 17.8 3.0 0.5 4.6 12.2 0.0 0.3 0.0 0.8 14.4 0.7 0.0 0.0 5.0 2.7 23.9 11.0 19.5 12.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 1.0 0.0 7.5 2.4 0.0 0.0 10.7 0.1 0.3 0.5 2.0 0.1 16.6 0.7 0.0 0.1 9.8 36.5 15.3 0.6 22.6 0.2 0.0 0.0 20.7 0.0 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 1.1 1.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.5 0.3 0.2 0.3 0.3 0.8 0.0 0.5 0.3 38.7 30.7 2.7 9.2 2.5 0.8 0.2 0.0 1.4 36.4 10.4 0.0 33.7 23.2 27.0 11.0 1.3 0.0 0.0 14.2 17.5 2.1 5.2 0.0 71.0 3.2 0.0 1.7 3.7 0.6 8.2 0.3 0.8 27.0 0.0 0.0 0.0 15.1 0.0 0.7 53.7 0.0 0.0 1.0 1.7 0.4 0.6 104.4 0.0 0.0 10.0 EXOC3L1 "EXOC3L, FLJ35539, FLJ35587" ENSG00000179044 "Exocyst complex component 3 like 1" Q86VI1 16 67184366-67190204 "Predicted intracellular proteins" Exocytosis "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 26.6" "Cell type enhanced" "Detected in many" 13 "Endothelial cells: 11.7;Ito cells: 32.5;Leydig cells: 14.4;Peritubular cells: 17.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "neutrophil: 1.8;non-classical monocyte: 2.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.1;HUVEC TERT2: 5.8;SCLC-21H: 11.1;SuSa: 3.8;TIME: 4.0" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA029574 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA029574: AB_10602495" "unprognostic (1.15e-2)" "unprognostic (4.91e-2)" "unprognostic (6.87e-3)" "unprognostic (2.09e-3)" "unprognostic (2.33e-1)" "unprognostic (2.46e-2)" "unprognostic (6.77e-2)" "unprognostic (3.98e-2)" "unprognostic (1.55e-1)" "unprognostic (1.26e-2)" "unprognostic (6.48e-3)" "unprognostic (2.88e-1)" "unprognostic (6.64e-3)" "unprognostic (3.40e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.35e-1)" 4.5 2.4 0.3 1.8 0.9 0.0 2.4 0.4 1.2 1.4 0.6 0.3 0.3 0.8 3.6 0.8 1.2 0.9 1.5 4.5 1.3 0.2 3.3 1.4 8.7 1.8 0.3 0.8 2.0 1.0 0.4 1.1 6.0 1.0 1.6 0.3 2.4 1.1 0.5 1.8 0.7 1.0 0.8 1.0 26.6 0.7 1.0 0.3 0.3 4.1 1.0 0.5 1.0 0.5 0.0 0.7 1.8 2.0 0.0 0.0 0.3 0.2 0.1 1.2 0.4 0.0 0.1 3.1 0.4 0.0 0.0 0.0 1.4 0.3 0.1 1.7 0.0 0.3 0.1 0.0 0.0 0.0 0.2 0.3 0.8 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 5.8 0.6 0.5 0.0 0.1 0.2 0.3 0.1 0.5 0.1 0.6 1.3 1.2 0.2 0.0 0.2 11.1 1.3 1.5 0.3 0.1 3.8 1.0 0.1 4.0 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.8 0.0 0.3 0.0 1.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 1.8 0.0 2.0 0.0 0.0 0.3 0.3 0.9 0.4 1.2 1.3 0.2 0.3 0.8 1.0 0.3 0.0 0.0 0.0 1.6 0.8 1.7 0.8 0.0 0.0 0.0 3.5 0.0 0.4 6.6 0.7 1.6 11.7 4.2 0.0 3.3 2.5 0.2 0.3 0.0 0.8 0.8 3.2 1.2 32.5 1.5 3.1 14.4 0.3 0.0 1.0 3.3 0.2 0.5 1.7 17.3 0.1 0.8 0.0 0.1 0.4 0.9 1.8 0.7 0.0 2.3 1.3 FABP5 "E-FABP, KFABP, PA-FABP" ENSG00000164687 "Fatty acid binding protein 5" Q01469 8 81280363-81284777 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 237.0;tongue: 204.1;vagina: 141.9" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 1256.0;Hofbauer cells: 2357.3;monocytes: 1172.2" "Cancer enhanced" "Detected in all" "cervical cancer: 268.3;head and neck cancer: 288.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 93.8;MOLT-4: 91.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "CAB017831, CAB040577, HPA051895" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 28000000 Cytosol "Plasma membrane" "CAB017831: , CAB040577: , HPA051895: AB_2681654" "unprognostic (8.76e-2)" "unprognostic (7.28e-2)" "unprognostic (1.54e-2)" "unprognostic (9.04e-2)" "unprognostic (1.33e-3)" "unprognostic (1.37e-1)" "unprognostic (1.95e-3)" "unprognostic (4.03e-3)" "unprognostic (2.71e-1)" "unprognostic (3.13e-1)" "unprognostic (6.16e-2)" "unprognostic (3.57e-2)" "prognostic unfavorable (4.69e-10)" "unprognostic (1.99e-1)" "unprognostic (3.72e-1)" "unprognostic (1.61e-1)" "unprognostic (6.60e-2)" 41.4 1.5 8.5 11.8 13.2 8.5 37.3 5.5 8.9 78.7 20.6 7.9 2.2 8.0 5.7 3.1 237.0 2.1 8.5 27.1 8.5 9.8 1.6 2.7 24.8 15.1 7.6 5.0 2.0 8.7 0.7 1.9 30.0 19.1 4.4 18.2 4.2 32.9 1.6 9.4 42.9 9.7 4.5 23.0 14.9 15.6 3.8 10.6 6.6 4.4 204.1 25.7 19.5 141.9 6.8 20.3 2.5 5.9 8.2 5.2 4.3 5.8 16.7 10.2 0.0 48.8 4.6 0.0 11.9 0.6 9.3 11.8 0.2 8.0 93.8 6.8 2.9 0.1 5.4 24.8 19.1 8.0 47.6 53.9 33.8 11.9 25.2 4.3 32.3 8.8 3.5 39.3 11.5 23.7 9.4 53.4 24.9 9.7 10.2 5.6 5.6 91.6 16.5 13.5 57.9 64.9 40.9 0.0 9.9 15.0 72.5 42.4 16.1 5.8 1.9 4.4 18.5 0.1 16.6 7.6 0.0 26.5 0.1 0.1 12.6 4.9 66.8 4.3 31.0 14.9 2.5 5.0 0.3 2.3 5.9 3.7 6.8 2.7 5.2 20.3 3.3 1.3 4.5 2.0 8.2 2.0 20.1 3.5 4.3 8.5 13.2 5.5 8.9 8.5 9.8 7.6 5.0 19.1 10.6 268.0 1256.0 87.2 58.7 107.4 21.2 2.8 2.5 100.4 708.6 21.0 43.2 16.9 3.3 27.1 23.0 313.1 94.4 0.0 20.3 209.8 84.3 44.5 54.3 0.8 2357.3 20.6 189.4 31.9 161.8 37.2 5.8 624.3 195.7 1172.2 116.5 252.2 31.0 459.1 4.9 0.8 41.8 355.7 66.0 131.8 169.3 147.4 22.5 71.0 321.9 172.7 FAIM "FAIM1, FLJ10582" ENSG00000158234 "Fas apoptotic inhibitory molecule" Q9NVQ4 3 138608606-138633376 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "seminal vesicle: 61.9" "Cell type enhanced" "Detected in many" 8 "Rod photoreceptor cells: 189.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-698: 45.4" "Low region specificity" "Detected in all" "HPA042440, HPA052209" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042440: AB_2677999, HPA052209: AB_2681761" "unprognostic (6.45e-2)" "unprognostic (8.21e-3)" "unprognostic (5.97e-2)" "unprognostic (1.11e-1)" "unprognostic (3.24e-1)" "unprognostic (8.31e-2)" "prognostic unfavorable (3.96e-5)" "unprognostic (4.84e-2)" "unprognostic (4.15e-2)" "unprognostic (9.23e-3)" "unprognostic (2.29e-1)" "unprognostic (2.63e-2)" "prognostic favorable (6.63e-4)" "unprognostic (4.76e-2)" "unprognostic (3.51e-1)" "unprognostic (3.43e-1)" "unprognostic (6.98e-2)" 13.7 6.6 12.3 6.7 11.6 2.6 19.0 7.8 9.9 24.5 6.8 10.2 38.5 4.7 9.6 15.1 8.8 28.5 9.0 4.7 12.2 12.5 15.4 6.0 7.6 7.2 13.9 7.1 8.4 27.5 7.2 15.4 6.1 10.7 11.4 6.0 9.1 7.2 61.9 6.1 6.2 4.2 7.2 19.6 3.7 6.7 5.4 9.1 13.2 15.2 9.3 9.6 10.3 13.2 13.9 5.0 11.1 2.6 13.9 9.1 3.4 26.9 5.3 0.5 4.8 5.2 9.8 19.4 8.3 5.0 8.8 7.6 9.1 7.9 0.0 7.4 10.9 10.2 7.1 23.1 4.7 10.0 22.1 24.1 5.1 14.6 13.1 5.8 0.0 1.6 13.7 9.3 3.3 5.1 5.4 9.5 1.9 3.3 6.9 5.4 10.2 0.1 22.8 10.5 0.8 5.3 27.2 6.3 0.7 14.0 13.4 9.1 7.7 14.8 8.2 20.8 6.0 13.9 6.7 5.8 1.8 4.2 9.0 4.0 0.0 0.1 45.4 7.3 0.0 7.2 11.1 2.4 1.7 9.1 2.6 8.5 13.9 5.0 7.2 5.0 7.9 3.4 8.5 0.3 13.9 1.7 3.5 5.4 3.4 12.3 11.6 7.8 8.2 12.2 12.5 13.9 7.1 10.7 9.1 17.9 15.6 9.3 23.8 9.6 27.4 4.5 63.7 87.0 36.4 24.4 62.8 37.0 26.6 49.3 9.6 10.8 2.0 0.0 43.5 25.4 17.6 19.1 40.4 10.2 24.6 14.3 20.3 8.6 3.5 11.1 16.1 5.5 15.1 23.4 8.3 34.0 31.2 0.0 18.7 19.0 189.9 0.0 19.6 16.8 2.2 11.4 12.2 9.6 11.5 23.3 FAM126A "DRCTNNB1A, HCC, HYCC1, hyccin" ENSG00000122591 "Family with sequence similarity 126 member A" Q9BYI3 7 22889371-23014130 "Disease related genes, Predicted intracellular proteins" "Cataract, Disease mutation, Leukodystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042873 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042873: AB_2678207" "unprognostic (7.94e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-3)" "unprognostic (1.02e-1)" "unprognostic (1.96e-1)" "unprognostic (7.38e-2)" "unprognostic (3.54e-4)" "unprognostic (1.35e-1)" "unprognostic (9.76e-3)" "unprognostic (1.30e-2)" "unprognostic (7.23e-2)" "unprognostic (6.19e-2)" "prognostic unfavorable (6.04e-7)" "prognostic unfavorable (5.99e-4)" "unprognostic (1.87e-1)" "unprognostic (2.40e-2)" "prognostic unfavorable (9.03e-4)" 15.6 6.1 12.4 13.6 16.9 4.6 14.3 1.7 10.2 10.5 10.5 9.3 1.5 9.6 10.9 4.7 16.1 7.3 12.3 12.2 11.9 6.4 6.1 8.6 15.0 16.8 12.0 5.2 8.6 7.9 1.5 13.2 16.6 10.0 9.7 5.2 11.3 8.4 6.0 28.4 6.0 10.7 13.1 8.6 14.7 6.0 22.3 11.4 12.8 8.1 10.3 14.3 10.6 15.0 9.5 5.9 16.3 12.1 3.6 5.3 3.3 9.6 4.0 19.6 7.9 18.7 29.7 3.0 29.0 29.4 12.8 19.3 6.3 3.6 8.8 5.2 23.6 28.4 3.7 19.8 6.5 21.1 4.2 7.0 7.5 6.7 4.4 16.1 12.9 8.8 12.9 4.8 26.3 25.9 25.0 14.9 5.8 16.1 26.4 23.1 2.7 7.9 10.2 19.3 0.0 8.5 8.6 19.5 4.5 3.7 3.4 6.5 0.0 11.8 0.3 12.0 17.3 5.7 9.3 14.7 44.1 5.9 22.7 15.6 36.2 14.0 30.4 28.5 6.9 38.5 3.9 4.6 16.3 2.3 9.5 1.8 7.6 3.3 2.1 5.9 9.5 1.8 2.4 0.9 3.6 12.1 2.2 5.3 3.3 12.4 16.9 1.7 9.4 11.9 6.4 12.0 5.2 10.0 11.4 3.0 13.7 13.1 5.2 22.7 39.4 18.9 2.5 1.4 4.5 3.5 2.0 9.7 0.0 6.4 27.6 31.7 1.3 0.0 4.2 11.0 31.5 4.2 8.1 17.4 12.5 15.9 7.5 24.5 27.1 16.2 18.7 26.2 33.7 12.6 1.3 7.0 3.5 0.3 18.4 4.8 4.0 19.4 33.0 40.9 9.1 21.0 5.0 13.8 1.3 6.0 FAM129A "C1orf24, GIG39, NIBAN" ENSG00000135842 "Family with sequence similarity 129 member A" Q9BZQ8 1 184790724-184974550 "Cancer-related genes, Predicted intracellular proteins" "Stress response, Translation regulation" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 129.1;urinary bladder: 90.3" "Group enriched" "Detected in many" 5 "Cardiomyocytes: 641.6;monocytes: 234.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 5 "neutrophil: 32.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 32.7" "Cell line enhanced" "Detected in many" "Karpas-707: 29.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA028172, HPA028231, HPA028657" Approved Supported "Plasma membrane,Cytosol" NA NA 40000 "Plasma membrane, Cytosol" "HPA028172: AB_10599602, HPA028231: AB_10601886, HPA028657: AB_10601680" "unprognostic (4.61e-3)" "unprognostic (3.45e-2)" "unprognostic (1.64e-3)" "unprognostic (9.46e-2)" "unprognostic (2.77e-1)" "unprognostic (3.87e-1)" "unprognostic (3.23e-2)" "unprognostic (1.30e-2)" "unprognostic (1.68e-1)" "unprognostic (6.32e-2)" "unprognostic (4.12e-1)" "unprognostic (1.32e-1)" "unprognostic (2.94e-3)" "unprognostic (9.01e-3)" "unprognostic (4.38e-2)" "unprognostic (3.73e-2)" "prognostic unfavorable (4.52e-4)" 10.1 3.5 1.1 16.9 1.8 2.3 7.8 0.8 1.3 13.0 39.3 1.0 14.9 2.5 14.6 11.0 32.3 10.7 30.4 52.2 1.1 1.1 1.8 1.2 6.1 10.7 3.0 0.5 8.0 27.3 0.8 1.9 2.9 1.7 34.6 5.1 13.8 59.3 14.7 21.4 4.1 8.3 129.1 2.1 6.5 30.0 4.1 1.3 4.9 4.7 14.7 8.7 90.3 20.3 0.5 2.3 32.7 1.5 2.6 5.3 0.8 13.8 0.1 0.0 0.0 9.9 15.1 0.5 7.1 14.7 6.2 7.8 0.0 5.9 0.0 4.7 18.3 1.6 15.7 0.8 0.5 10.0 27.6 1.1 5.8 2.9 0.0 23.2 18.8 6.6 13.8 22.7 18.0 21.9 4.4 0.0 2.1 1.3 29.4 0.2 0.0 0.6 3.3 3.8 0.0 1.5 4.4 3.4 0.2 8.5 0.2 0.8 0.7 0.1 0.0 10.2 2.5 3.1 6.0 1.1 12.3 0.0 2.2 14.6 24.7 9.7 2.9 24.1 7.9 12.0 7.1 1.5 4.7 2.5 0.9 2.1 0.5 2.2 2.3 2.3 0.1 0.2 0.9 32.7 2.6 0.3 0.2 5.3 0.8 1.1 1.8 0.8 1.3 1.1 1.1 3.0 0.5 1.7 1.3 8.9 24.2 6.6 12.3 11.2 0.1 641.6 7.6 9.4 48.9 1.8 0.0 0.2 0.0 2.5 0.0 17.7 0.0 0.0 61.8 0.9 15.1 45.2 2.3 0.0 13.2 4.8 1.7 11.6 31.3 0.2 10.0 78.8 13.5 234.4 0.1 0.0 33.4 0.0 6.7 0.3 0.0 84.1 72.3 0.0 0.1 7.3 0.3 29.8 0.6 15.6 FAM171A1 "C10orf38, FLJ12884" ENSG00000148468 "Family with sequence similarity 171 member A1" Q5VUB5 10 15211643-15371062 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.9" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 104.4;Ito cells: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "gdT-cell: 2.6;MAIT T-cell: 6.8;memory CD4 T-cell: 3.8;memory CD8 T-cell: 3.3;naive CD4 T-cell: 7.4;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 23 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "TIME: 42.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051345 Approved Approved "Nucleoplasm,Plasma membrane" NA NA 96000 "Plasma membrane" Nucleoplasm "HPA051345: AB_2681449" "unprognostic (3.60e-2)" "unprognostic (7.15e-2)" "unprognostic (2.21e-1)" "unprognostic (5.28e-2)" "unprognostic (1.57e-1)" "unprognostic (4.11e-2)" "unprognostic (9.84e-2)" "unprognostic (9.19e-2)" "unprognostic (2.28e-1)" "unprognostic (3.97e-2)" "unprognostic (3.09e-2)" "unprognostic (1.87e-1)" "prognostic favorable (2.71e-5)" "unprognostic (3.08e-1)" "unprognostic (1.86e-1)" "prognostic unfavorable (4.90e-6)" "unprognostic (3.28e-2)" 6.9 3.7 22.1 5.5 37.9 0.2 4.6 11.1 31.8 8.8 16.1 25.3 6.5 13.7 9.7 4.8 4.7 11.8 9.3 7.0 24.1 17.5 17.8 6.2 5.3 3.7 25.1 14.3 10.9 13.8 8.9 1.9 2.9 21.5 8.4 12.9 2.5 10.0 9.4 5.1 2.4 8.9 9.0 43.9 8.5 10.3 2.4 21.9 0.6 4.3 1.1 4.6 6.0 6.2 0.0 0.0 0.0 0.0 0.3 7.4 1.3 0.0 6.3 13.0 5.0 5.3 10.1 0.1 7.9 1.5 4.0 3.5 1.1 7.4 0.0 9.6 20.5 9.1 0.6 9.3 0.1 4.5 2.6 14.6 18.4 2.0 18.2 5.8 0.0 14.9 7.9 1.9 10.9 1.6 14.6 20.0 2.7 7.2 0.0 12.7 0.5 3.1 0.0 12.5 3.5 3.5 12.4 6.9 1.9 5.0 0.0 9.0 11.5 4.4 0.1 0.0 14.5 0.0 0.2 42.6 5.5 23.2 19.9 8.3 2.7 0.7 0.0 12.2 0.0 4.2 0.0 0.0 0.0 2.6 0.0 6.8 0.0 3.8 3.3 0.0 0.0 7.4 3.7 0.0 0.3 0.0 0.0 0.7 1.3 22.1 37.9 11.1 23.1 24.1 17.5 25.1 14.3 21.5 21.9 0.0 0.0 0.0 3.3 1.1 3.8 5.1 104.4 2.7 2.3 14.0 0.0 0.1 3.3 17.1 0.6 18.9 12.0 0.0 10.5 0.1 8.9 13.8 1.1 18.3 0.3 6.4 20.2 41.1 4.4 1.0 4.9 0.0 1.7 1.0 25.9 1.5 15.9 8.6 5.3 4.1 1.1 0.0 6.2 2.3 3.5 1.6 0.1 1.3 31.1 2.1 FAM193A "C4orf8, RES4-22" ENSG00000125386 "Family with sequence similarity 193 member A" P78312 4 2536631-2732565 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043116 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043116: AB_10795767" "unprognostic (1.56e-1)" "unprognostic (1.95e-1)" "unprognostic (2.54e-1)" "unprognostic (1.17e-3)" "unprognostic (1.97e-1)" "unprognostic (3.66e-3)" "unprognostic (6.34e-3)" "unprognostic (1.02e-1)" "unprognostic (7.16e-2)" "unprognostic (4.84e-1)" "prognostic favorable (4.80e-4)" "unprognostic (1.38e-2)" "unprognostic (2.15e-1)" "unprognostic (5.58e-2)" "unprognostic (3.47e-2)" "unprognostic (5.55e-2)" "unprognostic (4.96e-3)" 17.1 14.1 17.8 25.5 17.7 22.4 19.7 33.0 23.2 17.4 14.5 18.2 21.3 15.3 23.5 16.0 12.1 16.4 17.2 11.9 16.7 14.3 12.4 13.7 20.2 17.3 18.0 11.8 23.7 17.4 20.4 21.5 15.3 16.1 16.4 11.9 18.8 16.4 19.3 18.1 16.6 15.8 16.0 13.9 17.0 14.7 29.1 17.2 26.3 15.4 13.7 16.0 14.6 30.7 2.5 3.9 5.7 6.3 3.2 2.9 1.0 7.1 9.0 16.7 9.5 10.2 10.5 9.1 11.0 9.4 10.8 9.1 9.1 11.7 14.0 6.8 11.9 13.3 6.2 11.6 7.8 8.9 8.7 7.6 21.0 11.1 9.4 12.4 12.6 14.8 11.5 8.3 10.6 10.8 9.8 10.6 8.4 14.7 15.5 8.8 7.5 20.5 20.5 13.7 7.1 10.2 20.3 8.8 6.9 7.2 9.4 14.7 12.6 9.3 6.5 9.5 9.4 12.0 13.0 14.3 16.5 9.8 8.9 14.2 15.7 11.5 13.6 9.3 10.6 11.7 5.7 2.2 1.8 2.2 1.5 1.5 1.5 1.9 2.9 1.4 2.5 1.9 2.7 4.2 3.2 6.3 3.9 1.4 1.0 17.8 17.7 33.0 23.2 16.7 14.3 18.0 11.8 16.1 17.2 11.9 15.6 2.7 6.0 8.4 24.2 13.1 0.0 4.0 21.6 1.8 45.2 5.9 1.7 7.9 6.7 12.6 11.6 0.0 6.5 5.7 10.8 9.1 8.1 4.9 7.5 14.3 13.8 10.4 8.2 11.0 15.8 11.3 13.5 8.2 9.0 15.4 8.7 9.0 13.8 2.2 24.7 6.5 10.0 29.8 28.5 8.7 4.7 6.4 8.9 6.4 FAM205A C9orf144B ENSG00000205108 "Family with sequence similarity 205 member A" Q6ZU69 9 34723055-34729467 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 243 "testis: 24.3" "Cell type enriched" "Detected in some" 6 "Early spermatids: 99.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 1.0;THP-1: 2.3" HPA071267 Enhanced Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA071267: AB_2686376" "unprognostic (2.25e-1)" "unprognostic (3.66e-3)" "unprognostic (6.29e-3)" "unprognostic (1.90e-1)" "unprognostic (2.73e-3)" "unprognostic (7.82e-2)" "unprognostic (9.61e-2)" "unprognostic (6.41e-2)" "unprognostic (4.78e-1)" "unprognostic (7.34e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 24.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 99.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.8 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 FAM210B "C20orf108, dJ1167H4.1, DKFZP434A1114" ENSG00000124098 "Family with sequence similarity 210 member B" Q96KR6 20 56358915-56368663 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Erythroid cells: 233.6;Peritubular cells: 146.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "SK-MEL-30: 73.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042652 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA042652: AB_2678098" "unprognostic (3.29e-1)" "prognostic favorable (5.44e-4)" "unprognostic (3.24e-2)" "unprognostic (1.66e-3)" "unprognostic (1.26e-1)" "unprognostic (3.34e-2)" "unprognostic (9.45e-2)" "prognostic favorable (4.26e-4)" "unprognostic (1.77e-1)" "unprognostic (2.24e-2)" "unprognostic (7.60e-2)" "unprognostic (2.90e-1)" "prognostic favorable (1.44e-10)" "unprognostic (1.08e-1)" "unprognostic (3.27e-2)" "unprognostic (1.84e-1)" "unprognostic (3.00e-1)" 19.8 47.7 13.2 9.3 22.8 30.5 29.0 13.4 12.3 23.4 18.1 10.9 24.0 10.7 22.3 24.7 24.4 18.5 29.5 48.1 13.0 12.9 15.2 43.2 16.3 11.8 15.2 9.3 50.5 21.8 13.1 15.1 17.6 13.7 30.9 13.8 21.4 29.0 33.5 54.2 17.5 15.0 19.9 11.1 12.2 16.3 11.1 9.7 5.9 19.8 25.7 12.3 22.8 30.9 1.9 2.8 10.3 5.6 2.2 4.0 1.5 4.8 1.9 7.5 18.2 21.7 24.6 14.6 6.0 13.4 10.9 12.6 3.4 2.4 0.4 3.1 10.2 6.3 14.1 4.0 17.2 18.4 0.7 6.3 3.0 4.4 32.5 14.3 0.3 1.9 21.0 19.3 6.2 8.8 12.7 17.5 2.6 22.5 3.2 13.3 5.0 2.5 1.3 6.3 7.1 11.8 0.0 15.5 3.8 5.6 5.7 10.4 18.7 14.5 31.7 73.1 16.7 14.0 2.7 12.1 9.8 6.5 15.6 3.6 2.5 2.6 0.1 7.8 1.9 6.3 3.3 3.8 10.3 2.9 5.6 2.2 1.9 3.4 4.0 2.8 1.8 3.6 3.4 1.7 2.2 2.4 2.4 3.7 1.5 13.2 22.8 13.4 12.3 13.0 12.9 15.2 9.3 13.7 9.7 14.9 21.1 2.2 74.0 22.0 7.6 52.5 68.8 1.4 14.8 15.7 37.3 61.4 54.7 24.7 0.6 24.8 25.3 233.6 16.9 19.6 25.7 58.3 19.5 106.8 25.0 1.6 48.9 44.2 41.8 2.6 61.9 18.3 35.4 32.5 26.7 25.1 32.5 7.0 146.3 38.9 16.9 19.4 28.4 1.2 10.4 28.4 35.0 13.1 32.1 44.8 FAM47E "FLJ42946, LOC100129583" ENSG00000189157 "Family with sequence similarity 47 member E" Q6ZV65 4 76214040-76283780 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 4 "Ciliated cells: 75.0;Early spermatids: 25.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "naive B-cell: 3.1;plasmacytoid DC: 2.3" "Group enriched" "Detected in many" 5 "B-cells: 3.1;dendritic cells: 2.3" "Cell line enriched" "Detected in many" 5 "OE19: 24.0" HPA053331 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (1.59e-1)" "unprognostic (1.76e-2)" "unprognostic (3.68e-2)" "unprognostic (3.90e-4)" "unprognostic (1.37e-2)" "unprognostic (1.66e-1)" "unprognostic (1.04e-1)" "unprognostic (5.63e-2)" "unprognostic (1.06e-1)" "unprognostic (2.21e-2)" "unprognostic (3.73e-2)" "unprognostic (1.31e-1)" "unprognostic (2.16e-8)" "unprognostic (1.01e-1)" "unprognostic (1.84e-2)" "unprognostic (3.04e-2)" "unprognostic (3.01e-2)" 5.5 6.8 12.5 0.8 8.5 1.2 8.9 2.4 14.8 3.7 3.2 9.2 4.4 4.3 2.4 15.5 1.6 23.5 5.1 3.2 10.1 13.7 9.1 11.2 4.8 0.9 10.7 15.5 1.2 9.7 9.9 10.3 10.0 12.1 5.2 3.8 2.7 5.4 4.0 9.5 2.0 4.2 3.0 13.3 1.8 6.0 9.2 6.2 0.0 13.2 1.5 0.9 2.6 1.1 3.1 2.3 0.1 0.4 0.1 0.5 0.1 0.4 2.0 1.8 0.5 1.4 0.2 0.4 0.2 1.3 0.3 0.4 2.3 1.7 0.1 0.5 0.7 4.1 0.6 0.8 0.4 0.7 1.8 0.1 0.1 1.1 3.3 0.8 0.4 0.3 0.8 0.5 0.5 0.5 0.7 0.2 0.2 0.2 1.1 0.6 2.8 0.1 0.2 0.4 24.0 0.9 0.3 0.5 0.3 2.5 1.6 3.1 2.2 0.8 1.0 0.3 0.5 1.0 0.2 0.5 0.4 0.4 1.1 0.3 4.4 1.0 0.1 1.3 0.2 0.6 0.0 0.4 0.1 0.2 0.0 0.5 0.2 0.2 0.1 0.2 3.1 0.4 0.1 0.1 0.1 0.4 2.3 0.0 0.1 12.5 8.5 2.4 14.8 10.1 13.7 10.7 15.5 12.1 6.2 8.9 1.6 0.5 2.2 0.6 11.4 6.2 5.1 75.0 7.9 0.0 11.8 2.2 8.3 5.8 25.0 1.5 5.4 0.0 6.9 0.9 1.5 4.2 0.0 3.0 0.7 1.6 7.5 2.5 0.0 3.1 0.6 0.0 1.7 0.0 4.9 4.3 5.1 2.9 0.4 7.8 6.9 0.0 1.2 10.9 3.9 0.3 2.9 0.0 2.7 1.6 FAM47E-STBD1 ENSG00000272414 "FAM47E-STBD1 readthrough" 4 76251721-76311129 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "liver: 38.2;skeletal muscle: 41.3" "Group enriched" "Detected in some" 4 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 1.7;Ciliated cells: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 17.1;Karpas-707: 23.8" HPA053331 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA053331: AB_2682115" "unprognostic (3.52e-3)" "unprognostic (3.44e-1)" "unprognostic (1.53e-1)" "unprognostic (8.98e-2)" "unprognostic (5.45e-2)" "unprognostic (2.66e-1)" "unprognostic (1.99e-1)" "unprognostic (2.51e-2)" "unprognostic (1.91e-1)" "unprognostic (6.92e-6)" "unprognostic (5.59e-2)" "unprognostic (1.52e-1)" "unprognostic (3.77e-1)" 17.4 2.3 7.8 1.6 8.0 4.0 7.6 1.9 13.9 2.5 8.2 8.6 4.1 2.1 3.0 7.3 3.5 5.0 4.2 16.5 9.4 3.9 4.2 38.2 7.5 0.6 5.4 14.6 2.6 4.6 2.8 9.2 9.4 11.4 6.3 9.0 2.5 5.0 5.0 41.3 1.6 10.7 6.5 9.6 1.6 3.7 6.1 5.8 0.0 8.1 1.3 0.9 4.9 2.5 0.2 1.0 2.2 1.5 3.4 1.6 0.4 2.0 2.4 1.0 2.1 17.1 5.8 2.2 3.4 7.1 2.9 3.0 4.0 2.2 0.0 2.1 8.1 7.9 1.1 3.5 1.4 2.7 2.6 0.5 0.8 4.8 5.7 1.8 1.7 2.4 2.5 9.0 2.8 3.6 11.1 0.3 0.0 0.2 23.8 7.0 3.7 0.0 1.8 1.0 13.2 1.6 0.0 0.5 1.5 3.3 6.0 1.0 4.2 1.5 4.7 0.1 2.2 0.9 1.0 0.9 1.5 0.7 3.8 2.9 5.7 2.6 0.0 4.2 1.8 1.3 0.0 0.5 2.2 1.1 1.5 0.6 0.2 1.1 1.2 0.9 0.1 0.9 1.3 1.3 3.4 0.1 1.0 1.6 0.4 7.8 8.0 1.9 13.9 9.4 3.9 5.4 14.6 11.4 5.8 6.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 6.7 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FASN "FAS, SDR27X1" ENSG00000169710 "Fatty acid synthase" P49327 17 82078333-82098332 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism" "Hydrolase, Lyase, Multifunctional enzyme, Oxidoreductase, Transferase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 147.6" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 2: 103.0;Hepatocytes: 169.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SK-BR-3: 155.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005192, HPA006461, CAB015417, HPA056108" Enhanced Enhanced "Plasma membrane,Cytosol" No No 1600000 "Plasma membrane, Cytosol" "CAB005192: AB_2101095, CAB015417: AB_2231427, HPA006461: AB_1848437, HPA056108: AB_2683039" "unprognostic (3.35e-2)" "prognostic unfavorable (1.42e-5)" "unprognostic (9.69e-3)" "unprognostic (4.09e-2)" "unprognostic (3.46e-3)" "unprognostic (1.55e-2)" "unprognostic (3.09e-2)" "unprognostic (4.74e-3)" "unprognostic (3.15e-1)" "unprognostic (3.15e-1)" "unprognostic (2.87e-3)" "unprognostic (1.05e-1)" "prognostic unfavorable (7.16e-5)" "unprognostic (4.50e-2)" "unprognostic (9.62e-2)" "unprognostic (1.35e-2)" "unprognostic (7.03e-3)" 147.6 7.8 8.2 14.2 11.5 11.1 57.5 19.1 23.0 6.6 27.7 17.0 14.1 8.2 4.7 14.2 17.1 4.3 19.4 6.3 7.9 6.7 3.7 30.8 26.8 9.8 7.3 11.5 6.4 10.4 6.7 15.3 8.4 21.7 28.8 3.4 7.6 16.9 10.8 7.5 17.2 6.5 4.6 8.4 5.1 11.9 6.6 8.8 1.9 5.1 10.7 5.4 8.0 6.6 0.5 1.4 0.0 0.8 0.2 1.9 0.8 23.6 24.8 11.5 7.9 18.7 12.7 24.7 4.7 6.1 5.0 9.2 25.9 16.1 7.9 3.9 3.6 14.0 19.7 11.1 21.7 0.9 3.7 48.3 16.3 18.5 34.6 5.3 8.8 2.5 12.1 5.7 12.7 3.0 1.7 5.6 7.4 24.6 7.0 1.7 40.9 9.5 14.0 22.4 3.7 14.4 8.5 6.5 15.6 5.6 30.3 28.7 16.0 6.9 155.8 12.6 4.4 27.8 16.8 9.7 7.3 15.1 6.0 11.3 9.5 2.1 8.1 4.4 9.6 10.8 0.0 0.8 0.0 1.2 0.5 0.7 0.5 1.9 1.4 1.4 0.2 0.7 0.6 0.0 0.2 0.4 1.1 0.6 0.8 8.2 11.5 19.1 23.0 7.9 6.7 7.3 11.5 21.7 8.8 23.8 103.0 0.8 10.3 6.9 24.9 4.8 25.5 6.7 10.3 10.4 5.9 28.9 3.3 18.9 1.2 4.5 20.8 23.3 24.9 65.8 10.4 65.5 12.7 169.2 11.7 28.6 17.4 11.1 6.9 1.3 15.3 5.0 16.9 8.2 18.9 12.3 16.1 17.5 10.6 5.5 9.5 0.0 9.6 1.9 13.9 12.0 24.7 10.7 18.3 17.5 FBLN7 "FLJ37440, TM14" ENSG00000144152 "Fibulin 7" Q53RD9 2 112138385-112188216 "Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" Heparin-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Melanocytes: 16.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 25 "memory CD4 T-cell: 18.5;naive CD4 T-cell: 16.2;T-reg: 17.4" "Lineage enriched" "Detected in single" 36 "T-cells: 18.5" "Cell line enhanced" "Detected in some" "AF22: 17.5;BJ hTERT+: 12.5;hTERT-RPE1: 9.2;SCLC-21H: 11.3;SH-SY5Y: 9.0;U-2197: 18.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA034992 Approved "Plasma membrane,Cell Junctions" "Secreted to extracellular matrix" NA NA 27000 "Plasma membrane" "Cell Junctions" "HPA034992: AB_10601469" "unprognostic (1.72e-1)" "unprognostic (1.47e-1)" "unprognostic (5.88e-2)" "unprognostic (4.88e-3)" "unprognostic (1.24e-1)" "unprognostic (1.70e-3)" "unprognostic (4.34e-2)" "unprognostic (4.80e-2)" "unprognostic (5.77e-2)" "unprognostic (2.01e-1)" "unprognostic (7.91e-2)" "unprognostic (2.02e-2)" "unprognostic (2.35e-2)" "unprognostic (3.11e-2)" "unprognostic (8.10e-2)" "unprognostic (1.21e-2)" "unprognostic (9.33e-2)" 7.5 5.8 2.9 9.0 3.4 1.1 10.4 10.3 16.4 12.4 2.3 1.6 4.1 1.7 6.5 8.2 2.9 10.5 7.1 3.3 4.0 3.8 2.5 6.6 3.7 11.8 6.9 4.2 2.8 3.4 16.7 27.4 13.6 10.5 4.7 2.0 14.7 3.9 9.0 1.9 7.1 3.8 3.2 2.2 7.3 4.1 2.0 1.1 8.7 14.9 5.5 9.5 3.6 10.4 0.0 0.5 0.0 0.0 0.0 18.5 3.5 0.0 0.1 17.5 0.0 1.9 1.4 0.0 3.8 12.5 4.2 6.6 0.0 0.1 0.0 0.1 5.7 0.7 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.3 0.8 0.9 0.0 0.0 1.3 0.1 7.0 0.0 9.2 1.0 0.2 0.0 0.0 1.4 0.0 0.4 0.0 0.4 0.0 0.3 0.0 0.0 4.4 0.2 0.0 11.3 9.0 0.0 0.0 0.5 0.1 0.5 0.1 3.6 0.6 0.5 18.1 0.5 0.0 0.0 0.0 0.5 0.0 1.5 0.0 0.0 0.0 0.2 0.0 0.7 0.0 18.5 0.2 0.0 0.0 16.2 0.5 0.0 0.0 0.0 0.5 17.4 3.5 2.9 3.4 10.3 16.4 4.0 3.8 6.9 4.2 10.5 1.1 3.0 0.3 0.0 0.7 3.9 3.7 0.8 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.3 1.9 2.1 0.0 0.0 0.2 5.9 4.7 0.4 1.1 1.0 0.4 3.2 0.0 0.6 0.0 1.7 0.3 0.0 16.9 0.0 0.0 2.2 0.4 0.0 4.9 0.5 7.2 6.5 4.7 0.1 0.2 3.3 1.3 4.4 0.0 0.3 FBP2 ENSG00000130957 "Fructose-bisphosphatase 2" O00757 9 94558720-94593793 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carbohydrate metabolism, Gluconeogenesis" "Allosteric enzyme, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "brain: 33.7;skeletal muscle: 134.7;tongue: 45.6" "Cell type enhanced" "Detected in some" 29 "Exocrine glandular cells: 1.2;Spermatogonia: 3.8" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in single" 36 "pons and medulla: 33.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 7.1;CACO-2: 3.6;HMC-1: 4.0;MCF7: 5.3;OE19: 5.0;PC-3: 3.7;SiHa: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA012513, HPA077371" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012513: AB_1848446, HPA077371: " "unprognostic (3.88e-2)" "unprognostic (3.54e-4)" "unprognostic (2.38e-1)" "unprognostic (6.03e-2)" "unprognostic (2.21e-1)" "unprognostic (1.54e-2)" "unprognostic (9.40e-4)" "unprognostic (3.95e-3)" "unprognostic (5.11e-2)" "unprognostic (2.39e-2)" "unprognostic (4.69e-2)" "unprognostic (2.53e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.48e-4)" 2.0 0.4 0.1 0.0 0.1 0.0 0.2 0.1 0.9 0.1 0.1 3.8 4.4 1.0 0.1 1.0 1.6 0.1 0.0 0.1 0.7 0.1 0.1 0.1 0.2 0.1 0.1 0.0 0.1 1.2 4.1 0.1 0.0 33.7 0.2 0.0 5.0 1.4 1.8 134.7 0.1 0.1 0.1 0.2 0.1 9.0 0.4 0.0 0.0 0.2 45.6 2.7 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.3 0.0 2.5 0.0 0.0 7.1 0.0 0.0 0.1 0.0 3.6 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 1.9 2.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.3 0.0 0.0 0.0 5.0 3.7 0.0 0.0 0.1 0.0 2.4 0.6 0.1 4.9 1.1 0.0 0.2 0.4 0.1 0.0 0.0 2.3 2.2 0.0 0.0 0.1 1.0 0.2 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.9 0.7 0.1 0.1 0.0 33.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.8 0.0 0.1 0.0 0.0 0.0 FCGR2A "CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2" ENSG00000143226 "Fc fragment of IgG receptor IIa" P12318 1 161505430-161524013 "CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Immunity "IgG-binding protein, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 182.8" "Cell type enhanced" "Detected in many" 17 "Hofbauer cells: 145.9;Kupffer cells: 155.0;Macrophages: 311.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "neutrophil: 182.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 182.8" "Cell line enhanced" "Detected in some" "HEL: 14.3;HMC-1: 28.9;K-562: 8.4;NB-4: 8.1;THP-1: 30.7;U-937: 13.2" "HPA010718, HPA010776, HPA014730" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA 55000000 "Plasma membrane" "Golgi apparatus" "HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074" "unprognostic (2.57e-2)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (4.12e-2)" "unprognostic (5.89e-2)" "unprognostic (6.17e-2)" "unprognostic (1.24e-2)" "unprognostic (1.17e-1)" "unprognostic (7.63e-2)" "unprognostic (1.17e-3)" "unprognostic (2.43e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (6.49e-7)" "unprognostic (8.85e-3)" "unprognostic (6.47e-3)" "unprognostic (1.54e-1)" "unprognostic (3.42e-2)" 36.8 12.6 13.2 44.6 19.2 18.6 8.2 2.2 10.1 9.1 7.1 10.0 0.0 3.8 4.7 6.6 5.5 11.6 17.0 11.3 17.0 8.9 11.5 7.1 44.1 50.0 25.9 1.7 8.0 5.8 2.8 6.1 47.5 19.6 7.0 9.9 10.8 8.3 4.8 7.3 3.0 7.3 17.6 30.9 43.4 5.9 4.8 19.2 3.2 6.3 2.5 4.4 19.3 4.5 0.2 7.0 182.8 27.2 0.0 0.0 10.6 0.0 0.0 0.0 1.2 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.2 0.0 0.3 4.1 28.9 0.3 0.0 0.0 0.0 0.4 0.0 0.0 8.4 0.2 0.0 0.0 0.2 8.1 0.0 0.0 0.6 0.1 0.6 3.9 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 30.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 13.2 3.6 0.1 27.2 31.6 0.0 20.7 0.0 0.2 0.0 0.0 7.0 0.1 0.0 0.0 182.8 0.0 16.7 0.2 0.0 10.6 13.2 19.2 2.2 10.1 17.0 8.9 25.9 1.7 19.6 19.2 20.8 63.3 13.7 0.4 7.7 0.0 1.2 5.1 6.7 21.6 0.0 0.0 0.8 8.3 0.2 37.5 2.6 0.0 0.0 0.5 1.1 5.8 0.3 29.0 0.8 145.9 0.0 0.0 4.3 155.0 35.2 1.4 311.2 16.9 1.8 0.0 0.3 0.7 0.0 0.0 7.9 0.1 6.5 5.8 0.3 0.4 6.8 1.4 4.1 0.0 0.3 FGD1 "FGDY, ZFYVE3" ENSG00000102302 "FYVE, RhoGEF and PH domain containing 1" P98174 X 54445454-54496166 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Melanocytes: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000911 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA000911: AB_1078853" "unprognostic (2.49e-1)" "unprognostic (1.56e-1)" "unprognostic (1.64e-2)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.17e-1)" "unprognostic (1.02e-1)" "unprognostic (3.36e-2)" "unprognostic (8.74e-2)" "unprognostic (1.57e-2)" "unprognostic (2.94e-2)" "unprognostic (2.77e-3)" "unprognostic (1.49e-1)" "unprognostic (3.40e-3)" "unprognostic (1.70e-2)" "unprognostic (4.92e-2)" "unprognostic (3.41e-2)" "unprognostic (9.40e-3)" 5.9 7.7 15.6 5.9 10.9 1.6 7.1 16.3 15.6 12.3 7.2 3.7 3.4 4.5 12.4 4.4 9.3 7.6 7.8 9.2 9.6 7.1 5.1 1.9 4.6 4.0 4.8 11.2 13.7 6.9 6.9 5.4 9.4 5.7 6.5 3.8 6.8 7.7 7.9 3.3 11.8 5.5 11.9 3.7 5.8 5.2 4.6 4.8 0.0 5.6 7.3 4.3 7.6 7.8 1.6 0.6 0.5 2.6 1.2 3.2 1.1 13.6 5.8 11.2 14.6 5.2 9.3 5.4 8.1 8.2 6.9 5.6 1.7 1.2 0.8 6.7 12.6 8.7 5.3 9.4 5.8 3.8 1.4 8.2 0.4 4.5 2.0 5.6 0.7 0.5 7.5 3.7 10.5 5.0 8.7 6.2 3.3 2.2 0.5 5.4 2.9 1.6 1.5 11.0 1.6 9.2 7.8 6.4 0.5 5.9 0.8 10.5 9.8 8.9 0.8 13.4 18.6 9.8 1.2 6.0 8.6 7.7 18.9 7.5 1.0 2.0 1.5 9.6 1.6 4.7 0.0 0.6 0.5 2.0 1.3 2.0 1.5 1.6 2.2 0.6 1.6 3.2 1.8 0.0 1.2 2.6 0.2 1.4 1.1 15.6 10.9 16.3 15.6 9.6 7.1 4.8 11.2 5.7 4.8 0.0 0.0 0.0 1.1 2.6 2.5 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.2 0.4 3.5 0.0 0.0 0.9 1.0 4.7 0.7 0.0 0.0 0.3 1.6 1.2 3.1 0.0 0.0 2.6 0.0 6.8 0.0 0.8 2.3 0.6 0.0 3.9 1.4 3.3 0.0 2.1 0.2 1.5 3.6 0.2 0.0 2.6 0.8 FGR "c-fgr, p55c-fgr, SRC2" ENSG00000000938 "FGR proto-oncogene, Src family tyrosine kinase" P09769 1 27612064-27635277 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "adipose tissue: 20.8;blood: 68.0;bone marrow: 73.6;lung: 30.9;lymphoid tissue: 54.3" "Cell type enhanced" "Detected in many" 19 "Hofbauer cells: 58.9;Kupffer cells: 187.9;Macrophages: 86.1;T-cells: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Daudi: 30.1;U-266/70: 55.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA002024 Enhanced Approved "Plasma membrane,Aggresome" NA NA "Plasma membrane" Aggresome "HPA002024: AB_1078503" "unprognostic (2.66e-2)" "unprognostic (1.51e-2)" "unprognostic (6.32e-2)" "unprognostic (9.74e-3)" "unprognostic (6.66e-3)" "unprognostic (6.71e-2)" "unprognostic (5.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.81e-2)" "unprognostic (7.45e-2)" "unprognostic (2.79e-2)" "unprognostic (1.10e-1)" "unprognostic (1.94e-2)" "unprognostic (6.26e-2)" "unprognostic (3.93e-2)" "unprognostic (2.30e-1)" "unprognostic (8.12e-3)" 20.8 2.6 2.2 23.6 4.5 73.6 5.6 1.1 4.2 2.9 2.8 1.5 4.2 1.6 4.0 2.3 2.2 6.3 5.3 8.5 2.6 2.3 3.0 4.2 30.9 34.1 6.6 1.7 1.9 2.4 0.4 1.2 3.3 4.2 2.5 1.8 2.1 2.9 2.6 4.4 1.7 3.7 6.4 4.8 54.3 2.5 2.6 4.1 1.9 2.9 2.5 7.8 5.1 6.1 13.3 28.9 40.8 68.0 36.3 29.6 55.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.5 10.7 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.0 0.0 55.9 0.7 2.3 0.0 6.8 0.0 3.1 52.4 32.3 29.6 68.0 1.7 7.7 2.6 13.6 28.9 13.3 1.3 12.8 40.8 36.3 55.6 1.3 0.1 55.0 2.2 4.5 1.1 4.2 2.6 2.3 6.6 1.7 4.2 4.1 6.0 30.7 12.5 0.5 2.5 0.0 1.6 2.5 2.7 10.3 1.8 0.0 0.4 0.0 0.0 0.2 11.5 0.0 0.0 0.2 0.5 1.4 0.3 12.7 0.9 58.9 0.0 0.0 4.3 187.9 0.4 0.3 86.1 1.7 7.2 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.2 0.5 1.0 0.8 45.8 0.0 0.9 FHIT "AP3Aase, FRA3B" ENSG00000189283 "Fragile histidine triad" P49789 3 59749310-61251459 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" Hydrolase "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 138.8;Proximal tubular cells: 112.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "naive CD4 T-cell: 38.3" "Lineage enriched" "Detected in all" 14 "T-cells: 38.3" "Cell line enhanced" "Detected in many" "RPMI-8226: 12.1;U-266/70: 24.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002684, HPA018840, HPA018909" Enhanced Approved "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center, Plasma membrane" "CAB002684: , HPA018840: AB_1848538, HPA018909: AB_1848537" "unprognostic (2.36e-3)" "unprognostic (6.38e-2)" "unprognostic (1.59e-1)" "unprognostic (4.42e-2)" "unprognostic (1.10e-1)" "unprognostic (1.08e-2)" "unprognostic (1.18e-1)" "unprognostic (3.16e-2)" "unprognostic (2.77e-2)" "unprognostic (8.49e-2)" "unprognostic (2.36e-1)" "unprognostic (6.77e-2)" "prognostic favorable (1.36e-4)" "unprognostic (1.54e-1)" "unprognostic (5.96e-2)" "unprognostic (1.29e-2)" "unprognostic (1.80e-2)" 6.4 24.0 13.7 8.0 17.5 9.0 12.1 4.7 13.3 7.9 8.0 21.0 12.4 8.2 6.2 9.5 5.1 9.2 13.0 14.9 15.3 13.8 30.9 10.7 5.2 9.3 19.5 9.3 8.9 11.8 16.3 15.2 4.1 14.4 5.8 7.8 14.0 11.4 9.9 11.6 7.0 7.6 9.1 17.1 6.0 8.1 10.5 18.2 3.7 15.6 5.7 6.9 7.3 6.1 1.6 2.4 1.8 1.8 2.6 38.3 4.7 0.0 0.0 1.0 0.0 0.6 0.0 1.7 0.1 0.1 0.0 0.0 1.8 3.1 2.6 0.5 0.1 1.9 0.0 10.1 2.1 0.0 1.4 3.5 2.2 1.3 4.2 2.7 5.7 0.1 6.9 4.2 0.1 5.1 0.2 0.0 2.8 1.7 8.4 0.1 2.5 10.2 4.6 0.8 8.7 0.6 7.6 0.0 12.1 11.3 1.4 2.1 2.9 1.0 7.0 6.6 4.1 0.4 0.1 0.0 1.2 0.4 0.1 1.6 24.7 7.5 0.0 2.7 0.0 1.5 1.8 1.8 0.2 0.9 1.2 0.5 1.6 6.9 0.7 2.2 1.4 38.3 6.7 0.3 2.6 0.4 2.4 7.4 4.7 13.7 17.5 4.7 13.3 15.3 13.8 19.5 9.3 14.4 18.2 6.0 8.8 14.1 16.1 6.8 12.4 9.2 33.1 2.7 3.4 26.2 55.0 33.8 66.3 17.3 41.1 6.2 12.3 0.0 4.1 6.5 4.3 10.2 5.7 20.8 17.6 28.6 7.5 11.6 6.7 138.8 17.8 9.6 11.8 6.4 11.4 17.8 11.6 14.0 9.2 112.3 19.5 0.0 3.1 18.1 6.4 9.8 27.3 7.5 17.2 19.0 FHL1 "bA535K18.1, FHL1B, FLH1A, KYO-T, MGC111107, SLIM1, XMPMA" ENSG00000022267 "Four and a half LIM domains 1" Q13642 X 136146702-136211359 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Differentiation "Developmental protein" "Disease mutation, Emery-Dreifuss muscular dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 557.6;tongue: 239.4" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 1067.5;Early spermatids: 313.2;Late spermatids: 886.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 20.6" "Group enriched" "Detected in many" 4 "dendritic cells: 12.5;NK-cells: 20.6;T-cells: 11.4" "Cell line enhanced" "Detected in many" "BJ hTERT+: 58.7;fHDF/TERT166: 53.1" "Low region specificity" "Detected in all" "HPA001040, HPA001391, CAB020817" Enhanced Supported "Plasma membrane,Cytosol" NA NA 18000000 Cytosol "Plasma membrane" "CAB020817: , HPA001040: AB_1848541, HPA001391: AB_1848542" "unprognostic (2.16e-1)" "unprognostic (5.13e-2)" "unprognostic (1.33e-2)" "unprognostic (1.89e-1)" "unprognostic (1.61e-3)" "unprognostic (1.76e-2)" "unprognostic (2.51e-2)" "unprognostic (9.34e-2)" "unprognostic (7.12e-3)" "unprognostic (1.20e-1)" "unprognostic (2.21e-3)" "unprognostic (1.72e-1)" "unprognostic (6.17e-3)" "unprognostic (4.04e-2)" "unprognostic (7.52e-2)" "unprognostic (2.05e-3)" "prognostic unfavorable (2.11e-4)" 61.9 4.1 7.6 11.0 9.5 0.7 30.6 6.3 7.2 31.5 30.6 3.9 10.0 5.0 25.5 27.7 43.2 14.2 11.7 79.0 6.1 8.1 3.3 2.5 13.7 2.5 5.5 8.1 6.7 2.4 13.4 5.0 13.5 4.4 23.4 10.0 13.5 16.5 30.1 557.6 4.9 11.4 77.7 4.3 2.5 22.1 5.7 3.0 0.6 18.2 239.4 22.1 47.0 14.3 3.4 12.5 0.7 0.4 20.6 11.4 6.2 0.0 9.6 13.3 12.5 29.0 11.7 0.2 37.3 58.7 7.5 18.1 0.0 2.7 0.1 13.0 53.1 21.0 0.1 25.8 31.8 6.3 0.1 29.7 0.1 7.9 0.0 27.2 0.0 6.2 21.7 5.2 9.0 28.6 3.1 7.8 7.3 0.0 5.6 17.5 0.4 5.2 0.3 4.1 0.0 11.3 14.6 0.5 7.9 0.2 0.0 9.4 14.1 1.4 0.0 2.7 5.6 0.0 0.5 22.0 34.7 16.1 1.3 9.3 1.5 3.2 0.2 2.6 0.3 3.8 0.0 0.4 0.0 3.2 0.0 8.6 3.4 11.4 4.5 1.8 2.3 7.6 2.3 0.7 20.6 0.0 12.5 1.2 6.2 7.6 9.5 6.3 7.2 6.1 8.1 5.5 8.1 4.4 3.0 44.7 16.0 6.4 17.4 50.3 30.5 1067.5 0.0 5.3 7.9 10.4 7.9 0.7 1.7 3.3 313.2 63.3 0.0 0.0 0.2 1.0 98.8 2.5 15.1 4.7 3.8 93.8 13.2 131.3 5.9 886.8 114.8 9.8 30.4 10.8 0.5 182.0 0.6 0.2 143.2 4.8 16.9 103.5 304.9 6.0 79.0 39.1 2.3 13.4 0.6 1.8 FILIP1 "FILIP, KIAA1275" ENSG00000118407 "Filamin A interacting protein 1" Q7Z7B0 6 75291859-75493738 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 37.6;smooth muscle: 44.7" "Cell type enriched" "Detected in many" 5 "Cardiomyocytes: 542.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 10.7;HUVEC TERT2: 2.7;RPTEC TERT1: 3.0;U-266/70: 10.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA053564 Enhanced Approved "Plasma membrane,Actin filaments" No NA "Plasma membrane, Actin filaments" "HPA053564: AB_2682192" "unprognostic (4.90e-2)" "unprognostic (3.77e-2)" "unprognostic (9.77e-3)" "unprognostic (3.83e-1)" "unprognostic (1.52e-1)" "unprognostic (4.98e-1)" "unprognostic (2.27e-2)" "unprognostic (1.51e-1)" "unprognostic (1.06e-1)" "unprognostic (5.17e-3)" "unprognostic (3.29e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-3)" "unprognostic (3.97e-3)" "unprognostic (2.34e-1)" "unprognostic (4.65e-2)" "unprognostic (7.66e-3)" 11.0 1.3 2.0 6.3 3.0 0.2 2.5 0.6 2.5 8.2 10.9 0.0 4.1 1.3 8.8 4.1 10.5 4.5 5.9 37.6 3.7 1.2 2.7 2.4 7.5 1.2 1.1 0.7 4.4 1.4 5.4 5.1 3.7 0.8 14.9 2.6 4.3 1.5 2.8 29.4 0.9 4.1 44.7 1.4 0.6 3.9 2.8 0.0 0.0 2.3 10.8 0.7 30.7 6.0 1.4 0.9 1.8 0.8 0.6 0.9 0.0 0.1 1.9 0.3 0.1 0.1 0.3 0.2 0.3 0.1 0.1 0.0 0.0 0.2 0.2 10.7 0.0 0.1 0.1 0.1 0.0 0.1 0.3 0.2 0.2 0.2 0.1 0.0 0.3 0.2 1.4 0.1 0.2 0.1 0.1 2.7 0.4 0.1 0.4 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.0 0.1 3.0 0.6 0.2 0.2 0.0 0.1 0.1 2.5 0.1 0.4 0.0 0.1 0.0 0.1 0.1 10.7 1.0 0.1 0.1 0.5 0.1 1.2 0.6 0.6 0.6 0.6 0.5 0.6 0.5 0.4 0.2 1.4 0.9 0.6 1.8 0.6 0.8 0.9 0.3 0.0 2.0 3.0 0.6 1.9 3.7 1.2 1.1 0.7 0.8 0.0 119.1 78.3 0.0 0.6 0.6 3.3 542.5 0.0 83.0 14.8 0.0 0.0 0.7 1.7 0.0 36.1 36.8 0.0 0.0 0.3 0.3 26.7 0.6 1.1 0.6 1.2 0.0 0.0 58.3 1.9 16.2 2.3 2.0 1.7 0.0 0.0 4.5 0.0 0.0 4.2 0.0 3.8 90.5 88.2 4.5 6.4 0.6 0.7 0.0 0.0 0.4 FLAD1 "FAD1, PP591" ENSG00000160688 "Flavin adenine dinucleotide synthetase 1" Q8NFF5 1 154983338-154993111 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Nucleotidyltransferase, Transferase" "Disease mutation, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028476, HPA028486, HPA028563" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA028476: AB_10599974, HPA028486: AB_10600206, HPA028563: AB_10602286" "unprognostic (2.64e-1)" "unprognostic (2.60e-1)" "unprognostic (2.72e-1)" "unprognostic (3.84e-2)" "unprognostic (7.34e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.31e-1)" "unprognostic (2.32e-1)" "unprognostic (8.08e-2)" "unprognostic (6.51e-2)" "unprognostic (9.74e-2)" "prognostic unfavorable (2.55e-6)" "unprognostic (1.67e-2)" "unprognostic (5.06e-2)" "unprognostic (5.50e-2)" "unprognostic (1.17e-2)" 16.5 16.5 20.3 15.5 18.9 12.1 17.4 15.9 20.8 14.1 16.4 19.3 14.7 19.6 15.9 21.2 19.8 16.7 11.8 16.1 18.2 10.4 19.0 36.5 13.5 20.0 20.8 15.6 14.5 19.0 13.6 12.0 18.5 15.9 18.7 19.0 16.1 16.2 16.3 26.3 23.3 23.9 17.6 12.4 22.9 16.1 19.1 18.9 15.7 20.8 18.4 22.0 15.5 15.4 25.1 24.5 15.2 24.1 14.9 26.4 22.7 13.0 20.9 13.3 22.7 11.6 8.6 25.4 9.9 8.2 14.4 12.4 18.6 16.1 15.2 20.0 9.1 7.5 17.1 25.6 20.5 9.4 15.8 19.2 12.3 16.6 13.1 15.9 17.8 16.1 12.3 26.9 16.4 17.6 7.0 16.7 16.3 19.8 12.4 12.2 28.1 12.2 12.5 29.1 28.4 21.7 20.7 6.6 34.9 13.7 18.2 22.5 30.9 15.5 35.1 19.5 27.0 30.0 27.1 10.5 9.1 12.5 11.6 15.5 19.4 24.0 26.2 10.9 14.5 14.5 15.2 23.0 14.8 24.0 20.9 26.4 25.1 22.1 22.7 24.1 20.5 20.5 20.2 5.2 14.9 24.1 24.5 23.3 22.7 20.3 18.9 15.9 20.8 18.2 10.4 20.8 15.6 15.9 18.9 8.9 8.8 15.9 13.2 23.6 15.2 34.3 20.4 16.0 11.4 24.4 5.9 36.7 26.6 22.3 20.5 11.2 23.6 23.3 24.5 35.2 12.7 16.8 8.1 24.5 24.6 14.3 11.5 9.8 14.6 61.7 9.5 14.0 13.5 41.5 18.3 19.0 20.5 17.5 9.2 27.4 14.7 6.5 13.3 20.0 17.9 24.1 30.1 16.0 19.9 17.0 FLCN "BHD, MGC17998, MGC23445" ENSG00000154803 Folliculin Q8NFG4 17 17212212-17237188 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Cone photoreceptor cells: 74.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SuSa: 34.9" "CAB015158, HPA028760" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB015158: AB_2231645, HPA028760: AB_10601323" "unprognostic (1.99e-1)" "unprognostic (1.77e-1)" "unprognostic (1.53e-2)" "unprognostic (1.74e-1)" "unprognostic (3.85e-2)" "unprognostic (3.69e-1)" "unprognostic (3.73e-2)" "unprognostic (1.32e-1)" "unprognostic (3.58e-2)" "unprognostic (3.90e-1)" "prognostic favorable (4.49e-4)" "unprognostic (6.45e-3)" "unprognostic (2.55e-3)" "unprognostic (1.92e-1)" "unprognostic (9.71e-2)" "unprognostic (2.62e-2)" "unprognostic (1.65e-1)" 11.9 15.3 23.6 10.8 41.6 15.6 13.9 49.4 26.9 18.0 21.3 18.5 10.4 25.0 22.1 15.8 11.0 14.5 17.6 17.2 17.2 8.6 9.6 15.5 15.6 11.6 24.2 13.5 25.2 13.7 6.1 20.3 13.3 18.1 15.4 10.7 14.8 10.5 14.8 22.7 12.6 20.2 15.4 14.8 16.5 15.3 12.5 29.1 6.6 15.8 3.9 8.0 15.0 14.8 6.0 2.4 10.5 6.8 4.5 5.0 3.1 5.9 14.5 5.3 6.9 17.4 9.9 7.9 5.3 8.9 8.5 11.8 11.0 4.9 2.9 7.4 6.4 19.6 6.9 6.5 3.3 4.4 5.6 5.5 6.0 4.3 6.3 16.1 2.2 16.8 14.6 11.4 13.3 9.9 7.7 6.9 4.3 8.2 7.7 8.1 7.7 3.9 3.7 5.4 8.2 3.6 8.0 24.7 3.4 5.1 6.6 6.5 4.1 5.6 3.4 9.3 34.9 5.1 4.2 8.1 20.0 8.7 27.6 7.0 3.8 3.6 2.8 12.7 5.1 7.9 3.6 4.7 2.8 2.9 6.8 4.1 5.3 3.5 2.5 2.4 6.0 3.9 3.4 10.5 4.5 2.2 2.4 5.0 3.1 23.6 41.6 49.4 26.9 17.2 8.6 24.2 13.5 18.1 29.1 23.8 13.0 15.9 10.7 16.4 17.0 17.3 7.6 4.0 4.5 7.0 74.6 8.1 1.7 10.3 10.9 10.1 26.4 46.7 7.2 5.4 15.2 11.3 1.1 20.2 14.4 44.5 24.6 23.4 23.7 13.4 25.9 13.7 10.1 5.4 9.4 18.9 9.6 12.2 19.1 4.3 16.8 19.4 11.4 5.2 10.2 15.8 28.3 11.3 10.6 11.6 FLNC "ABP-280, ABPL, FLN2" ENSG00000128591 "Filamin C" Q14315 7 128830377-128859274 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" Actin-binding "Cardiomyopathy, Disease mutation, Myofibrillar myopathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "skeletal muscle: 546.8" "Cell type enriched" "Detected in many" 40 "Cardiomyocytes: 1815.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BJ: 80.1;fHDF/TERT166: 36.4;hTEC/SVTERT24-B: 39.6;U-2 OS: 34.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA006135, HPA071007" Enhanced Supported "Plasma membrane,Cytosol" NA NA 54000000 "Plasma membrane, Cytosol" "HPA006135: AB_1848602, HPA071007: " "unprognostic (1.25e-1)" "unprognostic (7.38e-2)" "unprognostic (4.47e-2)" "unprognostic (1.40e-2)" "prognostic unfavorable (2.80e-4)" "unprognostic (1.64e-3)" "unprognostic (4.42e-3)" "prognostic unfavorable (2.17e-5)" "unprognostic (1.03e-3)" "unprognostic (2.35e-2)" "unprognostic (1.35e-3)" "unprognostic (6.37e-2)" "prognostic unfavorable (5.69e-4)" "unprognostic (5.68e-3)" "unprognostic (1.15e-1)" "unprognostic (1.52e-3)" "prognostic unfavorable (3.73e-5)" 2.6 0.8 0.5 7.1 0.7 0.2 0.7 0.3 1.0 5.2 24.4 1.4 18.4 1.9 14.0 10.1 16.0 4.8 13.3 70.0 0.8 0.5 0.4 0.3 1.4 0.3 1.4 0.5 3.1 0.6 1.0 0.3 0.6 1.9 11.9 2.1 1.7 3.1 20.2 546.8 1.0 5.2 69.0 4.7 0.3 10.0 1.3 0.6 0.0 4.7 40.0 2.2 39.6 20.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 7.3 8.8 0.8 80.1 15.2 22.8 11.0 24.9 0.2 0.0 13.5 36.4 9.3 0.0 4.8 0.1 13.6 0.0 2.7 0.0 4.1 0.0 9.2 0.0 0.0 16.6 0.0 39.6 0.0 9.3 14.2 0.0 9.6 0.0 15.5 0.0 0.0 0.3 13.3 0.0 4.6 0.0 26.5 0.2 0.0 0.0 0.4 1.4 0.1 0.0 0.0 19.2 0.1 0.3 29.3 8.0 34.2 2.0 0.0 0.0 0.0 0.0 27.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.7 0.3 0.6 0.8 0.5 1.4 0.5 1.9 0.6 3.0 0.3 0.0 0.1 3.3 0.4 1815.4 0.0 0.0 3.4 1.8 0.0 0.3 0.0 0.6 0.2 6.2 0.0 0.0 0.2 0.7 11.9 1.4 0.0 0.0 0.8 0.0 0.0 1.8 0.0 0.0 4.9 0.8 5.0 0.0 0.0 0.1 1.8 0.0 9.9 1.0 0.1 0.0 45.3 0.2 0.4 4.0 1.6 0.0 0.0 0.4 FLOT2 "ECS-1, ECS1, ESA, ESA1, M17S1" ENSG00000132589 "Flotillin 2" Q14254 17 28879335-28897679 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001396, CAB004395, HPA071038" Supported Supported "Vesicles,Plasma membrane" NA NA 1900000 "Plasma membrane" Vesicles "CAB004395: AB_627618, HPA001396: AB_1078894, HPA071038: " "unprognostic (6.04e-2)" "unprognostic (8.76e-3)" "unprognostic (3.01e-1)" "unprognostic (8.92e-2)" "unprognostic (4.15e-3)" "unprognostic (2.17e-2)" "unprognostic (4.36e-3)" "unprognostic (2.12e-1)" "unprognostic (5.21e-2)" "unprognostic (1.20e-1)" "unprognostic (9.98e-2)" "unprognostic (2.80e-1)" "unprognostic (4.12e-3)" "unprognostic (2.64e-2)" "unprognostic (1.09e-1)" "unprognostic (1.11e-3)" "unprognostic (2.20e-2)" 26.1 19.5 21.5 28.3 21.9 47.8 21.1 17.3 35.9 17.3 20.7 14.4 13.7 11.1 15.7 14.3 25.9 21.0 15.0 24.5 17.3 18.7 36.4 52.5 24.7 40.1 15.3 17.8 19.8 18.5 18.8 9.1 30.4 31.9 27.6 14.8 20.9 24.3 29.5 21.1 17.7 19.2 25.5 12.8 49.6 17.5 8.4 12.3 17.4 21.8 14.5 33.1 36.7 34.4 25.7 29.4 84.8 21.3 14.8 21.4 24.1 15.0 25.6 19.9 17.0 10.1 12.9 21.5 11.7 16.1 17.3 20.4 26.4 12.9 20.9 22.7 13.0 11.8 17.8 21.5 19.4 7.5 66.3 25.3 25.4 24.0 19.0 13.5 20.6 4.3 15.6 15.0 14.3 19.2 18.3 27.3 6.2 23.8 18.4 8.0 22.7 5.7 15.6 17.5 13.7 6.8 8.8 20.0 51.2 30.5 47.0 17.6 29.5 27.4 19.6 21.2 19.9 20.4 37.1 22.2 6.2 11.1 9.9 17.7 10.4 18.0 10.7 17.3 19.9 11.5 28.0 21.3 41.2 21.4 19.5 15.8 21.4 16.4 18.1 29.4 25.7 12.3 15.2 84.8 14.8 20.8 8.0 19.3 24.1 21.5 21.9 17.3 35.9 17.3 18.7 15.3 17.8 31.9 12.3 20.8 25.3 27.9 21.2 11.2 6.9 30.3 20.4 13.4 17.0 19.2 9.8 82.0 13.3 34.2 11.7 29.2 15.6 0.0 27.1 58.0 13.4 18.0 5.8 38.9 38.5 4.8 24.8 39.9 41.6 28.5 10.0 26.9 8.5 90.2 24.2 9.1 25.0 10.5 8.1 23.7 11.1 19.4 9.2 1.7 7.1 8.2 31.0 21.7 26.0 23.5 FLT1 "FLT, VEGFR1" ENSG00000102755 "Fms related tyrosine kinase 1" P17948 13 28300344-28495145 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Angiogenesis, Chemotaxis, Differentiation" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 8 "placenta: 155.3" "Cell type enhanced" "Detected in many" 16 "Extravillous trophoblasts: 778.4;Ito cells: 284.2;Syncytiotrophoblasts: 942.6" "Cancer enhanced" "Detected in all" "renal cancer: 28.7" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.1;naive B-cell: 3.7;neutrophil: 2.1" "Group enriched" "Detected in many" 5 "B-cells: 3.7;granulocytes: 2.1" "Cell line enhanced" "Detected in some" "BJ: 17.4;BJ hTERT+: 13.8;HMC-1: 86.4;HUVEC TERT2: 15.6;WM-115: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA011740, HPA014290, CAB068189, CAB068190" Enhanced Supported "Plasma membrane,Actin filaments" "Secreted to blood" NA NA 876000 54000 "Plasma membrane" "Actin filaments" "CAB068189: AB_2665636, CAB068190: AB_2665637, HPA011740: AB_1858737, HPA014290: AB_1858738" "unprognostic (3.33e-2)" "unprognostic (3.52e-3)" "unprognostic (1.13e-3)" "unprognostic (5.02e-2)" "unprognostic (3.65e-1)" "unprognostic (5.03e-2)" "unprognostic (8.25e-2)" "unprognostic (2.27e-3)" "unprognostic (9.91e-2)" "unprognostic (6.61e-2)" "unprognostic (2.33e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.19e-4)" "unprognostic (4.20e-2)" "unprognostic (6.00e-2)" "unprognostic (1.57e-1)" "unprognostic (6.32e-2)" 18.9 4.0 9.9 4.0 14.3 1.2 13.5 8.0 15.9 7.1 4.6 3.5 1.7 3.5 7.2 2.2 3.4 4.0 6.9 18.3 11.4 7.3 10.3 7.6 12.3 2.5 10.3 3.2 5.1 5.4 13.4 3.7 155.3 13.8 5.1 3.1 9.1 3.0 5.0 12.5 2.6 3.4 7.3 9.6 7.2 4.6 6.8 10.2 0.0 19.1 3.8 2.8 7.6 9.2 3.7 0.5 2.1 0.1 0.2 0.4 0.2 0.0 0.0 0.0 0.1 0.1 0.2 0.0 17.4 13.8 6.3 3.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.6 0.0 11.2 0.0 0.4 0.0 0.0 0.0 0.0 0.0 86.4 0.1 0.0 0.0 0.2 0.0 15.6 1.4 0.4 0.0 0.0 0.0 1.0 0.8 9.2 0.0 0.0 0.6 0.0 0.0 0.0 0.0 2.0 0.1 0.0 0.0 0.0 11.4 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.5 0.2 0.0 0.1 0.0 31.0 0.2 0.1 0.1 0.1 0.1 0.0 1.1 0.1 0.1 0.0 3.7 0.4 0.4 2.1 0.2 0.1 0.5 0.2 0.2 9.9 14.3 8.0 15.9 11.4 7.3 10.3 3.2 13.8 10.2 0.0 8.9 2.2 0.5 3.7 5.9 12.6 5.1 2.7 1.2 0.0 3.9 155.4 1.7 0.0 116.6 192.1 0.0 0.0 0.0 778.4 17.5 1.1 1.1 2.1 28.1 1.6 0.0 284.2 16.1 130.7 17.3 5.3 0.0 0.0 0.0 172.0 0.0 0.0 45.6 0.0 7.3 90.5 6.6 12.9 2.8 4.3 942.6 2.9 0.0 0.5 FMN2 ENSG00000155816 "Formin 2" Q9NZ56 1 240014348-240475189 "Disease related genes, Predicted intracellular proteins" "DNA damage, Protein transport, Stress response, Transport" "Actin-binding, Developmental protein" "Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 41.0;parathyroid gland: 26.6" "Cell type enhanced" "Detected in some" 25 "Bipolar cells: 28.2;Cone photoreceptor cells: 47.1;Horizontal cells: 117.6" "Group enriched" "Detected in some" 8 "glioma: 5.9;testis cancer: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 27.0;BJ hTERT+: 14.3;fHDF/TERT166: 26.6;LHCN-M2: 29.3;U-138 MG: 19.4;WM-115: 30.2" "Low region specificity" "Detected in all" HPA050649 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA050649: AB_2681202" "unprognostic (1.55e-2)" "unprognostic (8.21e-2)" "unprognostic (4.01e-2)" "unprognostic (8.06e-2)" "unprognostic (2.77e-1)" "unprognostic (1.76e-1)" "unprognostic (7.97e-3)" "unprognostic (2.11e-2)" "unprognostic (2.93e-1)" "unprognostic (3.92e-2)" "unprognostic (3.35e-3)" "unprognostic (4.08e-1)" "unprognostic (1.11e-2)" "unprognostic (8.03e-3)" "unprognostic (9.78e-2)" "unprognostic (3.10e-2)" "unprognostic (1.40e-3)" 1.2 7.3 17.1 1.3 14.5 0.9 1.3 17.2 41.0 1.1 3.2 9.4 0.0 1.4 2.5 2.1 2.1 3.7 2.0 0.9 16.2 11.8 2.9 0.9 1.4 0.9 9.9 15.5 3.9 2.1 26.6 5.6 1.2 12.2 2.9 3.0 1.4 1.3 3.6 0.9 1.0 1.3 2.7 12.3 1.2 1.2 3.4 12.3 0.0 1.3 0.0 1.0 1.2 0.4 0.5 0.4 0.6 0.3 0.4 2.3 0.0 0.0 0.8 2.9 0.0 7.4 5.6 0.0 27.0 14.3 10.7 5.8 0.0 0.0 0.0 0.0 26.6 0.5 0.0 0.4 0.0 10.5 0.0 2.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 3.5 0.7 6.8 0.0 0.0 0.0 0.0 29.3 0.0 0.0 0.0 0.9 0.0 0.9 0.0 0.1 0.0 0.0 0.0 4.5 4.0 0.0 0.1 0.1 0.1 1.1 0.0 0.1 19.4 0.1 7.3 7.0 0.0 0.0 0.0 3.8 0.0 30.2 0.6 0.3 0.1 0.3 0.2 0.2 0.1 0.9 0.1 0.1 0.5 2.3 1.4 0.5 0.4 0.1 0.4 0.3 0.0 17.1 14.5 17.2 19.3 16.2 11.8 9.9 15.5 12.2 12.3 0.0 0.0 0.0 0.0 0.1 28.2 1.2 0.0 0.0 0.0 1.8 47.1 0.0 0.0 0.0 9.1 0.3 0.0 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.1 117.6 11.6 0.6 1.2 2.4 0.3 0.2 1.7 0.0 0.2 1.8 0.0 0.0 0.0 0.0 2.4 0.0 0.3 1.6 4.4 0.0 0.5 0.0 0.0 0.0 FNBP1 "FBP17, KIAA0554" ENSG00000187239 "Formin binding protein 1" Q96RU3 9 129887187-130043194 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "monocytes: 605.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 42.6;JURKAT: 45.5;MOLT-4: 42.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019635, HPA019691, HPA022119, HPA067742" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA019635: AB_2732423, HPA019691: AB_2670231, HPA022119: AB_2670897, HPA067742: " "unprognostic (2.86e-1)" "unprognostic (2.59e-3)" "unprognostic (1.22e-2)" "unprognostic (2.10e-1)" "unprognostic (3.20e-1)" "unprognostic (1.43e-2)" "unprognostic (6.30e-3)" "unprognostic (9.10e-2)" "unprognostic (2.90e-1)" "unprognostic (6.17e-2)" "unprognostic (9.26e-2)" "unprognostic (2.65e-1)" "prognostic unfavorable (8.45e-5)" "unprognostic (6.84e-2)" "unprognostic (1.37e-1)" "unprognostic (2.10e-1)" "unprognostic (1.21e-1)" 11.5 6.5 20.7 30.5 27.3 20.0 10.1 56.0 21.3 16.9 42.5 30.1 12.2 8.5 23.6 10.2 23.0 15.6 15.9 8.7 22.3 18.6 7.8 10.4 14.1 39.8 25.1 14.5 13.4 5.5 6.2 8.6 9.2 22.8 20.8 17.4 11.4 7.7 26.7 12.2 13.4 15.7 64.7 29.9 32.1 15.3 9.1 27.3 52.1 15.7 5.7 40.4 34.6 12.4 13.5 8.2 12.3 6.9 6.5 13.4 4.9 13.1 6.1 11.3 13.1 6.9 8.6 9.5 7.5 6.4 5.7 4.8 6.3 5.1 25.8 6.6 14.0 6.7 6.6 10.5 6.8 5.7 42.6 3.1 7.1 7.4 4.2 11.9 19.1 24.5 6.2 3.0 10.5 6.4 8.3 8.3 45.5 1.6 0.3 5.2 10.5 42.8 18.8 8.8 1.7 10.4 9.9 9.1 7.4 7.1 7.2 1.8 5.7 13.7 13.8 5.2 11.3 9.6 8.8 10.0 5.4 6.8 9.8 4.6 5.3 19.5 1.2 6.5 13.2 8.0 12.3 6.0 10.5 13.4 6.6 11.7 13.5 12.2 12.7 6.8 9.0 11.3 10.9 11.4 6.5 6.9 8.2 12.3 4.9 20.7 27.3 56.0 21.3 22.3 18.6 25.1 14.5 22.8 27.3 32.8 31.8 93.1 17.5 29.5 17.2 13.2 7.6 44.2 37.5 21.0 49.1 14.3 16.6 18.3 1.3 38.0 14.7 0.0 15.0 20.9 49.4 46.8 77.5 14.7 40.2 27.0 17.4 46.1 165.2 3.6 43.1 119.6 72.6 605.1 8.3 55.6 16.4 17.3 48.4 11.3 28.0 58.2 45.6 12.6 39.8 35.9 53.4 178.7 14.4 26.8 FOXN3 "C14orf116, CHES1" ENSG00000053254 "Forkhead box N3" O00409 14 89124871-89619149 "Predicted intracellular proteins, Transcription factors" "Cell cycle, Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA059209 Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA059209: AB_2683949" "unprognostic (1.69e-1)" "unprognostic (6.13e-3)" "unprognostic (2.08e-1)" "unprognostic (1.84e-1)" "unprognostic (4.09e-2)" "unprognostic (2.03e-1)" "unprognostic (3.03e-1)" "unprognostic (1.34e-2)" "unprognostic (8.75e-2)" "unprognostic (1.09e-1)" "unprognostic (2.64e-1)" "unprognostic (1.19e-1)" "prognostic favorable (9.58e-5)" "unprognostic (2.22e-2)" "unprognostic (1.88e-1)" "unprognostic (5.53e-2)" "unprognostic (2.11e-1)" 26.8 14.5 12.6 23.2 11.3 33.9 35.2 46.9 10.7 17.2 28.4 15.3 12.2 18.2 19.3 11.2 21.0 17.4 11.9 20.2 12.8 7.8 7.5 15.4 14.1 20.1 11.3 7.4 28.8 15.1 35.0 10.1 11.3 13.2 15.7 11.1 17.8 13.4 12.6 44.3 29.5 31.1 25.1 14.0 13.2 15.9 12.6 13.2 34.0 8.8 18.4 19.9 25.7 31.7 9.6 19.3 21.4 14.2 17.3 24.3 15.2 0.1 2.7 7.3 4.3 29.7 9.6 5.0 5.5 5.9 5.1 8.5 2.6 2.1 8.6 2.9 8.8 3.6 1.9 12.5 8.1 7.6 37.2 2.4 2.8 5.4 9.0 9.6 5.6 5.1 22.5 4.7 0.4 3.6 6.3 10.9 12.1 3.3 24.6 8.6 3.3 11.1 5.6 7.6 5.0 4.9 17.5 24.8 8.0 0.6 8.9 3.8 13.0 8.1 8.1 2.3 24.7 4.5 16.2 19.2 8.9 11.9 8.6 8.3 22.0 37.3 15.5 3.0 10.0 5.2 21.4 13.0 18.8 24.3 14.2 19.5 7.8 16.4 20.8 19.3 9.6 21.5 20.5 5.4 17.3 8.7 4.3 19.2 15.2 12.6 11.3 46.9 10.7 12.8 7.8 11.3 7.4 13.2 13.2 29.8 33.4 42.2 20.1 79.3 120.0 94.3 45.9 13.4 46.6 8.7 0.0 28.4 18.3 8.5 51.6 50.4 42.4 23.3 18.2 16.8 35.5 24.5 12.7 73.7 37.8 74.7 57.0 52.2 76.4 26.5 89.2 69.9 30.4 26.2 40.3 32.4 15.4 24.6 80.2 10.5 9.3 38.8 52.6 2.3 10.0 129.0 24.7 76.1 43.5 22.0 FP565260.3 ENSG00000277117 21 5022493-5040666 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 9.2" "Cell type enriched" "Detected in single" 22 "monocytes: 8.2" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive B-cell: 5.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 16.3;REH: 12.7;SiHa: 10.9" HPA029179 Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane, Cytoplasmic bodies" "HPA029179: AB_2732445" "unprognostic (3.34e-2)" "unprognostic (1.52e-1)" "unprognostic (2.82e-1)" "unprognostic (3.58e-4)" "unprognostic (6.66e-4)" "unprognostic (1.24e-2)" "unprognostic (1.12e-1)" "unprognostic (3.36e-1)" "unprognostic (2.46e-1)" "unprognostic (6.63e-2)" "unprognostic (1.14e-1)" "unprognostic (7.43e-2)" "unprognostic (2.13e-1)" "unprognostic (3.17e-1)" "unprognostic (3.60e-2)" "unprognostic (1.12e-1)" "unprognostic (2.09e-1)" 1.5 0.2 0.6 3.4 4.5 2.4 1.9 0.4 7.0 2.6 2.0 9.2 0.6 4.3 0.8 1.7 1.4 2.1 2.6 2.9 2.2 2.5 2.3 1.2 4.5 4.2 3.1 0.2 1.8 0.0 0.0 1.9 4.3 1.3 1.6 0.1 1.3 1.0 0.7 3.1 2.8 0.7 2.6 2.3 4.1 0.5 3.6 0.0 1.0 1.9 5.7 1.6 1.2 5.3 0.9 0.0 3.0 0.0 1.1 0.8 0.2 0.6 0.0 1.1 0.3 0.7 16.3 1.3 1.0 0.2 0.0 3.9 0.7 8.7 2.6 0.0 2.1 3.1 1.0 1.2 0.2 0.2 0.8 0.0 0.5 2.1 0.2 6.7 6.4 0.1 1.7 0.9 0.8 0.0 0.9 0.0 1.0 0.3 0.1 2.2 0.0 4.0 0.6 10.8 5.3 12.7 0.4 8.9 0.4 5.5 0.7 0.0 10.9 9.6 0.1 0.6 2.9 9.0 0.3 0.0 2.5 0.0 0.2 6.0 6.1 5.7 6.9 3.8 1.5 0.0 0.6 0.0 0.0 3.0 0.3 2.9 0.5 0.2 0.7 5.3 0.1 0.5 0.0 0.0 0.6 0.9 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 FSCN1 "FLJ38511, p55, SNL" ENSG00000075618 "Fascin actin-bundling protein 1" Q16658 7 5592823-5606655 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 56.9" "Cell type enriched" "Detected in many" 9 "monocytes: 1791.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "myeloid DC: 5.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 82.1;K-562: 68.7;NB-4: 78.0;PC-3: 68.7;SH-SY5Y: 65.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000121, HPA005723, CAB035991, HPA050654" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 4500000 Cytosol "Plasma membrane" "CAB000121: AB_2278596, CAB035991: , HPA005723: AB_1849159, HPA050654: AB_2681203" "unprognostic (1.91e-1)" "unprognostic (2.03e-2)" "unprognostic (3.12e-2)" "unprognostic (5.00e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (5.76e-4)" "unprognostic (2.16e-3)" "prognostic unfavorable (2.28e-4)" "unprognostic (6.31e-2)" "unprognostic (1.25e-1)" "unprognostic (3.27e-3)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.15e-7)" "unprognostic (1.21e-2)" "unprognostic (8.57e-2)" "unprognostic (1.05e-2)" "unprognostic (6.93e-3)" 26.3 13.3 23.7 29.6 30.1 6.3 8.1 5.5 56.9 9.9 5.5 35.1 0.0 5.4 11.7 2.3 22.3 5.9 8.9 10.6 27.7 16.8 5.5 7.1 11.3 15.2 26.9 23.6 21.8 5.1 2.3 7.0 29.4 20.1 4.1 3.0 8.1 11.0 3.9 7.8 17.3 6.6 7.0 29.6 39.3 7.6 15.9 28.3 9.3 8.5 15.9 11.4 14.7 12.3 0.2 5.4 1.0 1.9 0.0 0.1 1.4 8.0 18.6 12.4 44.5 4.8 9.2 82.1 19.3 8.6 3.3 3.6 12.9 2.0 0.1 23.6 8.5 3.2 30.5 7.1 31.0 0.2 9.1 3.8 0.5 19.8 60.8 2.5 0.0 1.6 5.7 9.2 6.2 5.1 5.5 16.2 0.0 68.7 0.1 4.2 0.8 0.2 78.0 32.5 0.5 68.7 18.1 2.9 0.3 4.8 0.7 9.9 65.9 16.1 0.2 0.6 8.4 0.4 4.9 32.8 22.9 40.3 13.3 19.8 0.1 0.1 0.0 14.8 0.0 43.0 0.0 1.9 0.1 0.0 0.5 0.0 0.2 0.1 0.0 5.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 1.4 23.7 30.1 5.5 41.3 27.7 16.8 26.9 23.6 20.1 28.3 3.0 5.5 2.4 19.0 161.1 7.2 6.9 2.5 1.4 0.0 1.8 0.0 4.4 0.0 6.8 13.1 49.6 1.3 0.0 4.2 90.3 72.6 6.3 16.1 0.8 207.2 0.0 40.2 97.6 22.0 7.9 23.6 10.6 49.0 1791.8 0.7 69.1 10.4 0.0 8.5 0.2 2.3 0.0 16.5 4.7 9.0 128.6 12.2 4.3 0.9 28.3 FTCD ENSG00000160282 "Formimidoyltransferase cyclodeaminase" O95954 21 46136262-46155567 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Histidine metabolism" "Lyase, Multifunctional enzyme, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "liver: 126.8" "Cell type enhanced" "Detected in many" 16 "Hepatocytes: 338.0;Late spermatids: 92.6;Proximal tubular cells: 322.0" "Cancer enriched" "Detected in some" 8 "liver cancer: 87.3" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "T-reg: 2.5" "Lineage enriched" "Detected in single" 25 "T-cells: 2.5" "Cell line enriched" "Detected in some" 29 "Hep G2: 45.4" "HPA020073, HPA030928, HPA030929, HPA036114" Enhanced Approved "Plasma membrane,Cytosol" No NA 580000 Cytosol "Plasma membrane" "HPA020073: AB_1849005, HPA030928: AB_2673664, HPA030929: AB_2673665, HPA036114: AB_2674947" "unprognostic (1.71e-1)" "unprognostic (2.27e-1)" "unprognostic (4.62e-5)" "unprognostic (2.90e-2)" "unprognostic (1.13e-1)" "unprognostic (2.96e-1)" "prognostic favorable (1.70e-4)" "unprognostic (1.85e-1)" "unprognostic (2.67e-1)" "unprognostic (1.99e-1)" "prognostic favorable (6.78e-5)" "unprognostic (1.80e-1)" "prognostic favorable (5.78e-4)" "unprognostic (3.80e-2)" "unprognostic (3.60e-1)" "unprognostic (9.37e-2)" "unprognostic (2.10e-1)" 0.2 0.0 0.6 0.2 1.6 0.0 0.2 0.2 0.7 0.2 0.3 0.2 0.2 0.3 0.2 2.0 0.2 0.0 0.2 0.2 0.5 0.4 25.9 126.8 0.2 0.2 0.4 0.2 0.2 1.0 0.0 0.2 0.2 0.2 0.3 0.0 0.2 0.2 0.2 0.2 0.0 0.4 0.2 0.2 0.2 0.1 1.5 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 45.4 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.5 0.5 0.0 0.0 0.5 0.7 0.0 0.0 0.0 0.0 2.5 0.1 0.6 1.6 0.2 0.7 0.5 0.4 0.4 0.2 0.2 0.2 0.0 0.0 24.9 0.0 0.1 1.0 1.0 68.8 0.0 0.0 8.7 0.0 0.0 39.7 0.0 75.4 0.6 0.0 0.0 0.0 0.0 0.8 0.5 0.0 338.0 0.1 3.2 0.0 22.7 22.3 92.6 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.5 322.0 0.4 0.0 0.1 10.7 12.2 0.4 0.0 6.9 0.0 0.0 FUT2 "SE, Se2, SEC2, sej" ENSG00000176920 "Fucosyltransferase 2" Q10981 19 48695971-48705950 "Blood group antigen proteins, Enzymes, Predicted membrane proteins" "Blood group antigen, Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 41.3;salivary gland: 58.1" "Cell type enhanced" "Detected in many" 12 "Cholangiocytes: 43.3;Enterocytes: 109.6;Exocrine glandular cells: 41.1;Mucus-secreting cells: 39.5;Paneth cells: 73.7;Undifferentiated cells: 44.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 8.7" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 6 "CAPAN-2: 34.7;OE19: 38.7" "Not detected" "Not detected" "Not detected" "Not detected" HPA014402 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014402: AB_1849194" "unprognostic (2.95e-2)" "unprognostic (6.07e-2)" "unprognostic (2.80e-3)" "unprognostic (4.63e-3)" "unprognostic (2.63e-1)" "prognostic favorable (5.83e-4)" "unprognostic (6.30e-3)" "unprognostic (6.55e-3)" "unprognostic (1.58e-1)" "unprognostic (8.44e-2)" "unprognostic (7.89e-2)" "unprognostic (5.11e-1)" "unprognostic (4.04e-2)" "unprognostic (6.52e-3)" "unprognostic (1.73e-1)" "unprognostic (3.12e-1)" "unprognostic (2.87e-1)" 0.4 0.6 0.7 5.3 0.8 0.0 0.8 8.7 1.6 9.3 25.0 0.3 13.9 24.1 1.3 0.1 16.0 1.2 23.3 0.5 0.7 0.7 0.8 0.4 1.1 0.1 0.7 0.1 1.0 7.5 0.0 1.5 0.2 0.7 1.2 10.9 0.1 58.1 14.5 0.5 2.6 41.3 0.4 0.7 0.6 15.8 0.7 0.2 0.5 0.6 16.1 19.3 3.1 5.4 1.7 1.8 3.5 1.0 1.4 2.5 0.6 0.9 0.9 0.2 0.5 0.0 0.0 0.1 0.1 0.0 0.0 0.0 4.1 34.7 0.3 0.2 0.0 0.2 6.1 0.0 0.0 0.0 0.3 0.2 0.3 0.2 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.6 0.0 0.4 0.0 0.4 0.4 0.8 0.2 38.7 0.3 0.3 0.1 1.5 0.0 0.3 1.8 0.2 0.1 0.3 0.0 0.2 5.2 0.0 0.1 0.1 0.2 0.2 0.1 0.3 0.2 0.0 0.1 0.2 0.1 3.5 0.8 0.4 2.0 0.7 1.1 1.5 2.3 1.0 0.5 1.7 2.1 0.7 3.4 1.4 1.0 1.8 2.5 0.6 0.7 0.8 8.7 1.6 0.7 0.7 0.7 0.1 0.7 0.2 0.0 1.1 0.0 2.5 0.8 2.7 0.4 43.3 12.0 10.3 19.2 2.0 0.0 1.7 5.5 0.5 0.3 109.6 0.0 41.1 0.0 0.2 2.5 0.0 0.0 0.1 0.0 10.9 0.0 0.3 0.0 0.0 0.0 1.7 0.0 39.5 0.8 25.6 73.7 0.0 0.0 3.8 0.0 0.2 0.2 0.2 1.3 0.1 2.2 44.3 14.7 FXYD3 "MAT-8, PLML" ENSG00000089356 "FXYD domain containing ion transport regulator 3" Q14802 19 35115879-35124324 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 160.2;salivary gland: 141.7" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 1850.8;Mucus-secreting cells: 1977.6;Paneth cells: 3546.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 5 "plasmacytoid DC: 3.2" "Lineage enriched" "Detected in single" 5 "dendritic cells: 3.2" "Cell line enhanced" "Detected in some" "HaCaT: 70.3;hTCEpi: 128.0;OE19: 239.6;RT4: 66.8;SK-BR-3: 65.8;WM-115: 47.1" HPA010856 Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA Nucleoplasm "Plasma membrane" "HPA010856: AB_1078915" "unprognostic (2.18e-3)" "unprognostic (2.78e-2)" "unprognostic (8.37e-3)" "unprognostic (3.31e-3)" "unprognostic (6.38e-2)" "unprognostic (3.02e-1)" "unprognostic (2.64e-3)" "unprognostic (1.60e-1)" "unprognostic (3.59e-1)" "unprognostic (1.03e-1)" "unprognostic (2.32e-2)" "unprognostic (3.88e-1)" "prognostic unfavorable (1.15e-6)" "unprognostic (4.17e-2)" "unprognostic (2.08e-1)" "unprognostic (5.06e-2)" "unprognostic (7.69e-3)" 0.4 0.1 1.6 29.5 2.3 0.0 20.4 1.7 2.1 30.0 133.2 1.1 2.3 8.6 3.9 2.9 82.1 9.0 56.6 0.8 1.4 0.3 2.1 0.5 35.8 0.3 2.1 0.8 1.9 28.9 0.0 3.7 41.9 2.2 58.4 160.2 15.8 141.7 3.5 0.5 64.2 36.4 7.5 1.8 0.4 50.6 0.7 1.0 2.5 0.5 93.2 49.8 48.7 42.5 0.3 3.2 0.6 0.1 0.0 0.2 0.5 12.6 0.0 0.0 0.0 0.0 0.0 12.0 0.0 0.0 0.0 0.0 0.4 18.5 0.0 0.0 0.0 0.1 70.3 0.0 26.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 128.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.2 0.0 0.1 0.0 239.6 0.1 0.0 0.0 0.0 0.0 66.8 15.7 0.1 0.0 65.8 4.8 0.1 12.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.1 0.2 0.6 0.0 0.0 3.2 0.0 0.5 1.6 2.3 1.7 2.1 1.4 0.3 2.1 0.8 2.2 1.0 708.7 211.8 0.0 720.0 512.4 2.3 1.3 239.5 860.6 417.5 127.4 0.0 696.6 1.7 18.8 0.1 3.8 1850.8 0.0 640.2 148.4 41.3 1079.2 23.0 0.6 70.8 1.6 937.0 0.0 0.0 0.0 0.0 12.2 391.4 2.8 1977.6 233.2 377.2 3546.9 0.0 0.6 8.5 0.0 25.8 0.2 0.2 756.6 1264.5 0.7 1253.7 1183.0 FYB1 "ADAP, FYB, FYB-120/130, SLAP-130" ENSG00000082074 "FYN binding protein 1" O15117 5 39105255-39274528 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 153.7;lymphoid tissue: 63.5" "Cell type enhanced" "Detected in some" 17 "Extravillous trophoblasts: 65.7;Hofbauer cells: 145.5;Macrophages: 50.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 153.7" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "HEL: 16.3;JURKAT: 58.0;MOLT-4: 55.5;REH: 16.2;U-937: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025336, HPA026796, HPA067427" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6600000 "Plasma membrane" Nucleoplasm "CAB025336: , HPA026796: AB_10964126, HPA067427: " "unprognostic (5.65e-2)" "unprognostic (2.92e-2)" "unprognostic (1.56e-2)" "unprognostic (6.26e-2)" "unprognostic (4.08e-1)" "unprognostic (3.29e-2)" "unprognostic (2.60e-1)" "unprognostic (1.97e-1)" "unprognostic (1.24e-1)" "unprognostic (5.63e-2)" "unprognostic (5.35e-2)" "unprognostic (3.21e-1)" "prognostic unfavorable (2.24e-4)" "unprognostic (2.40e-1)" "unprognostic (4.14e-2)" "unprognostic (8.99e-2)" "unprognostic (1.51e-1)" 7.0 3.5 6.3 36.0 18.3 22.1 3.9 1.8 10.1 3.5 4.4 8.3 0.3 4.1 2.7 6.5 4.9 4.2 7.9 3.5 6.8 6.6 5.7 6.2 13.8 35.5 15.5 2.7 2.6 2.5 1.3 3.5 8.7 11.7 3.8 5.3 3.0 5.4 1.5 1.9 2.4 11.7 5.6 29.4 41.5 5.2 3.5 12.2 63.5 4.1 1.8 28.0 10.1 3.6 0.1 11.9 153.7 41.3 8.6 28.7 30.8 0.0 1.1 0.0 0.0 0.1 0.0 6.2 0.0 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 2.2 4.5 0.0 0.1 0.0 0.0 0.0 16.3 0.0 0.0 0.0 6.1 5.2 0.0 0.1 0.0 0.1 0.0 0.0 58.0 0.0 0.0 0.0 0.0 55.5 3.5 0.0 0.0 0.0 16.2 0.0 0.0 0.2 1.1 0.0 0.0 0.0 0.1 1.6 0.4 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 21.5 0.0 11.9 33.8 32.3 7.9 38.6 5.5 0.1 22.5 13.8 11.9 0.1 28.7 17.3 153.7 8.6 41.3 3.0 21.7 30.8 6.3 18.3 1.8 10.1 6.8 6.6 15.5 2.7 11.7 12.2 14.9 34.3 0.0 0.0 0.0 0.0 0.0 0.0 6.7 10.3 14.0 0.0 25.9 8.3 0.0 0.0 0.0 0.0 0.0 0.0 65.7 0.0 0.0 14.0 0.0 145.5 0.0 0.0 0.0 0.0 0.0 0.0 50.3 0.0 10.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 0.0 0.0 0.0 0.0 33.6 0.0 0.0 0.0 FYN "MGC45350, SLK, SYN" ENSG00000010810 "FYN proto-oncogene, Src family tyrosine kinase" P06241 6 111660332-111873452 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Developmental protein, Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Proximal tubular cells: 145.7;T-cells: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "NK-cells: 15.3;T-cells: 43.2" "Cell line enhanced" "Detected in many" "U-2197: 105.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005034, CAB018387, HPA023887, HPA063770" Approved Enhanced "Plasma membrane,Cytosol" NA NA 2000000 "Plasma membrane" Cytosol "CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119" "unprognostic (8.62e-3)" "unprognostic (8.25e-2)" "unprognostic (2.11e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (2.43e-2)" "prognostic favorable (1.84e-4)" "unprognostic (4.60e-2)" "unprognostic (2.89e-2)" "unprognostic (2.92e-1)" "prognostic favorable (4.78e-4)" "unprognostic (1.43e-1)" "prognostic unfavorable (1.43e-4)" "unprognostic (6.95e-2)" "unprognostic (3.10e-1)" "unprognostic (6.62e-3)" "unprognostic (2.40e-1)" 29.1 7.2 49.2 29.0 38.4 16.3 18.1 33.9 62.1 25.7 12.1 33.7 4.1 10.1 21.8 21.4 10.2 32.0 19.4 21.2 39.4 34.0 9.5 12.2 25.2 57.2 35.7 23.1 18.6 4.4 15.0 12.5 17.7 25.6 9.6 10.0 11.0 6.4 8.4 7.0 16.5 19.0 24.2 30.9 39.8 15.4 10.1 31.3 34.8 27.5 5.6 38.5 22.6 19.3 1.6 1.7 0.7 1.5 15.3 43.2 10.7 1.9 0.3 34.9 5.8 26.7 16.4 0.6 5.5 17.5 4.7 8.5 0.2 0.3 3.9 3.6 10.7 4.1 0.2 4.9 7.6 9.2 0.1 12.8 10.7 2.6 0.5 15.8 3.6 3.7 15.8 11.6 17.7 15.2 12.4 19.2 19.2 0.9 27.3 16.8 0.2 17.1 3.3 5.0 0.6 3.5 5.4 4.7 0.2 0.0 1.7 24.5 9.9 1.0 0.4 23.3 8.1 0.2 10.8 12.2 14.3 2.6 105.3 3.5 3.9 3.5 6.0 26.9 8.4 24.8 0.2 1.5 0.0 34.1 1.2 43.2 1.1 21.2 37.5 1.7 1.6 7.0 18.7 0.7 15.3 0.9 1.0 17.6 10.7 49.2 38.4 33.9 35.3 39.4 34.0 35.7 23.1 25.6 31.3 0.0 11.7 18.8 1.9 15.1 53.9 9.2 12.7 5.3 3.4 7.0 0.0 2.2 14.9 8.1 2.8 56.2 3.5 0.0 0.9 2.1 36.8 1.4 51.8 59.3 2.8 44.5 12.7 71.8 42.5 0.9 24.5 33.6 35.4 3.6 2.4 88.8 6.3 0.0 6.7 145.7 7.8 12.9 23.1 2.6 4.3 11.7 43.5 208.1 1.2 0.9 FZD4 "CD344, EVR1" ENSG00000174804 "Frizzled class receptor 4" Q9ULV1 11 86945679-86955391 "CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 75.7" "Cell type enhanced" "Detected in many" 18 "Collecting duct cells: 34.9;Endothelial cells: 26.3;Ito cells: 108.6;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 25.9;Hep G2: 32.6;HSkMC: 18.8;HUVEC TERT2: 36.8;TIME: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA042328, HPA074833" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA042328: AB_10962494, HPA074833: AB_2686716" "unprognostic (6.49e-2)" "unprognostic (1.49e-2)" "unprognostic (1.03e-1)" "unprognostic (1.03e-1)" "unprognostic (5.87e-2)" "unprognostic (5.51e-2)" "unprognostic (1.82e-1)" "unprognostic (6.97e-2)" "unprognostic (3.33e-2)" "unprognostic (3.79e-2)" "unprognostic (1.36e-2)" "unprognostic (2.22e-1)" "prognostic favorable (8.60e-5)" "unprognostic (1.05e-2)" "unprognostic (9.96e-2)" "unprognostic (9.22e-2)" "unprognostic (1.97e-1)" 75.7 5.3 3.4 6.0 4.8 0.5 57.8 1.5 4.3 11.5 9.0 1.4 32.6 2.0 13.1 13.5 6.3 9.6 8.7 12.5 3.1 2.2 17.0 8.9 19.0 4.7 2.9 3.2 12.8 6.0 4.4 10.1 7.3 5.5 9.3 4.3 20.0 7.1 56.0 17.9 3.7 5.4 8.6 2.8 8.6 8.2 5.5 1.6 0.5 11.4 11.1 3.0 8.3 20.7 0.4 0.2 0.8 0.4 1.4 0.3 0.0 0.5 0.4 1.1 2.0 25.9 6.8 1.5 3.2 2.9 1.2 1.3 2.7 0.3 0.0 0.7 1.0 1.7 1.1 1.2 0.5 1.0 0.1 0.8 1.0 0.8 32.6 7.7 0.0 0.0 18.8 0.2 1.1 0.2 3.0 36.8 0.0 1.4 0.1 0.8 0.8 0.0 0.0 1.5 2.8 7.4 0.0 1.9 0.0 3.6 5.3 0.2 0.3 1.3 0.4 0.5 2.3 4.7 0.0 18.0 3.1 2.1 3.6 0.6 0.1 0.5 0.0 0.4 0.0 0.8 0.7 0.3 0.1 0.3 0.2 0.1 0.2 0.3 0.2 0.1 0.4 0.2 0.3 0.8 1.4 0.4 0.2 0.0 0.0 3.4 4.8 1.5 4.3 3.1 2.2 2.9 3.2 5.5 1.6 0.0 2.2 1.9 0.4 1.3 0.7 7.8 7.6 1.4 1.2 34.9 9.8 0.1 3.3 0.6 0.4 26.3 0.8 0.0 1.4 0.1 4.3 0.8 0.0 10.4 0.2 0.0 0.0 108.6 11.2 1.7 8.6 0.9 0.0 0.0 1.1 0.3 1.0 0.0 6.3 6.9 0.1 32.3 5.1 0.2 3.0 0.5 0.2 0.0 0.6 0.1 GABRA1 EJM5 ENSG00000022355 "Gamma-aminobutyric acid type A receptor alpha1 subunit" P14867 5 161847063-161899981 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 58.6" "Cell type enriched" "Detected in some" 24 "Bipolar cells: 209.5" "Cancer enriched" "Detected in single" 5 "glioma: 1.1" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 3.7;SCLC-21H: 1.1;U-2 OS: 1.6;U-87 MG: 2.3;WM-115: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022502, HPA029363, HPA055746" Enhanced Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022502: , HPA029363: , HPA055746: AB_2682904" "unprognostic (2.58e-2)" "unprognostic (4.78e-3)" "unprognostic (1.84e-1)" "unprognostic (3.31e-1)" "unprognostic (2.43e-1)" 1.0 2.6 8.5 1.0 21.9 1.0 1.0 35.2 58.6 1.0 1.0 1.8 0.0 1.1 1.0 1.0 1.0 1.0 1.0 1.0 10.5 8.8 1.0 1.0 1.0 1.0 6.7 22.0 1.0 1.0 1.0 0.1 1.0 7.4 1.2 1.0 0.2 1.0 1.1 1.0 1.0 1.0 1.0 1.3 1.1 1.5 1.1 0.0 0.0 1.0 0.0 1.3 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.1 0.0 0.0 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 21.9 35.2 49.8 10.5 8.8 6.7 22.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 209.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GABRA2 ENSG00000151834 "Gamma-aminobutyric acid type A receptor alpha2 subunit" P47869 4 46248427-46475230 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 52.6" "Group enriched" "Detected in some" 4 "Collecting duct cells: 38.4;Enterocytes: 16.9;Intestinal endocrine cells: 30.6" "Cancer enhanced" "Detected in some" "glioma: 0.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "U-2 OS: 9.6;U-87 MG: 4.5;WM-115: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029363, CAB079061" Supported Uncertain "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079061: , HPA029363: " "unprognostic (2.03e-2)" "unprognostic (2.77e-1)" "unprognostic (2.45e-4)" "unprognostic (6.87e-3)" "unprognostic (2.65e-1)" "unprognostic (2.08e-1)" "unprognostic (1.01e-1)" "unprognostic (4.09e-1)" "unprognostic (6.90e-3)" "unprognostic (8.83e-2)" "unprognostic (2.22e-5)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.67e-1)" "unprognostic (3.04e-2)" 2.2 1.3 38.5 1.4 34.4 1.2 1.9 10.4 52.6 1.7 4.5 4.9 0.0 2.0 1.4 11.7 1.7 1.0 1.6 1.0 38.9 7.7 8.8 1.4 1.0 1.4 3.7 31.0 1.9 1.0 0.9 0.6 1.5 10.5 1.0 3.5 0.0 1.2 1.9 1.0 1.3 7.7 1.3 6.9 2.3 1.6 1.5 7.1 0.0 1.1 0.0 1.4 1.2 0.8 0.2 0.3 1.0 0.1 0.1 0.1 0.0 0.5 0.5 0.1 0.6 0.0 0.0 0.5 0.3 0.0 0.0 0.0 2.1 0.6 0.2 0.5 0.0 0.1 0.8 0.0 0.0 0.2 0.5 0.5 0.1 0.7 0.3 0.8 0.1 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.8 0.2 0.0 0.4 0.0 0.3 0.9 1.8 0.1 0.0 0.6 0.4 0.1 0.6 0.2 0.0 0.1 0.3 0.0 0.6 0.4 0.4 0.1 0.5 9.6 0.5 0.1 0.8 1.2 0.2 4.5 0.4 5.1 1.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.9 0.1 0.1 0.3 0.0 0.0 38.5 34.4 10.4 31.4 38.9 7.7 3.7 31.0 10.5 7.1 0.0 0.0 0.0 0.0 0.1 1.5 0.4 0.0 0.0 0.0 38.4 3.9 0.0 3.3 0.0 6.4 0.2 16.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 30.6 0.0 0.0 6.9 0.6 0.0 1.7 0.0 1.9 0.3 0.0 0.9 0.0 0.0 1.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.6 0.0 GABRA3 ENSG00000011677 "Gamma-aminobutyric acid type A receptor alpha3 subunit" P34903 X 152166234-152451358 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 30.1" "Cell type enriched" "Detected in some" 4 "Hofbauer cells: 12.1" "Cancer enriched" "Detected in many" 7 "testis cancer: 16.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "GAMG: 9.1;HMC-1: 7.7;Karpas-707: 13.0;PC-3: 7.6;U-266/70: 7.0;U-266/84: 11.6;U-87 MG: 7.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000839, HPA029363" Approved Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA000839: AB_1078929, HPA029363: " "unprognostic (9.63e-3)" "unprognostic (2.04e-1)" "unprognostic (2.02e-1)" "unprognostic (1.18e-2)" "unprognostic (7.07e-2)" "unprognostic (5.42e-2)" "unprognostic (2.34e-6)" "unprognostic (1.24e-1)" "unprognostic (2.70e-1)" "unprognostic (2.39e-2)" "unprognostic (2.63e-2)" "unprognostic (1.73e-1)" "unprognostic (7.29e-6)" "unprognostic (7.42e-3)" "unprognostic (6.20e-2)" "unprognostic (8.13e-2)" 0.7 0.7 7.7 0.6 15.2 0.7 0.7 1.3 30.1 2.2 0.8 3.3 0.0 0.8 1.2 0.8 1.3 0.7 0.7 0.7 10.9 15.9 0.7 0.7 0.7 0.7 4.7 10.5 0.6 0.7 0.6 0.9 5.2 6.2 0.8 0.8 0.4 0.7 1.8 0.8 1.1 0.9 0.8 2.1 0.7 0.7 1.8 1.1 0.0 0.7 0.0 0.9 1.8 0.4 0.0 0.1 1.5 0.3 0.3 0.2 0.0 0.0 0.8 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 4.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 13.0 0.0 0.0 0.0 0.0 2.4 5.5 7.6 0.0 0.0 0.0 0.0 0.0 0.2 4.7 0.0 4.8 0.4 0.3 0.1 1.2 0.0 4.9 6.5 0.3 1.4 7.0 11.6 0.0 7.7 0.0 4.9 1.5 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.3 0.1 0.2 0.0 7.7 15.2 1.3 28.4 10.9 15.9 4.7 10.5 6.2 1.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.0 3.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.9 0.0 1.6 0.0 0.0 0.3 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Cell type enhanced" "Detected in single" 18 "Spermatogonia: 1.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "A549: 26.4;HAP1: 9.1;NTERA-2: 10.9;U-2 OS: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029363, HPA077031, CAB079022" Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB079022: , HPA029363: , HPA077031: AB_2686825" "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 9.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.0 9.6 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.1 0.0 0.0 0.0 GADL1 ENSG00000144644 "Glutamate decarboxylase like 1" Q6ZQY3 3 30726200-30894765 "Enzymes, Predicted intracellular proteins" "Decarboxylase, Lyase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "skeletal muscle: 21.6" "Cell type enhanced" "Detected in some" 18 "Club cells: 2.3;Collecting duct cells: 1.8" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 9.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039160, HPA040229" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039160: AB_10796222, HPA040229: AB_10796118" "unprognostic (4.96e-2)" "unprognostic (1.30e-2)" "unprognostic (9.83e-2)" "unprognostic (1.39e-2)" "unprognostic (5.60e-2)" "unprognostic (7.32e-2)" "unprognostic (5.05e-3)" "unprognostic (8.37e-2)" "unprognostic (1.23e-2)" "unprognostic (2.02e-3)" "unprognostic (1.63e-1)" "unprognostic (1.98e-5)" "unprognostic (8.81e-2)" "unprognostic (4.54e-2)" "unprognostic (4.39e-1)" "unprognostic (1.06e-1)" 0.5 0.3 0.2 0.2 0.3 1.0 0.4 0.5 0.7 0.4 0.2 0.0 0.0 0.1 0.2 1.6 1.4 0.2 2.0 2.3 0.2 0.3 0.7 0.2 1.6 0.3 0.3 0.8 0.5 0.3 0.1 0.6 0.5 2.1 0.5 0.1 0.3 0.3 0.0 21.6 0.8 0.2 2.5 0.7 0.5 0.2 1.1 0.0 0.0 1.2 3.3 0.7 0.5 0.3 1.7 0.5 1.9 0.8 0.5 1.3 0.3 1.3 0.3 0.8 1.1 0.9 0.5 1.6 0.6 0.3 0.3 0.2 1.3 1.2 1.1 0.5 0.2 0.7 0.9 9.9 0.3 0.4 1.7 0.5 1.6 1.6 0.5 0.4 0.9 3.4 0.4 0.6 0.7 0.3 1.0 0.6 1.0 1.2 4.1 0.9 1.1 0.7 1.3 1.9 0.7 0.5 1.9 2.1 1.0 1.0 1.5 1.2 1.0 1.2 0.7 2.9 1.2 1.2 0.8 5.1 1.5 1.4 1.9 0.7 1.6 0.8 0.7 0.6 0.9 1.9 1.9 0.7 0.8 1.0 0.6 0.8 1.2 0.9 0.6 0.4 1.7 1.1 1.0 1.7 0.5 0.8 0.5 1.3 0.3 0.2 0.3 0.5 0.7 0.2 0.3 0.3 0.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 2.3 1.8 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GALR1 "GALNR, GALNR1" ENSG00000166573 "Galanin receptor 1" P47211 18 77250549-77277896 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 5.3;brain: 3.5;pituitary gland: 4.9" "Group enriched" "Detected in some" 6 "Ciliated cells: 21.4;Early spermatids: 46.5;Intestinal endocrine cells: 16.9" "Cancer enriched" "Detected in single" 6 "glioma: 1.0" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in some" "Region enhanced" "Detected in some" "hypothalamus: 6.1" "Low region specificity" "Detected in many" HPA074584 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074584: " "unprognostic (1.65e-1)" "unprognostic (1.56e-2)" "unprognostic (2.85e-1)" "unprognostic (3.00e-1)" "unprognostic (2.11e-1)" "unprognostic (2.77e-3)" "unprognostic (1.31e-2)" "unprognostic (5.34e-3)" "unprognostic (7.33e-3)" "unprognostic (9.49e-2)" "unprognostic (2.18e-1)" 1.1 5.3 1.2 0.3 0.8 0.7 0.5 0.0 3.5 0.0 0.3 0.4 0.2 0.5 0.0 0.3 0.1 0.1 0.7 2.0 0.1 0.5 0.0 0.1 0.8 0.1 0.5 0.0 4.9 0.0 0.8 0.5 0.5 0.7 0.1 0.4 0.5 0.1 0.9 0.0 0.3 0.4 0.3 0.0 0.0 0.1 0.4 0.4 1.6 0.2 0.5 0.3 0.0 0.3 0.4 0.6 0.8 0.5 1.2 0.6 0.2 0.5 0.1 0.1 0.8 1.1 0.8 0.2 0.4 0.2 0.4 0.4 0.3 0.1 1.1 0.6 1.1 0.8 0.5 0.3 0.5 0.8 0.8 0.4 0.3 0.3 0.5 0.3 0.5 0.4 1.6 0.1 0.9 0.4 0.9 0.6 0.1 0.5 0.5 0.4 0.4 0.2 0.6 1.5 0.5 0.2 0.4 0.4 0.9 0.5 0.4 0.6 0.6 0.7 1.1 0.1 0.6 0.3 0.4 0.8 0.3 0.4 1.0 0.2 0.3 0.3 0.2 0.3 0.3 0.3 0.2 0.1 0.4 0.2 0.2 1.6 0.5 0.2 0.4 0.1 0.0 0.0 5.1 0.0 0.7 0.0 1.8 0.4 0.0 21.4 1.2 1.8 0.0 0.0 0.0 0.0 46.5 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.1 0.0 0.1 0.0 16.9 0.0 0.0 3.6 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.0 GAPVD1 "DKFZP434C212, KIAA1521" ENSG00000165219 "GTPase activating protein and VPS9 domains 1" Q14C86 9 125261794-125367207 "Predicted intracellular proteins" Endocytosis "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029386, HPA029387" Uncertain Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029386: AB_10599604, HPA029387: AB_10600311" "unprognostic (8.43e-3)" "unprognostic (3.84e-2)" "unprognostic (3.53e-1)" "unprognostic (1.97e-1)" "unprognostic (5.43e-2)" "unprognostic (4.04e-2)" "unprognostic (7.08e-2)" "unprognostic (1.31e-2)" "unprognostic (7.56e-2)" "unprognostic (1.23e-1)" "unprognostic (2.77e-1)" "unprognostic (1.27e-1)" "unprognostic (2.54e-3)" "unprognostic (2.77e-1)" "unprognostic (4.19e-2)" "unprognostic (1.67e-2)" "unprognostic (5.82e-2)" 17.6 16.2 16.0 14.9 18.6 26.6 16.9 25.7 21.3 17.5 16.1 20.9 18.0 10.8 19.1 14.0 24.3 16.0 13.7 15.4 15.5 14.1 17.6 14.5 20.5 15.1 21.1 15.6 18.9 14.1 30.3 20.2 23.3 20.1 14.7 13.2 16.4 15.9 17.2 31.6 23.5 14.6 17.4 15.3 17.3 14.6 32.1 20.2 18.6 24.8 12.2 19.9 16.2 17.7 10.4 14.8 19.2 17.8 13.6 14.8 10.0 11.6 12.2 11.5 10.7 14.0 15.3 16.8 13.1 15.0 15.2 12.8 19.3 8.4 15.6 7.1 16.4 15.2 23.8 23.9 13.7 16.2 14.3 14.3 17.7 29.9 9.5 16.5 21.0 30.0 10.9 13.4 18.0 14.6 9.9 18.0 12.6 34.4 8.7 12.6 17.1 15.7 9.2 11.7 21.1 13.9 13.8 25.2 15.1 8.7 12.0 15.4 10.3 19.1 17.7 10.4 12.1 21.7 11.0 18.9 10.8 7.9 19.1 13.9 11.1 21.0 16.1 13.2 12.0 13.8 18.6 15.0 18.0 13.7 15.6 13.4 10.2 14.2 14.8 14.8 10.4 14.2 14.7 19.2 13.6 17.8 5.6 10.9 10.0 16.0 18.6 25.7 21.3 15.5 14.1 21.1 15.6 20.1 20.2 101.3 47.6 9.5 14.1 28.3 29.0 55.7 15.3 50.9 35.2 26.2 49.1 33.2 8.3 14.4 33.5 20.2 12.1 23.3 16.7 19.4 21.6 17.0 15.1 13.9 23.4 33.4 12.1 23.4 25.4 10.0 21.3 27.3 16.9 16.2 16.0 21.3 17.3 14.0 22.6 13.4 38.0 19.4 22.1 63.7 35.1 32.2 56.1 19.1 16.1 22.1 GAS2L1 GAR22 ENSG00000185340 "Growth arrest specific 2 like 1" Q99501 22 29306582-29312785 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "ductus deferens: 40.5" "Cell type enhanced" "Detected in many" 6 "Ito cells: 77.3;Late spermatids: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.0;eosinophil: 3.1" "Group enriched" "Detected in many" 10 "dendritic cells: 1.1;granulocytes: 3.1;monocytes: 2.0" "Cell line enhanced" "Detected in many" "U-138 MG: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019858 Approved Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA019858: AB_1849486" "unprognostic (3.66e-1)" "unprognostic (5.22e-2)" "unprognostic (1.38e-1)" "unprognostic (4.95e-3)" "unprognostic (1.77e-1)" "unprognostic (1.11e-1)" "unprognostic (1.84e-3)" "unprognostic (8.99e-2)" "unprognostic (1.28e-1)" "unprognostic (6.05e-2)" "unprognostic (1.90e-1)" "unprognostic (1.21e-1)" "prognostic favorable (8.44e-4)" "unprognostic (4.23e-2)" "unprognostic (9.04e-2)" "unprognostic (1.32e-1)" "unprognostic (1.19e-2)" 15.1 10.7 15.2 5.3 13.4 5.4 7.6 10.5 19.8 4.5 5.6 6.8 40.5 17.9 5.1 8.4 8.6 4.6 4.3 7.0 12.9 8.1 6.0 6.6 7.5 2.2 11.3 10.2 2.9 10.0 4.6 6.8 4.3 9.5 7.1 2.2 3.2 12.7 22.9 4.9 22.4 13.0 4.5 10.0 11.5 8.3 16.6 8.8 0.0 4.5 9.2 3.5 3.9 4.7 0.0 1.1 3.1 2.0 0.0 0.2 1.2 8.3 9.8 1.5 6.2 2.4 2.3 9.8 12.6 3.8 5.4 2.8 4.4 6.0 0.0 5.7 6.7 5.6 25.6 2.6 7.1 1.0 11.4 1.2 11.0 7.8 3.1 3.1 0.1 7.7 2.5 4.9 5.1 2.0 3.9 7.1 11.2 5.2 1.7 3.8 7.1 0.2 6.1 2.2 5.6 22.1 0.2 4.4 0.7 3.2 5.4 0.5 8.3 9.7 13.0 7.0 2.0 13.0 1.7 15.0 33.7 23.2 15.0 12.6 0.1 0.1 0.1 14.9 0.4 8.2 0.0 2.0 3.1 0.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 0.2 0.0 0.5 0.0 1.4 0.0 0.0 1.2 15.2 13.4 10.5 19.8 12.9 8.1 11.3 10.2 9.5 8.8 6.0 1.7 0.8 5.7 25.0 2.6 3.5 7.6 1.4 9.1 1.8 5.9 19.1 6.6 10.8 26.3 19.3 19.0 23.3 6.0 10.4 10.8 6.1 1.1 10.5 13.1 12.7 1.7 77.3 12.6 73.5 8.9 10.7 11.8 4.6 5.4 4.5 8.3 9.3 11.0 7.0 19.2 38.8 14.1 2.3 10.8 28.2 5.6 0.7 9.0 2.2 GAS8 "DRC4, GAS11" ENSG00000141013 "Growth arrest specific 8" O95995 16 90019629-90044975 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 84.3;Early spermatids: 174.5;Late spermatids: 126.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MCF7: 26.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041311, HPA048238" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041311: AB_2677402, HPA048238: AB_2680324" "unprognostic (2.23e-3)" "unprognostic (1.26e-1)" "unprognostic (1.73e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.73e-1)" "unprognostic (3.91e-1)" "unprognostic (1.96e-1)" "unprognostic (1.82e-1)" "unprognostic (1.16e-1)" "unprognostic (4.47e-1)" "prognostic favorable (7.67e-4)" "unprognostic (3.06e-2)" "prognostic favorable (1.09e-7)" "unprognostic (1.98e-1)" "unprognostic (2.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.19e-2)" 7.1 11.1 8.5 6.5 13.2 2.3 7.6 13.5 12.2 11.7 6.8 10.0 10.8 4.1 12.7 16.2 7.8 26.5 11.6 21.0 8.7 9.8 12.4 6.3 9.9 4.0 8.9 8.9 12.8 12.9 23.2 22.0 3.5 10.1 8.9 4.6 11.0 16.2 12.6 18.8 4.2 4.2 8.4 7.5 4.2 7.6 16.1 6.4 1.7 15.5 5.5 5.2 6.6 5.1 2.5 4.8 4.3 5.0 0.0 3.7 2.3 10.8 8.8 1.1 5.5 5.1 4.0 9.4 2.2 5.5 8.9 2.6 8.8 8.3 0.6 6.0 4.5 5.4 10.8 3.6 6.4 2.0 0.0 6.5 2.3 5.6 10.0 5.8 1.3 1.8 5.2 3.7 6.7 3.1 3.8 5.3 3.8 8.7 1.2 3.8 26.1 1.5 5.5 7.3 6.9 4.6 0.4 10.2 0.6 11.2 5.3 9.3 6.7 11.5 6.2 13.1 1.0 11.7 5.1 3.7 5.5 6.4 3.0 5.1 2.0 3.3 0.0 14.0 1.7 9.6 4.3 3.1 3.7 1.8 5.0 1.8 1.2 2.8 3.7 4.4 2.5 2.3 2.0 4.0 0.0 3.1 4.8 3.5 2.3 8.5 13.2 13.5 12.2 8.7 9.8 8.9 8.9 10.1 6.4 20.8 9.9 0.5 4.2 1.0 8.8 6.4 28.1 84.3 15.9 21.0 19.6 2.6 11.6 14.7 174.5 4.5 4.3 0.0 9.6 3.0 3.3 6.4 2.3 3.6 3.3 25.4 5.8 4.9 0.0 126.7 13.0 3.3 5.0 1.8 5.4 11.4 10.1 3.5 7.1 23.0 25.1 6.5 3.7 18.9 13.6 2.3 1.4 0.0 5.0 4.8 GBP4 Mpa2 ENSG00000162654 "Guanylate binding protein 4" Q96PP9 1 89181148-89198932 "Plasma proteins, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Ciliated cells: 56.2;Endothelial cells: 79.8;Ito cells: 89.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "CAPAN-2: 10.0;HDLM-2: 8.0;HEL: 10.7;REH: 9.0;RT4: 15.1;U-266/70: 13.6" "HPA030101, HPA062039" Enhanced Supported "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus" "Plasma membrane" "HPA030101: AB_10601654, HPA062039: " "unprognostic (1.32e-2)" "unprognostic (3.89e-3)" "unprognostic (1.02e-2)" "unprognostic (1.07e-3)" "unprognostic (3.22e-1)" "unprognostic (9.93e-3)" "unprognostic (5.65e-2)" "unprognostic (1.09e-1)" "unprognostic (3.22e-1)" "prognostic favorable (9.29e-5)" "unprognostic (1.91e-3)" "unprognostic (3.38e-1)" "prognostic unfavorable (1.30e-5)" "unprognostic (1.22e-1)" "unprognostic (3.91e-2)" "unprognostic (2.68e-2)" "unprognostic (2.02e-3)" 25.4 4.4 3.9 18.4 5.9 3.6 9.4 2.1 5.0 7.8 5.8 4.4 2.9 8.0 10.5 7.4 7.9 6.3 5.7 9.2 4.6 4.4 8.5 9.8 34.7 20.5 5.8 4.4 12.8 2.4 9.3 4.8 9.1 6.9 12.7 4.8 17.4 4.8 4.8 12.0 3.2 11.0 5.1 7.4 23.4 7.4 2.6 2.7 8.1 23.3 5.7 15.2 9.3 7.7 3.3 2.0 5.1 12.6 12.2 7.6 4.4 0.7 0.0 0.1 0.3 0.1 0.1 0.6 1.5 6.4 6.8 6.2 0.1 10.0 0.5 0.9 1.9 0.6 0.8 0.0 0.3 0.3 8.0 0.1 10.7 0.3 0.3 0.9 0.2 0.3 0.3 0.0 0.1 0.0 1.0 1.6 0.2 0.3 2.0 0.0 0.1 5.3 0.3 0.4 0.0 0.1 9.0 0.2 0.3 0.1 15.1 0.2 0.5 0.2 0.5 0.3 0.7 0.5 1.1 0.4 0.2 1.4 0.2 0.1 13.6 0.2 0.3 0.3 0.1 1.9 0.4 3.8 0.4 6.6 12.6 5.8 2.3 7.3 7.3 2.0 3.3 5.5 5.1 5.1 12.2 11.5 0.7 7.6 4.4 3.9 5.9 2.1 5.0 4.6 4.4 5.8 4.4 6.9 2.7 29.8 44.9 10.0 7.8 4.0 2.1 2.8 10.2 56.2 37.5 5.2 7.9 0.7 0.0 1.9 1.5 79.8 2.5 23.3 2.9 1.1 5.6 14.8 20.8 6.4 8.7 0.0 0.0 89.0 20.0 0.5 3.4 22.5 5.0 29.7 2.8 16.2 21.4 1.9 1.8 0.7 10.6 0.0 5.7 2.6 4.5 2.6 1.3 21.3 0.5 12.5 GCA GCL ENSG00000115271 Grancalcin P28676 2 162318840-162371595 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "blood: 112.7;bone marrow: 116.0;brain: 30.2;lymphoid tissue: 51.8" "Cell type enhanced" "Detected in many" 6 "Kupffer cells: 188.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 41.1;neutrophil: 112.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 112.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035033, HPA035034" Enhanced Supported "Plasma membrane,Cytosol" NA NA 890000 Cytosol "Plasma membrane" "HPA035033: AB_10669854, HPA035034: AB_10669900" "unprognostic (9.62e-2)" "unprognostic (9.76e-2)" "unprognostic (3.33e-1)" "unprognostic (3.82e-2)" "unprognostic (2.60e-1)" "unprognostic (1.06e-1)" "unprognostic (2.33e-3)" "unprognostic (1.36e-1)" "unprognostic (8.87e-2)" "unprognostic (2.49e-2)" "unprognostic (1.20e-1)" "unprognostic (9.78e-2)" "unprognostic (6.56e-2)" "unprognostic (5.80e-2)" "unprognostic (3.07e-1)" "unprognostic (3.06e-2)" "unprognostic (1.32e-2)" 13.1 6.8 13.4 24.8 21.3 116.0 7.8 6.9 15.8 6.0 7.7 15.3 3.2 8.2 4.6 11.0 5.0 7.2 9.7 11.2 15.9 13.0 8.5 7.6 15.6 51.8 26.0 9.7 4.4 11.5 4.8 8.1 10.6 24.6 5.7 8.6 3.7 6.9 4.9 2.2 3.7 7.8 7.7 30.2 50.0 10.3 10.7 20.8 5.8 7.4 2.5 10.3 10.0 6.3 3.1 8.9 112.7 18.2 0.3 1.3 8.4 1.4 2.1 5.9 0.0 1.4 1.3 0.2 2.1 6.2 3.4 6.2 4.8 16.4 1.9 15.2 0.1 7.8 0.8 2.2 6.9 4.2 9.2 9.3 17.3 1.5 9.2 1.7 21.5 5.0 1.5 2.4 3.1 0.7 9.0 0.4 14.1 0.3 6.7 0.3 16.9 0.5 12.5 3.7 12.0 8.4 7.5 1.4 9.7 18.1 9.6 3.8 6.5 2.8 12.7 10.7 7.2 8.6 9.7 0.4 0.8 6.3 9.8 3.2 6.3 11.8 0.3 5.4 8.4 4.0 4.4 18.2 41.1 0.4 10.7 0.5 3.0 0.6 0.6 8.9 3.1 1.1 0.7 112.7 0.3 8.0 2.2 1.3 8.4 13.4 21.3 6.9 15.8 15.9 13.0 26.0 9.7 24.6 20.8 14.9 44.6 45.9 25.1 13.7 9.0 2.8 50.9 26.8 12.5 31.4 2.0 46.0 64.6 39.8 106.9 25.9 14.7 0.0 53.4 16.4 13.6 27.8 42.8 11.6 91.1 11.1 37.8 39.3 188.7 17.6 10.0 119.8 15.1 66.7 26.1 17.3 34.6 28.1 6.0 52.8 4.6 6.5 18.9 62.9 11.5 15.8 39.2 10.7 26.4 20.4 GFI1B ZNF163B ENSG00000165702 "Growth factor independent 1B transcriptional repressor" Q5VTD9 9 132944000-132991687 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Developmental protein, DNA-binding, Repressor" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "blood: 71.0;bone marrow: 29.2" "Cell type enriched" "Detected in some" 5 "Erythroid cells: 70.0" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 19 "basophil: 31.2;eosinophil: 71.0" "Lineage enriched" "Detected in many" 26 "granulocytes: 71.0" "Group enriched" "Detected in some" 5 "HEL: 55.6;HMC-1: 36.0;K-562: 17.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB004420, HPA006291" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB004420: AB_2110132, HPA006291: " "unprognostic (1.79e-2)" "unprognostic (2.90e-4)" "unprognostic (6.54e-2)" "unprognostic (1.76e-1)" "unprognostic (2.33e-1)" "unprognostic (1.54e-2)" "unprognostic (2.53e-3)" "unprognostic (1.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.54e-1)" "unprognostic (4.61e-2)" "unprognostic (3.71e-2)" "unprognostic (2.17e-1)" "unprognostic (2.53e-1)" "unprognostic (1.53e-2)" "unprognostic (1.41e-1)" 0.2 0.0 0.2 2.2 0.2 29.2 0.1 0.1 0.2 0.9 4.2 0.2 0.0 0.8 0.4 0.7 0.8 0.2 3.5 0.8 0.2 0.1 0.3 0.4 2.5 0.0 0.1 0.0 0.1 0.2 0.0 0.1 1.2 0.0 4.2 0.3 0.2 0.1 0.1 0.3 0.8 6.3 1.0 0.2 3.3 0.3 4.0 0.0 1.0 0.2 0.0 0.5 0.4 0.2 0.0 0.3 71.0 2.7 0.1 0.1 2.4 0.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 0.1 7.8 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 55.6 0.1 0.0 0.0 0.0 36.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 17.1 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 31.2 0.0 71.0 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.8 0.1 2.7 0.1 0.0 2.4 0.2 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.8 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 70.0 0.0 0.1 0.0 0.5 13.9 0.0 0.1 0.0 1.2 0.0 0.8 9.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.2 0.0 0.3 0.1 GFRA3 GFRa-3 ENSG00000146013 "GDNF family receptor alpha 3" O60609 5 138252379-138274671 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 23 "granulocytes: 27.5;Intestinal endocrine cells: 51.2;Late spermatids: 11.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 5 "cerebellum: 7.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 10 "SH-SY5Y: 27.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA020731 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA020731: AB_1849635" "unprognostic (1.22e-1)" "unprognostic (6.35e-2)" "unprognostic (1.64e-1)" "unprognostic (1.28e-1)" "unprognostic (2.57e-1)" "unprognostic (4.47e-2)" "unprognostic (1.47e-3)" "unprognostic (2.77e-3)" "unprognostic (1.27e-1)" "unprognostic (7.65e-3)" "unprognostic (1.44e-1)" "unprognostic (1.33e-2)" "unprognostic (1.90e-5)" "unprognostic (2.19e-2)" "unprognostic (3.35e-1)" "unprognostic (1.79e-1)" "unprognostic (6.23e-2)" 2.4 2.4 0.3 7.1 1.0 0.0 1.8 7.0 0.6 7.9 13.0 0.1 11.0 3.8 3.0 6.1 9.3 1.2 9.4 6.2 0.3 0.3 0.9 0.4 2.9 0.1 0.6 0.1 4.7 7.0 0.0 2.3 0.1 1.3 4.4 5.8 10.0 7.5 10.9 1.3 3.6 4.7 8.6 1.4 0.1 6.9 8.4 0.5 0.4 1.0 2.8 0.8 4.4 8.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.0 1.5 0.9 0.4 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 27.0 0.4 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 7.0 0.6 0.3 0.3 0.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 6.3 0.0 0.0 0.0 0.2 0.2 0.0 0.1 27.5 0.0 0.1 0.0 51.2 0.0 0.0 11.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.9 8.1 0.0 0.2 0.0 0.0 0.0 GINM1 "C6orf72, dJ12G14.2" ENSG00000055211 "Glycoprotein integral membrane 1" Q9NU53 6 149566294-149591748 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Late spermatids: 261.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017210, HPA041679" Approved Approved "Nucleoli fibrillar center,Plasma membrane" NA NA 8700 "Nucleoli fibrillar center, Plasma membrane" "HPA017210: AB_1845743, HPA041679: AB_2677611" "unprognostic (6.09e-3)" "unprognostic (2.19e-2)" "unprognostic (2.38e-1)" "unprognostic (2.48e-1)" "unprognostic (7.24e-2)" "unprognostic (1.32e-3)" "unprognostic (3.18e-2)" "unprognostic (1.27e-1)" "unprognostic (2.31e-1)" "unprognostic (8.23e-2)" "unprognostic (1.05e-1)" "unprognostic (2.10e-2)" "unprognostic (2.09e-2)" "unprognostic (2.88e-2)" "unprognostic (2.64e-2)" "unprognostic (4.87e-2)" "unprognostic (4.79e-3)" 32.1 26.3 21.3 17.8 34.7 20.0 51.5 26.1 27.6 28.8 25.7 22.4 29.0 14.2 29.3 36.9 21.5 24.1 24.3 48.2 20.3 18.3 51.3 29.6 28.4 32.9 43.6 21.4 31.7 28.3 27.1 17.5 34.0 23.0 23.6 19.8 21.7 20.7 40.1 29.2 20.9 17.3 36.7 31.3 18.6 22.8 31.0 30.2 11.5 41.5 21.6 13.1 28.6 22.6 16.8 12.6 23.7 16.0 8.0 8.1 7.7 7.9 5.7 9.3 12.5 50.2 30.1 15.2 27.2 31.9 20.7 26.0 7.4 10.7 5.9 15.0 25.7 19.1 16.4 6.0 13.6 27.1 9.8 13.4 5.6 5.5 8.8 19.2 11.0 5.4 33.4 11.8 17.5 12.1 22.7 22.2 8.1 7.2 9.8 19.4 10.2 6.9 8.3 3.2 11.7 6.1 7.4 16.7 4.4 29.4 7.0 5.9 5.7 27.1 16.1 5.6 10.7 10.1 11.2 15.5 11.2 11.8 28.5 17.9 9.7 11.2 7.3 20.8 9.9 10.3 11.9 13.7 17.1 6.8 13.2 7.9 16.8 8.1 7.4 10.0 11.7 7.9 6.4 23.7 8.0 16.0 12.6 7.5 7.7 21.3 34.7 26.1 27.6 20.3 18.3 43.6 21.4 23.0 30.2 74.5 47.2 33.3 50.3 41.6 20.9 44.8 30.6 33.5 43.3 62.8 27.5 69.7 33.2 80.6 144.2 73.7 38.6 0.0 70.5 63.5 82.2 48.5 27.8 35.6 40.9 15.9 25.7 88.4 45.9 261.3 120.0 45.3 40.5 82.0 22.0 80.5 55.4 29.4 106.1 117.9 21.9 97.0 65.6 141.4 88.4 41.0 102.6 28.7 25.1 50.0 GJB7 "bA136M9.1, CX25" ENSG00000164411 "Gap junction protein beta 7" Q6PEY0 6 87282978-87329278 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "fallopian tube: 12.3;pituitary gland: 10.0;placenta: 4.5" "Cell type enhanced" "Detected in some" 28 "Ciliated cells: 29.4;Cytotrophoblasts: 7.7;Extravillous trophoblasts: 4.4;Syncytiotrophoblasts: 6.1" "Low cancer specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 1.3" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 6.5;HDLM-2: 10.5;MCF7: 5.8;OE19: 6.7;RT4: 5.2;SuSa: 3.6" "Low region specificity" "Detected in many" HPA014392 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014392: " "unprognostic (8.30e-2)" "unprognostic (2.45e-1)" "unprognostic (3.06e-1)" "unprognostic (4.20e-1)" "unprognostic (2.84e-1)" "unprognostic (4.07e-3)" "unprognostic (2.61e-1)" "unprognostic (5.13e-3)" "unprognostic (6.69e-3)" "unprognostic (1.59e-1)" "unprognostic (3.82e-2)" "unprognostic (4.15e-2)" "unprognostic (3.24e-1)" "unprognostic (5.64e-2)" "unprognostic (2.09e-2)" "unprognostic (3.10e-2)" 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 12.3 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 10.0 4.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 1.3 0.0 0.1 0.5 0.0 0.7 0.1 1.0 0.0 0.0 1.3 0.0 2.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 5.8 0.0 0.1 1.8 6.7 0.0 0.2 0.0 0.0 0.0 5.2 0.1 0.0 1.2 0.0 0.0 3.6 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 0.1 0.6 1.3 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 29.4 0.0 0.0 0.0 7.7 0.0 0.0 0.6 0.0 0.0 0.0 0.2 4.4 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.1 0.0 6.1 0.0 0.2 0.1 GJC2 "CX46.6, CX47, GJA12, SPG44" ENSG00000198835 "Gap junction protein gamma 2" Q5T442 1 228149852-228159826 "Disease related genes, Predicted membrane proteins" "Disease mutation, Hereditary spastic paraplegia, Leukodystrophy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 34.3" "Cell type enhanced" "Detected in some" 14 "Cone photoreceptor cells: 11.8;Peritubular cells: 3.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.6" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.6" "Cell line enhanced" "Detected in many" "EFO-21: 9.9;SCLC-21H: 5.2;TIME: 4.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069619 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA069619: " "unprognostic (2.67e-1)" "unprognostic (1.81e-2)" "unprognostic (6.42e-2)" "unprognostic (8.19e-3)" "unprognostic (4.24e-1)" "unprognostic (1.57e-1)" "unprognostic (6.94e-2)" "unprognostic (2.56e-1)" "unprognostic (4.99e-2)" "unprognostic (7.09e-2)" "unprognostic (7.88e-3)" "unprognostic (9.67e-2)" "unprognostic (6.09e-3)" "unprognostic (2.53e-2)" "unprognostic (7.36e-2)" "unprognostic (1.54e-1)" "unprognostic (2.02e-1)" 2.4 1.9 4.6 1.2 10.0 0.5 2.0 2.2 14.8 2.8 2.6 34.3 0.0 0.6 4.5 2.0 1.7 4.8 1.4 1.6 9.3 5.3 0.6 0.5 3.1 1.2 27.2 5.6 3.4 0.9 2.9 0.6 1.2 18.3 2.1 0.8 0.0 1.5 4.0 1.5 2.4 1.2 3.8 32.6 1.9 1.2 1.0 15.7 0.0 0.9 0.0 0.7 1.3 1.8 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.2 0.5 1.4 0.7 1.9 1.4 0.4 0.6 0.8 0.9 1.2 0.2 9.9 2.6 0.8 1.0 0.3 0.3 0.3 0.4 1.6 0.3 2.5 2.2 2.5 0.0 0.0 0.4 0.2 0.8 0.5 1.2 0.2 1.7 1.1 0.3 0.4 0.6 1.9 0.6 0.6 0.0 2.0 0.4 0.3 0.1 0.8 0.0 5.2 3.0 0.4 0.1 0.3 0.1 0.1 0.3 4.6 1.4 3.8 4.5 1.6 0.3 0.6 0.2 0.5 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 4.6 10.0 2.2 10.4 9.3 5.3 27.2 5.6 18.3 15.7 0.0 1.1 0.0 1.2 3.1 1.5 1.4 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.4 0.0 1.2 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.6 0.0 2.3 0.0 1.7 0.0 0.0 0.3 0.7 0.0 3.9 0.0 0.6 0.0 1.7 0.0 0.0 1.5 0.0 0.0 0.1 0.9 GLRX "GRX, GRX1" ENSG00000173221 Glutaredoxin P35754 5 95751319-95823005 "Plasma proteins, Predicted intracellular proteins" "Electron transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 94.4;skeletal muscle: 141.6" "Cell type enhanced" "Detected in many" 8 "Distal tubular cells: 613.5;Extravillous trophoblasts: 605.3;Proximal tubular cells: 870.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 85.0;RPTEC TERT1: 65.0;U-87 MG: 69.9" "Low region specificity" "Detected in all" "CAB008634, HPA046431, CAB069419" Approved Supported "Plasma membrane,Cytosol" NA NA 13000000 "Plasma membrane, Cytosol" "CAB008634: AB_1616672, CAB069419: AB_1616670, HPA046431: AB_2679663" "unprognostic (1.69e-1)" "unprognostic (1.32e-1)" "unprognostic (1.94e-2)" "unprognostic (4.81e-2)" "unprognostic (2.01e-2)" "unprognostic (2.22e-2)" "unprognostic (8.62e-3)" "unprognostic (9.31e-3)" "unprognostic (1.99e-2)" "unprognostic (1.65e-2)" "unprognostic (2.34e-1)" "unprognostic (1.82e-1)" "unprognostic (8.11e-2)" "unprognostic (2.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.61e-1)" "unprognostic (2.61e-1)" 17.7 20.7 6.2 15.0 6.6 30.6 10.5 15.5 15.5 5.4 22.6 3.1 4.0 40.2 2.9 4.6 3.1 3.7 9.5 25.2 12.1 7.8 45.9 46.9 23.1 21.5 7.8 5.9 3.5 2.6 9.5 6.4 63.9 7.6 5.7 8.8 2.4 17.9 5.5 141.6 7.3 42.5 4.5 7.3 15.2 8.2 2.2 4.0 14.4 6.3 6.4 14.3 11.6 5.8 16.0 52.2 94.4 81.6 11.2 48.9 71.1 3.3 15.0 1.1 2.4 32.4 46.6 0.2 50.1 85.0 5.4 9.1 3.7 1.5 13.0 7.1 15.0 12.2 1.3 1.9 23.8 15.1 11.3 3.7 9.4 9.9 34.4 61.7 10.0 27.9 29.1 2.9 34.3 3.3 12.0 10.3 26.7 1.2 7.8 34.0 1.1 17.2 17.7 3.3 0.4 17.1 27.9 10.2 16.1 65.0 2.4 3.4 1.8 13.1 6.5 5.7 3.1 1.8 9.9 11.9 14.2 16.0 11.3 2.1 5.6 28.7 10.4 69.9 25.1 3.0 3.8 81.6 94.4 26.2 51.0 35.7 16.0 24.1 19.5 52.2 10.7 24.1 22.1 85.7 11.2 40.5 18.0 48.9 71.1 6.2 6.6 15.5 15.5 12.1 7.8 7.8 5.9 7.6 4.0 20.8 27.9 60.2 35.5 15.2 1.5 153.4 79.0 53.5 27.3 89.0 0.0 19.8 613.5 47.8 0.2 38.0 373.9 23.3 81.2 605.3 54.7 75.6 30.1 177.3 241.8 0.0 30.4 44.2 275.4 0.9 17.5 243.9 65.8 117.2 64.0 5.5 118.2 157.8 13.1 870.9 3.3 19.4 70.2 0.5 1.1 18.1 238.6 103.6 64.3 137.4 GNB1 ENSG00000078369 "G protein subunit beta 1" P62873 1 1785285-1891117 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 1104.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040736 Supported Approved "Golgi apparatus,Plasma membrane" NA NA 60000000 "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (9.49e-2)" "unprognostic (4.91e-3)" "unprognostic (1.24e-1)" "unprognostic (1.56e-1)" "unprognostic (3.34e-1)" "unprognostic (9.07e-3)" "prognostic unfavorable (3.61e-6)" "unprognostic (1.99e-2)" "unprognostic (3.60e-1)" "unprognostic (7.27e-2)" "unprognostic (8.47e-3)" "unprognostic (1.95e-1)" "unprognostic (9.76e-2)" "unprognostic (1.08e-1)" "unprognostic (4.62e-2)" "unprognostic (1.14e-1)" "unprognostic (7.90e-2)" 55.2 42.1 84.7 55.1 82.3 41.7 37.8 78.8 112.5 44.0 52.1 46.4 26.0 55.4 44.3 31.2 41.7 38.8 36.6 39.6 74.7 65.7 43.9 38.7 47.1 47.1 68.5 52.1 45.0 33.9 48.9 36.9 45.3 56.6 40.1 41.0 70.7 37.6 41.7 19.7 35.5 65.3 51.2 61.0 51.0 40.8 31.4 39.2 44.5 37.6 19.5 45.6 42.2 54.1 7.7 18.8 18.4 13.2 10.6 9.9 6.0 54.7 51.8 61.6 42.9 35.2 38.8 23.8 77.8 51.9 70.7 55.6 42.3 54.9 57.2 57.4 78.5 40.1 28.9 61.7 56.4 64.7 87.8 30.3 55.5 49.2 48.0 44.4 33.3 61.0 34.3 39.8 67.5 62.9 47.8 57.3 45.4 34.3 51.8 67.3 34.1 73.0 26.3 35.4 28.2 42.0 71.3 47.6 45.2 48.4 34.1 75.8 86.4 72.1 47.0 63.1 44.3 32.9 45.8 87.3 62.3 41.8 48.4 56.4 35.1 61.2 131.0 53.3 70.4 35.0 7.4 11.1 17.1 8.7 13.2 8.0 7.4 8.7 9.7 10.9 7.7 5.9 6.5 18.4 10.6 13.2 18.8 9.9 6.0 84.7 82.3 78.8 112.5 74.7 65.7 68.5 52.1 56.6 39.2 65.5 41.8 61.1 42.7 76.6 128.2 51.2 58.6 30.8 35.2 71.5 164.9 36.8 39.7 78.1 24.7 107.9 139.4 0.0 86.3 77.4 70.2 78.2 52.0 51.3 89.1 170.0 118.1 93.9 126.8 25.1 70.5 95.3 50.6 74.9 88.7 159.0 130.7 84.2 82.7 56.2 1104.1 77.6 76.5 56.5 67.9 89.0 30.4 48.0 64.7 70.1 GNB3 ENSG00000111664 "G protein subunit beta 3" P16520 12 6839954-6847393 "Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "pituitary gland: 27.0;retina: 79.9" "Group enriched" "Detected in some" 9 "Bipolar cells: 509.6;Cone photoreceptor cells: 877.7;Rod photoreceptor cells: 442.8" "Cancer enhanced" "Detected in some" "testis cancer: 3.1" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "memory B-cell: 1.5" "Lineage enriched" "Detected in single" 9 "B-cells: 1.5" "Cell line enhanced" "Detected in many" "Daudi: 8.5;NTERA-2: 10.3;U-698: 25.9" "Not detected" "Not detected" "Region enriched" "Detected in single" 4 "cerebellum: 10.4" HPA040736 Uncertain Approved "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA040736: AB_2677106" "unprognostic (3.86e-2)" "unprognostic (1.58e-1)" "unprognostic (4.96e-2)" "unprognostic (8.75e-2)" "unprognostic (2.53e-2)" "unprognostic (5.74e-3)" "unprognostic (5.98e-2)" "unprognostic (4.43e-3)" "unprognostic (1.19e-1)" "unprognostic (1.98e-1)" "unprognostic (2.25e-5)" "unprognostic (3.21e-2)" "unprognostic (4.77e-11)" "unprognostic (2.43e-1)" "unprognostic (6.48e-2)" "unprognostic (1.36e-1)" "unprognostic (1.07e-2)" 0.8 1.6 0.9 1.4 2.0 0.5 0.8 6.9 1.6 1.1 1.0 0.8 0.8 2.3 2.7 0.8 0.8 1.0 1.1 5.4 1.0 1.3 0.8 0.8 0.8 1.4 1.1 0.8 3.5 0.8 3.2 27.0 0.8 1.6 1.6 0.4 79.9 2.6 1.8 1.5 0.6 1.6 4.1 0.9 0.9 0.9 0.8 0.8 0.8 1.2 1.0 1.8 2.1 0.8 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 0.4 5.0 0.8 0.6 0.9 0.5 2.9 0.6 1.6 1.1 1.1 0.3 8.5 0.0 3.1 0.1 0.3 4.9 0.2 1.5 0.7 1.1 2.2 2.7 0.7 0.5 0.6 1.4 1.2 0.2 1.5 2.1 5.3 1.4 1.1 0.8 0.7 0.4 0.4 0.4 0.5 10.3 0.0 0.3 0.4 1.7 0.5 0.3 0.2 0.8 1.2 0.2 0.0 0.6 1.7 0.0 0.5 2.6 1.3 2.1 2.5 3.8 0.7 0.5 25.9 0.6 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.9 2.0 6.9 1.5 1.0 1.3 1.1 0.8 1.6 0.8 0.0 0.0 0.0 0.4 0.3 509.6 4.6 0.0 0.0 0.0 0.0 877.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.4 0.0 0.0 0.1 69.9 0.0 0.0 0.0 0.0 3.4 0.0 1.7 0.0 0.0 58.9 0.2 0.0 3.2 0.0 442.8 0.0 1.9 0.0 0.4 0.0 0.0 0.0 0.0 0.1 GNG2 ENSG00000186469 "G protein subunit gamma 2" P59768 14 51826195-51979342 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 68.4;brain: 50.5;testis: 55.7" "Group enriched" "Detected in many" 4 "Early spermatids: 648.7;Late spermatids: 811.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.9;fHDF/TERT166: 36.9;MOLT-4: 28.7;SH-SY5Y: 24.3;WM-115: 66.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003534, CAB018380" Uncertain Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB018380: AB_631547, HPA003534: AB_1079004" "unprognostic (6.11e-2)" "unprognostic (5.78e-3)" "unprognostic (2.06e-3)" "unprognostic (6.55e-2)" "unprognostic (1.33e-1)" "unprognostic (4.01e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (5.72e-2)" "unprognostic (1.24e-1)" "prognostic favorable (1.64e-4)" "unprognostic (8.47e-2)" "prognostic unfavorable (3.90e-6)" "unprognostic (9.82e-2)" "unprognostic (1.29e-1)" "unprognostic (1.08e-1)" "unprognostic (3.59e-2)" 22.0 10.4 50.5 17.4 18.5 25.0 11.7 4.9 46.1 5.9 13.0 5.2 1.6 6.8 5.7 4.7 6.5 3.5 7.9 6.6 30.9 50.3 4.0 5.6 8.5 19.4 10.7 20.7 7.1 3.3 1.6 12.2 8.6 8.9 6.6 9.1 8.3 4.5 4.4 2.3 3.5 9.9 8.8 8.5 41.2 7.3 55.7 2.5 39.6 3.9 4.3 19.5 8.5 4.0 8.0 13.9 68.4 34.9 5.0 36.5 27.6 0.0 0.8 20.9 13.0 3.2 4.2 0.3 3.4 4.2 1.6 1.3 1.7 0.0 0.0 0.5 36.9 2.4 0.0 2.7 0.0 1.1 9.4 0.3 0.0 0.2 0.0 1.6 1.9 0.1 6.9 0.0 1.6 0.1 8.8 0.0 18.1 0.0 1.7 10.6 0.0 28.7 3.1 11.0 0.0 2.5 10.2 1.6 0.5 1.7 0.0 3.1 24.3 0.0 0.0 9.0 0.7 0.0 0.0 0.0 5.1 0.8 0.1 2.6 0.0 0.0 1.4 4.2 10.2 66.5 68.4 13.5 36.0 36.5 23.3 24.6 8.0 20.3 29.7 13.9 7.3 12.9 22.8 39.9 5.0 34.9 6.0 28.8 27.6 50.5 18.5 4.9 44.2 30.9 50.3 10.7 20.7 8.9 2.5 6.0 11.1 29.6 0.2 10.2 12.4 0.6 0.0 0.0 0.0 3.5 2.0 0.4 1.7 0.1 648.7 6.3 0.1 0.0 0.0 0.6 18.4 0.2 31.2 0.9 39.5 0.0 168.9 12.3 83.7 811.3 9.2 65.9 52.3 14.4 1.0 0.5 0.8 0.0 5.6 0.8 1.8 38.8 8.0 11.9 3.8 5.8 0.6 100.2 0.4 0.1 GPAT3 "AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324" ENSG00000138678 "Glycerol-3-phosphate acyltransferase 3" Q53EU6 4 83535914-83605875 "Enzymes, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 47.2;kidney: 43.7" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 41.3;Early spermatids: 68.5;Proximal tubular cells: 50.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "basophil: 42.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 51.6;GAMG: 39.2;HMC-1: 19.0;U-87 MG: 22.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA029414, CAB033749" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB033749: AB_2224941, HPA029414: AB_10601562" "unprognostic (9.51e-2)" "unprognostic (1.43e-2)" "unprognostic (5.67e-2)" "unprognostic (1.70e-1)" "unprognostic (3.50e-3)" "unprognostic (2.61e-2)" "unprognostic (2.05e-1)" "unprognostic (1.25e-1)" "unprognostic (1.09e-2)" "unprognostic (4.30e-2)" "unprognostic (1.12e-1)" "unprognostic (2.92e-1)" "prognostic favorable (2.71e-9)" "unprognostic (3.74e-1)" "unprognostic (3.45e-2)" "unprognostic (2.53e-3)" "prognostic unfavorable (8.21e-4)" 7.9 0.7 0.7 5.2 1.4 5.2 17.5 4.2 2.9 3.7 18.0 1.2 1.3 20.2 3.0 2.1 5.1 2.1 6.0 24.8 1.2 2.2 43.7 9.0 3.2 4.5 1.9 0.8 12.9 1.7 11.8 5.8 1.2 9.5 2.6 5.7 1.3 3.6 1.9 35.9 1.9 47.2 3.7 3.0 4.3 7.4 4.6 1.4 0.9 26.6 14.6 3.4 4.5 7.2 0.0 23.2 42.0 9.7 0.5 1.8 2.9 9.8 9.7 0.0 0.1 0.5 1.2 0.2 0.7 1.4 0.2 0.2 0.7 51.6 0.0 1.1 1.8 39.2 2.2 4.6 0.9 0.1 0.6 2.2 0.0 3.1 9.5 1.4 2.8 19.0 0.6 0.0 0.3 1.1 3.8 4.8 2.7 7.9 7.8 0.2 1.0 0.7 0.7 0.2 14.5 4.2 0.1 2.2 3.7 9.8 0.6 0.2 0.0 1.9 2.0 5.4 0.5 0.4 0.5 0.2 2.3 4.2 2.3 9.3 0.4 0.6 0.0 22.6 5.6 17.2 42.0 9.7 1.0 0.2 7.7 1.8 0.0 1.0 0.6 23.2 0.0 0.7 0.3 26.4 0.5 6.1 0.1 0.6 2.9 0.7 1.4 4.2 2.9 1.2 2.2 1.9 0.8 9.5 1.4 6.0 5.0 0.0 41.3 0.0 0.0 0.0 7.6 2.7 9.1 10.4 0.0 0.2 13.3 1.6 68.5 0.6 21.6 0.0 5.9 1.0 0.1 25.8 7.0 11.9 15.3 4.8 1.2 5.5 16.7 17.2 1.1 28.3 0.0 5.4 4.8 0.0 6.6 8.0 0.7 50.3 0.2 6.5 0.0 8.8 1.7 0.0 0.8 0.0 2.1 25.4 GPC1 glypican ENSG00000063660 "Glypican 1" P35052 2 240435671-240468078 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 142.6" "Cell type enhanced" "Detected in many" 9 "Extravillous trophoblasts: 181.5;Syncytiotrophoblasts: 85.9;Urothelial cells: 90.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030571, HPA070449" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 6500000 "Plasma membrane, Cytosol" "HPA030571: AB_10602322, HPA070449: " "unprognostic (1.22e-2)" "unprognostic (2.53e-2)" "prognostic unfavorable (5.78e-5)" "prognostic unfavorable (1.55e-4)" "unprognostic (1.95e-1)" "unprognostic (1.83e-3)" "prognostic unfavorable (2.44e-6)" "unprognostic (1.00e-2)" "unprognostic (2.15e-1)" "unprognostic (5.08e-3)" "unprognostic (2.28e-1)" "unprognostic (4.38e-1)" "unprognostic (1.91e-1)" "unprognostic (4.40e-2)" "unprognostic (2.92e-1)" "unprognostic (1.95e-2)" "unprognostic (2.12e-2)" 13.6 22.8 32.4 7.2 21.0 1.9 8.1 42.7 33.6 11.5 8.1 10.1 9.5 5.4 9.6 9.8 26.3 7.8 7.1 40.7 26.5 11.9 8.5 11.0 7.4 4.0 8.8 22.5 14.1 18.1 5.8 14.4 20.2 13.6 29.5 4.0 6.3 16.3 17.6 62.9 142.6 4.9 12.0 8.3 5.2 6.5 20.0 10.5 1.7 4.5 24.3 10.7 10.5 15.2 0.9 0.1 0.0 0.0 0.1 0.8 0.3 16.2 22.4 5.3 13.9 16.2 15.6 21.6 39.0 19.4 4.5 5.3 7.9 18.2 0.4 5.4 41.3 24.7 44.9 2.8 27.7 0.9 7.8 2.4 0.0 20.6 9.8 23.3 0.3 1.5 13.7 18.1 10.1 5.3 9.5 2.3 0.8 0.1 0.8 11.5 8.5 0.3 0.1 8.3 1.8 5.0 2.9 24.2 3.7 3.6 26.3 5.3 3.5 25.5 22.5 2.3 5.0 7.1 1.6 10.9 24.3 41.2 11.5 16.1 0.1 0.1 0.1 17.3 0.4 27.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.2 0.1 0.9 0.0 0.2 0.0 0.1 0.0 0.0 0.8 0.3 32.4 21.0 42.7 33.6 26.5 11.9 8.8 22.5 13.6 10.5 14.9 6.7 0.0 52.5 40.8 12.0 50.2 22.9 8.1 23.9 24.4 2.0 58.0 6.6 25.6 0.6 3.7 0.9 0.0 9.3 181.5 28.8 15.7 4.6 19.2 8.0 23.8 0.0 15.4 0.0 2.1 17.5 2.7 33.7 2.8 4.3 27.8 13.4 0.0 7.1 2.2 4.9 25.8 16.5 0.5 4.9 40.4 85.9 0.7 2.7 90.8 GPC4 K-glypican ENSG00000076716 "Glypican 4" O75487 X 133300103-133415490 "Plasma proteins, Predicted membrane proteins" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 1: 47.6;Extravillous trophoblasts: 33.8;Proximal tubular cells: 34.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 47.7;HAP1: 27.3;NTERA-2: 25.0;RPTEC TERT1: 63.0;SuSa: 57.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA030834, HPA030836" Approved Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 170000 "Plasma membrane" Nucleoplasm "HPA030834: , HPA030836: AB_10601327" "unprognostic (9.60e-2)" "unprognostic (8.67e-2)" "unprognostic (2.29e-1)" "unprognostic (8.21e-2)" "unprognostic (8.51e-3)" "unprognostic (5.90e-3)" "unprognostic (5.68e-2)" "prognostic favorable (3.51e-4)" "unprognostic (2.54e-2)" "unprognostic (1.26e-1)" "unprognostic (5.87e-3)" "unprognostic (1.30e-1)" "prognostic favorable (1.25e-5)" "unprognostic (1.97e-1)" "unprognostic (2.89e-1)" "unprognostic (2.75e-1)" "unprognostic (2.72e-1)" 39.7 9.9 16.3 10.7 5.3 0.3 6.8 3.7 4.9 14.6 21.6 8.2 3.4 10.0 11.7 16.3 18.6 11.2 23.7 9.6 9.5 5.0 39.6 2.4 25.6 7.1 5.1 6.6 12.4 12.5 9.4 20.4 26.9 9.5 10.3 10.7 9.3 12.2 11.6 20.3 4.3 11.3 16.9 7.9 6.5 19.8 7.2 6.4 5.2 12.4 11.6 2.0 17.1 11.7 0.9 0.6 0.1 0.7 0.0 0.0 0.2 0.0 0.0 47.7 1.8 2.0 0.3 5.9 0.3 0.0 0.0 0.0 0.0 0.1 0.0 16.4 0.2 0.0 0.0 27.3 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 25.0 0.0 0.7 0.1 4.3 0.0 63.0 1.8 0.0 0.3 0.2 0.0 0.0 57.9 0.7 0.7 0.0 4.9 5.8 0.0 3.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 16.3 5.3 3.7 4.9 9.5 5.0 5.1 6.6 9.5 6.4 47.6 20.3 0.0 3.3 1.3 0.0 3.4 5.1 9.4 9.1 22.7 0.0 0.3 3.3 6.4 0.4 0.6 2.9 0.0 10.9 33.8 6.9 1.1 0.0 0.0 2.5 0.0 2.4 0.0 0.8 0.9 2.0 2.4 1.7 1.8 9.3 0.8 12.6 3.5 0.4 34.9 0.0 0.0 14.4 1.2 21.2 0.4 2.6 0.0 10.2 0.6 GPR173 SREB3 ENSG00000184194 "G protein-coupled receptor 173" Q9NS66 X 53049091-53080615 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 23.2" "Cell type enhanced" "Detected in some" 8 "Bipolar cells: 6.4;Horizontal cells: 6.4;Intestinal endocrine cells: 3.4;Peritubular cells: 4.2" "Cancer enhanced" "Detected in many" "glioma: 8.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 5.7" "Group enriched" "Detected in many" 4 "granulocytes: 5.7;NK-cells: 1.8" "Cell line enhanced" "Detected in many" "HAP1: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003905 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA003905: AB_1078922" "unprognostic (2.68e-1)" "unprognostic (2.33e-1)" "unprognostic (4.95e-3)" "prognostic unfavorable (2.88e-6)" "unprognostic (3.87e-2)" "unprognostic (8.58e-2)" "unprognostic (2.73e-1)" "unprognostic (1.47e-1)" "unprognostic (1.92e-1)" "unprognostic (1.70e-2)" "prognostic favorable (2.33e-5)" "unprognostic (1.03e-1)" "prognostic unfavorable (2.47e-4)" "unprognostic (1.08e-4)" "unprognostic (2.83e-1)" "unprognostic (3.92e-2)" "unprognostic (6.95e-2)" 2.5 5.2 8.2 3.0 9.4 2.2 3.1 15.4 23.2 4.2 2.8 11.6 0.8 1.8 6.4 5.0 2.4 7.7 3.3 4.2 7.9 10.0 2.4 1.1 2.8 2.1 7.3 11.2 15.0 1.3 1.3 14.6 4.5 9.7 3.2 2.6 6.4 2.0 5.4 4.6 3.9 2.1 4.5 6.5 4.0 2.1 2.4 9.6 0.7 3.1 0.1 1.5 3.3 2.8 0.9 0.7 5.7 0.4 1.8 0.7 0.0 0.0 0.0 8.1 0.5 4.6 2.7 0.0 1.3 2.9 2.1 2.5 0.8 0.1 0.2 2.0 2.8 6.4 0.6 10.2 0.0 1.9 0.6 1.0 0.5 8.3 0.3 6.7 0.5 0.1 6.6 0.0 3.3 4.6 7.5 3.5 0.0 0.0 5.7 3.2 4.2 0.0 0.0 6.3 0.4 3.6 0.1 2.4 0.3 0.5 0.4 5.9 8.3 0.0 0.4 0.0 5.5 1.1 0.1 6.4 3.5 5.1 2.3 1.1 0.2 0.3 0.7 2.5 0.0 1.9 5.7 0.2 0.3 0.7 0.1 0.5 0.3 0.2 0.1 0.1 0.9 0.5 0.4 1.2 1.8 0.4 0.7 0.0 0.0 8.2 9.4 15.4 15.1 7.9 10.0 7.3 11.2 9.7 9.6 0.0 0.0 0.0 0.4 0.2 6.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.2 6.4 3.4 1.8 0.3 0.0 2.8 0.0 1.7 0.0 0.1 2.7 0.1 0.0 4.2 0.0 2.8 0.0 1.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 GPR20 ENSG00000204882 "G protein-coupled receptor 20" Q99678 8 141356500-141367267 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 71.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "intermediate monocyte: 3.7;non-classical monocyte: 5.4" "Lineage enriched" "Detected in single" 14 "monocytes: 5.4" "Cell line enriched" "Detected in some" 4 "EFO-21: 7.0" "Not detected" "Not detected" "Region enhanced" "Detected in single" "midbrain: 1.3" HPA071337 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA071337: " "unprognostic (4.47e-2)" "unprognostic (2.64e-3)" "unprognostic (5.18e-2)" "unprognostic (2.00e-2)" "unprognostic (7.47e-2)" "unprognostic (2.28e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (3.54e-1)" "unprognostic (2.13e-2)" "unprognostic (1.57e-1)" "unprognostic (1.13e-1)" "unprognostic (1.07e-2)" "unprognostic (7.41e-2)" "unprognostic (5.50e-2)" "unprognostic (6.23e-2)" "unprognostic (4.07e-1)" 2.8 0.5 0.7 2.7 1.4 0.1 2.5 0.2 2.0 10.6 9.1 1.0 4.3 2.2 6.7 1.9 3.4 3.9 6.1 2.1 0.8 0.4 1.1 0.4 3.5 0.3 1.4 0.9 3.7 0.5 0.5 0.5 3.2 2.1 2.2 1.0 1.1 0.5 3.0 2.1 1.0 10.5 4.5 0.5 0.8 4.3 1.6 0.7 0.0 1.4 1.5 0.5 1.7 3.4 0.0 0.3 0.3 5.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.5 0.1 0.0 7.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.2 0.5 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.1 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 5.4 0.0 0.0 0.1 0.7 1.4 0.2 2.0 0.8 0.4 1.4 0.9 2.1 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 71.1 16.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 GPR50 "H9, Mel1c" ENSG00000102195 "G protein-coupled receptor 50" Q13585 X 151176653-151181465 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "pituitary gland: 64.9" "Not detected" "Not detected" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in single" "hypothalamus: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HEK 293: 9.6;SuSa: 8.1" "Region enriched" "Detected in some" 6 "hypothalamus: 16.8" "Region enriched" "Detected in some" 9 "hypothalamus: 6.4" "HPA049862, HPA054678" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA049862: AB_2680920, HPA054678: AB_2682570" "unprognostic (8.84e-3)" "unprognostic (5.59e-2)" "unprognostic (1.15e-1)" 0.6 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.3 1.4 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 64.9 3.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.8 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GPRC5A "PEIG-1, RAI3, RAIG1, TIG1" ENSG00000013588 "G protein-coupled receptor class C group 5 member A" Q8NFJ5 12 12890782-12917937 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 155.0" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 872.5;Glandular cells: 325.5;Pancreatic endocrine cells: 368.5;Urothelial cells: 1048.5" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in single" 5 "pons and medulla: 3.1" "Cell type enhanced" "Detected in some" "basophil: 3.1" "Lineage enriched" "Detected in single" 5 "granulocytes: 3.1" "Cell line enhanced" "Detected in many" "A-431: 42.7;CAPAN-2: 164.8;HaCaT: 43.2;SiHa: 60.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA007928, HPA046526" Enhanced Enhanced "Vesicles,Plasma membrane" NA Yes "Vesicles, Plasma membrane" "HPA007928: AB_1849318, HPA046526: AB_2679685" "unprognostic (4.79e-2)" "unprognostic (8.35e-2)" "unprognostic (4.21e-2)" "unprognostic (1.64e-1)" "unprognostic (4.65e-3)" "unprognostic (1.73e-1)" "unprognostic (2.38e-2)" "unprognostic (1.89e-2)" "unprognostic (3.48e-1)" "unprognostic (8.69e-3)" "prognostic unfavorable (4.63e-6)" "unprognostic (3.81e-1)" "prognostic unfavorable (9.02e-5)" "unprognostic (9.30e-2)" "unprognostic (4.34e-1)" "unprognostic (1.62e-2)" "unprognostic (2.49e-1)" 9.8 1.4 0.2 6.0 0.6 0.4 5.4 0.1 0.3 12.1 19.8 0.5 2.0 6.2 4.3 1.9 9.1 3.0 15.5 7.1 0.1 0.2 5.1 0.6 155.0 0.1 0.5 0.1 18.5 1.1 0.0 0.9 20.1 3.1 10.4 16.9 4.8 9.6 1.5 1.1 2.0 36.9 14.2 1.1 0.1 11.4 4.8 0.3 0.1 54.2 14.9 11.5 32.1 14.0 0.6 0.6 3.1 0.3 0.5 0.4 0.0 42.7 34.2 0.0 0.1 0.4 0.2 2.2 12.9 4.9 8.4 6.4 6.0 164.8 0.0 1.1 10.3 8.9 43.2 0.1 6.2 12.9 0.0 0.5 0.0 14.1 0.2 3.1 0.0 0.0 0.2 8.4 3.5 0.8 10.4 5.1 0.0 0.0 0.0 0.3 30.0 0.0 0.0 0.1 15.6 5.4 0.0 0.9 0.0 16.6 8.5 0.0 0.0 60.6 4.6 1.9 6.9 1.3 0.1 0.5 0.3 10.9 19.6 0.5 0.0 0.0 0.0 4.4 0.0 0.2 3.1 0.3 0.4 0.3 0.2 0.3 0.3 0.2 0.3 0.1 0.6 0.4 0.4 1.3 0.5 0.2 0.6 0.3 0.0 0.2 0.6 0.1 0.3 0.1 0.2 0.5 0.1 3.1 0.3 872.5 165.8 0.0 282.3 11.1 0.0 1.0 5.1 69.6 257.0 43.6 0.0 0.7 0.0 49.3 0.0 7.5 159.2 0.0 63.3 8.9 57.8 325.5 9.3 0.0 1.5 0.0 7.9 4.9 0.0 0.0 12.4 10.7 49.0 1.0 28.8 1.3 368.5 52.7 9.6 0.0 0.2 0.0 24.7 0.0 0.2 8.0 0.9 1.3 79.7 1048.5 GPRIN1 "GRIN1, KIAA1893" ENSG00000169258 "G protein regulated inducer of neurite outgrowth 1" Q7Z2K8 5 176595802-176610133 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 28.2" "Group enriched" "Detected in some" 5 "Bipolar cells: 13.2;Horizontal cells: 20.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 27.7;SCLC-21H: 30.7" "Low region specificity" "Detected in all" "HPA036478, HPA070892" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA036478: AB_2675145, HPA070892: AB_2686321" "unprognostic (1.70e-1)" "unprognostic (7.38e-2)" "unprognostic (4.41e-2)" "unprognostic (5.66e-2)" "unprognostic (6.54e-3)" "unprognostic (3.06e-1)" "unprognostic (4.76e-6)" "prognostic unfavorable (6.83e-6)" "unprognostic (1.11e-1)" "unprognostic (1.45e-1)" "unprognostic (2.59e-3)" "unprognostic (1.56e-3)" "prognostic unfavorable (2.79e-7)" "unprognostic (4.24e-3)" "unprognostic (5.60e-2)" "unprognostic (2.21e-1)" "unprognostic (3.32e-3)" 1.3 3.2 16.9 1.8 6.4 0.9 0.9 16.9 28.2 1.1 1.6 0.2 0.0 6.4 1.3 0.6 1.1 0.7 1.1 0.7 11.1 11.1 0.7 0.7 1.1 1.7 3.6 11.4 0.5 1.5 0.7 5.8 1.0 4.4 0.7 1.3 0.7 0.7 0.6 0.7 1.5 4.0 1.7 1.9 0.9 1.9 2.2 0.7 0.0 0.8 0.0 2.3 0.9 0.1 0.9 0.0 0.0 0.0 0.5 0.3 0.0 3.6 3.9 5.0 7.2 1.1 2.4 4.2 4.9 2.5 3.8 5.0 4.7 2.4 8.4 10.1 2.6 11.3 3.2 3.2 3.4 3.4 27.7 2.1 0.1 2.1 1.6 0.4 0.2 2.1 1.2 2.6 4.1 0.6 0.8 2.8 1.9 4.4 12.2 3.2 9.6 0.8 0.0 5.0 2.5 7.8 15.6 5.6 4.9 4.3 3.8 30.7 17.6 5.7 1.6 8.7 0.6 3.8 3.2 3.4 7.2 8.3 2.7 7.2 0.2 1.1 2.4 6.2 0.4 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 16.9 6.4 16.9 14.3 11.1 11.1 3.6 11.4 4.4 0.7 0.0 0.0 0.0 0.0 2.2 13.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.7 0.0 0.0 1.5 0.7 0.4 0.2 0.0 0.0 0.7 20.6 1.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 1.2 0.0 0.0 0.0 3.1 0.0 0.0 0.5 2.3 1.3 0.1 0.0 0.2 0.0 GRAMD1A "FLJ90346, KIAA1533" ENSG00000089351 "GRAM domain containing 1A" Q96CP6 19 34994784-35026471 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Autophagy, Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "monocytes: 235.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 42.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008852, HPA012570" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA008852: AB_1079203, HPA012570: AB_2112577" "unprognostic (3.09e-2)" "unprognostic (4.62e-2)" "unprognostic (8.65e-2)" "unprognostic (1.01e-1)" "unprognostic (1.05e-1)" "unprognostic (2.87e-1)" "unprognostic (3.42e-3)" "unprognostic (5.96e-2)" "unprognostic (4.54e-1)" "unprognostic (5.70e-2)" "unprognostic (1.07e-2)" "unprognostic (2.91e-1)" "prognostic unfavorable (7.95e-12)" "unprognostic (2.04e-1)" "unprognostic (4.40e-1)" "unprognostic (2.90e-2)" "unprognostic (4.36e-2)" 15.6 19.1 14.6 21.4 14.0 17.1 19.4 13.8 18.1 16.8 13.2 10.4 17.4 13.0 16.9 12.9 7.8 17.2 13.8 17.2 15.9 12.0 13.3 11.0 27.5 42.0 13.7 12.2 21.8 44.1 11.5 14.9 14.1 16.6 15.6 7.5 11.5 45.3 17.2 35.7 6.8 10.9 21.3 12.8 21.1 16.1 11.7 12.1 17.9 12.7 11.5 12.1 17.3 21.4 1.1 4.1 13.1 14.9 3.8 5.5 2.5 5.5 42.9 8.4 16.6 9.8 11.2 7.0 6.7 11.1 9.0 8.9 16.2 4.8 3.1 13.4 10.0 7.9 3.6 8.7 13.2 3.4 13.3 15.2 9.2 10.6 14.9 19.8 6.5 14.7 19.8 8.2 6.4 10.9 14.2 29.2 20.5 10.0 2.2 6.2 5.3 14.8 8.0 13.2 11.0 4.8 14.0 2.6 3.9 9.6 1.0 12.7 25.6 6.8 5.1 11.0 7.7 7.8 7.2 15.9 14.4 7.4 2.9 9.5 2.4 7.9 7.6 9.5 7.2 10.7 13.1 4.5 3.6 2.9 7.3 5.5 0.5 3.9 2.1 4.1 1.1 2.9 4.2 9.8 3.8 14.9 1.4 3.1 2.5 14.6 14.0 13.8 18.1 15.9 12.0 13.7 12.2 16.6 12.1 20.8 34.1 13.4 49.1 18.4 13.5 8.1 0.0 16.0 14.8 15.7 15.7 10.8 3.3 29.5 0.8 46.6 1.8 0.0 49.7 25.1 19.4 49.8 9.2 6.7 44.3 7.9 37.8 51.0 37.3 1.8 23.9 26.0 32.1 235.4 12.5 28.8 44.0 10.5 23.7 11.5 14.9 12.9 32.0 0.0 2.7 13.4 27.7 41.5 18.6 48.2 GRAMD1C DKFZp434C0328 ENSG00000178075 "GRAM domain containing 1C" Q8IYS0 3 113828182-113947174 "Predicted intracellular proteins, Predicted membrane proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 74.3;Late spermatids: 57.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory B-cell: 5.1;naive B-cell: 4.1;neutrophil: 4.0" "Group enriched" "Detected in many" 11 "B-cells: 5.1;granulocytes: 4.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 14.4;HUVEC TERT2: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA012316 Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA012316: AB_1849949" "unprognostic (2.73e-3)" "unprognostic (6.16e-3)" "unprognostic (3.27e-1)" "unprognostic (1.93e-1)" "unprognostic (5.50e-2)" "unprognostic (9.81e-3)" "unprognostic (1.43e-3)" "unprognostic (1.99e-1)" "unprognostic (1.25e-1)" "unprognostic (1.39e-1)" "unprognostic (1.85e-1)" "unprognostic (5.49e-2)" "prognostic favorable (4.22e-15)" "unprognostic (8.48e-2)" "unprognostic (9.96e-2)" "unprognostic (3.61e-2)" "unprognostic (2.09e-2)" 1.7 2.6 12.6 2.5 13.0 0.5 9.1 5.0 13.4 3.4 8.0 2.6 0.5 7.6 5.2 5.1 6.0 10.3 2.9 1.5 13.6 7.6 23.3 26.5 5.0 2.0 9.4 8.1 1.1 12.5 11.8 24.1 6.2 9.2 2.9 4.2 4.5 10.8 2.8 1.1 12.0 24.5 1.0 8.2 1.7 8.6 14.5 9.3 0.0 6.9 1.6 3.7 3.8 3.8 5.1 0.1 4.0 0.0 0.3 0.4 0.1 1.5 0.0 4.1 3.2 0.8 2.1 5.9 3.7 3.3 0.7 2.2 0.0 14.4 0.4 1.1 1.9 1.3 1.6 0.7 1.6 1.7 1.9 0.6 0.3 0.1 0.0 1.6 0.2 0.1 3.3 1.1 0.6 0.1 7.5 11.2 4.5 0.0 0.2 1.1 0.4 1.6 0.2 0.3 1.5 0.5 0.0 0.8 2.5 4.5 2.0 0.8 1.0 1.0 5.9 3.0 1.6 4.1 0.0 2.3 1.5 2.9 0.0 0.3 2.2 1.3 1.8 2.4 0.1 1.7 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.4 0.1 4.1 0.3 0.4 4.0 0.3 0.0 0.1 0.0 0.1 12.6 13.0 5.0 13.4 13.6 7.6 9.4 8.1 9.2 9.3 11.9 10.9 0.0 5.9 0.9 0.0 0.8 20.4 18.7 7.9 14.0 35.3 14.6 26.6 2.1 74.3 2.9 12.0 0.0 2.4 3.7 1.0 2.9 0.0 14.8 1.3 11.1 4.7 3.7 0.0 57.8 2.6 0.0 1.7 0.0 4.7 14.5 2.1 5.9 1.4 11.2 18.3 0.0 0.9 25.7 5.1 4.1 35.5 0.0 3.9 5.7 GRB7 ENSG00000141738 "Growth factor receptor bound protein 7" Q14451 17 39737927-39747291 "Cancer-related genes, Predicted intracellular proteins" "Repressor, RNA-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 53.9" "Cell type enhanced" "Detected in many" 6 "Basal glandular cells: 79.7;Glandular cells: 69.7;Syncytiotrophoblasts: 82.5;Urothelial cells: 65.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in some" 4 "cerebellum: 7.4" "Cell type enriched" "Detected in single" 20 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 20 "B-cells: 2.0" "Cell line enriched" "Detected in some" 5 "OE19: 193.7" "Region enhanced" "Detected in some" "cerebellum: 9.3" "Low region specificity" "Detected in all" "CAB005226, HPA057084, CAB073538" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005226: AB_2113278, CAB073538: , HPA057084: AB_2683330" "unprognostic (8.46e-2)" "unprognostic (2.06e-2)" "unprognostic (1.45e-1)" "prognostic unfavorable (6.60e-7)" "unprognostic (7.06e-3)" "unprognostic (2.09e-2)" "unprognostic (1.02e-1)" "unprognostic (1.85e-1)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.10e-4)" "prognostic unfavorable (6.90e-4)" "unprognostic (2.59e-2)" "prognostic favorable (8.23e-5)" "unprognostic (1.83e-2)" "unprognostic (4.77e-2)" "unprognostic (5.49e-3)" "unprognostic (4.01e-2)" 2.9 0.1 0.1 2.8 0.6 0.0 16.1 7.4 1.2 6.7 12.7 0.3 25.0 6.7 2.6 8.1 53.9 14.5 16.3 0.8 0.2 0.1 23.4 5.2 12.3 0.1 0.1 0.4 3.1 20.5 5.8 3.7 42.6 1.6 10.2 6.4 0.7 14.0 25.5 0.5 19.1 12.4 2.0 0.1 0.3 7.2 2.3 0.3 0.5 8.5 6.5 17.2 7.2 11.7 2.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.6 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.0 0.0 4.9 2.8 0.0 0.4 0.0 0.1 2.6 0.0 1.8 0.0 0.0 0.2 0.0 0.6 4.3 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.5 193.7 0.4 0.0 0.0 1.9 2.2 1.6 1.1 0.0 2.1 42.8 0.0 2.1 1.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.6 7.4 1.2 0.2 0.1 0.1 0.4 1.6 0.3 20.8 10.0 0.0 79.7 34.0 0.0 2.0 15.3 17.4 7.9 21.0 0.0 27.0 8.3 29.6 0.0 0.5 18.0 0.0 16.9 18.8 1.9 69.7 1.1 4.0 2.5 0.0 13.8 0.0 0.0 0.0 2.6 0.9 5.0 2.8 16.8 0.3 20.5 24.6 1.1 8.6 0.0 0.0 1.0 0.4 0.2 36.6 82.5 0.9 22.1 65.1 GRIK5 "GluK5, GRIK2, KA2" ENSG00000105737 "Glutamate ionotropic receptor kainate type subunit 5" Q16478 19 41998321-42069498 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.9" "Cell type enhanced" "Detected in some" 12 "Bipolar cells: 21.4;Horizontal cells: 17.5;Muller glia cells: 8.3;Rod photoreceptor cells: 20.6" "Cancer enhanced" "Detected in many" "glioma: 15.4" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "eosinophil: 1.0" "Lineage enriched" "Detected in single" 11 "granulocytes: 1.0" "Cell line enhanced" "Detected in some" "HEL: 9.0;hTERT-RPE1: 14.5;NTERA-2: 8.9;REH: 24.4;SCLC-21H: 7.0;SH-SY5Y: 15.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074001 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA074001: AB_2732248" "unprognostic (4.99e-2)" "unprognostic (3.40e-1)" "unprognostic (1.30e-3)" "unprognostic (6.68e-3)" "unprognostic (4.28e-2)" "unprognostic (3.86e-1)" "unprognostic (5.82e-1)" "unprognostic (2.23e-1)" "unprognostic (3.89e-2)" "unprognostic (1.73e-2)" "prognostic favorable (7.23e-4)" "unprognostic (8.43e-2)" "prognostic unfavorable (9.32e-4)" "unprognostic (6.47e-3)" "unprognostic (5.77e-2)" "unprognostic (4.57e-2)" "unprognostic (6.12e-2)" 1.7 5.4 9.6 2.3 12.2 3.4 2.4 17.2 23.9 2.7 6.9 4.9 1.3 1.2 3.8 2.7 2.4 4.5 2.6 5.6 21.7 8.9 3.8 0.3 0.6 2.6 5.0 5.3 5.3 3.5 17.8 9.1 0.3 5.5 4.5 1.6 5.8 0.7 8.9 1.0 1.1 1.4 6.7 7.6 1.8 2.7 13.6 3.5 1.0 10.3 0.3 1.0 2.2 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.2 9.0 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 14.5 0.0 0.4 0.0 0.4 0.0 0.1 0.1 0.0 8.9 0.1 0.0 24.4 0.0 0.1 4.0 0.0 7.0 15.5 0.1 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 1.0 0.1 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.6 12.2 17.2 12.7 21.7 8.9 5.0 5.3 5.5 3.5 0.0 0.0 0.0 0.1 0.3 21.4 2.3 0.0 0.0 0.0 1.8 2.0 0.0 0.0 0.8 1.4 0.0 0.0 0.0 0.0 0.0 0.4 0.1 4.6 0.0 0.0 17.5 0.0 0.0 0.0 2.2 0.9 0.0 0.0 0.0 0.0 8.3 0.1 0.0 0.4 0.0 20.6 0.0 0.9 3.8 1.5 0.4 0.0 0.0 0.0 0.0 GRK3 "ADRBK2, BARK2" ENSG00000100077 "G protein-coupled receptor kinase 3" P35626 22 25564849-25729294 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 28.0" "Cell type enhanced" "Detected in many" 10 "Alveolar cells type 2: 44.1;Club cells: 30.7;Extravillous trophoblasts: 22.7;Hofbauer cells: 25.0;monocytes: 47.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 4.8;eosinophil: 5.6;intermediate monocyte: 8.0;memory B-cell: 4.9;myeloid DC: 3.7;naive B-cell: 6.2;non-classical monocyte: 7.4;plasmacytoid DC: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 20.4;JURKAT: 33.6;SH-SY5Y: 18.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA000804 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA000804: AB_1078281" "unprognostic (1.02e-1)" "unprognostic (4.38e-2)" "unprognostic (5.68e-3)" "unprognostic (4.33e-2)" "unprognostic (2.09e-1)" "unprognostic (3.67e-2)" "unprognostic (3.29e-1)" "unprognostic (1.78e-2)" "unprognostic (1.97e-1)" "unprognostic (3.54e-1)" "unprognostic (1.95e-3)" "unprognostic (5.79e-2)" "unprognostic (1.01e-3)" "unprognostic (1.74e-1)" "unprognostic (2.87e-3)" "unprognostic (1.89e-2)" "prognostic favorable (1.29e-4)" 28.0 6.0 11.9 12.4 10.8 7.0 11.3 7.9 18.9 4.7 4.0 3.1 0.7 3.0 5.7 3.1 2.7 9.1 5.0 4.6 15.7 8.3 3.0 3.4 9.4 14.1 9.7 9.8 4.1 8.4 4.4 8.2 4.5 9.6 8.2 4.3 4.8 3.7 1.9 1.4 4.1 6.1 6.2 4.9 23.2 4.0 14.8 2.7 11.6 4.5 1.3 15.2 6.7 2.5 6.2 3.7 5.6 8.0 0.0 0.4 1.6 0.0 1.9 5.8 1.9 4.1 0.5 8.5 0.6 1.8 1.8 3.2 3.0 3.3 10.6 0.1 0.1 5.2 0.1 5.8 4.3 5.5 20.4 3.8 4.9 0.6 6.7 0.1 15.8 8.3 1.0 3.0 1.3 2.3 0.3 0.3 33.6 0.5 0.0 2.1 2.6 11.3 1.1 4.1 5.7 0.0 5.1 9.3 1.8 0.0 3.1 13.7 18.5 1.0 0.0 4.4 5.6 1.6 6.3 0.1 0.0 12.0 0.1 2.3 1.2 4.2 8.3 7.8 5.6 1.8 0.6 4.8 5.6 0.0 8.0 0.3 4.9 0.0 0.3 3.7 6.2 0.1 0.2 0.3 0.0 7.4 3.2 0.4 1.6 11.9 10.8 7.9 18.9 15.7 8.3 9.7 9.8 9.6 2.7 14.9 44.1 0.0 0.0 0.0 0.0 0.0 0.0 12.0 30.7 0.0 0.0 1.5 1.7 7.0 0.0 0.0 0.0 0.0 1.6 22.7 0.0 0.0 17.4 0.0 25.0 0.0 0.0 0.0 0.0 0.0 0.0 10.5 0.0 47.7 0.0 0.0 3.4 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 GTSE1 "B99, GTSE-1" ENSG00000075218 "G2 and S-phase expressed 1" Q9NYZ3 22 46296741-46330810 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 20.0;testis: 22.3" "Cell type enhanced" "Detected in many" 18 "Erythroid cells: 93.5;Extravillous trophoblasts: 27.0;Spermatocytes: 47.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" HPA029457 Approved "Plasma membrane,Centrosome" Yes Yes Centrosome "Plasma membrane" "HPA029457: " "unprognostic (1.97e-1)" "unprognostic (3.07e-2)" "unprognostic (1.71e-3)" "unprognostic (2.59e-1)" "unprognostic (7.16e-2)" "unprognostic (2.40e-2)" "prognostic unfavorable (1.90e-10)" "prognostic unfavorable (4.66e-4)" "unprognostic (1.09e-1)" "unprognostic (8.37e-2)" "prognostic unfavorable (1.29e-4)" "unprognostic (3.49e-3)" "unprognostic (0.00e+0)" "unprognostic (6.52e-3)" "unprognostic (3.25e-1)" "unprognostic (1.14e-1)" "unprognostic (4.85e-2)" 1.1 1.3 0.3 10.4 0.8 10.2 1.3 1.0 1.1 1.2 2.5 0.7 0.1 4.1 1.1 1.3 6.6 0.4 0.4 0.8 1.0 0.3 0.9 0.9 1.3 9.0 0.6 0.4 0.9 0.5 0.0 0.9 2.8 1.8 0.6 2.6 0.7 1.5 0.1 0.3 2.4 3.3 1.0 0.6 4.6 2.4 22.3 0.3 20.0 0.5 5.8 8.8 1.1 2.1 1.4 1.9 3.0 0.2 1.8 1.6 0.9 21.8 10.4 20.5 16.2 0.4 1.2 9.8 19.0 9.0 27.7 22.9 10.8 8.3 20.7 5.0 7.3 12.7 11.5 18.3 4.8 17.8 12.4 19.7 13.8 14.6 8.4 0.0 24.7 16.9 0.2 0.3 11.9 6.1 2.9 11.9 15.0 10.5 26.0 16.5 12.2 22.1 12.1 14.3 9.0 11.7 22.0 23.0 13.5 4.5 4.0 10.6 14.5 18.1 11.8 8.4 9.6 10.0 9.6 9.4 15.8 30.0 12.9 19.9 14.9 7.1 21.0 10.0 11.9 23.0 0.1 0.2 1.5 1.3 0.1 0.4 1.4 0.6 0.6 0.3 0.6 0.4 0.3 3.0 1.8 0.1 1.9 1.6 0.9 0.3 0.8 1.0 1.1 1.0 0.3 0.6 0.4 1.8 0.3 0.0 0.0 0.8 0.6 2.5 0.6 1.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 3.9 0.4 0.5 93.5 0.2 27.0 1.1 0.6 0.0 0.5 16.0 0.0 1.2 5.5 6.2 3.8 0.3 3.5 0.0 0.0 2.0 0.2 0.4 0.0 0.7 0.4 0.1 6.5 0.9 47.7 20.4 2.3 1.3 2.9 3.7 1.4 HAPLN3 "EXLD1, HsT19883" ENSG00000140511 "Hyaluronan and proteoglycan link protein 3" Q96S86 15 88877288-88895626 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.4;lymphoid tissue: 23.6" "Cell type enriched" "Detected in many" 8 "Extravillous trophoblasts: 899.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 25.4" "Lineage enriched" "Detected in many" 5 "T-cells: 25.4" "Cell line enhanced" "Detected in many" "HDLM-2: 21.0;U-2 OS: 21.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039237 Approved Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA "Plasma membrane, Cytosol" "HPA039237: AB_10805357" "unprognostic (1.67e-2)" "unprognostic (1.04e-3)" "unprognostic (2.57e-1)" "unprognostic (2.53e-2)" "unprognostic (3.27e-1)" "unprognostic (2.24e-2)" "unprognostic (4.21e-1)" "unprognostic (3.82e-1)" "unprognostic (3.37e-3)" "unprognostic (7.37e-3)" "unprognostic (1.13e-3)" "unprognostic (4.30e-1)" "prognostic unfavorable (4.18e-13)" "unprognostic (1.95e-1)" "unprognostic (3.01e-2)" "unprognostic (6.12e-2)" "unprognostic (1.12e-1)" 9.9 1.3 1.1 20.6 2.7 4.4 8.7 1.0 2.3 5.3 2.6 1.1 0.3 1.4 4.4 4.9 5.7 6.0 4.7 9.8 3.2 1.0 3.0 0.8 8.7 23.6 3.1 0.9 5.2 2.3 0.9 2.2 2.7 3.6 5.2 1.1 3.2 6.4 1.6 4.2 6.0 4.1 4.7 6.2 6.9 3.6 1.9 1.8 5.7 7.2 7.6 10.9 6.0 5.6 0.8 1.1 0.7 0.6 4.8 25.4 3.2 1.2 4.4 0.9 9.8 2.8 3.0 3.1 2.7 0.6 1.0 1.3 2.8 4.1 0.0 7.8 3.4 1.6 1.0 9.3 1.2 0.0 21.0 8.2 3.0 0.2 0.0 0.4 0.0 0.1 1.1 0.5 2.0 0.1 0.1 4.6 0.4 0.0 6.0 0.4 0.1 0.0 0.0 7.3 0.0 0.1 0.0 0.4 7.3 1.8 0.1 0.1 2.7 0.5 0.5 3.7 1.2 0.0 0.4 0.8 7.1 21.0 5.3 0.4 0.9 0.0 0.0 2.5 0.0 6.1 0.7 0.6 0.0 0.6 0.3 3.0 0.1 10.0 4.1 1.1 0.8 10.2 4.5 0.1 4.8 0.1 0.4 25.4 3.2 1.1 2.7 1.0 2.3 3.2 1.0 3.1 0.9 3.6 1.8 0.0 4.3 0.9 6.0 28.4 2.6 7.7 0.0 1.4 5.7 1.8 9.8 5.6 0.0 5.7 0.0 18.6 0.0 0.0 1.8 899.6 9.3 3.9 1.1 0.0 17.6 0.0 0.0 3.1 0.0 0.0 0.9 2.9 16.9 16.2 0.2 2.4 8.7 0.0 0.7 0.1 108.4 12.9 38.9 0.5 1.7 21.1 17.0 3.2 0.2 6.8 HARBI1 "C11orf77, FLJ32675" ENSG00000180423 "Harbinger transposase derived 1" Q96MB7 11 46602861-46617909 "Predicted intracellular proteins" "Hydrolase, Nuclease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 63.9;Late spermatids: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038671, HPA045457" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038671: AB_10675947, HPA045457: AB_2679332" "unprognostic (1.29e-1)" "unprognostic (6.82e-2)" "unprognostic (7.76e-2)" "unprognostic (2.65e-1)" "unprognostic (1.61e-1)" "unprognostic (3.95e-1)" "unprognostic (1.23e-5)" "unprognostic (2.10e-1)" "unprognostic (1.66e-2)" "unprognostic (9.58e-2)" "unprognostic (3.15e-1)" "unprognostic (6.34e-2)" "unprognostic (6.96e-2)" "unprognostic (1.47e-1)" "unprognostic (1.66e-1)" "unprognostic (5.01e-2)" "unprognostic (1.13e-1)" 3.3 5.9 6.3 3.3 13.9 7.5 3.7 2.6 8.5 3.8 4.4 11.8 5.4 4.0 3.6 5.4 4.4 3.3 3.7 3.7 6.0 4.4 4.6 4.9 3.2 4.6 16.6 4.2 2.6 4.8 5.4 8.3 5.9 9.2 3.6 5.3 3.4 4.5 3.0 4.9 5.0 4.1 4.5 7.7 4.3 6.2 19.2 13.0 4.8 4.1 0.6 5.0 4.4 3.1 6.7 8.2 20.3 10.2 6.0 10.1 4.5 3.7 6.0 5.0 4.7 10.0 6.1 5.9 5.4 5.2 7.4 9.4 4.2 4.2 6.5 3.5 4.4 8.3 7.2 5.3 4.7 6.9 7.5 6.3 6.6 4.7 4.6 11.6 6.1 8.9 7.7 12.6 4.9 9.6 2.8 4.6 7.1 10.2 8.1 6.1 7.8 7.5 2.6 13.6 12.1 7.4 5.0 7.1 11.4 5.7 4.4 4.8 3.9 6.4 6.9 7.6 7.0 11.4 5.4 4.3 7.4 5.8 9.7 4.8 7.8 8.2 7.0 5.7 3.6 7.5 20.3 7.5 10.2 10.1 10.2 7.1 5.0 8.3 7.5 6.2 6.7 8.1 8.9 11.1 6.0 9.2 8.2 9.8 4.5 6.3 13.9 2.6 8.5 6.0 4.4 16.6 4.2 9.2 13.0 0.0 2.2 4.4 2.2 0.9 3.1 1.6 0.0 5.3 3.4 0.0 2.0 4.2 5.0 3.3 63.9 1.4 2.1 0.0 1.9 3.0 1.4 1.6 0.0 1.7 2.9 3.2 1.2 0.6 3.4 52.4 2.8 1.8 1.7 5.4 1.3 2.3 2.4 0.0 1.8 2.9 3.4 0.0 1.4 16.5 11.9 2.4 7.8 2.1 1.4 1.7 HAS1 HAS ENSG00000105509 "Hyaluronan synthase 1" Q92839 19 51713112-51723994 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.7;lymphoid tissue: 13.7;ovary: 23.6" "Cell type enhanced" "Detected in some" 13 "Basal keratinocytes: 23.7;Fibroblasts: 9.0;Melanocytes: 8.5;Smooth muscle cells: 24.7;Suprabasal keratinocytes: 15.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "eosinophil: 5.9;neutrophil: 1.6" "Lineage enriched" "Detected in single" 15 "granulocytes: 5.9" "Cell line enriched" "Detected in some" 4 "U-87 MG: 51.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA067602 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA067602: AB_2685871" "unprognostic (3.56e-2)" "unprognostic (1.19e-1)" "unprognostic (4.43e-2)" "unprognostic (5.26e-4)" "unprognostic (7.17e-3)" "unprognostic (7.05e-2)" "unprognostic (1.02e-1)" "unprognostic (5.49e-4)" "unprognostic (4.80e-2)" "unprognostic (1.99e-2)" "unprognostic (8.43e-2)" "unprognostic (1.72e-1)" "unprognostic (2.30e-11)" "unprognostic (9.12e-4)" "unprognostic (8.99e-2)" "unprognostic (3.73e-4)" "unprognostic (2.43e-2)" 23.7 0.5 0.6 13.7 1.3 2.8 1.0 1.5 1.9 0.6 1.2 0.4 1.1 0.1 0.8 2.5 1.3 5.8 5.5 5.9 1.4 2.0 0.3 0.6 4.5 0.3 0.6 0.3 23.6 2.2 0.0 0.3 0.3 0.6 0.4 0.5 1.0 0.3 1.2 2.1 2.7 4.0 3.6 0.9 0.7 0.7 0.9 0.3 0.3 0.3 0.8 0.3 1.8 0.3 0.1 0.1 5.9 0.1 0.0 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 12.0 0.0 0.0 0.0 0.0 0.0 0.1 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 51.0 0.0 0.1 0.0 0.1 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.6 0.0 0.0 0.1 0.0 0.1 0.6 1.3 1.5 1.7 1.4 2.0 0.6 0.3 0.6 0.3 0.0 2.6 0.0 0.1 23.7 4.2 0.6 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 9.0 0.1 2.3 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.3 0.3 8.5 0.0 0.0 0.1 0.2 0.0 0.4 0.0 0.6 0.0 24.7 0.0 0.1 15.6 0.1 0.0 0.0 0.1 HAUS4 "C14orf94, FLJ20424" ENSG00000092036 "HAUS augmin like complex subunit 4" Q9H6D7 14 22946228-22957161 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "monocytes: 42.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA029803, HPA071195" Approved Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA029803: AB_10601428, HPA071195: " "unprognostic (8.47e-3)" "unprognostic (3.52e-1)" "unprognostic (6.47e-2)" "unprognostic (7.59e-2)" "unprognostic (3.08e-2)" "unprognostic (1.73e-1)" "unprognostic (7.54e-2)" "unprognostic (4.32e-3)" "unprognostic (2.92e-2)" "unprognostic (2.87e-2)" "unprognostic (7.70e-2)" "unprognostic (8.66e-2)" "unprognostic (3.00e-2)" "unprognostic (6.94e-2)" "unprognostic (3.16e-1)" "unprognostic (1.96e-1)" "prognostic unfavorable (2.24e-4)" 17.2 16.7 11.0 28.8 15.0 29.8 22.3 9.9 15.6 20.3 24.0 13.8 22.3 15.3 17.8 20.7 25.4 16.9 30.6 19.5 12.3 8.3 16.8 17.9 24.0 30.6 17.7 9.2 33.8 29.1 17.5 9.8 12.1 13.4 19.1 16.9 14.2 22.0 19.2 14.4 21.7 24.9 23.3 17.6 24.5 19.3 12.2 17.4 33.7 23.2 17.2 21.2 18.9 19.5 14.0 35.3 34.5 28.2 7.8 15.4 15.3 25.8 17.6 20.4 20.1 15.0 18.8 30.6 13.0 17.4 14.2 20.0 12.6 30.9 50.0 6.2 7.8 10.5 26.1 10.8 15.5 12.0 13.4 8.1 16.8 12.4 30.7 13.7 21.5 28.0 12.8 30.1 6.1 18.6 17.7 24.7 29.2 11.7 25.0 15.2 19.9 23.5 19.1 10.7 20.6 17.9 22.5 24.5 19.2 12.3 14.2 8.2 13.3 18.6 19.3 11.4 9.2 16.8 17.4 13.6 13.0 16.8 9.4 11.4 26.5 22.7 23.2 6.1 24.4 7.4 2.1 28.2 5.8 5.8 18.3 7.8 14.0 10.9 8.3 35.3 11.6 15.4 11.8 34.5 7.8 11.3 9.9 14.6 15.3 11.0 15.0 9.9 15.6 12.3 8.3 17.7 9.2 13.4 17.4 20.8 5.0 11.0 5.1 11.0 0.4 0.8 20.4 10.7 5.7 1.8 0.0 10.2 5.0 13.0 0.2 5.8 8.7 0.0 23.7 11.7 5.8 2.6 3.5 3.9 15.2 0.0 7.5 7.4 24.9 0.0 5.2 13.2 5.0 42.3 17.3 3.9 20.7 17.5 3.9 4.9 0.3 0.0 5.2 2.5 5.4 9.7 6.9 7.9 30.1 5.4 HCK JTK9 ENSG00000101336 "HCK proto-oncogene, Src family tyrosine kinase" P08631 20 32052188-32101856 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Exocytosis, Host-virus interaction, Immunity, Inflammatory response, Innate immunity, Phagocytosis" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 107.1;lymphoid tissue: 72.6" "Group enriched" "Detected in many" 8 "Hofbauer cells: 131.2;Kupffer cells: 133.2;Macrophages: 170.5;monocytes: 221.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 15 "classical monocyte: 50.8;eosinophil: 62.5;intermediate monocyte: 96.5;myeloid DC: 31.6;neutrophil: 73.0;non-classical monocyte: 107.1" "Group enriched" "Detected in many" 15 "dendritic cells: 31.6;granulocytes: 73.0;monocytes: 107.1" "Group enriched" "Detected in some" 8 "THP-1: 23.1;U-937: 66.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB005195, HPA063768" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "CAB005195: AB_631619, HPA063768: AB_2685118" "unprognostic (6.22e-2)" "unprognostic (6.16e-3)" "unprognostic (2.26e-2)" "unprognostic (7.98e-2)" "unprognostic (8.83e-2)" "unprognostic (5.50e-2)" "unprognostic (4.09e-2)" "unprognostic (1.72e-2)" "unprognostic (4.34e-2)" "unprognostic (1.59e-1)" "unprognostic (4.08e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (1.66e-4)" "unprognostic (4.92e-2)" "unprognostic (4.42e-2)" "unprognostic (6.95e-2)" "unprognostic (1.12e-1)" 12.3 5.8 5.9 40.8 13.1 20.8 4.0 1.8 5.3 3.0 5.8 6.1 0.9 5.9 2.5 5.7 3.1 5.9 6.5 8.8 6.0 3.7 4.0 7.9 20.9 50.3 11.2 1.2 3.4 2.8 0.7 2.9 8.8 8.0 3.8 5.9 3.1 4.1 1.9 3.1 2.8 7.8 10.2 9.1 72.6 3.7 2.6 8.2 5.8 3.3 1.2 16.4 9.4 3.5 4.7 31.6 73.0 107.1 1.1 0.1 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.3 0.0 23.1 0.0 0.0 0.1 0.0 0.0 0.7 0.1 3.4 0.0 66.3 0.0 0.5 50.8 62.5 0.1 96.5 0.1 4.7 0.1 0.1 31.6 3.7 0.1 0.0 73.0 1.1 107.1 2.8 0.1 40.2 5.9 13.1 1.8 5.3 6.0 3.7 11.2 1.2 8.0 8.2 6.0 21.8 10.3 3.5 2.7 0.0 1.7 2.5 2.7 6.8 7.0 0.0 0.8 1.7 0.0 0.2 1.4 0.0 0.0 0.5 0.7 1.3 0.0 5.8 0.8 131.2 0.0 1.7 1.8 133.2 0.0 0.0 170.5 1.7 221.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 1.0 1.4 0.5 0.0 4.6 HCLS1 "CTTNL, HS1" ENSG00000180353 "Hematopoietic cell-specific Lyn substrate 1" P14317 3 121631399-121660927 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 149.7;lymphoid tissue: 110.1" "Cell type enhanced" "Detected in many" 15 "Kupffer cells: 535.9;Macrophages: 194.3;monocytes: 183.1;T-cells: 152.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 43.1;HMC-1: 61.2;Karpas-707: 39.8;RPMI-8226: 40.9;THP-1: 42.7;U-266/70: 60.6;U-698: 60.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA019143 Enhanced Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "HPA019143: AB_1850532" "unprognostic (2.27e-2)" "unprognostic (1.79e-3)" "unprognostic (5.38e-3)" "unprognostic (6.29e-2)" "unprognostic (1.01e-2)" "unprognostic (4.02e-3)" "unprognostic (2.35e-1)" "unprognostic (4.88e-3)" "unprognostic (1.70e-2)" "unprognostic (1.19e-1)" "unprognostic (6.76e-2)" "unprognostic (2.28e-1)" "unprognostic (1.03e-3)" "unprognostic (2.93e-1)" "unprognostic (3.46e-2)" "unprognostic (2.60e-2)" "unprognostic (2.01e-1)" 24.7 10.7 7.8 44.9 14.7 35.5 9.1 1.3 7.4 6.3 10.4 8.5 2.2 5.5 5.6 8.2 4.8 9.1 10.1 7.5 6.7 5.0 10.5 10.1 18.7 59.4 12.9 3.2 4.6 5.1 1.4 6.1 15.4 10.9 6.1 8.6 4.9 7.4 3.1 7.0 4.6 23.0 8.9 15.1 110.1 7.1 3.6 11.6 41.0 6.1 4.4 61.5 12.5 5.6 33.4 59.6 149.7 84.9 24.3 44.1 103.5 0.1 0.0 0.0 0.0 3.6 2.0 0.9 0.6 0.6 0.1 0.2 0.0 0.0 43.1 21.0 0.0 0.0 0.0 1.1 1.6 0.1 19.2 0.0 27.9 0.0 0.0 2.0 30.6 61.2 0.3 0.0 0.0 0.3 0.0 25.4 17.6 5.5 39.8 0.0 0.0 21.7 25.9 0.0 0.0 0.7 22.0 0.0 40.9 0.0 11.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 42.7 33.1 0.0 0.3 0.0 0.1 60.6 18.4 60.6 0.3 29.5 0.0 26.6 64.1 104.2 40.2 80.6 32.9 33.4 33.3 36.8 59.6 29.4 28.5 33.0 149.7 24.3 84.9 18.5 44.1 103.5 7.8 14.7 1.3 7.4 6.7 5.0 12.9 3.2 10.9 11.6 8.9 51.2 119.0 0.8 2.9 0.4 1.7 7.6 18.7 12.5 0.0 0.0 96.0 0.0 0.3 0.8 14.6 0.1 23.3 0.2 50.7 6.0 0.3 70.6 2.1 117.6 0.0 0.0 33.2 535.9 0.9 3.1 194.3 18.6 183.1 0.3 0.6 0.3 0.0 1.1 0.6 0.7 12.9 6.6 0.3 0.6 3.9 121.6 152.2 0.2 1.8 HDAC8 "HDACL1, MRXS6, RPD3, WTS" ENSG00000147099 "Histone deacetylase 8" Q9BY41 X 72329516-72573103 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Hydrolase, Repressor" "Disease mutation, FDA approved drug targets, Mental retardation, Obesity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048560 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048560: AB_2680442" "unprognostic (1.42e-1)" "unprognostic (6.62e-3)" "unprognostic (3.20e-2)" "unprognostic (9.24e-3)" "unprognostic (1.10e-1)" "unprognostic (1.10e-1)" "unprognostic (4.64e-2)" "unprognostic (6.03e-2)" "unprognostic (1.58e-1)" "unprognostic (2.81e-2)" "unprognostic (3.17e-2)" "unprognostic (9.68e-2)" "unprognostic (8.42e-2)" "unprognostic (2.33e-3)" "unprognostic (9.10e-2)" "unprognostic (7.15e-3)" "unprognostic (2.12e-3)" 9.6 22.5 14.7 9.9 16.2 10.2 12.4 31.4 20.6 12.6 10.4 13.9 11.5 8.6 12.3 28.2 11.0 9.4 9.4 12.6 15.0 15.2 16.8 18.6 10.2 9.6 14.9 9.4 12.8 15.9 13.6 22.0 11.2 19.3 13.3 12.8 14.3 12.2 10.3 10.4 9.3 8.4 13.1 12.2 9.5 10.7 3.6 14.0 8.0 15.0 8.2 11.9 10.4 10.1 9.4 12.8 19.7 13.2 7.7 11.4 7.7 12.5 17.1 12.6 17.4 17.3 12.9 8.7 7.3 14.1 11.2 12.7 12.4 12.9 8.7 23.0 10.0 17.5 9.2 23.5 14.2 14.9 14.3 16.7 11.5 22.0 14.4 9.5 19.1 20.4 13.5 10.4 13.7 10.3 15.9 17.2 11.7 12.8 24.4 14.9 15.8 8.9 25.1 17.5 19.3 24.8 12.2 16.2 15.6 19.5 13.2 9.0 19.7 17.1 13.7 17.5 16.4 6.9 16.3 12.9 9.2 13.3 13.2 8.1 9.4 15.0 11.1 12.5 21.1 11.9 7.2 13.2 19.7 8.8 11.8 6.9 9.4 9.5 7.3 12.8 9.1 7.6 7.1 0.7 7.7 10.5 4.8 11.4 7.7 14.7 16.2 31.4 20.6 15.0 15.2 14.9 9.4 19.3 14.0 3.0 18.8 8.1 10.0 5.5 16.0 10.8 12.7 13.4 10.3 7.0 41.2 14.3 8.3 11.9 0.5 10.5 8.1 0.0 10.7 11.6 8.6 13.3 11.5 9.7 13.8 22.3 8.7 11.6 7.8 1.3 10.9 10.6 6.8 6.4 9.1 10.8 10.1 2.9 9.9 17.8 16.8 25.8 9.5 5.1 0.7 5.5 11.3 11.4 9.7 10.9 HEG1 "HEG, KIAA1237" ENSG00000173706 "Heart development protein with EGF like domains 1" Q9ULI3 3 124965710-125055958 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Alveolar cells type 1: 80.4;Cardiomyocytes: 80.5;Cone photoreceptor cells: 249.4;Ito cells: 95.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 42.0;HHSteC: 51.1;hTERT-RPE1: 77.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010952, HPA011559" Approved Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 360000000 Vesicles "Plasma membrane" "HPA010952: AB_2668389, HPA011559: AB_1850580" "unprognostic (1.10e-1)" "unprognostic (2.21e-1)" "unprognostic (6.52e-2)" "unprognostic (2.23e-1)" "unprognostic (1.30e-1)" "unprognostic (5.40e-2)" "unprognostic (6.48e-2)" "unprognostic (2.89e-2)" "unprognostic (2.36e-1)" "unprognostic (9.80e-2)" "unprognostic (1.69e-1)" "unprognostic (8.33e-2)" "prognostic unfavorable (1.93e-5)" "unprognostic (1.11e-2)" "unprognostic (4.99e-2)" "unprognostic (6.20e-3)" "prognostic unfavorable (1.16e-4)" 23.6 8.2 5.8 12.1 8.4 0.7 16.4 2.6 8.9 12.2 9.6 14.7 8.0 3.9 12.0 7.3 9.0 11.4 29.6 36.3 6.9 5.5 8.9 5.5 42.4 7.7 9.7 4.7 8.1 16.6 14.2 4.0 17.4 11.6 7.2 6.5 26.2 7.1 7.4 6.2 4.3 7.9 14.4 11.9 11.5 7.5 11.3 6.5 3.0 29.1 10.8 8.7 13.0 15.6 1.0 0.9 1.2 3.9 7.3 4.0 1.1 1.8 1.9 13.4 1.1 16.6 14.7 5.0 15.7 20.6 17.5 19.3 13.7 0.2 0.5 10.7 42.0 12.8 3.3 2.0 7.7 21.1 1.4 1.0 0.3 10.2 1.6 51.1 0.3 20.4 18.0 2.2 22.8 5.4 77.1 17.0 1.2 0.0 0.2 5.3 0.2 0.8 0.0 2.3 0.0 1.2 1.2 10.2 0.0 3.0 0.3 0.2 1.2 34.9 2.4 1.3 12.4 5.7 0.8 26.4 9.9 11.0 35.4 6.7 1.4 4.3 0.0 18.6 1.5 19.2 1.2 0.3 0.0 4.0 3.6 2.7 0.9 1.6 3.6 0.7 1.0 2.4 1.5 0.0 7.3 3.9 0.9 0.5 1.1 5.8 8.4 2.6 8.9 6.9 5.5 9.7 4.7 11.6 6.5 80.4 7.2 4.9 7.1 4.4 3.0 80.5 5.1 0.0 4.5 26.2 249.4 0.8 0.0 31.8 5.1 76.0 0.0 0.0 5.8 53.1 23.5 2.8 26.5 2.5 5.7 1.6 0.0 95.2 15.8 7.6 4.6 4.8 6.8 2.8 0.6 4.1 6.9 0.0 13.1 1.2 62.4 0.0 21.2 0.2 0.2 3.9 2.7 14.6 0.1 0.9 HENMT1 "C1orf59, FLJ30525, HEN1" ENSG00000162639 "HEN methyltransferase 1" Q5T8I9 1 108648290-108661526 "Enzymes, Predicted intracellular proteins" "RNA-mediated gene silencing" "Methyltransferase, RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.8;testis: 45.2" "Group enriched" "Detected in many" 4 "Spermatocytes: 118.4;Spermatogonia: 74.4;T-cells: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "JURKAT: 25.7;MOLT-4: 23.6;NB-4: 26.4;U-937: 34.8" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 15 "cerebellum: 18.1" "HPA028464, HPA028497" Uncertain Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA028464: AB_10600103, HPA028497: AB_10601552" "unprognostic (1.82e-1)" "prognostic favorable (2.56e-4)" "prognostic favorable (9.95e-4)" "unprognostic (2.92e-3)" "unprognostic (1.91e-1)" "unprognostic (3.88e-3)" "unprognostic (2.01e-2)" "unprognostic (1.49e-1)" "unprognostic (7.01e-2)" "unprognostic (1.25e-1)" "unprognostic (2.95e-1)" "unprognostic (1.19e-1)" "prognostic unfavorable (2.48e-5)" "unprognostic (2.53e-1)" "unprognostic (2.43e-1)" "unprognostic (2.18e-1)" "unprognostic (1.65e-1)" 3.5 2.2 6.7 5.1 10.2 7.7 5.5 3.6 11.6 6.1 4.4 4.2 1.4 3.4 2.8 3.4 1.9 1.8 4.5 3.1 9.5 10.1 1.8 1.4 4.9 9.8 8.2 5.6 3.8 1.5 0.6 3.9 3.8 10.7 2.7 6.6 1.3 2.4 2.6 2.0 2.6 5.2 2.5 6.9 8.0 3.2 45.2 2.5 10.3 1.7 1.2 7.3 5.5 1.6 5.4 10.6 18.2 12.0 22.9 28.8 15.9 5.8 3.0 0.2 0.0 0.2 0.2 0.0 1.4 0.5 3.5 0.5 8.8 9.3 0.0 3.2 2.6 0.0 0.0 0.0 0.0 2.2 1.9 0.0 15.0 11.3 0.0 3.0 8.8 13.4 2.9 0.1 0.7 0.0 0.0 0.7 25.7 0.0 6.7 0.1 14.9 23.6 26.4 8.7 4.7 1.3 10.3 0.0 0.5 0.0 6.4 14.7 0.0 12.6 3.5 0.0 0.9 0.0 19.8 0.1 0.0 11.7 6.4 0.0 4.1 5.1 0.0 0.0 34.8 0.1 16.0 8.8 18.2 28.8 10.1 26.0 5.4 14.2 26.0 10.6 2.9 11.8 21.7 8.6 22.9 12.0 8.5 13.1 15.9 6.7 10.2 3.6 11.6 9.5 10.1 8.2 5.6 10.7 2.5 0.0 0.6 0.0 1.4 1.4 3.8 1.5 17.8 1.4 1.2 5.2 0.0 10.4 3.3 2.8 8.7 2.6 3.9 0.0 1.2 16.4 3.1 0.6 6.9 0.4 14.0 0.0 4.7 6.7 11.7 17.0 4.6 8.5 1.7 7.2 2.5 2.0 1.9 6.8 2.8 0.7 2.6 6.5 2.8 118.4 74.4 1.4 4.3 38.3 5.6 2.5 HERC2 "D15F37S1, jdf2, p528" ENSG00000128731 "HECT and RLD domain containing E3 ubiquitin protein ligase 2" O95714 15 28111040-28322152 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017188, HPA048389, HPA074166" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB017188: , HPA048389: AB_2680382, HPA074166: " "unprognostic (1.59e-1)" "unprognostic (1.44e-1)" "unprognostic (1.92e-1)" "unprognostic (6.64e-2)" "unprognostic (6.62e-2)" "unprognostic (5.74e-2)" "unprognostic (9.17e-2)" "unprognostic (2.08e-1)" "unprognostic (1.87e-1)" "unprognostic (4.11e-2)" "unprognostic (9.40e-3)" "unprognostic (3.60e-2)" "prognostic favorable (1.41e-7)" "unprognostic (7.66e-2)" "unprognostic (2.10e-1)" "unprognostic (2.34e-2)" "unprognostic (1.71e-1)" 2.5 3.3 3.2 2.2 4.5 3.9 3.1 7.0 5.7 3.2 4.6 2.7 4.4 1.7 2.8 4.1 2.1 4.6 3.5 3.6 3.3 1.6 2.5 2.1 3.8 8.5 3.6 9.2 3.5 2.7 3.0 3.0 2.3 3.3 8.2 3.1 3.1 4.1 4.1 2.3 3.4 3.2 5.6 2.4 3.3 2.3 1.0 1.1 0.5 0.4 0.2 1.1 0.4 5.2 10.3 7.2 3.0 6.0 4.5 2.0 3.8 4.5 4.9 4.7 5.3 0.7 5.2 4.6 6.4 7.4 5.3 7.6 3.7 3.6 3.2 4.9 33.3 12.0 1.7 2.3 7.8 2.7 3.7 2.9 5.8 7.3 3.1 6.4 4.4 12.8 2.2 4.6 2.4 1.7 2.6 2.1 4.0 4.5 6.2 10.3 0.4 1.7 11.3 7.9 4.6 9.1 2.6 3.0 3.9 3.0 9.2 9.6 9.1 5.9 3.5 5.6 1.4 2.0 4.9 4.2 3.7 4.8 0.0 0.4 0.5 1.1 0.1 0.6 0.5 0.2 0.5 1.1 1.0 0.9 0.5 0.0 0.2 0.3 0.9 0.4 0.4 20.8 19.7 23.1 13.0 14.5 100.9 54.0 28.1 17.4 25.0 61.1 139.4 22.6 1.7 24.7 11.1 39.4 24.9 0.0 26.5 13.6 21.3 18.7 3.5 30.6 16.6 116.0 27.0 36.8 21.8 10.6 52.0 17.3 65.8 26.2 29.8 46.8 29.3 31.6 49.1 16.6 140.1 64.7 24.7 57.9 59.4 18.3 14.9 30.2 30.9 10.1 HERPUD1 "HERP, KIAA0025, Mif1, SUP" ENSG00000051108 "Homocysteine inducible ER protein with ubiquitin like domain 1" Q15011 16 56932048-56944863 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Unfolded protein response" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Melanocytes: 899.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 78.5;U-266/70: 89.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037041, CAB037104, HPA040754, HPA041219" Approved Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB037041: AB_1840910, CAB037104: AB_1840912, HPA040754: AB_10794068, HPA041219: AB_10794268" "unprognostic (1.92e-1)" "unprognostic (3.47e-1)" "unprognostic (8.64e-2)" "unprognostic (3.93e-3)" "unprognostic (3.39e-1)" "unprognostic (5.00e-3)" "unprognostic (1.17e-1)" "unprognostic (9.69e-3)" "unprognostic (3.33e-1)" "unprognostic (2.56e-1)" "unprognostic (2.84e-1)" "unprognostic (3.50e-1)" "prognostic favorable (1.41e-9)" "unprognostic (1.06e-1)" "unprognostic (3.93e-2)" "unprognostic (2.19e-2)" "unprognostic (2.27e-3)" 22.7 38.8 16.2 35.6 20.7 21.6 39.4 17.7 20.0 30.1 32.1 20.0 48.8 21.4 21.6 51.6 15.0 20.2 32.5 28.8 15.8 15.5 42.9 57.7 30.4 40.0 25.6 12.5 44.8 148.6 37.6 26.7 26.2 25.6 49.5 32.3 35.3 108.6 76.1 34.6 18.3 24.7 17.6 24.2 38.3 37.2 10.6 20.8 9.6 64.2 20.4 53.8 24.4 25.9 50.8 121.9 29.0 39.5 22.4 33.4 46.5 4.5 5.0 4.9 10.2 11.4 15.0 17.6 10.8 17.2 14.0 11.0 6.9 10.4 18.5 13.9 10.5 14.3 7.9 8.3 3.8 13.9 10.7 5.0 1.6 8.3 25.0 62.5 3.3 8.3 18.1 36.5 6.3 20.2 16.9 10.6 20.7 2.5 26.5 39.0 3.8 6.2 6.8 3.1 26.5 11.4 4.3 12.5 78.5 30.0 5.1 5.4 6.3 9.4 46.4 47.9 7.3 5.2 12.5 6.5 5.8 5.8 5.1 4.3 89.5 29.1 28.9 8.3 4.6 7.6 23.9 39.5 18.0 16.1 31.0 17.4 50.8 17.5 21.1 30.6 37.8 11.4 17.4 29.0 22.4 21.5 121.9 33.4 46.5 16.2 20.7 17.7 20.0 15.8 15.5 25.6 12.5 25.6 20.8 65.5 113.2 400.7 628.3 323.4 125.0 136.3 71.4 44.2 47.8 68.0 265.1 118.1 144.2 165.3 52.0 119.9 168.3 70.0 173.1 150.4 186.1 478.3 152.0 140.9 178.2 44.5 416.3 118.4 182.3 185.2 96.4 276.3 899.3 227.2 208.8 76.2 141.3 182.4 89.8 157.6 103.7 97.0 210.0 43.1 8.9 223.2 580.2 183.3 123.2 295.1 HFE HLA-H ENSG00000010704 Hemochromatosis Q30201 6 26087281-26098343 "Disease related genes, Predicted membrane proteins" "Ion transport, Iron transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 26.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017276, HPA053470" Approved Supported "Nucleoplasm,Plasma membrane" No No "Plasma membrane" Nucleoplasm "HPA017276: AB_1850677, HPA053470: AB_2682163" "unprognostic (6.96e-2)" "unprognostic (7.87e-2)" "unprognostic (1.73e-1)" "unprognostic (1.24e-2)" "unprognostic (6.07e-3)" "unprognostic (7.58e-2)" "unprognostic (4.23e-1)" "unprognostic (1.77e-1)" "unprognostic (8.21e-3)" "unprognostic (1.78e-1)" "unprognostic (3.31e-3)" "unprognostic (1.82e-1)" "unprognostic (1.33e-2)" "unprognostic (2.12e-2)" "unprognostic (1.38e-1)" "unprognostic (1.33e-1)" "unprognostic (3.17e-1)" 7.2 13.7 2.2 4.4 2.7 0.0 6.2 1.2 2.5 6.7 7.1 3.5 10.3 4.2 6.8 13.9 7.6 5.2 13.3 8.9 2.0 1.4 5.4 12.8 9.0 16.1 2.3 2.0 8.1 16.2 14.6 2.2 7.6 4.3 12.6 5.3 13.7 7.0 8.1 3.1 3.2 5.8 10.4 3.2 14.4 6.1 4.9 1.2 2.0 7.7 3.9 5.0 8.6 5.2 3.5 4.6 1.9 10.5 0.2 2.2 3.4 8.2 18.9 0.3 9.2 14.0 10.8 0.0 5.9 14.1 7.6 12.0 1.6 16.8 0.8 16.1 9.7 11.5 5.3 0.0 6.9 9.7 2.1 0.1 0.2 4.5 1.2 2.7 0.0 0.3 11.1 2.0 8.4 0.7 6.7 5.1 0.0 0.3 0.2 6.5 3.4 0.0 0.1 0.4 3.9 0.0 1.1 0.0 0.1 6.3 5.5 0.0 0.0 3.5 0.0 5.1 0.1 26.9 0.9 3.9 5.4 0.5 5.3 5.1 0.1 0.1 0.1 8.0 0.1 11.6 1.2 10.5 0.0 1.7 10.2 1.3 3.5 1.7 2.2 4.6 1.5 0.4 1.2 1.9 0.2 8.2 0.3 0.3 3.4 2.2 2.7 1.2 2.5 2.0 1.4 2.3 2.0 4.3 1.2 3.0 3.2 1.9 2.3 1.4 0.7 2.8 5.1 6.7 7.9 5.2 2.0 1.2 0.0 2.5 0.1 3.0 3.4 0.0 3.0 0.6 3.0 3.8 2.3 8.1 8.8 0.0 1.7 8.6 21.1 0.0 3.4 5.7 0.0 0.0 3.7 3.7 2.5 0.0 5.6 2.2 2.0 0.0 1.4 0.2 1.0 3.0 1.5 0.7 3.7 1.3 HLA-A ENSG00000206503 "Major histocompatibility complex, class I, A" "P04439, P13746, P16188" 6 29941260-29945884 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity, Innate immunity" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "monocytes: 4504.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "A-431: 158.0;fHDF/TERT166: 42.3;HBEC3-KT: 43.4;RPMI-8226: 41.2;U-266/70: 42.1" CAB078470 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "CAB078470: AB_10985125" "unprognostic (1.56e-2)" "unprognostic (9.14e-2)" "unprognostic (1.34e-2)" "prognostic favorable (9.59e-4)" "unprognostic (3.49e-1)" "unprognostic (1.21e-1)" "unprognostic (1.12e-1)" "unprognostic (7.28e-2)" "unprognostic (3.42e-2)" "prognostic favorable (6.47e-4)" "unprognostic (2.96e-1)" "unprognostic (3.24e-1)" "unprognostic (1.84e-2)" "unprognostic (1.01e-1)" "unprognostic (2.32e-2)" "unprognostic (1.20e-2)" "unprognostic (1.54e-2)" 69.4 57.5 16.0 69.1 18.2 41.2 40.8 9.1 20.7 54.4 92.6 20.4 28.6 105.7 38.4 76.2 48.4 27.8 92.3 59.1 14.6 16.6 80.5 47.6 112.0 90.5 19.5 8.9 57.2 30.0 22.5 33.3 38.7 22.7 64.1 38.5 52.4 28.3 19.2 44.0 110.4 129.4 30.3 22.8 150.0 115.9 26.6 12.3 71.1 62.3 38.5 97.7 86.4 41.0 23.0 10.9 65.8 25.2 25.9 46.7 45.4 158.0 4.0 0.0 0.0 25.5 24.1 0.1 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.0 42.3 21.5 3.9 0.0 43.4 0.0 0.3 1.6 27.6 1.2 0.8 1.4 0.0 1.8 0.2 0.0 0.3 0.1 0.0 0.0 21.2 0.0 0.1 0.0 0.0 0.1 2.5 0.3 0.0 0.4 3.3 0.3 41.2 29.6 32.5 0.0 1.4 3.5 0.0 1.4 10.4 0.2 3.7 0.6 2.4 0.1 0.7 0.5 42.1 10.7 8.9 0.0 23.3 0.0 65.8 25.2 35.4 38.3 17.9 28.8 23.0 29.6 34.4 4.1 14.9 21.7 29.7 47.9 25.9 19.8 10.9 46.7 45.4 16.0 18.2 9.1 20.7 14.6 16.6 19.5 8.9 22.7 12.3 345.4 508.3 1064.2 718.5 760.7 31.3 128.4 937.6 317.2 366.3 478.1 5.9 16.7 74.6 2692.4 38.8 1227.5 2851.3 186.9 1168.0 15.8 685.4 823.3 585.8 217.5 1814.8 35.0 917.5 1170.5 1323.9 66.9 652.4 1239.0 602.3 4504.1 1496.2 150.9 1505.1 2283.0 455.0 258.2 20.0 549.7 859.0 132.4 24.5 828.4 26.5 2218.3 1070.6 1059.3 HMOX1 "bK286B10, HO-1" ENSG00000100292 "Heme oxygenase 1" P09601 22 35380361-35394214 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis Oxidoreductase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 209.8" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 439.8;Kupffer cells: 915.4;monocytes: 247.9;Syncytiotrophoblasts: 419.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 4 "classical monocyte: 17.7;intermediate monocyte: 40.5;non-classical monocyte: 53.4" "Lineage enriched" "Detected in many" 6 "monocytes: 53.4" "Cell line enhanced" "Detected in many" "BEWO: 108.8;GAMG: 71.3;U-138 MG: 63.5;U-87 MG: 61.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA000635, CAB017444" Enhanced Uncertain "Golgi apparatus,Plasma membrane" NA NA 17000 "Golgi apparatus, Plasma membrane" "CAB017444: AB_10617276, HPA000635: AB_1079089" "unprognostic (3.12e-1)" "unprognostic (1.00e-1)" "unprognostic (9.42e-2)" "unprognostic (6.94e-2)" "unprognostic (5.57e-2)" "unprognostic (2.47e-2)" "prognostic unfavorable (1.59e-4)" "unprognostic (7.56e-2)" "unprognostic (1.71e-1)" "unprognostic (4.91e-2)" "unprognostic (1.62e-1)" "unprognostic (2.76e-1)" "unprognostic (1.95e-3)" "unprognostic (1.91e-1)" "unprognostic (4.82e-2)" "unprognostic (2.26e-1)" "unprognostic (7.54e-2)" 28.4 10.3 4.1 12.5 8.7 16.3 13.8 0.8 20.6 5.7 12.0 6.1 0.6 22.0 2.5 8.5 8.8 9.8 9.8 10.2 4.1 3.1 23.0 63.7 54.0 76.3 12.5 1.3 28.6 8.8 0.5 2.7 21.1 7.5 3.6 4.9 3.3 3.5 0.8 21.9 13.8 22.8 6.9 11.2 209.8 4.6 5.9 7.6 3.6 4.2 7.3 8.3 6.7 10.2 4.8 7.9 8.4 53.4 1.1 0.3 10.1 1.4 22.1 0.2 4.5 18.1 5.3 108.8 10.2 6.0 4.8 5.2 9.8 1.3 0.0 2.3 8.3 71.3 1.2 1.3 0.2 1.5 36.6 1.1 0.5 6.7 20.0 25.2 1.3 6.9 16.6 0.4 31.7 2.1 7.7 14.4 0.0 0.0 10.6 15.3 1.1 0.0 0.5 2.2 13.6 2.5 0.1 1.9 3.4 3.4 11.9 0.3 0.3 26.4 2.3 1.7 9.6 1.0 0.3 5.4 63.5 2.8 10.3 9.9 6.6 8.5 1.0 61.6 0.6 1.0 2.0 17.7 1.2 0.2 40.5 0.0 4.8 0.1 0.3 7.9 0.5 0.0 0.0 8.4 1.1 53.4 0.2 0.2 10.1 4.1 8.7 0.8 4.8 4.1 3.1 12.5 1.3 7.5 7.6 3.0 21.3 13.8 5.9 14.5 0.0 3.1 10.2 1.4 0.0 5.2 0.0 39.4 18.3 10.3 1.6 20.2 43.4 0.0 1.3 204.4 21.6 85.9 11.5 19.5 439.8 0.0 15.3 30.7 915.4 1.3 28.7 175.5 33.7 247.9 5.3 0.2 8.7 10.5 4.9 128.1 0.4 0.0 16.5 0.9 2.7 13.7 419.8 10.0 4.1 91.1 HPS3 "BLOC2S1, SUTAL" ENSG00000163755 "HPS3, biogenesis of lysosomal organelles complex 2 subunit 1" Q969F9 3 149129584-149173732 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Albinism, Disease mutation, Hermansky-Pudlak syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "GAMG: 49.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046281, HPA052778" Approved Approved "Golgi apparatus,Plasma membrane" NA NA "Golgi apparatus, Plasma membrane" "HPA046281: AB_10961641, HPA052778: AB_2681943" "unprognostic (1.47e-2)" "unprognostic (7.83e-2)" "unprognostic (1.04e-1)" "unprognostic (1.11e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-1)" "prognostic unfavorable (6.04e-4)" "unprognostic (1.33e-1)" "unprognostic (1.75e-1)" "unprognostic (1.08e-1)" "unprognostic (1.82e-2)" "unprognostic (1.08e-1)" "prognostic unfavorable (4.38e-4)" "unprognostic (2.00e-1)" "unprognostic (1.28e-1)" "unprognostic (3.03e-1)" "unprognostic (3.06e-2)" 14.4 17.6 10.5 16.1 11.5 6.3 18.8 8.1 11.8 13.0 11.7 12.8 6.2 13.7 17.1 10.3 10.2 12.4 11.5 8.9 9.9 8.7 15.3 10.1 12.1 25.1 11.5 10.4 18.7 13.8 10.1 11.8 13.3 11.9 13.4 11.8 13.9 13.4 11.5 5.9 8.9 16.3 13.4 17.1 19.8 12.5 8.5 12.6 23.8 13.7 4.5 19.9 16.3 17.9 16.3 19.9 16.1 15.4 9.3 16.0 10.7 19.8 11.0 6.6 6.8 9.3 12.0 5.0 8.2 16.1 10.8 14.0 3.7 13.2 5.1 10.5 9.8 49.5 6.8 7.3 5.6 14.0 12.4 5.8 2.3 5.3 4.1 8.3 6.3 3.9 7.8 5.7 10.4 4.3 22.2 11.0 8.4 2.6 12.4 13.7 12.3 4.5 8.9 15.9 10.8 8.9 5.4 4.3 13.6 5.9 10.0 2.0 5.3 7.0 7.5 15.2 15.0 8.1 8.4 5.5 10.8 1.9 10.9 11.8 10.2 4.0 12.6 16.1 12.4 2.6 16.1 12.8 11.9 13.4 15.4 16.0 16.3 12.2 13.8 19.9 13.3 9.5 12.5 5.8 9.3 10.1 11.3 10.5 10.7 10.5 11.5 8.1 11.8 9.9 8.7 11.5 10.4 11.9 12.6 11.9 15.0 15.9 4.2 3.3 6.4 2.0 5.1 24.1 30.7 7.0 2.0 20.2 5.0 9.2 2.4 7.7 8.4 0.0 15.5 11.9 8.0 7.2 15.0 6.7 18.3 3.2 8.6 20.3 25.2 2.6 10.6 17.8 13.5 3.6 8.6 26.3 10.6 3.5 28.3 18.9 5.0 0.0 5.1 2.6 9.3 4.5 11.8 20.0 6.0 4.4 HRH1 ENSG00000196639 "Histamine receptor H1" P35367 3 11137093-11263557 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal keratinocytes: 41.0;Club cells: 30.7;Enterocytes: 29.3;Suprabasal keratinocytes: 36.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "T-reg: 3.5" "Group enriched" "Detected in many" 7 "granulocytes: 1.2;T-cells: 3.5" "Cell line enhanced" "Detected in many" "ASC TERT1: 17.5;hTEC/SVTERT24-B: 17.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029740 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA029740: AB_10601578" "unprognostic (4.60e-3)" "unprognostic (3.41e-2)" "unprognostic (6.37e-3)" "unprognostic (9.55e-2)" "unprognostic (3.32e-2)" "unprognostic (1.07e-2)" "unprognostic (9.60e-3)" "unprognostic (4.00e-3)" "unprognostic (7.54e-2)" "unprognostic (4.98e-2)" "prognostic unfavorable (1.27e-5)" "unprognostic (1.43e-1)" "unprognostic (1.70e-2)" "unprognostic (1.66e-1)" "unprognostic (3.13e-2)" "unprognostic (7.19e-2)" "unprognostic (1.20e-1)" 9.1 4.4 7.3 4.6 4.4 0.2 9.6 0.5 10.6 8.0 13.5 1.3 2.4 3.8 6.2 7.2 5.7 10.6 9.9 7.0 5.1 4.0 3.3 1.1 8.2 1.8 2.2 2.1 8.7 2.1 1.7 1.2 5.5 3.2 7.2 7.2 2.0 3.4 6.1 3.0 8.0 10.5 9.2 8.6 1.4 3.3 2.4 2.0 0.1 2.5 7.2 3.1 11.2 16.2 0.1 0.3 1.2 0.2 0.1 3.5 0.1 1.5 3.5 0.0 0.0 1.6 17.5 2.4 2.6 8.8 7.8 5.3 0.6 12.6 0.0 7.8 6.1 8.0 9.9 0.0 3.6 10.7 5.5 0.0 0.8 5.7 0.0 5.3 2.4 1.4 6.1 2.2 17.7 6.2 10.9 10.9 0.1 0.0 0.0 3.5 0.0 0.0 1.1 0.0 1.5 3.2 0.2 0.9 0.3 14.0 2.0 0.1 0.0 3.7 2.7 0.0 0.1 0.0 2.0 16.2 8.8 5.5 9.0 13.1 0.0 0.9 0.0 13.5 2.2 7.6 0.4 0.2 0.0 0.1 0.2 0.0 0.0 1.3 0.5 0.3 0.1 0.1 0.1 1.2 0.1 0.0 0.1 3.5 0.1 7.3 4.4 0.5 8.4 5.1 4.0 2.2 2.1 3.2 2.0 6.0 1.4 0.0 7.7 41.0 0.0 0.4 0.0 2.7 30.7 1.8 0.0 0.2 0.0 0.4 0.3 9.3 29.3 0.0 0.6 1.0 6.7 3.9 2.3 0.0 21.0 0.0 3.4 0.6 6.9 0.0 3.4 5.7 0.0 0.0 8.0 0.0 8.3 11.4 0.0 0.3 0.1 0.0 2.3 2.3 2.8 36.3 0.5 0.0 8.8 18.2 HSPB1 "CMT2F, Hs.76067, Hsp25, HSP27, HSP28" ENSG00000106211 "Heat shock protein family B (small) member 1" P04792 7 76302544-76304295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Stress response" Chaperone "Cancer-related genes, Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "vagina: 565.5" "Group enriched" "Detected in many" 4 "Basal glandular cells: 13325.7;Exocrine glandular cells: 5786.9;Urothelial cells: 14386.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "hTCEpi: 165.4;MCF7: 232.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000497, CAB004439, CAB047330, CAB047331, CAB047332" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 57000000 "Plasma membrane, Cytosol" "CAB004439: AB_627755, CAB047330: , CAB047331: , CAB047332: , HPA000497: AB_1851172" "unprognostic (2.55e-1)" "unprognostic (7.25e-3)" "prognostic unfavorable (9.94e-5)" "unprognostic (7.07e-3)" "unprognostic (3.47e-3)" "unprognostic (6.61e-3)" "unprognostic (4.08e-3)" "unprognostic (4.50e-2)" "unprognostic (1.27e-1)" "unprognostic (9.78e-2)" "unprognostic (8.70e-2)" "unprognostic (2.21e-1)" "unprognostic (5.72e-2)" "unprognostic (5.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.56e-1)" "unprognostic (3.63e-1)" 67.6 41.7 23.0 42.9 22.8 7.3 186.2 10.1 21.3 127.6 84.9 10.8 89.2 27.1 126.5 65.9 410.5 57.7 52.2 164.8 21.4 22.5 85.4 26.3 43.3 25.1 25.7 14.3 63.4 34.7 16.6 15.5 106.9 32.8 99.6 12.0 31.1 50.5 101.3 439.2 164.4 24.6 139.7 27.3 17.8 37.6 22.0 23.4 31.9 72.9 207.3 126.8 146.2 565.5 27.8 17.8 4.1 27.9 23.2 36.8 14.4 74.1 55.2 6.0 44.0 35.9 31.7 0.3 31.5 16.7 17.1 21.5 4.9 43.5 0.6 24.4 40.9 35.3 68.1 25.8 18.4 5.6 41.4 8.7 3.4 42.6 23.3 19.2 5.0 31.1 39.4 165.4 25.8 3.8 32.5 56.6 12.7 27.0 75.8 19.6 232.3 8.4 34.3 30.2 15.0 48.3 26.2 12.1 60.3 25.5 28.3 0.4 33.8 22.2 90.4 28.2 17.6 106.6 35.5 30.5 51.5 76.9 16.0 79.5 5.3 8.7 0.7 37.7 15.5 37.5 4.1 4.5 2.8 18.6 21.1 9.6 27.5 30.6 20.2 11.1 27.8 36.8 31.5 1.7 23.2 27.9 17.8 19.7 14.4 23.0 22.8 10.1 21.3 21.4 22.5 25.7 14.3 32.8 23.4 253.1 212.2 115.1 13325.7 1643.2 181.1 724.5 257.4 163.3 246.9 1085.2 304.3 116.8 1271.6 1614.7 8.7 728.0 540.2 0.0 5786.9 328.3 1183.3 2785.1 218.6 220.1 1062.0 66.7 404.2 589.9 103.8 18.4 277.3 433.3 1950.2 307.4 101.7 223.5 2381.8 1422.3 502.4 1699.1 24.3 601.5 2360.7 6.2 90.5 1959.6 2034.5 83.1 148.1 14386.7 HUNK ENSG00000142149 "Hormonally up-regulated Neu-associated kinase" P57058 21 31873315-32044633 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Cholangiocytes: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 10.6;BEWO: 13.0;RH-30: 14.4;SCLC-21H: 11.7;SiHa: 10.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027295, HPA027372" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA027295: AB_2672203, HPA027372: AB_2672239" "unprognostic (9.09e-3)" "unprognostic (7.29e-2)" "unprognostic (1.42e-1)" "unprognostic (5.95e-3)" "unprognostic (1.99e-1)" "unprognostic (2.12e-4)" "unprognostic (4.00e-2)" "unprognostic (6.90e-2)" "unprognostic (5.07e-1)" "unprognostic (2.27e-1)" "unprognostic (9.09e-2)" "unprognostic (1.13e-1)" "prognostic favorable (7.48e-5)" "unprognostic (8.84e-2)" "unprognostic (2.22e-1)" "unprognostic (1.39e-1)" "unprognostic (6.69e-2)" 1.7 1.9 2.7 2.9 3.5 0.5 2.1 3.2 6.4 1.1 5.9 0.2 12.6 2.4 9.0 3.4 1.1 3.3 1.0 1.7 3.7 3.2 6.0 1.3 1.7 0.7 1.2 2.1 1.8 15.7 0.2 4.7 7.6 1.4 4.0 6.5 9.1 1.5 11.1 0.6 5.0 4.4 4.1 0.9 0.4 2.1 1.8 0.2 0.4 1.1 2.2 1.0 3.8 7.7 1.0 0.7 1.7 0.5 0.5 0.5 0.1 0.0 3.0 10.6 0.1 0.0 0.0 13.0 1.0 0.0 0.2 0.0 4.2 0.1 0.0 0.4 4.9 0.2 0.1 6.2 0.0 0.0 0.0 3.2 0.0 2.8 2.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.9 0.2 0.9 8.0 0.0 0.1 0.1 14.4 0.0 1.1 0.0 11.7 7.8 10.3 0.8 0.4 7.7 4.3 1.1 0.0 0.0 7.5 0.0 0.0 0.1 0.0 1.4 0.0 0.0 5.0 0.8 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.3 0.2 1.0 0.5 0.5 1.7 0.5 0.3 0.7 0.4 0.1 2.7 3.5 3.2 6.4 3.7 3.2 1.2 2.1 1.4 0.2 6.0 7.8 0.0 1.8 4.5 4.3 3.2 17.8 1.4 4.5 7.0 2.0 8.1 0.0 3.8 0.0 0.9 2.7 0.0 2.9 11.6 10.6 1.6 0.0 0.9 2.3 3.2 4.7 0.0 0.0 0.0 0.3 0.0 3.3 0.0 3.9 11.4 2.6 2.9 0.0 1.5 1.2 0.0 1.4 0.9 0.7 5.1 5.1 0.0 9.0 0.8 HYDIN "CILD5, DKFZp434D0513, KIAA1864, PPP1R31" ENSG00000157423 "HYDIN, axonemal central pair apparatus protein" Q4G0P3 16 70807378-71230722 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5;pituitary gland: 23.6;testis: 19.1" "Cell type enhanced" "Detected in many" 22 "Ciliated cells: 180.7;Cone photoreceptor cells: 49.1" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "GAMG: 3.5;RPTEC TERT1: 5.3;SiHa: 11.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA067155, HPA074129" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA067155: AB_2685792, HPA074129: AB_2686665" "unprognostic (8.90e-2)" "unprognostic (1.04e-2)" "unprognostic (8.65e-2)" "unprognostic (4.88e-4)" "unprognostic (4.25e-3)" "unprognostic (1.81e-1)" "unprognostic (3.87e-2)" "unprognostic (2.45e-1)" "unprognostic (3.95e-1)" "unprognostic (3.42e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (2.52e-5)" "unprognostic (2.13e-3)" "unprognostic (1.02e-2)" "unprognostic (1.42e-1)" "unprognostic (3.97e-2)" 0.8 0.9 6.3 1.2 13.9 1.7 1.5 2.9 4.2 2.1 1.2 13.3 4.4 1.0 2.4 18.4 0.9 14.5 1.9 1.0 6.9 4.3 3.5 1.8 7.1 1.1 2.3 4.1 7.2 1.6 9.0 23.6 0.7 21.5 1.4 0.8 3.9 0.9 1.5 0.8 1.7 1.1 1.0 3.1 1.5 1.1 19.1 3.8 0.0 3.2 0.0 0.6 1.2 0.8 0.9 1.1 3.7 1.3 0.7 1.2 0.2 0.1 0.1 2.1 0.2 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.9 0.3 0.2 0.4 0.3 3.5 0.7 0.3 0.2 1.6 0.4 0.5 0.1 0.1 0.2 0.4 0.5 0.2 0.4 0.5 0.0 0.0 0.8 0.0 2.2 0.4 0.1 0.1 0.0 0.7 0.8 1.3 0.1 0.7 0.3 0.2 0.8 5.3 0.7 2.5 0.5 11.0 0.3 0.4 0.4 0.7 0.0 0.3 0.3 0.8 0.1 0.3 1.8 0.1 1.0 0.9 0.2 0.6 1.5 1.0 0.8 1.2 0.9 1.2 0.6 1.0 1.1 0.3 0.9 0.9 0.8 3.7 0.7 1.3 1.1 0.6 0.2 6.3 13.9 2.9 4.2 6.9 4.3 2.3 4.1 21.5 3.8 3.0 1.6 0.0 0.2 0.0 13.2 2.0 0.0 180.7 29.6 8.7 49.1 0.0 1.7 1.7 26.1 0.1 0.0 0.0 0.5 0.0 0.9 0.8 0.0 0.0 0.1 0.0 3.4 0.0 0.0 21.2 2.3 0.0 3.3 0.0 0.0 12.9 0.5 0.0 4.2 1.4 26.6 0.0 0.7 17.1 6.1 0.0 0.0 0.0 0.0 0.1 HYLS1 FLJ32915 ENSG00000198331 "HYLS1, centriolar and ciliogenesis associated" Q96M11 11 125883614-125900648 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 28.6" "Cell type enhanced" "Detected in many" 10 "Early spermatids: 72.7;Late spermatids: 40.2;Spermatocytes: 98.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041210 Enhanced Supported "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA041210: AB_10794987" "unprognostic (2.46e-1)" "unprognostic (1.60e-1)" "unprognostic (1.49e-1)" "unprognostic (2.35e-1)" "unprognostic (3.53e-3)" "unprognostic (1.17e-2)" "prognostic unfavorable (1.92e-4)" "unprognostic (3.28e-1)" "unprognostic (1.04e-3)" "unprognostic (6.56e-3)" "unprognostic (7.63e-2)" "unprognostic (4.81e-3)" "unprognostic (3.00e-2)" "unprognostic (2.19e-1)" "unprognostic (2.49e-1)" "unprognostic (1.03e-1)" "unprognostic (4.56e-2)" 4.3 4.3 6.5 3.6 8.8 2.8 5.2 12.3 11.6 5.9 5.5 2.7 6.0 7.0 5.3 8.3 5.7 5.0 3.2 5.7 6.7 7.2 8.7 7.2 3.1 6.7 5.0 8.6 5.0 3.4 3.4 5.5 5.1 7.6 6.2 6.0 2.2 3.9 7.6 3.7 5.7 6.7 7.1 3.5 5.6 6.2 28.6 4.3 7.6 5.1 4.6 9.6 5.0 3.8 11.8 14.3 3.2 6.0 4.6 10.3 4.7 4.6 10.2 3.7 2.7 7.4 5.0 6.5 11.8 4.7 11.1 7.5 0.1 7.7 2.0 5.0 10.3 3.7 7.0 5.3 4.1 12.9 11.4 3.7 1.5 1.1 2.1 5.5 5.2 7.9 3.2 4.8 11.0 12.5 2.4 8.0 4.6 2.6 12.7 14.5 7.9 3.8 15.7 8.3 19.6 17.3 8.0 0.0 6.8 11.9 7.8 5.3 3.3 12.5 9.7 4.7 5.0 23.9 11.6 7.2 0.8 9.7 8.8 2.0 4.7 4.6 4.9 2.3 11.5 9.7 3.2 5.5 1.1 8.1 6.0 7.6 11.5 10.2 9.4 6.7 11.8 10.3 7.4 0.9 4.6 4.2 14.3 10.3 4.7 6.5 8.8 12.3 11.6 6.7 7.2 5.0 8.6 7.6 4.3 0.0 0.3 8.0 2.4 3.8 7.9 4.0 2.5 4.0 0.0 1.8 3.9 12.5 10.0 3.9 72.7 3.5 3.3 23.3 3.6 10.5 5.1 2.6 0.0 5.5 6.3 0.0 4.7 4.3 1.9 40.2 7.8 2.2 6.8 14.4 2.1 4.4 3.9 6.0 5.6 10.2 5.6 6.5 5.0 98.2 33.7 3.8 3.7 6.4 5.0 1.4 ICAM1 "BB2, CD54" ENSG00000090339 "Intercellular adhesion molecule 1" P05362 19 10270835-10286615 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 68.3;lung: 91.3" "Cell type enhanced" "Detected in many" 9 "Alveolar cells type 1: 568.7;Alveolar cells type 2: 522.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 31.6;Karpas-707: 90.1;RPMI-8226: 28.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA002126, CAB002142, HPA004877" Enhanced Approved "Plasma membrane,Cytosol" NA NA 87900000 3100000000 "Plasma membrane, Cytosol" "CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317" "prognostic favorable (7.09e-4)" "unprognostic (1.88e-1)" "unprognostic (1.94e-1)" "unprognostic (2.63e-2)" "unprognostic (3.25e-3)" "unprognostic (3.05e-1)" "unprognostic (1.45e-2)" "unprognostic (3.48e-1)" "unprognostic (3.18e-2)" "unprognostic (1.09e-2)" "unprognostic (1.49e-2)" "unprognostic (1.79e-1)" "prognostic unfavorable (1.32e-6)" "unprognostic (2.77e-1)" "unprognostic (2.16e-2)" "unprognostic (2.25e-1)" "unprognostic (3.70e-3)" 26.1 8.6 4.0 41.0 4.1 36.5 15.0 1.0 4.5 5.6 10.0 2.7 1.6 6.1 8.5 7.7 7.9 10.7 19.8 16.3 2.6 2.1 10.9 68.3 91.3 32.8 5.4 1.7 12.4 7.2 2.5 4.0 9.3 6.8 10.4 6.6 10.6 7.2 3.6 13.9 6.9 7.9 8.0 7.8 42.2 7.3 6.5 3.6 8.3 11.6 13.7 13.4 14.8 17.1 2.2 13.3 22.2 14.2 7.9 5.6 8.9 8.4 0.1 1.5 0.0 0.4 0.9 2.1 1.7 18.8 4.2 12.7 2.8 9.5 7.7 26.2 0.7 19.3 1.7 0.3 0.0 8.9 23.1 0.0 0.7 0.2 11.5 31.6 0.2 4.5 11.1 0.7 2.6 4.1 0.4 2.1 0.9 2.9 90.1 0.3 0.6 0.1 6.5 0.5 0.1 4.8 0.2 0.0 28.6 7.2 0.0 0.0 0.2 11.6 0.6 18.4 0.7 1.4 0.5 6.5 4.3 0.4 2.4 0.1 27.5 28.3 4.8 7.0 4.9 6.3 2.2 13.9 2.6 3.0 14.2 5.6 2.2 2.4 3.6 13.3 0.9 1.0 2.2 22.2 7.9 7.9 7.5 3.4 8.9 4.0 4.1 1.0 4.5 2.6 2.1 5.4 1.7 6.8 3.6 568.7 522.3 12.0 22.9 75.8 0.0 0.8 20.4 80.3 159.3 3.5 0.0 1.0 0.0 152.6 1.9 139.3 0.5 0.0 84.4 2.5 171.6 19.1 133.1 12.9 75.0 0.0 2.4 56.4 41.3 1.1 4.4 160.6 72.6 168.7 0.3 2.3 107.4 0.0 1.4 9.4 0.3 6.5 95.4 0.5 1.7 60.6 1.0 12.7 0.5 10.0 ICAM2 CD102 ENSG00000108622 "Intercellular adhesion molecule 2" P13598 17 64002594-64020634 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 74.5;lymphoid tissue: 63.9" "Cell type enhanced" "Detected in many" 13 "B-cells: 46.1;Endothelial cells: 80.1;Ito cells: 147.3;Kupffer cells: 54.5;T-cells: 52.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in many" 6 "HUVEC TERT2: 167.1;TIME: 42.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA071155 Approved "Plasma membrane,Cytosol" NA NA 1200000000 "Plasma membrane" Cytosol "HPA071155: " "unprognostic (9.43e-3)" "unprognostic (3.31e-2)" "unprognostic (5.15e-2)" "unprognostic (1.15e-1)" "unprognostic (8.97e-2)" "unprognostic (1.64e-3)" "unprognostic (1.34e-1)" "unprognostic (3.74e-1)" "unprognostic (8.28e-2)" "unprognostic (2.15e-1)" "unprognostic (4.18e-2)" "unprognostic (1.55e-2)" "unprognostic (9.07e-2)" "unprognostic (1.48e-1)" "unprognostic (3.93e-2)" "unprognostic (6.04e-2)" "unprognostic (2.29e-1)" 36.0 3.6 8.4 13.0 11.5 8.3 34.1 3.5 7.7 9.4 9.7 5.6 2.8 6.4 9.8 5.2 9.5 7.4 8.8 22.8 9.5 8.9 10.5 8.7 27.9 24.0 12.3 3.1 6.3 7.4 3.1 4.5 36.8 9.1 7.9 8.5 8.1 8.8 4.3 17.1 5.5 10.8 13.9 10.5 63.9 8.0 4.0 7.4 14.3 11.6 9.0 18.0 12.8 23.6 49.0 30.9 56.5 74.5 26.0 65.3 67.5 0.0 0.0 0.0 0.0 1.4 1.5 0.4 0.1 0.1 0.0 0.1 0.3 6.9 11.7 2.1 0.0 0.0 0.0 0.1 0.0 0.2 2.6 0.0 10.5 0.6 1.2 0.2 1.7 0.0 0.0 0.0 0.1 0.0 0.0 167.1 9.9 8.6 6.9 0.0 0.0 13.1 1.5 0.0 0.0 0.0 7.9 0.0 16.3 0.8 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 42.2 0.0 0.1 0.8 0.0 6.6 2.2 10.5 0.0 2.2 0.0 56.5 30.0 8.9 45.8 66.5 52.8 36.5 60.1 42.8 30.9 49.0 65.3 40.7 3.6 26.0 74.5 10.0 64.5 67.5 8.4 11.5 3.5 7.7 9.5 8.9 12.3 3.1 9.1 7.4 0.0 12.5 46.1 3.4 6.5 0.0 0.3 0.0 6.7 6.8 7.0 0.0 0.4 0.0 0.8 0.5 80.1 0.3 0.0 1.2 0.3 6.9 1.6 11.5 1.0 18.7 0.0 1.2 147.3 54.5 0.0 0.3 23.4 27.0 6.4 1.4 0.4 5.1 5.8 1.8 0.5 0.3 6.5 4.4 0.2 0.2 4.6 0.8 52.4 1.7 2.6 ICOS "AILIM, CD278" ENSG00000163600 "Inducible T cell costimulator" Q9Y6W8 2 203936748-203961577 "CD markers, Disease related genes, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 18.4;bone marrow: 13.8;lymphoid tissue: 51.8" "Cell type enriched" "Detected in some" 4 "T-cells: 23.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 18.4" "Lineage enriched" "Detected in single" 58 "T-cells: 18.4" "Group enriched" "Detected in some" 7 "HEL: 6.0;MOLT-4: 15.7" "Low region specificity" "Detected in single" "CAB032575, HPA034865" Approved Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "CAB032575: AB_2122593, HPA034865: " "unprognostic (2.66e-2)" "unprognostic (2.13e-3)" "unprognostic (4.19e-4)" "unprognostic (2.35e-5)" "unprognostic (1.07e-1)" "prognostic favorable (1.80e-4)" "unprognostic (9.38e-2)" "unprognostic (2.89e-2)" "unprognostic (1.49e-2)" "unprognostic (3.51e-4)" "unprognostic (7.50e-2)" "unprognostic (2.12e-1)" "unprognostic (2.86e-5)" "unprognostic (7.05e-2)" "unprognostic (2.48e-2)" "unprognostic (1.93e-1)" "unprognostic (8.82e-3)" 1.5 0.3 0.2 15.6 0.2 13.8 0.7 0.2 0.2 0.8 1.2 0.0 0.2 0.5 1.2 0.5 1.1 1.2 1.6 0.5 0.2 0.2 1.0 0.8 4.0 19.4 0.3 0.0 0.6 0.3 0.0 0.4 0.1 0.1 0.7 1.1 0.7 2.9 0.0 0.2 0.6 6.2 0.3 0.4 6.1 1.0 0.6 0.0 51.8 1.4 2.4 28.9 3.0 0.9 0.0 0.0 0.0 0.0 0.3 18.4 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 2.9 0.0 10.5 4.6 0.0 0.0 11.0 5.0 0.0 0.3 0.0 0.0 18.4 3.0 0.2 0.2 0.2 0.2 0.2 0.2 0.3 0.0 0.1 0.0 0.0 2.2 0.0 0.0 2.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 5.8 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.6 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 1.6 0.1 23.5 0.0 0.0 ICOSLG "B7-H2, B7H2, B7RP-1, B7RP1, CD275, GL50, ICOS-L, ICOSL, KIAA0653" ENSG00000160223 "Inducible T cell costimulator ligand" O75144 21 44217014-44240966 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, B-cell activation, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 14.1" "Cell type enhanced" "Detected in many" 9 "B-cells: 17.5;monocytes: 34.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Daudi: 14.1" "CAB026037, HPA029179" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA 150000000 "Plasma membrane, Cytoplasmic bodies" "CAB026037: , HPA029179: AB_2732445" "unprognostic (3.03e-2)" "unprognostic (1.40e-4)" "unprognostic (3.52e-2)" "unprognostic (1.94e-2)" "unprognostic (6.74e-2)" "unprognostic (9.40e-2)" "unprognostic (6.94e-2)" "unprognostic (3.71e-1)" "unprognostic (1.40e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (2.42e-1)" "unprognostic (3.00e-2)" "unprognostic (3.11e-1)" "unprognostic (1.36e-1)" "unprognostic (1.47e-1)" "unprognostic (1.84e-1)" 2.3 3.0 5.3 3.9 7.1 14.1 2.3 2.3 5.9 2.9 2.3 2.3 2.3 1.8 2.3 2.3 4.0 2.7 3.5 3.7 8.8 3.7 5.3 2.7 2.3 6.5 6.5 2.3 2.3 2.3 0.0 2.3 2.3 2.3 2.3 1.2 2.3 2.3 2.3 2.3 5.5 2.9 2.3 8.4 3.2 4.2 2.3 2.3 2.3 2.3 2.3 4.5 2.4 2.6 6.5 1.6 1.0 0.8 0.5 1.1 0.4 0.3 3.3 0.1 2.8 0.8 1.1 7.7 0.7 0.7 0.4 0.2 5.6 0.4 14.1 2.1 0.3 1.3 4.3 2.0 1.3 0.2 1.4 1.4 0.4 2.7 1.6 0.7 6.1 10.4 1.1 1.9 0.9 0.9 0.2 0.8 0.5 2.3 1.3 0.2 3.7 0.3 8.0 2.0 9.5 3.5 12.0 0.9 8.2 0.6 7.5 1.4 0.0 9.4 13.3 0.3 1.1 3.9 8.7 0.8 0.4 3.3 0.3 0.2 12.1 8.3 11.8 4.4 5.7 1.9 0.6 0.8 0.4 0.3 0.8 0.3 3.7 0.8 0.5 0.5 6.5 0.8 1.1 1.0 0.5 0.5 1.6 0.4 0.4 5.3 7.1 2.3 2.3 8.8 3.7 6.5 2.3 2.3 2.3 0.0 1.0 17.5 5.3 6.6 0.4 0.3 0.0 0.0 1.2 8.7 0.0 0.3 0.0 1.3 0.7 3.1 4.2 0.0 0.6 0.9 4.8 11.7 0.0 1.9 3.4 0.0 5.1 1.3 6.7 2.7 2.8 10.5 8.5 34.3 4.4 1.3 0.7 1.4 10.3 3.6 0.8 0.0 8.1 0.0 0.2 5.6 0.5 0.0 3.9 5.9 IFFO2 ENSG00000169991 "Intermediate filament family orphan 2" Q5TF58 1 18904281-18956686 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skin 1: 76.8" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 68.5;Basal keratinocytes: 107.4;Suprabasal keratinocytes: 87.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 11 "basophil: 10.6" "Lineage enriched" "Detected in many" 11 "granulocytes: 10.6" "Cell line enhanced" "Detected in many" "HDLM-2: 50.5" "HPA015987, HPA064603" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015987: AB_2121678, HPA064603: AB_2685296" "unprognostic (1.43e-1)" "unprognostic (1.06e-2)" "unprognostic (2.81e-2)" "unprognostic (1.18e-1)" "unprognostic (1.39e-1)" "unprognostic (2.08e-2)" "unprognostic (2.03e-2)" "unprognostic (1.78e-1)" "unprognostic (4.34e-2)" "unprognostic (2.27e-3)" "unprognostic (3.24e-3)" "unprognostic (7.42e-2)" "unprognostic (3.24e-2)" "unprognostic (5.24e-3)" "unprognostic (2.72e-1)" "unprognostic (4.71e-1)" "unprognostic (1.36e-1)" 3.5 5.1 3.8 5.0 7.8 5.7 8.9 22.3 6.4 6.7 4.6 6.2 4.9 1.4 4.7 2.2 28.7 3.6 4.8 2.7 4.4 4.0 4.9 8.9 5.0 5.3 6.8 3.6 2.4 14.5 13.0 4.0 4.7 9.3 6.6 2.0 3.4 7.9 6.5 4.3 76.8 2.5 13.5 8.9 3.9 2.9 1.4 4.6 3.2 4.3 33.2 11.3 6.3 8.8 0.8 0.6 10.6 0.3 0.3 1.0 0.1 8.4 13.8 3.7 10.3 2.4 1.9 6.0 6.4 4.2 3.5 2.4 18.9 9.9 0.1 8.2 4.8 4.0 21.2 2.8 13.5 2.8 50.5 2.5 0.1 2.6 7.4 1.7 1.4 16.2 1.2 13.8 4.7 6.0 5.8 7.4 0.4 0.6 1.7 2.3 1.7 1.4 1.3 1.6 8.7 3.3 4.7 2.3 3.6 2.0 5.4 11.9 0.6 4.8 6.8 4.7 4.0 1.8 0.7 20.2 4.7 6.6 2.7 18.3 3.6 3.9 0.2 3.2 2.1 5.5 10.6 0.3 0.0 0.6 0.3 0.8 0.8 0.5 0.7 0.1 0.3 0.5 1.0 0.1 0.3 0.0 0.6 0.5 0.1 3.8 7.8 22.3 6.4 4.4 4.0 6.8 3.6 9.3 4.6 3.0 4.8 0.9 68.5 107.4 5.7 5.5 15.3 12.0 4.5 1.8 0.0 4.1 1.7 12.7 1.2 7.1 1.0 0.0 15.2 5.8 3.6 12.6 3.5 3.9 2.0 23.8 2.4 6.2 0.8 2.2 1.1 4.0 13.5 2.8 0.6 5.1 13.4 2.9 2.8 8.1 1.6 0.0 8.5 0.7 0.5 87.7 3.3 2.9 1.0 39.7 IFRD1 "PC4, TIS7" ENSG00000006652 "Interferon related developmental regulator 1" O00458 7 112422968-112481017 "Predicted intracellular proteins, Predicted membrane proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 93.0" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 6 "eosinophil: 25.6;neutrophil: 44.2" "Lineage enriched" "Detected in all" 12 "granulocytes: 44.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024122, HPA072413" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA024122: AB_1851452, HPA072413: " "unprognostic (2.29e-1)" "unprognostic (3.47e-1)" "unprognostic (1.10e-1)" "unprognostic (9.82e-3)" "unprognostic (1.36e-2)" "unprognostic (2.39e-1)" "unprognostic (5.73e-3)" "unprognostic (1.37e-1)" "unprognostic (2.48e-2)" "prognostic favorable (5.45e-4)" "unprognostic (6.41e-2)" "unprognostic (2.93e-3)" "unprognostic (1.50e-3)" "unprognostic (4.81e-2)" "unprognostic (1.98e-1)" "unprognostic (2.89e-1)" "unprognostic (4.70e-2)" 19.5 18.0 16.7 12.9 19.6 83.1 24.0 14.3 15.7 10.7 18.3 15.6 11.7 18.7 15.7 12.5 12.7 11.4 12.7 16.0 15.2 13.3 11.9 14.1 19.2 7.9 30.9 13.2 16.9 93.0 12.5 23.1 18.7 16.9 14.7 11.7 11.2 14.3 11.0 37.6 12.3 19.0 23.9 28.2 11.7 17.7 17.9 22.0 7.5 16.5 13.5 7.4 14.7 37.5 3.8 2.9 44.2 3.2 3.4 3.7 2.6 15.0 10.1 15.7 14.8 26.9 17.5 14.6 14.9 14.3 19.3 17.4 16.7 12.7 7.3 28.5 7.7 38.4 9.0 10.9 12.6 26.4 12.4 15.5 8.2 18.8 16.0 30.8 11.1 6.5 13.3 27.0 20.4 23.4 15.5 8.0 12.6 25.0 16.5 7.8 13.6 14.1 18.7 35.8 14.0 17.8 12.3 6.3 13.6 5.8 4.2 25.3 13.1 17.0 14.5 48.1 29.7 5.6 12.0 6.9 32.9 7.0 25.6 44.9 14.8 17.5 20.0 8.9 30.9 37.6 5.7 3.2 25.6 3.6 2.8 2.8 3.8 3.5 3.4 2.9 3.0 3.4 3.3 44.2 3.4 2.8 2.1 3.7 2.6 16.7 19.6 14.3 15.7 15.2 13.3 30.9 13.2 16.9 22.0 29.8 31.8 25.5 140.2 175.3 48.0 49.5 22.9 13.4 33.0 17.4 84.4 63.5 14.9 41.7 32.2 54.5 231.2 23.3 49.6 52.8 71.4 123.0 75.8 18.7 104.1 20.6 132.5 47.9 76.5 7.5 33.9 78.9 97.8 73.1 82.8 22.6 50.8 210.5 38.5 11.0 72.9 38.8 197.8 13.7 11.5 110.2 126.9 55.4 87.9 126.0 IGFL2 UNQ645 ENSG00000204866 "IGF like family member 2" Q6UWQ7 19 46143106-46161299 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "skin 1: 26.8;tongue: 24.8" "Cell type enhanced" "Detected in some" 8 "Early spermatids: 5.9;Late spermatids: 3.9;Spermatocytes: 8.0;Spermatogonia: 7.0;Suprabasal keratinocytes: 4.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 24 "memory CD4 T-cell: 2.4" "Lineage enriched" "Detected in single" 24 "T-cells: 2.4" "Group enriched" "Detected in some" 64 "CACO-2: 28.9;OE19: 58.1" HPA059137 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in other tissues" NA NA Nucleoplasm "Plasma membrane" "HPA059137: AB_2683920" "unprognostic (1.53e-1)" "unprognostic (7.87e-2)" "unprognostic (1.64e-1)" "unprognostic (1.69e-2)" "unprognostic (7.30e-2)" "unprognostic (9.74e-2)" "unprognostic (1.92e-1)" "unprognostic (1.81e-1)" "unprognostic (1.84e-1)" "unprognostic (1.68e-1)" "unprognostic (4.26e-3)" "unprognostic (9.63e-3)" "unprognostic (4.14e-9)" "unprognostic (1.27e-1)" "unprognostic (2.76e-2)" "unprognostic (8.73e-2)" "unprognostic (9.91e-3)" 1.5 0.0 0.4 0.1 0.1 0.0 1.8 0.1 0.4 0.3 0.3 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.1 1.1 0.1 0.1 0.1 0.1 0.8 1.2 0.4 0.1 0.1 0.1 3.4 0.1 1.6 0.9 0.1 0.7 0.1 0.5 0.1 0.1 26.8 0.1 0.1 0.3 0.1 0.0 2.4 0.1 0.4 0.1 24.8 0.1 0.1 0.4 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 28.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 58.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.1 0.4 0.1 0.9 0.1 0.0 0.0 0.0 0.0 1.9 1.9 0.4 0.0 0.0 1.2 0.0 0.0 3.2 0.0 0.0 5.9 0.0 0.5 0.0 0.2 0.1 1.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 1.7 0.0 0.2 0.4 0.0 0.0 0.0 0.0 1.9 0.0 0.4 8.0 7.0 4.1 2.2 0.0 1.3 0.0 IL10RA "CD210, CD210a, CDW210A, HIL-10R, IL10R" ENSG00000110324 "Interleukin 10 receptor subunit alpha" Q13651 11 117986348-118003037 "CD markers, Disease related genes, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 56.2" "Cell type enhanced" "Detected in many" 11 "Extravillous trophoblasts: 88.9;Kupffer cells: 162.4;Macrophages: 88.5;monocytes: 146.1;T-cells: 102.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 14.9;HDLM-2: 37.1;Karpas-707: 13.9;RPMI-8226: 16.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA065647, HPA069086" Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA065647: , HPA069086: " "unprognostic (1.01e-2)" "unprognostic (2.07e-3)" "unprognostic (1.58e-2)" "unprognostic (7.08e-2)" "unprognostic (8.27e-2)" "prognostic favorable (4.47e-4)" "unprognostic (5.27e-2)" "unprognostic (4.84e-2)" "unprognostic (7.70e-3)" "unprognostic (5.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.83e-1)" "prognostic unfavorable (1.45e-5)" "unprognostic (1.82e-1)" "unprognostic (8.43e-3)" "unprognostic (2.19e-1)" "unprognostic (1.27e-1)" 11.3 6.5 2.9 29.6 3.5 27.2 7.2 1.1 3.0 3.4 7.9 4.7 0.5 3.8 5.5 11.0 4.3 4.9 9.7 7.6 3.0 3.6 5.0 6.4 13.6 49.8 4.7 1.4 3.4 3.6 1.3 3.4 6.9 4.5 5.8 7.5 6.4 7.9 1.9 2.6 3.0 17.6 5.0 8.0 56.2 4.9 3.1 3.5 9.6 3.6 3.9 32.2 9.5 3.4 4.6 15.4 1.2 23.9 23.7 30.7 22.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.9 0.1 0.0 0.3 0.0 0.2 0.0 0.0 37.1 0.0 0.1 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.7 13.9 0.0 0.0 0.2 2.9 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.0 2.9 0.4 3.9 0.0 5.6 0.0 1.1 15.8 0.8 19.7 23.9 14.2 4.6 19.0 22.7 15.4 2.3 6.9 12.3 1.2 23.7 18.8 6.0 30.7 22.8 2.9 3.5 1.1 3.0 3.0 3.6 4.7 1.4 4.5 3.5 6.0 26.0 27.4 0.5 5.0 0.0 2.0 0.0 2.7 2.3 0.0 0.0 1.2 0.0 0.1 0.0 1.2 0.0 0.0 0.7 88.9 2.8 0.0 11.6 0.5 54.1 0.0 0.0 4.3 162.4 0.0 0.3 88.5 16.9 146.1 0.0 0.5 0.1 0.0 0.0 0.6 0.0 0.0 1.0 0.1 0.2 3.6 2.7 102.0 0.0 0.4 IL13 "ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600" ENSG00000169194 "Interleukin 13" P35225 5 132656263-132661110 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins" Cytokine "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 20.7" "Group enriched" "Detected in some" 7 "Early spermatids: 74.4;Late spermatids: 141.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 177 "HDLM-2: 30.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA042421 Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 40000 "Plasma membrane, Cytosol" "HPA042421: AB_10795504" "unprognostic (2.17e-1)" "unprognostic (2.29e-2)" "unprognostic (7.48e-2)" "unprognostic (2.18e-2)" "unprognostic (1.92e-1)" "unprognostic (5.21e-3)" "unprognostic (1.79e-1)" "unprognostic (2.69e-1)" "unprognostic (5.20e-1)" "unprognostic (7.10e-2)" "unprognostic (3.61e-3)" "unprognostic (3.34e-1)" "unprognostic (5.97e-4)" "unprognostic (4.70e-2)" "unprognostic (2.05e-1)" "unprognostic (7.39e-2)" "unprognostic (1.38e-1)" 0.3 0.0 0.1 0.8 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.6 0.1 3.0 0.0 0.0 0.1 0.0 0.0 1.8 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 3.1 0.2 0.2 0.6 0.0 0.0 0.0 0.0 20.7 0.0 2.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.8 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 74.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 16.3 0.0 0.0 0.0 0.0 0.0 0.0 141.6 2.6 0.3 1.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 2.2 1.2 0.5 0.0 0.0 0.0 0.0 IL21R CD360 ENSG00000103522 "Interleukin 21 receptor" Q9HBE5 16 27402162-27452042 "Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 17.9;lymphoid tissue: 47.8" "Cell type enhanced" "Detected in some" 10 "B-cells: 11.8;Early spermatids: 5.2;Hofbauer cells: 7.0;T-cells: 8.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 10.3;HDLM-2: 43.9;Karpas-707: 20.4;RH-30: 15.4;RPMI-8226: 24.5;U-266/70: 10.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042296 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042296: AB_10806236" "unprognostic (2.91e-2)" "unprognostic (2.65e-3)" "unprognostic (6.64e-4)" "unprognostic (1.58e-3)" "unprognostic (2.14e-1)" "prognostic favorable (7.29e-4)" "unprognostic (8.33e-2)" "unprognostic (2.06e-1)" "unprognostic (8.50e-6)" "unprognostic (2.26e-2)" "unprognostic (1.13e-2)" "unprognostic (8.71e-2)" "unprognostic (2.34e-10)" "unprognostic (8.79e-2)" "unprognostic (4.42e-2)" "unprognostic (1.50e-1)" "unprognostic (9.58e-2)" 0.8 0.6 0.6 33.6 3.7 5.7 0.6 0.5 1.6 0.5 0.9 0.3 0.0 0.5 0.5 1.3 1.0 0.8 1.1 1.8 0.6 2.3 1.6 1.3 5.6 20.9 1.3 0.0 0.5 0.5 0.0 0.9 0.9 1.9 0.9 0.9 1.8 3.7 0.3 0.7 0.7 4.0 0.6 1.7 11.2 1.3 1.0 1.4 47.8 1.3 0.8 31.7 2.7 0.8 11.5 1.6 0.7 17.9 6.3 10.3 4.2 0.0 0.0 0.1 0.1 0.0 0.5 0.3 0.3 0.0 0.0 0.9 0.0 0.0 10.3 0.1 0.8 0.5 0.0 0.0 0.0 0.0 43.9 0.0 2.1 0.0 0.3 1.4 0.0 0.6 1.6 0.0 2.8 0.0 0.3 0.0 0.2 0.1 20.4 1.5 0.0 0.0 0.2 0.3 0.0 0.0 0.1 15.4 24.5 0.0 0.0 0.1 0.0 0.0 0.0 1.1 0.1 0.0 0.5 1.1 0.8 0.3 0.2 0.0 10.3 3.6 2.3 2.1 0.5 0.0 0.2 0.3 0.0 9.8 5.8 3.6 1.0 6.3 10.3 1.6 11.5 6.9 6.7 0.7 6.3 17.9 0.7 7.6 4.2 0.6 3.7 0.5 1.6 0.6 2.3 1.3 0.0 1.9 1.4 0.0 2.2 11.8 0.1 0.3 1.5 2.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 5.2 0.6 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 7.0 0.0 0.0 1.3 4.5 4.0 0.0 2.2 1.7 1.0 0.0 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.1 0.0 0.6 0.1 8.2 0.0 0.0 IL6ST "CD130, GP130" ENSG00000134352 "Interleukin 6 signal transducer" P40189 5 55935095-55994993 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction" Receptor "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 10 "Ito cells: 851.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 21.0" "Lineage enriched" "Detected in many" 5 "T-cells: 21.0" "Cell line enhanced" "Detected in many" "ASC TERT1: 57.7;BJ hTERT+: 58.7;HHSteC: 65.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010558, CAB025784" Approved Supported "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA 100000000 "Plasma membrane" "Golgi apparatus" "CAB025784: , HPA010558: AB_1078439" "unprognostic (1.81e-2)" "unprognostic (1.25e-1)" "unprognostic (7.61e-2)" "unprognostic (3.95e-2)" "unprognostic (8.93e-2)" "unprognostic (3.99e-2)" "unprognostic (5.18e-2)" "unprognostic (9.53e-3)" "unprognostic (1.89e-2)" "unprognostic (2.29e-1)" "unprognostic (4.78e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (5.05e-4)" "unprognostic (3.69e-2)" "unprognostic (1.06e-1)" "unprognostic (1.80e-1)" "unprognostic (1.25e-1)" 44.8 34.2 24.7 25.5 23.4 8.8 76.9 15.9 22.9 38.1 23.9 15.0 29.0 8.7 26.1 24.9 22.7 23.1 31.1 31.9 21.9 19.7 37.2 71.2 36.3 70.0 25.8 14.7 42.1 16.4 35.8 36.2 97.0 22.5 31.9 17.1 20.0 26.3 33.0 27.1 12.5 20.6 36.6 33.8 35.5 19.7 13.7 20.3 19.4 37.6 12.5 18.7 33.7 51.1 0.7 2.1 0.9 3.8 0.8 21.0 4.0 9.5 11.9 3.9 9.2 27.6 57.7 15.9 28.5 58.7 15.4 22.9 16.7 9.2 0.3 21.4 17.6 35.0 4.1 3.0 8.5 31.6 0.8 3.1 2.2 9.8 13.7 65.6 0.2 4.6 50.5 4.6 33.4 16.3 22.9 35.1 0.8 1.6 40.2 17.7 1.6 0.4 0.4 0.6 1.2 3.9 0.5 10.8 5.5 8.4 5.6 2.1 3.4 11.5 3.8 11.7 10.7 19.2 1.5 56.4 5.9 6.7 24.1 15.0 9.9 4.2 0.3 15.9 0.4 15.5 0.2 3.8 0.1 0.8 3.5 0.4 0.7 4.9 0.8 2.1 0.6 21.0 5.9 0.9 0.8 0.6 1.8 3.4 4.0 24.7 23.4 15.9 22.9 21.9 19.7 25.8 14.7 22.5 20.3 125.0 112.6 23.8 82.7 92.3 54.8 67.9 140.1 99.0 149.0 64.6 33.4 63.8 6.6 64.2 9.5 210.0 31.1 23.3 53.6 60.1 240.2 110.2 31.3 186.2 46.3 15.9 19.0 851.3 103.7 11.5 98.1 51.0 75.9 21.6 29.0 179.7 66.2 30.6 122.7 46.2 33.9 97.0 142.0 37.1 34.3 73.0 85.1 35.0 13.3 89.2 INPP5A 5PTASE ENSG00000068383 "Inositol polyphosphate-5-phosphatase A" Q14642 10 132537820-132783480 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "basophil: 8.4" "Lineage enriched" "Detected in single" 21 "granulocytes: 8.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012285 Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA012285: AB_1851802" "prognostic unfavorable (7.47e-4)" "unprognostic (2.38e-1)" "unprognostic (2.54e-1)" "unprognostic (1.68e-3)" "unprognostic (1.43e-1)" "unprognostic (3.25e-2)" "unprognostic (2.08e-1)" "unprognostic (1.16e-1)" "unprognostic (5.65e-2)" "unprognostic (4.35e-1)" "unprognostic (4.70e-2)" "unprognostic (1.70e-2)" "prognostic favorable (3.15e-4)" "unprognostic (2.14e-1)" "unprognostic (1.44e-1)" "unprognostic (8.91e-3)" "unprognostic (8.66e-2)" 13.6 11.8 10.3 11.3 49.8 5.8 10.3 40.7 20.8 17.4 24.0 10.1 11.5 12.9 25.8 13.9 20.3 15.2 13.6 48.8 9.5 8.5 9.4 7.2 13.8 6.0 9.2 10.4 13.1 11.6 8.9 9.4 19.0 9.1 17.1 11.7 17.1 8.5 16.9 43.7 11.5 14.8 27.9 10.6 8.9 14.8 14.9 16.6 4.2 9.5 12.1 7.8 19.4 22.4 0.3 0.1 8.4 0.2 0.0 0.3 0.6 18.7 7.5 12.6 12.1 19.3 13.6 10.3 19.9 15.3 13.0 8.7 17.7 7.7 1.7 7.7 21.1 8.5 10.7 13.6 8.3 15.7 5.7 7.9 2.7 9.4 24.0 14.0 6.8 6.6 9.2 8.3 8.3 15.9 10.5 9.0 3.6 3.9 10.1 6.9 15.2 1.9 21.9 5.7 11.3 13.4 4.0 8.3 3.0 10.8 10.7 3.0 10.3 9.9 14.7 12.0 12.0 9.5 16.5 7.5 8.4 9.7 11.2 11.6 2.0 9.3 5.8 8.1 4.7 3.6 8.4 0.2 1.1 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.2 0.0 0.0 1.5 0.0 0.2 0.0 0.3 0.6 10.3 49.8 40.7 20.8 9.5 8.5 9.2 10.4 9.1 16.6 8.9 22.4 1.4 3.6 4.7 10.7 9.0 5.1 2.7 9.1 7.0 0.0 3.3 0.0 5.7 9.4 6.4 18.4 0.0 7.9 3.3 6.2 6.4 8.1 16.0 2.6 7.9 5.8 19.0 6.3 11.2 6.6 3.1 1.7 0.0 9.3 7.8 9.9 11.5 11.0 3.8 4.9 6.5 20.0 5.5 6.6 5.1 2.1 1.9 10.9 5.0 INSR CD220 ENSG00000171105 "Insulin receptor" P06213 19 7112255-7294034 "CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Carbohydrate metabolism" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Diabetes mellitus, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 64.5" "Cell type enhanced" "Detected in many" 4 "Peritubular cells: 230.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 7 "dendritic cells: 8.8;granulocytes: 5.1;monocytes: 10.5" "Cell line enhanced" "Detected in many" "Karpas-707: 31.3;U-266/70: 23.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036302, HPA036303" Uncertain Approved "Vesicles,Plasma membrane" NA NA 72000 Vesicles "Plasma membrane" "HPA036302: AB_2675048, HPA036303: " "unprognostic (4.64e-2)" "unprognostic (2.42e-1)" "unprognostic (9.65e-3)" "unprognostic (9.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.15e-2)" "unprognostic (2.58e-1)" "unprognostic (5.09e-2)" "unprognostic (1.97e-1)" "unprognostic (3.05e-1)" "unprognostic (9.29e-2)" "unprognostic (1.86e-1)" "unprognostic (6.33e-2)" "unprognostic (3.45e-3)" "unprognostic (2.43e-1)" "unprognostic (2.75e-1)" "unprognostic (8.82e-2)" 13.9 14.7 7.1 3.5 8.2 4.5 12.0 12.0 8.2 10.3 15.2 11.7 10.6 8.4 15.5 6.1 4.7 13.1 7.7 17.7 6.4 5.8 18.7 32.5 5.3 2.2 10.1 4.9 28.3 64.5 11.6 11.6 26.2 8.0 10.5 8.9 11.0 12.0 10.6 15.1 7.3 16.0 10.6 6.8 47.3 8.7 6.9 9.7 2.2 17.1 5.0 3.2 11.3 16.0 1.1 8.8 5.1 10.5 0.8 0.7 1.3 3.8 2.1 2.0 3.0 10.9 3.8 6.5 2.2 2.0 1.2 1.2 5.4 4.4 4.8 5.4 3.9 2.6 1.0 4.7 1.0 0.7 0.0 3.8 0.0 1.5 11.8 4.7 2.2 3.9 5.9 2.4 0.1 2.8 2.4 2.2 2.7 5.9 31.3 0.9 1.7 1.7 3.9 1.8 2.0 3.4 16.7 1.1 4.2 0.1 15.8 3.7 2.9 3.9 2.1 2.1 3.7 1.0 11.0 2.0 2.3 1.4 4.9 2.8 23.1 12.6 11.2 2.6 3.9 0.0 2.0 8.2 5.1 0.2 7.8 0.3 0.8 0.3 0.1 8.8 1.1 0.7 0.1 1.7 0.8 10.5 7.4 0.0 1.3 7.1 8.2 12.0 8.2 6.4 5.8 10.1 4.9 8.0 9.7 44.7 26.7 8.2 54.6 57.7 38.7 85.3 107.0 41.5 50.0 59.3 74.6 15.8 13.3 41.1 2.9 52.3 87.1 0.0 68.2 39.2 29.8 84.0 3.5 214.7 8.6 36.5 157.1 201.3 47.7 3.6 89.2 26.7 49.0 8.2 103.9 26.9 67.8 56.1 230.5 116.2 22.2 58.2 42.3 6.2 1.2 60.1 32.0 6.4 56.3 113.2 IQGAP1 "HUMORFA01, KIAA0051, p195, SAR1" ENSG00000140575 "IQ motif containing GTPase activating protein 1" P46940 15 90388218-90502243 "Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013302, HPA014055" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 890000 "Plasma membrane, Cell Junctions" "CAB013302: AB_2533146, HPA014055: AB_1851856" "unprognostic (2.83e-1)" "unprognostic (7.73e-2)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (5.95e-2)" "unprognostic (4.24e-2)" "unprognostic (7.07e-2)" "unprognostic (1.17e-1)" "unprognostic (3.82e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.67e-5)" "unprognostic (2.01e-1)" "unprognostic (1.26e-1)" "unprognostic (2.02e-1)" "unprognostic (1.03e-2)" "unprognostic (1.87e-1)" "unprognostic (1.25e-3)" 46.2 23.2 9.9 27.8 17.1 23.7 31.7 5.9 11.2 41.8 26.7 18.1 19.7 12.3 50.8 28.8 41.3 27.4 22.0 17.6 12.0 9.1 25.9 9.8 38.3 45.3 17.5 6.6 31.3 16.4 27.6 19.1 53.7 15.5 28.9 27.1 12.0 37.8 22.0 23.1 32.7 25.8 37.6 17.4 48.0 20.3 11.4 15.4 39.5 32.7 29.6 34.9 43.0 40.8 5.9 9.9 39.3 12.4 11.5 9.9 6.3 31.5 17.5 8.7 10.3 22.7 29.6 51.2 30.2 28.0 27.8 30.0 20.0 33.0 17.6 14.8 50.4 24.8 57.0 17.5 33.7 33.8 22.4 12.4 11.8 33.8 7.3 27.5 21.5 25.3 17.4 31.2 32.7 46.8 34.5 38.1 11.6 10.1 24.9 42.4 16.4 11.6 6.5 11.4 51.0 10.0 14.3 23.6 15.4 28.7 50.2 11.1 8.3 42.0 21.6 22.4 38.3 18.8 18.6 48.3 31.8 16.5 26.6 31.1 9.7 13.8 17.9 28.9 21.2 17.0 10.5 11.6 8.1 9.9 10.9 8.9 5.6 6.2 8.5 9.9 5.9 3.8 6.6 39.3 11.5 12.4 6.0 6.7 6.3 9.9 17.1 5.9 11.2 12.0 9.1 17.5 6.6 15.5 15.4 247.1 255.8 85.7 86.1 91.5 2.3 11.8 40.8 176.7 226.3 73.3 15.7 77.6 6.6 78.9 6.5 111.9 155.2 23.3 85.6 126.0 70.8 89.0 199.2 6.8 130.4 1.6 58.3 93.3 343.0 9.3 44.3 168.0 67.4 158.7 118.3 14.0 97.0 121.4 45.3 15.9 25.3 77.6 70.3 11.5 32.6 99.1 80.0 132.1 104.7 126.4 IQGAP2 ENSG00000145703 "IQ motif containing GTPase activating protein 2" Q13576 5 76403249-76708132 "Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 66.1" "Cell type enhanced" "Detected in many" 16 "Early spermatids: 913.2;Late spermatids: 268.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 22.0;Hep G2: 18.2;HMC-1: 65.2;RPMI-8226: 23.8;U-937: 17.0" "Region enhanced" "Detected in many" "hippocampal formation: 34.4" "Low region specificity" "Detected in all" "CAB004241, HPA037403, HPA037404" Uncertain Approved "Vesicles,Plasma membrane" NA NA 8400000 "Vesicles, Plasma membrane" "CAB004241: AB_2125909, HPA037403: AB_2675459, HPA037404: AB_2675460" "unprognostic (9.46e-2)" "unprognostic (1.27e-1)" "unprognostic (1.35e-1)" "unprognostic (1.48e-1)" "unprognostic (9.03e-3)" "unprognostic (8.85e-2)" "prognostic favorable (5.65e-4)" "unprognostic (5.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.34e-1)" "unprognostic (2.14e-1)" "unprognostic (1.41e-1)" "prognostic favorable (9.44e-12)" "unprognostic (3.29e-2)" "unprognostic (9.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.27e-2)" 11.1 11.3 1.4 14.7 1.7 6.3 8.0 1.1 1.2 6.1 21.6 0.6 36.2 16.8 2.6 14.7 3.3 2.7 21.7 4.2 1.6 1.6 13.2 66.1 7.8 13.0 1.3 0.7 4.2 14.8 25.5 2.3 42.5 2.1 9.1 6.8 15.2 18.9 34.3 1.4 3.7 35.7 3.4 2.0 16.5 12.4 30.7 0.4 7.7 12.8 2.8 7.7 4.3 4.2 0.6 7.8 14.9 3.2 4.1 5.9 1.3 0.0 2.8 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.2 0.8 0.0 0.8 0.0 3.6 0.0 0.0 2.5 3.6 8.1 2.1 18.2 0.0 4.5 65.2 0.0 0.0 0.0 0.0 0.0 0.3 4.5 7.1 6.5 0.0 0.0 3.9 12.3 4.5 7.5 0.1 1.4 0.0 23.8 0.0 0.0 0.1 1.0 5.1 0.3 0.0 10.1 0.0 2.7 0.1 0.0 0.1 0.0 0.0 6.1 0.0 5.6 0.0 17.0 0.9 14.9 3.2 1.8 4.8 2.4 4.0 0.6 5.0 4.1 2.9 0.2 2.0 3.6 6.3 4.1 3.1 7.8 5.9 1.3 1.4 1.7 1.1 1.2 1.6 1.6 1.3 0.7 2.1 0.4 11.9 16.4 11.2 18.7 4.1 5.9 2.4 101.9 20.1 13.6 33.2 102.1 11.9 6.6 28.5 913.2 3.6 83.5 23.3 58.0 0.6 7.5 28.7 91.4 219.4 58.8 1.6 8.7 20.3 125.0 268.6 6.9 72.8 15.1 19.0 45.0 11.3 23.8 38.6 4.9 53.7 118.4 0.0 2.3 14.9 4.4 3.3 6.1 66.1 31.5 5.5 ISLR HsT17563 ENSG00000129009 "Immunoglobulin superfamily containing leucine rich repeat" O14498 15 74173671-74176872 "Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 5 "Fibroblasts: 63.6;Leydig cells: 199.0;Peritubular cells: 150.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 33.9;ASC TERT1: 18.2;fHDF/TERT166: 76.1;HSkMC: 13.8;RPMI-8226: 23.3" "Region enriched" "Detected in all" 5 "olfactory region: 145.0" "Low region specificity" "Detected in many" "HPA040326, HPA050811" Approved Approved "Golgi apparatus,Plasma membrane" "Secreted - unknown location" NA NA 110000000 "Plasma membrane" "Golgi apparatus" "HPA040326: AB_2676928, HPA050811: AB_2681243" "unprognostic (2.58e-1)" "unprognostic (1.36e-2)" "unprognostic (3.54e-2)" "unprognostic (3.06e-2)" "unprognostic (1.30e-1)" "unprognostic (1.76e-2)" "unprognostic (1.51e-1)" "unprognostic (1.21e-1)" "unprognostic (6.76e-3)" "unprognostic (1.16e-2)" "unprognostic (6.81e-2)" "unprognostic (8.93e-3)" "prognostic unfavorable (4.89e-8)" "unprognostic (1.64e-2)" "unprognostic (3.42e-2)" "unprognostic (2.28e-1)" "unprognostic (9.86e-3)" 24.6 6.8 3.3 10.4 4.6 0.1 21.4 2.0 12.1 72.8 19.7 2.9 13.2 4.1 67.3 36.3 23.0 22.1 29.6 17.7 1.7 1.7 8.0 2.5 10.2 5.8 3.3 7.2 80.2 3.4 1.2 13.8 31.5 3.9 32.2 4.0 36.4 10.0 17.9 12.5 13.6 8.8 27.5 9.0 9.8 10.3 16.3 0.6 1.3 18.9 17.0 9.9 27.9 35.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 33.9 18.2 0.1 5.2 0.0 0.0 0.0 0.0 2.1 0.0 0.3 76.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 23.3 0.0 0.0 0.2 3.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.2 4.0 0.0 0.1 0.5 0.0 0.2 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 4.6 2.0 12.1 1.7 1.7 3.3 7.2 3.9 0.6 0.0 2.2 0.0 0.1 10.4 0.0 3.1 0.0 2.7 1.2 0.0 0.0 1.1 0.0 0.2 1.7 8.7 0.0 0.0 0.2 1.6 63.6 0.1 0.0 0.0 3.5 0.0 0.0 7.4 0.0 3.2 199.0 0.8 11.8 0.0 0.0 0.1 1.3 0.0 150.3 0.0 0.3 25.8 21.7 0.9 0.5 7.8 0.8 0.0 0.0 0.2 ITGB2 "CD18, LFA-1, MAC-1, MFI7" ENSG00000160255 "Integrin subunit beta 2" P05107 21 44885953-44931989 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Phagocytosis" "Integrin, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 159.7;bone marrow: 91.4;lymphoid tissue: 75.6" "Group enriched" "Detected in many" 4 "Hofbauer cells: 620.8;Kupffer cells: 458.1;Macrophages: 428.6;T-cells: 303.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 5 "THP-1: 117.5;U-937: 87.3" "Low region specificity" "Detected in all" "HPA008877, HPA016894" Enhanced Supported "Plasma membrane,Rods & Rings" NA NA 2500000 "Plasma membrane" "Rods & Rings" "HPA008877: AB_1846256, HPA016894: AB_1846257" "unprognostic (1.94e-2)" "unprognostic (7.66e-3)" "unprognostic (1.23e-1)" "unprognostic (6.21e-3)" "unprognostic (2.95e-2)" "unprognostic (9.73e-3)" "unprognostic (2.53e-2)" "unprognostic (1.82e-1)" "unprognostic (1.18e-2)" "unprognostic (1.36e-1)" "unprognostic (1.20e-1)" "unprognostic (6.34e-2)" "unprognostic (1.87e-3)" "unprognostic (1.42e-1)" "unprognostic (4.42e-2)" "unprognostic (2.65e-2)" "unprognostic (4.83e-2)" 59.1 9.8 9.0 47.5 16.8 91.4 8.4 1.7 8.0 5.6 7.4 12.2 1.2 6.3 4.9 9.0 4.8 10.7 10.3 9.7 7.2 6.4 8.1 7.0 32.9 73.8 14.3 2.9 6.6 5.1 1.1 3.3 12.7 12.1 6.9 4.2 5.2 8.8 2.7 3.0 4.1 13.2 12.3 18.3 75.6 7.6 4.2 12.2 53.5 4.5 2.2 29.0 15.7 4.2 9.5 76.0 104.6 122.9 41.0 57.4 159.7 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 2.5 20.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.4 0.0 0.4 0.0 15.3 4.0 0.2 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.2 1.0 0.5 17.4 18.5 0.0 0.0 0.3 0.2 3.6 9.5 0.7 0.0 0.1 0.2 0.5 0.3 0.3 0.0 0.0 117.5 0.3 0.0 1.0 0.0 0.5 0.1 0.8 0.4 0.0 87.3 0.1 10.5 122.9 85.7 57.4 84.1 25.8 6.7 28.4 39.5 76.0 9.5 19.1 32.0 104.6 41.0 81.0 11.6 20.7 159.7 9.0 16.8 1.7 8.0 7.2 6.4 14.3 2.9 12.1 12.2 14.9 42.5 86.5 0.5 4.8 0.0 3.5 15.3 5.3 19.4 5.2 0.0 3.4 0.0 2.7 0.5 5.2 0.0 0.0 0.3 3.3 5.7 0.5 23.1 4.3 620.8 0.0 0.0 11.6 458.1 2.1 0.6 428.6 5.0 109.2 0.1 0.3 0.4 0.0 1.4 3.4 0.6 6.5 3.1 0.2 1.1 4.4 4.7 303.6 0.2 0.6 ITGB3 "CD61, GP3A, GPIIIa" ENSG00000259207 "Integrin subunit beta 3" P05106 17 47253846-47311816 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 36.6" "Cell type enhanced" "Detected in some" 10 "Late spermatids: 4.1;Proximal tubular cells: 3.5;Sertoli cells: 6.5" "Group enriched" "Detected in many" 6 "melanoma: 7.5;renal cancer: 3.6;thyroid cancer: 11.5" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 19 "basophil: 2.8;neutrophil: 2.8" "Lineage enriched" "Detected in single" 19 "granulocytes: 2.8" "Cell line enhanced" "Detected in many" "EFO-21: 46.6;HEL: 41.2;RPTEC TERT1: 26.8;U-87 MG: 21.1;WM-115: 67.2" HPA027852 Approved Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 710000000 "Plasma membrane" Nucleoplasm "HPA027852: AB_10601760" "unprognostic (1.13e-2)" "unprognostic (1.97e-3)" "unprognostic (2.47e-1)" "unprognostic (3.00e-2)" "unprognostic (1.91e-2)" "unprognostic (6.04e-3)" "unprognostic (3.70e-1)" "unprognostic (3.00e-1)" "unprognostic (1.44e-1)" "unprognostic (3.85e-1)" "unprognostic (6.35e-2)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.03e-2)" "unprognostic (2.72e-2)" "unprognostic (1.48e-1)" "unprognostic (1.17e-3)" 10.0 0.6 1.0 6.2 2.5 2.7 7.0 0.4 1.6 4.6 13.6 0.9 2.4 2.2 9.7 5.7 6.4 6.4 2.8 8.5 0.7 0.6 16.0 3.7 5.2 1.2 2.3 0.1 4.6 0.6 0.7 1.6 23.5 1.6 6.4 4.8 1.8 2.5 11.5 4.9 2.4 5.0 17.0 1.8 9.5 3.6 2.6 0.6 0.2 36.6 1.9 0.9 11.0 7.8 0.1 0.0 2.8 0.1 0.0 0.0 9.5 0.0 0.4 0.1 0.0 2.4 1.0 0.0 1.2 6.1 2.6 2.4 0.0 0.0 0.1 46.6 0.3 3.6 0.0 0.0 0.0 3.4 0.9 0.0 41.2 0.1 0.0 2.0 0.0 0.0 1.0 0.0 15.6 0.4 1.8 11.6 0.6 0.1 0.0 0.5 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 26.8 0.0 0.0 0.1 1.5 0.0 8.4 2.4 0.0 0.0 12.6 0.5 0.7 0.3 2.8 0.0 0.0 0.3 21.1 0.0 67.2 2.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 9.5 1.0 2.5 0.4 1.6 0.7 0.6 2.3 0.1 1.6 0.6 0.0 0.0 0.0 0.1 0.1 0.0 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 2.7 1.4 0.0 0.0 0.4 0.0 0.8 0.1 0.0 0.8 0.8 0.0 0.0 1.8 0.0 4.1 0.3 0.3 0.0 0.0 0.0 0.0 1.0 0.0 1.1 3.5 0.0 6.5 1.9 0.0 2.3 0.4 1.0 0.0 0.0 0.1 ITGB4 CD104 ENSG00000132470 "Integrin subunit beta 4" P16144 17 75721328-75757818 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Enterocytes: 84.6;Pancreatic endocrine cells: 175.0;Syncytiotrophoblasts: 92.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 120.2;HaCaT: 46.0;HBEC3-KT: 102.5;hTCEpi: 35.1;RT4: 33.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB002422, CAB005258, HPA036348, HPA036349" Enhanced Supported "Plasma membrane,Cell Junctions" NA NA 79000 "Plasma membrane, Cell Junctions" "CAB002422: AB_563480, CAB005258: AB_2129021, HPA036348: AB_2675077, HPA036349: AB_2675078" "unprognostic (3.17e-3)" "unprognostic (3.52e-1)" "unprognostic (4.19e-1)" "unprognostic (2.27e-1)" "unprognostic (5.75e-2)" "unprognostic (6.11e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.18e-4)" "unprognostic (1.05e-1)" "unprognostic (4.14e-2)" "prognostic unfavorable (6.39e-4)" "unprognostic (1.02e-1)" "unprognostic (2.23e-2)" "unprognostic (1.65e-2)" "unprognostic (1.05e-1)" "unprognostic (1.07e-1)" "unprognostic (1.43e-1)" 6.3 3.4 9.7 10.9 9.7 1.4 13.7 4.7 7.7 14.3 32.1 15.6 10.0 35.3 9.7 8.8 24.0 13.7 47.8 4.3 9.4 7.9 4.8 1.5 7.4 3.7 10.1 9.1 4.7 6.7 3.1 5.7 50.0 17.2 19.7 10.4 9.8 52.3 13.2 2.4 47.0 58.5 7.4 10.7 17.0 41.0 3.9 9.8 1.8 3.2 22.1 15.9 17.2 20.5 2.4 8.2 1.3 0.7 0.0 2.2 0.8 22.3 19.7 0.0 0.2 0.0 0.1 27.2 0.1 0.0 0.0 0.1 2.1 120.2 0.0 4.3 0.0 0.1 46.0 0.1 102.5 0.0 0.1 0.0 0.1 5.0 2.2 0.1 0.0 0.2 0.1 35.1 0.0 21.9 2.4 0.7 0.0 0.0 2.1 0.0 12.5 0.2 0.2 0.1 12.1 17.2 0.3 0.6 0.2 27.5 33.8 0.0 0.2 0.6 2.0 0.3 0.7 8.6 0.2 2.2 0.6 1.1 0.0 0.2 0.7 0.2 0.0 0.2 0.1 0.3 0.0 0.4 0.0 0.7 0.7 2.2 1.4 0.3 1.0 0.1 2.4 0.9 0.6 1.3 0.0 0.0 8.2 1.4 0.8 9.7 9.7 4.7 7.7 9.4 7.9 10.1 9.1 17.2 9.8 11.9 2.1 0.5 35.9 44.0 0.2 5.9 20.4 12.0 14.8 22.7 2.0 70.7 1.7 26.1 0.3 15.7 84.6 0.0 25.5 15.4 4.9 5.9 2.3 0.0 8.2 0.0 9.2 9.8 0.0 0.0 3.4 2.5 11.8 0.0 49.0 40.4 175.0 66.4 1.4 2.0 0.4 0.0 2.5 0.1 5.9 11.4 92.9 2.2 50.4 34.6 ITGB5 ENSG00000082781 "Integrin subunit beta 5" P18084 3 124761948-124901418 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 71.2;hTERT-RPE1: 81.6;WM-115: 74.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001820, CAB022050" Approved Approved "Plasma membrane,Mitochondria" NA NA 95000 "Plasma membrane, Mitochondria" "CAB022050: , HPA001820: AB_1079142" "unprognostic (2.63e-1)" "unprognostic (1.04e-1)" "unprognostic (3.57e-1)" "unprognostic (4.44e-2)" "unprognostic (1.37e-2)" "unprognostic (6.07e-2)" "unprognostic (3.49e-3)" "unprognostic (3.16e-3)" "unprognostic (1.68e-1)" "unprognostic (1.53e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.16e-1)" "unprognostic (2.16e-3)" "unprognostic (2.49e-3)" "unprognostic (1.12e-1)" "unprognostic (1.01e-1)" "unprognostic (4.38e-3)" 72.5 13.8 9.7 9.7 10.0 0.8 50.1 5.7 8.2 34.2 18.8 14.8 28.0 12.9 31.7 17.2 25.6 13.9 29.1 32.9 9.4 5.1 19.6 22.1 20.4 3.5 12.0 6.2 17.4 12.1 8.9 8.4 36.4 13.0 23.0 10.1 27.1 18.6 23.1 15.9 33.3 16.1 25.1 9.0 18.7 12.4 17.0 8.7 2.8 18.8 16.2 10.9 24.4 27.1 0.1 1.1 0.4 0.6 0.9 2.1 5.8 28.5 71.2 5.1 12.9 48.3 14.1 26.4 30.6 19.0 5.7 9.2 14.2 37.3 0.1 14.9 51.9 28.1 22.9 4.6 15.9 5.0 0.3 3.1 10.1 11.0 14.9 8.4 0.0 18.5 8.4 3.7 14.3 7.5 81.6 19.1 0.0 9.0 15.3 19.5 29.0 0.1 0.1 22.9 16.0 7.9 0.0 8.2 10.7 16.1 6.3 0.1 10.7 22.7 33.8 25.8 9.4 19.1 0.6 49.1 21.5 32.5 18.6 15.8 2.6 2.7 0.1 22.5 0.1 74.2 0.4 0.6 0.2 2.1 0.2 0.0 0.0 0.2 0.0 1.1 0.1 0.3 0.4 0.4 0.9 0.4 0.1 0.0 5.8 9.7 10.0 5.7 8.2 9.4 5.1 12.0 6.2 13.0 8.7 6.0 7.9 2.2 18.8 15.2 6.2 26.4 43.3 5.3 10.3 27.9 3.9 56.6 10.0 34.5 7.5 22.6 19.6 0.0 16.3 4.7 30.7 22.0 0.0 32.1 60.3 33.4 3.4 41.1 27.6 2.3 18.7 16.7 10.1 0.0 13.3 47.4 43.9 27.4 15.6 10.2 15.2 38.8 35.3 1.4 6.4 19.4 46.1 0.0 15.0 12.0 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 ITK "EMT, LYK, PSCTK2" ENSG00000113263 "IL2 inducible T cell kinase" Q08881 5 157142933-157255191 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.0;lymphoid tissue: 60.5" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 2: 10.4;granulocytes: 32.2;T-cells: 47.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 28 "gdT-cell: 13.8;MAIT T-cell: 9.1;memory CD4 T-cell: 19.5;memory CD8 T-cell: 18.9;naive CD4 T-cell: 28.0;naive CD8 T-cell: 22.8;NK-cell: 9.2;T-reg: 23.1" "Group enriched" "Detected in many" 29 "NK-cells: 9.2;T-cells: 28.0" "Group enriched" "Detected in some" 9 "JURKAT: 36.5;MOLT-4: 13.3" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA043670 Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043670: " "unprognostic (2.08e-3)" "unprognostic (6.57e-4)" "unprognostic (5.06e-3)" "unprognostic (4.96e-5)" "unprognostic (1.52e-2)" "unprognostic (1.12e-4)" "unprognostic (8.45e-4)" "unprognostic (1.56e-2)" "unprognostic (1.87e-2)" "unprognostic (5.99e-3)" "unprognostic (1.76e-1)" "unprognostic (2.52e-1)" "unprognostic (4.52e-6)" "unprognostic (3.64e-1)" "unprognostic (4.42e-2)" "unprognostic (1.46e-1)" "unprognostic (3.26e-2)" 2.3 0.7 0.5 12.2 0.6 2.5 1.3 1.9 0.5 1.4 3.3 0.0 0.0 0.5 1.2 1.1 1.8 1.4 4.3 0.9 0.5 0.5 1.4 1.2 6.6 60.5 0.9 0.0 0.7 0.7 0.0 0.9 0.1 0.3 1.1 1.3 1.5 3.5 1.1 0.5 1.0 8.9 0.4 1.2 10.7 2.3 1.4 0.0 60.3 1.6 2.7 24.3 4.1 1.3 0.0 0.0 0.4 0.6 9.2 28.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 36.5 0.0 0.0 0.0 0.0 13.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 13.8 0.0 9.1 0.0 19.5 18.9 0.0 0.0 28.0 22.8 0.4 9.2 0.6 0.0 23.1 13.6 0.5 0.6 1.9 0.5 0.5 0.5 0.9 0.0 0.3 0.0 0.0 10.4 0.0 0.6 2.4 0.0 0.8 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.0 0.0 0.5 0.2 32.2 0.6 0.0 0.0 0.0 1.8 0.6 5.5 0.0 1.5 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 2.1 0.0 0.0 3.0 0.1 47.3 0.0 0.4 ITPKA "IP3-3KA, IP3KA" ENSG00000137825 "Inositol-trisphosphate 3-kinase A" P23677 15 41493393-41503551 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 28.8;intestine: 19.8;stomach 1: 10.7" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 36.6;Enterocytes: 34.8;Late spermatids: 119.2" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2" "Cell type enriched" "Detected in single" 8 "MAIT T-cell: 4.7" "Lineage enriched" "Detected in single" 13 "T-cells: 4.7" "Cell line enhanced" "Detected in many" "Hep G2: 22.7;OE19: 12.5" "Group enriched" "Detected in many" 13 "amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9" "Group enriched" "Detected in many" 7 "amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6" HPA040454 Enhanced Approved Approved "Vesicles,Plasma membrane" No No Vesicles "Plasma membrane" "HPA040454: AB_10672897" "unprognostic (5.91e-2)" "unprognostic (2.16e-3)" "unprognostic (4.19e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.77e-4)" "unprognostic (2.25e-2)" "unprognostic (2.69e-2)" "unprognostic (1.01e-1)" "unprognostic (3.58e-1)" "unprognostic (1.28e-1)" "unprognostic (1.21e-1)" "unprognostic (2.06e-1)" "prognostic unfavorable (3.76e-9)" "unprognostic (2.15e-1)" "unprognostic (2.87e-1)" "unprognostic (1.12e-3)" "unprognostic (2.10e-2)" 0.4 3.0 12.3 1.1 21.2 0.8 0.4 3.0 28.8 0.6 8.5 0.3 0.0 19.8 0.6 0.5 0.4 0.6 0.6 0.7 10.4 0.9 0.4 0.8 0.4 0.4 1.6 8.2 0.6 2.5 1.7 0.0 0.7 0.3 0.8 3.4 0.0 2.1 0.8 1.4 0.4 19.7 0.7 0.2 0.4 10.7 3.5 0.6 0.0 0.4 0.0 0.4 0.4 0.2 0.0 0.0 0.0 0.0 0.3 4.7 0.0 4.7 1.3 0.2 5.6 0.0 1.8 10.2 3.0 2.4 2.0 2.1 11.2 0.2 0.0 2.5 0.2 4.5 0.5 2.4 0.2 0.1 4.5 3.0 6.8 3.0 22.7 9.2 2.3 0.3 0.1 0.1 1.9 0.6 1.1 0.1 0.9 8.6 1.3 0.7 3.1 0.2 4.4 0.6 12.5 4.0 1.1 1.0 0.4 0.2 0.3 0.5 1.1 2.2 0.0 0.2 0.0 0.6 3.4 0.2 4.9 5.1 5.4 8.1 0.7 7.1 0.0 9.1 9.0 1.6 0.0 0.0 0.0 0.3 0.0 4.7 0.0 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 12.3 21.2 3.0 28.8 10.4 0.9 1.6 8.2 0.3 0.6 0.0 0.0 0.0 0.4 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 36.6 0.0 34.8 0.0 0.6 0.4 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.0 119.2 2.3 0.0 0.0 0.0 12.0 7.3 0.4 19.3 1.4 0.0 0.1 6.5 0.7 1.9 3.0 0.0 0.1 0.0 14.4 0.1 ITSN2 "KIAA1256, PRO2015, SH3D1B, SH3P18, SWA, SWAP" ENSG00000198399 "Intersectin 2" Q9NZM3 2 24202864-24360714 "Predicted intracellular proteins" "Differentiation, Endocytosis, Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036475 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA036475: AB_10670718" "unprognostic (2.36e-1)" "unprognostic (1.28e-1)" "unprognostic (1.24e-1)" "unprognostic (5.95e-2)" "unprognostic (4.64e-1)" "prognostic favorable (2.98e-4)" "unprognostic (3.32e-2)" "unprognostic (3.83e-2)" "unprognostic (2.77e-1)" "unprognostic (1.66e-1)" "unprognostic (2.69e-2)" "unprognostic (1.02e-1)" "unprognostic (1.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.72e-2)" "unprognostic (2.41e-2)" "unprognostic (2.12e-2)" 16.8 18.8 13.4 30.7 14.8 41.4 16.6 15.2 18.3 17.4 16.8 11.5 17.9 11.3 15.1 11.8 31.4 13.3 12.6 17.3 12.0 10.3 15.3 17.7 23.6 31.7 15.0 11.7 16.4 42.6 16.1 27.2 15.9 14.3 19.1 13.5 9.9 17.2 17.2 23.5 20.5 20.2 18.0 13.3 27.8 16.2 9.6 17.0 27.0 35.1 15.6 31.8 19.8 22.9 27.2 10.6 43.0 20.4 8.9 13.0 6.8 16.3 8.0 2.0 5.9 5.8 7.8 18.0 10.0 9.4 4.6 5.6 7.7 8.7 25.4 8.8 8.2 13.7 7.4 9.0 6.3 7.7 20.1 8.4 34.5 4.9 8.6 9.8 17.6 19.9 6.0 7.4 8.1 14.2 8.9 14.5 9.7 9.8 19.4 7.2 6.7 7.2 8.7 3.7 10.0 7.9 9.1 23.2 7.5 8.2 30.8 1.3 4.1 7.9 8.5 12.0 8.4 5.8 9.5 19.9 9.9 8.7 8.2 9.2 21.2 23.4 26.6 7.9 16.4 8.6 20.6 11.4 19.9 12.4 13.9 13.0 24.1 10.8 10.8 10.6 27.2 11.0 9.9 43.0 8.9 20.4 7.0 11.2 6.8 13.4 14.8 15.2 18.3 12.0 10.3 15.0 11.7 14.3 17.0 89.3 88.9 91.3 70.6 45.9 22.7 60.0 28.1 38.8 61.4 27.9 19.6 21.9 14.9 44.1 3.8 51.3 36.0 23.3 66.3 28.1 26.7 69.2 100.6 25.2 37.6 12.7 23.5 39.3 73.8 3.3 27.9 98.8 23.6 86.6 22.0 17.9 67.9 45.6 17.0 28.3 34.8 12.9 26.8 64.6 43.3 50.7 20.3 66.0 19.3 94.5 JAG1 "AGS, AHD, AWS, CD339, HJ1, JAGL1" ENSG00000101384 "Jagged 1" P78504 20 10637684-10673999 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Notch signaling pathway" "Developmental protein" "Deafness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Smooth muscle cells: 154.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "eosinophil: 2.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 56.7;hTERT-HME1: 35.0;U-251 MG: 47.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB010343, HPA021555" Supported Approved "Golgi apparatus,Plasma membrane" NA NA 14000000 "Golgi apparatus, Plasma membrane" "CAB010343: AB_649685, HPA021555: AB_1851969" "unprognostic (2.23e-1)" "unprognostic (2.04e-2)" "unprognostic (1.78e-1)" "unprognostic (4.15e-2)" "unprognostic (1.21e-1)" "unprognostic (6.42e-2)" "unprognostic (4.21e-2)" "unprognostic (8.94e-3)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (4.10e-6)" "unprognostic (5.48e-2)" "unprognostic (1.71e-3)" "unprognostic (2.22e-1)" "unprognostic (1.66e-1)" "unprognostic (3.10e-1)" "unprognostic (1.41e-3)" 27.7 5.6 6.8 14.5 5.4 9.7 56.5 2.9 6.7 34.2 20.1 4.3 17.4 7.2 26.1 22.8 33.9 16.7 23.1 18.8 5.4 5.1 12.9 3.8 22.0 12.4 5.4 4.0 14.7 22.2 21.7 6.0 36.3 6.0 19.2 12.7 21.4 11.2 23.4 16.8 34.8 11.7 21.4 13.0 14.2 13.4 9.1 3.8 1.5 14.5 24.6 16.1 18.7 31.4 0.0 0.9 2.4 2.0 0.4 0.1 0.4 1.0 5.3 16.6 20.4 3.2 3.1 0.6 0.6 3.1 0.9 0.4 4.7 2.9 0.1 15.7 0.6 4.7 22.2 2.4 56.7 0.7 0.0 1.1 1.7 0.5 22.2 1.5 7.1 0.1 1.2 16.8 2.8 35.0 3.3 5.5 0.0 0.0 2.3 1.5 0.0 0.0 5.1 4.8 17.5 5.3 1.3 1.0 3.3 8.0 6.5 0.7 0.5 1.6 1.1 6.7 13.8 0.1 0.8 20.7 3.8 2.6 3.1 47.7 0.9 0.1 0.2 2.4 2.6 2.9 0.0 2.0 2.4 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.0 1.6 0.4 0.3 0.9 0.0 0.4 6.8 5.4 2.9 6.7 5.4 5.1 5.4 4.0 6.0 3.8 38.7 12.5 0.0 46.4 93.0 10.0 12.5 35.7 20.1 22.7 15.7 41.2 12.0 1.7 26.8 3.9 70.8 26.0 0.0 27.0 0.9 33.7 18.4 6.9 1.5 3.7 20.6 5.1 38.1 3.7 6.3 19.8 7.7 13.5 1.8 10.2 9.3 60.7 22.4 31.8 2.1 72.6 84.1 154.6 0.7 2.8 93.3 1.8 0.0 22.9 32.5 JAK3 "JAK-3, JAK3_HUMAN, JAKL, L-JAK, LJAK" ENSG00000105639 "Janus kinase 3" P52333 19 17824780-17848071 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Adaptive immunity, Immunity, Innate immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, SCID" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "lymphoid tissue: 68.3" "Cell type enhanced" "Detected in many" 7 "B-cells: 18.2;Ito cells: 14.1;Peritubular cells: 13.8;T-cells: 24.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.6;HEL: 9.2;HMC-1: 9.4;Karpas-707: 24.0;U-266/70: 9.3;U-266/84: 13.8;U-937: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA070314 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA070314: AB_2686251" "unprognostic (5.59e-3)" "prognostic favorable (6.42e-5)" "unprognostic (5.71e-2)" "unprognostic (2.34e-1)" "unprognostic (6.13e-3)" "unprognostic (1.11e-3)" "unprognostic (4.21e-2)" "unprognostic (2.60e-1)" "unprognostic (2.38e-2)" "unprognostic (2.36e-1)" "unprognostic (3.58e-2)" "unprognostic (1.94e-1)" "prognostic unfavorable (2.89e-14)" "unprognostic (2.28e-1)" "unprognostic (2.21e-2)" "unprognostic (4.43e-2)" "unprognostic (7.61e-2)" 6.8 1.7 4.0 24.5 8.5 12.0 2.7 2.4 3.1 1.9 2.3 1.0 0.0 2.2 1.7 2.0 2.5 3.5 3.6 4.3 2.7 2.8 3.8 2.0 8.4 68.3 7.5 0.0 11.0 2.0 0.4 2.3 4.1 5.3 3.0 2.4 1.6 6.1 1.5 0.7 1.3 9.5 2.5 8.4 36.1 3.2 1.8 5.8 20.9 3.4 1.7 28.8 5.3 2.4 7.4 4.5 16.9 9.6 8.4 15.0 6.8 0.1 0.3 0.3 1.1 0.4 1.5 0.2 0.5 0.0 0.0 0.1 0.0 0.9 0.4 2.0 0.4 0.3 0.1 0.0 0.2 0.0 20.6 0.0 9.2 0.0 0.8 0.7 0.0 9.4 5.1 0.2 0.0 0.0 0.0 0.2 2.1 0.0 24.0 0.0 0.4 3.6 0.0 0.2 0.5 0.7 4.7 0.0 0.4 0.5 0.0 0.0 0.3 0.1 0.2 0.0 0.1 2.0 1.4 0.4 0.0 0.4 0.0 0.0 9.3 13.8 2.5 0.1 14.0 0.2 1.2 4.9 0.2 12.6 9.6 14.5 6.5 15.0 13.1 4.5 7.4 14.9 13.0 16.9 8.4 8.8 3.7 11.8 6.8 4.0 8.5 2.4 3.1 2.7 2.8 7.5 0.0 5.3 5.8 0.0 5.8 18.2 0.5 0.7 0.3 1.4 0.0 0.0 1.2 1.8 0.0 0.9 0.0 0.6 1.0 5.8 0.0 0.0 0.3 0.7 2.3 0.2 4.7 0.0 11.5 0.0 0.0 14.1 10.8 0.9 11.5 3.5 3.3 12.6 0.0 0.8 0.4 0.0 13.8 0.1 0.5 6.5 2.1 0.3 0.7 0.9 1.1 24.5 0.0 0.5 JAM2 "C21orf43, CD322, JAM-B, JAMB, VE-JAM" ENSG00000154721 "Junctional adhesion molecule 2" P57087 21 25639272-25717562 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 66.7" "Cell type enhanced" "Detected in many" 20 "Cardiomyocytes: 31.9;Endothelial cells: 151.0;Ito cells: 49.7" "Cancer enriched" "Detected in all" 9 "glioma: 27.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.2;BJ hTERT+: 11.6;HDLM-2: 11.3;hTERT-RPE1: 16.2;U-138 MG: 13.1;U-87 MG: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028789, HPA077346" Supported "Nucleoplasm,Plasma membrane" NA NA 17000 "Plasma membrane" Nucleoplasm "HPA028789: AB_2732443, HPA077346: AB_2732341" "unprognostic (1.42e-1)" "unprognostic (6.39e-2)" "unprognostic (1.23e-1)" "unprognostic (1.73e-1)" "unprognostic (2.02e-2)" "unprognostic (1.53e-2)" "unprognostic (7.51e-4)" "unprognostic (2.61e-2)" "unprognostic (4.55e-1)" "unprognostic (1.02e-1)" "unprognostic (3.46e-2)" "unprognostic (3.81e-1)" "unprognostic (8.86e-2)" "unprognostic (5.71e-3)" "unprognostic (2.18e-1)" "unprognostic (2.20e-1)" "unprognostic (4.85e-3)" 16.6 17.2 13.8 8.4 18.9 1.5 14.6 9.9 23.4 18.1 14.7 14.5 8.0 7.5 20.5 13.5 13.3 12.0 14.4 21.9 13.5 12.5 6.5 3.5 17.1 4.6 17.6 13.5 18.9 3.9 5.8 7.7 66.7 18.5 12.0 9.7 11.1 5.5 18.0 8.4 6.9 9.2 21.8 23.0 2.8 9.7 25.8 12.2 0.6 9.5 10.1 6.3 13.5 15.1 3.1 1.9 1.9 0.7 2.8 1.1 0.4 0.0 0.0 18.2 0.1 0.7 0.2 0.4 0.5 11.6 1.5 5.5 0.0 0.0 0.1 0.0 0.2 7.0 0.0 1.6 0.0 3.4 11.3 0.5 0.1 0.0 0.0 0.0 0.0 0.1 1.0 0.0 1.3 0.0 16.2 0.0 0.4 0.0 0.2 5.6 0.1 0.3 0.1 5.7 0.1 0.0 2.1 3.7 0.0 0.0 0.0 0.3 2.7 0.1 0.2 0.0 0.2 0.6 0.1 0.0 13.1 1.2 0.1 1.8 1.5 0.0 0.0 9.6 0.1 0.5 1.4 0.7 0.3 0.4 0.5 0.6 0.3 0.4 0.9 0.4 3.1 0.7 1.1 1.9 2.8 0.6 1.9 0.2 0.4 13.8 18.9 9.9 20.5 13.5 12.5 17.6 13.5 18.5 12.2 0.0 2.9 1.4 1.4 6.6 1.5 31.9 0.0 1.4 0.0 3.5 13.7 0.3 0.0 0.3 12.9 151.0 0.0 0.0 0.2 2.2 18.5 1.2 0.0 0.0 1.0 0.0 0.0 49.7 2.2 13.2 9.2 1.4 15.1 0.0 0.0 0.9 0.1 0.0 23.0 0.0 3.6 0.0 7.6 4.8 3.9 5.8 0.7 0.0 0.0 0.7 JAML "AMICA, AMICA1, Gm638" ENSG00000160593 "Junction adhesion molecule like" Q86YT9 11 118193740-118225094 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "blood: 202.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 2: 48.3;Kupffer cells: 117.5;Macrophages: 185.0;T-cells: 45.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 202.6" "Group enriched" "Detected in many" 4 "dendritic cells: 60.5;granulocytes: 202.6;monocytes: 59.0" "Cell line enriched" "Detected in some" 5 "HMC-1: 24.9" "Region enriched" "Detected in single" 9 "cerebellum: 7.0" "Region enriched" "Detected in many" 12 "cerebellum: 113.6" "HPA005854, HPA047919" Approved Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Plasma membrane" Nucleoplasm "HPA005854: , HPA047919: AB_2680209" "unprognostic (3.91e-3)" "unprognostic (1.55e-3)" "unprognostic (3.00e-2)" "unprognostic (1.28e-3)" "unprognostic (2.87e-3)" "prognostic favorable (3.11e-4)" "unprognostic (2.80e-1)" "prognostic favorable (3.92e-4)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (8.69e-2)" "unprognostic (5.08e-1)" "unprognostic (6.43e-3)" "unprognostic (8.96e-2)" "unprognostic (3.12e-2)" "unprognostic (4.10e-2)" "unprognostic (1.58e-2)" 6.7 2.1 0.9 23.1 1.1 6.6 2.1 5.3 0.8 4.1 8.4 0.7 1.3 6.1 3.8 9.6 4.0 3.1 8.9 3.1 0.9 0.9 3.4 4.3 34.4 43.2 3.7 0.5 2.1 1.8 0.0 2.7 4.2 2.3 3.4 8.3 6.7 6.7 1.1 1.0 2.2 14.0 4.7 1.8 43.4 3.9 1.9 0.6 14.3 2.6 5.9 25.0 9.8 3.0 0.3 60.5 202.6 59.0 1.4 25.2 40.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.1 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 1.7 0.0 0.0 24.9 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.0 0.3 2.3 0.3 2.7 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.2 0.0 5.8 59.0 202.6 3.9 36.6 25.2 0.3 7.0 7.4 60.5 0.1 8.3 6.7 126.6 1.4 17.1 46.6 11.1 40.1 0.9 1.1 5.3 0.8 0.9 0.9 3.7 0.5 2.3 0.6 6.0 48.3 15.4 0.1 0.0 0.0 0.0 0.0 4.0 10.3 1.8 0.0 0.1 0.0 0.1 0.7 0.0 0.0 0.0 0.3 0.2 0.4 0.1 14.0 2.1 29.9 0.0 0.0 8.0 117.5 0.9 0.0 185.0 0.0 11.8 0.0 0.0 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.1 1.4 0.0 0.3 45.3 0.0 0.1 JMJD4 FLJ12517 ENSG00000081692 "Jumonji domain containing 4" Q9H9V9 1 227730425-227735411 "Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Early spermatids: 59.1;Late spermatids: 160.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027260, HPA052861" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA027260: AB_10602608, HPA052861: AB_2681975" "unprognostic (1.80e-1)" "unprognostic (1.37e-1)" "unprognostic (4.86e-2)" "unprognostic (2.29e-1)" "unprognostic (1.43e-1)" "unprognostic (2.86e-1)" "unprognostic (1.23e-1)" "unprognostic (6.19e-2)" "unprognostic (1.74e-2)" "unprognostic (4.31e-2)" "unprognostic (8.69e-3)" "unprognostic (8.68e-3)" "prognostic unfavorable (3.16e-4)" "unprognostic (4.45e-2)" "unprognostic (2.82e-1)" "unprognostic (2.05e-1)" "unprognostic (4.68e-1)" 10.1 17.5 9.6 8.3 8.3 5.9 13.1 10.1 17.1 10.1 12.0 9.7 13.1 7.9 11.7 12.8 10.0 13.5 11.7 11.7 10.0 9.6 8.7 19.8 7.9 25.0 9.7 10.0 14.9 17.5 9.5 14.4 12.0 6.3 12.2 4.6 11.8 18.2 11.6 14.9 9.8 8.7 8.3 7.2 13.7 8.6 20.1 3.2 21.5 9.7 11.1 14.4 8.5 6.8 8.5 11.6 2.9 6.4 13.2 12.7 7.0 10.7 16.0 5.2 5.7 5.7 3.2 19.2 6.8 7.2 10.6 6.6 13.6 9.3 14.5 10.4 6.5 5.7 11.0 3.6 10.9 1.2 7.7 17.2 8.9 7.9 10.5 10.1 9.3 4.4 5.7 6.9 10.1 7.5 4.2 5.4 10.7 11.5 4.9 5.1 9.2 11.4 4.9 9.0 8.3 25.2 10.6 6.4 13.0 6.2 10.2 10.3 6.9 6.5 23.2 8.7 2.8 18.7 10.1 4.7 5.4 5.5 6.5 12.5 9.0 2.8 5.6 5.4 4.5 14.8 2.9 6.4 2.3 10.2 6.4 11.7 8.3 7.9 7.2 5.8 8.5 12.7 11.0 0.6 13.2 3.4 11.6 8.8 7.0 9.6 8.3 10.1 17.1 10.0 9.6 9.7 10.0 6.3 3.2 6.0 7.4 8.1 5.9 3.7 12.2 3.1 5.1 6.7 4.5 7.0 0.0 10.9 5.0 17.7 59.1 4.2 9.7 46.7 25.0 11.7 6.9 8.8 6.9 13.4 14.4 11.1 8.6 5.5 7.9 160.3 10.6 4.3 11.8 14.4 5.8 11.7 19.1 5.5 3.9 9.2 13.7 6.5 4.2 20.2 7.4 4.1 8.0 8.7 6.4 6.7 JPT2 "C16orf34, FLJ13092, HN1L, KIAA1426, L11" ENSG00000206053 "Jupiter microtubule associated homolog 2" Q9H910 16 1678256-1702280 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 82.6;Ductal cells: 81.9;Extravillous trophoblasts: 170.9;Syncytiotrophoblasts: 141.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041888, HPA041908" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041888: AB_10793937, HPA041908: AB_10794160" "unprognostic (1.49e-2)" "unprognostic (1.76e-1)" "unprognostic (1.30e-3)" "prognostic favorable (7.85e-4)" "unprognostic (3.60e-1)" "unprognostic (2.37e-2)" "prognostic unfavorable (9.14e-4)" "unprognostic (1.10e-2)" "unprognostic (3.14e-2)" "unprognostic (1.50e-2)" "unprognostic (1.12e-3)" "unprognostic (4.27e-2)" "unprognostic (1.01e-2)" "unprognostic (9.22e-3)" "unprognostic (1.65e-1)" "unprognostic (4.14e-2)" "unprognostic (2.78e-2)" 10.6 11.3 6.7 10.4 24.3 4.9 19.9 11.1 12.3 22.5 16.7 24.1 12.6 11.3 11.5 11.1 28.6 34.4 12.4 10.1 10.5 8.7 18.5 37.3 12.0 11.7 33.8 6.2 12.3 31.0 13.2 10.1 33.6 37.7 26.3 16.5 6.8 15.7 12.7 12.8 16.2 12.8 12.4 72.4 8.7 14.8 14.1 17.3 20.3 16.1 15.7 16.8 16.9 16.8 9.7 8.2 4.7 4.6 7.5 10.0 5.4 31.6 32.6 37.8 21.0 5.5 9.2 34.3 31.6 10.0 26.7 22.8 42.4 41.7 20.6 24.4 15.6 26.3 31.3 49.8 42.9 30.7 16.5 30.0 16.9 18.7 24.1 8.4 19.9 10.1 6.4 27.2 26.2 34.1 14.8 16.8 18.8 39.7 8.3 15.4 36.7 24.8 9.9 41.5 35.7 24.8 45.7 35.8 29.7 41.6 18.0 35.3 19.5 47.5 46.1 14.4 38.0 55.8 12.8 19.4 26.0 45.7 12.3 30.7 7.1 28.3 42.9 8.1 15.5 37.8 2.6 4.6 4.7 7.1 4.1 10.0 6.3 7.8 5.6 3.6 9.7 8.5 7.1 0.4 7.5 2.0 8.2 7.0 5.4 6.7 24.3 11.1 12.3 10.5 8.7 33.8 6.2 37.7 17.3 23.8 8.8 0.0 0.0 0.0 0.0 0.0 0.0 49.5 22.7 8.7 0.0 82.6 36.5 81.9 0.0 0.0 0.0 0.0 22.2 170.9 0.0 0.0 2.3 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 49.5 0.0 0.0 59.7 0.0 0.0 18.9 0.0 0.0 0.0 0.0 0.0 0.0 141.1 0.0 0.0 0.0 KARS "DFNB89, KARS1, KARS2" ENSG00000065427 "Lysyl-tRNA synthetase" Q15046 16 75627474-75648643 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Host-virus interaction, Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase, Transferase" "Charcot-Marie-Tooth disease, Deafness, Disease mutation, Neurodegeneration, Neuropathy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041345, HPA041550" Enhanced Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA Cytosol "Plasma membrane" "HPA041345: AB_10795589, HPA041550: AB_10794520" "unprognostic (1.56e-1)" "unprognostic (7.93e-2)" "unprognostic (3.36e-2)" "unprognostic (1.02e-2)" "unprognostic (5.39e-2)" "prognostic unfavorable (8.84e-6)" "unprognostic (6.24e-3)" "unprognostic (8.97e-3)" "unprognostic (1.18e-1)" "unprognostic (9.11e-3)" "unprognostic (8.71e-3)" "unprognostic (8.46e-2)" "unprognostic (7.86e-2)" "unprognostic (1.56e-1)" "unprognostic (1.03e-1)" "unprognostic (3.07e-2)" "unprognostic (2.13e-1)" 25.4 21.1 19.2 29.2 22.0 24.6 28.0 17.5 19.5 26.3 28.3 15.2 28.1 20.6 23.4 26.7 35.8 24.1 27.5 49.6 16.3 18.6 31.7 47.1 25.8 26.6 18.8 16.2 34.9 62.6 28.5 22.4 30.4 19.6 30.7 29.7 20.1 31.7 23.2 80.0 26.6 32.3 28.4 17.1 37.3 26.3 33.6 14.5 41.3 34.4 43.6 34.7 38.6 33.4 32.8 39.0 35.5 44.2 35.0 62.4 39.5 27.2 31.9 23.3 32.0 25.0 25.3 45.9 23.1 28.4 50.9 38.4 56.3 35.9 49.2 25.6 30.7 24.3 39.3 46.9 42.2 55.7 14.3 24.1 27.0 27.9 58.2 45.9 40.6 30.5 29.7 30.4 45.0 73.3 26.0 41.4 43.5 45.0 11.8 38.4 63.0 41.7 43.5 49.3 40.1 23.5 55.0 20.9 60.0 40.8 23.2 35.1 28.5 58.1 21.2 25.8 26.6 28.7 38.5 22.8 28.2 29.1 21.5 33.0 25.4 29.0 117.4 24.6 34.8 34.3 20.9 31.5 35.5 34.1 44.2 62.4 32.8 42.3 40.2 39.0 27.6 40.1 36.1 7.2 35.0 43.2 24.6 43.5 39.5 19.2 22.0 17.5 19.5 16.3 18.6 18.8 16.2 19.6 14.5 41.7 22.7 66.3 80.5 40.9 19.6 83.2 53.5 42.8 59.1 38.4 33.4 104.3 89.5 100.0 165.6 61.2 50.2 46.7 126.0 122.6 54.5 53.6 38.2 37.5 80.9 11.1 54.8 39.3 59.8 236.5 43.4 52.9 33.7 143.3 61.7 20.0 101.6 42.1 47.7 58.7 38.2 45.3 49.9 89.9 114.1 39.5 92.0 63.4 85.8 94.5 KCNN2 "hSK2, KCa2.2" ENSG00000080709 "Potassium calcium-activated channel subfamily N member 2" Q9H2S1 5 114360945-114496500 "FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Transport" "Calmodulin-binding, Ion channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 25.3;brain: 23.1;liver: 33.2" "Cell type enhanced" "Detected in some" 12 "Cardiomyocytes: 10.8;Hepatocytes: 14.7;Melanocytes: 20.3;Rod photoreceptor cells: 7.2" "Group enriched" "Detected in some" 7 "glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 15.0;NTERA-2: 5.7;SK-MEL-30: 10.6;THP-1: 18.7;U-937: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038221 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA038221: AB_10673044" "unprognostic (9.22e-3)" "unprognostic (1.90e-1)" "unprognostic (2.04e-1)" "unprognostic (5.65e-2)" "unprognostic (1.43e-1)" "unprognostic (1.40e-1)" "unprognostic (2.94e-1)" "unprognostic (1.42e-1)" "unprognostic (1.11e-2)" "unprognostic (1.56e-1)" "unprognostic (1.09e-1)" "unprognostic (1.15e-1)" "unprognostic (1.66e-1)" "unprognostic (1.23e-2)" "unprognostic (4.61e-1)" "unprognostic (3.16e-1)" "unprognostic (4.25e-1)" 0.8 25.3 12.6 0.8 7.3 0.6 1.1 21.7 15.0 1.7 1.2 9.5 0.0 0.9 3.9 0.9 0.8 1.0 1.0 7.7 23.1 3.6 4.8 33.2 2.5 0.9 4.5 16.9 1.4 3.8 1.0 16.0 0.6 9.1 11.7 1.3 4.2 1.1 5.4 9.9 2.1 0.9 2.8 8.4 1.1 1.1 3.8 6.5 0.0 0.9 0.0 0.8 2.4 1.1 0.3 0.3 0.8 0.3 0.1 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.8 15.0 2.3 0.3 0.1 0.0 0.2 0.0 0.5 0.0 2.0 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.3 0.0 0.1 0.0 0.2 0.0 1.2 5.7 0.0 0.0 0.1 0.0 0.7 0.3 0.1 1.8 0.0 0.0 0.2 10.6 0.3 0.2 18.7 0.2 0.0 0.4 1.7 0.0 0.1 0.0 0.1 1.8 6.7 0.5 0.5 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.3 0.1 0.3 0.8 0.1 0.3 0.3 0.1 0.0 12.6 7.3 21.7 15.0 23.1 3.6 4.5 16.9 9.1 6.5 0.0 0.6 0.0 0.1 0.2 6.8 10.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.7 5.2 0.0 0.0 0.8 0.0 0.9 4.5 0.0 14.7 0.0 0.0 0.0 6.2 1.0 0.0 0.0 0.0 20.3 0.0 0.5 0.3 1.4 0.0 0.0 0.5 7.2 0.0 0.5 0.5 3.2 0.3 0.0 0.0 0.4 0.1 KEL "CD238, ECE3" ENSG00000197993 "Kell blood group, metallo-endopeptidase" P23276 7 142941114-142962681 "Blood group antigen proteins, Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Blood group antigen, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "bone marrow: 21.1;testis: 36.4" "Cell type enriched" "Detected in some" 14 "Erythroid cells: 46.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 7 "intermediate monocyte: 1.4" "Lineage enriched" "Detected in single" 14 "monocytes: 1.4" "Group enriched" "Detected in some" 12 "HEL: 15.3;K-562: 12.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA064442 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA064442: " "unprognostic (5.78e-3)" "unprognostic (1.08e-5)" "unprognostic (5.29e-3)" "unprognostic (4.85e-3)" "unprognostic (9.68e-2)" "unprognostic (1.96e-2)" "unprognostic (1.03e-1)" "unprognostic (1.54e-2)" "unprognostic (5.18e-2)" "unprognostic (1.08e-2)" "unprognostic (3.71e-2)" "unprognostic (3.57e-2)" "unprognostic (2.29e-3)" "unprognostic (9.24e-2)" "unprognostic (7.05e-2)" "unprognostic (3.32e-2)" "unprognostic (3.25e-3)" 0.2 0.0 0.9 2.5 1.1 21.1 0.2 0.2 0.4 0.4 0.2 0.3 0.2 0.0 0.2 0.2 0.6 0.1 0.2 0.2 1.4 0.7 0.4 0.2 1.4 5.0 2.0 0.2 0.2 0.2 0.0 0.2 1.1 0.3 0.2 0.0 0.3 2.5 0.2 0.2 0.0 0.5 0.2 4.4 3.8 0.0 36.4 0.3 0.4 0.2 0.2 3.7 0.2 0.2 0.0 0.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 12.4 0.1 0.0 0.0 0.5 0.3 0.3 0.0 0.0 0.1 0.0 0.1 0.0 1.2 0.0 0.1 0.2 0.0 0.5 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.9 1.1 0.2 0.4 1.4 0.7 2.0 0.2 0.3 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 2.3 3.5 0.0 0.0 1.7 0.2 1.9 0.0 0.0 46.7 0.0 0.2 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.0 0.0 1.0 KIAA0556 "JBTS26, KATNIP" ENSG00000047578 KIAA0556 O60303 16 27550133-27780369 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Joubert syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 33.6;Ciliated cells: 36.1;Cone photoreceptor cells: 64.8;Rod photoreceptor cells: 54.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 11.0" "Group enriched" "Detected in all" 4 "granulocytes: 11.0;NK-cells: 5.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035089, HPA035090" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA035089: AB_10671509, HPA035090: AB_10601129" "unprognostic (1.81e-1)" "unprognostic (1.13e-1)" "unprognostic (1.55e-1)" "unprognostic (3.65e-3)" "unprognostic (7.76e-2)" "prognostic favorable (3.00e-4)" "unprognostic (2.72e-2)" "unprognostic (3.58e-2)" "unprognostic (2.02e-1)" "unprognostic (1.22e-1)" "unprognostic (2.94e-1)" "unprognostic (2.12e-1)" "unprognostic (1.47e-3)" "unprognostic (2.98e-1)" "unprognostic (2.11e-1)" "unprognostic (1.50e-3)" "unprognostic (1.45e-1)" 6.1 6.2 7.1 8.7 10.9 7.9 6.8 6.3 10.8 8.4 8.2 12.0 13.2 6.5 15.1 13.1 11.2 38.6 7.5 7.0 7.1 6.7 9.7 5.0 8.2 5.6 6.5 7.3 8.2 11.7 14.9 19.0 6.8 8.6 11.9 9.8 11.8 9.8 9.7 4.1 11.0 7.9 8.4 9.3 7.9 12.1 22.8 8.4 8.7 20.9 5.0 11.1 7.6 9.0 1.4 1.5 11.0 2.0 5.5 1.8 0.4 5.4 11.2 6.3 5.9 9.6 8.8 10.5 7.4 8.0 6.6 9.0 9.8 9.1 4.6 10.6 10.5 12.8 9.1 8.0 9.5 13.2 21.4 5.6 3.6 11.3 5.7 5.7 4.9 9.3 9.3 8.4 14.4 15.6 8.5 12.9 5.3 5.8 3.9 9.3 12.5 5.4 6.0 3.8 7.0 4.6 7.7 7.7 5.0 12.1 7.6 8.1 5.2 7.4 6.7 4.1 9.2 14.9 4.3 11.1 8.4 5.4 6.5 6.4 5.3 4.5 5.0 9.7 4.8 7.5 9.5 2.0 3.8 0.8 1.3 0.8 0.9 0.4 1.4 1.3 1.4 1.8 0.3 11.0 5.5 0.5 1.5 1.5 0.4 7.1 10.9 6.3 10.8 7.1 6.7 6.5 7.3 8.6 8.4 6.0 1.9 2.9 4.8 1.3 33.6 4.5 0.0 36.1 9.1 1.8 64.8 2.5 0.0 3.0 11.2 3.5 5.9 0.0 3.2 2.2 2.7 6.5 0.0 0.8 2.3 3.2 11.6 3.1 1.8 12.0 2.3 3.2 5.0 2.8 3.3 6.5 3.6 3.5 1.1 1.7 54.4 0.0 2.0 9.9 4.9 1.3 1.8 3.3 3.3 4.4 KIAA1958 FLJ39294 ENSG00000165185 KIAA1958 Q8N8K9 9 112486847-112669397 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 19.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020625 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020625: AB_1852451" "unprognostic (3.09e-3)" "unprognostic (1.04e-1)" "unprognostic (1.61e-2)" "unprognostic (1.33e-1)" "unprognostic (7.48e-2)" "unprognostic (2.08e-2)" "unprognostic (2.01e-1)" "unprognostic (4.95e-2)" "unprognostic (1.14e-1)" "unprognostic (1.65e-2)" "unprognostic (2.73e-2)" "unprognostic (7.67e-2)" "unprognostic (5.48e-3)" "unprognostic (3.14e-2)" "unprognostic (1.82e-1)" "unprognostic (2.10e-2)" "unprognostic (2.58e-1)" 2.6 14.7 8.6 2.8 14.4 8.7 6.3 21.2 11.7 10.4 3.0 10.8 5.6 3.7 7.0 3.1 3.6 6.3 3.1 2.8 7.8 5.2 11.7 6.9 7.8 2.9 14.0 6.2 19.9 10.8 4.1 8.0 1.9 11.3 3.5 3.4 5.5 5.5 8.0 2.7 4.0 3.9 6.5 10.6 3.2 8.8 11.0 16.5 4.7 5.0 0.4 2.9 3.8 4.8 2.1 2.4 2.6 2.8 2.4 2.7 1.5 2.9 4.2 17.3 5.0 1.2 0.3 8.3 2.2 0.7 2.7 3.0 7.7 2.0 9.5 2.6 7.2 1.8 2.6 12.7 1.2 3.8 2.9 5.1 3.7 5.7 5.4 0.7 5.6 4.7 0.5 1.0 3.5 1.7 2.4 2.1 9.0 8.6 2.4 0.8 3.4 8.7 3.2 9.5 6.9 2.0 7.1 9.9 2.7 3.6 4.1 8.9 9.4 3.7 3.9 2.2 10.0 3.5 5.7 0.4 0.9 5.2 0.6 2.7 4.5 8.1 5.7 1.2 3.9 0.7 1.4 2.8 0.2 2.1 0.9 0.9 0.3 0.8 1.6 0.9 2.1 2.0 2.7 2.6 2.4 0.8 2.4 0.4 1.5 8.6 14.4 21.2 11.7 7.8 5.2 14.0 6.2 11.3 16.5 3.0 13.4 0.0 3.6 4.1 19.3 3.6 2.5 2.7 9.1 1.8 13.7 1.0 6.6 2.5 3.4 0.8 3.6 0.0 5.9 0.9 1.7 5.6 0.0 6.8 0.8 6.4 4.6 0.6 3.5 1.5 6.1 4.1 1.7 0.0 4.4 11.6 3.3 4.3 4.9 9.8 11.0 6.5 2.1 1.1 4.7 4.1 0.7 1.0 5.2 3.5 KIF17 "KIAA1405, KIF17B, KIF3X, KLP-2, OSM-3" ENSG00000117245 "Kinesin family member 17" Q9P2E2 1 20664014-20718017 "Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Motor protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 5.2;testis: 19.4" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 35.8;Ito cells: 16.5;Late spermatids: 60.3;Sertoli cells: 19.4" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "amygdala: 2.4;basal ganglia: 5.2;cerebral cortex: 3.6;hippocampal formation: 1.8;hypothalamus: 3.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ hTERT+: 3.8;hTERT-HME1: 8.4;U-2 OS: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA032085 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032085: AB_10669917" "unprognostic (4.15e-3)" "unprognostic (8.60e-3)" "unprognostic (6.43e-2)" "unprognostic (1.12e-2)" "unprognostic (7.68e-2)" "unprognostic (3.70e-1)" "unprognostic (1.07e-2)" "unprognostic (1.04e-1)" "unprognostic (7.11e-2)" "unprognostic (1.08e-1)" "unprognostic (7.34e-3)" "unprognostic (8.73e-2)" "unprognostic (3.63e-3)" "unprognostic (1.08e-2)" "unprognostic (2.26e-1)" "unprognostic (1.22e-1)" "unprognostic (1.20e-2)" 0.1 0.4 2.4 0.2 5.2 0.1 0.1 0.0 3.9 0.4 0.2 0.4 0.0 0.3 0.4 0.8 0.1 3.1 0.2 0.2 1.8 3.5 0.2 0.1 0.4 0.1 0.4 0.7 0.6 0.1 0.2 1.5 0.7 0.5 0.4 0.1 0.0 0.1 0.8 0.1 0.1 0.2 0.9 0.3 0.1 0.1 19.4 0.0 0.0 0.9 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 1.5 0.9 0.0 0.0 0.1 0.2 2.7 3.8 1.5 0.9 0.4 1.0 0.0 1.2 2.0 0.7 0.0 1.3 0.9 1.1 0.0 0.3 0.0 0.0 0.4 1.6 0.0 0.0 0.3 0.8 1.0 8.4 1.0 0.0 0.1 0.6 0.0 1.8 0.1 0.0 0.0 2.5 0.1 1.8 0.0 0.1 0.0 0.6 0.0 0.7 1.5 0.5 0.0 0.3 1.6 0.0 0.0 0.0 0.6 5.1 0.5 0.4 0.1 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 5.2 0.0 3.6 1.8 3.5 0.4 0.7 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 1.6 0.0 2.7 0.0 1.8 3.9 0.1 0.0 0.0 35.8 12.6 0.0 0.0 0.0 0.1 0.6 0.1 0.0 0.4 4.0 0.0 0.0 16.5 1.5 60.3 1.1 3.3 1.7 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.3 19.4 1.4 1.5 4.2 1.1 1.4 0.0 0.0 0.1 KIF21A "FEOM1, FLJ20052" ENSG00000139116 "Kinesin family member 21A" Q7Z4S6 12 39293228-39443390 "Disease related genes, Predicted intracellular proteins" "Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 41.5" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 235.9;Ciliated cells: 303.8;Cone photoreceptor cells: 290.6;Rod photoreceptor cells: 184.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "gdT-cell: 8.4;MAIT T-cell: 4.1;memory CD4 T-cell: 5.2;memory CD8 T-cell: 8.5;naive CD8 T-cell: 5.9;NK-cell: 3.1;T-reg: 2.3" "Group enriched" "Detected in many" 8 "NK-cells: 3.1;T-cells: 8.5" "Cell line enriched" "Detected in many" 4 "SH-SY5Y: 63.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022079, HPA058432" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "CAB022079: , HPA058432: AB_2683717" "unprognostic (1.08e-3)" "unprognostic (3.40e-1)" "unprognostic (2.06e-2)" "unprognostic (7.67e-2)" "unprognostic (1.13e-1)" "unprognostic (3.09e-1)" "unprognostic (2.24e-3)" "unprognostic (7.77e-2)" "unprognostic (3.17e-2)" "unprognostic (4.56e-3)" "unprognostic (1.36e-1)" "unprognostic (1.73e-2)" "prognostic favorable (8.07e-8)" "unprognostic (4.05e-2)" "unprognostic (1.66e-1)" "unprognostic (2.14e-1)" "unprognostic (2.34e-2)" 3.4 10.1 17.7 3.1 18.5 0.8 5.1 22.1 36.7 8.4 9.2 7.7 2.9 7.1 7.7 4.7 16.0 26.8 5.1 13.4 18.0 28.7 20.9 15.6 4.8 2.2 26.4 18.0 3.2 10.1 17.4 12.3 6.4 41.5 9.3 10.6 5.9 16.4 3.5 8.0 8.5 7.9 7.2 29.2 5.0 9.6 9.5 9.6 0.0 7.1 2.5 4.1 3.6 6.0 0.7 0.0 0.1 0.0 3.1 8.5 1.1 5.9 7.6 10.7 4.5 2.0 1.0 8.6 1.5 0.7 2.0 1.4 13.7 7.4 0.0 4.8 0.6 3.2 5.3 6.1 3.7 1.8 11.7 4.9 0.0 13.4 12.5 1.6 9.9 0.0 0.6 8.2 2.5 12.0 4.6 2.6 2.6 11.2 12.3 1.6 3.5 1.2 0.0 14.4 0.0 6.7 0.0 0.0 6.8 7.6 9.9 14.7 63.8 5.8 9.3 3.5 11.4 10.8 1.2 1.8 1.1 4.7 0.3 4.2 5.6 1.9 0.0 2.8 1.4 0.9 0.0 0.0 0.0 8.4 0.0 4.1 0.7 5.2 8.5 0.0 0.0 1.3 5.9 0.1 3.1 0.0 0.0 2.3 1.1 17.7 18.5 22.1 31.6 18.0 28.7 26.4 18.0 41.5 9.6 35.7 17.4 0.8 18.1 16.5 235.9 106.3 17.8 303.8 69.4 12.2 290.6 12.6 8.3 23.9 92.2 5.8 23.8 0.0 35.7 84.3 10.0 29.0 13.8 39.9 3.5 130.3 23.1 8.0 2.4 60.6 2.8 2.1 13.5 12.6 25.5 106.4 33.2 20.1 2.5 41.7 184.9 0.0 9.8 22.7 7.2 26.8 49.4 20.8 23.4 14.6 KIF26B FLJ10157 ENSG00000162849 "Kinesin family member 26B" Q2KJY2 1 245154985-245709431 "Predicted intracellular proteins" "Developmental protein, Motor protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 7 "Collecting duct cells: 7.0;Cone photoreceptor cells: 3.9;Exocrine glandular cells: 4.4;Pancreatic endocrine cells: 5.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "plasmacytoid DC: 6.3" "Lineage enriched" "Detected in single" 58 "dendritic cells: 6.3" "Cell line enhanced" "Detected in some" "HSkMC: 10.6;REH: 18.9;SH-SY5Y: 10.3;U-937: 9.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027709, HPA028478, HPA028561, HPA028562" Enhanced Approved "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA027709: AB_10600215, HPA028478: AB_10601231, HPA028561: AB_10601960, HPA028562: AB_10602417" "unprognostic (3.66e-1)" "unprognostic (5.67e-2)" "unprognostic (7.90e-3)" "unprognostic (4.50e-3)" "unprognostic (3.23e-2)" "unprognostic (1.49e-1)" "unprognostic (4.17e-2)" "unprognostic (1.61e-1)" "unprognostic (9.63e-2)" "prognostic unfavorable (1.24e-4)" "unprognostic (8.30e-3)" "unprognostic (3.63e-1)" "unprognostic (1.38e-1)" "unprognostic (1.13e-2)" "unprognostic (5.77e-2)" "unprognostic (1.17e-4)" "unprognostic (7.22e-3)" 0.7 3.9 7.1 3.0 6.3 0.7 2.1 10.2 9.7 5.2 1.7 8.7 6.0 1.2 3.7 2.9 1.3 2.1 4.2 1.3 5.6 7.2 3.2 1.1 2.7 1.7 7.8 4.6 1.2 1.8 1.4 1.4 7.6 9.6 3.7 0.8 1.1 1.2 7.7 0.9 2.7 1.1 2.3 4.9 1.1 2.9 2.9 3.7 1.3 3.4 1.2 1.4 4.0 0.8 0.0 6.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 2.6 0.5 0.8 1.9 2.1 1.5 0.1 0.1 3.2 0.0 0.0 3.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 1.5 0.3 0.3 10.6 0.6 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 18.9 0.1 0.0 1.9 0.0 2.6 10.3 0.0 0.0 0.0 1.8 0.0 1.0 0.3 2.0 0.1 0.0 0.8 0.0 0.0 0.1 0.3 9.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 6.3 0.0 0.0 7.1 6.3 10.2 9.7 5.6 7.2 7.8 4.6 9.6 3.7 0.0 0.3 0.0 0.1 0.8 0.8 2.2 0.0 2.7 0.0 7.0 3.9 1.8 0.0 1.8 1.7 0.0 0.0 0.0 4.4 2.0 0.9 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.4 0.6 0.4 3.3 1.0 0.0 0.3 5.5 0.0 0.0 0.0 0.1 0.0 0.4 0.5 1.0 1.1 2.1 0.0 0.0 0.0 KISS1R "AXOR12, GPR54, HOT7T175" ENSG00000116014 "KISS1 receptor" Q969F8 19 917287-921015 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, Hypogonadotropic hypogonadism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 6.8;lymphoid tissue: 12.4" "Cell type enriched" "Detected in some" 18 "Extravillous trophoblasts: 31.2" "Cancer enhanced" "Detected in many" "renal cancer: 3.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.0;neutrophil: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "K-562: 10.8;RPMI-8226: 26.3;SCLC-21H: 5.5;SH-SY5Y: 14.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007156, HPA071913" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA007156: , HPA071913: AB_2686471" "unprognostic (1.54e-1)" "unprognostic (3.01e-2)" "unprognostic (9.42e-2)" "unprognostic (2.15e-1)" "unprognostic (8.46e-3)" "unprognostic (9.23e-2)" "unprognostic (1.65e-2)" "unprognostic (3.23e-1)" "unprognostic (1.37e-1)" "unprognostic (1.16e-1)" "unprognostic (1.48e-2)" "unprognostic (7.17e-2)" "prognostic unfavorable (3.33e-6)" "unprognostic (1.87e-1)" "unprognostic (8.09e-3)" "unprognostic (1.05e-1)" "unprognostic (2.05e-2)" 0.2 0.2 2.1 2.1 4.1 0.2 0.3 0.1 4.7 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.1 0.2 0.1 0.1 1.0 6.8 1.4 0.1 0.3 12.4 1.1 0.1 0.4 3.6 0.1 2.0 1.0 0.8 0.2 0.2 0.3 0.3 0.1 0.1 0.1 0.7 0.5 1.0 2.4 0.4 0.1 0.1 0.1 0.1 0.1 0.6 0.5 0.1 0.6 0.0 1.8 0.0 0.0 2.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.2 2.9 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 10.8 0.0 0.0 0.2 0.1 0.0 0.4 0.8 0.3 0.7 0.0 26.3 0.0 0.0 5.5 14.7 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.6 0.7 0.0 0.0 0.1 2.0 0.6 1.8 0.0 0.0 0.0 0.1 0.0 2.1 4.1 0.1 1.5 1.0 6.8 1.1 0.1 0.8 0.1 0.0 0.0 1.4 0.1 0.1 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.2 31.2 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.3 1.4 0.0 0.0 0.0 KLK7 "PRSS6, SCCE" ENSG00000169035 "Kallikrein related peptidase 7" P49862 19 50976482-50984099 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "esophagus: 29.1;skin 1: 77.5;tongue: 90.2" "Cell type enhanced" "Detected in some" 20 "Alveolar cells type 1: 6.0;Basal keratinocytes: 4.4;Suprabasal keratinocytes: 9.4" "Cancer enhanced" "Detected in many" "ovarian cancer: 139.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 6 "CAPAN-2: 6.7;HaCaT: 26.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA018994, CAB026342, HPA062126" Enhanced Supported "Nuclear membrane,Plasma membrane" "Secreted in other tissues" NA NA 960000 "Plasma membrane" "Nuclear membrane" "CAB026342: , HPA018994: AB_1852607, HPA062126: AB_2684691" "unprognostic (1.88e-2)" "unprognostic (6.41e-2)" "unprognostic (8.57e-2)" "prognostic unfavorable (8.06e-5)" "unprognostic (4.33e-3)" "unprognostic (2.28e-1)" "unprognostic (4.44e-3)" "unprognostic (2.99e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (1.16e-4)" "unprognostic (2.10e-1)" "unprognostic (2.82e-3)" "unprognostic (3.25e-1)" "unprognostic (4.47e-2)" "unprognostic (1.12e-2)" "unprognostic (5.60e-3)" 2.1 0.3 5.4 0.3 4.3 0.4 5.6 0.5 11.3 5.4 0.3 0.0 0.0 0.5 0.7 0.3 29.1 7.8 3.3 0.2 4.8 0.5 2.6 0.2 1.6 0.3 0.3 3.5 1.0 0.2 0.2 0.1 0.5 4.2 0.3 0.2 0.0 7.4 0.3 0.6 77.5 0.3 0.4 0.3 0.5 0.4 0.3 0.0 0.0 0.4 90.2 15.3 0.2 9.0 1.1 0.4 1.3 0.8 2.1 1.0 0.6 2.7 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 6.7 0.0 1.0 0.0 0.1 26.6 0.0 0.9 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 0.1 1.3 0.8 0.4 0.4 0.4 0.7 0.6 0.6 0.4 0.4 1.1 1.0 0.9 0.9 2.1 0.4 0.4 0.7 0.6 5.4 4.3 0.5 11.3 4.8 0.5 0.3 3.5 4.2 0.0 6.0 0.6 0.0 0.1 4.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 9.4 0.0 0.0 0.0 1.8 KNTC1 "KIAA0166, ROD" ENSG00000184445 "Kinetochore associated 1" P50748 12 122527246-122626396 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 39.6" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 23.5;Erythroid cells: 23.3;Spermatocytes: 24.6;Spermatogonia: 35.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025241 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA025241: AB_1852629" "unprognostic (1.17e-1)" "unprognostic (2.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.53e-2)" "unprognostic (9.34e-2)" "prognostic favorable (8.69e-4)" "prognostic unfavorable (4.79e-6)" "unprognostic (4.04e-2)" "unprognostic (7.20e-3)" "unprognostic (1.59e-2)" "unprognostic (4.78e-2)" "unprognostic (1.92e-2)" "prognostic unfavorable (7.89e-8)" "unprognostic (2.17e-2)" "unprognostic (3.08e-1)" "unprognostic (8.04e-2)" "unprognostic (1.74e-1)" 5.6 5.6 4.5 15.3 5.4 28.9 5.8 7.5 5.6 5.2 6.4 2.7 3.9 7.0 5.4 5.5 9.6 4.9 2.9 2.9 4.6 1.8 4.9 4.5 5.8 11.8 4.0 3.8 6.7 4.9 3.5 5.9 8.1 3.6 5.3 9.7 3.9 6.1 2.8 1.6 11.7 10.9 7.7 3.1 14.1 5.5 23.2 2.8 39.6 4.0 7.0 15.6 4.4 6.6 4.8 2.1 5.0 2.6 2.2 3.6 0.8 13.1 11.0 31.7 7.3 2.5 4.5 14.3 12.2 7.9 12.1 11.5 10.4 11.1 15.8 6.4 5.9 8.0 18.2 13.7 7.6 16.1 11.2 9.5 19.4 20.5 10.6 0.8 19.0 13.4 2.4 1.7 12.5 8.3 6.3 8.2 20.2 19.3 11.9 9.1 9.7 15.7 44.1 16.0 6.4 13.9 21.6 15.4 17.5 7.2 14.1 9.8 12.7 22.2 4.7 6.5 19.7 17.9 11.0 6.0 13.9 13.3 13.5 14.2 16.1 16.1 24.3 8.3 12.4 15.8 5.0 1.4 4.6 2.0 1.9 1.8 4.8 3.3 3.6 1.3 3.0 2.5 2.9 4.4 2.2 2.6 2.1 1.4 0.8 4.5 5.4 7.5 5.6 4.6 1.8 4.0 3.8 3.6 2.8 0.0 1.6 6.0 1.2 3.8 2.5 1.2 0.0 6.7 2.3 5.2 3.9 5.0 0.0 1.2 23.5 2.1 1.0 23.3 0.3 5.0 2.1 0.8 1.1 0.9 4.0 0.0 0.0 1.3 2.4 13.7 4.4 3.1 1.7 1.8 1.2 0.9 0.7 0.0 2.8 0.3 3.6 6.5 1.4 24.6 35.8 1.9 2.4 3.3 5.2 0.6 KRT75 K6HF ENSG00000170454 "Keratin 75" O95678 12 52424070-52434525 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "skin 1: 22.9;tongue: 18.8" "Cell type enhanced" "Detected in some" 14 "Basal keratinocytes: 2.5;Ductal cells: 1.2;Early spermatids: 2.0;Late spermatids: 1.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 36.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "PC-3: 22.2;U-2 OS: 29.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019367, HPA076201" Enhanced Approved "Plasma membrane,Cytosol" NA NA 2200000000 Cytosol "Plasma membrane" "HPA019367: AB_1852239, HPA076201: AB_2686786" "unprognostic (2.83e-2)" "unprognostic (2.81e-2)" "unprognostic (1.65e-2)" "unprognostic (5.79e-2)" "unprognostic (8.85e-3)" "unprognostic (2.67e-1)" "unprognostic (2.17e-2)" "unprognostic (1.72e-1)" "unprognostic (6.60e-2)" "unprognostic (9.20e-2)" "unprognostic (5.19e-2)" "unprognostic (2.45e-1)" "unprognostic (8.98e-2)" "unprognostic (1.94e-1)" 0.4 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.1 0.0 0.4 0.0 3.5 0.0 18.8 3.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.8 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 KRT77 KRT1B ENSG00000189182 "Keratin 77" Q7Z794 12 52689626-52703463 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "skin 1: 77.7" "Cell type enriched" "Detected in some" 9 "Suprabasal keratinocytes: 17.7" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 36 "HaCaT: 9.1" "Group enriched" "Detected in many" 5 "amygdala: 9.3;basal ganglia: 6.7;cerebral cortex: 4.7;hippocampal formation: 8.3;hypothalamus: 6.3" "Not detected" "Not detected" HPA045934 Enhanced Approved "Nuclear membrane,Plasma membrane" NA NA 2100000000 "Nuclear membrane, Plasma membrane" "HPA045934: AB_10960065" "unprognostic (3.52e-2)" "unprognostic (1.54e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-1)" "unprognostic (2.61e-1)" "unprognostic (2.11e-1)" "unprognostic (2.06e-1)" 0.1 0.0 0.1 0.1 0.1 0.0 6.4 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 77.7 0.1 0.1 0.1 0.1 0.0 0.1 0.1 4.6 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 2.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.7 0.0 0.0 0.0 0.0 L1CAM "CD171, HSAS, HSAS1, MASA, MIC5, S10, SPG1" ENSG00000198910 "L1 cell adhesion molecule" P32004 X 153861514-153886174 "CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Differentiation, Neurogenesis" "Developmental protein" "Disease mutation, Hereditary spastic paraplegia, Hirschsprung disease, Mental retardation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 29.6;brain: 54.5" "Group enriched" "Detected in some" 6 "Collecting duct cells: 80.3;Horizontal cells: 31.8;Melanocytes: 42.2" "Cancer enhanced" "Detected in many" "melanoma: 34.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "memory B-cell: 1.0;naive B-cell: 2.2" "Lineage enriched" "Detected in single" 7 "B-cells: 2.2" "Cell line enhanced" "Detected in many" "BJ hTERT+: 73.5;BJ hTERT+ SV40 Large T+ RasG12V: 40.4;HeLa: 53.0;RH-30: 32.2;RPTEC TERT1: 43.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB010896 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 59000000 "Nucleoplasm, Plasma membrane" "CAB010896: AB_609903" "unprognostic (1.33e-3)" "unprognostic (3.43e-2)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.51e-10)" "unprognostic (2.04e-2)" "prognostic unfavorable (3.81e-4)" "unprognostic (9.44e-2)" "prognostic unfavorable (2.36e-6)" "unprognostic (1.13e-1)" "unprognostic (9.12e-2)" "unprognostic (8.52e-3)" "unprognostic (8.02e-2)" "prognostic unfavorable (1.17e-4)" "unprognostic (3.07e-1)" "unprognostic (6.31e-2)" "unprognostic (1.69e-1)" "unprognostic (7.47e-3)" 4.4 29.6 19.9 8.0 21.9 1.2 1.7 54.5 43.6 2.8 16.3 1.5 2.0 4.9 1.7 3.0 5.3 2.6 3.2 5.2 11.2 20.6 12.3 1.3 1.3 3.7 7.3 22.4 1.4 3.0 1.0 6.1 1.4 19.3 3.5 5.7 6.2 5.9 10.8 1.6 9.9 7.6 6.1 3.5 1.7 4.8 1.5 3.4 0.0 1.2 1.3 2.6 2.3 3.9 2.2 0.0 0.0 0.0 0.0 0.3 0.2 17.9 1.4 5.4 0.0 0.0 0.0 2.3 25.5 73.5 24.6 40.4 7.3 0.1 0.0 24.3 0.1 20.6 0.7 0.6 0.4 12.9 0.0 0.1 0.0 53.0 1.1 0.0 0.0 4.0 0.1 0.3 3.7 2.5 0.0 0.0 0.0 0.0 0.0 0.1 24.4 0.0 0.5 1.2 0.0 0.9 0.0 32.2 0.1 43.2 0.3 16.2 10.6 14.3 12.7 10.3 12.7 1.3 0.3 0.0 0.0 10.8 1.1 12.1 0.2 0.3 0.1 0.1 0.2 20.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.3 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 19.9 21.9 54.5 30.2 11.2 20.6 7.3 22.4 19.3 3.4 0.0 0.0 0.8 0.0 1.0 8.5 0.8 0.0 0.0 0.0 80.3 3.9 0.0 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.0 0.0 0.1 31.8 0.0 1.8 0.0 0.0 0.9 0.0 42.2 0.0 0.0 0.8 0.0 0.0 0.0 0.2 8.6 0.0 0.4 0.0 0.1 1.1 0.1 0.0 0.0 0.1 L3MBTL1 "dJ138B7.3, DKFZp586P1522, KIAA0681, L3MBTL, ZC2HC3" ENSG00000185513 "L3MBTL1, histone methyl-lysine binding protein" Q9Y468 20 43507680-43550950 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 16.2;Cone photoreceptor cells: 13.7;Spermatocytes: 15.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BEWO: 10.7;SuSa: 11.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA068051 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA068051: AB_2732778" "unprognostic (2.32e-1)" "unprognostic (2.77e-1)" "unprognostic (5.66e-2)" "unprognostic (7.19e-3)" "unprognostic (1.28e-1)" "unprognostic (1.50e-2)" "unprognostic (7.65e-4)" "unprognostic (6.02e-2)" "unprognostic (6.00e-2)" "unprognostic (2.23e-2)" "unprognostic (1.15e-3)" "unprognostic (1.20e-2)" "unprognostic (1.44e-3)" "unprognostic (2.01e-1)" "unprognostic (1.65e-1)" "unprognostic (2.89e-1)" "unprognostic (1.56e-4)" 3.3 5.7 12.6 4.3 11.7 6.4 5.2 25.0 14.3 5.6 4.9 10.5 8.3 4.3 8.2 10.7 4.0 10.4 3.9 5.7 13.8 16.4 4.5 1.8 4.2 4.7 16.3 9.6 11.2 3.3 7.1 14.6 5.1 10.1 6.6 4.4 7.5 8.1 8.0 9.0 9.7 4.7 6.0 7.4 5.6 4.2 13.3 14.5 4.6 7.2 0.7 5.5 4.3 5.4 0.5 1.3 1.5 0.2 2.5 1.8 1.4 0.2 2.0 5.5 3.7 0.1 0.0 10.7 1.2 1.5 1.8 3.1 0.5 5.7 3.1 2.0 2.0 2.4 4.8 0.0 1.1 1.5 0.0 4.9 2.5 4.9 3.8 1.4 0.0 2.9 2.2 2.5 1.2 0.0 5.1 1.1 4.3 2.9 2.1 1.0 0.6 1.3 3.2 2.7 2.0 2.9 2.4 1.3 0.8 4.1 1.3 2.0 6.2 2.0 1.3 0.3 11.1 2.7 3.2 2.0 1.0 3.7 0.0 0.9 4.0 1.0 1.1 3.9 3.9 1.1 0.0 0.2 0.6 0.8 0.2 1.3 0.5 1.0 1.0 0.9 0.4 1.8 0.6 1.5 2.5 0.1 1.3 0.3 1.4 12.6 11.7 25.0 14.3 13.8 16.4 16.3 9.6 10.1 14.5 3.0 2.7 0.0 1.9 0.8 16.2 1.6 0.0 6.7 5.7 5.2 13.7 1.9 1.7 1.1 1.6 1.0 1.1 0.0 0.2 2.8 1.1 2.0 4.7 0.8 1.1 6.4 1.2 1.3 1.9 2.1 4.6 2.4 3.3 0.0 1.1 6.4 0.6 1.9 5.6 0.3 11.7 0.0 1.4 15.1 10.2 1.0 1.6 1.5 1.7 1.4 LAMA4 LAMA3 ENSG00000112769 "Laminin subunit alpha 4" Q16363 6 112108760-112254939 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 76.6;Fibroblasts: 77.1;Leydig cells: 154.2;Peritubular cells: 76.4;Smooth muscle cells: 100.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC diff: 51.9;ASC TERT1: 79.0;HSkMC: 61.5;hTERT-RPE1: 38.0;HUVEC TERT2: 64.8;TIME: 59.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA015693, CAB078156" Enhanced Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 350000 "Plasma membrane, Cytosol" "CAB078156: AB_2665814, HPA015693: AB_1852687" "unprognostic (1.87e-2)" "unprognostic (6.48e-2)" "unprognostic (8.37e-2)" "unprognostic (2.39e-2)" "unprognostic (1.04e-1)" "unprognostic (1.15e-1)" "unprognostic (2.52e-2)" "unprognostic (5.07e-2)" "unprognostic (4.59e-2)" "unprognostic (2.93e-2)" "unprognostic (9.06e-2)" "unprognostic (1.78e-1)" "prognostic unfavorable (2.00e-4)" "unprognostic (4.40e-3)" "unprognostic (1.85e-1)" "unprognostic (2.80e-2)" "unprognostic (1.15e-2)" 42.3 3.6 5.8 20.7 5.4 0.0 21.7 3.7 4.6 28.7 28.6 4.7 12.9 6.3 41.0 24.8 29.7 29.6 23.3 13.8 5.1 4.1 4.6 1.8 27.9 8.8 5.5 2.1 19.9 1.6 3.6 5.6 25.4 5.0 21.3 13.2 18.4 22.9 15.7 5.7 6.8 13.1 53.6 3.6 0.4 15.6 9.4 2.5 1.1 9.1 15.2 6.6 35.6 19.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.0 51.9 79.0 0.0 13.0 7.8 1.3 0.2 0.0 4.9 0.0 8.6 22.4 3.0 0.0 0.5 0.0 0.2 0.0 6.7 0.0 6.5 0.0 10.6 0.0 0.0 61.5 0.0 9.4 0.0 38.0 64.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 21.2 0.3 0.0 0.3 2.0 0.0 10.0 0.2 0.0 0.0 59.2 21.4 1.1 23.8 4.3 0.0 0.0 0.0 5.3 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.4 3.7 4.6 5.1 4.1 5.5 2.1 5.0 2.5 3.0 5.0 0.0 1.2 20.1 1.0 47.4 0.0 0.0 3.4 3.5 0.0 0.9 3.3 0.4 76.6 56.3 0.0 0.0 0.6 71.2 77.1 1.1 1.1 28.2 2.7 0.0 0.0 19.6 2.2 34.0 154.2 1.7 54.0 1.0 0.0 0.0 0.6 0.0 76.4 0.0 0.2 64.7 100.7 0.7 0.5 16.3 2.5 0.0 0.0 5.2 LAMC1 LAMB2 ENSG00000135862 "Laminin subunit gamma 1" P11047 1 183023460-183145592 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Leydig cells: 111.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 1.1;naive B-cell: 3.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 15 "B-cells: 3.2;dendritic cells: 1.3" "Cell line enhanced" "Detected in many" "ASC diff: 170.5;ASC TERT1: 93.8;HSkMC: 105.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001908, HPA001909, CAB004486, CAB078163" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to extracellular matrix" NA NA 90000000 "Endoplasmic reticulum, Plasma membrane" "CAB004486: AB_627870, CAB078163: AB_2665817, HPA001908: AB_1079229, HPA001909: AB_1079230" "unprognostic (1.46e-1)" "unprognostic (1.05e-2)" "unprognostic (8.30e-2)" "unprognostic (8.84e-3)" "unprognostic (3.75e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (1.54e-2)" "unprognostic (1.38e-2)" "unprognostic (2.71e-2)" "unprognostic (1.10e-1)" "unprognostic (1.80e-1)" "unprognostic (1.88e-3)" "unprognostic (1.10e-3)" "unprognostic (1.53e-1)" "unprognostic (1.54e-1)" "prognostic unfavorable (8.85e-5)" 49.0 6.8 2.9 11.3 4.0 0.2 51.5 5.9 3.4 30.4 27.7 2.8 12.8 4.9 30.5 28.7 31.5 21.5 25.9 39.5 3.4 2.0 10.0 6.8 22.5 10.6 3.9 2.7 22.7 9.8 7.4 4.1 73.1 3.5 23.9 11.4 11.7 11.6 17.3 32.2 15.6 17.6 41.3 3.0 4.7 22.3 16.1 2.7 3.5 21.7 16.4 7.3 40.2 37.6 3.2 1.3 0.0 0.1 0.0 0.0 0.2 5.2 8.5 28.2 8.0 170.5 93.8 42.7 38.6 38.8 15.6 9.2 25.3 6.0 1.9 17.8 18.5 9.2 13.1 5.3 10.2 11.9 0.0 5.4 0.0 7.7 9.2 26.8 1.6 0.9 105.6 5.5 18.6 14.7 27.9 27.1 0.0 0.0 5.7 18.9 2.3 0.0 1.7 11.4 9.7 1.6 1.3 23.8 0.9 25.2 14.0 1.8 5.3 10.1 0.0 9.9 50.7 2.2 4.4 50.0 19.1 7.5 17.6 9.6 2.2 0.0 1.2 15.8 1.2 18.4 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 2.9 4.0 5.9 3.4 3.4 2.0 3.9 2.7 3.5 2.7 32.8 16.3 4.5 38.6 27.8 1.9 48.8 25.5 10.7 17.0 34.9 3.9 80.1 1.7 50.0 5.4 59.4 0.7 0.0 19.8 53.9 99.3 48.3 2.3 17.8 16.1 1.6 1.2 26.4 10.8 3.8 111.9 5.3 32.1 10.0 1.7 2.0 39.3 3.5 58.7 10.2 0.6 71.1 83.0 7.0 39.9 14.8 60.3 0.5 2.6 21.6 LAMP2 CD107b ENSG00000005893 "Lysosomal associated membrane protein 2" P13473 X 120427827-120469365 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Autophagy "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Syncytiotrophoblasts: 336.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 112.9" "Lineage enriched" "Detected in all" 5 "granulocytes: 112.9" "Cell line enhanced" "Detected in all" "ASC diff: 112.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005272, HPA029100, HPA029101" Supported Supported "Vesicles,Plasma membrane" NA NA 820000000 "Vesicles, Plasma membrane" "CAB005272: AB_647855, HPA029100: AB_10795022, HPA029101: " "unprognostic (2.99e-3)" "unprognostic (5.26e-2)" "unprognostic (2.66e-3)" "unprognostic (1.74e-1)" "unprognostic (3.10e-1)" "unprognostic (2.50e-2)" "unprognostic (4.84e-1)" "unprognostic (1.56e-1)" "unprognostic (1.15e-1)" "unprognostic (1.55e-1)" "unprognostic (9.73e-2)" "unprognostic (1.11e-2)" "unprognostic (2.50e-2)" "unprognostic (2.85e-1)" "unprognostic (6.78e-2)" "unprognostic (2.66e-1)" "unprognostic (5.53e-3)" 21.8 33.6 39.9 16.1 87.9 22.6 27.1 16.2 55.5 33.0 18.3 88.7 27.9 25.1 20.8 37.5 34.6 22.4 43.3 20.9 52.5 30.3 55.0 83.7 25.3 14.3 131.0 36.9 22.7 27.4 28.8 20.2 35.4 58.6 37.3 19.7 17.2 47.8 32.9 32.4 26.9 20.5 21.1 84.3 17.9 23.6 11.9 116.9 21.2 33.7 14.3 15.4 21.1 27.0 3.7 11.6 112.9 21.7 5.4 5.8 10.5 11.7 11.6 8.6 10.9 112.3 38.3 23.6 20.3 35.4 19.7 37.0 9.6 21.0 8.3 17.9 35.2 63.0 19.7 12.4 15.3 32.2 9.3 8.8 6.5 12.9 12.9 37.4 28.7 18.2 41.5 30.9 26.3 17.4 52.1 26.9 5.9 7.5 29.7 31.9 21.6 8.0 14.7 6.6 16.8 10.2 6.2 14.5 14.8 28.9 8.7 2.9 4.5 21.7 22.1 43.3 15.8 13.1 32.1 27.8 28.4 13.8 36.5 54.7 14.9 14.2 5.4 27.1 34.7 67.9 4.9 21.7 41.3 5.0 18.7 4.0 3.1 4.8 4.7 11.6 3.7 4.3 4.1 112.9 5.4 17.3 6.3 5.8 10.5 39.9 87.9 16.2 55.5 52.5 30.3 131.0 36.9 58.6 116.9 68.5 48.0 23.8 73.6 89.6 15.0 29.0 186.0 44.2 52.4 62.8 13.7 140.2 33.2 170.8 2.3 65.2 53.1 0.0 62.0 111.7 86.5 124.2 16.3 167.8 191.1 17.5 35.2 100.7 120.2 4.2 105.3 97.6 124.9 124.4 31.2 128.8 66.8 43.5 103.3 128.2 9.3 38.8 61.8 5.6 13.2 119.1 336.5 30.5 31.0 76.1 LAT LAT1 ENSG00000213658 "Linker for activation of T cells" O43561 16 28984826-28990783 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 10 "blood: 58.1;lymphoid tissue: 193.6" "Group enriched" "Detected in many" 5 "granulocytes: 73.2;T-cells: 103.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 18 "basophil: 38.2;gdT-cell: 47.9;MAIT T-cell: 33.5;memory CD4 T-cell: 46.9;memory CD8 T-cell: 47.9;naive CD4 T-cell: 44.6;naive CD8 T-cell: 42.6;NK-cell: 15.7;T-reg: 58.1" "Group enriched" "Detected in many" 134 "granulocytes: 38.2;NK-cells: 15.7;T-cells: 58.1" "Cell line enhanced" "Detected in some" "HEL: 31.0;HMC-1: 131.1;MOLT-4: 44.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" "CAB002223, HPA011157, CAB012978" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 75000 "Plasma membrane" "Golgi apparatus" "CAB002223: AB_563852, CAB012978: , HPA011157: AB_1079237" "unprognostic (4.35e-3)" "unprognostic (5.17e-3)" "unprognostic (1.25e-2)" "unprognostic (1.21e-1)" "unprognostic (1.62e-1)" "unprognostic (7.15e-5)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (1.27e-1)" "unprognostic (3.25e-2)" "unprognostic (1.52e-3)" "unprognostic (5.33e-2)" "unprognostic (1.02e-8)" "unprognostic (1.04e-2)" "unprognostic (5.58e-2)" "unprognostic (3.25e-1)" "unprognostic (1.51e-4)" 4.8 1.8 1.6 27.6 3.0 8.5 2.5 6.6 2.3 3.9 10.8 2.0 2.0 4.9 7.7 3.1 4.3 4.2 5.8 3.1 1.9 1.9 6.0 3.3 7.8 33.2 1.7 1.7 3.0 2.7 1.4 6.0 2.8 1.8 8.5 2.8 3.1 12.2 5.4 2.0 5.8 9.0 3.1 1.9 13.9 5.1 2.3 1.7 193.6 7.3 4.6 50.3 6.4 5.4 0.2 0.2 38.2 0.2 15.7 58.1 26.8 0.1 0.3 0.2 0.4 0.6 0.3 0.8 0.8 0.2 0.2 0.3 0.3 0.5 0.1 1.1 0.3 0.1 0.4 0.4 0.2 0.1 0.2 0.5 31.0 0.7 0.5 0.1 0.9 131.1 0.3 0.6 0.2 0.1 0.4 0.1 10.5 0.4 3.7 0.1 0.8 44.6 6.1 0.5 0.0 0.4 0.5 0.1 3.9 0.3 0.2 0.8 0.1 0.1 0.3 0.3 0.2 0.4 5.1 0.6 0.6 3.0 0.6 0.2 1.2 1.0 0.4 7.9 0.4 0.5 38.2 0.2 0.1 47.9 0.2 33.5 0.2 46.9 47.9 0.1 0.2 44.6 42.6 2.3 15.7 0.1 0.2 58.1 26.8 1.6 3.0 6.6 2.3 1.9 1.9 1.7 1.7 1.8 1.7 0.0 19.1 1.9 1.7 6.4 10.4 0.4 7.6 0.0 4.5 8.7 5.9 1.9 1.7 1.3 0.1 2.4 0.7 0.0 0.5 0.8 2.7 1.8 73.2 2.6 14.9 6.4 0.0 8.6 6.5 0.0 1.4 9.0 10.1 1.8 1.5 5.7 0.7 0.0 0.7 0.4 10.7 0.0 3.4 1.4 2.4 4.5 2.3 103.8 1.3 0.7 LCTL "FLJ33279, KLG, KLPH" ENSG00000188501 "Lactase like" Q6UWM7 15 66547179-66565979 "Cancer-related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.4" "Group enriched" "Detected in some" 4 "Early spermatids: 5.0;Late spermatids: 7.5;Spermatogonia: 2.7" "Group enriched" "Detected in some" 5 "glioma: 1.5;melanoma: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "neutrophil: 3.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 6.3;hTERT-RPE1: 7.5;NTERA-2: 5.8;SuSa: 7.0;U-2 OS: 16.2;U-251 MG: 6.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA071640 Approved "Endoplasmic reticulum,Plasma membrane" NA NA "Plasma membrane" "Endoplasmic reticulum" "HPA071640: AB_2686428" "unprognostic (4.60e-2)" "unprognostic (5.46e-2)" "unprognostic (8.70e-2)" "unprognostic (1.56e-2)" "unprognostic (3.22e-3)" "unprognostic (3.53e-2)" "unprognostic (6.67e-2)" "unprognostic (1.06e-2)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "unprognostic (3.47e-1)" "unprognostic (4.51e-3)" "unprognostic (4.44e-16)" "unprognostic (6.06e-2)" "unprognostic (3.39e-1)" "unprognostic (5.48e-2)" "unprognostic (1.39e-1)" 0.4 0.7 6.0 0.9 4.3 3.1 0.4 0.7 3.1 0.4 0.5 3.1 0.0 1.4 0.8 0.9 0.7 0.3 1.0 0.4 3.3 1.2 0.4 0.4 0.4 1.0 5.3 3.1 0.6 0.7 0.2 0.4 0.3 4.9 0.4 0.3 1.1 0.6 0.3 3.0 2.6 0.7 0.4 10.4 0.8 0.7 1.5 2.3 0.0 0.5 0.0 0.2 0.3 0.3 0.9 0.6 3.9 0.7 1.0 0.5 0.2 0.3 0.3 3.2 0.3 0.1 0.1 0.8 0.8 0.0 0.0 0.3 0.4 0.4 0.4 6.3 0.2 0.6 0.6 0.0 0.0 0.2 0.2 0.2 0.7 1.0 1.5 0.0 0.2 0.4 0.4 0.0 0.3 0.0 7.5 0.0 0.2 0.4 0.4 0.2 0.1 0.2 0.4 5.8 0.4 0.1 0.2 3.4 0.3 0.0 0.4 0.4 0.3 0.1 0.3 1.8 7.0 0.4 0.5 0.4 1.6 16.2 0.6 6.9 0.2 0.2 0.2 2.1 0.7 2.9 1.6 0.7 0.5 0.5 0.4 0.3 0.4 0.5 0.3 0.2 0.9 0.5 0.4 3.9 1.0 0.4 0.6 0.5 0.2 6.0 4.3 0.7 2.7 3.3 1.2 5.3 3.1 4.9 2.3 0.0 0.0 0.0 0.5 0.3 0.6 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 5.0 0.1 0.0 0.0 0.0 0.3 0.1 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.3 7.5 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 1.1 0.0 0.4 1.2 2.7 0.3 0.2 0.0 0.0 0.3 LENG1 ENSG00000105617 "Leukocyte receptor cluster member 1" Q96BZ8 19 54155161-54159882 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "AF22: 5.7;HaCaT: 8.3;HDLM-2: 5.1;HSkMC: 3.9;LHCN-M2: 4.8;U-87 MG: 5.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043541 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA043541: AB_10961190" "unprognostic (8.75e-2)" "unprognostic (4.36e-2)" "unprognostic (2.72e-2)" "unprognostic (2.30e-1)" "unprognostic (5.69e-2)" "unprognostic (1.91e-1)" "unprognostic (1.10e-1)" "unprognostic (8.73e-2)" "unprognostic (6.42e-2)" "unprognostic (5.22e-2)" "prognostic favorable (8.12e-4)" "unprognostic (7.51e-2)" "prognostic favorable (3.72e-4)" "unprognostic (2.21e-1)" "unprognostic (2.84e-1)" "unprognostic (4.82e-2)" "unprognostic (1.14e-2)" 9.6 8.0 8.2 8.0 11.1 6.1 7.3 10.1 9.5 7.5 10.8 11.5 10.8 7.6 13.4 8.7 6.1 11.9 9.6 12.7 8.2 7.9 7.6 7.2 8.9 6.3 11.2 7.6 10.3 9.7 7.3 8.5 7.3 10.3 9.3 10.7 6.6 21.6 10.4 13.1 9.9 14.8 7.5 10.8 21.8 8.8 12.3 13.1 10.1 10.8 7.6 6.8 8.2 15.8 3.8 3.2 4.1 3.3 2.8 3.8 0.8 0.1 0.4 5.7 0.2 0.6 0.2 0.4 0.8 0.1 0.6 0.3 0.2 0.0 0.0 0.2 0.0 0.5 8.3 0.3 0.2 0.2 5.1 1.3 0.0 0.5 0.1 0.0 0.0 0.5 3.9 0.7 0.2 0.5 0.2 0.1 0.5 0.1 0.0 4.8 0.6 0.4 0.5 0.0 0.2 0.6 0.0 0.1 0.8 0.5 0.5 0.2 0.2 0.3 0.0 0.3 0.0 0.2 0.1 0.7 0.4 0.4 0.2 0.4 0.1 0.2 0.0 5.6 0.1 2.7 1.0 2.7 4.1 2.5 3.3 2.8 1.6 3.7 3.8 2.2 3.8 3.7 2.9 3.7 2.8 1.6 3.2 2.7 0.8 8.2 11.1 10.1 9.5 8.2 7.9 11.2 7.6 10.3 13.1 17.9 9.1 29.1 20.5 18.3 10.2 6.4 15.3 18.7 6.8 17.4 0.0 24.4 19.9 18.7 76.0 20.3 33.5 0.0 24.7 12.4 18.9 14.1 54.2 15.5 26.7 6.4 25.9 25.8 16.2 6.4 20.8 26.0 20.3 26.2 20.4 14.5 21.8 17.8 14.2 21.2 13.9 38.8 26.8 23.1 29.4 18.7 35.8 35.5 16.6 14.7 LGR6 FLJ14471 ENSG00000133067 "Leucine rich repeat containing G protein-coupled receptor 6" Q9HBX8 1 202193901-202319781 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Wnt signaling pathway" "G-protein coupled receptor, Receptor, Transducer" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 49.6" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 2.8;Cardiomyocytes: 8.3;Late spermatids: 3.2;Spermatocytes: 6.0;Spermatogonia: 3.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 17.8" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "gdT-cell: 14.3;memory CD8 T-cell: 8.3;naive CD8 T-cell: 4.7" "Lineage enriched" "Detected in single" 41 "T-cells: 14.3" "Cell line enhanced" "Detected in some" "A549: 16.6;CAPAN-2: 14.8;HaCaT: 8.0;HeLa: 4.0" "Region enriched" "Detected in some" 9 "olfactory region: 30.0" HPA008556 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA008556: " "unprognostic (4.72e-3)" "unprognostic (5.29e-2)" "unprognostic (1.21e-1)" "unprognostic (2.89e-2)" "prognostic unfavorable (4.35e-4)" "unprognostic (1.08e-1)" "unprognostic (5.13e-2)" "unprognostic (9.23e-2)" "unprognostic (1.12e-1)" "unprognostic (2.54e-2)" "unprognostic (4.01e-2)" "unprognostic (7.89e-2)" "unprognostic (1.00e-2)" "unprognostic (1.17e-3)" "unprognostic (2.08e-1)" "unprognostic (1.70e-1)" "unprognostic (7.83e-2)" 1.1 0.1 0.9 0.8 3.2 1.8 7.9 6.0 2.4 2.6 2.2 1.5 0.5 0.2 1.6 7.3 4.4 13.8 49.6 12.3 0.7 3.3 0.9 1.4 6.9 1.1 6.8 0.2 2.2 0.5 0.1 15.9 0.9 9.3 6.7 1.1 0.8 8.5 2.5 0.3 3.2 1.6 2.6 1.6 5.3 0.7 4.9 3.9 0.2 4.1 2.6 3.4 3.2 2.9 0.0 0.0 0.0 0.0 0.3 14.3 2.5 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 1.7 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.3 0.0 0.9 0.0 1.7 8.3 0.0 0.0 0.7 4.7 0.0 0.3 0.0 0.0 0.4 2.5 0.9 3.2 6.0 2.4 0.7 3.3 6.8 0.2 9.3 3.9 0.0 0.0 0.0 2.8 1.1 0.0 8.3 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 2.4 0.0 0.2 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.0 3.2 0.0 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 6.0 3.3 0.1 0.7 0.5 1.7 0.3 LHX6 LHX6.1 ENSG00000106852 "LIM homeobox 6" Q9UPM6 9 122202577-122229626 "Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4" "Group enriched" "Detected in some" 9 "Early spermatids: 64.4;Late spermatids: 142.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 11.7;K-562: 8.5;NB-4: 16.1;PC-3: 11.1;U-87 MG: 8.9" "Group enriched" "Detected in many" 5 "amygdala: 11.3;basal ganglia: 16.2;cerebral cortex: 8.5;hippocampal formation: 9.5;hypothalamus: 10.7" "Group enriched" "Detected in many" 7 "amygdala: 13.1;basal ganglia: 12.2;cerebral cortex: 13.3;hippocampal formation: 13.4;hypothalamus: 4.9" "HPA047854, HPA058319" Approved Uncertain "Nucleoli fibrillar center,Plasma membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA047854: AB_2680183, HPA058319: " "unprognostic (2.96e-1)" "unprognostic (2.86e-1)" "unprognostic (8.06e-2)" "unprognostic (6.18e-2)" "unprognostic (7.72e-2)" "unprognostic (4.49e-2)" "unprognostic (5.83e-2)" "unprognostic (3.47e-1)" "unprognostic (5.94e-3)" "unprognostic (2.15e-1)" "unprognostic (2.98e-2)" "unprognostic (9.14e-2)" "unprognostic (5.64e-6)" "unprognostic (1.77e-3)" "unprognostic (1.96e-1)" "unprognostic (1.08e-1)" "unprognostic (3.51e-2)" 14.4 1.2 7.3 4.2 11.5 0.5 10.6 0.4 17.4 3.6 3.0 0.9 0.9 2.6 3.8 2.5 4.1 2.6 6.1 6.4 12.3 3.5 1.9 0.9 5.2 2.2 2.0 12.4 2.1 1.1 2.3 0.3 6.0 1.1 2.4 3.2 1.4 2.3 2.3 4.3 2.5 3.1 7.4 1.5 0.6 2.3 7.8 2.2 0.0 3.2 4.6 2.5 5.3 7.3 0.0 0.0 0.0 0.1 0.0 0.5 0.1 2.4 0.0 0.0 0.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 11.7 3.0 0.0 2.6 0.0 1.0 0.0 1.3 3.3 0.0 0.0 1.9 0.1 0.8 0.5 0.0 2.2 0.6 0.0 0.8 0.0 0.2 0.0 4.3 0.6 8.5 0.0 0.0 2.4 0.0 16.1 2.6 0.4 11.1 0.0 5.6 0.0 2.0 0.0 1.7 0.4 3.0 0.9 3.0 0.5 2.5 0.0 0.7 0.8 1.2 0.0 0.2 0.3 0.1 0.2 8.9 3.8 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 7.3 11.5 0.4 17.4 12.3 3.5 2.0 12.4 1.1 2.2 0.0 0.0 0.0 0.1 0.1 0.0 2.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 64.4 11.9 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 142.7 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.5 2.3 6.9 0.3 0.0 0.0 0.0 0.1 LONRF3 "FLJ22612, RNF127" ENSG00000175556 "LON peptidase N-terminal domain and ring finger 3" Q496Y0 X 118974614-119018355 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 2: 14.9;Basal glandular cells: 13.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "MAIT T-cell: 7.4" "Lineage enriched" "Detected in single" 8 "T-cells: 7.4" "Cell line enhanced" "Detected in many" "GAMG: 9.9;K-562: 10.6;OE19: 12.0;PC-3: 12.1;SiHa: 11.0;SK-MEL-30: 9.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA050422, HPA061162" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050422: AB_2681122, HPA061162: AB_2732658" "unprognostic (1.80e-2)" "unprognostic (1.48e-1)" "unprognostic (1.24e-1)" "unprognostic (1.92e-1)" "unprognostic (4.24e-2)" "unprognostic (1.64e-1)" "unprognostic (6.06e-3)" "unprognostic (1.29e-2)" "unprognostic (3.21e-1)" "unprognostic (8.01e-2)" "prognostic unfavorable (4.32e-4)" "unprognostic (4.29e-2)" "unprognostic (2.31e-3)" "unprognostic (6.34e-2)" "unprognostic (6.16e-2)" "unprognostic (1.70e-1)" "unprognostic (1.27e-3)" 3.8 3.9 4.2 2.1 3.4 4.6 10.8 15.8 6.1 1.9 4.1 2.0 1.6 2.9 2.4 3.1 1.7 2.5 3.9 3.9 5.0 1.9 3.6 15.4 11.8 0.8 1.7 3.7 2.0 8.1 0.4 3.5 0.9 4.4 3.0 5.5 4.1 8.1 3.0 13.8 1.4 2.3 10.8 2.7 1.1 4.5 2.7 2.5 0.0 9.9 1.9 1.1 4.7 6.6 0.0 0.1 0.8 0.8 0.0 7.4 0.7 3.7 5.5 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 4.6 0.0 2.7 0.0 9.9 0.0 1.1 0.0 0.0 0.1 3.1 4.7 9.0 5.3 3.1 4.0 0.6 0.0 0.0 0.0 0.0 1.7 1.4 0.4 10.6 0.0 0.8 4.5 0.0 1.8 0.0 12.0 12.1 0.0 2.5 0.0 3.3 1.5 0.2 0.0 11.0 0.3 9.6 0.1 0.0 3.5 0.2 0.1 0.2 0.0 5.8 1.2 4.7 0.0 2.6 4.1 2.4 0.0 0.8 0.0 4.5 0.0 7.4 0.0 2.0 1.5 0.1 0.0 1.1 1.6 0.8 0.0 0.0 0.0 0.7 0.7 4.2 3.4 15.8 6.1 5.0 1.9 1.7 3.7 4.4 2.5 6.0 14.9 0.0 13.8 1.3 3.6 3.2 0.0 0.0 10.3 1.8 0.0 0.5 1.7 2.4 1.3 1.9 5.8 0.0 3.8 0.0 2.8 4.7 5.8 4.0 2.9 1.6 1.2 3.1 3.7 0.4 0.9 3.8 3.3 0.0 2.3 6.1 4.6 3.1 1.4 0.7 0.2 0.0 3.1 1.7 4.1 0.1 0.3 1.3 2.5 9.8 LPAR1 "edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1" ENSG00000198121 "Lysophosphatidic acid receptor 1" Q92633 9 110873263-111038458 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.4" "Cell type enhanced" "Detected in many" 12 "Fibroblasts: 45.6;Leydig cells: 35.9;Peritubular cells: 66.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 7.5;eosinophil: 15.6" "Group enriched" "Detected in many" 6 "granulocytes: 15.6;monocytes: 7.5" "Cell line enhanced" "Detected in many" "ASC diff: 98.3;ASC TERT1: 57.4;BJ hTERT+: 69.5;HSkMC: 41.7" "Low region specificity" "Detected in all" HPA050667 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA050667: " "unprognostic (1.35e-1)" "unprognostic (1.41e-1)" "unprognostic (4.79e-2)" "unprognostic (6.08e-3)" "unprognostic (1.03e-1)" "unprognostic (1.16e-1)" "unprognostic (2.17e-2)" "unprognostic (2.10e-1)" "unprognostic (1.40e-2)" "unprognostic (4.13e-2)" "unprognostic (1.02e-1)" "unprognostic (4.29e-3)" "unprognostic (2.12e-2)" "unprognostic (5.42e-3)" "unprognostic (2.78e-2)" "unprognostic (9.97e-3)" "unprognostic (1.65e-1)" 16.3 9.5 55.8 12.0 56.2 0.3 14.8 4.7 30.9 43.7 12.3 71.4 3.4 9.4 12.1 12.3 10.6 10.1 9.8 8.5 55.6 30.6 5.7 1.9 7.3 10.5 59.4 17.0 8.9 4.6 1.1 2.3 25.7 29.1 9.4 12.8 3.5 5.6 17.2 3.3 6.9 10.2 14.0 69.8 9.5 6.5 4.8 49.4 0.1 6.2 3.2 11.3 15.4 17.8 0.0 1.9 15.6 7.5 1.8 0.0 1.6 1.8 3.5 5.0 0.0 98.3 57.4 0.0 24.5 69.5 17.2 7.8 0.4 0.3 0.0 0.0 25.3 3.1 7.3 0.0 19.1 14.2 0.0 0.6 0.0 0.2 0.0 26.6 0.0 0.0 41.7 1.1 8.5 16.2 10.3 0.3 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.9 0.0 19.8 0.0 3.7 0.0 3.9 3.3 0.1 1.2 0.5 0.0 0.0 1.0 1.7 0.0 0.0 8.1 0.2 5.8 0.0 0.2 0.0 0.0 1.2 0.0 8.9 0.9 7.5 15.6 0.0 2.6 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 1.6 1.8 1.1 0.1 0.0 1.6 55.8 56.2 4.7 29.5 55.6 30.6 59.4 17.0 29.1 49.4 0.0 0.6 0.0 10.4 11.6 0.0 0.8 0.0 2.7 10.3 0.0 0.0 0.5 1.7 1.3 1.0 1.7 5.1 0.0 2.5 0.3 45.6 9.6 0.0 0.0 3.3 0.0 0.0 3.1 3.3 1.5 35.9 2.5 13.5 12.6 3.7 1.1 1.7 0.0 66.4 0.0 0.0 0.0 7.2 0.0 2.4 8.2 0.7 0.0 4.0 5.5 LPIN1 KIAA0188 ENSG00000134324 "Lipin 1" Q14693 2 11677595-11827409 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Fatty acid metabolism, Lipid metabolism, Transcription, Transcription regulation" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 88.4" "Cell type enriched" "Detected in many" 4 "Late spermatids: 1310.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-266/70: 38.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024591, HPA038021" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA024591: , HPA038021: AB_10669514" "unprognostic (1.97e-1)" "unprognostic (2.47e-1)" "unprognostic (1.32e-1)" "unprognostic (1.87e-2)" "unprognostic (9.17e-2)" "unprognostic (2.69e-2)" "unprognostic (8.20e-2)" "unprognostic (5.28e-3)" "unprognostic (1.09e-1)" "unprognostic (1.07e-2)" "unprognostic (2.45e-3)" "unprognostic (2.55e-2)" "unprognostic (1.06e-1)" "unprognostic (5.58e-3)" "unprognostic (1.25e-1)" "unprognostic (9.60e-2)" "unprognostic (4.02e-1)" 18.1 10.1 13.0 10.7 18.3 6.0 22.1 20.0 16.4 10.5 8.6 10.9 7.3 8.9 11.0 15.0 20.0 7.0 10.4 12.8 11.6 11.9 7.6 13.2 8.0 15.4 13.2 11.2 19.3 7.5 17.2 32.0 9.0 17.9 9.6 7.1 9.0 14.4 11.6 88.4 6.5 9.2 11.0 10.3 8.4 7.6 39.0 13.2 8.3 8.1 14.0 19.2 10.4 21.7 6.5 9.6 11.6 2.8 8.0 11.1 3.2 5.5 6.6 5.5 12.3 25.5 28.4 2.8 7.8 13.4 5.0 8.7 2.4 5.5 2.7 1.0 6.6 14.8 6.0 6.2 17.0 4.6 11.4 3.4 6.8 3.7 3.5 9.0 4.7 32.1 25.6 7.7 20.8 7.9 14.7 9.7 6.7 9.4 24.7 3.7 2.1 4.4 4.1 5.7 1.8 6.7 6.1 10.1 17.3 12.7 3.6 15.3 12.1 2.8 6.8 17.5 5.5 1.7 2.6 6.8 8.0 7.2 5.1 6.7 38.8 30.0 5.2 11.3 8.4 5.9 9.5 2.8 11.6 10.3 2.1 11.1 6.5 9.6 9.7 2.5 5.0 8.4 7.1 1.1 8.0 2.1 9.6 10.5 3.2 13.0 18.3 20.0 14.4 11.6 11.9 13.2 11.2 17.9 13.2 20.8 49.1 22.9 38.9 16.9 40.6 49.5 25.5 61.6 63.7 10.4 80.5 7.3 6.6 18.7 314.7 24.6 9.7 0.0 24.2 5.3 24.6 29.2 33.6 21.9 8.1 46.1 34.7 15.4 15.7 1310.7 110.1 27.2 16.9 7.2 23.9 16.4 25.5 11.6 169.0 3.4 47.2 32.3 20.6 18.4 17.8 10.5 10.3 57.5 13.6 26.8 LRCH2 KIAA1495 ENSG00000130224 "Leucine rich repeats and calponin homology domain containing 2" Q5VUJ6 X 115110616-115234072 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 11 "Alveolar cells type 2: 10.5;Sertoli cells: 25.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HAP1: 17.8;hTERT-RPE1: 9.1;U-266/70: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003233 Approved Approved "Nucleoli,Plasma membrane" NA NA Nucleoli "Plasma membrane" "HPA003233: AB_2265929" "unprognostic (9.74e-2)" "unprognostic (9.48e-2)" "unprognostic (1.14e-2)" "unprognostic (4.22e-5)" "unprognostic (2.88e-2)" "unprognostic (1.17e-1)" "unprognostic (1.42e-1)" "unprognostic (9.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.43e-1)" "unprognostic (1.01e-2)" "unprognostic (1.84e-1)" "unprognostic (4.29e-5)" "unprognostic (1.09e-3)" "unprognostic (1.34e-1)" "unprognostic (7.75e-2)" "unprognostic (1.16e-2)" 5.1 8.7 11.6 3.4 10.2 0.7 3.3 11.2 10.6 11.2 11.6 5.5 4.0 1.6 9.9 4.5 3.6 4.6 5.3 4.7 7.9 8.9 2.6 1.0 5.7 1.8 5.7 4.6 13.8 1.6 1.3 20.9 13.7 7.6 16.4 4.2 2.5 1.3 14.5 1.2 1.1 3.2 13.7 6.4 3.7 3.6 4.3 7.9 0.0 4.8 0.4 1.1 11.6 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 3.9 5.5 4.6 0.0 3.5 7.6 3.4 7.9 0.0 0.0 0.1 0.0 4.6 2.7 0.3 17.8 0.0 5.2 0.0 4.8 0.0 0.0 0.0 4.4 0.0 0.1 2.7 0.0 1.4 0.2 9.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 0.0 5.2 0.0 3.8 0.0 4.3 0.5 0.0 6.8 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.0 2.1 0.0 4.9 11.8 2.0 0.0 1.5 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 10.2 11.2 8.4 7.9 8.9 5.7 4.6 7.6 7.9 3.0 10.5 0.0 0.0 0.6 6.7 5.5 0.0 0.0 0.0 1.8 0.0 0.1 1.7 0.0 5.7 4.5 0.0 0.0 0.0 0.1 5.4 1.2 0.0 0.0 0.5 1.6 0.0 1.8 0.0 1.5 8.1 0.0 1.7 0.0 0.0 6.6 0.0 0.0 6.0 0.0 2.4 25.8 7.1 3.6 3.0 0.1 0.2 0.0 0.0 0.0 LRP11 "bA350J20.3, MANSC3" ENSG00000120256 "LDL receptor related protein 11" Q86VZ4 6 149818798-149864026 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 3.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017267 Approved "Vesicles,Plasma membrane" NA NA 640000 "Plasma membrane" Vesicles "HPA017267: " "prognostic unfavorable (2.31e-8)" "unprognostic (3.85e-3)" "unprognostic (1.68e-1)" "unprognostic (1.30e-2)" "unprognostic (5.17e-2)" "unprognostic (4.25e-3)" "prognostic unfavorable (2.01e-5)" "unprognostic (5.05e-2)" "unprognostic (1.47e-1)" "unprognostic (2.49e-1)" "unprognostic (3.29e-1)" "unprognostic (2.63e-1)" "unprognostic (4.76e-2)" "unprognostic (2.47e-1)" "unprognostic (6.75e-2)" "unprognostic (1.34e-2)" "unprognostic (4.23e-2)" 12.0 16.5 17.8 4.4 26.9 1.6 11.2 17.9 25.6 14.0 11.5 15.1 9.4 10.5 10.6 14.8 20.2 20.2 10.5 8.0 19.7 19.3 18.2 9.0 12.1 2.2 15.0 16.9 15.3 17.2 46.2 15.2 14.7 20.6 23.3 11.4 10.8 14.2 12.3 8.1 20.2 8.7 10.9 13.3 3.6 14.4 7.2 15.6 0.8 20.8 13.8 6.4 17.3 14.2 3.5 1.0 0.0 1.7 0.0 0.7 0.1 9.5 8.4 6.4 5.6 14.3 26.2 1.2 10.0 19.6 7.0 8.5 2.5 20.0 0.1 13.7 15.7 30.9 25.6 7.2 18.2 5.0 15.4 7.2 4.5 30.9 11.0 8.8 4.6 0.1 16.3 35.5 9.0 17.8 19.9 10.8 4.4 9.3 4.3 8.3 16.5 0.1 0.1 3.8 19.0 8.4 5.0 9.6 2.2 12.6 19.6 8.5 5.7 31.6 17.7 6.0 3.3 14.5 9.6 8.4 8.8 2.0 18.3 7.6 0.0 3.0 2.2 15.9 4.7 5.1 0.0 0.1 0.0 0.2 0.4 0.0 3.5 0.7 0.6 1.0 0.6 0.2 0.3 0.0 0.0 1.7 0.0 0.0 0.1 17.8 26.9 17.9 25.6 19.7 19.3 15.0 16.9 20.6 15.6 6.0 3.2 0.8 10.9 10.1 10.5 7.6 20.4 24.1 5.7 19.2 2.0 1.4 5.0 5.6 26.8 6.8 3.9 0.0 19.4 2.2 12.9 21.0 0.0 8.3 2.9 7.9 28.3 11.1 1.8 24.2 15.3 1.1 13.5 0.0 3.7 6.3 16.2 2.9 13.8 5.4 5.4 0.0 5.6 6.1 5.9 12.5 4.7 0.0 11.3 20.6 LRRC15 LIB ENSG00000172061 "Leucine rich repeat containing 15" Q8TF66 3 194355247-194369743 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 48.1" "Cell type enhanced" "Detected in some" 17 "Basal keratinocytes: 1.6;Suprabasal keratinocytes: 1.3" "Cancer enhanced" "Detected in many" "breast cancer: 25.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 48.9;U-138 MG: 9.5;U-87 MG: 26.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA035503 Uncertain Approved "Vesicles,Plasma membrane" NA NA 1800000 Vesicles "Plasma membrane" "HPA035503: AB_10961253" "unprognostic (3.20e-2)" "unprognostic (1.45e-2)" "unprognostic (3.11e-1)" "unprognostic (6.30e-2)" "unprognostic (1.19e-2)" "unprognostic (2.04e-1)" "unprognostic (7.11e-2)" "unprognostic (2.95e-2)" "unprognostic (1.84e-1)" "unprognostic (3.53e-2)" "unprognostic (3.97e-2)" "unprognostic (1.88e-3)" "unprognostic (1.22e-8)" "unprognostic (5.81e-2)" "unprognostic (1.11e-1)" "unprognostic (5.62e-3)" "unprognostic (7.54e-3)" 3.3 0.5 0.5 3.1 0.6 0.0 5.3 0.5 0.5 4.6 2.1 0.2 0.0 0.4 3.5 0.3 1.0 1.3 2.0 1.8 0.5 0.5 0.5 0.5 2.5 0.8 0.5 0.0 3.1 0.8 0.0 0.5 48.1 0.3 0.6 4.2 0.7 1.6 0.0 1.0 9.1 0.8 0.7 0.5 1.3 1.9 0.9 0.0 1.1 1.8 7.7 7.7 2.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.7 0.0 0.0 0.1 0.0 0.0 0.4 48.9 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 9.5 1.6 1.2 0.0 0.0 0.0 0.0 26.4 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.5 0.5 0.5 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.0 0.0 0.0 0.0 LRRC26 bA350O14.10 ENSG00000184709 "Leucine rich repeat containing 26" Q2I0M4 9 137168758-137170051 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "salivary gland: 173.1" "Cell type enriched" "Detected in some" 9 "Mucus-secreting cells: 513.0" "Cancer enriched" "Detected in many" 5 "prostate cancer: 47.6" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 408 "plasmacytoid DC: 40.8" "Lineage enriched" "Detected in single" 408 "dendritic cells: 40.8" "Cell line enriched" "Detected in some" 6 "RPMI-8226: 52.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA056312 Approved Supported "Nucleoli fibrillar center,Plasma membrane" NA NA "Plasma membrane" "Nucleoli fibrillar center" "HPA056312: AB_2683098" "unprognostic (1.75e-1)" "unprognostic (2.28e-2)" "unprognostic (1.04e-2)" "prognostic favorable (4.82e-6)" "unprognostic (3.39e-1)" "unprognostic (1.67e-2)" "unprognostic (1.82e-1)" "unprognostic (2.13e-2)" "unprognostic (1.98e-1)" "unprognostic (1.06e-1)" "unprognostic (1.75e-1)" "prognostic favorable (3.48e-4)" "unprognostic (3.27e-1)" "unprognostic (2.29e-1)" 0.1 0.0 0.0 1.3 0.0 0.0 2.1 0.7 0.1 0.3 6.8 0.0 11.2 1.2 0.3 0.1 0.7 0.3 0.4 0.0 0.0 0.1 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 15.4 0.4 0.0 173.1 20.0 0.0 1.3 4.0 0.0 0.0 0.1 1.0 0.0 0.0 0.7 0.0 10.3 4.6 0.0 0.1 0.0 40.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 2.2 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.3 8.7 0.0 52.8 0.0 0.0 0.4 0.1 0.2 2.6 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.8 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 0.9 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.2 0.0 13.9 0.0 0.4 0.0 0.1 45.8 0.0 0.0 0.1 0.0 8.6 0.0 0.0 0.6 0.0 0.0 54.0 1.0 513.0 0.0 0.2 12.5 0.0 0.0 0.0 0.0 0.0 0.2 2.6 0.3 0.0 0.0 16.2 3.3 LRRFIP2 HUFI-2 ENSG00000093167 "LRR binding FLII interacting protein 2" Q9Y608 3 37052656-37183689 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Early spermatids: 388.9;Urothelial cells: 309.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035956, HPA042023" Uncertain Approved "Plasma membrane,Actin filaments" NA NA 1000000 "Plasma membrane, Actin filaments" "HPA035956: AB_10671238, HPA042023: AB_2677802" "unprognostic (2.03e-3)" "prognostic favorable (6.31e-4)" "unprognostic (1.16e-2)" "unprognostic (7.90e-2)" "unprognostic (2.48e-1)" "unprognostic (2.97e-1)" "unprognostic (5.41e-2)" "unprognostic (1.82e-1)" "unprognostic (3.09e-2)" "unprognostic (2.56e-2)" "unprognostic (4.99e-3)" "unprognostic (1.98e-1)" "unprognostic (4.13e-3)" "unprognostic (2.62e-1)" "unprognostic (1.37e-1)" "unprognostic (4.84e-3)" "unprognostic (3.76e-2)" 15.4 17.3 23.0 17.5 22.0 27.5 21.9 30.0 22.8 35.7 35.8 26.5 17.7 24.7 28.2 20.0 33.0 15.7 22.8 47.4 23.8 25.3 19.8 33.9 18.7 19.3 24.2 19.4 20.6 16.9 33.9 18.3 16.9 24.4 30.3 24.8 19.6 19.3 19.5 58.5 23.2 37.1 27.3 31.2 29.7 17.0 47.2 24.8 11.6 20.6 33.6 21.6 23.7 25.1 7.1 9.8 22.7 17.2 11.9 8.8 7.5 15.6 8.7 10.1 7.9 13.5 20.8 8.8 42.7 42.6 24.1 27.8 8.1 7.2 6.2 7.0 41.1 11.9 8.2 7.4 21.1 39.5 13.8 5.8 11.1 12.5 7.9 19.3 8.7 6.8 9.2 15.2 31.3 32.5 13.4 16.7 9.7 8.8 10.9 20.0 4.0 7.4 4.7 6.6 6.4 11.2 3.6 28.9 6.3 16.9 6.1 3.6 5.8 16.5 15.3 13.8 8.5 8.8 9.1 16.0 18.5 12.5 27.1 20.0 8.5 15.2 9.5 10.9 7.9 26.2 12.2 15.0 22.7 6.6 10.4 8.5 7.1 7.0 7.0 9.8 5.4 5.2 6.2 14.0 11.9 17.2 5.5 8.8 7.5 23.0 22.0 30.0 22.8 23.8 25.3 24.2 19.4 24.4 24.8 26.8 32.2 18.0 127.0 120.9 34.6 89.3 25.5 36.1 66.0 22.7 27.5 25.5 54.7 70.3 388.9 46.3 105.3 23.3 82.3 35.6 59.0 267.5 50.8 52.9 22.7 116.0 51.9 60.8 39.4 269.5 39.1 42.2 70.9 77.5 39.2 48.7 85.8 59.6 54.1 33.1 51.1 38.8 54.0 116.1 61.4 149.1 32.8 24.5 60.8 309.6 LRRIQ3 "LRRC44, MGC22773" ENSG00000162620 "Leucine rich repeats and IQ motif containing 3" A6PVS8 1 74026015-74198187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "testis: 34.1" "Cell type enhanced" "Detected in many" 17 "Early spermatids: 144.3;Late spermatids: 74.3;Spermatocytes: 156.8" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "GAMG: 12.2;JURKAT: 7.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA030799 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA030799: AB_10601337" "unprognostic (5.94e-3)" "unprognostic (6.00e-2)" "unprognostic (6.49e-3)" "unprognostic (1.63e-1)" "unprognostic (6.62e-2)" "unprognostic (2.78e-1)" "unprognostic (2.27e-2)" "unprognostic (2.27e-1)" "unprognostic (8.17e-2)" "unprognostic (2.44e-1)" "unprognostic (1.12e-3)" "unprognostic (1.71e-1)" "unprognostic (1.41e-1)" "unprognostic (1.05e-1)" "unprognostic (1.13e-1)" "unprognostic (1.88e-2)" "unprognostic (4.65e-2)" 1.8 1.3 0.9 0.9 2.7 0.2 0.9 0.3 1.5 0.8 0.4 1.1 0.1 0.3 0.4 1.2 0.6 2.8 0.6 0.6 1.0 1.1 3.5 1.7 1.6 0.9 2.5 1.4 2.5 0.6 2.1 7.2 0.3 2.4 0.6 0.3 0.6 0.8 0.6 0.4 0.3 0.4 0.2 1.3 1.6 0.5 34.1 1.0 1.4 1.9 0.0 0.8 0.5 0.4 3.9 1.1 1.9 1.1 1.1 4.0 0.9 0.3 1.5 0.2 0.6 1.6 0.6 1.0 0.9 0.6 1.3 1.4 0.2 2.1 2.1 1.9 0.2 12.2 0.2 3.3 3.0 1.6 5.2 0.0 1.9 0.5 1.0 0.2 3.4 1.1 1.1 1.6 2.2 0.8 0.5 0.6 7.3 1.6 3.0 2.1 0.0 1.3 0.5 1.7 3.7 1.0 1.6 1.2 2.1 1.9 0.2 1.6 1.1 0.2 0.2 4.6 0.3 1.3 1.9 0.2 0.2 1.1 0.8 1.8 3.1 1.1 1.7 2.3 0.3 1.6 0.0 0.2 1.9 2.3 1.1 2.9 3.9 2.6 2.9 0.3 2.0 2.5 3.5 0.0 1.1 0.3 1.1 4.0 0.9 0.9 2.7 0.3 1.5 1.0 1.1 2.5 1.4 2.4 1.0 0.0 1.0 0.0 1.0 1.0 0.8 0.4 0.0 36.1 1.2 0.0 3.9 1.4 11.6 1.4 144.3 0.1 0.0 0.0 1.6 1.5 0.2 1.2 0.0 1.0 1.1 0.0 2.9 0.0 0.6 74.3 1.7 0.4 0.0 1.0 0.9 1.1 0.7 0.0 1.4 4.2 0.6 0.0 0.4 156.8 22.6 0.1 0.2 0.7 0.6 0.7 LSMEM2 "C3orf45, FLJ38608" ENSG00000179564 "Leucine rich single-pass membrane protein 2" Q8N112 3 50279027-50288114 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "heart muscle: 26.6;skeletal muscle: 16.3;tongue: 7.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 197.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Cell line enhanced" "Detected in some" "HeLa: 3.7;WM-115: 3.5" "Low region specificity" "Detected in many" HPA079523 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA079523: " "unprognostic (2.84e-3)" "unprognostic (6.54e-2)" "unprognostic (2.36e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (2.30e-1)" "unprognostic (8.96e-2)" "unprognostic (1.02e-1)" "unprognostic (1.55e-2)" "unprognostic (2.65e-1)" "unprognostic (3.17e-2)" "unprognostic (2.82e-1)" "unprognostic (1.82e-1)" "unprognostic (2.46e-2)" "unprognostic (2.48e-1)" "unprognostic (6.49e-3)" "unprognostic (1.71e-1)" 0.6 0.3 1.2 0.2 2.1 0.4 0.2 0.7 1.9 1.1 0.3 2.1 0.1 0.4 1.4 0.4 0.7 0.8 0.4 26.6 1.4 0.7 0.3 0.1 0.3 0.1 1.3 0.6 0.9 0.3 0.1 0.1 0.2 1.3 0.4 0.3 1.6 1.4 0.5 16.3 0.1 0.5 0.5 1.6 0.2 0.2 3.0 0.9 0.1 0.2 7.2 0.2 0.3 0.7 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.2 0.3 0.0 0.0 0.4 0.4 0.4 0.4 0.2 0.3 0.5 0.1 0.1 0.0 0.5 0.1 0.1 1.1 0.1 0.0 0.5 0.2 3.7 0.2 0.0 0.3 0.2 0.2 0.0 0.1 0.2 0.5 0.0 1.1 0.0 1.0 0.0 0.2 0.1 0.7 0.5 0.4 0.0 0.0 0.3 0.0 0.3 0.3 0.1 0.5 0.0 0.8 1.0 0.4 0.0 0.0 0.0 0.2 1.3 0.4 0.4 0.9 0.6 0.6 0.1 0.9 3.5 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.3 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.2 2.1 0.7 1.9 1.4 0.7 1.3 0.6 1.3 0.9 0.0 1.1 0.0 0.1 0.9 0.1 3.0 0.0 0.0 1.2 1.8 0.0 0.0 0.0 0.1 41.7 0.0 0.9 0.0 0.2 0.1 0.3 0.3 4.7 0.0 0.1 0.0 0.0 0.0 0.0 197.4 1.1 0.0 1.7 0.0 0.4 0.5 0.1 0.0 0.7 0.0 0.2 0.0 0.7 1.6 1.0 1.1 0.1 0.0 0.6 0.1 LTB4R2 "BLT2, BLTR2, JULF2, NOP9" ENSG00000213906 "Leukotriene B4 receptor 2" Q9NPC1 14 24305734-24312053 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 38.9;lymphoid tissue: 26.8;skin 1: 21.4;tongue: 43.6" "Cell type enhanced" "Detected in some" 7 "Basal glandular cells: 3.0;Horizontal cells: 3.2;Kupffer cells: 2.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 15.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB022689, HPA029680, HPA072921" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB022689: , HPA029680: AB_10603013, HPA072921: AB_2686557" "unprognostic (2.01e-1)" "unprognostic (1.04e-1)" "unprognostic (9.53e-2)" "unprognostic (8.82e-2)" "unprognostic (1.42e-1)" "unprognostic (1.12e-2)" "unprognostic (1.40e-1)" "unprognostic (7.22e-2)" "unprognostic (1.36e-1)" "unprognostic (1.37e-1)" "unprognostic (1.48e-3)" "unprognostic (7.18e-2)" "unprognostic (7.05e-11)" "unprognostic (1.84e-1)" "unprognostic (1.04e-1)" "unprognostic (4.23e-2)" "unprognostic (1.19e-1)" 1.5 1.2 0.4 1.8 0.5 4.8 1.1 0.4 0.6 7.9 0.4 0.6 0.8 2.4 1.0 4.7 38.9 0.8 0.7 0.4 0.5 0.1 6.1 0.5 1.1 1.8 0.4 0.7 0.7 0.5 0.3 0.7 0.8 0.5 1.8 0.3 0.5 4.7 1.1 0.9 21.4 1.8 0.4 0.4 3.5 1.0 1.4 0.4 3.1 0.9 43.6 26.8 0.6 9.0 0.3 2.2 1.4 2.0 0.9 2.7 1.1 2.5 4.4 1.9 1.8 0.4 0.6 7.7 0.9 0.4 1.3 0.9 3.4 1.5 3.2 1.6 0.6 1.9 15.9 1.3 2.7 1.0 4.0 4.9 2.2 3.5 1.6 0.5 3.6 4.2 0.5 3.6 2.0 2.3 1.2 0.6 5.8 2.8 3.6 0.6 4.8 1.9 3.8 1.0 0.1 5.4 7.9 1.7 1.8 0.4 3.1 3.4 1.6 1.6 2.0 1.3 2.1 3.7 2.7 1.6 2.6 3.2 4.0 1.3 7.9 2.3 5.2 0.5 6.1 2.0 0.0 2.0 1.4 2.7 1.6 1.6 0.1 2.2 2.0 2.2 0.3 1.7 0.9 1.3 0.9 0.8 0.6 0.4 1.1 0.4 0.5 0.4 0.6 0.5 0.1 0.4 0.7 0.5 0.4 0.0 0.0 0.0 3.0 0.2 0.2 0.0 0.0 1.4 0.0 1.8 0.0 0.1 0.0 0.2 0.0 0.9 0.3 0.0 1.2 0.1 0.0 0.2 0.0 0.8 0.6 3.2 1.7 1.3 2.2 0.0 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.0 0.0 0.2 0.5 0.0 0.0 0.7 0.2 0.1 0.2 0.0 0.6 0.9 LY6K "CT97, FLJ35226, HSJ001348" ENSG00000160886 "Lymphocyte antigen 6 family member K" Q17RY6 8 142700111-142705127 "Predicted membrane proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 39.3" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 132.9;Glandular cells: 88.0;Spermatocytes: 359.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "neutrophil: 5.3" "Lineage enriched" "Detected in single" 11 "granulocytes: 5.3" "Cell line enhanced" "Detected in many" "A-431: 28.8;BJ: 31.3;HeLa: 34.1;SiHa: 49.0;U-2197: 66.2" "HPA017770, CAB075742, CAB075743" Enhanced Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "CAB075742: AB_2665748, CAB075743: AB_2665749, HPA017770: AB_1853414" "unprognostic (1.25e-1)" "unprognostic (1.95e-2)" "unprognostic (1.48e-1)" "unprognostic (7.23e-3)" "unprognostic (3.47e-2)" "unprognostic (2.39e-1)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.17e-5)" "unprognostic (4.18e-2)" "unprognostic (6.89e-2)" "unprognostic (9.75e-2)" "unprognostic (1.40e-1)" "unprognostic (5.27e-5)" "unprognostic (1.71e-1)" "unprognostic (1.46e-1)" "unprognostic (2.03e-1)" "unprognostic (4.61e-2)" 6.6 0.4 1.4 0.3 1.8 0.4 7.6 0.9 3.8 1.8 1.6 0.1 9.8 0.5 0.7 0.8 10.9 0.8 1.2 1.2 1.5 1.9 2.0 0.2 0.6 1.9 1.7 0.0 0.7 0.4 0.0 0.3 6.3 1.0 1.1 0.1 0.1 1.4 7.0 6.3 4.3 0.2 0.6 1.1 0.3 0.4 39.3 0.2 0.2 1.1 4.5 6.8 1.0 3.2 0.1 0.1 5.3 0.2 0.4 0.2 0.0 28.8 0.5 0.0 1.5 0.6 1.9 0.3 31.3 3.7 9.7 5.9 0.0 0.2 0.0 2.6 3.5 3.4 2.6 0.0 1.7 8.2 0.3 0.0 0.0 34.1 0.0 0.4 0.0 0.0 2.9 5.1 7.2 9.3 0.0 0.8 0.0 0.0 0.1 18.2 0.2 0.0 0.0 1.0 0.9 0.5 0.0 0.1 0.0 1.6 0.4 0.9 0.1 49.0 0.6 9.5 1.7 0.1 0.0 1.2 0.4 2.8 66.2 0.0 0.0 0.0 0.0 0.1 0.0 3.2 0.5 0.2 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 5.3 0.4 0.1 0.1 0.0 0.0 1.4 1.8 0.9 1.7 1.5 1.9 1.7 0.0 1.0 0.2 3.0 0.3 0.0 65.7 34.6 0.3 0.1 10.2 1.4 7.9 24.4 0.0 11.3 0.0 0.5 5.0 3.3 0.0 0.0 0.0 132.9 2.9 88.0 0.0 0.0 5.3 0.0 0.0 1.3 0.0 10.1 3.7 2.8 11.8 0.0 0.0 0.5 3.9 0.0 2.8 0.0 0.7 0.0 13.3 359.5 76.0 39.3 21.2 0.0 0.0 76.5 LZTS1 FEZ1 ENSG00000061337 "Leucine zipper tumor suppressor 1" Q9Y250 8 20246165-20303963 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 19.0;parathyroid gland: 64.9" "Cell type enhanced" "Detected in some" 21 "Horizontal cells: 19.1;Melanocytes: 18.6;Rod photoreceptor cells: 17.9;Sertoli cells: 64.7" "Cancer enhanced" "Detected in all" "melanoma: 59.2" "Group enriched" "Detected in many" 5 "amygdala: 13.3;basal ganglia: 19.0;cerebral cortex: 19.0;hippocampal formation: 8.9;olfactory region: 8.8" "Cell type enhanced" "Detected in single" "gdT-cell: 2.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "SK-MEL-30: 36.7;U-698: 11.2;WM-115: 24.8" "Group enriched" "Detected in many" 5 "amygdala: 47.8;basal ganglia: 76.8;cerebral cortex: 46.2;hippocampal formation: 41.3;olfactory region: 26.1" "Group enriched" "Detected in many" 9 "amygdala: 28.4;basal ganglia: 66.4;cerebral cortex: 45.3;hippocampal formation: 38.6;olfactory region: 47.4" "HPA006294, HPA022046" Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA006294: AB_1079288, HPA022046: AB_1853455" "unprognostic (7.76e-2)" "unprognostic (1.02e-1)" "unprognostic (3.49e-3)" "prognostic unfavorable (3.03e-4)" "unprognostic (6.27e-2)" "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (5.76e-2)" "unprognostic (1.41e-2)" "unprognostic (9.06e-3)" "unprognostic (6.81e-2)" "unprognostic (3.63e-2)" "prognostic unfavorable (9.28e-6)" "unprognostic (3.35e-2)" "unprognostic (2.71e-1)" "unprognostic (1.11e-1)" "unprognostic (6.82e-3)" 2.4 2.1 13.3 1.8 19.0 0.8 1.9 0.6 19.0 1.6 1.1 2.2 0.4 1.1 2.2 1.5 3.5 1.4 3.5 2.3 8.9 2.6 1.9 1.1 4.0 1.5 2.5 8.8 1.7 1.6 64.9 1.4 5.8 1.9 1.7 1.1 10.3 1.3 1.7 1.6 4.2 1.2 2.7 0.8 1.1 1.3 6.6 1.5 0.3 2.0 0.9 1.1 1.9 1.0 0.2 0.1 0.7 0.1 0.1 2.2 0.5 0.0 0.0 4.8 4.0 0.0 0.0 0.6 2.4 0.0 2.1 1.8 0.1 0.0 5.3 1.7 1.5 0.8 0.1 0.2 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.8 0.5 0.0 0.8 0.0 0.3 0.0 5.7 0.0 0.0 7.0 0.0 9.2 0.0 6.0 0.0 0.0 0.0 7.7 0.0 1.3 0.2 7.4 6.4 0.0 0.0 36.7 4.2 0.0 0.2 0.0 2.5 1.7 0.0 0.7 0.0 0.0 11.2 0.0 0.5 24.8 0.2 0.1 0.0 2.2 0.0 0.8 0.0 0.7 0.4 0.0 0.2 0.2 0.3 0.7 0.1 0.0 0.1 0.0 0.5 13.3 19.0 0.6 19.0 8.9 2.6 2.5 8.8 1.9 1.5 0.0 0.0 0.0 0.6 1.1 1.5 1.0 0.0 0.0 0.0 0.0 3.9 6.1 1.7 0.0 0.4 0.7 0.0 0.0 0.0 1.6 1.0 0.1 0.0 0.0 0.8 19.1 0.0 0.0 0.0 0.4 1.1 0.0 18.6 0.0 0.0 0.9 0.0 0.0 0.4 0.2 17.9 64.7 10.5 0.2 1.1 0.1 0.7 0.0 0.0 0.0 LZTS2 "KIAA1813, LAPSER1" ENSG00000107816 "Leucine zipper tumor suppressor 2" Q9BRK4 10 100996618-101007836 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044956 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044956: AB_10795989" "unprognostic (1.42e-2)" "unprognostic (1.96e-1)" "prognostic unfavorable (8.23e-4)" "unprognostic (8.18e-2)" "unprognostic (4.64e-2)" "unprognostic (1.56e-1)" "unprognostic (5.49e-3)" "unprognostic (3.56e-1)" "unprognostic (7.57e-2)" "unprognostic (4.58e-2)" "unprognostic (2.72e-1)" "unprognostic (1.38e-1)" "prognostic unfavorable (3.39e-4)" "unprognostic (7.63e-2)" "unprognostic (1.86e-1)" "unprognostic (5.46e-3)" "unprognostic (1.76e-3)" 34.2 25.8 14.6 12.4 21.4 10.9 24.7 15.4 25.0 29.3 30.2 41.0 16.4 15.2 33.7 18.6 28.0 22.6 21.0 20.0 19.0 13.6 18.2 7.4 18.6 9.5 32.8 14.4 30.1 13.9 22.7 16.1 24.5 20.6 32.9 8.2 22.3 34.6 38.4 28.5 24.7 14.9 32.0 29.9 20.1 19.6 18.7 25.6 9.5 29.7 11.8 13.7 38.8 22.7 5.0 2.8 0.5 1.2 4.4 6.1 2.3 11.1 15.0 12.3 21.1 16.4 13.3 25.3 13.5 25.9 11.4 13.0 17.4 9.3 4.5 12.6 18.2 8.2 19.0 7.6 9.8 2.8 4.3 11.2 4.1 14.8 22.5 23.3 2.1 5.4 24.2 7.2 8.9 10.8 24.2 11.6 5.5 13.0 2.6 10.1 10.7 1.9 5.3 13.7 4.3 12.4 25.5 36.1 4.5 8.6 13.6 3.0 22.5 9.2 4.2 34.6 6.9 21.6 17.8 14.7 13.6 15.6 14.4 7.0 5.0 3.4 1.1 23.1 6.1 6.8 0.0 1.2 0.5 4.5 0.5 6.1 3.7 5.4 4.9 1.8 5.0 5.8 4.9 0.5 4.4 0.1 2.8 4.5 2.3 14.6 21.4 15.4 25.0 19.0 13.6 32.8 14.4 20.6 25.6 14.9 10.9 3.2 7.8 11.8 10.0 3.9 10.2 2.7 4.5 5.2 5.9 14.4 6.6 17.8 4.6 17.7 5.6 0.0 10.7 11.4 17.3 13.7 1.1 2.4 18.1 17.5 16.0 22.7 6.1 2.7 23.9 6.5 15.1 6.4 16.1 17.4 13.0 5.8 27.6 6.8 3.6 25.8 21.5 3.1 11.2 10.7 39.4 4.9 13.5 8.0 MADD "DENN, KIAA0358, RAB3GEP" ENSG00000110514 "MAP kinase activating death domain" Q8WXG6 11 47269161-47330031 "Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 66.3" "Cell type enhanced" "Detected in many" 7 "Bipolar cells: 72.8;Cone photoreceptor cells: 117.8;Horizontal cells: 125.5;Rod photoreceptor cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 20.8" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038568 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038568: AB_10795030" "unprognostic (3.16e-1)" "unprognostic (1.81e-1)" "unprognostic (8.51e-3)" "prognostic favorable (6.62e-5)" "unprognostic (1.27e-1)" "unprognostic (6.36e-3)" "unprognostic (4.82e-3)" "unprognostic (1.16e-1)" "unprognostic (1.91e-1)" "unprognostic (3.78e-2)" "prognostic favorable (5.69e-5)" "unprognostic (1.53e-1)" "unprognostic (3.55e-1)" "unprognostic (8.07e-2)" "unprognostic (1.06e-1)" "unprognostic (2.76e-1)" "prognostic favorable (8.25e-4)" 7.7 18.2 18.3 11.5 27.6 16.9 8.7 66.3 46.5 9.2 10.8 15.5 13.1 8.6 9.4 8.9 6.9 9.4 8.6 13.8 20.2 18.4 9.8 7.7 11.0 13.2 15.5 19.8 14.0 12.2 18.8 26.7 11.2 20.7 12.5 12.0 16.0 10.2 14.0 16.1 14.0 9.8 10.5 11.3 12.3 13.2 19.4 11.0 14.6 8.4 6.0 12.2 11.0 7.8 3.5 4.1 20.8 5.8 4.5 5.7 4.4 6.5 13.6 14.9 13.3 10.2 7.1 3.3 9.2 12.3 11.7 12.7 9.9 6.2 13.8 2.9 10.0 15.2 12.9 12.0 6.4 10.2 15.3 12.3 24.5 25.2 8.4 7.4 16.6 33.8 6.9 6.9 6.2 7.8 8.0 10.7 8.9 15.7 10.2 10.3 9.1 7.8 17.9 8.9 15.3 9.4 10.8 24.0 9.1 6.1 31.1 23.6 15.3 11.8 14.0 8.1 9.2 11.0 12.7 9.1 11.0 7.0 15.6 6.1 12.1 12.5 7.9 10.2 11.8 10.3 20.8 2.6 4.8 4.8 4.6 4.2 3.5 3.4 4.0 4.1 3.3 4.0 3.1 0.7 4.5 5.8 2.2 5.7 4.4 18.3 27.6 66.3 44.6 20.2 18.4 15.5 19.8 20.7 11.0 11.9 8.6 9.0 3.5 9.5 72.8 22.6 10.2 1.4 3.4 7.0 117.8 3.9 0.0 7.0 11.4 9.5 12.1 0.0 4.2 1.9 6.1 7.5 26.5 5.0 10.1 125.5 15.6 17.8 18.3 4.0 6.6 10.6 10.1 9.0 17.0 13.7 8.8 10.5 12.0 4.2 106.1 6.5 6.2 14.6 21.5 7.2 3.7 6.9 11.2 4.8 MAMDC2 MGC21981 ENSG00000165072 "MAM domain containing 2" Q7Z304 9 70043581-70226970 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 37.9;Leydig cells: 89.5;Peritubular cells: 77.1;Sertoli cells: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 4 "NK-cell: 2.6" "Lineage enriched" "Detected in single" 4 "NK-cells: 2.6" "Cell line enhanced" "Detected in some" "ASC diff: 23.0;HHSteC: 24.0;LHCN-M2: 29.9;TIME: 28.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA021814, HPA022249" Uncertain Approved "Nuclear speckles,Plasma membrane" "Secreted in other tissues" NA NA "Nuclear speckles, Plasma membrane" "HPA021814: AB_1853508, HPA022249: AB_2139157" "unprognostic (1.88e-1)" "unprognostic (3.16e-3)" "unprognostic (2.21e-3)" "unprognostic (2.71e-2)" "unprognostic (4.30e-2)" "unprognostic (8.49e-2)" "unprognostic (1.27e-2)" "unprognostic (8.25e-2)" "unprognostic (5.91e-2)" "unprognostic (3.65e-2)" "unprognostic (1.92e-1)" "unprognostic (3.67e-1)" "unprognostic (3.03e-2)" "unprognostic (4.23e-3)" "unprognostic (2.35e-1)" "prognostic unfavorable (7.78e-4)" "unprognostic (2.79e-3)" 9.0 4.3 0.6 11.1 0.5 0.0 14.7 0.6 0.8 32.3 27.7 0.3 9.1 4.3 40.7 33.7 31.6 28.7 44.9 13.5 0.6 0.6 2.0 1.0 42.4 2.3 0.7 0.8 35.5 2.4 1.0 0.8 2.6 1.3 13.9 6.6 16.1 5.4 10.8 15.5 5.0 14.2 46.3 2.6 12.0 10.7 20.0 0.0 0.3 6.8 24.6 6.1 36.4 27.5 0.0 0.3 0.0 0.0 2.6 0.6 0.0 0.1 0.0 0.2 0.0 23.0 7.8 0.7 4.5 2.0 1.0 1.9 0.0 0.5 0.0 0.3 0.8 0.6 3.6 0.0 0.3 0.9 0.0 0.0 0.0 7.4 0.0 24.0 0.0 0.0 1.4 0.2 0.6 0.4 8.2 1.9 0.0 0.0 0.2 29.9 0.0 0.0 0.0 3.2 0.0 0.0 0.0 3.6 2.8 10.1 0.0 0.3 0.0 0.0 0.0 0.0 8.9 0.0 0.0 28.7 0.0 0.9 0.0 0.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.6 0.5 0.6 0.8 0.6 0.6 0.7 0.8 1.3 0.0 0.0 1.0 0.0 0.4 5.5 0.4 3.1 0.0 0.0 0.0 3.5 3.9 0.1 0.0 0.0 37.9 2.9 0.0 0.0 0.2 5.7 21.0 0.1 1.1 0.0 2.6 0.0 0.0 0.0 0.0 9.1 89.5 0.7 10.1 0.0 0.0 15.4 0.3 0.0 77.1 0.3 0.2 38.8 25.0 0.3 0.4 4.3 0.2 0.0 0.0 0.0 MAP2 "MAP2A, MAP2B, MAP2C" ENSG00000078018 "Microtubule associated protein 2" P11137 2 209424058-209734118 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "brain: 122.3" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 824.7;Rod photoreceptor cells: 453.2" "Cancer enhanced" "Detected in many" "glioma: 30.4" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 13 "memory B-cell: 2.6;naive B-cell: 3.4" "Lineage enriched" "Detected in single" 15 "B-cells: 3.4" "Cell line enhanced" "Detected in some" "AF22: 76.3;NTERA-2: 27.3;SCLC-21H: 38.4;SH-SY5Y: 21.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB001984, HPA008273, HPA012558, HPA012828" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB001984: , HPA008273: AB_1853945, HPA012558: , HPA012828: AB_1853946" "unprognostic (2.47e-2)" "unprognostic (2.81e-1)" "unprognostic (2.58e-2)" "prognostic unfavorable (1.98e-6)" "unprognostic (2.29e-2)" "unprognostic (1.79e-1)" "unprognostic (1.13e-2)" "unprognostic (6.06e-2)" "unprognostic (1.31e-1)" "unprognostic (9.84e-2)" "unprognostic (1.09e-2)" "unprognostic (1.60e-1)" "unprognostic (1.23e-1)" "unprognostic (2.69e-3)" "unprognostic (2.54e-1)" "unprognostic (7.28e-2)" "unprognostic (4.10e-5)" 4.6 9.2 62.1 2.1 63.1 1.5 4.9 24.7 122.3 4.4 2.5 3.8 0.0 2.0 2.9 4.0 5.6 2.8 6.3 6.2 73.6 53.8 3.9 3.7 9.3 2.4 31.0 48.8 6.4 8.2 12.5 14.7 1.9 35.4 6.5 2.5 7.6 4.9 4.7 2.2 12.1 2.0 3.2 19.9 2.4 2.6 5.4 11.4 0.0 12.2 0.4 2.9 2.8 1.5 3.4 0.1 0.0 0.0 0.0 0.2 0.3 0.6 0.1 76.3 0.0 1.0 0.5 0.0 0.4 0.5 0.1 0.5 0.0 4.0 0.0 0.4 0.9 3.6 1.0 5.9 0.4 0.2 0.0 0.3 0.2 2.4 0.0 9.7 0.0 0.0 0.8 2.4 0.0 1.5 4.4 2.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 27.3 0.1 0.1 0.0 0.1 0.0 1.0 0.0 38.4 21.5 1.6 0.2 0.9 9.4 2.1 0.0 0.0 0.0 0.4 0.0 1.0 0.5 0.0 0.0 4.0 0.0 11.4 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.3 62.1 63.1 24.7 79.6 73.6 53.8 31.0 48.8 35.4 11.4 89.3 2.7 0.0 3.1 5.3 111.0 3.6 30.6 1.4 4.5 5.2 824.7 0.3 3.3 19.1 16.8 7.1 0.0 0.0 9.4 0.0 1.9 10.4 1.1 0.0 0.5 31.8 31.2 16.0 3.0 7.5 26.4 0.8 18.6 0.0 0.0 125.4 13.7 0.0 14.5 0.4 453.2 32.3 17.6 3.3 19.9 5.6 0.2 0.0 0.0 0.6 MAP2K1 "MAPKK1, MEK1, PRKMK1" ENSG00000169032 "Mitogen-activated protein kinase kinase 1" Q02750 15 66386817-66492312 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, RAS pathway related proteins" "Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Cardiomyopathy, Disease mutation, Ectodermal dysplasia, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003834, HPA026430" Approved Enhanced "Plasma membrane,Cytosol" NA NA 62000 "Plasma membrane, Cytosol" "CAB003834: AB_562310, HPA026430: AB_1853742" "unprognostic (4.05e-2)" "unprognostic (1.23e-2)" "unprognostic (2.07e-1)" "unprognostic (4.92e-2)" "prognostic unfavorable (1.95e-4)" "unprognostic (1.81e-3)" "unprognostic (5.78e-2)" "unprognostic (9.91e-3)" "unprognostic (1.11e-1)" "unprognostic (1.77e-1)" "unprognostic (1.45e-1)" "unprognostic (7.62e-3)" "unprognostic (1.20e-1)" "unprognostic (2.71e-1)" "unprognostic (1.96e-1)" "unprognostic (1.15e-1)" "unprognostic (9.40e-3)" 28.6 16.9 33.9 19.1 54.1 29.0 23.6 32.5 48.4 12.5 12.1 8.4 10.2 10.0 11.8 16.5 22.0 10.6 14.4 19.1 49.2 26.4 15.3 53.1 16.4 23.3 17.6 31.2 13.5 11.7 23.4 12.0 15.4 17.2 14.4 12.9 9.1 13.2 12.4 39.5 12.3 10.9 16.9 17.4 14.5 10.8 7.8 12.6 12.6 12.3 9.7 27.9 13.6 18.7 4.6 16.2 5.5 8.2 8.4 7.9 2.7 33.6 15.9 31.9 13.3 19.3 14.5 18.5 24.4 20.9 26.5 23.7 23.8 27.7 30.9 30.3 20.1 20.2 30.0 29.8 35.7 31.3 24.9 17.8 9.9 16.6 12.9 15.6 13.0 14.8 11.2 22.1 19.2 28.5 28.3 20.7 15.8 17.5 39.6 38.7 13.0 10.5 17.1 16.3 31.2 13.9 11.9 19.7 27.5 25.7 14.5 19.7 11.0 19.8 15.5 20.5 26.9 14.0 11.2 28.5 34.6 21.2 24.4 36.2 24.5 43.6 19.7 36.5 23.1 16.1 3.2 8.2 5.5 7.4 8.2 6.7 3.0 6.6 6.9 8.3 4.6 7.9 4.9 3.9 8.4 7.3 16.2 4.9 2.7 33.9 54.1 32.5 46.9 49.2 26.4 17.6 31.2 17.2 12.6 26.8 21.9 30.2 40.5 73.6 8.5 16.9 38.2 6.7 13.6 24.4 13.7 40.9 39.7 65.3 10.2 19.0 20.0 46.7 20.4 39.4 31.3 59.4 9.2 116.5 44.9 9.5 20.8 17.2 91.3 18.3 20.8 67.7 50.6 88.4 17.0 33.9 70.1 21.0 20.5 28.5 5.6 6.5 53.6 16.3 44.5 58.8 43.3 40.5 16.8 65.5 MAP3K12 "DLK, MEKK12, MUK, ZPK, ZPKP1" ENSG00000139625 "Mitogen-activated protein kinase kinase kinase 12" Q12852 12 53479669-53500063 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 40.3" "Cell type enhanced" "Detected in many" 10 "Cone photoreceptor cells: 35.3;Rod photoreceptor cells: 81.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "granulocytes: 3.4;monocytes: 1.7;T-cells: 2.8" "Cell line enhanced" "Detected in many" "ASC diff: 26.4;HHSteC: 25.2;HSkMC: 25.1;hTERT-RPE1: 33.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039936, HPA071996" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039936: AB_10795239, HPA071996: AB_2686481" "unprognostic (4.01e-1)" "unprognostic (3.30e-1)" "unprognostic (8.89e-3)" "unprognostic (6.40e-3)" "unprognostic (1.10e-1)" "unprognostic (2.22e-1)" "unprognostic (6.97e-2)" "unprognostic (3.61e-2)" "unprognostic (2.39e-1)" "unprognostic (2.70e-1)" "prognostic favorable (1.51e-4)" "unprognostic (8.50e-3)" "prognostic unfavorable (5.43e-10)" "unprognostic (1.65e-2)" "unprognostic (2.44e-1)" "unprognostic (1.32e-1)" "unprognostic (1.18e-1)" 8.0 8.7 12.3 5.8 16.0 3.0 5.1 40.3 20.6 14.1 6.1 7.0 7.8 3.6 15.1 5.8 4.6 11.5 16.1 4.2 9.4 7.7 4.5 1.4 8.8 4.5 6.4 14.7 13.7 1.8 3.0 12.7 7.3 10.8 5.9 4.6 9.5 2.4 13.5 1.2 4.5 4.1 16.9 5.3 5.3 3.9 6.5 7.4 2.7 4.3 1.4 3.2 11.3 6.4 0.3 0.6 3.4 1.7 0.6 2.8 0.5 0.2 7.0 4.4 6.8 26.4 14.1 0.5 4.7 8.9 5.2 5.3 0.1 0.8 1.5 2.7 5.1 4.2 0.0 2.0 3.1 2.1 2.3 2.4 1.7 3.6 0.0 25.2 0.0 1.7 25.1 2.3 7.1 3.7 33.3 8.1 3.5 0.0 7.5 4.9 3.0 1.7 0.3 1.5 0.0 2.6 2.4 2.9 0.4 2.6 0.0 4.4 6.0 2.5 3.2 6.7 1.0 2.2 4.4 5.9 5.0 5.4 2.3 1.2 3.0 3.4 0.0 8.1 3.0 4.9 0.0 1.7 0.0 1.5 1.3 2.8 0.3 2.1 2.3 0.6 0.0 0.9 1.2 3.4 0.6 0.4 0.3 0.4 0.5 12.3 16.0 40.3 20.6 9.4 7.7 6.4 14.7 10.8 7.4 6.0 13.4 5.6 1.9 0.7 26.7 0.7 10.2 8.1 11.4 1.8 35.3 1.6 8.3 5.4 1.2 3.7 4.6 0.0 1.6 1.8 3.8 2.7 12.7 7.7 3.6 28.6 3.4 7.4 12.7 1.4 7.5 5.9 0.0 7.2 2.5 17.4 4.5 2.6 7.8 7.0 81.9 6.5 4.9 2.3 1.9 0.9 1.8 7.5 3.5 2.0 MAP3K21 "KIAA1804, MLK4" ENSG00000143674 "Mitogen-activated protein kinase kinase kinase 21" Q5TCX8 1 233327768-233385148 "Enzymes, Predicted intracellular proteins" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 28.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 1: 32.8;Alveolar cells type 2: 7.7;Collecting duct cells: 14.0;Ductal cells: 9.7;Exocrine glandular cells: 8.4;Pancreatic endocrine cells: 7.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 6 "NK-cell: 5.0" "Lineage enriched" "Detected in single" 6 "NK-cells: 5.0" "Cell line enhanced" "Detected in many" "HEK 293: 18.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA007636 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007636: AB_1079392" "unprognostic (3.29e-2)" "unprognostic (5.10e-2)" "unprognostic (2.00e-1)" "unprognostic (2.42e-3)" "unprognostic (4.30e-2)" "unprognostic (1.23e-1)" "unprognostic (1.82e-2)" "unprognostic (1.84e-1)" "unprognostic (1.51e-1)" "unprognostic (1.25e-1)" "unprognostic (2.09e-1)" "unprognostic (8.21e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (1.71e-1)" "unprognostic (9.22e-2)" "unprognostic (4.84e-2)" 0.6 3.2 2.0 3.4 2.2 1.3 2.2 10.0 3.3 1.5 11.4 0.6 9.1 9.9 0.8 5.2 2.4 3.9 3.9 0.7 1.3 2.1 12.5 13.3 5.6 0.5 0.9 1.7 0.8 28.9 4.4 2.6 1.0 1.2 1.3 6.0 1.0 3.7 2.5 0.4 2.7 17.2 0.3 0.9 0.7 10.1 12.4 0.6 0.5 2.4 0.8 1.3 1.1 1.6 0.5 0.8 0.1 0.3 5.0 0.2 0.1 7.4 12.7 0.2 0.0 0.0 0.0 6.4 0.2 0.0 0.3 0.5 7.0 6.5 0.7 5.2 0.1 2.4 4.0 9.5 3.9 0.8 13.8 18.3 0.1 7.1 0.0 0.5 12.1 2.9 0.1 5.2 0.2 7.4 1.4 0.4 5.8 0.1 2.4 0.0 1.6 3.8 4.3 9.1 8.7 5.6 0.0 0.0 13.3 8.8 3.1 9.4 2.5 4.3 0.2 0.0 1.0 3.7 3.9 0.0 0.0 1.2 0.0 7.4 2.3 2.9 0.0 1.2 3.3 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.3 0.2 0.1 0.8 0.5 0.0 0.0 0.1 5.0 0.0 0.2 0.2 0.1 2.0 2.2 10.0 3.3 1.3 2.1 0.9 1.7 1.2 0.6 32.8 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 14.0 0.0 0.0 3.3 9.7 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.8 0.0 0.0 7.8 0.0 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 MAP4K5 "GCKR, KHS, KHS1" ENSG00000012983 "Mitogen-activated protein kinase kinase kinase kinase 5" 14 50418501-50561126 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 26.1" "Lineage enriched" "Detected in all" 5 "granulocytes: 26.1" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036696, HPA078030" Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036696: AB_10672362, HPA078030: " "unprognostic (1.39e-1)" "unprognostic (1.00e-1)" "unprognostic (3.80e-1)" "unprognostic (1.66e-1)" "unprognostic (4.41e-2)" "unprognostic (1.43e-1)" "unprognostic (8.58e-3)" "unprognostic (4.13e-2)" "unprognostic (6.31e-2)" "unprognostic (2.24e-2)" "unprognostic (1.53e-3)" "unprognostic (7.34e-2)" "unprognostic (1.78e-2)" "unprognostic (3.71e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (2.02e-2)" 17.4 11.8 23.4 12.1 44.4 16.5 19.7 24.6 32.3 25.8 17.1 43.5 13.4 11.3 29.9 12.1 18.7 17.4 19.3 10.3 24.4 14.0 10.9 8.7 15.2 9.9 48.8 17.1 29.9 13.3 16.7 17.5 17.3 26.0 16.6 15.1 9.1 16.9 19.9 10.7 24.8 12.7 22.3 30.7 13.0 14.4 6.8 51.1 8.4 15.3 8.7 11.2 19.3 21.2 5.0 2.7 26.1 1.8 5.4 3.9 1.0 22.9 6.9 17.0 14.6 15.7 16.6 16.6 27.1 24.5 18.5 16.5 8.7 16.1 15.9 16.2 24.8 9.8 16.5 15.8 14.6 28.2 13.1 11.5 9.7 12.2 7.8 13.3 8.7 15.4 12.0 12.0 16.2 17.0 29.6 24.2 14.5 9.2 10.4 27.0 8.7 11.7 8.3 8.3 7.4 13.6 14.2 25.8 6.0 18.3 17.9 5.5 12.5 15.3 10.7 10.5 14.3 11.9 6.6 24.6 24.1 16.8 16.4 12.7 7.6 7.7 10.6 9.0 6.1 17.1 26.1 1.5 13.5 3.9 1.8 2.2 3.2 2.4 3.3 1.6 5.0 2.6 2.7 0.6 5.4 1.1 2.7 0.5 1.0 23.4 44.4 24.6 32.3 24.4 14.0 48.8 17.1 26.0 51.1 38.7 17.3 14.6 29.9 62.2 51.9 7.3 20.4 26.8 27.3 26.2 45.2 9.4 16.6 24.0 2.8 33.1 15.9 23.3 18.3 16.7 46.1 53.8 28.9 7.8 7.5 31.8 22.5 35.6 13.9 2.2 39.4 20.9 21.9 17.2 14.2 18.2 23.1 15.0 48.1 9.9 33.6 12.9 40.4 11.2 13.6 75.3 5.5 21.8 16.2 55.0 MAPT "DDPAC, FLJ31424, FTDP-17, MAPTL, MGC138549, MSTD, MTBT1, MTBT2, PPND, PPP1R103, tau" ENSG00000186868 "Microtubule associated protein tau" P10636 17 45894382-46028334 "Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Alzheimer disease, Disease mutation, FDA approved drug targets, Neurodegeneration, Parkinsonism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 89.9;skeletal muscle: 43.7" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 300.5;Early spermatids: 153.8;Horizontal cells: 341.7;Late spermatids: 194.8;Muller glia cells: 139.1" "Group enriched" "Detected in many" 11 "breast cancer: 9.5;glioma: 13.3;prostate cancer: 3.0;renal cancer: 4.7" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HDLM-2: 27.9;SCLC-21H: 10.1;T-47d: 12.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000151, HPA048895, HPA069524, HPA069570, CAB072344" Enhanced Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "CAB000151: , CAB072344: , HPA048895: AB_2680550, HPA069524: AB_2686145, HPA069570: AB_2686155" "unprognostic (1.78e-3)" "unprognostic (7.51e-2)" "unprognostic (3.71e-2)" "unprognostic (8.40e-5)" "unprognostic (1.40e-1)" "unprognostic (1.31e-2)" "unprognostic (4.06e-5)" "unprognostic (6.04e-2)" "unprognostic (2.19e-2)" "unprognostic (3.49e-2)" "unprognostic (3.88e-3)" "unprognostic (2.65e-1)" "unprognostic (1.72e-3)" "unprognostic (6.53e-2)" "unprognostic (3.43e-1)" "unprognostic (1.85e-2)" "unprognostic (5.47e-2)" 3.8 7.1 28.9 2.4 31.2 2.1 8.8 40.1 89.9 2.4 2.7 21.4 1.7 2.5 2.6 2.3 6.4 2.5 2.8 6.5 28.7 29.7 15.3 2.2 2.4 2.3 22.6 35.2 2.3 2.8 8.5 8.8 5.2 29.1 5.1 2.5 2.2 8.1 5.3 43.7 4.6 2.8 2.5 13.6 2.2 2.3 6.5 27.7 0.0 2.3 3.1 2.3 3.2 0.8 0.0 0.0 0.3 0.1 0.5 1.7 0.1 0.8 0.3 0.2 2.6 0.0 0.5 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.3 0.0 1.3 0.1 0.0 27.9 1.4 0.0 0.0 2.6 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.0 1.6 0.2 1.4 0.0 4.2 0.5 0.1 0.0 0.4 1.1 0.0 2.3 2.8 0.0 3.6 10.1 4.7 1.0 0.0 1.0 0.6 12.7 0.0 0.0 0.2 0.3 0.6 0.1 0.5 0.2 0.0 0.2 0.5 0.3 0.0 0.1 0.3 0.8 0.0 0.6 0.0 0.4 1.2 0.0 0.0 0.9 0.9 0.0 0.5 0.1 0.0 1.7 0.1 28.9 31.2 40.1 46.3 28.7 29.7 22.6 35.2 29.1 27.7 0.0 9.8 0.8 1.1 0.9 300.5 32.3 0.0 0.0 0.0 1.8 60.9 0.1 6.6 0.4 153.8 1.3 0.0 0.0 0.4 8.0 1.9 2.9 4.6 0.5 0.3 341.7 0.0 0.6 0.3 194.8 2.6 1.3 5.0 1.0 0.0 139.1 0.6 0.0 2.5 44.6 24.8 0.0 4.1 11.4 5.9 2.9 0.2 0.0 0.1 0.5 MARCH10 "FLJ35757, MARCH-X, RNF190" ENSG00000173838 "Membrane associated ring-CH-type finger 10" Q8NA82 17 62701314-62808344 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "testis: 80.2" "Group enriched" "Detected in some" 7 "Early spermatids: 371.3;Late spermatids: 1043.9" "Low cancer specificity" "Detected in single" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "gdT-cell: 3.4" "Lineage enriched" "Detected in single" 5 "T-cells: 3.4" "Cell line enhanced" "Detected in some" "BEWO: 3.9;EFO-21: 7.3;HSkMC: 3.2;SCLC-21H: 12.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA023322 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023322: AB_1856351" "unprognostic (2.79e-2)" "unprognostic (2.32e-1)" "unprognostic (9.60e-3)" "unprognostic (6.95e-2)" "unprognostic (1.21e-1)" "unprognostic (1.21e-1)" "unprognostic (1.03e-2)" "unprognostic (1.67e-1)" "unprognostic (1.39e-1)" "unprognostic (7.99e-4)" "unprognostic (3.16e-1)" "unprognostic (2.85e-3)" "unprognostic (1.38e-1)" "unprognostic (4.83e-2)" "unprognostic (9.37e-3)" "unprognostic (2.66e-1)" 0.2 0.1 0.7 0.2 1.6 0.0 0.1 0.1 0.3 0.5 0.1 1.9 0.6 0.0 0.3 4.8 0.1 7.9 0.1 0.1 1.0 1.0 0.6 0.1 1.4 0.1 0.2 0.5 1.0 0.1 0.3 4.5 0.1 1.8 0.1 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.0 80.2 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.7 0.0 0.0 0.6 3.4 0.3 0.1 0.0 0.2 0.0 0.0 0.2 3.9 1.7 0.2 1.2 0.3 0.0 0.1 0.0 7.3 0.5 0.1 0.0 0.0 0.4 1.4 0.0 0.0 1.3 0.7 0.0 1.5 0.0 0.0 3.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.9 1.5 0.1 0.1 0.3 0.0 0.2 0.0 0.0 0.2 1.1 0.0 12.7 0.0 0.0 0.7 0.1 0.5 0.2 0.0 0.0 0.0 0.7 0.1 1.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 3.4 0.0 1.5 0.0 0.7 0.3 0.7 0.1 0.6 1.8 0.0 0.6 0.0 0.0 0.7 0.3 0.7 1.6 0.1 0.3 1.0 1.0 0.2 0.5 1.8 0.3 3.0 1.0 0.0 0.0 0.1 0.0 0.3 0.0 105.7 15.9 3.5 0.0 0.1 44.7 0.0 371.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.0 0.1 0.0 0.0 0.6 0.0 1043.9 4.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 6.5 0.0 42.4 10.6 0.0 0.1 0.5 0.0 0.0 MARCH7 "AXOT, MARCH-VII, RNF177" ENSG00000136536 "Membrane associated ring-CH-type finger 7" Q9H992 2 159712457-159771027 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 208.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014275, HPA022152" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA014275: AB_10599820, HPA022152: AB_10601107" "unprognostic (2.42e-1)" "unprognostic (2.24e-1)" "unprognostic (1.02e-2)" "unprognostic (1.92e-2)" "unprognostic (1.62e-2)" "unprognostic (2.10e-1)" "prognostic unfavorable (2.41e-4)" "unprognostic (2.46e-2)" "unprognostic (6.42e-2)" "unprognostic (3.44e-1)" "unprognostic (3.17e-2)" "unprognostic (3.53e-2)" "prognostic unfavorable (1.84e-4)" "unprognostic (1.41e-3)" "unprognostic (1.38e-1)" "unprognostic (2.57e-1)" "unprognostic (1.61e-1)" 31.6 21.1 18.3 27.4 29.0 22.6 28.9 33.1 23.0 33.4 25.3 17.0 22.0 17.1 32.3 24.1 47.6 22.7 22.4 28.1 16.9 14.4 21.8 30.9 29.5 32.9 21.6 17.8 31.6 15.4 25.3 31.5 41.3 21.5 28.8 22.3 24.8 25.7 22.6 48.0 24.2 25.2 33.8 20.4 28.9 20.0 34.1 21.8 60.4 28.5 25.5 32.9 30.0 35.1 10.0 10.1 46.1 14.5 14.0 14.6 10.5 18.4 12.7 34.2 15.3 24.9 32.9 33.1 31.0 31.3 31.9 29.3 26.2 22.2 26.2 14.1 32.2 18.1 23.3 21.0 28.6 40.9 26.8 15.5 35.6 18.4 19.8 24.2 29.1 27.8 29.2 32.7 38.9 33.8 36.4 38.2 19.2 27.0 25.4 32.2 15.1 18.6 27.9 32.3 20.3 18.2 27.7 25.3 21.7 29.3 38.5 20.4 19.1 25.3 18.6 24.8 38.8 21.6 35.4 34.4 34.2 20.6 20.9 17.5 20.2 21.3 35.8 21.2 17.6 31.8 24.8 10.3 20.6 11.1 10.6 13.3 10.0 12.1 12.6 10.1 9.7 14.6 14.1 46.1 14.0 14.5 7.9 12.5 10.5 18.3 29.0 33.1 23.0 16.9 14.4 21.6 17.8 21.5 21.8 68.5 35.6 53.7 0.0 76.4 37.4 78.7 10.2 57.6 44.3 34.9 25.5 31.0 16.6 0.0 208.1 38.3 17.5 23.3 0.0 29.9 37.4 0.0 53.3 28.0 29.4 46.1 27.6 52.2 38.4 46.0 45.8 42.0 21.9 0.0 24.9 38.9 0.0 17.5 38.5 32.1 34.2 58.2 45.3 77.0 31.7 79.3 37.0 41.5 21.9 0.0 MARK2 "EMK1, PAR-1, PAR-1B, Par1b" ENSG00000072518 "Microtubule affinity regulating kinase 2" Q7KZI7 11 63838928-63911019 "Enzymes, Predicted intracellular proteins" "Differentiation, Wnt signaling pathway" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038790, HPA074905" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA038790: AB_10674840, HPA074905: AB_2686722" "unprognostic (1.33e-2)" "unprognostic (2.45e-2)" "unprognostic (1.64e-1)" "prognostic unfavorable (3.21e-4)" "unprognostic (7.13e-2)" "unprognostic (3.82e-2)" "prognostic unfavorable (1.30e-4)" "unprognostic (2.73e-3)" "unprognostic (4.41e-1)" "unprognostic (5.79e-2)" "unprognostic (3.94e-3)" "unprognostic (3.77e-1)" "unprognostic (5.20e-3)" "unprognostic (5.15e-3)" "unprognostic (6.78e-2)" "unprognostic (1.03e-1)" "unprognostic (2.40e-1)" 9.7 11.6 16.5 16.3 21.4 18.5 13.8 24.7 26.1 15.2 20.5 20.0 11.1 21.3 13.6 7.5 48.4 13.6 14.4 14.7 17.0 10.1 11.9 12.4 15.4 16.3 18.1 13.7 11.0 17.3 21.8 22.4 21.1 15.0 14.9 19.8 10.6 20.7 14.3 15.7 35.8 26.9 13.3 13.3 21.6 16.8 9.8 18.7 22.9 15.9 13.6 23.5 14.8 21.3 2.9 1.9 9.8 1.9 3.3 4.5 1.2 22.7 15.2 12.5 13.1 6.9 9.0 17.3 9.3 8.9 13.4 10.4 16.3 24.1 16.8 16.4 9.7 14.5 29.5 12.0 14.5 11.6 11.6 9.4 18.5 12.0 10.6 7.7 20.1 24.5 4.9 19.8 12.3 10.7 6.3 11.0 15.9 15.7 19.4 8.8 28.0 21.0 14.3 14.2 18.4 11.1 17.4 9.3 18.6 10.0 18.8 17.2 11.6 16.0 41.1 10.7 14.0 29.9 12.0 10.4 14.2 8.9 18.3 10.3 11.8 12.2 16.5 9.7 10.6 11.3 2.7 1.7 4.4 2.9 1.5 4.5 2.3 3.2 3.1 1.9 2.9 2.6 2.4 9.8 3.3 1.9 1.7 1.5 1.2 16.5 21.4 24.7 26.1 17.0 10.1 18.1 13.7 15.0 18.7 6.0 5.0 13.9 16.2 22.3 26.0 10.9 35.7 6.7 6.8 19.2 7.9 19.2 1.7 18.5 0.4 11.9 59.3 0.0 18.5 16.8 10.6 28.8 17.3 12.1 15.7 19.1 28.7 13.5 19.5 0.7 11.8 11.3 3.3 8.2 35.1 19.1 20.0 35.9 10.3 6.9 17.8 19.4 9.2 8.4 21.8 30.1 54.3 23.6 28.2 30.9 MCF2L2 "ARHGEF22, KIAA0861" ENSG00000053524 "MCF.2 cell line derived transforming sequence-like 2" Q86YR7 3 183178043-183428778 "Disease related genes, Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Diabetes mellitus" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 16.4;brain: 23.7" "Group enriched" "Detected in many" 11 "Bipolar cells: 64.6;Cone photoreceptor cells: 208.1;Early spermatids: 86.7;Rod photoreceptor cells: 135.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "T-reg: 4.6" "Lineage enriched" "Detected in single" 8 "T-cells: 4.6" "Cell line enhanced" "Detected in many" "HDLM-2: 9.4;Karpas-707: 8.2;REH: 5.4" "Low region specificity" "Detected in all" "HPA038946, HPA038947" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038946: AB_10670914, HPA038947: AB_10672655" "unprognostic (2.17e-2)" "unprognostic (4.42e-1)" "unprognostic (3.08e-1)" "unprognostic (1.95e-3)" "unprognostic (1.98e-1)" "unprognostic (2.87e-2)" "unprognostic (3.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.46e-1)" "unprognostic (5.08e-2)" "unprognostic (4.80e-4)" "unprognostic (1.32e-1)" "unprognostic (8.75e-6)" "unprognostic (1.09e-1)" "unprognostic (5.47e-2)" "unprognostic (2.95e-1)" "unprognostic (1.78e-1)" 0.9 16.4 12.8 1.4 14.9 1.1 1.1 11.3 23.7 1.3 1.4 3.6 0.0 0.9 1.3 1.3 1.3 1.0 1.5 1.1 12.2 7.6 1.4 0.8 1.2 1.7 5.6 13.0 1.2 1.2 10.5 8.9 0.8 7.3 2.1 1.4 7.5 0.8 1.6 1.4 1.0 1.2 1.4 4.5 5.3 1.2 5.5 4.3 0.0 0.9 0.0 2.1 1.6 0.4 0.1 0.0 0.6 0.0 0.1 4.6 0.2 0.1 0.6 0.2 1.8 0.1 0.2 0.4 0.0 0.1 0.3 0.0 1.2 0.2 1.5 0.2 0.1 1.9 0.0 0.3 0.2 0.1 9.4 1.4 4.0 0.3 0.0 0.3 1.2 0.8 0.3 0.0 0.0 0.7 0.0 0.7 2.5 1.2 8.2 0.5 1.2 1.2 0.9 1.3 0.0 1.6 5.4 0.0 1.5 0.4 0.2 2.6 0.9 1.0 0.0 2.1 0.6 0.5 0.9 0.6 0.0 0.9 0.1 0.1 3.3 3.5 1.7 0.8 1.4 0.1 0.1 0.0 0.1 0.4 0.0 1.0 0.0 1.0 0.6 0.0 0.1 0.0 0.9 0.6 0.1 0.0 0.0 4.6 0.2 12.8 14.9 11.3 23.7 12.2 7.6 5.6 13.0 7.3 4.3 0.0 2.1 0.0 0.4 0.3 64.6 1.2 0.0 4.0 0.0 5.2 208.1 0.2 0.0 0.1 86.7 0.7 0.3 0.0 0.2 0.1 0.7 0.2 1.1 0.0 0.4 7.9 0.0 3.1 0.6 11.7 0.9 1.0 1.7 2.8 0.0 3.0 0.2 0.0 0.4 0.0 135.4 0.0 0.4 0.7 3.4 0.4 1.1 2.1 0.0 0.6 MCTS1 MCT-1 ENSG00000232119 "MCTS1, re-initiation and release factor" Q9ULC4 X 120594010-120621074 "Predicted intracellular proteins" "Cell cycle, DNA damage, Growth regulation, Protein biosynthesis, Transcription, Transcription regulation" "Initiation factor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001045 Supported "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA001045: " "prognostic unfavorable (1.38e-4)" "unprognostic (1.44e-1)" "unprognostic (4.50e-1)" "unprognostic (9.37e-3)" "unprognostic (7.29e-2)" "prognostic unfavorable (3.27e-5)" "unprognostic (2.94e-3)" "unprognostic (9.59e-2)" "unprognostic (8.28e-2)" "unprognostic (4.89e-2)" "unprognostic (7.42e-2)" "unprognostic (2.82e-1)" "prognostic unfavorable (4.35e-5)" "unprognostic (1.95e-1)" "unprognostic (7.58e-2)" "unprognostic (1.04e-1)" "unprognostic (1.49e-1)" 20.2 26.8 23.7 22.5 29.3 16.9 27.4 16.8 33.8 20.7 24.0 14.3 26.6 23.2 17.4 30.7 31.7 16.6 16.8 24.6 25.2 22.4 22.7 37.9 17.2 31.1 22.6 25.0 14.7 42.0 21.1 38.2 20.7 22.3 16.6 29.7 13.4 31.0 27.3 20.9 18.1 21.2 19.2 20.8 24.1 22.9 13.1 19.0 28.5 23.1 32.1 36.1 20.5 19.1 28.2 32.0 13.7 24.4 17.7 24.5 15.5 31.3 22.1 18.0 18.0 23.0 33.5 24.5 23.6 21.7 29.8 28.6 19.2 31.1 33.8 34.0 29.1 53.9 20.9 31.6 30.1 43.2 21.3 21.0 10.9 24.5 15.1 26.2 27.4 21.0 23.0 26.6 25.9 28.3 25.3 35.9 24.3 29.7 22.6 36.6 36.1 26.2 36.6 20.1 58.6 43.8 20.2 16.6 40.9 31.8 15.7 22.8 21.2 16.5 26.9 21.3 23.2 19.8 25.3 24.5 24.2 14.8 26.1 43.3 17.1 23.1 46.0 28.1 40.4 26.3 11.9 20.1 13.7 15.1 24.4 24.5 28.2 19.8 19.3 24.8 20.7 18.3 18.5 9.9 17.7 22.4 32.0 22.9 15.5 23.7 29.3 16.8 33.8 25.2 22.4 22.6 25.0 22.3 19.0 17.9 22.2 67.0 49.4 28.6 12.4 74.2 43.3 28.1 29.6 43.6 7.9 83.5 109.5 76.8 43.6 38.3 78.6 0.0 76.9 150.4 40.7 48.4 51.8 84.7 116.3 14.3 53.5 53.4 77.2 73.5 38.9 64.4 59.1 54.1 77.4 19.3 85.0 71.9 26.2 116.5 16.5 38.8 36.0 9.3 15.1 30.2 94.4 51.1 64.3 66.0 MDGA1 "GPIM, MAMDC3" ENSG00000112139 "MAM domain containing glycosylphosphatidylinositol anchor 1" Q8NFP4 6 37630679-37699306 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 11 "brain: 94.7" "Group enriched" "Detected in many" 5 "Bipolar cells: 31.7;Cone photoreceptor cells: 47.1;Horizontal cells: 54.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 17 "cerebellum: 94.7" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 3.1" "Group enriched" "Detected in many" 22 "B-cells: 1.1;T-cells: 3.1" "Cell line enhanced" "Detected in many" "ASC diff: 13.8;HaCaT: 8.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA031235, HPA050382" Enhanced Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 490000 "Plasma membrane" "Golgi apparatus" "HPA031235: AB_10603017, HPA050382: AB_2681108" "unprognostic (4.67e-2)" "unprognostic (6.97e-3)" "unprognostic (3.24e-1)" "unprognostic (5.69e-4)" "unprognostic (2.75e-2)" "unprognostic (2.41e-1)" "unprognostic (1.45e-2)" "unprognostic (2.00e-1)" "unprognostic (2.02e-2)" "unprognostic (1.45e-1)" "unprognostic (2.16e-2)" "unprognostic (3.00e-1)" "unprognostic (1.52e-5)" "unprognostic (9.19e-3)" "unprognostic (5.28e-3)" "unprognostic (3.80e-3)" "unprognostic (4.60e-2)" 1.5 3.7 3.4 3.1 2.4 0.0 1.0 94.7 5.1 3.0 1.3 1.5 1.0 0.0 3.0 1.5 1.8 2.1 3.4 1.2 5.0 2.0 0.8 0.5 3.5 3.4 1.7 2.4 8.4 2.6 6.6 2.6 0.5 5.4 1.5 1.1 3.4 0.7 1.2 0.9 6.7 1.5 2.6 4.1 3.9 1.2 1.4 1.3 0.6 1.1 1.7 2.7 1.1 3.1 1.1 0.0 0.0 0.0 0.0 3.1 0.4 0.1 3.8 6.9 2.6 13.8 5.6 3.0 2.7 2.7 3.4 3.9 0.7 0.0 0.9 0.6 1.7 3.6 8.9 0.5 0.0 1.1 6.9 4.0 0.0 0.5 0.0 0.6 0.0 0.9 1.0 0.1 1.4 0.0 8.0 0.0 0.1 0.1 0.0 1.2 0.1 0.0 0.5 0.0 0.1 0.4 7.3 2.4 0.0 0.8 4.2 6.3 0.0 1.5 0.4 3.3 0.2 3.2 0.6 0.5 3.7 1.2 1.3 5.0 0.0 0.1 0.0 5.8 1.1 2.4 0.0 0.0 0.0 1.4 0.0 0.4 1.1 1.2 0.8 0.0 1.0 3.1 0.8 0.0 0.0 0.0 0.0 1.8 0.4 3.4 2.4 94.7 2.7 5.0 2.0 1.7 2.4 5.4 1.3 8.9 0.3 0.0 1.7 2.1 31.7 5.2 0.0 2.7 1.2 3.5 47.1 0.1 0.0 0.6 1.9 1.0 0.0 0.0 0.0 1.2 2.4 1.5 0.0 0.0 0.1 54.0 1.7 1.8 0.0 0.0 9.5 0.0 1.7 0.0 0.0 2.3 0.6 0.0 4.6 0.1 1.3 0.0 3.4 2.3 1.0 2.6 0.6 0.5 0.0 3.8 MET "DFNB97, HGFR, RCCP2" ENSG00000105976 "MET proto-oncogene, receptor tyrosine kinase" P08581 7 116672390-116798386 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Deafness, Disease mutation, FDA approved drug targets, Non-syndromic deafness, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 78.1;Club cells: 116.0;Urothelial cells: 88.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "A-431: 45.3;CAPAN-2: 49.5" "Group enriched" "Detected in many" 5 "amygdala: 3.5;basal ganglia: 9.9;cerebral cortex: 7.6;hippocampal formation: 8.0;olfactory region: 9.1" "Low region specificity" "Detected in many" "CAB005282, CAB018577, HPA055607" Approved Approved "Plasma membrane,Cytosol" "Secreted to blood" NA NA 179000000 70000000 "Plasma membrane, Cytosol" "CAB005282: AB_631940, CAB018577: AB_649068, HPA055607: AB_2682860" "unprognostic (1.60e-2)" "unprognostic (7.71e-2)" "unprognostic (2.53e-2)" "unprognostic (1.58e-1)" "unprognostic (3.57e-3)" "prognostic unfavorable (6.75e-4)" "unprognostic (1.68e-1)" "unprognostic (3.22e-2)" "unprognostic (3.81e-2)" "unprognostic (2.52e-2)" "prognostic unfavorable (1.21e-7)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (5.53e-2)" "unprognostic (8.88e-2)" "unprognostic (2.01e-2)" "unprognostic (2.20e-1)" 16.2 1.1 1.8 4.5 2.3 4.3 11.2 0.9 15.2 9.9 6.5 2.4 2.4 4.4 7.5 5.2 5.1 4.6 12.3 5.4 5.7 1.8 20.1 30.2 15.6 1.4 3.6 2.1 2.0 9.3 0.7 8.1 24.4 2.6 8.0 6.6 34.1 12.2 8.4 12.8 7.2 8.6 4.0 2.3 5.7 10.6 2.7 2.4 0.5 21.4 7.0 2.1 10.1 15.0 0.2 0.3 1.2 0.2 0.3 0.4 0.0 45.3 26.1 0.0 0.1 2.0 2.0 1.8 25.9 10.5 14.0 11.8 5.4 49.5 2.0 43.2 16.2 37.7 12.0 4.4 24.7 28.6 0.1 5.6 0.0 27.1 4.7 0.3 0.0 0.0 2.6 9.8 9.1 30.0 25.3 9.6 0.0 0.9 0.2 25.9 1.0 0.0 0.0 3.9 7.2 26.6 0.0 22.0 0.0 24.5 5.2 3.8 0.0 10.6 3.4 10.1 4.7 0.0 0.2 17.6 20.9 7.4 11.0 20.0 0.5 4.0 0.2 22.9 0.0 2.9 1.1 0.2 0.4 0.4 0.1 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 1.2 0.3 0.1 0.3 0.1 0.0 1.8 2.3 0.9 15.2 5.7 1.8 3.6 2.1 2.6 2.4 26.8 78.1 2.4 56.1 34.7 0.9 10.0 15.3 22.7 116.0 29.6 0.0 57.9 0.0 28.0 0.0 11.7 11.2 0.0 39.8 5.0 4.0 55.8 0.0 26.0 6.1 0.0 6.9 1.3 1.0 0.0 0.6 2.0 3.3 1.8 19.7 7.4 69.4 7.0 0.0 13.5 0.3 0.0 2.3 0.0 0.6 15.6 18.2 0.0 12.7 88.5 METAP2 "MAP2, MNPEP, p67" ENSG00000111142 "Methionyl aminopeptidase 2" P50579 12 95473520-95515839 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB013025, HPA019095" Enhanced Supported "Plasma membrane,Cytosol" NA NA 22000 "Plasma membrane, Cytosol" "CAB013025: AB_2533993, HPA019095: AB_1853823" "unprognostic (1.91e-1)" "unprognostic (1.02e-1)" "unprognostic (5.92e-2)" "unprognostic (2.44e-1)" "unprognostic (3.27e-2)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.51e-6)" "unprognostic (1.25e-1)" "unprognostic (2.28e-2)" "unprognostic (1.40e-2)" "unprognostic (8.53e-2)" "unprognostic (1.66e-1)" "unprognostic (1.49e-1)" "unprognostic (2.51e-1)" "unprognostic (1.07e-1)" "unprognostic (2.95e-2)" "unprognostic (1.03e-1)" 24.2 36.4 25.8 49.9 33.7 39.1 25.1 25.9 32.3 23.9 26.2 16.3 102.5 16.6 28.7 25.4 30.1 22.5 21.7 30.7 29.6 24.0 26.0 46.8 22.1 32.6 29.1 23.4 29.4 31.9 21.0 36.1 25.1 42.9 24.2 24.0 10.1 22.1 140.7 94.4 28.7 19.7 26.1 48.2 25.2 22.2 26.3 27.7 32.1 24.1 29.0 55.2 33.4 37.3 39.4 31.8 21.3 27.1 25.7 32.0 16.2 33.9 28.6 30.6 23.8 18.7 30.0 23.6 33.5 23.4 33.0 23.5 41.5 16.3 98.8 21.1 23.9 19.2 21.9 34.4 25.6 38.0 23.5 29.7 44.2 21.8 29.2 19.9 54.7 21.7 25.9 27.4 31.2 30.6 39.6 35.1 34.1 57.2 11.2 24.4 22.3 40.5 37.4 37.5 19.6 42.8 31.9 26.5 32.4 22.6 36.0 23.8 31.3 29.7 24.3 29.3 27.6 29.3 26.0 30.1 19.0 18.4 21.2 35.3 16.2 42.1 105.9 10.8 30.9 23.8 21.3 27.1 11.1 23.8 19.1 29.2 39.4 26.7 26.6 24.4 37.6 32.0 29.7 1.2 25.7 22.3 31.8 25.3 16.2 25.8 33.7 25.9 32.3 29.6 24.0 29.1 23.4 42.9 27.7 262.0 228.6 96.8 102.9 207.2 62.7 117.4 91.7 104.4 160.3 275.7 62.8 125.5 139.3 94.7 135.8 104.6 80.2 256.9 126.2 136.4 102.7 68.6 119.0 278.9 86.9 71.5 88.0 102.5 122.4 83.3 92.9 93.2 87.7 80.2 109.6 67.6 105.7 83.4 100.4 81.6 68.7 97.0 97.6 340.7 217.0 187.9 143.8 93.5 118.5 90.7 MFSD1 "FLJ14153, UG0581B09" ENSG00000118855 "Major facilitator superfamily domain containing 1" Q9H3U5 3 158732198-158829719 "Predicted intracellular proteins, Predicted membrane proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Hofbauer cells: 192.2;Kupffer cells: 259.8;Macrophages: 135.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 4 "dendritic cells: 45.3;granulocytes: 42.6;monocytes: 49.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065858 Approved Approved "Plasma membrane,Cytosol" NA NA 14000 "Plasma membrane" Cytosol "HPA065858: AB_2685569" "unprognostic (9.94e-2)" "unprognostic (3.12e-3)" "unprognostic (3.54e-2)" "unprognostic (1.00e-1)" "unprognostic (2.16e-2)" "unprognostic (7.37e-2)" "unprognostic (1.28e-2)" "unprognostic (2.61e-2)" "unprognostic (2.52e-1)" "unprognostic (1.15e-1)" "unprognostic (6.48e-2)" "unprognostic (2.92e-1)" "prognostic favorable (5.60e-5)" "unprognostic (1.62e-1)" "unprognostic (6.33e-3)" "unprognostic (4.66e-2)" "unprognostic (2.57e-1)" 26.2 29.5 11.4 22.0 11.8 17.2 24.2 9.1 14.0 18.7 15.7 13.4 18.9 13.2 18.3 20.6 37.0 18.4 17.5 17.7 10.8 10.3 20.7 24.8 24.9 39.8 15.7 11.7 15.3 16.8 16.5 16.8 18.3 13.6 14.7 11.5 14.5 34.5 17.9 9.2 18.6 16.8 15.0 14.5 29.1 19.9 15.0 14.3 11.3 18.7 16.3 16.7 23.8 24.1 10.5 45.3 42.6 49.6 5.4 7.3 35.3 14.9 6.4 1.6 5.0 8.7 8.2 10.3 23.4 10.5 8.3 8.2 2.6 14.8 4.2 17.2 14.9 5.0 7.8 4.0 5.1 7.8 16.6 10.9 11.2 4.9 1.1 9.4 41.3 28.1 12.2 6.7 7.5 2.1 3.3 6.5 2.8 8.7 8.6 14.7 3.4 2.5 12.2 1.6 6.3 16.4 5.6 2.4 36.6 3.0 3.9 4.8 7.2 17.2 13.3 4.1 2.0 10.5 16.2 21.3 11.9 4.6 17.6 11.5 27.4 19.2 2.3 15.0 30.0 8.3 14.0 49.6 42.6 7.3 38.5 6.6 10.5 5.8 6.5 45.3 8.5 6.4 7.0 17.6 5.4 31.6 14.7 6.8 35.3 11.4 11.8 9.1 14.0 10.8 10.3 15.7 11.7 13.6 14.3 17.9 31.3 39.5 33.3 19.1 11.9 17.1 12.7 40.2 29.6 21.0 5.9 23.7 16.6 28.2 3.5 25.1 25.5 23.3 24.8 27.2 23.6 39.9 47.4 30.1 192.2 17.5 21.9 39.3 259.8 5.3 11.2 135.3 30.4 15.4 26.6 23.4 26.7 20.1 10.6 25.9 10.0 12.9 15.5 8.8 7.0 22.7 46.8 15.4 24.0 47.5 MIB1 "DIP-1, KIAA1323, MIB, ZZANK2, ZZZ6" ENSG00000101752 "Mindbomb E3 ubiquitin protein ligase 1" Q86YT6 18 21704957-21870957 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019100, CAB037044" Approved Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB037044: AB_1841007, HPA019100: AB_1853934" "unprognostic (1.38e-1)" "unprognostic (6.92e-2)" "unprognostic (7.29e-2)" "unprognostic (6.99e-2)" "unprognostic (5.66e-2)" "unprognostic (3.23e-2)" "unprognostic (8.45e-3)" "unprognostic (2.70e-1)" "unprognostic (5.42e-2)" "unprognostic (4.69e-2)" "unprognostic (3.78e-2)" "unprognostic (4.70e-2)" "unprognostic (8.33e-3)" "unprognostic (4.91e-3)" "unprognostic (1.73e-1)" "unprognostic (4.86e-2)" "unprognostic (1.85e-2)" 12.1 9.1 15.3 7.9 20.6 5.9 15.7 16.1 17.4 16.6 10.9 16.3 9.7 6.9 19.1 13.7 11.4 11.5 12.0 9.4 16.3 12.9 15.7 14.1 10.1 9.6 17.4 16.5 17.2 11.7 18.4 11.5 14.9 15.5 14.7 10.1 14.6 12.0 12.6 9.6 12.5 8.4 17.9 13.8 9.4 10.7 11.5 18.1 13.9 19.1 9.8 10.6 13.0 13.8 1.2 1.2 3.5 1.7 2.5 2.0 0.6 8.5 3.4 16.8 11.7 9.0 10.8 4.0 6.9 7.8 5.0 7.3 5.0 3.2 7.3 6.4 9.6 5.4 5.8 9.7 9.4 11.3 9.6 4.5 8.2 4.4 6.9 7.3 16.6 3.5 6.9 10.4 5.8 14.9 7.3 12.4 2.9 11.2 21.7 7.7 4.2 8.0 6.3 4.2 5.3 4.5 52.4 13.9 18.1 8.5 7.6 5.5 13.6 11.9 5.6 6.1 8.9 3.9 10.9 10.6 12.8 6.4 5.3 9.2 11.4 4.0 11.3 5.4 10.6 7.6 3.5 1.7 0.6 1.0 0.9 1.2 1.2 1.5 1.0 0.6 0.6 1.2 0.9 1.5 2.5 0.5 1.2 2.0 0.6 15.3 20.6 16.1 17.4 16.3 12.9 17.4 16.5 15.5 18.1 44.7 17.7 5.9 14.0 19.5 29.4 15.1 20.4 21.4 34.2 15.7 23.6 10.7 3.3 11.3 3.3 22.5 10.5 0.0 11.2 6.2 22.6 33.3 13.9 26.3 10.8 14.3 23.1 21.5 18.7 3.7 19.0 11.5 25.3 5.4 15.4 16.5 16.7 5.8 23.3 14.4 14.7 0.0 23.4 16.7 11.5 21.5 21.2 10.1 9.4 14.4 MISP "C19orf21, Caprice, DKFZp686H18209, MISP1" ENSG00000099812 "Mitotic spindle positioning" Q8IVT2 19 751126-764318 "Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "gallbladder: 24.6;intestine: 63.8" "Group enriched" "Detected in many" 5 "Enterocytes: 892.4;Paneth cells: 434.9" "Cancer enhanced" "Detected in many" "colorectal cancer: 133.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 37.2;HaCaT: 27.6;hTCEpi: 25.9;MCF7: 19.0;OE19: 23.2;SK-BR-3: 42.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA049511, HPA062232" Enhanced Enhanced "Plasma membrane,Focal adhesion sites" No No "Plasma membrane, Focal adhesion sites" "HPA049511: AB_2680798, HPA062232: AB_2684719" "unprognostic (7.48e-2)" "unprognostic (2.04e-1)" "unprognostic (1.44e-1)" "unprognostic (3.99e-2)" "unprognostic (1.02e-1)" "unprognostic (6.50e-2)" "unprognostic (1.78e-3)" "unprognostic (1.64e-2)" "unprognostic (8.64e-2)" "unprognostic (1.49e-1)" "unprognostic (2.56e-3)" "unprognostic (2.09e-1)" "unprognostic (1.19e-3)" "unprognostic (6.78e-3)" "unprognostic (2.29e-1)" "unprognostic (4.80e-1)" "unprognostic (5.27e-2)" 0.5 0.1 0.3 7.9 0.3 0.0 0.7 0.2 0.2 1.5 42.8 0.2 0.2 45.9 0.7 0.8 0.4 2.4 24.6 0.2 0.5 0.2 6.9 0.4 6.8 0.2 0.3 0.3 2.2 2.0 0.0 4.2 2.1 0.2 2.2 13.0 0.2 0.5 0.5 0.2 0.3 63.8 0.7 0.2 0.2 5.8 0.2 0.2 0.3 0.2 0.8 0.2 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 37.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 12.8 13.7 3.2 3.6 0.0 0.0 27.6 0.0 11.6 0.0 0.0 0.0 0.0 14.6 3.9 0.0 0.0 0.5 0.0 25.9 0.1 1.4 0.0 0.0 0.0 0.0 0.1 0.0 19.0 0.0 0.2 0.0 23.2 7.6 0.0 0.1 0.3 9.3 10.3 0.4 0.1 13.2 42.0 0.0 0.0 9.1 0.0 0.0 0.0 4.7 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.2 0.2 0.5 0.2 0.3 0.3 0.2 0.2 35.7 10.1 2.2 4.0 0.1 0.0 0.4 2.5 26.8 15.9 10.4 0.0 0.3 1.7 48.8 0.4 0.0 892.4 0.0 41.8 2.6 0.3 34.5 9.2 0.0 0.1 0.0 55.7 0.0 0.0 0.7 0.0 0.8 0.0 1.0 139.5 0.0 94.0 434.9 0.0 21.7 0.0 0.0 0.0 0.0 1.5 0.3 1.7 0.0 93.0 40.9 MMP10 STMY2 ENSG00000166670 "Matrix metallopeptidase 10" P09238 11 102770503-102780628 "Cancer-related genes, Enzymes, FDA approved drug targets, Predicted secreted proteins" "Collagen degradation" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "endometrium 1: 89.4" "Cell type enhanced" "Detected in some" 14 "Basal glandular cells: 38.9;Club cells: 70.5;Collecting duct cells: 27.9;Pancreatic endocrine cells: 62.0" "Cancer enhanced" "Detected in many" "head and neck cancer: 102.2" "Region enriched" "Detected in single" 9 "pons and medulla: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BJ: 12.6;HUVEC TERT2: 16.2;SCLC-21H: 5.2" "Not detected" "Not detected" CAB002159 Uncertain Approved "Plasma membrane,Cytosol" "Secreted to extracellular matrix" NA NA 765000 Cytosol "Plasma membrane" "CAB002159: AB_564103" "unprognostic (8.76e-2)" "unprognostic (3.38e-1)" "unprognostic (1.98e-3)" "unprognostic (2.72e-3)" "unprognostic (7.17e-3)" "unprognostic (1.52e-2)" "unprognostic (5.67e-8)" "unprognostic (2.08e-3)" "unprognostic (2.20e-1)" "unprognostic (1.75e-1)" "unprognostic (1.67e-2)" "unprognostic (2.67e-1)" "unprognostic (6.99e-5)" "unprognostic (2.66e-2)" "unprognostic (7.98e-2)" "unprognostic (5.46e-2)" "prognostic favorable (7.12e-4)" 0.1 0.1 0.0 2.6 0.2 0.1 0.1 0.0 0.3 1.7 0.5 0.0 0.0 0.4 89.4 0.1 0.2 0.1 0.5 0.1 0.0 0.1 0.1 3.6 11.0 0.1 0.0 0.0 0.5 0.3 0.1 0.9 19.8 2.8 3.2 0.2 0.0 2.9 0.1 0.1 0.1 0.7 0.1 0.0 0.2 3.3 0.5 0.0 1.2 0.1 0.0 1.9 0.6 5.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.2 0.0 0.0 0.2 12.6 0.7 0.1 0.1 0.3 0.0 0.0 3.7 1.9 0.2 2.9 0.0 1.4 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.4 0.6 0.0 16.2 0.0 0.7 0.0 0.0 0.0 0.0 0.3 3.0 0.5 1.7 0.0 0.0 0.0 0.0 0.7 5.2 0.0 2.5 0.0 0.0 0.9 0.0 0.0 2.0 3.9 1.3 0.4 0.5 0.0 0.0 0.0 0.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.1 0.0 0.0 2.8 0.0 0.0 0.0 0.0 38.9 0.7 0.0 0.0 0.0 5.3 70.5 27.9 0.0 0.0 0.0 9.8 5.0 0.0 0.0 0.0 12.9 0.0 0.2 5.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 1.2 0.0 2.8 0.0 0.0 62.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.0 0.0 7.4 MMP24 MT5-MMP ENSG00000125966 "Matrix metallopeptidase 24" Q9Y5R2 20 35226654-35277000 "Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 38.5" "Cell type enhanced" "Detected in some" 10 "Alveolar cells type 1: 14.9;Cholangiocytes: 12.7;Ductal cells: 7.5;Horizontal cells: 14.3;Proximal tubular cells: 7.3" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 38.5" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 20.1;CACO-2: 30.6;EFO-21: 9.0;RPTEC TERT1: 13.8;U-2 OS: 10.4" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 4 "cerebellum: 91.3" "HPA049280, HPA078816" Approved Approved "Nucleoli,Plasma membrane" "Secreted to extracellular matrix" Yes No "Nucleoli, Plasma membrane" "HPA049280: , HPA078816: " "unprognostic (1.52e-3)" "unprognostic (1.36e-1)" "unprognostic (1.18e-1)" "unprognostic (4.51e-4)" "unprognostic (2.47e-2)" "unprognostic (7.61e-3)" "unprognostic (1.22e-1)" "unprognostic (4.59e-2)" "unprognostic (2.32e-2)" "unprognostic (8.82e-2)" "unprognostic (9.20e-3)" "unprognostic (7.12e-2)" "prognostic favorable (8.17e-11)" "unprognostic (3.32e-2)" "unprognostic (5.63e-2)" "unprognostic (1.69e-2)" "unprognostic (9.90e-4)" 1.6 1.3 4.0 0.4 7.8 0.6 0.4 38.5 8.9 0.7 0.3 1.3 0.2 2.8 1.6 0.9 0.2 2.8 0.6 1.0 2.7 3.2 8.6 0.9 6.1 0.3 1.8 1.5 0.9 8.0 0.0 3.8 0.6 1.7 2.2 0.1 0.5 0.4 6.0 0.2 1.5 1.7 2.5 0.9 0.6 0.7 0.4 1.4 0.2 0.8 0.2 0.2 0.5 0.2 0.8 0.4 2.2 0.8 0.6 1.2 0.3 0.3 20.1 0.0 0.1 0.1 0.0 0.6 1.1 1.3 2.1 1.1 30.6 5.4 0.0 9.0 1.4 0.7 0.3 4.7 0.0 0.9 0.1 0.2 1.1 0.6 0.3 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.6 0.0 0.1 0.0 0.3 0.2 0.2 0.1 0.1 7.7 0.0 1.4 0.0 0.1 0.0 13.8 0.1 8.0 5.5 1.4 0.5 0.2 1.8 0.3 0.1 0.3 4.3 10.4 1.0 0.4 0.1 0.1 0.0 0.9 0.1 0.6 1.0 0.6 0.1 1.0 0.7 1.2 0.6 0.7 0.8 0.4 0.8 0.6 0.6 2.2 0.6 0.8 0.2 0.0 0.3 4.0 7.8 38.5 5.3 2.7 3.2 1.8 1.5 1.7 1.4 14.9 1.0 0.0 0.1 0.1 3.6 0.6 12.7 0.0 2.3 1.8 0.0 0.0 5.0 7.5 0.6 0.7 0.3 0.0 0.8 0.1 0.2 0.4 0.0 0.2 0.0 14.3 0.0 0.0 0.3 0.0 0.3 0.0 1.7 0.0 0.0 0.2 2.1 0.0 0.0 7.3 0.3 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 MPI ENSG00000178802 "Mannose phosphate isomerase" P34949 15 74890005-74902219 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Isomerase "Congenital disorder of glycosylation, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007200 Approved Approved "Plasma membrane,Cytosol" NA NA 170000 Cytosol "Plasma membrane" "HPA007200: AB_1854079" "unprognostic (1.38e-1)" "unprognostic (7.18e-2)" "unprognostic (1.63e-1)" "unprognostic (1.65e-3)" "unprognostic (7.34e-2)" "prognostic unfavorable (2.39e-4)" "unprognostic (1.79e-1)" "unprognostic (2.76e-1)" "unprognostic (3.20e-1)" "unprognostic (2.93e-2)" "unprognostic (1.47e-1)" "unprognostic (1.27e-1)" "unprognostic (3.34e-2)" "unprognostic (2.11e-1)" "unprognostic (1.15e-1)" "unprognostic (2.09e-1)" "unprognostic (6.58e-2)" 13.6 33.3 24.2 11.2 26.2 7.4 14.7 19.2 33.7 16.7 22.6 26.1 15.3 32.6 15.7 26.8 17.1 20.7 13.4 28.8 22.7 22.2 22.5 30.2 10.6 16.2 28.1 28.3 23.2 34.2 24.7 15.0 11.4 37.4 20.6 23.1 18.3 18.6 17.9 33.3 11.7 27.4 16.4 21.7 14.7 14.3 23.5 17.7 16.4 17.1 15.0 16.6 15.6 11.7 12.8 10.2 2.4 7.4 17.7 27.1 12.9 10.6 14.7 12.2 13.8 28.0 13.6 10.7 9.2 15.0 15.8 22.1 14.5 14.1 15.1 20.0 13.4 12.6 26.6 24.2 26.7 15.0 11.5 30.3 27.1 14.0 15.6 19.9 12.5 8.0 18.1 6.9 14.8 26.7 24.0 21.4 18.2 9.0 12.4 20.3 9.1 13.3 5.5 6.7 16.1 12.6 13.7 11.5 37.0 18.5 12.1 22.9 10.0 10.7 19.4 11.5 18.7 26.5 8.6 9.6 9.5 8.1 7.0 8.9 30.8 18.2 9.9 19.8 18.1 6.9 0.7 7.2 2.4 13.5 7.4 17.5 12.8 18.3 15.4 10.2 12.5 27.1 19.7 1.1 17.7 6.3 8.5 22.7 12.9 24.2 26.2 19.2 33.7 22.7 22.2 28.1 28.3 37.4 17.7 6.0 15.9 13.7 6.7 1.6 21.7 47.5 10.2 5.3 7.9 14.0 3.9 26.1 13.3 15.5 13.7 8.7 34.2 0.0 7.5 9.1 12.2 5.4 15.0 15.8 20.6 33.4 10.4 6.2 5.3 24.3 10.3 5.6 3.3 11.8 18.1 18.3 14.3 17.3 8.1 25.8 16.8 6.5 6.6 23.8 10.1 2.4 13.6 6.9 11.8 4.7 MPL "CD110, TPOR" ENSG00000117400 "MPL proto-oncogene, thrombopoietin receptor" P40238 1 43337849-43352772 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in single" 5 "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enriched" "Detected in single" 78 "HEL: 41.7" "Region enhanced" "Detected in single" "cerebral cortex: 1.4" "Low region specificity" "Detected in all" HPA007619 Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "HPA007619: AB_1854080" "unprognostic (2.74e-1)" "unprognostic (6.56e-2)" "unprognostic (2.95e-1)" "unprognostic (8.71e-2)" "unprognostic (1.37e-2)" "unprognostic (1.06e-3)" "unprognostic (1.19e-1)" "unprognostic (1.22e-2)" "unprognostic (5.83e-2)" "unprognostic (1.03e-1)" "unprognostic (5.94e-4)" "unprognostic (1.51e-1)" "unprognostic (1.19e-4)" "unprognostic (2.39e-1)" "unprognostic (3.26e-1)" "unprognostic (1.03e-4)" "unprognostic (1.42e-1)" 1.1 0.3 0.9 0.5 0.8 2.0 0.9 0.5 2.2 0.6 0.6 0.5 0.5 0.3 0.9 1.7 0.9 2.1 0.5 3.9 0.8 0.6 0.5 0.5 2.0 0.5 0.9 0.5 6.6 1.1 0.6 0.6 2.2 0.5 1.5 0.7 0.5 0.5 0.7 0.6 0.4 1.2 2.1 2.5 8.6 0.5 2.1 0.5 0.5 2.2 2.4 0.5 0.9 0.5 0.0 0.0 1.6 0.3 0.0 0.0 4.0 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 41.7 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 4.0 0.9 0.8 0.5 2.2 0.8 0.6 0.9 0.5 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 MPP1 "DXS552E, PEMP" ENSG00000130830 "Membrane palmitoylated protein 1" Q00013 X 154778684-154821007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 338.8;Erythroid cells: 163.5;Hofbauer cells: 251.9;Syncytiotrophoblasts: 380.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 46.4;neutrophil: 45.3" "Group enriched" "Detected in all" 7 "dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9" "Cell line enhanced" "Detected in many" "HEL: 59.4;REH: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076675 Enhanced Supported "Plasma membrane,Centriolar satellite" NA NA 4300000 "Plasma membrane" "Centriolar satellite" "HPA076675: " "unprognostic (2.15e-1)" "unprognostic (4.06e-2)" "unprognostic (4.52e-2)" "unprognostic (1.83e-3)" "unprognostic (7.14e-2)" "unprognostic (2.60e-2)" "unprognostic (7.47e-2)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (7.79e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-3)" "prognostic favorable (4.60e-6)" "unprognostic (6.69e-2)" "unprognostic (2.53e-2)" "unprognostic (4.68e-2)" "unprognostic (6.67e-3)" 18.7 18.2 12.7 14.4 19.2 52.9 9.9 25.8 30.9 7.1 18.3 10.0 15.1 32.0 8.9 9.5 6.1 10.0 13.5 14.1 14.3 13.0 23.3 20.4 18.2 11.9 15.9 13.5 7.2 18.9 19.5 6.5 45.6 28.8 9.1 10.1 6.4 17.1 10.9 14.6 6.3 42.7 11.0 15.8 27.4 7.9 4.1 7.4 27.1 8.3 6.4 6.9 10.0 7.1 1.6 12.7 46.4 20.9 2.0 3.8 15.8 11.3 2.3 5.3 5.3 5.5 5.8 17.1 4.3 6.5 7.2 8.9 6.4 1.0 8.8 8.4 4.7 19.3 1.3 6.0 1.9 5.7 9.4 10.6 59.4 1.6 6.8 8.3 12.1 34.5 5.6 2.5 7.9 2.0 7.4 16.3 12.0 25.6 1.4 8.1 0.0 27.4 16.0 0.5 1.0 7.8 37.5 1.3 4.2 4.1 0.9 1.3 2.1 3.5 0.3 3.7 5.5 0.9 7.1 7.5 6.6 3.6 14.5 11.5 10.4 14.2 3.4 9.3 17.0 3.1 9.0 20.9 46.4 1.2 16.7 1.4 1.6 1.4 1.3 12.7 0.7 3.8 1.9 45.3 2.0 20.3 3.5 0.7 15.8 12.7 19.2 25.8 30.9 14.3 13.0 15.9 13.5 28.8 7.4 3.0 15.7 7.6 4.2 7.7 10.2 15.7 25.5 4.0 11.4 7.0 3.9 338.8 18.3 8.9 0.5 15.7 22.0 163.5 2.4 10.5 13.4 3.6 87.8 9.6 251.9 15.9 11.1 9.2 95.5 1.9 8.1 69.1 10.1 33.3 4.1 14.8 4.2 4.3 12.4 51.8 6.7 0.0 12.0 0.7 2.5 5.3 380.0 8.9 4.6 0.7 MPZL1 "FLJ21047, PZR" ENSG00000197965 "Myelin protein zero like 1" O95297 1 167721192-167791919 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 51.4" "Lineage enriched" "Detected in all" 4 "granulocytes: 51.4" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026966, HPA063538" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA026966: AB_10600931, HPA063538: AB_2685034" "unprognostic (6.54e-2)" "unprognostic (9.26e-3)" "unprognostic (4.59e-2)" "unprognostic (4.88e-1)" "unprognostic (2.18e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (4.27e-6)" "prognostic unfavorable (3.98e-4)" "unprognostic (1.22e-1)" "unprognostic (3.41e-2)" "unprognostic (2.59e-1)" "unprognostic (2.27e-1)" "prognostic unfavorable (3.99e-7)" "unprognostic (3.55e-1)" "unprognostic (2.35e-1)" "prognostic unfavorable (8.08e-4)" "unprognostic (4.21e-2)" 34.4 19.1 13.6 21.4 13.9 3.2 42.0 14.3 13.7 32.2 27.3 15.4 15.9 18.5 34.8 25.2 32.1 30.1 34.3 29.2 12.0 14.0 22.2 20.9 22.2 20.7 14.4 10.0 38.3 25.4 13.7 24.3 34.0 14.3 28.3 28.2 28.0 51.7 19.4 11.0 17.7 26.6 30.5 13.0 19.6 21.3 27.7 10.9 9.7 29.0 25.8 28.0 33.6 35.0 4.2 12.5 51.4 8.9 2.9 2.4 3.0 18.1 26.5 20.8 16.1 67.3 30.5 65.9 28.4 36.8 18.6 23.2 48.9 25.4 6.4 33.3 35.9 16.4 30.7 20.7 31.4 15.8 14.5 11.2 5.3 14.2 11.7 41.9 6.2 3.4 28.0 39.7 29.7 33.4 26.3 24.7 19.7 19.7 13.5 22.0 6.0 20.9 7.4 13.2 36.6 11.4 12.8 17.9 28.3 28.5 17.6 12.1 19.9 25.3 26.4 14.6 50.2 14.2 3.3 28.0 21.4 9.6 27.4 15.3 20.3 31.3 29.8 30.6 7.3 3.3 1.9 8.1 5.4 0.8 6.8 0.4 4.2 0.8 1.2 10.9 2.5 2.4 0.8 51.4 2.9 8.9 12.5 0.1 3.0 13.6 13.9 14.3 13.7 12.0 14.0 14.4 10.0 14.3 10.9 26.8 25.9 20.1 58.0 67.9 7.6 5.3 20.4 21.4 37.5 19.2 5.9 107.3 5.0 59.9 1.4 40.7 44.8 0.0 66.1 111.2 70.6 98.3 3.5 16.9 33.1 9.5 45.9 22.7 24.2 2.4 64.7 22.2 15.1 124.4 41.1 10.6 61.2 28.8 78.8 10.2 13.2 19.4 47.4 9.7 24.9 48.6 64.3 5.2 51.7 53.8 MRGPRF "GPR140, GPR168, MGC21621, mrgF" ENSG00000172935 "MAS related GPR family member F" Q96AM1 11 69004395-69013409 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 6 "Fibroblasts: 34.7;Leydig cells: 61.2;Peritubular cells: 94.7;Sertoli cells: 51.8;Smooth muscle cells: 90.4" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 4 "cerebellum: 7.8" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 26.8;ASC TERT1: 12.0;BJ: 15.1;BJ hTERT+: 38.1;BJ hTERT+ SV40 Large T+: 14.3;fHDF/TERT166: 11.6;U-2197: 18.2" "Region enriched" "Detected in some" 5 "cerebellum: 16.6" "Low region specificity" "Detected in all" HPA028811 Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Nuclear membrane, Plasma membrane" "HPA028811: AB_10603875" "unprognostic (2.49e-2)" "unprognostic (3.89e-2)" "unprognostic (1.20e-1)" "unprognostic (9.03e-2)" "unprognostic (5.16e-2)" "unprognostic (6.52e-3)" "unprognostic (3.20e-1)" "unprognostic (1.33e-1)" "unprognostic (1.00e-1)" "unprognostic (1.36e-1)" "unprognostic (8.32e-2)" "unprognostic (1.47e-1)" "unprognostic (4.55e-7)" "unprognostic (2.75e-2)" "unprognostic (2.27e-1)" "unprognostic (2.86e-2)" "unprognostic (3.62e-3)" 10.8 1.7 0.8 7.6 1.2 0.0 26.6 7.8 1.5 61.9 39.5 1.2 13.9 4.8 49.2 22.3 28.2 28.0 30.6 6.2 0.7 0.4 4.2 2.1 4.8 5.6 1.1 1.3 25.6 0.9 0.4 1.1 5.9 1.8 29.6 4.8 5.8 2.9 25.5 3.1 4.0 10.1 41.1 1.0 8.2 14.2 13.1 0.6 0.1 3.8 6.4 2.7 42.2 19.6 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 26.8 12.0 0.5 15.1 38.1 14.3 9.5 0.0 0.6 0.0 0.3 11.6 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 1.1 0.0 3.3 0.0 0.0 8.8 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.6 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 8.8 0.0 18.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 1.2 7.8 1.5 0.7 0.4 1.1 1.3 1.8 0.6 0.0 0.0 0.0 0.2 4.4 0.0 0.6 2.5 0.0 0.0 10.4 0.0 0.6 0.0 0.0 3.6 0.6 0.0 0.0 0.0 0.6 34.7 0.3 0.0 3.4 0.9 0.0 0.0 5.5 0.0 5.2 61.2 0.0 6.8 0.0 0.0 2.8 0.1 0.0 94.7 0.6 0.2 51.8 90.4 1.0 0.5 3.3 0.9 0.0 0.0 0.2 MRNIP "C5orf45, DKFZp686L2452, LOC51149, MGC65027, MGC78537" ENSG00000161010 "MRN complex interacting protein" Q6NTE8 5 179835133-179862173 "Predicted intracellular proteins" "DNA damage, DNA repair" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 12 "Ciliated cells: 54.9;Club cells: 21.6;Distal tubular cells: 39.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043975 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043975: AB_2678754" "unprognostic (4.97e-2)" "unprognostic (2.79e-1)" "unprognostic (7.98e-2)" "unprognostic (1.08e-1)" "unprognostic (1.63e-1)" "unprognostic (5.15e-3)" "unprognostic (1.68e-3)" "unprognostic (2.51e-2)" "unprognostic (1.10e-1)" "unprognostic (6.11e-2)" "unprognostic (3.63e-3)" "unprognostic (2.05e-2)" "prognostic unfavorable (2.64e-5)" "unprognostic (1.18e-1)" "unprognostic (3.73e-1)" "unprognostic (7.00e-2)" "unprognostic (1.43e-3)" 6.6 6.3 11.8 10.7 12.2 4.6 10.8 30.0 16.1 14.8 8.5 14.2 14.3 7.8 13.7 16.1 4.8 23.5 7.7 7.8 12.6 11.8 8.8 6.0 8.8 14.1 16.0 13.4 21.1 9.7 11.2 22.7 5.0 12.1 11.1 8.4 12.9 9.1 19.8 5.8 12.0 11.0 11.7 10.1 13.3 7.1 8.0 14.7 2.7 11.6 3.5 14.0 8.6 10.5 10.7 5.5 2.9 1.0 4.0 8.1 2.8 1.3 2.8 4.5 10.9 9.1 8.2 5.4 3.2 2.8 4.0 5.8 4.6 4.2 5.2 3.8 1.5 1.9 3.5 5.0 10.3 3.1 4.9 5.0 1.7 4.9 3.2 5.6 2.2 2.1 6.1 8.3 4.6 3.6 3.2 4.4 5.4 2.5 2.5 4.1 5.3 3.4 2.2 2.2 1.6 2.5 4.1 1.7 3.8 7.1 1.0 8.5 2.7 1.5 4.4 3.7 3.7 5.5 1.8 1.0 2.5 2.0 1.9 2.2 3.0 1.8 3.6 2.4 3.6 1.7 1.3 0.7 2.9 3.4 0.7 4.5 10.7 5.1 4.2 0.9 10.3 8.1 5.9 1.1 4.0 1.0 5.5 2.9 2.8 11.8 12.2 30.0 16.1 12.6 11.8 16.0 13.4 12.1 14.7 14.9 14.1 0.0 0.0 0.0 0.0 0.0 0.0 54.9 21.6 17.4 0.0 8.6 39.7 3.6 0.0 0.0 0.0 0.0 2.0 5.9 0.0 0.0 10.5 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 3.0 0.0 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 MRPL42 "HSPC204, MRP-L31, MRPL31, MRPS32, PTD007, RPML31" ENSG00000198015 "Mitochondrial ribosomal protein L42" Q9Y6G3 12 93467488-93516213 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 276.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039398 Approved Supported "Plasma membrane,Mitochondria" NA NA "Plasma membrane, Mitochondria" "HPA039398: AB_10673529" "unprognostic (9.32e-2)" "unprognostic (4.18e-2)" "unprognostic (4.50e-2)" "unprognostic (3.89e-2)" "unprognostic (1.27e-2)" "unprognostic (1.75e-1)" "prognostic unfavorable (7.49e-4)" "unprognostic (6.13e-2)" "unprognostic (3.66e-2)" "unprognostic (1.95e-1)" "unprognostic (2.18e-2)" "unprognostic (1.90e-1)" "unprognostic (1.51e-1)" "unprognostic (2.45e-2)" "unprognostic (4.92e-1)" "unprognostic (1.62e-1)" "prognostic favorable (8.12e-4)" 18.4 35.6 16.7 13.9 23.6 14.6 22.5 23.2 24.4 22.0 21.5 16.6 16.3 17.0 18.7 16.5 26.7 20.5 15.1 24.2 16.8 16.4 31.0 28.9 16.0 15.3 21.4 16.7 18.4 16.3 26.1 35.8 18.5 26.2 19.3 26.4 13.7 17.8 19.0 15.1 15.8 18.4 19.8 20.4 18.8 18.1 34.5 17.1 25.7 19.5 14.9 21.5 19.1 21.0 29.9 18.8 23.3 23.1 29.3 32.0 21.0 17.3 18.7 30.1 24.4 18.0 27.1 25.4 21.5 21.8 32.9 26.6 25.1 13.9 24.5 9.4 19.6 15.6 15.7 38.7 29.0 50.4 28.7 29.9 28.2 12.8 31.1 24.6 32.6 14.2 20.0 31.8 28.5 42.3 24.9 31.8 27.6 37.2 13.4 37.4 18.5 36.5 25.5 45.0 27.7 34.4 30.3 15.2 29.9 36.3 35.7 36.9 20.1 18.4 30.8 23.1 25.6 30.5 18.0 15.7 24.2 13.8 15.3 28.8 16.0 23.2 27.0 9.5 25.7 36.2 18.0 17.7 23.3 19.0 23.1 24.4 29.9 24.9 20.9 18.8 23.9 26.1 26.8 7.4 29.3 21.5 13.3 32.0 21.0 16.7 23.6 23.2 24.4 16.8 16.4 21.4 16.7 26.2 17.1 26.8 28.6 54.8 70.8 59.8 33.3 73.5 40.8 62.9 31.8 43.6 56.9 85.2 180.8 81.9 276.9 50.6 37.0 0.0 67.3 120.5 56.8 91.3 58.7 45.9 48.2 44.5 89.3 28.3 38.6 81.3 47.8 37.0 57.3 27.9 49.8 19.9 75.9 42.1 52.6 106.7 35.0 51.8 64.3 114.9 71.6 65.6 79.9 55.1 63.5 104.3 MS4A14 "DKFZp434H092, FLJ32856, MS4A16, NYD-SP21" ENSG00000166928 "Membrane spanning 4-domains A14" Q96JA4 11 60378530-60417756 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 79.3;testis: 53.6" "Group enriched" "Detected in some" 41 "Early spermatids: 207.0;Late spermatids: 514.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.8;non-classical monocyte: 9.2" "Lineage enriched" "Detected in many" 5 "monocytes: 9.2" "Cell line enriched" "Detected in single" 24 "THP-1: 14.6" HPA058973 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058973: " "unprognostic (1.78e-1)" "unprognostic (1.76e-1)" "unprognostic (5.75e-2)" "unprognostic (1.77e-1)" "unprognostic (1.27e-1)" "unprognostic (1.79e-2)" "unprognostic (1.24e-1)" "unprognostic (3.45e-2)" "unprognostic (4.00e-2)" "unprognostic (1.05e-1)" "unprognostic (1.77e-1)" "unprognostic (2.14e-1)" "unprognostic (4.50e-6)" "unprognostic (3.73e-2)" "unprognostic (7.16e-3)" "unprognostic (8.40e-2)" "unprognostic (7.11e-2)" 14.5 4.4 2.0 4.6 2.3 1.5 5.4 0.8 1.5 2.4 3.9 1.9 1.1 1.5 1.9 6.4 1.8 1.3 2.3 6.4 2.5 2.3 3.5 13.3 18.0 11.3 2.4 0.1 1.3 1.5 1.2 3.2 6.0 2.4 3.0 2.2 4.5 2.1 1.6 1.3 1.3 4.0 2.4 5.5 79.3 1.5 53.6 1.5 3.7 1.7 0.7 3.0 2.4 1.7 0.5 1.8 0.1 9.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 14.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.0 0.0 4.3 0.0 0.0 6.8 0.0 0.0 0.0 0.0 1.8 0.5 0.0 0.0 0.1 0.0 9.2 0.0 0.0 0.9 2.0 2.3 0.8 1.5 2.5 2.3 2.4 0.1 2.4 1.5 0.0 0.6 0.0 0.0 0.1 0.0 0.2 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 207.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 7.5 514.6 3.7 8.8 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 6.5 0.0 5.7 2.4 0.3 0.1 0.0 0.0 0.0 MS4A15 ENSG00000166961 "Membrane spanning 4-domains A15" Q8N5U1 11 60756953-60776732 "Predicted membrane proteins" Receptor "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 9 "blood: 9.9;lung: 32.4" "Cell type enriched" "Detected in some" 8 "Alveolar cells type 1: 89.3" "Cancer enhanced" "Detected in many" "lung cancer: 6.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 9.9" "Lineage enriched" "Detected in single" 15 "T-cells: 9.9" "Cell line enhanced" "Detected in some" "HEL: 9.2;JURKAT: 3.4;Karpas-707: 3.8;MOLT-4: 4.1;U-266/70: 13.5;U-266/84: 5.7" "Region enriched" "Detected in single" 28 "olfactory region: 205.0" "Region enriched" "Detected in single" 30 "olfactory region: 39.1" HPA054563 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA054563: " "unprognostic (1.85e-1)" "unprognostic (4.31e-3)" "unprognostic (8.59e-2)" "unprognostic (5.89e-4)" "unprognostic (4.49e-1)" "unprognostic (1.09e-3)" "unprognostic (3.92e-3)" "unprognostic (5.43e-3)" "unprognostic (1.20e-1)" "unprognostic (7.30e-2)" "unprognostic (3.14e-1)" "unprognostic (1.04e-9)" "unprognostic (7.02e-2)" "unprognostic (8.63e-2)" "unprognostic (2.75e-1)" "unprognostic (1.47e-1)" 0.3 0.2 0.3 0.3 0.3 0.0 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 1.8 0.3 0.4 1.0 0.3 0.3 0.3 0.2 0.3 0.3 32.4 0.3 0.3 0.3 2.4 0.3 0.0 0.3 1.1 0.3 0.3 0.5 0.3 0.3 1.9 0.3 0.2 1.4 1.7 0.3 0.3 0.2 0.6 0.3 0.3 0.3 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 9.2 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.4 1.6 3.8 0.0 0.0 4.1 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 1.1 0.0 0.0 0.0 0.5 0.0 0.0 13.5 5.7 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.2 2.9 0.5 0.0 0.0 1.8 0.7 0.0 0.6 0.0 0.0 9.9 0.7 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 89.3 4.8 0.0 0.0 0.0 0.0 0.2 0.0 2.7 11.4 0.0 0.0 0.7 0.0 0.0 4.7 0.0 0.0 0.0 0.0 2.2 0.0 0.0 1.1 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.7 0.0 0.0 0.0 MTCP1 "P13MTCP1, p8MTCP1" ENSG00000214827 "Mature T cell proliferation 1" P56278 X 155061622-155147937 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 9 "Ciliated cells: 4.0;Club cells: 2.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "HeLa: 14.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032040 Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA032040: AB_2674122" "unprognostic (2.42e-2)" "unprognostic (2.07e-2)" "unprognostic (1.14e-1)" "unprognostic (6.29e-3)" "unprognostic (8.30e-2)" "unprognostic (4.10e-1)" "unprognostic (2.40e-5)" "unprognostic (9.30e-2)" "unprognostic (1.17e-1)" "unprognostic (4.94e-2)" "unprognostic (5.72e-2)" "unprognostic (1.15e-2)" "prognostic unfavorable (4.52e-8)" "unprognostic (1.55e-3)" "unprognostic (1.06e-2)" "unprognostic (1.39e-2)" "unprognostic (1.75e-2)" 6.4 7.1 4.1 5.3 5.3 7.2 15.8 4.4 4.8 6.0 6.2 3.4 7.7 5.7 6.0 8.2 7.0 6.1 4.4 30.1 4.7 2.9 6.7 12.8 8.5 15.5 4.5 2.7 9.1 20.7 3.9 6.5 3.5 6.4 5.8 6.1 3.9 7.3 7.0 11.4 12.0 6.7 8.7 7.2 6.7 6.2 16.1 3.8 2.5 8.2 5.4 7.2 6.9 4.0 0.2 0.0 0.8 0.7 0.5 2.0 0.1 1.4 4.9 2.4 3.9 1.6 1.3 2.7 3.0 1.5 1.9 4.8 4.3 7.5 2.7 3.1 0.6 3.0 4.8 3.2 3.5 2.4 1.8 3.2 1.2 14.3 2.3 1.4 2.9 3.3 2.4 1.7 3.2 3.0 2.3 1.8 4.7 1.1 4.9 1.3 2.0 3.7 6.1 1.1 1.8 0.8 4.0 2.6 6.1 2.4 2.1 1.2 1.8 2.2 1.2 2.1 1.7 2.2 1.3 1.8 2.2 3.9 2.1 2.2 10.7 4.6 5.2 4.3 3.5 3.1 0.0 0.6 0.8 1.1 0.0 2.0 0.2 1.2 0.4 0.0 0.1 0.2 1.4 0.0 0.5 0.7 0.0 0.0 0.1 4.1 5.3 4.4 4.8 4.7 2.9 4.5 2.7 6.4 3.8 0.0 1.0 0.0 0.2 0.2 0.0 0.6 0.0 4.0 2.3 0.0 0.0 0.1 0.0 0.5 0.0 0.3 0.0 0.0 1.1 0.2 0.3 0.3 0.0 1.0 0.4 0.0 1.7 0.0 1.0 0.2 1.1 0.5 1.7 1.0 0.0 0.0 1.1 0.0 0.4 0.2 0.0 0.0 0.3 0.5 0.2 0.6 0.2 0.0 0.5 0.0 MTPN "GCDP, MYOTROPHIN, V-1" ENSG00000105887 Myotrophin P58546 7 135926761-135977353 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA019735 Approved Approved "Plasma membrane,Cytosol" NA NA 48000000 "Plasma membrane, Cytosol" "HPA019735: AB_1858710" "unprognostic (5.97e-2)" "unprognostic (2.53e-2)" "unprognostic (8.52e-2)" "unprognostic (3.62e-3)" "unprognostic (2.20e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (1.19e-4)" "unprognostic (2.06e-3)" "unprognostic (3.30e-2)" "unprognostic (8.11e-2)" "prognostic unfavorable (3.05e-4)" "unprognostic (4.50e-2)" "unprognostic (1.83e-2)" "unprognostic (2.60e-2)" "unprognostic (2.43e-1)" "unprognostic (9.00e-3)" "unprognostic (4.86e-3)" 31.0 22.1 40.2 28.5 53.2 55.1 39.6 34.4 50.0 30.9 21.4 20.4 16.0 17.2 29.5 21.9 62.1 27.0 23.7 31.6 38.0 31.6 25.1 20.5 31.6 49.3 24.2 32.4 22.0 10.7 29.2 22.5 26.3 22.9 23.4 23.6 21.5 22.2 24.0 27.4 19.1 23.1 27.9 23.3 42.4 17.6 23.4 19.9 36.4 36.9 24.9 42.8 26.1 30.5 37.9 24.6 50.6 43.5 12.8 16.7 17.0 27.7 22.0 24.3 36.3 34.9 41.5 12.7 44.0 44.7 28.2 30.9 25.0 30.0 49.0 32.6 54.0 43.2 17.7 22.7 34.5 52.4 36.2 22.4 33.4 23.8 16.3 28.7 44.8 48.2 30.3 34.2 33.5 31.5 39.1 43.9 39.3 39.6 29.6 53.1 21.2 45.1 33.2 34.4 25.6 31.3 26.3 18.6 39.8 30.6 23.0 31.3 57.2 35.8 22.3 33.8 23.0 16.4 27.4 47.0 42.7 19.6 42.4 41.4 24.7 36.3 72.3 68.3 39.4 90.8 25.4 21.4 22.6 16.7 28.9 14.3 30.9 10.4 12.5 24.6 37.9 6.9 9.9 50.6 12.8 43.5 24.2 9.0 17.0 40.2 53.2 34.4 50.0 38.0 31.6 24.2 32.4 22.9 19.9 44.7 37.6 120.5 45.1 105.9 0.0 68.2 66.2 34.8 50.0 66.3 0.0 53.8 76.3 60.3 68.1 93.1 49.6 70.0 44.7 56.8 87.2 72.5 93.8 50.8 91.4 0.0 31.8 97.0 229.9 24.5 80.0 156.1 96.2 119.0 41.0 0.0 73.4 59.1 116.3 67.4 0.0 90.5 53.6 60.7 100.9 130.2 57.6 66.6 47.3 89.4 MTSS1 "KIAA0429, MIM, MIMA, MIMB" ENSG00000170873 "MTSS1, I-BAR domain containing" O43312 8 124550790-124728429 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 152.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 44.8" "Group enriched" "Detected in many" 4 "B-cells: 16.1;monocytes: 44.8" "Cell line enhanced" "Detected in many" "ASC diff: 21.1;HDLM-2: 24.2;HEL: 83.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019613, HPA064003, HPA075540" Approved Supported Approved "Plasma membrane,Cytosol" NA NA 10000 "Plasma membrane, Cytosol" "HPA019613: , HPA064003: , HPA075540: AB_2686756" "unprognostic (1.70e-1)" "unprognostic (4.13e-2)" "unprognostic (9.50e-2)" "unprognostic (1.38e-1)" "unprognostic (3.87e-2)" "unprognostic (7.02e-2)" "unprognostic (4.24e-2)" "unprognostic (1.26e-2)" "unprognostic (2.18e-1)" "unprognostic (2.50e-1)" "unprognostic (8.12e-2)" "unprognostic (1.48e-1)" "prognostic favorable (2.11e-7)" "unprognostic (6.74e-2)" "unprognostic (1.04e-1)" "unprognostic (2.41e-1)" "unprognostic (8.92e-3)" 18.7 27.3 14.0 9.2 16.3 8.5 12.4 36.0 19.1 8.1 8.2 32.1 1.7 5.0 5.6 15.8 32.4 8.9 7.0 13.4 13.5 13.6 18.2 51.5 12.0 12.1 18.1 10.3 8.2 21.0 2.6 10.5 25.3 16.9 7.9 7.0 19.8 10.2 5.3 16.5 21.3 5.0 7.2 20.9 23.9 9.0 15.8 20.0 8.2 4.1 12.1 12.2 9.7 13.7 16.1 3.3 0.6 44.8 0.6 6.9 6.8 0.9 0.2 13.2 0.3 21.1 10.9 0.0 0.5 3.5 0.2 0.1 1.2 0.1 0.4 1.3 0.0 0.1 0.2 0.1 7.3 0.2 24.2 0.4 83.0 0.2 6.6 4.8 0.0 8.9 17.3 16.8 4.0 10.5 0.5 7.9 0.1 0.1 0.1 1.4 0.7 0.2 1.0 0.5 13.5 0.1 0.1 0.0 0.1 2.9 2.8 9.5 0.8 2.0 2.0 6.7 0.7 0.3 0.2 4.1 0.7 0.4 0.0 0.2 0.2 0.2 1.4 7.6 0.2 2.7 0.6 3.9 0.0 6.9 25.6 0.8 13.2 1.5 2.6 3.3 16.1 0.7 2.1 0.6 0.6 44.8 0.0 0.1 6.8 14.0 16.3 36.0 16.7 13.5 13.6 18.1 10.3 16.9 20.0 0.0 21.1 45.6 48.9 31.8 0.0 27.4 30.6 33.5 18.2 62.8 0.0 25.3 18.3 13.8 44.0 23.2 2.5 0.0 4.6 1.9 16.6 37.6 45.1 69.1 57.6 0.0 42.4 74.3 152.0 42.3 3.4 94.8 25.3 120.0 19.1 0.0 21.1 14.0 4.2 16.2 0.0 38.8 12.2 2.8 11.5 55.5 78.9 13.4 15.0 51.5 MYH11 "SMHC, SMMHC" ENSG00000133392 "Myosin heavy chain 11" P35749 16 15703172-15857033 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Muscle protein, Myosin" "Aortic aneurysm, Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 507.4;urinary bladder: 394.5" "Group enriched" "Detected in many" 29 "Peritubular cells: 1569.5;Sertoli cells: 614.4;Smooth muscle cells: 1327.8" "Cancer enhanced" "Detected in many" "prostate cancer: 173.2" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 3.6;NB-4: 3.9;U-698: 9.9" "Low region specificity" "Detected in many" "Region enhanced" "Detected in single" "midbrain: 54.5" "CAB002302, HPA014539, HPA015310" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 130000000 "Plasma membrane, Cytosol" "CAB002302: AB_563902, HPA014539: AB_1234906, HPA015310: AB_1854261" "unprognostic (7.99e-2)" "unprognostic (3.07e-2)" "unprognostic (4.18e-2)" "unprognostic (9.21e-3)" "unprognostic (6.70e-2)" "unprognostic (2.75e-2)" "prognostic favorable (1.10e-5)" "unprognostic (1.41e-2)" "unprognostic (1.87e-1)" "unprognostic (3.44e-2)" "unprognostic (1.28e-1)" "unprognostic (1.14e-1)" "unprognostic (1.19e-3)" "unprognostic (4.06e-2)" "unprognostic (9.53e-2)" "unprognostic (5.00e-2)" "unprognostic (5.45e-3)" 13.2 3.0 0.6 31.5 1.2 0.0 5.9 0.5 1.7 90.3 227.5 1.3 100.0 11.6 102.0 38.4 233.0 43.8 94.3 6.2 0.6 0.7 4.7 0.7 8.5 1.5 1.4 2.6 45.5 1.3 0.0 1.0 5.3 3.6 164.7 22.2 37.0 8.8 127.2 6.4 5.0 50.6 507.4 1.4 3.7 77.7 22.3 0.2 0.1 3.7 6.2 3.0 394.5 57.5 1.5 0.9 6.0 0.9 1.1 1.5 0.4 0.1 0.4 0.2 0.1 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.4 0.1 0.2 0.0 0.2 0.6 0.0 0.0 0.0 0.4 0.4 0.2 0.1 0.0 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.1 1.5 0.0 0.3 0.3 3.9 0.4 0.1 0.1 0.4 0.2 1.9 0.0 0.2 0.7 1.4 0.2 0.5 1.2 0.2 0.5 0.0 0.3 0.1 0.3 2.0 0.1 0.5 0.4 9.9 0.4 0.4 0.4 3.1 0.9 2.7 1.2 0.6 1.2 1.5 1.5 1.4 0.5 1.2 1.4 1.4 6.0 1.1 0.6 0.9 1.4 0.4 0.6 1.2 0.5 1.7 0.6 0.7 1.4 2.6 3.6 0.2 0.0 2.6 4.5 1.6 11.7 1.5 38.7 0.0 1.4 2.3 0.0 7.9 0.2 0.0 0.0 36.6 5.7 0.0 0.0 0.3 0.2 8.0 5.1 0.0 0.0 1.1 0.0 1.2 4.3 0.0 30.8 39.7 3.8 11.8 2.8 0.3 0.3 0.2 0.0 1569.5 0.0 1.6 614.4 1327.8 3.2 7.5 16.3 0.0 4.9 0.4 2.5 MYLK "MLCK, MLCK1, MYLK1, smMLCK" ENSG00000065534 "Myosin light chain kinase" Q15746 3 123610049-123884331 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Actin-binding, Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 191.1" "Cell type enhanced" "Detected in many" 16 "Peritubular cells: 649.2;Sertoli cells: 271.7;Smooth muscle cells: 829.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "basophil: 3.6;classical monocyte: 1.3;myeloid DC: 2.8;neutrophil: 4.5;plasmacytoid DC: 2.7" "Group enriched" "Detected in many" 13 "dendritic cells: 2.8;granulocytes: 4.5;monocytes: 1.3" "Cell line enhanced" "Detected in many" "BJ: 36.4;BJ hTERT+: 55.1;fHDF/TERT166: 45.0;HBF TERT88: 29.0;hTERT-RPE1: 38.5;RPTEC TERT1: 59.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020789, HPA031677, HPA048055" Enhanced Enhanced "Plasma membrane,Actin filaments" NA NA 3000000 "Actin filaments" "Plasma membrane" "CAB020789: , HPA031677: AB_10794617, HPA048055: AB_2732543" "unprognostic (2.80e-2)" "unprognostic (5.05e-2)" "unprognostic (5.55e-2)" "unprognostic (2.85e-2)" "unprognostic (1.69e-1)" "unprognostic (1.41e-1)" "unprognostic (4.86e-2)" "unprognostic (8.55e-2)" "unprognostic (1.20e-1)" "unprognostic (1.40e-1)" "unprognostic (8.21e-2)" "unprognostic (1.58e-1)" "prognostic unfavorable (2.04e-6)" "unprognostic (5.26e-3)" "unprognostic (9.60e-2)" "unprognostic (3.00e-1)" "prognostic unfavorable (4.46e-4)" 14.9 4.9 4.5 19.8 10.9 0.0 14.4 0.8 5.8 77.1 107.3 22.0 93.2 9.4 111.2 48.3 96.0 56.3 40.6 6.6 4.7 3.2 8.3 5.4 13.2 6.5 25.8 2.8 50.2 1.6 0.5 1.1 8.0 16.0 85.1 27.6 6.0 17.6 158.6 1.6 4.8 33.3 191.1 28.8 7.4 38.7 17.4 13.0 0.2 4.1 2.5 3.4 137.1 21.3 0.2 2.8 4.5 1.3 0.0 0.2 17.3 2.5 7.7 2.0 1.3 2.1 0.4 0.9 36.4 55.1 23.6 16.9 1.6 1.4 0.1 8.2 45.0 11.2 0.9 0.9 0.3 29.0 0.0 0.1 20.3 0.2 5.0 10.9 0.1 1.9 6.8 0.7 4.6 6.9 38.5 1.8 0.2 0.2 0.1 17.4 0.3 0.0 0.5 2.2 0.1 1.0 2.3 1.2 6.6 59.6 1.4 0.3 1.1 3.7 0.4 0.6 5.0 0.2 0.0 6.7 7.2 2.6 1.7 5.9 0.6 0.7 0.0 18.5 0.2 1.8 3.6 1.3 0.3 0.1 0.2 0.0 0.2 0.0 0.0 2.8 0.1 0.2 0.1 4.5 0.0 0.0 2.7 0.1 17.3 4.5 10.9 0.8 5.8 4.7 3.2 25.8 2.8 16.0 13.0 14.9 34.7 2.9 24.1 18.2 2.5 16.5 33.1 5.3 6.8 26.2 117.8 0.6 3.3 4.5 38.5 34.3 13.8 0.0 3.6 0.6 23.4 4.9 2.3 169.4 4.0 3.2 10.9 66.9 9.2 26.0 97.0 8.0 18.6 0.0 3.0 4.8 2.7 24.0 649.2 9.6 18.7 271.7 829.4 3.0 3.3 17.7 2.1 0.5 3.7 1.6 MYO1C myr2 ENSG00000197879 "Myosin IC" O00159 17 1464186-1492812 "Predicted intracellular proteins, Transporters" "mRNA transport, Protein transport, Translocation, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001768, HPA005924, CAB037023" Enhanced Enhanced "Nuclear bodies,Plasma membrane" NA NA 30000 "Nuclear bodies, Plasma membrane" "CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469" "unprognostic (3.60e-1)" "unprognostic (4.71e-3)" "unprognostic (2.89e-1)" "unprognostic (2.96e-3)" "unprognostic (1.38e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" "prognostic unfavorable (5.22e-4)" "unprognostic (4.65e-2)" "unprognostic (2.00e-2)" "unprognostic (2.48e-1)" "unprognostic (3.07e-2)" "unprognostic (1.99e-2)" "unprognostic (5.02e-2)" "unprognostic (4.66e-2)" "unprognostic (4.93e-2)" "unprognostic (3.47e-2)" 61.5 8.6 3.3 20.1 4.1 0.9 45.7 4.4 4.3 33.8 35.5 5.3 17.2 14.0 36.0 20.5 34.3 20.3 38.2 29.3 3.3 2.5 24.8 24.8 30.3 13.4 3.3 3.8 23.7 44.8 8.6 7.6 32.2 6.1 27.4 12.7 20.0 44.5 19.0 20.0 17.1 29.9 40.8 3.6 12.3 24.2 12.6 2.9 9.4 23.0 21.3 18.6 32.0 32.4 7.9 1.7 0.8 3.1 0.0 3.5 2.2 36.1 39.7 4.3 17.6 20.3 20.2 16.6 36.9 30.7 24.4 20.6 26.4 19.9 3.6 26.7 56.8 16.3 30.7 6.4 25.7 12.8 16.0 16.2 3.4 21.6 9.7 30.1 0.3 18.3 15.7 12.8 22.4 12.9 22.4 31.3 2.3 2.7 3.0 20.6 27.6 0.4 0.2 2.7 22.7 7.4 1.4 5.9 6.5 22.4 18.9 1.7 9.6 23.2 33.9 14.8 11.1 27.8 1.8 41.0 35.4 27.2 17.3 31.8 2.4 1.9 1.5 28.2 0.8 30.6 0.2 1.3 0.0 1.5 3.1 0.8 7.9 3.5 1.6 1.7 6.7 1.3 0.7 0.8 0.0 2.6 1.6 3.0 2.2 3.3 4.1 4.4 4.3 3.3 2.5 3.3 3.8 6.1 2.9 116.1 28.1 21.6 34.2 35.3 2.0 63.8 53.5 6.7 40.9 82.0 0.0 49.1 18.3 52.4 13.7 49.6 118.0 23.3 44.8 23.7 45.2 47.9 11.5 36.3 17.3 4.8 37.9 89.0 11.3 8.0 39.1 20.0 60.8 33.3 90.6 4.0 74.6 84.6 45.6 11.3 2.2 116.4 76.0 2.1 8.1 37.3 39.8 6.4 57.2 33.6 MYO1G HA-2 ENSG00000136286 "Myosin IG" B0I1T2 7 44962662-44979098 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 37.9;bone marrow: 27.4;lymphoid tissue: 46.8" "Cell type enriched" "Detected in many" 7 "monocytes: 573.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 20.2;HEL: 24.5;HL-60: 14.0;JURKAT: 30.5;MOLT-4: 31.0;NB-4: 13.1;THP-1: 27.5;U-937: 20.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA021252 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 120000 "Plasma membrane" Nucleoplasm "HPA021252: AB_1854254" "unprognostic (2.74e-2)" "prognostic favorable (8.26e-4)" "unprognostic (5.20e-3)" "unprognostic (9.91e-3)" "unprognostic (1.27e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (1.35e-1)" "unprognostic (4.54e-3)" "unprognostic (6.47e-2)" "unprognostic (6.40e-2)" "unprognostic (6.24e-2)" "prognostic unfavorable (8.71e-8)" "unprognostic (3.20e-1)" "unprognostic (2.04e-1)" "unprognostic (1.85e-1)" "unprognostic (7.92e-2)" 2.5 1.2 1.6 11.0 3.0 27.4 1.5 0.4 2.0 1.0 1.9 0.7 0.0 1.8 1.2 2.1 2.4 1.9 3.6 3.2 1.0 0.9 1.9 1.9 13.0 18.6 4.5 0.0 0.9 0.8 0.0 0.9 1.5 2.7 1.5 1.1 1.5 5.8 0.5 0.6 1.2 8.3 1.9 2.6 22.3 2.1 0.9 1.8 46.8 2.1 2.2 26.6 4.7 1.3 9.9 14.0 9.4 37.9 6.7 24.4 19.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.2 0.0 24.5 0.8 0.0 0.0 14.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 30.5 0.0 0.0 0.0 0.0 31.0 13.1 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 20.2 0.0 9.4 17.0 5.2 19.9 29.6 12.6 9.9 12.7 17.4 14.0 6.6 4.6 9.0 1.7 6.7 37.9 1.2 24.4 19.3 1.6 3.0 0.4 2.0 1.0 0.9 4.5 0.0 2.7 1.8 3.0 11.4 56.6 0.3 2.5 0.0 1.1 0.0 1.4 2.3 0.0 0.0 0.1 0.0 0.1 0.3 0.6 0.0 0.0 0.9 0.2 1.7 0.4 30.0 0.9 10.8 3.2 0.0 2.5 71.9 1.2 0.0 51.5 3.3 573.5 0.0 0.2 0.2 0.0 0.4 0.3 0.0 6.5 1.6 0.4 0.2 1.5 0.1 86.3 0.0 0.1 MYOF "FER1L3, KIAA1207" ENSG00000138119 Myoferlin Q9NZM1 10 93306429-93482317 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 4 "Pancreatic endocrine cells: 95.7;Urothelial cells: 93.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 15.9;non-classical monocyte: 18.0" "Group enriched" "Detected in many" 65 "dendritic cells: 6.2;monocytes: 18.0" "Cell line enhanced" "Detected in many" "BJ hTERT+: 76.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA014245 Enhanced Supported "Vesicles,Plasma membrane" NA NA 14000 Vesicles "Plasma membrane" "HPA014245: AB_1848495" "unprognostic (3.41e-2)" "unprognostic (3.85e-1)" "unprognostic (2.88e-2)" "unprognostic (7.44e-2)" "unprognostic (3.50e-2)" "unprognostic (8.57e-3)" "unprognostic (3.48e-2)" "unprognostic (7.75e-2)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.55e-1)" "unprognostic (5.74e-3)" "unprognostic (1.87e-1)" "unprognostic (1.94e-2)" "unprognostic (9.17e-2)" "unprognostic (9.18e-2)" 27.5 7.3 2.1 8.9 4.1 0.2 21.7 1.3 2.7 27.0 12.3 5.1 16.0 2.0 27.2 17.7 27.2 16.2 11.4 7.2 3.5 2.1 12.2 1.7 18.7 7.5 5.8 2.5 12.7 3.3 16.1 4.2 31.9 15.0 20.7 12.8 10.1 14.9 17.4 5.7 22.4 6.8 49.0 9.4 10.0 8.8 5.7 4.4 1.5 15.7 14.2 9.4 35.0 20.0 0.0 6.2 0.1 18.0 0.0 0.1 1.1 36.1 34.2 3.7 2.3 25.6 57.0 10.4 31.8 76.2 19.4 19.2 8.2 28.4 0.0 12.7 58.2 19.9 55.3 0.3 32.6 14.3 0.2 0.1 0.0 13.4 0.3 8.9 0.0 0.0 29.9 11.3 13.1 53.6 48.5 50.3 0.0 0.0 0.0 45.7 5.7 0.0 0.1 0.2 10.9 30.5 0.0 2.6 0.0 50.3 45.2 0.0 0.0 21.8 4.6 8.0 14.3 22.6 0.7 62.8 28.6 1.9 18.9 18.5 0.0 0.0 0.0 21.2 0.4 33.7 0.0 4.3 0.0 0.0 15.9 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 0.1 0.0 18.0 2.1 0.1 1.1 2.1 4.1 1.3 2.7 3.5 2.1 5.8 2.5 15.0 4.4 56.6 42.0 2.7 42.9 21.1 0.0 7.6 10.2 32.1 66.0 21.0 0.0 48.8 1.7 48.5 0.5 20.4 36.0 0.0 28.8 20.4 33.3 62.3 1.1 0.0 21.2 0.0 1.7 27.0 31.3 0.6 5.5 20.9 8.5 3.6 24.4 0.0 95.7 18.2 8.5 0.5 0.9 6.5 31.9 0.1 0.1 26.8 42.8 0.0 13.3 93.6 NAP1L2 "BPX, MGC26243" ENSG00000186462 "Nucleosome assembly protein 1 like 2" Q9ULW6 X 73212299-73214848 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 49.8" "Cell type enhanced" "Detected in many" 8 "Bipolar cells: 24.8;Horizontal cells: 17.5;Muller glia cells: 12.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.1;Karpas-707: 10.2;NTERA-2: 13.0;U-2197: 10.5;U-266/84: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA054050, HPA057065" Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA054050: AB_2682357, HPA057065: AB_2797258" "unprognostic (1.12e-1)" "unprognostic (6.64e-5)" "unprognostic (4.22e-2)" "unprognostic (9.64e-4)" "unprognostic (1.78e-1)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (8.51e-3)" "unprognostic (1.76e-2)" "unprognostic (2.66e-1)" "prognostic favorable (5.41e-4)" "unprognostic (1.53e-2)" "unprognostic (1.54e-2)" "unprognostic (6.95e-4)" "unprognostic (1.07e-1)" "unprognostic (1.19e-1)" "unprognostic (2.45e-2)" 2.3 5.8 15.7 2.2 20.0 0.9 3.2 37.5 49.8 4.5 2.8 2.0 0.2 1.3 4.9 8.0 2.8 4.2 2.5 7.2 21.0 22.8 8.0 1.3 2.5 2.9 15.7 28.7 8.6 2.6 10.5 10.2 0.5 20.5 10.4 3.1 2.6 3.1 5.9 1.1 4.9 1.7 4.6 8.3 3.9 2.0 2.2 4.9 0.0 8.0 0.0 1.8 2.6 2.5 0.9 0.0 0.0 0.0 1.2 3.6 1.4 0.0 3.4 0.1 6.7 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.2 0.0 12.1 0.0 6.5 0.7 2.4 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.6 0.3 0.9 0.1 1.8 0.0 0.2 4.7 0.2 10.2 0.0 1.2 4.0 0.0 13.0 0.0 6.0 0.0 0.0 0.3 1.5 0.0 0.0 0.0 0.0 0.8 0.0 2.7 1.2 0.0 0.1 0.0 7.6 10.5 0.8 4.8 21.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 2.7 0.0 1.4 0.9 3.4 2.3 0.0 0.1 1.6 3.6 0.0 1.2 0.0 0.0 2.6 1.4 15.7 20.0 37.5 42.1 21.0 22.8 15.7 28.7 20.5 4.9 0.0 4.0 0.0 4.6 5.7 24.8 10.9 5.1 0.0 1.2 12.2 0.0 0.0 11.6 0.8 0.0 2.2 0.0 0.0 0.2 0.0 0.5 2.4 4.6 0.8 0.1 17.5 6.9 2.5 0.8 0.0 0.3 0.0 0.0 0.0 0.2 12.4 1.1 0.0 0.4 3.1 8.7 0.0 3.3 0.2 0.0 2.6 0.0 3.2 0.2 0.8 NAPG ENSG00000134265 "NSF attachment protein gamma" Q99747 18 10525905-10552761 "Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 54.1" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008208, HPA011389" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA008208: AB_1854305, HPA011389: AB_1854306" "unprognostic (1.23e-1)" "unprognostic (7.64e-3)" "unprognostic (6.96e-2)" "unprognostic (1.53e-1)" "unprognostic (9.83e-2)" "unprognostic (2.28e-1)" "unprognostic (1.28e-1)" "unprognostic (4.59e-2)" "unprognostic (1.55e-2)" "unprognostic (2.77e-3)" "unprognostic (1.46e-3)" "unprognostic (5.85e-2)" "prognostic favorable (8.14e-4)" "unprognostic (3.81e-2)" "unprognostic (2.87e-1)" "unprognostic (4.97e-2)" "unprognostic (6.96e-2)" 11.0 14.0 20.5 9.1 31.2 6.1 12.1 24.0 40.2 11.6 11.6 17.8 4.9 9.3 11.0 12.7 12.3 11.3 13.5 19.3 26.3 20.8 16.9 13.3 9.6 8.7 24.1 21.4 7.6 12.4 12.8 10.5 13.7 54.1 14.3 14.1 10.1 10.7 11.6 9.0 8.8 10.3 12.5 25.2 8.5 13.4 7.1 11.9 6.9 14.8 8.2 10.6 12.6 8.7 8.4 4.7 15.2 7.1 6.6 7.1 3.6 5.0 3.0 5.3 4.6 15.2 10.5 7.7 10.7 15.4 10.5 13.4 6.6 7.6 6.7 8.6 14.6 9.6 4.9 7.0 9.7 15.1 5.7 4.3 4.9 5.3 6.8 14.6 13.5 9.2 11.0 11.2 12.0 9.0 6.9 9.8 8.7 7.9 16.0 15.3 7.0 10.4 5.8 4.1 38.5 4.5 4.6 8.8 11.2 12.3 11.9 21.2 5.6 8.7 9.3 12.3 9.0 4.2 9.0 11.0 16.6 8.0 15.2 11.3 10.3 10.5 7.4 11.1 9.5 7.6 11.3 5.7 15.2 6.5 7.1 5.8 8.4 5.2 6.3 4.2 4.1 7.1 6.1 9.7 6.6 6.9 4.7 5.1 3.6 20.5 31.2 24.0 40.2 26.3 20.8 24.1 21.4 54.1 11.9 26.8 26.7 24.1 23.8 21.6 62.1 30.5 22.9 17.4 22.7 26.2 11.8 20.2 34.9 43.8 12.0 21.5 22.5 0.0 37.3 25.1 18.2 29.7 43.9 18.8 22.3 42.9 22.5 17.2 23.1 2.1 7.2 19.7 25.3 19.8 17.1 28.2 53.8 34.5 19.8 31.9 31.3 25.8 21.7 12.7 37.9 18.4 37.8 20.1 14.3 46.1 NARFL "FLJ21988, HPRN, IOP1, NAR1, PRN" ENSG00000103245 "Nuclear prelamin A recognition factor like" Q9H6Q4 16 729753-741329 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "REH: 56.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040851 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA040851: AB_10794427" "unprognostic (6.31e-2)" "prognostic favorable (1.32e-5)" "unprognostic (7.61e-2)" "unprognostic (8.25e-2)" "unprognostic (1.01e-1)" "unprognostic (1.27e-3)" "unprognostic (8.85e-2)" "unprognostic (3.76e-2)" "unprognostic (2.23e-1)" "unprognostic (8.39e-2)" "unprognostic (4.45e-3)" "unprognostic (3.02e-1)" "prognostic favorable (9.83e-5)" "unprognostic (2.49e-2)" "unprognostic (8.15e-2)" "unprognostic (2.62e-1)" "unprognostic (8.33e-3)" 10.2 11.9 16.4 15.3 19.7 15.0 10.3 21.8 28.8 10.0 12.6 21.6 21.1 20.9 11.1 19.2 15.2 13.7 10.6 20.9 18.1 14.2 16.1 17.6 9.1 16.2 15.1 9.8 11.3 18.4 18.5 13.1 11.1 16.7 15.7 8.1 14.3 25.4 17.5 24.1 14.9 15.5 8.7 14.1 15.0 14.5 8.7 13.1 18.4 12.6 13.7 18.9 11.7 11.3 16.0 11.8 8.3 10.9 13.9 12.9 9.4 3.5 10.5 4.2 6.0 4.4 3.1 10.1 5.1 3.8 7.2 6.2 7.4 8.9 5.1 7.9 3.2 5.2 8.1 4.1 6.2 2.6 9.4 9.3 4.3 6.0 6.0 5.6 7.6 6.2 3.8 7.8 4.2 3.5 4.7 5.2 20.5 7.9 4.9 3.5 13.2 6.8 3.5 3.4 7.3 6.7 56.0 6.3 9.2 4.3 3.6 4.8 6.6 6.1 14.7 5.2 2.6 13.4 7.7 5.6 6.0 5.6 6.6 4.5 6.4 4.5 14.1 4.1 4.3 7.7 2.7 10.9 8.3 11.5 9.9 8.9 16.0 11.7 9.5 11.8 10.5 9.5 12.9 2.3 13.9 10.6 9.5 11.1 9.4 16.4 19.7 21.8 28.8 18.1 14.2 15.1 9.8 16.7 13.1 6.0 6.4 14.5 7.7 4.9 20.9 9.7 7.6 5.3 5.7 14.0 13.7 17.8 6.6 15.0 1.0 7.2 23.1 0.0 13.6 10.0 4.7 8.1 15.0 5.9 13.5 36.5 7.5 4.9 9.5 1.9 9.5 7.2 10.1 29.7 16.3 14.6 10.4 15.0 9.9 11.3 16.3 12.9 4.7 11.3 8.9 5.3 11.9 8.7 15.0 7.0 NCAM1 "CD56, NCAM" ENSG00000149294 "Neural cell adhesion molecule 1" P13591 11 112961247-113278436 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 110.6;heart muscle: 67.7" "Group enriched" "Detected in many" 4 "Bipolar cells: 108.7;Cardiomyocytes: 109.4;Horizontal cells: 165.3;Muller glia cells: 263.9;Rod photoreceptor cells: 95.4" "Cancer enriched" "Detected in many" 8 "glioma: 31.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 14 "NK-cell: 27.2" "Lineage enriched" "Detected in many" 14 "NK-cells: 27.2" "Cell line enhanced" "Detected in some" "HEL: 19.5;RH-30: 44.0;SCLC-21H: 35.8;SH-SY5Y: 17.6;U-138 MG: 24.5;WM-115: 25.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000142, CAB018071, HPA039835" Enhanced Enhanced "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1200000 2800000000 "Plasma membrane" Cytosol "CAB000142: , CAB018071: AB_627129, HPA039835: AB_2676705" "unprognostic (7.04e-2)" "unprognostic (1.16e-1)" "unprognostic (2.77e-2)" "unprognostic (2.18e-2)" "unprognostic (2.91e-1)" "unprognostic (1.74e-3)" "unprognostic (2.82e-1)" "unprognostic (4.42e-3)" "unprognostic (2.13e-1)" "unprognostic (1.63e-2)" "prognostic favorable (9.11e-6)" "unprognostic (8.13e-2)" "prognostic unfavorable (8.20e-4)" "unprognostic (2.97e-2)" "unprognostic (2.24e-1)" "unprognostic (3.75e-2)" "unprognostic (5.82e-5)" 3.5 36.4 22.7 3.0 35.7 1.8 2.1 20.2 110.6 13.3 9.0 55.8 0.3 3.4 24.7 3.0 4.8 8.3 3.6 67.7 22.5 19.2 2.3 2.6 2.0 1.7 45.0 27.1 21.9 2.3 1.1 9.1 1.4 38.8 8.4 4.6 5.5 2.5 10.9 14.6 1.8 5.3 25.6 27.6 3.4 6.7 2.9 39.2 0.0 16.9 0.7 1.7 7.0 6.5 0.0 0.0 0.4 0.1 27.2 2.0 0.9 0.0 0.0 6.9 0.1 0.0 0.1 0.1 0.3 0.0 0.2 0.4 0.1 0.1 1.0 6.1 6.5 0.2 0.1 0.0 0.0 0.0 0.1 3.9 19.5 0.0 0.0 0.7 0.0 3.1 4.2 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.3 6.8 0.0 0.0 1.6 0.6 0.0 0.1 0.0 44.0 3.1 0.0 0.0 35.8 17.6 0.0 0.1 0.0 0.7 0.0 0.2 0.0 24.5 11.4 0.1 10.2 0.0 0.1 0.0 2.7 9.2 25.9 0.0 0.1 0.0 2.0 0.0 0.6 0.0 0.1 0.2 0.0 0.0 0.0 0.8 0.4 27.2 0.0 0.0 0.1 0.9 22.7 35.7 20.2 41.6 22.5 19.2 45.0 27.1 38.8 39.2 0.0 0.0 0.0 0.4 1.4 108.7 109.4 0.0 1.4 0.0 0.0 35.3 0.5 1.7 14.4 4.5 0.3 0.0 0.0 0.0 0.2 7.6 0.3 1.1 0.5 0.4 165.3 5.2 6.7 5.1 3.9 14.1 1.7 0.0 0.0 0.0 263.9 1.7 0.0 9.6 0.0 95.4 0.0 3.8 0.5 2.3 1.5 0.1 11.4 0.0 0.1 NCAM2 "MGC51008, NCAM21" ENSG00000154654 "Neural cell adhesion molecule 2" O15394 21 20998315-21543329 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 15.9;brain: 52.7" "Group enriched" "Detected in some" 4 "Early spermatids: 44.1;Late spermatids: 20.9" "Cancer enhanced" "Detected in some" "glioma: 5.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "T-47d: 45.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030900, HPA030901" Enhanced Supported Supported "Nuclear bodies,Plasma membrane" No No 100000000 "Nuclear bodies, Plasma membrane" "HPA030900: AB_10602037, HPA030901: AB_2673650" "unprognostic (9.70e-2)" "unprognostic (1.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.54e-2)" "unprognostic (1.85e-1)" "unprognostic (1.81e-1)" "unprognostic (1.37e-2)" "unprognostic (3.01e-2)" "unprognostic (5.90e-2)" "unprognostic (1.62e-1)" "unprognostic (1.31e-1)" "unprognostic (5.61e-1)" "unprognostic (3.07e-4)" "unprognostic (2.47e-4)" "unprognostic (1.62e-1)" "unprognostic (8.05e-2)" "unprognostic (1.35e-3)" 2.0 15.9 25.8 2.0 22.3 1.1 3.1 7.0 52.7 3.3 2.1 14.7 0.0 1.3 2.3 1.8 1.7 1.8 2.6 3.1 18.7 13.9 1.3 9.1 4.4 1.2 21.6 19.4 1.4 1.3 1.1 1.0 1.7 17.9 2.2 2.4 0.5 1.8 2.3 1.5 2.0 1.9 2.7 17.3 2.0 1.3 8.3 26.6 0.0 1.5 0.0 1.3 1.4 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.3 2.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.2 0.6 0.0 1.1 0.0 0.0 5.7 0.0 1.7 0.0 0.2 0.0 0.0 5.3 1.2 0.1 7.2 0.1 0.0 0.2 0.0 0.0 0.5 0.0 2.2 0.0 0.0 0.0 2.6 0.0 0.4 0.3 0.0 45.2 3.4 0.0 0.6 0.4 0.0 0.0 0.3 0.0 0.0 1.2 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 22.3 7.0 22.4 18.7 13.9 21.6 19.4 17.9 26.6 3.0 2.2 0.0 0.2 0.5 0.2 1.6 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 44.1 0.0 0.0 0.0 0.0 0.4 2.4 0.8 0.0 0.0 0.3 0.0 0.0 3.7 0.0 20.9 0.9 0.0 1.7 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.1 3.3 8.0 0.1 0.2 0.0 0.0 0.1 NCK1 "NCK, NCKalpha" ENSG00000158092 "NCK adaptor protein 1" P16333 3 136862208-136949823 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005063, HPA030766" Supported Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB005063: AB_562169, HPA030766: AB_2673602" "unprognostic (7.47e-2)" "unprognostic (2.07e-1)" "unprognostic (3.98e-2)" "unprognostic (3.03e-2)" "unprognostic (1.06e-2)" "unprognostic (8.77e-3)" "unprognostic (4.24e-3)" "unprognostic (8.30e-2)" "unprognostic (9.31e-2)" "unprognostic (1.22e-1)" "prognostic unfavorable (9.14e-5)" "unprognostic (5.96e-2)" "prognostic unfavorable (1.08e-4)" "unprognostic (1.64e-1)" "unprognostic (2.58e-1)" "unprognostic (1.66e-1)" "unprognostic (4.17e-2)" 44.5 15.7 11.5 24.5 13.4 19.3 38.9 22.6 11.6 23.7 18.3 8.4 16.5 10.2 20.8 19.2 35.9 14.6 13.9 16.8 11.8 11.1 14.0 20.9 22.4 33.0 13.9 12.1 19.6 14.3 17.9 17.7 22.7 13.5 26.3 19.5 10.8 24.0 15.8 29.0 27.3 14.3 24.0 13.5 18.7 12.8 14.7 12.7 41.1 23.8 23.5 29.0 27.3 43.3 8.5 13.3 26.8 27.1 11.2 20.2 11.9 20.0 8.9 11.8 9.7 27.4 26.6 13.2 14.9 26.8 17.3 18.1 12.9 20.0 19.7 30.9 17.4 22.4 15.5 16.6 15.1 23.1 14.2 6.8 17.1 12.6 10.1 44.6 12.3 11.8 24.1 19.9 16.8 33.5 17.7 26.5 18.7 10.2 17.6 18.1 10.9 27.9 10.0 11.2 18.1 11.3 15.3 11.0 18.9 16.1 13.8 8.4 8.1 26.8 12.0 23.9 15.0 17.3 13.6 13.1 11.3 7.3 16.0 8.4 17.7 13.8 24.4 11.9 11.1 12.0 26.8 12.4 13.2 19.7 27.1 20.2 8.1 15.6 19.8 13.3 8.5 12.6 15.0 7.2 11.2 13.4 5.2 15.0 11.9 11.5 13.4 22.6 11.6 11.8 11.1 13.9 12.1 13.5 12.7 8.9 15.7 26.5 64.7 66.4 18.9 9.4 15.3 10.7 23.9 8.7 5.9 42.1 13.3 38.5 9.2 68.0 17.2 0.0 24.2 41.6 41.4 45.8 9.2 33.7 45.3 23.8 13.3 25.2 28.8 7.3 40.9 45.6 40.5 48.7 17.1 19.3 29.4 23.0 25.1 18.7 12.7 12.9 33.0 44.9 32.9 72.8 51.0 68.2 15.6 120.8 NCKAP1L HEM1 ENSG00000123338 "NCK associated protein 1 like" P55160 12 54497711-54548238 "Plasma proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 39.1;lymphoid tissue: 56.7" "Group enriched" "Detected in many" 5 "B-cells: 52.5;granulocytes: 53.3;Hofbauer cells: 98.9;Kupffer cells: 144.7;Macrophages: 81.9;monocytes: 90.2;T-cells: 53.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HL-60: 33.5;HMC-1: 35.4;NB-4: 24.7;REH: 17.7;THP-1: 36.7;U-937: 21.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039490, HPA040772" Approved Uncertain "Plasma membrane,Cytosol" NA NA 52000 Cytosol "Plasma membrane" "HPA039490: AB_2676540, HPA040772: AB_2677129" "unprognostic (4.54e-2)" "unprognostic (5.20e-3)" "unprognostic (1.61e-2)" "unprognostic (1.22e-3)" "unprognostic (9.29e-2)" "unprognostic (1.01e-2)" "unprognostic (3.69e-1)" "unprognostic (2.95e-2)" "unprognostic (6.53e-3)" "unprognostic (4.80e-1)" "unprognostic (1.76e-1)" "unprognostic (2.08e-1)" "unprognostic (1.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.76e-2)" "unprognostic (3.63e-2)" "unprognostic (4.74e-2)" 18.1 5.0 5.9 22.0 10.5 16.9 7.2 1.2 5.8 3.1 15.0 8.1 0.6 4.0 3.1 4.3 4.8 4.0 5.1 6.5 4.1 3.5 3.9 6.5 19.7 56.7 9.3 2.5 2.2 2.4 4.4 2.3 7.3 6.6 4.8 6.9 3.0 4.3 4.0 1.5 2.8 15.4 7.0 13.9 44.7 4.7 1.7 7.9 47.2 2.8 1.8 30.0 22.2 3.3 11.2 25.4 18.4 39.1 12.3 15.2 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 12.1 0.1 14.4 0.0 0.0 0.0 33.5 35.4 0.0 0.0 0.0 0.0 0.0 0.2 12.4 2.3 13.6 0.0 0.0 14.1 24.7 0.0 0.0 0.0 17.7 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.7 0.0 0.0 0.0 0.0 0.0 0.7 0.8 11.8 0.0 21.5 0.0 8.6 23.3 18.4 11.9 36.4 9.8 11.2 10.7 12.1 25.4 11.0 6.9 10.0 5.9 12.3 39.1 14.4 15.2 19.2 5.9 10.5 1.2 5.8 4.1 3.5 9.3 2.5 6.6 7.9 0.0 15.2 52.5 0.4 1.1 0.9 1.3 7.6 1.4 3.4 0.0 0.0 0.6 0.0 0.0 0.6 2.0 0.0 0.0 0.3 0.7 1.7 0.1 53.3 0.9 98.9 0.0 0.0 9.2 144.7 1.5 1.1 81.9 5.0 90.2 0.0 0.2 0.0 0.0 0.0 0.3 0.8 0.0 1.4 0.5 1.0 0.5 1.1 53.6 0.0 0.3 NEXN "NELIN, nexilin" ENSG00000162614 "Nexilin F-actin binding protein" Q0ZGT2 1 77888513-77943895 "Disease related genes, Predicted intracellular proteins" Actin-binding "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 110.8;skeletal muscle: 198.5" "Cell type enriched" "Detected in many" 6 "Cardiomyocytes: 2090.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ: 43.5;LHCN-M2: 40.0;RH-30: 31.7" "Low region specificity" "Detected in many" "HPA011185, HPA011904" Approved Supported "Plasma membrane,Actin filaments" NA NA 12000000 "Plasma membrane, Actin filaments" "HPA011185: AB_1854409, HPA011904: " "unprognostic (9.73e-2)" "unprognostic (6.72e-2)" "prognostic unfavorable (5.60e-4)" "unprognostic (1.72e-2)" "unprognostic (1.11e-1)" "unprognostic (1.42e-2)" "unprognostic (1.62e-2)" "unprognostic (1.09e-1)" "unprognostic (3.03e-2)" "unprognostic (2.22e-1)" "unprognostic (1.46e-1)" "unprognostic (3.25e-1)" "unprognostic (5.41e-2)" "unprognostic (5.60e-2)" "unprognostic (2.48e-1)" "unprognostic (9.65e-3)" "unprognostic (3.68e-2)" 8.9 4.3 0.4 10.4 0.8 0.0 5.0 0.5 0.4 14.1 17.0 0.2 12.5 1.9 16.6 12.5 24.1 9.9 8.7 110.8 0.4 0.5 4.0 1.2 6.2 3.8 0.6 0.5 8.2 2.0 0.3 0.5 2.6 0.7 13.1 3.2 0.9 4.1 14.8 198.5 1.4 5.5 45.8 0.8 3.9 10.6 4.2 1.2 0.0 5.1 40.1 1.0 29.7 10.3 1.4 1.7 2.9 3.4 0.6 0.6 7.0 7.1 0.4 1.3 0.0 23.5 22.8 3.5 43.5 19.3 8.9 6.0 1.2 0.0 0.0 2.5 15.8 10.1 0.9 0.9 4.1 16.0 0.2 0.9 1.7 2.2 0.4 17.6 0.3 0.0 17.0 0.9 12.3 6.9 19.0 6.7 1.7 0.0 0.0 40.0 0.0 8.1 0.5 6.9 0.0 5.3 6.8 31.7 0.0 10.4 0.3 0.0 0.3 3.8 0.0 0.2 9.1 0.0 0.9 6.8 21.3 15.6 9.0 21.6 0.0 0.0 0.0 1.2 0.8 0.0 0.0 3.4 0.0 0.4 2.0 0.1 1.4 0.3 0.4 1.7 1.1 0.6 0.2 2.9 0.6 1.4 1.2 0.0 7.0 0.4 0.8 0.5 0.4 0.4 0.5 0.6 0.5 0.7 1.2 98.3 8.2 0.0 0.8 1.5 2.8 2090.8 0.0 0.0 9.1 0.0 3.9 0.3 1.7 15.9 15.1 11.3 0.9 0.0 27.4 2.8 19.0 0.9 1.1 0.8 1.1 1.6 0.0 53.4 2.6 5.4 67.9 5.3 0.0 0.0 0.0 0.2 23.5 0.0 325.3 0.5 2.6 213.4 98.6 0.7 2.1 0.6 0.2 2.2 0.3 0.2 NGEF ARHGEF27 ENSG00000066248 "Neuronal guanine nucleotide exchange factor" Q8N5V2 2 232878686-233013272 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 29.1;brain: 55.6;intestine: 23.2" "Cell type enhanced" "Detected in many" 12 "Enterocytes: 44.3;Hepatocytes: 17.7;Paneth cells: 20.1;Undifferentiated cells: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A-431: 25.6;HDLM-2: 21.6;HeLa: 10.4;PC-3: 28.1;T-47d: 15.9" "Group enriched" "Detected in many" 4 "amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2" "Low region specificity" "Detected in many" HPA008160 Approved Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008160: AB_1854450" "unprognostic (3.92e-1)" "unprognostic (1.78e-1)" "unprognostic (4.12e-3)" "unprognostic (1.66e-1)" "unprognostic (5.25e-2)" "unprognostic (5.46e-2)" "unprognostic (1.15e-1)" "unprognostic (2.39e-3)" "unprognostic (5.41e-3)" "unprognostic (2.58e-1)" "unprognostic (6.94e-3)" "unprognostic (1.24e-1)" "unprognostic (6.16e-2)" "unprognostic (2.31e-1)" "unprognostic (1.10e-1)" "unprognostic (2.80e-2)" "unprognostic (2.74e-1)" 0.8 29.1 15.8 1.4 55.6 0.3 1.4 0.8 53.8 1.4 7.9 1.6 0.0 23.2 2.8 2.6 5.3 3.1 2.0 0.9 7.0 5.1 4.2 9.7 0.6 0.3 3.2 26.7 1.5 1.8 7.9 0.9 0.4 5.4 1.3 6.1 0.0 0.8 0.7 0.7 16.5 16.6 4.0 1.4 0.5 6.2 2.3 12.0 0.0 0.8 1.0 0.4 0.9 1.6 0.0 0.5 0.5 0.3 0.0 0.0 0.0 25.6 7.5 0.3 0.1 0.1 4.2 0.4 0.4 0.0 0.2 0.0 0.3 2.5 0.0 7.6 5.3 2.7 3.3 5.7 1.4 0.2 21.6 1.8 0.0 10.4 8.0 0.1 0.0 0.1 0.0 0.1 1.7 0.3 0.1 0.9 0.1 0.1 0.1 0.2 1.9 0.0 0.0 0.6 0.1 28.1 0.0 0.0 0.0 0.5 0.7 0.9 0.2 3.2 1.6 0.0 1.0 15.9 0.2 0.0 0.2 2.3 0.1 0.5 0.2 0.1 0.0 1.9 0.0 1.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 15.8 55.6 0.8 53.8 7.0 5.1 3.2 26.7 5.4 12.0 0.0 0.0 0.0 1.0 8.9 0.2 2.0 2.5 0.0 0.0 0.0 0.0 0.1 0.0 3.1 0.6 0.4 44.3 0.0 9.2 0.2 0.3 0.6 0.0 17.7 0.1 1.6 4.7 0.0 0.3 1.3 0.0 0.2 1.7 0.0 13.6 5.2 7.7 20.1 1.1 6.3 0.0 0.0 0.7 1.1 0.4 6.6 0.0 0.0 17.8 0.3 NGFR "CD271, p75NTR, TNFRSF16" ENSG00000064300 "Nerve growth factor receptor" P08138 17 49495293-49515017 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins" "Apoptosis, Biological rhythms, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 17 "Basal glandular cells: 33.8;Leydig cells: 88.9;Muller glia cells: 122.0;Sertoli cells: 32.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 4.2" "Lineage enriched" "Detected in single" 7 "dendritic cells: 4.2" "Group enriched" "Detected in some" 7 "RH-30: 56.0;WM-115: 62.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basal ganglia: 13.1;hypothalamus: 8.2;pons and medulla: 3.7" "CAB000143, CAB001995, HPA004765" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 100000 "Nucleoplasm, Plasma membrane" "CAB000143: , CAB001995: , HPA004765: AB_1079233" "unprognostic (6.25e-3)" "unprognostic (1.06e-3)" "unprognostic (3.39e-3)" "unprognostic (6.67e-2)" "unprognostic (1.46e-2)" "unprognostic (2.26e-1)" "unprognostic (8.22e-2)" "unprognostic (4.94e-2)" "unprognostic (1.08e-2)" "unprognostic (4.10e-3)" "unprognostic (1.85e-2)" "unprognostic (1.25e-1)" "unprognostic (3.37e-2)" "unprognostic (4.01e-2)" "unprognostic (3.06e-2)" "unprognostic (2.77e-3)" "prognostic unfavorable (3.40e-4)" 30.9 24.0 1.2 9.2 7.4 1.0 11.7 6.1 4.5 7.6 9.4 10.4 7.9 3.2 6.8 15.0 11.3 12.6 10.8 22.2 2.4 2.9 4.8 29.1 1.4 11.6 13.8 1.3 7.6 6.2 2.8 6.7 16.7 15.9 17.7 3.4 20.2 17.2 9.7 4.8 8.4 5.0 10.7 22.4 18.9 4.9 12.2 4.4 0.4 25.8 7.4 7.0 13.1 6.8 0.0 4.2 0.0 0.4 0.0 0.5 0.2 0.0 0.0 1.7 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.9 1.3 0.4 1.2 0.0 0.1 0.2 0.1 0.0 1.0 0.1 0.0 0.1 6.0 0.0 0.1 0.4 0.0 0.0 0.0 0.0 0.0 8.1 0.1 0.0 0.0 1.0 0.0 0.0 1.0 56.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 3.7 2.2 0.1 0.0 0.0 0.0 1.0 0.1 2.7 0.0 0.0 0.0 0.0 0.5 62.2 0.0 0.0 0.0 0.5 0.2 0.1 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.4 4.2 0.0 0.2 1.2 7.4 6.1 4.0 2.4 2.9 13.8 1.3 15.9 4.4 0.0 0.0 0.5 33.8 3.2 6.1 0.5 0.0 1.4 2.3 0.0 3.9 0.2 0.0 0.0 0.6 1.3 0.0 0.0 0.0 0.4 3.3 2.4 0.0 0.0 0.1 0.0 0.0 3.1 0.0 0.9 88.9 1.8 15.1 0.0 0.0 122.0 0.0 0.0 26.2 0.0 5.7 32.3 9.5 0.5 0.9 1.5 0.1 1.0 0.0 2.0 NHSL2 ENSG00000204131 "NHS like 2" Q5HYW2 X 71910818-72161750 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 27.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 52.1;Glandular cells: 82.4;Ito cells: 55.3;Kupffer cells: 52.6;Urothelial cells: 89.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.5" "Group enriched" "Detected in many" 4 "dendritic cells: 3.5;granulocytes: 13.5;monocytes: 5.7" "Cell line enhanced" "Detected in some" "AF22: 16.8;EFO-21: 19.9;HUVEC TERT2: 18.3;TIME: 10.6;U-937: 13.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049771 Uncertain Approved "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "HPA049771: AB_2680872" "unprognostic (9.71e-3)" "unprognostic (1.96e-1)" "unprognostic (1.92e-1)" "unprognostic (4.56e-2)" "unprognostic (1.40e-1)" "unprognostic (5.50e-2)" "unprognostic (2.88e-2)" "unprognostic (5.72e-4)" "unprognostic (5.46e-2)" "unprognostic (3.36e-2)" "unprognostic (1.50e-2)" "unprognostic (1.91e-1)" "unprognostic (1.61e-2)" "unprognostic (4.27e-3)" "unprognostic (9.99e-2)" "unprognostic (7.76e-2)" "unprognostic (4.37e-4)" 7.8 2.3 11.0 4.8 22.5 3.4 5.2 27.1 9.4 6.6 5.5 1.5 0.9 1.3 8.7 2.7 5.5 3.8 7.4 3.6 4.9 3.2 2.0 1.6 5.5 1.3 2.2 4.9 3.1 1.6 3.1 6.1 3.7 4.3 6.4 3.3 6.2 2.6 8.7 2.8 2.3 2.6 11.7 2.4 4.5 3.4 9.6 2.7 0.3 5.3 4.6 1.6 6.3 4.4 0.0 3.5 13.5 5.7 0.9 1.8 1.7 0.2 0.4 16.8 0.1 0.2 0.7 0.1 0.5 3.1 0.1 0.2 0.1 0.0 0.1 19.9 1.7 0.0 0.0 1.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.9 0.3 0.0 0.6 0.0 0.0 18.3 0.0 0.0 2.7 0.1 0.1 0.1 1.3 3.2 0.0 0.0 0.0 1.0 0.0 0.1 1.9 0.4 3.8 0.0 0.0 0.0 4.9 0.0 1.1 10.6 0.0 1.1 1.3 0.0 0.0 0.0 0.1 0.8 13.3 0.0 4.1 5.7 11.8 1.8 3.9 1.7 0.0 1.0 1.6 3.5 0.0 0.1 0.2 13.5 0.9 3.0 0.0 0.1 1.7 11.0 22.5 27.1 9.4 4.9 3.2 2.2 4.9 4.3 2.7 0.0 3.4 0.0 52.1 0.5 0.6 16.3 10.2 0.0 0.0 1.8 0.0 15.3 0.0 0.2 3.0 21.8 2.4 23.3 0.6 18.6 11.2 82.4 7.0 14.3 16.2 0.0 1.2 55.3 52.6 4.9 29.4 3.4 1.7 0.0 4.5 1.2 0.3 0.0 20.1 1.4 0.3 25.8 2.2 2.5 1.7 0.3 20.8 27.7 4.9 89.4 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580579-36582607 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 9.6;lung: 7.7;testis: 22.9" "Cell type enhanced" "Detected in single" 18 "Basal glandular cells: 2.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "pons and medulla: 5.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.0;HaCaT: 10.0;HEK 293: 2.4;PC-3: 5.8;SiHa: 2.3" "Region enhanced" "Detected in single" "pons and medulla: 2.3" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.3 0.3 0.2 0.4 0.7 0.3 0.3 0.0 1.2 0.3 0.3 2.0 0.0 0.3 0.3 0.3 5.3 0.3 0.3 0.3 0.3 2.0 0.3 0.3 7.7 0.3 2.0 0.0 0.3 0.3 1.5 2.1 0.3 5.7 0.4 0.3 0.0 2.0 0.3 0.3 1.1 0.3 0.3 9.6 0.3 0.3 22.9 0.5 0.0 4.2 1.6 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.5 10.0 0.0 0.5 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.5 1.4 0.0 2.3 0.4 0.2 0.0 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 1.2 0.3 2.0 2.0 0.0 5.7 0.5 0.0 0.0 0.0 2.3 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.4 0.0 0.0 0.0 0.3 NLGN1 KIAA1070 ENSG00000169760 "Neuroligin 1" Q8N2Q7 3 173396284-174286644 "Predicted intracellular proteins, Predicted membrane proteins" "Biological rhythms, Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 26.9" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 50.9;Leydig cells: 23.9;Muller glia cells: 30.8" "Group enriched" "Detected in some" 9 "glioma: 3.8;melanoma: 2.2;renal cancer: 3.0" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 16.2;HUVEC TERT2: 15.8;RH-30: 16.9;WM-115: 17.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006572, HPA006680, CAB033261" Enhanced Uncertain "Nuclear bodies,Plasma membrane" NA NA 40000 "Plasma membrane" "Nuclear bodies" "CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400" "unprognostic (2.81e-1)" "unprognostic (9.86e-2)" "unprognostic (3.08e-5)" "unprognostic (7.52e-5)" "unprognostic (1.03e-1)" "unprognostic (2.31e-1)" "unprognostic (6.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.78e-1)" "unprognostic (8.07e-2)" "unprognostic (3.21e-3)" "unprognostic (1.86e-2)" "unprognostic (1.97e-1)" "unprognostic (4.08e-2)" "unprognostic (8.81e-2)" "unprognostic (2.41e-3)" "unprognostic (5.37e-2)" 3.9 2.4 13.4 1.4 9.4 0.6 1.6 20.2 26.9 6.3 3.2 5.6 0.0 1.0 4.3 5.0 4.8 5.9 3.3 5.7 8.8 9.1 5.6 0.6 1.2 1.0 6.3 7.8 2.8 2.0 0.6 6.9 1.4 6.8 4.4 2.2 4.3 0.9 5.9 0.7 1.0 1.6 8.2 4.6 0.7 2.0 11.1 8.9 0.0 2.2 0.4 0.8 5.1 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 7.7 8.3 0.0 3.2 8.1 0.4 0.5 0.0 0.3 0.0 0.1 16.2 3.0 0.0 2.3 0.0 0.8 0.0 3.8 1.1 0.0 0.0 0.0 0.0 0.0 6.3 0.0 0.0 0.0 6.5 15.8 0.0 0.0 1.0 0.1 0.0 0.0 0.0 4.6 0.0 1.1 0.0 16.9 3.9 3.0 0.0 1.6 1.1 0.0 0.0 7.9 0.7 0.4 0.0 1.9 8.8 0.9 6.3 7.2 7.6 0.0 0.0 3.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 9.4 20.2 10.9 8.8 9.1 6.3 7.8 6.8 8.9 0.0 0.3 0.0 0.6 0.7 11.4 2.0 0.0 0.0 0.0 3.5 3.9 0.2 0.0 0.3 50.9 0.3 0.0 0.0 0.0 0.1 2.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.9 23.9 0.0 13.5 0.0 0.0 30.8 0.1 0.0 13.4 7.1 9.7 6.5 1.0 0.4 0.7 0.6 0.1 0.0 0.0 0.1 NMBR "BB1, BB1R" ENSG00000135577 "Neuromedin B receptor" P28336 6 142058330-142088799 "G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 2.5;fallopian tube: 3.3;testis: 5.1" "Cell type enhanced" "Detected in some" 35 "Early spermatids: 5.9;Late spermatids: 1.6;Spermatocytes: 1.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 2.9;RPTEC TERT1: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA026665 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026665: AB_1854527" "unprognostic (6.24e-2)" "unprognostic (3.05e-1)" "unprognostic (2.77e-2)" "unprognostic (7.88e-2)" "unprognostic (3.54e-2)" "unprognostic (8.21e-2)" "unprognostic (3.63e-2)" "unprognostic (1.54e-1)" "unprognostic (3.95e-1)" "unprognostic (7.94e-3)" "unprognostic (3.44e-1)" "unprognostic (2.11e-1)" "unprognostic (8.45e-2)" 0.1 0.0 0.6 0.0 2.5 0.0 0.4 0.0 0.8 0.5 0.0 0.0 0.2 0.3 0.6 3.3 0.0 0.0 0.5 1.6 0.2 0.0 0.2 0.0 0.6 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.2 0.8 0.1 0.2 5.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.9 0.9 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.2 0.0 0.1 0.4 0.2 0.2 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.9 0.0 0.6 0.1 0.0 0.3 0.5 0.0 0.0 0.5 0.2 0.0 0.4 0.0 0.2 1.3 0.0 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.1 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 NMT1 NMT ENSG00000136448 "N-myristoyltransferase 1" P30419 17 45051610-45109016 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Hepatocytes: 304.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022949, HPA022963" Supported Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA022949: AB_1854534, HPA022963: AB_1854535" "unprognostic (1.40e-1)" "unprognostic (2.87e-1)" "unprognostic (1.30e-2)" "unprognostic (6.14e-2)" "unprognostic (1.65e-1)" "unprognostic (1.64e-1)" "prognostic unfavorable (4.94e-4)" "unprognostic (4.96e-3)" "unprognostic (3.86e-1)" "unprognostic (3.04e-2)" "unprognostic (2.19e-1)" "unprognostic (1.98e-1)" "unprognostic (3.77e-3)" "unprognostic (1.01e-2)" "unprognostic (4.89e-2)" "unprognostic (4.17e-3)" "unprognostic (9.45e-2)" 28.8 32.6 44.9 28.2 37.3 12.0 26.1 34.5 64.3 23.7 24.4 17.2 22.9 23.4 27.3 29.3 26.6 30.9 17.3 26.8 37.7 29.6 28.8 36.6 26.7 27.2 27.7 43.6 29.3 21.8 41.6 23.7 32.7 38.1 23.7 23.1 18.1 34.9 30.1 75.5 28.8 24.8 30.1 36.6 28.2 23.4 26.1 34.0 20.7 29.4 18.6 30.9 25.1 43.3 10.2 18.2 7.6 9.3 7.4 10.0 3.3 17.0 22.6 19.5 17.2 35.3 22.8 20.5 19.0 25.2 37.1 30.6 25.2 14.7 20.5 27.6 26.1 26.6 16.1 33.5 26.6 34.4 52.1 23.4 20.4 15.1 24.8 23.2 26.3 24.6 28.7 24.2 27.5 21.9 19.9 24.8 21.0 32.3 10.4 20.6 14.6 31.9 17.9 18.2 31.4 23.6 21.9 29.1 15.6 29.3 15.8 16.3 14.7 12.0 11.0 17.2 34.8 23.7 20.9 19.9 22.7 17.4 18.2 25.3 16.2 23.0 20.5 24.3 14.8 23.9 6.5 8.1 7.6 7.9 9.3 7.2 10.2 7.8 9.3 6.6 7.6 10.0 7.6 5.3 7.4 6.9 18.2 7.5 3.3 44.9 37.3 34.5 64.3 37.7 29.6 27.7 43.6 38.1 34.0 35.7 35.1 55.6 14.2 12.4 85.1 38.9 94.3 16.0 27.3 66.3 110.0 63.6 66.3 62.0 17.1 41.3 50.2 116.8 61.6 49.6 39.9 11.1 22.0 304.8 40.7 122.3 48.9 77.3 77.9 6.8 50.9 41.1 10.1 108.2 32.8 38.5 58.3 45.6 48.1 45.3 119.2 58.2 14.4 60.6 32.8 12.3 68.4 41.5 52.5 15.0 NOS1 "nNOS, NOS" ENSG00000089250 "Nitric oxide synthase 1" P29475 12 117208142-117452170 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Calmodulin-binding, Oxidoreductase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "brain: 13.4;skeletal muscle: 36.3" "Cell type enhanced" "Detected in some" 12 "Basal glandular cells: 7.9;Basal keratinocytes: 3.4;Glandular cells: 2.8;Ito cells: 8.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HaCaT: 6.3;RH-30: 13.1;RPTEC TERT1: 8.2;U-2 OS: 2.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002167, HPA058312, HPA069509" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB002167: AB_564073, HPA058312: AB_2683676, HPA069509: " "unprognostic (1.63e-1)" "unprognostic (3.14e-2)" "unprognostic (2.18e-2)" "unprognostic (6.64e-3)" "unprognostic (4.91e-2)" "unprognostic (2.74e-1)" "unprognostic (2.54e-1)" "unprognostic (9.12e-3)" "unprognostic (2.51e-1)" "unprognostic (1.10e-1)" "unprognostic (1.07e-1)" "unprognostic (7.56e-2)" "unprognostic (1.01e-1)" "unprognostic (3.73e-2)" "unprognostic (1.34e-1)" "unprognostic (5.97e-4)" "unprognostic (1.87e-1)" 0.5 0.6 3.8 3.5 13.4 0.7 0.6 4.4 4.8 0.7 2.0 1.1 0.0 0.5 0.6 0.7 1.3 0.8 0.5 0.5 2.8 4.4 1.9 0.5 1.4 0.6 2.4 1.6 0.5 1.9 0.4 0.8 0.4 5.9 1.6 0.9 0.6 3.8 0.6 36.3 2.2 0.6 0.8 1.2 0.5 0.5 0.9 3.0 0.0 0.6 0.0 0.5 0.9 0.6 0.9 0.6 2.1 0.5 0.8 0.5 0.0 0.0 0.4 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.3 0.0 0.0 6.3 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.2 0.0 1.5 0.0 13.1 0.1 8.2 0.1 0.3 1.3 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 2.5 0.0 0.0 0.1 0.0 0.1 0.4 0.1 0.0 2.1 0.5 0.5 0.5 0.4 0.4 0.7 0.4 0.3 0.2 0.9 0.5 0.5 1.9 0.8 0.5 0.6 0.3 0.0 3.8 13.4 4.4 4.8 2.8 4.4 2.4 1.6 5.9 3.0 0.0 0.0 0.0 7.9 3.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 1.9 0.4 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.2 0.3 0.2 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.5 0.0 0.0 0.0 1.0 NOTCH2 ENSG00000134250 "Notch 2" Q04721 1 119911553-120069626 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Notch signaling pathway, Transcription, Transcription regulation" "Activator, Developmental protein, Receptor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 129.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048743 Approved Supported "Nucleoplasm,Plasma membrane" NA NA 67000000 "Nucleoplasm, Plasma membrane" "HPA048743: AB_2680508" "unprognostic (1.33e-1)" "unprognostic (1.43e-2)" "unprognostic (2.66e-1)" "unprognostic (1.40e-3)" "unprognostic (7.98e-2)" "unprognostic (4.01e-2)" "unprognostic (1.22e-1)" "unprognostic (7.32e-2)" "unprognostic (1.18e-2)" "prognostic unfavorable (5.24e-4)" "prognostic unfavorable (9.48e-4)" "unprognostic (3.86e-2)" "unprognostic (6.12e-3)" "unprognostic (1.55e-2)" "unprognostic (2.65e-2)" "unprognostic (1.12e-2)" "unprognostic (7.35e-3)" 12.0 7.3 6.0 9.4 6.8 4.4 10.6 3.0 5.6 14.5 7.6 4.4 11.3 1.6 12.3 11.8 13.4 11.4 12.8 7.9 6.8 2.3 5.5 11.4 10.6 5.7 5.3 7.6 15.5 27.6 6.1 3.3 10.3 6.5 9.9 5.2 9.4 17.7 10.0 9.3 17.2 6.1 12.4 6.2 11.5 5.8 15.7 4.4 8.0 11.4 8.6 6.6 9.6 13.0 4.2 5.2 7.7 9.6 1.5 1.7 2.0 15.0 5.1 7.9 6.1 33.0 28.3 7.9 11.5 15.9 15.4 16.7 4.7 4.1 0.3 9.7 21.8 13.7 5.7 12.5 10.2 24.6 18.1 8.0 8.7 13.7 0.4 12.3 9.1 2.3 22.7 6.6 46.1 30.7 23.3 7.8 4.1 0.1 19.2 18.5 16.9 3.8 2.6 10.2 1.4 5.7 2.5 27.9 9.7 8.1 9.6 0.3 4.0 15.6 14.7 8.3 16.7 8.1 3.1 27.4 20.1 13.9 30.1 18.0 8.0 3.9 4.4 29.5 8.4 19.1 5.6 6.4 6.4 1.5 6.6 1.7 4.2 1.3 1.1 5.2 3.9 1.0 1.7 7.7 1.5 9.6 4.2 0.8 2.0 6.0 6.8 3.0 5.6 6.8 2.3 5.3 7.6 6.5 4.4 32.8 21.6 24.1 40.5 41.1 3.5 11.2 25.5 2.7 13.6 17.4 5.9 1.2 0.0 37.1 15.7 3.7 3.0 0.0 11.3 6.7 53.5 36.6 15.1 35.0 29.9 3.2 5.8 5.5 68.6 9.3 50.9 36.3 37.1 13.6 7.5 46.7 22.9 129.8 80.2 4.3 10.2 19.4 32.3 4.8 3.6 77.8 1.4 13.6 13.8 52.7 NPFFR2 "GPR74, NPFF2, NPGPR" ENSG00000056291 "Neuropeptide FF receptor 2" Q9Y5X5 4 72031804-72148067 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 15.4;seminal vesicle: 10.1" "Group enriched" "Detected in some" 6 "Cytotrophoblasts: 5.4;Extravillous trophoblasts: 7.3;Horizontal cells: 3.2;Muller glia cells: 4.8;Syncytiotrophoblasts: 8.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 7 "GAMG: 22.5;NTERA-2: 7.3;RPTEC TERT1: 9.5;SH-SY5Y: 11.2;U-2 OS: 11.2" "Region enriched" "Detected in single" 4 "olfactory region: 5.3" "Low region specificity" "Detected in many" HPA026825 Approved "Plasma membrane,Actin filaments" "Intracellular and membrane" NA NA "Plasma membrane" "Actin filaments" "HPA026825: AB_10603123" "unprognostic (1.28e-1)" "unprognostic (1.05e-2)" "unprognostic (1.53e-1)" "unprognostic (1.23e-1)" "unprognostic (6.07e-2)" "unprognostic (4.68e-2)" "unprognostic (5.77e-2)" "unprognostic (1.43e-2)" "unprognostic (1.34e-1)" "unprognostic (1.51e-1)" "unprognostic (2.40e-5)" "unprognostic (5.75e-2)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (1.48e-1)" 0.9 0.2 5.5 0.7 2.6 0.2 1.4 0.2 3.5 0.5 0.5 0.0 0.0 0.5 0.1 2.8 0.3 0.8 0.4 0.4 0.9 2.9 0.6 0.2 0.2 0.6 0.5 4.0 0.3 1.2 0.1 1.0 4.6 1.5 3.2 0.9 1.4 0.3 10.1 0.3 0.7 0.5 0.2 0.6 0.5 0.4 1.6 0.0 15.4 1.2 0.0 0.6 2.5 0.7 0.6 0.3 2.3 0.3 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 11.2 0.0 0.0 0.0 1.6 0.0 0.0 1.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.2 0.4 0.2 0.2 0.1 0.3 0.2 0.1 0.1 0.6 0.2 0.2 1.1 0.8 0.3 0.3 0.2 0.1 5.5 2.6 0.2 3.5 0.9 2.9 0.5 4.0 1.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.2 0.4 0.1 0.0 0.0 0.2 7.3 1.0 0.0 0.0 0.0 0.9 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 4.8 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 8.1 0.0 0.0 0.0 NPL "C1orf13, DHDPS1, NPL1" ENSG00000135838 "N-acetylneuraminate pyruvate lyase" Q9BXD5 1 182789293-182830384 "Enzymes, Predicted intracellular proteins" "Carbohydrate metabolism" Lyase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 76.0" "Cell type enhanced" "Detected in many" 18 "Cytotrophoblasts: 103.5;Hofbauer cells: 387.9;Ito cells: 109.2;Kupffer cells: 121.2;Syncytiotrophoblasts: 89.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 76.0" "Group enriched" "Detected in many" 36 "granulocytes: 76.0;monocytes: 23.6" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA028345, HPA075808" Enhanced Approved "Vesicles,Plasma membrane" NA NA 190000 Vesicles "Plasma membrane" "HPA028345: AB_10610145, HPA075808: " "unprognostic (2.43e-2)" "unprognostic (5.71e-3)" "unprognostic (1.72e-2)" "unprognostic (1.06e-1)" "unprognostic (1.57e-1)" "unprognostic (3.06e-1)" "prognostic unfavorable (8.05e-4)" "unprognostic (4.41e-2)" "unprognostic (6.54e-3)" "unprognostic (1.45e-1)" "unprognostic (1.49e-1)" "unprognostic (6.18e-2)" "prognostic unfavorable (6.63e-4)" "unprognostic (2.11e-1)" "unprognostic (2.93e-2)" "unprognostic (2.35e-2)" "unprognostic (7.44e-2)" 14.9 6.8 10.9 14.2 12.3 12.4 5.3 3.5 10.2 3.9 5.3 15.0 11.4 2.4 2.5 23.7 8.0 4.1 10.1 4.7 9.2 8.7 37.4 15.4 14.3 20.4 16.0 8.6 2.8 3.2 2.5 2.5 32.9 15.4 4.4 7.4 3.9 5.7 5.8 2.4 6.5 4.8 5.8 15.3 32.1 4.0 4.0 14.4 3.1 3.4 1.3 10.9 11.8 5.5 0.7 1.3 76.0 23.6 0.0 1.3 10.3 2.7 0.5 0.8 0.0 2.4 2.4 0.7 0.9 1.8 1.0 0.5 0.0 1.2 7.3 1.3 0.0 0.0 1.1 1.6 2.0 0.2 0.0 1.2 11.6 0.3 0.1 1.3 4.4 7.0 1.9 7.8 0.2 0.0 0.1 0.1 8.5 8.7 11.7 1.8 0.9 0.2 2.9 9.3 5.7 0.9 1.1 0.6 8.9 0.2 6.1 2.6 3.9 4.2 0.2 3.7 0.9 2.4 7.1 0.2 1.0 2.0 0.6 0.1 8.4 10.1 7.4 2.1 7.8 3.0 3.6 23.6 18.0 1.0 20.8 0.9 0.3 0.8 0.9 1.3 0.7 0.7 0.9 76.0 0.0 16.0 0.2 1.3 10.3 10.9 12.3 3.5 10.2 9.2 8.7 16.0 8.6 15.4 14.4 0.0 5.6 9.1 4.0 5.5 5.1 2.5 2.5 0.0 1.2 7.0 2.0 103.5 16.6 1.0 14.0 2.1 1.3 23.3 2.1 6.6 3.3 1.2 5.7 2.4 387.9 6.4 1.7 109.2 121.2 20.9 0.9 25.3 10.1 21.6 1.1 2.4 1.4 0.0 0.4 55.2 2.4 0.0 2.9 8.6 8.3 6.1 89.7 3.5 0.8 3.9 NRSN1 "p24, VMP" ENSG00000152954 "Neurensin 1" Q8IZ57 6 24126122-24154900 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 67.2" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 114.4" "Cancer enriched" "Detected in single" 17 "glioma: 3.1" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 1.8" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "SCLC-21H: 14.6;SH-SY5Y: 11.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019681, HPA061006" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019681: , HPA061006: AB_2684413" "unprognostic (1.22e-1)" "unprognostic (4.26e-2)" "unprognostic (8.00e-3)" "unprognostic (8.01e-3)" "unprognostic (1.70e-1)" "unprognostic (4.53e-3)" "unprognostic (7.29e-2)" "unprognostic (1.36e-3)" "unprognostic (2.40e-3)" "unprognostic (1.45e-1)" "unprognostic (1.57e-1)" 1.3 6.9 21.5 1.7 27.7 1.7 1.3 5.3 67.2 1.3 1.7 2.1 0.0 1.7 1.5 1.4 1.4 1.3 1.5 1.4 15.3 25.0 1.5 1.4 1.4 1.5 12.4 25.4 1.3 2.6 1.4 12.9 1.3 27.4 1.4 1.7 0.3 1.5 1.3 3.3 1.5 1.6 1.6 6.7 1.5 1.9 1.6 5.0 0.0 1.4 0.0 1.3 1.3 0.1 0.5 0.2 1.8 0.2 0.1 0.3 0.0 0.7 0.0 0.3 0.7 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.2 0.7 0.1 1.7 0.0 0.0 0.3 0.1 0.0 0.1 1.7 0.6 0.0 0.1 0.2 0.0 0.1 0.2 0.1 0.0 0.1 0.0 0.1 0.0 0.3 2.0 1.3 0.1 0.2 0.3 0.9 0.7 0.2 2.5 0.5 0.2 0.5 0.0 0.0 14.6 11.7 0.0 0.1 0.9 0.2 1.7 3.5 0.2 0.5 0.6 0.1 0.4 0.8 2.3 0.9 0.7 0.0 1.3 1.8 0.1 0.3 0.2 0.2 0.1 0.2 0.1 0.1 0.0 0.5 0.1 0.3 1.0 0.1 0.2 0.2 0.0 0.0 21.5 27.7 5.3 34.1 15.3 25.0 12.4 25.4 27.4 5.0 0.0 0.0 0.0 0.0 0.0 24.4 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 114.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NSD1 "ARA267, FLJ22263, KMT3B, STO" ENSG00000165671 "Nuclear receptor binding SET domain protein 1" Q96L73 5 177133025-177300215 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Transcription, Transcription regulation" "Activator, Chromatin regulator, Methyltransferase, Repressor, Transferase" "Cancer-related genes, Disease mutation, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 141.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA048431, HPA070333, HPA073705" Supported Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA048431: AB_2680388, HPA070333: AB_2686255, HPA073705: AB_2732239" "unprognostic (3.48e-2)" "unprognostic (7.46e-2)" "unprognostic (7.14e-3)" "unprognostic (2.64e-3)" "unprognostic (1.38e-1)" "unprognostic (9.67e-2)" "unprognostic (2.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.68e-3)" "unprognostic (8.04e-2)" "unprognostic (1.48e-1)" "unprognostic (2.09e-1)" "unprognostic (7.77e-3)" "unprognostic (3.53e-2)" "unprognostic (1.01e-1)" "unprognostic (7.51e-2)" "unprognostic (7.32e-2)" 11.8 13.2 11.9 25.4 15.7 23.9 14.0 28.9 16.7 15.6 14.2 18.5 17.0 10.6 19.0 13.9 17.8 13.6 15.8 11.7 12.8 11.5 14.4 10.5 12.3 19.4 12.9 11.7 16.6 27.1 24.6 19.3 16.0 13.4 14.2 14.3 13.8 13.5 18.7 20.6 16.1 14.5 15.6 13.2 16.1 13.1 28.1 16.1 27.3 20.1 10.6 22.7 13.4 20.2 10.2 8.9 18.7 10.8 10.9 7.8 2.9 9.9 12.8 13.3 11.5 6.6 8.5 0.4 9.0 9.0 12.7 11.8 2.8 8.3 20.5 10.2 12.4 11.7 8.5 21.2 20.0 15.4 34.7 12.8 9.1 14.5 0.1 10.9 19.6 10.8 8.0 12.1 15.0 14.1 9.0 18.4 13.0 12.4 7.2 12.7 20.8 13.6 6.3 14.5 6.7 11.3 15.1 1.7 6.3 8.2 12.1 16.3 11.2 23.4 10.2 7.0 12.9 10.2 16.3 13.5 8.8 12.9 5.6 11.1 8.5 7.4 14.7 5.1 9.6 9.4 10.7 9.1 9.4 7.5 6.1 6.3 8.5 6.3 5.0 6.7 10.2 7.8 6.3 18.7 10.9 10.8 8.9 5.7 2.9 11.9 15.7 28.9 16.7 12.8 11.5 12.9 11.7 13.4 16.1 20.8 26.1 42.4 26.2 15.0 91.7 37.5 33.1 13.4 36.4 52.4 141.4 34.8 14.9 22.8 25.5 31.5 21.9 0.0 18.5 20.4 23.3 24.0 39.4 16.3 24.2 84.2 40.3 31.3 29.2 33.9 47.2 39.1 15.1 50.5 19.4 35.7 20.1 24.6 31.1 13.9 100.0 51.8 19.6 63.2 47.7 18.1 29.6 51.1 21.5 23.5 NUDT16L1 SDOS ENSG00000168101 "Nudix hydrolase 16 like 1" Q9BRJ7 16 4693694-4695859 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044186, HPA063605" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA044186: AB_10968571, HPA063605: AB_2685058" "unprognostic (1.35e-2)" "unprognostic (1.70e-1)" "unprognostic (6.65e-2)" "unprognostic (2.17e-2)" "unprognostic (1.02e-1)" "unprognostic (2.34e-2)" "unprognostic (3.14e-1)" "prognostic favorable (2.79e-4)" "unprognostic (2.51e-1)" "unprognostic (1.89e-1)" "unprognostic (6.12e-3)" "unprognostic (6.81e-2)" "prognostic favorable (1.02e-6)" "unprognostic (2.78e-1)" "unprognostic (1.47e-1)" "unprognostic (4.08e-2)" "unprognostic (6.81e-3)" 11.2 21.7 19.3 13.2 22.1 19.3 11.0 25.3 33.1 13.6 20.6 15.9 25.5 21.7 10.4 17.1 14.0 16.5 16.8 31.8 19.7 17.5 20.1 27.2 15.2 18.5 18.3 15.8 13.9 14.8 15.7 19.6 10.5 13.4 19.7 12.2 16.3 16.8 16.3 22.4 10.9 18.6 8.9 16.2 15.9 15.3 13.0 15.9 18.2 21.6 14.2 15.9 10.5 9.8 30.1 40.4 44.9 27.0 28.5 39.6 42.7 7.4 12.3 11.3 15.1 8.5 6.6 10.3 8.9 6.8 10.9 6.9 13.8 6.0 7.8 13.0 10.7 5.5 8.7 12.1 12.2 5.1 11.4 20.4 8.6 10.6 16.6 9.3 12.3 10.2 10.2 11.3 9.1 5.7 7.4 8.0 11.8 15.6 9.8 10.5 29.0 18.4 18.2 17.8 12.5 14.2 25.9 11.9 12.2 13.0 9.3 22.3 16.7 13.0 13.7 5.9 9.2 20.2 28.9 10.3 9.0 13.5 21.1 8.1 17.1 10.1 13.1 5.6 16.5 18.2 23.1 27.0 44.9 27.2 22.5 32.6 28.8 33.3 32.4 24.5 30.1 39.6 33.6 33.3 28.5 24.0 40.4 36.7 42.7 19.3 22.1 25.3 33.1 19.7 17.5 18.3 15.8 13.4 15.9 14.9 19.0 34.7 19.4 12.5 52.0 47.7 12.7 17.4 12.5 40.1 9.8 43.2 92.9 25.8 3.1 23.2 52.5 0.0 27.2 25.3 19.0 19.1 27.6 35.5 35.0 44.5 41.3 15.4 17.0 5.5 29.1 17.5 28.7 51.3 44.4 75.6 24.1 42.1 47.0 80.4 54.6 45.3 22.1 10.9 35.7 14.4 41.1 37.4 46.0 14.6 NUS1 "C6orf68, MGC7199, NgBR, TANGO14" ENSG00000153989 "NUS1 dehydrodolichyl diphosphate synthase subunit" Q96E22 6 117675502-117710640 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Angiogenesis, Differentiation, Lipid metabolism" "Developmental protein, Receptor, Transferase" "Congenital disorder of glycosylation, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027504 Supported Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA027504: AB_10603124" "unprognostic (1.21e-2)" "prognostic unfavorable (6.99e-4)" "unprognostic (1.09e-2)" "unprognostic (2.31e-1)" "unprognostic (1.21e-1)" "unprognostic (8.26e-3)" "unprognostic (1.42e-3)" "unprognostic (2.42e-2)" "unprognostic (8.62e-2)" "unprognostic (2.99e-1)" "unprognostic (2.62e-1)" "unprognostic (8.35e-2)" "unprognostic (1.00e-1)" "unprognostic (2.27e-1)" "unprognostic (3.22e-2)" "unprognostic (1.56e-1)" "unprognostic (7.97e-2)" 8.4 10.2 14.7 9.3 14.7 7.0 10.0 8.8 13.4 29.6 9.2 6.8 2.0 7.1 9.6 13.5 9.5 8.8 7.1 8.2 12.7 9.9 13.1 17.4 9.5 8.4 16.4 15.7 8.8 28.9 15.0 20.0 10.6 16.2 9.6 9.3 7.1 13.8 14.9 7.9 6.1 14.4 8.5 7.3 9.1 10.6 5.6 12.2 7.2 16.5 3.1 8.7 9.1 18.0 2.4 8.1 3.3 4.9 4.1 4.5 2.3 10.3 7.6 16.4 18.3 16.6 21.8 40.4 18.9 19.7 15.8 18.2 17.2 11.6 24.4 20.6 17.4 20.1 9.4 24.4 18.5 29.5 18.2 22.5 27.9 12.8 30.7 25.6 35.1 16.5 19.0 21.0 17.3 35.4 16.2 16.2 18.3 33.3 21.8 23.6 11.6 16.5 22.4 19.1 14.2 13.9 15.9 11.8 17.5 31.4 10.3 19.5 15.4 11.4 14.8 13.8 19.1 9.4 36.9 14.2 9.8 12.1 15.6 27.1 30.3 22.6 26.0 23.2 27.1 19.5 3.3 3.0 1.8 3.1 3.0 4.5 2.4 3.7 4.1 3.2 2.1 3.1 4.0 0.2 4.1 4.9 8.1 3.4 2.3 14.7 14.7 8.8 13.4 12.7 9.9 16.4 15.7 16.2 12.2 0.0 21.1 21.6 29.1 53.8 14.3 6.1 15.3 10.7 14.8 24.4 9.8 21.6 23.2 19.8 11.9 17.5 19.7 0.0 26.2 41.6 19.7 52.1 31.1 35.9 32.9 14.3 12.6 27.0 29.1 11.8 16.7 32.9 30.4 22.6 26.8 7.5 29.9 21.0 19.1 29.2 8.2 6.5 37.6 21.8 28.8 49.1 48.4 14.1 21.0 80.5 OBSCN "ARHGEF30, KIAA1556, KIAA1639, UNC89" ENSG00000154358 "Obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF" Q5VST9 1 228208130-228378874 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Differentiation "Calmodulin-binding, Developmental protein, Kinase, Muscle protein, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "skeletal muscle: 180.2;tongue: 48.4" "Cell type enriched" "Detected in many" 14 "Cardiomyocytes: 136.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 16.0" "Low region specificity" "Detected in single" "HPA021186, HPA065801" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021186: AB_1854761, HPA065801: " "unprognostic (8.47e-3)" "unprognostic (1.56e-1)" "unprognostic (9.99e-2)" "prognostic unfavorable (1.64e-4)" "unprognostic (5.30e-3)" "unprognostic (6.36e-2)" "unprognostic (4.54e-3)" "unprognostic (1.82e-1)" "unprognostic (8.81e-2)" "unprognostic (1.93e-2)" "unprognostic (3.38e-1)" "unprognostic (1.45e-1)" "unprognostic (1.57e-3)" "unprognostic (1.34e-1)" "unprognostic (1.77e-1)" "unprognostic (3.53e-1)" "unprognostic (1.16e-2)" 2.5 0.9 0.5 0.9 4.4 0.6 0.7 3.1 0.6 0.6 0.8 0.5 0.5 0.6 0.8 4.4 2.4 1.0 0.6 21.2 0.5 0.7 1.6 0.5 1.0 1.0 0.5 0.5 1.7 1.4 0.4 2.4 0.5 0.9 1.7 0.3 5.2 2.6 1.1 180.2 1.1 0.8 0.5 0.6 1.4 0.5 0.7 0.6 0.5 2.2 48.4 3.5 0.6 0.7 1.0 1.1 0.1 0.4 0.6 3.2 0.7 2.9 2.8 8.0 4.5 0.2 0.1 5.6 1.5 0.5 1.0 0.9 2.0 2.1 5.7 8.1 0.5 0.6 1.0 0.4 1.1 0.2 2.2 5.1 1.9 16.0 0.0 2.0 1.3 6.1 3.0 1.0 0.4 0.2 5.4 0.4 9.4 5.3 1.3 0.3 5.0 2.1 1.6 8.8 0.8 1.8 8.1 0.1 1.3 4.6 1.5 3.0 9.0 0.2 2.9 1.1 2.4 8.0 3.7 0.7 0.0 9.3 0.2 0.1 4.7 0.9 1.4 0.0 0.8 2.1 0.1 0.4 0.0 0.9 0.1 0.9 0.5 0.9 0.7 0.9 1.0 3.2 0.5 0.1 0.6 0.1 1.1 0.8 0.7 0.5 4.4 3.1 0.6 0.5 0.7 0.5 0.5 0.9 0.6 0.0 5.6 0.0 5.9 1.9 3.2 136.5 2.5 1.4 4.5 5.2 9.8 0.1 10.0 2.9 3.8 1.6 0.4 0.0 0.4 0.4 1.5 1.9 6.9 0.5 0.1 0.0 0.0 1.3 0.0 4.0 2.8 0.3 1.7 0.0 1.7 9.7 1.0 0.0 4.2 4.2 2.8 0.0 1.2 0.1 2.5 1.5 1.0 1.8 1.1 3.4 OCA2 "BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P" ENSG00000104044 "OCA2 melanosomal transmembrane protein" Q04671 15 27754875-28099358 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Albinism, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 37.9;skin 1: 12.3" "Cell type enhanced" "Detected in some" 24 "Leydig cells: 8.6;Melanocytes: 40.5;Peritubular cells: 13.8" "Cancer enriched" "Detected in many" 17 "melanoma: 19.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "SH-SY5Y: 5.9;SK-MEL-30: 22.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA036402 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA036402: " "unprognostic (6.07e-3)" "unprognostic (1.97e-2)" "unprognostic (3.25e-1)" "unprognostic (2.82e-2)" "unprognostic (4.60e-4)" "unprognostic (7.11e-2)" "unprognostic (1.10e-1)" "unprognostic (4.12e-2)" "unprognostic (3.47e-2)" "unprognostic (4.95e-2)" "unprognostic (1.96e-2)" "unprognostic (1.60e-2)" "unprognostic (2.20e-6)" "unprognostic (2.61e-1)" "unprognostic (4.21e-1)" "unprognostic (3.28e-2)" "unprognostic (2.28e-2)" 0.4 0.1 0.9 1.3 4.8 0.0 0.3 0.2 2.9 2.4 0.3 3.6 0.2 0.0 0.4 1.7 2.9 1.6 0.5 0.2 1.3 3.6 0.4 0.4 1.2 3.1 0.3 0.4 0.4 0.2 0.0 1.0 2.9 9.5 0.9 0.2 37.9 1.9 2.7 0.4 12.3 0.2 0.2 0.2 2.0 0.1 2.6 0.2 0.3 7.0 0.5 1.5 0.8 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.0 0.5 0.0 0.0 0.0 2.3 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 0.0 0.0 0.5 0.0 0.0 0.1 5.9 0.0 0.0 22.7 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 4.8 0.2 2.9 1.3 3.6 0.3 0.4 9.5 0.2 0.0 0.0 0.0 0.1 1.8 0.0 0.3 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.1 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.7 8.6 0.0 40.5 0.0 0.0 0.0 0.0 0.0 13.8 0.0 0.0 0.0 1.7 2.9 3.9 0.6 0.1 0.0 0.0 0.1 OCLN PPP1R115 ENSG00000197822 Occludin Q16625 5 69492292-69558104 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 58.1" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 101.3;Urothelial cells: 183.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 21.3;CAPAN-2: 28.4;HaCaT: 22.9;MCF7: 22.6;RPTEC TERT1: 17.7;RT4: 19.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005933, CAB013075, CAB068212, CAB068213, CAB068214" Enhanced Supported "Plasma membrane,Cell Junctions" "Intracellular and membrane" NA NA "Plasma membrane, Cell Junctions" "CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520" "unprognostic (2.28e-1)" "unprognostic (1.88e-1)" "unprognostic (2.50e-2)" "unprognostic (9.94e-2)" "unprognostic (3.65e-1)" "unprognostic (1.39e-1)" "unprognostic (2.24e-1)" "unprognostic (1.08e-2)" "unprognostic (8.25e-2)" "unprognostic (8.20e-2)" "unprognostic (2.58e-2)" "unprognostic (3.48e-1)" "prognostic favorable (6.59e-11)" "unprognostic (2.83e-1)" "unprognostic (4.01e-1)" "unprognostic (1.33e-1)" "unprognostic (3.35e-1)" 1.2 0.8 3.4 3.8 3.7 0.5 7.6 3.9 2.9 4.3 15.5 3.2 21.9 10.2 1.7 7.4 10.6 7.9 17.1 1.1 4.0 2.9 15.3 31.7 29.2 0.4 4.0 1.7 2.3 33.2 12.0 3.2 9.0 6.7 5.7 10.9 7.7 7.1 25.0 0.5 8.7 24.5 1.2 3.8 2.1 15.1 2.0 1.5 0.4 58.1 9.8 8.6 5.0 6.5 1.2 1.2 1.8 0.3 2.0 0.9 0.1 15.4 6.2 0.1 0.5 0.2 0.4 12.5 0.0 1.5 2.1 3.1 21.3 28.4 0.1 5.4 0.3 7.8 22.9 6.3 3.0 5.8 0.1 11.1 1.2 0.2 6.5 0.1 0.5 1.6 0.0 3.2 4.8 0.2 1.1 1.2 2.1 0.0 0.1 0.0 22.6 0.6 0.4 2.4 6.8 2.6 0.0 4.7 0.5 17.7 19.3 2.1 1.0 0.1 16.9 0.2 4.4 9.5 1.9 0.2 0.1 6.4 1.3 1.5 0.3 0.1 0.1 0.1 0.1 0.1 0.8 0.3 0.7 0.8 0.2 0.2 0.8 0.9 0.3 0.1 1.2 0.7 0.9 1.8 2.0 0.2 1.2 0.4 0.1 3.4 3.7 3.9 2.9 4.0 2.9 4.0 1.7 6.7 1.5 101.3 47.6 3.2 51.5 3.3 6.0 1.3 56.0 48.2 55.7 24.4 13.7 26.5 8.3 49.2 2.0 5.3 55.1 0.0 52.8 1.2 3.2 76.5 2.3 42.9 2.6 6.4 25.2 16.0 25.3 1.1 2.8 2.6 1.7 5.4 35.4 3.5 63.1 47.2 1.4 11.3 6.2 12.9 2.7 4.2 7.8 13.6 13.7 4.9 33.9 183.7 OCM OCM1 ENSG00000122543 Oncomodulin P0CE72 7 5879827-5886362 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 5.7;brain: 9.5;lymphoid tissue: 5.5" "Cell type enhanced" "Detected in some" 13 "Early spermatids: 1.7;Late spermatids: 1.8;Spermatogonia: 1.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 5.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.1;PC-3: 1.9;THP-1: 1.5;U-937: 2.2" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " "unprognostic (1.79e-2)" "unprognostic (2.55e-2)" "unprognostic (3.97e-1)" "unprognostic (1.50e-1)" "unprognostic (5.39e-2)" "unprognostic (1.31e-2)" "unprognostic (2.30e-2)" "unprognostic (7.62e-3)" "unprognostic (2.47e-1)" "unprognostic (1.52e-1)" "unprognostic (1.92e-3)" "unprognostic (6.13e-2)" "unprognostic (2.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.02e-1)" "unprognostic (3.23e-1)" "unprognostic (3.90e-4)" 0.1 0.5 9.5 0.7 1.7 1.8 1.6 3.1 1.4 0.2 0.5 0.0 0.2 2.7 0.3 0.3 0.5 0.0 2.0 1.8 0.3 0.1 0.1 5.5 0.9 0.5 0.3 0.0 0.2 0.0 0.2 0.6 0.9 0.8 0.0 2.0 0.7 0.2 0.8 1.4 0.1 2.3 0.6 2.3 0.3 0.1 2.1 0.1 2.0 0.8 0.0 5.7 1.3 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.8 0.4 0.6 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.0 0.5 0.1 0.0 0.0 1.5 0.0 0.0 0.2 0.5 0.4 0.3 0.3 0.1 0.0 2.2 0.0 0.0 0.8 2.0 1.1 0.5 0.4 0.9 2.8 0.8 0.1 2.1 3.7 1.0 1.6 0.0 0.4 0.0 5.7 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.6 0.6 1.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 OCM2 ENSG00000135175 "Oncomodulin 2" P0CE71 7 97984684-97991169 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in single" "testis: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 17 "WM-115: 1.7" "HPA046422, HPA052483" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046422: AB_2679659, HPA052483: " 0.0 0.0 0.4 0.0 0.1 0.0 0.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.1 0.4 0.1 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ODC1 ODC ENSG00000115758 "Ornithine decarboxylase 1" P11926 2 10439968-10448504 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Polyamine biosynthesis" "Decarboxylase, Lyase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Early spermatids: 459.5;Late spermatids: 626.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001536, CAB035996" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB035996: , HPA001536: AB_1079521" "unprognostic (2.33e-1)" "unprognostic (3.41e-1)" "unprognostic (7.25e-3)" "unprognostic (5.21e-3)" "unprognostic (4.22e-2)" "unprognostic (2.70e-1)" "prognostic unfavorable (3.07e-5)" "unprognostic (3.06e-2)" "unprognostic (4.18e-2)" "unprognostic (6.27e-2)" "unprognostic (3.04e-1)" "unprognostic (6.65e-2)" "unprognostic (1.67e-3)" "unprognostic (1.18e-1)" "unprognostic (1.05e-1)" "unprognostic (2.26e-2)" "unprognostic (5.86e-2)" 13.2 8.2 11.6 33.5 11.1 41.8 9.1 7.2 11.8 11.7 17.4 11.5 33.8 8.6 22.9 21.6 16.5 16.5 30.0 33.8 9.7 10.6 31.5 48.7 14.2 42.3 11.3 6.5 29.2 48.7 13.4 35.4 6.9 11.2 26.3 20.7 18.2 11.0 27.2 64.2 9.6 14.9 26.2 10.2 20.4 19.2 54.6 6.3 31.0 16.4 19.8 39.6 16.1 14.6 13.4 10.8 2.4 2.4 1.2 4.4 3.0 19.0 15.3 21.3 25.2 3.8 11.4 49.4 27.6 13.6 26.1 12.1 81.2 8.9 100.7 13.8 16.8 25.2 3.5 65.2 31.3 31.8 38.3 27.2 46.0 26.3 49.5 30.9 77.6 11.0 7.6 8.5 59.0 74.1 13.5 20.9 28.1 76.4 32.8 14.4 12.5 76.8 30.6 38.8 26.5 49.9 54.9 66.9 67.9 15.8 14.0 29.8 25.3 34.6 10.6 13.9 17.1 7.1 34.8 14.6 21.2 43.7 27.3 59.1 15.3 46.3 91.6 19.0 51.5 13.0 0.0 1.3 2.4 2.7 2.4 3.2 13.4 3.8 4.4 3.0 11.0 2.7 4.3 0.5 1.2 1.5 10.8 3.8 3.0 11.6 11.1 7.2 11.8 9.7 10.6 11.3 6.5 11.2 6.3 41.7 217.2 112.6 112.8 51.5 34.5 48.8 71.4 25.4 36.4 38.4 29.5 1.0 61.3 55.5 459.5 35.3 38.6 0.0 23.5 53.1 21.2 276.8 57.7 46.1 43.4 6.4 260.2 11.6 30.9 626.4 14.4 29.0 21.9 12.6 143.2 85.1 24.6 48.9 10.6 101.8 62.6 0.0 40.8 91.4 74.0 76.5 2.9 37.6 120.9 94.9 ODR4 "C1orf27, FLJ20505, odr-4, TTG1" ENSG00000157181 "Odr-4 GPCR localization factor homolog" Q5SWX8 1 186375838-186421378 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Alveolar cells type 2: 28.6;Ciliated cells: 28.1;Club cells: 54.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015988, HPA031352" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA015988: AB_1845644, HPA031352: AB_2673838" "unprognostic (1.19e-2)" "unprognostic (4.23e-2)" "unprognostic (1.12e-2)" "unprognostic (3.07e-2)" "unprognostic (1.08e-1)" "unprognostic (1.30e-2)" "unprognostic (2.11e-1)" "unprognostic (8.57e-2)" "unprognostic (8.11e-3)" "prognostic favorable (9.92e-4)" "unprognostic (1.15e-2)" "unprognostic (9.85e-2)" "unprognostic (2.18e-2)" "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "unprognostic (1.03e-2)" "unprognostic (4.20e-2)" 11.9 15.9 18.2 7.0 22.9 12.2 13.7 27.7 18.7 13.9 10.3 11.4 16.2 12.5 9.6 16.6 9.5 9.1 10.3 11.8 14.3 11.3 16.1 20.0 10.4 6.1 21.9 14.0 12.1 26.5 44.8 26.5 13.4 16.0 16.1 12.8 9.7 18.3 15.3 10.3 9.5 14.8 9.0 21.3 10.1 12.8 8.1 19.1 9.0 19.0 10.1 6.9 10.4 9.7 4.1 8.6 4.4 11.8 10.6 6.2 4.6 7.5 8.5 9.5 7.5 11.6 11.1 18.0 12.4 7.9 8.1 8.0 16.7 17.5 5.4 14.8 6.1 7.3 19.5 6.9 6.6 7.8 4.7 7.1 5.0 10.9 9.5 10.7 8.3 6.3 8.4 13.5 9.4 15.2 8.5 8.6 5.6 18.9 11.0 9.8 8.0 5.9 8.2 13.1 29.4 2.9 6.7 6.4 14.8 16.0 7.7 6.8 10.6 9.4 20.3 14.4 17.5 17.7 7.2 7.9 11.3 7.1 7.8 11.5 13.4 8.1 8.4 6.3 4.5 10.2 1.5 10.5 2.7 3.8 10.0 5.5 4.1 4.8 5.0 8.6 3.1 6.0 4.6 4.4 10.6 11.8 5.4 6.2 4.6 18.2 22.9 27.7 18.7 14.3 11.3 21.9 14.0 16.0 19.1 26.8 28.6 0.0 0.0 0.0 0.0 0.0 0.0 28.1 54.6 24.4 0.0 20.7 8.3 18.4 0.0 0.0 0.0 0.0 22.2 19.9 0.0 0.0 11.6 0.0 13.7 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 11.8 0.0 0.0 21.7 0.0 0.0 11.3 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 OGT "FLJ23071, HRNT1, MGC22921, O-GLCNAC, OGT1" ENSG00000147162 "O-linked N-acetylglucosamine (GlcNAc) transferase" O15294 X 71533083-71575897 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Apoptosis, Biological rhythms, Host-virus interaction, Ubl conjugation pathway" "Chromatin regulator, Glycosyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030751, HPA030752, HPA030753, HPA030754, CAB034099" Approved Supported "Nucleoplasm,Plasma membrane" Yes No Nucleoplasm "Plasma membrane" "CAB034099: AB_2157067, HPA030751: AB_10600217, HPA030752: AB_10601445, HPA030753: AB_2673594, HPA030754: AB_2673595" "unprognostic (1.37e-1)" "unprognostic (2.20e-1)" "unprognostic (2.32e-2)" "prognostic unfavorable (8.33e-4)" "unprognostic (3.40e-2)" "prognostic favorable (1.97e-4)" "unprognostic (9.56e-3)" "unprognostic (1.96e-3)" "unprognostic (5.58e-2)" "unprognostic (2.29e-1)" "unprognostic (1.06e-1)" "unprognostic (9.74e-3)" "prognostic unfavorable (2.36e-6)" "unprognostic (2.99e-3)" "unprognostic (2.28e-1)" "unprognostic (8.03e-3)" "prognostic favorable (6.85e-7)" 26.1 24.0 33.3 39.7 36.6 38.7 33.7 75.7 43.8 25.0 23.0 22.0 31.1 22.5 36.7 48.3 24.3 33.4 21.2 25.1 29.3 15.4 27.4 20.3 31.0 47.9 30.2 25.6 42.8 46.1 26.5 34.5 19.5 26.6 34.2 30.3 29.9 35.9 30.9 35.0 45.4 38.4 31.1 32.3 56.7 28.2 11.8 36.6 35.7 34.1 27.6 41.4 24.9 31.0 9.7 7.6 3.2 7.2 12.5 9.9 6.0 14.2 13.3 17.3 15.2 18.7 17.3 11.7 10.9 19.8 11.9 18.3 14.0 16.4 17.0 7.7 13.4 12.4 17.8 18.9 10.7 14.7 14.5 19.4 10.7 31.9 10.0 14.2 22.0 17.8 16.5 21.8 13.0 24.6 20.6 11.1 36.5 10.8 59.1 11.3 12.1 16.9 26.5 11.5 12.7 18.3 16.8 19.5 21.7 18.4 16.5 8.9 7.8 17.0 11.3 10.5 13.7 8.3 15.0 12.8 12.9 10.5 13.4 6.3 16.1 11.6 20.4 9.1 23.2 7.8 3.2 5.3 2.3 9.9 7.2 9.0 9.7 8.3 8.0 7.5 8.5 9.7 9.5 2.4 12.5 6.5 7.6 7.6 6.0 33.3 36.6 75.7 43.8 29.3 15.4 30.2 25.6 26.6 36.6 32.8 80.7 38.6 31.8 78.3 24.7 38.6 20.4 20.1 31.8 47.1 7.9 11.8 8.3 11.5 1.7 42.7 29.0 46.7 12.1 7.0 45.0 42.9 26.6 24.9 14.0 38.1 33.6 45.4 64.9 1.8 49.5 36.1 33.7 15.4 36.2 13.8 15.0 31.6 28.0 12.2 23.2 32.3 32.5 1.8 6.0 73.5 9.2 59.0 30.2 38.6 OLIG2 "BHLHB1, bHLHe19, OLIGO2, PRKCBP2, RACK17" ENSG00000205927 "Oligodendrocyte transcription factor 2" Q13516 21 33025845-33029196 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Cancer-related genes, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "brain: 66.2" "Not detected" "Not detected" "Cancer enriched" "Detected in some" 52 "glioma: 46.9" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "eosinophil: 15.4" "Lineage enriched" "Detected in single" 154 "granulocytes: 15.4" "Cell line enhanced" "Detected in some" "HMC-1: 30.0;NB-4: 21.7;THP-1: 18.8;WM-115: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003254, CAB019381" Enhanced Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB019381: , HPA003254: AB_1854795" "unprognostic (5.14e-1)" "unprognostic (4.56e-1)" "unprognostic (1.44e-2)" "unprognostic (8.27e-2)" "unprognostic (3.24e-2)" "unprognostic (4.34e-2)" "unprognostic (4.81e-2)" "unprognostic (5.41e-2)" "unprognostic (1.39e-1)" "unprognostic (5.78e-5)" "unprognostic (2.76e-1)" 1.3 1.3 24.1 1.4 19.1 1.4 1.3 4.2 66.2 1.3 1.3 41.4 0.0 1.7 1.3 1.3 1.3 1.3 1.3 1.3 23.6 15.6 1.3 1.3 1.3 1.3 20.9 15.5 1.3 1.3 1.3 0.0 1.3 17.1 1.3 1.3 0.0 1.3 1.3 1.3 1.3 1.5 1.3 16.8 1.3 1.4 1.3 16.6 0.0 1.3 0.0 1.3 1.4 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.0 0.0 0.0 0.6 4.3 0.0 0.0 0.0 0.8 30.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 21.7 1.9 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 18.8 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.8 0.0 6.1 1.8 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.1 19.1 4.2 27.6 23.6 15.6 20.9 15.5 17.1 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 OPHN1 "ARHGAP41, MRX60, OPN1" ENSG00000079482 "Oligophrenin 1" O60890 X 68042344-68433913 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Endocytosis, Neurogenesis" "GTPase activation" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Syncytiotrophoblasts: 56.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002919 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA002919: AB_1079526" "unprognostic (1.21e-1)" "unprognostic (3.21e-2)" "unprognostic (1.96e-1)" "unprognostic (7.31e-2)" "unprognostic (3.85e-3)" "unprognostic (4.32e-2)" "unprognostic (3.52e-2)" "unprognostic (3.09e-3)" "unprognostic (2.22e-1)" "unprognostic (6.62e-2)" "unprognostic (4.37e-2)" "unprognostic (2.30e-1)" "unprognostic (2.21e-4)" "unprognostic (1.98e-1)" "unprognostic (1.29e-2)" "unprognostic (2.08e-3)" "unprognostic (2.64e-3)" 5.8 8.2 21.9 2.4 22.6 3.6 7.1 12.3 21.6 9.9 4.9 10.7 3.2 3.5 9.7 4.8 6.1 5.3 4.5 4.1 19.5 9.7 7.0 1.7 6.6 2.0 9.6 12.2 7.1 4.0 6.6 4.8 20.7 9.1 16.2 5.1 7.9 7.2 8.0 7.8 8.6 4.1 6.3 6.2 2.9 5.9 2.9 12.4 0.1 7.2 2.0 2.3 3.9 6.2 2.7 3.3 4.1 1.7 1.7 1.2 0.3 15.1 3.8 2.4 5.9 5.5 5.7 3.9 2.8 3.9 5.3 6.4 2.4 3.1 0.7 10.8 3.4 2.4 4.1 2.1 1.2 8.2 0.4 1.5 3.2 4.3 2.4 1.8 0.8 3.8 3.3 3.9 4.9 4.8 8.9 4.3 0.6 2.1 1.4 3.1 7.8 0.5 0.8 4.6 7.6 3.2 0.4 4.8 0.7 6.9 5.9 0.9 2.3 5.5 7.0 12.4 5.9 4.7 1.3 4.7 3.6 5.8 12.7 3.6 2.1 2.5 0.5 2.8 1.9 2.6 1.1 1.7 0.6 1.2 0.9 1.0 1.3 1.0 0.8 0.7 2.7 1.1 1.2 4.1 1.7 1.2 3.3 0.7 0.3 21.9 22.6 12.3 18.6 19.5 9.7 9.6 12.2 9.1 12.4 14.9 13.4 0.0 4.9 2.9 5.3 3.1 2.5 17.4 7.9 17.4 5.9 18.1 0.0 0.9 1.6 4.5 3.4 0.0 0.7 9.5 11.0 11.1 8.1 0.0 3.9 0.0 4.1 3.7 1.9 0.2 19.5 6.3 8.5 0.0 2.8 18.4 1.0 3.2 11.3 1.6 5.2 0.0 5.1 0.2 1.3 4.4 56.0 0.0 3.4 3.1 OR6B2 OR6B2P ENSG00000182083 "Olfactory receptor family 6 subfamily B member 2" Q6IFH4 2 240028965-240030456 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MCF7: 1.5" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6B3 "OR6B3P, OR6B3Q" ENSG00000178586 "Olfactory receptor family 6 subfamily B member 3" Q8NGW1 2 240045077-240047027 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Group enriched" "Detected in some" 6 "brain: 1.6;epididymis: 6.5;testis: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HaCaT: 1.2" HPA047529 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA047529: AB_2680077" 0.1 0.0 0.8 0.0 0.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.8 0.3 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 2.3 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OR6C6 ENSG00000188324 "Olfactory receptor family 6 subfamily C member 6" A6NF89 12 55293988-55296569 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "blood: 2.3;skin 1: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HeLa: 1.1;MCF7: 1.6;THP-1: 1.0" HPA051090 Uncertain Approved "Lipid droplets,Plasma membrane" NA NA "Lipid droplets, Plasma membrane" "HPA051090: AB_2681341" 0.0 0.0 0.0 0.4 0.1 1.1 0.1 0.1 0.2 0.5 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.5 1.7 0.0 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 1.1 1.0 2.3 0.5 0.5 0.6 0.1 0.0 0.6 0.0 0.3 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.4 0.0 0.0 0.4 0.0 0.4 0.0 0.5 0.0 0.0 1.1 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.5 0.8 0.0 1.6 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.0 0.0 0.1 0.2 1.0 0.0 0.0 0.3 0.0 0.3 0.2 0.2 0.0 0.0 0.5 0.2 2.3 0.5 0.9 0.6 0.1 0.3 0.6 0.5 0.4 0.1 1.1 0.5 0.6 1.8 0.5 0.3 1.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSGEP "GCPL1, KAE1, OSGEP1, PRSMG1, TCS3" ENSG00000092094 "O-sialoglycoprotein endopeptidase" Q9NPF4 14 20446411-20455105 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "tRNA processing" "Acyltransferase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039751 Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA039751: AB_10794754" "prognostic favorable (1.48e-4)" "unprognostic (4.15e-3)" "unprognostic (1.29e-1)" "unprognostic (4.33e-3)" "unprognostic (1.54e-2)" "unprognostic (3.95e-2)" "unprognostic (5.54e-3)" "unprognostic (2.80e-3)" "unprognostic (2.98e-1)" "unprognostic (1.05e-1)" "unprognostic (3.35e-3)" "unprognostic (1.22e-1)" "prognostic unfavorable (4.64e-6)" "unprognostic (4.83e-2)" "unprognostic (1.86e-2)" "unprognostic (2.53e-2)" "unprognostic (9.91e-2)" 11.2 14.2 13.2 13.1 14.5 10.7 14.4 21.3 18.3 14.3 15.6 18.6 11.6 8.8 16.0 19.2 12.9 13.1 13.6 15.8 13.4 10.2 12.3 22.2 12.4 16.9 13.4 12.5 12.4 12.4 10.6 20.8 13.6 15.5 10.8 14.0 14.5 12.4 18.6 19.6 9.9 12.4 16.8 12.3 18.8 13.6 5.7 15.2 16.2 15.7 9.6 18.7 16.6 11.0 24.5 28.8 23.4 19.1 13.0 14.2 15.7 6.3 10.2 3.3 10.0 5.9 4.0 10.4 5.0 6.5 12.7 12.3 14.0 7.5 13.2 6.5 6.3 5.5 5.5 10.2 10.0 8.0 10.4 13.0 8.3 8.6 18.0 4.3 14.3 11.9 3.1 3.0 15.2 8.1 2.7 8.3 12.0 8.0 7.6 9.9 11.8 14.0 6.2 5.1 18.3 20.3 22.3 6.3 7.4 7.2 7.2 13.2 2.6 8.8 9.3 6.7 2.0 6.2 13.6 3.8 5.3 13.0 6.7 5.9 2.3 12.3 18.0 3.3 22.3 6.4 5.1 19.1 23.4 13.7 17.6 11.9 20.5 14.2 12.0 28.8 24.5 11.3 12.9 8.7 13.0 13.6 12.4 12.9 15.7 13.2 14.5 21.3 18.3 13.4 10.2 13.4 12.5 15.5 15.2 32.8 30.4 31.8 18.6 10.2 35.1 14.5 17.8 25.4 31.8 22.7 35.3 58.5 29.9 21.8 2.7 18.3 27.1 0.0 25.9 38.4 17.9 13.7 24.4 16.6 56.2 9.5 25.8 22.7 27.5 2.5 17.8 30.6 20.3 17.2 21.1 28.4 19.2 31.5 20.1 30.7 52.1 12.9 23.0 5.1 15.6 10.0 38.6 22.5 29.5 13.6 OSR2 FLJ90037 ENSG00000164920 "Odd-skipped related transciption factor 2" Q8N2R0 8 98944403-98952104 "Predicted intracellular proteins, Transcription factors" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "endometrium 1: 47.9" "Group enriched" "Detected in many" 7 "Leydig cells: 726.0;Peritubular cells: 712.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "eosinophil: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 17 "ASC diff: 113.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA052425, HPA063486" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA052425: AB_2681826, HPA063486: AB_2685022" "unprognostic (1.72e-1)" "unprognostic (1.92e-3)" "unprognostic (1.03e-1)" "unprognostic (5.94e-2)" "unprognostic (1.57e-1)" "prognostic favorable (2.44e-5)" "unprognostic (1.70e-2)" "unprognostic (1.15e-2)" "unprognostic (1.89e-2)" "unprognostic (3.73e-3)" "unprognostic (3.01e-2)" "unprognostic (6.19e-2)" "unprognostic (1.57e-7)" "unprognostic (1.37e-2)" "unprognostic (2.39e-1)" "unprognostic (2.56e-4)" "unprognostic (8.54e-3)" 10.6 2.4 0.5 4.2 0.7 0.0 10.9 0.6 0.5 41.7 3.1 0.5 10.2 0.0 47.9 18.9 4.6 37.6 7.3 1.9 0.5 0.0 1.3 0.5 1.3 2.0 0.8 0.5 36.3 1.4 0.6 1.0 7.7 0.7 20.9 0.8 0.5 1.4 23.7 3.5 6.7 7.4 15.3 0.8 0.5 1.3 27.0 0.6 0.8 1.8 1.8 3.0 6.7 24.1 0.0 0.0 1.0 0.0 0.0 0.6 0.6 6.3 0.9 0.0 0.8 113.9 3.6 0.9 3.5 6.7 2.8 2.8 0.6 0.8 0.0 0.6 5.3 0.1 2.5 0.5 0.9 1.4 0.3 2.6 0.1 0.6 0.3 1.8 0.1 0.1 3.5 2.0 0.4 0.3 0.1 0.0 0.9 0.7 0.0 0.1 2.8 0.5 1.1 0.0 0.5 0.5 2.7 0.3 0.2 0.2 0.5 0.2 0.0 0.3 1.5 0.0 0.0 0.8 1.4 0.0 0.4 0.0 2.8 0.2 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.5 0.7 0.6 0.5 0.5 0.0 0.8 0.5 0.7 0.6 0.0 0.0 0.0 4.2 12.6 0.0 0.6 0.0 0.0 2.3 0.0 0.0 11.1 0.0 0.0 5.0 0.6 1.3 0.0 0.0 96.9 87.0 2.9 0.0 0.0 8.4 0.0 0.0 0.0 0.8 6.4 726.0 1.5 15.1 0.0 1.7 0.0 0.0 0.0 712.8 0.0 0.0 32.3 19.6 3.4 4.7 8.0 20.3 0.0 1.2 0.9 OTULIN "FAM105B, FLJ34884" ENSG00000154124 "OTU deubiquitinase with linear linkage specificity" Q96BN8 5 14664664-14699711 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Immunity, Innate immunity, Ubl conjugation pathway, Wnt signaling pathway" "Hydrolase, Protease, Thiol protease" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051074 Uncertain Approved "Plasma membrane,Mitochondria" NA NA Mitochondria "Plasma membrane" "HPA051074: AB_2681334" "unprognostic (4.81e-3)" "unprognostic (1.11e-1)" "unprognostic (4.00e-2)" "unprognostic (1.19e-2)" "unprognostic (7.48e-2)" "unprognostic (1.91e-2)" "unprognostic (7.94e-3)" "unprognostic (1.43e-1)" "unprognostic (2.48e-2)" "unprognostic (9.55e-2)" "unprognostic (1.02e-1)" "unprognostic (7.13e-2)" "prognostic unfavorable (2.59e-7)" "unprognostic (2.92e-2)" "unprognostic (2.28e-2)" "unprognostic (1.60e-1)" "unprognostic (5.02e-2)" 10.0 7.4 5.9 22.6 7.8 32.3 8.4 7.2 6.6 8.2 9.3 8.3 8.9 10.7 9.5 7.7 13.8 6.1 10.8 15.5 6.7 4.9 8.5 19.5 11.1 16.0 9.6 2.8 9.1 12.2 7.5 9.8 11.8 7.0 11.1 7.0 7.7 10.6 10.8 16.5 18.1 11.7 8.1 10.5 12.5 7.1 11.5 7.4 15.0 7.8 9.7 19.3 8.5 15.8 3.4 2.9 3.1 3.0 1.0 4.6 0.9 6.4 7.5 7.5 8.5 7.0 7.3 8.3 6.5 4.6 9.3 7.0 10.1 4.8 11.6 12.8 4.2 13.4 7.4 9.3 8.5 6.4 20.0 7.7 8.3 23.9 5.4 6.0 7.9 14.3 4.1 10.5 7.6 6.5 5.1 7.8 9.8 8.2 18.6 6.6 4.0 7.8 6.9 4.6 6.8 8.0 12.1 6.8 4.6 6.0 6.7 3.4 5.6 23.1 5.2 5.0 9.6 5.7 9.1 7.2 12.1 13.7 9.0 8.5 8.4 12.7 13.2 6.9 15.1 6.2 0.4 2.0 3.1 1.0 2.2 3.0 0.9 2.5 3.4 2.9 3.4 1.8 3.9 2.2 1.0 3.0 2.5 4.6 0.9 5.9 7.8 7.2 6.6 6.7 4.9 9.6 2.8 7.0 7.4 3.0 8.6 13.4 20.2 0.0 10.9 13.4 15.3 9.4 7.9 5.2 13.7 13.2 6.6 4.2 7.3 8.7 13.9 0.0 5.0 8.6 4.9 19.7 10.3 32.7 12.3 7.9 9.1 8.0 11.8 2.5 9.8 10.6 0.0 13.6 11.6 13.0 7.1 8.4 6.0 8.9 32.3 0.0 6.2 23.8 30.4 0.0 11.9 15.0 8.9 19.3 PACSIN3 SDPIII ENSG00000165912 "Protein kinase C and casein kinase substrate in neurons 3" Q9UKS6 11 47177525-47186443 "Plasma proteins, Predicted intracellular proteins" Endocytosis "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 40.6;skeletal muscle: 121.6;tongue: 44.6" "Cell type enhanced" "Detected in many" 7 "Cardiomyocytes: 102.9;Muller glia cells: 62.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "T-47d: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA039480, HPA043904" Approved Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039480: AB_2676531, HPA043904: AB_2678725" "unprognostic (1.75e-1)" "unprognostic (1.11e-1)" "unprognostic (1.73e-2)" "unprognostic (3.10e-2)" "unprognostic (1.21e-1)" "unprognostic (6.89e-2)" "unprognostic (4.66e-2)" "unprognostic (8.17e-2)" "unprognostic (2.85e-1)" "prognostic favorable (2.09e-4)" "unprognostic (3.86e-3)" "unprognostic (1.26e-1)" "unprognostic (2.75e-2)" "unprognostic (9.72e-2)" "unprognostic (1.92e-1)" "unprognostic (1.29e-1)" "unprognostic (4.76e-2)" 4.1 17.0 3.9 2.2 5.7 0.4 4.3 3.5 4.7 6.5 8.5 8.6 7.1 1.6 6.7 7.6 12.6 4.8 5.8 40.6 4.0 2.4 2.9 10.0 3.9 0.8 7.6 3.6 6.3 14.6 4.8 1.0 8.0 4.4 8.6 1.1 4.6 11.3 6.7 121.6 11.9 1.9 7.4 8.3 1.5 6.0 1.6 6.5 0.3 8.5 44.6 7.1 6.4 5.7 0.0 0.1 0.0 0.9 0.0 0.2 0.9 16.7 8.4 3.9 16.9 3.4 3.4 19.0 5.3 7.6 11.1 6.2 12.5 2.4 0.1 1.6 2.9 7.3 27.7 7.7 12.7 4.4 2.6 13.2 2.6 32.0 28.9 6.7 0.5 2.6 9.5 17.2 5.8 9.3 8.9 4.9 4.5 5.6 0.2 4.5 33.3 0.3 12.4 4.8 13.6 16.9 10.3 14.7 2.7 4.6 16.0 0.1 13.3 8.3 5.9 7.7 8.6 41.9 2.2 2.3 19.3 19.4 2.4 14.4 2.9 1.3 1.5 6.3 5.9 9.9 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 3.9 5.7 3.5 4.7 4.0 2.4 7.6 3.6 4.4 6.5 0.0 7.2 0.0 23.5 31.9 0.2 102.9 25.5 1.4 7.9 5.2 0.0 27.6 8.3 35.7 0.0 5.9 0.0 0.0 13.1 53.0 16.3 28.4 0.0 29.9 5.0 0.0 0.0 9.2 1.8 0.0 15.0 1.9 16.9 0.0 0.0 62.8 30.4 0.0 11.7 18.2 2.3 32.3 27.0 0.2 10.2 26.1 15.3 0.0 0.2 20.9 PAG1 "CBP, PAG" ENSG00000076641 "Phosphoprotein membrane anchor with glycosphingolipid microdomains 1" Q9NWQ8 8 80967810-81112068 "Predicted intracellular proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "granulocytes: 124.4;Melanocytes: 133.3;Sertoli cells: 122.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 19.6;HMC-1: 26.2;SK-MEL-30: 20.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001632, HPA066527" Enhanced Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001632: AB_1079557, HPA066527: AB_2685685" "unprognostic (8.30e-2)" "unprognostic (3.84e-2)" "unprognostic (5.89e-2)" "unprognostic (4.79e-2)" "unprognostic (1.55e-1)" "unprognostic (6.91e-2)" "unprognostic (3.71e-3)" "unprognostic (3.84e-2)" "unprognostic (3.73e-2)" "unprognostic (4.52e-2)" "unprognostic (2.93e-1)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.24e-6)" "unprognostic (2.12e-1)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.80e-1)" "unprognostic (1.94e-3)" 5.5 3.8 5.3 20.2 6.1 12.2 4.1 22.3 7.6 2.7 12.3 5.4 2.3 8.6 3.5 2.8 2.9 3.2 12.1 5.5 6.4 4.3 3.2 6.4 20.3 21.2 7.5 4.2 2.6 16.6 0.8 4.2 17.7 7.7 3.9 10.1 10.6 5.0 4.4 3.8 6.2 14.9 3.5 9.9 12.1 5.1 1.4 7.4 15.2 3.4 0.4 15.3 6.2 4.4 2.2 4.1 10.9 13.3 1.6 6.8 2.4 0.0 0.0 2.7 0.1 5.2 5.0 0.1 1.1 8.8 0.5 1.1 0.1 0.0 19.6 0.1 0.3 4.4 0.8 0.0 1.0 0.5 0.5 2.5 11.4 0.2 0.0 5.3 1.8 26.2 2.4 0.7 5.1 4.8 0.5 0.0 3.5 0.1 0.1 8.4 0.1 6.8 0.1 0.2 4.4 0.8 5.2 1.4 0.1 0.9 4.2 0.5 1.0 0.0 0.2 20.3 0.5 0.6 1.9 0.1 0.6 0.3 0.0 0.6 3.2 0.8 7.0 5.6 6.5 4.8 10.9 1.4 1.9 2.6 6.3 6.5 2.2 6.6 4.6 1.8 1.4 5.4 4.0 2.3 1.6 13.3 4.1 6.8 2.4 5.3 6.1 22.3 7.6 6.4 4.3 7.5 4.2 7.7 7.4 0.0 11.3 16.6 3.6 27.9 36.6 12.1 12.7 0.0 18.2 3.5 0.0 0.5 0.0 2.2 3.2 10.5 93.4 0.0 5.7 19.0 22.5 7.3 124.4 8.1 23.3 60.4 3.5 17.2 58.9 1.5 2.3 68.1 133.3 38.7 19.5 45.0 2.3 48.0 7.4 0.3 3.0 122.9 31.9 0.2 0.7 19.7 1.9 59.0 19.2 3.4 PAIP1 ENSG00000172239 "Poly(A) binding protein interacting protein 1" Q9H074 5 43526267-43557758 "Predicted intracellular proteins" "Translation regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA073653, HPA076187" Approved Enhanced "Plasma membrane,Cytosol" No No 18000 "Plasma membrane, Cytosol" "HPA073653: AB_2732234, HPA076187: AB_2686784" "unprognostic (4.70e-2)" "unprognostic (4.30e-2)" "unprognostic (5.37e-2)" "unprognostic (2.65e-2)" "unprognostic (1.62e-2)" "unprognostic (4.74e-2)" "unprognostic (1.13e-3)" "unprognostic (2.98e-1)" "unprognostic (3.17e-2)" "unprognostic (1.62e-2)" "prognostic unfavorable (4.79e-4)" "unprognostic (3.54e-1)" "unprognostic (1.73e-1)" "unprognostic (1.39e-1)" "unprognostic (1.20e-1)" "unprognostic (1.52e-1)" "unprognostic (1.30e-1)" 30.1 26.6 26.9 15.4 26.0 20.6 35.9 22.7 32.6 30.2 27.8 25.0 19.6 18.3 28.4 26.0 26.1 22.8 23.3 45.6 26.8 24.4 34.0 38.3 21.3 20.8 28.6 21.5 24.8 23.5 30.9 24.0 29.0 23.0 32.1 24.3 21.3 23.4 31.7 62.8 16.6 24.2 38.7 33.4 21.0 23.8 44.3 27.3 29.9 38.5 20.6 18.6 31.5 36.8 14.1 35.0 23.4 12.4 12.5 16.4 10.9 22.3 19.9 39.1 37.8 41.0 32.5 32.0 19.7 44.0 37.6 32.8 18.5 27.5 14.9 34.2 27.8 56.7 14.7 60.9 23.8 38.5 12.3 23.6 11.7 39.9 29.1 36.2 17.4 18.5 34.4 46.1 25.4 48.0 38.3 35.8 11.1 27.0 20.2 37.5 24.0 19.2 24.1 19.3 21.3 25.7 15.1 29.5 20.8 46.7 27.6 22.2 33.7 63.2 24.4 43.7 37.5 34.8 25.4 19.9 34.2 28.4 17.0 24.7 15.3 25.8 22.3 19.9 27.1 29.4 17.4 12.4 23.4 10.5 10.4 14.0 14.1 13.1 14.5 12.4 13.2 16.4 13.0 4.6 12.5 11.1 35.0 11.4 10.9 26.9 26.0 22.7 32.6 26.8 24.4 28.6 21.5 23.0 27.3 29.8 43.3 27.5 65.7 65.1 49.0 115.4 68.8 36.1 22.7 41.8 19.6 65.0 134.3 105.9 128.9 65.0 26.0 0.0 80.1 76.8 67.2 70.0 23.2 46.9 51.3 33.4 43.1 41.7 35.2 40.9 70.8 42.8 79.2 64.1 51.5 68.8 98.5 49.1 62.6 115.0 51.4 25.8 65.1 136.3 84.8 58.1 57.0 27.4 45.2 69.7 PAK1 ENSG00000149269 "P21 (RAC1) activated kinase 1" Q13153 11 77321707-77474635 "Enzymes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Exocytosis" "Allosteric enzyme, Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Epilepsy, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 70.0;brain: 71.4" "Cell type enhanced" "Detected in many" 4 "granulocytes: 126.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 9 "classical monocyte: 29.3;eosinophil: 45.0;intermediate monocyte: 28.7;myeloid DC: 42.3;neutrophil: 70.0;non-classical monocyte: 30.4" "Group enriched" "Detected in all" 11 "dendritic cells: 42.3;granulocytes: 70.0;monocytes: 30.4" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003565, CAB005312" Enhanced Supported Supported "Plasma membrane,Cytosol" NA NA 200000 "Plasma membrane, Cytosol" "CAB005312: AB_2160720, HPA003565: AB_1854935" "unprognostic (1.15e-2)" "unprognostic (3.23e-2)" "prognostic favorable (5.87e-4)" "unprognostic (1.30e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (6.62e-2)" "unprognostic (8.19e-3)" "unprognostic (4.84e-2)" "unprognostic (1.05e-1)" "unprognostic (1.22e-3)" "unprognostic (1.86e-2)" "unprognostic (2.76e-1)" "unprognostic (1.02e-1)" "unprognostic (6.91e-2)" "unprognostic (1.57e-1)" "unprognostic (4.00e-3)" "unprognostic (1.52e-2)" 5.4 6.0 30.5 13.8 39.5 22.9 7.8 49.1 71.4 9.8 18.2 8.4 2.3 18.2 9.1 13.3 9.9 9.8 13.2 5.3 19.0 16.9 11.3 6.0 6.9 7.5 12.8 40.6 10.4 9.2 11.8 10.8 11.9 39.2 12.2 20.2 5.4 10.4 8.8 34.0 6.7 18.9 11.6 7.8 11.7 17.1 11.1 6.6 7.6 17.7 3.9 9.4 10.5 10.4 2.7 42.3 70.0 30.4 4.3 2.4 12.2 11.4 7.7 16.8 7.6 6.8 11.5 13.4 13.1 9.4 12.4 14.7 11.0 15.3 10.2 4.8 11.3 16.2 5.9 11.7 13.8 19.7 11.8 9.4 10.8 5.2 0.7 4.5 18.2 16.0 8.5 8.4 14.6 21.7 11.0 2.9 12.0 7.1 18.0 22.6 0.8 11.6 8.4 24.7 47.4 6.6 17.8 21.7 0.4 3.1 9.5 7.2 7.1 7.0 3.0 5.5 17.3 13.4 8.3 0.2 8.3 14.4 44.3 10.9 49.6 25.5 6.8 6.9 12.2 8.9 0.3 29.3 45.0 1.9 28.7 1.5 2.7 1.4 1.8 42.3 1.9 1.3 2.4 70.0 4.3 30.4 3.6 1.1 12.2 30.5 39.5 49.1 71.4 19.0 16.9 12.8 40.6 39.2 6.6 3.0 21.5 16.1 27.9 10.5 48.2 3.1 33.1 41.5 33.0 24.4 7.9 23.0 38.1 26.3 31.5 3.0 46.3 0.0 49.4 46.4 13.1 25.6 126.2 10.9 45.2 1.6 36.2 3.1 43.9 20.0 13.3 71.3 28.7 94.6 47.0 14.0 41.8 55.2 12.4 28.6 6.7 12.9 18.2 25.6 42.1 9.2 79.4 12.2 47.1 27.2 PAK4 ENSG00000130669 "P21 (RAC1) activated kinase 4" O96013 19 39125770-39182816 "Enzymes, Predicted intracellular proteins, RAS pathway related proteins" "Apoptosis, Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 45.4;MCF7: 50.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025747, CAB044670, HPA070175, HPA072220" Uncertain Supported "Plasma membrane,Cell Junctions" NA Yes "Plasma membrane, Cell Junctions" "CAB025747: , CAB044670: AB_1854940, HPA070175: AB_2686232, HPA072220: AB_2686497" "unprognostic (1.71e-1)" "unprognostic (2.84e-1)" "unprognostic (5.86e-2)" "unprognostic (2.84e-2)" "unprognostic (1.93e-1)" "unprognostic (8.51e-2)" "unprognostic (3.56e-3)" "unprognostic (1.13e-3)" "unprognostic (3.90e-2)" "unprognostic (4.04e-2)" "unprognostic (7.29e-2)" "prognostic unfavorable (9.85e-4)" "prognostic favorable (5.29e-5)" "unprognostic (2.39e-1)" "unprognostic (7.05e-2)" "unprognostic (2.02e-1)" "unprognostic (4.85e-2)" 6.8 11.1 11.0 12.7 12.3 4.8 11.9 13.7 12.4 17.3 19.6 13.7 19.9 26.0 12.2 17.3 20.1 15.3 16.5 8.1 10.9 8.1 19.4 17.0 18.7 5.4 13.7 7.7 13.8 29.6 11.2 17.0 23.0 10.3 29.6 8.1 19.7 40.9 18.5 10.3 18.6 25.1 9.0 8.3 7.9 18.6 22.3 12.5 8.8 15.2 10.1 14.7 11.5 15.0 2.8 3.4 4.2 2.5 3.6 4.5 1.9 17.9 45.4 6.8 10.3 2.1 2.3 20.5 8.6 3.5 5.8 5.9 29.7 15.3 4.1 13.1 5.4 7.6 6.6 3.7 6.8 2.2 10.9 10.4 4.8 8.3 14.4 3.4 4.9 7.1 2.7 3.0 5.4 3.9 3.8 7.5 6.3 9.7 3.2 3.4 50.0 5.2 5.4 12.3 15.9 10.9 5.3 5.3 3.1 5.6 19.8 21.7 15.0 8.7 39.0 9.7 3.7 17.3 8.2 12.5 9.9 17.0 11.3 15.3 3.7 3.5 3.4 12.1 2.9 11.8 1.0 2.5 4.2 2.6 1.4 3.6 2.2 2.9 4.5 3.4 2.8 2.2 2.2 2.1 3.6 2.1 2.9 3.0 1.9 11.0 12.3 13.7 12.4 10.9 8.1 13.7 7.7 10.3 12.5 0.0 1.0 0.5 15.0 12.8 14.8 1.2 20.4 6.7 0.0 17.4 23.6 35.6 26.6 18.7 2.7 15.8 35.5 0.0 17.2 46.7 10.8 17.8 5.7 10.5 8.3 20.6 43.0 12.3 5.6 4.9 10.9 2.5 6.8 14.4 30.6 14.1 16.5 40.3 9.9 10.6 13.1 0.0 7.2 5.7 17.7 16.4 54.7 8.7 29.9 20.6 PALM KIAA0270 ENSG00000099864 Paralemmin O75781 19 708939-748329 "Predicted intracellular proteins" "Cell shape" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 47.6;brain: 56.5" "Cell type enhanced" "Detected in many" 7 "Distal tubular cells: 44.7;Ito cells: 46.6;Leydig cells: 44.8;Muller glia cells: 69.4;Peritubular cells: 42.5;Proximal tubular cells: 43.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "non-classical monocyte: 4.7" "Lineage enriched" "Detected in single" 35 "monocytes: 4.7" "Cell line enhanced" "Detected in many" "AN3-CA: 16.5;EFO-21: 15.3;REH: 27.2;SH-SY5Y: 17.5;U-2197: 14.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041713, HPA049578" Approved Enhanced "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041713: AB_10794305, HPA049578: AB_2680822" "unprognostic (9.08e-3)" "unprognostic (2.97e-2)" "unprognostic (2.11e-2)" "unprognostic (3.53e-3)" "unprognostic (1.61e-1)" "unprognostic (3.77e-2)" "unprognostic (1.42e-1)" "unprognostic (8.39e-2)" "unprognostic (7.62e-2)" "unprognostic (1.36e-2)" "prognostic favorable (9.81e-4)" "unprognostic (2.74e-2)" "prognostic favorable (5.44e-4)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (1.55e-2)" "unprognostic (6.00e-2)" 47.6 11.8 49.1 5.1 39.9 2.2 11.3 13.3 56.5 22.7 8.2 12.4 4.2 9.2 10.7 6.7 5.8 17.7 7.2 9.6 37.7 18.9 21.9 3.5 9.0 2.2 19.2 28.1 21.2 2.1 1.2 10.2 17.6 11.9 12.2 2.7 6.1 5.9 18.6 7.0 6.9 7.5 9.0 14.7 10.5 3.6 8.2 12.5 0.0 3.3 3.3 1.9 5.0 8.4 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.0 4.4 8.6 16.5 1.3 0.1 1.2 1.1 0.0 1.1 0.3 1.0 0.0 0.0 15.3 0.1 0.1 1.5 4.3 0.0 0.2 0.0 8.5 0.0 3.5 5.4 6.0 0.0 0.1 3.9 0.0 0.7 0.0 2.4 0.6 1.9 3.0 0.1 1.1 8.7 0.6 5.1 3.5 0.8 2.4 27.2 0.0 0.1 0.4 0.0 0.9 17.5 4.4 0.0 0.1 2.8 1.5 4.1 0.0 0.0 9.0 14.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 49.1 39.9 13.3 44.4 37.7 18.9 19.2 28.1 11.9 12.5 0.0 1.7 1.4 5.5 6.4 7.6 3.6 0.0 0.0 3.4 5.2 11.8 0.8 44.7 1.6 1.1 26.3 2.1 0.0 0.2 2.5 21.8 8.7 0.0 0.2 0.8 23.8 0.0 46.6 2.2 5.3 44.8 1.6 16.9 0.0 0.0 69.4 0.3 0.3 42.5 43.5 4.2 0.0 13.3 0.9 1.3 6.0 1.6 0.0 0.0 5.0 PAQR8 "C6orf33, LMPB1, MPRB" ENSG00000170915 "Progestin and adipoQ receptor family member 8" Q8TEZ7 6 52361421-52407777 "Predicted membrane proteins" "Differentiation, Oogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 69.2" "Cell type enhanced" "Detected in many" 11 "Enterocytes: 94.7;Mucus-secreting cells: 40.0;Paneth cells: 55.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 19.4;OE19: 41.1;SuSa: 17.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA064625 Supported "Golgi apparatus,Plasma membrane" NA NA "Plasma membrane" "Golgi apparatus" "HPA064625: AB_2685304" "prognostic favorable (4.61e-4)" "unprognostic (7.39e-3)" "unprognostic (2.77e-3)" "unprognostic (8.23e-2)" "unprognostic (4.33e-1)" "unprognostic (4.08e-3)" "unprognostic (2.66e-2)" "unprognostic (5.67e-2)" "unprognostic (6.37e-2)" "unprognostic (4.30e-3)" "unprognostic (2.10e-1)" "unprognostic (5.55e-2)" "unprognostic (8.82e-3)" "unprognostic (1.04e-1)" "unprognostic (2.12e-1)" "unprognostic (3.14e-2)" "prognostic favorable (6.40e-4)" 2.4 3.5 25.6 6.6 32.4 1.3 2.2 14.9 31.0 4.2 28.9 35.5 14.2 14.5 4.4 6.7 13.7 5.4 4.9 2.9 27.3 17.5 5.3 1.5 5.8 7.2 48.5 15.8 19.5 2.5 3.7 1.8 5.5 28.2 3.8 28.1 1.9 1.9 28.5 1.1 2.7 25.1 5.2 69.2 4.8 24.1 3.1 36.5 3.1 2.6 0.4 6.0 7.3 3.3 1.0 6.0 2.0 2.6 7.0 16.3 3.2 0.4 0.4 5.2 2.2 3.1 5.1 3.5 1.5 5.8 1.0 2.1 1.9 1.8 0.5 0.5 1.0 2.3 0.2 0.6 2.5 1.6 6.9 0.8 3.1 0.4 19.4 0.8 0.8 0.4 1.4 0.3 0.6 3.7 3.6 5.5 6.1 0.7 3.1 4.0 0.7 2.0 2.8 2.6 41.1 0.2 5.3 0.8 1.2 6.0 1.4 1.9 4.2 0.4 0.1 5.8 17.5 0.1 6.9 2.3 2.0 0.8 0.5 0.9 0.9 1.2 0.7 1.8 8.0 10.3 2.0 2.6 1.3 2.5 0.5 3.8 0.9 7.6 5.2 6.0 1.0 16.3 7.6 0.5 7.0 0.5 3.0 4.7 3.2 25.6 32.4 14.9 22.8 27.3 17.5 48.5 15.8 28.2 36.5 3.0 8.8 0.0 3.2 1.8 1.6 4.6 15.3 0.0 1.2 3.5 7.9 1.4 0.0 3.2 0.4 3.8 94.7 0.0 1.0 2.6 4.7 6.0 4.6 0.0 7.9 0.0 22.1 3.7 16.7 1.0 5.2 3.9 13.5 5.4 40.0 4.5 3.0 55.1 9.6 0.0 3.0 0.0 1.9 11.4 2.9 0.9 0.7 5.9 24.1 7.8 PARD3 "ASIP, Baz, Bazooka, PAR3, PARD3A, PPP1R118" ENSG00000148498 "Par-3 family cell polarity regulator" Q8TEW0 10 34109560-34815325 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Differentiation" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 25 "basophil: 9.0" "Lineage enriched" "Detected in single" 73 "granulocytes: 9.0" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030443 Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA030443: AB_10600926" "unprognostic (9.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.62e-1)" "unprognostic (2.83e-2)" "unprognostic (1.81e-2)" "unprognostic (3.52e-2)" "prognostic unfavorable (1.73e-5)" "unprognostic (3.48e-1)" "unprognostic (3.49e-1)" "unprognostic (8.07e-2)" "unprognostic (5.82e-3)" "unprognostic (1.28e-1)" "unprognostic (1.05e-1)" "unprognostic (1.20e-2)" "unprognostic (3.54e-1)" "unprognostic (9.20e-2)" "prognostic unfavorable (4.41e-4)" 16.4 12.9 13.8 7.0 15.8 0.3 16.8 4.4 8.3 24.8 20.3 7.4 19.7 7.1 21.4 13.6 34.5 14.7 13.2 17.1 10.7 6.3 18.0 15.9 15.2 3.0 7.8 4.3 28.4 26.2 19.0 15.8 14.4 8.8 20.5 15.3 11.7 15.5 17.3 28.3 34.4 14.9 21.1 8.7 3.3 14.2 9.1 9.2 12.8 15.6 14.6 13.4 20.7 29.5 0.0 0.0 9.0 0.1 0.0 0.0 2.1 19.3 47.1 16.0 10.8 12.0 10.3 22.9 8.8 10.6 15.6 17.6 17.2 16.5 0.1 12.8 18.4 11.8 14.1 13.6 22.8 20.3 0.1 10.2 0.0 5.9 17.6 15.3 2.1 0.0 12.4 21.9 20.5 15.5 14.4 9.8 12.7 13.0 6.1 18.7 13.5 21.8 1.5 6.7 12.0 16.7 17.4 16.2 8.4 32.4 14.9 8.2 8.3 10.4 15.0 16.3 19.8 8.3 2.5 11.3 7.9 22.9 14.6 9.2 5.0 6.2 0.0 8.5 0.0 8.6 9.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 2.1 13.8 15.8 4.4 8.3 10.7 6.3 7.8 4.3 8.8 9.2 32.8 27.0 0.0 30.8 30.2 12.2 34.3 20.4 34.8 27.3 14.0 27.5 21.2 0.0 30.4 13.4 7.7 15.1 0.0 31.0 18.3 12.5 26.7 1.1 20.2 2.9 11.1 23.1 10.4 0.3 11.2 28.1 2.1 5.0 0.0 24.6 29.8 33.8 23.0 36.0 21.0 19.8 25.8 17.0 4.2 23.4 53.8 33.5 1.3 19.5 41.6 PAWR "par-4, PAR4" ENSG00000177425 "Pro-apoptotic WT1 regulator" Q96IZ0 12 79574979-79691097 "Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "memory B-cell: 5.0;naive B-cell: 6.2;NK-cell: 2.9" "Group enriched" "Detected in many" 8 "B-cells: 6.2;NK-cells: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012640, CAB020779" Approved Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "CAB020779: , HPA012640: AB_1855748" "unprognostic (2.42e-1)" "unprognostic (5.58e-2)" "unprognostic (9.77e-3)" "unprognostic (5.39e-2)" "unprognostic (9.44e-3)" "unprognostic (4.21e-3)" "unprognostic (9.21e-2)" "unprognostic (1.37e-1)" "unprognostic (4.78e-1)" "unprognostic (3.03e-1)" "unprognostic (2.42e-3)" "unprognostic (4.97e-3)" "unprognostic (2.22e-2)" "unprognostic (2.58e-2)" "unprognostic (4.64e-1)" "unprognostic (2.22e-1)" "unprognostic (4.23e-2)" 10.3 6.1 3.4 16.1 8.9 2.1 16.4 6.2 3.3 27.4 16.6 3.8 20.1 9.4 35.0 19.3 20.8 20.4 20.2 5.6 5.5 3.3 14.4 15.5 14.6 5.0 5.7 2.6 22.1 15.1 14.6 19.0 24.8 5.3 21.8 12.6 7.9 14.3 21.1 2.7 14.5 15.0 31.5 3.6 6.1 10.8 15.4 4.9 6.7 24.5 8.4 8.6 27.5 26.2 6.2 0.3 0.5 0.0 2.9 0.4 0.1 19.8 18.5 3.3 0.1 1.7 0.7 22.2 12.7 3.7 6.4 3.9 22.8 7.6 13.2 23.6 7.0 4.6 22.1 11.6 9.5 9.3 5.4 15.6 0.0 10.6 9.8 9.2 0.2 0.3 1.6 20.3 5.1 29.1 24.1 10.7 5.5 0.7 1.8 7.0 15.1 3.1 0.0 16.1 5.7 10.2 0.0 7.6 8.5 12.3 15.0 9.7 0.0 22.7 12.1 2.0 11.7 10.8 0.1 15.7 9.8 8.8 0.3 8.4 5.9 7.5 9.7 1.6 0.0 4.2 0.5 0.0 0.1 0.1 0.0 0.0 5.0 0.3 0.2 0.3 6.2 0.4 0.4 0.5 2.9 0.0 0.2 0.0 0.1 3.4 8.9 6.2 3.3 5.5 3.3 5.7 2.6 5.3 4.9 74.5 31.8 17.5 137.7 177.7 5.8 14.9 58.6 45.5 73.9 62.8 0.0 46.7 14.9 39.3 50.0 23.5 79.7 0.0 33.3 69.4 22.7 157.7 1.1 50.5 5.6 15.9 66.0 17.8 0.6 75.0 78.6 4.6 16.9 0.0 95.3 2.4 61.3 69.1 85.6 39.3 0.9 84.1 81.4 80.9 61.3 157.1 64.3 7.2 83.0 127.7 PCDH7 "BH-Pcdh, PPP1R120" ENSG00000169851 "Protocadherin 7" O60245 4 30720415-31146805 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 66.6;Basal keratinocytes: 75.6;Cardiomyocytes: 73.6;Collecting duct cells: 61.1;Urothelial cells: 51.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HEK 293: 16.7;RH-30: 47.0;RT4: 24.8" "Low region specificity" "Detected in all" "HPA011866, HPA046521" Uncertain Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA011866: AB_1855047, HPA046521: AB_2679682" "unprognostic (1.87e-1)" "unprognostic (8.88e-2)" "unprognostic (4.48e-2)" "unprognostic (3.32e-1)" "unprognostic (1.38e-1)" "unprognostic (2.45e-1)" "unprognostic (1.04e-2)" "prognostic unfavorable (6.46e-5)" "unprognostic (1.96e-1)" "unprognostic (8.39e-2)" "unprognostic (1.02e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-4)" "prognostic unfavorable (6.42e-4)" "unprognostic (1.55e-1)" "unprognostic (7.65e-2)" "unprognostic (1.56e-2)" 2.0 3.2 11.9 4.9 11.5 0.4 3.0 1.2 25.3 23.2 18.4 1.7 34.3 3.1 15.3 22.9 13.0 8.9 7.4 16.7 13.4 11.9 2.2 1.2 2.8 1.4 8.0 11.0 4.5 1.1 0.5 0.8 0.5 11.7 9.9 7.3 6.2 1.6 32.2 0.9 10.1 5.3 23.7 5.3 15.3 14.2 1.2 4.4 0.0 3.9 1.3 1.4 20.1 7.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.4 5.6 7.8 11.7 11.5 0.0 1.4 0.0 0.7 0.3 0.7 10.2 0.0 0.0 0.0 0.0 5.8 0.5 14.7 1.3 0.0 16.7 0.0 10.6 0.0 12.1 0.2 0.0 6.8 3.4 0.3 4.2 6.9 2.8 0.0 0.0 0.0 3.4 0.0 0.0 0.0 3.4 3.5 1.5 0.0 47.0 0.0 0.3 24.8 0.3 0.1 0.1 0.4 0.5 3.3 0.7 2.6 0.0 9.5 2.4 2.6 0.0 0.0 0.0 0.0 7.4 0.0 6.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.9 11.5 1.2 24.9 13.4 11.9 8.0 11.0 11.7 4.4 0.0 0.0 0.0 66.6 75.6 29.7 73.6 0.0 13.4 3.4 61.1 0.0 0.1 0.0 0.1 12.1 4.8 0.0 0.0 0.6 0.1 7.7 12.5 1.1 0.0 0.3 9.5 0.0 12.9 0.6 7.9 0.3 0.8 20.3 0.0 0.0 1.3 15.4 0.0 26.9 0.0 2.9 0.0 12.2 1.1 2.4 33.8 0.1 0.0 0.0 51.1 PCDHA12 PCDH-ALPHA12 ENSG00000251664 "Protocadherin alpha 12" Q9UN75 5 140875302-141012344 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6" "Cell type enhanced" "Detected in some" 19 "Alveolar cells type 1: 26.8;Bipolar cells: 11.2;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Region enhanced" "Detected in many" "cerebellum: 14.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 10.2;AN3-CA: 4.1;hTCEpi: 6.4;PC-3: 7.8;RT4: 7.7;SH-SY5Y: 4.4" HPA035812 Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA035812: AB_2674796" "unprognostic (3.95e-2)" "unprognostic (7.74e-2)" "unprognostic (7.55e-2)" "unprognostic (3.87e-2)" "unprognostic (2.74e-2)" "unprognostic (2.24e-2)" "unprognostic (2.08e-2)" "unprognostic (4.29e-2)" "unprognostic (1.07e-2)" "unprognostic (1.98e-4)" "unprognostic (3.18e-4)" "unprognostic (1.11e-1)" "unprognostic (3.21e-3)" "unprognostic (6.97e-2)" 1.0 1.7 0.9 0.3 1.2 0.0 0.9 14.6 3.7 3.5 0.4 1.1 0.0 0.1 1.0 0.5 0.2 1.9 4.3 0.3 1.0 0.7 3.8 1.7 5.7 0.2 0.5 0.8 0.3 2.4 0.9 4.6 0.0 2.3 0.4 0.1 1.5 5.7 0.3 0.1 0.2 0.2 0.6 0.8 0.2 0.3 2.1 0.2 0.0 3.4 0.0 0.1 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.2 2.5 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 0.0 6.4 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 1.4 0.0 0.0 2.4 2.6 7.8 0.0 0.0 0.0 0.3 7.7 0.3 4.4 0.0 0.9 0.1 0.5 1.6 0.0 0.0 0.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.2 14.6 3.7 1.0 0.7 0.5 0.8 2.3 0.2 26.8 3.2 0.0 0.0 0.0 11.2 0.4 5.1 0.0 0.0 1.8 5.9 0.0 0.0 0.9 1.1 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 4.8 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 1.3 0.0 0.4 0.2 2.9 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.1 PCDHB1 PCDH-BETA1 ENSG00000171815 "Protocadherin beta 1" Q9Y5F3 5 141051135-141059344 "Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skeletal muscle: 4.9" "Cell type enhanced" "Detected in some" 18 "Alveolar cells type 2: 1.4;Basal glandular cells: 1.1;Cardiomyocytes: 2.2;Ciliated cells: 4.0;Club cells: 1.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA053921 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA053921: AB_2682310" "unprognostic (5.54e-2)" "unprognostic (1.60e-2)" "unprognostic (9.01e-4)" "unprognostic (8.65e-2)" "unprognostic (8.00e-2)" "unprognostic (7.82e-2)" "unprognostic (2.63e-2)" "unprognostic (1.40e-1)" "unprognostic (8.17e-5)" "unprognostic (3.38e-2)" "unprognostic (9.40e-2)" "unprognostic (1.23e-1)" "unprognostic (5.77e-4)" 0.1 0.3 0.3 0.1 0.5 1.0 0.1 0.1 0.2 0.5 0.5 0.4 0.1 0.6 0.1 1.8 0.0 0.1 0.4 0.4 0.7 0.1 0.2 0.4 0.2 0.1 1.1 0.7 1.9 0.0 0.1 0.0 0.5 0.0 4.9 0.8 0.5 0.0 0.3 0.3 0.8 1.8 0.3 0.0 0.1 0.1 1.3 0.7 2.5 0.6 1.0 0.6 0.2 0.8 0.4 0.8 1.1 0.2 0.2 1.1 1.1 0.2 0.1 0.1 1.6 1.4 1.1 1.6 0.3 1.1 1.5 0.0 0.1 0.2 0.9 1.2 1.2 1.9 0.7 0.1 1.4 1.2 0.2 0.3 0.2 0.2 1.7 0.2 1.0 0.8 2.6 0.2 1.4 0.7 0.9 1.2 1.2 0.4 1.2 1.0 0.9 0.1 1.0 2.2 0.8 0.1 1.8 1.3 1.2 0.6 0.5 1.2 1.0 0.7 0.8 0.6 1.5 0.6 1.0 1.1 1.1 1.2 2.3 0.6 0.7 0.5 0.4 0.5 0.7 0.5 0.4 0.2 1.3 0.6 0.5 2.5 1.0 0.4 0.7 0.3 0.2 0.0 1.4 0.0 1.1 0.0 0.2 2.2 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.6 PCDHB16 "KIAA1621, ME1, PCDH-BETA16, PCDH3X, PCDHB8a" ENSG00000272674 "Protocadherin beta 16" Q9NRJ7 5 141181399-141186399 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 17.5" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 13.4;Horizontal cells: 7.9;Muller glia cells: 6.3" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 12.2;LHCN-M2: 6.5;T-47d: 6.8;U-138 MG: 26.9;U-2197: 7.2;U-87 MG: 6.4" HPA014668 Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014668: AB_1855055" "unprognostic (3.44e-3)" "unprognostic (4.03e-2)" "unprognostic (8.14e-2)" "unprognostic (8.60e-2)" "unprognostic (2.78e-2)" "unprognostic (1.36e-2)" "unprognostic (1.17e-1)" "unprognostic (4.03e-2)" "unprognostic (3.13e-2)" "unprognostic (7.55e-3)" "unprognostic (3.49e-2)" "unprognostic (9.57e-2)" "unprognostic (3.55e-2)" "unprognostic (7.49e-3)" "unprognostic (2.00e-2)" "unprognostic (7.92e-3)" "unprognostic (2.83e-3)" 3.7 2.6 2.1 1.4 2.7 0.2 2.5 9.7 3.1 8.4 1.1 5.3 0.0 0.4 6.4 6.2 3.3 2.8 2.5 4.5 1.8 2.5 1.0 3.2 0.5 1.7 0.4 9.8 2.6 10.9 17.5 1.5 3.4 6.2 1.1 7.1 2.2 1.1 3.6 1.5 1.1 3.5 2.5 1.1 0.5 2.3 5.0 0.0 3.1 0.0 0.3 6.5 3.3 0.9 1.0 1.4 0.6 0.9 0.8 0.1 0.0 0.0 0.6 12.2 5.5 3.9 0.3 0.5 2.8 0.0 0.2 0.1 0.2 0.0 4.5 0.6 1.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.2 0.0 0.0 2.0 0.1 0.1 0.0 1.1 6.5 0.3 0.0 0.0 0.9 0.0 0.1 0.0 2.3 0.0 0.3 0.1 0.4 1.7 0.2 0.4 2.1 0.3 6.8 0.0 0.3 26.9 1.3 7.2 1.3 0.0 0.0 0.0 6.4 0.0 3.4 0.7 0.5 0.4 0.6 0.5 0.3 0.6 0.5 0.6 0.3 0.9 0.8 0.6 1.4 0.9 0.6 1.0 0.5 0.1 3.0 1.0 0.0 0.0 0.7 13.4 1.2 2.5 0.0 0.0 1.8 0.0 0.0 1.7 0.7 1.0 2.7 0.0 0.0 4.1 0.0 3.8 0.1 0.0 0.0 0.1 7.9 1.7 1.3 0.3 1.1 4.4 0.0 0.0 0.0 0.0 6.3 1.7 0.0 5.3 0.6 1.1 0.0 3.5 4.1 0.0 1.3 0.0 0.0 0.0 0.0 PCDHB5 "DKFZp586B0217, PCDH-BETA5" ENSG00000113209 "Protocadherin beta 5" Q9Y5E4 5 141135218-141138625 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 9 "Early spermatids: 4.5;Spermatocytes: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 12.0;GAMG: 8.9;NTERA-2: 11.3;RH-30: 9.0;SCLC-21H: 10.6;SuSa: 14.6;T-47d: 11.2;U-138 MG: 21.0;U-2 OS: 9.4;WM-115: 9.3" "Low region specificity" "Detected in all" "HPA013191, HPA067473" Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA013191: AB_1855059, HPA067473: " "unprognostic (2.21e-1)" "unprognostic (4.71e-2)" "unprognostic (4.05e-3)" "unprognostic (1.81e-1)" "unprognostic (2.84e-2)" "unprognostic (5.23e-2)" "unprognostic (2.27e-2)" "unprognostic (1.76e-1)" "unprognostic (9.41e-2)" "unprognostic (1.25e-1)" "unprognostic (1.32e-2)" "unprognostic (3.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.06e-3)" "unprognostic (6.65e-2)" "unprognostic (3.14e-2)" "unprognostic (1.55e-3)" 3.8 4.6 8.1 1.6 10.7 0.7 3.6 7.7 11.0 9.0 2.9 7.9 3.6 1.2 10.4 9.2 2.5 7.5 4.9 4.9 7.9 4.1 6.6 2.3 4.0 1.1 3.6 7.1 14.9 11.2 6.3 7.6 1.6 6.4 7.6 1.4 6.9 5.6 5.9 3.0 1.9 1.5 5.7 5.2 2.2 2.4 6.1 5.9 0.0 6.6 0.7 1.0 4.4 3.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.6 12.0 0.2 0.9 0.5 0.1 0.2 0.0 0.2 0.2 0.0 0.0 0.0 6.2 0.0 8.9 0.0 6.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.6 0.5 0.0 0.0 0.0 2.4 0.5 0.0 0.4 0.0 0.0 0.0 0.0 0.0 11.3 0.0 0.0 0.0 9.0 0.0 0.0 0.0 10.6 0.3 0.0 0.1 3.6 14.6 11.2 2.6 0.0 21.0 9.4 3.4 0.0 0.0 0.0 0.0 1.1 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.1 10.7 7.7 10.5 7.9 4.1 3.6 7.1 6.4 5.9 0.0 0.0 0.0 1.5 0.0 3.7 0.6 2.5 0.0 0.0 1.8 0.0 0.0 0.0 2.4 4.5 0.1 0.0 0.0 3.1 0.0 1.0 0.9 0.0 0.2 0.0 3.2 0.0 0.6 0.0 2.7 2.8 0.0 0.0 0.0 0.0 4.3 3.1 0.0 4.2 0.2 0.7 0.0 1.5 10.3 0.0 0.1 0.0 0.0 0.0 0.6 PCLO "ACZ, DKFZp779G1236, KIAA0559" ENSG00000186472 "Piccolo presynaptic cytomatrix protein" Q9Y6V0 7 82754013-83162930 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Neurodegeneration "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 50.3" "Cell type enhanced" "Detected in many" 9 "Bipolar cells: 95.6;Cone photoreceptor cells: 123.7;Horizontal cells: 81.0;Intestinal endocrine cells: 57.6;Rod photoreceptor cells: 84.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 28 "REH: 62.4;U-2 OS: 71.7" "Low region specificity" "Detected in all" "HPA015858, HPA029579, CAB079012" Approved Supported Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles, Plasma membrane" "CAB079012: , HPA015858: AB_1855071, HPA029579: AB_10602044" "unprognostic (1.32e-2)" "unprognostic (1.99e-1)" "unprognostic (9.33e-2)" "unprognostic (1.31e-1)" "unprognostic (2.08e-2)" "unprognostic (1.52e-1)" "unprognostic (4.49e-3)" "unprognostic (6.14e-2)" "unprognostic (4.61e-2)" "unprognostic (1.82e-1)" "unprognostic (3.00e-1)" "unprognostic (1.56e-1)" "unprognostic (4.79e-6)" "unprognostic (5.15e-2)" "unprognostic (2.42e-2)" "unprognostic (1.36e-5)" "unprognostic (6.62e-5)" 3.1 7.9 8.8 0.8 26.3 0.4 4.7 50.3 19.4 3.2 3.9 1.6 0.4 2.9 1.0 7.3 2.3 2.0 1.9 2.2 9.8 5.7 8.2 0.6 1.8 0.6 4.6 12.6 1.9 4.0 11.4 19.2 1.0 9.1 4.9 3.5 3.6 2.5 5.0 0.6 2.6 2.4 0.7 5.3 1.1 2.9 4.5 4.4 0.0 8.4 0.0 0.8 1.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.0 0.2 1.9 0.1 1.4 0.5 0.6 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.4 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.4 0.2 1.1 62.4 1.0 0.0 0.4 0.2 1.2 0.8 0.0 0.6 0.1 0.3 0.8 0.1 0.0 0.0 71.7 0.3 0.1 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 8.8 26.3 50.3 19.4 9.8 5.7 4.6 12.6 9.1 4.4 8.9 14.1 0.0 8.3 2.3 95.6 24.6 20.4 9.4 18.2 1.8 123.7 0.9 6.6 4.6 9.0 4.1 14.6 0.0 4.4 0.3 0.4 5.3 0.0 0.0 1.3 81.0 57.6 0.0 0.0 5.6 2.6 0.0 0.0 0.0 12.3 17.5 2.5 14.4 6.0 16.7 84.6 0.0 0.3 3.9 13.8 3.0 0.6 0.0 7.7 4.8 PCMTD1 FLJ10883 ENSG00000168300 "Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1" Q96MG8 8 51817575-51899186 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025696, HPA061444" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA025696: AB_1855077, HPA061444: AB_2684519" "unprognostic (3.16e-2)" "unprognostic (1.24e-1)" "unprognostic (1.47e-1)" "unprognostic (2.79e-1)" "unprognostic (1.41e-1)" "unprognostic (6.73e-3)" "unprognostic (2.58e-2)" "unprognostic (2.53e-1)" "unprognostic (1.05e-1)" "unprognostic (1.66e-1)" "unprognostic (2.18e-2)" "unprognostic (8.38e-2)" "unprognostic (3.73e-1)" "unprognostic (2.48e-2)" "unprognostic (1.13e-1)" "unprognostic (3.11e-3)" "unprognostic (3.11e-3)" 22.0 24.1 13.1 18.2 17.1 9.0 41.1 24.3 21.7 22.8 24.4 11.7 33.2 14.8 29.0 24.5 21.6 21.5 22.1 26.1 13.5 12.6 21.5 16.7 29.2 21.0 18.4 11.4 33.3 53.8 57.9 34.2 19.2 15.6 22.8 14.8 15.0 39.8 38.8 45.7 18.0 18.7 38.5 18.9 24.3 19.6 10.4 16.9 27.8 33.6 23.6 15.5 28.4 28.6 16.5 15.4 32.4 12.1 22.3 15.2 10.6 6.5 4.2 14.5 2.6 21.4 20.1 8.3 8.7 15.5 3.7 5.9 1.9 15.1 6.3 12.2 11.6 6.2 16.2 2.5 10.2 6.5 8.0 4.9 7.2 7.5 4.4 28.3 2.6 7.4 19.9 19.5 4.6 12.7 22.7 17.5 9.4 5.5 20.7 5.8 2.7 15.1 6.6 5.6 9.7 1.9 4.7 2.8 8.1 15.1 13.0 9.6 8.1 6.1 8.0 8.7 12.1 7.9 4.0 14.3 3.3 4.4 5.0 3.1 12.6 9.4 2.2 9.9 6.3 4.0 19.6 9.6 22.9 10.2 12.1 12.4 16.2 13.0 12.1 9.7 16.5 15.2 13.4 32.4 22.3 12.1 15.4 13.8 10.6 13.1 17.1 24.3 21.7 13.5 12.6 18.4 11.4 15.6 16.9 107.2 59.0 50.0 62.9 48.0 67.0 80.0 43.3 58.9 44.3 80.3 9.8 30.3 54.7 23.7 3.8 68.6 25.0 46.7 35.1 30.0 62.0 88.3 49.9 30.5 22.5 55.6 44.9 57.1 47.5 4.7 96.4 57.4 67.4 34.3 40.3 112.9 43.4 28.1 112.8 59.7 23.9 38.8 59.7 9.3 14.7 51.8 57.3 41.5 27.0 64.6 PDAP1 "HASPP28, PAP, PAP1" ENSG00000106244 "PDGFA associated protein 1" Q13442 7 99392048-99408829 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB021103, HPA050294, HPA060836" Approved Enhanced "Plasma membrane,Cytosol" NA NA 40000 Cytosol "Plasma membrane" "CAB021103: AB_10057973, HPA050294: AB_2681077, HPA060836: AB_2684374" "unprognostic (2.27e-1)" "unprognostic (1.45e-1)" "unprognostic (3.87e-2)" "unprognostic (1.49e-1)" "unprognostic (1.41e-2)" "unprognostic (4.01e-3)" "prognostic unfavorable (6.67e-4)" "unprognostic (5.77e-2)" "unprognostic (3.50e-1)" "unprognostic (2.65e-2)" "unprognostic (2.63e-1)" "unprognostic (3.35e-2)" "unprognostic (1.45e-2)" "unprognostic (3.51e-2)" "unprognostic (1.79e-1)" "unprognostic (3.49e-1)" "unprognostic (2.97e-2)" 26.7 25.7 25.5 25.0 23.9 23.0 22.4 23.4 28.5 22.8 25.9 18.3 21.6 21.1 25.8 21.6 32.2 20.5 23.4 30.2 23.4 20.4 25.2 31.8 20.5 20.2 23.2 23.5 23.4 28.2 23.3 18.0 28.8 24.2 23.0 22.0 19.0 27.8 26.4 103.5 24.8 19.6 26.9 22.2 20.5 22.6 19.7 24.3 20.1 22.4 37.2 25.2 24.1 28.2 11.3 15.8 24.2 11.9 20.4 14.2 4.6 31.3 27.4 18.6 23.6 14.4 15.0 12.0 26.0 15.1 21.1 17.9 27.7 15.7 13.8 23.1 24.5 26.8 17.0 22.3 26.1 20.6 19.7 24.8 14.0 26.5 24.1 21.1 26.2 13.9 15.7 19.7 23.1 38.0 19.1 21.0 22.9 33.0 25.3 20.6 65.4 36.3 35.8 23.7 32.0 29.8 16.8 18.6 23.9 21.3 24.2 19.0 38.2 19.5 31.1 13.2 21.8 13.7 13.8 19.0 28.4 31.5 33.7 40.7 24.3 27.8 30.7 22.8 23.5 29.6 7.6 9.4 8.6 12.4 11.9 11.1 11.3 11.5 8.9 7.4 11.1 8.3 10.3 24.2 20.4 10.6 15.8 14.2 4.6 25.5 23.9 23.4 28.5 23.4 20.4 23.2 23.5 24.2 24.3 80.4 78.5 58.8 93.4 55.3 99.3 58.0 66.2 127.2 88.7 40.1 31.4 195.3 142.6 147.5 43.9 96.1 85.9 0.0 148.5 178.1 80.5 110.4 69.4 70.3 101.3 73.1 113.2 60.8 32.4 62.9 77.3 76.3 97.8 137.1 82.1 110.3 138.1 86.8 86.7 87.8 76.8 51.8 85.5 104.4 108.0 57.3 154.2 80.4 92.4 105.8 PDCD7 "ES18, HES18" ENSG00000090470 "Programmed cell death 7" Q8N8D1 15 65117379-65133836 "Predicted intracellular proteins" Apoptosis "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 165.8;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 177.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049388 Approved Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA049388: AB_2680741" "unprognostic (7.71e-3)" "unprognostic (3.25e-1)" "unprognostic (4.09e-1)" "unprognostic (1.52e-1)" "unprognostic (1.54e-1)" "unprognostic (1.22e-1)" "unprognostic (6.68e-3)" "unprognostic (2.36e-2)" "unprognostic (3.18e-3)" "unprognostic (8.18e-2)" "unprognostic (3.28e-2)" "unprognostic (5.36e-2)" "prognostic unfavorable (1.00e-4)" "unprognostic (5.29e-2)" "unprognostic (3.42e-2)" "unprognostic (1.44e-1)" "unprognostic (1.62e-2)" 16.0 16.8 22.4 17.6 26.9 13.1 23.8 43.7 28.5 19.0 19.4 21.3 12.6 14.6 23.8 19.8 23.2 18.6 12.7 14.4 21.0 16.3 13.7 15.6 21.5 19.5 22.9 24.7 26.5 16.6 16.5 15.7 17.4 20.6 17.4 14.3 15.0 14.2 19.0 17.5 16.4 15.4 20.4 17.5 18.7 15.1 27.4 32.1 19.7 18.0 12.7 21.5 18.4 18.6 5.9 4.0 4.0 3.2 7.1 4.5 1.4 8.8 7.4 12.6 13.0 12.7 17.9 7.6 10.2 11.3 12.6 9.7 8.9 9.9 17.1 11.1 8.1 9.4 16.9 32.0 7.3 9.1 10.3 8.6 16.6 6.3 7.8 11.7 22.5 11.2 10.4 11.2 6.9 13.1 12.1 9.9 12.8 21.1 14.0 10.9 6.7 23.6 16.1 15.3 10.3 6.7 20.9 16.2 19.0 7.6 14.2 10.4 12.4 11.4 9.7 14.9 14.4 7.8 18.6 10.1 13.1 12.8 7.5 15.7 25.1 28.6 12.3 11.8 25.0 6.6 4.0 3.2 1.8 4.5 2.6 3.8 4.8 4.3 4.1 2.8 5.9 4.5 4.5 0.8 7.1 2.5 4.0 3.1 1.4 22.4 26.9 43.7 28.5 21.0 16.3 22.9 24.7 20.6 32.1 0.0 11.0 24.3 63.5 33.8 165.8 15.9 15.3 9.4 14.8 27.9 208.1 49.6 24.9 7.2 4.9 27.4 10.0 0.0 7.0 25.2 28.2 37.6 19.6 16.1 20.7 71.5 13.8 16.5 21.8 6.6 53.8 17.5 11.8 5.4 17.4 63.4 6.5 10.5 45.3 17.1 177.0 45.3 24.4 137.9 102.2 34.9 59.7 40.6 21.3 41.6 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell type enhanced" "Detected in many" 13 "Late spermatids: 164.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HMC-1: 22.0;NB-4: 25.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB017632: AB_1127109, HPA043310: AB_2678419, HPA076091: AB_2686775" "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.6 6.9 2.2 3.3 6.6 0.4 1.1 3.5 3.2 1.5 9.7 8.5 0.2 0.3 2.3 0.4 0.2 3.8 3.3 13.6 4.7 3.8 7.5 2.2 22.0 5.1 0.4 3.7 0.0 0.4 3.1 1.2 10.7 3.3 2.3 1.0 1.3 25.3 1.8 3.9 2.8 8.9 2.2 11.7 0.6 0.8 2.5 0.9 0.2 0.1 3.6 0.6 0.5 4.5 6.6 5.0 6.5 3.4 2.1 6.5 0.5 7.2 2.1 0.1 4.0 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 3.0 15.2 8.0 2.7 9.0 23.9 5.8 12.7 10.7 7.9 8.7 0.0 0.3 0.0 2.8 44.2 10.9 1.3 0.0 11.1 4.3 13.4 3.1 32.2 0.8 9.8 52.4 0.0 11.6 18.3 164.4 16.1 37.2 13.5 14.4 6.2 1.3 10.6 0.0 17.0 0.0 2.6 6.5 8.1 7.7 7.8 7.0 0.3 16.0 6.8 1.4 PDE4D DPDE3 ENSG00000113448 "Phosphodiesterase 4D" Q08499 5 58969038-60522120 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 60.0" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 2: 76.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "eosinophil: 28.1" "Lineage enriched" "Detected in many" 5 "granulocytes: 28.1" "Cell line enhanced" "Detected in many" "A549: 25.3;AN3-CA: 29.1;HeLa: 41.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045895 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA045895: AB_10960275" "unprognostic (1.14e-1)" "unprognostic (8.73e-3)" "unprognostic (4.35e-2)" "unprognostic (7.87e-2)" "unprognostic (5.97e-2)" "unprognostic (2.03e-1)" "unprognostic (8.10e-4)" "unprognostic (1.17e-1)" "unprognostic (6.59e-2)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (2.65e-1)" "prognostic favorable (4.00e-5)" "unprognostic (1.51e-1)" "unprognostic (8.20e-2)" "unprognostic (1.77e-2)" "unprognostic (2.56e-2)" 8.2 1.9 4.4 6.8 8.6 46.2 5.3 4.2 13.0 13.5 18.6 1.4 14.7 4.1 17.1 14.0 10.3 6.6 12.7 15.5 4.5 5.8 12.8 3.4 11.1 3.7 5.2 6.6 5.3 2.9 7.0 9.0 11.8 2.7 18.2 11.2 8.6 24.4 16.5 60.0 5.1 7.5 35.8 5.0 3.8 10.2 2.6 2.8 4.4 6.2 11.3 9.5 20.0 11.2 6.1 0.7 28.1 1.1 0.1 0.8 0.5 0.0 25.3 5.3 29.1 1.0 1.9 4.2 0.6 0.7 1.4 2.1 9.9 0.8 1.9 0.1 0.2 4.3 4.3 0.0 1.1 2.5 1.1 2.9 3.7 41.9 2.1 3.9 1.7 0.2 3.9 0.9 4.0 0.7 0.4 3.0 0.1 0.0 0.6 2.4 1.8 1.4 4.1 1.0 0.7 1.3 0.4 6.7 4.2 6.6 9.5 0.9 3.3 6.7 11.3 5.7 5.0 0.8 3.7 3.4 0.3 0.1 5.0 1.3 1.4 0.0 0.2 4.3 7.0 1.1 2.0 1.1 28.1 0.8 0.0 0.8 6.1 0.7 0.3 0.7 6.1 0.5 0.4 1.5 0.1 0.1 0.0 0.4 0.5 4.4 8.6 4.2 13.0 4.5 5.8 5.2 6.6 2.7 2.8 29.8 76.9 9.1 30.5 9.4 13.6 32.7 10.2 22.7 48.9 40.1 68.7 9.2 10.0 0.5 16.6 12.4 16.7 0.0 1.6 14.8 13.1 46.1 21.9 0.8 4.3 1.6 32.0 14.1 6.0 29.3 1.4 9.4 10.1 4.6 18.4 16.1 5.4 10.5 4.6 17.7 52.1 0.0 5.3 0.5 7.1 7.8 2.6 37.3 10.1 21.1 PDGFC "fallotein, SCDGF" ENSG00000145431 "Platelet derived growth factor C" Q9NRA1 4 156760454-156971394 "Predicted secreted proteins, RAS pathway related proteins" "Developmental protein, Growth factor, Mitogen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Basal keratinocytes: 44.1;Cholangiocytes: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 8 "classical monocyte: 2.1;intermediate monocyte: 1.0;non-classical monocyte: 1.4" "Lineage enriched" "Detected in single" 11 "monocytes: 2.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 27.1;hTERT-RPE1: 26.6;U-138 MG: 19.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA009134 Approved Supported "Plasma membrane,Cytosol" "Secreted to blood" NA NA "Plasma membrane, Cytosol" "HPA009134: AB_10601981" "unprognostic (3.12e-1)" "unprognostic (1.91e-2)" "unprognostic (5.79e-2)" "unprognostic (3.67e-2)" "unprognostic (3.97e-1)" "unprognostic (3.41e-2)" "unprognostic (8.78e-2)" "unprognostic (1.60e-2)" "unprognostic (1.36e-1)" "unprognostic (8.12e-2)" "unprognostic (2.43e-3)" "unprognostic (1.14e-1)" "prognostic favorable (1.35e-5)" "prognostic unfavorable (3.05e-4)" "unprognostic (1.25e-1)" "unprognostic (1.19e-2)" "prognostic unfavorable (3.17e-4)" 11.5 9.1 3.2 6.5 3.4 0.7 7.9 1.3 3.5 21.8 6.1 1.9 8.4 2.2 21.3 9.4 6.1 9.0 12.7 3.6 2.4 2.0 9.7 10.3 6.9 4.3 2.2 3.8 10.4 9.8 28.0 2.2 4.9 1.9 17.7 2.4 5.5 26.6 9.3 6.5 4.1 5.4 11.9 2.0 4.1 5.6 4.3 1.7 2.2 10.4 4.4 1.5 8.3 4.7 0.0 0.2 0.0 2.1 0.0 0.0 0.7 1.0 1.6 17.8 11.7 3.3 6.5 0.4 9.3 9.9 5.6 7.5 1.0 4.2 0.0 1.6 27.1 4.3 1.1 4.9 6.1 7.7 0.0 2.2 10.8 1.6 1.0 8.7 1.6 0.1 6.7 3.0 14.2 10.2 26.6 2.7 0.0 0.0 0.0 13.8 0.0 0.0 0.0 0.2 0.0 0.7 0.0 3.7 0.0 10.6 0.4 0.0 0.0 0.0 0.0 0.1 2.9 1.4 0.5 12.0 19.4 0.2 4.9 7.5 0.0 0.0 0.0 7.4 0.0 0.7 0.0 2.1 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.7 3.2 3.4 1.3 3.5 2.4 2.0 2.2 3.8 1.9 1.7 6.0 13.9 0.0 18.3 44.1 0.3 13.7 45.9 0.0 7.9 12.2 0.0 0.4 0.0 13.8 31.1 4.9 0.4 0.0 6.2 0.2 15.8 6.7 1.1 13.0 10.6 0.0 0.0 11.6 21.7 18.1 4.9 14.8 10.1 16.2 2.0 6.7 12.6 0.0 21.5 14.9 0.3 6.5 17.3 0.2 2.2 11.8 0.5 0.5 1.3 4.3 PDZD2 "KIAA0300, PDZK3" ENSG00000133401 "PDZ domain containing 2" O15018 5 31639410-32110931 "Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.8" "Cell type enhanced" "Detected in many" 13 "Cone photoreceptor cells: 92.3;Early spermatids: 193.7;Rod photoreceptor cells: 66.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 9.1;EFO-21: 5.1;SiHa: 12.7;SK-BR-3: 11.8;T-47d: 6.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB020784, HPA036503, HPA036504, HPA064387, HPA076072" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "CAB020784: , HPA036503: AB_2675161, HPA036504: , HPA064387: AB_2685252, HPA076072: " "unprognostic (3.65e-2)" "unprognostic (4.06e-2)" "unprognostic (6.63e-2)" "unprognostic (5.42e-5)" "unprognostic (2.39e-1)" "unprognostic (9.67e-3)" "unprognostic (2.55e-1)" "unprognostic (6.49e-2)" "unprognostic (3.38e-2)" "unprognostic (2.45e-2)" "unprognostic (1.71e-2)" "unprognostic (1.93e-1)" "unprognostic (2.33e-3)" "unprognostic (4.13e-2)" "unprognostic (6.92e-2)" "unprognostic (7.67e-2)" "unprognostic (1.79e-1)" 16.3 1.3 7.8 1.0 28.8 0.3 5.6 3.6 18.1 2.9 1.9 5.1 2.4 0.8 3.0 7.4 6.1 2.8 1.2 19.6 6.6 4.8 9.5 0.4 10.0 0.5 5.4 8.8 16.7 1.5 0.8 2.6 11.9 11.5 2.0 1.1 4.3 2.3 2.5 2.6 11.1 1.1 2.9 3.2 0.5 2.0 6.2 6.1 0.3 1.3 0.7 2.0 1.1 2.9 0.4 0.7 0.7 0.6 0.2 1.0 0.0 0.1 0.0 3.5 0.1 0.0 0.0 9.1 0.0 0.0 0.6 0.6 0.0 0.0 0.0 5.1 0.0 1.3 4.7 1.8 1.0 0.0 0.0 0.4 0.0 2.8 0.0 0.0 0.0 2.7 0.3 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.2 0.0 0.8 0.0 0.0 0.0 4.0 0.1 0.1 0.8 12.7 11.8 0.0 3.1 6.1 0.0 0.0 0.0 2.5 0.0 0.5 0.0 0.0 3.0 0.0 0.0 1.2 0.4 0.5 0.4 0.5 0.1 1.0 0.1 0.3 0.1 0.1 0.4 0.1 0.1 0.7 0.2 0.6 0.7 0.0 0.0 7.8 28.8 3.6 18.1 6.6 4.8 5.4 8.8 11.5 6.1 41.7 30.5 0.0 3.4 14.9 5.2 41.8 0.0 1.4 5.7 5.2 92.3 19.5 0.0 0.1 193.7 6.8 0.0 0.0 0.2 2.5 5.6 1.0 1.1 0.0 1.9 14.3 0.0 6.2 0.3 37.2 6.9 1.7 6.8 0.0 0.0 5.2 2.1 0.0 9.9 8.7 66.0 45.3 2.0 10.1 2.7 16.2 17.6 0.0 0.0 1.3 PDZD8 "bA129M16.2, FLJ34427, PDZK8" ENSG00000165650 "PDZ domain containing 8" Q8NEN9 10 117277274-117375467 "Predicted intracellular proteins" "Host-virus interaction, Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 61.7" "Cell type enhanced" "Detected in all" 11 "Early spermatids: 174.2;Late spermatids: 366.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HEL: 52.1" "Low region specificity" "Detected in all" "HPA015716, HPA051610" Uncertain Approved "Nucleoli fibrillar center,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoli fibrillar center" "Plasma membrane" "HPA015716: AB_1855162, HPA051610: AB_2681549" "unprognostic (1.12e-1)" "unprognostic (2.87e-1)" "unprognostic (9.65e-3)" "unprognostic (2.75e-2)" "unprognostic (6.29e-2)" "unprognostic (3.36e-2)" "unprognostic (2.42e-1)" "unprognostic (1.43e-1)" "unprognostic (2.53e-1)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.10e-4)" "unprognostic (1.90e-2)" "unprognostic (5.37e-3)" "unprognostic (7.60e-3)" "unprognostic (1.44e-2)" "unprognostic (3.18e-2)" "unprognostic (2.01e-2)" 8.1 7.8 12.2 5.1 13.3 61.7 8.2 8.7 12.9 9.1 14.8 11.4 32.8 14.0 10.7 15.1 11.4 7.7 10.3 7.0 12.0 10.4 13.5 21.1 7.4 3.7 14.7 7.4 10.1 20.1 18.9 8.6 6.0 12.9 7.3 12.0 6.3 12.4 21.3 6.7 6.6 13.7 7.6 14.8 5.0 10.6 23.2 12.4 8.9 7.5 5.4 4.2 8.0 15.3 1.0 1.7 5.7 2.0 2.5 2.5 0.5 5.2 9.0 3.3 6.3 5.7 5.1 1.8 5.0 4.4 2.3 1.8 4.5 7.0 6.2 4.6 7.6 2.6 7.9 5.7 5.4 4.5 3.9 5.1 52.1 3.7 4.4 4.2 21.7 4.9 5.0 6.4 4.1 12.3 8.5 4.0 5.1 4.7 6.5 5.6 2.1 4.2 2.8 2.6 2.7 8.1 3.4 12.7 2.6 6.7 3.8 2.6 4.2 5.4 2.3 3.9 3.1 1.6 3.2 6.4 3.8 4.2 6.8 8.6 3.5 2.9 4.5 4.7 10.0 3.3 2.7 1.4 5.7 2.2 1.1 2.5 0.9 1.8 1.8 1.7 1.0 1.5 2.0 5.6 2.5 2.0 1.3 0.8 0.5 12.2 13.3 8.7 12.9 12.0 10.4 14.7 7.4 12.9 12.4 11.9 27.8 8.8 17.7 26.4 29.3 16.7 43.3 38.8 25.0 17.4 21.6 8.3 8.3 27.0 174.2 17.8 23.8 23.3 70.7 5.7 19.5 25.1 41.7 45.8 6.8 30.2 32.4 16.5 12.3 366.0 21.9 15.2 21.9 9.0 31.7 24.9 56.7 21.0 26.9 23.1 40.1 25.8 18.9 16.9 29.3 28.2 5.6 18.7 39.0 34.2 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118135858-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 260.7" "Cell type enhanced" "Detected in all" 7 "Distal tubular cells: 3140.1;Proximal tubular cells: 3872.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA008819, CAB009906, CAB013493, HPA063904" Enhanced Approved "Plasma membrane,Cytosol" NA NA 62000000 "Plasma membrane, Cytosol" "CAB009906: AB_2163173, CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: AB_2732708" "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favorable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favorable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 26.8 207.3 83.0 15.2 82.3 13.5 32.3 63.3 102.7 35.5 50.4 58.0 18.9 75.3 22.9 52.8 24.3 28.5 22.6 57.6 77.6 69.7 132.7 260.7 22.1 16.0 77.8 71.5 43.5 46.2 139.2 30.8 16.5 59.1 35.4 25.4 41.2 43.6 33.1 65.1 20.9 75.4 23.4 79.1 15.3 20.6 22.7 43.5 8.7 94.9 26.1 19.7 20.2 17.8 45.2 37.3 3.0 12.1 20.9 45.3 36.4 32.2 27.6 39.1 40.6 61.7 30.2 60.8 25.7 30.0 40.6 20.9 16.4 11.1 52.0 25.9 38.4 16.2 23.2 57.8 23.9 31.7 13.0 55.3 26.1 31.1 114.3 35.7 47.2 11.4 29.9 39.7 24.0 16.7 46.7 18.8 27.8 43.3 19.4 40.6 38.2 25.7 95.7 37.9 27.1 33.4 50.8 29.1 94.8 49.8 31.5 46.9 36.4 53.4 37.1 50.3 25.0 53.4 32.2 20.4 31.2 17.8 30.5 25.8 19.0 33.7 26.8 36.7 35.4 33.8 0.7 11.0 3.0 26.9 12.1 42.4 45.2 45.3 33.3 33.3 32.5 43.9 35.3 1.2 20.9 10.3 37.3 41.2 36.4 83.0 82.3 63.3 102.7 77.6 69.7 77.8 71.5 59.1 43.5 375.2 339.6 254.0 392.9 282.7 501.7 637.3 598.7 327.9 273.0 743.2 90.3 819.2 3140.1 396.3 35.6 178.6 306.2 116.8 213.3 686.7 314.8 422.6 353.3 1736.5 486.8 681.7 307.9 178.0 167.5 50.5 502.8 218.5 705.2 448.2 324.1 1385.1 201.0 263.6 687.7 3872.6 306.7 362.2 321.6 273.2 133.6 284.3 514.8 194.5 466.9 324.1 PGAP3 "CAB2, MGC9753, PER1, PERLD1, PP1498" ENSG00000161395 "Post-GPI attachment to proteins 3" Q96FM1 17 39671122-39696797 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 6 "OE19: 133.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016591 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016591: AB_1855203" "unprognostic (1.29e-1)" "unprognostic (8.64e-2)" "unprognostic (1.65e-1)" "unprognostic (6.53e-3)" "unprognostic (9.19e-2)" "unprognostic (1.68e-2)" "prognostic favorable (3.94e-4)" "unprognostic (1.61e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (6.82e-4)" "unprognostic (1.57e-2)" "unprognostic (7.79e-2)" "prognostic favorable (3.89e-4)" "unprognostic (5.16e-2)" "unprognostic (1.31e-1)" "unprognostic (9.05e-2)" "unprognostic (1.94e-2)" 6.8 8.2 8.9 7.6 14.3 3.4 10.2 6.4 17.3 11.3 19.2 10.0 15.1 12.5 8.3 16.5 16.2 14.0 19.7 9.9 11.3 7.3 13.7 20.7 9.5 6.5 6.3 10.7 9.7 22.7 16.0 10.1 39.2 6.1 11.2 11.7 14.2 16.7 15.6 5.0 16.0 20.7 7.3 5.5 8.1 13.4 9.0 7.3 4.4 20.3 8.7 15.8 8.1 8.9 7.8 5.3 4.0 10.5 9.0 15.1 6.3 0.6 1.6 1.3 1.2 1.4 1.4 1.3 0.7 1.7 1.1 1.0 0.9 4.0 0.6 3.3 1.3 0.3 2.1 0.4 0.4 0.5 1.4 1.3 0.8 0.9 1.5 1.8 2.1 2.2 2.6 2.6 0.5 1.1 1.3 0.3 0.3 0.7 1.6 1.0 1.4 0.4 1.9 1.3 133.7 0.3 0.5 0.8 1.9 1.8 2.0 1.2 0.8 1.9 22.9 1.1 0.1 1.9 2.0 0.5 1.2 1.3 0.6 0.5 1.4 0.3 0.2 1.4 0.8 1.3 2.4 6.7 4.0 15.1 10.5 8.3 7.8 10.6 12.3 5.3 7.6 10.5 10.1 1.7 9.0 3.8 3.6 5.1 6.3 8.9 14.3 6.4 17.3 11.3 7.3 6.3 10.7 6.1 7.3 3.0 12.2 0.0 3.5 3.4 12.1 5.2 12.7 4.0 9.1 14.0 7.9 6.8 1.7 6.0 0.1 4.3 16.0 0.0 9.6 5.2 6.7 4.9 9.2 7.7 4.0 12.7 8.1 4.3 2.7 0.0 2.8 3.5 1.7 1.8 16.3 7.8 5.1 11.5 1.4 3.5 21.6 0.0 2.3 0.7 2.0 2.5 8.7 1.7 13.0 2.5 PGLYRP4 "PGLYRPIbeta, PGRP-Ibeta, PGRPIB, SBBI67" ENSG00000163218 "Peptidoglycan recognition protein 4" Q96LB8 1 153330120-153348840 "Predicted secreted proteins" "Immunity, Innate immunity" "Antibiotic, Antimicrobial" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "cervix, uterine: 8.1;skin 1: 19.5;tongue: 13.7;vagina: 8.5" "Cell type enhanced" "Detected in some" 15 "Basal keratinocytes: 1.8;Early spermatids: 1.6;Melanocytes: 1.7;Suprabasal keratinocytes: 3.0" "Group enriched" "Detected in some" 9 "cervical cancer: 2.7;head and neck cancer: 7.8;lung cancer: 1.9;melanoma: 1.6;urothelial cancer: 2.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "neutrophil: 1.3" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.3" "Cell line enhanced" "Detected in some" "HaCaT: 8.2;HDLM-2: 5.3;hTCEpi: 1.7;Karpas-707: 4.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" CAB025879 Approved "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB025879: " "unprognostic (2.76e-2)" "unprognostic (1.19e-1)" "unprognostic (6.10e-2)" "unprognostic (1.34e-2)" "unprognostic (3.61e-3)" "unprognostic (1.46e-1)" "unprognostic (3.13e-1)" "unprognostic (5.42e-2)" "unprognostic (3.99e-2)" "unprognostic (1.07e-2)" "unprognostic (2.15e-1)" "unprognostic (1.81e-1)" "unprognostic (1.88e-1)" 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.0 0.0 8.1 0.0 0.0 0.0 0.1 2.0 0.0 7.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.0 0.3 0.0 1.2 0.0 0.2 0.2 0.0 1.5 0.0 0.1 19.5 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 13.7 6.5 0.0 8.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 5.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.9 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.0 0.2 0.0 0.0 0.1 PHF20L1 "CGI-72, FLJ13649, FLJ21615, MGC64923, TDRD20B" ENSG00000129292 "PHD finger protein 20 like 1" A8MW92 8 132775358-132848807 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025060, HPA028417" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA025060: AB_10599822, HPA028417: AB_10602278" "unprognostic (9.12e-3)" "unprognostic (2.29e-1)" "unprognostic (2.77e-1)" "unprognostic (2.10e-3)" "unprognostic (1.25e-1)" "unprognostic (1.51e-1)" "unprognostic (2.79e-2)" "unprognostic (7.53e-2)" "unprognostic (9.66e-2)" "unprognostic (1.24e-2)" "unprognostic (8.85e-2)" "unprognostic (1.19e-1)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (1.78e-1)" "unprognostic (2.24e-2)" "unprognostic (7.83e-2)" 14.5 19.9 15.3 15.7 26.6 27.1 17.6 22.2 22.0 15.7 14.2 12.6 11.7 11.6 17.6 13.0 16.0 12.4 13.6 22.5 15.9 10.5 13.6 16.4 12.9 13.5 11.8 14.8 16.9 12.7 22.4 18.6 15.1 12.9 13.1 12.9 10.0 14.9 14.6 27.0 9.5 12.9 14.5 12.9 15.4 12.8 15.9 13.7 38.9 28.5 9.2 14.7 14.7 16.9 2.4 4.0 14.7 4.3 3.0 3.4 1.6 10.1 10.2 16.7 9.6 13.1 15.7 6.0 14.9 11.7 10.3 10.1 5.7 7.0 11.6 13.1 14.9 8.9 6.0 11.3 7.9 12.8 19.5 8.0 12.5 12.1 4.0 13.8 9.9 8.9 11.7 9.9 10.7 16.0 10.0 11.3 18.6 15.3 18.3 15.3 10.1 32.3 4.4 7.4 11.6 13.6 15.8 11.2 10.0 8.4 8.8 41.5 12.1 9.5 6.8 12.0 7.3 13.3 11.3 14.7 16.7 13.4 10.9 14.2 10.9 14.2 14.9 14.8 17.6 14.8 3.7 4.3 7.5 2.5 2.5 2.5 2.2 2.3 2.9 4.0 2.4 3.4 2.7 14.7 3.0 3.8 3.3 2.6 1.6 15.3 26.6 22.2 22.0 15.9 10.5 11.8 14.8 12.9 13.7 23.8 45.9 43.8 43.6 29.9 53.6 77.9 17.8 29.4 46.6 34.9 41.2 23.1 19.9 33.0 47.6 43.8 33.8 23.3 27.3 24.9 37.5 35.9 58.9 30.1 32.0 50.9 42.0 35.6 44.0 39.6 37.2 48.6 21.9 31.5 24.8 47.4 32.7 24.1 40.3 22.0 52.6 45.3 42.3 61.6 42.6 31.7 37.6 42.1 22.2 54.3 PHLDB2 "FLJ21791, LL5b, LL5beta" ENSG00000144824 "Pleckstrin homology like domain family B member 2" Q86SQ0 3 111732497-111976517 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 104.0" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 138.6;Basal keratinocytes: 222.0;Smooth muscle cells: 129.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.4;HaCaT: 33.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA035146, HPA035147" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035146: AB_10600927, HPA035147: AB_2674492" "unprognostic (2.83e-2)" "unprognostic (4.93e-3)" "unprognostic (2.15e-2)" "unprognostic (8.01e-2)" "unprognostic (1.00e-2)" "prognostic unfavorable (2.59e-4)" "unprognostic (5.14e-2)" "unprognostic (2.20e-2)" "unprognostic (1.43e-1)" "unprognostic (9.03e-2)" "unprognostic (2.00e-2)" "unprognostic (3.53e-1)" "prognostic favorable (7.03e-8)" "unprognostic (3.24e-3)" "unprognostic (3.47e-2)" "unprognostic (1.53e-1)" "unprognostic (2.83e-1)" 15.5 3.8 1.3 13.2 1.9 0.4 9.9 1.6 2.9 13.9 22.8 1.4 8.4 2.8 17.4 10.1 10.7 10.7 9.1 21.7 1.3 1.2 36.6 24.6 14.4 2.2 2.1 1.9 8.5 6.4 0.9 5.3 104.0 7.1 16.7 4.4 6.9 7.0 14.3 6.0 5.8 6.5 49.3 2.4 7.9 11.4 4.3 0.4 1.7 5.9 6.8 2.3 33.8 17.8 1.0 1.0 0.4 0.1 1.7 5.6 1.3 32.4 3.6 20.4 0.0 6.6 10.9 8.4 18.8 9.2 12.5 14.8 10.2 2.4 0.0 19.8 7.2 12.6 33.8 0.3 12.1 22.8 0.5 0.4 0.0 8.7 3.3 7.2 0.0 0.1 12.8 7.2 8.6 16.0 14.1 20.0 0.3 0.0 0.1 3.7 0.0 1.3 0.0 8.2 0.3 6.3 2.8 26.3 0.0 7.4 7.8 0.5 1.5 18.5 0.3 1.9 11.7 0.6 0.1 17.4 3.4 28.6 9.0 4.5 1.7 0.0 0.0 3.4 0.0 6.4 0.2 0.0 0.0 5.2 0.0 3.7 0.4 3.6 5.6 0.1 1.0 0.0 2.3 0.4 1.7 0.1 1.0 0.8 1.3 1.3 1.9 1.6 2.9 1.3 1.2 2.1 1.9 7.1 0.4 74.5 9.8 2.4 138.6 222.0 0.1 94.0 25.5 5.3 12.5 31.4 2.0 21.1 19.9 56.7 10.2 32.4 0.0 0.0 17.6 42.7 33.9 48.7 6.9 28.4 3.0 0.0 10.4 43.6 3.2 3.9 13.3 3.2 21.9 1.8 3.4 0.0 37.0 0.0 21.2 28.0 0.3 12.9 129.6 0.3 2.1 100.2 55.8 7.0 1.4 85.9 PHOSPHO1 ENSG00000173868 "Phosphoethanolamine/phosphocholine phosphatase" Q8TCT1 17 49223362-49230766 "Enzymes, Predicted intracellular proteins" "Mineral balance" Hydrolase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 80.0;testis: 52.3" "Cell type enriched" "Detected in some" 6 "Late spermatids: 1098.7" "Low cancer specificity" "Detected in some" "Group enriched" "Detected in many" 4 "cerebral cortex: 10.2;pons and medulla: 8.2" "Group enriched" "Detected in some" 171 "eosinophil: 30.6;neutrophil: 80.0" "Lineage enriched" "Detected in single" 248 "granulocytes: 80.0" "Cell line enhanced" "Detected in some" "Daudi: 8.6;EFO-21: 5.8;HDLM-2: 6.1;SuSa: 8.9" "Low region specificity" "Detected in all" HPA065025 Approved "Plasma membrane,Actin filaments" NA NA "Actin filaments" "Plasma membrane" "HPA065025: AB_2732727" "unprognostic (1.37e-1)" "unprognostic (3.01e-3)" "unprognostic (7.53e-2)" "unprognostic (4.41e-3)" "unprognostic (1.57e-1)" "unprognostic (4.70e-2)" "unprognostic (1.44e-1)" "unprognostic (1.39e-2)" "unprognostic (2.04e-1)" "unprognostic (6.88e-2)" "unprognostic (1.02e-2)" "unprognostic (2.88e-1)" "unprognostic (2.03e-1)" "unprognostic (1.45e-1)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (1.87e-1)" 2.5 1.3 1.1 2.9 1.9 15.3 0.7 1.0 10.2 0.6 0.6 0.2 0.2 2.5 0.9 2.7 0.9 1.3 2.1 1.0 1.7 1.3 1.0 0.9 2.5 2.0 2.1 1.5 1.1 1.0 0.1 0.8 7.6 8.2 0.9 0.0 1.6 0.9 0.5 2.2 1.1 2.6 0.3 1.5 12.6 0.7 52.3 0.1 0.0 0.8 0.1 0.1 1.4 1.3 0.0 0.0 80.0 0.3 0.0 0.0 0.1 0.0 1.1 0.0 2.0 0.1 0.2 0.0 0.3 0.4 0.0 0.1 2.7 0.0 8.6 5.8 0.0 3.3 0.0 1.6 0.5 0.1 6.1 0.2 1.2 1.1 0.4 0.0 0.0 1.1 0.4 0.0 0.6 0.0 0.6 0.0 1.1 0.0 0.0 0.6 0.1 0.0 0.4 0.0 0.3 1.6 1.7 3.2 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 8.9 0.2 0.1 3.5 0.4 2.8 1.9 0.0 0.2 0.3 0.6 2.5 3.3 0.3 0.0 0.1 30.6 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 80.0 0.0 0.3 0.0 0.0 0.1 1.1 1.9 1.0 10.2 1.7 1.3 2.1 1.5 8.2 0.1 0.0 0.0 0.0 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.0 0.0 7.5 0.0 0.0 185.3 0.1 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 2.3 0.0 0.0 0.6 0.0 1098.7 7.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 5.6 0.0 0.4 0.0 0.0 8.2 3.8 0.0 198.7 0.0 0.0 0.0 PI4KA "PI4K-ALPHA, pi4K230, PIK4CA" ENSG00000241973 "Phosphatidylinositol 4-kinase alpha" P42356 22 20707691-20859417 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 48.0" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "K-562: 52.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009092, HPA075515" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 18000 Nucleoplasm "Plasma membrane" "CAB009092: AB_2164033, HPA075515: AB_2686753" "unprognostic (8.06e-2)" "unprognostic (1.53e-1)" "unprognostic (1.20e-2)" "unprognostic (4.45e-2)" "unprognostic (1.21e-1)" "unprognostic (5.01e-3)" "unprognostic (3.19e-2)" "prognostic favorable (5.24e-4)" "unprognostic (2.08e-1)" "unprognostic (4.21e-2)" "unprognostic (1.88e-2)" "unprognostic (1.29e-1)" "prognostic favorable (7.22e-5)" "unprognostic (1.37e-1)" "unprognostic (1.33e-1)" "unprognostic (2.35e-1)" "unprognostic (1.50e-1)" 7.7 9.2 28.8 10.5 34.2 12.5 6.5 14.1 48.0 9.7 8.8 10.1 4.9 9.1 9.7 6.1 8.3 8.4 8.0 8.5 30.4 19.2 9.0 12.6 9.0 11.2 19.0 25.9 10.2 8.6 25.6 12.5 10.4 19.3 9.8 8.9 10.8 6.8 10.6 7.1 6.6 10.0 13.2 6.8 10.2 9.9 13.1 8.2 17.9 9.9 2.9 10.2 8.4 4.8 5.0 12.5 7.6 5.5 9.1 7.7 2.9 9.9 8.4 7.4 11.1 21.2 12.8 10.6 9.0 13.7 13.3 13.1 6.5 4.2 18.7 5.4 18.1 13.1 8.8 14.0 8.7 8.2 15.9 21.5 19.2 11.3 7.4 10.6 19.0 15.4 11.4 5.5 11.3 6.3 8.7 10.8 5.7 52.4 15.9 10.3 13.7 16.6 6.5 5.8 17.8 8.7 16.7 16.2 3.4 7.4 15.9 18.2 13.3 11.8 13.8 9.4 10.8 11.6 8.7 10.9 24.3 12.6 8.9 7.6 12.2 12.4 14.9 16.0 13.7 10.1 3.1 5.5 7.3 5.1 5.4 4.9 4.6 5.6 6.1 3.6 5.0 5.7 7.7 7.6 9.1 4.6 12.5 5.8 2.9 28.8 34.2 14.1 48.0 30.4 19.2 19.0 25.9 19.3 8.2 11.9 25.4 14.0 5.7 9.0 32.8 25.7 25.5 6.7 9.1 7.0 45.2 15.6 1.7 8.5 30.2 12.8 18.2 0.0 5.5 16.0 10.8 10.3 11.5 15.5 17.4 35.0 18.4 14.7 15.5 19.2 18.4 16.5 10.1 6.4 16.8 22.8 7.1 10.5 22.6 9.1 23.8 25.8 10.5 32.1 28.9 8.5 16.7 13.3 12.7 7.0 PIEZO2 "C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771" ENSG00000154864 "Piezo type mechanosensitive ion channel component 2" Q9H5I5 18 10666483-11148762 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport" "Ion channel" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.3" "Cell type enhanced" "Detected in some" 10 "Cholangiocytes: 10.2;Ciliated cells: 13.4;Early spermatids: 23.3;Ito cells: 22.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 9.6;BJ hTERT+ SV40 Large T+: 10.7;BJ hTERT+ SV40 Large T+ RasG12V: 14.9;HeLa: 23.8;U-266/70: 15.2;U-698: 9.9" "Low region specificity" "Detected in single" "HPA015986, HPA031974, HPA040616" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043" "unprognostic (1.36e-1)" "unprognostic (1.92e-1)" "unprognostic (9.21e-2)" "unprognostic (2.53e-2)" "unprognostic (7.84e-2)" "unprognostic (3.16e-2)" "unprognostic (3.87e-2)" "unprognostic (4.34e-3)" "unprognostic (6.55e-2)" "unprognostic (3.89e-2)" "unprognostic (6.06e-2)" "unprognostic (2.23e-1)" "prognostic unfavorable (9.57e-7)" "unprognostic (1.12e-3)" "unprognostic (1.09e-1)" "unprognostic (9.04e-2)" "unprognostic (1.83e-2)" 0.9 0.3 3.1 0.9 2.3 0.0 1.9 0.1 3.6 0.9 3.3 0.0 0.3 1.6 5.8 0.8 5.9 0.0 5.2 2.1 0.9 4.5 7.4 0.5 5.8 0.6 1.7 0.0 0.6 0.0 3.4 1.3 0.0 3.3 0.0 0.8 0.9 1.9 10.3 2.7 1.4 0.9 1.3 0.2 4.6 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 1.2 9.6 0.0 0.0 0.0 0.0 0.5 2.8 10.7 14.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 6.9 0.0 0.3 0.0 23.8 5.6 3.4 0.0 0.0 0.0 0.2 2.7 0.7 0.1 3.3 0.3 0.0 0.2 1.7 0.0 0.1 0.0 3.0 4.1 0.0 0.0 0.0 4.2 0.0 3.3 8.3 0.0 0.1 0.0 0.5 4.5 0.0 2.7 0.0 0.0 3.8 0.2 0.5 15.2 0.1 9.9 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 0.0 0.4 0.7 0.0 1.4 10.2 13.4 1.2 0.0 0.0 0.0 0.0 0.1 23.3 0.9 0.0 0.0 0.2 0.0 3.1 0.1 4.7 4.5 0.7 0.0 0.0 22.1 4.0 8.6 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 6.5 0.4 0.0 0.4 0.6 0.3 0.0 0.0 0.0 PIGB ENSG00000069943 "Phosphatidylinositol glycan anchor biosynthesis class B" Q92521 15 55318960-55355648 "Predicted membrane proteins" "GPI-anchor biosynthesis" "Glycosyltransferase, Transferase" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039929 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039929: AB_10673539" "unprognostic (1.91e-2)" "unprognostic (7.45e-2)" "unprognostic (3.00e-1)" "unprognostic (2.03e-2)" "unprognostic (2.96e-2)" "unprognostic (4.65e-2)" "unprognostic (2.04e-1)" "unprognostic (3.37e-3)" "unprognostic (7.52e-2)" "unprognostic (3.52e-2)" "unprognostic (2.56e-2)" "unprognostic (4.27e-2)" "unprognostic (2.13e-1)" "unprognostic (1.30e-1)" "unprognostic (2.86e-1)" "unprognostic (5.93e-2)" "unprognostic (4.24e-2)" 9.5 11.9 5.7 13.0 11.9 11.2 10.4 3.9 9.3 7.1 8.5 8.2 6.6 9.1 10.5 13.2 11.1 9.5 10.0 6.3 5.9 5.9 12.4 10.3 8.8 20.1 6.9 6.8 8.7 8.1 19.2 12.5 8.7 8.6 9.7 9.4 13.0 9.6 8.4 3.2 8.1 11.6 7.0 8.9 14.2 9.3 17.4 6.0 11.5 16.3 6.2 16.2 10.7 9.3 8.4 8.1 20.1 11.5 5.6 8.9 6.4 7.5 8.7 4.0 3.1 4.4 9.0 5.7 6.3 12.7 7.1 11.4 3.8 7.9 7.3 8.4 8.8 11.0 12.7 2.5 6.6 6.0 7.3 5.7 7.2 10.9 4.7 7.9 20.5 6.3 9.4 8.2 5.6 7.2 9.1 8.8 6.6 8.5 6.2 9.4 6.6 2.5 8.0 2.5 5.8 4.4 3.2 3.9 16.7 11.0 8.3 2.3 4.5 5.8 9.4 11.0 3.8 10.1 14.9 6.7 9.6 3.2 2.5 12.7 6.2 11.1 6.5 8.5 23.1 6.9 10.5 8.9 4.1 8.3 10.4 8.9 8.4 8.3 8.6 8.1 5.4 7.0 7.8 20.1 5.6 11.5 6.3 8.6 6.4 5.7 11.9 3.9 9.3 5.9 5.9 6.9 6.8 8.6 6.0 8.9 7.4 8.6 8.7 4.0 2.7 2.6 2.5 8.1 12.5 0.0 11.8 10.0 1.7 6.2 16.8 4.5 5.2 0.0 9.7 9.3 4.1 4.1 8.1 3.8 7.5 1.6 6.3 7.4 6.5 2.4 1.4 6.3 3.3 8.2 3.7 3.1 5.9 4.2 1.4 8.2 9.1 6.5 4.7 2.6 3.0 3.4 5.5 8.6 3.7 3.3 PIGN "MDC4, PIG-N" ENSG00000197563 "Phosphatidylinositol glycan anchor biosynthesis class N" O95427 18 61905255-62187118 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GPI-anchor biosynthesis" Transferase "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 13 "Alveolar cells type 1: 300.7;Alveolar cells type 2: 289.2;Ciliated cells: 257.0;Club cells: 244.5;granulocytes: 147.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039922, HPA040374" Approved Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039922: AB_10805597, HPA040374: AB_10794738" "unprognostic (1.93e-2)" "unprognostic (1.71e-1)" "prognostic favorable (6.51e-4)" "unprognostic (1.03e-1)" "unprognostic (9.99e-2)" "unprognostic (3.99e-2)" "unprognostic (1.23e-1)" "unprognostic (3.99e-1)" "unprognostic (1.64e-2)" "unprognostic (1.75e-1)" "unprognostic (1.15e-1)" "unprognostic (2.81e-1)" "unprognostic (1.78e-1)" "unprognostic (6.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.75e-2)" "unprognostic (2.71e-1)" 12.6 14.1 8.3 10.2 13.2 13.7 13.5 10.5 12.4 15.1 13.2 16.6 12.2 12.0 18.3 12.7 33.2 9.2 11.0 12.8 9.6 7.8 11.2 15.9 9.0 9.5 10.4 8.8 12.9 16.6 19.7 27.2 17.1 11.9 15.2 15.7 14.7 20.3 13.7 15.2 19.0 12.7 9.6 15.4 9.3 17.4 16.2 12.2 18.6 15.3 12.7 18.6 16.8 18.1 13.1 13.4 14.8 10.0 16.3 11.5 4.5 16.7 10.1 10.0 12.7 12.5 17.0 13.4 16.7 13.1 10.9 13.1 13.0 17.1 18.5 24.4 12.6 9.8 23.2 13.4 14.1 17.3 15.4 9.0 11.3 15.5 10.2 9.0 23.1 13.2 9.9 9.5 11.0 12.9 11.9 13.7 13.3 13.3 27.8 12.0 15.2 11.5 7.0 16.9 13.3 9.4 12.4 18.7 17.9 13.5 25.8 11.4 11.8 22.2 15.7 7.0 29.1 25.0 14.8 15.6 22.2 16.3 8.8 12.4 29.5 27.4 9.2 12.2 13.2 21.6 11.4 10.0 7.6 9.6 8.5 9.9 10.3 9.7 9.2 10.8 13.1 11.2 11.5 14.8 16.3 9.0 13.4 7.8 4.5 8.3 13.2 10.5 12.4 9.6 7.8 10.4 8.8 11.9 12.2 300.7 289.2 3.4 7.8 7.1 6.5 7.7 17.8 257.0 244.5 10.4 3.9 7.7 1.7 9.6 3.9 5.3 5.9 0.0 8.3 8.5 5.8 12.6 147.5 11.3 8.7 6.4 6.4 11.6 5.9 5.3 6.6 7.5 3.3 8.2 13.4 8.0 8.7 10.5 3.5 3.7 6.8 6.5 4.1 18.4 4.7 14.9 8.7 5.0 11.9 10.7 PIK3CG ENSG00000105851 "Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma" P48736 7 106865278-106907145 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Angiogenesis, Chemotaxis, Endocytosis, Immunity, Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 24.5;bone marrow: 27.8;lymphoid tissue: 40.8" "Cell type enhanced" "Detected in some" 8 "B-cells: 17.3;Early spermatids: 26.6;granulocytes: 19.7;monocytes: 24.4;T-cells: 17.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 12.4;HL-60: 12.1;HMC-1: 15.5;Karpas-707: 12.9;MOLT-4: 23.5;U-266/70: 31.5;U-937: 22.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA069976 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA069976: AB_2686224" "unprognostic (8.34e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (1.71e-2)" "unprognostic (3.20e-2)" "unprognostic (3.82e-3)" "unprognostic (3.02e-1)" "unprognostic (6.77e-2)" "unprognostic (1.16e-1)" "unprognostic (7.06e-3)" "unprognostic (1.15e-1)" "unprognostic (1.97e-1)" "unprognostic (1.77e-2)" "unprognostic (9.08e-2)" "unprognostic (1.23e-1)" "unprognostic (5.38e-1)" "unprognostic (5.24e-2)" 5.0 1.8 2.2 16.0 3.1 27.8 2.3 0.8 1.7 1.7 4.1 2.7 0.0 2.8 1.7 2.0 2.0 1.8 3.5 1.7 1.7 1.5 1.9 1.5 4.3 13.1 3.0 1.0 1.7 1.5 0.6 1.4 2.0 2.5 2.2 2.6 1.9 3.1 0.5 1.1 1.3 6.1 1.9 6.4 17.4 2.5 7.6 3.0 40.8 2.3 0.9 21.2 4.1 1.5 6.2 5.6 14.2 24.5 5.3 5.6 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 7.6 0.0 0.0 0.0 12.1 15.5 0.0 0.0 0.0 0.0 0.0 4.8 7.4 8.6 12.9 0.0 0.0 23.5 4.6 0.0 0.0 0.0 6.2 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 1.2 0.0 0.1 0.0 0.0 31.5 0.0 11.7 0.0 22.2 2.9 4.6 3.4 14.2 5.6 10.6 5.1 4.7 2.6 4.2 5.6 6.2 2.8 3.8 13.9 5.3 24.5 4.9 2.6 3.6 2.2 3.1 0.8 1.7 1.7 1.5 3.0 1.0 2.5 3.0 0.0 2.6 17.3 0.0 0.7 0.0 0.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 26.6 0.9 0.0 0.0 0.0 0.0 0.1 0.0 19.7 0.5 5.9 0.0 0.0 1.8 11.0 12.8 0.6 13.3 6.8 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.2 3.1 0.3 0.1 17.5 0.0 0.0 PIRT ENSG00000233670 "Phosphoinositide interacting regulator of transient receptor potential channels" P0C851 17 10822475-10838445 "Predicted membrane proteins, Transporters" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "adrenal gland: 7.3;brain: 24.8;intestine: 7.5" "Not detected" "Not detected" "Cancer enriched" "Detected in single" 40 "glioma: 5.4" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HMC-1: 1.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA042337 Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042337: AB_10794795" "unprognostic (2.95e-1)" "unprognostic (2.19e-2)" "unprognostic (7.57e-2)" "unprognostic (6.58e-3)" "unprognostic (9.42e-2)" "unprognostic (2.05e-1)" "unprognostic (2.85e-3)" 0.4 7.3 9.9 3.2 14.0 0.3 0.3 5.6 5.2 0.4 6.3 10.8 0.0 2.9 0.4 0.4 0.8 0.9 0.7 0.3 13.1 11.6 0.3 0.3 0.4 0.3 12.5 2.3 0.4 0.3 0.3 0.1 0.3 24.8 0.4 7.5 0.0 0.4 0.4 0.4 0.4 5.2 2.5 19.9 0.3 4.9 0.5 12.8 0.0 0.3 0.0 0.3 0.4 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.9 14.0 5.6 5.2 13.1 11.6 12.5 2.3 24.8 12.8 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PKD2L2 TRPP5 ENSG00000078795 "Polycystin 2 like 2, transient receptor potential cation channel" Q9NZM6 5 137887968-137942747 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 7.5;testis: 29.3" "Group enriched" "Detected in many" 5 "Early spermatids: 25.9;Spermatocytes: 19.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Karpas-707: 5.9;U-266/70: 4.6" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA041903, HPA043634" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA041903: AB_2677734, HPA043634: AB_2678591" "unprognostic (7.53e-3)" "unprognostic (2.21e-2)" "unprognostic (1.90e-1)" "unprognostic (3.59e-1)" "unprognostic (4.04e-1)" "unprognostic (1.21e-2)" "unprognostic (3.06e-1)" "unprognostic (1.40e-4)" "unprognostic (1.64e-2)" "unprognostic (2.13e-2)" "unprognostic (3.00e-2)" "unprognostic (5.85e-2)" "unprognostic (1.05e-3)" "unprognostic (2.21e-2)" "unprognostic (1.12e-1)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" 0.5 1.5 2.0 0.6 2.5 2.2 1.2 1.7 1.9 0.5 0.3 0.7 0.7 0.3 0.5 1.0 0.5 0.4 0.6 1.7 1.0 0.8 0.4 0.3 0.4 1.3 1.2 1.3 0.6 1.1 0.0 1.5 0.2 1.8 0.5 0.1 0.2 0.7 0.0 3.3 0.8 0.3 0.0 0.7 1.0 0.6 29.3 0.4 0.0 1.0 0.0 0.2 0.4 0.6 3.9 3.5 7.5 1.7 1.9 1.9 0.8 1.6 1.2 0.2 0.1 0.4 0.5 1.8 0.6 0.0 0.0 0.0 0.1 3.2 2.3 3.5 0.0 0.1 0.7 0.1 0.0 0.1 1.5 1.1 1.3 4.2 0.1 0.0 0.4 1.8 0.1 0.2 0.0 0.0 0.7 0.6 3.3 1.5 5.9 0.8 0.5 1.1 2.4 0.6 0.1 1.0 0.0 0.1 0.0 0.0 2.3 0.8 0.9 1.5 0.2 0.9 0.7 0.4 0.5 0.5 1.0 1.8 0.7 1.0 4.6 3.4 0.4 2.3 0.7 1.8 7.1 1.7 3.0 1.8 1.2 1.0 2.5 1.6 1.4 0.9 3.9 1.9 1.7 7.5 1.9 1.0 3.5 1.1 0.8 2.0 2.5 1.7 1.9 1.0 0.8 1.2 1.3 1.8 0.4 3.0 2.1 0.5 1.6 1.9 2.3 1.5 0.0 0.0 1.2 0.0 0.0 0.3 0.0 0.1 25.9 0.8 0.0 0.0 0.0 0.1 1.3 1.3 1.1 0.2 0.2 3.2 0.0 1.3 0.6 4.7 0.6 0.2 3.3 0.0 0.0 0.9 0.1 0.0 0.4 0.2 3.9 0.0 1.2 19.5 2.2 1.0 0.1 0.7 0.0 0.5 PKP1 B6P ENSG00000081277 "Plakophilin 1" Q13835 1 201283452-201332993 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Developmental protein" "Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 80.1;skin 1: 137.6;tongue: 129.6" "Group enriched" "Detected in many" 5 "Basal keratinocytes: 124.1;Suprabasal keratinocytes: 357.5" "Cancer enhanced" "Detected in many" "head and neck cancer: 295.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "HaCaT: 45.1;HBEC3-KT: 27.6;hTCEpi: 98.2;hTERT-HME1: 26.1;PC-3: 37.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027221, CAB033130" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 2700000 "Nucleoplasm, Plasma membrane" "CAB033130: AB_2164139, HPA027221: AB_10599737" "unprognostic (3.55e-3)" "unprognostic (7.63e-2)" "unprognostic (1.99e-1)" "unprognostic (2.13e-1)" "unprognostic (1.03e-1)" "unprognostic (7.17e-2)" "unprognostic (2.40e-2)" "unprognostic (3.48e-2)" "unprognostic (1.49e-1)" "unprognostic (5.02e-2)" "unprognostic (2.20e-3)" "unprognostic (2.67e-1)" "unprognostic (9.17e-3)" "unprognostic (2.52e-2)" "unprognostic (1.61e-1)" "unprognostic (1.45e-1)" "unprognostic (6.59e-3)" 10.1 0.1 0.0 0.1 0.0 0.1 7.0 0.0 0.4 19.7 0.5 0.0 2.5 0.1 1.5 1.9 80.1 0.3 0.1 0.1 0.0 0.0 0.1 0.1 1.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 1.6 0.0 6.8 0.1 4.9 10.1 3.9 2.1 137.6 0.2 0.1 0.0 0.1 0.1 0.1 0.0 9.2 0.1 129.6 37.2 1.2 27.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 45.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.2 1.1 26.1 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 37.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.5 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 46.2 124.1 6.7 1.3 0.0 0.0 4.5 0.0 2.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 1.0 0.0 7.1 21.9 0.0 0.0 0.1 4.8 0.0 0.0 0.0 0.0 0.0 0.0 15.1 0.0 1.2 3.2 9.4 0.0 0.0 0.0 37.2 0.0 3.9 0.0 0.0 357.5 0.1 0.0 0.0 44.2 PKP4 p0071 ENSG00000144283 "Plakophilin 4" Q99569 2 158456964-158682879 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 111.7" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.3" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037334, HPA066647, HPA070648" Approved Enhanced "Plasma membrane,Cell Junctions" NA NA "Cell Junctions" "Plasma membrane" "CAB037334: , HPA066647: AB_2685696, HPA070648: AB_2686291" "unprognostic (2.76e-1)" "unprognostic (5.26e-2)" "unprognostic (1.48e-2)" "prognostic favorable (5.80e-4)" "unprognostic (2.34e-2)" "unprognostic (1.63e-1)" "unprognostic (1.02e-3)" "unprognostic (2.43e-1)" "unprognostic (1.04e-2)" "unprognostic (9.53e-2)" "unprognostic (1.82e-2)" "unprognostic (9.69e-2)" "prognostic favorable (3.29e-7)" "unprognostic (2.23e-1)" "unprognostic (9.80e-2)" "unprognostic (1.33e-3)" "unprognostic (2.28e-3)" 7.3 3.9 42.7 3.7 42.1 4.2 15.5 14.5 26.6 19.8 7.1 49.9 6.9 7.1 8.3 8.9 10.7 11.8 8.9 12.1 47.7 31.2 34.2 9.7 7.3 3.0 66.9 14.7 8.3 8.7 12.2 6.6 3.4 28.4 7.8 8.1 10.4 19.3 13.1 4.0 9.4 6.4 8.5 111.7 3.2 7.7 5.6 31.6 3.3 18.2 2.4 5.5 9.1 6.9 0.1 0.7 1.0 5.3 0.0 2.1 0.5 16.7 9.3 12.9 14.6 5.9 6.5 12.3 14.0 7.5 21.1 18.3 31.3 15.9 10.7 10.4 16.2 7.7 13.6 16.6 13.9 35.3 16.1 8.5 10.1 10.5 25.5 10.0 16.0 2.2 2.8 13.5 14.5 22.1 12.8 10.6 13.8 13.7 17.1 16.0 18.5 7.0 6.8 13.7 23.4 7.1 9.3 19.2 9.2 31.1 12.1 22.4 4.0 9.7 14.6 11.4 12.4 17.3 14.7 4.9 12.6 14.2 9.3 17.5 9.8 8.2 7.9 7.4 8.8 12.2 0.0 1.0 0.0 0.4 0.3 0.7 0.0 1.5 0.6 0.4 0.1 1.2 0.4 1.0 0.0 5.3 0.7 2.1 0.5 42.7 42.1 14.5 26.6 47.7 31.2 66.9 14.7 28.4 31.6 38.7 17.6 4.9 19.0 24.0 32.4 44.7 50.9 33.5 34.2 45.4 27.5 0.3 19.9 20.4 10.2 56.2 10.3 23.3 15.9 0.3 10.4 28.3 9.3 23.7 2.6 4.8 8.6 20.3 8.1 7.0 10.0 6.7 6.8 1.8 17.6 8.1 14.4 10.5 15.9 25.9 18.6 12.9 13.4 10.7 5.9 26.6 0.2 3.5 19.5 18.6 PLCB2 FLJ38135 ENSG00000137841 "Phospholipase C beta 2" Q00722 15 40278176-40307935 "Enzymes, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 30.5;lymphoid tissue: 36.3" "Group enriched" "Detected in many" 4 "Alveolar cells type 2: 25.1;granulocytes: 25.5;Hofbauer cells: 26.0;Kupffer cells: 49.0;Macrophages: 28.1;T-cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HEL: 31.5;HMC-1: 39.3;THP-1: 11.4;U-937: 21.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB009443, HPA041298, HPA068595, HPA069308" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB009443: AB_632197, HPA041298: AB_2677395, HPA068595: , HPA069308: " "unprognostic (5.52e-2)" "unprognostic (4.96e-3)" "unprognostic (6.09e-3)" "unprognostic (1.88e-2)" "unprognostic (1.31e-1)" "prognostic favorable (3.00e-4)" "unprognostic (1.66e-1)" "unprognostic (3.08e-2)" "unprognostic (1.28e-1)" "unprognostic (2.34e-1)" "unprognostic (1.42e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (7.20e-5)" "unprognostic (9.89e-2)" "unprognostic (2.06e-3)" "unprognostic (5.81e-2)" "unprognostic (1.13e-1)" 6.3 3.6 8.1 17.6 11.6 30.5 2.9 1.1 7.5 2.9 3.3 16.2 1.7 4.0 2.8 3.2 2.4 4.6 6.5 3.3 6.9 5.1 3.3 4.2 12.5 17.2 12.7 2.4 1.6 2.0 1.3 2.9 4.6 9.3 3.2 5.5 4.1 5.2 2.9 1.3 1.5 10.2 4.8 17.9 36.3 3.6 1.4 10.9 12.2 2.8 1.8 17.6 6.9 2.5 1.0 4.5 8.5 4.3 1.8 3.1 2.0 0.1 0.0 0.2 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 7.8 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 6.7 39.3 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.3 1.7 0.0 0.0 1.8 3.6 0.4 0.0 0.1 5.5 0.8 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 2.3 0.0 11.4 4.1 0.0 3.8 0.0 0.0 0.0 0.0 1.5 0.0 21.6 0.0 2.7 4.2 8.5 3.1 4.3 2.0 0.7 1.6 1.6 4.5 1.0 1.6 1.8 6.9 1.8 4.2 1.6 2.9 2.0 8.1 11.6 1.1 7.5 6.9 5.1 12.7 2.4 9.3 10.9 6.0 25.1 3.4 0.1 0.8 0.0 2.8 2.5 6.7 5.7 1.8 0.0 0.4 0.0 0.1 1.0 0.4 0.0 0.0 0.0 0.4 1.0 0.0 25.5 0.2 26.0 0.0 0.0 1.8 49.0 0.4 0.3 28.1 3.3 0.0 0.8 0.0 0.2 0.0 0.0 0.7 0.2 0.0 0.3 0.2 2.1 0.5 0.3 15.9 1.2 0.0 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "brain: 18.6;testis: 5.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 7.2;Horizontal cells: 3.2" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 12.3;SH-SY5Y: 22.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.5 1.8 7.8 0.7 8.7 0.5 0.5 0.8 18.6 1.4 0.6 2.1 0.0 0.7 0.7 0.5 0.6 0.5 0.6 0.5 8.0 6.6 0.7 0.5 0.7 0.5 2.5 4.5 0.6 1.6 0.5 0.3 0.5 3.6 0.6 0.8 1.8 0.5 1.0 0.9 0.6 0.7 0.6 1.0 0.5 0.7 5.5 1.8 0.0 0.5 0.0 0.5 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 12.3 0.0 0.0 0.0 0.5 0.1 0.4 22.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.8 8.7 0.8 11.6 8.0 6.6 2.5 4.5 3.6 1.8 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.7 0.2 1.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 PLS3 T-plastin ENSG00000102024 "Plastin 3" P13797 X 115561174-115650861 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Alveolar cells type 1: 196.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "NK-cell: 4.2;plasmacytoid DC: 13.1" "Group enriched" "Detected in many" 6 "dendritic cells: 13.1;NK-cells: 4.2" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020433, HPA076083" Approved Approved "Plasma membrane,Cytosol" NA NA 110000000 "Plasma membrane, Cytosol" "HPA020433: AB_2670440, HPA076083: AB_2686773" "unprognostic (1.32e-1)" "unprognostic (1.85e-2)" "unprognostic (6.10e-2)" "unprognostic (4.37e-2)" "unprognostic (9.63e-2)" "prognostic unfavorable (6.07e-5)" "unprognostic (2.40e-1)" "unprognostic (1.71e-1)" "unprognostic (1.83e-2)" "unprognostic (1.31e-1)" "prognostic unfavorable (4.59e-4)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (5.15e-2)" "unprognostic (1.54e-1)" "prognostic favorable (3.72e-4)" "prognostic unfavorable (7.04e-4)" 41.9 11.0 11.8 9.8 12.5 0.2 24.6 3.6 16.7 43.8 14.3 13.9 24.1 6.0 37.4 27.6 54.4 21.5 23.6 18.8 12.2 8.2 40.7 100.5 64.7 6.0 14.7 13.7 44.4 8.9 2.7 4.6 21.9 22.7 21.6 9.2 10.6 16.6 31.4 17.7 38.4 8.2 34.6 14.5 31.6 13.3 14.9 13.0 5.1 64.8 34.7 12.5 38.7 29.0 0.0 13.1 0.4 0.1 4.2 1.5 0.2 28.1 29.0 25.4 7.3 25.7 24.0 38.8 29.4 33.2 28.2 34.2 31.4 23.5 0.1 85.2 24.2 20.9 36.3 26.9 47.9 45.9 0.4 33.7 2.7 36.0 13.1 23.3 0.0 1.4 15.2 23.0 43.6 30.8 45.6 61.1 2.3 0.0 0.0 26.9 8.2 0.0 0.3 33.7 12.2 34.8 0.0 17.0 0.6 33.7 15.3 0.0 5.3 61.8 15.4 12.4 38.4 8.5 0.4 66.8 45.8 7.8 46.6 58.8 1.1 4.1 0.5 20.0 0.1 18.9 0.4 0.0 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.4 0.0 0.0 0.0 0.1 4.2 0.0 13.1 1.5 0.2 11.8 12.5 3.6 16.7 12.2 8.2 14.7 13.7 22.7 13.0 196.5 74.7 2.9 91.8 110.9 0.2 12.5 20.4 13.4 73.9 94.2 0.0 2.1 11.6 57.0 8.6 106.8 2.5 0.0 46.9 97.6 65.4 15.9 0.0 74.6 3.6 0.0 12.7 79.2 6.3 6.5 48.1 4.7 54.0 1.0 5.7 24.0 49.2 4.3 77.8 17.5 1.2 51.8 106.6 1.2 20.9 117.2 3.8 4.3 11.8 92.1 POLE POLE1 ENSG00000177084 "DNA polymerase epsilon, catalytic subunit" Q07864 12 132623753-132687365 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, DNA replication" "DNA-binding, DNA-directed DNA polymerase, Hydrolase, Nucleotidyltransferase, Transferase" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Sertoli cells: 25.8;Spermatocytes: 25.4" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 34.8" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA058210, HPA067385" Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA058210: AB_2683639, HPA067385: AB_2685830" "unprognostic (1.60e-1)" "unprognostic (1.77e-3)" "unprognostic (2.00e-1)" "unprognostic (9.17e-2)" "unprognostic (1.68e-1)" "unprognostic (2.01e-2)" "unprognostic (3.96e-3)" "unprognostic (2.23e-1)" "prognostic unfavorable (1.44e-4)" "unprognostic (7.12e-2)" "unprognostic (2.21e-1)" "unprognostic (1.67e-1)" "prognostic unfavorable (3.19e-8)" "unprognostic (8.60e-2)" "unprognostic (3.18e-1)" "unprognostic (1.28e-1)" "unprognostic (9.95e-2)" 6.1 3.4 6.7 10.2 4.4 29.3 6.2 34.8 14.4 7.0 6.6 2.0 7.6 7.3 6.1 4.4 7.5 6.2 6.5 4.7 5.6 1.6 3.8 8.6 5.4 8.2 3.3 4.3 8.7 6.8 3.6 3.1 6.5 5.1 6.8 7.7 4.3 8.7 7.4 8.9 17.9 8.5 6.8 3.7 16.7 7.8 25.6 4.4 29.8 5.1 6.0 10.3 6.7 8.7 0.5 1.7 0.8 0.8 4.8 0.7 0.5 11.2 15.0 22.3 10.6 4.7 3.7 19.9 11.5 5.2 13.8 10.1 18.2 6.7 12.9 4.9 6.2 5.3 15.7 15.5 7.8 8.4 6.0 19.6 20.4 19.4 8.9 0.9 15.9 11.7 2.8 3.1 14.4 4.7 3.8 4.8 16.6 22.8 7.3 6.8 18.2 26.1 29.2 17.3 5.3 9.0 21.7 12.6 5.8 4.4 18.4 18.6 10.7 13.4 11.0 2.5 11.2 16.2 9.9 4.4 12.6 12.9 9.5 11.6 9.7 6.5 20.3 6.9 22.0 8.9 0.0 0.3 0.8 0.5 0.1 0.7 0.5 0.3 0.4 0.7 0.3 0.5 0.3 0.1 4.8 0.8 1.7 0.6 0.5 6.7 4.4 34.8 14.4 5.6 1.6 3.3 4.3 5.1 4.4 0.0 7.9 4.5 3.5 5.0 8.1 5.6 0.0 2.7 0.0 1.8 0.0 6.2 0.0 2.1 6.5 3.0 4.7 0.0 2.7 9.0 4.7 3.7 2.3 8.9 10.4 0.0 6.9 12.9 7.9 7.0 6.4 3.2 5.0 1.0 6.7 3.7 2.4 5.8 3.2 0.8 5.0 25.8 3.3 25.4 7.9 6.8 3.3 5.7 9.8 2.5 PPEF1 "PPEF, PPP7CA" ENSG00000086717 "Protein phosphatase with EF-hand domain 1" O14829 X 18675909-18827921 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;testis: 20.2" "Group enriched" "Detected in some" 11 "Early spermatids: 51.1;Late spermatids: 94.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "myeloid DC: 1.3" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 3.6;HAP1: 1.3;HeLa: 5.3;SH-SY5Y: 2.9;SK-MEL-30: 1.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA034577 Uncertain "Plasma membrane,Cytokinetic bridge" Yes NA "Plasma membrane" "Cytokinetic bridge" "HPA034577: AB_10602817" "unprognostic (4.13e-2)" "unprognostic (1.30e-1)" "unprognostic (9.06e-2)" "unprognostic (9.85e-2)" "unprognostic (3.84e-2)" "unprognostic (5.00e-2)" "unprognostic (2.38e-1)" "unprognostic (3.43e-2)" "unprognostic (4.96e-3)" "unprognostic (9.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.89e-1)" "unprognostic (1.10e-11)" "unprognostic (5.41e-3)" "unprognostic (2.75e-1)" "unprognostic (2.97e-2)" "unprognostic (1.19e-2)" 0.1 0.5 3.1 0.2 6.4 1.4 3.9 0.2 10.6 0.2 0.2 0.1 0.0 0.1 0.3 0.9 0.2 0.2 0.3 0.3 1.9 1.0 0.3 0.1 0.4 0.3 1.7 6.9 0.2 0.2 0.1 0.7 1.0 0.2 0.5 0.1 0.0 0.3 0.6 0.1 0.7 0.1 0.2 10.5 0.3 0.1 20.2 0.0 0.1 0.4 0.0 0.3 0.4 0.1 0.2 1.3 0.0 0.9 0.0 0.0 0.2 0.0 3.6 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.3 0.0 0.0 0.3 1.2 0.0 5.3 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.3 2.9 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.6 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.1 6.4 0.2 10.6 1.9 1.0 1.7 6.9 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 51.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 6.4 0.0 0.0 0.0 94.3 0.6 0.0 3.3 0.0 0.0 0.5 0.0 0.0 0.7 0.1 0.5 0.0 0.0 0.7 0.7 0.1 0.0 0.0 0.0 0.0 PPFIBP1 "hSGT2, hSgt2p, L2, SGT2" ENSG00000110841 "PPFIA binding protein 1" Q86W92 12 27523431-27695564 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Cardiomyocytes: 154.9;Endothelial cells: 139.6;Ito cells: 144.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive B-cell: 7.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "SuSa: 53.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA001924 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA001924: AB_1079665" "unprognostic (5.27e-2)" "unprognostic (5.71e-2)" "unprognostic (3.10e-2)" "prognostic unfavorable (6.29e-4)" "unprognostic (4.73e-2)" "unprognostic (6.94e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (5.11e-4)" "unprognostic (7.33e-2)" "unprognostic (3.84e-2)" "prognostic unfavorable (2.56e-4)" "unprognostic (1.92e-2)" "prognostic favorable (5.11e-7)" "unprognostic (8.54e-2)" "unprognostic (7.54e-2)" "unprognostic (2.64e-1)" "unprognostic (4.09e-2)" 21.3 17.1 15.5 8.0 16.8 2.2 22.6 4.9 25.0 18.3 15.4 13.3 13.0 7.1 28.1 9.3 17.1 16.5 12.2 43.3 17.1 9.0 23.8 15.7 25.0 7.8 13.1 16.4 53.1 13.7 12.7 22.2 34.5 15.3 15.3 11.1 8.1 14.2 18.4 13.7 17.8 10.0 20.5 11.2 16.6 15.1 7.1 13.3 6.2 23.9 14.9 6.2 17.2 18.4 7.0 2.0 1.5 0.6 0.3 1.8 0.6 4.4 8.9 7.3 6.2 12.1 33.8 13.0 16.1 18.1 9.5 13.7 23.4 13.5 3.3 18.8 32.6 12.7 11.1 3.9 14.7 17.1 7.6 2.2 7.4 6.8 3.4 5.3 2.2 4.1 26.2 10.3 27.6 28.4 18.6 32.4 4.5 3.8 3.4 33.7 3.4 2.1 0.6 13.0 6.3 6.9 3.4 18.1 1.2 14.1 9.8 0.6 3.0 8.0 4.3 22.4 53.2 5.5 3.4 31.5 26.8 9.0 14.6 16.4 0.0 0.0 0.2 29.8 3.2 42.2 1.5 0.6 0.3 0.7 0.2 1.4 0.7 1.3 0.7 0.6 7.0 1.3 1.3 1.5 0.3 0.2 2.0 1.8 0.6 15.5 16.8 4.9 25.0 17.1 9.0 13.1 16.4 15.3 13.3 92.3 20.3 24.3 55.3 36.5 2.3 154.9 2.5 9.4 14.8 76.8 3.9 28.5 10.0 37.2 2.6 139.6 7.0 0.0 21.6 18.9 41.3 34.7 3.5 12.7 8.3 42.9 17.9 144.9 21.5 3.1 19.5 6.4 59.1 3.6 14.6 7.5 26.9 14.4 39.6 16.6 1.7 19.4 44.8 1.7 9.1 24.1 76.9 5.9 11.5 75.3 PPIP5K1 "HISPPD2A, IPS1, KIAA0377, VIP1" ENSG00000168781 "Diphosphoinositol pentakisphosphate kinase 1" Q6PFW1 15 43533462-43590253 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.4" "Cell type enhanced" "Detected in many" 9 "Cone photoreceptor cells: 39.3;Rod photoreceptor cells: 42.3" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039380 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039380: AB_10673528" "unprognostic (8.72e-2)" "unprognostic (6.49e-2)" "unprognostic (1.90e-2)" "unprognostic (1.12e-1)" "unprognostic (2.38e-1)" "unprognostic (2.78e-1)" "unprognostic (8.18e-2)" "unprognostic (5.78e-2)" "unprognostic (2.59e-3)" "prognostic unfavorable (8.57e-4)" "unprognostic (6.67e-2)" "unprognostic (2.85e-3)" "prognostic favorable (7.14e-8)" "unprognostic (2.67e-2)" "unprognostic (3.35e-2)" "unprognostic (5.92e-3)" "unprognostic (7.95e-3)" 1.7 5.2 3.4 1.8 6.4 1.1 3.4 28.4 7.0 2.8 6.1 9.1 2.2 5.6 3.7 3.1 2.5 2.1 3.6 5.0 2.5 1.4 1.4 2.0 3.3 3.0 2.9 13.4 7.6 0.9 3.4 6.5 4.7 2.7 6.3 7.2 8.8 2.3 2.8 2.3 5.3 4.5 5.0 3.0 3.3 2.7 5.3 3.2 4.3 2.8 3.5 3.8 3.0 8.4 5.6 4.9 9.1 3.0 1.9 8.4 4.2 5.4 6.1 9.0 6.4 8.1 7.9 6.4 5.8 9.1 23.1 9.5 18.4 6.2 7.8 7.5 11.9 16.9 3.4 6.8 13.6 12.4 3.4 16.2 7.4 11.4 8.3 6.4 18.6 8.6 11.8 4.5 6.6 4.5 7.7 2.4 15.9 6.0 9.7 5.0 4.0 6.6 15.3 14.8 4.6 10.9 10.4 4.1 7.3 19.2 11.4 2.8 5.3 6.4 6.7 10.2 2.6 3.2 9.8 10.0 15.6 5.1 4.3 1.4 0.0 2.7 2.8 3.8 5.3 3.3 3.6 3.2 3.6 2.7 2.5 1.0 3.5 2.1 2.4 0.8 3.0 0.0 2.1 0.0 1.5 3.5 15.3 4.0 5.1 0.0 2.3 7.0 39.3 2.7 0.0 2.1 1.7 2.4 8.8 0.0 1.3 0.8 0.8 1.3 0.0 1.1 1.6 9.5 2.4 4.3 2.7 1.6 1.7 1.6 0.0 1.0 5.0 4.3 1.8 3.5 6.7 1.4 42.3 6.5 1.0 6.6 1.3 2.9 1.8 2.1 7.6 3.2 PPM1A "MGC9201, PP2CA, PP2Calpha" ENSG00000100614 "Protein phosphatase, Mg2+/Mn2+ dependent 1A" P35813 14 60245752-60299087 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 4 "Early spermatids: 362.9;Late spermatids: 423.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029209 Approved Supported "Plasma membrane,Cytosol" NA NA 850000 Cytosol "Plasma membrane" "HPA029209: AB_2672951" "unprognostic (3.14e-1)" "unprognostic (2.14e-1)" "unprognostic (5.64e-2)" "unprognostic (1.85e-1)" "unprognostic (4.00e-2)" "unprognostic (2.30e-2)" "unprognostic (4.50e-2)" "unprognostic (1.11e-1)" "unprognostic (3.43e-1)" "unprognostic (2.89e-2)" "unprognostic (7.96e-2)" "unprognostic (1.29e-1)" "prognostic favorable (1.57e-9)" "unprognostic (1.58e-2)" "unprognostic (1.12e-1)" "unprognostic (1.57e-2)" "unprognostic (1.37e-1)" 16.2 11.7 13.8 15.0 18.3 64.0 15.1 20.5 28.6 15.5 32.4 13.3 9.4 19.1 17.4 12.7 15.2 10.7 10.8 37.1 13.5 16.1 22.8 26.7 14.6 11.8 15.6 19.1 12.1 13.3 18.2 12.2 15.8 24.3 16.5 19.4 12.3 18.7 13.5 56.1 16.7 25.2 15.0 13.8 11.6 14.9 29.7 12.7 23.4 13.3 11.6 13.4 15.2 16.5 4.0 2.7 8.0 2.1 4.7 4.5 1.9 48.6 11.0 9.6 8.1 14.7 13.6 12.2 13.4 15.7 10.0 9.5 6.2 14.4 29.3 12.8 15.1 7.4 10.8 9.9 13.8 17.5 26.3 5.6 18.0 7.8 9.6 12.3 20.4 12.9 11.5 16.6 11.7 16.0 11.7 9.7 15.0 9.9 23.3 12.1 21.3 26.5 4.8 9.0 9.7 9.3 9.5 22.2 9.4 12.0 23.4 16.3 12.2 13.9 16.3 11.3 9.1 16.4 8.9 13.4 20.8 20.8 9.1 9.5 18.2 10.3 34.3 9.5 8.1 10.5 6.7 1.8 5.1 3.5 1.8 3.8 1.7 2.8 3.1 2.7 4.0 2.2 2.1 8.0 4.7 2.1 1.6 4.5 1.9 13.8 18.3 20.5 28.6 13.5 16.1 15.6 19.1 24.3 12.7 14.9 23.5 24.8 36.4 68.7 40.5 85.1 38.2 9.4 15.9 36.6 60.9 27.7 28.2 22.7 362.9 29.7 97.1 70.0 21.2 20.1 41.4 73.1 26.5 65.2 24.8 55.6 58.3 21.5 27.7 423.8 39.1 33.5 57.3 16.2 52.8 37.7 29.2 66.2 49.1 73.2 62.7 38.8 44.2 46.9 24.8 72.0 61.4 35.5 36.5 38.6 PPM1F "CAMKP, CaMKPase, FEM-2, KIAA0015, POPX2" ENSG00000100034 "Protein phosphatase, Mg2+/Mn2+ dependent 1F" P49593 22 21919420-21952837 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ito cells: 61.4;Kupffer cells: 32.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 17.7" "Group enriched" "Detected in many" 7 "dendritic cells: 5.5;granulocytes: 17.7;monocytes: 13.9" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 36.5;K-562: 55.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030989, HPA030990" Approved Approved "Nucleoplasm,Plasma membrane" NA NA 780000 Nucleoplasm "Plasma membrane" "HPA030989: AB_10669549, HPA030990: AB_10601249" "unprognostic (6.26e-2)" "unprognostic (2.50e-1)" "unprognostic (1.82e-1)" "unprognostic (2.11e-1)" "unprognostic (2.51e-1)" "unprognostic (4.77e-3)" "unprognostic (4.88e-3)" "unprognostic (1.94e-1)" "unprognostic (1.70e-1)" "unprognostic (1.65e-2)" "unprognostic (1.45e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (6.03e-5)" "unprognostic (6.44e-2)" "unprognostic (3.02e-2)" "unprognostic (3.30e-1)" "unprognostic (4.11e-2)" 25.0 15.6 14.0 21.8 14.3 24.3 18.4 16.9 16.3 18.1 13.2 7.6 12.5 9.6 17.6 9.7 23.6 12.3 13.1 17.0 13.9 14.9 13.2 8.5 21.6 15.1 11.6 10.1 14.4 10.7 8.3 7.7 28.1 14.5 15.6 4.9 11.2 11.2 16.5 15.8 15.5 11.1 15.4 15.5 31.4 10.5 6.7 10.9 6.2 10.9 15.1 10.2 15.8 37.6 0.7 5.5 17.7 13.9 1.7 1.4 2.8 9.2 9.9 6.4 6.2 3.5 6.3 8.1 10.6 6.3 9.4 6.5 4.5 3.7 5.6 13.3 7.4 4.0 11.2 2.8 6.6 3.3 8.0 9.0 21.7 4.6 4.3 5.9 8.0 5.9 5.9 2.0 9.1 4.3 6.7 36.5 5.6 55.2 2.4 12.0 8.6 4.7 6.2 2.7 2.9 10.9 7.1 16.5 1.6 3.2 3.9 2.6 10.0 10.0 3.3 8.6 2.6 4.1 5.6 30.7 11.3 11.5 10.3 10.1 4.7 3.7 6.2 11.4 15.3 21.6 0.0 7.7 3.3 1.0 12.9 0.7 0.7 0.7 0.6 5.5 0.6 0.7 0.8 17.7 1.7 13.9 1.4 1.4 2.8 14.0 14.3 16.9 16.3 13.9 14.9 11.6 10.1 14.5 10.9 6.0 5.9 5.1 4.4 7.2 7.0 13.1 15.3 4.0 3.4 1.8 2.0 13.3 3.3 4.9 1.1 31.9 2.0 0.0 4.3 7.2 7.7 3.9 3.5 5.5 17.5 7.9 5.8 61.4 32.9 1.1 6.6 18.0 6.8 8.2 3.9 3.8 5.6 0.0 6.3 3.4 6.5 6.5 5.7 7.4 10.5 5.0 2.5 5.7 3.8 5.4 PPP1R12B "MGC131980, MGC87886, MYPT2, PP1bp55" ENSG00000077157 "Protein phosphatase 1 regulatory subunit 12B" O60237 1 202348699-202592706 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "endometrium 1: 105.2" "Cell type enriched" "Detected in many" 7 "Cardiomyocytes: 719.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 7 "neutrophil: 15.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 15.9" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024171, HPA024640" Enhanced Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA024171: AB_1854266, HPA024640: AB_1854265" "unprognostic (5.24e-2)" "unprognostic (8.59e-2)" "unprognostic (1.38e-1)" "unprognostic (2.75e-2)" "unprognostic (3.04e-1)" "unprognostic (5.45e-3)" "unprognostic (3.12e-2)" "unprognostic (9.13e-3)" "unprognostic (4.05e-2)" "unprognostic (3.74e-2)" "unprognostic (2.79e-2)" "unprognostic (1.80e-1)" "unprognostic (3.60e-3)" "unprognostic (6.98e-3)" "unprognostic (1.27e-1)" "unprognostic (1.28e-1)" "unprognostic (1.19e-1)" 10.6 2.8 6.9 8.1 9.0 1.8 7.7 13.9 10.5 55.3 62.0 15.0 31.0 5.8 105.2 9.4 37.4 21.9 17.4 83.1 5.8 4.5 5.0 2.9 8.1 4.2 10.1 9.2 18.7 2.3 2.0 4.5 8.4 9.5 36.4 16.3 13.7 5.7 50.3 17.6 5.3 14.1 59.5 7.3 6.9 20.8 3.4 11.1 1.3 5.0 11.2 3.5 35.1 11.4 2.3 1.7 15.9 1.8 0.7 1.7 0.5 2.6 5.3 4.1 3.9 5.8 4.2 6.7 2.1 2.1 2.2 2.1 2.2 4.7 3.0 1.0 3.9 5.3 8.4 6.0 3.2 2.4 3.8 3.7 3.0 7.7 1.4 1.4 6.3 3.4 3.3 3.7 3.1 3.3 11.3 1.8 3.4 4.4 3.5 3.8 2.0 4.7 4.0 2.8 2.9 1.1 3.1 10.5 4.3 1.8 9.6 5.0 3.8 4.0 4.8 2.4 5.6 4.2 2.9 2.3 3.1 1.9 2.3 1.8 5.2 4.8 3.2 2.9 5.2 12.3 1.8 1.8 1.3 1.7 0.9 1.4 1.7 1.1 1.0 1.4 2.3 1.4 1.0 15.9 0.7 1.4 1.7 1.6 0.5 6.9 9.0 13.9 10.5 5.8 4.5 10.1 9.2 9.5 11.1 11.9 17.5 3.7 31.2 15.3 56.6 719.4 12.7 16.0 18.2 12.2 70.7 12.7 10.0 7.2 30.9 9.2 21.3 0.0 11.3 7.2 19.0 16.4 17.4 6.8 7.8 25.4 23.1 20.9 18.5 10.9 11.2 6.0 8.5 1.8 14.0 11.8 6.3 11.5 48.1 4.5 32.3 32.3 105.4 11.9 13.7 9.5 21.3 11.5 30.2 28.9 PPP1R16B "ANKRD4, KIAA0823, TIMAP" ENSG00000101445 "Protein phosphatase 1 regulatory subunit 16B" Q96T49 20 38805705-38923024 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.4;lymphoid tissue: 35.0" "Cell type enhanced" "Detected in many" 9 "Horizontal cells: 35.0;Ito cells: 32.5;monocytes: 35.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 22.7;HMC-1: 24.5;HUVEC TERT2: 14.5;U-266/70: 39.9;U-266/84: 16.0;U-698: 15.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049571, HPA079512" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA049571: , HPA079512: " "unprognostic (2.62e-2)" "prognostic favorable (2.11e-4)" "unprognostic (2.67e-3)" "unprognostic (3.35e-3)" "unprognostic (2.19e-1)" "prognostic favorable (7.87e-5)" "unprognostic (1.13e-1)" "unprognostic (4.17e-2)" "unprognostic (4.31e-2)" "unprognostic (6.28e-2)" "unprognostic (4.09e-3)" "unprognostic (4.77e-2)" "unprognostic (3.45e-2)" "unprognostic (8.53e-2)" "unprognostic (3.75e-2)" "unprognostic (1.73e-1)" "unprognostic (7.90e-2)" 11.2 3.2 26.3 15.9 44.4 13.0 4.4 19.7 35.1 3.6 4.5 25.6 0.0 3.6 3.5 1.9 3.3 5.8 5.3 4.9 25.5 9.1 24.4 2.6 7.3 30.1 15.0 18.8 1.6 1.5 1.2 1.8 3.7 10.9 2.1 5.1 1.6 2.3 2.3 3.4 1.8 9.2 6.8 18.6 14.4 4.9 1.2 15.1 5.1 3.2 0.5 35.0 7.5 3.7 8.4 4.9 3.5 1.3 3.9 5.2 1.6 0.0 0.3 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 22.7 0.3 0.0 0.3 0.0 0.4 0.0 0.0 0.5 0.1 1.7 0.0 0.0 0.0 0.1 24.5 0.0 0.0 0.0 0.0 0.0 14.5 3.1 0.3 4.8 0.0 0.0 2.8 3.8 3.2 0.0 0.0 1.9 0.0 0.0 0.0 0.0 7.3 8.1 0.0 0.0 0.0 0.3 0.0 1.2 2.2 0.0 0.3 0.0 0.0 39.9 16.0 15.6 0.0 0.0 0.0 0.0 0.3 3.5 5.2 0.7 2.8 8.4 3.7 5.1 1.1 5.4 2.2 3.0 0.0 3.9 1.3 4.9 3.7 1.6 26.3 44.4 19.7 35.1 25.5 9.1 15.0 18.8 10.9 15.1 3.0 4.8 8.3 0.0 0.9 1.2 15.2 0.0 4.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 14.6 0.0 0.0 0.0 0.0 0.5 0.0 3.5 0.0 0.1 35.0 0.0 32.5 3.0 0.6 0.0 2.4 8.5 35.1 0.0 0.2 0.0 0.0 0.0 10.8 0.2 0.0 0.3 0.0 0.2 1.1 0.0 15.0 0.0 0.1 PPP1R18 "KIAA1949, phostensin" ENSG00000146112 "Protein phosphatase 1 regulatory subunit 18" Q6NYC8 6 30676389-30687895 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 54.5" "Cell type enhanced" "Detected in many" 7 "Hofbauer cells: 175.4;monocytes: 233.6;T-cells: 186.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "eosinophil: 54.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 54.5" "Cell line enhanced" "Detected in many" "HMC-1: 35.0;U-937: 36.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044745, HPA051000" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA044745: AB_2679070, HPA051000: AB_2681304" "unprognostic (3.25e-2)" "unprognostic (1.19e-1)" "prognostic unfavorable (4.71e-4)" "unprognostic (1.01e-1)" "unprognostic (2.11e-2)" "unprognostic (1.59e-2)" "unprognostic (2.90e-2)" "unprognostic (3.37e-2)" "unprognostic (2.44e-1)" "unprognostic (1.18e-1)" "unprognostic (3.61e-2)" "unprognostic (2.40e-1)" "prognostic unfavorable (1.11e-16)" "unprognostic (1.73e-1)" "unprognostic (4.42e-2)" "unprognostic (9.33e-2)" "unprognostic (4.76e-2)" 17.2 7.1 5.6 24.7 7.9 34.0 16.1 1.7 4.7 12.6 15.9 6.2 4.6 5.3 17.5 7.3 11.5 10.9 13.9 10.1 6.5 3.4 6.1 8.3 20.2 44.9 7.2 1.8 14.9 4.0 2.3 2.9 13.3 6.0 11.2 3.7 7.3 7.9 6.1 6.6 9.5 11.3 13.9 9.8 37.4 9.1 4.9 6.2 48.2 7.8 7.8 23.6 18.2 18.0 4.2 3.4 54.5 4.1 10.2 11.9 5.2 10.0 1.6 6.0 7.2 4.3 11.6 0.2 6.0 7.0 5.3 3.6 1.2 2.0 9.8 5.5 10.5 12.0 6.7 3.0 6.6 2.8 8.2 0.6 23.6 2.9 1.2 3.4 6.1 35.0 7.1 7.7 13.1 11.8 6.3 4.3 16.6 4.3 4.9 6.2 1.1 8.7 12.1 0.0 0.3 0.4 27.8 5.3 8.0 3.1 0.6 0.4 2.0 5.6 2.2 11.1 0.3 1.6 8.4 14.2 21.0 5.3 0.0 14.9 1.8 9.6 12.1 6.0 36.4 24.5 8.1 2.8 54.5 11.7 4.1 8.5 3.1 5.7 11.9 1.8 4.2 4.7 9.0 13.2 10.2 3.0 3.4 9.4 5.2 5.6 7.9 1.7 4.7 6.5 3.4 7.2 1.8 6.0 6.2 3.0 20.7 66.3 25.5 96.9 1.3 2.8 10.2 6.7 4.5 8.7 0.0 2.5 0.0 20.1 23.9 64.4 0.4 0.0 7.1 17.8 32.0 15.2 51.9 7.8 175.4 3.2 1.7 30.7 131.5 14.6 25.6 119.9 37.1 233.6 0.5 0.9 18.0 0.0 21.9 1.3 2.9 25.8 79.5 0.5 1.4 52.1 3.3 186.8 0.4 22.5 PPP1R27 "DYSFIP1, toonin" ENSG00000182676 "Protein phosphatase 1 regulatory subunit 27" Q86WC6 17 81833492-81835050 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 22 "skeletal muscle: 211.0" "Cell type enriched" "Detected in some" 10 "Early spermatids: 22.1" "Cancer enriched" "Detected in single" 10 "head and neck cancer: 3.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 3.2" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 23 "HL-60: 63.9;THP-1: 123.9" "Not detected" "Not detected" "Not detected" "Not detected" "HPA042227, HPA048632" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042227: , HPA048632: AB_2680469" "unprognostic (3.35e-2)" "unprognostic (1.12e-4)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (1.29e-1)" "unprognostic (1.85e-2)" "unprognostic (1.37e-1)" "unprognostic (2.21e-2)" "unprognostic (7.07e-2)" "unprognostic (1.32e-1)" "unprognostic (5.38e-2)" "unprognostic (8.70e-2)" "unprognostic (4.98e-6)" "unprognostic (7.97e-2)" "unprognostic (1.21e-1)" "unprognostic (2.19e-3)" "unprognostic (1.30e-1)" 1.8 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.7 0.0 0.0 1.7 0.0 211.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 9.6 1.2 0.0 0.0 0.8 0.4 3.2 0.4 0.7 0.4 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 63.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 123.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 0.4 0.3 0.3 0.2 0.3 0.4 0.2 0.2 0.3 0.8 0.3 0.4 3.2 0.7 0.3 0.4 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 22.1 0.0 2.0 0.0 0.4 2.1 0.2 0.1 0.0 1.0 0.5 0.0 1.2 0.0 0.0 0.5 0.9 0.2 0.0 0.0 0.7 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.7 0.7 0.1 1.1 0.0 0.9 0.1 PPP2R1B "PP2A-Abeta, PR65B" ENSG00000137713 "Protein phosphatase 2 scaffold subunit Abeta" P30154 11 111726908-111766427 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 94.9" "Group enriched" "Detected in all" 5 "Early spermatids: 249.6;Hepatocytes: 68.4;Late spermatids: 93.2;Spermatocytes: 71.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 60.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004034, HPA018908" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB004034: AB_490763, HPA018908: AB_1855655" "unprognostic (8.37e-2)" "unprognostic (3.87e-2)" "unprognostic (4.84e-3)" "unprognostic (3.27e-3)" "unprognostic (3.43e-1)" "unprognostic (4.93e-2)" "prognostic favorable (3.80e-4)" "unprognostic (4.58e-1)" "unprognostic (8.20e-3)" "unprognostic (2.26e-1)" "unprognostic (1.72e-1)" "unprognostic (8.41e-2)" "unprognostic (1.25e-3)" "unprognostic (1.25e-1)" "unprognostic (5.30e-1)" "unprognostic (2.12e-2)" "unprognostic (1.22e-1)" 31.6 7.2 7.1 7.6 9.8 7.7 13.5 14.8 7.1 7.9 8.2 13.6 5.7 7.7 6.3 5.6 7.9 5.0 7.8 4.6 7.4 5.0 10.3 94.9 5.4 6.2 12.6 3.4 8.7 18.5 5.4 19.4 6.7 9.8 4.6 8.5 6.6 8.8 4.0 6.2 6.7 9.4 5.9 8.7 4.2 11.9 28.6 13.9 10.1 6.1 7.2 9.4 6.0 5.1 11.5 14.7 9.9 11.9 14.1 14.3 12.0 13.0 8.8 12.7 8.6 12.8 6.9 12.8 13.0 9.1 9.7 8.9 29.7 13.8 16.6 9.8 8.4 9.2 12.4 18.8 10.7 12.4 11.5 5.8 16.2 5.2 12.9 6.3 18.9 12.9 7.8 6.5 10.9 8.0 6.8 11.9 17.4 19.6 22.1 10.6 4.2 20.4 7.7 15.6 14.2 9.6 15.7 8.4 20.3 14.4 14.5 4.1 11.3 11.6 10.7 2.1 14.3 12.4 7.1 12.8 11.3 13.7 5.6 8.2 2.3 5.8 60.8 4.0 22.1 14.3 5.4 10.0 9.9 13.7 11.9 13.4 10.4 13.9 12.7 14.7 11.5 12.3 13.1 2.5 14.1 10.7 6.3 14.3 12.0 7.1 9.8 14.8 7.1 7.4 5.0 12.6 3.4 9.8 13.9 17.9 8.0 12.6 9.8 12.7 4.9 3.0 10.2 16.0 6.8 12.2 7.9 11.5 11.6 16.5 249.6 12.3 16.1 23.3 20.0 14.9 9.4 9.7 8.1 68.4 8.4 1.6 15.0 8.6 7.8 93.2 6.1 5.6 8.5 11.8 11.5 9.1 21.0 7.0 7.1 15.9 10.5 12.9 9.5 71.5 18.5 12.8 14.8 7.5 11.5 13.6 PPP3R1 "CALNB1, CNB, CNB1" ENSG00000221823 "Protein phosphatase 3 regulatory subunit B, alpha" P63098 2 68178857-68256237 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 78.2" "Cell type enhanced" "Detected in all" 5 "Rod photoreceptor cells: 86.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 6.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005610, HPA047157" Approved Approved "Plasma membrane,Cytosol" NA NA 43000 "Plasma membrane, Cytosol" "CAB005610: AB_325975, HPA047157: AB_2679960" "unprognostic (2.12e-1)" "unprognostic (2.09e-2)" "unprognostic (1.55e-1)" "prognostic unfavorable (9.08e-6)" "unprognostic (5.90e-2)" "unprognostic (1.86e-1)" "prognostic unfavorable (5.37e-4)" "unprognostic (3.59e-1)" "unprognostic (3.96e-2)" "unprognostic (1.28e-1)" "unprognostic (1.13e-2)" "unprognostic (1.74e-1)" "prognostic unfavorable (1.70e-5)" "unprognostic (5.24e-3)" "unprognostic (5.35e-1)" "unprognostic (8.70e-2)" "unprognostic (1.24e-1)" 25.8 20.1 43.3 15.9 66.2 32.3 25.7 47.9 78.2 14.8 14.0 7.7 6.9 13.1 16.6 14.2 15.7 10.5 14.7 10.2 56.2 28.7 11.3 29.6 15.5 18.8 23.7 45.1 13.6 9.8 9.4 8.9 18.5 25.4 14.3 14.8 6.8 12.1 16.6 41.7 17.1 12.0 18.5 21.6 16.5 12.6 10.4 16.5 12.7 12.6 7.7 20.1 14.4 13.3 1.0 1.8 6.4 1.4 0.9 1.4 0.9 17.8 15.2 20.6 14.1 14.2 16.5 21.0 25.9 22.1 29.3 25.9 21.9 16.2 24.9 8.9 17.5 20.9 12.1 21.7 18.7 35.8 17.5 15.5 80.8 12.4 20.1 28.1 31.7 27.3 16.6 17.0 22.7 23.3 16.6 19.6 21.1 19.5 28.5 21.3 15.4 26.8 27.9 24.2 15.0 13.0 19.6 27.2 39.6 18.1 19.0 27.2 19.2 14.9 21.2 18.6 14.0 10.0 14.8 20.5 25.3 23.2 19.1 22.3 16.1 17.7 36.9 18.4 33.4 15.8 3.2 1.2 2.9 0.7 0.8 1.4 0.5 0.8 0.5 1.3 1.0 0.9 1.4 6.4 0.9 1.4 1.8 0.9 0.9 43.3 66.2 47.9 78.2 56.2 28.7 23.7 45.1 25.4 16.5 8.9 16.7 16.6 10.6 66.4 21.5 16.1 10.2 2.7 6.8 15.7 49.1 9.8 10.0 5.9 11.6 21.5 14.4 23.3 7.5 14.8 14.0 14.4 19.6 18.5 21.1 11.1 14.6 15.4 42.9 6.5 9.2 22.7 33.7 4.6 14.0 20.4 10.5 10.1 8.1 12.9 86.2 12.9 17.3 2.6 5.3 61.6 10.1 20.3 12.0 16.8 PPP3R2 PPP3RL ENSG00000188386 "Protein phosphatase 3 regulatory subunit B, beta" Q96LZ3 9 101591615-101595021 "FDA approved drug targets, Predicted intracellular proteins" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 90 "testis: 81.9" "Group enriched" "Detected in some" 25 "Early spermatids: 271.7;Late spermatids: 141.7;Spermatocytes: 319.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in single" HPA047157 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA047157: AB_2679960" "unprognostic (8.81e-2)" "unprognostic (2.65e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 81.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 271.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.7 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.0 0.0 6.5 0.0 319.9 3.0 0.0 0.0 0.0 0.0 0.0 PPTC7 TA-PP2C ENSG00000196850 "PTC7 protein phosphatase homolog" Q8NI37 12 110533245-110583320 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 53.8" "Cell type enhanced" "Detected in all" 4 "Cardiomyocytes: 96.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039335, HPA040614" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039335: AB_10805474, HPA040614: AB_10795526" "unprognostic (2.44e-1)" "unprognostic (2.38e-2)" "unprognostic (1.11e-1)" "unprognostic (9.44e-2)" "unprognostic (2.38e-1)" "unprognostic (3.46e-2)" "unprognostic (2.14e-1)" "unprognostic (3.51e-2)" "unprognostic (1.47e-2)" "prognostic unfavorable (1.43e-5)" "prognostic unfavorable (6.76e-4)" "unprognostic (1.09e-1)" "prognostic favorable (4.48e-5)" "unprognostic (5.34e-2)" "unprognostic (2.83e-1)" "unprognostic (5.01e-3)" "unprognostic (1.83e-1)" 10.4 15.3 6.5 10.3 9.6 26.2 10.3 8.3 12.9 9.7 11.8 5.7 4.9 7.5 9.3 4.6 12.6 7.8 8.8 35.3 9.0 9.0 12.6 11.9 13.1 10.9 10.4 6.8 8.9 7.5 13.0 12.7 6.9 15.3 7.7 9.8 8.0 12.9 8.2 53.8 13.4 11.7 13.1 7.4 9.4 8.4 8.2 6.5 16.1 8.0 15.5 13.1 12.4 12.4 2.1 1.4 6.1 1.7 1.7 2.4 0.6 12.2 7.0 6.0 6.3 15.0 13.2 8.6 5.6 7.5 6.2 6.2 7.9 4.8 21.5 5.9 5.5 8.9 11.9 12.0 13.1 12.6 15.6 10.0 19.0 7.5 8.5 14.3 21.0 15.7 11.4 21.6 8.8 25.9 9.3 11.7 15.0 14.1 6.1 10.0 3.1 18.5 18.0 8.5 6.6 13.1 15.5 8.1 13.1 25.7 13.7 9.7 7.6 10.7 14.8 12.4 6.1 7.0 11.3 13.4 5.7 6.1 17.3 9.5 17.8 19.7 24.0 9.6 11.6 11.2 0.1 1.7 1.3 2.3 1.5 2.4 1.3 1.9 1.8 1.3 2.1 2.2 1.9 6.1 1.7 1.1 1.4 1.3 0.6 6.5 9.6 8.3 12.9 9.0 9.0 10.4 6.8 15.3 6.5 20.8 21.2 21.7 47.9 81.6 8.5 96.6 15.3 25.4 22.7 8.7 13.7 6.3 14.9 6.8 29.6 22.2 18.4 23.3 7.1 7.0 37.6 42.4 23.1 24.9 15.0 12.7 16.1 14.7 25.1 17.5 10.6 19.9 32.1 10.0 14.2 3.9 11.1 14.4 9.2 10.5 24.1 12.9 39.1 12.5 22.5 91.1 5.6 20.8 13.8 64.3 PRAME "CT130, MAPE" ENSG00000185686 "Preferentially expressed antigen in melanoma" P78395 22 22547701-22559361 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, Differentiation, Growth regulation, Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "testis: 54.3" "Cell type enriched" "Detected in some" 8 "Spermatogonia: 241.6" "Group enriched" "Detected in many" 5 "endometrial cancer: 73.4;melanoma: 139.6;ovarian cancer: 29.4;testis cancer: 51.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "K-562: 143.2" "Not detected" "Not detected" "HPA045153, HPA068562" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA045153: AB_10797259, HPA068562: " "unprognostic (9.36e-3)" "unprognostic (9.74e-2)" "unprognostic (1.02e-1)" "unprognostic (3.87e-2)" "unprognostic (5.20e-2)" "prognostic unfavorable (3.41e-4)" "unprognostic (3.43e-2)" "unprognostic (4.00e-2)" "unprognostic (1.33e-1)" "unprognostic (6.52e-3)" "unprognostic (9.68e-3)" "unprognostic (2.06e-1)" "prognostic unfavorable (7.48e-9)" "unprognostic (1.95e-1)" "unprognostic (2.21e-1)" "unprognostic (8.87e-2)" "unprognostic (1.26e-1)" 0.1 1.7 0.1 0.3 0.3 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.5 0.0 2.8 10.9 0.1 0.2 0.1 0.3 0.2 0.0 0.7 0.1 0.1 0.1 0.1 0.1 2.2 0.1 0.0 0.1 0.4 0.4 0.1 0.0 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.8 0.2 0.0 54.3 0.1 0.3 0.1 0.1 0.4 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 9.4 0.0 19.8 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.1 0.5 14.2 0.0 0.0 0.0 0.6 0.0 0.0 8.6 2.1 5.0 3.7 0.1 0.0 0.4 27.3 0.0 0.0 0.0 0.0 0.0 0.0 2.2 143.2 2.3 0.0 1.2 0.0 0.0 0.0 4.2 0.6 0.8 0.0 0.0 0.0 0.0 0.1 29.4 0.0 0.0 0.0 0.0 4.3 3.5 0.7 0.0 25.8 0.0 0.0 0.4 2.0 0.1 0.0 0.1 3.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.3 0.1 0.2 0.0 0.1 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.1 9.5 0.0 0.0 0.0 30.6 5.2 0.0 0.0 5.4 0.0 0.2 0.1 0.0 3.2 0.8 0.3 6.5 0.0 29.8 241.6 0.0 0.0 0.0 0.0 0.0 PRDX6 "1-Cys, aiPLA2, AOP2, KIAA0106, MGC46173, NSGPx, p29, PRX" ENSG00000117592 "Peroxiredoxin 6" P30041 1 173477266-173488807 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Antioxidant, Hydrolase, Multifunctional enzyme, Oxidoreductase, Peroxidase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006983, CAB008663" Supported Supported "Plasma membrane,Cytosol" NA NA 180000000 "Plasma membrane, Cytosol" "CAB008663: AB_1620994, HPA006983: AB_1079595" "unprognostic (9.92e-2)" "unprognostic (1.50e-1)" "unprognostic (3.67e-1)" "unprognostic (2.99e-3)" "unprognostic (1.96e-1)" "prognostic unfavorable (1.23e-5)" "unprognostic (5.71e-3)" "unprognostic (2.80e-2)" "unprognostic (5.27e-3)" "unprognostic (3.96e-3)" "unprognostic (3.19e-3)" "unprognostic (1.59e-1)" "prognostic unfavorable (9.51e-4)" "unprognostic (2.50e-1)" "unprognostic (7.12e-2)" "unprognostic (1.15e-1)" "unprognostic (4.73e-3)" 80.0 42.1 32.8 30.8 38.9 21.8 106.3 19.8 32.8 27.2 46.7 37.4 35.8 12.1 30.8 54.1 39.9 40.2 22.3 70.5 29.0 23.9 45.9 116.1 29.2 37.5 34.0 28.2 31.5 39.3 63.9 19.1 36.9 30.3 40.0 56.0 21.3 22.6 35.4 128.0 25.7 20.2 40.5 19.7 23.1 33.2 44.9 24.1 17.4 46.9 68.6 25.7 36.5 46.2 17.2 37.9 14.3 23.9 12.0 25.0 30.6 52.1 16.0 26.6 29.5 103.2 50.5 22.5 106.5 36.3 44.5 31.6 30.2 35.1 33.9 34.1 87.2 16.4 30.5 34.8 34.3 36.2 29.8 32.1 22.5 27.4 34.1 58.2 23.5 7.4 41.8 34.8 24.4 34.2 28.0 43.6 14.2 50.0 7.0 50.5 10.7 15.9 31.0 58.5 28.7 99.6 19.1 30.8 34.6 66.6 11.9 12.4 23.0 36.7 43.2 24.4 40.0 36.5 33.2 29.3 17.3 19.9 26.2 28.9 10.6 15.7 27.9 20.8 20.5 15.8 13.9 23.9 12.9 17.0 20.6 18.9 17.2 17.6 21.1 29.3 13.6 23.2 25.0 14.3 12.0 17.5 37.9 20.4 30.6 32.8 38.9 19.8 32.8 29.0 23.9 34.0 28.2 30.3 24.1 163.8 131.5 140.0 350.9 209.2 31.5 477.5 249.7 195.4 161.5 263.5 27.5 589.1 729.5 163.2 193.0 183.6 264.7 256.9 175.5 640.5 290.3 337.6 341.6 875.0 302.1 42.9 136.4 174.3 152.8 441.3 315.2 140.2 173.7 230.0 253.4 390.8 159.2 306.9 391.7 634.8 41.0 181.1 254.2 113.1 58.3 231.0 805.7 161.9 278.6 280.8 PRKCA PKCA ENSG00000154229 "Protein kinase C alpha" P17252 17 66302636-66810743 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "Angiogenesis, Apoptosis, Cell adhesion" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 77.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 17 "dendritic cells: 1.4;monocytes: 2.7;T-cells: 4.0" "Cell line enhanced" "Detected in many" "U-87 MG: 53.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003844, HPA006563, HPA006564, CAB016290" Enhanced Approved Enhanced "Plasma membrane,Cytosol" NA NA 1900000 Cytosol "Plasma membrane" "CAB003844: AB_562331, CAB016290: AB_628141, HPA006563: AB_1079626, HPA006564: AB_1079625" "unprognostic (3.06e-1)" "unprognostic (3.56e-2)" "unprognostic (1.38e-2)" "unprognostic (1.01e-1)" "unprognostic (1.53e-1)" "unprognostic (7.41e-3)" "unprognostic (7.43e-2)" "unprognostic (6.86e-3)" "unprognostic (4.93e-2)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" "unprognostic (2.24e-2)" "unprognostic (5.50e-2)" "unprognostic (2.46e-1)" "unprognostic (1.83e-1)" "unprognostic (1.35e-3)" "unprognostic (8.77e-2)" 4.0 19.6 26.5 9.0 22.8 2.5 3.0 10.8 33.9 7.0 13.8 19.0 3.5 14.6 14.8 6.7 4.7 6.1 10.8 5.8 31.6 15.6 16.7 6.5 6.0 8.4 18.7 15.6 20.4 5.5 1.7 6.0 6.5 17.6 17.2 11.2 7.0 3.1 22.3 6.6 3.8 12.7 13.7 15.0 7.9 7.9 3.7 14.4 0.4 4.5 1.3 5.9 9.5 9.5 0.0 1.4 0.1 2.7 0.1 4.0 1.0 2.3 12.5 2.6 2.6 6.3 16.1 0.3 13.4 8.8 9.7 8.3 1.4 1.5 3.1 3.6 21.7 16.3 0.3 1.3 1.6 21.2 5.2 3.0 0.0 7.4 6.5 8.6 3.9 21.1 7.0 0.6 12.1 10.4 14.2 8.3 15.1 8.1 0.0 15.0 0.7 7.8 2.4 1.0 6.1 6.7 1.4 19.1 0.0 3.4 2.1 1.5 8.6 4.4 2.6 0.1 2.8 0.3 5.5 24.8 16.9 9.8 10.5 8.4 0.0 0.0 0.3 53.7 0.0 8.3 0.1 0.6 0.0 0.5 0.8 1.5 0.0 2.5 1.2 1.1 0.0 4.0 2.3 0.0 0.1 2.7 1.4 0.5 1.0 26.5 22.8 10.8 28.2 31.6 15.6 18.7 15.6 17.6 14.4 0.0 9.6 3.9 15.4 9.4 33.9 7.9 40.8 5.3 4.5 38.4 2.0 3.3 6.6 11.3 2.5 3.0 24.2 0.0 5.9 2.8 11.0 12.4 20.7 11.9 19.7 9.5 8.1 36.8 8.2 1.3 49.5 7.7 10.1 1.8 32.8 43.1 7.2 20.1 45.6 16.8 77.1 25.8 17.0 1.1 1.7 9.2 12.7 24.1 21.3 12.3 PRKCH "PKC-L, PKCL, PRKCL" ENSG00000027075 "Protein kinase C eta" P24723 14 61187559-61550976 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" Differentiation "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Endothelial cells: 56.0;Erythroid cells: 70.0;Ito cells: 55.9;T-cells: 137.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 12 "gdT-cell: 30.0;MAIT T-cell: 23.9;memory CD4 T-cell: 23.0;memory CD8 T-cell: 35.3;naive CD4 T-cell: 28.5;naive CD8 T-cell: 27.6;NK-cell: 27.3;T-reg: 18.6" "Group enriched" "Detected in many" 14 "NK-cells: 27.3;T-cells: 35.3" "Cell line enhanced" "Detected in many" "BEWO: 30.4;HUVEC TERT2: 39.9;MOLT-4: 26.5;RT4: 16.8;TIME: 26.1" "Group enriched" "Detected in many" 6 "basal ganglia: 25.0;thalamus: 19.5" "Low region specificity" "Detected in many" "HPA026294, HPA053709" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026294: AB_10603988, HPA053709: AB_2682237" "unprognostic (1.42e-1)" "unprognostic (3.89e-3)" "unprognostic (1.78e-1)" "unprognostic (1.96e-3)" "unprognostic (1.04e-1)" "prognostic favorable (8.55e-6)" "unprognostic (1.14e-2)" "unprognostic (2.97e-2)" "unprognostic (4.14e-1)" "unprognostic (1.94e-1)" "unprognostic (7.96e-2)" "unprognostic (1.60e-1)" "unprognostic (1.52e-3)" "unprognostic (1.13e-1)" "unprognostic (4.14e-2)" "unprognostic (6.98e-2)" "unprognostic (4.73e-3)" 17.5 5.4 5.0 21.6 22.0 11.2 14.7 2.8 6.1 13.6 10.3 6.2 6.9 5.1 19.1 7.0 20.1 8.6 12.7 10.1 6.8 4.4 8.1 5.5 24.1 27.6 5.9 2.5 7.1 5.9 8.8 15.5 22.7 7.2 9.8 5.0 9.1 24.7 10.8 9.1 15.9 16.0 10.5 5.7 25.9 6.0 4.3 6.4 54.6 15.1 10.6 34.6 13.2 14.4 0.4 2.2 1.5 0.7 27.3 35.3 17.9 6.4 2.2 0.3 1.7 1.0 0.2 30.4 0.1 0.5 0.3 0.3 0.7 3.8 0.1 4.6 0.0 0.6 4.4 0.2 4.9 0.5 0.8 2.9 0.0 0.7 0.2 0.4 0.0 0.9 0.8 5.1 0.2 3.5 0.4 39.9 12.9 0.0 0.1 2.3 11.7 26.5 0.2 0.5 4.6 3.1 2.2 1.1 0.0 0.0 16.8 1.1 1.9 0.7 5.9 3.6 5.6 5.8 0.5 26.1 0.7 5.2 0.8 0.3 0.5 0.1 0.2 1.1 0.4 1.3 0.1 0.7 0.5 30.0 0.4 23.9 0.4 23.0 35.3 2.2 0.3 28.5 27.6 1.5 27.3 0.2 0.7 18.6 17.9 5.0 22.0 2.8 6.1 6.8 4.4 5.9 2.5 7.2 6.4 6.0 10.7 4.6 15.8 16.7 0.2 3.9 10.2 10.7 18.2 0.0 0.0 23.4 3.3 4.6 25.5 56.0 1.7 70.0 5.9 16.9 3.7 13.1 1.1 1.0 5.6 0.0 11.3 55.9 11.1 3.6 1.7 9.0 15.1 5.4 2.6 9.3 4.4 2.9 6.3 0.8 0.3 0.0 4.1 0.0 2.1 23.3 40.4 137.1 0.7 24.4 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PRKD1 "PKC-mu, PKCM, PKD, PRKCM" ENSG00000184304 "Protein kinase D1" Q15139 14 29576479-30191898 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Angiogenesis, Apoptosis, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 6 "Distal tubular cells: 24.9;Early spermatids: 31.1;Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 18.2;fHDF/TERT166: 19.3;HSkMC: 18.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018367, HPA029834" Uncertain Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB018367: AB_2253119, HPA029834: AB_10602821" "unprognostic (5.35e-2)" "unprognostic (3.20e-1)" "unprognostic (2.27e-2)" "unprognostic (6.70e-2)" "unprognostic (2.37e-1)" "unprognostic (1.92e-1)" "unprognostic (1.08e-3)" "unprognostic (8.88e-2)" "unprognostic (2.37e-2)" "unprognostic (5.29e-2)" "unprognostic (7.08e-2)" "unprognostic (1.56e-1)" "prognostic favorable (2.44e-5)" "unprognostic (9.45e-4)" "unprognostic (1.99e-1)" "prognostic unfavorable (2.91e-4)" "unprognostic (3.89e-1)" 7.4 10.6 8.0 5.3 9.7 0.7 19.0 4.9 8.9 5.1 8.7 5.1 24.1 3.1 8.3 9.0 3.5 6.8 9.0 6.3 9.8 5.9 15.1 2.3 14.9 1.6 5.6 6.6 15.7 7.3 35.7 9.2 4.5 10.8 20.1 3.5 4.9 3.5 24.4 3.1 2.7 3.5 19.7 16.4 2.4 4.8 16.1 8.6 0.5 8.2 2.9 1.8 14.1 12.2 0.7 1.4 0.0 0.0 0.0 0.0 0.0 0.0 2.7 3.6 4.1 18.2 17.0 0.1 12.3 9.5 12.6 6.8 0.0 0.5 0.0 1.2 19.3 4.3 0.1 6.0 1.4 6.9 0.0 4.2 0.0 0.1 0.4 9.2 0.0 0.1 18.0 0.6 0.9 1.5 6.5 2.5 0.0 1.2 0.4 11.8 1.4 0.0 0.0 2.5 0.0 6.4 0.0 7.1 3.2 13.5 5.7 3.6 7.2 2.1 0.0 4.7 4.9 0.0 0.1 6.4 12.0 4.9 1.0 3.5 0.0 0.0 0.0 3.0 0.0 13.6 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 8.0 9.7 4.9 8.9 9.8 5.9 5.6 6.6 10.8 8.6 0.0 6.1 0.0 3.8 0.5 1.2 1.4 7.6 0.0 0.0 12.2 5.9 0.0 24.9 1.5 31.1 4.5 0.0 23.3 3.6 0.1 3.8 16.3 0.0 1.5 0.2 1.6 2.9 12.3 2.6 12.4 6.9 0.3 6.8 0.0 0.2 16.1 3.2 0.0 12.0 3.7 2.8 0.0 4.7 3.4 4.9 0.6 0.2 0.0 0.0 0.9 PROSER2 "C10orf47, MGC35403" ENSG00000148426 "Proline and serine rich 2" Q86WR7 10 11823339-11872277 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 40.8" "Cell type enhanced" "Detected in many" 13 "Hepatocytes: 26.1;Urothelial cells: 72.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 1.9" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A-431: 32.9;CAPAN-2: 39.5;HBEC3-KT: 25.2" "Low region specificity" "Detected in many" "Region enriched" "Detected in all" 5 "cerebellum: 32.0" HPA041337 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041337: AB_10794663" "unprognostic (2.36e-3)" "unprognostic (1.39e-1)" "unprognostic (3.55e-2)" "unprognostic (1.19e-1)" "unprognostic (4.60e-2)" "unprognostic (7.60e-3)" "unprognostic (4.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.20e-1)" "unprognostic (2.82e-1)" "unprognostic (1.25e-3)" "unprognostic (1.61e-1)" "unprognostic (1.26e-2)" "unprognostic (4.04e-2)" "unprognostic (3.01e-1)" "unprognostic (5.06e-2)" "unprognostic (8.69e-2)" 2.7 1.1 0.7 1.8 1.4 9.5 9.8 1.0 1.3 3.7 2.5 0.4 2.4 1.2 2.5 1.7 6.2 3.0 2.2 1.4 1.5 0.7 8.6 40.8 10.2 0.2 1.4 0.3 1.7 21.7 0.0 1.5 9.2 1.2 7.3 2.0 9.9 4.5 2.7 1.7 3.2 1.1 1.3 1.0 8.2 7.1 7.5 0.5 4.3 12.0 3.6 5.6 6.5 9.9 0.0 1.9 0.0 1.0 0.0 0.7 0.9 32.9 4.7 0.3 0.1 1.0 1.3 1.9 1.5 0.7 1.2 0.6 10.9 39.5 0.0 6.1 0.1 0.5 8.7 3.3 25.2 0.6 0.0 8.1 3.8 2.0 7.0 5.9 0.0 2.4 1.4 5.5 7.1 8.1 0.1 3.6 0.6 5.6 0.0 1.7 4.5 0.0 1.2 2.1 4.4 2.7 5.3 4.3 0.0 2.6 1.6 0.0 0.4 2.4 10.0 4.2 1.7 5.2 2.0 2.5 0.0 8.0 13.2 0.1 0.0 0.0 0.0 0.0 1.3 1.8 0.0 1.0 0.0 0.0 0.3 0.7 0.0 0.1 0.2 0.1 0.0 0.4 0.2 0.0 0.0 0.0 1.9 0.0 0.9 0.7 1.4 1.0 1.3 1.5 0.7 1.4 0.3 1.2 0.5 8.9 5.1 0.0 22.8 5.0 0.0 0.9 20.4 6.7 5.7 5.2 0.0 4.7 5.0 9.6 2.5 2.8 0.8 0.0 3.3 16.0 3.1 21.4 0.0 26.1 0.7 0.0 1.7 1.8 0.8 2.3 1.7 0.3 3.3 0.0 1.3 0.0 13.3 0.0 4.2 0.3 0.0 0.0 1.0 1.7 2.8 4.1 0.6 0.0 3.3 72.6 PRRT3 FLJ33674 ENSG00000163704 "Proline rich transmembrane protein 3" Q5FWE3 3 9945542-9952394 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 26.0;fallopian tube: 10.8;parathyroid gland: 24.7;pituitary gland: 6.9" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 23.6;Rod photoreceptor cells: 22.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 12.7;MCF7: 16.1;SK-BR-3: 24.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035127, HPA035128, HPA069859" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA 18000 "Plasma membrane" Nucleoplasm "HPA035127: AB_10602822, HPA035128: AB_2674482, HPA069859: " "unprognostic (1.55e-1)" "unprognostic (8.41e-2)" "unprognostic (3.42e-1)" "unprognostic (2.38e-3)" "unprognostic (1.27e-1)" "unprognostic (3.41e-2)" "unprognostic (1.15e-4)" "unprognostic (2.27e-3)" "unprognostic (1.37e-2)" "unprognostic (2.76e-2)" "unprognostic (2.20e-3)" "unprognostic (3.60e-1)" "unprognostic (1.01e-4)" "unprognostic (2.25e-1)" "unprognostic (1.39e-1)" "unprognostic (4.64e-2)" "unprognostic (2.09e-1)" 1.4 2.9 8.4 1.8 11.9 2.1 2.0 13.4 26.0 2.4 1.4 4.2 0.0 1.0 2.0 2.2 1.7 10.8 1.9 1.6 5.9 3.2 1.5 0.9 1.4 1.8 2.7 8.3 2.9 2.9 24.7 6.9 0.8 11.4 4.0 0.8 1.8 2.0 2.9 1.5 2.5 1.2 1.7 2.3 1.5 1.5 3.9 3.2 1.2 3.4 0.0 2.0 2.1 1.8 1.8 1.5 0.9 0.6 1.7 3.8 1.0 0.2 0.7 2.6 3.4 12.7 1.7 0.8 1.2 2.4 1.5 3.3 0.2 2.4 1.3 0.3 3.0 1.5 0.2 0.9 3.2 0.6 6.8 1.4 0.5 1.3 0.0 1.3 0.3 1.2 3.2 0.2 1.2 0.5 7.1 0.6 4.3 0.7 3.4 1.8 16.1 3.0 0.2 6.2 0.1 1.5 1.8 0.3 1.3 0.7 0.2 4.9 3.2 1.2 24.2 0.4 1.0 6.5 0.3 0.6 0.3 3.5 0.6 0.9 4.4 4.5 0.4 8.0 0.2 0.9 0.9 0.6 0.5 3.3 0.3 3.7 1.6 3.4 3.3 0.2 1.8 3.8 3.5 0.8 1.7 0.4 1.5 0.6 1.0 8.4 11.9 13.4 26.0 5.9 3.2 2.7 8.3 11.4 3.2 0.0 1.3 3.0 3.6 2.4 23.6 2.5 7.6 8.1 1.2 10.4 13.7 0.6 3.3 2.6 3.1 2.8 4.2 0.0 4.4 0.4 4.8 3.6 1.1 2.4 3.1 14.3 10.9 1.8 1.3 2.7 5.2 2.1 1.7 17.2 4.7 9.8 3.2 0.0 2.5 6.2 22.5 0.0 4.7 9.7 5.7 1.9 0.3 4.6 3.6 2.0 PSMC5 "p45, p45/SUG, S8, SUG-1, SUG1, TBP10, TRIP1" ENSG00000087191 "Proteasome 26S subunit, ATPase 5" P62195 17 63827152-63832026 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 8 "Late spermatids: 1134.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017871, HPA064293" Enhanced Supported "Plasma membrane,Cytosol" NA NA 100000 "Plasma membrane, Cytosol" "HPA017871: AB_1857638, HPA064293: AB_2685234" "unprognostic (9.65e-2)" "unprognostic (1.63e-2)" "unprognostic (4.44e-1)" "unprognostic (2.91e-2)" "unprognostic (1.61e-1)" "unprognostic (1.35e-1)" "unprognostic (8.29e-3)" "unprognostic (1.24e-2)" "unprognostic (3.38e-1)" "unprognostic (2.85e-1)" "unprognostic (2.17e-2)" "unprognostic (1.25e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (9.54e-2)" "unprognostic (8.57e-2)" "unprognostic (1.15e-1)" "unprognostic (2.32e-1)" 36.8 43.1 44.8 35.8 42.6 26.7 30.3 47.7 48.3 29.5 36.5 30.3 40.8 26.2 32.0 42.4 46.0 32.2 42.0 41.7 38.6 42.9 52.3 48.7 26.3 33.5 50.1 42.2 28.2 36.7 77.0 32.6 42.9 41.8 32.7 36.7 26.7 36.0 41.7 94.2 45.2 28.9 41.8 39.3 33.4 33.2 32.7 35.7 33.0 37.8 60.4 43.9 33.3 32.4 30.4 31.2 30.9 40.9 34.2 57.7 40.5 42.1 63.6 44.4 28.8 31.2 33.1 36.6 43.0 30.9 52.1 41.5 68.3 26.4 28.5 29.6 43.0 40.3 31.5 44.7 39.9 74.8 25.5 47.2 62.6 52.1 55.6 31.2 62.7 41.9 32.9 30.0 53.4 49.4 24.4 47.0 30.6 47.0 36.5 48.3 74.0 46.2 23.7 39.1 42.8 54.9 43.4 88.2 41.3 36.8 49.7 37.4 50.9 29.5 52.0 24.3 46.9 51.3 30.4 44.0 64.0 60.1 29.4 86.3 38.8 59.9 46.1 38.4 45.1 40.6 22.8 25.6 30.9 37.8 37.2 51.4 30.4 44.8 40.4 31.2 24.4 37.7 42.2 8.1 34.2 40.9 22.4 57.7 40.5 44.8 42.6 47.7 48.3 38.6 42.9 50.1 42.2 41.8 35.7 47.6 76.5 84.8 121.6 84.0 80.6 136.5 122.3 78.9 86.4 64.6 17.7 224.0 208.9 141.7 473.4 88.7 101.6 140.2 187.9 149.0 99.1 113.3 89.9 118.0 143.6 68.3 87.2 75.5 81.1 1134.0 123.1 93.9 94.5 174.1 65.9 151.7 136.7 83.4 144.2 267.3 72.5 109.9 142.6 128.6 136.3 89.8 308.6 95.8 77.1 118.0 PSMD9 "p27, Rpn4" ENSG00000110801 "Proteasome 26S subunit, non-ATPase 9" O00233 12 121888731-121918297 "Plasma proteins, Predicted intracellular proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA040512, HPA044220" Enhanced Supported "Plasma membrane,Cytosol" NA NA 330000 Cytosol "Plasma membrane" "HPA040512: AB_2677014, HPA044220: AB_2678860" "unprognostic (2.24e-1)" "unprognostic (2.48e-3)" "unprognostic (2.12e-1)" "unprognostic (3.36e-1)" "unprognostic (1.20e-2)" "unprognostic (1.51e-1)" "prognostic unfavorable (1.32e-5)" "unprognostic (1.86e-1)" "unprognostic (6.80e-2)" "unprognostic (1.01e-1)" "unprognostic (1.46e-1)" "unprognostic (1.30e-1)" "unprognostic (9.64e-3)" "unprognostic (3.17e-2)" "unprognostic (5.73e-2)" "unprognostic (6.19e-2)" "unprognostic (8.63e-2)" 25.6 10.7 11.5 12.9 12.1 27.8 18.7 15.3 12.0 9.6 22.1 9.2 14.8 19.5 14.4 13.6 12.3 10.7 12.5 13.9 10.6 11.2 19.2 19.8 12.3 14.8 10.6 9.0 13.0 28.6 4.9 8.3 8.7 12.7 9.5 4.8 9.4 15.3 14.2 28.6 12.4 16.3 15.7 11.6 14.8 24.7 13.6 8.7 13.8 10.9 17.1 9.2 8.2 11.8 24.5 36.7 29.6 26.3 14.9 25.9 27.3 20.5 31.6 2.6 4.8 4.4 4.5 5.5 21.1 6.8 10.6 6.0 23.1 2.5 15.4 17.9 10.8 3.6 8.4 7.5 11.1 6.3 29.6 16.7 12.5 14.7 11.4 11.0 8.8 8.9 8.0 5.3 11.8 4.5 3.8 6.3 9.6 11.2 2.2 6.6 24.1 17.6 6.6 5.5 2.6 24.7 13.4 7.2 9.4 5.1 20.7 5.5 7.7 21.1 3.1 11.3 2.3 9.1 4.4 16.7 10.1 11.6 19.8 14.7 12.0 26.0 22.4 18.1 11.5 9.2 20.3 26.3 29.6 20.9 25.4 16.7 24.5 20.1 18.9 22.2 19.5 15.8 13.6 24.1 14.9 22.0 36.7 25.9 27.3 11.5 12.1 15.3 12.0 10.6 11.2 10.6 9.0 12.7 8.7 44.7 31.8 34.3 9.8 53.8 6.7 7.1 30.6 33.5 38.7 33.2 17.7 25.4 44.7 101.5 24.4 23.2 71.9 93.5 106.1 25.7 39.1 8.6 43.8 24.3 35.7 14.3 44.7 28.8 45.7 8.3 35.1 46.2 52.3 130.8 56.1 12.5 112.4 56.1 36.4 69.8 12.6 38.8 43.4 26.5 32.8 62.6 31.6 49.0 62.2 9.2 PTCHD4 "C6orf138, dJ402H5.2, FLJ41841, PTCH53" ENSG00000244694 "Patched domain containing 4" Q6ZW05 6 47878028-48068689 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.3" "Cell type enhanced" "Detected in some" 12 "Ciliated cells: 1.4;Collecting duct cells: 1.8" "Group enriched" "Detected in some" 6 "melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 10.1;BEWO: 13.5;Hep G2: 22.5;LHCN-M2: 10.7;SuSa: 22.9;TIME: 11.4;WM-115: 9.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041276 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041276: AB_10796570" "unprognostic (1.35e-4)" "unprognostic (1.66e-2)" "unprognostic (3.25e-1)" "unprognostic (3.11e-3)" "unprognostic (1.07e-2)" "unprognostic (1.57e-3)" "unprognostic (7.94e-2)" "unprognostic (3.59e-3)" "unprognostic (2.80e-1)" "unprognostic (1.50e-1)" "unprognostic (2.55e-1)" "unprognostic (1.92e-1)" "prognostic favorable (1.49e-6)" "unprognostic (5.03e-4)" "unprognostic (9.84e-2)" "unprognostic (1.57e-2)" "unprognostic (5.56e-3)" 2.1 0.7 4.6 0.1 7.4 0.2 1.3 2.7 11.3 3.8 1.2 0.3 0.0 0.6 1.7 3.7 1.9 3.2 1.4 1.4 2.2 1.3 2.2 2.1 3.1 0.2 1.4 5.5 1.1 1.1 0.4 3.9 1.9 1.8 2.3 1.2 1.6 2.1 6.4 0.6 0.3 0.4 1.9 1.3 0.2 0.5 0.9 0.8 0.0 3.6 0.0 0.3 2.8 1.3 0.4 0.4 0.8 0.2 0.1 0.2 0.0 0.0 0.0 10.1 0.0 1.7 5.0 13.5 1.5 3.2 0.1 0.4 0.0 0.6 0.0 0.0 0.8 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.3 22.5 0.5 0.0 0.0 7.4 7.2 0.0 0.1 5.4 1.5 2.3 0.0 0.0 10.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.4 0.5 0.0 0.0 0.0 22.9 0.0 0.0 11.4 2.5 1.6 0.0 0.2 0.0 0.0 0.0 3.4 0.0 9.9 0.8 0.1 0.5 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.2 0.8 0.1 0.2 0.4 0.0 0.0 4.6 7.4 2.7 11.3 2.2 1.3 1.4 5.5 1.8 0.8 0.0 0.6 0.0 0.0 0.1 0.4 0.2 0.0 1.4 0.0 1.8 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PTK2B "CADTK, CAKB, FAK2, PTK, PYK2, RAFTK" ENSG00000120899 "Protein tyrosine kinase 2 beta" Q14289 8 27311482-27459391 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Angiogenesis, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 46.7;brain: 65.2" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 73.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 37.7;REH: 41.9" "Group enriched" "Detected in many" 4 "amygdala: 202.9;basal ganglia: 236.9;cerebral cortex: 189.7;hippocampal formation: 443.3;olfactory region: 185.5" "Low region specificity" "Detected in all" "CAB003850, HPA026091, HPA026276" Approved Supported "Plasma membrane,Cytosol" NA NA 84000 "Plasma membrane, Cytosol" "CAB003850: AB_562205, HPA026091: AB_10599739, HPA026276: AB_10601234" "unprognostic (2.36e-2)" "prognostic favorable (3.32e-4)" "unprognostic (1.06e-1)" "unprognostic (7.36e-3)" "unprognostic (3.72e-2)" "unprognostic (3.11e-2)" "unprognostic (2.70e-2)" "unprognostic (2.13e-2)" "unprognostic (3.23e-1)" "unprognostic (1.45e-1)" "unprognostic (5.74e-2)" "unprognostic (3.32e-1)" "unprognostic (2.40e-3)" "unprognostic (1.44e-1)" "unprognostic (1.38e-1)" "prognostic favorable (5.11e-4)" "unprognostic (3.33e-3)" 7.2 4.7 20.4 24.3 30.0 46.7 4.9 65.2 48.3 5.4 14.5 7.8 5.0 16.6 4.3 4.7 7.9 6.8 6.4 4.7 30.5 7.0 6.8 5.0 11.5 35.6 4.3 25.4 2.4 5.4 5.2 5.3 4.1 3.9 10.1 11.9 8.3 12.6 6.7 2.2 15.1 18.4 5.5 4.8 32.0 10.8 4.3 3.7 37.8 5.6 2.9 35.4 13.0 6.0 26.9 18.7 24.0 25.8 14.7 19.0 21.5 11.1 3.1 0.8 0.9 24.0 1.7 6.5 0.9 0.6 0.6 0.8 2.9 6.5 37.7 1.2 1.7 0.9 10.3 0.3 9.4 0.3 2.5 0.2 7.8 3.0 0.6 4.9 8.3 14.0 13.0 14.0 0.8 5.4 4.0 0.3 10.9 9.1 26.3 0.6 1.1 14.3 16.8 0.6 9.7 0.8 41.9 0.2 25.8 2.6 8.8 6.0 1.1 4.0 2.8 1.5 2.1 3.3 21.6 5.3 0.4 0.8 0.7 0.3 21.1 9.1 20.4 1.6 18.1 0.7 22.3 23.7 18.0 19.0 22.4 12.5 25.5 9.6 13.3 18.7 26.9 12.1 14.2 24.0 14.7 25.8 6.2 9.5 21.5 20.4 30.0 65.2 48.3 30.5 7.0 4.3 25.4 3.9 3.7 3.0 30.9 54.0 32.1 33.5 4.1 3.1 12.7 13.4 13.6 14.0 0.0 2.4 0.0 6.4 1.1 7.5 48.3 0.0 7.0 23.9 3.8 16.5 27.7 21.8 20.9 7.9 7.5 3.1 73.4 0.8 1.4 42.5 8.5 34.3 18.6 3.4 9.4 35.1 0.7 14.7 4.0 0.0 1.6 4.2 5.5 26.3 1.6 39.9 14.9 14.8 PTPN12 "PTP-PEST, PTPG1" ENSG00000127947 "Protein tyrosine phosphatase, non-receptor type 12" Q05209 7 77537275-77640071 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007097 Approved Approved "Plasma membrane,Cytosol" NA NA 1100000 "Plasma membrane, Cytosol" "HPA007097: AB_1079689" "unprognostic (2.28e-1)" "prognostic unfavorable (1.15e-4)" "unprognostic (1.35e-1)" "unprognostic (3.35e-2)" "unprognostic (1.40e-3)" "unprognostic (4.48e-3)" "prognostic unfavorable (8.78e-4)" "unprognostic (1.29e-1)" "unprognostic (5.83e-2)" "unprognostic (2.64e-1)" "prognostic unfavorable (2.01e-4)" "unprognostic (1.09e-1)" "prognostic unfavorable (7.27e-6)" "unprognostic (4.99e-2)" "unprognostic (2.97e-1)" "unprognostic (1.81e-1)" "unprognostic (3.21e-1)" 29.6 15.1 14.3 20.5 19.6 29.7 25.1 15.7 22.7 20.0 28.9 8.1 13.8 8.8 20.7 9.6 22.0 18.1 19.8 45.6 17.3 12.6 16.9 14.8 34.7 17.4 15.3 13.4 19.0 10.7 12.4 19.8 36.0 18.6 14.1 13.8 9.9 12.8 17.1 17.6 17.6 14.6 23.0 24.0 25.0 14.4 13.9 17.7 9.7 16.7 11.9 12.9 23.2 61.2 2.5 3.9 9.9 4.9 12.8 3.8 2.8 17.2 10.6 25.2 12.8 17.7 18.5 13.5 18.0 23.0 14.2 20.3 5.2 27.0 2.0 5.8 21.0 31.1 12.3 8.4 18.0 28.7 5.0 4.7 10.8 10.7 21.2 17.4 6.1 7.2 15.1 20.1 30.9 39.9 25.5 30.0 0.5 12.9 3.0 45.2 11.8 0.8 17.1 20.3 23.5 12.2 3.6 20.2 1.0 24.4 9.3 3.1 16.7 22.1 20.3 17.5 45.3 9.8 22.5 21.8 30.8 18.6 11.2 33.9 3.1 1.7 5.3 18.1 15.9 53.3 3.7 4.2 6.6 3.6 2.9 1.4 2.5 1.2 2.7 3.9 1.1 0.6 3.8 9.9 12.8 4.9 0.3 1.5 2.8 14.3 19.6 15.7 22.7 17.3 12.6 15.3 13.4 18.6 17.7 65.5 54.6 13.7 41.5 61.1 15.5 35.1 22.9 16.0 46.6 19.2 7.9 34.1 3.3 38.7 2.6 99.1 17.1 0.0 34.2 48.2 53.7 44.4 13.9 19.2 45.4 33.4 11.6 98.8 74.4 5.4 43.1 86.9 33.7 25.2 19.9 63.0 55.1 20.1 44.2 15.8 14.3 64.7 55.6 14.7 57.8 88.7 60.3 26.2 18.0 78.6 PTPRS ENSG00000105426 "Protein tyrosine phosphatase, receptor type S" Q13332 19 5158495-5340803 "Enzymes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Heparin-binding, Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Basal keratinocytes: 54.1;Melanocytes: 75.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 82 "plasmacytoid DC: 13.4" "Lineage enriched" "Detected in single" 82 "dendritic cells: 13.4" "Cell line enhanced" "Detected in many" "AN3-CA: 41.4;HaCaT: 42.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054747 Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA 92000000 "Plasma membrane, Cytosol" "HPA054747: AB_2682591" "unprognostic (8.14e-2)" "unprognostic (4.59e-3)" "unprognostic (2.57e-2)" "unprognostic (9.20e-2)" "unprognostic (2.15e-1)" "unprognostic (6.96e-3)" "unprognostic (6.85e-2)" "unprognostic (2.36e-1)" "unprognostic (3.12e-3)" "unprognostic (1.86e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.25e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (4.05e-1)" "unprognostic (3.46e-2)" 59.1 17.3 14.4 9.4 14.8 3.1 32.0 27.6 53.3 28.7 11.4 29.6 14.4 4.6 21.4 15.4 13.3 24.0 22.2 18.6 15.9 15.1 10.7 6.9 13.9 8.6 20.5 12.1 29.2 38.4 10.5 16.6 4.3 12.0 23.1 3.6 28.9 21.5 20.1 11.9 23.8 6.5 17.5 13.8 8.3 12.7 10.8 18.7 4.4 21.1 7.2 7.5 19.1 22.7 0.0 13.4 0.0 0.0 0.0 0.1 0.0 3.7 21.3 19.2 41.4 8.8 7.2 2.5 6.4 7.7 7.8 6.4 0.2 2.0 0.0 15.3 10.8 6.2 42.1 5.1 0.0 3.5 0.4 8.2 0.0 8.7 13.2 4.0 0.0 4.8 7.6 1.8 1.6 0.3 10.2 0.2 2.6 5.9 0.0 3.1 15.7 1.6 4.0 10.8 0.1 9.1 0.0 4.2 0.0 1.6 7.5 14.8 20.3 6.1 1.1 11.7 3.9 7.4 1.6 0.9 7.0 12.1 16.0 7.8 2.1 0.0 12.2 3.6 0.0 15.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 14.4 14.8 27.6 17.6 15.9 15.1 20.5 12.1 12.0 18.7 6.0 0.6 3.2 32.4 54.1 33.8 10.9 12.7 1.4 2.3 12.2 2.0 0.5 8.3 1.4 2.3 10.2 0.0 0.0 0.8 23.7 30.9 35.7 0.0 18.3 1.5 11.1 2.9 28.3 0.3 2.9 43.1 1.4 75.9 0.0 0.0 37.3 0.5 0.0 33.9 2.4 7.7 12.9 39.2 7.2 5.3 32.0 0.8 0.0 0.0 21.1 PYGL ENSG00000100504 "Glycogen phosphorylase L" P06737 14 50857891-50944736 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Carbohydrate metabolism, Glycogen metabolism" "Allosteric enzyme, Glycosyltransferase, Transferase" "Disease mutation, Glycogen storage disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Extravillous trophoblasts: 117.8;Hofbauer cells: 137.9;Muller glia cells: 253.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 36.0;neutrophil: 41.4" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 57.0;HMC-1: 63.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000962, HPA004119" Enhanced Supported "Plasma membrane,Cytosol" NA NA 17000000 "Plasma membrane, Cytosol" "HPA000962: AB_1079722, HPA004119: AB_1079723" "unprognostic (2.70e-2)" "unprognostic (8.64e-3)" "unprognostic (1.46e-2)" "unprognostic (8.55e-2)" "unprognostic (9.41e-2)" "prognostic unfavorable (5.97e-4)" "unprognostic (1.66e-1)" "unprognostic (1.34e-2)" "unprognostic (3.34e-1)" "unprognostic (1.94e-2)" "prognostic unfavorable (2.63e-4)" "unprognostic (4.45e-3)" "unprognostic (3.15e-3)" "unprognostic (1.95e-2)" "unprognostic (1.76e-1)" "unprognostic (9.72e-2)" "unprognostic (1.12e-3)" 47.6 9.9 4.9 9.7 6.8 40.0 28.1 1.3 3.9 17.2 10.1 3.0 23.7 1.7 10.9 7.3 24.8 7.8 5.5 15.0 3.9 3.4 6.8 58.8 19.6 25.6 6.5 1.6 15.4 4.1 12.5 3.7 23.3 5.3 11.4 10.3 17.8 11.8 55.2 7.1 15.3 3.5 11.2 8.7 38.8 4.5 6.8 5.4 2.4 7.1 9.1 7.3 18.4 24.3 0.0 7.3 41.4 13.8 0.1 0.0 5.5 28.7 8.1 2.1 13.4 10.0 12.0 23.4 5.8 4.9 16.0 24.4 21.4 3.7 0.0 11.3 34.4 19.0 57.0 21.7 29.2 27.8 0.1 9.2 5.5 13.0 16.6 17.9 20.9 63.0 25.5 11.9 21.6 9.1 15.9 14.1 0.1 2.2 0.1 11.3 28.7 0.0 28.9 8.1 2.6 30.2 0.5 7.5 1.1 22.1 19.3 0.9 0.9 26.3 9.1 0.3 8.5 4.3 41.1 0.6 6.2 10.4 11.5 18.6 0.2 0.0 0.0 5.7 21.7 3.3 11.3 13.8 36.0 0.0 6.3 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 41.4 0.1 3.9 0.3 0.0 5.5 4.9 6.8 1.3 3.9 3.9 3.4 6.5 1.6 5.3 5.4 20.8 7.5 2.7 8.9 27.2 4.1 2.0 7.6 10.7 15.9 7.0 0.0 29.4 3.3 9.4 0.4 6.0 3.4 0.0 1.8 117.8 14.4 8.6 5.8 53.3 137.9 1.6 1.2 6.7 43.8 0.7 13.3 29.1 18.6 15.4 6.9 253.1 7.2 0.0 20.5 3.4 9.1 6.5 7.1 0.7 0.6 19.4 17.6 2.9 11.5 7.4 PYGO2 ENSG00000163348 "Pygopus family PHD finger 2" Q9BRQ0 1 154957026-154963853 "Predicted intracellular proteins" "Wnt signaling pathway" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023689, HPA074813" Supported Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA023689: AB_1855974, HPA074813: " "unprognostic (1.49e-2)" "unprognostic (1.33e-1)" "unprognostic (6.96e-3)" "unprognostic (2.58e-2)" "unprognostic (5.85e-2)" "unprognostic (4.32e-3)" "prognostic unfavorable (3.88e-6)" "unprognostic (2.45e-1)" "unprognostic (2.07e-1)" "unprognostic (2.00e-2)" "unprognostic (1.51e-1)" "unprognostic (3.74e-1)" "unprognostic (7.40e-3)" "unprognostic (1.63e-2)" "unprognostic (2.81e-2)" "unprognostic (2.17e-1)" "prognostic favorable (1.76e-4)" 14.0 28.4 22.2 22.8 23.7 6.6 26.1 28.5 26.8 20.8 20.5 23.4 22.1 21.3 18.7 27.9 21.4 24.1 21.6 15.0 18.7 22.9 19.1 17.4 17.2 26.7 22.2 19.4 32.5 17.5 37.7 31.0 18.4 21.3 24.5 17.9 21.3 25.3 32.6 16.4 25.0 22.5 18.3 22.1 26.4 19.1 15.7 22.1 30.9 35.5 12.9 30.1 20.3 21.8 8.9 4.3 10.5 8.2 6.3 12.8 5.7 12.9 9.2 19.6 17.3 19.8 9.7 18.0 8.1 11.0 12.9 11.1 12.3 16.3 16.3 12.9 9.4 14.0 17.7 17.0 11.3 8.5 16.1 12.1 13.0 15.0 10.9 9.2 11.9 11.6 8.0 16.4 11.6 9.8 14.7 7.9 25.0 17.0 27.8 12.1 19.8 16.4 13.9 20.9 26.1 16.6 18.6 12.5 25.7 13.1 12.3 23.6 35.1 12.8 23.4 16.1 19.9 28.7 21.5 6.6 11.5 17.4 12.4 11.7 27.6 24.4 17.4 9.6 15.2 15.2 2.4 3.9 10.5 9.0 6.8 11.6 7.5 11.5 11.9 4.3 8.9 12.8 9.6 4.0 6.3 8.2 4.2 6.0 5.7 22.2 23.7 28.5 26.8 18.7 22.9 22.2 19.4 21.3 22.1 8.9 8.2 8.4 3.2 4.8 10.2 4.2 5.1 1.4 6.8 12.2 2.0 12.8 16.6 5.0 2.7 6.8 7.0 0.0 5.1 10.1 5.3 4.2 0.0 7.8 5.5 20.6 5.2 6.7 6.9 1.8 8.3 3.9 5.0 4.6 9.7 9.8 8.0 8.6 8.5 7.6 6.1 6.5 6.6 4.1 10.9 4.5 9.7 11.7 9.5 2.8 RAB13 ENSG00000143545 "RAB13, member RAS oncogene family" P51153 1 153981617-153986358 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 7.7;myeloid DC: 10.7;plasmacytoid DC: 12.0" "Group enriched" "Detected in many" 9 "dendritic cells: 12.0;monocytes: 7.7" "Cell line enhanced" "Detected in many" "ASC TERT1: 116.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003996 Approved Supported "Plasma membrane,Cytosol" NA NA 4600000 "Plasma membrane, Cytosol" "HPA003996: AB_1079728" "unprognostic (4.39e-3)" "unprognostic (1.20e-1)" "unprognostic (2.51e-2)" "unprognostic (4.11e-2)" "unprognostic (4.28e-3)" "unprognostic (3.20e-2)" "unprognostic (1.18e-3)" "unprognostic (2.80e-1)" "unprognostic (3.53e-2)" "unprognostic (2.11e-2)" "unprognostic (2.10e-1)" "unprognostic (5.93e-2)" "unprognostic (1.06e-3)" "unprognostic (2.45e-1)" "unprognostic (1.03e-1)" "unprognostic (9.51e-3)" "unprognostic (1.28e-2)" 49.0 40.4 18.1 28.7 30.2 29.7 52.1 13.6 23.5 33.1 33.6 13.7 46.6 17.8 28.5 47.1 43.2 25.0 46.7 36.9 21.9 17.0 61.3 51.5 40.8 36.7 22.9 11.1 39.2 65.6 28.4 11.1 29.0 29.1 41.5 24.5 21.6 47.4 44.4 26.8 25.0 28.7 35.3 31.3 44.8 34.5 24.0 24.7 5.9 54.8 35.0 24.9 41.0 78.4 1.0 12.0 0.9 7.7 0.0 0.7 2.4 17.2 21.3 19.3 20.3 65.0 116.2 6.3 21.1 50.0 19.1 19.5 21.5 14.7 0.0 31.8 25.1 9.7 11.9 11.4 19.2 26.6 11.1 8.8 14.4 13.4 12.0 27.3 0.0 10.2 84.5 16.6 32.9 14.6 53.9 33.2 0.0 3.0 0.0 32.4 35.9 0.0 7.3 31.0 23.7 20.4 4.2 25.2 0.0 43.0 18.3 1.2 16.0 27.6 23.9 42.5 30.0 39.3 11.5 61.5 34.8 20.6 21.5 22.8 0.1 0.0 0.2 54.2 2.5 52.7 0.0 7.7 0.1 0.0 1.4 0.1 0.8 0.1 0.1 10.7 1.0 0.1 0.7 0.9 0.0 0.2 12.0 0.0 2.4 18.1 30.2 13.6 23.5 21.9 17.0 22.9 11.1 29.1 24.7 38.7 70.7 13.4 148.7 81.7 1.1 69.4 104.4 56.2 63.7 102.9 2.0 102.3 114.4 187.9 86.7 180.9 76.1 0.0 130.8 137.5 109.8 182.0 40.3 126.2 237.1 0.0 85.5 141.2 101.8 184.7 98.4 112.5 94.5 413.0 147.2 16.7 149.6 95.1 116.7 162.0 3.2 148.8 189.5 61.2 17.1 85.7 77.7 12.5 130.8 173.5 RAB23 ENSG00000112210 "RAB23, member RAS oncogene family" Q9ULC3 6 57186992-57222314 "Disease related genes, Predicted intracellular proteins" "Protein transport, Transport" "Developmental protein" "Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "smooth muscle: 62.4;urinary bladder: 48.9" "Cell type enhanced" "Detected in many" 6 "Fibroblasts: 23.8;Leydig cells: 18.4;Peritubular cells: 28.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 32.6;U-2197: 57.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029135, HPA029136" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA029135: AB_10602070, HPA029136: AB_10601794" "unprognostic (8.78e-2)" "unprognostic (6.55e-2)" "unprognostic (7.17e-2)" "unprognostic (1.10e-1)" "unprognostic (2.14e-2)" "unprognostic (2.28e-2)" "unprognostic (2.55e-2)" "unprognostic (5.33e-3)" "unprognostic (6.41e-2)" "unprognostic (6.55e-2)" "unprognostic (1.05e-1)" "unprognostic (2.97e-2)" "unprognostic (9.12e-3)" "unprognostic (1.36e-2)" "unprognostic (2.38e-1)" "unprognostic (6.37e-2)" "unprognostic (1.46e-3)" 6.0 3.0 6.7 5.7 5.1 0.2 4.0 7.3 4.8 23.1 32.9 5.1 9.6 3.0 34.1 8.0 9.7 8.1 12.4 7.0 7.4 4.5 3.3 1.8 4.9 1.7 6.4 5.4 8.2 1.6 2.9 3.5 12.3 6.7 24.9 7.5 3.6 2.8 26.9 4.7 3.1 7.0 62.4 6.6 1.1 8.7 4.3 7.2 1.4 15.1 3.9 1.7 48.9 11.2 0.3 1.5 1.3 0.6 0.9 2.0 0.3 4.8 1.9 7.0 4.9 10.7 32.6 6.4 14.3 24.8 12.6 13.1 4.2 2.3 0.9 4.4 22.9 6.3 1.7 7.2 5.2 15.0 3.6 3.4 3.5 3.2 3.3 6.6 1.8 0.5 12.1 6.0 15.6 14.7 6.1 6.5 2.1 5.4 3.0 13.9 4.0 1.6 1.9 2.6 3.2 2.6 1.7 10.3 1.4 8.7 3.4 3.6 2.5 7.1 3.4 3.6 9.1 3.1 2.1 8.7 19.6 6.1 57.6 8.3 2.6 2.8 2.4 11.0 3.9 9.6 0.3 0.4 1.3 0.3 0.4 0.0 0.3 1.1 0.5 0.3 0.3 2.0 0.8 0.0 0.9 0.6 1.5 0.0 0.3 6.7 5.1 7.3 4.8 7.4 4.5 6.4 5.4 6.7 7.2 11.9 5.3 0.0 1.6 3.7 2.9 3.1 2.5 6.7 1.2 0.0 2.0 10.0 0.0 2.8 2.1 1.4 1.3 0.0 2.5 8.4 23.8 3.6 0.0 3.0 3.7 1.6 1.2 4.9 0.6 1.3 18.4 1.3 5.0 12.6 1.2 3.2 2.8 0.0 28.7 4.4 0.7 0.0 9.0 6.7 7.1 4.4 11.4 0.0 1.2 1.4 RAB3GAP2 "DKFZP434D245, KIAA0839, RAB3-GAP150, SPG69" ENSG00000118873 "RAB3 GTPase activating non-catalytic protein subunit 2" Q9H2M9 1 220148293-220272454 "Disease related genes, Predicted intracellular proteins" "GTPase activation" "Cataract, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026273, HPA027299" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA026273: AB_1856007, HPA027299: AB_1856008" "prognostic unfavorable (3.05e-4)" "unprognostic (2.80e-3)" "unprognostic (1.76e-2)" "unprognostic (6.07e-2)" "unprognostic (5.20e-2)" "unprognostic (1.69e-1)" "unprognostic (2.40e-2)" "unprognostic (7.00e-2)" "unprognostic (4.61e-2)" "unprognostic (1.75e-1)" "unprognostic (4.63e-2)" "unprognostic (2.13e-1)" "unprognostic (7.75e-2)" "unprognostic (1.27e-1)" "unprognostic (1.17e-1)" "unprognostic (3.99e-2)" "unprognostic (1.56e-1)" 16.7 16.2 14.9 19.6 18.7 14.3 17.8 24.2 22.4 15.6 13.5 14.3 13.9 12.2 16.8 14.9 15.6 12.8 12.8 15.3 16.5 18.8 18.9 15.6 14.3 18.2 17.1 15.6 16.2 14.5 35.6 28.3 19.8 21.9 14.2 13.5 11.6 15.6 15.8 19.9 13.1 15.0 14.9 15.2 14.9 14.5 10.1 15.5 26.1 20.5 11.9 21.7 16.0 15.8 7.1 5.2 12.3 5.1 3.6 8.9 4.6 13.9 10.6 12.9 9.7 14.8 17.7 14.6 14.4 13.7 13.0 15.4 9.7 11.6 17.3 10.2 13.8 9.8 13.3 13.3 11.0 15.1 14.5 8.7 13.5 14.1 9.1 19.6 19.3 13.9 14.0 12.6 12.6 19.7 14.6 11.8 7.6 23.3 11.3 14.6 3.9 14.8 6.8 27.7 7.5 6.3 8.1 17.8 15.4 11.1 11.5 12.9 15.6 14.9 14.5 23.3 14.5 15.2 18.4 17.1 14.3 6.7 9.8 15.3 10.0 12.1 15.3 12.2 16.3 16.7 12.3 3.9 7.5 7.1 4.9 8.6 7.1 7.0 8.9 5.2 5.5 6.3 7.4 2.5 3.6 5.1 3.3 8.0 4.6 14.9 18.7 24.2 22.4 16.5 18.8 17.1 15.6 21.9 15.5 38.7 21.6 17.1 12.0 10.3 54.4 31.3 22.9 12.0 23.9 24.4 64.8 15.7 5.0 16.3 2.6 17.6 16.9 0.0 14.3 11.2 17.7 17.2 18.5 20.3 21.2 39.7 34.0 25.8 29.8 1.6 16.7 20.6 13.5 16.2 20.3 46.1 17.6 14.0 24.4 14.5 51.3 6.5 14.4 15.6 11.8 8.5 19.3 19.3 18.8 11.3 RAB8A "MEL, RAB8" ENSG00000167461 "RAB8A, member RAS oncogene family" P61006 19 16111629-16134234 "Predicted intracellular proteins" "Autophagy, Cilium biogenesis/degradation, Protein transport, Transport" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041945 Supported "Nucleoplasm,Plasma membrane" No No 16000000 "Nucleoplasm, Plasma membrane" "HPA041945: " "unprognostic (1.10e-1)" "unprognostic (3.95e-3)" "unprognostic (1.98e-2)" "unprognostic (2.59e-1)" "unprognostic (1.63e-1)" "unprognostic (1.66e-1)" "unprognostic (1.19e-1)" "unprognostic (2.11e-1)" "unprognostic (2.57e-1)" "unprognostic (1.14e-2)" "unprognostic (2.52e-3)" "unprognostic (1.29e-2)" "prognostic unfavorable (6.56e-5)" "unprognostic (6.60e-2)" "unprognostic (7.25e-2)" "prognostic favorable (1.71e-4)" "unprognostic (9.99e-2)" 23.4 22.8 15.6 24.5 14.1 32.5 15.9 16.6 13.6 18.2 23.1 18.5 15.0 37.6 17.2 11.8 22.9 18.0 17.1 10.6 13.6 11.2 24.8 57.8 19.3 24.9 14.2 8.4 23.3 24.7 8.8 15.5 30.9 13.6 16.3 20.1 16.5 27.4 14.7 5.2 22.3 56.2 14.1 16.7 43.4 20.1 15.9 14.7 33.4 18.5 12.7 36.1 19.7 17.9 34.3 45.4 55.2 81.1 39.0 31.8 75.5 29.0 19.6 16.2 13.6 13.2 11.7 25.4 17.7 15.3 23.6 24.8 22.4 33.6 20.1 20.2 17.3 20.6 19.3 21.7 21.8 15.0 41.2 12.7 42.1 18.3 23.0 15.1 36.5 42.0 12.1 11.3 22.2 9.7 12.7 19.3 20.7 19.5 30.7 18.7 33.5 30.4 32.0 20.3 34.9 31.6 34.6 17.8 35.6 17.4 22.3 15.0 14.8 17.9 21.2 11.2 10.9 17.2 13.6 19.1 19.8 12.9 38.6 30.1 16.7 34.3 30.3 19.1 36.5 21.4 36.0 50.6 55.2 31.8 69.8 28.4 34.3 28.4 28.6 45.4 31.8 22.5 26.5 53.8 39.0 81.1 32.5 26.6 75.5 15.6 14.1 16.6 13.6 13.6 11.2 14.2 8.4 13.6 14.7 23.8 26.1 58.8 41.8 42.4 14.1 2.8 17.8 45.5 23.9 29.6 13.7 78.7 69.6 59.2 24.1 29.5 105.7 0.0 45.1 81.2 38.0 31.1 46.3 44.5 79.7 6.4 29.1 23.9 36.3 12.6 25.6 79.9 32.1 147.9 48.7 29.6 58.4 77.2 23.3 44.7 12.2 32.3 24.7 24.4 19.0 45.9 66.6 64.7 40.4 32.5 RAD52 ENSG00000002016 "RAD52 homolog, DNA repair protein" P43351 12 912077-990053 "Cancer-related genes, Predicted intracellular proteins" "DNA damage, DNA recombination, DNA repair" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028957 Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA028957: AB_2672842" "unprognostic (4.53e-1)" "unprognostic (8.08e-3)" "unprognostic (4.68e-2)" "unprognostic (5.27e-2)" "unprognostic (7.37e-2)" "unprognostic (1.42e-2)" "unprognostic (1.82e-3)" "unprognostic (1.88e-1)" "unprognostic (2.80e-2)" "unprognostic (8.43e-2)" "unprognostic (1.03e-2)" "unprognostic (3.27e-1)" "prognostic unfavorable (2.22e-6)" "unprognostic (1.54e-1)" "unprognostic (1.61e-1)" "unprognostic (1.68e-1)" "unprognostic (3.74e-2)" 7.4 8.5 12.4 8.1 15.1 5.0 10.0 18.8 15.9 12.6 11.7 14.5 13.6 9.4 12.5 14.2 8.2 11.0 9.0 7.8 14.3 7.3 9.9 10.5 6.9 8.9 15.0 9.6 17.6 11.4 9.6 15.6 8.5 15.0 10.5 11.7 9.5 8.4 11.0 16.5 14.9 10.4 12.8 17.0 10.3 8.8 6.8 20.9 9.4 14.6 4.3 9.7 9.7 13.3 7.0 9.6 7.4 3.8 4.0 6.0 1.4 3.1 12.2 9.5 10.7 10.4 7.8 10.2 6.3 5.9 7.0 7.0 11.7 11.2 10.0 2.0 6.3 6.1 9.4 7.2 4.2 6.2 13.4 6.4 11.1 11.7 8.1 5.9 11.9 3.4 4.5 7.5 7.4 22.7 14.0 5.9 9.8 7.4 5.7 6.7 6.6 8.1 11.9 12.4 7.9 7.9 8.3 9.3 3.7 7.3 5.7 3.4 3.9 8.1 8.8 4.5 14.6 8.2 5.8 5.8 9.8 11.9 7.7 6.6 2.2 3.4 10.4 5.1 5.0 3.6 7.4 3.4 2.0 4.6 2.9 6.0 4.8 4.9 4.0 4.4 7.0 5.7 5.2 2.8 4.0 3.8 9.6 4.4 1.4 12.4 15.1 18.8 15.9 14.3 7.3 15.0 9.6 15.0 20.9 3.0 5.1 0.0 1.1 1.5 3.7 3.1 0.0 1.4 4.5 3.5 2.0 3.6 1.7 1.9 3.2 3.0 4.0 0.0 1.4 2.2 2.2 1.3 5.7 2.1 2.3 3.2 1.7 0.6 1.0 4.5 0.6 2.2 0.0 2.8 2.3 1.9 0.6 2.9 0.7 1.4 2.3 6.5 3.1 4.6 4.1 0.9 1.7 1.3 2.9 0.9 RALA RAL ENSG00000006451 "RAS like proto-oncogene A" P11233 7 39623483-39708124 "Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Exocytosis" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Pancreatic endocrine cells: 277.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "HUVEC TERT2: 78.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047037, HPA065232" Approved Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA047037: , HPA065232: AB_2685440" "unprognostic (1.20e-3)" "unprognostic (1.03e-2)" "unprognostic (2.91e-1)" "unprognostic (7.73e-3)" "unprognostic (1.98e-2)" "unprognostic (9.14e-2)" "prognostic unfavorable (5.32e-5)" "unprognostic (7.71e-2)" "unprognostic (2.17e-1)" "prognostic favorable (7.46e-4)" "prognostic unfavorable (6.30e-4)" "unprognostic (3.32e-1)" "unprognostic (4.95e-3)" "unprognostic (5.38e-2)" "unprognostic (7.15e-2)" "unprognostic (2.79e-1)" "unprognostic (2.95e-2)" 19.2 25.2 24.7 14.3 24.6 4.8 24.4 16.1 22.0 18.4 22.3 17.2 8.0 23.5 15.7 15.5 44.9 15.0 20.0 13.8 24.7 20.2 15.9 15.4 30.3 14.8 27.6 18.9 17.4 11.6 12.8 14.2 23.7 20.3 12.9 23.6 9.1 18.5 12.7 16.8 19.5 25.5 15.7 36.0 16.0 24.4 12.2 21.9 19.9 13.8 31.0 28.9 15.2 20.8 13.3 16.3 21.5 11.2 15.7 20.4 11.5 20.1 4.6 11.4 9.9 21.8 18.2 7.9 17.7 25.6 16.1 17.9 11.5 9.9 10.4 6.7 13.7 15.1 21.0 16.1 11.5 27.9 9.9 7.6 8.1 7.6 8.4 35.4 14.0 11.5 14.3 14.1 28.7 40.9 20.2 78.1 10.2 16.2 6.9 16.3 6.5 9.8 16.7 32.1 22.1 9.2 12.3 10.3 9.0 16.4 9.4 20.5 19.9 10.9 17.5 12.0 21.5 16.4 15.4 25.0 9.5 8.5 12.0 12.6 12.3 9.5 12.7 10.7 14.6 17.3 21.5 9.8 11.0 9.7 11.2 12.0 11.5 15.7 12.4 16.3 13.3 20.4 17.9 4.5 15.7 8.6 10.6 19.7 11.5 24.7 24.6 16.1 20.8 24.7 20.2 27.6 18.9 20.3 21.9 77.4 36.8 45.3 32.8 80.0 10.9 33.0 45.9 29.4 21.6 22.7 5.9 45.4 18.3 162.0 51.6 66.4 59.6 23.3 107.3 77.4 54.6 33.5 31.1 26.2 97.6 11.1 45.8 69.3 24.5 12.3 44.3 67.7 28.7 146.1 46.5 37.7 277.8 66.0 65.4 28.4 15.8 32.3 24.7 52.6 55.6 95.7 51.8 25.5 51.1 47.7 RALGAPA2 "AS250, C20orf74, dJ1049G11.4, KIAA1272, RapGAPalpha2" ENSG00000188559 "Ral GTPase activating protein catalytic alpha subunit 2" Q2PPJ7 20 20389552-20712488 "Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RT4: 47.7;SCLC-21H: 26.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA042707, HPA043622" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA042707: AB_2678124, HPA043622: AB_2678585" "unprognostic (7.40e-2)" "unprognostic (1.71e-1)" "unprognostic (1.69e-2)" "unprognostic (1.09e-2)" "unprognostic (2.36e-1)" "unprognostic (3.34e-2)" "unprognostic (3.36e-1)" "unprognostic (3.29e-2)" "unprognostic (1.95e-1)" "unprognostic (3.56e-2)" "unprognostic (1.74e-1)" "unprognostic (8.23e-2)" "prognostic favorable (3.77e-5)" "unprognostic (6.52e-2)" "unprognostic (1.54e-1)" "unprognostic (3.48e-1)" "unprognostic (5.33e-2)" 26.5 7.0 7.3 9.9 8.1 19.4 16.9 11.4 8.7 10.6 12.7 9.6 14.9 10.5 15.2 9.6 8.9 10.7 13.0 7.8 8.3 4.2 11.0 26.4 26.5 13.0 10.8 4.4 8.0 18.5 14.1 20.9 18.5 7.4 13.2 13.5 8.2 22.6 12.8 26.0 15.3 10.0 9.6 8.4 8.2 18.1 8.6 9.3 8.2 23.2 6.0 10.2 13.9 15.7 1.7 2.0 7.0 2.1 2.6 2.4 0.6 3.5 2.3 4.7 2.5 2.4 1.9 5.3 0.9 0.9 1.2 1.5 1.9 4.9 1.6 3.1 1.4 5.1 3.7 4.9 4.0 2.2 7.1 2.4 5.4 1.2 3.3 0.9 6.9 3.2 1.7 3.1 1.9 0.9 2.0 6.7 7.5 1.1 3.0 1.8 2.3 2.6 9.2 2.0 11.3 2.1 3.8 3.2 2.2 4.1 47.7 26.7 2.3 3.6 2.6 3.0 4.7 1.8 6.6 1.7 1.9 1.8 1.4 1.3 1.7 1.2 0.7 1.6 4.5 2.6 5.9 2.1 6.0 1.7 0.7 2.4 1.4 1.1 1.6 1.0 1.7 2.1 1.5 7.0 2.6 1.6 2.0 1.4 0.6 7.3 8.1 11.4 8.7 8.3 4.2 10.8 4.4 7.4 9.3 6.0 34.4 5.2 8.3 9.4 35.1 8.9 48.4 26.8 14.8 14.0 25.5 7.9 1.7 18.0 18.9 55.4 19.6 0.0 21.5 4.6 5.2 14.5 8.1 37.6 10.2 49.3 23.6 58.3 18.1 6.4 1.7 8.1 8.5 4.6 24.1 10.1 20.9 21.0 6.3 9.2 13.0 12.9 6.2 8.6 10.7 14.4 9.4 9.6 26.2 25.0 RAPGEF2 "DKFZP586O1422, KIAA0313, PDZ-GEF1, PDZGEF1, RA-GEF" ENSG00000109756 "Rap guanine nucleotide exchange factor 2" Q9Y4G8 4 159103013-159360174 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein, GTPase activation, Guanine-nucleotide releasing factor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 9.4" "Group enriched" "Detected in many" 5 "granulocytes: 9.4;NK-cells: 5.2" "Cell line enhanced" "Detected in many" "HMC-1: 40.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA068798 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA068798: " "unprognostic (4.88e-2)" "unprognostic (7.42e-2)" "unprognostic (1.67e-2)" "unprognostic (7.79e-3)" "unprognostic (8.16e-2)" "unprognostic (4.71e-3)" "unprognostic (4.20e-3)" "unprognostic (2.33e-1)" "unprognostic (2.17e-1)" "unprognostic (2.65e-2)" "unprognostic (9.71e-2)" "unprognostic (1.07e-1)" "prognostic favorable (1.76e-7)" "unprognostic (2.29e-1)" "unprognostic (2.07e-1)" "unprognostic (2.01e-2)" "unprognostic (1.78e-1)" 16.7 8.0 28.4 8.8 23.8 51.0 16.3 21.5 34.1 12.6 14.5 11.3 10.4 10.9 12.7 7.3 9.9 10.2 14.1 14.9 23.4 15.3 16.4 20.9 18.1 8.5 14.1 29.6 10.2 13.4 20.7 13.8 26.1 16.9 9.3 14.8 10.0 18.7 9.4 15.7 12.7 11.9 14.0 13.9 19.2 13.7 6.7 14.3 9.3 27.5 8.9 7.8 11.9 13.8 0.4 1.4 9.4 1.4 5.2 1.5 0.3 3.3 4.5 21.5 6.6 8.5 9.6 33.1 6.5 8.2 5.9 4.3 13.9 7.4 19.0 2.4 6.4 8.6 3.0 7.3 8.3 7.1 3.2 5.1 29.5 9.5 8.0 6.2 3.5 40.9 5.6 4.7 14.2 5.0 12.6 16.9 7.9 6.5 17.8 7.3 5.9 8.8 0.5 9.1 3.9 4.5 7.3 5.4 0.7 5.3 7.6 6.1 8.2 9.5 4.6 7.9 10.8 2.3 2.4 17.8 9.4 9.9 11.9 5.3 19.9 11.7 0.3 11.1 1.5 5.7 2.7 1.4 1.0 0.8 0.8 1.0 0.4 0.7 0.5 0.8 0.3 0.9 0.4 9.4 5.2 0.9 1.4 1.5 0.3 28.4 23.8 21.5 34.1 23.4 15.3 14.1 29.6 16.9 14.3 53.6 26.7 7.5 10.9 18.1 16.3 32.9 12.7 16.0 17.0 7.0 39.3 9.4 0.0 8.1 4.0 30.0 12.3 46.7 10.8 8.1 15.0 16.7 48.7 25.6 10.1 31.8 13.8 31.9 25.1 3.8 7.2 14.1 32.1 7.2 10.8 29.8 16.9 17.5 8.1 6.4 23.4 51.8 17.8 3.6 6.5 17.6 4.9 7.5 6.4 12.8 RASAL2 nGAP ENSG00000075391 "RAS protein activator like 2" Q9UJF2 1 178094141-178484147 "Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Cone photoreceptor cells: 143.3;Rod photoreceptor cells: 179.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive B-cell: 2.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 30.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018805, HPA020453" Enhanced Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA018805: AB_1856085, HPA020453: AB_1856086" "unprognostic (5.55e-3)" "unprognostic (6.49e-2)" "unprognostic (2.65e-1)" "unprognostic (6.33e-2)" "unprognostic (3.40e-2)" "unprognostic (5.59e-2)" "unprognostic (5.91e-2)" "unprognostic (1.72e-2)" "unprognostic (2.91e-1)" "unprognostic (2.92e-2)" "unprognostic (3.16e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-2)" "unprognostic (4.98e-2)" "unprognostic (2.45e-1)" "unprognostic (8.36e-2)" "prognostic unfavorable (2.05e-4)" 13.5 3.8 4.2 2.8 5.1 0.4 7.1 2.7 8.5 9.5 4.2 3.7 4.2 2.4 10.9 5.5 24.4 5.8 9.0 15.5 3.8 5.9 7.1 2.7 9.2 1.5 4.0 6.5 6.3 5.0 6.1 6.7 21.2 5.6 5.0 4.3 10.7 9.6 4.5 8.3 7.5 3.3 7.1 3.8 2.9 3.7 9.0 2.7 0.0 5.0 13.1 4.8 5.6 13.2 2.1 0.5 1.4 0.6 0.3 0.1 0.0 16.3 5.4 7.1 2.3 4.8 6.5 9.9 8.2 8.0 7.0 5.3 8.6 8.7 0.0 13.7 8.0 11.5 13.8 5.7 13.1 6.5 0.0 3.1 0.0 5.7 3.4 5.7 2.3 0.3 20.4 2.6 8.3 30.0 7.3 6.3 0.0 0.5 0.0 9.7 1.7 0.0 1.9 5.3 3.1 1.0 0.1 2.9 0.0 3.8 2.2 5.5 2.7 6.4 5.0 5.0 6.3 5.8 2.6 11.9 9.3 9.5 9.7 10.9 3.6 0.0 0.0 7.3 1.2 6.6 1.4 0.4 0.1 0.1 0.3 0.0 0.6 0.0 0.0 0.2 2.1 0.1 0.1 0.8 0.3 0.6 0.5 0.0 0.0 4.2 5.1 2.7 7.1 3.8 5.9 4.0 6.5 5.6 2.7 71.5 11.7 1.4 7.8 14.2 47.0 33.2 17.8 37.5 14.8 15.7 143.3 11.6 5.0 19.0 12.3 41.2 5.2 0.0 10.9 12.1 14.7 18.7 7.0 5.4 15.0 79.4 32.7 43.0 2.5 5.1 18.1 13.1 3.3 12.6 14.6 22.8 23.0 2.9 21.5 5.7 179.6 64.7 27.8 28.6 32.2 21.1 35.0 0.7 12.8 29.3 RASAL3 FLJ21438 ENSG00000105122 "RAS protein activator like 3" Q86YV0 19 15451624-15464571 "Predicted intracellular proteins, RAS pathway related proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 29.9" "Group enriched" "Detected in many" 5 "B-cells: 38.9;granulocytes: 39.2;T-cells: 62.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HDLM-2: 14.4;HEL: 11.9;HMC-1: 23.1;Karpas-707: 25.7;NB-4: 13.1;RPMI-8226: 10.9;TIME: 17.1;U-937: 16.1" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA043417 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA043417: AB_2678473" "unprognostic (2.72e-2)" "prognostic favorable (8.75e-4)" "unprognostic (3.27e-2)" "prognostic favorable (3.58e-5)" "unprognostic (2.31e-1)" "prognostic favorable (3.07e-4)" "unprognostic (1.82e-2)" "unprognostic (6.21e-3)" "unprognostic (7.40e-3)" "unprognostic (1.02e-1)" "unprognostic (3.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavorable (1.16e-6)" "unprognostic (2.98e-1)" "unprognostic (1.90e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" 2.8 2.1 3.1 19.2 3.8 16.7 1.7 0.5 1.9 1.4 3.4 4.6 0.7 3.6 1.7 1.1 3.0 1.9 4.5 1.1 4.1 1.8 3.3 2.8 8.0 23.5 4.5 1.3 0.9 1.3 0.3 1.4 0.8 3.7 2.3 1.9 1.5 7.5 1.1 0.7 1.2 14.5 0.9 5.1 29.9 4.0 0.6 4.6 27.3 3.1 1.6 28.9 4.5 2.0 2.9 3.2 8.8 9.3 8.9 16.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 3.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 11.9 0.0 0.0 0.2 9.5 23.1 0.0 0.0 0.0 0.0 0.0 0.1 3.9 0.0 25.7 0.0 0.1 5.0 13.1 0.0 0.0 0.0 1.4 0.0 10.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 17.1 0.0 0.0 0.0 0.0 0.2 4.6 7.0 0.0 16.1 0.0 4.3 1.7 8.8 14.9 3.4 8.9 2.2 9.5 16.4 2.6 2.9 8.0 9.6 2.5 8.9 9.3 3.2 6.4 3.5 3.1 3.8 0.5 1.9 4.1 1.8 4.5 1.3 3.7 4.6 3.0 9.3 38.9 0.0 0.2 0.0 2.2 0.0 8.1 2.3 0.0 0.0 0.1 0.0 0.1 0.4 2.9 0.0 0.0 0.5 0.2 0.9 0.1 39.2 3.9 9.8 0.0 0.0 4.3 9.2 0.6 0.0 7.4 0.0 2.8 0.0 0.1 0.3 0.0 1.1 0.8 0.0 0.0 0.5 0.4 0.3 0.5 0.3 62.3 0.0 0.1 RASD1 "AGS1, DEXRAS1" ENSG00000108551 "Ras related dexamethasone induced 1" Q9Y272 17 17494437-17496395 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Mucus-secreting cells: 239.8;Muller glia cells: 245.0;Peritubular cells: 441.6;Sertoli cells: 556.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 47 "plasmacytoid DC: 48.0" "Lineage enriched" "Detected in many" 47 "dendritic cells: 48.0" "Cell line enhanced" "Detected in some" "ASC diff: 34.4;HSkMC: 8.4;REH: 32.9" "Group enriched" "Detected in many" 5 "basal ganglia: 77.3;hippocampal formation: 60.2;thalamus: 58.1" "Low region specificity" "Detected in all" HPA047896 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA047896: AB_10960535" "unprognostic (1.59e-1)" "unprognostic (1.32e-1)" "unprognostic (3.28e-2)" "unprognostic (3.31e-2)" "unprognostic (6.40e-2)" "unprognostic (8.13e-2)" "unprognostic (8.65e-2)" "unprognostic (7.60e-2)" "unprognostic (5.50e-2)" "unprognostic (2.11e-1)" "unprognostic (3.17e-3)" "unprognostic (2.92e-1)" "unprognostic (7.40e-2)" "unprognostic (1.11e-2)" "unprognostic (1.38e-1)" "unprognostic (1.30e-1)" "unprognostic (1.38e-2)" 79.6 24.3 14.0 6.2 23.2 8.3 30.4 11.6 32.0 49.1 7.1 8.5 18.6 5.9 19.9 17.1 10.9 11.6 11.8 20.1 14.7 15.5 30.2 85.9 5.6 3.7 10.0 22.5 33.5 17.5 7.2 81.3 2.6 22.2 17.8 6.9 6.6 49.4 51.8 37.2 9.1 6.1 4.3 19.6 12.2 6.1 13.8 8.9 9.1 37.7 9.2 2.5 6.2 5.5 0.0 48.0 0.0 1.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 34.4 1.9 0.1 0.4 0.6 0.0 0.1 1.4 0.0 0.0 3.9 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 3.8 0.2 0.0 0.1 8.4 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.1 3.4 6.2 0.6 0.7 0.6 2.1 32.9 0.0 0.0 0.7 0.0 6.2 0.2 0.5 0.4 7.2 1.0 0.0 0.0 1.9 0.0 0.3 0.2 0.1 7.0 0.2 0.0 0.2 0.0 0.2 0.0 0.1 0.0 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 48.0 0.0 0.3 14.0 23.2 11.6 32.0 14.7 15.5 10.0 22.5 22.2 8.9 26.8 30.8 3.7 47.7 15.2 21.5 61.3 12.7 8.1 40.9 141.3 3.9 2.5 11.6 55.0 2.1 17.5 18.7 0.0 1.1 2.2 69.9 113.7 8.1 13.2 3.4 6.4 213.7 10.4 3.7 4.2 101.5 8.8 28.7 3.6 239.8 245.0 13.9 15.8 441.6 3.8 20.0 556.2 153.3 1.6 1.6 11.5 5.6 6.9 22.1 20.7 RASD2 "MGC:4834, Rhes, TEM2" ENSG00000100302 "RASD family member 2" Q96D21 22 35540868-35554001 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 71.0;seminal vesicle: 25.2" "Cell type enriched" "Detected in some" 4 "Sertoli cells: 45.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in all" "basal ganglia: 71.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 4.3;hTERT-RPE1: 13.4;SK-BR-3: 7.6;U-2 OS: 4.4;U-87 MG: 5.5" "Region enriched" "Detected in many" 8 "basal ganglia: 527.8" "Region enriched" "Detected in all" 8 "basal ganglia: 265.8" HPA005839 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA005839: AB_1079745" "unprognostic (1.76e-2)" "unprognostic (1.98e-1)" "unprognostic (3.33e-2)" "unprognostic (7.00e-2)" "unprognostic (1.43e-1)" "unprognostic (7.07e-3)" "unprognostic (9.76e-2)" "unprognostic (5.49e-2)" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (1.04e-1)" "unprognostic (9.00e-3)" "prognostic unfavorable (2.22e-5)" "unprognostic (3.75e-2)" "unprognostic (1.61e-1)" "unprognostic (8.42e-3)" "unprognostic (6.22e-2)" 1.6 7.9 8.6 2.5 71.0 3.4 1.3 1.8 23.5 1.1 8.3 2.2 3.2 2.5 3.5 16.4 5.2 6.2 2.5 2.8 4.1 5.0 0.8 0.5 1.5 0.6 3.4 8.0 0.8 1.0 0.9 1.0 0.4 2.1 9.6 4.4 3.5 4.0 25.2 13.6 0.8 3.4 7.5 2.2 0.4 1.8 0.6 15.3 0.0 1.4 0.1 1.4 3.8 1.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 2.8 0.0 0.5 0.0 0.0 0.1 0.7 0.2 1.1 0.9 0.1 0.5 0.0 0.2 2.4 4.3 0.1 0.2 0.0 1.0 0.0 0.7 0.0 0.1 0.0 1.4 0.0 0.0 0.2 3.3 2.2 0.3 13.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.2 0.2 0.2 0.3 1.3 0.0 0.9 0.0 0.0 2.0 0.3 2.2 7.6 0.0 0.2 0.6 0.2 0.1 1.8 4.4 0.2 0.8 1.9 0.6 0.0 5.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 8.6 71.0 1.8 23.5 4.1 5.0 3.4 8.0 2.1 15.3 0.0 0.0 0.0 0.2 0.0 0.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.4 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.9 0.0 0.0 0.2 0.7 0.0 0.1 45.3 4.1 0.0 0.1 0.1 0.0 0.0 0.2 0.1 RASGRP1 "CalDAG-GEFII, RASGRP" ENSG00000172575 "RAS guanyl releasing protein 1" O95267 15 38488103-38565575 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Differentiation "Guanine-nucleotide releasing factor" "Disease mutation, Systemic lupus erythematosus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 33.1;lymphoid tissue: 55.8" "Cell type enhanced" "Detected in many" 14 "Collecting duct cells: 31.4;Muller glia cells: 101.6;T-cells: 55.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Lineage enriched" "Detected in many" 4 "T-cells: 10.4" "Group enriched" "Detected in some" 4 "HDLM-2: 25.3;JURKAT: 33.6;MOLT-4: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA039389 Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039389: AB_2732481" "unprognostic (3.44e-3)" "unprognostic (1.86e-2)" "unprognostic (1.17e-2)" "unprognostic (3.43e-3)" "unprognostic (1.82e-2)" "unprognostic (3.33e-3)" "unprognostic (9.63e-2)" "unprognostic (4.23e-2)" "unprognostic (1.91e-1)" "unprognostic (1.21e-1)" "unprognostic (4.50e-1)" "unprognostic (3.01e-2)" "unprognostic (2.54e-1)" "unprognostic (2.55e-1)" "unprognostic (1.51e-1)" "unprognostic (3.40e-1)" "unprognostic (9.30e-2)" 1.7 1.0 5.7 9.9 17.0 7.8 1.9 33.1 18.5 1.4 1.6 0.8 0.0 2.5 1.6 1.6 6.7 4.7 2.7 1.6 6.1 3.2 5.9 1.2 4.2 20.0 3.0 6.2 0.8 2.0 0.3 1.2 4.9 22.3 1.0 2.3 1.4 2.5 1.0 0.8 7.3 3.7 0.7 1.6 8.6 4.8 2.2 1.1 55.8 1.2 1.6 16.3 4.3 2.4 1.2 0.0 0.8 0.0 2.4 10.4 1.4 0.0 0.1 0.5 0.1 0.0 0.0 0.0 1.9 0.6 1.0 0.8 2.1 0.0 5.4 0.4 0.0 0.1 0.1 1.1 0.0 0.9 25.3 1.0 0.4 0.2 0.0 0.3 0.2 0.4 0.0 0.0 0.5 0.0 0.0 0.0 33.6 0.2 1.7 0.0 0.8 23.9 0.0 0.3 0.0 0.0 6.7 0.1 0.0 1.0 0.0 2.3 0.8 1.2 0.0 0.1 0.7 0.6 0.0 0.1 0.2 0.8 2.7 0.3 4.2 2.0 6.4 0.1 0.0 0.2 0.0 0.0 0.8 5.7 0.0 4.2 1.2 6.4 5.7 0.0 0.7 6.0 6.0 0.3 2.4 0.0 0.0 10.4 1.4 5.7 17.0 33.1 11.7 6.1 3.2 3.0 6.2 22.3 1.1 6.0 15.4 11.3 0.4 2.2 9.4 2.6 10.2 0.0 0.0 31.4 9.8 0.2 3.3 16.1 1.2 0.0 0.0 0.0 8.9 0.1 1.0 0.4 3.5 0.0 0.6 6.4 0.0 0.6 0.3 0.2 0.0 0.0 6.8 0.0 0.5 101.6 22.6 0.0 0.0 5.9 18.1 0.0 1.5 0.9 2.8 7.2 0.0 55.4 0.4 0.3 RASSF3 ENSG00000153179 "Ras association domain family member 3" Q86WH2 12 64507001-64697567 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 44.4" "Lineage enriched" "Detected in all" 6 "granulocytes: 44.4" "Cell line enhanced" "Detected in all" "SK-MEL-30: 51.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022664, CAB034035, HPA038469" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB022664: , CAB034035: AB_2176848, HPA038469: AB_10671743" "unprognostic (1.63e-1)" "unprognostic (1.33e-1)" "unprognostic (1.35e-1)" "unprognostic (1.47e-1)" "unprognostic (1.55e-1)" "unprognostic (2.37e-2)" "unprognostic (2.55e-3)" "unprognostic (3.73e-1)" "unprognostic (2.37e-1)" "unprognostic (6.21e-2)" "unprognostic (3.66e-2)" "unprognostic (1.49e-1)" "unprognostic (1.45e-3)" "unprognostic (7.16e-2)" "unprognostic (2.01e-1)" "unprognostic (6.98e-2)" "unprognostic (1.59e-2)" 22.4 13.8 4.2 24.0 4.5 5.9 48.4 2.5 4.5 15.3 64.1 6.5 21.6 8.3 18.5 12.5 27.0 9.4 30.1 37.4 4.6 4.4 5.8 6.4 19.4 22.2 7.4 2.9 13.6 10.0 1.0 4.3 16.0 7.6 26.5 17.8 14.1 18.9 21.2 16.0 5.0 18.0 80.1 10.8 25.7 25.6 6.9 5.5 7.6 5.3 6.3 14.5 57.4 30.9 5.5 3.2 44.4 6.6 4.1 7.9 0.9 9.8 11.1 3.5 6.8 3.8 5.6 21.6 4.3 22.4 5.8 6.9 7.9 10.5 15.5 9.2 3.1 7.0 4.3 10.7 4.5 7.1 12.7 4.1 10.1 4.9 9.0 10.5 10.7 7.1 3.7 3.9 13.3 9.9 17.1 24.7 7.5 5.4 7.7 6.8 9.3 7.0 7.0 7.8 23.4 6.7 11.3 11.4 6.5 7.6 12.0 8.0 8.4 7.2 1.4 51.3 8.9 6.3 6.8 35.6 4.8 5.8 4.9 4.6 7.2 7.6 10.1 5.7 9.4 13.7 5.9 6.6 4.2 5.1 6.3 4.2 5.5 7.6 5.6 3.2 3.7 7.7 7.9 44.4 4.1 5.9 3.0 7.7 0.9 4.2 4.5 2.5 4.5 4.6 4.4 7.4 2.9 7.6 5.5 3.0 19.1 15.9 14.0 14.4 0.0 43.1 30.6 2.7 9.1 5.2 0.0 27.0 0.0 11.5 0.3 26.6 22.5 46.7 18.3 14.0 12.2 23.2 5.8 3.9 22.4 0.0 25.3 16.5 63.0 0.4 2.3 34.1 45.5 33.3 14.0 2.5 20.7 15.3 13.4 1.1 0.0 12.9 28.9 0.6 24.9 10.5 16.5 26.7 15.2 21.6 RCCD1 MGC14386 ENSG00000166965 "RCC1 domain containing 1" A6NED2 15 90954870-90963125 "Predicted intracellular proteins" "Chromatin regulator" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Erythroid cells: 70.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039683, HPA040776" Enhanced Enhanced "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA039683: AB_10794752, HPA040776: AB_10795478" "unprognostic (1.01e-2)" "unprognostic (1.69e-2)" "unprognostic (7.22e-3)" "unprognostic (8.63e-2)" "unprognostic (6.18e-2)" "unprognostic (2.91e-2)" "unprognostic (8.75e-2)" "unprognostic (5.86e-2)" "unprognostic (4.83e-2)" "unprognostic (5.10e-2)" "unprognostic (5.69e-2)" "unprognostic (2.72e-2)" "unprognostic (1.49e-3)" "unprognostic (1.32e-2)" "unprognostic (2.41e-1)" "unprognostic (4.71e-2)" "unprognostic (3.94e-2)" 5.2 9.9 6.1 12.5 8.1 6.1 17.3 14.3 7.0 5.3 9.2 3.3 5.8 8.0 6.4 5.9 9.2 6.2 8.7 6.2 5.5 6.7 8.5 11.3 6.6 5.7 8.4 1.5 8.2 12.1 9.3 3.2 9.4 6.0 5.6 7.4 3.1 8.2 6.2 5.2 11.8 9.7 8.6 5.6 10.1 6.5 18.9 7.2 21.9 11.0 8.3 14.5 6.4 5.7 3.1 2.3 0.1 2.0 1.7 2.9 0.8 4.9 7.3 1.7 3.6 4.3 5.1 12.9 5.7 1.0 1.6 1.7 3.5 9.4 17.3 9.2 3.5 0.1 10.6 5.6 1.5 2.8 14.5 11.5 12.5 12.3 5.0 3.6 5.9 4.9 3.8 5.1 1.7 2.3 6.6 2.7 10.2 9.4 11.4 4.9 1.6 7.1 6.2 6.6 5.9 3.0 8.5 8.7 18.4 7.7 2.3 5.6 6.4 9.9 6.3 6.7 9.5 7.3 11.5 4.3 1.0 7.2 4.2 0.2 20.5 8.4 10.3 1.9 13.2 4.8 0.1 0.7 0.1 0.8 2.0 2.1 3.1 1.7 2.7 1.6 2.1 2.9 1.0 0.1 1.7 1.1 2.3 2.1 0.8 6.1 8.1 14.3 7.0 5.5 6.7 8.4 1.5 6.0 7.2 0.0 2.1 13.7 10.1 6.5 6.0 8.1 0.0 1.4 1.2 7.0 3.9 12.3 3.3 7.2 1.8 4.5 11.8 70.0 4.2 16.3 7.1 7.3 0.0 7.4 10.2 0.0 21.2 3.1 7.5 3.9 8.1 5.4 5.0 4.6 16.7 10.6 4.9 14.0 7.4 10.4 2.7 25.8 6.4 20.6 18.3 7.9 7.6 3.2 21.5 7.4 RDX DFNB24 ENSG00000137710 Radixin P35241 11 109864295-110296722 "Disease related genes, Predicted intracellular proteins" "Actin capping, Actin-binding" "Deafness, Disease mutation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adrenal gland: 81.0" "Cell type enhanced" "Detected in all" 4 "Alveolar cells type 1: 449.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, HPA000763, CAB037312" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 77000000 "Plasma membrane" Nucleoplasm "CAB037312: AB_261933, HPA000263: AB_1856043, HPA000763: AB_1856042" "unprognostic (2.23e-3)" "unprognostic (2.56e-2)" "unprognostic (3.85e-1)" "unprognostic (2.74e-2)" "unprognostic (6.93e-2)" "unprognostic (9.82e-2)" "unprognostic (2.01e-2)" "unprognostic (1.44e-2)" "unprognostic (3.91e-2)" "unprognostic (6.91e-2)" "unprognostic (1.32e-3)" "unprognostic (6.47e-2)" "unprognostic (4.14e-3)" "unprognostic (5.43e-2)" "unprognostic (4.40e-1)" "unprognostic (1.24e-1)" "unprognostic (1.08e-3)" 15.9 81.0 17.9 7.0 29.2 4.2 22.3 9.3 20.2 14.7 10.1 19.5 11.1 2.9 12.7 9.1 11.9 8.8 11.6 16.9 20.8 17.0 21.7 28.6 20.4 8.7 27.5 15.2 23.7 22.0 16.0 16.1 16.4 31.6 11.3 4.9 7.4 9.0 11.9 35.5 5.5 5.3 14.9 50.4 10.6 8.3 13.9 30.6 3.5 19.7 11.8 5.9 13.4 11.9 9.4 9.6 17.1 11.4 13.1 15.8 5.6 17.1 9.1 36.3 14.4 21.4 23.8 20.7 21.8 12.4 14.4 15.9 25.5 30.1 0.0 33.5 27.0 22.6 15.8 20.1 20.9 21.6 10.3 11.1 12.7 30.4 18.9 20.0 4.7 8.8 24.3 11.9 17.9 32.2 23.9 39.1 2.8 18.1 7.7 33.3 30.3 2.7 3.8 11.5 1.0 14.9 7.9 25.5 7.5 18.3 8.6 9.9 10.7 38.4 17.4 13.7 28.5 22.3 7.6 24.1 24.0 17.9 11.5 16.9 2.5 4.1 16.6 9.1 2.8 55.1 17.1 11.4 16.5 9.4 9.4 12.5 9.4 8.4 6.9 9.6 6.1 5.7 4.6 1.3 13.1 7.1 7.8 15.8 5.6 17.9 29.2 9.3 19.0 20.8 17.0 27.5 15.2 31.6 30.6 449.6 96.4 30.6 43.1 49.8 78.4 144.4 71.4 41.5 64.8 71.5 41.2 104.4 92.9 108.4 11.2 193.3 6.7 70.0 374.9 158.2 87.8 55.0 65.8 217.4 75.7 95.3 21.4 279.3 93.7 28.8 254.9 61.2 69.2 186.7 9.3 84.0 127.6 20.1 250.7 141.1 88.4 122.9 79.0 72.1 242.5 35.4 190.1 31.6 16.8 27.6 RELL1 ENSG00000181826 "RELT like 1" Q8IUW5 4 37590800-37686376 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 16.1" "Lineage enriched" "Detected in many" 4 "granulocytes: 16.1" "Cell line enhanced" "Detected in many" "RH-30: 33.2;TIME: 21.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA013377 Approved Supported "Plasma membrane,Microtubules" NA NA "Plasma membrane, Microtubules" "HPA013377: AB_1844403" "unprognostic (1.70e-1)" "unprognostic (1.70e-1)" "unprognostic (4.78e-2)" "unprognostic (5.30e-2)" "unprognostic (6.80e-2)" "unprognostic (7.28e-2)" "unprognostic (7.35e-2)" "unprognostic (2.67e-2)" "unprognostic (2.19e-1)" "unprognostic (2.86e-2)" "unprognostic (1.46e-1)" "unprognostic (3.41e-1)" "unprognostic (7.88e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (6.15e-2)" "unprognostic (1.71e-2)" 21.1 3.0 5.5 6.2 9.7 28.8 19.3 6.4 6.5 8.4 10.4 6.5 2.8 7.2 8.3 7.8 9.8 7.3 9.7 12.1 5.1 5.0 4.9 5.5 10.4 14.6 9.1 2.1 8.9 4.0 2.6 3.2 20.7 17.9 6.2 7.5 8.1 5.3 5.0 10.1 11.5 8.6 11.1 28.2 10.9 14.7 4.1 5.3 6.0 18.1 9.6 6.6 15.6 13.3 0.1 3.2 16.1 4.0 0.9 1.7 1.3 2.9 3.8 9.2 6.5 6.4 5.3 7.3 5.2 5.4 4.6 5.8 11.6 3.6 0.6 4.0 4.8 6.7 2.8 3.0 5.5 7.2 0.0 1.5 1.2 3.2 9.9 3.8 4.3 3.0 7.2 4.5 5.6 5.6 1.8 18.3 2.3 2.2 3.0 3.4 2.4 4.5 2.3 1.8 3.1 1.1 1.6 33.2 1.5 4.5 4.3 2.0 5.7 4.8 3.6 4.6 1.9 12.3 1.5 21.8 9.3 5.4 7.0 5.8 1.5 1.6 4.9 8.4 6.8 7.0 0.0 4.0 2.5 1.3 0.8 1.2 0.1 1.2 1.1 1.6 0.0 1.1 1.7 16.1 0.9 0.5 3.2 1.1 1.3 5.5 9.7 6.4 6.5 5.1 5.0 9.1 2.1 17.9 5.3 8.9 1.9 2.4 1.2 3.0 0.4 1.7 10.2 4.0 5.7 0.0 0.0 1.0 0.0 2.6 5.2 6.4 5.1 0.0 7.3 3.0 2.1 2.3 2.3 0.8 2.3 3.2 1.2 8.0 2.8 4.0 3.4 3.1 1.7 2.8 1.1 4.9 9.3 1.9 5.6 0.0 1.5 12.9 2.8 1.2 0.1 4.1 4.3 5.7 0.6 3.8 RFPL1 RNF78 ENSG00000128250 "Ret finger protein like 1" O75677 22 29438583-29442455 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "brain: 20.4" "Cell type enhanced" "Detected in some" 28 "Early spermatids: 6.5;Ito cells: 12.9;Kupffer cells: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 11.2;HMC-1: 4.3;Karpas-707: 4.7;SH-SY5Y: 5.8;SiHa: 2.8;THP-1: 5.3" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (4.54e-1)" "unprognostic (6.63e-8)" "unprognostic (3.14e-3)" "unprognostic (1.89e-1)" 0.0 3.3 0.2 0.1 0.7 0.0 0.0 0.4 20.4 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.3 0.0 1.9 0.0 0.1 0.4 2.8 0.0 0.0 0.6 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.9 0.0 4.5 0.0 0.0 0.0 0.4 1.6 0.9 0.0 1.8 0.0 1.2 0.5 0.0 0.2 0.4 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 11.2 0.7 0.0 1.0 0.0 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.7 0.0 0.2 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 5.8 2.8 0.0 0.0 0.3 0.0 5.3 2.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.2 1.2 0.8 0.0 0.6 1.0 0.9 1.6 0.1 1.1 0.0 0.0 1.8 0.0 1.2 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 12.9 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL2 RNF79 ENSG00000128253 "Ret finger protein like 2" O75678 22 32190435-32203477 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 7 "brain: 7.9;prostate: 10.8" "Cell type enriched" "Detected in single" 4 "Glandular cells: 3.1" "Cancer enriched" "Detected in single" 15 "prostate cancer: 5.6" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "A549: 2.5;OE19: 1.1;REH: 1.0;SCLC-21H: 1.8;SK-MEL-30: 1.2" "HPA046608, HPA048320, HPA072380" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA046608: , HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (3.81e-2)" "unprognostic (4.05e-2)" "unprognostic (8.29e-2)" "unprognostic (9.66e-3)" "unprognostic (2.54e-1)" "unprognostic (9.90e-2)" "unprognostic (2.59e-1)" "unprognostic (6.02e-3)" "unprognostic (2.22e-2)" "unprognostic (3.44e-2)" "unprognostic (8.64e-3)" "prognostic favorable (4.16e-4)" "unprognostic (2.04e-4)" "unprognostic (6.02e-2)" "unprognostic (3.28e-2)" "unprognostic (5.62e-7)" "unprognostic (3.50e-2)" 0.1 0.3 2.3 0.2 3.9 1.1 0.1 2.7 7.9 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.1 3.1 5.6 0.2 0.5 0.1 0.4 1.9 0.1 0.1 0.1 0.0 0.1 10.8 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.4 0.2 0.2 0.2 0.2 0.1 0.1 0.0 0.0 0.5 0.0 0.8 0.0 1.2 0.2 0.0 2.5 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.0 0.4 0.0 0.3 0.0 1.1 0.0 1.0 0.1 0.0 0.0 0.2 1.8 0.0 0.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.8 0.0 0.0 0.1 0.8 0.0 1.2 1.2 0.5 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RFPL3 RNF120 ENSG00000128276 "Ret finger protein like 3" O75679 22 32354885-32361161 "Predicted intracellular proteins" "Host-virus interaction" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.4" "Cell type enriched" "Detected in single" 7 "Early spermatids: 1.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 3.8;NB-4: 4.8;U-266/70: 5.6;U-266/84: 5.5" "HPA048320, HPA072380" Approved "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA048320: AB_2680356, HPA072380: AB_2686515" "unprognostic (1.63e-1)" "unprognostic (9.90e-2)" "unprognostic (1.10e-1)" "unprognostic (1.05e-1)" "unprognostic (1.52e-2)" "unprognostic (1.97e-1)" "unprognostic (3.25e-2)" "unprognostic (4.31e-2)" "unprognostic (1.90e-1)" "unprognostic (6.32e-2)" 0.0 0.0 0.3 0.0 0.3 1.0 0.0 0.7 0.4 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.0 0.4 0.2 0.6 0.5 0.0 0.2 0.0 0.3 0.0 0.4 0.0 0.3 1.1 0.2 0.0 0.1 0.5 0.0 23.4 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.3 0.0 1.1 0.2 0.1 0.8 2.4 0.7 0.0 0.0 3.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.4 1.1 0.1 0.1 0.0 1.5 0.5 0.0 0.0 0.0 0.0 1.4 0.0 1.8 0.1 1.8 0.0 0.9 1.4 4.8 0.2 0.3 0.1 2.4 0.5 0.6 0.0 0.4 1.8 0.5 0.1 0.4 1.3 0.6 0.0 0.4 0.0 0.0 0.9 0.4 0.0 5.6 5.5 0.1 0.1 1.7 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 RGP1 KIAA0258 ENSG00000107185 "RGP1 homolog, RAB6A GEF complex partner 1" Q92546 9 35749287-35758575 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020414, HPA021085" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020414: AB_1852289, HPA021085: AB_1852291" "unprognostic (2.10e-1)" "unprognostic (3.22e-2)" "unprognostic (1.03e-1)" "unprognostic (2.01e-2)" "unprognostic (3.35e-2)" "unprognostic (1.47e-1)" "prognostic unfavorable (7.09e-4)" "unprognostic (2.22e-1)" "unprognostic (5.42e-2)" "unprognostic (1.51e-3)" "unprognostic (1.81e-3)" "unprognostic (9.77e-2)" "prognostic favorable (8.55e-13)" "unprognostic (2.46e-2)" "unprognostic (1.68e-1)" "unprognostic (3.03e-3)" "unprognostic (1.18e-1)" 13.4 18.2 12.0 11.4 16.8 7.1 12.3 13.7 24.8 12.2 17.7 18.3 23.8 14.9 15.3 12.5 14.0 12.3 12.1 17.6 11.6 11.2 16.7 14.2 13.2 9.8 10.7 14.8 15.0 17.6 32.6 18.3 14.1 13.0 12.9 19.1 15.4 18.3 22.5 25.8 13.1 17.2 14.1 10.6 12.8 16.5 13.2 13.7 11.2 17.3 11.9 13.0 13.5 10.6 4.0 2.1 3.4 1.9 3.7 3.7 0.9 11.3 10.7 12.5 10.3 11.7 12.7 7.4 9.0 13.1 12.5 11.7 9.1 4.3 8.8 6.5 11.4 23.2 6.5 11.9 17.0 10.4 11.7 7.0 7.6 20.4 6.8 11.0 8.2 10.7 12.7 21.7 13.2 16.1 18.0 14.8 6.9 5.1 4.9 11.3 5.3 2.5 2.9 5.2 9.4 12.6 8.3 8.9 6.2 11.0 8.0 9.2 9.9 7.9 11.2 7.3 11.5 9.3 3.9 18.7 10.1 12.8 6.9 7.5 7.4 10.2 9.4 14.4 3.4 12.9 3.4 0.9 1.4 2.6 1.5 3.7 2.8 1.9 3.0 0.6 4.0 2.3 2.4 2.3 3.7 1.9 2.1 1.6 0.9 12.0 16.8 13.7 24.8 11.6 11.2 10.7 14.8 13.0 13.7 6.0 9.3 26.0 21.1 5.0 40.9 16.3 20.4 8.1 10.3 26.2 19.6 9.3 11.6 16.1 16.4 13.4 35.4 0.0 15.2 8.8 6.0 21.5 5.7 15.3 6.4 15.9 41.6 8.0 10.3 27.7 7.8 5.6 1.7 7.2 23.9 21.8 17.1 31.7 10.3 12.9 22.1 6.5 7.2 15.8 4.3 4.5 8.6 15.2 26.3 26.2 RGS10 ENSG00000148908 "Regulator of G protein signaling 10" O43665 10 119499828-119542708 "Predicted intracellular proteins" "GTPase activation, Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 77.9;lymphoid tissue: 96.9" "Cell type enhanced" "Detected in many" 9 "Erythroid cells: 256.9;granulocytes: 281.0;Hofbauer cells: 444.1;Macrophages: 293.8;monocytes: 273.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 94.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004559, HPA021305, HPA058485" Enhanced Supported Supported "Nucleoplasm,Plasma membrane" NA NA 1400000 "Nucleoplasm, Plasma membrane" "CAB004559: AB_628216, HPA021305: AB_1856225, HPA058485: AB_2683732" "unprognostic (1.64e-2)" "prognostic favorable (6.81e-4)" "unprognostic (7.98e-2)" "prognostic favorable (6.32e-4)" "unprognostic (5.21e-2)" "unprognostic (6.19e-2)" "unprognostic (4.32e-3)" "unprognostic (6.35e-2)" "unprognostic (9.90e-3)" "unprognostic (1.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.30e-1)" "prognostic unfavorable (4.20e-10)" "unprognostic (2.50e-1)" "unprognostic (9.20e-2)" "unprognostic (7.70e-2)" "unprognostic (7.92e-3)" 9.6 7.7 11.9 28.2 12.1 23.6 15.4 2.8 12.4 25.8 44.0 17.0 5.3 12.5 15.3 13.1 21.9 10.8 18.8 11.7 12.0 10.5 8.3 3.9 13.5 47.6 17.4 6.7 10.3 3.9 0.8 6.6 16.9 10.5 17.8 18.9 6.4 18.1 8.2 13.2 9.3 23.1 19.1 28.5 18.7 12.8 3.7 11.1 96.9 14.7 11.1 34.3 17.9 20.0 6.9 40.2 20.5 26.3 7.6 77.9 63.0 30.1 5.6 0.4 53.0 7.6 49.0 5.0 14.1 21.4 8.5 13.7 1.7 7.2 12.9 7.5 10.9 8.3 6.7 7.9 8.5 22.6 6.3 9.1 34.6 1.6 4.1 12.3 7.0 94.1 19.0 11.4 16.5 15.4 29.1 16.1 12.7 8.8 10.5 9.8 13.7 40.9 24.5 2.4 3.7 15.3 8.0 0.0 4.8 4.3 7.1 2.1 1.7 2.7 34.7 49.6 6.8 6.6 12.5 21.3 4.9 4.2 7.0 12.0 0.5 8.1 4.7 1.5 30.7 2.1 20.5 21.5 0.2 15.0 26.3 15.7 6.9 32.5 25.8 40.2 3.6 77.9 58.5 9.9 7.6 21.6 23.9 35.0 63.0 11.9 12.1 2.8 12.4 12.0 10.5 17.4 6.7 10.5 11.1 0.0 19.1 64.8 23.8 32.6 0.0 1.2 0.0 2.7 11.4 1.8 0.0 10.7 51.4 0.7 1.8 5.3 4.2 256.9 5.6 30.7 57.9 75.3 281.0 0.4 444.1 0.0 18.0 14.7 196.4 3.9 46.3 293.8 89.4 273.3 63.2 1.4 8.0 5.8 8.9 3.8 0.8 12.9 31.9 0.2 1.7 24.6 8.5 117.2 14.2 34.9 RHCE "CD240CE, RH" ENSG00000188672 "Rh blood group CcEe antigens" P18577 1 25362249-25430192 "Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "bone marrow: 40.5" "Cell type enriched" "Detected in some" 33 "Erythroid cells: 210.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 7 "granulocytes: 2.4" "Cell line enriched" "Detected in some" 5 "HEL: 44.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (1.37e-1)" "unprognostic (3.53e-1)" "unprognostic (2.38e-1)" "unprognostic (6.75e-2)" "unprognostic (1.41e-2)" "unprognostic (4.91e-2)" "unprognostic (7.01e-2)" "unprognostic (3.12e-2)" "unprognostic (3.81e-2)" "unprognostic (1.35e-1)" "unprognostic (6.08e-2)" "unprognostic (4.61e-2)" "unprognostic (5.77e-5)" "unprognostic (1.38e-1)" "unprognostic (3.94e-2)" "unprognostic (7.15e-3)" "unprognostic (1.63e-1)" 0.6 0.8 2.0 0.6 5.1 40.5 0.9 3.3 4.7 0.8 0.7 3.5 1.0 0.7 0.7 5.2 1.4 1.6 0.8 2.1 2.6 1.5 0.8 2.2 0.7 1.0 2.1 2.5 0.9 9.6 0.5 4.0 1.6 5.9 1.6 0.8 2.2 8.4 0.8 1.9 1.1 0.6 0.5 2.9 2.1 0.8 2.6 1.4 1.2 1.1 1.2 0.8 0.5 0.6 0.1 0.2 2.4 0.2 0.1 0.3 0.9 0.1 0.0 0.1 0.2 0.4 0.3 0.0 0.1 0.1 0.2 0.0 0.0 0.7 0.3 0.5 0.5 0.0 0.1 0.0 0.1 0.1 0.2 0.0 44.7 0.0 0.0 0.6 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.3 8.7 0.2 0.2 0.4 0.0 0.3 0.9 0.3 0.2 0.1 0.1 1.2 0.0 0.0 0.3 0.4 0.1 0.1 0.5 0.4 0.2 0.0 0.0 0.1 0.0 0.4 0.0 2.6 0.6 0.5 1.5 0.4 0.2 2.4 0.2 0.6 0.3 0.0 0.3 0.1 0.0 0.1 0.2 0.0 0.2 0.0 1.0 0.1 0.0 0.1 0.3 0.9 2.0 5.1 3.3 4.7 2.6 1.5 2.1 2.5 5.9 1.4 0.0 0.0 0.0 0.5 0.5 3.3 0.4 2.5 0.0 0.0 0.0 0.0 0.7 0.0 0.3 0.8 0.0 0.0 210.2 0.2 0.4 0.2 0.4 4.6 0.4 0.2 6.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.7 0.0 2.5 6.5 0.0 2.8 5.1 1.3 0.7 0.0 0.1 0.7 RHD "CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI" ENSG00000187010 "Rh blood group D antigen" Q02161 1 25272393-25330445 "Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 10.0;bone marrow: 16.5;salivary gland: 7.1" "Cell type enriched" "Detected in some" 20 "Erythroid cells: 23.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in many" "neutrophil: 10.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 10.0" "Group enriched" "Detected in some" 6 "HEL: 28.2;K-562: 8.7" "HPA060951, HPA077385" Supported Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA060951: , HPA077385: " "unprognostic (4.75e-3)" "unprognostic (7.70e-2)" "unprognostic (1.34e-1)" "unprognostic (1.38e-1)" "unprognostic (1.09e-2)" "unprognostic (4.84e-2)" "unprognostic (1.11e-2)" "unprognostic (5.25e-2)" "unprognostic (1.11e-2)" "unprognostic (1.91e-1)" "unprognostic (1.27e-2)" "unprognostic (1.89e-1)" "unprognostic (4.96e-3)" "unprognostic (1.93e-1)" "unprognostic (8.09e-2)" "unprognostic (5.53e-2)" "unprognostic (4.92e-3)" 0.3 0.3 0.3 0.5 0.5 16.5 0.3 1.5 1.4 0.6 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.9 0.3 0.2 0.3 0.3 2.5 0.8 0.3 0.3 0.9 0.3 0.1 0.4 0.3 1.1 0.5 0.0 0.3 7.1 0.3 4.1 2.5 0.4 0.3 0.4 1.8 0.3 0.5 0.3 0.3 0.4 2.3 0.3 0.3 0.3 2.0 0.6 10.0 1.4 1.4 1.4 1.2 0.1 0.0 0.2 0.2 0.1 0.0 0.4 0.1 0.1 0.1 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.1 28.2 0.7 0.2 0.0 0.3 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 8.7 0.7 0.0 0.1 0.2 0.2 3.1 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.5 0.3 0.1 0.2 0.1 0.1 0.2 0.5 0.4 0.5 0.2 0.4 0.1 0.3 0.1 0.1 0.5 0.2 0.1 4.9 1.4 2.8 1.0 0.6 1.1 1.3 1.3 0.8 0.2 2.0 1.4 1.3 10.0 1.4 0.8 0.6 0.9 1.2 0.3 0.5 1.5 1.4 0.3 0.2 0.3 0.3 1.1 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 23.3 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 RHOA "ARH12, ARHA, Rho12, RhoA, RHOH12" ENSG00000067560 "Ras homolog family member A" P61586 3 49359145-49412998 "Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins" "Cell cycle, Cell division, Host-virus interaction" Hydrolase "Cancer-related genes, Disease mutation, Ectodermal dysplasia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB005052 Approved Supported "Plasma membrane,Cytosol" NA NA 65000000 "Plasma membrane, Cytosol" "CAB005052: AB_562216" "unprognostic (1.50e-1)" "unprognostic (3.38e-1)" "prognostic favorable (3.08e-4)" "unprognostic (8.75e-2)" "unprognostic (1.63e-1)" "unprognostic (1.24e-1)" "prognostic unfavorable (9.15e-4)" "unprognostic (1.39e-1)" "unprognostic (8.83e-2)" "unprognostic (9.44e-3)" "unprognostic (2.21e-2)" "unprognostic (4.29e-2)" "prognostic favorable (3.21e-6)" "unprognostic (5.14e-2)" "unprognostic (7.50e-2)" "unprognostic (1.57e-1)" "unprognostic (4.52e-2)" 141.1 89.5 63.0 79.8 60.6 91.4 93.1 34.3 77.3 80.3 79.1 100.4 48.9 63.6 84.4 66.4 116.7 67.8 74.2 72.5 57.6 54.8 104.0 80.7 104.6 102.4 74.0 43.8 102.7 64.9 45.8 48.2 105.3 68.8 76.0 80.3 81.6 66.5 72.0 86.0 73.9 90.8 88.9 97.3 116.0 73.4 57.3 60.3 127.1 108.1 80.1 99.8 103.4 75.7 42.6 78.4 124.2 125.7 38.3 50.5 151.5 55.7 43.0 54.0 57.9 62.0 94.0 42.2 121.4 77.8 84.9 78.3 36.4 58.5 81.8 34.9 145.8 49.3 31.8 59.3 66.2 87.2 63.1 35.3 78.1 57.9 42.7 66.5 77.0 58.6 73.4 47.1 69.4 55.9 85.8 108.6 43.5 41.6 51.5 100.6 26.6 83.8 75.1 51.6 56.0 54.8 38.8 54.3 64.3 73.4 63.7 19.8 45.1 72.9 52.8 54.7 55.8 34.2 86.8 117.2 68.2 61.8 89.9 87.2 51.2 103.7 93.9 66.4 75.8 77.8 52.5 99.7 106.8 49.1 125.7 41.6 42.6 41.4 47.6 78.4 37.5 32.2 40.1 124.2 38.3 120.4 58.7 50.5 151.5 63.0 60.6 34.3 77.3 57.6 54.8 74.0 43.8 68.8 60.3 360.3 233.2 266.1 228.8 240.6 42.2 113.5 155.4 182.0 182.0 171.0 5.9 328.4 288.5 303.4 30.3 372.7 339.7 93.5 302.0 572.5 345.6 260.3 251.7 153.0 691.2 77.9 225.0 312.5 712.8 42.2 310.4 490.6 310.4 582.5 261.8 172.7 313.0 270.7 383.3 255.4 33.0 271.7 354.1 227.5 221.8 244.4 439.3 304.1 267.8 270.4 RHOXF2 "CT107, PEPP-2, PEPP2, THG1" ENSG00000131721 "Rhox homeobox family member 2" Q9BQY4 X 120158561-120165630 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 23.0" "Group enriched" "Detected in some" 60 "Spermatocytes: 5.2;Spermatogonia: 6.8" "Cancer enhanced" "Detected in single" "testis cancer: 0.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HL-60: 10.1;K-562: 62.2;NB-4: 46.0;THP-1: 17.3;U-266/84: 27.6" "HPA003314, CAB020794" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "CAB020794: , HPA003314: AB_1855193" "unprognostic (1.60e-1)" "unprognostic (5.04e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 23.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 1.0 0.5 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 62.2 0.0 0.0 0.0 0.0 46.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.2 0.0 0.0 0.0 0.0 0.0 27.6 0.0 0.0 0.0 0.0 1.0 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.2 0.2 0.3 0.3 0.4 0.7 1.1 0.5 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 6.8 0.0 0.0 0.0 0.0 0.0 RHOXF2B ENSG00000203989 "Rhox homeobox family member 2B" P0C7M4 X 120070672-120077705 "Predicted intracellular proteins, Transcription factors" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "blood: 2.6;testis: 9.4" "Cell type enriched" "Detected in single" 20 "Spermatogonia: 2.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 348 "HL-60: 47.1;K-562: 47.2;NB-4: 76.4" HPA003314 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA003314: AB_1855193" 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.0 0.0 0.2 0.0 9.4 0.0 0.0 0.0 0.0 1.0 1.6 2.6 1.3 1.7 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.2 0.0 0.0 0.0 0.0 76.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.6 0.7 0.8 0.5 0.9 1.0 0.7 0.5 0.7 0.7 1.0 0.7 0.7 1.4 1.7 1.3 1.6 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 RIC8A "synembryn, synembryn-A" ENSG00000177963 "RIC8 guanine nucleotide exchange factor A" Q9NPQ8 11 207511-215113 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041491, CAB046012" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB046012: AB_11129402, HPA041491: AB_2677510" "unprognostic (3.93e-2)" "unprognostic (8.69e-2)" "unprognostic (1.62e-1)" "prognostic favorable (8.60e-4)" "unprognostic (1.61e-2)" "unprognostic (2.21e-1)" "prognostic unfavorable (1.11e-6)" "unprognostic (2.13e-3)" "unprognostic (8.70e-2)" "unprognostic (7.68e-2)" "unprognostic (1.56e-1)" "unprognostic (8.35e-2)" "unprognostic (2.63e-3)" "unprognostic (5.35e-2)" "unprognostic (2.57e-1)" "unprognostic (2.14e-1)" "unprognostic (1.60e-1)" 30.9 30.2 31.4 27.1 35.4 28.8 27.5 27.8 51.7 29.3 31.4 25.9 32.5 24.1 35.8 36.6 36.5 35.4 33.2 31.9 27.0 25.5 33.9 39.5 28.4 28.7 23.8 30.0 35.1 38.0 34.9 30.2 43.7 27.4 29.8 26.1 33.2 29.4 36.1 22.5 32.2 35.1 41.3 21.2 32.5 28.4 40.3 18.6 43.9 33.2 24.9 33.3 33.3 27.3 31.3 20.7 40.2 26.6 31.9 40.1 37.2 51.4 25.1 20.4 20.3 28.1 23.2 14.2 37.3 30.1 51.1 35.5 21.6 36.6 20.6 15.6 56.4 38.8 28.0 23.2 39.5 28.6 24.8 23.2 11.6 17.8 19.9 22.7 19.3 38.8 25.3 35.0 31.6 28.7 26.4 25.0 22.0 19.8 20.1 39.1 20.8 23.0 15.4 18.6 21.9 31.2 21.7 20.2 14.0 29.6 13.6 21.3 19.2 28.9 32.7 19.9 20.6 23.1 15.6 28.0 33.9 29.9 12.4 34.6 22.3 33.0 19.8 33.4 17.6 25.3 27.5 19.7 40.2 40.1 23.0 39.3 31.3 35.9 34.6 20.7 27.2 31.1 31.4 28.8 31.9 26.6 17.0 29.8 37.2 31.4 35.4 27.8 51.7 27.0 25.5 23.8 30.0 27.4 18.6 14.9 19.7 27.6 17.9 15.8 27.4 23.6 22.9 14.7 18.2 24.4 9.8 34.7 23.2 48.4 11.7 22.4 23.8 23.3 38.3 50.5 25.4 17.7 17.3 14.7 40.7 30.2 19.4 23.4 24.1 12.3 28.4 15.8 27.0 47.7 15.8 41.3 55.2 21.0 37.4 18.6 28.2 19.4 27.4 85.8 53.0 16.9 27.1 34.1 21.0 14.8 RIC8B "FLJ10620, hSyn, RIC8" ENSG00000111785 "RIC8 guanine nucleotide exchange factor B" Q9NVN3 12 106774595-106889316 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Rod photoreceptor cells: 42.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039970, HPA042746" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039970: , HPA042746: AB_2678143" "unprognostic (1.18e-1)" "unprognostic (1.61e-1)" "unprognostic (9.87e-3)" "unprognostic (5.43e-2)" "unprognostic (3.28e-2)" "unprognostic (8.09e-2)" "unprognostic (5.74e-2)" "unprognostic (2.60e-1)" "unprognostic (1.99e-2)" "unprognostic (3.83e-1)" "unprognostic (1.10e-3)" "unprognostic (5.13e-2)" "unprognostic (3.65e-3)" "unprognostic (2.21e-1)" "unprognostic (3.18e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-2)" 7.4 6.4 10.9 6.0 32.3 1.7 6.1 13.0 12.7 8.0 6.3 5.1 11.5 4.3 7.9 6.4 4.6 8.2 8.1 9.9 6.6 7.5 10.5 6.9 5.3 3.3 6.5 6.7 8.7 6.2 20.4 13.1 5.3 8.2 6.6 5.6 7.5 4.2 12.5 8.3 3.1 4.2 9.4 5.8 5.4 4.4 5.1 17.2 8.7 13.4 0.9 4.1 5.9 7.2 1.1 3.6 3.3 4.0 2.4 6.0 2.8 2.8 8.9 16.9 6.8 8.1 10.2 2.0 9.6 7.6 8.7 8.0 2.9 2.3 1.7 6.6 5.7 3.4 5.0 6.8 3.8 10.3 20.1 8.4 6.2 4.6 3.9 6.8 6.5 4.4 5.7 4.2 6.2 2.9 10.1 7.9 6.3 3.6 0.1 7.6 2.3 6.3 5.9 8.6 4.5 9.0 5.6 9.9 5.6 7.1 3.3 12.4 8.0 6.7 4.3 5.0 6.7 3.8 4.7 7.6 6.9 3.8 4.6 6.6 5.1 10.6 0.1 3.3 3.9 10.2 2.3 4.0 3.3 5.1 2.0 6.0 1.1 2.9 2.6 3.6 0.6 2.2 2.3 1.7 2.4 1.8 2.2 3.1 2.8 10.9 32.3 13.0 12.7 6.6 7.5 6.5 6.7 8.2 17.2 6.0 5.6 3.9 3.8 3.0 12.6 27.4 20.4 10.7 5.7 3.5 9.8 5.8 6.6 17.9 4.6 10.0 6.2 0.0 3.5 3.1 6.5 1.8 8.1 7.3 3.1 6.4 17.9 16.5 7.1 4.0 11.8 4.7 6.8 1.0 7.2 5.7 5.5 3.5 18.0 5.9 42.2 12.9 7.2 16.2 9.2 2.5 1.1 7.5 6.2 1.0 RIMBP3 "KIAA1666, RIMBP3.1, RIMBP3A" ENSG00000275793 "RIMS binding protein 3" Q9UFD9 22 18605815-18611919 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 22.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "MOLT-4: 6.0;THP-1: 6.5" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.55e-2)" "unprognostic (3.95e-3)" "unprognostic (1.62e-1)" "unprognostic (3.95e-2)" "unprognostic (2.29e-2)" "unprognostic (9.81e-3)" "unprognostic (1.83e-3)" "unprognostic (1.84e-1)" "unprognostic (2.71e-1)" "unprognostic (4.72e-3)" "unprognostic (6.06e-3)" "unprognostic (9.58e-2)" "unprognostic (8.49e-3)" "unprognostic (7.23e-2)" "unprognostic (1.03e-1)" "unprognostic (2.69e-3)" "unprognostic (7.95e-2)" 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 22.0 0.1 0.2 0.0 0.7 1.1 0.9 1.0 1.7 2.5 1.1 0.8 2.8 1.2 0.9 1.6 0.8 0.1 1.0 3.1 1.4 1.5 0.1 0.0 0.7 1.2 0.3 0.8 0.8 0.6 0.0 0.3 2.8 0.9 1.3 0.8 1.2 0.1 4.0 0.1 0.3 0.1 0.6 0.0 0.3 0.0 2.4 0.6 0.7 1.2 1.4 6.0 3.1 1.2 1.2 0.3 2.4 3.5 0.4 0.4 0.2 1.6 0.3 2.5 0.0 0.5 0.2 0.3 6.5 0.2 2.1 1.5 1.1 0.5 0.2 0.8 0.6 1.2 1.4 2.3 0.0 1.0 0.9 1.0 0.6 2.5 0.7 1.4 1.4 1.1 0.6 1.8 0.9 0.3 1.7 0.4 0.1 1.2 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3B ENSG00000274600 "RIMS binding protein 3B" A6NNM3 22 21383374-21389478 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at transcript level" "Tissue enriched" "Detected in some" 7 "testis: 11.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 2.8;RH-30: 3.5;THP-1: 4.9" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (3.78e-1)" "unprognostic (3.54e-2)" "unprognostic (1.53e-2)" "unprognostic (1.51e-1)" "unprognostic (3.28e-1)" "unprognostic (5.35e-2)" "unprognostic (4.37e-1)" "unprognostic (3.61e-4)" "unprognostic (1.69e-2)" "unprognostic (7.11e-2)" 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.6 0.0 0.2 0.0 0.3 0.4 0.4 0.9 1.0 1.5 0.4 0.1 1.7 0.2 0.4 1.1 0.7 0.3 0.5 1.2 0.5 0.9 0.2 0.3 0.3 1.0 0.2 0.1 0.0 0.7 0.0 0.1 1.7 1.1 0.6 0.3 0.2 0.0 0.6 0.0 0.1 0.0 0.1 0.2 0.0 0.0 1.0 0.6 0.3 0.6 0.2 2.0 2.8 0.4 0.6 0.4 2.0 3.5 0.0 0.1 0.0 0.5 0.0 1.6 0.0 0.5 0.0 0.1 4.9 0.0 0.4 0.5 0.4 0.2 0.1 0.1 0.0 0.9 0.4 1.5 0.0 0.5 0.4 1.1 0.2 1.4 0.1 0.7 1.5 0.4 0.3 1.1 0.7 0.1 1.0 0.9 0.1 1.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RIMBP3C ENSG00000183246 "RIMS binding protein 3C" A6NJZ7 22 21545357-21551461 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 16.6" "Group enriched" "Detected in some" 18 "Early spermatids: 22.4;Late spermatids: 37.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NB-4: 3.2;THP-1: 3.6" HPA001183 Supported Uncertain "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA001183: AB_1079205" "unprognostic (1.74e-1)" "unprognostic (4.05e-2)" "unprognostic (3.49e-2)" "unprognostic (2.18e-1)" "unprognostic (8.30e-2)" "unprognostic (4.53e-2)" "unprognostic (6.65e-2)" "unprognostic (1.15e-3)" "unprognostic (6.23e-2)" "unprognostic (2.17e-6)" "unprognostic (3.04e-1)" "unprognostic (3.29e-1)" "unprognostic (3.76e-6)" "unprognostic (1.66e-2)" 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 16.6 0.0 0.3 0.1 0.0 0.5 1.3 0.9 0.8 1.4 1.7 1.0 0.2 0.0 0.5 0.1 0.1 0.0 0.2 0.1 0.9 0.7 0.3 0.1 0.3 0.0 1.6 0.6 0.7 0.5 0.7 0.2 0.1 0.7 0.5 0.5 0.0 0.3 0.2 1.6 0.6 0.0 0.2 0.5 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.7 1.8 3.2 0.3 1.6 0.3 1.5 0.9 0.1 0.1 0.1 0.8 0.2 0.5 0.4 0.2 0.2 0.0 3.6 0.0 1.3 0.6 0.7 0.2 0.5 0.4 0.2 1.3 1.1 1.7 0.9 0.8 0.8 0.5 0.5 1.4 0.5 0.9 0.7 1.3 0.4 1.7 0.6 0.8 1.4 0.7 0.1 0.9 1.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 37.7 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.7 0.2 0.0 0.0 0.0 0.0 0.0 RIMS2 "KIAA0751, OBOE, RAB3IP3, RIM2" ENSG00000176406 "Regulating synaptic membrane exocytosis 2" Q9UQ26 8 103500748-104256094 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 51.1;brain: 28.7" "Group enriched" "Detected in many" 10 "Bipolar cells: 397.4;Cone photoreceptor cells: 665.6;Rod photoreceptor cells: 1047.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 6.0;Daudi: 11.7;RT4: 8.4;SCLC-21H: 20.8;SuSa: 8.3" "Low region specificity" "Detected in all" "HPA046538, HPA066498, CAB079049" Enhanced Supported Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB079049: , HPA046538: , HPA066498: AB_2685678" "unprognostic (2.98e-2)" "unprognostic (7.14e-2)" "unprognostic (4.47e-2)" "unprognostic (5.51e-2)" "unprognostic (2.82e-1)" "unprognostic (7.09e-3)" "unprognostic (2.02e-2)" "unprognostic (1.16e-2)" "unprognostic (7.61e-2)" "unprognostic (8.01e-3)" "unprognostic (1.40e-2)" "unprognostic (6.34e-2)" "unprognostic (1.67e-5)" "unprognostic (8.12e-4)" "unprognostic (1.04e-1)" "unprognostic (1.61e-1)" "unprognostic (9.08e-2)" 0.9 51.1 15.8 1.0 21.8 1.1 1.8 14.5 28.7 8.5 0.9 0.5 0.9 1.2 1.4 1.7 1.0 6.3 1.7 0.9 10.3 4.9 1.1 0.9 1.0 1.1 3.1 17.5 2.8 1.6 0.9 12.4 1.1 8.6 2.8 1.0 5.8 1.0 1.8 1.0 1.0 1.4 2.0 4.0 0.9 1.7 3.9 8.7 0.0 2.9 0.0 1.0 1.5 1.6 0.7 0.7 2.9 0.6 1.6 0.6 0.2 3.7 0.0 6.0 0.0 0.0 0.0 0.0 0.4 0.3 1.1 1.4 0.1 0.3 11.7 0.1 0.0 1.2 0.3 1.8 0.7 1.9 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.1 0.0 0.9 2.1 0.0 1.3 0.1 0.5 0.0 0.5 0.8 0.0 4.6 0.0 0.6 0.0 0.0 0.0 0.0 8.4 20.8 5.1 0.0 0.1 0.5 8.3 0.3 0.2 0.0 0.0 5.6 0.1 0.1 1.5 0.0 0.1 0.4 0.2 0.2 2.7 0.6 0.6 0.6 0.3 0.4 0.4 0.3 0.4 0.1 0.7 0.3 0.5 2.9 1.6 0.4 0.7 0.3 0.2 15.8 21.8 14.5 28.7 10.3 4.9 3.1 17.5 8.6 8.7 26.8 32.3 0.0 1.6 0.2 397.4 0.7 2.5 18.7 29.6 0.0 665.6 0.5 1.7 0.0 29.0 0.5 0.0 0.0 0.0 0.2 0.8 4.9 15.1 0.0 0.2 63.5 8.1 0.6 0.3 13.5 66.7 0.4 1.7 0.0 0.2 71.8 0.4 0.0 27.6 0.1 1047.7 0.0 0.3 15.3 9.9 0.4 0.1 0.5 0.0 0.9 RIOK2 FLJ11159 ENSG00000058729 "RIO kinase 2" Q9BVS4 5 97160867-97183260 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Ribosome biogenesis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" HPA005681 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA005681: AB_1856286" "unprognostic (6.36e-2)" "unprognostic (1.21e-1)" "unprognostic (1.13e-2)" "unprognostic (8.04e-2)" "unprognostic (1.38e-1)" "unprognostic (4.51e-2)" "unprognostic (2.71e-3)" "unprognostic (3.08e-1)" "unprognostic (3.90e-2)" "unprognostic (1.11e-1)" "unprognostic (8.76e-2)" "unprognostic (6.63e-2)" "unprognostic (1.26e-3)" "unprognostic (3.60e-1)" "unprognostic (9.98e-2)" "unprognostic (1.43e-2)" "unprognostic (1.39e-2)" 22.2 20.1 14.8 17.1 17.5 24.4 19.7 26.3 18.6 19.1 17.0 8.9 14.0 17.3 17.5 17.1 17.0 15.0 10.7 19.6 15.7 13.4 21.0 23.6 13.3 17.6 20.0 11.1 20.7 21.5 15.1 37.5 15.8 19.7 19.5 17.3 10.3 18.7 16.6 24.9 13.3 20.2 16.3 20.7 22.5 16.4 14.8 18.6 25.8 21.7 20.7 17.4 20.7 21.0 15.2 17.8 9.4 18.7 17.8 24.1 13.5 8.8 10.4 9.7 18.8 12.8 14.0 15.5 22.3 13.8 15.8 21.0 14.2 15.6 19.6 25.4 10.0 24.9 10.5 16.5 13.0 21.7 13.8 9.1 9.8 20.1 19.8 11.5 18.6 13.8 9.2 10.2 19.3 19.6 12.1 12.8 14.6 14.8 12.7 18.1 14.8 21.8 22.3 11.5 5.3 11.2 24.5 18.9 28.8 12.4 8.1 12.1 9.0 13.5 14.1 15.4 15.1 14.7 17.8 13.7 20.3 14.1 16.1 24.3 12.5 16.2 44.0 12.1 19.1 18.5 7.0 16.0 9.4 16.3 18.7 22.3 15.2 20.7 17.8 17.8 11.0 22.5 24.1 3.2 17.8 13.4 17.8 18.5 13.5 14.8 17.5 26.3 18.6 15.7 13.4 20.0 11.1 19.7 18.6 8.9 10.9 13.0 14.3 23.5 16.4 15.9 12.7 10.7 11.4 7.0 11.8 16.7 14.9 14.2 1.1 14.0 7.0 0.0 13.1 19.4 15.8 9.9 27.6 7.8 15.9 12.7 9.2 6.2 11.0 1.8 12.4 11.5 5.0 13.6 11.2 12.3 10.5 10.5 15.2 12.2 17.2 6.5 21.7 20.7 20.2 16.6 14.5 14.4 12.1 11.4 RIPK1 RIP ENSG00000137275 "Receptor interacting serine/threonine kinase 1" Q13546 6 3063991-3115187 "Enzymes, Predicted intracellular proteins" "Apoptosis, Host-virus interaction, Inflammatory response, Necrosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010302, HPA015257" Supported Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB010302: AB_2178118, HPA015257: AB_1856294" "unprognostic (1.24e-1)" "unprognostic (6.83e-2)" "unprognostic (1.87e-1)" "unprognostic (7.75e-2)" "unprognostic (6.08e-2)" "unprognostic (1.01e-2)" "unprognostic (1.26e-2)" "unprognostic (1.96e-1)" "unprognostic (9.46e-2)" "unprognostic (1.46e-1)" "unprognostic (5.00e-2)" "unprognostic (3.29e-1)" "unprognostic (9.65e-3)" "unprognostic (3.44e-1)" "unprognostic (9.01e-2)" "unprognostic (1.38e-2)" "prognostic favorable (6.71e-4)" 24.5 12.0 6.9 15.7 12.4 10.5 28.0 11.9 11.0 16.4 18.9 9.6 22.9 14.5 16.8 17.7 17.1 13.5 17.9 12.3 7.5 6.8 18.5 36.7 16.7 19.8 11.8 6.6 13.2 19.9 14.4 17.9 24.4 10.2 17.8 16.6 10.9 21.1 18.7 11.4 18.9 24.8 21.3 6.9 19.4 15.8 9.0 9.4 18.6 18.5 15.2 19.2 15.0 20.4 4.1 3.2 6.6 3.9 6.6 7.6 2.1 9.5 6.8 10.3 10.6 22.0 14.1 5.7 15.0 20.4 15.9 18.3 9.2 6.6 8.9 14.5 21.5 16.7 11.0 12.8 12.3 17.4 18.4 6.9 11.5 4.5 6.7 12.4 9.9 14.7 19.0 11.0 14.7 10.7 13.0 13.7 5.5 12.9 5.1 15.3 12.3 6.8 10.8 6.5 11.5 8.5 8.3 7.6 10.0 14.2 19.1 8.9 8.8 9.9 6.2 16.6 21.9 11.4 7.1 16.6 17.4 9.3 6.6 11.1 7.9 10.2 9.5 7.3 5.5 19.2 1.1 3.0 6.4 6.1 3.7 4.9 2.0 4.9 7.6 3.2 4.1 4.1 5.4 6.6 6.6 3.9 2.9 5.7 2.1 6.9 12.4 11.9 11.0 7.5 6.8 11.8 6.6 10.2 9.4 6.0 8.1 8.8 8.6 9.7 3.4 6.9 12.7 21.4 20.5 8.7 11.8 7.3 5.0 8.1 1.6 15.8 13.6 0.0 11.3 5.6 9.8 8.2 10.4 12.3 10.1 4.8 6.3 11.6 5.1 0.4 6.4 11.1 3.3 17.2 15.4 7.2 10.3 10.1 5.6 8.2 21.0 19.4 15.1 0.9 2.5 8.7 10.0 12.5 9.3 12.2 RNF114 "PSORS12, ZNF313" ENSG00000124226 "Ring finger protein 114" Q9Y508 20 49936336-49953892 "Enzymes, Predicted intracellular proteins" "Differentiation, Spermatogenesis, Ubl conjugation pathway" "Developmental protein, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in all" 5 "Early spermatids: 1239.3;Late spermatids: 628.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 110.4" "Low region specificity" "Detected in all" HPA021184 Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA021184: AB_1859185" "unprognostic (8.38e-2)" "unprognostic (3.56e-2)" "unprognostic (5.62e-2)" "prognostic unfavorable (8.10e-6)" "unprognostic (1.56e-1)" "unprognostic (2.96e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (2.50e-2)" "unprognostic (1.03e-2)" "unprognostic (2.12e-1)" "unprognostic (3.99e-1)" "unprognostic (2.70e-2)" "unprognostic (2.54e-3)" "unprognostic (1.33e-1)" "unprognostic (1.76e-1)" "prognostic favorable (3.01e-4)" "unprognostic (1.36e-2)" 23.2 21.3 24.4 18.3 25.7 31.2 20.6 26.7 23.1 24.0 29.7 32.6 21.1 29.5 20.3 23.4 20.2 23.6 20.1 21.9 23.0 25.3 30.3 31.6 24.4 24.0 28.3 19.4 28.4 36.8 16.1 21.6 40.6 23.7 24.5 21.3 27.1 27.8 24.1 43.8 15.2 33.9 17.6 29.3 36.3 24.2 101.9 24.1 28.3 37.9 20.0 24.1 22.6 25.0 28.5 32.5 43.4 44.6 23.7 29.4 34.9 15.9 15.7 8.1 8.5 16.7 11.5 23.8 14.3 16.2 29.6 12.6 46.6 13.1 7.7 28.6 7.5 18.1 12.8 12.0 14.4 10.3 14.0 8.8 9.8 10.5 32.7 14.7 17.8 11.8 10.0 13.3 11.3 7.8 10.1 7.0 13.4 18.4 9.1 8.6 53.8 14.9 18.5 8.3 12.5 22.6 16.3 8.5 14.0 15.6 13.0 12.4 8.9 17.5 110.4 22.1 6.9 29.4 16.6 9.2 26.8 12.5 14.0 16.4 18.7 19.5 14.7 15.2 11.6 14.8 38.5 42.5 35.7 22.0 39.2 24.6 28.2 24.6 22.4 32.5 28.5 29.4 23.7 43.4 23.7 44.6 26.7 28.8 34.9 24.4 25.7 26.7 23.1 23.0 25.3 28.3 19.4 23.7 24.1 44.7 50.1 53.6 105.2 95.2 25.2 37.5 28.1 32.1 28.4 66.3 11.8 79.1 61.3 83.5 1239.3 54.7 64.9 23.3 88.7 65.1 64.6 89.9 43.9 57.8 95.3 38.1 58.0 44.8 69.1 628.0 65.3 62.5 67.4 101.0 68.6 36.1 81.0 69.1 56.3 87.7 19.7 38.8 75.9 206.1 156.2 76.2 104.4 48.0 73.6 96.0 RNF149 FLJ90504 ENSG00000163162 "Ring finger protein 149" Q8NC42 2 101271219-101308701 "Enzymes, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 123.7" "Cell type enhanced" "Detected in many" 5 "Kupffer cells: 255.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 6 "neutrophil: 123.7" "Lineage enriched" "Detected in all" 6 "granulocytes: 123.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011424 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA011424: AB_1079825" "unprognostic (2.56e-2)" "unprognostic (4.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.49e-2)" "unprognostic (3.17e-2)" "unprognostic (5.17e-3)" "unprognostic (4.16e-2)" "unprognostic (4.77e-3)" "unprognostic (5.61e-2)" "unprognostic (1.43e-2)" "unprognostic (5.69e-3)" "unprognostic (1.51e-1)" "prognostic unfavorable (2.04e-8)" "unprognostic (1.39e-1)" "unprognostic (6.16e-2)" "unprognostic (2.70e-1)" "prognostic favorable (2.91e-4)" 20.3 13.4 7.9 29.0 10.9 32.9 13.5 7.9 10.8 12.5 16.6 10.8 11.4 12.3 11.3 12.8 28.9 14.3 14.5 12.1 9.5 9.4 15.1 19.6 24.5 47.4 13.7 6.2 14.3 21.1 14.3 10.6 19.4 11.2 11.1 12.0 12.8 15.8 8.1 8.8 20.2 16.8 9.6 13.9 65.0 13.8 15.2 9.7 17.0 12.7 13.1 24.4 14.9 17.2 2.1 9.3 123.7 21.3 2.3 9.0 9.9 9.7 5.8 4.4 5.5 16.5 16.6 25.7 12.1 15.9 16.4 18.5 14.5 25.8 2.9 14.7 11.9 21.7 19.9 6.2 12.3 15.3 8.4 8.5 6.0 5.1 24.5 22.1 6.5 9.8 15.1 20.3 19.4 12.9 12.6 29.8 6.4 5.3 9.1 16.4 8.3 8.7 6.5 3.0 13.2 10.5 5.7 7.3 11.2 19.3 23.9 5.8 4.3 7.3 18.1 17.5 5.0 4.9 8.8 19.7 8.3 4.7 12.4 2.6 18.4 10.8 0.1 2.7 9.1 6.1 5.8 13.0 14.8 8.2 20.4 7.4 2.1 7.3 8.1 4.8 1.5 5.1 5.3 123.7 2.3 21.3 9.3 9.0 9.9 7.9 10.9 7.9 10.8 9.5 9.4 13.7 6.2 11.2 9.7 44.7 56.9 34.7 63.4 68.3 20.3 10.6 48.4 24.1 23.9 52.4 53.0 48.5 1.7 48.9 61.2 33.8 33.9 0.0 36.5 60.6 44.7 62.7 37.1 38.9 76.7 7.9 8.2 28.8 255.2 27.7 28.4 171.2 38.8 16.2 35.9 11.9 49.2 36.6 18.4 25.1 19.7 58.2 44.3 31.2 36.2 80.0 107.1 69.8 31.9 137.0 RNF165 "ARKL2, RNF111L2" ENSG00000141622 "Ring finger protein 165" Q6ZSG1 18 46326809-46463140 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6" "Group enriched" "Detected in many" 8 "Bipolar cells: 36.3;Cone photoreceptor cells: 94.2;Horizontal cells: 76.3;Rod photoreceptor cells: 51.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "MAIT T-cell: 1.1;NK-cell: 3.9;plasmacytoid DC: 1.5" "Group enriched" "Detected in many" 4 "dendritic cells: 1.5;NK-cells: 3.9;T-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 12.7;HaCaT: 7.0;HeLa: 6.9;RPMI-8226: 6.7;SCLC-21H: 13.2;SH-SY5Y: 15.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041615, HPA047798" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA041615: AB_2677582, HPA047798: AB_2680158" "unprognostic (6.46e-3)" "unprognostic (7.25e-2)" "unprognostic (4.55e-2)" "unprognostic (1.24e-5)" "unprognostic (3.43e-1)" "unprognostic (4.57e-2)" "unprognostic (5.18e-2)" "unprognostic (1.69e-1)" "unprognostic (1.04e-3)" "unprognostic (1.95e-1)" "unprognostic (1.23e-1)" "unprognostic (2.07e-1)" "unprognostic (1.87e-5)" "unprognostic (3.53e-3)" "unprognostic (1.90e-1)" "unprognostic (1.29e-1)" "unprognostic (1.64e-1)" 1.9 1.7 9.9 1.0 9.5 0.9 2.1 28.6 13.8 1.0 0.8 1.7 1.7 0.4 1.0 8.4 2.7 3.0 1.0 2.5 6.1 4.4 2.3 8.3 1.0 0.9 2.2 7.2 0.5 1.0 13.1 4.8 0.8 2.0 3.6 0.6 2.7 1.4 3.9 3.6 3.5 1.0 0.7 1.7 5.3 0.7 1.3 1.0 1.7 8.8 1.2 1.3 1.2 1.0 0.0 1.5 0.5 0.0 3.9 1.1 0.0 1.5 0.1 12.7 0.1 0.0 0.0 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.2 7.0 0.5 1.0 0.0 0.0 1.0 0.1 6.9 0.0 0.0 2.9 0.0 0.0 0.8 0.0 0.0 0.3 0.0 2.2 0.0 0.2 0.0 0.0 2.3 1.0 1.7 0.3 1.2 2.4 0.5 6.7 0.8 2.1 13.2 15.0 2.3 0.0 0.0 0.9 0.3 0.6 0.0 0.0 0.9 0.0 0.4 0.0 0.0 0.0 0.0 4.1 0.4 0.0 0.0 0.5 0.0 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 3.9 0.0 1.5 0.0 0.0 9.9 9.5 28.6 13.8 6.1 4.4 2.2 7.2 2.0 1.0 3.0 1.7 0.0 8.3 2.4 36.3 7.9 0.0 0.0 3.4 0.0 94.2 0.1 3.3 0.0 2.7 1.9 0.0 0.0 0.0 0.2 1.5 1.7 0.0 5.7 0.1 76.3 0.0 0.6 0.8 3.1 2.3 0.0 1.7 0.0 0.0 3.7 0.1 0.0 3.9 0.0 51.7 0.0 0.8 0.5 0.5 1.8 0.2 2.9 0.0 1.6 ROBO3 "FLJ21044, HGPPS, HGPS, RBIG1" ENSG00000154134 "Roundabout guidance receptor 3" Q96MS0 11 124865386-124881470 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "epididymis: 20.1" "Cell type enhanced" "Detected in many" 11 "Muller glia cells: 42.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "eosinophil: 1.4" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 11 "AF22: 20.5" "Region enhanced" "Detected in single" "cerebral cortex: 2.0" "Low region specificity" "Detected in all" HPA071053 Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA071053: " "unprognostic (1.30e-1)" "unprognostic (2.17e-1)" "unprognostic (4.95e-3)" "unprognostic (3.42e-2)" "unprognostic (3.84e-2)" "unprognostic (6.25e-2)" "unprognostic (6.95e-3)" "unprognostic (9.65e-2)" "unprognostic (1.56e-2)" "unprognostic (1.18e-1)" "unprognostic (1.32e-1)" "unprognostic (7.15e-2)" "unprognostic (3.75e-8)" "unprognostic (7.27e-3)" "unprognostic (2.21e-1)" "unprognostic (1.47e-1)" "unprognostic (4.91e-3)" 2.4 1.5 1.5 0.5 1.4 1.3 1.7 0.5 3.1 0.8 0.9 0.5 0.5 1.9 1.8 20.1 0.5 2.1 0.5 1.5 1.5 0.6 0.7 0.5 1.7 0.8 1.1 1.1 7.4 0.5 0.2 0.5 1.5 1.0 1.0 0.2 1.0 1.7 0.5 2.6 0.2 2.2 4.5 0.7 3.0 0.8 1.0 0.5 0.8 1.1 0.5 0.5 0.5 1.0 0.0 1.3 1.4 0.3 0.0 0.8 0.0 0.0 0.0 20.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.0 1.5 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 1.2 0.0 0.0 1.7 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.0 0.1 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.4 0.0 0.1 0.1 0.0 0.8 1.1 0.0 1.0 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.4 0.0 0.3 0.4 0.0 0.6 0.3 0.0 0.0 0.2 0.0 0.2 0.0 0.2 1.3 0.8 0.0 1.5 1.4 0.5 2.7 1.5 0.6 1.1 1.1 1.0 0.5 0.0 5.3 0.0 13.5 2.6 0.6 2.8 0.0 0.0 5.7 12.2 0.0 0.1 0.0 6.6 0.2 10.3 1.1 0.0 0.7 0.1 7.6 6.0 9.2 0.0 1.5 0.0 3.4 4.9 2.1 0.0 12.4 8.5 3.3 1.8 0.9 42.6 1.1 2.9 7.8 0.4 1.7 0.0 4.9 3.2 5.9 0.9 0.1 1.7 2.3 5.6 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 RPGRIP1L "CORS3, FTM, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134" ENSG00000103494 "RPGRIP1 like" Q68CZ1 16 53598153-53703938 "Disease related genes, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Joubert syndrome, Meckel syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 25.8" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 109.7;Spermatocytes: 38.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039405, HPA040530" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039405: AB_10794636, HPA040530: AB_2677023" "prognostic unfavorable (6.93e-4)" "unprognostic (1.52e-1)" "unprognostic (2.19e-3)" "unprognostic (2.26e-2)" "unprognostic (3.43e-2)" "unprognostic (1.46e-2)" "unprognostic (1.26e-4)" "unprognostic (1.24e-1)" "unprognostic (1.05e-1)" "unprognostic (3.63e-1)" "unprognostic (1.05e-1)" "unprognostic (3.31e-1)" "prognostic unfavorable (5.95e-4)" "unprognostic (5.22e-3)" "unprognostic (1.52e-1)" "unprognostic (4.92e-4)" "unprognostic (5.95e-2)" 3.0 6.5 8.0 3.8 13.8 2.7 6.1 5.3 12.7 6.3 3.3 2.4 6.8 2.4 7.3 7.8 3.9 11.7 4.9 3.3 9.1 9.9 5.5 2.2 3.5 3.1 5.9 13.2 6.5 3.2 18.5 25.8 3.8 9.0 5.2 3.5 1.7 3.4 5.3 2.3 3.6 2.0 6.3 3.5 1.9 3.5 20.9 4.7 3.1 7.6 2.3 3.1 4.4 3.6 4.9 2.0 1.8 1.0 2.1 5.6 1.3 9.1 11.3 10.2 9.4 12.3 12.0 4.5 10.2 6.7 9.5 2.7 6.2 7.4 6.1 7.4 10.4 6.4 10.6 8.5 9.7 16.9 3.7 5.9 2.2 9.6 6.2 5.1 5.5 4.2 7.5 6.0 10.6 6.6 10.4 7.1 8.5 5.6 3.5 14.0 3.5 9.0 3.9 6.5 3.2 5.4 15.4 14.0 7.3 12.3 2.4 17.8 6.7 12.6 5.3 4.6 6.5 8.0 4.4 6.4 10.4 7.4 8.5 9.0 4.6 5.3 10.8 15.7 3.3 6.1 1.7 0.9 1.1 3.6 1.0 3.5 3.2 2.6 3.3 0.8 4.9 2.6 5.6 1.8 2.1 1.0 2.0 2.1 1.3 8.0 13.8 5.3 12.7 9.1 9.9 5.9 13.2 9.0 4.7 6.0 3.7 3.2 2.8 4.0 5.1 7.3 0.0 109.7 19.4 10.4 7.9 4.6 14.9 6.5 13.1 2.5 0.1 0.0 2.7 6.2 9.3 1.4 6.9 3.8 2.4 3.2 0.0 3.7 1.2 9.0 4.4 2.8 1.7 2.8 3.8 6.1 3.5 0.0 6.0 14.2 8.4 6.5 4.1 38.1 11.0 4.6 1.4 1.0 3.8 2.1 RPSA "37LRP, LAMR1, LRP, p40, SA" ENSG00000168028 "Ribosomal protein SA" P08865 3 39406689-39412542 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Ribosomal proteins" "Host-virus interaction" "Host cell receptor for virus entry, Receptor, Ribonucleoprotein, Ribosomal protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" CAB009561 Approved Supported "Plasma membrane,Cytosol" NA NA 710000 "Plasma membrane, Cytosol" "CAB009561: AB_2182543" "unprognostic (3.67e-3)" "unprognostic (2.92e-1)" "unprognostic (3.97e-2)" "unprognostic (3.72e-2)" "unprognostic (5.38e-2)" "unprognostic (5.10e-2)" "unprognostic (5.84e-3)" "unprognostic (2.54e-1)" "unprognostic (1.69e-1)" "unprognostic (2.36e-2)" "unprognostic (8.56e-2)" "unprognostic (7.50e-2)" "unprognostic (2.91e-2)" "unprognostic (3.18e-1)" "unprognostic (2.77e-1)" "unprognostic (1.73e-1)" "unprognostic (1.46e-1)" 47.5 42.9 48.8 88.4 56.9 107.0 76.7 26.3 56.2 50.9 63.6 29.1 65.6 48.4 73.5 50.1 93.4 82.4 52.2 67.3 43.2 33.7 44.1 63.8 67.5 300.2 41.7 37.7 145.1 264.7 35.7 42.2 45.0 43.5 58.9 71.5 31.4 148.1 50.2 60.4 70.5 53.0 73.9 48.1 76.8 58.4 60.2 26.8 83.5 72.8 105.2 112.4 53.8 80.4 92.4 64.0 6.9 24.8 61.5 101.2 114.8 94.0 86.2 75.0 123.6 66.0 150.6 117.9 67.2 109.0 153.3 89.8 94.2 82.0 213.0 41.3 132.2 40.9 37.6 162.1 155.2 132.2 76.8 84.8 96.4 81.9 91.4 127.9 135.4 90.9 167.2 258.7 117.8 189.1 111.8 157.7 127.2 100.1 103.3 110.7 65.8 157.2 101.3 250.8 146.3 148.3 74.3 107.5 156.3 107.1 43.5 54.3 110.8 36.6 283.1 116.5 106.9 82.6 188.5 62.1 47.1 86.9 78.3 163.4 79.9 121.4 127.0 75.6 131.9 62.2 6.9 20.6 4.8 53.8 24.8 93.5 92.4 89.8 71.4 58.1 89.5 101.2 88.4 3.0 61.5 20.4 64.0 66.1 114.8 48.8 56.9 26.3 56.2 43.2 33.7 41.7 37.7 43.5 26.8 482.4 691.4 2495.2 2051.4 1601.1 264.3 56.9 960.5 540.7 781.4 308.8 90.3 2456.3 840.6 1172.8 115.3 934.8 552.2 584.0 2956.9 3841.9 1034.7 1574.0 748.4 620.0 1468.8 163.7 993.6 761.1 1046.6 195.0 1148.6 961.8 700.1 1430.1 1771.7 254.3 1913.9 673.4 702.5 847.9 249.3 465.7 1029.7 293.8 1026.5 1675.1 2024.4 2012.8 2593.9 2441.2 RSBN1L "FLJ42526, FLJ45813, MGC71764" ENSG00000187257 "Round spermatid basic protein 1 like" Q6PCB5 7 77696443-77783022 "Cancer-related genes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Rod photoreceptor cells: 337.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 31.5" "Lineage enriched" "Detected in all" 4 "granulocytes: 31.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020406, HPA020413" Approved Supported "Nuclear speckles,Plasma membrane" NA NA "Nuclear speckles" "Plasma membrane" "HPA020406: AB_1856488, HPA020413: AB_2253910" "unprognostic (2.02e-1)" "unprognostic (2.61e-2)" "unprognostic (2.41e-1)" "unprognostic (1.72e-1)" "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (2.43e-2)" "prognostic favorable (3.74e-4)" "unprognostic (1.27e-2)" "unprognostic (3.78e-2)" "unprognostic (1.25e-1)" "unprognostic (9.02e-2)" "unprognostic (7.30e-3)" "unprognostic (1.93e-1)" "unprognostic (1.46e-1)" "unprognostic (2.25e-3)" "unprognostic (1.53e-3)" 12.9 10.6 15.0 22.1 14.6 9.5 15.5 28.7 17.0 22.8 23.5 8.9 12.1 11.1 17.2 13.6 15.0 14.2 13.4 10.6 12.4 10.3 12.0 14.9 15.7 18.2 11.1 11.0 19.2 14.9 19.5 16.2 12.2 11.8 18.8 15.1 13.9 14.0 15.4 13.6 11.7 14.9 18.0 11.0 20.7 14.3 29.8 13.8 34.5 21.1 6.7 18.0 23.6 28.2 7.2 7.0 31.5 4.0 3.0 5.2 1.2 9.0 7.0 11.7 20.5 8.2 10.5 5.7 6.7 7.3 9.6 11.0 8.6 16.2 18.6 2.6 6.9 12.1 7.9 15.8 8.7 13.8 10.1 8.5 14.8 11.0 8.4 6.9 18.1 14.0 7.5 6.4 8.8 9.7 7.3 7.9 12.4 20.1 19.6 9.9 10.4 15.5 18.3 8.3 11.7 6.3 16.2 11.7 19.5 6.0 11.9 13.8 14.4 10.2 18.6 7.3 12.4 11.3 9.7 7.5 14.4 13.3 8.6 10.2 8.8 9.3 29.9 6.8 16.9 9.4 9.1 4.0 6.4 5.2 2.9 3.9 5.4 4.5 3.8 2.2 7.2 4.3 4.7 31.5 3.0 3.2 7.0 4.5 1.2 15.0 14.6 28.7 17.0 12.4 10.3 11.1 11.0 11.8 13.8 53.6 44.7 77.1 91.4 69.9 234.2 15.9 38.2 69.6 80.8 52.4 221.9 45.1 33.2 32.4 254.3 67.5 45.0 0.0 43.8 30.0 64.1 42.7 68.2 48.3 38.0 149.4 74.4 43.0 41.9 50.1 94.0 54.7 60.8 45.1 68.1 88.8 31.9 58.5 112.4 18.0 337.1 71.1 85.6 98.9 156.4 65.7 32.4 99.1 57.8 72.2 S100A16 "DT1P1A7, MGC17528, S100F" ENSG00000188643 "S100 calcium binding protein A16" Q96FQ6 1 153606886-153613145 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 223.9;tongue: 102.1" "Cell type enhanced" "Detected in many" 8 "Basal glandular cells: 744.7;Glandular cells: 697.0;Pancreatic endocrine cells: 790.1;Suprabasal keratinocytes: 794.3;Urothelial cells: 1359.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 7 "plasmacytoid DC: 2.0" "Lineage enriched" "Detected in single" 20 "dendritic cells: 2.0" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 117.9;SK-BR-3: 142.9" "Low region specificity" "Detected in all" HPA045841 Enhanced Approved "Plasma membrane,Cytosol" NA NA 92000 Cytosol "Plasma membrane" "HPA045841: AB_10966282" "unprognostic (9.86e-3)" "unprognostic (1.69e-1)" "unprognostic (2.23e-2)" "unprognostic (3.06e-1)" "unprognostic (1.71e-1)" "unprognostic (7.03e-2)" "prognostic unfavorable (3.18e-4)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.70e-1)" "unprognostic (4.59e-1)" "prognostic unfavorable (2.04e-4)" "unprognostic (2.60e-1)" "prognostic unfavorable (3.91e-5)" "unprognostic (1.01e-1)" "unprognostic (1.92e-1)" "unprognostic (3.45e-2)" "unprognostic (5.29e-3)" 20.1 5.5 9.3 8.0 7.2 0.0 11.9 3.4 8.3 37.2 21.1 8.3 3.2 16.2 8.7 7.2 223.9 7.6 18.2 9.5 6.7 5.4 14.3 27.0 18.3 7.5 7.1 5.7 15.3 4.1 6.5 3.3 14.9 7.2 9.3 14.5 5.1 35.5 5.4 9.8 43.1 31.2 10.6 5.9 13.4 10.6 12.3 4.6 3.2 11.3 102.1 87.5 11.3 51.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 56.4 27.2 1.4 3.2 9.4 35.7 3.7 32.3 29.7 26.6 23.6 25.5 31.6 0.0 51.9 48.3 6.0 41.5 0.0 72.5 15.6 0.1 0.0 0.0 23.7 7.5 10.8 0.0 0.0 16.9 69.7 64.4 50.7 34.8 117.9 0.0 0.6 0.0 58.5 75.0 0.0 0.1 6.0 100.1 73.6 0.0 16.4 0.1 100.2 20.3 0.0 0.1 23.8 142.9 4.7 12.9 44.4 0.3 63.2 16.0 25.6 15.4 73.0 0.0 0.2 0.1 47.6 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 9.3 7.2 3.4 8.3 6.7 5.4 7.1 5.7 7.2 4.6 35.7 18.0 15.1 744.7 563.0 0.4 29.7 119.8 26.8 103.5 102.9 2.0 12.3 61.3 584.7 3.2 283.5 336.2 0.0 172.2 7.2 105.8 697.0 19.5 109.5 4.7 0.0 133.3 333.3 22.5 10.0 62.2 11.1 106.3 12.6 178.6 38.3 790.1 294.7 57.7 126.7 1.8 6.5 41.5 1.7 1.2 794.3 6.9 12.8 201.3 1359.9 S100A6 "2A9, CABP, CACY, PRA" ENSG00000197956 "S100 calcium binding protein A6" P06703 1 153534599-153536244 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Pancreatic endocrine cells: 22500.8;Urothelial cells: 12910.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "OE19: 325.2;RPTEC TERT1: 363.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002601, HPA007575, CAB040549, CAB047354" Enhanced Enhanced "Plasma membrane,Cytosol" NA NA 5100000 "Plasma membrane, Cytosol" "CAB002601: , CAB040549: , CAB047354: , HPA007575: AB_1079859" "unprognostic (8.80e-3)" "unprognostic (6.96e-2)" "unprognostic (2.31e-1)" "unprognostic (2.47e-2)" "unprognostic (1.19e-1)" "unprognostic (1.19e-1)" "unprognostic (1.23e-3)" "unprognostic (1.36e-1)" "unprognostic (1.27e-1)" "unprognostic (3.51e-1)" "unprognostic (6.86e-3)" "unprognostic (1.66e-1)" "unprognostic (3.59e-1)" "unprognostic (1.10e-1)" "unprognostic (2.88e-1)" "unprognostic (1.46e-2)" "prognostic favorable (7.56e-4)" 126.4 32.6 14.8 104.9 29.9 73.8 223.6 13.3 14.6 95.4 176.8 10.1 51.2 70.2 65.0 135.5 126.5 42.2 264.5 112.3 13.0 22.5 103.4 6.0 151.9 61.5 45.6 7.9 38.1 13.5 0.5 17.7 100.1 27.3 85.1 85.5 28.5 58.7 55.2 59.1 45.1 98.1 88.9 35.5 27.5 69.9 29.6 17.8 4.9 76.9 183.0 36.2 150.9 145.0 30.7 130.1 303.7 180.7 9.1 69.2 201.7 75.2 84.2 0.0 6.9 141.8 184.0 0.2 92.3 230.5 46.8 61.5 5.8 157.5 0.1 29.3 137.0 43.4 32.7 1.5 132.6 22.1 31.0 0.0 15.8 56.4 5.1 53.7 0.7 10.8 85.8 110.2 50.1 86.8 64.3 103.8 0.0 0.0 0.1 116.7 11.3 0.2 6.4 0.1 325.2 138.6 0.0 10.4 27.2 363.5 69.9 21.7 3.8 125.5 127.9 94.9 0.0 17.6 24.4 151.6 45.2 11.8 92.4 149.8 0.2 0.2 0.2 175.8 16.8 96.6 139.8 180.7 74.1 62.0 96.8 67.3 30.7 58.5 60.3 130.1 17.2 37.3 49.5 303.7 9.1 86.9 68.3 69.2 201.7 14.8 29.9 13.3 14.6 13.0 22.5 45.6 7.9 27.3 17.8 4374.3 2209.1 330.5 4451.5 1322.1 4.2 292.3 1518.5 3121.1 4082.2 7746.6 0.0 1050.2 6310.0 5079.5 17.9 1309.7 5409.4 186.9 8886.8 1881.7 3759.3 5823.6 1721.8 17.4 2462.8 55.6 1958.6 890.1 3762.1 37.4 2790.2 5314.3 2911.9 5195.8 5391.4 88.0 22500.8 7016.5 1075.2 111.0 7.4 129.4 3153.8 7.1 13.9 872.0 1315.7 897.0 2304.5 12910.1 SAMHD1 "AGS5, HDDC1, Mg11, MOP-5, SBBI88" ENSG00000101347 "SAM and HD domain containing deoxynucleoside triphosphate triphosphohydrolase 1" Q9Y3Z3 20 36889773-36951901 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Antiviral defense, DNA damage, DNA repair, DNA replication, Host-virus interaction, Immunity, Innate immunity" "Allosteric enzyme, Hydrolase" "Aicardi-Goutieres syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Hofbauer cells: 131.6;Kupffer cells: 243.3;Macrophages: 175.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 46.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.1;BJ hTERT+ SV40 Large T+: 24.6;BJ hTERT+ SV40 Large T+ RasG12V: 26.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA047072 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 100000 Nucleoplasm "Plasma membrane" "HPA047072: AB_2679921" "unprognostic (1.09e-1)" "unprognostic (7.30e-3)" "unprognostic (1.65e-2)" "unprognostic (3.85e-2)" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (2.15e-1)" "unprognostic (4.07e-2)" "unprognostic (2.03e-1)" "unprognostic (3.63e-1)" "unprognostic (1.88e-1)" "unprognostic (1.04e-1)" "prognostic unfavorable (5.12e-4)" "unprognostic (1.44e-1)" "unprognostic (9.06e-2)" "unprognostic (3.18e-2)" "unprognostic (2.72e-2)" 54.3 18.6 8.7 31.8 13.0 9.9 35.9 4.9 9.7 14.5 21.2 9.0 8.7 15.8 13.5 20.2 24.1 33.4 15.3 25.4 8.7 6.0 12.5 12.4 25.7 48.3 14.5 4.9 22.1 18.1 4.9 22.4 13.7 10.2 14.0 13.2 11.6 14.7 9.7 9.2 11.4 20.6 21.3 13.7 40.7 19.2 15.1 15.0 9.7 14.9 10.7 18.5 23.2 50.2 0.4 46.7 2.8 23.4 6.0 10.9 19.1 3.9 1.5 0.7 1.5 58.1 11.0 0.7 2.3 4.2 24.6 26.4 4.9 1.3 8.3 3.3 1.6 15.0 3.0 6.1 2.9 5.2 2.4 2.0 0.4 2.1 2.6 5.1 4.7 1.5 13.5 0.1 8.6 0.2 1.4 3.2 0.0 1.5 2.0 0.5 1.2 0.0 1.8 0.7 2.4 3.2 0.2 4.0 3.2 0.9 0.6 3.0 0.4 3.0 1.1 2.9 0.2 1.4 7.6 0.8 1.9 2.1 2.0 3.4 1.2 3.0 3.5 1.6 0.4 0.6 0.2 19.4 0.6 6.1 23.4 5.6 0.4 6.9 6.4 46.7 0.4 8.5 6.3 2.8 6.0 20.4 11.0 10.9 19.1 8.7 13.0 4.9 9.7 8.7 6.0 14.5 4.9 10.2 15.0 26.8 30.5 23.8 1.9 5.7 5.3 16.9 25.5 83.0 53.4 1.8 3.9 2.5 0.0 9.3 2.3 36.5 1.1 0.0 8.6 2.8 23.4 2.7 11.6 17.4 131.6 6.4 5.8 47.9 243.3 2.3 76.2 175.7 5.0 16.2 4.3 30.6 11.1 20.1 90.5 1.2 2.6 58.2 29.8 5.1 5.4 5.1 2.4 54.9 4.5 4.7 SAMSN1 "HACS1, NASH1, SASH2, SH3D6B, SLy2" ENSG00000155307 "SAM domain, SH3 domain and nuclear localization signals 1" Q9NSI8 21 14485228-14658821 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 53.6;bone marrow: 72.1;lymphoid tissue: 43.6" "Group enriched" "Detected in many" 6 "granulocytes: 1107.2;monocytes: 1399.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 53.6;eosinophil: 49.9" "Low lineage specificity" "Detected in all" "Group enriched" "Detected in some" 4 "HEL: 60.9;K-562: 72.4;Karpas-707: 31.6" "Region enriched" "Detected in some" 7 "olfactory region: 25.4" "Low region specificity" "Detected in all" "HPA010645, HPA017055, HPA046639" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA010645: AB_1856559, HPA017055: AB_1856560, HPA046639: AB_2679732" "unprognostic (7.62e-3)" "unprognostic (1.46e-2)" "unprognostic (1.03e-2)" "unprognostic (3.11e-2)" "unprognostic (2.44e-1)" "unprognostic (3.91e-2)" "unprognostic (1.41e-1)" "unprognostic (1.01e-1)" "unprognostic (2.17e-1)" "unprognostic (6.13e-2)" "unprognostic (2.10e-2)" "unprognostic (1.28e-1)" "prognostic unfavorable (4.52e-6)" "unprognostic (9.14e-2)" "unprognostic (3.05e-2)" "unprognostic (2.17e-1)" "unprognostic (1.68e-2)" 14.4 3.9 5.8 33.0 10.4 72.1 4.2 1.1 5.1 2.9 4.7 4.9 0.0 3.1 3.4 4.6 4.1 6.8 10.1 5.1 4.4 3.4 5.9 7.2 27.9 28.3 11.1 1.4 3.3 2.3 1.0 2.7 6.7 6.7 4.1 7.0 3.4 3.4 1.2 1.6 1.9 13.6 4.7 17.5 43.6 5.0 2.4 7.1 12.6 2.6 2.8 16.7 11.8 4.5 6.5 5.6 53.6 17.3 3.7 12.9 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.4 0.0 3.1 0.0 60.9 0.0 0.0 0.0 7.1 2.9 0.0 0.0 0.0 9.0 2.4 0.8 1.1 72.4 31.6 0.0 0.0 3.4 8.7 0.0 0.0 0.0 5.9 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 7.9 0.0 0.0 0.0 0.0 13.6 0.1 0.0 0.3 4.6 0.0 53.6 8.8 49.9 5.3 11.6 3.6 6.5 10.3 7.8 5.6 2.6 6.6 4.6 11.0 3.7 17.3 0.2 12.9 6.8 5.8 10.4 1.1 5.1 4.4 3.4 11.1 1.4 6.7 7.1 20.8 87.5 39.7 0.8 13.9 54.7 1.2 2.5 14.7 20.5 34.9 0.0 0.4 0.0 0.4 0.0 7.1 0.0 23.3 5.4 0.5 6.2 0.4 1107.2 0.9 57.4 0.0 0.0 3.1 159.2 0.0 0.6 220.5 20.3 1399.5 0.1 1.5 0.6 0.0 0.0 0.4 4.2 0.0 3.3 0.0 0.0 11.5 0.5 120.4 0.0 0.7 SCNN1D "dNaCh, ENaCdelta" ENSG00000162572 "Sodium channel epithelial 1 delta subunit" P51172 1 1280436-1292029 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Early spermatids: 9.6" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "U-266/70: 11.4" HPA026884 Enhanced Supported "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA026884: AB_10601501" "unprognostic (2.08e-2)" "unprognostic (2.08e-1)" "unprognostic (7.39e-4)" "unprognostic (1.06e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.60e-4)" "unprognostic (1.44e-2)" "unprognostic (1.81e-1)" "unprognostic (2.08e-2)" "unprognostic (1.14e-1)" "prognostic favorable (1.32e-4)" "unprognostic (5.27e-2)" "prognostic unfavorable (6.67e-5)" "unprognostic (3.13e-1)" "unprognostic (4.18e-2)" "unprognostic (2.13e-1)" "unprognostic (7.06e-2)" 3.2 3.8 4.0 1.9 5.1 3.6 1.2 12.8 6.3 1.7 2.0 7.0 3.2 1.1 1.1 3.9 1.5 1.5 4.1 3.3 1.4 3.2 1.5 2.5 3.1 4.6 3.0 0.8 5.9 1.3 2.3 0.2 8.6 2.4 3.9 4.6 5.1 1.0 3.2 3.8 2.4 10.2 1.3 0.7 0.7 1.8 0.5 0.9 0.0 0.2 0.0 0.8 0.2 0.6 5.0 2.0 5.2 1.4 0.8 0.9 3.3 1.0 1.7 1.9 0.9 2.8 3.6 1.8 1.5 2.5 0.8 0.9 0.8 0.3 6.7 3.1 0.4 6.0 1.3 1.4 0.1 3.6 2.3 1.1 2.6 0.0 2.2 0.5 6.5 2.4 8.5 0.4 1.8 1.4 2.4 1.0 0.6 3.7 9.3 0.4 0.8 0.8 0.2 2.7 3.8 1.4 1.5 2.2 0.8 6.6 1.8 1.4 3.2 2.7 5.0 1.1 11.4 0.7 2.9 2.9 6.1 3.6 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.3 0.1 0.0 0.0 0.0 0.9 0.0 0.2 3.0 2.9 0.0 0.2 0.7 3.2 4.0 0.0 2.7 2.3 0.0 3.9 0.1 0.0 0.4 9.6 0.0 1.7 0.0 0.4 0.2 1.0 0.1 2.3 2.1 0.3 4.8 1.2 0.6 0.6 3.2 0.9 0.9 0.0 0.0 0.2 2.0 1.2 3.5 1.8 0.6 2.5 0.0 0.9 1.8 2.1 1.4 0.0 0.0 0.6 0.3 SCNN1G "ENaCgamma, SCNEG" ENSG00000166828 "Sodium channel epithelial 1 gamma subunit" P51170 16 23182715-23216883 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Sodium transport, Taste, Transport" "Ion channel, Sodium channel" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 42.9;salivary gland: 26.8" "Cell type enhanced" "Detected in some" 29 "Alveolar cells type 1: 17.9;Club cells: 21.6;Collecting duct cells: 85.5" "Cancer enhanced" "Detected in many" "urothelial cancer: 15.6" "Region enriched" "Detected in some" 6 "cerebellum: 9.7" "Cell type enhanced" "Detected in single" "neutrophil: 1.8" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.8" "Group enriched" "Detected in some" 7 "hTCEpi: 31.4;RT4: 14.2" "Region enriched" "Detected in single" 13 "cerebellum: 2.8" "Low region specificity" "Detected in all" HPA071194 Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071194: AB_2686359" "unprognostic (2.90e-1)" "unprognostic (5.21e-3)" "unprognostic (5.79e-2)" "unprognostic (4.31e-2)" "unprognostic (1.92e-3)" "unprognostic (1.71e-3)" "unprognostic (1.97e-1)" "unprognostic (4.85e-2)" "unprognostic (7.84e-3)" "unprognostic (1.90e-1)" "unprognostic (2.57e-2)" "prognostic unfavorable (3.20e-7)" "unprognostic (2.80e-2)" "unprognostic (1.34e-1)" "unprognostic (2.63e-1)" "unprognostic (4.17e-3)" 1.1 0.3 0.6 0.2 0.0 0.4 2.5 9.7 0.4 14.0 5.5 0.0 4.8 0.2 3.2 1.7 10.3 0.5 0.2 0.2 1.5 0.0 42.9 0.2 15.6 0.2 0.0 0.3 0.2 3.8 0.2 6.5 0.7 0.7 10.2 1.1 0.0 26.8 12.8 2.2 6.6 0.2 0.3 0.3 0.2 6.9 0.3 0.0 1.5 25.5 3.3 3.9 1.7 11.3 0.3 0.3 1.8 0.2 0.2 0.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 14.2 1.0 0.0 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.2 0.3 0.2 0.1 0.1 0.1 0.1 0.0 0.3 0.2 0.1 1.8 0.2 0.1 0.3 0.1 0.0 0.6 0.0 9.7 0.4 1.5 0.0 0.0 0.3 0.7 0.0 17.9 3.4 0.0 4.0 0.3 0.0 0.8 0.0 2.7 21.6 85.5 0.0 0.1 0.0 1.3 0.0 0.0 0.3 0.0 1.5 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.1 0.0 0.0 1.4 SDC2 "CD362, fibroglycan, HSPG, HSPG1, SYND2" ENSG00000169439 "Syndecan 2" P34741 8 96493351-96611780 "CD markers, Predicted membrane proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 115.1;thyroid gland: 111.2" "Cell type enhanced" "Detected in many" 5 "Fibroblasts: 194.4;Hepatocytes: 184.9;Smooth muscle cells: 188.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "neutrophil: 13.9" "Lineage enriched" "Detected in many" 7 "granulocytes: 13.9" "Cell line enhanced" "Detected in many" "AF22: 102.6;EFO-21: 48.2;fHDF/TERT166: 44.4;RPTEC TERT1: 53.6;U-138 MG: 49.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025123, HPA044416" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB025123: , HPA044416: AB_2678934" "unprognostic (1.25e-1)" "unprognostic (1.04e-1)" "unprognostic (1.25e-1)" "unprognostic (3.61e-2)" "unprognostic (6.52e-3)" "unprognostic (4.18e-2)" "unprognostic (2.43e-1)" "unprognostic (2.35e-2)" "unprognostic (2.89e-2)" "unprognostic (4.56e-1)" "unprognostic (1.48e-1)" "unprognostic (6.16e-2)" "unprognostic (1.56e-2)" "unprognostic (1.45e-3)" "unprognostic (1.91e-1)" "unprognostic (2.50e-2)" "unprognostic (1.23e-1)" 43.2 9.9 13.9 9.1 16.9 2.5 17.0 12.7 8.4 43.4 18.7 7.3 21.2 5.8 21.9 15.3 13.3 21.0 15.0 19.1 12.0 12.6 23.9 115.1 14.4 4.4 9.7 9.3 45.9 16.8 1.6 24.0 31.3 10.7 25.9 10.7 51.4 6.3 28.1 9.4 6.5 9.6 34.3 9.5 7.5 11.9 8.7 9.3 0.5 111.2 13.8 3.5 35.9 26.3 0.0 1.3 13.9 1.9 0.0 0.2 0.5 0.0 0.0 102.6 0.0 37.1 34.7 0.1 14.8 17.6 8.6 9.6 3.0 0.0 0.0 48.2 44.4 1.2 0.0 17.7 0.2 7.4 0.0 6.9 0.0 9.9 37.7 1.2 0.2 0.4 13.3 0.4 19.5 0.5 33.3 0.3 0.0 9.7 0.0 3.6 0.8 0.0 2.5 10.8 0.0 0.1 0.1 16.1 0.3 53.6 8.7 3.0 8.0 0.0 0.0 0.7 35.9 4.4 11.4 8.0 49.7 15.2 0.2 8.2 0.9 0.0 0.1 15.8 0.0 15.5 0.0 1.9 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 13.9 0.0 0.1 0.0 0.0 0.5 13.9 16.9 12.7 8.4 12.0 12.6 9.7 9.3 10.7 9.3 53.6 30.2 4.7 67.2 47.9 22.0 25.8 33.1 5.3 3.4 54.1 11.8 1.8 24.9 11.7 25.6 10.2 0.1 23.3 13.2 2.0 194.4 44.9 1.1 184.9 114.7 4.8 3.4 20.3 22.0 14.5 48.6 87.0 59.1 118.2 0.5 18.4 12.7 0.0 98.6 44.8 10.2 32.3 188.5 3.2 57.1 34.4 3.2 3.2 1.2 14.5 SDC4 "amphiglycan, ryudocan, SYND4" ENSG00000124145 "Syndecan 4" P31431 20 45325288-45348424 "Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 141.1" "Cell type enhanced" "Detected in many" 4 "Exocrine glandular cells: 450.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 75.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005716, CAB013240" Enhanced Approved "Golgi apparatus,Plasma membrane" "Secreted to blood" NA NA "Golgi apparatus" "Plasma membrane" "CAB013240: AB_2533250, HPA005716: AB_1080160" "unprognostic (1.34e-2)" "unprognostic (1.80e-1)" "unprognostic (1.71e-2)" "unprognostic (2.16e-1)" "unprognostic (5.39e-2)" "unprognostic (6.59e-3)" "unprognostic (1.16e-1)" "unprognostic (5.93e-2)" "unprognostic (2.68e-1)" "unprognostic (2.95e-2)" "prognostic unfavorable (4.20e-4)" "unprognostic (1.97e-1)" "prognostic favorable (2.44e-7)" "unprognostic (3.00e-1)" "unprognostic (2.18e-1)" "prognostic favorable (2.67e-4)" "unprognostic (7.42e-2)" 15.9 26.2 19.9 15.7 24.3 3.5 40.5 6.9 20.1 20.4 24.8 19.2 9.0 13.3 17.6 14.7 42.4 27.4 26.2 19.5 19.8 12.1 56.6 141.1 56.7 4.8 23.5 20.5 14.7 36.6 6.2 12.5 23.0 30.9 19.5 22.3 21.8 47.6 17.5 25.5 45.5 13.8 38.7 23.0 9.0 46.9 33.7 15.7 2.0 26.5 25.2 23.5 34.4 16.4 0.7 2.8 2.0 3.1 1.4 8.1 1.2 23.0 3.0 1.6 0.1 41.2 25.4 71.1 29.5 40.3 33.5 24.0 35.1 58.9 0.0 13.2 37.1 33.8 30.0 1.2 75.0 40.8 6.6 1.1 0.7 2.4 13.7 44.9 0.1 1.2 34.1 50.4 13.8 33.8 18.6 4.4 0.5 1.1 0.0 19.2 22.9 0.0 2.0 3.0 20.1 9.3 0.0 14.9 0.0 55.0 30.8 0.6 2.3 40.6 25.2 7.2 19.6 18.2 1.4 8.2 25.6 21.3 2.5 19.0 1.2 0.9 0.1 40.2 2.3 15.2 2.0 3.1 0.7 1.3 1.1 4.1 0.6 4.1 1.6 2.8 0.7 0.9 1.1 1.6 1.4 1.1 2.5 8.1 1.2 19.9 24.3 6.9 20.1 19.8 12.1 23.5 20.5 30.9 15.7 271.0 364.7 7.8 299.2 332.0 10.3 49.5 201.2 113.8 195.7 179.7 11.8 27.4 54.7 239.6 0.5 9.0 87.8 0.0 450.4 202.4 50.9 254.2 12.8 232.3 18.5 0.0 52.9 14.7 15.1 2.9 3.7 36.5 72.6 56.9 103.4 8.5 443.3 93.4 4.9 128.2 23.3 0.0 42.6 0.9 2.8 413.3 56.3 18.8 79.5 364.0 SEMA3D "coll-2, Sema-Z2" ENSG00000153993 "Semaphorin 3D" O95025 7 84995553-85186855 "Predicted intracellular proteins, Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 33.8;thyroid gland: 33.0" "Cell type enhanced" "Detected in many" 20 "Early spermatids: 137.5;Leydig cells: 48.6;Peritubular cells: 58.7" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "amygdala: 17.1" "Cell type enriched" "Detected in single" 5 "naive B-cell: 2.0" "Lineage enriched" "Detected in single" 5 "B-cells: 2.0" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 17.0;HaCaT: 17.3;TIME: 26.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037522 Uncertain Approved "Golgi apparatus,Plasma membrane" "Secreted in other tissues" NA NA 77000 "Golgi apparatus" "Plasma membrane" "HPA037522: AB_10672494" "unprognostic (7.05e-2)" "unprognostic (1.24e-1)" "unprognostic (2.40e-1)" "unprognostic (1.44e-2)" "unprognostic (1.54e-1)" "unprognostic (2.51e-1)" "unprognostic (7.58e-3)" "unprognostic (4.02e-3)" "unprognostic (9.94e-2)" "unprognostic (5.62e-2)" "unprognostic (1.63e-1)" "unprognostic (9.46e-2)" "unprognostic (1.17e-2)" "unprognostic (1.26e-3)" "unprognostic (1.63e-1)" "unprognostic (2.75e-3)" "unprognostic (5.25e-3)" 4.1 2.2 17.1 1.9 2.3 0.1 4.3 0.8 2.8 4.6 2.9 1.8 2.5 1.4 1.9 7.4 1.3 3.9 1.4 2.0 3.6 2.7 3.0 1.0 3.6 6.1 2.4 3.1 4.1 0.8 0.4 1.5 0.6 5.4 6.2 2.6 2.6 5.6 2.9 0.7 2.1 2.7 3.2 4.8 33.8 2.4 4.3 2.5 0.0 33.0 0.6 1.1 4.7 3.9 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.3 4.6 5.0 5.4 2.6 0.0 0.0 0.0 1.4 17.0 0.1 17.3 1.9 0.0 3.6 0.0 3.5 0.0 2.0 0.0 0.0 0.0 0.0 0.1 0.0 0.9 4.4 6.3 8.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.3 4.5 1.2 5.5 4.0 1.7 0.0 0.1 0.6 0.0 0.0 0.2 8.9 0.2 0.0 26.5 0.0 1.7 0.2 0.0 3.3 1.9 0.0 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 17.1 2.3 0.8 2.2 3.6 2.7 2.4 3.1 5.4 2.5 0.0 3.5 0.8 2.3 3.2 1.5 0.8 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 137.5 5.2 0.0 0.0 0.2 0.0 6.7 7.1 2.3 0.0 0.9 1.6 25.4 1.8 0.0 14.9 48.6 0.8 11.8 0.0 0.0 0.9 0.0 0.0 58.7 4.5 4.1 0.0 2.1 0.7 0.7 2.0 0.0 0.0 0.1 0.4 SEMA6D "FLJ11598, KIAA1479" ENSG00000137872 "Semaphorin 6D" Q8NFY4 15 47184101-47774223 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 40.8;placenta: 36.7" "Cell type enhanced" "Detected in many" 12 "Alveolar cells type 1: 47.6;Cone photoreceptor cells: 108.0;Enterocytes: 37.0;Horizontal cells: 74.7" "Cancer enhanced" "Detected in many" "glioma: 8.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.9" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BJ hTERT+: 13.4;SCLC-21H: 11.9;SH-SY5Y: 11.0;SuSa: 13.2;U-266/70: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043109 Approved "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA 480000 "Plasma membrane" "Golgi apparatus" "HPA043109: AB_10793941" "unprognostic (2.00e-1)" "unprognostic (4.62e-2)" "unprognostic (3.10e-2)" "unprognostic (3.83e-3)" "unprognostic (1.38e-1)" "unprognostic (3.85e-2)" "unprognostic (1.98e-1)" "unprognostic (2.17e-3)" "unprognostic (1.24e-1)" "unprognostic (5.36e-2)" "unprognostic (7.96e-4)" "unprognostic (1.42e-1)" "prognostic favorable (5.96e-5)" "unprognostic (3.74e-2)" "unprognostic (8.56e-2)" "unprognostic (3.30e-3)" "unprognostic (2.39e-4)" 5.3 1.9 10.3 3.7 16.7 0.8 5.3 5.4 17.1 5.3 14.7 15.3 4.3 18.9 2.1 2.9 2.0 5.2 4.0 8.3 10.3 11.2 14.2 3.0 8.2 2.2 14.0 13.6 25.0 14.8 16.2 6.1 36.7 15.9 4.8 12.0 10.0 4.4 8.5 15.6 3.1 40.8 3.4 12.7 2.5 3.4 2.6 11.0 0.2 6.3 1.5 1.1 3.1 9.6 0.5 0.0 1.9 0.6 0.0 0.8 0.0 0.0 0.0 2.2 0.0 1.3 1.1 0.2 0.5 13.4 0.3 0.0 0.3 0.1 1.8 0.0 3.4 0.0 7.0 2.8 0.9 0.0 0.9 1.6 0.0 4.1 0.0 3.6 0.0 0.1 1.0 7.3 0.0 0.4 0.0 0.9 4.8 0.1 2.9 0.4 0.7 2.2 0.5 4.2 0.0 0.0 1.3 0.0 2.0 1.0 0.9 11.9 11.0 0.1 0.9 3.7 13.2 0.4 0.0 0.0 6.2 0.3 0.2 0.0 8.8 0.0 2.0 1.6 0.2 1.6 0.0 0.6 0.0 0.5 0.0 0.0 0.5 0.3 0.8 0.0 0.0 0.1 0.2 1.9 0.0 0.0 0.0 0.0 0.0 10.3 16.7 5.4 17.1 10.3 11.2 14.0 13.6 15.9 11.0 47.6 1.0 0.0 4.0 1.8 3.3 9.4 0.0 0.0 3.4 10.4 108.0 14.7 5.0 1.0 0.1 6.7 37.0 0.0 0.2 1.2 6.7 0.9 3.5 0.8 2.3 74.7 16.7 4.9 0.0 0.0 21.6 0.0 8.5 0.0 2.6 14.3 0.4 6.0 12.7 0.2 2.0 0.0 12.2 0.7 5.1 1.0 3.9 0.0 9.8 1.4 SERINC2 "FKSG84, PRO0899, TDE2, TDE2L" ENSG00000168528 "Serine incorporator 2" Q96SA4 1 31409565-31434680 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 113.9" "Cell type enhanced" "Detected in many" 7 "Ductal cells: 546.6;Enterocytes: 427.6;Pancreatic endocrine cells: 386.0;Syncytiotrophoblasts: 373.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "plasmacytoid DC: 12.0" "Lineage enriched" "Detected in many" 4 "dendritic cells: 12.0" "Cell line enhanced" "Detected in many" "CAPAN-2: 47.3;HaCaT: 53.9;HBEC3-KT: 85.2;hTCEpi: 48.5;RT4: 58.3;SK-BR-3: 48.8" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA005974 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005974: AB_10603239" "unprognostic (1.41e-1)" "unprognostic (3.70e-3)" "unprognostic (8.78e-3)" "prognostic favorable (1.69e-7)" "unprognostic (6.78e-2)" "unprognostic (5.31e-2)" "prognostic unfavorable (2.11e-4)" "prognostic unfavorable (5.70e-4)" "unprognostic (3.12e-2)" "unprognostic (3.19e-2)" "unprognostic (1.11e-2)" "unprognostic (1.09e-2)" "unprognostic (3.74e-2)" "unprognostic (1.39e-1)" "unprognostic (2.48e-1)" "unprognostic (4.63e-3)" "unprognostic (2.67e-2)" 2.0 6.6 0.6 13.5 1.2 1.1 12.1 0.8 0.8 17.3 32.9 0.8 52.1 27.4 3.7 26.5 32.5 4.3 34.4 2.0 1.0 0.6 57.5 113.9 10.3 7.1 1.8 0.5 1.7 12.9 5.7 5.1 33.9 1.4 17.0 12.8 5.0 58.6 74.4 20.2 14.2 73.0 6.7 1.2 1.7 20.7 3.5 0.8 5.7 13.1 12.7 19.1 31.1 19.9 0.2 12.0 2.3 2.7 0.0 0.0 0.5 13.0 3.1 2.7 8.9 6.0 8.1 7.6 25.2 18.7 1.6 2.0 4.7 47.3 8.6 33.2 23.6 2.0 53.9 0.3 85.2 0.3 0.8 2.0 0.0 2.7 2.4 6.8 0.0 10.1 7.4 48.5 10.4 22.9 7.2 1.0 1.0 0.3 0.0 2.8 2.1 0.3 0.3 2.8 26.1 6.6 0.0 5.4 2.9 9.0 58.3 1.2 6.7 6.4 48.8 1.0 1.4 28.5 1.5 6.2 0.4 2.1 0.2 0.5 0.4 0.3 0.4 0.2 0.2 2.1 0.0 2.7 2.3 0.0 0.8 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.1 12.0 0.0 0.5 0.6 1.2 0.8 0.8 1.0 0.6 1.8 0.5 1.4 0.8 14.9 6.2 0.5 97.8 11.0 0.0 0.6 127.4 8.1 21.6 111.7 0.0 323.0 61.3 546.6 3.9 4.4 427.6 0.0 288.5 86.2 3.3 137.4 0.0 45.6 43.7 0.0 111.9 8.6 7.6 6.6 2.0 6.8 38.8 83.8 168.4 0.6 386.0 170.9 0.0 57.4 0.0 0.0 1.4 0.6 3.6 18.4 373.5 0.0 116.2 257.8 SERPINB3 "HsT1196, SCC, SCCA1, T4-A" ENSG00000057149 "Serpin family B member 3" P29508 18 63655197-63661963 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "cervix, uterine: 50.7;esophagus: 140.0;vagina: 80.0" "Group enriched" "Detected in some" 8 "Ciliated cells: 141.8;Club cells: 465.2;Urothelial cells: 238.3" "Cancer enhanced" "Detected in many" "cervical cancer: 186.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.6;HaCaT: 9.1;HBEC3-KT: 2.2;SiHa: 5.6;U-2197: 11.6" "CAB018772, CAB036006, CAB036007, HPA048341, HPA049988, HPA055992" Enhanced Approved "Plasma membrane,Cytosol" NA NA 11000000 Cytosol "Plasma membrane" "CAB018772: AB_2285759, CAB036006: , CAB036007: , HPA048341: AB_2680364, HPA049988: AB_2680985, HPA055992: AB_2682998" "unprognostic (2.95e-3)" "unprognostic (1.66e-1)" "unprognostic (2.03e-1)" "unprognostic (2.91e-2)" "unprognostic (2.11e-1)" "prognostic unfavorable (3.19e-4)" "unprognostic (6.68e-2)" "unprognostic (2.58e-1)" "unprognostic (4.19e-3)" 0.2 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 50.7 0.2 0.2 0.2 0.0 3.8 0.2 140.0 0.0 0.2 0.2 0.2 0.0 0.2 0.2 5.4 0.2 0.2 0.2 0.2 0.2 0.0 2.4 0.2 0.2 1.1 0.0 0.2 13.0 0.2 0.2 7.1 0.2 0.2 0.2 0.2 0.0 0.2 0.2 1.4 0.2 21.3 3.1 13.1 80.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.1 0.2 9.1 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 11.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 10.3 0.0 15.8 0.0 0.0 0.0 0.0 141.8 465.2 0.0 0.0 0.0 0.0 3.7 24.6 0.0 0.0 0.0 7.4 0.0 0.0 36.6 2.3 0.0 0.1 0.0 0.0 0.0 0.0 33.0 1.1 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 238.3 SH3BGR 21-GARP ENSG00000185437 "SH3 domain binding glutamate rich protein" P55822 21 39445855-39515506 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 219.7" "Cell type enhanced" "Detected in many" 14 "Cardiomyocytes: 161.5;Early spermatids: 91.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 11.5" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 15.6;U-87 MG: 48.5" "Group enriched" "Detected in many" 5 "cerebellum: 34.0;midbrain: 14.7;olfactory region: 12.3;pons and medulla: 29.7" "Low region specificity" "Detected in all" "CAB003685, HPA030690" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB003685: AB_425682, HPA030690: AB_2673570" "unprognostic (3.41e-2)" "unprognostic (1.26e-1)" "unprognostic (5.84e-3)" "unprognostic (1.68e-3)" "unprognostic (6.05e-2)" "unprognostic (6.12e-3)" "unprognostic (3.89e-2)" "unprognostic (9.78e-2)" "unprognostic (2.06e-1)" "unprognostic (6.97e-3)" "unprognostic (3.59e-2)" "unprognostic (4.75e-1)" "unprognostic (5.98e-3)" "unprognostic (7.16e-2)" "unprognostic (4.60e-2)" "unprognostic (1.68e-2)" "unprognostic (2.06e-2)" 2.4 5.2 7.2 1.2 7.3 0.9 2.9 1.1 4.3 2.9 6.1 3.0 2.0 1.9 2.1 6.6 5.3 2.1 5.0 30.0 6.6 5.4 3.2 2.8 1.5 0.9 7.5 5.0 1.8 2.8 2.1 4.5 1.1 6.1 5.8 2.0 1.2 3.2 5.2 219.7 0.9 1.4 12.4 7.9 1.2 2.9 3.7 5.9 0.1 3.9 41.5 2.2 7.3 8.6 2.7 11.5 2.6 1.7 2.8 4.0 1.2 1.1 1.3 1.7 2.5 3.8 4.4 0.5 2.0 0.9 0.9 0.7 0.7 2.2 3.4 5.2 5.1 7.0 0.1 0.9 1.5 1.4 2.0 3.5 3.4 0.6 1.4 7.7 1.2 0.7 3.6 6.3 3.2 6.4 3.2 1.0 6.5 2.6 4.4 3.6 4.1 2.2 2.0 1.7 2.9 2.9 3.6 6.5 2.1 4.7 0.8 5.0 2.1 3.0 2.4 3.1 1.6 9.2 0.6 0.8 2.6 0.3 1.5 3.8 15.6 3.3 3.4 48.5 3.0 3.3 2.3 0.7 0.0 1.2 1.7 3.1 2.7 1.1 1.8 1.9 1.4 4.0 3.0 2.6 2.8 1.7 11.5 0.7 1.2 7.2 7.3 1.1 4.3 6.6 5.4 7.5 5.0 6.1 5.9 3.0 3.8 0.9 6.0 2.4 2.1 161.5 5.1 5.3 2.3 5.2 3.9 3.1 39.7 3.5 91.7 1.8 1.3 0.0 19.1 1.3 3.5 3.4 4.6 6.4 2.2 4.8 1.2 1.8 2.1 20.4 2.0 1.3 11.8 1.8 1.9 14.0 5.8 1.9 5.3 11.9 6.1 6.5 27.4 23.3 21.1 1.5 1.6 1.9 3.2 4.8 SH3D21 "C1orf113, FLJ22938" ENSG00000214193 "SH3 domain containing 21" A4FU49 1 36306387-36324886 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "thyroid gland: 26.2" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 13.1;Late spermatids: 38.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.0;NK-cell: 2.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HaCaT: 13.5;hTERT-RPE1: 22.0;SuSa: 11.2" "HPA042212, HPA042456, HPA066168" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA042212: AB_10961180, HPA042456: AB_10959746, HPA066168: AB_2685627" "prognostic favorable (2.60e-4)" "unprognostic (8.35e-3)" "unprognostic (3.86e-3)" "unprognostic (9.01e-2)" "unprognostic (2.07e-3)" "unprognostic (7.32e-3)" "unprognostic (2.04e-4)" "unprognostic (7.47e-2)" "unprognostic (3.47e-2)" "unprognostic (1.01e-1)" "unprognostic (2.43e-2)" "unprognostic (7.38e-3)" "prognostic unfavorable (1.76e-6)" "unprognostic (8.88e-2)" "unprognostic (2.25e-1)" "unprognostic (7.99e-2)" "unprognostic (8.59e-2)" 1.6 1.1 11.6 3.4 9.5 1.9 10.1 12.2 11.3 4.4 5.3 1.1 1.4 16.6 2.8 2.7 7.1 1.9 3.0 2.2 5.2 2.2 8.6 1.4 4.5 2.8 1.9 7.0 4.0 1.0 1.3 2.2 19.4 7.4 7.0 6.0 12.4 12.7 2.6 1.0 16.2 24.3 2.0 2.4 1.6 2.3 6.6 1.9 0.0 26.2 4.1 4.5 3.7 6.7 0.1 0.3 2.0 0.5 2.7 0.6 0.0 8.3 0.2 1.6 1.9 0.5 1.0 9.1 4.0 0.8 3.0 1.3 4.7 3.4 1.5 4.4 1.7 0.3 13.5 1.4 3.0 2.5 0.4 0.6 1.3 2.9 3.7 1.3 0.7 2.0 0.5 2.5 2.0 1.5 22.0 1.1 4.1 0.2 2.6 1.4 4.9 1.4 0.7 1.0 2.2 1.6 2.0 0.1 1.0 3.4 1.0 3.4 1.7 0.9 10.1 3.1 11.2 0.3 0.3 2.3 1.2 0.7 4.0 0.4 3.0 0.9 1.7 3.4 0.7 0.3 0.0 0.5 0.0 0.4 0.0 0.0 0.1 0.6 0.0 0.3 0.0 0.0 0.0 2.0 2.7 0.0 0.0 0.0 0.0 11.6 9.5 12.2 11.3 5.2 2.2 1.9 7.0 7.4 1.9 0.0 1.3 0.8 1.5 2.7 5.2 0.9 0.0 0.0 0.0 5.2 0.0 2.5 1.7 0.5 13.1 0.9 11.8 0.0 0.3 2.1 1.4 2.0 1.1 0.0 7.0 11.1 0.0 0.6 3.2 38.8 1.1 4.7 3.3 3.6 2.0 1.0 2.7 0.8 2.5 0.8 1.1 0.0 1.7 2.1 1.5 2.8 4.8 0.0 1.6 1.1 SHANK3 "KIAA1650, prosap2, PSAP2, SPANK-2" ENSG00000251322 "SH3 and multiple ankyrin repeat domains 3" 22 50674415-50733298 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.4" "Cell type enriched" "Detected in some" 5 "Ito cells: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.4;TIME: 10.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003446 Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA003446: AB_1079958" "unprognostic (3.62e-1)" "unprognostic (1.08e-2)" "prognostic unfavorable (7.40e-4)" "unprognostic (6.02e-2)" "unprognostic (4.17e-1)" "unprognostic (1.72e-3)" "unprognostic (3.41e-2)" "unprognostic (3.13e-1)" "unprognostic (9.67e-2)" "unprognostic (5.62e-2)" "unprognostic (2.09e-2)" "unprognostic (7.52e-2)" "unprognostic (2.47e-2)" "unprognostic (7.81e-2)" "unprognostic (1.19e-1)" "unprognostic (4.89e-2)" "unprognostic (1.41e-1)" 9.5 5.4 23.5 1.3 26.1 2.6 8.7 13.0 32.4 3.5 2.0 2.4 0.1 5.2 3.8 3.4 2.5 2.8 1.1 4.4 21.6 2.4 2.9 5.1 5.3 2.9 2.5 18.1 1.6 7.6 7.9 1.0 1.7 2.6 1.9 1.9 0.6 8.5 3.4 3.6 3.1 6.6 1.5 2.0 12.3 1.3 3.4 6.4 0.2 4.1 1.4 2.6 5.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.5 0.9 0.6 2.9 0.5 0.5 0.0 0.6 0.0 0.2 0.0 0.6 1.7 0.0 1.2 0.2 1.7 0.6 0.9 0.4 0.0 0.0 0.0 6.4 0.4 1.7 1.5 0.8 0.3 1.6 1.1 0.1 0.3 0.1 2.0 0.7 0.1 0.1 0.1 0.9 0.5 0.2 1.3 0.7 1.8 1.7 0.0 0.7 0.3 0.5 1.3 1.9 1.7 0.0 0.8 0.4 0.3 0.4 10.2 0.2 1.7 0.7 0.4 0.1 0.1 0.0 0.1 0.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.5 26.1 13.0 32.4 21.6 2.4 2.5 18.1 2.6 6.4 0.0 1.4 0.0 0.0 0.2 0.5 19.6 0.0 1.4 1.2 0.0 0.0 0.0 0.0 0.0 1.8 16.8 0.0 0.0 0.0 0.0 0.2 0.1 0.0 5.6 0.3 0.0 2.4 90.2 5.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.1 0.0 0.4 0.7 0.0 0.0 0.9 0.2 0.4 0.3 0.0 0.0 0.0 0.3 SHISA6 FLJ45455 ENSG00000188803 "Shisa family member 6" Q6ZSJ9 17 11241263-11564063 "Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.6;cervix, uterine: 22.4" "Group enriched" "Detected in some" 4 "Late spermatids: 9.9;Peritubular cells: 27.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 22 "OE19: 34.1" "Low region specificity" "Detected in many" HPA023440 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA023440: AB_1848945" "unprognostic (1.70e-1)" "unprognostic (2.78e-2)" "unprognostic (1.44e-1)" "unprognostic (2.39e-3)" "prognostic unfavorable (8.41e-4)" "unprognostic (3.11e-2)" "unprognostic (1.71e-1)" "unprognostic (8.80e-2)" "unprognostic (1.84e-1)" "unprognostic (1.11e-1)" "unprognostic (9.63e-2)" "unprognostic (1.27e-1)" "unprognostic (2.40e-4)" "unprognostic (1.14e-1)" "unprognostic (1.32e-1)" "unprognostic (4.20e-2)" "unprognostic (2.47e-2)" 2.2 0.7 5.8 0.6 5.5 0.2 1.2 9.8 7.5 22.4 0.9 2.5 1.9 0.4 4.2 2.4 0.9 1.7 0.5 1.1 12.1 9.9 2.5 0.2 1.5 0.2 11.8 2.9 0.6 1.4 6.0 0.0 0.3 13.6 5.9 0.8 0.8 0.2 10.1 1.0 0.5 0.4 1.2 9.6 0.2 6.0 2.9 2.1 0.0 0.7 0.0 0.2 0.6 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 34.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 5.5 9.8 4.9 12.1 9.9 11.8 2.9 13.6 2.1 0.0 0.0 0.0 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.2 0.0 0.0 0.0 0.0 0.2 1.1 0.0 0.0 0.1 0.0 1.2 0.0 0.0 9.9 4.6 0.0 1.7 0.0 0.0 0.4 0.0 0.0 27.3 0.0 0.1 0.0 0.1 0.5 1.9 0.1 0.0 0.0 0.0 0.1 SIGLEC14 ENSG00000254415 "Sialic acid binding Ig like lectin 14" Q08ET2 19 51642553-51646801 "Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 48.7;bone marrow: 13.3;lymphoid tissue: 21.6" "Cell type enhanced" "Detected in some" 22 "Hofbauer cells: 16.1;Kupffer cells: 31.5;Macrophages: 9.8" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "classical monocyte: 25.8;intermediate monocyte: 29.7;myeloid DC: 15.9;neutrophil: 48.7;non-classical monocyte: 21.3" "Group enriched" "Detected in many" 6 "dendritic cells: 15.9;granulocytes: 48.7;monocytes: 29.7" "Cell line enriched" "Detected in some" 4 "HMC-1: 47.5" "HPA014377, HPA014428" Uncertain Uncertain "Vesicles,Plasma membrane" NA NA 18000000 Vesicles "Plasma membrane" "HPA014377: AB_2189277, HPA014428: " "unprognostic (3.05e-1)" "unprognostic (1.75e-1)" "unprognostic (6.47e-3)" "unprognostic (1.60e-1)" "unprognostic (3.83e-2)" "unprognostic (1.50e-2)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (9.77e-3)" "unprognostic (9.28e-2)" "unprognostic (6.73e-2)" "unprognostic (1.02e-1)" "unprognostic (4.28e-3)" "unprognostic (8.38e-2)" "unprognostic (4.17e-2)" "unprognostic (1.34e-1)" "unprognostic (1.89e-1)" 1.6 1.6 0.6 13.0 0.5 13.3 0.5 0.0 0.3 0.6 0.6 0.0 0.4 0.0 0.2 1.7 1.0 0.8 0.6 0.6 0.4 1.4 5.1 6.2 1.3 0.1 0.3 0.0 0.1 0.9 0.4 0.4 0.7 0.1 0.0 0.0 4.0 0.9 1.9 21.6 0.7 1.3 0.2 7.0 2.2 0.2 4.9 15.9 48.7 29.7 0.1 0.0 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.7 47.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.0 3.6 25.8 0.4 0.0 29.7 0.0 4.9 0.0 0.0 15.9 4.8 0.0 0.0 48.7 0.1 21.3 2.9 0.0 7.6 0.0 1.4 0.9 0.0 0.0 0.0 0.1 2.5 1.4 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.2 16.1 0.0 0.0 0.0 31.5 0.0 0.3 9.8 0.0 1.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 SIGLEC6 "CD327, CD33L, CD33L1, OB-BP1, SIGLEC-6" ENSG00000105492 "Sialic acid binding Ig like lectin 6" O43699 19 51519525-51531856 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "placenta: 87.4" "Group enriched" "Detected in some" 12 "Cytotrophoblasts: 56.9;granulocytes: 52.1;Syncytiotrophoblasts: 157.8" "Cancer enhanced" "Detected in some" "thyroid cancer: 2.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "memory B-cell: 6.5;plasmacytoid DC: 6.8" "Group enriched" "Detected in many" 33 "B-cells: 6.5;dendritic cells: 6.8;granulocytes: 2.3" "Cell line enriched" "Detected in some" 7 "HMC-1: 103.0" "HPA008945, HPA009084, HPA018198" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane, Cytosol" "HPA008945: , HPA009084: AB_1079967, HPA018198: AB_1856868" "unprognostic (1.97e-1)" "unprognostic (1.41e-1)" "unprognostic (2.38e-3)" "unprognostic (9.31e-3)" "unprognostic (8.46e-4)" "unprognostic (2.91e-1)" "unprognostic (2.02e-2)" "unprognostic (2.64e-1)" "unprognostic (8.96e-2)" "unprognostic (2.03e-1)" "unprognostic (6.89e-2)" "unprognostic (1.10e-2)" "unprognostic (4.15e-2)" "unprognostic (4.42e-2)" "unprognostic (3.28e-2)" "unprognostic (5.57e-3)" 1.8 0.0 0.0 5.6 0.0 0.1 0.8 0.0 0.1 1.2 1.7 0.0 0.3 0.9 2.0 1.2 1.5 0.5 8.6 0.4 0.0 0.0 0.4 0.1 4.2 1.5 0.0 0.0 0.1 0.3 0.1 0.1 87.4 0.0 3.7 1.5 0.5 1.4 1.0 0.2 1.3 6.0 3.1 0.0 1.3 1.7 1.0 0.0 0.3 0.2 1.0 2.6 2.2 1.9 6.5 6.8 2.3 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.8 0.0 0.0 0.0 0.2 103.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 2.3 0.0 0.0 0.0 0.0 0.0 6.5 0.0 0.0 1.4 2.8 0.0 0.0 0.0 0.1 0.0 6.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 56.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.1 0.0 52.1 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.8 0.0 0.0 0.0 SIGLEC7 "CD328, p75/AIRM1, QA79, SIGLEC-7, SIGLEC19P, SIGLECP2" ENSG00000168995 "Sialic acid binding Ig like lectin 7" Q9Y286 19 51142299-51153526 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 51.5;lymphoid tissue: 29.4" "Group enriched" "Detected in some" 5 "Hofbauer cells: 29.4;Kupffer cells: 51.3;Macrophages: 24.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "eosinophil: 51.5" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 9 "Karpas-707: 31.5;RPMI-8226: 18.3;U-937: 19.4" HPA075513 Approved "Vesicles,Plasma membrane" "Intracellular and membrane" NA NA 1100000 "Plasma membrane" Vesicles "HPA075513: " "unprognostic (3.14e-1)" "unprognostic (5.87e-2)" "unprognostic (1.03e-1)" "unprognostic (2.66e-1)" "unprognostic (3.90e-2)" "unprognostic (1.85e-1)" "unprognostic (2.53e-1)" "unprognostic (2.78e-1)" "unprognostic (1.69e-1)" "unprognostic (4.95e-2)" "unprognostic (1.10e-1)" "unprognostic (2.66e-1)" "unprognostic (8.27e-2)" "unprognostic (6.61e-2)" "unprognostic (1.14e-3)" "unprognostic (2.58e-1)" "unprognostic (2.26e-2)" 6.9 3.7 1.6 10.0 5.8 3.7 3.0 0.3 2.2 0.9 1.6 1.0 0.6 1.4 0.9 2.1 1.1 1.8 2.4 1.9 0.8 1.0 2.8 9.8 4.7 18.4 3.3 0.0 1.3 0.9 0.2 0.9 5.9 2.9 1.0 2.3 0.7 2.3 0.2 0.4 0.5 2.3 3.5 3.3 29.4 1.1 1.8 2.5 0.7 1.0 0.0 2.1 3.2 1.7 0.6 14.9 51.5 32.0 20.0 4.4 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 31.5 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.6 0.6 0.0 0.1 19.4 0.0 0.5 32.0 51.5 2.5 23.0 4.4 0.6 0.0 1.1 14.9 0.0 0.0 1.0 26.8 20.0 9.1 0.6 0.0 15.8 1.6 5.8 0.3 2.2 0.8 1.0 3.3 0.0 2.9 2.5 0.0 2.1 1.4 0.0 0.1 0.0 0.0 0.0 1.4 1.2 1.8 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.1 0.6 29.4 0.0 0.0 7.4 51.3 0.0 1.4 24.5 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 2.2 0.0 0.0 SIN3B KIAA0700 ENSG00000127511 "SIN3 transcription regulator family member B" O75182 19 16829400-16880353 "Predicted intracellular proteins" "Transcription, Transcription regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Peritubular cells: 62.6;Syncytiotrophoblasts: 104.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050329 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA050329: AB_2681089" "unprognostic (2.71e-3)" "unprognostic (8.89e-2)" "unprognostic (1.32e-3)" "unprognostic (6.22e-2)" "unprognostic (1.24e-1)" "unprognostic (2.05e-2)" "unprognostic (5.44e-2)" "unprognostic (9.89e-2)" "unprognostic (5.42e-3)" "unprognostic (2.77e-1)" "prognostic favorable (4.37e-4)" "prognostic unfavorable (3.58e-4)" "unprognostic (1.18e-3)" "unprognostic (8.45e-2)" "unprognostic (1.49e-1)" "unprognostic (9.36e-2)" "unprognostic (1.06e-1)" 19.1 17.9 22.2 17.2 28.1 9.8 21.5 25.1 38.6 24.4 16.0 20.8 50.0 12.8 37.5 21.5 14.5 23.3 17.3 15.7 24.2 20.8 15.9 9.8 21.7 20.8 16.5 30.4 32.5 16.2 60.8 17.7 53.2 24.8 22.7 11.0 15.5 20.2 54.7 17.1 22.7 17.7 26.5 14.8 25.1 13.7 30.2 13.4 9.3 22.5 9.6 15.8 17.2 22.2 4.8 2.6 6.1 6.7 1.9 2.0 2.3 14.7 7.9 13.4 17.2 11.1 10.2 42.4 12.6 10.4 17.5 15.6 19.4 13.9 13.3 14.1 14.5 14.8 12.7 11.1 11.3 16.2 13.8 20.0 14.2 17.3 8.8 14.6 8.3 11.5 16.8 14.9 11.7 10.1 13.9 15.8 10.7 11.5 8.2 12.2 17.7 11.2 13.4 16.6 7.7 25.4 14.9 12.3 8.7 9.9 12.6 9.9 12.4 15.9 12.3 9.9 18.8 8.6 7.8 20.7 17.0 10.4 24.5 14.0 11.8 8.6 13.3 11.8 10.9 12.6 0.1 6.7 6.1 1.8 6.0 1.2 4.8 1.7 2.0 2.1 3.8 2.0 1.4 3.3 1.9 5.3 2.6 0.5 2.3 22.2 28.1 25.1 38.6 24.2 20.8 16.5 30.4 24.8 13.4 20.8 14.8 10.7 8.6 7.0 18.1 6.9 2.5 5.3 7.9 3.5 13.7 17.1 3.3 9.2 7.9 11.7 4.7 0.0 7.4 24.5 8.6 10.0 4.7 5.6 15.1 9.5 4.7 8.0 13.0 18.2 46.9 6.6 5.0 10.0 7.9 8.7 12.5 3.5 62.6 4.5 15.7 6.5 6.6 9.3 10.4 7.0 104.5 6.4 5.8 11.2 SIPA1L1 "E6TP1, KIAA0440" ENSG00000197555 "Signal induced proliferation associated 1 like 1" O43166 14 71320449-71741229 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 18.7" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-138 MG: 41.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002875, HPA077689" Approved Enhanced "Plasma membrane,Actin filaments" NA NA "Plasma membrane" "Actin filaments" "HPA002875: AB_1079974, HPA077689: " "unprognostic (1.50e-3)" "unprognostic (2.99e-1)" "unprognostic (3.34e-2)" "unprognostic (5.64e-3)" "unprognostic (4.19e-2)" "unprognostic (4.14e-1)" "unprognostic (7.89e-2)" "unprognostic (4.86e-2)" "unprognostic (3.09e-1)" "unprognostic (8.62e-2)" "unprognostic (2.61e-1)" "unprognostic (5.27e-2)" "prognostic favorable (6.80e-8)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.42e-1)" "unprognostic (7.03e-2)" 4.5 12.0 27.1 8.2 36.4 7.8 6.8 21.7 35.7 7.7 8.9 5.3 1.0 7.6 5.4 8.7 11.2 10.6 11.8 2.4 17.5 10.4 11.7 9.3 8.6 7.6 8.1 23.9 3.6 9.5 23.6 13.0 3.6 10.1 6.2 9.0 7.3 7.6 6.9 2.2 6.4 8.0 8.0 6.8 18.1 13.8 14.5 7.2 3.1 11.0 3.2 11.5 7.7 4.8 6.8 1.0 18.7 5.3 1.6 3.3 1.6 10.4 3.3 7.6 5.7 2.3 6.7 13.9 14.3 17.0 5.8 7.4 18.9 5.9 4.9 3.7 23.3 5.3 10.4 5.5 12.8 11.1 4.4 2.6 10.3 21.6 4.4 19.3 1.2 4.0 4.8 10.8 9.0 21.3 6.6 6.2 6.9 4.5 12.4 7.9 15.8 4.1 1.1 4.3 9.6 9.0 6.1 8.2 5.2 4.2 16.2 9.5 25.3 14.6 11.5 1.0 5.1 6.8 0.5 17.1 41.7 15.4 4.7 8.1 10.1 11.4 7.3 7.1 3.4 13.8 4.0 4.0 0.8 1.5 4.7 3.3 2.6 1.3 2.0 1.0 6.8 0.9 1.0 18.7 1.6 5.3 0.3 1.2 1.6 27.1 36.4 21.7 35.7 17.5 10.4 8.1 23.9 10.1 7.2 62.5 26.2 15.9 13.3 10.5 18.4 4.7 20.4 41.5 25.0 14.0 17.7 6.5 11.6 19.2 55.7 10.5 16.7 0.0 17.6 7.2 9.7 8.7 12.8 15.3 4.8 55.6 31.2 4.9 19.1 22.9 7.2 29.8 5.0 36.1 16.2 65.5 16.4 14.0 33.2 23.3 13.7 0.0 12.2 23.2 34.3 7.3 7.9 13.8 22.1 23.8 SLAMF6 "CD352, KALI, KALIb, Ly108, NTB-A, NTBA, SF2000" ENSG00000162739 "SLAM family member 6" Q96DU3 1 160485030-160523262 "CD markers, Predicted membrane proteins" "Adaptive immunity, Immunity, Innate immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 51.9" "Cell type enhanced" "Detected in some" 15 "B-cells: 8.3;Early spermatids: 9.3;Late spermatids: 16.5;T-cells: 20.8" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 5 "Daudi: 33.3;U-698: 49.0" "HPA051363, HPA051903" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA051363: AB_2681454, HPA051903: AB_2681658" "prognostic favorable (9.42e-4)" "prognostic favorable (2.78e-4)" "unprognostic (8.65e-2)" "prognostic favorable (9.53e-4)" "unprognostic (5.85e-2)" "prognostic favorable (7.34e-5)" "unprognostic (3.16e-3)" "unprognostic (9.78e-2)" "prognostic favorable (1.25e-4)" "unprognostic (2.31e-3)" "unprognostic (2.09e-1)" "unprognostic (1.57e-1)" "prognostic unfavorable (2.09e-6)" "unprognostic (2.78e-1)" "unprognostic (1.01e-1)" "unprognostic (2.33e-2)" "unprognostic (8.21e-3)" 3.9 0.8 0.4 21.0 0.4 1.2 1.0 0.4 0.4 1.1 3.8 0.3 0.4 1.1 1.0 0.6 2.3 1.6 2.8 1.2 0.4 0.4 2.1 1.6 4.7 51.9 0.6 0.4 0.6 0.8 0.0 0.6 1.7 0.7 1.4 1.5 1.5 5.6 1.0 0.5 0.7 11.9 0.4 0.8 29.6 2.3 0.9 0.2 12.9 1.8 0.6 30.4 4.1 1.3 15.2 0.3 8.4 1.0 15.9 28.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 2.5 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.3 0.0 0.0 0.0 8.0 0.5 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 5.2 49.0 0.0 0.2 0.0 2.5 0.1 8.4 22.9 0.3 15.8 14.7 14.6 28.6 0.1 15.2 8.2 16.4 1.0 15.9 1.0 0.3 16.8 7.4 0.4 0.4 0.4 0.4 0.4 0.4 0.6 0.4 0.7 0.2 0.0 2.2 8.3 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.2 0.0 0.0 0.2 1.1 0.8 0.9 0.0 0.0 3.7 3.8 16.5 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 20.8 0.0 0.0 SLC12A2 "BSC, BSC2, NKCC1, PPP1R141" ENSG00000064651 "Solute carrier family 12 member 2" P55011 5 128083766-128189688 "FDA approved drug targets, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Symport, Transport" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 50.7;salivary gland: 61.2" "Cell type enhanced" "Detected in many" 8 "Glandular cells: 203.2;Mucus-secreting cells: 402.7;Undifferentiated cells: 269.5" "Cancer enhanced" "Detected in all" "colorectal cancer: 54.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 9.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 55.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020130, HPA063697" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA020130: AB_1854502, HPA063697: AB_2685094" "unprognostic (4.61e-2)" "unprognostic (2.63e-1)" "unprognostic (4.20e-3)" "prognostic favorable (8.60e-4)" "unprognostic (3.99e-1)" "unprognostic (5.65e-3)" "unprognostic (1.44e-3)" "unprognostic (1.81e-1)" "unprognostic (3.30e-1)" "unprognostic (2.95e-2)" "unprognostic (7.22e-2)" "unprognostic (1.39e-1)" "prognostic favorable (7.09e-4)" "unprognostic (1.63e-1)" "unprognostic (2.30e-1)" "unprognostic (3.79e-1)" "unprognostic (3.88e-3)" 5.5 11.0 10.8 9.4 24.1 2.7 26.2 11.4 18.1 5.1 28.5 37.2 0.0 24.6 5.7 1.9 3.8 4.1 50.7 4.1 15.5 9.9 4.5 2.9 6.5 3.5 36.1 13.5 5.6 5.3 11.2 5.5 3.3 30.0 14.8 36.3 8.5 61.2 2.1 8.5 23.0 28.8 6.6 27.7 2.9 36.3 5.5 26.7 2.0 5.6 6.8 18.3 4.2 3.6 3.6 9.8 0.5 1.2 3.6 3.0 0.4 4.8 24.1 24.8 9.6 6.2 4.0 5.1 4.5 3.4 3.2 3.4 9.6 7.7 7.2 6.1 3.9 2.9 14.7 4.7 5.2 5.0 7.2 5.9 2.0 4.3 1.4 1.9 2.6 3.6 4.2 1.9 7.2 4.3 2.4 5.3 3.1 3.3 4.9 5.0 5.1 4.6 2.2 2.9 55.9 7.9 2.5 7.0 2.9 3.8 16.5 4.4 2.8 9.1 4.0 3.5 2.8 2.2 1.3 8.8 8.1 5.4 6.1 5.7 4.1 3.7 8.0 4.2 1.5 6.5 0.5 0.7 0.2 1.9 1.2 3.0 2.7 1.8 2.3 0.9 3.6 2.0 2.7 0.3 3.6 0.8 9.8 1.6 0.4 10.8 24.1 11.4 18.1 15.5 9.9 36.1 13.5 30.0 26.7 14.9 37.4 13.4 18.3 20.4 45.1 14.0 99.3 10.7 38.7 31.4 119.8 0.9 1.7 45.3 45.7 23.6 29.9 0.0 41.4 2.1 14.8 203.2 18.4 7.4 3.6 76.3 71.5 6.7 7.3 70.8 79.1 10.2 194.0 0.0 402.7 27.8 49.2 77.2 27.3 9.6 76.9 71.1 24.5 27.0 21.5 26.2 1.1 12.1 269.5 16.9 SLC16A1 "MCT, MCT1" ENSG00000155380 "Solute carrier family 16 member 1" P53985 1 112911847-112957013 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 149.2;Muller glia cells: 221.8;Rod photoreceptor cells: 246.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003324, CAB017489, HPA071055, CAB079035" Enhanced Supported Enhanced "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337" "unprognostic (1.19e-1)" "unprognostic (1.61e-2)" "unprognostic (2.97e-1)" "prognostic unfavorable (8.37e-6)" "unprognostic (1.53e-1)" "unprognostic (2.89e-2)" "unprognostic (2.15e-3)" "prognostic unfavorable (4.05e-4)" "unprognostic (6.92e-2)" "unprognostic (6.31e-3)" "prognostic unfavorable (2.10e-4)" "unprognostic (1.18e-1)" "prognostic unfavorable (6.78e-8)" "unprognostic (1.30e-1)" "unprognostic (2.31e-1)" "unprognostic (1.04e-2)" "unprognostic (1.53e-3)" 11.6 7.2 17.4 8.7 19.5 3.1 4.4 10.0 24.0 4.6 23.4 12.7 3.3 18.4 19.3 15.1 10.4 8.7 8.3 39.0 19.5 12.3 6.5 26.9 3.2 5.8 19.2 6.5 6.0 1.9 5.6 3.7 18.8 16.6 8.3 18.1 22.8 2.5 6.5 31.4 7.5 9.5 20.0 16.1 4.8 14.5 17.9 22.5 4.9 5.4 17.7 6.2 9.6 6.2 3.0 5.9 0.6 3.2 2.0 11.4 2.4 20.2 4.7 14.6 12.4 10.1 8.6 48.0 10.9 8.3 8.6 13.9 16.0 11.8 22.2 15.3 9.9 6.4 19.4 20.4 20.3 16.3 13.9 20.7 18.2 12.9 18.6 17.9 23.2 1.9 12.0 24.9 12.7 25.0 13.9 20.8 11.6 23.0 14.8 9.6 3.9 13.6 11.7 47.2 5.6 15.2 12.2 23.0 15.3 10.6 0.4 16.2 8.5 21.2 0.6 16.2 21.9 0.9 8.8 14.0 8.3 14.6 16.3 16.1 7.8 6.8 22.4 24.1 14.7 10.2 0.6 3.2 0.0 4.1 2.6 6.3 3.0 4.1 4.4 5.9 2.1 4.4 3.8 0.3 2.0 0.7 1.0 11.4 2.4 17.4 19.5 10.0 24.0 19.5 12.3 19.2 6.5 16.6 22.5 0.0 1.6 15.2 6.7 79.3 17.1 109.7 5.1 0.0 1.2 0.0 149.2 57.9 0.0 2.0 102.1 20.4 27.6 0.0 2.9 62.5 30.5 13.5 9.2 34.7 13.7 19.1 3.4 8.0 9.1 75.6 10.9 4.8 37.1 1.8 14.9 221.8 5.1 5.7 7.1 10.2 246.9 0.0 20.6 35.1 10.2 34.5 38.4 6.9 13.6 0.9 SLC16A3 "MCT3, MCT4" ENSG00000141526 "Solute carrier family 16 member 3" O15427 17 82228397-82261129 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.2" "Cell type enhanced" "Detected in many" 18 "Extravillous trophoblasts: 1393.3;Syncytiotrophoblasts: 626.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "CAB017490, HPA021451" Approved Supported "Nuclear membrane,Plasma membrane" NA NA "Plasma membrane" "Nuclear membrane" "CAB017490: AB_2189333, HPA021451: AB_1853663" "unprognostic (2.49e-1)" "prognostic unfavorable (6.07e-4)" "unprognostic (4.31e-1)" "unprognostic (1.74e-1)" "unprognostic (3.47e-3)" "unprognostic (4.26e-3)" "prognostic unfavorable (1.19e-7)" "prognostic unfavorable (2.02e-5)" "unprognostic (2.52e-1)" "unprognostic (2.09e-2)" "unprognostic (4.35e-3)" "unprognostic (1.53e-1)" "prognostic unfavorable (3.71e-7)" "unprognostic (2.27e-1)" "unprognostic (4.00e-2)" "unprognostic (8.00e-2)" "unprognostic (1.36e-2)" 10.4 4.8 3.9 16.9 5.2 11.2 8.8 1.0 5.2 8.0 10.5 3.8 1.7 8.0 4.8 4.7 12.4 5.0 10.4 7.4 4.1 3.8 10.9 3.7 19.0 14.2 9.6 0.6 8.3 3.9 1.4 3.6 36.7 8.4 6.9 4.3 42.9 8.1 4.8 81.2 2.1 8.0 4.5 8.0 17.3 13.9 12.7 6.9 3.9 8.7 7.3 11.0 13.0 7.4 3.7 10.3 40.4 12.4 9.9 6.2 5.4 11.5 5.8 0.1 0.1 2.6 8.3 11.5 48.2 29.7 34.3 38.9 2.7 30.2 0.1 38.0 34.0 29.7 4.1 4.1 69.9 14.4 20.7 0.2 22.0 42.9 50.4 44.2 32.3 27.2 17.1 10.3 23.0 10.6 45.1 18.6 0.4 0.1 6.8 29.7 3.1 0.3 31.8 0.4 4.8 47.0 0.1 0.5 7.6 18.1 0.5 0.7 0.3 46.4 41.3 0.6 4.8 6.0 27.2 32.2 68.4 1.1 1.0 50.3 22.1 0.3 1.0 33.5 20.4 0.6 17.5 12.4 34.6 4.1 11.7 6.2 3.7 3.5 4.6 10.3 2.8 1.8 2.2 40.4 9.9 11.8 6.1 3.0 5.4 3.9 5.2 1.0 5.2 4.1 3.8 9.6 0.6 8.4 6.9 8.9 12.7 14.3 34.8 5.8 9.7 4.8 7.6 14.7 14.8 54.1 3.9 56.0 0.0 116.4 3.0 22.8 93.3 0.0 16.0 1393.3 24.4 12.4 75.9 0.8 262.7 120.8 20.1 17.2 103.7 2.7 2.8 101.0 13.5 232.6 23.8 21.4 199.4 84.2 3.5 3.8 7.4 0.0 14.7 1.6 7.1 5.8 626.2 40.6 16.6 118.3 SLC16A7 MCT2 ENSG00000118596 "Solute carrier family 16 member 7" O60669 12 59596067-59789855 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 34.7" "Cell type enhanced" "Detected in many" 6 "Cardiomyocytes: 116.7;Cholangiocytes: 104.4;Early spermatids: 85.1;Late spermatids: 90.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 64.5" HPA005911 Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA005911: AB_1853659" "unprognostic (1.52e-2)" "unprognostic (9.47e-3)" "unprognostic (9.48e-2)" "unprognostic (3.22e-2)" "unprognostic (1.17e-1)" "unprognostic (1.29e-2)" "unprognostic (5.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.90e-1)" "unprognostic (1.04e-1)" "unprognostic (8.39e-2)" "unprognostic (9.79e-2)" "prognostic favorable (8.85e-5)" "unprognostic (2.19e-3)" "unprognostic (3.11e-1)" "unprognostic (9.35e-2)" "unprognostic (2.45e-2)" 20.1 10.0 2.2 9.2 4.3 4.5 9.2 6.4 8.3 5.4 4.8 1.1 1.1 2.2 8.6 2.7 12.3 4.4 8.9 34.7 2.0 1.9 16.4 5.7 9.4 12.1 3.2 3.3 4.7 13.7 2.2 9.5 2.1 5.5 3.8 3.7 2.7 6.2 2.6 4.2 9.4 4.6 10.5 3.7 16.8 12.8 6.2 2.3 12.8 4.0 8.6 9.4 9.7 8.5 5.8 2.8 0.3 9.1 3.0 7.2 2.4 0.1 2.3 0.5 0.3 10.7 16.3 0.1 9.9 6.4 3.4 3.1 0.2 5.9 5.1 2.3 16.7 3.2 0.5 0.6 1.2 5.2 1.4 0.3 9.2 10.4 0.3 5.6 14.9 0.1 8.4 3.2 0.9 9.8 6.1 1.2 6.2 0.1 11.2 5.5 2.1 4.3 2.2 0.6 1.0 3.1 0.3 0.0 2.4 7.6 14.4 2.6 0.6 0.0 0.2 4.7 0.6 0.3 1.8 0.0 8.1 2.7 14.8 0.3 10.8 0.1 8.6 9.3 0.0 1.3 0.3 2.0 0.0 5.4 3.7 7.2 2.4 4.3 4.8 2.1 5.8 4.9 6.9 0.2 3.0 9.1 2.8 4.8 2.4 2.2 4.3 6.4 8.3 2.0 1.9 3.2 3.3 5.5 2.3 26.8 21.3 14.7 5.7 9.0 23.7 116.7 104.4 24.1 15.9 43.6 9.8 0.2 19.9 46.2 85.1 7.1 0.7 0.0 57.0 0.2 12.5 1.9 9.3 10.5 3.0 7.9 0.0 11.1 27.7 90.6 6.4 8.4 3.3 1.8 24.4 1.3 30.7 0.0 9.6 1.0 5.3 6.5 16.0 4.1 3.0 11.0 0.6 20.8 0.9 2.8 SLC17A5 "AST, ISSD, NSD, SD, SIALIN, SIASD, SLD" ENSG00000119899 "Solute carrier family 17 member 5" Q9NRA2 6 73593379-73654155 "Disease related genes, Predicted membrane proteins" "Amino-acid transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 5 "parathyroid gland: 155.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 41.7;ASC TERT1: 31.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044479 Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA044479: " "unprognostic (6.48e-3)" "unprognostic (7.95e-3)" "unprognostic (9.23e-2)" "unprognostic (1.45e-2)" "unprognostic (1.48e-1)" "unprognostic (1.08e-1)" "unprognostic (2.59e-3)" "unprognostic (4.44e-2)" "unprognostic (4.18e-2)" "unprognostic (2.60e-1)" "unprognostic (3.14e-2)" "unprognostic (8.29e-2)" "unprognostic (4.59e-2)" "unprognostic (2.50e-1)" "unprognostic (1.40e-1)" "prognostic favorable (3.52e-4)" "unprognostic (1.09e-1)" 7.2 5.8 6.4 2.9 6.8 2.9 9.6 6.3 6.8 4.9 7.8 4.7 12.5 6.5 5.1 17.2 5.0 3.4 6.2 6.2 4.5 6.7 24.3 13.2 7.6 4.9 5.0 4.5 3.4 8.7 155.6 9.3 12.6 6.7 6.9 8.6 6.6 15.5 8.6 3.5 4.8 12.9 4.6 5.9 4.3 6.0 4.1 4.7 3.0 30.5 2.6 7.1 5.9 4.3 5.2 9.9 12.4 10.6 12.0 9.4 6.0 2.8 3.8 3.9 6.2 41.7 31.1 5.2 9.3 23.5 2.5 8.9 2.5 6.9 2.6 4.5 13.1 5.9 5.0 5.4 2.3 4.5 1.8 6.3 1.1 2.1 5.9 8.4 2.1 4.4 14.2 3.5 5.7 4.0 10.7 6.4 3.5 2.7 2.9 8.8 1.9 0.8 1.2 2.8 11.9 2.3 1.9 4.8 11.1 6.6 7.9 1.5 2.7 1.9 5.6 5.4 6.0 2.5 13.2 9.3 1.2 1.1 5.0 2.2 8.2 11.4 0.7 4.2 4.6 3.7 12.4 10.6 4.2 8.5 9.7 8.3 5.2 9.4 8.1 9.9 3.7 7.8 8.6 7.4 12.0 6.0 7.4 8.2 6.0 6.4 6.8 6.3 6.8 4.5 6.7 5.0 4.5 6.7 4.7 20.8 20.2 7.8 12.1 8.5 7.8 5.3 15.3 14.7 9.1 48.8 27.5 14.4 3.3 12.2 27.9 15.0 21.9 0.0 11.9 12.0 22.1 30.0 13.9 31.0 53.7 0.0 11.6 25.8 26.5 32.1 6.9 22.4 10.1 7.2 42.3 7.3 16.7 17.5 10.6 30.8 24.7 0.0 8.0 11.1 2.3 9.8 19.1 7.9 15.0 18.6 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "brain: 52.1;testis: 23.3" "Cell type enhanced" "Detected in some" 11 "Bipolar cells: 12.3;Early spermatids: 29.3;Horizontal cells: 22.3;Late spermatids: 27.3;Syncytiotrophoblasts: 33.4" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in many" 5 "cerebellum: 52.1" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HAP1: 6.6;NTERA-2: 5.4;U-698: 24.6" "Region enriched" "Detected in many" 6 "cerebellum: 152.9" "Low region specificity" "Detected in all" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.4 0.5 3.2 0.5 9.6 1.2 0.8 52.1 12.8 0.4 0.5 0.6 0.0 0.6 0.8 4.2 0.4 0.5 0.5 0.4 4.8 4.0 0.4 0.5 0.5 0.5 1.6 3.4 0.6 0.9 0.6 0.0 4.3 3.0 0.9 0.6 0.1 0.7 0.9 0.5 9.2 0.5 0.5 1.4 0.7 0.5 23.3 0.9 0.0 0.6 0.0 0.6 0.4 0.0 2.0 0.7 2.2 0.7 0.5 0.6 0.1 0.1 0.1 0.3 0.3 0.2 0.2 0.8 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.2 6.6 0.1 0.1 0.2 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.5 0.0 0.3 5.4 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.4 0.2 0.2 2.6 0.0 1.1 0.3 0.1 0.0 0.3 1.0 0.2 0.1 0.4 0.1 24.6 0.1 0.3 0.1 1.6 0.7 0.5 0.6 0.4 0.4 1.0 0.5 0.3 0.3 2.0 0.6 0.6 2.2 0.5 0.4 0.7 0.3 0.1 3.2 9.6 52.1 6.5 4.8 4.0 1.6 3.4 3.0 0.9 0.0 0.0 0.0 0.6 2.9 12.3 1.6 0.0 0.0 0.0 1.8 0.0 0.5 0.0 0.0 29.3 0.0 0.0 0.0 0.3 8.5 1.0 0.2 0.0 0.0 0.4 22.3 0.0 0.0 0.0 27.3 0.6 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.7 0.0 0.7 0.0 0.3 1.7 1.5 5.9 33.4 0.0 0.0 0.1 SLC22A16 "CT2, FLIPT2, OAT6, OKB1" ENSG00000004809 "Solute carrier family 22 member 16" Q86VW1 6 110424687-110476641 "Predicted membrane proteins" "Differentiation, Ion transport, Spermatogenesis, Transport" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 9.5;bone marrow: 16.0;parathyroid gland: 9.6;testis: 26.4" "Group enriched" "Detected in some" 5 "Early spermatids: 28.2;Erythroid cells: 23.3;Late spermatids: 23.1;Spermatocytes: 35.7" "Cancer enriched" "Detected in single" 5 "endometrial cancer: 0.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "classical monocyte: 9.5" "Group enriched" "Detected in many" 66 "dendritic cells: 5.1;granulocytes: 5.0;monocytes: 9.5" "Group enriched" "Detected in some" 18 "NB-4: 9.8;REH: 9.0;THP-1: 31.3;U-937: 18.4" "Low region specificity" "Detected in all" HPA036902 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036902: AB_10672274" "unprognostic (1.01e-1)" "unprognostic (1.88e-2)" "unprognostic (5.11e-3)" "unprognostic (2.19e-3)" "unprognostic (2.70e-4)" "unprognostic (1.45e-1)" "unprognostic (8.15e-2)" "unprognostic (6.93e-2)" "unprognostic (1.48e-2)" "unprognostic (4.98e-2)" "unprognostic (1.02e-3)" "unprognostic (2.49e-1)" "unprognostic (2.61e-6)" "unprognostic (5.78e-4)" "unprognostic (2.72e-2)" "unprognostic (2.74e-2)" "unprognostic (2.65e-2)" 3.5 0.2 0.2 0.4 0.2 16.0 0.2 0.1 0.2 0.1 0.7 0.0 0.0 0.0 4.9 0.8 0.1 0.3 0.7 0.1 0.2 0.1 1.1 0.3 1.6 0.0 0.2 0.0 0.9 0.1 9.6 0.1 0.3 0.2 0.2 0.0 0.0 0.6 0.0 0.2 0.3 0.1 1.6 0.2 0.8 0.2 26.4 0.0 2.2 0.1 0.8 0.1 0.1 0.1 0.0 5.1 5.0 9.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 31.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 18.4 0.0 5.0 9.5 1.6 0.0 2.1 0.0 0.0 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.7 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 5.3 0.0 0.0 0.0 0.0 0.0 0.0 28.2 0.0 0.0 23.3 0.0 0.1 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 2.2 23.1 1.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 35.7 0.2 0.4 0.0 0.0 0.0 0.0 SLC2A12 "GLUT12, GLUT8" ENSG00000146411 "Solute carrier family 2 member 12" Q8TD20 6 133988697-134052636 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 46.6" "Cell type enhanced" "Detected in many" 15 "Ciliated cells: 9.4;Glandular cells: 11.7;Muller glia cells: 11.4;Syncytiotrophoblasts: 30.7" "Cancer enriched" "Detected in many" 6 "prostate cancer: 18.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.3;myeloid DC: 1.0" "Group enriched" "Detected in many" 6 "dendritic cells: 1.0;monocytes: 1.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.4;hTERT-RPE1: 13.5;SuSa: 22.1;U-2 OS: 8.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA031593, HPA031594" Approved Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA031593: AB_10600810, HPA031594: AB_2673948" "unprognostic (2.06e-1)" "unprognostic (1.21e-1)" "unprognostic (1.69e-2)" "unprognostic (5.55e-3)" "unprognostic (2.18e-1)" "unprognostic (6.02e-2)" "unprognostic (2.24e-3)" "unprognostic (2.54e-2)" "unprognostic (2.08e-2)" "unprognostic (3.69e-2)" "unprognostic (2.38e-1)" "unprognostic (1.83e-1)" "unprognostic (2.33e-3)" "unprognostic (3.04e-1)" "unprognostic (1.65e-1)" "unprognostic (1.04e-2)" "unprognostic (1.55e-3)" 0.9 1.2 5.2 0.4 6.7 0.1 1.5 14.6 5.5 4.8 3.0 7.1 4.9 8.1 9.7 2.6 7.0 3.4 3.0 11.4 6.5 2.8 6.7 7.9 3.4 0.2 3.4 5.2 1.5 1.3 1.2 2.5 1.9 19.7 27.0 1.4 46.6 5.2 11.2 4.2 3.9 11.9 14.8 1.6 0.3 14.4 0.5 3.3 0.6 0.6 1.9 2.7 6.7 2.0 0.0 1.0 0.0 1.3 0.0 0.1 0.1 2.1 0.7 1.8 0.0 1.4 0.7 0.1 1.3 5.4 0.7 3.0 0.0 7.4 0.2 1.1 0.1 5.5 5.6 0.0 0.5 1.0 0.0 4.7 0.0 0.6 0.1 0.2 0.0 0.0 1.0 0.5 0.6 0.1 13.5 0.4 0.3 0.4 0.6 0.1 0.6 0.1 0.1 1.6 0.0 0.5 0.0 0.9 2.0 1.6 0.7 0.2 0.5 0.0 1.7 0.0 22.1 0.0 0.0 0.0 0.2 8.0 0.2 0.7 2.8 2.1 0.0 0.4 0.0 0.0 0.0 0.5 0.0 0.0 1.3 0.1 0.0 0.0 0.0 1.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.1 5.2 6.7 14.6 5.5 6.5 2.8 3.4 5.2 19.7 3.3 0.0 4.8 0.0 0.8 1.8 0.1 5.7 0.0 9.4 2.3 0.0 0.0 1.9 3.3 1.2 0.0 0.4 0.0 0.0 0.2 0.5 0.3 11.7 0.0 0.9 0.2 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.4 0.8 2.9 1.4 0.3 0.5 0.0 0.1 0.0 0.0 1.6 30.7 0.0 0.3 1.4 SLC30A1 "ZNT1, ZRC1" ENSG00000170385 "Solute carrier family 30 member 1" Q9Y6M5 1 211571568-211578742 "Predicted membrane proteins, Transporters" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 53.3" "Cell type enhanced" "Detected in all" 5 "Hepatocytes: 83.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015275, HPA049000" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA015275: AB_1857083, HPA049000: AB_2680593" "unprognostic (1.13e-1)" "unprognostic (2.67e-3)" "unprognostic (6.94e-2)" "unprognostic (1.81e-3)" "unprognostic (3.47e-1)" "unprognostic (1.80e-1)" "unprognostic (2.27e-2)" "unprognostic (1.82e-3)" "unprognostic (4.72e-1)" "unprognostic (1.01e-1)" "unprognostic (1.42e-3)" "unprognostic (4.78e-2)" "unprognostic (2.23e-2)" "unprognostic (3.03e-1)" "unprognostic (2.55e-1)" "unprognostic (1.02e-1)" "unprognostic (4.53e-2)" 11.4 16.6 9.3 7.5 11.4 15.5 17.3 5.2 13.6 13.0 15.3 6.9 4.9 17.2 7.1 7.6 9.0 9.2 12.9 6.1 9.7 7.9 13.4 53.3 12.0 3.5 9.5 8.0 9.5 8.9 8.8 4.8 9.3 8.7 7.3 8.9 7.7 5.9 9.2 3.6 13.9 28.1 7.5 8.3 10.7 6.4 12.5 5.5 3.1 11.0 5.2 4.4 7.7 8.4 0.5 2.5 3.9 4.2 1.3 1.7 1.0 4.7 6.9 3.8 4.9 16.6 7.7 33.7 13.0 9.6 6.9 6.9 3.0 22.6 2.6 11.4 11.9 9.6 8.1 5.7 7.5 8.3 6.7 4.3 2.1 14.1 6.9 9.3 7.4 4.8 11.5 19.0 8.8 14.4 10.4 4.2 1.6 8.4 12.5 8.5 4.3 1.4 4.6 11.7 5.1 5.5 4.5 1.8 9.6 21.5 12.7 3.8 6.7 12.7 6.7 29.0 7.5 3.4 9.7 6.8 5.2 12.1 17.3 10.3 5.5 8.4 2.2 4.8 7.5 4.5 3.9 3.9 1.3 1.2 4.2 1.7 0.5 0.9 0.8 2.5 0.3 0.9 1.2 0.4 1.3 3.2 1.7 0.8 1.0 9.3 11.4 5.2 13.6 9.7 7.9 9.5 8.0 8.7 5.5 8.9 9.8 5.1 7.2 25.3 10.9 17.9 17.8 6.7 2.3 34.9 5.9 9.8 1.7 5.4 21.7 18.0 37.9 46.7 10.7 27.0 15.0 12.6 4.7 83.9 29.4 6.4 9.1 15.4 33.3 2.8 9.2 15.1 20.3 5.4 23.6 26.5 7.9 31.7 7.1 29.5 8.5 6.5 11.6 33.0 9.4 40.4 20.5 10.2 20.5 11.4 SLC39A2 ZIP2 ENSG00000165794 "Solute carrier family 39 member 2" Q9NP94 14 20999255-21001871 "Predicted membrane proteins" "Ion transport, Transport, Zinc transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 44.3;seminal vesicle: 50.6;skin 1: 23.8" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 67 "HaCaT: 23.1" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA030489, HPA073231" Uncertain Approved "Plasma membrane,Cytoplasmic bodies" NA NA "Plasma membrane" "Cytoplasmic bodies" "HPA030489: AB_10601488, HPA073231: " "unprognostic (2.76e-2)" "unprognostic (4.86e-2)" "unprognostic (9.72e-2)" "unprognostic (2.37e-1)" "unprognostic (2.46e-1)" "unprognostic (2.71e-1)" "unprognostic (3.42e-1)" "unprognostic (1.70e-1)" "unprognostic (4.43e-1)" "unprognostic (6.20e-3)" "unprognostic (3.31e-1)" "unprognostic (2.80e-1)" "unprognostic (3.62e-2)" "unprognostic (1.91e-1)" "unprognostic (5.80e-2)" "unprognostic (3.71e-1)" "unprognostic (2.30e-3)" 0.1 0.1 0.1 0.0 0.1 0.0 1.3 0.3 0.4 5.6 1.2 0.0 44.3 0.0 0.8 0.0 13.0 0.3 0.1 0.2 0.4 0.0 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.0 0.4 0.2 1.0 0.2 8.5 0.8 0.4 2.7 50.6 0.1 23.8 0.1 0.2 0.1 0.1 0.0 0.1 0.0 1.3 0.1 6.1 3.3 1.2 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 23.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.3 0.2 0.0 0.2 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 0.4 0.4 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 1.5 0.7 0.0 0.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 3.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 5.3 0.2 0.0 0.8 4.2 SLC3A2 "4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE" ENSG00000168003 "Solute carrier family 3 member 2" P08195 11 62856102-62888875 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 7 "Syncytiotrophoblasts: 652.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 132.2;SiHa: 134.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010455, HPA017980" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 210000000 "Plasma membrane" Nucleoplasm "CAB010455: AB_638288, HPA017980: AB_2669723" "unprognostic (1.79e-1)" "unprognostic (9.61e-3)" "unprognostic (3.59e-1)" "unprognostic (7.87e-3)" "unprognostic (2.06e-1)" "unprognostic (2.41e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (2.09e-3)" "unprognostic (2.62e-1)" "unprognostic (4.16e-2)" "unprognostic (2.29e-2)" "unprognostic (3.71e-1)" "prognostic favorable (8.22e-4)" "unprognostic (2.92e-2)" "unprognostic (5.52e-3)" "unprognostic (3.49e-3)" "prognostic unfavorable (1.48e-4)" 28.5 30.8 34.6 23.0 36.8 62.4 30.8 18.7 34.8 26.0 26.8 25.3 30.4 34.3 29.2 41.2 31.2 23.8 19.9 14.7 31.3 27.1 71.4 31.8 33.5 17.8 37.8 24.1 29.9 39.2 138.6 19.3 75.5 32.9 28.3 13.9 52.5 39.0 27.5 32.5 32.1 33.8 19.6 38.0 21.9 28.2 33.4 30.8 13.6 33.7 33.4 22.2 20.6 56.6 16.6 73.9 11.6 36.2 20.3 39.8 37.3 16.4 69.3 7.1 22.0 8.6 6.9 65.6 28.6 11.0 15.0 13.3 66.2 31.2 18.1 31.8 16.8 28.7 57.0 12.9 56.2 8.0 32.9 12.2 13.0 50.5 29.2 79.9 15.2 19.0 15.1 132.2 18.3 56.1 5.5 8.7 39.4 25.0 40.1 9.2 79.2 15.6 19.4 11.8 20.5 23.5 16.2 10.7 35.4 10.5 9.2 12.1 5.8 134.7 50.5 97.2 12.0 18.1 19.9 16.0 15.3 22.8 22.4 20.1 49.9 55.3 57.4 15.0 23.9 43.6 8.5 36.2 11.6 30.1 34.8 39.8 14.4 27.7 30.8 22.1 16.6 23.5 25.2 7.5 20.3 27.6 73.9 26.2 37.3 34.6 36.8 18.7 34.7 31.3 27.1 37.8 24.1 32.9 30.8 44.7 40.7 54.9 229.6 193.7 59.3 10.9 20.4 36.1 40.9 47.1 62.8 187.9 28.2 148.4 23.7 94.0 85.3 93.5 129.2 134.7 88.4 145.6 82.0 22.5 178.6 50.9 80.9 70.6 47.5 19.5 28.1 97.7 212.6 153.3 33.1 212.1 128.6 31.6 28.7 161.8 52.2 6.5 137.2 12.6 29.8 131.6 652.9 75.6 40.7 193.5 SLC46A1 "HCP1, MGC9564, PCFT" ENSG00000076351 "Solute carrier family 46 member 1" Q96NT5 17 28394756-28407197 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 52.7" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 25.6;Hepatocytes: 24.9;Hofbauer cells: 21.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in many" 5 "CACO-2: 67.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB011614 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "CAB011614: AB_2270597" "unprognostic (1.10e-1)" "unprognostic (8.62e-2)" "unprognostic (1.40e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (5.62e-4)" "unprognostic (9.11e-2)" "unprognostic (4.05e-2)" "unprognostic (1.36e-2)" "unprognostic (1.94e-1)" "unprognostic (3.80e-2)" "unprognostic (1.04e-3)" "unprognostic (6.15e-2)" "unprognostic (2.10e-3)" "unprognostic (2.16e-1)" "unprognostic (2.94e-1)" "unprognostic (2.15e-1)" "unprognostic (1.04e-1)" 3.1 17.8 4.6 2.5 7.0 1.3 5.1 13.2 5.2 2.9 43.8 5.2 9.4 45.4 2.2 4.5 1.8 6.7 3.0 2.2 4.4 6.0 3.8 17.9 3.2 4.9 4.0 4.0 4.4 5.0 8.1 7.8 5.0 5.0 3.7 2.7 6.1 5.7 5.8 2.0 2.0 52.7 2.6 4.6 4.9 2.3 2.2 4.2 2.2 4.0 0.4 1.2 2.4 2.4 2.7 2.6 7.1 5.9 2.9 1.7 0.8 1.7 7.4 2.5 4.1 2.0 0.4 7.8 2.1 1.5 1.7 2.0 67.6 2.1 0.2 1.2 1.1 5.0 5.8 2.8 4.7 1.5 4.3 6.6 0.0 4.6 5.7 0.7 0.0 3.4 1.0 8.7 1.8 5.4 2.4 0.1 0.6 2.8 0.4 0.3 2.3 0.0 0.2 1.5 1.7 1.0 0.1 2.0 0.8 1.3 3.9 6.6 3.5 14.5 6.8 0.9 3.6 5.3 1.1 0.2 0.2 3.0 0.4 2.2 3.1 3.5 0.1 0.4 0.4 1.6 7.1 1.6 1.1 0.8 5.9 1.4 2.7 0.9 0.7 2.6 1.7 1.0 1.7 2.3 2.9 4.3 1.1 1.6 0.8 4.6 7.0 13.2 5.2 4.4 6.0 4.0 4.0 5.0 4.2 11.9 4.0 3.2 1.9 0.3 25.6 1.8 15.3 4.0 1.2 7.0 3.9 16.6 0.0 2.8 3.4 1.0 1.3 0.0 3.9 7.3 3.1 2.2 1.1 24.9 21.1 19.1 1.2 2.5 13.0 13.5 3.7 3.9 0.0 1.0 2.1 1.6 3.5 0.9 3.2 4.1 5.6 6.5 1.0 0.0 0.2 0.3 3.7 0.0 1.2 1.4 SLC5A12 "MGC52019, SMCT2" ENSG00000148942 "Solute carrier family 5 member 12" Q1EHB4 11 26667019-26723427 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "intestine: 60.8;kidney: 90.3" "Cell type enriched" "Detected in some" 18 "Proximal tubular cells: 145.9" "Cancer enriched" "Detected in single" 26 "renal cancer: 9.0" "Region enriched" "Detected in single" 7 "basal ganglia: 1.2" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Karpas-707: 5.2;NTERA-2: 3.8;SuSa: 7.8;T-47d: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA060904 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA060904: AB_2684385" "unprognostic (3.69e-3)" "unprognostic (6.92e-2)" "unprognostic (1.79e-1)" "unprognostic (2.86e-1)" "unprognostic (2.01e-2)" "unprognostic (9.35e-3)" "unprognostic (4.21e-3)" "unprognostic (4.49e-2)" "unprognostic (2.36e-3)" "unprognostic (1.71e-1)" "unprognostic (2.03e-2)" "unprognostic (3.43e-1)" "unprognostic (2.91e-3)" "unprognostic (1.34e-1)" "unprognostic (8.53e-2)" "unprognostic (1.42e-2)" "unprognostic (9.40e-3)" 0.0 0.0 0.1 0.0 1.2 0.2 0.0 0.0 0.1 0.0 11.3 0.0 0.2 1.7 0.0 18.5 0.0 0.0 0.0 3.4 0.1 0.1 90.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.8 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.8 1.0 0.7 0.9 0.7 0.1 0.4 0.1 0.2 0.6 0.1 0.0 0.5 0.1 0.0 0.0 0.0 0.6 0.2 0.6 0.8 0.2 0.1 0.2 0.2 0.1 0.1 0.0 0.0 0.1 0.7 0.1 0.2 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.3 0.4 5.2 0.1 0.3 0.2 0.5 3.8 0.7 0.1 0.1 0.0 0.6 0.1 1.1 2.0 0.3 1.7 0.2 0.0 7.8 2.8 0.5 0.6 0.4 0.2 0.4 0.2 2.3 0.7 0.2 0.2 0.0 0.0 1.0 0.5 0.1 0.6 0.7 0.4 1.1 0.4 0.4 0.5 1.5 0.7 0.6 0.4 0.9 0.6 0.8 0.1 0.1 0.1 1.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 3.5 0.0 0.1 8.3 0.0 0.7 0.0 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.8 0.0 0.3 0.0 145.9 0.2 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.4 0.0 SLC7A2 "ATRC2, CAT-2, HCAT2" ENSG00000003989 "Solute carrier family 7 member 2" P52569 8 17497088-17570573 "Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 68.1;parathyroid gland: 78.2;skeletal muscle: 57.8" "Cell type enhanced" "Detected in many" 11 "Hepatocytes: 230.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HHSteC: 67.7;RT4: 17.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA009277 Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane" "Cell Junctions" "HPA009277: AB_2668229" "unprognostic (1.31e-1)" "unprognostic (2.28e-1)" "unprognostic (1.07e-1)" "unprognostic (1.13e-2)" "unprognostic (1.06e-1)" "unprognostic (5.20e-2)" "unprognostic (7.24e-3)" "unprognostic (3.11e-1)" "unprognostic (1.76e-1)" "unprognostic (4.49e-1)" "unprognostic (1.34e-2)" "unprognostic (1.11e-2)" "prognostic unfavorable (2.65e-7)" "prognostic unfavorable (3.08e-4)" "unprognostic (1.46e-2)" "unprognostic (8.98e-2)" "unprognostic (1.79e-1)" 10.6 3.8 8.6 1.4 3.4 0.1 18.0 2.5 8.3 11.5 2.5 2.4 2.9 0.8 6.4 11.8 3.7 13.6 5.1 9.7 6.8 0.9 3.8 68.1 3.3 2.8 4.4 3.5 35.1 32.2 78.2 3.0 29.0 9.1 4.9 1.5 13.0 2.4 3.3 57.8 3.3 2.0 4.3 10.9 1.8 3.3 7.7 3.5 0.0 14.3 10.4 1.2 3.4 6.4 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.9 0.3 10.4 0.0 0.1 11.3 0.0 7.0 0.5 0.6 3.3 0.0 0.0 2.4 0.0 1.5 0.0 7.5 1.7 2.4 0.0 3.9 0.0 8.1 7.2 67.7 3.1 0.0 9.1 1.4 8.8 8.4 0.0 3.2 0.0 0.0 0.0 7.9 11.0 0.4 3.6 3.8 2.3 0.9 0.0 5.2 5.4 0.8 17.4 0.1 1.4 0.5 0.2 3.1 8.0 0.0 0.3 7.2 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 8.6 3.4 2.5 8.3 6.8 0.9 4.4 3.5 9.1 3.5 11.9 63.8 0.0 6.1 7.3 1.8 14.3 33.1 84.3 27.3 7.0 33.4 17.0 0.0 4.5 10.8 5.2 0.1 0.0 79.6 13.8 18.2 28.5 2.3 230.6 4.7 0.0 84.5 6.7 6.9 17.4 35.1 1.5 3.3 1.0 2.2 15.0 29.6 0.0 26.2 1.8 38.5 58.2 52.8 0.4 0.4 3.3 21.7 2.5 2.6 1.8 SLC7A6 "KIAA0245, LAT-2, LAT3, y+LAT-2" ENSG00000103064 "Solute carrier family 7 member 6" Q92536 16 68264516-68301823 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Antiport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 58.8" "Cell type enhanced" "Detected in many" 4 "Alveolar cells type 1: 38.7;Syncytiotrophoblasts: 40.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050713 Uncertain Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA050713: AB_2681218" "unprognostic (6.35e-2)" "unprognostic (4.63e-2)" "unprognostic (1.41e-1)" "unprognostic (1.40e-2)" "unprognostic (2.41e-1)" "unprognostic (5.02e-2)" "unprognostic (1.24e-3)" "unprognostic (1.16e-1)" "unprognostic (1.48e-1)" "unprognostic (5.16e-2)" "unprognostic (1.11e-1)" "unprognostic (2.76e-2)" "unprognostic (1.89e-3)" "unprognostic (7.82e-2)" "unprognostic (2.66e-1)" "unprognostic (4.79e-3)" "prognostic unfavorable (1.84e-4)" 25.9 7.6 5.4 12.9 6.7 6.9 18.7 9.0 8.0 5.3 7.1 3.4 6.7 3.6 5.5 14.0 4.0 7.1 4.7 13.1 5.3 3.3 5.4 2.3 9.8 16.3 3.3 4.6 3.0 3.2 2.5 11.1 16.3 5.4 6.6 10.8 9.0 5.8 5.1 58.8 8.4 9.4 8.3 3.4 9.4 5.3 5.2 3.7 31.8 15.0 8.0 19.6 5.7 8.0 7.2 16.2 5.9 3.6 6.7 12.6 1.7 9.4 9.7 7.2 7.7 21.4 12.8 20.3 11.1 8.1 16.6 13.9 41.3 7.2 18.8 8.8 14.2 4.8 14.5 14.0 13.9 18.1 3.8 10.0 10.0 19.1 13.1 3.9 11.8 9.1 8.6 12.2 12.9 6.5 5.3 11.1 9.8 14.7 3.4 9.0 5.1 15.3 8.2 5.4 6.4 3.5 19.5 4.5 15.8 5.8 8.3 10.6 5.8 32.1 9.0 3.8 6.3 13.5 6.4 16.3 11.0 8.4 9.2 13.9 7.2 13.5 21.5 7.0 8.7 7.4 2.5 3.6 3.0 4.9 1.7 6.1 6.6 7.3 4.6 3.4 7.2 12.6 7.4 5.9 6.7 1.4 16.2 3.1 1.7 5.4 6.7 9.0 8.0 5.3 3.3 3.3 4.6 5.4 3.7 38.7 16.8 11.1 8.0 17.4 3.7 17.3 0.0 8.1 3.4 17.4 35.3 20.4 0.0 3.0 4.0 9.0 4.2 0.0 3.4 1.6 10.5 3.0 4.6 1.3 12.0 9.5 2.4 7.4 6.7 14.6 5.5 7.5 10.1 3.6 8.9 2.1 4.1 6.2 3.5 0.3 2.6 0.0 7.3 14.2 9.4 19.2 40.0 17.5 6.9 2.3 SLC8A1 NCX1 ENSG00000183023 "Solute carrier family 8 member A1" P32418 2 40097270-40611053 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sodium transport, Transport" Calmodulin-binding "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 67.7" "Cell type enriched" "Detected in many" 11 "Cardiomyocytes: 601.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 4 "neutrophil: 25.2" "Lineage enriched" "Detected in many" 4 "granulocytes: 25.2" "Cell line enhanced" "Detected in many" "BJ: 15.4;fHDF/TERT166: 37.3;hTERT-HME1: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022694, HPA070007" Uncertain Supported "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Nucleoplasm, Plasma membrane" "CAB022694: , HPA070007: AB_2686227" "unprognostic (2.46e-1)" "unprognostic (1.33e-2)" "unprognostic (1.42e-2)" "unprognostic (7.57e-6)" "unprognostic (1.56e-1)" "unprognostic (3.94e-1)" "unprognostic (2.28e-2)" "unprognostic (4.60e-2)" "unprognostic (1.31e-1)" "unprognostic (7.71e-2)" "unprognostic (1.21e-2)" "unprognostic (1.07e-1)" "unprognostic (3.66e-2)" "unprognostic (7.04e-3)" "unprognostic (3.93e-2)" "unprognostic (5.46e-2)" "unprognostic (6.77e-2)" 3.9 2.9 7.7 4.4 14.3 1.4 2.0 3.5 15.3 5.5 7.3 1.8 7.1 3.3 12.2 3.9 4.0 3.9 5.3 67.7 7.7 6.6 11.0 2.2 3.7 2.5 5.2 8.2 2.1 1.5 1.1 1.9 6.8 7.6 12.2 3.4 1.0 1.5 17.2 1.5 2.1 3.6 20.5 2.8 4.4 2.5 1.4 2.5 0.1 1.6 0.0 1.3 9.8 2.8 0.0 2.4 25.2 6.0 0.0 0.0 0.5 1.5 1.2 1.1 0.1 1.7 3.6 0.0 15.4 6.0 5.1 3.3 0.0 2.5 0.0 1.2 37.3 5.5 0.6 0.3 2.5 5.3 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.0 5.9 10.9 2.3 0.4 0.0 0.0 0.2 6.5 0.0 0.4 0.0 0.8 0.1 2.1 4.1 8.1 0.0 1.8 0.2 1.7 0.3 0.0 0.0 0.0 5.6 0.0 0.3 5.2 4.8 0.1 0.0 1.6 0.8 0.0 0.0 0.8 0.9 0.7 0.0 4.9 0.0 0.0 5.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 25.2 0.0 6.0 0.1 0.0 0.5 7.7 14.3 3.5 15.3 7.7 6.6 5.2 8.2 7.6 2.5 3.0 3.2 2.9 0.0 1.1 50.8 601.5 2.5 0.0 1.2 33.2 3.9 0.4 0.0 0.0 0.8 3.3 0.0 0.0 0.0 1.4 4.8 0.1 0.0 0.0 28.3 0.0 0.0 20.3 56.6 0.7 0.0 46.7 1.7 1.0 0.6 35.9 0.1 0.0 7.8 0.1 6.9 12.9 19.6 0.2 0.4 2.8 0.9 0.0 0.0 0.0 SLC9A4 NHE4 ENSG00000180251 "Solute carrier family 9 member A4" Q6AI14 2 102473303-102533972 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 6 "gallbladder: 23.2;kidney: 12.3;stomach 1: 33.9" "Cell type enriched" "Detected in some" 8 "Collecting duct cells: 24.4" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HDLM-2: 3.9;OE19: 11.4;RT4: 7.1" "Group enriched" "Detected in some" 18 "hippocampal formation: 11.6;olfactory region: 8.3" "Not detected" "Not detected" HPA036096 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA036096: AB_2674939" "unprognostic (1.41e-1)" "unprognostic (3.76e-2)" "unprognostic (9.31e-2)" "unprognostic (3.09e-3)" "unprognostic (7.58e-2)" "unprognostic (1.46e-1)" "unprognostic (7.17e-2)" "unprognostic (5.35e-1)" "unprognostic (9.44e-3)" "unprognostic (3.26e-2)" "unprognostic (1.30e-1)" "unprognostic (2.46e-2)" "unprognostic (3.12e-1)" "unprognostic (5.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.98e-2)" 0.0 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.1 0.2 0.1 0.3 0.0 1.1 0.1 0.0 1.3 0.1 23.2 0.2 0.1 0.1 12.3 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.7 0.0 0.0 3.7 2.4 0.7 0.2 0.2 0.0 0.1 0.1 33.9 0.3 0.0 0.2 0.1 0.5 0.4 0.6 0.2 1.5 0.9 1.8 0.8 1.2 1.2 0.1 0.2 0.2 0.2 0.6 0.0 0.0 0.1 0.2 0.0 0.0 0.0 1.1 0.4 0.1 2.4 0.0 0.3 0.3 0.0 0.0 0.0 3.9 0.1 0.2 0.4 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.9 0.0 0.4 0.1 0.1 1.1 11.4 0.4 0.2 0.5 0.3 0.0 7.1 0.2 0.2 0.1 0.4 0.0 0.3 0.2 0.1 0.5 0.4 1.1 0.7 0.2 0.2 0.2 0.0 0.5 0.1 0.1 1.6 0.7 1.1 1.2 0.6 0.8 0.8 0.9 0.9 0.5 1.5 1.0 1.2 1.8 1.2 0.8 0.9 0.6 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 3.0 2.7 0.0 0.0 0.0 0.0 0.2 0.0 2.7 1.2 24.4 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.3 SLC9A5 NHE5 ENSG00000135740 "Solute carrier family 9 member A5" Q14940 16 67237683-67272190 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 13.5;lymphoid tissue: 14.5" "Cell type enriched" "Detected in some" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-138 MG: 8.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041004, HPA041329" Uncertain Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA041004: AB_10794433, HPA041329: AB_10794373" "unprognostic (8.90e-2)" "unprognostic (9.70e-2)" "unprognostic (3.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.44e-1)" "unprognostic (1.43e-1)" "unprognostic (2.24e-2)" "unprognostic (5.17e-2)" "unprognostic (1.50e-1)" "unprognostic (1.12e-1)" "unprognostic (2.50e-3)" "unprognostic (4.84e-2)" "unprognostic (9.85e-11)" "unprognostic (9.21e-2)" "unprognostic (1.95e-1)" "unprognostic (8.12e-3)" "unprognostic (9.07e-2)" 1.7 1.7 2.9 1.1 8.8 0.5 1.1 13.5 8.6 0.9 1.4 0.5 3.6 1.3 1.1 3.2 0.6 0.6 1.9 2.3 2.9 3.6 1.1 0.6 2.9 2.1 2.1 2.3 1.4 1.5 0.5 0.6 1.7 4.3 1.0 1.1 0.5 1.0 2.5 1.7 4.2 0.9 0.6 2.7 14.5 0.8 3.3 1.2 0.0 1.0 0.0 1.3 1.6 0.4 1.5 0.8 1.0 0.5 0.6 0.9 0.1 0.5 4.1 3.7 1.2 6.8 4.7 0.4 1.3 5.8 3.4 3.1 0.2 2.9 0.0 0.8 1.6 1.7 0.2 1.0 0.7 1.3 1.2 1.2 3.2 0.3 0.9 0.8 1.4 6.7 5.3 1.4 1.9 0.4 6.3 0.7 1.2 0.7 1.9 2.2 2.3 0.1 0.3 2.5 0.2 0.4 0.0 0.8 0.9 0.6 0.7 2.1 0.9 3.5 0.2 1.8 0.9 1.4 0.3 1.0 8.8 1.4 1.6 0.6 3.6 0.9 1.8 6.3 0.7 2.2 0.0 0.4 0.0 0.0 0.0 0.6 1.5 0.4 0.9 0.1 0.0 0.4 0.4 1.0 0.6 0.5 0.8 0.0 0.1 2.9 8.8 13.5 8.6 2.9 3.6 2.1 2.3 4.3 1.2 3.0 3.2 0.0 0.1 0.6 1.9 1.2 2.5 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.6 0.7 0.0 0.0 0.2 0.1 0.6 0.4 0.0 0.0 0.1 15.9 1.2 2.5 0.0 0.0 0.3 0.0 0.0 1.0 0.0 0.3 0.4 0.0 2.1 0.0 0.6 0.0 0.7 1.7 1.1 0.6 0.0 0.0 0.2 0.1 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500464-173603094 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "testis: 24.9" "Cell type enhanced" "Detected in some" 13 "Club cells: 2.3;Cone photoreceptor cells: 5.9;Early spermatids: 4.2;Late spermatids: 2.3;Spermatocytes: 4.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in single" 17 "plasmacytoid DC: 1.7" "Lineage enriched" "Detected in single" 17 "dendritic cells: 1.7" "Group enriched" "Detected in some" 4 "BEWO: 1.8;THP-1: 3.7" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.4 0.1 0.3 0.0 1.3 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.5 0.0 0.1 0.4 0.0 1.7 0.0 0.1 0.5 0.3 0.2 0.0 0.4 0.1 0.0 0.4 0.8 0.3 0.1 0.4 0.5 0.5 0.1 0.0 0.1 0.0 2.7 0.0 0.0 0.0 0.1 0.3 1.0 0.3 24.9 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.3 1.3 0.0 1.6 0.5 0.3 0.0 0.4 0.5 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 2.3 0.0 5.9 0.1 0.0 0.0 4.2 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.4 0.0 0.1 0.0 0.0 0.0 SLCO5A1 "OATP-J, OATP5A1, OATPRP4, SLC21A15" ENSG00000137571 "Solute carrier organic anion transporter family member 5A1" Q9H2Y9 8 69667047-69835064 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "heart muscle: 21.4;lymphoid tissue: 9.5;skeletal muscle: 13.9;tongue: 16.2" "Group enriched" "Detected in many" 6 "Bipolar cells: 12.4;Cardiomyocytes: 13.6;Glandular cells: 10.0;Intestinal endocrine cells: 15.0;monocytes: 36.9" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HAP1: 9.0;NTERA-2: 6.0;RPMI-8226: 5.7;SCLC-21H: 6.5;U-266/70: 3.5" "Group enriched" "Detected in some" 7 "basal ganglia: 2.3;olfactory region: 8.2" HPA025062 Uncertain Supported "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA025062: AB_1857220" "unprognostic (1.30e-3)" "unprognostic (7.35e-3)" "unprognostic (4.13e-2)" "unprognostic (1.14e-2)" "unprognostic (1.48e-1)" "unprognostic (5.70e-2)" "unprognostic (1.46e-2)" "unprognostic (1.51e-1)" "unprognostic (2.37e-4)" "unprognostic (1.75e-1)" "unprognostic (4.48e-4)" "unprognostic (1.74e-2)" "unprognostic (2.92e-6)" "unprognostic (2.20e-1)" "unprognostic (1.23e-1)" "unprognostic (2.13e-1)" "unprognostic (4.50e-2)" 0.7 0.2 0.5 1.5 0.7 1.5 0.2 0.1 0.8 0.3 0.4 0.1 0.0 0.4 0.5 1.5 1.0 0.5 0.4 21.4 0.7 0.7 0.2 0.4 0.3 4.1 0.3 0.3 0.2 0.7 0.0 4.7 0.0 0.5 4.2 0.7 0.6 0.9 0.0 13.9 0.3 0.7 0.2 0.2 0.8 0.3 0.4 0.0 9.5 0.5 16.2 1.7 0.9 0.2 1.7 0.1 0.7 0.0 0.2 0.3 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.0 0.0 0.0 2.4 2.9 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 1.1 6.0 0.0 0.9 1.0 0.9 5.7 0.1 0.0 6.5 0.0 0.0 0.0 2.5 0.1 0.0 0.0 0.0 0.0 0.6 0.1 1.2 3.5 0.6 0.0 0.3 0.0 1.7 0.7 0.0 0.1 0.3 0.0 0.0 0.5 0.1 0.2 0.0 1.7 0.1 0.2 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.7 0.1 0.7 0.7 0.7 0.3 0.3 0.5 0.0 3.0 0.0 1.9 1.1 0.2 12.4 13.6 0.0 0.0 1.2 0.0 2.0 0.0 0.0 1.5 0.4 0.7 0.0 0.0 1.2 0.0 0.6 10.0 0.0 0.0 0.1 1.6 15.0 0.0 0.0 0.4 0.0 0.3 0.0 36.9 1.6 0.3 2.4 0.0 0.0 0.0 0.2 0.0 1.0 0.9 1.7 0.4 0.0 0.0 0.9 0.7 SLK "KIAA0204, se20-9, STK2" ENSG00000065613 "STE20 like kinase" Q9H2G2 10 103967201-104029233 "Enzymes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Urothelial cells: 181.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015757 Approved Approved "Plasma membrane,Cytosol" NA NA 17000 "Plasma membrane, Cytosol" "HPA015757: AB_1857236" "unprognostic (1.89e-1)" "unprognostic (1.80e-1)" "unprognostic (1.38e-1)" "unprognostic (8.28e-2)" "unprognostic (1.01e-1)" "unprognostic (3.64e-1)" "unprognostic (8.67e-2)" "unprognostic (6.85e-2)" "unprognostic (1.01e-1)" "unprognostic (2.31e-1)" "prognostic unfavorable (2.77e-5)" "unprognostic (1.95e-1)" "prognostic favorable (3.95e-5)" "unprognostic (8.48e-2)" "unprognostic (3.95e-1)" "unprognostic (3.09e-2)" "unprognostic (1.07e-1)" 15.2 11.2 13.7 11.0 36.7 14.6 16.1 16.7 13.1 16.6 19.0 9.9 10.9 9.1 17.0 12.1 40.2 12.1 13.6 17.2 10.6 7.1 14.9 12.2 17.1 10.1 11.2 13.4 17.2 12.5 22.6 13.1 17.4 12.8 19.3 13.6 11.4 19.8 12.7 19.3 16.6 15.5 29.8 13.0 12.1 15.7 10.2 12.8 12.0 15.8 21.6 12.5 24.9 23.6 1.4 2.2 6.5 1.4 1.3 3.6 0.7 21.6 12.7 15.1 10.8 16.4 22.9 6.4 13.5 18.0 10.1 9.5 8.0 23.3 11.5 8.5 13.9 8.6 23.6 8.0 17.1 14.8 9.2 11.0 11.7 10.4 6.7 12.3 13.9 10.1 11.7 22.5 13.6 39.9 14.1 18.1 7.5 14.6 8.0 13.2 7.5 9.7 7.7 3.7 14.0 8.1 9.5 18.6 6.0 13.2 25.0 3.5 6.2 11.7 11.4 11.2 8.0 5.9 10.1 27.3 7.4 7.8 13.6 15.8 9.7 11.8 7.3 11.0 18.8 4.7 1.2 1.4 3.3 3.6 1.2 3.6 1.1 2.2 2.2 1.2 1.4 1.5 2.5 6.5 1.3 1.0 2.2 1.4 0.7 13.7 36.7 16.7 13.1 10.6 7.1 11.2 13.4 12.8 12.8 166.7 108.1 23.8 57.3 50.6 27.3 89.7 28.1 66.9 138.8 41.8 23.6 27.8 3.3 28.4 6.3 53.4 45.3 23.3 46.5 11.5 39.3 60.5 32.5 21.7 17.3 23.8 17.7 41.7 24.0 11.0 43.1 31.1 8.5 37.9 31.8 23.4 61.5 54.9 59.4 11.3 24.1 6.5 34.9 42.3 39.1 59.8 43.8 21.8 29.4 181.1 SNAP25 "bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25" ENSG00000132639 "Synaptosome associated protein 25" P60880 20 10218830-10307418 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters" "Congenital myasthenic syndrome, Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 22 "brain: 356.9" "Cell type enhanced" "Detected in many" 23 "Bipolar cells: 497.2;Cone photoreceptor cells: 100.1;Rod photoreceptor cells: 186.3" "Group enriched" "Detected in many" 6 "glioma: 28.9;pancreatic cancer: 6.4" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in many" 4 "Karpas-707: 11.0;SCLC-21H: 36.6;SH-SY5Y: 21.8;U-87 MG: 26.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000360, HPA001830, HPA071013" Enhanced Supported Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: " "unprognostic (1.64e-3)" "unprognostic (7.26e-3)" "unprognostic (4.36e-2)" "unprognostic (2.49e-7)" "unprognostic (6.86e-3)" "unprognostic (5.87e-3)" "unprognostic (1.15e-2)" "unprognostic (9.94e-2)" "unprognostic (3.13e-1)" "unprognostic (5.82e-3)" "unprognostic (4.80e-3)" "unprognostic (8.06e-2)" "unprognostic (1.09e-1)" "unprognostic (6.18e-3)" "unprognostic (2.48e-1)" "unprognostic (6.28e-3)" "unprognostic (1.02e-2)" 2.2 16.4 81.0 3.3 60.0 2.1 3.4 202.9 356.9 2.2 2.8 3.4 3.7 3.2 4.6 6.4 2.2 4.0 2.8 2.4 86.5 37.1 2.5 2.3 2.6 2.2 46.7 65.2 3.7 4.1 2.1 5.5 2.3 97.7 3.1 2.8 4.0 2.2 11.9 2.1 2.2 3.3 4.7 13.9 2.1 4.3 3.2 7.4 0.0 2.3 0.0 2.2 2.6 0.1 0.0 1.6 0.7 0.0 0.0 0.6 0.3 0.0 2.1 1.8 0.0 0.2 0.0 0.0 0.9 0.0 2.2 0.6 0.0 0.0 0.0 2.0 0.0 1.6 0.4 0.2 0.0 4.5 0.2 0.1 0.0 3.0 0.3 1.6 0.0 0.2 2.1 0.0 1.8 0.0 5.0 0.0 1.3 0.0 11.0 0.7 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.0 0.0 0.4 0.0 36.6 21.8 0.3 0.0 0.0 1.1 0.0 2.9 0.0 2.3 3.1 0.0 1.0 0.0 5.6 0.0 26.3 0.0 2.1 0.0 0.0 0.7 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 1.6 0.6 0.3 81.0 60.0 202.9 163.5 86.5 37.1 46.7 65.2 97.7 7.4 0.0 0.0 0.0 1.7 0.7 497.2 0.4 7.6 0.0 0.0 0.0 100.1 0.0 0.0 0.1 16.5 0.6 0.0 0.0 0.0 0.1 1.0 0.5 0.0 0.0 0.1 62.0 41.6 0.0 0.0 56.7 15.8 0.2 1.7 0.0 0.0 42.9 1.6 0.2 64.7 1.4 186.3 0.0 1.0 0.9 0.3 0.6 0.0 0.0 0.0 0.0 SNTG2 "G2SYN, SYN5" ENSG00000172554 "Syntrophin gamma 2" Q9NY99 2 950868-1367613 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 21 "Early spermatids: 58.0;Horizontal cells: 85.8;Late spermatids: 26.8;Spermatocytes: 17.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Daudi: 3.7;HAP1: 4.1;JURKAT: 3.8;MOLT-4: 2.4;NTERA-2: 5.0;SCLC-21H: 4.9" "Low region specificity" "Detected in single" "HPA065258, HPA077904" Approved Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA065258: , HPA077904: " "unprognostic (7.52e-3)" "unprognostic (7.52e-4)" "unprognostic (4.15e-1)" "unprognostic (3.50e-2)" "unprognostic (2.52e-2)" "unprognostic (1.39e-3)" "unprognostic (2.46e-3)" "unprognostic (2.05e-1)" "unprognostic (2.23e-1)" "unprognostic (3.26e-2)" "unprognostic (7.87e-3)" "unprognostic (3.58e-3)" "unprognostic (3.64e-1)" "unprognostic (2.52e-1)" "unprognostic (1.77e-2)" "unprognostic (5.05e-2)" 8.8 2.2 0.9 1.2 1.7 0.7 7.5 1.7 1.4 5.6 1.8 0.4 1.0 1.3 10.2 8.1 4.3 2.5 4.9 1.0 2.6 1.4 0.8 0.6 1.3 0.9 1.1 0.3 1.2 6.7 0.9 9.2 0.7 5.1 1.6 1.6 3.5 1.4 0.8 6.4 3.5 1.4 5.2 2.9 7.7 1.4 5.7 0.9 2.2 2.0 3.1 2.0 2.8 2.6 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 3.7 0.0 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 2.4 0.0 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 1.7 1.7 1.4 2.6 1.4 1.1 0.3 5.1 0.9 0.0 0.0 0.0 0.1 0.8 0.7 0.6 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 58.0 5.2 0.0 0.0 0.2 0.4 0.4 0.3 0.0 0.0 0.1 85.8 0.0 0.0 0.0 26.8 0.3 0.0 1.7 0.0 0.0 0.5 0.0 0.0 3.9 0.2 4.0 0.0 0.4 17.7 3.1 0.1 0.0 0.0 0.0 0.1 SNX9 "SDP1, SH3PX1, SH3PXD3A" ENSG00000130340 "Sorting nexin 9" Q9Y5X1 6 157700387-157945077 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 42.9;GAMG: 41.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031410, HPA057203" Approved Enhanced "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA031410: AB_10603339, HPA057203: AB_2683368" "unprognostic (1.63e-3)" "prognostic unfavorable (5.95e-4)" "unprognostic (1.39e-1)" "unprognostic (8.09e-2)" "unprognostic (8.09e-2)" "unprognostic (1.40e-2)" "unprognostic (4.06e-2)" "prognostic unfavorable (3.77e-4)" "unprognostic (7.93e-2)" "unprognostic (4.99e-3)" "unprognostic (4.45e-2)" "unprognostic (2.42e-1)" "prognostic favorable (9.95e-4)" "unprognostic (2.14e-1)" "unprognostic (2.46e-1)" "unprognostic (1.13e-2)" "unprognostic (2.57e-1)" 44.7 18.9 13.0 16.5 14.7 17.2 35.4 6.7 16.2 27.4 24.6 19.8 43.5 18.1 32.1 19.5 31.4 17.2 26.4 20.4 12.2 10.8 17.8 25.4 14.6 22.5 19.7 11.4 19.8 22.5 17.7 10.8 45.0 13.3 25.0 17.7 11.1 25.2 41.7 16.5 21.2 28.0 44.6 16.4 19.8 21.5 10.9 18.4 5.0 18.4 17.9 20.3 34.0 40.2 4.1 11.2 1.3 7.3 0.5 6.7 1.0 7.5 5.0 5.3 6.2 26.5 23.6 11.2 15.2 42.9 10.4 13.9 4.3 7.7 0.0 7.6 23.5 41.6 5.0 6.2 10.2 8.7 6.2 7.2 4.8 7.6 6.6 13.3 2.5 9.7 14.0 9.1 10.7 10.5 18.8 14.4 7.4 24.1 0.0 5.1 4.3 0.0 3.8 4.2 5.1 6.4 0.0 5.3 8.6 16.7 4.5 3.4 6.2 9.7 4.5 23.2 5.5 2.1 5.5 11.7 11.5 5.2 36.8 8.0 0.0 0.0 0.0 23.0 1.9 6.7 0.0 1.0 1.3 0.6 3.2 2.4 4.1 1.7 1.3 2.0 3.4 6.7 2.1 0.1 0.5 7.3 11.2 2.8 1.0 13.0 14.7 6.7 16.2 12.2 10.8 19.7 11.4 13.3 18.4 0.0 0.6 20.4 84.5 38.5 12.7 24.6 17.8 12.0 18.2 8.7 0.0 31.7 18.3 44.5 37.1 48.9 55.8 46.7 48.8 32.8 55.0 114.0 11.5 28.7 37.1 3.2 15.1 32.5 39.6 18.9 41.4 29.1 20.3 62.3 31.0 12.4 78.9 45.0 43.9 32.7 1.5 38.8 46.7 17.9 13.8 26.1 91.9 10.2 26.0 107.8 SOCS3 "CIS3, Cish3, SOCS-3, SSI-3" ENSG00000184557 "Suppressor of cytokine signaling 3" O14543 17 78356778-78360077 "Disease related genes, Predicted intracellular proteins" "Growth regulation, Ubl conjugation pathway" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Endothelial cells: 259.3;Smooth muscle cells: 425.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "neutrophil: 11.6" "Group enriched" "Detected in many" 6 "granulocytes: 11.6;T-cells: 4.3" "Cell line enhanced" "Detected in many" "HDLM-2: 49.9;HSkMC: 25.4;U-266/70: 25.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB012220, HPA068569" Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB012220: AB_443287, HPA068569: AB_2686008" "prognostic favorable (4.80e-4)" "unprognostic (2.67e-1)" "unprognostic (5.05e-2)" "unprognostic (1.64e-3)" "unprognostic (4.41e-3)" "unprognostic (2.48e-3)" "unprognostic (1.81e-1)" "unprognostic (1.46e-1)" "unprognostic (6.88e-2)" "unprognostic (9.61e-3)" "unprognostic (1.84e-1)" "unprognostic (2.00e-2)" "prognostic unfavorable (9.34e-9)" "unprognostic (1.08e-2)" "unprognostic (8.80e-2)" "unprognostic (7.59e-3)" "unprognostic (8.40e-2)" 94.9 16.8 6.3 42.5 21.4 33.9 25.7 3.0 12.8 27.6 26.6 5.6 1.9 6.2 13.9 9.2 22.7 88.0 59.6 23.5 11.4 5.1 13.5 30.4 52.1 30.2 13.9 0.1 31.2 14.5 13.9 13.4 23.5 38.0 20.8 9.2 10.3 9.2 6.7 26.0 12.1 15.6 39.0 29.6 36.7 32.2 12.1 8.7 5.6 14.2 40.9 10.3 38.1 41.1 0.0 1.3 11.6 1.3 0.4 4.3 0.6 2.0 3.3 2.4 1.3 0.9 15.5 6.5 10.4 9.5 10.9 4.6 2.1 1.4 0.0 2.2 2.4 6.9 0.6 0.5 1.0 4.3 49.9 0.3 1.9 7.3 0.4 5.0 0.0 0.9 25.4 0.8 8.4 3.2 6.6 4.7 0.1 5.5 19.6 5.0 1.0 1.0 0.3 1.7 0.3 4.3 0.0 12.5 0.3 17.3 2.0 0.1 1.5 3.1 0.8 0.4 9.5 0.9 0.4 2.7 21.5 6.1 7.5 6.0 25.9 14.5 0.0 17.6 0.2 1.4 0.0 1.3 0.3 1.0 0.1 2.6 0.0 2.8 1.2 1.3 0.0 4.3 0.8 11.6 0.4 0.0 1.2 1.6 0.6 6.3 21.4 3.0 12.8 11.4 5.1 13.9 0.1 38.0 8.7 44.7 145.2 37.8 106.0 146.0 1.0 23.1 5.1 20.1 55.7 36.6 2.0 8.0 5.0 34.0 0.6 259.3 21.3 0.0 34.0 41.1 225.0 61.7 33.7 14.4 86.4 0.0 31.8 133.8 82.4 0.2 72.5 182.0 81.0 48.7 21.3 2.0 36.2 24.3 2.1 6.8 1.6 12.9 425.2 0.5 0.2 116.2 51.9 47.9 36.7 70.2 SORCS1 sorCS1 ENSG00000108018 "Sortilin related VPS10 domain containing receptor 1" Q8WY21 10 106573663-107164534 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 18.5" "Cell type enriched" "Detected in some" 4 "Muller glia cells: 59.3" "Cancer enhanced" "Detected in some" "melanoma: 3.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 24 "intermediate monocyte: 2.4" "Lineage enriched" "Detected in single" 24 "monocytes: 2.4" "Group enriched" "Detected in some" 12 "RH-30: 33.9;SH-SY5Y: 44.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011948 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA011948: AB_1857366" "unprognostic (5.86e-3)" "unprognostic (8.45e-3)" "unprognostic (1.55e-2)" "unprognostic (1.67e-1)" "unprognostic (1.13e-1)" "unprognostic (1.36e-1)" "unprognostic (1.05e-2)" "unprognostic (2.92e-2)" "unprognostic (3.52e-2)" "unprognostic (5.58e-2)" "unprognostic (6.82e-3)" "unprognostic (5.81e-2)" "unprognostic (6.48e-4)" "unprognostic (2.51e-2)" "unprognostic (8.89e-3)" "unprognostic (2.22e-1)" "unprognostic (2.69e-4)" 1.4 5.8 6.0 4.5 14.1 0.4 1.8 0.5 13.2 2.2 10.7 1.1 1.9 1.4 2.1 1.2 2.0 3.2 2.8 4.2 2.6 4.7 8.0 0.5 0.5 1.9 2.1 6.6 1.2 3.0 0.6 1.2 0.4 3.3 2.7 3.6 6.5 2.4 4.9 0.8 2.3 4.5 2.7 2.1 1.7 3.4 2.3 2.7 0.2 18.5 1.1 2.7 4.7 3.8 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 33.9 0.0 0.0 0.0 0.0 44.4 0.0 0.0 1.3 0.1 0.0 0.0 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.0 14.1 0.5 11.3 2.6 4.7 2.1 6.6 3.3 2.7 0.0 0.3 0.0 0.0 0.6 1.8 1.8 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.6 14.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.3 3.4 0.0 0.0 1.7 0.0 0.0 59.3 0.1 0.0 0.4 2.2 1.7 0.0 0.0 0.0 1.5 0.1 0.0 0.0 0.0 0.0 SOX11 ENSG00000176887 "SRY-box 11" P35716 2 5692667-5701385 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7" "Group enriched" "Detected in some" 5 "Cardiomyocytes: 10.1;Ductal cells: 2.5" "Group enriched" "Detected in many" 6 "breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 26.5;NTERA-2: 12.9;REH: 9.4;RH-30: 10.1;SCLC-21H: 16.3;SH-SY5Y: 24.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA000448, HPA000536, CAB056152, CAB056153" Approved Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060" "unprognostic (2.17e-2)" "unprognostic (2.02e-2)" "unprognostic (1.44e-2)" "unprognostic (7.35e-6)" "unprognostic (2.79e-1)" "unprognostic (1.19e-1)" "unprognostic (4.04e-8)" "unprognostic (2.79e-2)" "unprognostic (7.27e-2)" "unprognostic (3.17e-1)" "unprognostic (3.35e-3)" "unprognostic (2.42e-1)" "unprognostic (8.45e-8)" "unprognostic (1.35e-1)" "unprognostic (1.96e-1)" "unprognostic (5.50e-3)" "unprognostic (7.47e-2)" 0.5 0.5 4.2 0.5 7.1 0.6 0.6 0.3 12.3 0.4 3.3 5.8 0.0 0.6 0.7 0.6 0.5 0.5 0.6 5.3 4.4 5.1 0.5 0.5 0.6 0.5 3.3 5.0 0.5 0.4 0.5 0.7 0.5 4.5 0.5 0.8 0.0 0.9 0.4 1.0 0.6 0.7 1.3 6.3 1.0 0.6 3.7 3.6 0.0 0.6 0.0 0.6 0.5 0.1 1.1 0.8 3.1 1.5 1.6 1.1 0.5 0.0 0.0 26.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.8 0.0 1.3 0.0 0.0 2.4 0.0 0.0 0.0 12.9 0.0 0.0 9.4 10.1 0.4 0.0 0.0 16.3 24.6 0.0 0.1 0.0 4.8 0.0 0.0 0.0 0.3 0.1 0.0 0.0 1.8 0.3 0.6 0.0 0.0 6.1 3.1 0.5 1.0 0.5 0.8 1.1 1.1 0.6 0.7 0.6 0.7 0.9 0.9 1.6 1.6 1.5 0.8 0.9 0.5 4.2 7.1 0.3 6.4 4.4 5.1 3.3 5.0 4.5 3.6 0.0 0.0 0.0 0.0 0.0 1.3 10.1 0.0 0.0 1.2 0.0 0.0 0.1 0.0 2.5 0.7 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 SPAG16 "DKFZp666P1710, FLJ22724, PF20, WDR29" ENSG00000144451 "Sperm associated antigen 16" Q8N0X2 2 213284379-214410501 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 6 "Ciliated cells: 261.0;Early spermatids: 200.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "T-47d: 33.9" "Low region specificity" "Detected in many" HPA037542 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA037542: AB_10672353" "unprognostic (4.20e-2)" "unprognostic (2.73e-1)" "unprognostic (2.67e-1)" "unprognostic (9.79e-2)" "unprognostic (1.83e-1)" "unprognostic (1.30e-1)" "unprognostic (2.04e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (1.15e-1)" "unprognostic (2.66e-1)" "prognostic unfavorable (4.90e-4)" "prognostic favorable (3.82e-4)" "unprognostic (1.10e-2)" "unprognostic (1.01e-1)" "unprognostic (3.41e-1)" "unprognostic (1.17e-1)" 11.1 13.0 28.2 5.4 29.8 1.7 15.8 12.0 22.0 16.7 11.5 21.9 23.1 13.7 14.0 24.8 16.0 34.8 17.0 15.7 27.7 24.6 22.6 13.8 8.1 7.7 31.5 22.0 20.2 11.2 24.0 32.8 7.3 25.7 17.1 13.1 11.1 11.8 19.8 6.1 18.2 7.9 14.3 36.9 5.7 19.2 34.3 18.1 10.5 19.9 11.4 9.8 14.8 11.9 7.5 4.1 1.1 1.1 12.1 10.6 3.0 12.4 5.0 14.3 0.0 9.8 17.6 0.1 6.8 8.2 8.9 9.5 9.8 13.8 5.2 8.2 7.5 14.3 8.8 6.4 8.3 19.0 0.0 5.1 2.7 12.7 12.7 10.9 2.9 0.0 15.0 11.5 7.9 4.6 12.3 3.6 5.5 8.7 6.0 8.9 0.0 9.8 0.0 7.9 0.0 4.2 10.5 15.0 0.2 14.3 12.2 10.4 12.3 7.9 7.3 9.6 12.9 33.9 1.2 3.8 8.6 5.2 4.5 7.1 9.8 4.4 0.2 14.0 0.0 3.8 1.1 0.2 0.7 7.1 1.1 10.1 7.5 8.0 8.9 2.5 7.3 10.6 9.2 0.4 12.1 0.8 4.1 7.4 3.0 28.2 29.8 12.0 22.0 27.7 24.6 31.5 22.0 25.7 18.1 14.9 17.9 11.0 36.9 37.5 34.4 59.6 58.6 261.0 58.0 38.4 90.3 41.9 64.6 34.0 200.5 21.0 10.6 23.3 21.5 17.0 30.9 34.4 9.3 16.0 10.0 38.1 36.7 9.2 4.5 48.7 38.3 6.9 21.9 49.5 35.2 69.4 27.0 10.5 42.1 72.5 64.3 12.9 31.9 158.7 19.0 49.3 19.7 12.1 36.5 43.0 SPART "KIAA0610, SPG20, TAHCCP1" ENSG00000133104 Spartin Q8N0X7 13 36301638-36370180 "Disease related genes, Predicted intracellular proteins" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Ciliated cells: 120.5;Club cells: 73.9;Proximal tubular cells: 72.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "basophil: 45.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 45.8" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039053, HPA039054" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039053: AB_10672769, HPA039054: AB_2676323" "unprognostic (3.73e-2)" "unprognostic (9.39e-2)" "unprognostic (3.06e-2)" "unprognostic (4.60e-2)" "unprognostic (2.21e-2)" "unprognostic (1.10e-2)" "unprognostic (9.18e-3)" "unprognostic (9.58e-2)" "unprognostic (3.36e-2)" "unprognostic (2.22e-1)" "unprognostic (7.62e-2)" "unprognostic (8.14e-2)" "unprognostic (1.54e-1)" "unprognostic (9.26e-2)" "unprognostic (1.22e-1)" "unprognostic (1.54e-2)" "unprognostic (5.79e-2)" 28.7 34.7 23.2 12.1 28.0 14.5 44.9 21.3 26.7 37.1 22.5 23.1 26.2 9.1 29.9 48.4 17.7 26.1 26.2 17.5 24.7 22.3 33.7 13.7 18.4 12.9 31.8 19.4 46.1 10.3 13.2 29.8 32.2 28.9 26.6 10.0 17.2 11.9 27.0 20.6 12.4 9.7 37.0 35.7 20.2 14.4 18.3 32.5 7.0 25.1 8.7 7.8 31.4 58.7 3.2 6.0 45.8 6.8 4.1 8.3 5.3 0.0 5.9 16.1 0.0 35.4 29.8 11.5 14.4 21.7 14.5 14.4 0.0 0.0 0.0 9.0 17.3 26.7 8.3 21.7 10.0 15.7 1.1 12.5 17.9 7.7 3.8 35.6 18.6 36.3 29.4 16.1 12.0 16.9 36.0 21.2 5.0 7.8 3.1 26.1 1.3 5.5 31.2 8.1 0.0 2.1 0.0 27.0 0.6 16.9 7.4 1.6 3.9 12.2 4.9 15.2 24.2 2.8 22.1 17.5 10.9 5.5 15.0 8.4 3.8 0.0 0.0 12.1 16.2 18.9 45.8 6.7 8.7 4.4 6.7 4.3 3.2 6.2 1.8 4.8 3.2 8.3 4.4 10.6 4.1 6.8 6.0 1.5 5.3 23.2 28.0 21.3 26.7 24.7 22.3 31.8 19.4 28.9 32.5 32.8 45.1 0.0 0.0 0.0 0.0 0.0 0.0 120.5 73.9 26.2 0.0 37.7 56.3 22.0 0.0 0.0 0.0 0.0 13.1 50.7 0.0 0.0 53.5 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 17.0 0.0 42.3 0.0 0.0 15.2 0.0 0.0 72.6 0.0 0.0 0.0 0.0 0.0 0.0 53.8 0.0 0.0 0.0 SPERT "CBY2, NURIT" ENSG00000174015 "Spermatid associated" Q8NA61 13 45702311-45714559 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "testis: 66.5" "Group enriched" "Detected in some" 81 "Early spermatids: 730.0;Late spermatids: 1376.0" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "T-reg: 3.2" "Lineage enriched" "Detected in single" 32 "T-cells: 3.2" "Cell line enhanced" "Detected in some" "EFO-21: 1.8;HDLM-2: 3.5;hTCEpi: 1.2;JURKAT: 1.1;MCF7: 1.3;SCLC-21H: 1.2;SK-BR-3: 2.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA039359, HPA040046" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA039359: AB_10794088, HPA040046: AB_10796117" "unprognostic (2.86e-1)" "unprognostic (3.38e-1)" "unprognostic (1.64e-2)" "unprognostic (1.65e-1)" "unprognostic (3.76e-2)" "unprognostic (4.19e-4)" "unprognostic (8.52e-2)" "unprognostic (8.87e-2)" "unprognostic (1.23e-1)" "unprognostic (4.38e-1)" "unprognostic (2.38e-2)" "unprognostic (1.21e-1)" "unprognostic (1.56e-2)" "unprognostic (1.97e-2)" "unprognostic (4.15e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 1.8 0.8 0.0 0.0 0.1 0.0 0.0 3.5 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 1.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 0.0 2.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.7 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 3.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 730.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1376.0 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.0 12.9 0.0 7.4 5.3 0.0 0.0 0.0 0.0 0.0 SPHK1 SPHK ENSG00000176170 "Sphingosine kinase 1" Q9NYA1 17 76376584-76387860 "Enzymes, Predicted intracellular proteins" "Calmodulin-binding, Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 9 "Ductal cells: 89.4;monocytes: 99.2;Muller glia cells: 144.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 34.4;hTEC/SVTERT24-B: 30.0;TIME: 30.0;U-138 MG: 30.2;U-251 MG: 38.5" "Low region specificity" "Detected in many" "Region enriched" "Detected in single" 5 "olfactory region: 11.7" "HPA022829, HPA028761" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA022829: AB_1857438, HPA028761: AB_10600814" "unprognostic (1.04e-1)" "unprognostic (6.30e-2)" "unprognostic (1.09e-2)" "unprognostic (8.66e-2)" "unprognostic (2.25e-2)" "unprognostic (1.82e-1)" "unprognostic (1.68e-2)" "unprognostic (9.32e-3)" "unprognostic (3.13e-1)" "unprognostic (7.43e-2)" "unprognostic (8.99e-3)" "unprognostic (2.18e-1)" "prognostic unfavorable (5.14e-6)" "unprognostic (1.39e-1)" "unprognostic (4.82e-2)" "unprognostic (8.29e-2)" "unprognostic (1.10e-3)" 9.3 2.2 4.7 10.5 3.5 15.0 20.4 0.4 3.2 5.5 5.0 4.0 0.4 1.9 6.3 8.3 13.8 5.3 12.7 10.5 5.3 2.1 4.1 2.4 12.9 10.1 4.4 1.5 5.5 15.1 3.1 2.7 7.4 4.7 4.3 1.1 11.0 11.5 1.7 6.8 8.7 6.3 5.2 4.0 2.7 3.8 3.7 6.3 3.0 9.4 16.2 12.1 5.6 7.0 0.2 8.0 2.4 3.4 0.1 1.4 1.3 9.8 1.0 4.3 0.2 2.2 2.0 4.4 22.8 15.1 19.2 11.6 5.3 1.0 0.4 2.1 16.8 8.2 2.1 3.2 29.2 4.7 0.4 1.7 0.1 7.3 34.4 4.8 0.3 0.8 3.9 0.6 30.0 11.8 8.2 18.5 1.0 4.6 0.0 3.7 12.6 0.9 0.1 0.2 2.2 8.3 0.6 1.1 0.7 1.0 0.1 0.5 1.0 2.3 0.2 19.7 2.7 0.8 1.4 30.0 30.2 5.8 23.1 38.5 0.4 0.1 0.4 22.9 1.7 4.5 2.4 3.4 0.0 1.4 1.7 0.4 0.0 0.2 0.4 1.0 0.2 0.0 0.3 0.4 0.1 0.3 8.0 0.0 1.3 4.7 3.5 0.4 3.2 5.3 2.1 4.4 1.5 4.7 6.3 0.0 0.0 0.5 42.7 11.2 1.3 3.9 33.1 0.0 3.4 1.8 0.0 0.6 0.0 89.4 0.2 35.0 0.7 0.0 10.7 14.8 17.3 28.4 6.9 0.0 31.0 31.8 0.0 4.3 5.7 0.9 3.4 17.1 11.8 99.2 1.1 144.5 62.5 0.3 18.7 1.1 1.8 0.0 39.2 0.0 7.7 9.4 1.1 5.7 0.2 22.4 SPINK13 "HESPINTOR, LiESP6, MGC149260, SPINK5L3" ENSG00000214510 "Serine peptidase inhibitor, Kazal type 13 (putative)" Q1W4C9 5 148268180-148286254 "Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "ductus deferens: 85.5;epididymis: 86.8;seminal vesicle: 26.7" "Group enriched" "Detected in some" 7 "Leydig cells: 36.8;Peritubular cells: 25.1" "Group enriched" "Detected in some" 6 "cervical cancer: 0.9;lung cancer: 0.9;renal cancer: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 20 "HeLa: 102.0" HPA036456 Uncertain Approved "Nucleoplasm,Plasma membrane" "Secreted in male reproductive system" NA NA "Plasma membrane" Nucleoplasm "HPA036456: AB_10673496" "unprognostic (5.22e-2)" "unprognostic (2.03e-1)" "unprognostic (1.44e-1)" "unprognostic (2.51e-1)" "unprognostic (1.22e-1)" "unprognostic (1.41e-2)" "unprognostic (6.43e-3)" "unprognostic (1.25e-3)" "unprognostic (5.01e-3)" "unprognostic (1.25e-1)" "prognostic unfavorable (4.03e-10)" "unprognostic (4.31e-2)" "unprognostic (1.72e-1)" "unprognostic (2.43e-1)" "unprognostic (2.95e-2)" 0.1 4.6 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.2 2.2 0.0 85.5 0.0 0.4 86.8 0.1 1.0 0.1 0.8 0.0 0.1 2.1 0.0 0.1 0.1 0.0 0.0 1.4 0.4 0.0 1.0 0.1 0.0 4.0 0.0 0.0 0.1 26.7 0.1 0.2 0.0 0.1 0.0 0.0 2.9 2.7 0.0 0.0 0.4 0.1 0.1 0.4 0.1 0.4 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 102.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 5.1 0.0 0.0 0.0 5.0 0.0 0.0 0.0 0.4 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.2 0.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 1.7 0.0 25.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPPL3 "DKFZP586C1324, IMP2, MGC126674, MGC126676, MGC90402, PSL4" ENSG00000157837 "Signal peptide peptidase like 3" Q8TCT6 12 120762510-120904371 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004194, HPA059958" Uncertain Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA004194: AB_2667171, HPA059958: AB_2684179" "unprognostic (3.29e-1)" "unprognostic (2.29e-2)" "unprognostic (3.39e-2)" "unprognostic (1.63e-1)" "unprognostic (2.06e-1)" "unprognostic (7.96e-3)" "prognostic unfavorable (1.29e-5)" "unprognostic (3.17e-2)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "unprognostic (2.48e-1)" "unprognostic (2.44e-1)" "unprognostic (2.66e-1)" "unprognostic (9.34e-2)" "unprognostic (9.92e-2)" "unprognostic (7.54e-2)" "unprognostic (9.40e-2)" 17.8 15.3 18.9 12.8 23.1 13.9 19.4 21.8 31.4 25.2 20.4 25.6 18.4 14.0 23.1 13.3 39.5 23.3 18.2 13.9 17.4 18.3 18.3 14.9 20.8 21.5 19.2 20.6 25.9 19.6 42.4 14.3 21.9 16.5 16.9 21.7 19.1 19.2 22.7 13.8 48.3 18.5 23.5 17.1 19.0 14.2 34.7 20.8 25.2 24.7 22.2 20.6 19.8 29.3 4.1 6.3 7.3 2.9 2.8 4.4 1.5 12.4 12.5 18.9 11.8 25.0 16.9 13.3 9.6 28.6 20.7 16.7 12.9 12.8 11.5 0.1 16.7 18.4 15.3 19.2 20.7 21.5 9.1 11.8 9.8 7.4 9.8 26.5 11.3 12.8 17.0 33.2 17.7 16.7 24.6 20.3 17.8 10.8 5.8 17.8 11.0 15.1 9.1 12.6 11.7 8.8 9.0 15.9 8.2 16.2 35.5 13.0 14.0 18.3 8.4 14.4 21.1 25.5 7.9 15.1 9.6 13.2 5.9 7.1 13.5 24.2 11.2 14.3 9.4 15.9 7.3 2.9 2.6 3.2 2.8 4.4 3.2 4.0 4.0 4.9 4.1 3.9 4.3 5.5 2.8 2.4 6.3 3.1 1.5 18.9 23.1 21.8 31.4 17.4 18.3 19.2 20.6 16.5 20.8 17.9 17.3 21.4 28.0 48.9 33.5 17.7 17.8 8.1 13.6 38.4 25.5 32.4 1.7 16.9 6.4 28.1 32.5 0.0 21.2 21.9 34.3 27.4 4.6 27.7 32.0 35.0 26.0 32.5 31.3 6.2 26.4 27.5 25.3 13.6 36.3 27.5 19.2 31.7 32.9 18.7 22.1 12.9 21.7 48.8 40.1 74.0 54.0 16.0 33.6 30.8 SPTBN2 SCA5 ENSG00000173898 "Spectrin beta, non-erythrocytic 2" O15020 11 66685248-66729226 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Disease mutation, Neurodegeneration, Spinocerebellar ataxia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.7;skin 1: 36.9" "Cell type enhanced" "Detected in many" 13 "Collecting duct cells: 82.0;Cone photoreceptor cells: 98.2;Late spermatids: 50.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HeLa: 20.3;NTERA-2: 23.5;SCLC-21H: 23.9;SK-BR-3: 16.7;T-47d: 19.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009844, HPA039293, HPA043529" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA 4800000 "Plasma membrane" "Cell Junctions" "CAB009844: AB_2194521, HPA039293: AB_2676430, HPA043529: AB_2678531" "unprognostic (9.34e-2)" "unprognostic (5.71e-2)" "unprognostic (4.89e-2)" "unprognostic (3.41e-3)" "unprognostic (4.91e-1)" "unprognostic (6.05e-3)" "unprognostic (4.45e-2)" "unprognostic (1.38e-2)" "unprognostic (7.25e-2)" "unprognostic (1.67e-2)" "prognostic unfavorable (3.14e-5)" "unprognostic (1.64e-1)" "unprognostic (1.05e-3)" "unprognostic (1.34e-1)" "unprognostic (1.84e-1)" "unprognostic (3.99e-2)" "unprognostic (1.00e-3)" 0.8 4.9 26.2 1.0 38.3 1.7 4.5 29.6 46.7 9.6 0.9 2.0 0.0 1.0 1.1 1.2 12.7 2.6 1.2 0.7 19.7 8.2 12.7 7.1 0.9 0.5 6.5 24.7 0.8 8.3 12.2 3.9 0.7 14.4 6.8 0.7 1.7 13.4 3.1 0.7 36.9 0.9 1.2 1.9 0.9 1.2 18.9 6.2 0.0 0.5 0.1 3.3 1.1 3.6 0.1 0.0 0.4 0.0 0.0 0.0 0.0 6.5 3.4 1.6 0.2 0.0 0.0 0.2 0.1 0.0 0.0 0.0 2.2 8.1 0.0 1.8 0.0 0.3 7.8 11.9 1.1 0.0 0.0 4.7 0.0 20.3 1.1 0.3 3.3 0.3 0.1 5.5 0.0 3.5 1.9 2.9 2.4 3.3 0.0 0.0 12.8 2.6 1.5 23.5 9.2 10.5 10.9 1.3 6.7 4.5 1.1 23.9 14.1 6.6 16.7 1.5 1.3 19.1 0.9 0.6 0.0 4.2 0.6 5.2 0.3 1.2 7.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 26.2 38.3 29.6 46.7 19.7 8.2 6.5 24.7 14.4 6.2 3.0 0.6 0.0 1.7 3.3 7.4 1.6 2.5 1.4 2.3 82.0 98.2 0.8 0.0 2.4 24.4 0.6 0.0 0.0 8.7 0.3 0.5 3.1 0.0 20.2 0.1 0.0 2.9 1.3 0.0 50.4 1.7 0.0 0.0 1.0 1.6 1.4 6.9 0.0 1.4 1.2 21.0 0.0 0.0 2.7 8.6 10.9 0.2 0.0 0.6 1.4 SRD5A3 "FLJ13352, SRD5A2L, SRD5A2L1" ENSG00000128039 "Steroid 5 alpha-reductase 3" Q9H8P0 4 55346109-55373096 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Cataract, Congenital disorder of glycosylation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Exocrine glandular cells: 92.9;Extravillous trophoblasts: 88.2;Pancreatic endocrine cells: 133.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SK-BR-3: 42.6" "Low region specificity" "Detected in all" HPA027006 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027006: AB_1857469" "unprognostic (1.12e-2)" "unprognostic (1.01e-1)" "unprognostic (4.02e-2)" "prognostic favorable (9.39e-4)" "unprognostic (1.50e-2)" "unprognostic (4.81e-2)" "prognostic unfavorable (1.80e-6)" "unprognostic (9.31e-2)" "unprognostic (5.28e-2)" "unprognostic (1.81e-2)" "unprognostic (3.29e-3)" "unprognostic (1.18e-1)" "prognostic unfavorable (4.85e-10)" "unprognostic (4.16e-2)" "unprognostic (1.42e-1)" "unprognostic (1.43e-2)" "unprognostic (9.52e-2)" 13.8 12.2 11.5 5.9 13.4 6.6 17.8 7.3 18.3 22.9 11.3 20.3 3.5 6.9 13.8 9.6 24.4 5.9 22.6 10.5 13.2 10.7 12.3 15.0 12.4 10.1 15.5 12.0 3.5 26.8 14.0 7.0 8.8 13.6 8.9 10.9 6.8 16.3 6.6 5.8 15.6 8.3 6.2 22.1 6.9 13.8 4.0 15.3 10.0 7.6 9.9 12.1 12.1 12.1 5.9 28.4 10.3 25.2 3.6 9.2 10.3 4.8 3.2 5.8 5.5 19.5 12.5 2.9 5.3 6.2 2.2 3.6 3.2 10.1 11.5 6.0 8.3 6.2 3.8 4.1 4.9 2.8 3.3 7.3 6.3 3.6 8.6 5.2 11.6 3.5 11.4 9.1 3.8 3.5 4.8 9.0 21.5 10.7 25.8 12.6 6.3 17.0 5.1 7.3 27.6 4.3 5.5 1.8 6.5 7.4 5.2 9.0 5.0 5.6 42.6 3.8 6.0 5.2 10.2 4.4 14.2 2.6 1.0 4.0 13.8 7.6 4.2 18.0 16.0 13.8 10.3 16.5 4.9 7.9 25.1 9.2 5.9 6.0 7.4 14.1 5.2 5.3 7.1 0.8 3.6 25.2 28.4 5.8 10.3 11.5 13.4 7.3 18.3 13.2 10.7 15.5 12.0 13.6 15.3 8.9 15.7 3.0 9.5 12.0 4.6 4.6 45.9 12.0 12.5 5.2 3.9 22.7 3.3 67.0 2.0 14.3 8.4 0.0 92.9 88.2 17.0 22.1 13.9 17.1 62.0 9.5 11.5 17.8 20.9 0.0 1.7 27.9 23.6 24.4 19.3 18.6 133.4 5.8 5.3 12.2 3.8 12.9 9.5 2.1 18.8 26.0 6.3 4.9 20.9 49.7 ST8SIA5 SIAT8E ENSG00000101638 "ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5" O15466 18 46667821-46759257 "Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "adrenal gland: 12.8;brain: 36.4" "Cell type enhanced" "Detected in some" 16 "Cardiomyocytes: 6.9;Collecting duct cells: 1.8;Early spermatids: 2.7;Late spermatids: 5.2" "Cancer enriched" "Detected in single" 8 "glioma: 2.6" "Region enhanced" "Detected in many" "cerebellum: 36.4" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in some" 8 "WM-115: 52.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043813, HPA046771" Approved Approved "Plasma membrane,Midbody" NA NA "Plasma membrane, Midbody" "HPA043813: AB_2678683, HPA046771: AB_2679798" "unprognostic (3.19e-2)" "unprognostic (1.16e-1)" "unprognostic (2.47e-2)" "unprognostic (1.33e-4)" "unprognostic (2.99e-2)" "unprognostic (4.83e-2)" "unprognostic (1.90e-2)" "unprognostic (1.39e-2)" "unprognostic (1.35e-1)" "unprognostic (1.36e-1)" "unprognostic (1.57e-2)" "unprognostic (1.84e-2)" "unprognostic (6.55e-2)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" "unprognostic (1.12e-1)" "unprognostic (1.79e-2)" 0.6 12.8 3.6 0.6 7.8 0.9 0.5 36.4 16.1 0.5 0.5 1.0 0.0 0.7 0.5 0.9 0.4 0.7 0.6 7.2 4.0 1.8 1.5 0.4 0.5 0.5 2.0 6.9 0.7 0.4 4.9 0.7 0.4 4.1 0.6 0.5 0.0 0.4 0.5 8.2 0.7 0.5 0.5 2.5 0.5 0.7 0.9 0.7 0.0 0.6 0.0 0.5 0.5 0.1 0.8 0.4 1.5 0.4 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.1 0.1 0.0 0.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.0 0.0 52.9 1.0 0.4 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.8 0.3 0.3 1.5 0.5 0.2 0.4 0.1 0.0 3.6 7.8 36.4 16.1 4.0 1.8 2.0 6.9 4.1 0.7 0.0 0.0 0.0 0.0 0.0 1.0 6.9 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.4 0.0 0.7 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 STAC STAC1 ENSG00000144681 "SH3 and cysteine rich domain" Q99469 3 36380344-36548007 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in some" 22 "Distal tubular cells: 5.0;Early spermatids: 4.5;granulocytes: 5.8;Muller glia cells: 21.3" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebellum: 21.3" "Group enriched" "Detected in some" 5 "eosinophil: 3.2;NK-cell: 2.8;T-reg: 3.8" "Group enriched" "Detected in many" 5 "granulocytes: 3.2;NK-cells: 2.8;T-cells: 3.8" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 22.0;HaCaT: 16.2;hTERT-RPE1: 13.5;SH-SY5Y: 23.2;U-251 MG: 14.1;U-87 MG: 23.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035143 Uncertain Uncertain "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035143: AB_10603892" "unprognostic (5.29e-2)" "unprognostic (7.61e-2)" "unprognostic (2.58e-1)" "unprognostic (1.44e-6)" "unprognostic (4.24e-2)" "unprognostic (1.83e-2)" "unprognostic (3.06e-2)" "unprognostic (3.89e-1)" "unprognostic (2.02e-1)" "unprognostic (3.31e-3)" "unprognostic (1.77e-3)" "unprognostic (5.82e-2)" "unprognostic (8.07e-2)" "unprognostic (1.73e-4)" "unprognostic (8.93e-2)" "unprognostic (1.95e-1)" "unprognostic (7.94e-3)" 3.7 6.4 1.4 1.1 5.4 0.6 5.7 21.3 0.8 9.2 4.6 1.2 4.7 0.3 9.0 2.2 3.3 4.0 5.1 0.7 0.9 3.9 3.3 1.8 15.0 0.7 1.6 0.2 3.2 0.6 18.8 1.8 0.6 5.2 17.2 1.1 1.9 1.8 5.7 4.0 1.6 0.6 12.5 1.2 0.9 1.5 2.4 0.2 0.7 1.0 4.4 0.5 8.4 15.5 0.0 0.6 3.2 0.4 2.8 3.8 0.2 3.5 1.5 0.8 0.0 3.2 1.0 0.0 9.0 0.2 1.9 2.3 0.0 0.0 0.0 3.7 22.0 6.3 16.2 1.1 3.9 2.0 0.0 2.8 0.5 4.9 0.1 0.0 9.0 0.1 1.2 0.1 0.0 0.3 13.5 0.0 0.9 0.0 0.2 0.2 0.0 1.8 0.1 6.7 0.0 1.4 0.0 0.0 0.0 5.1 0.0 3.0 23.2 3.6 2.5 0.0 7.0 0.0 0.9 4.0 0.2 9.4 0.3 14.1 0.0 0.0 0.0 23.9 3.6 4.0 0.0 0.1 3.2 0.0 0.4 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 2.8 0.1 0.0 3.8 0.2 1.4 5.4 21.3 0.8 0.9 3.9 1.6 0.2 5.2 0.2 0.0 0.3 0.0 0.0 0.0 0.7 1.1 0.0 0.0 2.3 0.0 0.0 0.0 5.0 0.1 4.5 0.1 0.0 0.0 0.0 0.1 0.2 0.0 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.8 0.0 0.0 0.0 21.3 0.1 0.0 0.0 0.0 0.6 0.0 2.0 0.6 0.0 0.3 0.0 0.0 0.0 0.0 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210536-39225872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 94.0;seminal vesicle: 101.5" "Cell type enriched" "Detected in many" 11 "Muller glia cells: 446.6" "Group enriched" "Detected in many" 7 "breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "GAMG: 8.3;HeLa: 25.8;hTEC/SVTERT24-B: 3.8;U-87 MG: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavorable (4.05e-5)" "prognostic unfavorable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavorable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 2.4 0.9 4.2 1.0 7.4 0.7 29.7 9.5 21.9 4.0 0.9 0.0 94.0 0.9 2.5 13.9 0.8 1.4 0.8 1.0 6.8 3.2 4.8 0.7 0.9 0.8 3.5 6.6 1.2 1.1 0.7 0.5 1.0 13.1 1.8 0.9 8.2 7.8 101.5 0.8 20.1 0.8 1.7 1.4 0.8 0.8 0.9 0.2 0.0 0.7 0.0 0.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 8.3 0.0 3.3 0.0 0.0 0.0 0.4 0.0 25.8 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.2 2.7 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.4 9.5 21.7 6.8 3.2 3.5 6.6 13.1 0.2 3.0 8.0 0.0 1.2 0.3 4.8 2.9 0.0 2.7 4.5 3.5 9.8 0.1 5.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.6 0.3 0.0 0.0 0.1 17.5 0.0 0.0 0.0 0.0 2.6 0.0 40.5 0.0 0.0 446.6 0.0 0.0 0.0 0.0 11.1 0.0 3.4 0.2 0.9 1.5 0.2 0.0 0.0 0.1 STAT2 STAT113 ENSG00000170581 "Signal transducer and activator of transcription 2" P52630 12 56341597-56360155 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Antiviral defense, Host-virus interaction, Transcription, Transcription regulation" "Activator, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003858, HPA018888" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "CAB003858: AB_562227, HPA018888: AB_1857550" "unprognostic (3.03e-1)" "unprognostic (8.59e-2)" "unprognostic (6.92e-3)" "prognostic unfavorable (4.75e-4)" "unprognostic (1.10e-1)" "unprognostic (1.52e-1)" "unprognostic (7.27e-2)" "unprognostic (1.93e-1)" "unprognostic (2.60e-1)" "unprognostic (4.12e-3)" "unprognostic (1.56e-1)" "unprognostic (7.45e-3)" "prognostic unfavorable (4.78e-13)" "unprognostic (1.88e-1)" "unprognostic (5.56e-2)" "unprognostic (2.77e-1)" "unprognostic (1.46e-3)" 30.8 14.7 10.4 24.2 20.8 11.9 18.4 21.3 18.6 21.4 13.8 39.8 12.2 15.1 24.0 12.6 13.9 16.7 23.0 11.6 10.9 9.2 12.8 25.7 22.1 19.9 27.3 13.3 22.9 13.1 18.3 28.0 18.7 29.1 15.8 15.1 24.5 18.7 12.4 10.6 15.2 17.3 22.9 29.2 29.4 13.9 7.0 22.1 19.9 20.3 7.6 23.1 24.2 16.7 6.6 8.5 8.2 16.9 3.5 6.8 8.1 4.7 2.5 5.9 4.7 30.5 21.1 9.6 8.5 30.4 33.9 33.6 3.5 6.3 6.2 7.9 13.8 8.5 6.5 6.9 5.0 6.7 5.2 2.1 9.4 4.7 3.5 20.9 2.1 9.1 31.4 4.5 7.7 7.7 28.7 7.9 5.6 5.1 17.3 10.9 2.8 3.2 2.6 1.8 4.4 3.3 3.0 7.0 4.9 6.9 6.9 1.7 3.5 12.2 6.7 12.7 8.3 6.3 5.3 5.2 11.8 4.2 4.0 1.5 13.8 10.0 3.2 10.9 2.7 4.0 8.2 11.2 7.6 5.8 16.9 5.8 3.7 5.7 5.9 8.5 6.6 4.4 3.7 5.7 3.5 12.6 7.6 6.8 8.1 10.4 20.8 21.3 18.6 10.9 9.2 27.3 13.3 29.1 22.1 11.9 48.6 22.1 6.7 12.7 16.2 10.1 22.9 18.7 28.4 17.4 19.6 9.4 1.7 10.6 10.6 22.4 17.5 0.0 9.4 22.2 18.4 10.4 9.3 62.1 24.2 3.2 14.9 25.8 41.9 23.3 18.1 29.9 30.4 10.8 13.8 10.3 11.6 17.5 16.3 7.8 19.8 25.8 14.6 2.3 4.4 12.7 9.3 14.0 11.0 10.1 STEAP4 "FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9" ENSG00000127954 "STEAP4 metalloreductase" Q687X5 7 88270892-88306891 "Predicted membrane proteins, Transporters" "Electron transport, Ion transport, Iron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "adipose tissue: 122.8" "Cell type enhanced" "Detected in many" 15 "Alveolar cells type 2: 320.5;Club cells: 178.6;Sertoli cells: 452.7" "Cancer enhanced" "Detected in many" "prostate cancer: 45.9" "Group enriched" "Detected in some" 5 "midbrain: 1.7;pons and medulla: 6.4" "Cell type enriched" "Detected in some" 13 "neutrophil: 48.9" "Lineage enriched" "Detected in many" 13 "granulocytes: 48.9" "Group enriched" "Detected in some" 6 "HSkMC: 39.3;SiHa: 36.9;U-2197: 52.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA065201 Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA065201: " "unprognostic (3.76e-2)" "unprognostic (2.16e-2)" "unprognostic (8.82e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-1)" "unprognostic (9.96e-2)" "prognostic favorable (2.97e-4)" "unprognostic (7.40e-2)" "unprognostic (3.12e-1)" "unprognostic (4.66e-2)" "unprognostic (4.21e-1)" "unprognostic (2.98e-1)" "unprognostic (7.51e-3)" "prognostic unfavorable (5.77e-4)" "unprognostic (1.72e-1)" "unprognostic (2.00e-1)" "unprognostic (4.53e-2)" 122.8 29.3 0.3 12.7 0.8 2.4 55.6 0.6 0.7 15.9 14.0 1.1 5.3 1.4 10.7 22.3 23.7 17.1 9.3 18.7 0.5 0.3 10.8 71.7 27.5 49.4 1.7 0.2 17.8 13.3 12.0 35.1 45.0 6.4 25.8 3.9 4.9 14.6 4.6 22.1 10.5 5.2 13.9 1.8 5.3 5.7 27.3 0.4 0.4 40.9 8.4 5.2 28.4 26.3 0.0 0.3 48.9 3.8 0.0 0.0 0.7 1.4 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.1 5.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 39.3 0.0 0.1 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 36.9 3.1 0.0 0.0 0.2 0.0 0.0 0.1 0.1 52.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 3.8 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 48.9 0.0 0.0 0.0 0.0 0.7 0.3 0.8 0.6 0.7 0.5 0.3 1.7 0.2 6.4 0.4 50.6 320.5 0.0 6.3 8.4 1.1 4.0 0.0 97.7 178.6 0.0 2.0 0.3 0.0 11.7 12.9 8.9 0.0 0.0 8.2 9.0 11.1 62.8 15.1 0.4 2.1 0.0 0.0 19.0 5.1 1.9 106.4 7.7 5.0 0.0 0.0 2.4 16.5 0.0 8.5 0.0 0.2 452.7 115.4 0.9 0.2 16.4 9.2 0.0 0.0 12.2 STIL "MCPH7, SIL" ENSG00000123473 "STIL, centriolar assembly protein" Q15468 1 47250139-47314147 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Developmental protein" "Cancer-related genes, Disease mutation, Mental retardation, Primary microcephaly, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 36.0;testis: 23.8" "Cell type enhanced" "Detected in many" 9 "Spermatocytes: 18.6;Spermatogonia: 17.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA046543 Approved "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA046543: AB_2679692" "unprognostic (2.07e-1)" "unprognostic (6.29e-2)" "unprognostic (5.54e-3)" "unprognostic (2.67e-3)" "unprognostic (1.76e-1)" "unprognostic (1.56e-2)" "unprognostic (2.90e-5)" "unprognostic (7.35e-3)" "unprognostic (4.04e-3)" "unprognostic (1.41e-1)" "prognostic unfavorable (1.33e-4)" "unprognostic (5.81e-2)" "unprognostic (3.36e-14)" "unprognostic (5.76e-3)" "unprognostic (2.58e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" 1.2 1.4 1.3 10.8 2.4 11.0 2.9 1.4 2.2 1.2 4.1 0.9 2.5 3.6 1.5 2.2 5.8 0.9 1.7 2.0 1.4 1.2 1.5 1.6 1.7 5.0 1.3 1.5 1.2 1.5 0.9 0.9 5.5 1.1 1.7 6.4 0.8 3.6 0.5 0.8 4.2 4.0 1.3 1.2 3.4 2.2 23.8 1.0 36.0 1.1 3.5 7.1 1.3 2.1 1.9 1.6 5.4 0.7 3.3 1.2 0.5 16.9 9.1 13.1 11.7 0.9 2.3 8.4 15.0 7.2 16.8 17.7 9.8 8.4 20.0 7.1 7.5 17.3 11.3 15.3 7.9 18.1 14.9 6.9 22.5 11.3 8.6 0.5 18.2 11.5 0.8 1.3 14.4 9.4 2.1 11.1 15.3 15.9 19.1 12.6 7.7 17.6 5.7 15.9 9.4 7.5 11.5 21.4 9.6 4.7 10.2 11.7 7.0 16.1 11.9 7.8 16.3 7.7 10.4 6.5 15.9 16.1 11.4 20.3 6.3 13.1 19.7 7.4 13.9 14.7 4.3 0.7 1.1 1.1 0.4 0.5 1.7 1.2 1.0 0.5 1.9 0.8 0.8 5.4 3.3 0.3 1.6 1.1 0.5 1.3 2.4 1.4 2.2 1.4 1.2 1.3 1.5 1.1 1.0 3.0 0.3 2.2 0.5 0.8 1.2 0.5 0.0 6.7 2.3 0.0 3.9 1.2 0.0 1.2 0.7 0.9 1.8 0.0 0.4 3.8 0.8 1.2 2.3 0.5 2.3 0.0 1.7 1.8 1.9 1.3 0.3 1.2 0.0 4.6 4.3 0.8 1.8 1.5 0.7 0.3 0.7 0.0 0.0 18.6 17.8 2.0 0.7 0.8 3.4 1.4 STK10 "LOK, PRO2729" ENSG00000072786 "Serine/threonine kinase 10" O94804 5 172042073-172188386 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 40.9" "Cell type enhanced" "Detected in many" 7 "Kupffer cells: 78.5;T-cells: 70.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in all" 5 "cerebellum: 27.5" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "WM-115: 52.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015083, CAB020840" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 24000 "Nucleoplasm, Plasma membrane" "CAB020840: , HPA015083: AB_2669151" "unprognostic (1.17e-1)" "unprognostic (5.43e-2)" "prognostic favorable (2.76e-4)" "unprognostic (2.88e-1)" "unprognostic (6.96e-3)" "unprognostic (1.02e-1)" "unprognostic (5.25e-3)" "unprognostic (3.07e-2)" "unprognostic (1.07e-1)" "unprognostic (1.03e-1)" "unprognostic (2.65e-1)" "unprognostic (3.43e-1)" "prognostic unfavorable (1.63e-4)" "unprognostic (1.09e-1)" "unprognostic (1.01e-2)" "unprognostic (3.10e-1)" "unprognostic (1.84e-1)" 15.0 4.7 2.6 25.8 4.4 38.3 13.5 27.5 3.0 3.6 5.0 4.8 3.4 4.7 4.4 4.4 3.6 4.2 11.0 9.0 2.4 2.5 5.3 4.5 15.4 40.9 5.4 1.9 3.5 4.1 2.5 3.7 16.2 4.5 4.3 4.0 5.6 7.8 2.5 3.1 9.0 12.2 5.7 4.6 33.0 6.2 13.1 3.5 20.6 4.6 3.1 23.7 9.5 11.3 5.0 10.3 22.3 30.8 7.4 18.0 15.6 7.8 7.3 4.5 6.8 5.3 6.6 11.6 10.2 8.5 7.4 6.9 3.8 10.4 9.5 5.4 12.6 15.7 9.2 2.0 12.5 4.8 12.3 3.4 11.4 3.0 2.1 7.6 11.5 13.5 6.5 2.7 10.1 8.4 2.7 6.4 3.7 1.0 13.3 5.2 12.6 8.2 25.8 1.8 3.9 5.8 13.6 3.6 6.2 3.0 9.9 3.1 3.8 5.9 8.3 28.0 5.9 2.9 24.4 8.9 8.3 4.2 5.8 5.5 11.2 16.5 6.0 10.9 17.7 52.3 7.1 10.8 10.0 18.0 21.4 13.3 5.0 9.4 12.8 10.3 4.4 5.6 9.6 22.3 7.4 30.8 3.2 12.2 15.6 2.6 4.4 27.5 3.0 2.4 2.5 5.4 1.9 4.5 3.5 3.0 12.8 25.0 7.9 6.0 3.8 3.6 2.5 5.3 5.7 1.8 5.9 2.8 1.7 4.4 1.7 17.8 8.4 0.0 5.3 25.1 7.4 6.7 26.7 2.1 30.8 44.5 11.5 20.3 78.5 2.7 2.6 39.2 8.5 9.0 15.0 3.1 7.9 7.0 1.4 1.5 2.2 12.9 8.2 5.7 6.8 3.6 4.2 70.5 4.7 9.5 STK17A DRAK1 ENSG00000164543 "Serine/threonine kinase 17a" Q9UEE5 7 43582758-43626786 "Enzymes, Plasma proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 43.3" "Cell type enhanced" "Detected in many" 10 "Basal glandular cells: 549.3;Urothelial cells: 279.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "HPA018138, HPA037979" Uncertain Supported "Nuclear speckles,Plasma membrane" Yes No "Nuclear speckles" "Plasma membrane" "HPA018138: AB_2669784, HPA037979: AB_10795247" "unprognostic (1.81e-3)" "unprognostic (1.08e-2)" "unprognostic (2.67e-1)" "unprognostic (5.41e-2)" "unprognostic (5.11e-2)" "unprognostic (3.35e-2)" "unprognostic (1.03e-2)" "unprognostic (9.15e-3)" "unprognostic (2.07e-1)" "unprognostic (6.34e-2)" "unprognostic (1.36e-2)" "unprognostic (6.61e-2)" "unprognostic (2.99e-3)" "unprognostic (3.76e-2)" "unprognostic (3.08e-1)" "unprognostic (1.97e-3)" "unprognostic (3.66e-1)" 7.1 10.1 6.1 43.3 8.2 20.2 8.4 7.9 7.2 4.8 9.3 3.7 2.0 6.1 5.3 4.2 10.1 4.7 8.6 17.7 5.7 5.6 6.7 8.1 15.2 36.6 6.6 2.6 7.3 14.3 1.5 6.3 37.2 5.7 6.2 5.3 3.6 8.6 3.4 10.7 4.8 12.3 5.8 5.3 27.8 11.0 9.0 2.8 30.1 7.3 6.8 37.7 10.3 8.1 10.8 1.4 11.5 0.9 12.7 11.4 2.9 4.4 5.5 5.0 3.4 6.3 8.3 2.1 15.9 17.3 8.7 8.9 4.8 3.2 7.1 25.1 13.3 17.8 9.1 3.8 21.2 12.2 17.5 4.3 6.3 4.1 5.9 4.7 10.8 4.2 6.8 25.0 11.5 10.6 34.5 16.3 7.7 7.4 24.4 10.0 2.0 17.6 5.0 7.7 2.6 18.1 6.1 3.2 14.0 15.2 3.3 2.7 6.1 7.2 3.3 4.6 10.7 3.8 5.5 16.3 19.0 7.2 11.2 17.8 14.8 7.3 10.2 19.3 9.6 30.2 0.7 0.4 11.5 5.8 0.2 5.8 10.8 6.1 9.7 0.3 10.1 11.4 10.2 6.4 12.7 0.9 1.4 3.2 2.9 6.1 8.2 7.9 5.9 5.7 5.6 6.6 2.6 5.7 2.8 113.2 27.8 121.1 549.3 161.6 3.0 25.4 5.1 52.2 81.9 19.2 9.8 44.4 28.2 110.3 36.3 19.4 29.1 0.0 82.8 19.7 31.9 134.1 39.1 7.7 15.8 0.0 6.9 16.5 16.2 8.8 5.5 19.9 33.7 55.1 27.8 8.1 75.9 56.1 2.5 9.7 25.2 6.5 55.6 45.1 29.6 118.9 55.8 186.8 10.0 279.4 STK17B DRAK2 ENSG00000081320 "Serine/threonine kinase 17b" O94768 2 196133566-196176503 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Apoptosis "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 62.0;bone marrow: 103.4;lymphoid tissue: 72.2" "Cell type enhanced" "Detected in many" 5 "B-cells: 158.6;granulocytes: 189.5;Kupffer cells: 142.8;Macrophages: 145.8;T-cells: 178.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 36.3;HMC-1: 36.8;Karpas-707: 34.1;U-698: 39.5" "Region enriched" "Detected in many" 6 "cerebellum: 71.1" "Low region specificity" "Detected in all" HPA034858 Enhanced Uncertain "Plasma membrane,Cytosol" NA Yes "Plasma membrane, Cytosol" "HPA034858: AB_10670981" "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (3.68e-2)" "unprognostic (3.61e-2)" "unprognostic (3.63e-2)" "unprognostic (7.43e-3)" "unprognostic (1.75e-1)" "unprognostic (7.63e-2)" "unprognostic (9.15e-2)" "unprognostic (1.14e-1)" "unprognostic (9.90e-2)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.72e-8)" "unprognostic (1.88e-1)" "unprognostic (1.19e-2)" "unprognostic (2.64e-2)" "unprognostic (5.80e-2)" 21.0 4.1 3.2 42.8 3.8 103.4 10.1 3.2 3.3 8.2 18.8 1.1 3.8 8.5 3.4 3.9 8.9 6.3 8.6 5.7 3.3 2.2 7.2 2.9 26.2 53.7 2.3 1.8 3.1 5.0 0.7 3.8 6.5 1.7 6.8 5.7 3.5 16.7 6.1 3.4 10.9 31.8 5.3 2.7 59.3 6.0 4.6 1.4 72.2 7.5 7.0 56.2 11.3 6.0 16.9 13.6 62.0 27.0 10.3 28.4 19.0 3.2 2.2 3.4 1.2 15.0 5.7 3.8 7.7 11.6 8.5 8.9 6.8 1.1 36.3 7.1 4.4 2.2 2.2 1.4 3.3 10.4 6.4 3.8 3.4 2.9 0.6 4.5 13.7 36.8 7.2 3.3 10.5 5.5 12.1 3.5 8.6 2.6 34.1 21.1 1.7 17.8 31.0 1.9 5.9 5.2 2.9 20.7 11.0 5.0 7.6 1.3 1.3 1.9 1.9 1.6 5.5 1.3 7.2 4.2 8.3 4.1 5.9 4.3 14.0 22.6 39.5 6.2 4.7 3.6 35.9 19.7 40.2 12.0 20.7 15.3 13.3 21.5 14.5 13.6 16.9 28.4 23.1 62.0 10.3 27.0 9.7 18.5 19.0 3.2 3.8 3.2 3.3 3.3 2.2 2.3 1.8 1.7 1.4 83.4 80.3 158.6 22.9 53.1 0.3 2.2 10.2 34.8 52.4 10.4 0.0 5.9 3.3 5.2 4.6 11.6 59.1 46.7 2.5 20.9 21.2 28.7 189.5 2.4 23.5 0.0 2.9 7.4 142.8 2.0 5.2 145.8 55.6 40.5 11.0 0.9 7.9 38.6 4.2 1.4 0.2 6.5 20.5 28.6 24.9 55.5 4.2 178.5 10.5 39.9 STOML2 "HSPC108, SLP-2" ENSG00000165283 "Stomatin like 2" Q9UJZ1 9 35099776-35103195 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015944, HPA062016" Supported Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 98000 "Plasma membrane, Cytosol" "CAB015944: , HPA062016: AB_2684659" "unprognostic (2.49e-1)" "unprognostic (2.69e-1)" "unprognostic (1.20e-2)" "unprognostic (9.43e-2)" "unprognostic (1.29e-1)" "unprognostic (6.13e-2)" "prognostic unfavorable (4.77e-4)" "unprognostic (5.14e-2)" "unprognostic (4.25e-2)" "unprognostic (1.04e-2)" "unprognostic (9.06e-2)" "unprognostic (1.45e-1)" "prognostic favorable (3.00e-5)" "unprognostic (2.74e-2)" "unprognostic (5.26e-1)" "unprognostic (2.67e-1)" "unprognostic (5.47e-2)" 23.2 38.6 20.5 24.8 20.7 26.9 25.3 20.9 30.3 22.1 30.8 19.9 17.4 26.6 26.6 25.5 32.9 28.2 35.4 49.6 18.6 19.1 38.6 67.1 17.1 31.7 18.8 18.8 30.9 48.3 20.4 17.4 28.5 20.7 25.6 33.6 25.0 32.1 25.5 59.2 26.3 39.0 26.7 13.8 23.1 28.7 23.2 14.3 32.4 34.8 46.3 33.8 24.8 21.1 34.7 44.4 20.5 27.1 33.8 40.3 37.7 47.0 54.7 29.4 43.8 21.6 26.0 31.5 23.3 34.4 66.6 48.7 61.6 22.2 39.9 16.5 29.8 47.7 20.2 44.8 52.4 44.6 34.0 41.0 24.4 46.4 58.2 63.3 46.1 28.0 32.9 40.9 54.0 64.9 21.0 43.4 40.7 39.6 24.5 32.5 38.1 41.0 81.8 46.0 35.3 34.6 35.9 24.8 42.6 36.0 28.4 27.3 33.2 13.1 35.5 30.1 21.9 24.6 29.8 23.4 22.8 32.2 18.8 41.1 17.2 29.4 37.6 30.3 29.3 30.5 20.5 27.1 14.8 25.5 23.1 30.0 34.7 28.8 28.7 35.8 30.2 27.8 25.3 4.7 33.8 16.6 44.4 40.3 37.7 20.5 20.7 20.9 30.3 18.6 19.1 18.8 18.8 20.7 14.3 38.7 30.7 67.8 97.0 85.6 32.1 74.2 99.3 64.3 54.6 47.1 7.9 204.6 212.2 112.4 62.9 62.9 121.7 46.7 133.0 205.2 74.7 89.1 82.0 100.2 114.0 17.5 94.8 54.6 32.3 17.5 69.6 50.8 94.5 110.0 124.3 59.7 118.2 126.3 65.4 214.3 28.6 51.8 82.4 68.9 106.7 100.1 139.1 53.3 180.1 119.6 STXBP4 "MGC50337, Synip" ENSG00000166263 "Syntaxin binding protein 4" Q6ZWJ1 17 54968727-55173632 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pituitary gland: 36.3" "Cell type enhanced" "Detected in many" 6 "Cone photoreceptor cells: 39.3;Sertoli cells: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB007760, HPA022138, HPA022888, HPA024227" Approved Approved "Plasma membrane,Cytosol" No No "Plasma membrane" Cytosol "CAB007760: AB_562350, HPA022138: AB_1857628, HPA022888: AB_1857629, HPA024227: AB_1857630" "unprognostic (5.89e-2)" "unprognostic (2.50e-2)" "unprognostic (1.30e-3)" "unprognostic (9.27e-2)" "unprognostic (1.03e-3)" "unprognostic (1.48e-1)" "unprognostic (5.00e-5)" "unprognostic (4.11e-2)" "unprognostic (1.53e-1)" "unprognostic (1.28e-2)" "unprognostic (3.45e-2)" "unprognostic (2.11e-1)" "unprognostic (1.60e-2)" "unprognostic (2.98e-2)" "unprognostic (1.65e-1)" "unprognostic (1.31e-1)" "unprognostic (1.44e-1)" 7.7 6.4 5.5 4.3 6.0 3.4 5.2 10.6 4.7 9.9 6.4 4.2 7.5 6.3 12.0 7.2 5.1 7.3 6.6 5.9 6.7 4.7 14.5 3.8 8.0 3.2 4.2 4.5 9.9 5.4 19.3 36.3 4.7 6.8 9.5 4.6 7.6 4.5 9.4 4.0 3.7 5.1 13.2 8.6 5.0 5.5 5.6 5.1 7.2 7.9 2.7 3.5 9.6 8.2 3.2 2.9 4.0 1.2 5.1 2.9 0.7 5.5 8.3 7.7 6.8 6.5 6.4 3.1 4.3 4.2 5.7 5.6 4.9 3.0 3.8 9.3 4.3 5.0 3.3 9.8 4.3 10.5 5.7 5.6 4.9 5.7 10.0 2.7 3.1 1.5 7.3 1.3 8.1 2.0 2.6 5.6 3.3 7.9 3.0 6.7 2.5 10.2 2.0 5.5 4.7 6.0 4.3 8.9 2.3 10.0 3.4 7.4 5.6 6.7 1.1 3.6 4.3 9.7 2.1 4.3 8.0 6.3 4.9 4.5 2.7 2.5 6.5 5.2 4.1 4.7 4.0 1.1 0.1 2.6 0.8 2.9 2.1 2.3 1.7 1.4 3.2 2.1 2.7 0.3 5.1 1.2 2.9 2.1 0.7 5.5 6.0 10.6 4.7 6.7 4.7 4.2 4.5 6.8 5.1 0.0 7.8 0.8 2.2 0.8 5.5 8.1 5.1 22.7 6.8 8.7 39.3 1.3 8.3 5.7 5.2 2.1 2.6 0.0 2.3 1.7 2.8 2.6 7.0 4.0 1.9 7.9 5.8 6.2 2.5 4.6 16.4 2.6 6.8 1.8 1.6 6.6 3.3 2.3 11.0 6.3 19.0 32.3 3.9 8.6 5.8 2.6 0.2 2.9 3.0 1.0 STYK1 "DKFZp761P1010, NOK, SuRTK106" ENSG00000060140 "Serine/threonine/tyrosine kinase 1" Q6J9G0 12 10618939-10674318 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Transferase, Tyrosine-protein kinase" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 15.8;stomach 1: 16.0" "Cell type enhanced" "Detected in some" 8 "Ciliated cells: 8.1;Enterocytes: 12.5;Mucus-secreting cells: 8.3;Paneth cells: 9.5;Undifferentiated cells: 6.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 7 "NK-cell: 12.5" "Lineage enriched" "Detected in many" 7 "NK-cells: 12.5" "Cell line enhanced" "Detected in many" "CAPAN-2: 18.5;HDLM-2: 10.9;HMC-1: 12.1;HUVEC TERT2: 16.6;TIME: 15.4" "Region enhanced" "Detected in single" "basal ganglia: 2.3" "Not detected" "Not detected" "HPA040468, HPA048569" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040468: AB_2676998, HPA048569: AB_2680446" "unprognostic (2.30e-1)" "unprognostic (2.22e-1)" "unprognostic (1.21e-1)" "unprognostic (1.75e-1)" "unprognostic (3.11e-2)" "unprognostic (3.35e-2)" "unprognostic (6.85e-2)" "unprognostic (5.08e-3)" "unprognostic (3.37e-1)" "unprognostic (3.50e-1)" "unprognostic (2.21e-3)" "unprognostic (1.02e-1)" "unprognostic (1.70e-14)" "unprognostic (5.18e-3)" "unprognostic (1.22e-1)" "unprognostic (2.33e-1)" "unprognostic (1.45e-2)" 0.6 0.3 2.6 2.3 10.6 1.0 3.8 0.1 13.4 2.2 14.4 0.7 0.5 2.1 0.5 1.1 8.9 1.9 6.2 0.1 1.8 1.6 0.5 0.3 1.2 2.4 1.8 4.2 0.4 0.3 0.0 8.4 3.4 2.1 10.6 15.8 0.0 7.8 2.6 0.2 2.6 10.3 0.6 0.6 1.0 16.0 0.3 0.7 0.0 0.4 0.6 2.8 4.3 3.6 0.0 0.0 0.4 0.0 12.5 1.9 0.2 3.0 0.1 0.0 0.4 0.0 0.0 0.9 4.9 0.5 2.3 2.2 1.6 18.5 0.2 3.1 1.2 2.9 0.8 1.0 5.1 4.9 10.9 0.3 0.7 1.3 0.1 0.0 1.4 12.1 0.2 0.3 3.4 0.2 0.4 16.6 0.1 0.2 0.2 5.3 1.7 0.1 0.8 2.7 7.5 1.3 0.0 1.4 0.2 1.6 9.5 0.6 0.0 2.8 2.9 0.0 4.5 2.3 0.3 15.4 0.6 2.6 0.3 0.6 0.0 0.6 0.1 2.1 0.1 3.6 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 1.3 0.4 12.5 0.0 0.0 0.0 0.2 2.6 10.6 0.1 13.4 1.8 1.6 1.8 4.2 2.1 0.7 0.0 2.1 0.0 0.6 0.2 0.4 0.4 2.5 8.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 12.5 0.0 0.2 0.5 0.0 5.9 1.1 0.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.3 0.0 3.6 9.5 0.0 0.0 0.3 0.0 0.1 0.0 0.9 0.9 0.2 0.7 6.8 4.8 SUCLG2 ENSG00000172340 "Succinate-CoA ligase GDP-forming beta subunit" Q96I99 3 67360460-67654614 "Citric acid cycle related proteins, Enzymes, Plasma proteins, Predicted intracellular proteins" "Tricarboxylic acid cycle" Ligase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 90.9" "Cell type enhanced" "Detected in all" 4 "Hepatocytes: 290.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046705, HPA051998" Enhanced Approved "Plasma membrane,Mitochondria" NA NA 290000 Mitochondria "Plasma membrane" "HPA046705: AB_2679762, HPA051998: AB_2681687" "unprognostic (1.69e-1)" "unprognostic (2.31e-1)" "prognostic favorable (1.08e-4)" "unprognostic (2.12e-1)" "unprognostic (3.10e-1)" "unprognostic (5.32e-2)" "unprognostic (1.87e-2)" "unprognostic (1.69e-1)" "unprognostic (3.88e-1)" "unprognostic (3.26e-2)" "unprognostic (4.61e-3)" "unprognostic (5.59e-2)" "prognostic favorable (2.79e-10)" "unprognostic (3.08e-2)" "unprognostic (2.79e-1)" "unprognostic (1.07e-1)" "unprognostic (1.38e-1)" 17.0 19.3 8.8 26.5 10.0 3.4 12.4 2.4 7.2 15.3 38.9 9.5 16.4 31.4 11.5 18.3 18.6 9.9 27.9 23.6 6.6 6.2 38.3 90.9 14.6 21.1 9.8 6.5 16.5 20.9 5.9 8.5 8.5 7.6 14.0 34.5 9.6 21.0 17.3 57.0 9.3 42.4 23.5 8.6 24.7 25.4 6.5 8.1 9.6 16.4 27.0 16.7 19.9 13.2 19.2 10.2 5.8 18.2 27.1 31.1 18.9 12.8 11.2 11.1 13.5 18.7 32.4 13.5 15.4 22.5 18.1 20.3 12.3 28.7 16.4 5.0 21.6 11.9 6.6 8.6 21.2 23.5 6.9 5.9 14.8 10.1 19.2 24.1 19.5 10.4 24.2 18.5 14.2 32.6 22.5 19.2 12.6 11.3 15.0 39.4 9.0 7.3 6.2 10.4 58.8 6.9 5.1 17.2 24.5 30.7 19.9 2.2 7.5 24.4 28.2 20.3 7.8 21.7 12.5 16.7 18.0 11.9 19.7 18.2 10.3 15.0 11.5 26.5 15.3 21.1 5.8 15.3 5.2 13.8 18.2 16.7 19.2 20.0 17.4 10.2 16.7 31.1 23.7 0.7 27.1 14.8 4.0 18.5 18.9 8.8 10.0 2.4 7.2 6.6 6.2 9.8 6.5 7.6 8.1 32.8 40.3 57.4 34.0 33.0 2.6 146.2 84.1 61.6 42.1 76.8 7.9 46.8 207.2 71.1 2.4 35.8 224.3 46.7 70.7 37.8 47.4 43.6 29.0 290.2 50.0 4.8 55.9 44.8 60.1 4.1 38.3 46.7 40.5 32.5 187.4 22.3 55.1 140.3 44.6 211.1 3.8 32.3 67.3 1.4 6.8 43.2 31.8 55.8 241.0 45.3 SUMF2 DKFZp566I1024 ENSG00000129103 "Sulfatase modifying factor 2" Q8NBJ7 7 56064002-56080670 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA024040, CAB025743, HPA074892" Enhanced Uncertain "Vesicles,Plasma membrane" "Intracellular and membrane" Yes No 730000 "Vesicles, Plasma membrane" "CAB025743: , HPA024040: AB_1857651, HPA074892: " "unprognostic (2.93e-1)" "prognostic unfavorable (6.58e-6)" "unprognostic (2.42e-2)" "prognostic favorable (3.96e-4)" "unprognostic (3.87e-2)" "unprognostic (9.11e-3)" "unprognostic (1.69e-2)" "unprognostic (1.19e-1)" "unprognostic (1.41e-1)" "unprognostic (7.20e-2)" "unprognostic (1.92e-1)" "unprognostic (7.26e-2)" "unprognostic (1.74e-1)" "unprognostic (1.74e-2)" "unprognostic (2.64e-1)" "unprognostic (1.99e-3)" "prognostic unfavorable (7.71e-4)" 26.8 38.3 13.0 17.7 17.0 15.4 26.2 10.9 28.2 35.0 31.9 24.8 35.4 31.1 32.2 32.3 23.8 37.8 51.2 16.8 12.8 11.6 36.0 40.4 30.2 25.9 19.8 18.0 28.6 91.0 34.7 18.3 37.5 20.7 29.5 25.0 25.0 39.7 37.1 14.0 23.6 35.1 27.2 19.6 27.0 32.9 16.2 17.6 29.8 33.3 15.1 25.1 29.1 23.1 21.0 43.1 17.1 28.5 15.7 33.4 28.5 64.4 19.5 8.5 39.3 42.0 29.1 13.2 21.1 29.6 17.8 22.2 10.6 52.4 10.1 18.3 30.2 17.3 32.8 5.1 24.4 11.9 16.5 8.2 6.5 12.8 9.9 27.2 15.9 20.8 23.0 24.0 16.0 27.9 36.2 26.2 18.7 20.6 45.4 28.6 14.2 13.5 18.7 11.6 50.2 9.9 10.9 8.7 65.0 24.3 7.1 10.0 12.2 26.5 56.1 25.9 19.9 56.3 26.5 21.6 16.5 23.6 40.4 18.1 30.9 23.5 15.1 27.1 30.1 52.6 17.1 21.0 7.5 26.2 27.4 33.4 21.0 25.6 26.2 24.8 18.7 28.5 27.7 1.3 15.7 28.5 43.1 26.8 28.5 13.0 17.0 10.9 28.2 12.8 11.6 19.8 18.0 20.7 17.6 53.6 29.1 34.1 31.9 30.0 26.4 8.5 76.5 34.8 25.0 85.5 13.7 39.0 16.6 71.5 2.7 41.8 53.0 23.3 48.6 78.8 43.6 38.3 53.1 70.4 61.1 41.3 57.0 43.0 64.9 5.8 64.5 46.7 50.6 84.8 54.5 25.7 53.3 63.1 44.6 36.9 12.1 51.8 39.4 16.8 23.6 36.6 39.0 50.0 78.0 31.5 SWAP70 "KIAA0640, SWAP-70" ENSG00000133789 "Switching B cell complex subunit SWAP70" Q9UH65 11 9664077-9752991 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 29.5;naive B-cell: 29.6" "Group enriched" "Detected in all" 6 "B-cells: 29.6;granulocytes: 16.4;monocytes: 9.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006810, HPA006929" Supported Supported "Plasma membrane,Actin filaments" NA NA 7100 "Plasma membrane" "Actin filaments" "HPA006810: AB_1857683, HPA006929: " "unprognostic (4.16e-2)" "unprognostic (7.06e-2)" "unprognostic (2.35e-1)" "unprognostic (3.68e-2)" "unprognostic (1.67e-1)" "unprognostic (3.38e-2)" "unprognostic (3.16e-3)" "unprognostic (1.26e-1)" "unprognostic (4.04e-1)" "unprognostic (3.33e-1)" "unprognostic (1.75e-1)" "unprognostic (3.85e-2)" "unprognostic (2.79e-3)" "unprognostic (5.00e-2)" "unprognostic (1.14e-1)" "unprognostic (3.61e-1)" "unprognostic (1.44e-1)" 30.8 7.3 10.6 24.0 12.0 10.6 25.8 4.2 13.7 14.5 12.9 10.5 10.4 9.0 19.0 10.8 14.5 11.5 13.2 12.5 12.7 8.2 11.4 5.8 20.6 36.0 12.3 7.9 9.2 8.8 17.5 8.4 25.4 11.9 15.9 7.8 13.1 15.8 11.3 9.7 21.2 16.2 14.0 14.7 32.6 9.9 5.2 12.0 7.5 16.4 10.2 42.2 20.6 26.5 29.6 2.9 16.4 9.7 2.8 1.4 1.7 11.6 6.5 9.2 0.0 19.3 16.9 16.2 12.8 15.6 12.1 13.4 7.2 9.3 46.6 12.6 24.4 17.5 14.1 11.2 7.1 15.7 4.2 4.5 12.3 7.8 3.5 10.8 9.5 23.0 11.8 8.9 8.8 15.9 9.9 36.8 6.0 1.1 0.1 12.6 1.8 2.8 4.6 8.5 3.1 3.3 6.8 8.6 1.3 10.1 31.1 0.4 4.7 12.1 15.7 10.2 13.5 6.2 7.3 42.2 21.4 7.6 17.8 11.9 1.3 3.5 32.9 8.5 10.7 8.7 5.7 2.0 16.4 0.4 4.8 0.2 29.5 0.5 0.4 2.9 29.6 0.4 0.5 0.4 2.8 9.7 0.8 1.4 1.7 10.6 12.0 4.2 13.7 12.7 8.2 12.3 7.9 11.9 12.0 62.5 50.8 86.5 57.8 31.6 1.9 16.2 22.9 54.9 62.6 19.2 0.0 67.5 11.6 42.4 1.3 127.6 12.3 0.0 18.6 99.2 29.6 58.5 130.9 6.2 56.8 25.4 12.5 49.1 49.2 1.5 27.6 47.7 27.0 129.8 7.6 8.6 27.5 14.0 32.5 10.2 2.0 19.4 36.3 3.8 8.2 27.4 117.2 11.7 7.7 47.9 SYPL2 Mg29 ENSG00000143028 "Synaptophysin like 2" Q5VXT5 1 109466628-109482137 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "skeletal muscle: 102.5;tongue: 25.6" "Cell type enhanced" "Detected in some" 11 "Cardiomyocytes: 8.5;Collecting duct cells: 3.5;Hepatocytes: 4.5;Late spermatids: 8.5;Proximal tubular cells: 4.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 20.2;ASC TERT1: 8.5;BJ: 8.6;BJ hTERT+: 27.3;fHDF/TERT166: 14.1;HAP1: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA076657 Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA076657: " "unprognostic (1.82e-2)" "unprognostic (1.81e-1)" "unprognostic (2.90e-4)" "unprognostic (6.63e-2)" "unprognostic (1.35e-1)" "unprognostic (9.36e-3)" "unprognostic (2.84e-2)" "unprognostic (2.57e-1)" "unprognostic (2.35e-1)" "unprognostic (3.11e-1)" "unprognostic (2.34e-1)" "unprognostic (1.08e-1)" "prognostic favorable (3.05e-4)" "unprognostic (2.54e-3)" "unprognostic (3.40e-1)" "unprognostic (9.46e-3)" "unprognostic (6.39e-4)" 0.9 3.9 0.8 0.3 0.7 0.1 1.4 0.5 1.2 1.6 1.9 0.3 0.8 0.3 2.5 4.3 1.6 0.4 1.1 7.4 0.8 0.2 6.0 4.7 0.6 0.3 0.3 0.0 1.1 3.2 3.7 0.4 1.2 0.8 1.2 0.5 1.7 1.6 2.2 102.5 0.2 0.6 3.5 0.1 0.4 1.1 6.0 0.2 0.0 5.1 25.6 1.2 2.5 2.4 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.1 20.2 8.5 0.0 8.6 27.3 2.7 1.0 0.0 0.0 0.0 0.0 14.1 0.3 0.0 7.3 0.0 0.5 0.0 3.1 0.0 0.2 0.1 0.4 0.0 0.7 0.8 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.9 2.1 1.4 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.5 1.2 0.8 0.2 0.3 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.0 8.5 0.0 0.0 0.0 3.5 0.0 0.0 0.0 0.2 1.5 0.3 0.0 0.0 1.1 0.0 0.0 0.0 0.0 4.5 0.1 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 1.5 0.2 0.0 0.7 4.9 0.0 0.0 2.3 0.4 1.5 0.0 0.1 0.0 0.0 0.0 SYT4 "HsT1192, KIAA1342" ENSG00000132872 "Synaptotagmin 4" Q9H2B2 18 43267878-43277650 "Predicted intracellular proteins" Differentiation "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 60.8;pituitary gland: 31.5" "Group enriched" "Detected in some" 4 "Bipolar cells: 60.4;Cone photoreceptor cells: 21.6;Intestinal endocrine cells: 27.5" "Cancer enhanced" "Detected in some" "pancreatic cancer: 4.1" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 11 "SH-SY5Y: 74.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010574 Approved Approved "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA010574: AB_2668309" "unprognostic (2.91e-3)" "unprognostic (2.03e-1)" "unprognostic (2.37e-2)" "unprognostic (2.87e-1)" "unprognostic (7.67e-3)" "unprognostic (5.30e-3)" "unprognostic (3.95e-2)" "unprognostic (1.23e-3)" "unprognostic (3.61e-1)" "unprognostic (3.80e-2)" 1.4 17.5 5.7 2.2 24.1 1.0 0.9 60.8 54.6 0.9 1.7 0.9 0.0 1.7 0.9 0.9 1.0 0.9 1.0 1.4 12.9 19.9 1.0 0.9 1.8 1.0 5.9 16.0 1.3 4.7 0.9 31.5 1.0 22.3 1.5 1.7 0.4 1.0 9.8 0.9 1.0 1.7 1.5 5.0 0.9 4.6 2.4 1.4 0.0 1.3 0.0 0.9 0.9 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 74.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 24.1 60.8 35.7 12.9 19.9 5.9 16.0 22.3 1.4 0.0 1.4 0.0 0.0 0.1 60.4 2.8 0.0 1.4 4.5 0.0 21.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 1.6 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.8 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TBC1D24 "DFNA65, DFNB86, KIAA1171, TLDC6" ENSG00000162065 "TBC1 domain family member 24" Q9ULP9 16 2475051-2509560 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "GTPase activation" "Deafness, Disease mutation, Epilepsy, Mental retardation, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 33.4" "Cell type enhanced" "Detected in many" 5 "Cone photoreceptor cells: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "SCLC-21H: 26.8" "HPA044712, HPA068080" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA044712: AB_10795619, HPA068080: AB_2685948" "prognostic unfavorable (3.22e-4)" "unprognostic (5.23e-2)" "unprognostic (4.02e-2)" "unprognostic (6.41e-2)" "unprognostic (3.52e-1)" "unprognostic (1.52e-2)" "unprognostic (1.40e-1)" "unprognostic (2.03e-2)" "unprognostic (1.68e-1)" "unprognostic (7.37e-2)" "unprognostic (4.37e-2)" "unprognostic (1.28e-1)" "unprognostic (4.66e-3)" "unprognostic (2.02e-2)" "unprognostic (8.19e-2)" "unprognostic (7.78e-3)" "unprognostic (1.61e-1)" 6.0 5.8 11.0 2.9 9.6 3.7 4.9 15.8 17.7 4.2 3.5 2.8 6.7 3.8 3.3 5.0 2.2 4.3 3.5 4.9 9.0 5.4 7.6 6.6 6.4 3.0 3.8 12.2 2.1 16.6 5.2 5.6 3.6 7.5 4.5 1.9 5.4 33.4 6.4 6.1 3.5 2.8 3.1 3.7 3.4 3.8 2.4 4.5 0.8 5.5 1.0 2.3 4.0 2.9 0.2 1.3 0.0 0.9 0.2 2.2 1.0 2.6 5.0 3.4 6.9 4.0 4.0 2.9 4.7 2.5 3.1 2.7 4.7 2.2 6.6 4.3 3.6 1.5 4.7 5.3 1.5 2.3 7.1 6.3 5.9 6.6 4.0 2.4 4.3 2.6 1.5 2.1 2.7 1.1 2.1 3.9 2.4 7.2 3.7 2.9 4.6 2.9 8.6 3.0 2.3 3.3 15.3 6.5 4.6 2.2 1.7 26.8 6.5 3.2 11.8 1.9 1.3 3.8 3.9 4.0 6.1 6.7 6.0 4.6 2.4 2.2 8.2 2.6 6.3 5.5 0.0 0.7 0.0 2.2 0.8 0.7 0.2 0.5 0.7 1.3 0.1 0.5 0.3 0.0 0.2 0.9 0.6 0.0 1.0 11.0 9.6 15.8 12.4 9.0 5.4 3.8 12.2 7.5 4.5 26.8 22.4 2.7 2.7 0.5 15.4 4.7 15.3 4.0 10.3 5.2 41.2 1.3 28.2 4.8 0.2 3.6 1.7 23.3 5.3 0.7 8.4 3.5 3.5 15.1 3.0 25.4 10.9 12.3 5.4 0.7 8.3 2.3 1.7 1.8 2.6 11.1 4.8 3.5 5.6 3.3 25.0 0.0 3.7 2.7 3.8 1.3 0.2 2.6 4.4 1.4 TBC1D30 KIAA0984 ENSG00000111490 "TBC1 domain family member 30" Q9Y2I9 12 64781193-64881032 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 19.8" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 13.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Group enriched" "Detected in many" 17 "granulocytes: 2.4;monocytes: 1.1;T-cells: 1.3" "Cell line enhanced" "Detected in many" "MCF7: 23.0;OE19: 15.2;RPMI-8226: 13.6;RT4: 17.6;SCLC-21H: 16.5;SK-BR-3: 17.0;T-47d: 12.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039772, HPA040043" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA039772: AB_10795409, HPA040043: AB_10795411" "unprognostic (1.85e-1)" "unprognostic (6.95e-2)" "unprognostic (2.66e-1)" "prognostic favorable (3.61e-5)" "unprognostic (9.35e-2)" "unprognostic (2.09e-1)" "unprognostic (2.65e-5)" "prognostic favorable (5.08e-4)" "unprognostic (1.75e-3)" "unprognostic (2.16e-2)" "unprognostic (2.44e-1)" "unprognostic (9.72e-2)" "unprognostic (7.32e-2)" "unprognostic (7.62e-3)" "unprognostic (8.72e-2)" "unprognostic (2.67e-3)" "unprognostic (7.80e-3)" 1.8 1.6 4.7 2.3 11.4 0.5 5.3 13.4 15.8 7.6 3.3 1.5 12.4 5.0 3.1 2.5 1.2 2.1 4.8 1.1 7.1 5.5 3.9 1.7 3.9 0.9 4.7 7.0 1.5 19.8 8.9 6.5 1.4 16.5 3.7 3.5 2.0 14.4 11.6 0.9 1.3 3.5 2.4 3.0 2.5 6.9 3.2 2.8 0.0 3.3 0.2 0.7 4.9 1.9 0.0 0.0 2.4 1.1 0.0 1.3 0.3 6.9 1.4 0.4 0.4 0.0 0.5 0.6 0.0 0.0 0.0 0.1 6.5 2.2 0.3 1.1 0.0 0.3 0.1 6.8 0.1 0.0 0.0 6.7 0.3 1.2 0.3 0.1 2.3 1.4 0.4 0.0 0.0 0.2 0.6 5.6 1.0 0.0 2.4 0.2 23.0 0.0 0.4 0.9 15.2 6.8 0.1 0.1 13.6 0.8 17.6 16.5 1.3 1.4 17.0 0.2 0.7 12.4 1.1 5.3 0.0 1.0 0.5 3.4 0.0 0.0 0.2 0.1 0.7 0.3 0.0 1.1 0.0 0.4 1.1 0.0 0.0 0.3 1.3 0.0 0.0 0.0 0.0 2.4 0.0 0.7 0.0 0.0 0.3 4.7 11.4 13.4 15.8 7.1 5.5 4.7 7.0 16.5 2.8 0.0 4.6 0.5 2.1 0.8 9.4 0.4 5.1 2.7 5.7 3.5 7.9 0.4 8.3 3.1 13.6 4.2 2.6 0.0 4.3 0.3 0.5 7.1 9.2 0.0 1.5 0.0 0.0 2.5 2.5 1.0 0.3 2.8 5.0 1.0 6.3 2.5 3.6 3.5 0.0 1.7 0.5 0.0 0.3 3.3 1.5 1.3 0.1 0.9 3.3 8.4 TBXA2R ENSG00000006638 "Thromboxane A2 receptor" P21731 19 3594506-3606840 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in some" 7 "Ito cells: 35.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive B-cell: 12.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HeLa: 11.9;U-2197: 8.6;U-937: 7.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA077366 Supported "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA077366: AB_2686836" "unprognostic (1.59e-1)" "unprognostic (3.86e-2)" "unprognostic (1.21e-2)" "unprognostic (1.74e-1)" "unprognostic (8.97e-2)" "unprognostic (4.19e-2)" "unprognostic (1.52e-2)" "unprognostic (2.17e-3)" "unprognostic (8.41e-2)" "unprognostic (6.25e-2)" "prognostic favorable (7.17e-4)" "unprognostic (3.89e-2)" "prognostic unfavorable (1.45e-4)" "unprognostic (4.32e-2)" "unprognostic (9.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.02e-1)" 8.7 11.8 1.4 3.9 1.6 2.1 3.9 0.5 1.6 13.5 3.8 1.7 3.9 2.6 7.4 4.8 8.0 4.7 6.0 6.8 2.4 1.5 10.1 18.4 6.7 7.3 1.4 1.9 8.3 2.2 2.5 1.7 10.6 2.7 3.6 1.4 5.0 1.7 4.2 3.1 1.8 4.4 6.5 2.1 14.9 3.7 3.4 1.9 2.2 3.9 3.2 1.8 6.8 9.6 12.6 0.3 3.2 0.4 3.1 9.6 3.9 0.1 0.2 0.2 4.1 0.9 2.2 0.7 3.0 0.8 2.3 1.8 0.1 0.3 0.1 4.4 1.2 2.3 0.1 0.9 0.0 0.9 0.2 1.0 2.9 11.9 0.3 1.2 0.0 5.3 1.1 0.0 3.0 0.0 1.7 0.9 0.0 4.5 0.4 0.4 0.2 0.2 1.5 0.1 0.1 2.6 0.1 0.0 0.2 0.0 0.1 0.2 1.7 0.2 0.4 0.1 0.3 1.8 5.1 2.6 4.8 1.1 8.6 2.8 0.2 0.3 0.2 4.0 7.4 1.1 2.9 0.4 0.2 2.6 0.2 0.3 1.8 0.8 2.3 0.0 12.6 4.6 9.6 3.2 3.1 0.2 0.3 0.2 3.9 1.4 1.6 0.5 1.6 2.4 1.5 1.4 1.9 2.7 1.9 0.0 0.0 1.3 0.1 0.5 0.4 0.8 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.0 0.0 4.8 0.0 0.0 0.0 0.1 2.3 0.1 0.0 0.0 0.7 0.0 0.0 35.0 1.2 0.0 0.3 0.0 1.7 0.0 0.0 0.3 0.1 0.0 0.7 0.0 0.1 0.0 3.1 0.1 1.3 0.5 0.1 0.0 0.0 0.0 TCAF2 "FAM115C, FAM139A, FLJ40722, GATD9" ENSG00000170379 "TRPM8 channel associated factor 2" A6NFQ2 7 143620952-143730409 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 9 "Cytotrophoblasts: 12.2;Hepatocytes: 10.9;Syncytiotrophoblasts: 13.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HDLM-2: 9.2;HUVEC TERT2: 9.8;TIME: 15.5;U-87 MG: 13.4" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" "unprognostic (6.59e-2)" "unprognostic (4.99e-2)" "unprognostic (2.34e-2)" "unprognostic (8.86e-3)" "prognostic unfavorable (9.53e-5)" "unprognostic (1.89e-1)" "unprognostic (3.11e-2)" "unprognostic (4.47e-2)" "unprognostic (2.36e-1)" "unprognostic (2.04e-2)" "unprognostic (3.98e-2)" "unprognostic (2.21e-2)" "prognostic unfavorable (4.17e-6)" "unprognostic (7.19e-2)" "unprognostic (4.02e-2)" "unprognostic (5.41e-3)" "unprognostic (2.85e-2)" 3.1 2.7 1.5 5.8 2.7 5.8 8.4 2.0 4.0 5.2 1.8 0.6 2.0 1.8 6.1 2.1 13.1 2.2 3.5 3.5 2.3 1.9 3.1 6.4 7.1 12.4 1.6 1.2 4.2 3.2 2.1 3.8 8.1 2.8 5.5 1.6 1.7 5.7 9.2 2.1 6.7 3.5 5.0 4.7 4.0 3.1 2.2 2.0 7.3 2.3 7.6 7.0 8.0 12.1 2.6 1.0 7.0 0.4 3.5 6.5 1.3 4.8 0.3 0.3 0.3 1.0 1.0 1.9 1.5 2.6 0.7 1.9 0.2 0.5 0.3 2.1 1.2 0.6 0.9 0.1 2.5 2.2 9.2 0.5 0.8 0.7 0.3 1.1 0.3 0.6 2.6 1.1 0.3 0.9 2.0 9.8 0.7 2.7 4.8 4.1 0.9 0.7 0.9 0.4 4.7 2.4 0.4 2.0 2.2 0.0 1.9 0.3 0.2 0.5 3.5 0.3 0.9 1.8 0.3 15.5 1.4 1.0 5.2 0.4 7.7 2.4 0.2 13.4 0.5 2.8 7.0 0.4 0.4 4.0 0.4 4.2 2.6 6.5 4.1 0.3 2.5 5.8 4.6 1.6 3.5 0.3 1.0 6.2 1.3 1.5 2.7 2.0 4.0 2.3 1.9 1.6 1.2 2.8 2.0 0.0 2.6 0.0 1.1 0.0 0.2 0.4 0.0 0.0 3.4 0.0 0.0 12.2 0.0 0.4 0.9 2.1 0.0 0.0 0.3 4.3 0.5 2.7 2.3 10.9 1.8 0.0 0.0 0.6 1.6 0.4 1.7 0.7 0.0 0.0 0.1 1.7 1.3 0.0 0.7 0.3 0.0 0.0 0.6 3.2 0.2 0.0 13.2 2.9 0.0 1.0 TCAF2C ENSG00000283528 "TRPM8 channel associated factor 2C" 7 143639230-143647646 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 4 "blood: 2.2;parathyroid gland: 1.9;placenta: 1.3" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "basophil: 2.2;T-reg: 1.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 1.1;OE19: 1.5;U-266/70: 3.9;U-266/84: 1.8" "HPA038756, HPA038758" Uncertain Supported "Plasma membrane,Cell Junctions" NA NA "Plasma membrane, Cell Junctions" "HPA038756: AB_10960427, HPA038758: AB_10960353" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 1.8 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.9 1.8 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.4 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TDG ENSG00000139372 "Thymine DNA glycosylase" Q13569 12 103965804-103988874 "Enzymes, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" "Activator, Chromatin regulator, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA052263 Supported Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA052263: AB_2681777" "unprognostic (3.15e-1)" "unprognostic (1.36e-1)" "unprognostic (9.89e-3)" "unprognostic (6.93e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "prognostic unfavorable (6.27e-5)" "unprognostic (1.56e-2)" "prognostic unfavorable (6.90e-5)" "unprognostic (5.37e-2)" "unprognostic (1.82e-1)" "unprognostic (8.48e-2)" "prognostic unfavorable (1.90e-10)" "unprognostic (3.68e-1)" "unprognostic (2.90e-1)" "unprognostic (1.11e-1)" "unprognostic (1.16e-1)" 12.3 16.6 7.0 17.9 11.1 15.9 12.8 10.7 13.4 17.7 14.7 10.0 11.3 11.0 15.8 17.8 23.8 12.4 12.8 12.0 7.7 6.9 13.4 17.4 13.7 19.7 8.7 7.9 14.4 13.2 11.0 21.0 27.9 10.8 13.0 16.8 10.9 13.2 11.3 11.1 16.3 18.7 17.8 8.8 19.8 13.1 5.8 8.1 33.4 12.4 15.3 19.6 13.3 14.7 18.9 41.4 18.8 24.3 14.2 13.6 7.2 13.3 6.8 21.5 12.5 5.3 4.8 21.7 10.1 4.2 14.2 8.0 11.6 6.1 31.6 6.2 8.4 2.3 9.0 25.6 11.9 11.2 12.9 20.7 24.8 10.3 5.2 5.0 30.7 18.8 5.6 15.9 10.5 8.5 8.7 13.9 18.7 27.7 5.3 6.8 14.0 34.3 17.3 26.0 9.9 10.9 35.4 11.1 11.2 15.5 19.8 28.3 19.6 12.3 14.5 9.0 13.2 23.2 16.6 8.4 4.4 7.3 4.7 12.0 11.6 15.3 27.1 4.9 16.6 8.5 18.5 24.3 18.8 13.6 16.3 10.3 17.7 13.0 11.2 14.9 18.9 13.5 12.1 16.0 14.2 15.9 41.4 12.6 7.2 7.0 11.1 10.7 13.4 7.7 6.9 8.7 7.9 10.8 8.1 35.7 18.4 41.0 33.6 70.2 45.5 23.0 35.7 40.2 40.9 31.4 25.5 58.2 31.5 66.4 3.9 43.9 26.9 23.3 46.9 70.7 38.1 38.3 38.3 30.1 39.3 33.4 78.4 36.2 38.6 2.1 25.3 39.1 15.1 39.7 39.8 23.0 64.5 34.5 28.3 18.0 37.1 45.3 30.7 9.9 25.0 89.8 131.0 39.9 38.9 48.0 TDO2 "TDO, TPH2" ENSG00000151790 "Tryptophan 2,3-dioxygenase" P48775 4 155854738-155920406 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Tryptophan catabolism" "Dioxygenase, Oxidoreductase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 32 "liver: 187.9" "Cell type enriched" "Detected in some" 8 "Hepatocytes: 1048.1" "Cancer enriched" "Detected in many" 18 "liver cancer: 35.7" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 8.6;HDLM-2: 16.7;U-87 MG: 9.8" "Group enriched" "Detected in some" 9 "cerebellum: 7.0;hippocampal formation: 5.9" "Not detected" "Not detected" HPA039611 Uncertain Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039611: " "unprognostic (1.10e-1)" "unprognostic (3.00e-3)" "unprognostic (3.84e-2)" "unprognostic (1.95e-1)" "unprognostic (7.06e-2)" "unprognostic (3.50e-1)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (1.00e-1)" "unprognostic (2.13e-2)" "unprognostic (1.42e-1)" "unprognostic (1.01e-1)" "unprognostic (4.68e-8)" "unprognostic (7.99e-2)" "unprognostic (9.29e-3)" "unprognostic (1.28e-1)" "unprognostic (1.95e-2)" 0.2 0.5 0.2 2.5 0.5 0.0 0.1 0.1 2.0 0.1 0.2 0.0 0.1 0.6 0.1 0.2 0.2 0.1 0.3 0.1 1.5 0.2 0.2 187.9 0.8 2.9 0.2 0.7 0.1 0.1 0.0 5.8 0.1 0.1 0.1 0.2 0.0 0.1 0.0 0.1 0.1 1.1 0.4 0.2 1.5 0.3 0.1 0.0 0.0 0.1 0.0 0.4 1.2 0.1 0.0 0.0 0.2 0.1 0.0 0.2 0.0 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.0 1.5 0.0 0.0 0.1 0.0 0.0 8.6 0.0 0.2 0.0 0.1 0.0 0.0 16.7 0.0 0.1 0.0 0.0 0.3 0.2 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.1 2.9 0.3 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.1 1.3 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 1.1 0.4 0.4 0.0 2.7 0.0 0.0 9.8 0.1 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.5 0.1 2.0 1.5 0.2 0.2 0.7 0.1 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.4 132.5 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 23.3 0.0 0.0 0.1 0.3 0.0 1048.1 0.9 0.0 0.0 25.2 23.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.8 0.2 0.2 0.0 0.2 0.0 0.0 0.0 TDP1 "FLJ11090, SCAN1" ENSG00000042088 "Tyrosyl-DNA phosphodiesterase 1" Q9NUW8 14 89954939-90044768 "Disease related genes, Predicted intracellular proteins" "DNA damage, DNA repair" "Exonuclease, Hydrolase, Nuclease" "Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 13 "Early spermatids: 97.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071317 Approved Supported "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA071317: AB_2686388" "unprognostic (5.60e-3)" "unprognostic (3.53e-1)" "unprognostic (7.03e-3)" "unprognostic (1.34e-1)" "unprognostic (7.45e-2)" "unprognostic (7.22e-2)" "prognostic unfavorable (8.99e-5)" "unprognostic (2.61e-1)" "unprognostic (1.46e-2)" "unprognostic (5.84e-3)" "unprognostic (2.51e-1)" "unprognostic (6.46e-2)" "unprognostic (1.10e-1)" "unprognostic (3.41e-1)" "unprognostic (1.64e-1)" "unprognostic (2.91e-2)" "unprognostic (1.26e-1)" 5.5 6.3 6.9 10.8 10.4 11.4 8.3 11.0 10.8 6.6 7.1 7.3 8.4 5.9 9.1 5.6 11.1 8.8 6.2 3.5 5.5 6.3 6.8 5.9 5.5 16.1 6.2 8.1 6.8 7.0 5.5 11.0 7.5 6.3 5.7 9.6 6.1 8.1 4.2 3.1 7.7 7.9 5.8 5.7 11.7 7.0 23.3 3.7 29.8 4.5 4.4 21.0 7.6 7.0 16.4 11.2 15.5 10.6 16.3 23.2 10.7 13.8 7.9 17.6 15.9 4.4 6.1 14.0 13.3 11.0 16.5 15.0 5.7 15.0 17.7 10.0 9.1 5.5 14.3 7.7 12.4 24.1 17.9 8.3 17.9 7.2 6.9 3.8 29.9 10.4 4.4 5.6 11.6 10.8 9.5 20.9 24.3 12.3 18.6 19.5 14.6 22.8 16.1 4.2 16.5 18.6 17.4 33.3 14.0 10.6 11.4 13.2 9.0 11.3 33.2 4.2 12.2 13.2 12.8 16.6 7.2 6.8 9.8 11.9 13.7 23.8 21.6 15.4 13.5 10.4 15.5 6.6 10.7 14.5 10.6 14.3 16.4 15.7 16.3 10.4 13.5 17.7 18.2 4.5 16.3 9.7 11.2 23.2 10.7 6.9 10.4 11.0 10.8 5.5 6.3 6.2 8.1 6.3 3.7 0.0 1.4 6.7 4.6 4.1 3.0 1.1 2.5 12.0 3.4 14.0 7.9 9.1 5.0 7.3 97.8 2.7 2.3 0.0 4.8 12.5 3.9 3.6 2.3 2.9 7.8 3.2 3.5 4.3 5.6 25.8 2.6 6.1 1.7 9.0 5.0 0.6 5.0 3.2 2.8 5.7 2.2 0.0 4.7 26.1 23.8 4.0 8.5 8.7 7.6 2.6 TEK "CD202b, TIE-2, TIE2, VMCM, VMCM1" ENSG00000120156 "TEK receptor tyrosine kinase" Q02763 9 27109141-27230175 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, RAS pathway related proteins" Angiogenesis "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Glaucoma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 8 "Endothelial cells: 58.3;Ito cells: 110.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 2.2" "Lineage enhanced" "Detected in single" "granulocytes: 2.2" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 36.5;NTERA-2: 18.2;TIME: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010359, HPA073265" Approved Supported "Plasma membrane,Centriolar satellite" "Secreted to blood" NA NA 7750000 8300000 "Plasma membrane" "Centriolar satellite" "CAB010359: AB_2203226, HPA073265: AB_2686592" "unprognostic (2.24e-1)" "unprognostic (1.74e-1)" "unprognostic (5.55e-2)" "unprognostic (1.83e-2)" "unprognostic (1.68e-1)" "unprognostic (1.26e-3)" "prognostic favorable (2.31e-5)" "unprognostic (7.48e-2)" "unprognostic (1.72e-2)" "unprognostic (1.41e-1)" "unprognostic (5.58e-2)" "unprognostic (2.72e-1)" "prognostic favorable (7.81e-4)" "unprognostic (7.50e-3)" "unprognostic (6.87e-3)" "unprognostic (1.83e-1)" "unprognostic (5.24e-3)" 28.6 7.8 8.1 4.6 5.9 0.4 17.9 3.4 5.4 10.8 4.7 4.6 3.4 3.2 14.5 5.3 6.7 5.9 9.1 13.0 7.1 6.1 25.4 8.7 27.8 2.9 6.9 3.4 6.1 4.5 3.5 4.0 36.3 6.9 5.4 4.7 12.4 3.4 5.5 7.8 3.0 5.3 10.6 5.3 23.4 4.0 3.7 3.5 0.3 9.7 8.4 2.4 6.4 12.4 0.0 0.1 2.2 0.6 0.0 0.0 0.0 0.1 0.0 1.4 0.0 0.2 2.3 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 1.0 0.0 0.7 0.0 0.0 0.7 0.0 0.9 0.3 0.0 36.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 18.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.8 0.0 0.0 39.6 0.0 0.2 3.6 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 8.1 5.9 3.4 5.4 7.1 6.1 6.9 3.4 6.9 3.5 3.0 2.2 0.0 0.0 1.3 0.0 7.8 0.0 0.0 1.2 1.8 0.0 0.4 0.0 0.0 0.6 58.3 0.0 0.0 0.0 1.5 2.4 0.2 0.0 0.8 0.2 0.0 0.0 110.5 10.4 0.4 0.6 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.0 0.2 0.0 0.4 0.0 0.2 1.1 1.1 0.0 0.0 0.0 TEX9 ENSG00000151575 "Testis expressed 9" Q8N6V9 15 56244009-56445997 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 49.7" "Cell type enhanced" "Detected in many" 14 "Ciliated cells: 165.9;Early spermatids: 67.3;Spermatocytes: 52.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "basophil: 4.1;memory B-cell: 14.4;naive B-cell: 6.8" "Group enriched" "Detected in many" 11 "B-cells: 14.4;granulocytes: 4.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039415 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA039415: AB_10672775" "unprognostic (3.27e-1)" "unprognostic (2.77e-2)" "unprognostic (2.25e-1)" "unprognostic (4.71e-3)" "unprognostic (2.34e-1)" "unprognostic (5.13e-2)" "unprognostic (1.54e-2)" "unprognostic (1.22e-1)" "unprognostic (3.75e-2)" "unprognostic (8.85e-2)" "unprognostic (6.91e-3)" "unprognostic (2.00e-2)" "unprognostic (1.24e-2)" "unprognostic (8.00e-2)" "unprognostic (1.15e-1)" "unprognostic (1.06e-1)" "unprognostic (1.24e-1)" 1.7 5.4 5.3 9.0 14.8 2.0 7.6 4.0 2.3 7.0 4.6 7.8 6.0 8.5 5.7 11.6 7.3 21.6 6.2 1.6 6.1 7.5 11.9 1.2 5.8 4.1 4.0 3.2 7.5 4.1 13.5 49.7 1.0 25.2 5.4 3.5 9.2 9.0 4.5 0.9 4.1 9.6 2.3 4.9 5.5 9.0 19.3 4.0 2.0 14.8 2.0 8.2 2.7 2.2 14.4 0.3 4.1 0.6 0.4 0.8 0.8 5.8 5.3 11.7 10.4 2.9 8.5 1.5 1.3 4.9 3.7 4.4 1.4 5.2 11.7 5.6 0.9 6.4 5.2 5.0 5.5 4.3 1.4 6.1 6.7 5.4 3.8 0.9 3.0 1.3 4.6 10.2 4.1 3.1 5.3 0.1 8.4 3.8 1.3 1.9 3.3 4.8 2.6 5.6 9.7 2.3 1.9 5.5 4.2 12.3 3.3 18.7 7.5 6.5 4.0 4.0 9.0 11.1 3.4 0.6 15.7 4.8 5.0 4.7 1.6 11.8 8.9 6.2 1.3 3.0 4.1 0.1 0.1 0.3 0.6 0.1 14.4 0.4 0.3 0.2 6.8 0.2 0.8 0.3 0.4 0.3 0.3 0.5 0.8 5.3 14.8 4.0 2.3 6.1 7.5 4.0 3.2 25.2 4.0 6.0 6.9 13.7 6.8 3.8 5.1 0.4 2.5 165.9 35.2 10.4 11.8 1.4 18.3 11.8 67.3 2.6 2.6 0.0 6.1 0.4 2.3 2.9 1.1 0.0 1.1 1.6 7.5 1.8 0.0 28.6 4.4 1.1 3.3 1.8 2.5 4.8 3.9 4.3 3.5 15.3 35.9 0.0 3.1 52.4 32.6 1.9 0.2 0.0 3.0 5.2 TGM1 "ICR2, LI, LI1, TGASE, TGK" ENSG00000092295 "Transglutaminase 1" P22735 14 24249114-24264432 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" Keratinization "Acyltransferase, Transferase" "Disease mutation, Ichthyosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "esophagus: 106.0;lymphoid tissue: 70.0;tongue: 86.8" "Cell type enhanced" "Detected in some" 17 "Alveolar cells type 1: 11.9;Club cells: 6.8;Distal tubular cells: 24.9" "Cancer enhanced" "Detected in many" "head and neck cancer: 78.3" "Region enriched" "Detected in single" 11 "cerebellum: 3.0" "Cell type enhanced" "Detected in single" "memory CD4 T-cell: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "BEWO: 13.1;HaCaT: 18.0;HeLa: 11.8;MCF7: 12.9;SK-BR-3: 16.0" "Not detected" "Not detected" "Not detected" "Not detected" "CAB015159, HPA040171" Enhanced Approved "Vesicles,Plasma membrane" NA NA 430000 "Vesicles, Plasma membrane" "CAB015159: AB_2202870, HPA040171: AB_2676869" "unprognostic (2.95e-2)" "unprognostic (8.79e-2)" "unprognostic (2.92e-2)" "unprognostic (1.89e-2)" "unprognostic (2.36e-1)" "unprognostic (1.10e-1)" "unprognostic (4.04e-2)" "unprognostic (1.12e-2)" "unprognostic (2.39e-1)" "unprognostic (3.01e-2)" "unprognostic (6.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.94e-7)" "unprognostic (7.11e-2)" "unprognostic (7.38e-2)" "unprognostic (2.22e-3)" "unprognostic (1.86e-2)" 2.9 0.2 0.2 0.4 0.2 0.2 0.7 3.0 0.3 10.1 1.0 0.2 0.2 0.3 0.5 2.0 106.0 1.3 0.2 0.6 0.2 0.0 0.6 0.3 0.9 0.4 0.2 0.2 0.7 1.3 0.2 0.2 0.9 0.2 0.5 0.3 0.4 12.8 1.4 0.7 9.3 0.3 0.2 0.2 0.4 0.2 0.4 0.2 0.5 0.4 86.8 70.0 0.4 17.2 0.4 0.5 0.0 0.5 0.0 1.1 0.2 0.8 1.5 0.8 0.7 0.0 0.6 13.1 0.3 0.2 0.7 1.3 0.9 1.3 0.8 1.7 1.0 0.2 18.0 2.1 1.5 0.5 1.4 2.5 1.0 11.8 4.1 0.6 0.6 1.1 1.1 7.1 0.4 1.5 0.4 0.5 2.5 0.7 0.8 0.5 12.9 0.5 1.4 0.2 0.8 1.6 0.8 0.1 0.8 0.5 1.5 0.9 1.2 0.2 16.0 0.0 1.1 1.1 0.8 0.6 0.8 3.8 1.5 0.6 1.1 1.2 0.2 0.3 1.5 0.9 0.0 0.5 0.0 0.5 0.0 0.0 0.0 1.1 0.0 0.0 0.4 0.5 0.0 0.0 0.0 0.2 0.5 0.0 0.2 0.2 0.2 3.0 0.2 0.2 0.0 0.2 0.2 0.2 0.2 11.9 1.4 0.0 4.2 0.2 0.8 0.8 0.0 0.0 6.8 0.0 0.0 1.1 24.9 1.9 0.1 0.0 0.0 0.0 0.8 0.6 0.6 3.1 4.6 0.0 0.3 0.0 0.0 0.0 0.8 0.0 0.6 0.0 0.0 0.0 0.0 0.3 1.5 0.0 0.4 0.1 0.6 0.0 0.3 0.0 0.8 1.6 1.0 0.0 0.0 4.6 TGM2 TGC ENSG00000198959 "Transglutaminase 2" P21980 20 38127387-38166578 "Enzymes, Predicted intracellular proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 187.6;placenta: 212.7" "Cell type enhanced" "Detected in many" 7 "Cytotrophoblasts: 276.1;Ito cells: 326.6;Pancreatic endocrine cells: 240.4;Syncytiotrophoblasts: 312.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 9 "intermediate monocyte: 2.5;memory B-cell: 1.9;myeloid DC: 2.4" "Group enriched" "Detected in many" 23 "B-cells: 1.9;dendritic cells: 2.4;monocytes: 2.5" "Group enriched" "Detected in many" 4 "CAPAN-2: 155.5;EFO-21: 52.3;hTERT-RPE1: 102.6;HUVEC TERT2: 70.7;TIME: 92.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB002598, HPA021019, HPA029518" Enhanced Approved "Plasma membrane,Cytosol" Yes No 1700000 Cytosol "Plasma membrane" "CAB002598: , HPA021019: AB_1858247, HPA029518: AB_10603133" "unprognostic (7.80e-2)" "unprognostic (1.51e-1)" "unprognostic (5.22e-2)" "unprognostic (1.40e-2)" "unprognostic (1.56e-2)" "unprognostic (5.61e-3)" "unprognostic (2.81e-1)" "unprognostic (3.32e-3)" "unprognostic (3.29e-2)" "unprognostic (9.78e-3)" "prognostic unfavorable (2.97e-4)" "unprognostic (6.99e-2)" "prognostic unfavorable (1.67e-7)" "unprognostic (1.60e-2)" "unprognostic (1.93e-2)" "unprognostic (6.70e-2)" "unprognostic (6.40e-2)" 33.3 9.5 6.0 18.3 8.1 1.0 7.7 4.3 7.5 94.3 12.6 4.0 4.7 8.4 54.6 21.7 15.8 58.7 62.8 77.1 7.5 3.4 25.3 187.6 61.2 16.4 6.9 3.0 18.7 5.0 5.2 25.6 212.7 8.5 33.6 6.3 57.4 1.9 17.1 19.3 0.7 12.8 43.9 5.7 20.4 13.6 7.4 6.4 0.8 17.0 3.4 3.1 38.2 21.6 1.9 2.4 0.0 2.5 0.0 0.0 0.2 6.3 4.7 0.0 0.1 4.9 0.5 2.4 9.6 4.6 0.0 0.1 7.8 155.5 0.0 52.3 0.1 11.1 0.1 0.0 22.5 0.3 0.0 0.0 1.0 0.2 3.4 20.3 0.0 0.0 0.5 0.0 4.1 0.0 102.6 70.7 0.0 2.1 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 6.9 0.0 0.0 0.1 22.6 0.0 0.8 3.3 0.2 0.0 92.1 0.1 5.9 0.7 4.5 0.0 0.0 0.0 6.3 0.0 1.8 0.0 0.2 0.0 0.0 2.5 0.0 1.9 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 6.0 8.1 4.3 7.5 7.5 3.4 6.9 3.0 8.5 6.4 8.9 28.9 15.2 9.8 0.5 0.0 156.9 48.4 16.0 27.3 14.0 2.0 276.1 3.3 184.1 2.3 166.8 4.2 93.5 124.7 21.8 45.8 45.4 2.3 137.1 49.2 0.0 0.0 326.6 22.9 3.5 1.1 11.4 0.0 10.8 0.0 0.4 240.4 0.0 5.6 19.0 0.5 0.0 65.7 0.5 4.9 0.0 312.9 1.3 0.4 12.3 THY1 CD90 ENSG00000154096 "Thy-1 cell surface antigen" P04216 11 119417378-119424985 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 97.7;smooth muscle: 91.5" "Cell type enhanced" "Detected in many" 8 "Fibroblasts: 117.3;Leydig cells: 89.2;Muller glia cells: 84.4;Peritubular cells: 72.9;Proximal tubular cells: 127.2;Smooth muscle cells: 114.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "MAIT T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Cell line enhanced" "Detected in many" "ASC diff: 53.5;BJ: 83.7;BJ hTERT+: 93.7;fHDF/TERT166: 146.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003733, CAB068243, CAB068244" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 9800000 Nucleoplasm "Plasma membrane" "CAB068243: AB_2665687, CAB068244: AB_2665688, HPA003733: AB_1846340" "unprognostic (9.98e-2)" "unprognostic (2.71e-1)" "unprognostic (5.13e-2)" "unprognostic (2.61e-1)" "prognostic unfavorable (6.87e-4)" "unprognostic (7.43e-2)" "unprognostic (1.43e-3)" "unprognostic (2.38e-2)" "unprognostic (1.29e-1)" "unprognostic (2.90e-3)" "unprognostic (3.38e-2)" "unprognostic (3.52e-1)" "prognostic unfavorable (2.40e-6)" "unprognostic (1.75e-2)" "unprognostic (1.90e-2)" "unprognostic (3.03e-2)" "unprognostic (1.14e-2)" 28.7 5.9 42.0 23.2 72.4 0.4 7.0 17.6 97.7 26.9 9.0 7.2 2.1 3.5 20.3 13.9 9.8 7.5 31.6 4.3 63.4 41.1 46.6 2.6 6.5 10.9 29.8 34.8 3.2 5.0 7.3 5.5 19.1 53.8 4.6 13.6 8.5 2.9 15.7 1.4 4.2 4.6 91.5 9.3 6.7 5.7 4.0 6.9 3.1 12.0 1.0 10.8 36.9 7.2 0.0 0.0 0.0 0.0 0.0 1.7 0.3 0.0 0.3 12.5 0.0 53.5 38.7 0.0 83.7 93.7 30.0 33.3 0.0 0.0 0.0 0.0 146.5 14.5 0.1 0.4 0.1 22.9 7.1 0.0 4.4 1.5 0.0 16.5 0.0 0.0 28.7 0.0 38.1 1.3 41.7 0.0 2.6 0.0 0.0 23.1 0.0 0.0 0.0 20.0 0.0 0.1 0.0 5.9 0.0 0.0 0.0 2.1 5.7 0.0 0.0 0.0 4.0 0.1 0.2 0.0 43.2 14.4 12.4 12.3 0.0 2.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 42.0 72.4 17.6 97.7 63.4 41.1 29.8 34.8 53.8 6.9 0.0 2.6 0.0 0.4 15.8 13.9 0.8 0.0 0.0 0.0 8.7 0.0 1.5 18.3 1.1 0.8 14.3 0.0 0.0 0.0 2.3 117.3 0.2 1.1 0.0 3.6 30.2 0.0 27.0 0.0 0.9 89.2 1.4 16.9 0.0 0.0 84.4 0.5 0.0 72.9 127.2 19.0 32.3 114.6 0.4 0.4 15.4 3.3 0.0 0.0 0.1 TIGD7 Sancho ENSG00000140993 "Tigger transposable element derived 7" Q6NT04 16 3298832-3305729 "Predicted intracellular proteins" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA041357, HPA041474" Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041357: AB_10794992, HPA041474: AB_10795696" "unprognostic (7.69e-2)" "unprognostic (3.04e-4)" "unprognostic (6.56e-3)" "unprognostic (1.18e-3)" "unprognostic (1.79e-1)" "unprognostic (4.04e-2)" "unprognostic (6.50e-3)" "unprognostic (2.44e-1)" "unprognostic (2.78e-2)" "unprognostic (9.81e-2)" "unprognostic (8.56e-3)" "unprognostic (2.09e-1)" "unprognostic (2.25e-2)" "unprognostic (8.87e-2)" "unprognostic (4.04e-1)" "unprognostic (5.90e-3)" "unprognostic (3.12e-2)" 3.7 5.6 7.7 8.2 7.6 1.3 11.7 8.6 6.8 8.5 5.9 5.3 5.8 3.1 9.3 8.2 5.2 8.8 4.7 7.7 7.1 8.3 6.8 3.9 4.6 4.8 7.1 3.7 17.4 4.4 16.9 17.6 5.3 7.5 8.4 3.6 3.8 4.1 8.9 5.5 3.5 4.0 6.9 6.7 6.5 3.7 12.5 7.3 8.5 11.0 2.8 5.0 11.0 6.1 4.9 1.1 6.3 2.8 3.8 5.7 1.5 0.9 2.1 5.5 3.0 2.9 4.2 4.5 2.9 1.8 4.5 4.2 0.3 1.7 2.0 4.7 2.1 3.3 0.5 2.0 0.8 5.7 0.2 2.8 5.8 1.7 0.1 3.3 1.0 7.7 4.4 1.5 4.2 1.3 4.7 3.4 1.5 2.8 3.7 3.8 1.2 1.9 8.8 6.3 0.5 5.0 10.3 1.3 8.4 2.4 0.5 7.6 2.8 6.8 0.9 2.5 5.0 3.2 3.3 1.1 2.7 6.5 2.8 1.6 7.7 7.8 6.4 1.6 3.4 3.0 1.0 1.4 6.3 3.3 1.0 5.7 1.6 2.8 4.8 1.0 4.9 5.5 3.6 3.5 3.8 2.8 1.1 2.9 1.5 7.7 7.6 8.6 6.8 7.1 8.3 7.1 3.7 7.5 7.3 8.9 5.0 0.5 3.2 0.7 7.4 8.4 5.1 2.7 5.7 0.0 3.9 1.2 3.3 2.3 2.6 1.7 0.5 0.0 1.2 0.9 0.9 2.7 1.1 0.5 0.8 4.8 1.2 0.6 1.6 1.6 2.6 1.1 5.0 0.0 0.8 3.2 0.8 0.0 4.2 0.8 1.8 6.5 1.7 10.5 10.4 0.5 1.1 2.6 0.4 1.4 TLR4 "ARMD10, CD284, hToll, TLR-4" ENSG00000136869 "Toll like receptor 4" O00206 9 117704175-117724730 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "Hydrolase, Receptor" "Age-related macular degeneration, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 15 "Hofbauer cells: 31.7;Ito cells: 59.5;Kupffer cells: 88.0;Macrophages: 33.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 30.1" "Group enriched" "Detected in many" 30 "dendritic cells: 7.5;granulocytes: 30.1;monocytes: 21.4" "Cell line enhanced" "Detected in many" "Karpas-707: 29.6;TIME: 21.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB004025, HPA049174" Approved Supported "Golgi apparatus,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" "Golgi apparatus" "CAB004025: , HPA049174: AB_2680662" "unprognostic (1.60e-1)" "unprognostic (8.34e-2)" "unprognostic (7.22e-2)" "prognostic favorable (6.29e-4)" "unprognostic (3.39e-1)" "unprognostic (7.48e-2)" "unprognostic (8.68e-2)" "unprognostic (1.80e-1)" "unprognostic (3.38e-1)" "unprognostic (5.18e-2)" "unprognostic (8.00e-2)" "unprognostic (9.42e-2)" "unprognostic (4.08e-2)" "unprognostic (8.63e-2)" "prognostic unfavorable (3.79e-4)" "unprognostic (1.09e-2)" "unprognostic (1.96e-2)" 29.2 12.1 15.5 23.5 12.5 17.8 21.9 9.4 10.3 6.9 6.8 10.6 3.0 4.4 5.8 7.7 5.0 6.8 10.6 10.9 19.9 7.5 9.0 16.5 16.0 30.9 12.4 11.4 6.7 3.0 2.9 3.8 22.8 10.5 5.7 7.4 7.2 9.0 3.6 7.4 5.2 6.6 10.4 11.1 41.4 4.5 2.4 13.0 1.1 8.3 5.6 7.5 12.1 16.1 0.6 7.5 30.1 21.4 0.0 0.0 6.9 0.0 0.0 12.7 0.0 5.9 12.0 0.1 5.0 8.8 1.3 0.7 0.0 1.2 1.7 0.2 13.0 3.9 0.0 0.0 1.1 1.9 0.0 0.0 2.7 2.7 0.1 4.4 9.1 0.0 7.4 0.0 2.8 0.3 11.4 15.5 0.0 0.0 29.6 15.4 0.0 0.0 1.8 1.5 1.2 0.6 0.0 14.3 9.3 0.5 14.8 0.0 0.0 3.2 0.0 0.5 1.2 0.0 5.0 21.4 0.7 9.6 0.0 2.4 0.0 0.0 0.0 0.4 9.6 7.6 17.6 21.4 7.2 0.0 19.6 0.0 0.6 0.0 0.0 7.5 0.2 0.0 0.0 30.1 0.0 20.2 0.3 0.0 6.9 15.5 12.5 9.4 10.3 19.9 7.5 12.4 11.4 10.5 13.0 0.0 5.3 1.5 0.1 0.7 0.2 2.5 5.1 2.7 4.5 0.0 0.0 0.2 0.0 0.0 0.0 19.7 0.3 0.0 0.2 0.2 1.9 0.2 15.1 1.8 31.7 0.0 0.0 59.5 88.0 0.0 0.0 33.1 1.7 0.0 0.6 13.8 0.3 1.7 0.0 0.4 0.8 6.5 0.9 0.0 0.2 0.0 0.7 0.0 0.1 2.2 TM4SF20 "FLJ22800, TCCE518" ENSG00000168955 "Transmembrane 4 L six family member 20" Q53R12 2 227362156-227381995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Autism spectrum disorder" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 86 "intestine: 147.8" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 33.2;Enterocytes: 27.7;Late spermatids: 61.3;Paneth cells: 11.5" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A549: 7.2;RPMI-8226: 4.5" "Not detected" "Not detected" "Not detected" "Not detected" "HPA051838, HPA063184, HPA065531" Uncertain Supported "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane, Focal adhesion sites" "HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506" "unprognostic (4.68e-2)" "unprognostic (1.13e-1)" "unprognostic (8.75e-2)" "unprognostic (4.96e-2)" "unprognostic (2.84e-2)" "unprognostic (1.63e-1)" "unprognostic (2.51e-1)" "unprognostic (2.36e-1)" "unprognostic (2.95e-1)" "unprognostic (1.20e-2)" "unprognostic (1.19e-1)" "unprognostic (3.44e-3)" "unprognostic (7.76e-2)" "unprognostic (2.60e-2)" "unprognostic (3.04e-3)" 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.1 0.1 46.5 0.0 0.0 73.5 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 0.9 0.0 0.1 0.0 0.1 0.1 147.8 0.2 0.1 0.1 0.1 1.2 0.0 0.0 0.1 0.0 0.0 0.1 0.1 1.1 1.2 1.1 0.5 1.7 0.7 0.0 0.1 7.2 0.2 0.1 0.0 0.0 1.3 0.9 0.1 0.0 0.0 1.4 0.5 0.2 0.1 0.4 0.2 0.2 0.0 0.0 0.1 0.1 0.4 0.0 1.3 0.2 0.0 0.5 0.3 0.0 0.1 0.0 0.0 0.4 0.0 0.4 0.4 0.8 0.3 0.0 0.1 1.6 0.3 0.1 0.1 0.5 0.1 4.5 0.1 0.3 0.6 1.7 1.1 0.1 0.0 0.1 0.3 0.1 0.3 0.6 0.3 2.0 0.2 0.5 0.3 0.4 0.2 0.2 0.2 0.8 0.5 0.1 0.7 0.3 0.3 0.7 0.4 0.4 0.0 1.1 0.7 0.5 1.1 1.7 0.1 1.2 0.4 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.2 0.0 27.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 61.3 0.0 0.0 0.0 0.0 0.6 0.2 0.0 11.5 0.7 0.0 0.2 0.0 0.0 0.5 0.2 0.0 0.0 0.0 1.2 0.0 TM4SF4 il-TMP ENSG00000169903 "Transmembrane 4 L six family member 4" P48230 3 149473974-149503281 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "gallbladder: 196.0;intestine: 126.4;liver: 81.8" "Cell type enriched" "Detected in many" 5 "Cholangiocytes: 2236.9" "Group enriched" "Detected in many" 10 "liver cancer: 249.4;pancreatic cancer: 130.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "intermediate monocyte: 1.3" "Lineage enriched" "Detected in single" 13 "monocytes: 1.3" "Group enriched" "Detected in some" 6 "A549: 15.4;OE19: 14.2;RPTEC TERT1: 24.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046430 Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA046430: AB_2679662" "unprognostic (1.91e-2)" "unprognostic (1.71e-1)" "unprognostic (2.15e-1)" "unprognostic (1.66e-1)" "unprognostic (2.27e-1)" "unprognostic (1.67e-1)" "unprognostic (1.33e-1)" "unprognostic (4.96e-2)" "unprognostic (2.73e-1)" "unprognostic (1.98e-1)" "unprognostic (7.60e-2)" "unprognostic (1.83e-1)" "unprognostic (4.66e-2)" "unprognostic (1.91e-2)" "unprognostic (4.97e-1)" 0.3 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.2 0.2 68.2 0.0 0.0 70.3 0.2 0.1 0.3 0.3 196.0 0.2 0.2 0.2 0.4 81.8 0.3 0.0 0.2 0.0 0.2 24.2 0.0 0.3 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.2 0.2 126.4 0.0 0.2 0.3 2.3 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.2 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 1.1 0.5 0.0 0.0 0.0 0.3 0.2 0.2 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.6 0.1 14.2 0.0 0.0 0.3 0.9 24.0 0.0 0.5 0.9 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 3.0 0.3 0.0 0.0 0.1 0.0 3.4 2236.9 0.0 1.2 0.0 0.0 0.0 0.0 20.8 0.8 0.0 2.6 23.3 1.7 0.1 0.0 0.0 0.0 475.7 0.1 0.0 2.9 8.0 11.0 0.0 0.0 0.0 0.0 1.8 0.9 0.0 7.6 0.0 0.0 2.1 0.0 0.0 1.1 3.6 0.1 0.0 0.1 0.0 0.1 0.1 TMC5 FLJ13593 ENSG00000103534 "Transmembrane channel like 5" Q6UXY8 16 19410496-19499113 "Predicted membrane proteins" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "intestine: 108.7" "Cell type enhanced" "Detected in many" 11 "Ciliated cells: 547.4;Club cells: 299.1;Pancreatic endocrine cells: 236.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "CAPAN-2: 37.3;OE19: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA040810, HPA042037" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA040810: AB_10795627, HPA042037: AB_10804126" "unprognostic (2.47e-2)" "unprognostic (3.68e-1)" "unprognostic (3.50e-2)" "unprognostic (2.74e-3)" "unprognostic (1.01e-1)" "unprognostic (3.64e-2)" "prognostic unfavorable (7.96e-4)" "unprognostic (1.21e-1)" "unprognostic (1.59e-1)" "unprognostic (9.74e-2)" "unprognostic (3.27e-2)" "unprognostic (3.71e-1)" "unprognostic (2.28e-2)" "unprognostic (2.69e-1)" "unprognostic (7.88e-2)" "unprognostic (8.88e-3)" "unprognostic (1.75e-1)" 0.7 0.3 0.3 4.8 0.3 0.1 5.6 0.3 0.7 3.8 66.1 0.6 0.6 19.1 2.1 16.9 1.4 1.9 15.9 0.4 0.4 0.3 0.3 1.8 17.6 0.2 0.3 0.4 1.8 5.4 4.5 1.0 3.7 1.0 8.4 9.8 1.7 18.9 0.2 0.3 0.8 108.7 0.3 0.2 0.3 19.5 2.6 0.2 0.2 0.8 1.7 4.1 1.5 1.1 0.5 0.7 2.2 0.6 0.9 0.8 0.3 3.5 5.8 0.0 0.1 0.0 0.0 5.2 0.0 0.0 0.0 0.0 0.0 37.3 0.0 0.2 0.0 0.1 2.3 0.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.1 1.3 21.6 1.6 0.0 0.0 1.3 0.1 0.1 0.3 0.1 0.0 1.1 0.0 0.6 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.3 0.6 0.2 0.3 0.3 0.2 0.4 0.8 0.3 0.2 0.5 0.2 0.3 2.2 0.9 0.4 0.7 0.1 0.3 0.3 0.3 0.3 0.7 0.4 0.3 0.3 0.4 1.0 0.2 145.9 125.6 0.0 19.6 0.7 0.1 0.8 122.3 547.4 299.1 21.0 2.0 31.1 0.0 107.5 21.7 0.4 170.3 0.0 144.9 1.6 0.8 88.4 5.7 0.0 2.3 3.2 37.4 0.6 0.0 28.2 0.3 0.9 1.7 1.8 97.1 0.1 236.7 190.0 0.7 0.4 1.5 0.0 0.9 1.8 1.1 1.5 13.6 0.0 77.1 46.1 TMED8 FAM15B ENSG00000100580 "Transmembrane p24 trafficking protein family member 8" Q6PL24 14 77335021-77377109 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 102.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 31.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001205 Approved Approved "Vesicles,Plasma membrane" NA NA "Plasma membrane" Vesicles "HPA001205: AB_2204460" "unprognostic (1.07e-1)" "unprognostic (4.70e-2)" "unprognostic (4.85e-2)" "unprognostic (2.39e-1)" "unprognostic (1.13e-1)" "unprognostic (7.82e-2)" "unprognostic (1.68e-2)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (2.01e-1)" "unprognostic (2.81e-2)" "unprognostic (1.04e-1)" "unprognostic (1.03e-3)" "unprognostic (2.23e-3)" "unprognostic (1.12e-1)" "unprognostic (5.88e-2)" "unprognostic (2.77e-1)" 8.2 12.8 13.4 16.3 18.3 10.3 12.1 15.0 16.1 9.7 7.0 6.5 8.0 5.3 10.4 8.3 5.9 8.6 6.6 7.6 11.3 21.2 15.7 5.9 7.1 23.6 12.4 16.6 11.6 8.6 19.3 26.0 6.8 16.9 9.4 7.6 11.6 7.3 9.7 4.3 7.6 8.8 8.7 13.9 12.0 9.4 12.4 11.8 12.6 16.4 2.4 27.2 7.9 8.5 5.3 2.3 4.8 2.2 1.2 1.6 1.0 7.7 6.4 7.6 6.8 4.8 4.3 6.5 4.9 3.2 5.2 5.6 4.0 4.4 31.0 4.2 4.0 4.3 5.4 5.6 5.6 8.1 9.7 3.4 10.3 5.0 4.2 3.3 5.0 28.6 4.5 4.0 6.7 6.1 5.2 7.3 25.8 5.2 8.4 5.1 7.6 7.9 7.4 3.8 5.7 6.5 6.4 7.0 2.5 5.4 4.8 9.5 5.7 8.5 5.1 6.2 6.1 8.3 8.4 5.2 5.4 3.5 9.6 5.7 6.8 12.9 15.7 6.1 9.4 7.8 3.7 1.6 4.8 0.8 2.2 1.0 4.9 1.2 1.0 1.4 5.3 0.7 1.2 2.6 1.2 1.9 2.3 1.6 1.0 13.4 18.3 15.0 16.1 11.3 21.2 12.4 16.6 16.9 11.8 3.0 5.6 18.2 4.3 6.0 30.4 14.6 10.2 25.4 3.4 21.0 102.1 8.9 5.0 5.1 3.8 6.0 4.1 23.3 4.1 8.8 7.5 6.5 0.0 8.5 6.8 27.0 42.6 8.0 20.3 6.3 13.6 8.4 5.0 7.2 6.9 14.1 5.4 3.5 13.4 17.4 36.4 12.9 7.1 6.5 14.1 7.9 3.4 5.3 5.9 3.7 TMEM101 "FLJ23987, MGC4251" ENSG00000091947 "Transmembrane protein 101" Q96IK0 17 44011188-44023946 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039739, HPA075651" Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA039739: AB_2676657, HPA075651: " "unprognostic (1.40e-3)" "unprognostic (1.75e-1)" "unprognostic (1.67e-1)" "prognostic favorable (4.29e-4)" "unprognostic (5.91e-2)" "unprognostic (3.91e-3)" "prognostic unfavorable (7.10e-4)" "unprognostic (1.80e-2)" "unprognostic (2.43e-1)" "unprognostic (2.03e-1)" "unprognostic (1.53e-1)" "unprognostic (1.61e-1)" "prognostic favorable (4.10e-5)" "unprognostic (1.59e-2)" "unprognostic (2.02e-1)" "unprognostic (1.48e-1)" "unprognostic (2.32e-2)" 11.0 10.9 8.4 7.3 14.2 5.1 58.9 6.3 16.5 22.7 11.4 13.7 7.7 8.4 33.3 14.5 15.1 19.2 15.4 12.4 8.7 8.6 37.2 12.0 11.4 16.1 9.5 9.4 13.0 27.8 10.7 8.5 17.8 11.6 13.9 8.6 11.5 20.9 59.7 15.5 13.8 9.5 11.6 10.1 11.0 13.6 16.9 8.9 10.0 25.4 12.9 13.2 12.5 11.6 23.8 25.9 11.7 25.0 23.8 27.2 17.8 9.8 24.2 8.6 7.2 20.6 19.9 8.7 10.3 15.7 20.5 19.6 17.9 25.7 11.1 2.9 10.6 16.0 15.2 10.0 17.9 15.7 12.0 20.2 8.3 19.4 36.2 17.8 13.4 14.5 17.8 20.5 14.5 20.6 18.5 17.9 19.5 17.1 21.9 12.7 13.2 14.4 15.4 4.0 10.8 27.3 12.5 18.8 20.1 17.1 8.0 11.3 9.0 6.6 0.2 24.5 11.4 11.9 25.8 10.7 18.8 12.7 8.2 20.2 22.8 15.7 5.1 19.7 12.7 16.7 11.7 24.9 8.6 19.4 25.0 21.8 22.7 24.5 22.3 25.9 23.8 27.2 22.1 9.1 23.8 17.8 25.2 25.1 17.8 8.4 14.2 6.3 16.5 8.7 8.6 9.5 9.4 11.6 8.9 17.9 12.5 26.3 26.3 18.3 10.4 28.5 20.4 22.7 13.6 38.4 5.9 59.3 31.5 30.3 10.8 20.2 20.8 0.0 43.1 35.2 18.8 20.8 23.0 18.6 33.4 11.1 22.5 31.3 25.9 8.7 12.0 20.9 32.1 47.7 31.6 16.0 40.2 17.5 11.7 25.6 11.4 6.5 16.0 48.6 17.9 19.7 37.3 17.9 43.5 22.6 TMEM139 FLJ90586 ENSG00000178826 "Transmembrane protein 139" Q8IV31 7 143279957-143288048 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 25.1;kidney: 22.6;placenta: 28.0" "Cell type enhanced" "Detected in many" 7 "Collecting duct cells: 48.8;Ductal cells: 42.9;Enterocytes: 54.0;Proximal tubular cells: 67.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 3.2" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "A-431: 9.7;CAPAN-2: 18.3;EFO-21: 12.9;RPTEC TERT1: 32.2;SK-BR-3: 11.3;T-47d: 31.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA036982, HPA036983" Approved Approved "Plasma membrane,Focal adhesion sites" NA NA "Plasma membrane" "Focal adhesion sites" "HPA036982: AB_2675413, HPA036983: AB_10672275" "unprognostic (2.58e-1)" "unprognostic (4.38e-1)" "unprognostic (6.62e-3)" "unprognostic (1.41e-1)" "unprognostic (2.10e-1)" "unprognostic (2.16e-3)" "unprognostic (2.83e-2)" "unprognostic (4.90e-2)" "unprognostic (1.60e-1)" "unprognostic (2.82e-2)" "prognostic unfavorable (1.66e-4)" "unprognostic (2.89e-1)" "prognostic favorable (3.05e-5)" "unprognostic (1.73e-1)" "unprognostic (1.42e-2)" "unprognostic (2.83e-2)" "unprognostic (9.08e-3)" 1.5 2.2 0.9 2.8 1.9 0.0 2.1 0.6 1.6 6.3 14.7 6.0 1.5 22.7 1.6 3.5 0.4 4.6 4.8 2.3 1.6 1.1 22.6 7.8 5.5 0.1 4.2 0.7 0.9 9.6 6.4 2.0 28.0 4.8 1.6 2.9 1.4 6.1 2.2 0.1 1.1 25.1 0.4 13.4 0.8 2.0 3.0 2.1 0.1 8.8 0.4 0.7 2.1 2.4 0.5 0.3 0.9 3.2 0.0 2.0 0.4 9.7 0.7 0.1 0.0 0.0 0.0 6.5 0.1 0.0 0.0 0.0 2.3 18.3 0.1 12.9 0.0 0.8 8.3 0.0 4.2 0.0 0.1 0.0 0.0 1.1 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.6 0.7 0.4 0.0 0.2 0.7 0.1 0.1 0.0 32.2 2.5 0.1 0.0 0.5 11.3 0.0 0.2 31.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.9 0.0 3.2 0.0 0.5 1.3 0.8 0.0 0.0 1.1 0.6 0.0 0.0 2.4 0.3 2.0 0.4 0.9 1.9 0.6 1.6 1.6 1.1 4.2 0.7 4.8 2.1 14.9 5.1 0.0 2.4 0.1 0.0 2.0 35.7 2.7 5.7 48.8 0.0 26.6 29.9 42.9 12.0 0.3 54.0 0.0 4.0 4.7 0.3 0.3 0.0 13.4 1.7 0.0 3.5 1.3 0.6 8.8 0.0 0.1 5.0 1.8 4.3 8.3 23.3 23.0 0.0 67.4 0.0 0.0 0.0 0.0 0.1 0.0 5.4 0.0 7.4 1.2 TMEM2 ENSG00000135048 "Transmembrane protein 2" Q9UHN6 9 71683366-71816690 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" Angiogenesis "Developmental protein, Glycosidase, Hydrolase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 67.6" "Cell type enhanced" "Detected in many" 5 "Ito cells: 115.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 36.6;BEWO: 34.0;OE19: 36.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044889 Approved Supported "Vesicles,Plasma membrane" NA NA 130000 "Plasma membrane" Vesicles "HPA044889: AB_10962641" "unprognostic (2.06e-1)" "unprognostic (1.12e-1)" "unprognostic (3.85e-2)" "unprognostic (1.01e-2)" "unprognostic (6.15e-3)" "unprognostic (1.21e-2)" "unprognostic (2.93e-2)" "unprognostic (3.53e-1)" "unprognostic (3.29e-2)" "unprognostic (1.92e-1)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "prognostic unfavorable (1.31e-4)" "unprognostic (1.13e-2)" "unprognostic (2.33e-1)" "unprognostic (7.59e-2)" "unprognostic (1.16e-1)" 23.3 3.9 6.0 10.5 4.4 12.4 13.6 8.9 6.0 3.0 18.6 1.9 10.1 12.2 4.5 5.2 4.4 4.9 19.2 9.5 8.6 3.6 9.3 24.9 35.7 14.0 4.0 4.1 3.1 9.2 24.0 9.5 67.6 4.3 5.5 13.1 7.9 9.5 10.2 5.5 6.4 20.0 5.5 5.1 15.6 14.5 3.7 2.4 6.4 8.0 4.6 8.8 11.4 6.8 6.3 0.9 5.5 2.1 0.5 4.1 1.4 5.8 28.0 36.6 1.7 3.8 6.9 34.0 19.7 12.6 13.7 10.1 7.8 8.0 0.1 5.9 5.0 3.0 8.7 11.8 2.7 18.6 0.7 3.6 10.0 5.9 20.8 5.9 0.0 2.7 7.1 3.0 10.6 2.4 3.6 18.0 0.8 1.4 3.0 7.4 4.9 1.1 0.1 7.6 36.1 2.7 0.9 10.9 0.7 8.6 18.9 1.8 0.2 5.1 3.6 5.3 11.8 2.5 0.3 7.8 9.3 10.5 5.1 9.8 0.6 8.4 0.3 1.8 0.9 11.7 0.2 2.1 5.5 2.7 1.9 0.8 0.7 2.9 2.6 0.9 6.3 4.1 2.0 4.5 0.5 1.8 0.2 3.9 1.4 6.0 4.4 8.9 6.0 8.6 3.6 4.0 4.1 4.3 2.4 32.8 30.4 9.4 38.3 26.8 5.5 0.0 33.1 4.0 17.0 0.0 9.8 36.3 0.0 0.0 10.6 37.9 75.4 0.0 0.0 12.0 19.0 42.5 4.6 27.6 35.9 0.0 9.7 115.4 56.5 2.9 2.8 14.9 16.9 0.0 32.3 73.6 0.0 26.4 1.1 0.0 35.2 6.5 20.8 1.0 0.6 19.2 75.1 62.3 28.3 40.3 TMEM218 ENSG00000150433 "Transmembrane protein 218" A2RU14 11 125096545-125111763 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038489 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038489: AB_10672748" "unprognostic (3.70e-2)" "unprognostic (1.16e-1)" "unprognostic (7.60e-2)" "unprognostic (2.41e-3)" "unprognostic (8.86e-2)" "unprognostic (1.60e-1)" "prognostic unfavorable (1.93e-5)" "unprognostic (3.63e-2)" "unprognostic (7.09e-3)" "unprognostic (2.18e-1)" "unprognostic (6.45e-2)" "unprognostic (1.09e-1)" "unprognostic (9.95e-2)" "prognostic favorable (5.50e-4)" "unprognostic (6.53e-2)" "unprognostic (1.42e-1)" "unprognostic (6.72e-2)" 24.2 19.0 14.0 13.2 15.7 7.0 13.5 11.9 12.4 14.7 12.3 16.8 12.3 12.5 17.5 16.3 12.8 20.8 16.5 10.4 14.1 9.3 13.1 13.6 11.9 13.7 13.6 10.0 17.8 19.7 12.8 17.4 8.8 10.5 17.4 9.4 18.0 15.0 11.1 9.7 8.8 12.4 14.7 11.7 17.5 13.3 7.8 11.3 10.0 13.0 12.0 12.4 14.2 13.6 18.0 28.7 18.5 25.2 19.1 14.0 15.4 7.6 15.1 9.6 11.6 8.9 12.4 5.8 7.7 5.9 6.0 7.8 1.5 22.8 9.7 19.4 4.7 9.2 9.0 6.0 7.3 8.0 13.5 8.6 21.7 4.1 6.1 8.8 6.8 8.1 9.7 9.8 10.6 12.7 9.7 8.7 12.1 8.7 12.4 10.3 3.9 1.7 14.3 7.8 21.1 14.4 10.0 11.6 7.4 5.3 7.7 8.3 12.5 10.5 4.2 5.4 5.9 20.0 9.8 11.1 7.3 6.7 8.6 8.3 7.2 6.0 8.0 5.9 14.2 12.9 18.5 25.2 10.1 14.0 18.8 12.2 18.0 13.3 13.2 28.7 13.7 11.5 13.5 9.6 19.1 17.4 24.9 11.7 15.4 14.0 15.7 11.9 12.4 14.1 9.3 13.6 10.0 10.5 11.3 17.9 12.0 16.9 15.8 10.8 6.9 7.7 10.2 20.1 6.8 14.0 0.0 24.0 23.2 17.4 1.1 15.8 5.2 0.0 14.1 15.6 17.7 11.9 3.5 13.9 37.3 22.3 10.4 17.2 20.5 1.1 9.5 19.0 16.9 21.6 10.0 21.8 12.4 0.0 15.6 16.2 12.2 25.8 16.5 14.6 10.2 12.4 8.1 13.6 13.3 15.2 TMEM245 "C9orf5, CG-2" ENSG00000106771 "Transmembrane protein 245" Q9H330 9 109015152-109119945 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023892 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA023892: AB_1845828" "unprognostic (1.56e-2)" "unprognostic (1.65e-1)" "unprognostic (1.29e-1)" "unprognostic (9.58e-2)" "unprognostic (1.63e-1)" "unprognostic (6.43e-2)" "unprognostic (1.66e-1)" "unprognostic (5.96e-2)" "unprognostic (1.18e-1)" "unprognostic (1.03e-1)" "unprognostic (2.05e-1)" "unprognostic (1.85e-1)" "prognostic favorable (4.46e-9)" "unprognostic (6.11e-2)" "unprognostic (2.44e-1)" "unprognostic (2.41e-1)" "unprognostic (2.24e-2)" 16.5 35.5 14.4 7.2 18.1 4.0 24.2 15.7 20.6 14.0 19.2 14.7 22.0 7.7 18.4 17.3 14.6 18.7 15.3 25.2 12.6 14.9 29.0 16.2 20.5 12.3 14.5 14.8 29.0 20.3 43.2 14.9 17.5 13.7 16.4 10.7 22.1 14.5 22.3 29.8 9.2 16.8 23.1 13.6 10.4 17.2 12.2 14.3 12.3 52.1 8.9 7.5 20.8 11.2 3.5 3.5 6.3 3.3 5.4 9.0 2.7 13.7 18.4 13.6 4.6 32.0 18.4 30.0 19.9 15.4 21.5 17.0 24.6 27.7 12.5 20.4 15.1 20.9 21.8 17.2 12.8 25.5 16.1 7.4 15.4 15.4 14.5 14.0 11.7 12.2 19.6 13.1 20.9 19.4 23.2 17.9 13.8 10.3 13.8 24.4 9.1 15.5 5.4 15.1 18.6 16.6 8.9 27.0 7.7 22.9 13.5 7.5 7.4 13.1 13.2 13.1 21.1 17.5 6.6 19.6 16.8 12.6 15.6 22.6 9.2 23.8 4.0 23.3 6.3 24.3 6.3 2.6 2.2 4.0 1.8 4.9 2.7 6.8 5.6 2.5 3.5 9.0 6.2 1.0 5.4 3.3 3.5 6.5 2.7 14.4 18.1 15.7 20.6 12.6 14.9 14.5 14.8 13.7 14.3 107.2 79.6 16.9 16.5 22.3 43.1 117.8 63.7 32.1 31.8 82.0 100.1 40.7 3.3 19.7 5.9 48.2 31.1 93.5 27.0 14.5 19.9 23.7 30.1 82.0 15.7 60.4 30.0 48.5 21.0 5.4 38.0 15.7 21.9 10.0 34.9 49.9 24.5 34.3 48.1 28.4 30.3 45.3 36.0 28.7 40.4 24.8 12.6 17.3 34.3 19.9 TMEM254 "bA369J21.6, C10orf57, FLJ13263" ENSG00000133678 "Transmembrane protein 254" Q8TBM7 10 80078646-80092557 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA029105, HPA072613" Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA029105: AB_2672909, HPA072613: AB_2732205" "unprognostic (9.40e-2)" "unprognostic (1.76e-1)" "unprognostic (9.52e-2)" "unprognostic (5.74e-3)" "unprognostic (5.39e-2)" "unprognostic (6.04e-2)" "unprognostic (3.66e-1)" "unprognostic (3.90e-1)" "unprognostic (1.64e-2)" "unprognostic (1.87e-3)" "unprognostic (3.68e-2)" "unprognostic (1.46e-1)" "unprognostic (7.65e-2)" "unprognostic (2.46e-1)" "unprognostic (1.21e-1)" "unprognostic (3.45e-3)" "unprognostic (5.96e-2)" 8.4 13.4 10.8 6.0 14.1 4.7 15.9 6.9 13.5 14.1 13.1 11.7 14.7 10.1 12.4 40.1 35.8 17.3 10.5 4.8 9.4 6.3 10.0 30.8 6.8 9.0 7.7 9.0 8.7 12.1 8.3 10.1 14.8 9.5 25.8 13.7 10.7 16.3 9.1 3.0 43.9 13.4 6.6 8.2 6.9 9.0 21.5 8.8 8.6 11.8 12.4 15.4 13.0 20.5 12.6 14.7 27.7 18.1 9.8 22.9 11.9 7.3 7.0 11.9 9.1 14.6 18.3 18.1 7.1 5.2 5.2 5.3 5.3 22.7 5.6 12.1 9.0 4.9 7.8 4.8 5.9 5.5 9.2 8.5 1.5 2.3 7.4 6.6 6.9 7.5 11.8 26.9 4.6 4.0 11.3 4.6 4.8 4.1 12.2 5.2 14.9 5.6 5.1 6.4 6.4 23.0 6.9 1.4 4.8 7.2 6.1 4.2 6.9 6.6 16.5 7.1 8.3 23.4 4.6 6.7 4.1 7.1 6.9 4.0 8.4 11.9 0.4 10.3 7.1 3.4 27.7 16.2 7.4 11.9 18.1 14.9 12.6 13.8 12.3 13.2 9.6 22.9 15.6 1.7 9.8 17.6 14.7 16.0 11.9 10.8 14.1 6.9 13.5 9.4 6.3 7.7 9.0 9.5 8.8 8.9 8.1 6.0 5.0 7.2 7.4 2.6 15.3 37.5 14.8 8.7 15.7 33.9 18.3 12.1 3.1 5.2 10.5 0.0 7.5 30.9 5.3 21.9 5.7 28.8 17.1 15.9 8.1 5.5 11.1 5.9 8.6 9.2 3.3 16.2 22.8 14.5 9.5 18.2 11.0 17.0 11.1 12.9 3.8 24.2 8.7 21.0 19.0 6.9 18.7 6.5 TMEM258 C11orf10 ENSG00000134825 "Transmembrane protein 258" P61165 11 61768501-61792802 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044602 Approved Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA044602: AB_10961423" "unprognostic (6.35e-2)" "unprognostic (1.70e-1)" "unprognostic (7.49e-2)" "unprognostic (4.99e-3)" "unprognostic (9.95e-2)" "unprognostic (1.24e-2)" "unprognostic (3.18e-2)" "unprognostic (1.24e-1)" "unprognostic (8.48e-2)" "prognostic favorable (4.37e-4)" "unprognostic (1.34e-3)" "unprognostic (7.39e-2)" "unprognostic (4.75e-3)" "unprognostic (2.59e-2)" "unprognostic (1.02e-1)" "unprognostic (3.34e-2)" "unprognostic (2.58e-1)" 15.3 23.1 18.9 16.5 22.5 23.9 31.0 16.2 25.2 28.2 21.6 19.7 34.6 17.7 21.2 81.8 18.1 26.7 22.4 36.6 19.5 15.8 19.0 32.0 33.2 35.9 24.7 19.0 32.2 117.2 6.8 29.1 19.8 18.8 20.0 24.5 13.3 54.0 31.0 22.2 14.0 16.1 18.4 20.1 19.7 21.2 19.9 19.4 17.3 25.3 24.8 22.9 15.7 19.1 53.3 107.7 87.4 51.7 31.0 51.4 50.2 24.4 42.4 36.9 29.3 57.5 56.0 20.5 19.7 32.3 19.5 22.7 36.5 44.2 17.4 37.4 46.2 38.2 26.5 32.0 37.8 25.8 25.5 28.5 14.6 46.5 56.1 54.3 30.5 17.0 47.4 58.3 24.1 63.6 49.7 36.0 39.7 36.0 66.9 31.7 81.3 21.4 53.3 45.9 57.0 29.1 24.0 24.8 111.2 40.5 40.2 29.1 30.6 17.6 37.5 34.6 35.1 41.6 61.1 17.8 22.4 20.2 28.7 14.0 43.6 34.3 28.7 31.6 18.7 23.2 87.4 51.7 59.1 40.6 43.7 49.7 53.3 48.3 45.1 42.6 42.3 41.6 41.1 39.8 31.0 42.2 107.7 51.4 50.2 18.9 22.5 16.2 25.2 19.5 15.8 24.7 19.0 18.8 19.4 95.3 210.6 191.2 192.8 203.3 34.4 466.4 425.4 301.2 234.3 301.8 17.7 370.2 250.4 433.9 186.9 238.5 290.8 23.3 568.5 499.5 345.7 260.4 219.6 452.5 405.4 35.0 298.8 324.7 368.7 111.6 310.7 338.3 539.9 431.0 448.2 326.7 464.8 390.9 201.5 405.8 52.5 168.1 247.3 313.1 426.1 243.9 424.8 226.6 405.7 222.4 TMEM266 "C15orf27, FLJ38190" ENSG00000169758 "Transmembrane protein 266" Q2M3C6 15 76059837-76229121 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "brain: 50.7" "Cell type enhanced" "Detected in some" 8 "Cone photoreceptor cells: 9.8;Cytotrophoblasts: 12.8;Late spermatids: 11.1;Rod photoreceptor cells: 7.6;Sertoli cells: 6.5" "Cancer enhanced" "Detected in some" "testis cancer: 2.3" "Region enriched" "Detected in many" 12 "cerebellum: 50.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HDLM-2: 2.0;HEK 293: 3.6;NTERA-2: 3.7;U-937: 3.3" "Region enriched" "Detected in all" 6 "cerebellum: 65.8" "Region enriched" "Detected in all" 6 "cerebellum: 66.4" "HPA041921, HPA049425" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041921: AB_10796789, HPA049425: AB_2732552" "unprognostic (8.63e-3)" "unprognostic (6.11e-3)" "unprognostic (3.44e-3)" "unprognostic (9.17e-5)" "unprognostic (4.67e-1)" "unprognostic (2.61e-2)" "unprognostic (9.34e-3)" "unprognostic (5.61e-2)" "unprognostic (8.48e-3)" "unprognostic (2.89e-2)" "unprognostic (1.18e-2)" "unprognostic (3.95e-2)" "unprognostic (1.68e-3)" "unprognostic (1.25e-1)" "unprognostic (1.31e-1)" "unprognostic (1.13e-2)" "unprognostic (7.86e-2)" 0.1 1.9 1.1 0.2 1.9 0.2 0.4 50.7 4.2 0.2 0.2 0.6 0.0 0.3 0.2 0.1 0.3 0.3 0.1 0.1 0.9 1.3 0.9 0.1 1.1 0.3 0.7 0.3 0.1 2.4 0.2 5.1 2.4 1.9 0.4 0.2 1.1 0.2 0.1 10.6 1.5 0.1 0.1 0.4 0.6 0.3 1.4 0.0 0.0 0.2 0.7 0.5 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.9 0.1 0.8 0.8 0.0 2.0 3.6 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.9 50.7 4.2 0.9 1.3 0.7 0.3 1.9 0.0 0.0 0.0 0.0 0.9 0.0 2.6 0.0 0.0 2.7 0.0 1.8 9.8 12.8 1.7 0.0 5.9 0.0 0.0 0.0 0.2 1.7 0.7 0.8 0.0 0.0 4.2 1.6 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.7 0.5 7.6 6.5 0.0 0.5 2.1 0.0 4.9 0.0 0.0 0.4 TMEM268 "C9orf91, DKFZp547P234, FLJ38045" ENSG00000157693 "Transmembrane protein 268" Q5VZI3 9 114611206-114646422 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" 21 "Alveolar cells type 2: 9.3;Ciliated cells: 8.1;Hofbauer cells: 7.8;monocytes: 33.3;Syncytiotrophoblasts: 7.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 8.4" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Karpas-707: 30.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017199 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA017199: AB_1845845" "unprognostic (8.57e-2)" "unprognostic (3.37e-1)" "unprognostic (8.33e-2)" "prognostic favorable (3.61e-4)" "unprognostic (2.09e-1)" "unprognostic (7.16e-2)" "unprognostic (3.55e-2)" "unprognostic (1.26e-1)" "unprognostic (1.87e-1)" "unprognostic (2.26e-2)" "unprognostic (2.22e-3)" "unprognostic (1.44e-1)" "unprognostic (6.67e-2)" "unprognostic (6.10e-2)" "unprognostic (7.65e-3)" "unprognostic (1.09e-2)" "unprognostic (1.47e-1)" 9.1 9.0 9.6 8.5 15.8 3.8 9.7 4.4 31.0 7.3 6.6 5.1 3.4 4.3 7.7 7.6 4.8 5.7 4.8 3.7 12.5 9.1 3.8 6.3 6.6 10.6 8.5 15.3 10.2 5.6 15.1 4.6 5.9 8.7 15.9 6.8 11.1 8.9 9.1 5.0 4.3 6.4 8.8 7.7 15.5 7.5 4.8 5.0 10.3 7.9 2.0 11.4 7.8 5.4 4.3 8.4 2.3 2.5 1.5 1.9 0.9 2.6 4.6 2.2 4.7 6.3 4.6 1.7 2.6 4.5 3.6 3.6 3.5 1.0 11.6 2.2 2.9 10.2 4.5 4.3 2.1 3.0 5.9 2.9 3.6 3.4 2.1 10.8 7.5 1.8 4.1 3.8 4.9 5.2 4.5 2.3 14.9 7.1 30.3 2.5 7.8 8.7 2.2 5.7 3.3 4.6 9.9 2.5 9.8 2.0 2.1 7.5 4.8 8.5 11.2 22.9 1.4 14.9 7.0 1.3 3.5 4.1 1.4 4.6 16.8 15.7 12.5 1.9 6.4 6.4 0.5 2.5 0.5 1.3 2.1 0.5 2.3 1.3 0.7 1.4 4.3 1.9 1.5 2.3 1.5 1.8 8.4 0.2 0.9 9.6 15.8 4.4 31.0 12.5 9.1 8.5 15.3 8.7 5.0 0.0 9.3 0.0 0.0 0.0 0.0 0.0 0.0 8.1 2.3 0.0 0.0 3.8 0.0 1.5 0.0 0.0 0.0 0.0 4.0 0.9 0.0 0.0 0.0 0.0 7.8 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 33.3 0.0 0.0 1.8 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 TMEM63B "C6orf110, dJ421H19.2, DKFZp434P0531" ENSG00000137216 "Transmembrane protein 63B" Q5T3F8 6 44126914-44155519 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Late spermatids: 71.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "OE19: 58.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029249, HPA029250, HPA029251" Uncertain Enhanced "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967" "unprognostic (8.83e-3)" "unprognostic (2.16e-2)" "unprognostic (2.42e-3)" "unprognostic (3.61e-1)" "unprognostic (2.89e-1)" "unprognostic (1.85e-1)" "unprognostic (6.97e-3)" "unprognostic (1.25e-2)" "unprognostic (1.87e-1)" "unprognostic (1.75e-1)" "unprognostic (8.60e-2)" "unprognostic (1.83e-1)" "unprognostic (1.17e-2)" "unprognostic (1.59e-1)" "unprognostic (2.67e-2)" "unprognostic (6.12e-3)" "unprognostic (3.15e-1)" 9.7 13.2 24.4 8.7 21.4 14.0 9.4 33.2 34.3 9.1 19.7 14.8 7.5 17.1 8.2 11.7 21.1 8.6 13.2 16.6 21.6 15.2 10.7 28.6 35.0 5.2 13.1 18.2 8.0 10.6 19.6 10.2 12.8 22.8 12.9 18.4 18.6 13.9 8.8 29.4 29.6 17.0 9.7 13.8 6.3 24.5 22.7 16.0 4.7 11.4 14.8 8.9 14.4 13.4 1.3 1.3 1.7 2.1 0.3 2.6 1.2 15.4 8.2 7.8 13.2 12.3 7.3 13.2 6.3 8.6 7.8 7.4 5.8 5.7 2.6 10.5 9.4 11.6 15.3 9.1 23.6 4.5 7.2 7.9 7.6 6.0 17.0 8.7 1.5 8.0 10.0 20.5 10.0 6.3 14.1 7.1 6.0 24.6 4.6 7.8 15.3 1.6 3.7 4.0 58.7 4.1 2.0 4.8 4.9 19.1 14.7 8.5 6.9 5.9 13.6 14.1 9.9 16.0 4.0 8.4 9.3 11.1 7.1 7.7 5.5 4.0 3.0 14.5 2.6 11.5 1.1 2.1 1.3 1.4 1.1 2.5 1.3 0.7 0.7 0.9 0.8 1.0 1.1 1.7 0.3 1.4 1.3 2.6 1.2 24.4 21.4 33.2 34.3 21.6 15.2 13.1 18.2 22.8 16.0 14.9 29.0 1.4 12.3 12.0 16.3 2.8 10.2 0.0 7.9 10.4 15.7 12.5 1.7 13.4 56.9 6.8 47.1 0.0 13.3 14.8 10.8 15.8 0.0 31.6 21.1 15.9 17.9 12.9 8.3 71.4 10.9 7.0 6.8 7.2 26.3 11.1 25.1 40.4 8.5 10.2 26.6 6.5 9.2 1.6 5.8 15.9 16.7 4.3 18.0 22.6 TMPRSS15 "ENTK, MGC133046, PRSS7" ENSG00000154646 "Transmembrane serine protease 15" P98073 21 18269116-18485879 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Hydrolase, Protease, Serine protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 67 "intestine: 154.6" "Cell type enriched" "Detected in single" 11 "Early spermatids: 4.2" "Group enriched" "Detected in some" 12 "liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 20 "U-138 MG: 20.3;U-87 MG: 56.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "olfactory region: 9.3" "HPA015611, HPA034857, HPA072934" Enhanced Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214" "unprognostic (9.26e-2)" "unprognostic (4.14e-1)" "unprognostic (3.52e-1)" "unprognostic (8.33e-2)" "unprognostic (1.19e-1)" "unprognostic (7.20e-2)" "unprognostic (4.70e-2)" "unprognostic (6.35e-2)" "unprognostic (5.92e-2)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.0 0.0 80.5 0.0 0.0 154.6 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 42.4 0.0 0.1 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.3 0.0 0.5 0.1 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 20.3 0.0 0.1 0.0 0.3 0.0 0.1 56.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.1 0.5 0.6 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 TMPRSS2 PRSS10 ENSG00000184012 "Transmembrane serine protease 2" O15393 21 41464551-41531116 "Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Protease, Serine protease" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 75.6;pancreas: 64.5;prostate: 68.2" "Cell type enhanced" "Detected in many" 10 "Enterocytes: 190.3;Glandular cells: 290.4;Paneth cells: 127.7;Urothelial cells: 115.9" "Cancer enriched" "Detected in many" 7 "prostate cancer: 250.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 14.1;MCF7: 6.1;OE19: 20.6;RT4: 33.9;SK-BR-3: 6.9" "Not detected" "Not detected" "HPA034493, HPA035787" Enhanced Approved "Nucleoplasm,Plasma membrane" "Intracellular and membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034493: , HPA035787: AB_2674782" "unprognostic (4.80e-3)" "unprognostic (3.49e-1)" "unprognostic (2.16e-1)" "prognostic favorable (2.56e-4)" "unprognostic (1.72e-1)" "unprognostic (1.05e-2)" "unprognostic (4.28e-2)" "unprognostic (1.51e-3)" "unprognostic (9.43e-2)" "unprognostic (9.02e-3)" "unprognostic (6.24e-2)" "unprognostic (6.43e-2)" "prognostic favorable (7.86e-6)" "unprognostic (2.00e-2)" "unprognostic (1.68e-1)" "unprognostic (1.41e-1)" "unprognostic (2.15e-2)" 0.2 0.1 0.2 15.5 0.4 0.0 6.1 0.2 0.5 1.3 38.7 0.4 24.4 17.5 0.5 0.9 10.7 2.2 17.3 0.2 0.3 0.1 19.4 18.4 20.7 0.2 0.2 0.2 0.7 64.5 0.0 1.3 1.0 0.4 68.2 18.5 0.3 52.3 35.7 0.2 2.1 75.6 0.9 0.2 0.3 36.7 0.8 0.3 0.5 19.9 3.9 10.2 5.9 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 14.1 1.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.1 0.5 1.2 20.6 0.0 0.0 0.0 1.3 0.5 33.9 0.0 0.4 0.0 6.9 0.1 0.2 5.2 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.4 0.2 0.5 0.3 0.1 0.2 0.2 0.4 0.3 47.6 88.6 0.0 31.0 0.2 0.0 0.6 25.5 14.7 38.7 45.4 0.0 0.5 19.9 30.0 19.4 0.0 190.3 0.0 52.6 0.1 0.6 290.4 6.9 28.7 0.1 0.0 17.3 0.0 0.8 3.5 0.0 1.5 10.1 1.0 79.6 0.0 53.4 127.7 0.0 3.7 0.0 0.0 1.0 0.2 0.0 0.1 0.2 0.0 73.2 115.9 TMTC2 DKFZp762A217 ENSG00000179104 "Transmembrane and tetratricopeptide repeat containing 2" Q8N394 12 82686880-83134870 "Predicted membrane proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Bipolar cells: 30.2;Melanocytes: 30.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 3.1;myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AF22: 16.6;WM-115: 40.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026954, HPA026955" Uncertain Approved "Plasma membrane,Actin filaments" No No "Plasma membrane" "Actin filaments" "HPA026954: AB_2256025, HPA026955: AB_10602282" "unprognostic (1.56e-1)" "unprognostic (5.62e-2)" "unprognostic (9.61e-2)" "unprognostic (7.38e-2)" "unprognostic (2.60e-2)" "unprognostic (3.66e-2)" "unprognostic (1.05e-2)" "unprognostic (1.58e-1)" "unprognostic (1.25e-1)" "unprognostic (7.16e-2)" "unprognostic (1.73e-3)" "unprognostic (5.06e-2)" "prognostic favorable (2.84e-5)" "unprognostic (1.10e-1)" "unprognostic (1.60e-1)" "unprognostic (2.06e-2)" "unprognostic (8.06e-2)" 4.7 1.7 9.1 8.9 19.7 2.9 5.9 8.1 15.7 8.1 12.5 27.3 15.2 4.6 8.5 7.4 11.4 15.4 11.9 3.1 13.4 8.7 10.6 1.7 9.6 2.8 17.6 15.3 3.1 6.6 6.5 4.7 5.1 14.3 9.9 9.1 2.5 8.3 30.3 2.0 7.4 6.2 10.4 22.5 2.2 13.1 4.6 18.0 0.4 7.9 1.1 4.3 10.5 11.5 0.8 2.6 0.0 3.1 0.0 0.3 0.9 0.8 3.3 16.6 0.1 2.2 2.1 1.5 1.0 0.3 0.9 0.1 0.2 1.7 0.0 0.3 5.9 0.6 1.4 4.8 2.5 0.2 3.7 2.8 0.0 2.5 0.1 0.2 1.1 0.5 0.6 2.2 0.1 0.8 1.7 1.4 1.8 0.0 2.2 0.2 1.7 0.8 4.3 0.6 3.0 2.8 0.0 0.7 0.3 1.5 7.2 4.4 8.0 1.5 2.4 10.8 3.0 2.5 0.2 0.8 2.9 0.9 3.7 1.3 4.1 2.8 0.6 0.6 1.9 40.4 0.0 3.1 0.0 0.1 1.0 0.3 0.8 0.3 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.9 9.1 19.7 8.1 11.6 13.4 8.7 17.6 15.3 14.3 18.0 8.9 6.2 2.4 14.8 12.8 30.2 1.1 15.3 10.7 15.9 14.0 7.9 9.2 0.0 3.9 5.6 8.0 2.6 0.0 7.1 1.6 7.9 11.3 0.0 1.0 1.8 7.9 2.4 1.3 9.8 4.0 5.5 5.5 30.4 1.8 8.2 12.1 8.1 2.9 1.1 1.4 1.6 6.5 2.1 0.4 0.9 10.0 3.4 1.3 4.8 12.8 TNFRSF10D "CD264, DcR2, TRAILR4, TRUNDD" ENSG00000173530 "TNF receptor superfamily member 10d" Q9UBN6 8 23135588-23164030 "Cancer-related genes, CD markers, Predicted membrane proteins" Apoptosis Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Endothelial cells: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 9.0" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 24.5;LHCN-M2: 61.9;WM-115: 58.8" HPA070971 Approved "Plasma membrane,Actin filaments" NA NA "Plasma membrane, Actin filaments" "HPA070971: AB_2686330" "unprognostic (1.49e-1)" "prognostic unfavorable (1.70e-4)" "unprognostic (1.41e-1)" "unprognostic (8.78e-2)" "unprognostic (8.13e-2)" "unprognostic (7.49e-2)" "unprognostic (2.69e-1)" "unprognostic (7.06e-2)" "unprognostic (3.56e-2)" "unprognostic (1.66e-1)" "unprognostic (1.61e-2)" "unprognostic (1.32e-1)" "unprognostic (2.12e-2)" "unprognostic (2.70e-1)" "unprognostic (1.35e-2)" "unprognostic (6.32e-2)" "unprognostic (1.72e-1)" 16.0 3.1 4.9 7.3 10.0 10.5 10.2 3.4 10.3 5.9 8.5 2.6 5.5 6.2 8.9 5.7 4.1 8.0 11.5 6.5 7.0 3.4 12.1 31.5 12.5 5.1 9.0 0.9 9.8 5.2 2.5 4.3 4.1 9.0 9.0 10.9 3.9 3.9 4.4 3.9 3.1 11.2 10.9 6.3 6.9 7.2 4.3 9.2 2.9 6.0 6.8 6.6 7.3 26.0 2.1 4.5 2.4 3.3 0.3 9.0 2.4 3.5 3.1 4.0 2.3 3.1 12.3 0.0 19.2 7.3 1.4 2.0 5.9 3.0 0.0 4.0 11.4 0.0 1.2 3.3 16.8 12.7 0.0 3.0 1.0 1.8 5.0 13.5 0.6 1.3 15.4 18.8 5.1 3.5 18.0 24.5 0.1 0.0 0.0 61.9 0.0 0.0 1.9 3.2 10.6 0.0 0.7 0.0 0.9 4.7 1.6 0.0 0.0 2.0 0.0 0.0 9.5 0.0 2.4 14.5 0.0 0.0 1.1 0.0 0.0 0.0 0.0 16.0 0.9 58.8 2.4 3.3 1.5 0.0 1.4 0.1 2.1 3.2 1.1 4.5 0.8 9.0 3.5 2.2 0.3 1.9 0.0 1.0 2.4 4.9 10.0 3.4 10.3 7.0 3.4 9.0 0.9 9.0 9.2 0.0 12.7 0.5 3.2 4.4 0.0 1.4 2.5 5.3 5.7 1.8 0.0 0.1 0.0 5.7 0.4 31.4 5.9 0.0 1.8 0.2 2.5 4.7 7.0 6.6 2.6 0.0 1.7 11.6 9.8 0.0 0.3 3.6 8.5 1.0 4.8 0.3 8.4 2.9 0.4 2.1 0.0 0.0 11.7 0.7 2.7 2.0 0.1 1.3 6.3 3.3 TNFRSF11A "CD265, FEO, LOH18CR1, PDB2, RANK" ENSG00000141655 "TNF receptor superfamily member 11a" Q9Y6Q6 18 62325287-62391292 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Deafness, Disease mutation, Osteopetrosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3" "Cell type enhanced" "Detected in many" 7 "Enterocytes: 21.1;monocytes: 34.3;Mucus-secreting cells: 23.6;Paneth cells: 28.1;Undifferentiated cells: 33.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 8 "NK-cell: 8.9" "Lineage enriched" "Detected in many" 8 "NK-cells: 8.9" "Cell line enriched" "Detected in some" 6 "HDLM-2: 52.5" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB010391, HPA047976" Approved Supported "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA "Plasma membrane" Cytosol "CAB010391: AB_2205352, HPA047976: AB_2680227" "unprognostic (4.08e-1)" "unprognostic (2.71e-1)" "unprognostic (3.23e-3)" "unprognostic (1.73e-1)" "unprognostic (6.03e-2)" "unprognostic (1.35e-1)" "unprognostic (9.96e-4)" "unprognostic (4.24e-3)" "unprognostic (7.79e-4)" "unprognostic (1.52e-1)" "unprognostic (4.05e-2)" "unprognostic (2.88e-1)" "unprognostic (4.69e-5)" "unprognostic (1.56e-1)" "unprognostic (1.78e-1)" "unprognostic (4.02e-2)" "unprognostic (7.07e-2)" 6.5 1.7 1.7 4.8 1.2 0.2 4.3 0.4 2.3 1.5 18.4 0.8 7.6 23.1 0.9 1.9 3.8 1.3 28.7 1.1 1.3 0.7 0.9 0.8 2.3 7.4 1.0 1.0 0.7 2.9 0.1 10.1 2.8 0.7 2.1 13.9 1.3 34.3 12.9 0.6 3.3 23.9 1.3 2.9 1.2 4.3 1.2 0.8 0.7 2.0 1.8 2.3 2.3 2.3 0.0 0.6 0.2 0.0 8.9 1.0 0.0 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.1 0.2 0.0 1.5 0.1 0.6 0.9 3.5 0.3 0.1 52.5 2.3 0.0 0.5 0.7 0.0 0.2 0.5 0.1 0.1 0.3 1.3 1.8 1.3 0.1 0.0 0.0 0.0 0.4 0.0 0.0 2.5 2.9 8.3 0.1 0.0 0.2 0.6 0.6 8.9 0.3 0.2 1.3 0.0 0.3 0.5 0.1 0.8 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.2 8.9 0.0 0.6 1.0 0.0 1.7 1.2 0.4 2.3 1.3 0.7 1.0 1.0 0.7 0.8 0.0 2.1 0.0 2.9 1.1 0.4 1.1 10.2 0.0 0.0 0.0 0.0 0.1 0.0 7.3 0.2 2.2 21.1 0.0 6.5 0.6 0.3 2.6 0.0 0.0 12.8 3.2 10.4 3.7 15.0 0.0 0.6 2.5 1.7 34.3 23.6 0.0 9.6 28.1 0.0 0.0 0.0 0.0 0.3 0.7 1.4 1.9 0.1 0.0 33.6 3.8 TNFRSF12A "CD266, FN14, TweakR" ENSG00000006327 "TNF receptor superfamily member 12A" Q9NP84 16 3018445-3022383 "Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Angiogenesis, Apoptosis, Cell adhesion, Differentiation" "Developmental protein, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "placenta: 81.3" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 1094.9;Ductal cells: 954.3;Exocrine glandular cells: 607.7;Pancreatic endocrine cells: 874.5" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 25.0" "Group enriched" "Detected in many" 8 "eosinophil: 38.1;neutrophil: 29.9" "Lineage enriched" "Detected in many" 9 "granulocytes: 38.1" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA007853 Approved Approved "Plasma membrane,Cytosol" NA Yes 170000 "Plasma membrane, Cytosol" "HPA007853: AB_1858463" "unprognostic (1.44e-1)" "unprognostic (2.46e-3)" "unprognostic (8.90e-2)" "unprognostic (2.60e-1)" "unprognostic (4.06e-3)" "prognostic unfavorable (5.50e-4)" "unprognostic (7.04e-3)" "unprognostic (1.98e-3)" "unprognostic (4.17e-3)" "unprognostic (2.85e-1)" "unprognostic (5.02e-3)" "unprognostic (3.88e-1)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.98e-2)" "unprognostic (6.00e-2)" "unprognostic (2.80e-3)" "unprognostic (2.17e-2)" 10.8 14.2 2.4 11.3 5.1 2.7 21.2 0.9 3.0 8.0 18.9 3.2 4.1 14.5 11.6 10.2 10.7 6.4 28.1 27.0 5.0 2.6 50.4 36.2 23.0 2.6 4.8 0.5 6.4 47.0 51.1 20.0 81.3 25.0 11.1 1.9 2.8 17.3 6.9 23.3 5.0 31.0 16.8 4.3 3.9 13.2 5.3 3.3 1.2 11.5 11.5 4.7 14.8 5.2 0.0 4.1 38.1 3.5 2.0 2.4 1.1 24.5 19.9 2.2 4.1 4.1 9.3 13.2 51.8 37.5 44.4 28.6 8.6 43.9 0.1 68.6 34.4 51.6 27.2 0.5 37.9 17.0 0.9 1.3 0.1 6.7 7.2 28.0 0.4 1.8 8.6 26.3 46.6 55.9 38.3 12.8 0.0 2.7 0.3 46.7 46.5 0.0 3.3 10.7 11.0 43.8 0.2 24.9 1.0 44.9 4.9 2.5 0.9 36.9 17.2 30.5 7.7 9.0 0.7 22.5 80.0 36.9 52.9 84.9 0.8 0.3 0.3 25.0 2.3 62.8 3.5 3.5 38.1 1.8 2.0 2.4 0.0 0.8 1.5 4.1 0.0 0.4 0.8 29.9 2.0 1.3 0.1 1.0 1.1 2.4 5.1 0.9 3.0 5.0 2.6 4.8 0.5 25.0 3.3 95.3 43.1 5.0 1094.9 544.0 0.9 57.7 163.1 50.9 130.8 172.7 2.0 112.5 54.7 954.3 0.6 22.7 41.3 0.0 607.7 131.7 179.4 600.3 58.8 15.3 38.1 0.0 26.1 28.8 4.6 0.4 5.8 29.4 106.3 16.2 4.6 20.6 874.5 25.8 6.3 93.5 5.1 6.5 212.1 7.7 4.1 314.4 158.1 8.6 12.4 560.0 TNFRSF21 "CD358, DR6" ENSG00000146072 "TNF receptor superfamily member 21" O75509 6 47231532-47309905 "CD markers, Plasma proteins, Predicted membrane proteins" "Adaptive immunity, Apoptosis, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 63.4" "Cell type enhanced" "Detected in many" 11 "Basal glandular cells: 142.4;Glandular cells: 135.6;Syncytiotrophoblasts: 149.4;Urothelial cells: 360.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 35 "plasmacytoid DC: 31.6" "Lineage enriched" "Detected in single" 309 "dendritic cells: 31.6" "Cell line enhanced" "Detected in many" "OE19: 39.2;RT4: 99.8;SuSa: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006746, CAB009805" Approved Supported "Plasma membrane,Cytosol" NA NA 1300000 "Plasma membrane, Cytosol" "CAB009805: AB_2206956, HPA006746: AB_1078701" "unprognostic (1.19e-2)" "unprognostic (2.70e-1)" "unprognostic (3.26e-1)" "unprognostic (7.85e-2)" "unprognostic (1.44e-1)" "unprognostic (3.41e-2)" "unprognostic (9.80e-3)" "unprognostic (1.11e-1)" "unprognostic (1.46e-2)" "unprognostic (7.53e-2)" "unprognostic (1.38e-3)" "unprognostic (1.74e-1)" "prognostic favorable (7.23e-6)" "unprognostic (1.48e-1)" "unprognostic (1.34e-1)" "unprognostic (9.78e-2)" "unprognostic (1.45e-2)" 25.9 3.7 9.7 8.7 13.6 5.9 7.8 7.4 20.8 9.6 19.3 26.9 1.0 6.4 9.1 3.0 21.8 9.9 18.7 4.1 13.8 16.0 26.2 4.6 9.5 11.5 26.8 7.9 5.0 17.9 35.6 4.4 17.0 29.5 10.2 18.5 3.0 15.2 2.4 3.5 2.7 10.2 8.2 63.4 11.6 30.4 5.8 10.1 11.5 2.9 19.2 16.5 41.2 11.6 0.0 31.6 0.1 0.0 0.0 0.0 0.2 29.2 9.5 9.3 2.9 25.5 7.5 10.5 3.4 6.7 1.0 0.4 16.4 20.7 2.1 13.8 2.4 20.0 17.7 1.3 12.6 0.6 0.0 2.9 0.0 1.2 16.5 14.9 0.4 0.1 13.4 15.1 0.6 11.5 0.8 4.9 1.9 0.7 0.0 0.3 5.7 2.5 0.2 7.3 39.2 9.8 5.4 2.8 3.1 17.7 99.8 6.7 1.4 2.9 2.8 2.4 43.8 2.1 2.0 1.0 2.8 2.5 0.1 3.1 0.0 0.0 3.0 4.5 2.1 7.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 31.6 0.0 0.2 9.7 13.6 7.4 20.8 13.8 16.0 26.8 7.9 29.5 10.1 0.0 12.7 0.0 142.4 21.1 0.6 7.6 35.7 10.7 25.0 1.8 0.0 24.6 13.3 69.3 45.6 5.6 30.3 0.0 25.8 16.8 14.1 135.6 19.6 0.0 20.6 0.0 11.5 1.8 36.8 29.9 2.6 5.8 11.8 0.0 40.2 4.4 63.5 46.7 1.1 48.5 1.3 77.6 16.2 0.6 1.4 8.7 149.4 1.3 14.0 360.8 TNFRSF9 "4-1BB, CD137, ILA" ENSG00000049249 "TNF receptor superfamily member 9" Q07011 1 7915894-7943165 "Cancer-related genes, CD markers, Predicted membrane proteins" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "blood: 13.5;lymphoid tissue: 18.3" "Group enriched" "Detected in some" 4 "granulocytes: 62.3;monocytes: 53.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Group enriched" "Detected in many" 5 "memory CD8 T-cell: 8.0;neutrophil: 6.6;NK-cell: 4.1;T-reg: 13.5" "Group enriched" "Detected in many" 5 "granulocytes: 6.6;NK-cells: 4.1;T-cells: 13.5" "Cell line enriched" "Detected in some" 8 "HDLM-2: 47.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA071425 Approved "Nucleoli,Plasma membrane" NA NA "Plasma membrane" Nucleoli "HPA071425: AB_2686394" "unprognostic (7.23e-2)" "unprognostic (1.72e-2)" "unprognostic (8.26e-3)" "unprognostic (1.32e-3)" "unprognostic (1.10e-1)" "unprognostic (1.98e-2)" "unprognostic (2.52e-1)" "unprognostic (1.04e-1)" "unprognostic (1.19e-4)" "unprognostic (9.47e-3)" "unprognostic (2.17e-2)" "unprognostic (2.02e-1)" "prognostic unfavorable (2.69e-8)" "unprognostic (1.64e-2)" "unprognostic (2.25e-2)" "unprognostic (1.19e-1)" "unprognostic (9.55e-2)" 0.8 1.0 0.3 11.0 0.3 1.9 0.5 0.2 0.3 0.4 0.5 0.1 0.1 0.6 0.3 0.1 0.6 0.8 1.6 1.8 0.3 1.0 0.7 0.7 2.1 10.8 0.3 0.1 0.3 0.6 0.0 0.5 0.2 0.5 0.4 0.7 0.3 2.1 0.1 0.3 0.5 2.3 0.1 0.3 7.9 0.7 0.5 0.1 18.3 0.7 0.9 17.5 1.4 0.4 0.5 1.1 6.6 1.5 4.1 13.5 1.1 1.2 0.4 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.1 1.0 0.4 0.1 0.4 0.0 0.8 0.2 0.0 0.2 0.5 47.0 0.1 0.2 0.2 0.0 0.9 0.0 0.5 0.1 0.3 0.1 0.1 0.2 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.1 0.2 0.1 0.0 0.7 0.0 0.2 0.2 0.2 1.6 0.1 0.2 0.1 0.1 0.1 5.8 0.2 0.0 1.1 1.5 0.2 1.5 0.4 0.2 0.2 1.0 8.0 1.1 0.5 0.3 1.6 6.6 4.1 0.1 0.3 13.5 1.1 0.3 0.3 0.2 0.3 0.3 1.0 0.3 0.1 0.5 0.1 0.0 1.7 0.0 0.4 0.2 0.0 0.3 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.8 0.0 0.7 0.0 0.0 1.0 0.0 0.4 0.3 62.3 0.0 0.8 0.0 0.0 0.0 0.3 0.0 0.0 1.8 5.0 53.3 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.4 0.0 12.9 0.0 0.3 TNKS1BP1 "FLJ45975, KIAA1741, TAB182" ENSG00000149115 "Tankyrase 1 binding protein 1" Q9C0C2 11 57299638-57324952 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 74.2;Suprabasal keratinocytes: 77.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037929, HPA037930" Enhanced Supported "Plasma membrane,Actin filaments" NA NA 50000 "Plasma membrane" "Actin filaments" "HPA037929: AB_10672613, HPA037930: AB_2675745" "unprognostic (7.31e-2)" "unprognostic (1.66e-2)" "unprognostic (5.38e-2)" "unprognostic (2.25e-1)" "unprognostic (3.13e-1)" "unprognostic (9.17e-2)" "unprognostic (2.47e-2)" "unprognostic (7.90e-2)" "unprognostic (4.27e-1)" "unprognostic (2.67e-2)" "unprognostic (4.22e-3)" "unprognostic (9.21e-2)" "prognostic unfavorable (2.11e-8)" "unprognostic (2.46e-1)" "unprognostic (2.31e-2)" "unprognostic (2.41e-1)" "unprognostic (3.07e-1)" 35.1 15.5 8.4 10.6 9.1 1.2 37.8 4.2 8.3 33.0 18.3 5.9 32.0 13.6 22.8 31.7 35.8 19.0 29.0 12.8 6.6 4.4 12.6 35.8 22.0 4.8 5.3 5.9 25.7 17.5 10.8 11.0 34.4 5.7 22.2 7.8 11.8 24.0 33.4 33.1 39.6 18.2 23.4 4.5 8.0 24.6 13.8 5.2 7.8 17.6 28.6 18.1 29.3 33.5 0.1 0.9 0.0 0.0 0.0 2.0 0.1 22.5 15.2 10.9 8.8 34.6 26.5 8.2 15.9 29.9 12.3 11.4 6.7 15.5 0.5 10.2 26.1 13.2 39.4 8.2 27.4 8.0 8.6 2.6 2.9 9.4 3.1 23.6 3.6 1.1 26.3 32.9 18.8 14.6 15.4 15.7 3.2 3.3 2.4 17.1 11.5 2.7 3.7 12.0 11.9 12.0 4.2 15.2 6.4 14.4 30.1 3.8 6.0 21.1 32.0 11.4 8.0 48.0 3.0 29.8 12.7 12.3 14.9 8.9 4.0 0.9 2.8 28.7 1.0 6.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.3 0.9 0.1 0.2 0.3 0.0 0.0 0.0 0.0 2.0 0.1 8.4 9.1 4.2 8.3 6.6 4.4 5.3 5.9 5.7 5.2 11.9 34.4 0.8 26.4 74.2 5.2 3.9 33.1 1.4 20.5 41.8 2.0 12.3 0.0 28.2 1.5 23.2 20.0 0.0 19.3 2.7 23.3 28.6 2.3 38.5 3.5 7.9 17.3 17.2 1.2 2.3 44.5 3.9 16.9 0.0 23.7 3.8 29.7 14.2 46.3 1.1 1.3 32.3 19.9 1.2 3.4 77.0 20.5 0.7 12.1 30.4 TNNI2 "AMCD2B, DA2B, FSSV" ENSG00000130598 "Troponin I2, fast skeletal type" P48788 11 1838989-1841680 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Muscle protein" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 13 "skeletal muscle: 635.0;tongue: 527.7" "Group enriched" "Detected in many" 4 "Extravillous trophoblasts: 241.7;Syncytiotrophoblasts: 72.9" "Group enriched" "Detected in many" 10 "cervical cancer: 12.7;head and neck cancer: 33.6;pancreatic cancer: 12.9;urothelial cancer: 39.8" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 46.4" "Group enriched" "Detected in many" 4 "dendritic cells: 46.4;granulocytes: 26.7" "Group enriched" "Detected in some" 6 "CAPAN-2: 23.2;hTCEpi: 66.7" "Not detected" "Not detected" "Not detected" "Not detected" "CAB018697, HPA055938" Enhanced Approved "Plasma membrane,Intermediate filaments" NA NA 29000 "Plasma membrane" "Intermediate filaments" "CAB018697: AB_628400, HPA055938: AB_2682976" "unprognostic (2.03e-2)" "unprognostic (1.13e-1)" "unprognostic (1.29e-2)" "unprognostic (3.70e-1)" "unprognostic (1.85e-1)" "unprognostic (1.02e-2)" "unprognostic (9.99e-3)" "unprognostic (1.01e-1)" "unprognostic (1.73e-1)" "unprognostic (1.51e-1)" "unprognostic (1.10e-1)" "unprognostic (2.70e-1)" "unprognostic (1.23e-3)" "unprognostic (5.92e-3)" "unprognostic (5.62e-2)" "unprognostic (1.77e-1)" "unprognostic (2.79e-2)" 13.9 0.1 0.1 0.1 0.1 0.5 0.6 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.1 16.5 11.6 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.5 0.2 0.1 0.0 0.1 0.5 0.0 0.1 0.3 0.0 1.2 0.1 0.0 15.7 0.4 635.0 4.8 0.2 0.1 0.2 0.4 0.1 0.1 0.0 0.0 3.0 527.7 11.5 2.1 0.1 2.3 46.4 26.7 8.6 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 1.5 23.2 0.6 0.1 0.0 0.0 1.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.0 0.1 5.6 66.7 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 2.0 0.0 0.0 0.8 1.5 0.0 0.6 0.0 0.6 0.0 0.4 0.0 0.0 8.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 6.1 3.1 26.7 0.0 6.5 0.0 1.9 0.0 0.0 4.3 2.3 0.0 0.0 21.1 0.2 8.6 46.4 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 3.0 4.1 7.2 0.5 22.2 0.0 4.9 20.4 10.7 3.4 0.0 0.0 31.7 0.0 1.2 0.0 0.7 0.0 0.0 0.5 241.7 2.3 0.0 10.4 0.0 38.5 0.0 0.0 0.0 18.2 0.0 0.3 18.6 0.0 3.6 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.3 5.6 72.9 0.9 0.0 0.5 TOGARAM2 "Crescerin-2, FAM179A, FLJ43249, LOC165186" ENSG00000189350 "TOG array regulator of axonemal microtubules 2" Q6ZUX3 2 28956611-29061373 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 15.3;epididymis: 14.4;fallopian tube: 15.7;lung: 14.2" "Cell type enriched" "Detected in some" 5 "Ciliated cells: 56.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 3.7" "Lineage enriched" "Detected in single" 5 "T-cells: 3.7" "Cell line enhanced" "Detected in some" "HMC-1: 3.8;NB-4: 3.6" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA037561, HPA037562, HPA075216" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037561: AB_10670384, HPA037562: AB_2675545, HPA075216: " "unprognostic (8.35e-5)" "unprognostic (2.85e-3)" "unprognostic (1.41e-1)" "unprognostic (7.01e-3)" "unprognostic (6.41e-2)" "unprognostic (1.23e-2)" "unprognostic (1.11e-1)" "unprognostic (2.53e-3)" "unprognostic (3.93e-1)" "unprognostic (6.83e-2)" "unprognostic (2.32e-3)" "unprognostic (5.92e-2)" "unprognostic (3.94e-11)" "unprognostic (3.75e-2)" "unprognostic (4.46e-1)" "unprognostic (2.01e-2)" "unprognostic (2.81e-3)" 0.3 2.3 3.0 1.7 8.4 2.6 0.4 3.4 1.7 0.6 0.6 7.1 0.0 0.8 1.1 14.4 0.7 15.7 0.5 2.6 3.3 3.9 0.3 0.5 14.2 1.1 2.1 2.0 4.5 0.8 0.1 6.1 0.6 15.3 0.5 0.4 0.1 0.5 0.1 1.7 0.6 0.7 0.8 2.5 2.2 1.5 3.2 6.1 0.0 0.3 0.3 1.3 0.4 0.3 0.3 0.3 0.6 0.3 0.6 3.7 1.0 0.2 0.2 0.3 0.2 0.3 0.0 0.7 0.1 2.3 0.7 2.2 0.4 0.3 0.3 0.3 0.0 0.3 0.9 0.4 0.0 0.7 0.4 1.4 0.2 2.0 0.5 0.9 2.0 3.8 0.2 0.3 0.0 0.0 0.8 0.3 2.7 0.3 1.0 0.8 0.2 0.8 3.6 2.7 1.2 0.7 0.1 0.7 1.5 1.1 0.3 2.6 1.8 0.1 0.1 0.1 0.4 0.4 0.2 0.2 0.2 0.5 0.2 0.3 0.5 0.5 0.2 1.7 1.3 0.1 0.5 0.3 0.3 3.7 0.1 2.0 0.2 0.6 2.9 0.1 0.3 0.4 1.0 0.6 0.6 0.2 0.3 1.5 1.0 3.0 8.4 3.4 1.2 3.3 3.9 2.1 2.0 15.3 6.1 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 56.2 10.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 TOLLIP IL-1RAcPIP ENSG00000078902 "Toll interacting protein" Q9H0E2 11 1274371-1309654 "Plasma proteins, Predicted intracellular proteins" "Autophagy, Immunity, Inflammatory response, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 368.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038621, HPA038622" Enhanced Approved "Plasma membrane,Cytosol" NA NA 34000 "Plasma membrane, Cytosol" "HPA038621: AB_10673177, HPA038622: AB_10675946" "unprognostic (8.39e-2)" "unprognostic (1.89e-1)" "unprognostic (2.18e-2)" "unprognostic (6.08e-2)" "prognostic unfavorable (5.45e-4)" "unprognostic (8.89e-2)" "unprognostic (2.51e-1)" "unprognostic (8.53e-2)" "unprognostic (2.17e-1)" "unprognostic (1.55e-2)" "unprognostic (1.90e-2)" "unprognostic (2.74e-1)" "prognostic favorable (1.11e-16)" "unprognostic (2.72e-1)" "unprognostic (1.46e-1)" "unprognostic (3.21e-2)" "unprognostic (1.29e-2)" 15.3 16.7 31.2 8.8 32.5 9.0 11.9 28.3 63.0 10.7 12.7 12.9 8.6 18.6 8.3 10.3 29.4 10.7 13.7 15.8 28.0 20.3 20.9 37.1 12.3 9.6 18.1 32.1 12.8 41.8 13.7 18.7 9.9 17.4 15.6 6.6 12.9 15.9 16.8 23.4 24.0 15.7 9.0 13.5 13.2 15.1 24.5 11.8 5.9 12.6 11.8 10.9 14.6 14.8 13.9 26.9 49.0 34.8 11.1 12.6 18.3 15.5 16.5 8.4 9.5 18.0 11.3 7.3 13.8 12.6 16.3 14.5 17.8 9.9 7.3 13.4 12.7 24.9 14.1 7.5 16.9 4.4 14.9 15.3 5.9 3.5 26.7 25.7 11.2 15.1 17.0 19.9 9.6 9.3 8.9 10.1 11.1 9.7 19.8 13.3 13.0 14.2 13.8 10.2 16.9 21.9 10.8 8.6 7.2 10.7 20.8 22.6 13.3 12.4 15.1 15.2 4.5 11.9 12.8 18.4 17.7 7.6 7.4 7.9 20.2 17.9 8.9 27.8 7.4 13.8 9.5 34.8 35.9 9.6 30.0 8.0 10.9 10.3 8.9 26.9 13.9 8.1 7.6 49.0 11.1 27.5 14.1 12.6 18.3 31.2 32.5 28.3 63.0 28.0 20.3 18.1 32.1 17.4 11.8 8.9 20.0 26.9 36.3 59.4 38.5 20.3 48.4 8.1 11.4 22.7 7.9 44.1 59.7 60.5 147.2 26.6 50.7 0.0 59.7 34.1 29.7 40.2 38.0 95.4 77.7 69.9 49.7 36.8 41.9 368.3 20.1 32.1 67.4 51.3 30.4 38.6 64.1 38.6 29.0 95.9 16.9 6.5 26.9 57.0 27.2 86.4 87.3 22.3 24.9 55.4 TRAF7 "DKFZp586I021, MGC7807, RFWD1, RNF119" ENSG00000131653 "TNF receptor associated factor 7" Q6Q0C0 16 2155698-2178129 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Apoptosis, Transcription, Transcription regulation, Ubl conjugation pathway" Transferase "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041229 Approved Supported "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA041229: AB_10794194" "unprognostic (1.94e-1)" "unprognostic (5.97e-2)" "unprognostic (1.13e-1)" "unprognostic (4.23e-2)" "unprognostic (1.09e-1)" "unprognostic (1.03e-1)" "unprognostic (1.65e-2)" "unprognostic (2.77e-3)" "unprognostic (7.08e-2)" "unprognostic (3.52e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (9.23e-2)" "unprognostic (6.07e-2)" "unprognostic (2.99e-2)" "unprognostic (2.43e-1)" "unprognostic (8.48e-2)" 16.0 18.2 18.3 22.3 20.6 28.5 39.1 28.7 25.6 22.1 29.4 9.1 21.1 37.3 20.4 18.3 32.9 21.9 36.9 21.0 18.3 14.8 21.3 47.3 18.3 40.9 13.4 14.7 19.3 41.6 17.7 20.3 19.5 12.8 16.2 16.9 13.0 24.4 23.1 25.5 32.2 37.8 28.8 14.1 21.4 25.1 13.2 10.6 26.1 20.3 30.9 21.9 21.9 28.9 6.7 12.3 7.7 13.9 3.0 7.1 5.2 20.7 26.6 15.2 27.2 15.8 29.8 17.9 16.0 20.2 18.9 17.1 32.3 26.8 13.3 19.0 20.4 12.1 24.4 14.2 28.4 7.2 21.0 18.2 19.0 35.4 24.7 20.9 20.2 27.6 29.5 23.8 18.2 23.9 15.6 36.5 26.4 20.3 18.0 18.0 47.5 20.7 23.5 29.9 28.7 13.0 38.7 25.3 26.7 15.2 11.2 30.7 25.5 13.4 25.8 17.5 8.3 29.3 24.9 27.5 23.0 32.4 21.4 17.4 26.1 19.3 17.6 13.1 13.1 17.8 3.7 10.0 7.7 5.4 13.9 5.0 6.7 5.3 5.7 12.3 4.9 3.8 4.5 6.9 3.0 9.4 6.0 7.1 5.2 18.3 20.6 28.7 25.6 18.3 14.8 13.4 14.7 12.8 10.6 0.0 8.6 11.9 15.5 25.5 14.6 3.4 17.8 4.0 4.5 14.0 5.9 20.5 14.9 35.4 3.8 23.9 60.0 0.0 51.6 30.1 20.0 27.8 9.2 26.1 37.6 35.0 32.6 23.4 38.3 9.1 23.0 18.8 10.1 35.1 35.9 10.5 45.1 40.3 20.8 18.9 8.9 6.5 16.0 4.8 21.5 28.4 22.3 12.9 33.8 29.6 TRAIP "RNF206, TRIP" ENSG00000183763 "TRAF interacting protein" Q9BWF2 3 49828599-49856574 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Disease mutation, Dwarfism, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 25.0" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 11.8;Spermatogonia: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA036261, HPA036262" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA036261: AB_10673348, HPA036262: AB_2675029" "unprognostic (5.30e-3)" "unprognostic (9.41e-2)" "unprognostic (1.48e-1)" "unprognostic (6.50e-3)" "unprognostic (1.88e-1)" "unprognostic (7.68e-3)" "prognostic unfavorable (8.77e-5)" "unprognostic (4.61e-2)" "unprognostic (1.52e-2)" "unprognostic (8.61e-2)" "unprognostic (1.24e-2)" "unprognostic (7.97e-2)" "unprognostic (9.01e-5)" "unprognostic (5.84e-2)" "unprognostic (4.24e-1)" "unprognostic (1.78e-1)" "unprognostic (1.24e-1)" 4.8 1.6 3.4 6.0 10.7 9.5 3.0 7.4 3.0 3.5 3.7 2.0 3.2 2.3 3.8 2.4 4.5 3.0 2.9 1.5 2.7 2.7 1.6 1.2 1.3 8.1 2.0 2.8 3.4 1.6 1.6 2.0 2.5 3.0 2.9 4.8 2.7 3.1 1.7 2.8 6.7 3.4 3.4 5.1 3.7 1.9 25.0 3.4 11.5 2.2 3.1 6.8 1.9 3.0 5.1 1.6 0.6 3.0 2.7 4.9 1.6 6.4 7.9 11.3 11.4 1.0 1.6 9.4 7.8 3.8 16.6 15.9 9.6 7.5 16.0 5.6 4.5 11.6 8.6 11.9 9.0 12.4 9.2 7.9 12.0 9.6 8.5 0.4 9.8 10.1 1.1 1.3 13.3 7.1 2.0 4.3 14.3 8.6 11.6 7.3 9.4 16.2 12.5 9.1 7.7 13.1 9.0 7.7 9.3 3.0 9.1 5.5 9.4 8.7 7.3 5.5 8.5 6.6 13.9 3.3 10.6 12.7 14.6 15.3 8.5 20.3 17.1 5.3 13.3 9.5 0.0 1.5 0.6 2.3 0.8 2.0 5.1 1.3 4.9 1.3 3.8 1.7 2.6 0.3 2.7 3.0 1.6 0.8 1.6 3.4 10.7 7.4 3.0 2.7 2.7 2.0 2.8 3.0 3.4 3.0 1.1 2.2 0.6 1.0 3.1 2.0 0.0 0.0 0.0 3.5 0.0 2.1 0.0 1.3 3.3 0.7 0.5 0.0 0.8 6.7 1.4 0.5 0.0 0.8 3.0 0.0 0.0 0.6 0.3 4.0 2.3 0.5 1.7 2.8 1.3 1.9 0.9 0.0 1.1 0.3 3.6 0.0 1.0 11.8 9.5 0.3 0.8 2.9 2.3 0.1 TRAPPC13 "C5orf44, FLJ13611, FLJ26957, MGC48585" ENSG00000113597 "Trafficking protein particle complex 13" A5PLN9 5 65624716-65666233 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA037777 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA037777: AB_10672464" "unprognostic (3.66e-2)" "unprognostic (3.27e-1)" "unprognostic (1.54e-2)" "unprognostic (7.22e-2)" "unprognostic (4.79e-2)" "unprognostic (1.16e-2)" "unprognostic (2.55e-2)" "unprognostic (2.49e-2)" "unprognostic (5.70e-2)" "unprognostic (5.75e-2)" "unprognostic (3.49e-2)" "unprognostic (1.92e-1)" "prognostic favorable (8.66e-4)" "unprognostic (2.89e-1)" "unprognostic (2.58e-2)" "unprognostic (2.53e-2)" "unprognostic (6.25e-2)" 10.4 12.9 16.1 10.3 22.5 7.5 14.0 14.5 22.7 12.1 11.3 12.8 10.2 9.8 11.9 10.4 13.4 9.7 9.8 17.7 17.1 17.7 21.6 16.9 11.0 10.2 17.3 14.2 10.1 8.2 20.6 22.4 11.8 19.5 20.6 14.3 10.5 9.9 12.4 15.2 8.0 13.3 13.9 18.9 10.7 11.0 10.6 15.1 18.0 18.7 11.7 10.8 11.5 9.9 6.6 10.1 14.7 13.7 9.1 13.1 9.8 12.8 8.7 13.8 24.8 10.7 13.7 13.3 15.3 13.9 18.9 20.8 7.4 18.2 13.1 16.9 12.3 20.4 11.9 15.6 15.9 22.4 9.1 11.5 8.4 10.9 6.8 14.6 10.2 12.7 9.7 12.6 14.7 19.0 11.5 16.7 19.2 10.0 12.5 16.7 13.5 17.0 3.9 6.3 7.6 4.7 14.9 17.3 15.2 13.8 14.7 17.4 12.5 18.7 11.3 14.0 8.0 16.4 13.4 11.4 6.7 9.3 14.8 15.4 8.3 16.0 20.9 14.1 18.5 12.7 14.7 9.4 3.8 10.1 10.1 13.1 6.6 9.9 8.4 10.1 5.4 9.9 9.9 3.6 9.1 13.7 7.6 10.4 9.8 16.1 22.5 14.5 22.7 17.1 17.7 17.3 14.2 19.5 15.1 17.9 10.9 3.7 6.2 5.0 12.2 5.9 15.3 9.4 6.8 7.0 9.8 10.4 13.3 10.8 15.5 11.2 7.9 0.0 9.3 8.2 8.5 9.8 3.5 9.7 10.9 12.7 14.9 8.6 12.6 7.9 6.9 9.9 6.8 10.0 8.4 11.8 8.6 3.5 12.4 18.9 14.3 6.5 10.1 15.1 8.0 5.9 12.7 8.3 8.3 10.8 TRDN ENSG00000186439 Triadin Q13061 6 123216339-123637093 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 52.8;skeletal muscle: 215.5;tongue: 80.1" "Group enriched" "Detected in some" 21 "Cardiomyocytes: 855.7;Muller glia cells: 805.6" "Cancer enhanced" "Detected in some" "head and neck cancer: 2.2" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 30 "basophil: 2.9" "Lineage enriched" "Detected in single" 30 "granulocytes: 2.9" "Cell line enhanced" "Detected in some" "HAP1: 1.6;K-562: 1.8;MCF7: 6.1;SCLC-21H: 1.2;SK-BR-3: 2.0" "Region enriched" "Detected in single" 10 "olfactory region: 13.6" "HPA038226, HPA058226" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA038226: AB_10795574, HPA058226: AB_2683643" "unprognostic (1.05e-2)" "unprognostic (1.99e-1)" "unprognostic (9.20e-2)" "unprognostic (3.06e-3)" "unprognostic (2.40e-1)" "unprognostic (2.38e-1)" "unprognostic (2.42e-1)" "unprognostic (8.42e-2)" "unprognostic (8.71e-2)" "unprognostic (9.93e-3)" "unprognostic (2.12e-1)" "unprognostic (2.55e-2)" "unprognostic (3.97e-2)" 3.8 0.4 0.4 0.0 0.5 0.0 0.3 0.2 0.2 0.3 0.1 0.0 0.7 0.1 0.3 9.2 3.0 1.9 0.1 52.8 1.6 1.3 0.1 0.1 0.1 0.1 1.6 0.1 1.5 0.1 0.0 3.2 0.1 1.3 1.9 0.1 1.3 2.0 0.2 215.5 0.1 0.1 0.2 3.4 0.1 0.1 0.7 0.5 0.0 1.2 80.1 1.6 0.1 0.1 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.2 0.0 6.1 0.0 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 2.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.8 0.0 0.2 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.2 1.6 1.3 1.6 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 5.8 855.7 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 40.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 22.9 12.0 0.0 1.7 0.0 0.0 805.6 0.0 0.0 10.6 0.0 13.4 0.0 0.8 0.1 0.5 0.0 0.0 0.0 0.0 0.0 TRIB1 "C8FW, GIG2, TRB1" ENSG00000173334 "Tribbles pseudokinase 1" Q96RU8 8 125430321-125438405 "Enzymes, Predicted intracellular proteins" "Protein kinase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 84.2;thyroid gland: 90.7" "Cell type enhanced" "Detected in many" 6 "Alveolar cells type 2: 192.3;Basal glandular cells: 267.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "eosinophil: 10.8;neutrophil: 5.8;non-classical monocyte: 3.7;T-reg: 3.1" "Group enriched" "Detected in many" 11 "granulocytes: 10.8;monocytes: 3.7;T-cells: 3.1" "Cell line enhanced" "Detected in many" "HEL: 55.1;U-266/70: 33.8;U-266/84: 33.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA063982 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA063982: AB_2685165" "unprognostic (1.90e-3)" "unprognostic (1.45e-1)" "unprognostic (8.80e-3)" "unprognostic (1.34e-2)" "unprognostic (3.56e-1)" "unprognostic (2.32e-1)" "unprognostic (2.00e-1)" "unprognostic (4.57e-2)" "unprognostic (4.12e-2)" "unprognostic (1.62e-2)" "unprognostic (6.81e-3)" "unprognostic (9.36e-2)" "unprognostic (2.97e-3)" "unprognostic (1.94e-1)" "unprognostic (1.04e-2)" "unprognostic (5.55e-2)" "unprognostic (2.08e-2)" 26.7 6.5 5.9 17.6 6.5 84.2 13.3 4.3 6.1 10.4 12.4 4.4 6.6 4.9 6.2 6.7 10.9 10.9 21.0 11.1 4.3 4.0 16.6 63.5 28.9 14.6 4.2 3.9 6.4 23.6 20.9 7.2 15.5 4.5 12.1 13.3 15.0 14.5 9.1 22.3 10.4 16.9 11.3 3.1 15.9 18.5 5.6 3.1 9.2 90.7 17.6 12.1 12.4 9.0 0.2 0.5 10.8 3.7 0.0 3.1 0.1 4.1 4.7 0.6 1.3 1.3 2.7 7.5 2.7 3.8 2.0 0.6 6.3 5.5 7.5 2.5 1.9 12.1 3.1 2.0 2.6 1.7 3.3 9.9 55.1 2.1 12.3 3.5 27.5 5.0 2.6 4.0 8.2 18.8 9.8 5.8 0.1 4.8 24.0 0.2 4.4 2.5 4.3 4.6 9.9 9.2 5.2 0.9 8.2 16.2 15.8 4.0 1.5 6.6 7.2 26.2 4.3 1.9 1.3 3.0 2.2 2.8 2.1 3.3 33.8 33.7 10.5 3.9 0.2 5.1 0.0 0.9 10.8 0.0 1.2 0.0 0.2 0.1 0.0 0.5 0.0 0.0 0.0 5.8 0.0 3.7 0.3 3.1 0.1 5.9 6.5 4.3 6.1 4.3 4.0 4.2 3.9 4.5 3.1 125.0 192.3 11.2 267.7 89.0 20.4 14.4 17.8 33.5 64.8 15.7 0.0 9.2 10.0 31.3 0.4 32.9 172.0 0.0 21.2 17.2 32.4 153.9 29.9 128.8 29.9 20.6 107.4 8.6 53.9 1.4 0.3 47.3 54.0 40.5 87.2 21.4 42.4 51.5 0.4 21.6 3.4 0.0 14.4 0.0 1.3 56.1 25.6 4.5 56.6 79.9 TRIM16 EBBP ENSG00000221926 "Tripartite motif containing 16" O95361 17 15627960-15684311 "Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 52.9" "Cell type enhanced" "Detected in many" 8 "Pancreatic endocrine cells: 96.1;Suprabasal keratinocytes: 67.9;Urothelial cells: 116.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 8 "T-reg: 25.1" "Lineage enriched" "Detected in many" 11 "T-cells: 25.1" "Cell line enhanced" "Detected in many" "A549: 58.6;HaCaT: 47.3;HeLa: 42.7;OE19: 74.3" "HPA023623, HPA066431" Uncertain Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA023623: AB_1858273, HPA066431: AB_2685668" "unprognostic (2.14e-1)" "unprognostic (1.95e-1)" "unprognostic (9.61e-2)" "unprognostic (1.31e-2)" "unprognostic (6.19e-2)" "unprognostic (1.21e-1)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.94e-3)" "unprognostic (3.75e-2)" "unprognostic (4.65e-1)" "unprognostic (3.31e-3)" "unprognostic (1.70e-1)" "unprognostic (2.16e-3)" "unprognostic (2.08e-1)" "unprognostic (8.48e-2)" "unprognostic (9.21e-3)" "prognostic unfavorable (6.71e-4)" 6.1 13.5 7.4 4.8 12.8 7.0 6.7 7.4 11.7 16.0 5.0 7.8 6.6 10.2 7.0 2.8 52.9 4.0 7.5 6.5 8.0 4.4 5.7 2.2 6.2 10.9 11.3 5.6 3.7 6.2 1.9 5.7 15.8 9.8 4.1 5.2 5.0 14.7 5.7 11.4 15.6 5.5 5.4 5.9 4.6 14.4 5.5 7.8 4.7 7.4 5.3 16.3 11.7 23.3 0.4 1.5 0.6 2.3 0.5 25.1 1.3 18.3 58.6 1.8 4.0 8.7 10.0 2.0 3.0 10.8 3.8 5.3 3.5 24.0 2.0 11.6 13.3 22.7 47.3 5.3 13.6 2.5 24.3 3.4 0.9 42.7 1.9 14.5 1.0 2.0 5.5 8.6 8.3 4.8 10.6 8.1 2.3 1.1 9.6 10.2 6.5 4.0 2.3 2.7 74.3 3.5 1.7 15.1 1.4 19.4 23.9 1.3 3.8 13.4 15.2 4.5 11.1 2.3 2.5 12.5 4.8 5.7 2.3 10.4 2.3 2.5 0.1 7.4 2.5 12.1 0.1 2.3 0.6 0.8 0.6 0.5 0.3 3.0 0.9 1.5 0.4 0.8 1.6 0.5 0.5 0.3 0.3 25.1 1.3 7.4 12.8 7.4 11.7 8.0 4.4 11.3 5.6 9.8 7.8 35.7 1.6 3.7 46.8 27.4 6.4 8.8 10.2 5.3 12.5 10.4 17.7 12.0 0.0 46.8 0.8 16.1 4.3 0.0 15.3 6.7 10.5 16.4 4.6 2.4 3.5 3.2 4.1 3.7 2.6 2.0 6.6 4.4 6.8 18.0 16.5 6.7 96.1 24.6 4.2 3.7 8.7 6.5 8.3 7.6 11.5 67.9 3.9 5.7 13.3 116.8 TRIM16L TRIM70 ENSG00000108448 "Tripartite motif containing 16 like" Q309B1 17 18697998-18736118 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 22.5" "Cell type enhanced" "Detected in many" 5 "Pancreatic endocrine cells: 21.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 44.3;HaCaT: 22.6;HeLa: 35.4;OE19: 51.5" HPA066431 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA066431: AB_2685668" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (2.00e-1)" "unprognostic (7.89e-3)" "unprognostic (5.66e-2)" "unprognostic (3.97e-2)" "prognostic unfavorable (2.87e-4)" "unprognostic (7.08e-2)" "unprognostic (5.79e-2)" "unprognostic (6.28e-2)" "unprognostic (2.34e-1)" "unprognostic (3.11e-1)" "unprognostic (1.37e-1)" "unprognostic (5.74e-2)" "unprognostic (1.42e-1)" "prognostic unfavorable (2.29e-5)" "unprognostic (1.13e-2)" 2.8 4.4 2.0 1.0 3.1 0.5 7.1 1.0 3.0 2.2 3.6 1.3 1.0 2.0 1.4 3.2 10.5 3.3 8.1 16.8 2.0 2.5 3.5 2.8 2.4 1.0 4.7 1.0 1.3 1.3 0.1 1.0 1.8 3.1 3.6 1.0 2.1 2.6 3.7 22.5 0.8 1.1 6.5 4.7 1.0 3.0 2.9 1.4 1.0 4.5 12.7 3.4 6.7 11.8 1.5 0.8 0.4 1.4 2.7 2.1 1.8 4.7 44.3 0.2 1.9 5.4 2.2 3.5 0.4 3.7 1.6 3.3 0.8 19.1 0.5 3.5 12.7 8.8 22.6 0.5 1.0 0.8 0.1 0.6 0.3 35.4 0.4 13.3 0.0 0.4 2.3 1.3 2.4 0.9 7.0 0.5 0.4 0.0 0.0 4.3 4.7 0.1 0.5 0.4 51.5 0.9 0.5 2.3 0.0 3.2 2.8 0.1 1.0 5.0 1.0 2.7 0.3 2.3 0.3 9.9 1.1 5.7 1.8 6.3 0.5 0.5 0.0 3.7 0.4 8.4 0.1 0.7 0.4 0.7 1.4 1.0 1.5 1.0 0.6 0.8 1.1 1.6 1.5 0.3 2.7 0.5 0.2 2.1 1.8 2.0 3.1 1.0 1.9 2.0 2.5 4.7 1.0 3.1 1.4 6.0 3.2 0.8 8.5 3.4 2.7 5.5 10.2 8.1 1.2 1.8 7.9 2.0 3.3 9.0 0.5 2.6 0.9 0.0 5.3 3.7 2.5 3.8 3.5 2.5 1.4 3.2 2.4 2.5 3.4 0.7 3.4 2.1 0.0 15.4 3.2 3.5 21.6 0.0 1.8 6.8 2.4 0.0 2.8 3.2 5.6 5.6 0.9 1.3 3.4 6.3 TRIM4 RNF87 ENSG00000146833 "Tripartite motif containing 4" Q9C037 7 99876958-99919600 "Enzymes, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA019356, HPA029461" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA019356: AB_1856376, HPA029461: AB_10600834" "unprognostic (1.88e-1)" "unprognostic (2.97e-2)" "unprognostic (3.37e-1)" "unprognostic (3.46e-2)" "unprognostic (1.80e-2)" "unprognostic (7.06e-2)" "unprognostic (1.22e-1)" "unprognostic (5.42e-2)" "unprognostic (3.85e-2)" "unprognostic (2.67e-3)" "unprognostic (2.48e-2)" "unprognostic (1.60e-1)" "prognostic favorable (7.36e-6)" "unprognostic (1.00e-1)" "unprognostic (2.38e-1)" "unprognostic (7.46e-2)" "unprognostic (5.65e-2)" 19.1 22.6 13.5 22.1 15.9 6.7 22.1 20.1 15.5 19.5 17.3 12.4 22.5 13.9 21.9 18.8 16.4 19.0 19.8 11.1 13.3 9.3 16.6 17.9 21.1 22.4 15.3 8.8 35.0 23.2 18.9 27.4 16.1 12.2 21.9 15.7 18.4 19.4 33.8 9.4 20.7 18.3 18.1 11.9 18.2 17.4 16.2 14.5 18.4 20.5 11.9 18.8 20.0 28.9 18.6 17.0 20.0 19.2 13.9 30.3 17.4 9.7 11.7 7.0 5.8 18.4 17.3 3.1 16.4 20.0 13.7 16.0 6.2 9.6 14.2 0.1 13.9 12.1 11.6 9.2 10.1 14.0 14.4 0.7 11.6 6.2 9.7 26.0 16.7 16.6 18.4 21.5 10.6 27.0 18.7 11.9 7.2 16.9 22.0 11.4 12.1 12.3 15.0 5.3 14.7 10.1 7.0 10.0 16.2 15.2 12.6 8.2 5.8 12.5 19.2 19.5 10.7 8.8 9.6 14.5 15.2 13.6 29.1 15.7 18.5 20.2 11.5 10.0 18.8 20.1 20.0 19.2 15.3 20.6 19.2 23.8 18.6 21.6 23.5 17.0 18.6 30.3 22.2 8.2 13.9 16.6 12.7 21.5 17.4 13.5 15.9 20.1 15.5 13.3 9.3 15.3 8.8 12.2 14.5 23.8 15.3 18.2 24.1 22.2 20.2 4.8 12.7 16.0 10.3 21.0 17.7 13.3 8.3 12.8 5.2 16.1 9.7 23.3 11.3 5.9 15.1 19.8 27.6 17.5 12.8 6.4 8.6 17.8 20.0 8.4 28.7 15.4 21.9 18.0 10.3 34.3 12.7 11.8 25.8 13.4 20.0 0.0 23.1 19.3 8.2 20.1 13.6 18.7 12.1 22.0 TRIM44 "DIPB, MC7" ENSG00000166326 "Tripartite motif containing 44" Q96DX7 11 35662805-35818007 "Disease related genes, Predicted intracellular proteins" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049053, HPA057633" Approved Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA049053: AB_2680613, HPA057633: AB_2683484" "unprognostic (2.73e-1)" "unprognostic (2.74e-1)" "unprognostic (1.37e-1)" "unprognostic (5.53e-2)" "unprognostic (3.91e-2)" "unprognostic (1.81e-1)" "prognostic unfavorable (5.24e-5)" "unprognostic (9.06e-2)" "unprognostic (5.29e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (8.57e-2)" "unprognostic (1.49e-3)" "unprognostic (2.15e-2)" "unprognostic (1.59e-1)" "unprognostic (1.52e-1)" "unprognostic (3.00e-1)" 18.8 18.1 25.2 17.7 31.5 8.2 17.3 34.8 35.1 18.4 18.0 25.1 12.6 16.2 19.4 16.7 14.5 17.9 18.1 17.5 25.8 23.0 28.1 21.9 18.1 18.1 26.7 31.9 17.0 23.5 23.0 21.7 20.2 32.0 16.9 17.7 13.3 16.1 18.8 20.3 11.8 17.9 19.2 29.7 20.3 17.0 12.3 25.1 12.8 23.4 7.2 19.5 19.7 19.4 4.1 4.9 0.9 3.7 3.2 3.4 1.5 10.4 9.0 14.4 6.6 10.9 16.6 0.0 9.9 11.8 12.4 11.4 10.4 7.1 14.0 9.4 12.9 14.1 8.2 4.9 11.3 14.0 9.1 9.4 15.0 11.9 5.9 14.5 11.7 13.0 12.5 12.7 7.3 19.9 13.8 13.0 4.9 23.3 5.0 13.0 6.3 12.4 5.7 8.1 2.2 7.8 8.6 37.3 7.5 11.5 14.3 9.9 8.5 14.8 10.6 11.2 8.2 16.0 10.0 14.6 16.0 13.1 9.0 11.2 8.6 7.6 0.0 13.2 12.6 11.9 0.4 2.6 0.9 2.6 3.3 2.4 3.0 2.5 2.5 2.1 4.1 3.3 3.4 0.2 3.2 3.7 4.9 0.9 1.5 25.2 31.5 34.8 35.1 25.8 23.0 26.7 31.9 32.0 25.1 56.6 58.2 57.3 44.5 23.8 206.3 47.8 56.0 65.6 66.0 24.4 192.4 44.7 28.2 55.3 13.1 55.2 43.4 0.0 61.0 21.9 34.7 61.7 57.7 50.0 38.1 79.4 49.3 44.8 51.7 8.1 33.4 50.8 18.6 47.7 40.8 82.5 47.5 39.9 35.0 62.1 177.2 97.0 38.1 57.6 80.7 23.3 43.6 34.5 43.5 50.6 TRIM54 "MURF, MURF-3, RNF30" ENSG00000138100 "Tripartite motif containing 54" Q9BYV2 2 27282392-27307439 "Predicted intracellular proteins" Differentiation "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "skeletal muscle: 187.1" "Cell type enhanced" "Detected in some" 20 "Cardiomyocytes: 75.1;Exocrine glandular cells: 36.7;Pancreatic endocrine cells: 31.1" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in single" "cerebral cortex: 1.2" "Cell type enriched" "Detected in single" 16 "NK-cell: 7.0" "Lineage enriched" "Detected in single" 16 "NK-cells: 7.0" "Group enriched" "Detected in some" 9 "HAP1: 8.4;NTERA-2: 18.0" "Region enhanced" "Detected in some" "amygdala: 3.2" "Not detected" "Not detected" HPA019690 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA019690: AB_1858306" "unprognostic (6.98e-3)" "unprognostic (4.56e-3)" "unprognostic (3.22e-2)" "unprognostic (2.24e-2)" "unprognostic (1.58e-3)" "unprognostic (7.49e-2)" "unprognostic (1.25e-7)" "unprognostic (3.88e-3)" "unprognostic (2.29e-1)" "unprognostic (2.95e-1)" "unprognostic (2.56e-3)" "unprognostic (6.91e-2)" "prognostic unfavorable (6.46e-4)" "unprognostic (2.41e-2)" "unprognostic (3.19e-1)" "unprognostic (1.15e-1)" "unprognostic (6.92e-2)" 2.1 1.8 0.5 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.9 0.1 6.3 1.6 0.0 0.0 35.3 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 1.8 0.0 187.1 0.0 0.4 0.0 0.0 0.1 0.0 3.5 0.0 0.0 1.3 40.3 2.2 0.1 0.0 0.3 0.0 0.0 0.0 7.0 0.4 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 8.4 0.0 0.0 0.0 0.3 0.0 1.5 1.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 18.0 0.0 0.0 0.6 0.7 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.2 0.1 0.1 0.9 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.2 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 75.1 12.7 0.0 0.0 3.5 0.0 0.0 0.0 3.6 1.0 0.0 2.0 0.0 36.7 0.0 0.0 0.2 4.6 0.0 0.1 0.0 0.0 0.6 0.0 3.3 0.0 0.0 0.0 0.0 0.6 0.0 31.1 1.9 0.7 2.1 0.0 0.0 0.2 3.7 1.9 0.0 0.0 0.0 2.9 0.3 TRIML2 "FLJ25801, SPRYD6" ENSG00000179046 "Tripartite motif family like 2" Q8N7C3 4 188091273-188109603 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 6 "placenta: 9.8;testis: 6.2" "Cell type enhanced" "Detected in some" 17 "Cytotrophoblasts: 13.9;Early spermatids: 18.8;Extravillous trophoblasts: 5.5;Syncytiotrophoblasts: 7.4" "Cancer enriched" "Detected in some" 33 "testis cancer: 24.4" "Region enhanced" "Detected in single" "basal ganglia: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "SuSa: 58.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA043838 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA043838: AB_10963835" "unprognostic (3.32e-1)" "unprognostic (1.99e-1)" "unprognostic (1.30e-1)" "unprognostic (9.82e-2)" "unprognostic (1.21e-5)" "unprognostic (3.06e-2)" "unprognostic (1.65e-3)" "unprognostic (2.65e-1)" "unprognostic (0.00e+0)" "unprognostic (2.26e-2)" "unprognostic (1.20e-1)" "unprognostic (1.28e-3)" 0.1 0.1 0.2 0.1 1.4 0.0 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.0 0.1 9.8 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 6.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 12.6 0.0 0.0 0.0 0.0 7.0 0.1 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.9 0.3 2.4 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 58.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 13.9 0.0 0.0 18.8 0.0 0.0 0.0 0.0 5.5 0.3 0.1 0.0 0.0 1.2 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 2.5 0.0 7.4 0.0 0.0 0.3 TRMT10B "bA3J10.9, FLJ31455, RG9MTD3" ENSG00000165275 "TRNA methyltransferase 10B" Q6PF06 9 37753803-37778972 "Enzymes, Predicted intracellular proteins" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021800 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA021800: AB_1856214" "unprognostic (1.00e-2)" "unprognostic (1.78e-1)" "unprognostic (3.35e-2)" "unprognostic (3.89e-2)" "unprognostic (2.42e-2)" "unprognostic (7.68e-2)" "unprognostic (7.78e-2)" "prognostic favorable (3.91e-4)" "unprognostic (5.49e-3)" "unprognostic (1.71e-2)" "prognostic favorable (5.34e-4)" "unprognostic (1.40e-1)" "unprognostic (6.62e-2)" "unprognostic (1.76e-2)" "unprognostic (1.68e-1)" "unprognostic (9.58e-2)" "unprognostic (2.33e-3)" 7.4 10.3 9.9 10.9 10.3 10.1 9.8 13.7 12.3 10.6 11.8 12.7 12.8 8.3 17.3 9.5 10.4 9.6 10.6 7.0 9.9 9.2 8.2 8.0 8.6 13.1 16.4 9.8 15.4 10.5 9.0 13.8 7.4 10.0 14.8 7.1 12.1 10.3 12.1 7.8 20.4 9.7 11.8 12.7 12.1 10.8 5.0 10.4 10.0 12.4 5.6 13.6 14.8 10.1 9.2 4.6 6.6 5.3 4.6 7.6 2.7 5.3 6.3 8.2 7.3 5.0 4.1 3.8 5.3 3.8 5.4 4.7 3.8 4.7 10.0 3.9 4.0 3.2 6.2 3.9 6.4 4.9 4.3 6.9 8.7 15.6 3.9 9.2 8.9 6.3 4.7 6.6 4.7 9.1 6.5 5.5 12.1 7.0 4.4 4.1 3.8 9.1 7.0 7.3 5.6 7.8 9.3 2.9 5.2 5.2 4.9 11.2 10.8 4.3 5.4 4.7 5.4 5.9 6.5 5.4 4.2 6.1 6.7 4.6 5.0 6.8 7.9 2.5 7.1 8.5 6.6 5.3 2.8 6.7 4.6 7.6 6.6 6.0 6.3 2.5 9.2 7.3 6.7 5.4 4.6 3.2 4.6 3.9 2.7 9.9 10.3 13.7 12.3 9.9 9.2 16.4 9.8 10.0 10.4 3.0 6.2 23.8 10.8 6.5 15.5 7.4 10.2 8.1 9.1 3.5 5.9 13.3 10.0 9.6 1.6 12.0 7.8 23.3 11.0 7.0 7.4 11.1 13.9 6.6 7.2 15.9 13.3 9.2 11.4 0.2 13.6 12.3 10.1 7.2 12.9 12.8 8.8 7.0 22.3 6.7 12.8 25.8 8.6 4.4 3.2 6.6 10.2 19.2 9.0 7.8 TRPM4 FLJ20041 ENSG00000130529 "Transient receptor potential cation channel subfamily M member 4" Q8TD43 19 49157741-49211836 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Adaptive immunity, Immunity, Ion transport, Transport" "Calmodulin-binding, Ion channel" "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1" "Cancer enhanced" "Detected in all" "prostate cancer: 85.3" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8" "Cell line enhanced" "Detected in many" "OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" HPA041169 Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA 6500 "Nucleoplasm, Plasma membrane" "HPA041169: AB_2677343" "unprognostic (8.20e-3)" "unprognostic (1.41e-1)" "unprognostic (7.86e-2)" "prognostic favorable (2.88e-7)" "unprognostic (1.62e-2)" "unprognostic (9.78e-2)" "unprognostic (1.77e-2)" "unprognostic (2.90e-1)" "unprognostic (3.33e-2)" "unprognostic (3.38e-2)" "unprognostic (2.94e-2)" "unprognostic (2.79e-1)" "prognostic favorable (2.53e-7)" "unprognostic (8.46e-3)" "unprognostic (2.16e-1)" "unprognostic (5.70e-2)" "unprognostic (1.00e-2)" 6.7 3.8 3.5 13.7 3.7 4.3 8.5 3.0 6.8 8.2 25.2 4.5 8.6 20.6 7.9 9.1 7.7 5.4 24.8 9.3 2.7 2.2 14.2 23.6 9.4 3.5 2.6 5.7 2.7 17.4 3.4 3.3 5.0 6.9 20.2 11.4 10.6 16.2 13.2 16.4 16.1 26.8 9.4 2.5 3.4 18.3 4.2 2.2 0.4 10.1 11.5 6.8 9.9 8.6 1.1 5.4 4.9 6.8 1.0 0.7 2.1 6.0 4.5 1.1 5.0 3.8 3.6 3.6 5.1 3.0 1.4 1.9 3.3 9.5 0.2 1.3 3.4 1.9 7.9 0.7 1.5 0.6 0.1 1.6 1.0 1.9 2.0 3.4 0.1 6.6 4.3 7.0 2.6 1.2 1.7 2.4 0.5 2.4 1.2 3.5 9.0 0.4 0.5 0.6 15.6 6.9 2.2 1.0 0.3 2.4 32.4 0.4 1.1 2.1 21.3 1.1 0.4 11.6 2.0 6.1 7.6 4.2 4.2 0.1 2.2 2.2 0.2 4.3 3.9 2.8 2.7 6.8 1.1 0.6 4.0 0.5 0.8 0.5 0.4 5.4 1.1 0.6 0.7 4.9 1.0 1.5 4.9 0.3 2.1 3.5 3.7 3.0 6.8 2.7 2.2 2.6 5.7 6.9 2.2 29.8 1.6 11.7 13.4 11.1 2.1 14.9 22.9 2.7 3.4 14.0 0.0 5.3 16.6 7.6 2.1 9.2 120.1 0.0 16.1 5.7 6.6 47.1 5.7 64.7 16.1 0.0 20.8 15.4 9.7 3.1 6.4 7.9 37.1 14.4 88.2 6.3 25.2 80.4 6.7 3.8 2.4 32.3 9.1 6.6 11.9 10.0 2.9 0.0 78.1 25.3 TSHZ3 "KIAA1474, TSH3, ZNF537" ENSG00000121297 "Teashirt zinc finger homeobox 3" Q63HK5 19 31274945-31349547 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Fibroblasts: 18.6;Ito cells: 19.6;Leydig cells: 16.4;Peritubular cells: 27.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 4.9" "Group enriched" "Detected in many" 35 "granulocytes: 4.9;monocytes: 2.2;T-cells: 3.2" "Cell line enhanced" "Detected in many" "ASC TERT1: 13.0;RH-30: 26.7;U-138 MG: 18.9;U-87 MG: 12.2" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebral cortex: 20.4;hippocampal formation: 16.8" "HPA008834, HPA071010" Approved Enhanced "Nucleoplasm,Plasma membrane" No No Nucleoplasm "Plasma membrane" "HPA008834: AB_1080731, HPA071010: " "unprognostic (2.56e-1)" "unprognostic (3.88e-1)" "unprognostic (4.56e-2)" "unprognostic (3.66e-1)" "unprognostic (1.66e-3)" "unprognostic (4.07e-2)" "unprognostic (1.67e-1)" "unprognostic (2.46e-1)" "unprognostic (1.76e-1)" "unprognostic (3.58e-3)" "unprognostic (2.23e-1)" "unprognostic (3.91e-2)" "prognostic unfavorable (2.92e-4)" "unprognostic (8.76e-3)" "unprognostic (8.22e-2)" "unprognostic (1.91e-2)" "unprognostic (1.73e-3)" 5.7 3.3 4.4 4.0 6.6 1.0 5.2 1.1 17.3 13.0 11.6 0.7 2.4 2.5 19.4 8.5 5.6 9.5 11.5 4.6 3.3 2.0 2.8 1.3 4.9 1.2 1.6 8.0 28.0 1.5 1.1 7.2 4.8 2.8 9.5 3.7 4.9 2.8 8.9 1.6 2.5 4.3 16.4 3.3 4.5 6.1 3.3 1.2 0.0 8.5 1.7 0.7 11.1 11.4 0.0 0.0 4.9 2.2 0.0 3.2 0.7 0.0 1.1 0.4 0.0 5.9 13.0 0.0 3.4 4.9 2.1 3.8 0.0 0.7 0.0 0.0 8.4 4.4 0.5 1.5 3.1 4.7 0.0 1.3 0.0 0.0 0.0 11.4 2.8 5.3 7.6 2.8 7.8 3.9 0.0 0.0 2.5 0.0 0.0 9.8 0.5 0.0 0.0 0.5 0.0 0.0 3.3 26.7 0.0 0.0 0.0 0.0 8.1 0.0 0.0 2.6 2.7 0.0 2.0 0.0 18.9 6.0 2.1 4.8 0.0 0.0 0.0 12.2 4.9 0.5 0.0 2.2 0.0 3.2 0.8 0.1 0.0 0.9 1.0 0.0 0.0 0.3 0.8 4.9 0.0 0.4 0.0 0.7 0.7 4.4 6.6 1.1 17.3 3.3 2.0 1.6 8.0 2.8 1.2 3.0 0.6 0.0 6.8 4.2 13.9 1.6 0.0 1.4 6.8 3.5 0.0 0.3 0.0 0.3 0.1 6.7 0.0 0.0 0.6 0.2 18.6 3.3 1.1 0.0 9.1 15.9 0.0 19.6 11.6 0.0 16.4 6.1 5.0 0.0 0.0 0.2 0.5 0.0 27.6 0.0 0.1 0.0 10.3 0.0 5.0 1.5 0.7 0.5 0.0 2.4 TTC17 FLJ10890 ENSG00000052841 "Tetratricopeptide repeat domain 17" Q96AE7 11 43358932-43494933 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038508 Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA038508: AB_10671744" "unprognostic (2.71e-1)" "unprognostic (4.04e-3)" "unprognostic (6.48e-2)" "unprognostic (2.64e-1)" "unprognostic (1.17e-1)" "unprognostic (5.66e-2)" "unprognostic (1.74e-1)" "unprognostic (9.03e-2)" "unprognostic (5.01e-3)" "unprognostic (2.62e-1)" "unprognostic (1.34e-2)" "unprognostic (1.90e-2)" "prognostic unfavorable (4.75e-6)" "unprognostic (1.04e-2)" "unprognostic (4.40e-1)" "unprognostic (1.18e-1)" "unprognostic (1.54e-2)" 12.7 13.6 16.3 15.8 18.4 6.8 21.2 21.1 17.0 12.7 10.7 9.1 21.1 10.9 15.0 13.9 11.5 17.7 11.5 10.5 12.8 7.4 12.0 19.9 20.4 19.8 21.7 11.3 26.6 47.7 20.5 20.8 15.0 15.4 13.8 12.0 10.6 20.7 11.7 12.1 10.9 14.0 17.7 12.9 11.9 16.4 12.3 17.3 11.1 19.5 9.1 11.1 12.8 12.5 22.4 23.3 24.5 29.0 20.4 23.1 21.1 5.8 12.0 12.6 19.8 32.0 26.6 8.9 14.1 19.0 11.9 14.4 8.3 8.7 12.3 14.2 14.1 13.8 12.4 8.9 9.3 14.4 9.5 11.7 9.4 7.8 8.1 39.6 14.1 12.2 24.6 28.7 8.6 28.0 27.1 11.8 9.0 13.5 10.5 11.9 7.0 10.3 8.1 18.9 22.7 10.4 9.7 13.5 14.2 15.1 8.6 6.8 16.2 11.0 29.4 17.6 13.4 27.6 16.0 15.7 17.1 7.6 19.1 20.3 20.8 16.7 11.8 11.0 8.5 18.1 22.3 28.3 23.8 21.0 29.0 21.9 22.4 22.6 19.7 21.9 20.7 23.1 21.0 24.5 20.4 24.7 23.3 20.3 21.1 16.3 18.4 21.1 17.0 12.8 7.4 21.7 11.3 15.4 17.3 59.6 54.2 28.4 28.8 37.4 41.5 17.6 28.1 49.5 54.6 21.0 56.9 25.8 3.3 19.2 29.2 34.4 26.8 0.0 37.4 25.1 35.1 39.2 33.7 51.6 22.7 44.5 21.5 41.1 45.4 12.2 52.9 30.9 27.0 27.9 41.3 25.2 28.5 31.7 34.3 11.1 49.2 51.8 28.6 40.9 34.8 37.8 25.7 35.4 34.6 32.8 TTC23 "FLJ12572, HCC-8" ENSG00000103852 "Tetratricopeptide repeat domain 23" Q5W5X9 15 99136323-99251223 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039806, HPA040369" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039806: AB_10793921, HPA040369: AB_10795381" "prognostic favorable (3.17e-4)" "unprognostic (5.41e-2)" "unprognostic (1.45e-1)" "prognostic favorable (1.07e-4)" "unprognostic (1.40e-2)" "unprognostic (6.53e-2)" "unprognostic (9.25e-3)" "unprognostic (2.56e-1)" "unprognostic (6.18e-2)" "unprognostic (1.76e-3)" "unprognostic (1.88e-1)" "unprognostic (3.24e-1)" "unprognostic (3.21e-2)" "unprognostic (1.11e-2)" "unprognostic (4.31e-1)" "unprognostic (7.99e-2)" "unprognostic (1.23e-1)" 9.5 10.7 6.0 6.1 8.6 1.0 9.7 5.4 7.5 13.2 15.5 12.2 11.9 3.7 20.3 9.9 10.7 10.6 10.4 11.9 7.7 4.7 10.6 8.2 8.1 3.0 9.8 7.5 17.5 11.7 10.7 10.2 10.0 10.5 13.7 8.7 14.0 8.4 12.0 7.8 8.6 6.4 12.3 15.7 5.2 8.7 16.2 9.0 5.1 14.1 7.7 5.0 13.0 11.4 0.5 2.4 3.8 1.3 2.0 0.5 0.1 6.8 7.1 11.0 12.6 13.1 14.8 4.6 8.5 10.4 9.1 10.3 6.1 11.9 1.7 17.1 9.6 8.2 13.3 3.5 8.4 9.9 2.2 11.7 7.3 12.5 4.8 7.6 1.6 0.5 10.4 7.6 7.1 6.8 9.9 15.2 3.3 5.6 1.0 8.5 4.1 5.8 1.8 5.9 1.8 4.9 1.8 14.3 2.6 7.3 9.2 4.8 2.1 11.1 4.5 10.3 11.5 7.6 7.6 9.9 11.5 6.9 7.7 10.8 6.0 8.1 2.3 10.3 0.5 6.8 3.8 0.5 0.6 0.3 1.3 0.3 0.4 0.4 0.5 2.4 0.5 0.3 0.3 1.8 2.0 0.5 1.9 0.4 0.1 6.0 8.6 5.4 7.5 7.7 4.7 9.8 7.5 10.5 9.0 3.0 6.5 0.0 4.3 2.2 1.7 6.9 7.6 4.0 5.7 5.2 0.0 4.1 5.0 4.5 6.9 5.3 2.9 0.0 5.5 3.7 4.8 2.4 1.1 5.1 3.4 7.9 0.0 9.2 4.3 5.6 8.3 0.8 1.7 1.0 4.8 10.0 4.0 2.9 9.6 4.4 4.7 6.5 4.0 16.8 8.1 3.4 1.6 0.0 6.0 2.4 TTLL12 KIAA0153 ENSG00000100304 "Tubulin tyrosine ligase like 12" Q14166 22 43166622-43187133 "Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Paneth cells: 54.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003054, CAB046029" Approved Approved "Plasma membrane,Cytosol" NA NA 2100000 Cytosol "Plasma membrane" "CAB046029: AB_11128395, HPA003054: AB_2666770" "unprognostic (2.45e-2)" "unprognostic (3.47e-2)" "unprognostic (7.37e-3)" "unprognostic (5.40e-2)" "unprognostic (2.65e-1)" "unprognostic (3.50e-1)" "prognostic unfavorable (2.84e-4)" "unprognostic (5.81e-3)" "unprognostic (2.24e-1)" "unprognostic (6.08e-2)" "unprognostic (4.75e-2)" "unprognostic (1.73e-1)" "unprognostic (1.15e-1)" "unprognostic (1.17e-3)" "unprognostic (1.40e-1)" "unprognostic (6.66e-2)" "unprognostic (2.81e-2)" 7.3 13.8 7.2 14.7 8.3 14.0 11.2 13.6 12.3 10.9 21.5 5.5 8.9 15.0 7.1 8.7 46.3 9.0 36.0 6.9 7.3 7.1 8.4 19.4 5.3 9.2 6.5 5.9 16.5 29.8 4.4 7.0 6.8 7.1 9.4 12.1 7.0 13.5 7.9 5.5 16.4 13.9 5.9 4.0 9.7 20.7 18.3 5.3 10.7 7.6 23.7 23.5 8.3 15.2 3.5 3.8 1.3 4.7 4.3 5.6 3.3 31.6 13.4 5.4 13.4 8.3 5.7 17.6 10.5 3.7 10.1 5.3 21.7 18.2 30.6 12.7 8.6 4.9 22.7 22.6 19.2 2.6 3.8 35.8 7.5 21.5 18.6 13.1 33.6 7.8 9.1 23.3 12.0 12.9 5.4 10.6 15.1 46.0 7.2 4.6 29.5 23.3 18.2 19.7 22.3 13.4 23.8 18.7 44.0 8.5 10.5 16.6 6.8 22.2 32.6 11.7 2.6 12.8 15.0 10.1 6.7 9.5 12.9 14.5 12.3 15.1 22.6 7.6 17.3 9.1 0.0 4.7 0.7 5.6 2.4 5.5 3.5 5.5 4.1 3.8 2.7 5.5 3.7 1.3 4.3 3.1 3.3 3.5 3.3 7.2 8.3 13.6 12.3 7.3 7.1 6.5 5.9 7.1 5.3 6.0 7.0 9.9 8.6 10.0 8.4 3.6 20.4 2.7 3.4 7.0 3.9 5.7 5.0 13.9 0.7 3.6 35.1 23.3 7.3 14.1 4.1 13.4 0.0 30.4 8.7 0.0 8.7 9.2 13.8 1.6 8.1 5.0 10.1 4.6 29.3 3.8 18.9 54.1 15.9 7.7 4.6 0.0 7.2 2.2 12.8 15.8 3.4 3.8 33.9 13.1 TTLL5 KIAA0998 ENSG00000119685 "Tubulin tyrosine ligase like 5" Q6EMB2 14 75633625-75955078 "Disease related genes, Predicted intracellular proteins" Transcription Ligase "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 51.1" "Cell type enhanced" "Detected in many" 8 "Cone photoreceptor cells: 119.8;Early spermatids: 86.9;Late spermatids: 71.0;Rod photoreceptor cells: 81.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032128 Uncertain Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA032128: AB_10600835" "unprognostic (7.35e-2)" "unprognostic (7.29e-2)" "unprognostic (7.73e-2)" "unprognostic (1.10e-1)" "unprognostic (1.33e-1)" "unprognostic (5.96e-2)" "unprognostic (7.21e-5)" "unprognostic (1.26e-1)" "unprognostic (1.70e-1)" "unprognostic (7.93e-2)" "unprognostic (1.10e-2)" "unprognostic (3.43e-1)" "unprognostic (5.67e-3)" "unprognostic (1.70e-1)" "unprognostic (1.57e-1)" "unprognostic (8.97e-2)" "unprognostic (2.15e-2)" 5.9 6.5 7.6 5.9 11.1 10.1 7.4 12.0 10.4 8.0 6.5 18.0 6.4 4.9 11.8 7.7 8.1 11.8 6.7 6.8 7.9 7.1 6.6 4.4 6.6 5.0 10.1 6.9 8.1 5.8 13.2 9.5 7.6 13.9 7.4 7.6 8.2 7.7 7.5 5.2 7.2 4.8 8.9 15.8 4.2 6.0 51.1 10.5 10.1 8.1 5.5 7.3 7.1 7.1 3.8 5.7 12.4 3.8 3.4 5.1 2.3 14.3 10.5 9.3 9.5 7.3 11.4 8.5 8.5 10.3 10.2 13.1 6.5 13.5 4.0 4.7 8.9 7.5 13.7 7.9 14.0 19.4 4.8 4.8 7.9 11.0 7.1 6.2 5.7 7.7 8.7 7.0 12.8 14.3 11.1 21.9 11.4 4.5 6.9 10.1 20.1 9.7 7.9 6.6 11.3 10.8 6.0 13.0 5.5 9.8 14.2 12.2 7.8 17.9 13.1 4.4 7.5 18.0 6.3 24.7 13.6 12.1 12.0 7.8 5.8 8.3 9.4 13.8 6.6 9.0 12.4 3.5 2.7 4.6 3.3 4.0 3.8 4.2 4.5 5.1 3.5 5.1 4.7 3.8 3.4 3.8 5.7 3.4 2.3 7.6 11.1 12.0 10.4 7.9 7.1 10.1 6.9 13.9 10.5 3.0 8.5 2.4 5.1 4.4 8.9 7.6 20.4 34.8 13.6 10.4 119.8 6.8 3.3 6.0 86.9 9.0 6.3 0.0 4.6 11.2 7.8 7.7 11.6 5.8 5.0 0.0 7.5 24.5 7.0 71.0 11.5 6.4 5.0 9.0 6.1 8.1 4.3 9.9 11.0 1.4 81.7 12.9 4.4 28.7 15.8 5.5 5.0 6.9 6.8 4.1 TXNDC11 EFP1 ENSG00000153066 "Thioredoxin domain containing 11" Q6PKC3 16 11679080-11742878 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "RPMI-8226: 48.2;U-266/70: 39.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041174, HPA041390" Supported Supported "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA041174: AB_10794191, HPA041390: AB_10796670" "unprognostic (1.96e-2)" "unprognostic (1.43e-1)" "unprognostic (6.82e-3)" "prognostic favorable (2.12e-5)" "prognostic unfavorable (1.36e-4)" "unprognostic (2.43e-2)" "unprognostic (1.83e-1)" "unprognostic (2.68e-3)" "unprognostic (4.90e-2)" "unprognostic (2.17e-1)" "unprognostic (1.08e-1)" "unprognostic (2.01e-1)" "unprognostic (2.35e-2)" "unprognostic (9.96e-2)" "unprognostic (8.30e-2)" "unprognostic (3.23e-2)" "unprognostic (2.34e-2)" 12.5 12.5 6.1 10.9 8.1 24.1 12.3 12.8 9.9 12.7 20.8 8.3 13.2 19.2 12.9 16.0 12.6 12.7 17.5 11.4 7.3 4.4 21.2 47.2 22.4 21.3 7.4 4.4 13.9 22.9 28.6 11.4 15.0 7.1 13.2 15.4 18.6 24.1 14.3 23.2 9.9 27.4 7.8 5.0 23.6 17.6 5.6 6.7 15.9 28.6 11.6 33.2 15.0 10.2 5.7 3.6 9.6 3.3 7.8 9.2 3.5 8.8 6.2 2.9 4.0 7.9 6.6 5.1 8.9 12.2 8.1 10.5 3.0 14.2 22.5 15.0 11.1 11.1 8.0 3.6 7.4 6.7 10.0 4.7 4.7 7.1 14.9 11.6 7.0 9.7 5.0 8.5 9.1 14.4 6.3 10.2 5.1 7.2 29.0 7.1 8.1 5.4 2.7 3.8 6.4 3.2 7.0 5.9 48.2 9.3 4.8 4.1 3.9 17.3 13.5 9.4 3.4 8.3 9.7 10.5 3.8 4.4 17.7 5.0 39.6 21.6 13.6 8.0 8.9 6.3 4.9 3.3 9.6 2.7 2.5 6.6 5.7 4.9 6.0 3.6 4.9 4.8 3.1 1.0 7.8 2.8 2.8 9.2 3.5 6.1 8.1 12.8 9.9 7.3 4.4 7.4 4.4 7.1 6.7 41.7 44.0 21.5 22.2 13.1 15.1 7.6 20.4 10.7 26.1 17.4 47.1 17.5 13.3 17.8 2.3 13.1 35.1 0.0 34.6 26.3 14.1 29.3 15.0 32.5 27.0 22.3 23.5 16.0 15.1 1.1 18.7 21.9 21.9 24.4 36.5 14.5 23.5 21.0 12.4 11.8 22.2 6.5 18.1 11.2 9.5 10.3 20.9 18.7 22.7 27.1 TXNIP "ARRDC6, EST01027, HHCPA78, THIF, VDUP1" ENSG00000265972 "Thioredoxin interacting protein" Q9H3M7 1 145992435-145996600 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, Transcription, Transcription regulation" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 5 "Sertoli cells: 1177.1;T-cells: 976.9" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC TERT1: 109.0;HSkMC: 145.0;hTCEpi: 73.9;hTERT-RPE1: 87.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031085, HPA053694" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA031085: AB_10601706, HPA053694: AB_2682232" "unprognostic (1.45e-1)" "unprognostic (1.57e-2)" "unprognostic (1.67e-2)" "unprognostic (4.16e-2)" "unprognostic (1.92e-2)" "unprognostic (3.93e-2)" "unprognostic (1.55e-2)" "unprognostic (2.51e-1)" "unprognostic (9.23e-2)" "unprognostic (1.20e-1)" "unprognostic (3.65e-2)" "unprognostic (1.19e-1)" "unprognostic (8.49e-3)" "unprognostic (1.35e-2)" "unprognostic (1.31e-1)" "unprognostic (8.19e-2)" "unprognostic (2.22e-3)" 127.7 10.6 4.1 17.0 4.6 10.5 73.6 2.5 6.0 45.9 49.8 16.1 25.0 6.3 39.3 22.8 41.0 20.3 20.4 55.3 4.8 34.8 11.7 52.3 82.6 6.5 4.2 34.1 25.8 9.3 20.2 19.1 8.3 47.4 16.1 18.8 18.5 19.5 97.0 15.3 27.7 34.6 9.2 39.0 13.6 23.1 6.0 29.0 85.3 16.0 41.5 52.5 32.3 64.9 35.5 134.9 58.3 65.3 90.0 132.5 5.9 0.0 1.4 0.1 33.1 109.0 3.3 7.1 14.4 6.5 8.9 3.8 8.1 1.6 42.4 1.9 1.0 1.6 1.4 13.5 17.4 7.8 0.7 4.8 2.1 3.4 1.5 19.9 10.2 145.0 73.9 13.2 23.2 87.5 2.5 6.7 19.3 13.4 3.3 8.1 3.3 19.0 4.0 12.0 5.3 3.0 11.9 51.8 16.9 13.3 6.8 11.1 30.7 8.9 24.4 3.0 3.2 28.5 6.1 18.0 1.1 33.6 11.6 18.8 17.9 1.5 4.4 9.2 9.4 94.7 53.3 123.0 90.0 58.3 83.1 58.8 76.5 79.9 35.5 64.9 76.0 80.3 134.9 65.3 49.9 16.7 70.6 132.5 211.4 256.3 523.2 152.7 62.8 5.2 378.6 219.1 167.3 228.6 258.2 27.5 4.8 381.3 68.3 6.0 390.7 127.9 140.2 46.4 5.0 157.0 217.7 358.0 65.3 218.0 6.4 157.7 332.7 859.8 16.4 606.1 469.7 102.9 128.0 291.4 3.4 148.2 357.3 420.4 90.8 3.3 1177.1 168.0 6.4 34.1 63.1 9.2 976.9 145.3 211.3 TYW3 "C1orf171, FLJ40918" ENSG00000162623 "TRNA-yW synthesizing protein 3 homolog" Q6IPR3 1 74733152-74766678 "Enzymes, Predicted intracellular proteins" "tRNA processing" "Methyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA029641 Approved Approved "Plasma membrane,Cytosol" No No Cytosol "Plasma membrane" "HPA029641: AB_2272535" "unprognostic (6.89e-3)" "unprognostic (1.06e-1)" "unprognostic (1.08e-1)" "unprognostic (1.09e-1)" "unprognostic (1.42e-1)" "unprognostic (7.24e-2)" "prognostic unfavorable (1.49e-7)" "unprognostic (3.79e-1)" "unprognostic (2.23e-1)" "unprognostic (2.96e-1)" "unprognostic (4.08e-2)" "unprognostic (1.59e-1)" "unprognostic (1.70e-1)" "unprognostic (1.13e-1)" "unprognostic (2.05e-1)" "unprognostic (8.90e-2)" "unprognostic (2.98e-3)" 16.5 19.7 13.7 13.5 17.7 11.9 18.3 15.0 19.9 20.4 17.7 7.5 13.7 9.5 21.0 15.2 20.6 16.4 10.0 21.1 11.1 12.9 20.4 17.0 11.3 14.3 16.2 17.2 30.0 14.4 22.2 34.3 13.5 17.0 20.7 12.3 8.6 13.8 15.7 12.3 10.5 10.9 24.7 15.6 16.0 14.8 12.3 18.1 12.3 23.5 14.3 16.9 23.5 33.3 9.7 9.0 6.0 8.0 13.6 13.9 5.2 8.6 7.3 12.6 8.9 14.3 15.7 19.1 14.9 13.7 14.3 12.6 15.4 7.4 22.7 13.7 12.8 21.0 7.1 14.4 17.2 17.9 14.1 12.4 17.8 22.3 29.8 9.4 35.6 11.6 11.9 17.4 18.2 17.6 11.5 12.7 15.8 30.8 17.5 18.3 7.3 17.3 11.9 33.5 13.0 17.0 16.4 26.3 10.2 12.2 11.3 9.8 8.3 7.1 19.4 22.9 14.3 10.6 13.1 8.2 6.3 17.3 17.1 17.8 10.1 18.3 15.9 14.2 12.9 18.2 6.0 6.0 1.6 10.3 8.0 9.9 9.7 9.1 9.3 9.0 8.8 13.2 13.9 0.5 13.6 5.9 8.7 8.4 5.2 13.7 17.7 15.0 19.9 11.1 12.9 16.2 17.2 17.0 18.1 14.9 22.9 32.0 34.6 22.8 31.3 26.5 17.8 24.1 36.4 15.7 3.9 37.5 66.3 29.4 14.9 24.8 8.0 0.0 51.1 41.5 28.2 34.8 20.7 29.2 29.0 47.7 13.3 17.8 27.2 18.5 40.3 22.8 20.3 29.7 17.0 18.0 31.2 7.0 57.7 43.8 19.9 12.9 38.0 31.8 45.3 19.8 18.7 27.7 24.9 23.3 UBE2C UBCH10 ENSG00000175063 "Ubiquitin conjugating enzyme E2 C" O00762 20 45812576-45816957 "Cancer-related genes, Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis, Ubl conjugation pathway" Transferase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "lymphoid tissue: 130.8" "Group enriched" "Detected in many" 5 "Erythroid cells: 397.1;Extravillous trophoblasts: 368.9" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "T-reg: 10.0" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" "CAB011464, HPA034569, CAB035990, HPA054975" Approved Supported "Plasma membrane,Cytosol" Yes Yes "Plasma membrane, Cytosol" "CAB011464: AB_442965, CAB035990: , HPA034569: AB_2674226, HPA054975: AB_2682658" "unprognostic (1.45e-2)" "unprognostic (2.19e-1)" "unprognostic (1.06e-1)" "unprognostic (2.11e-3)" "unprognostic (2.54e-1)" "unprognostic (1.35e-1)" "prognostic unfavorable (6.24e-6)" "unprognostic (2.27e-3)" "unprognostic (2.59e-2)" "unprognostic (1.04e-1)" "prognostic unfavorable (6.91e-4)" "unprognostic (3.76e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.09e-1)" "unprognostic (3.61e-1)" "unprognostic (4.65e-2)" "unprognostic (2.68e-1)" 3.1 2.3 0.4 24.0 0.9 25.1 4.3 0.4 0.7 3.8 9.5 0.4 0.8 7.8 2.0 2.6 25.6 0.6 3.2 2.8 0.5 0.4 2.1 2.1 4.6 15.6 0.6 0.5 1.2 1.3 0.0 0.6 12.6 0.9 1.3 11.7 0.7 3.7 0.6 1.0 8.3 10.0 3.5 1.2 11.6 7.0 15.3 0.5 130.8 0.8 17.6 26.3 2.8 7.8 1.2 0.9 2.7 0.6 2.4 10.0 4.2 39.3 28.9 52.2 25.0 1.4 3.2 30.0 31.3 15.9 51.6 37.1 94.9 45.6 41.8 30.7 14.9 64.3 38.9 0.2 33.5 52.7 17.8 27.5 12.9 22.2 24.9 0.4 18.4 32.3 1.0 3.6 34.9 34.2 7.8 25.1 26.7 0.2 35.6 42.4 64.9 30.3 5.2 31.3 44.8 69.3 32.2 47.3 0.2 17.4 13.7 30.1 25.1 49.3 36.1 19.8 27.4 36.5 27.1 9.1 46.3 40.5 31.4 60.5 11.3 0.3 46.5 28.1 13.1 43.8 0.0 0.1 0.0 0.2 0.0 0.0 1.2 1.2 2.3 0.9 0.2 0.2 0.1 2.7 2.4 0.6 0.5 10.0 4.2 0.4 0.9 0.4 0.7 0.5 0.4 0.6 0.5 0.9 0.5 0.0 5.9 29.5 3.6 15.3 0.0 0.0 2.5 0.0 7.9 0.0 0.0 15.5 0.0 0.8 5.8 0.2 5.5 397.1 0.4 368.9 5.1 2.7 5.7 3.9 75.1 0.0 1.2 22.7 19.9 5.4 0.9 9.3 0.0 1.8 12.8 0.0 1.0 6.2 0.0 0.0 0.0 0.0 1.9 6.1 18.0 10.2 26.1 10.1 15.1 8.2 UBE2D1 "E2(17)KB1, SFT, UBC4/5, UBCH5, UbcH5A" ENSG00000072401 "Ubiquitin conjugating enzyme E2 D1" P51668 10 58334975-58370753 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 74.9" "Cell type enhanced" "Detected in many" 4 "Basal keratinocytes: 172.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 41.0" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.12e-1)" "unprognostic (2.08e-1)" "unprognostic (4.23e-3)" "unprognostic (1.76e-1)" "unprognostic (1.52e-2)" "unprognostic (1.21e-2)" "prognostic unfavorable (5.58e-4)" "unprognostic (2.20e-2)" "unprognostic (1.03e-1)" "unprognostic (2.24e-2)" "unprognostic (4.37e-3)" "unprognostic (2.17e-1)" "prognostic unfavorable (8.04e-6)" "unprognostic (9.71e-3)" "unprognostic (4.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.66e-2)" 8.2 10.6 8.1 10.0 7.9 17.1 7.5 7.7 9.0 6.3 7.3 5.5 4.8 4.7 8.5 5.5 8.2 5.5 6.4 25.6 7.6 7.2 5.5 5.4 7.0 13.7 8.1 6.7 5.9 4.8 5.3 7.4 6.8 7.4 6.5 7.9 3.5 6.4 5.0 74.9 4.6 5.8 8.8 8.4 11.0 5.6 3.2 8.4 5.5 6.0 25.1 7.1 9.5 10.0 3.7 7.2 41.0 13.7 2.8 3.5 7.1 10.7 5.8 10.9 14.0 22.4 18.1 7.1 7.1 12.1 8.1 12.0 11.8 9.3 0.0 11.2 10.6 6.0 9.8 21.1 10.3 11.5 11.1 12.4 2.8 2.1 6.7 14.7 8.5 6.9 20.9 11.6 8.5 15.8 11.0 16.2 7.5 5.5 4.5 11.0 3.4 9.1 9.5 13.4 6.5 9.2 7.7 9.9 5.9 12.2 6.3 8.3 11.1 13.9 23.5 11.3 17.5 8.6 5.7 13.1 3.1 10.9 10.6 7.8 11.6 9.0 9.5 9.9 17.7 3.5 2.8 13.7 6.2 2.4 9.5 2.8 3.3 2.9 3.0 7.2 3.7 3.0 2.3 41.0 2.8 7.9 3.0 3.5 7.1 8.1 7.9 7.7 9.0 7.6 7.2 8.1 6.7 7.4 8.4 11.9 9.1 36.6 70.2 172.6 16.8 82.7 20.4 12.0 15.9 26.2 17.7 26.7 64.6 55.7 3.4 26.3 20.4 0.0 37.1 42.2 48.3 73.3 23.0 12.3 68.9 15.9 39.9 20.3 88.9 2.2 30.8 81.6 50.6 49.5 35.6 15.8 57.2 16.4 30.4 41.3 13.7 6.5 58.7 28.6 16.0 166.2 124.6 28.7 24.7 105.6 UBE2D2 "UBC4, UbcH5B" ENSG00000131508 "Ubiquitin conjugating enzyme E2 D2" P62837 5 139526431-139628433 "Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (1.14e-1)" "unprognostic (2.75e-3)" "prognostic favorable (5.09e-5)" "prognostic favorable (5.90e-4)" "unprognostic (2.33e-1)" "unprognostic (8.19e-3)" "prognostic unfavorable (9.63e-7)" "unprognostic (7.41e-3)" "unprognostic (2.17e-1)" "unprognostic (1.21e-1)" "unprognostic (9.33e-2)" "unprognostic (1.41e-3)" "prognostic unfavorable (2.09e-5)" "unprognostic (8.00e-2)" "unprognostic (1.01e-1)" "unprognostic (4.20e-1)" "unprognostic (1.07e-1)" 35.6 25.0 41.2 31.5 39.9 44.2 35.9 31.9 49.6 43.9 50.4 35.5 31.5 22.2 35.5 52.2 44.8 47.6 27.1 34.8 39.5 40.5 37.2 39.5 34.8 55.6 40.5 36.1 35.3 41.7 23.8 35.3 33.6 35.9 30.8 46.4 30.7 30.5 37.9 80.6 33.2 37.4 39.3 41.9 41.3 29.1 68.0 29.3 71.0 34.4 31.2 64.5 42.2 36.1 34.3 39.3 40.8 23.0 22.5 41.7 19.5 34.1 22.8 40.0 27.9 27.0 34.7 25.6 36.1 33.8 42.6 49.9 58.6 32.5 48.8 47.6 37.2 52.7 21.7 39.2 60.9 57.1 31.5 22.9 27.7 25.2 33.7 52.9 27.0 24.7 27.2 31.5 42.3 63.3 36.9 45.4 32.3 24.0 41.8 39.5 34.3 41.6 38.5 22.0 12.0 24.8 31.8 41.6 35.3 44.8 40.4 36.5 24.1 31.5 40.6 57.4 89.9 25.4 24.0 29.7 32.6 18.1 27.0 44.1 30.1 48.9 68.5 23.3 44.6 25.9 14.8 20.9 40.8 22.6 18.8 24.7 34.1 32.7 31.7 23.4 34.3 41.7 35.2 34.5 22.5 23.0 39.3 40.0 19.5 41.2 39.9 31.9 49.6 39.5 40.5 40.5 36.1 35.9 29.3 29.8 71.1 173.0 150.9 152.6 68.0 80.9 79.0 36.1 43.3 64.6 76.6 160.4 182.4 173.6 500.3 117.4 113.7 70.0 156.3 191.8 125.8 164.5 136.2 71.0 157.1 89.0 118.5 93.9 121.3 409.1 96.7 157.7 145.1 191.2 112.3 128.4 182.8 103.7 88.1 147.6 99.0 116.4 156.8 337.7 125.2 178.2 208.7 191.8 148.1 221.1 UBE2D3 UbcH5C ENSG00000109332 "Ubiquitin conjugating enzyme E2 D3" P61077 4 102794383-102868896 "Enzymes, Predicted intracellular proteins" "Apoptosis, DNA damage, DNA repair, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003920 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (7.43e-2)" "unprognostic (3.19e-1)" "unprognostic (1.27e-2)" "unprognostic (5.78e-2)" "unprognostic (6.44e-2)" "unprognostic (4.96e-2)" "unprognostic (1.17e-1)" "unprognostic (8.44e-3)" "unprognostic (1.14e-1)" "unprognostic (1.95e-1)" "unprognostic (5.75e-2)" "unprognostic (3.31e-2)" "prognostic favorable (4.51e-4)" "unprognostic (5.08e-2)" "unprognostic (2.79e-1)" "unprognostic (4.54e-2)" "unprognostic (1.34e-2)" 67.2 70.6 39.1 52.7 44.6 132.7 70.4 36.9 50.9 45.5 51.8 37.5 38.4 49.3 46.3 39.1 63.2 45.7 47.5 72.5 37.3 39.5 63.0 91.9 67.5 68.1 43.4 36.9 60.6 53.4 42.8 49.1 66.5 45.2 49.6 48.5 38.4 46.7 43.3 91.1 53.2 58.9 48.4 44.4 68.2 49.5 40.0 42.2 88.8 66.3 55.4 61.4 74.6 81.4 24.7 31.2 118.0 36.2 29.7 33.2 50.9 53.5 30.7 51.2 41.3 54.7 79.0 44.0 54.5 72.7 48.7 46.0 46.0 76.5 57.4 35.7 55.3 63.2 30.7 54.6 73.2 67.1 53.2 27.5 52.2 31.6 37.5 57.4 73.4 45.0 59.9 46.4 53.7 75.3 63.0 63.1 47.3 65.6 58.7 64.8 43.2 107.7 41.8 37.1 61.3 30.7 56.8 50.3 41.4 49.1 51.2 51.8 43.6 33.5 86.1 61.5 63.1 35.7 43.4 57.9 51.0 43.6 33.3 49.5 52.0 67.0 87.8 54.3 40.9 54.7 71.1 35.9 54.6 25.1 36.1 33.2 24.7 31.8 29.6 31.2 20.1 32.6 29.7 118.0 29.7 36.2 21.5 32.6 50.9 39.1 44.6 36.9 50.9 37.3 39.5 43.4 36.9 45.2 42.2 154.9 181.2 227.9 605.7 749.7 127.0 210.7 150.3 190.1 129.7 132.6 117.8 279.1 464.2 286.3 668.3 228.0 265.9 93.5 333.2 474.9 260.0 477.5 219.4 203.4 354.6 116.0 231.0 159.0 357.1 423.2 152.5 359.3 339.1 356.1 198.5 111.8 351.4 245.4 140.0 328.0 157.1 103.5 376.3 128.5 151.0 711.0 533.9 297.5 192.3 680.6 UBE2D4 HBUCE1 ENSG00000078967 "Ubiquitin conjugating enzyme E2 D4 (putative)" Q9Y2X8 7 43926438-43956136 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 48.6" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "SH-SY5Y: 25.3" "Low region specificity" "Detected in all" HPA003920 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA003920: AB_1858519" "unprognostic (9.95e-3)" "unprognostic (6.76e-2)" "unprognostic (6.87e-2)" "unprognostic (8.94e-2)" "unprognostic (8.24e-2)" "unprognostic (5.24e-2)" "unprognostic (2.42e-1)" "unprognostic (3.58e-3)" "unprognostic (4.74e-2)" "unprognostic (5.04e-2)" "prognostic favorable (4.86e-4)" "prognostic favorable (5.77e-4)" "prognostic favorable (6.51e-4)" "unprognostic (1.11e-1)" "unprognostic (8.74e-3)" "unprognostic (1.89e-1)" "unprognostic (1.34e-1)" 10.1 13.1 14.7 5.0 13.3 4.5 9.1 13.8 17.4 8.8 7.6 11.4 7.9 5.3 7.5 11.2 8.0 9.0 7.2 23.8 14.2 10.0 12.7 15.3 8.4 5.3 12.1 9.4 7.9 17.4 8.7 6.9 5.9 11.9 8.7 6.2 8.1 10.6 9.1 48.6 9.4 5.3 10.3 12.8 7.3 6.5 5.1 6.1 2.7 9.6 16.1 5.7 7.7 6.5 10.7 11.8 12.9 20.5 7.7 14.0 6.7 3.8 3.2 2.0 9.1 9.4 3.8 1.5 1.9 4.7 2.4 3.2 1.7 4.6 3.7 5.3 5.0 6.8 4.4 2.5 2.1 3.7 8.3 4.2 4.0 5.0 4.4 3.5 8.7 8.2 2.9 4.4 2.7 4.2 3.5 3.0 4.6 4.4 7.8 3.3 2.5 5.1 5.0 4.4 4.7 4.2 3.2 2.8 5.8 5.1 4.7 7.4 25.3 4.0 8.1 3.0 3.8 4.0 2.6 2.6 1.6 5.1 3.4 5.5 11.2 8.4 1.8 4.8 11.4 8.9 6.3 11.7 12.9 9.3 18.4 9.5 10.3 11.6 10.5 11.8 10.7 14.0 11.5 1.1 7.7 20.5 10.2 9.4 6.7 14.7 13.3 13.8 17.4 14.2 10.0 12.1 9.4 11.9 6.1 0.0 6.2 8.8 8.1 5.6 8.3 21.8 5.1 2.7 6.8 15.7 2.0 9.7 46.4 15.9 5.0 11.9 8.4 0.0 24.7 17.3 10.8 9.8 4.6 22.2 24.7 11.1 18.0 9.2 7.3 8.0 11.2 12.9 15.1 24.4 7.1 9.1 14.6 5.8 20.5 38.0 10.4 6.5 12.0 15.1 8.3 9.8 6.4 6.9 7.9 9.3 UBE2K "HIP2, HYPG, UBC1" ENSG00000078140 "Ubiquitin conjugating enzyme E2 K" P61086 4 39698044-39782792 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028869, CAB033212, CAB033515" Supported Approved "Plasma membrane,Cytosol" NA NA 150000 Cytosol "Plasma membrane" "CAB033212: AB_2272506, CAB033515: AB_2304024, HPA028869: AB_10602487" "unprognostic (1.14e-2)" "unprognostic (6.02e-2)" "unprognostic (2.42e-3)" "unprognostic (3.06e-1)" "unprognostic (6.81e-2)" "unprognostic (2.05e-1)" "unprognostic (5.05e-3)" "unprognostic (1.44e-2)" "unprognostic (2.71e-3)" "unprognostic (1.01e-1)" "prognostic unfavorable (8.60e-4)" "unprognostic (1.08e-1)" "unprognostic (3.67e-1)" "unprognostic (4.83e-2)" "unprognostic (6.88e-2)" "unprognostic (1.22e-1)" "unprognostic (4.10e-3)" 27.2 21.8 27.0 21.2 27.6 17.3 21.6 38.6 40.7 17.0 33.2 11.8 14.1 29.1 19.9 18.5 29.9 14.9 18.5 28.1 27.7 26.8 26.6 44.5 17.1 17.9 24.1 26.4 16.9 15.8 18.9 26.9 29.8 25.2 19.7 24.0 13.4 18.4 17.3 31.8 22.0 24.6 18.8 19.2 16.9 29.3 16.0 15.9 21.3 23.6 19.7 18.8 22.8 20.4 17.6 23.7 20.6 19.9 10.9 14.1 8.9 24.2 24.9 13.4 12.7 8.4 7.9 22.8 33.4 7.1 9.0 9.4 37.6 25.0 30.3 29.4 9.4 22.1 10.2 25.8 14.6 14.4 20.3 18.5 39.2 25.2 32.5 10.6 42.1 22.2 7.4 16.5 12.6 13.6 9.4 11.7 13.3 39.8 10.9 9.2 23.5 29.3 23.4 17.8 14.0 19.0 17.3 40.3 11.3 12.5 33.8 27.9 12.3 25.0 9.5 14.9 15.5 12.2 14.1 32.0 14.0 29.7 16.6 30.7 15.4 45.0 33.3 7.3 27.0 16.4 13.9 16.6 20.6 13.5 14.3 12.7 17.6 14.1 12.6 16.6 12.5 10.7 12.0 13.3 10.9 19.9 23.7 13.7 8.9 27.0 27.6 38.6 37.7 27.7 26.8 24.1 26.4 25.2 15.9 53.6 50.8 35.6 49.5 109.2 60.1 57.3 45.9 71.0 67.1 47.1 27.5 74.8 56.3 76.3 97.5 58.3 92.6 70.0 77.7 144.5 61.6 76.6 33.5 101.0 71.4 98.5 57.3 61.4 71.5 150.7 60.4 73.4 54.0 103.6 63.5 70.2 109.4 73.0 53.0 81.7 38.2 38.8 67.9 71.4 46.9 120.6 123.3 48.4 65.5 98.3 UBE2QL1 FLJ25076 ENSG00000215218 "Ubiquitin conjugating enzyme E2 Q family like 1" A1L167 5 6448623-6494909 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 28.1;heart muscle: 11.3;retina: 8.2;seminal vesicle: 8.6;skeletal muscle: 21.3" "Group enriched" "Detected in some" 4 "Bipolar cells: 23.6;Cardiomyocytes: 25.0;Horizontal cells: 42.9;Rod photoreceptor cells: 49.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "eosinophil: 1.2" "Lineage enhanced" "Detected in single" "granulocytes: 1.2" "Cell line enhanced" "Detected in some" "Karpas-707: 18.2;PC-3: 15.2;SCLC-21H: 14.2;U-266/70: 34.1;U-266/84: 30.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA057414 Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA057414: " "unprognostic (1.45e-2)" "unprognostic (1.58e-2)" "unprognostic (1.79e-2)" "unprognostic (2.10e-1)" "unprognostic (1.08e-2)" "unprognostic (7.43e-2)" "unprognostic (1.15e-2)" "unprognostic (1.36e-1)" "unprognostic (3.10e-1)" "unprognostic (7.16e-2)" "unprognostic (2.15e-3)" "unprognostic (8.41e-2)" "prognostic favorable (6.81e-8)" "unprognostic (3.18e-3)" "unprognostic (2.81e-1)" "unprognostic (1.27e-2)" "unprognostic (1.41e-2)" 0.6 2.3 8.6 0.8 4.2 0.3 0.9 20.7 28.1 1.0 1.8 1.0 0.5 0.7 1.4 1.8 1.0 0.5 0.8 11.3 12.6 8.2 2.6 1.1 0.4 0.7 5.2 4.6 3.6 0.8 0.3 1.3 0.3 8.7 3.1 0.8 8.2 1.0 8.6 21.3 2.4 1.0 1.3 1.4 0.4 2.2 0.9 0.0 0.0 1.9 2.0 0.5 0.5 0.9 0.5 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 18.2 0.0 3.1 0.0 0.0 0.2 0.0 15.2 0.1 0.0 6.7 0.0 0.0 14.2 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 34.1 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.6 4.2 20.7 19.4 12.6 8.2 5.2 4.6 8.7 0.0 0.0 0.0 0.0 0.6 1.1 23.6 25.0 0.0 0.0 0.0 0.0 5.9 0.0 5.0 0.0 0.0 0.5 0.0 0.0 0.2 0.0 0.5 0.7 0.0 0.8 0.1 42.9 5.2 0.0 0.3 0.0 3.7 0.0 0.0 0.0 0.0 8.4 0.2 0.0 6.3 0.0 49.0 0.0 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 UBE2S E2-EPF ENSG00000108106 "Ubiquitin conjugating enzyme E2 S" Q16763 19 55399745-55407777 "Enzymes, Predicted intracellular proteins" "Cell cycle, Cell division, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 68.0;lymphoid tissue: 60.2;testis: 69.4" "Cell type enhanced" "Detected in many" 4 "Extravillous trophoblasts: 226.9;Spermatocytes: 216.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015228, HPA057150" Approved Approved "Nucleoplasm,Plasma membrane" NA Yes "Plasma membrane" Nucleoplasm "CAB015228: , HPA057150: AB_2683351" "unprognostic (2.79e-1)" "unprognostic (2.42e-1)" "unprognostic (2.57e-1)" "prognostic unfavorable (2.05e-4)" "unprognostic (9.54e-2)" "unprognostic (1.41e-1)" "prognostic unfavorable (8.00e-6)" "unprognostic (1.42e-3)" "unprognostic (2.32e-1)" "unprognostic (2.31e-1)" "unprognostic (8.08e-2)" "unprognostic (4.52e-2)" "prognostic unfavorable (8.16e-8)" "unprognostic (1.05e-1)" "unprognostic (9.51e-2)" "unprognostic (1.58e-1)" "unprognostic (1.75e-1)" 10.2 9.2 18.0 19.5 15.9 68.0 4.7 11.4 21.6 6.1 12.0 9.1 4.5 8.4 7.1 7.2 17.1 6.0 9.7 18.0 18.7 18.1 5.9 5.6 6.3 22.9 13.7 14.4 6.4 6.0 3.7 12.9 9.8 12.9 7.0 7.1 6.2 4.9 5.3 7.3 6.2 7.3 10.7 15.3 11.0 10.6 69.4 8.2 60.2 5.9 14.3 21.1 10.0 7.1 4.5 3.1 6.0 1.9 0.6 2.6 0.3 60.3 32.7 28.8 22.9 1.8 2.6 5.1 49.2 14.9 30.4 27.7 22.1 21.6 58.8 20.4 12.3 36.6 17.8 28.8 12.8 13.5 46.0 95.7 35.1 18.8 7.1 5.5 42.0 34.2 2.9 3.6 22.3 21.6 6.6 11.9 32.1 34.9 41.2 19.0 16.0 56.8 21.8 72.2 16.9 55.5 50.1 22.2 21.1 8.1 12.9 73.1 39.6 62.7 15.6 27.9 9.1 11.1 22.8 18.2 18.3 52.1 15.6 116.9 33.2 79.7 69.0 19.2 29.7 66.3 1.1 1.9 2.9 1.8 1.5 1.2 4.5 2.6 2.6 1.5 1.6 2.5 1.5 6.0 0.6 0.9 3.1 1.0 0.3 18.0 15.9 11.4 21.6 18.7 18.1 13.7 14.4 12.9 8.2 0.0 4.3 37.3 136.4 144.5 56.5 2.4 7.6 0.0 0.0 19.2 51.1 34.3 13.3 44.4 86.7 31.2 25.8 70.0 26.4 226.9 94.9 63.2 18.4 9.6 55.5 30.2 88.9 22.7 24.7 27.7 16.1 39.9 70.9 55.1 28.4 76.7 57.6 28.1 11.7 14.8 59.0 12.9 96.6 216.2 140.8 101.4 50.0 44.7 30.4 121.0 UBQLN2 "Chap1, CHAP1/DSK2, Dsk2, LIC-2, N4BP4, PLIC-2, PLIC2, RIHFB2157" ENSG00000188021 "Ubiquilin 2" Q9UHD9 X 56563639-56567868 "Disease related genes, Plasma proteins, Predicted intracellular proteins" Autophagy "Amyotrophic lateral sclerosis, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006431, CAB013481" Enhanced Supported "Plasma membrane,Cytosol" NA Yes 200000 Cytosol "Plasma membrane" "CAB013481: AB_2533341, HPA006431: AB_1078707" "unprognostic (1.23e-2)" "unprognostic (2.88e-1)" "unprognostic (1.47e-1)" "unprognostic (1.51e-3)" "unprognostic (1.76e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (2.29e-4)" "unprognostic (2.66e-1)" "unprognostic (1.25e-1)" "unprognostic (4.42e-1)" "unprognostic (1.55e-1)" "unprognostic (1.13e-1)" "unprognostic (8.81e-2)" "unprognostic (1.35e-1)" "unprognostic (1.45e-1)" "unprognostic (8.88e-2)" "unprognostic (8.42e-3)" 13.4 20.8 27.0 13.9 40.7 9.4 16.2 34.9 35.3 17.3 13.6 17.8 15.0 11.1 17.0 16.7 18.1 18.2 14.5 20.8 26.2 28.6 13.9 18.9 14.0 16.4 21.2 26.6 27.0 10.6 25.5 18.3 15.6 20.8 21.1 12.5 13.3 13.7 21.5 24.6 13.5 11.6 18.7 18.8 13.9 12.9 5.4 16.7 18.0 20.9 10.9 17.7 16.4 14.1 5.5 10.9 25.0 19.4 12.1 20.4 10.9 18.6 13.9 14.0 16.3 32.2 20.6 8.8 15.1 18.0 11.4 12.6 7.8 8.8 14.3 16.6 17.8 17.8 11.0 26.6 16.9 13.8 22.1 16.0 5.8 19.2 8.2 16.9 11.3 12.8 19.1 21.4 15.3 13.4 16.5 9.9 9.3 6.7 15.8 17.9 8.7 14.5 9.9 11.6 6.0 16.6 13.0 18.1 13.5 23.0 14.6 17.3 16.2 21.8 9.7 8.8 25.6 16.2 8.4 11.1 12.1 12.4 17.4 9.1 6.0 7.4 9.9 13.6 12.0 10.2 25.0 14.1 14.1 9.9 19.3 11.1 5.1 15.1 11.5 10.9 5.5 20.4 12.2 12.4 12.1 19.4 3.9 14.1 10.9 27.0 40.7 34.9 35.3 26.2 28.6 21.2 26.6 20.8 16.7 20.8 12.1 13.7 34.3 27.7 41.9 31.1 12.7 13.4 9.1 17.4 17.7 23.0 14.9 17.9 0.0 17.1 14.4 0.0 14.5 22.2 23.5 24.0 12.7 19.2 21.1 39.7 32.8 18.4 34.3 0.4 23.0 18.9 16.9 27.9 18.1 22.1 15.8 14.0 34.3 10.9 31.2 12.9 32.5 0.3 0.2 26.6 33.4 17.5 18.8 32.1 UBR2 "bA49A4.1, C6orf133, dJ392M17.3, KIAA0349" ENSG00000024048 "Ubiquitin protein ligase E3 component n-recognin 2" Q8IWV8 6 42564062-42693504 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" 4 "Erythroid cells: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 25.2" "Lineage enriched" "Detected in all" 4 "granulocytes: 25.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027869, HPA027880" Approved Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027869: AB_10600416, HPA027880: AB_10601217" "unprognostic (3.26e-1)" "unprognostic (1.29e-1)" "unprognostic (8.33e-2)" "unprognostic (2.95e-2)" "unprognostic (1.08e-2)" "unprognostic (4.23e-2)" "unprognostic (1.32e-1)" "unprognostic (7.24e-2)" "unprognostic (5.05e-2)" "prognostic favorable (1.65e-4)" "unprognostic (1.12e-1)" "unprognostic (7.53e-2)" "unprognostic (1.30e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-1)" "unprognostic (5.78e-2)" "unprognostic (7.77e-3)" 19.8 18.8 14.4 21.8 16.7 22.1 18.6 26.6 20.4 17.2 19.3 17.8 17.8 20.1 29.5 16.8 16.2 15.6 16.2 16.8 13.8 13.2 17.8 24.0 19.3 18.0 16.7 12.9 20.8 24.6 28.0 26.3 16.3 17.2 16.5 20.1 15.8 18.3 15.6 33.5 18.0 24.6 19.9 15.9 21.3 18.2 9.2 17.2 26.1 20.1 14.9 17.7 18.9 29.8 3.6 3.5 25.2 5.7 3.9 4.4 1.9 14.4 7.3 8.5 13.3 17.5 16.9 11.5 11.1 12.0 9.9 10.3 10.5 6.0 9.9 8.9 12.0 11.5 14.6 12.2 9.5 12.6 13.3 8.6 15.7 10.8 13.6 14.2 15.1 10.8 11.9 10.4 9.8 10.8 12.2 11.1 14.4 18.3 12.6 9.4 11.6 11.8 13.4 7.7 28.5 7.1 10.6 12.7 14.8 11.3 12.6 10.1 8.0 11.2 10.8 10.9 13.5 10.6 14.7 16.0 9.0 7.1 11.0 8.0 11.7 10.3 15.3 4.7 11.4 5.4 10.4 4.6 9.2 4.4 4.8 3.7 3.4 2.9 3.4 3.5 3.6 3.0 3.3 25.2 3.9 5.7 2.6 3.3 1.9 14.4 16.7 26.6 20.4 13.8 13.2 16.7 12.9 17.2 17.2 14.9 21.1 12.8 17.4 14.7 41.6 32.9 22.9 25.4 22.7 19.2 56.9 14.8 14.9 14.7 4.6 21.1 31.4 93.5 13.2 11.0 18.8 19.9 19.7 28.1 12.0 60.4 12.1 18.4 28.9 3.9 23.6 24.6 18.6 17.2 19.6 23.5 14.1 22.9 22.6 9.6 50.0 38.8 23.4 9.2 8.1 14.2 14.4 32.0 18.0 18.7 ULBP1 RAET1I ENSG00000111981 "UL16 binding protein 1" Q9BZM6 6 149964007-149973710 "Predicted membrane proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 13.9;lung: 9.7;testis: 10.5" "Cell type enhanced" "Detected in some" 16 "Alveolar cells type 1: 6.0;Alveolar cells type 2: 2.1;Ciliated cells: 4.0" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 13.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 23.1;JURKAT: 17.8" "HPA007547, HPA071005" Enhanced Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA007547: AB_1079430, HPA071005: AB_2686332" "unprognostic (8.94e-3)" "unprognostic (2.44e-1)" "unprognostic (2.85e-2)" "unprognostic (2.33e-2)" "unprognostic (3.28e-4)" "unprognostic (6.69e-3)" "unprognostic (5.27e-2)" "unprognostic (2.47e-2)" "unprognostic (5.75e-2)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (1.15e-2)" "unprognostic (5.57e-12)" "unprognostic (1.95e-1)" "unprognostic (1.33e-1)" "unprognostic (1.12e-1)" "unprognostic (7.16e-2)" 0.7 0.6 2.0 0.4 0.6 0.5 0.5 13.9 1.5 0.4 0.7 0.2 0.0 0.4 0.5 0.5 0.8 0.9 0.5 1.2 1.5 0.3 1.2 0.9 9.7 0.2 0.3 0.0 1.2 0.4 0.6 0.6 1.3 1.0 0.8 0.4 0.5 1.0 0.2 1.6 0.6 0.3 0.3 1.2 0.3 0.9 10.5 0.2 0.2 3.8 0.6 0.5 0.7 4.9 0.7 0.1 0.9 1.8 0.3 3.5 0.3 2.7 1.3 2.6 1.4 2.6 7.7 2.7 3.6 1.1 1.6 2.8 1.8 3.1 2.7 2.9 12.4 6.6 2.6 23.1 4.5 4.3 12.0 3.8 0.2 0.9 0.0 13.6 0.1 1.0 8.4 5.6 11.4 3.0 1.3 2.3 17.8 2.2 0.0 4.0 3.2 2.8 0.0 0.9 1.7 4.2 1.2 2.4 0.3 4.9 2.0 0.9 0.3 5.3 3.3 0.8 1.6 2.6 5.3 1.9 1.3 2.3 5.1 3.2 0.4 0.4 2.5 7.9 4.0 3.3 0.1 0.2 0.1 2.4 1.3 3.5 0.7 1.2 2.8 0.1 0.2 0.7 1.2 0.9 0.3 1.8 0.0 1.9 0.3 2.0 0.6 13.9 1.5 1.5 0.3 0.3 0.0 1.0 0.2 6.0 2.1 0.0 0.4 0.1 0.0 0.4 0.0 4.0 1.2 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.5 0.2 0.0 0.0 0.1 0.0 0.0 0.6 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.5 0.0 0.0 0.0 0.1 ULBP2 RAET1H ENSG00000131015 "UL16 binding protein 2" Q9BZM5 6 149942000-149949235 "Predicted membrane proteins, Predicted secreted proteins" "Host-virus interaction, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 10.8" "Cell type enhanced" "Detected in many" 6 "Ductal cells: 6.9;Exocrine glandular cells: 7.4;Ito cells: 9.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "gdT-cell: 5.5;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.2;naive CD8 T-cell: 3.9;T-reg: 3.0" "Lineage enriched" "Detected in single" 7 "T-cells: 5.5" "Cell line enhanced" "Detected in many" "SiHa: 32.0;U-2197: 23.1" CAB018974 Approved Supported "Vesicles,Plasma membrane" "Secreted in other tissues" NA NA "Vesicles, Plasma membrane" "CAB018974: " "unprognostic (2.09e-5)" "prognostic unfavorable (8.07e-4)" "unprognostic (2.38e-3)" "unprognostic (3.90e-1)" "prognostic unfavorable (2.44e-4)" "unprognostic (1.26e-2)" "unprognostic (2.38e-3)" "unprognostic (1.47e-1)" "unprognostic (1.02e-1)" "unprognostic (1.05e-1)" "unprognostic (1.99e-1)" "unprognostic (1.75e-2)" "unprognostic (1.42e-4)" "unprognostic (1.68e-1)" "unprognostic (2.06e-1)" "unprognostic (2.14e-1)" "unprognostic (4.86e-1)" 3.3 1.7 4.5 1.9 2.3 4.3 5.9 5.3 6.5 1.6 0.6 0.0 0.0 0.9 0.6 0.5 10.8 0.5 1.6 4.1 4.4 1.0 1.9 1.7 6.2 1.1 1.0 2.1 0.2 1.6 0.3 1.1 4.4 3.9 0.6 0.7 0.3 1.5 0.4 0.6 1.0 0.4 2.0 0.6 0.5 0.7 3.6 0.1 0.5 3.5 4.6 2.4 4.1 5.2 0.0 0.0 0.0 0.0 0.8 5.5 0.9 9.2 0.8 0.2 2.9 0.5 2.8 1.6 9.6 5.6 10.1 8.3 3.5 5.3 0.0 14.7 10.9 14.5 6.6 3.6 8.8 5.8 4.2 1.9 0.5 1.4 0.0 3.6 0.0 0.7 1.3 6.8 8.9 3.9 8.2 5.7 8.0 1.1 0.0 7.4 6.4 0.8 0.0 0.0 1.7 4.9 1.4 2.2 0.0 14.3 2.7 0.3 0.0 32.0 0.7 0.9 1.6 0.9 4.0 8.9 6.6 8.3 23.1 11.0 0.0 0.0 0.4 9.5 5.1 4.7 0.0 0.0 0.0 5.5 0.0 0.6 0.0 1.8 3.2 0.0 0.0 0.6 3.9 0.0 0.8 0.0 0.0 3.0 0.9 4.5 2.3 5.3 6.5 4.4 1.0 1.0 2.1 3.9 0.1 0.0 2.2 0.0 5.4 3.3 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.0 0.0 6.9 6.3 3.8 0.0 0.0 7.4 0.2 0.9 0.9 0.0 0.0 1.8 0.0 0.0 9.2 1.2 6.4 0.0 1.7 1.7 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 1.0 2.3 3.2 2.5 0.0 2.9 0.0 3.2 UNC5A "KIAA1976, UNC5H1" ENSG00000113763 "Unc-5 netrin receptor A" Q6ZN44 5 176810477-176880898 "Predicted membrane proteins" Apoptosis "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "adrenal gland: 11.9;brain: 35.3" "Cell type enhanced" "Detected in some" 24 "Horizontal cells: 4.8;Late spermatids: 1.9;Muller glia cells: 10.3;Rod photoreceptor cells: 2.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 7.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8;eosinophil: 1.4" "Lineage enhanced" "Detected in single" "granulocytes: 2.8" "Cell line enriched" "Detected in some" 9 "SCLC-21H: 44.3" "Group enriched" "Detected in all" 4 "amygdala: 42.5;basal ganglia: 24.9;cerebral cortex: 36.4;hippocampal formation: 44.5;hypothalamus: 19.1" "Low region specificity" "Detected in all" HPA071450 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA071450: AB_2686397" "unprognostic (5.95e-2)" "unprognostic (1.15e-1)" "unprognostic (4.18e-3)" "prognostic unfavorable (2.23e-4)" "unprognostic (5.26e-2)" "unprognostic (2.23e-1)" "unprognostic (6.66e-3)" "unprognostic (5.06e-3)" "unprognostic (3.52e-1)" "unprognostic (1.36e-1)" "unprognostic (5.07e-1)" "unprognostic (9.95e-2)" "unprognostic (3.77e-5)" "unprognostic (6.39e-2)" "unprognostic (2.89e-1)" "unprognostic (2.27e-1)" "unprognostic (5.17e-2)" 0.9 11.9 10.5 1.1 11.1 1.2 1.4 35.3 30.9 1.1 0.7 0.4 0.0 1.3 0.8 0.9 0.7 1.5 1.0 0.7 7.6 4.6 0.7 0.7 0.9 1.7 1.6 12.6 0.9 3.2 0.6 5.1 0.6 2.1 0.8 0.7 0.3 0.9 0.7 0.6 0.7 0.9 0.8 0.8 0.6 1.2 1.3 0.5 0.0 0.8 0.0 0.7 0.9 0.2 0.0 0.0 2.8 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.7 1.7 0.0 0.0 0.0 1.2 5.1 0.0 44.3 1.9 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 2.8 0.3 1.4 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 10.5 11.1 35.3 22.2 7.6 4.6 1.6 12.6 2.1 0.5 0.0 0.0 0.0 0.0 0.0 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 10.3 0.2 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 UNC79 KIAA1409 ENSG00000133958 "Unc-79 homolog, NALCN channel complex subunit" Q9P2D8 14 93333219-93707876 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.6;pituitary gland: 18.9" "Cell type enhanced" "Detected in some" 14 "Bipolar cells: 42.7;Early spermatids: 28.8;Horizontal cells: 38.1;Late spermatids: 12.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "REH: 8.5;SCLC-21H: 6.3;SH-SY5Y: 4.0;U-937: 3.0" "Low region specificity" "Detected in all" HPA071881 Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA071881: AB_2732189" "unprognostic (8.42e-2)" "unprognostic (2.07e-1)" "unprognostic (6.70e-2)" "unprognostic (6.91e-2)" "unprognostic (1.06e-1)" "unprognostic (7.73e-2)" "unprognostic (2.99e-2)" "unprognostic (1.17e-1)" "unprognostic (2.31e-1)" "unprognostic (5.73e-3)" "unprognostic (8.03e-3)" "unprognostic (2.87e-1)" "unprognostic (3.39e-2)" "unprognostic (2.66e-2)" "unprognostic (5.57e-2)" "unprognostic (3.03e-2)" "unprognostic (7.47e-2)" 1.1 3.9 7.1 1.0 12.1 0.9 1.0 17.6 14.6 1.0 1.1 4.5 0.0 1.1 1.1 1.1 1.2 2.0 1.1 1.2 6.7 5.8 1.4 1.1 1.0 1.0 3.2 9.1 1.1 5.0 1.4 18.9 1.0 6.8 1.0 1.1 1.3 1.0 1.0 1.6 1.0 1.1 1.2 3.0 0.9 1.9 7.0 3.5 0.0 1.3 0.0 1.0 1.0 0.3 0.1 0.2 0.6 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.1 1.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 1.1 0.0 0.0 8.5 0.0 0.0 0.2 0.2 6.3 4.0 0.1 0.0 0.0 0.2 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 3.0 0.0 0.0 0.0 0.6 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 7.1 12.1 17.6 14.6 6.7 5.8 3.2 9.1 6.8 3.5 0.0 0.0 0.0 0.2 0.2 42.7 2.0 0.0 0.0 0.0 0.0 9.8 0.1 0.0 0.3 28.8 0.3 0.4 0.0 0.2 0.1 0.2 0.3 0.0 0.0 0.2 38.1 0.0 0.0 0.6 12.6 0.6 0.0 0.0 0.0 0.0 1.9 0.3 0.0 0.4 1.4 4.7 0.0 1.0 3.3 1.6 0.3 0.6 0.0 0.1 0.3 USP14 TGT ENSG00000101557 "Ubiquitin specific peptidase 14" P54578 18 158383-214629 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Immunity, Innate immunity, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001308 Approved Supported "Plasma membrane,Cytosol" NA NA 1400000 "Plasma membrane, Cytosol" "HPA001308: AB_1080499" "unprognostic (2.21e-1)" "unprognostic (4.05e-2)" "unprognostic (1.90e-1)" "unprognostic (2.59e-3)" "unprognostic (6.04e-2)" "prognostic unfavorable (7.81e-5)" "prognostic unfavorable (4.30e-5)" "unprognostic (5.14e-2)" "unprognostic (5.00e-2)" "prognostic favorable (7.91e-4)" "unprognostic (1.64e-2)" "unprognostic (2.39e-1)" "unprognostic (1.51e-3)" "unprognostic (2.58e-1)" "unprognostic (1.55e-1)" "unprognostic (2.20e-2)" "unprognostic (3.76e-2)" 24.8 24.2 25.9 20.7 32.1 19.4 21.7 21.7 28.4 16.5 17.1 17.9 19.1 13.4 19.4 24.3 25.3 14.7 14.4 23.3 22.1 27.6 23.2 24.4 15.8 21.9 22.6 28.8 16.2 16.2 22.3 18.0 25.1 29.2 29.9 19.4 14.5 16.7 20.5 53.3 15.7 12.9 23.9 22.1 15.4 15.6 17.2 16.5 19.5 20.1 25.4 28.6 17.8 17.8 13.1 15.2 7.7 15.2 23.0 21.2 11.0 27.1 22.3 19.0 19.3 18.8 18.8 34.0 35.7 19.5 36.3 34.0 29.0 14.5 40.3 27.3 29.2 34.9 15.3 37.4 27.2 41.4 11.4 18.5 22.7 15.0 22.7 18.9 55.7 21.8 15.0 21.1 37.1 21.3 16.8 27.9 19.9 31.2 29.9 35.8 22.0 31.1 15.2 18.5 16.3 26.2 25.9 24.9 29.3 26.8 23.6 22.2 18.6 37.0 17.9 15.2 21.6 17.5 15.1 31.5 42.7 32.3 39.2 50.5 19.8 35.9 40.0 24.6 23.3 26.5 5.0 10.7 7.7 17.8 15.2 21.2 13.1 17.7 18.4 15.2 10.1 17.5 16.9 0.8 23.0 11.4 11.1 16.7 11.0 25.9 32.1 21.7 27.1 22.1 27.6 22.6 28.8 29.2 16.5 20.8 33.1 28.2 36.7 52.1 52.7 40.0 22.9 42.8 51.2 41.8 29.5 80.1 38.1 58.5 41.3 39.3 15.4 23.3 46.8 58.4 42.1 56.1 33.5 39.4 45.0 109.7 21.2 28.3 30.4 14.7 29.4 39.1 33.7 54.1 19.4 35.6 58.1 19.5 43.2 43.1 50.1 0.0 45.7 26.2 61.2 45.8 113.4 38.8 27.3 39.1 USP15 "KIAA0529, UNPH4" ENSG00000135655 "Ubiquitin specific peptidase 15" Q9Y4E8 12 62260338-62417431 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 88.9" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 68.5" "Lineage enriched" "Detected in all" 5 "granulocytes: 68.5" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006237, HPA006428, HPA071014" Approved Supported "Plasma membrane,Cytosol" NA NA 280000 Cytosol "Plasma membrane" "HPA006237: AB_1080502, HPA006428: AB_2667588, HPA071014: AB_2686333" "unprognostic (8.18e-2)" "unprognostic (3.22e-1)" "unprognostic (9.63e-2)" "unprognostic (2.09e-1)" "unprognostic (1.10e-1)" "unprognostic (2.75e-1)" "prognostic unfavorable (8.04e-4)" "unprognostic (6.59e-2)" "unprognostic (7.70e-3)" "unprognostic (2.19e-1)" "unprognostic (2.47e-1)" "unprognostic (4.51e-2)" "prognostic unfavorable (1.58e-5)" "unprognostic (9.28e-2)" "unprognostic (5.81e-3)" "unprognostic (1.11e-2)" "unprognostic (1.26e-1)" 23.1 16.8 11.5 22.5 11.9 88.9 17.8 21.1 15.7 14.5 14.5 5.2 11.9 11.4 12.7 12.4 16.1 14.1 11.2 15.2 9.6 6.2 13.8 20.4 23.8 26.2 11.6 9.4 22.5 15.8 18.9 22.5 31.0 14.9 12.4 13.8 7.6 16.2 10.7 28.5 23.0 19.7 16.3 16.2 35.6 14.3 20.0 11.0 33.1 14.1 15.4 18.9 18.4 17.9 5.7 6.0 68.5 14.2 3.3 12.1 4.8 9.4 8.9 8.9 7.8 14.1 16.5 16.0 15.4 13.7 13.6 12.2 8.9 9.5 10.1 8.8 13.2 5.8 10.4 11.9 13.4 16.0 11.2 7.3 13.9 7.6 6.8 13.6 22.0 33.8 12.0 14.0 16.1 14.3 12.8 16.2 10.3 45.0 19.6 12.6 10.5 13.1 11.1 13.0 8.6 13.2 8.4 9.4 16.3 12.7 10.9 11.3 5.4 17.8 11.3 8.7 9.7 15.0 13.2 19.3 10.6 10.6 16.5 9.5 9.3 10.4 11.6 12.2 17.9 12.0 27.2 14.2 13.8 3.4 7.3 3.5 5.7 4.6 3.2 4.9 4.7 5.9 3.5 68.5 3.3 5.8 6.0 12.1 4.8 11.5 11.9 21.1 15.7 9.6 6.2 11.6 9.4 14.9 11.0 35.7 31.3 91.0 32.3 52.2 54.5 62.7 17.8 42.8 59.1 22.7 104.1 25.1 10.0 31.3 139.8 44.6 32.3 93.5 36.2 36.1 49.5 31.6 85.6 42.0 41.1 39.7 40.4 22.1 108.1 130.5 57.2 94.6 50.6 36.1 22.9 24.4 41.2 45.6 27.6 19.4 146.4 38.8 56.5 62.9 41.8 67.2 55.0 65.0 23.3 54.9 USP2 UBP41 ENSG00000036672 "Ubiquitin specific peptidase 2" O75604 11 119355215-119381726 "Enzymes, Predicted intracellular proteins" "Biological rhythms, Cell cycle, Myogenesis, Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 79.9" "Group enriched" "Detected in many" 5 "Early spermatids: 399.1;Late spermatids: 802.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD4 T-cell: 1.3" "Lineage enriched" "Detected in single" 13 "T-cells: 1.3" "Cell line enriched" "Detected in many" 4 "U-266/70: 35.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA006777, HPA007222" Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA006777: AB_1080507, HPA007222: AB_1080505" "unprognostic (6.83e-2)" "unprognostic (2.02e-2)" "unprognostic (5.54e-2)" "unprognostic (1.37e-2)" "unprognostic (1.25e-1)" "unprognostic (7.46e-3)" "unprognostic (1.00e-1)" "unprognostic (5.27e-2)" "unprognostic (1.24e-1)" "unprognostic (5.24e-3)" "unprognostic (8.02e-3)" "unprognostic (7.33e-2)" "prognostic favorable (3.09e-11)" "unprognostic (1.58e-1)" "unprognostic (1.20e-1)" "unprognostic (1.96e-2)" "unprognostic (2.66e-2)" 3.1 4.8 6.9 1.4 12.2 1.5 1.6 12.6 16.1 2.5 5.9 10.0 0.0 7.9 2.6 6.4 5.9 7.0 2.2 26.8 5.7 3.1 29.7 10.6 2.2 0.7 5.7 6.2 2.9 10.1 18.4 7.6 1.3 6.7 2.3 3.9 19.1 3.2 2.4 79.9 4.6 11.7 4.2 3.8 0.8 2.7 36.1 8.8 0.0 2.2 25.2 1.0 1.9 2.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 3.5 0.3 0.5 2.0 0.1 0.1 0.8 0.4 0.2 0.0 0.4 3.6 0.5 6.1 1.1 0.6 0.9 0.6 4.8 1.8 0.1 4.2 0.6 1.7 2.6 7.5 1.7 0.0 1.7 0.6 0.3 0.4 1.2 0.8 0.3 4.6 8.4 0.5 1.0 2.4 0.0 0.4 0.9 1.2 0.8 0.0 1.3 0.9 2.8 0.2 7.4 2.2 2.1 1.6 0.4 1.1 5.4 3.7 0.0 0.0 0.9 0.5 0.6 35.2 7.7 0.1 0.0 1.1 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.7 0.0 0.0 1.3 0.7 0.0 0.0 0.0 0.0 0.3 0.3 6.9 12.2 12.6 16.1 5.7 3.1 5.7 6.2 6.7 8.8 3.0 2.4 0.0 4.5 2.2 73.3 74.6 5.1 42.8 9.1 5.2 90.3 0.3 96.2 2.6 399.1 2.2 31.5 0.0 1.4 0.5 4.6 1.0 0.0 19.8 13.2 9.5 0.0 1.3 1.5 802.9 6.1 1.3 0.0 0.0 1.6 37.9 1.5 10.5 6.7 24.9 128.7 19.4 18.6 19.9 14.9 3.4 1.1 1.5 2.2 2.0 USP4 "UNP, Unph" ENSG00000114316 "Ubiquitin specific peptidase 4" Q13107 3 49277831-49340712 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Early spermatids: 100.2;Late spermatids: 90.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018499 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA018499: AB_1858689" "unprognostic (2.34e-3)" "unprognostic (1.52e-1)" "unprognostic (2.22e-3)" "unprognostic (6.12e-2)" "unprognostic (3.51e-1)" "unprognostic (4.33e-2)" "unprognostic (9.42e-2)" "prognostic favorable (4.46e-5)" "unprognostic (3.54e-1)" "unprognostic (9.07e-3)" "unprognostic (2.78e-2)" "unprognostic (1.70e-3)" "prognostic favorable (4.29e-5)" "unprognostic (7.30e-2)" "unprognostic (1.00e-1)" "unprognostic (1.18e-2)" "unprognostic (1.65e-2)" 22.1 18.4 21.4 22.4 29.3 41.4 23.1 30.3 32.5 20.7 20.1 26.8 16.9 16.1 23.6 20.9 23.5 19.3 17.5 22.8 22.2 18.0 20.2 18.5 25.7 25.5 20.2 17.5 23.6 17.1 23.6 19.7 22.1 24.3 20.9 21.9 23.6 19.1 21.3 25.7 27.6 19.4 25.9 20.4 30.6 17.7 25.0 19.7 36.8 21.2 14.1 42.4 22.1 22.0 17.0 24.1 59.4 27.3 21.5 18.6 22.2 6.4 7.4 10.2 13.6 19.0 20.4 6.9 17.5 15.6 22.7 20.5 7.8 16.2 12.4 7.0 25.5 13.1 8.7 13.6 24.8 21.2 19.1 4.0 27.5 14.7 8.7 27.9 14.5 15.9 20.9 10.9 24.9 20.5 16.5 26.2 14.1 9.6 19.7 21.0 10.9 17.1 24.6 8.7 8.0 12.9 7.1 6.4 10.8 17.8 13.3 8.5 11.4 12.7 9.0 6.5 10.7 6.2 23.3 23.2 15.3 8.3 19.1 10.2 15.8 7.6 18.1 13.7 23.0 17.5 18.0 27.3 30.0 16.9 22.1 18.6 17.0 17.6 16.9 24.1 14.1 17.1 15.0 59.4 21.5 24.4 9.6 18.6 22.2 21.4 29.3 30.3 32.5 22.2 18.0 20.2 17.5 24.3 19.7 38.7 21.4 18.1 15.0 16.7 16.6 15.3 15.3 33.5 25.0 19.2 19.6 18.9 18.3 14.2 100.2 17.9 11.6 0.0 11.9 12.1 12.3 13.1 32.4 12.1 21.7 11.1 10.3 16.0 38.8 90.2 14.4 25.3 15.1 30.7 11.4 12.0 14.6 5.8 18.0 10.5 21.5 12.9 14.7 18.5 13.6 16.2 20.3 24.9 11.9 11.8 USP53 KIAA1350 ENSG00000145390 "Ubiquitin specific peptidase 53" Q70EK8 4 119212587-119295517 "Enzymes, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "BJ hTERT+: 84.0;SK-MEL-30: 26.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035844, HPA035845" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035844: AB_10669532, HPA035845: AB_2674817" "unprognostic (9.33e-2)" "unprognostic (1.49e-2)" "prognostic favorable (3.15e-6)" "unprognostic (4.37e-3)" "unprognostic (4.82e-2)" "unprognostic (5.03e-2)" "unprognostic (1.55e-1)" "unprognostic (9.54e-2)" "unprognostic (1.77e-1)" "unprognostic (9.81e-3)" "unprognostic (1.28e-1)" "prognostic unfavorable (7.54e-6)" "prognostic favorable (3.58e-8)" "unprognostic (9.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.58e-1)" "unprognostic (3.70e-2)" 26.7 11.9 4.6 11.2 7.9 0.7 20.7 10.9 6.2 16.5 15.0 2.9 27.4 4.5 11.6 16.1 17.9 24.7 8.2 18.6 6.4 5.3 20.2 6.6 26.1 8.7 8.8 4.0 11.4 19.3 6.2 33.9 10.4 13.4 10.7 13.1 17.2 17.7 25.8 33.7 11.3 11.2 9.0 15.5 14.1 13.6 10.2 4.9 4.8 10.7 15.6 8.0 20.5 27.0 1.9 0.8 3.1 0.0 2.2 5.1 0.9 2.8 1.7 0.6 0.0 16.1 16.2 3.5 18.0 84.0 1.6 2.1 1.8 2.6 11.5 0.6 5.3 3.1 1.4 1.4 1.3 4.2 1.5 1.1 0.7 1.3 0.6 12.6 0.9 0.1 5.4 3.9 5.7 8.2 3.1 7.6 0.7 1.7 0.4 2.1 0.6 0.7 1.3 1.7 1.7 0.9 0.2 2.9 2.2 4.2 1.8 0.9 0.7 1.0 7.1 26.0 3.6 1.8 0.6 8.2 0.5 1.8 6.8 1.6 0.8 1.2 1.9 8.2 0.4 2.0 3.1 0.0 0.2 1.3 0.0 1.4 1.7 2.6 2.0 0.4 1.9 5.1 2.7 0.6 2.2 0.0 0.8 2.2 0.9 4.6 7.9 10.9 6.2 6.4 5.3 8.8 4.0 13.4 4.9 32.8 45.2 11.8 55.8 55.0 22.5 82.3 28.1 24.1 35.2 113.4 27.5 41.0 38.1 22.7 3.3 36.0 117.1 0.0 53.9 14.3 44.2 81.1 67.2 21.7 7.6 23.8 33.3 24.5 17.1 2.6 17.5 32.4 13.5 78.5 63.2 26.1 75.8 58.3 10.3 14.2 29.1 6.5 33.5 14.1 3.0 36.9 41.6 17.0 43.2 107.0 UTP20 "1A6/DRIM, DRIM" ENSG00000120800 "UTP20, small subunit processome component" O75691 12 101280109-101386616 "Predicted intracellular proteins" "rRNA processing" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049341 Supported "Nucleoli,Plasma membrane" No No Nucleoli "Plasma membrane" "HPA049341: AB_2680720" "unprognostic (3.04e-2)" "unprognostic (1.22e-1)" "unprognostic (3.92e-2)" "unprognostic (1.51e-2)" "unprognostic (1.39e-1)" "unprognostic (1.15e-1)" "prognostic unfavorable (1.15e-5)" "unprognostic (8.34e-2)" "unprognostic (4.30e-2)" "unprognostic (8.15e-3)" "unprognostic (2.81e-1)" "unprognostic (2.22e-2)" "prognostic favorable (8.87e-4)" "unprognostic (2.88e-1)" "unprognostic (3.44e-1)" "unprognostic (8.30e-2)" "unprognostic (6.92e-3)" 14.7 11.9 8.4 10.7 9.7 8.3 15.3 8.4 9.6 14.1 8.0 11.8 7.0 5.0 12.5 8.4 10.9 10.3 5.8 8.3 6.7 5.8 8.0 12.0 12.0 17.8 9.0 6.3 16.3 14.2 17.9 9.5 9.7 8.2 8.8 10.1 9.9 13.8 8.5 13.1 10.8 8.0 9.4 7.1 11.3 8.6 12.6 9.7 11.9 9.8 11.0 12.9 9.4 13.8 3.1 2.8 0.1 1.1 2.0 2.8 0.6 4.5 11.3 8.6 4.0 7.7 9.1 10.6 7.9 6.2 12.6 7.0 13.0 3.3 12.1 4.2 8.7 9.5 9.5 19.0 8.1 16.4 5.4 7.7 12.8 6.1 9.7 4.3 21.2 5.9 5.9 4.2 17.4 6.0 4.8 8.6 6.2 20.1 2.5 9.1 5.9 9.2 6.0 22.6 6.3 11.9 10.5 14.1 9.4 5.3 13.8 9.9 6.7 14.7 9.3 8.9 7.4 9.8 4.7 9.7 14.9 7.3 10.3 15.2 4.6 6.8 20.3 8.1 9.7 22.8 0.1 0.8 0.1 1.9 1.1 1.9 3.1 2.1 2.4 1.4 2.4 2.3 2.8 0.1 2.0 0.7 2.8 1.8 0.6 8.4 9.7 8.4 9.6 6.7 5.8 9.0 6.3 8.2 9.7 8.9 6.9 6.5 7.6 9.0 9.5 9.8 7.6 8.1 14.8 3.5 9.8 6.7 5.0 5.6 1.3 9.0 1.3 0.0 9.7 7.0 7.8 8.4 12.7 6.7 5.1 20.6 6.3 7.4 6.3 0.9 8.9 3.8 3.3 1.0 4.4 3.4 6.1 0.0 7.8 2.3 8.0 6.5 6.2 15.6 22.4 9.7 2.4 5.7 8.0 7.5 UTRN "DMDL, DRP, DRP1" ENSG00000152818 Utrophin P46939 6 144285701-144853034 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Alveolar cells type 1: 381.2;Early spermatids: 418.2;Late spermatids: 250.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HAP1: 58.4;HUVEC TERT2: 41.7;TIME: 53.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016348, HPA018894" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA 6000000 "Nucleoplasm, Plasma membrane" "CAB016348: AB_628424, HPA018894: AB_10600839" "unprognostic (3.47e-2)" "unprognostic (2.82e-1)" "unprognostic (2.32e-1)" "unprognostic (6.87e-3)" "unprognostic (1.75e-1)" "unprognostic (3.30e-2)" "unprognostic (3.99e-3)" "unprognostic (2.44e-1)" "unprognostic (9.24e-2)" "unprognostic (1.29e-1)" "unprognostic (2.72e-1)" "unprognostic (7.10e-2)" "prognostic favorable (7.61e-5)" "unprognostic (6.32e-2)" "unprognostic (2.20e-1)" "unprognostic (1.66e-1)" "unprognostic (1.49e-2)" 34.5 14.1 11.6 34.5 23.5 22.9 25.4 3.1 11.3 32.6 15.3 6.8 21.9 7.7 28.8 21.5 17.7 21.4 15.8 13.8 9.2 12.8 15.5 11.8 35.2 30.9 12.7 8.8 22.7 23.8 53.1 13.0 21.1 16.0 23.4 15.2 17.3 18.4 24.8 11.7 16.7 14.8 19.8 16.6 45.8 13.3 45.0 8.5 27.4 32.4 20.0 25.7 20.7 23.4 11.7 15.0 10.6 48.0 10.3 12.6 3.7 6.9 5.9 10.5 13.6 18.3 16.8 6.3 10.3 10.1 8.4 12.3 22.5 2.6 2.2 9.1 23.1 9.9 4.1 58.4 8.7 12.1 23.3 6.7 8.3 6.4 13.3 7.2 9.2 0.1 9.7 1.8 12.4 6.5 7.9 41.7 6.6 0.5 6.1 11.8 4.6 7.3 4.0 4.2 4.3 6.3 6.6 19.0 0.2 9.7 0.2 13.4 0.2 16.1 2.2 6.4 16.8 8.9 12.5 53.6 8.1 10.1 4.1 9.8 4.7 6.3 0.3 4.9 5.6 13.2 9.8 12.3 6.6 12.6 36.3 9.0 7.4 8.0 10.2 5.1 11.7 7.0 7.3 10.6 10.3 48.0 15.0 6.4 3.7 11.6 23.5 3.1 11.3 9.2 12.8 12.7 8.8 16.0 8.5 381.2 100.6 59.6 24.2 26.2 6.0 51.2 35.7 125.8 185.4 29.6 0.0 73.5 0.0 20.7 418.2 142.7 5.3 0.0 27.6 3.8 38.2 40.0 27.8 12.1 19.7 57.2 30.0 68.2 90.1 250.3 22.2 56.1 37.1 8.2 14.2 29.3 24.9 10.5 31.5 4.9 3.4 142.3 109.3 5.7 4.6 39.6 108.1 64.0 20.4 18.4 VAMP5 ENSG00000168899 "Vesicle associated membrane protein 5" O95183 2 85584408-85593412 "Predicted membrane proteins" "Differentiation, Myogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 6 "Endothelial cells: 294.0;Ito cells: 443.2;Kupffer cells: 298.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 34.3;HUVEC TERT2: 64.1;LHCN-M2: 75.3;TIME: 43.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035082 Supported Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA035082: AB_10610564" "unprognostic (1.92e-1)" "unprognostic (3.09e-2)" "unprognostic (6.09e-2)" "unprognostic (1.13e-2)" "unprognostic (4.16e-2)" "unprognostic (1.25e-3)" "unprognostic (1.28e-2)" "unprognostic (5.29e-2)" "unprognostic (1.17e-2)" "unprognostic (3.49e-2)" "unprognostic (2.22e-1)" "unprognostic (7.59e-2)" "prognostic unfavorable (1.28e-5)" "unprognostic (9.61e-3)" "unprognostic (3.46e-2)" "unprognostic (1.71e-2)" "unprognostic (2.60e-1)" 26.2 25.8 12.6 18.9 14.1 11.7 27.5 4.3 9.2 17.9 22.1 8.5 9.2 7.6 18.9 27.2 24.3 18.3 18.8 37.0 11.0 10.9 18.5 31.2 28.8 32.1 16.8 9.6 19.6 6.3 3.2 7.2 24.4 17.7 29.0 6.9 16.0 7.7 13.0 70.9 9.5 17.0 25.5 14.1 33.3 12.3 13.7 8.1 18.0 17.5 19.8 13.0 21.8 25.8 10.2 13.8 27.5 80.4 14.3 39.4 39.3 0.1 0.0 0.4 0.0 16.3 28.6 0.4 17.3 27.5 17.0 18.8 6.8 2.6 0.0 0.4 29.9 9.2 0.2 0.0 0.4 7.6 24.5 0.5 0.3 0.4 9.5 34.3 0.7 0.1 19.8 1.7 7.1 0.2 25.1 64.1 10.9 0.0 0.0 75.3 2.4 10.6 2.3 0.0 4.7 0.1 15.9 0.0 0.4 0.4 0.6 0.0 0.6 0.1 4.9 0.1 0.4 0.5 0.8 43.8 0.4 1.2 1.3 0.0 0.0 0.5 0.4 20.0 0.9 11.6 8.2 38.1 27.5 31.7 80.4 29.8 9.7 24.1 23.5 12.8 10.2 18.5 22.3 11.8 14.3 64.4 13.8 39.4 39.3 12.6 14.1 4.3 9.2 11.0 10.9 16.8 9.6 17.7 8.1 17.9 30.0 50.0 38.6 54.0 0.8 75.5 81.5 29.4 37.5 41.8 0.0 16.6 24.9 28.6 1.2 294.0 58.6 0.0 43.2 6.9 187.6 42.9 43.8 141.5 73.6 3.2 12.1 443.2 298.8 4.7 178.4 77.9 261.5 100.0 11.0 11.5 39.6 48.9 155.2 64.7 0.5 58.2 94.7 4.8 3.2 39.5 18.1 106.6 7.6 32.9 VCPIP1 "DUBA3, FLJ23132, KIAA1850, VCIP135" ENSG00000175073 "Valosin containing protein interacting protein 1" Q96JH7 8 66628487-66667217 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease, Thiol protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023932 Uncertain Approved "Plasma membrane,Centrosome" NA NA "Plasma membrane" Centrosome "HPA023932: AB_2671373" "unprognostic (1.12e-1)" "unprognostic (1.31e-2)" "unprognostic (9.13e-2)" "unprognostic (1.10e-2)" "unprognostic (4.01e-2)" "unprognostic (5.56e-2)" "unprognostic (5.23e-2)" "unprognostic (7.21e-2)" "unprognostic (2.80e-1)" "unprognostic (3.96e-1)" "unprognostic (5.23e-3)" "unprognostic (7.28e-2)" "unprognostic (6.12e-3)" "unprognostic (2.03e-2)" "unprognostic (1.83e-1)" "unprognostic (2.13e-2)" "unprognostic (8.58e-3)" 9.5 8.7 15.7 12.6 14.5 30.9 8.9 14.4 15.1 7.5 8.4 7.0 3.8 7.0 7.8 8.7 8.1 6.9 7.0 6.7 10.2 9.2 8.3 12.3 10.5 13.6 10.3 13.7 7.8 9.0 14.0 5.9 8.0 12.3 7.0 7.8 6.0 9.0 7.1 14.8 7.3 10.0 6.3 9.6 14.7 8.0 10.8 11.7 11.6 8.0 2.8 13.3 7.9 7.0 2.6 3.4 11.3 8.8 2.8 4.3 1.7 9.0 8.2 4.2 5.6 13.0 9.2 4.1 7.3 7.4 5.6 6.5 4.8 8.5 12.2 2.1 9.7 6.9 8.0 6.8 6.1 8.0 9.0 4.9 13.5 8.1 6.0 7.8 4.5 14.6 9.9 9.0 6.1 11.1 6.9 6.0 6.7 9.1 11.8 8.2 4.4 9.7 7.8 8.0 7.6 5.7 6.3 6.6 6.1 8.1 7.1 2.5 4.8 5.6 8.6 6.3 5.6 8.8 7.5 12.0 7.4 5.5 6.5 4.8 10.5 5.1 13.1 7.3 6.5 5.5 9.2 3.2 6.7 4.3 5.2 3.6 2.0 2.7 3.1 3.4 2.6 2.2 2.9 11.3 2.8 8.8 1.3 3.3 1.7 15.7 14.5 14.4 15.1 10.2 9.2 10.3 13.7 12.3 11.7 17.9 14.6 9.0 8.1 15.0 11.1 16.5 12.7 12.0 11.4 7.0 21.6 8.8 3.3 9.7 4.3 9.9 14.0 23.3 11.7 4.8 12.3 11.3 18.5 20.2 12.4 11.1 5.8 15.4 47.5 4.5 7.5 18.0 10.1 10.8 15.0 11.8 10.8 15.3 14.9 9.9 10.8 6.5 10.8 26.8 14.7 18.1 8.2 26.6 13.3 14.2 VPS50 "CCDC132, DKFZp313I2429, FLJ20097, KIAA1861, VPS54L" ENSG00000004766 "VPS50, EARP/GARPII complex subunit" Q96JG6 7 93232340-93361121 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026679 Approved Uncertain "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA026679: AB_1846135" "unprognostic (2.09e-1)" "unprognostic (1.44e-1)" "unprognostic (1.46e-1)" "unprognostic (3.12e-2)" "unprognostic (7.43e-2)" "unprognostic (4.97e-2)" "prognostic unfavorable (7.21e-5)" "unprognostic (1.05e-1)" "unprognostic (4.79e-2)" "unprognostic (1.37e-1)" "unprognostic (3.69e-1)" "unprognostic (5.17e-2)" "prognostic favorable (1.35e-6)" "unprognostic (2.08e-1)" "unprognostic (3.46e-2)" "unprognostic (1.18e-1)" "unprognostic (1.35e-1)" 15.9 16.3 16.4 15.3 24.2 6.9 21.6 26.1 28.3 13.0 16.0 9.9 13.3 11.5 17.7 17.5 15.7 11.9 10.4 12.6 19.8 16.0 20.0 12.1 13.2 15.3 16.4 22.2 15.4 13.5 23.9 30.8 12.8 26.7 14.3 18.5 7.5 15.0 14.2 18.7 16.8 12.8 14.8 15.9 15.5 14.1 13.8 19.2 15.8 15.8 14.0 15.3 14.2 12.9 5.5 10.4 4.2 8.1 5.2 11.2 4.3 11.1 6.7 8.7 13.4 16.2 11.6 8.7 10.5 9.0 10.9 12.0 9.4 13.0 9.9 11.9 9.1 20.1 9.6 12.9 10.0 15.2 11.5 9.0 18.4 13.0 5.9 9.9 9.4 10.1 9.8 11.6 13.2 13.3 10.7 14.1 9.7 14.5 12.8 14.5 11.1 8.8 8.4 6.0 15.2 9.5 7.0 11.5 13.4 10.2 8.9 6.3 13.4 12.2 26.8 10.8 13.7 9.2 7.1 12.7 15.9 9.4 29.0 10.7 7.0 15.5 11.9 11.7 9.3 12.6 4.2 7.0 3.4 6.2 8.1 11.2 5.5 6.9 7.6 10.4 5.5 5.5 7.4 1.7 5.2 4.8 5.1 8.1 4.3 16.4 24.2 26.1 28.3 19.8 16.0 16.4 22.2 26.7 19.2 11.9 9.9 3.4 3.8 0.0 11.8 0.0 2.5 10.7 9.1 5.2 15.7 5.9 3.3 6.3 12.3 5.3 1.1 23.3 4.7 9.2 1.9 2.7 7.0 6.4 9.4 9.5 2.4 9.8 10.4 11.0 8.3 6.4 0.0 6.4 9.9 8.5 6.3 7.0 6.7 6.9 13.7 6.5 0.0 17.2 12.5 0.0 7.9 6.9 5.9 2.0 VPS8 "FLJ32099, KIAA0804" ENSG00000156931 "VPS8, CORVET complex subunit" Q8N3P4 3 184812143-185052614 "Predicted intracellular proteins" "Protein transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036871 Uncertain Approved "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA036871: AB_10672103" "unprognostic (4.36e-2)" "unprognostic (3.97e-3)" "unprognostic (1.53e-1)" "unprognostic (7.95e-2)" "unprognostic (5.11e-2)" "unprognostic (4.43e-2)" "unprognostic (1.27e-3)" "unprognostic (1.74e-1)" "unprognostic (3.21e-2)" "unprognostic (5.98e-3)" "unprognostic (1.98e-1)" "unprognostic (8.82e-2)" "unprognostic (4.74e-2)" "unprognostic (3.15e-1)" "unprognostic (2.56e-1)" "unprognostic (8.10e-3)" "unprognostic (4.97e-2)" 12.6 11.1 14.9 11.1 20.9 22.6 12.0 21.6 24.8 15.5 12.5 18.2 8.0 9.1 16.4 19.0 11.5 10.1 12.5 20.3 17.1 19.3 12.5 9.2 13.8 14.8 21.5 13.6 16.7 10.1 21.8 23.6 13.3 28.4 12.8 16.7 12.1 9.5 12.0 28.4 14.2 9.9 14.5 21.9 14.9 14.1 17.8 15.9 13.2 17.5 9.0 11.5 12.5 11.6 3.9 6.0 17.7 4.9 3.9 6.4 3.1 10.2 6.3 9.6 9.6 20.0 17.9 6.4 10.1 11.2 7.4 10.4 7.9 5.4 11.1 17.8 15.8 30.6 12.2 10.3 12.4 14.4 20.0 9.2 12.1 7.8 4.7 12.4 8.2 16.3 12.7 11.9 10.5 10.7 13.7 18.7 10.4 6.2 8.0 13.5 7.3 6.5 4.9 6.3 10.6 6.0 8.1 18.4 8.6 7.4 18.0 9.8 6.4 11.8 12.5 9.2 14.9 19.8 4.3 16.4 11.5 6.5 11.6 8.9 9.9 12.0 15.2 13.1 10.3 8.9 11.7 4.9 16.2 4.0 3.7 3.8 3.5 4.3 4.0 6.0 3.9 6.4 4.3 17.7 3.9 4.6 1.7 3.5 3.1 14.9 20.9 21.6 24.8 17.1 19.3 21.5 13.6 28.4 15.9 11.9 8.6 13.7 7.9 9.3 20.3 23.2 12.7 16.0 7.9 8.7 17.7 10.2 6.6 7.7 11.6 12.0 9.3 0.0 4.0 4.9 9.5 7.7 2.3 6.7 17.6 11.1 17.3 12.3 16.2 13.6 9.8 20.2 10.1 31.5 14.3 12.1 6.3 11.9 12.0 7.0 16.6 6.5 8.1 45.6 24.9 14.1 6.4 14.4 10.7 12.9 VWA7 "C6orf27, G7c, NG37" ENSG00000204396 "Von Willebrand factor A domain containing 7" Q9Y334 6 31765590-31777294 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 19.6;pituitary gland: 20.5" "Cell type enhanced" "Detected in some" 11 "Collecting duct cells: 1.8;Distal tubular cells: 1.7;Enterocytes: 1.8;Intestinal endocrine cells: 4.1;Paneth cells: 2.3;Proximal tubular cells: 1.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "basophil: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "CAPAN-2: 2.2;HeLa: 3.4;Karpas-707: 3.0;RPTEC TERT1: 2.2;U-266/70: 4.5" "Group enriched" "Detected in some" 5 "cerebellum: 7.8;pons and medulla: 4.1" "Low region specificity" "Detected in many" "HPA046954, HPA054262" Approved Approved "Plasma membrane,Cytosol" "Secreted - unknown location" NA NA "Plasma membrane, Cytosol" "HPA046954: AB_2679875, HPA054262: AB_2682430" "unprognostic (9.13e-2)" "unprognostic (8.60e-4)" "unprognostic (9.99e-2)" "unprognostic (2.43e-1)" "unprognostic (2.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.38e-2)" "unprognostic (4.40e-2)" "unprognostic (2.68e-1)" "unprognostic (5.84e-2)" "unprognostic (1.65e-2)" "unprognostic (9.25e-2)" "prognostic favorable (4.35e-8)" "unprognostic (3.75e-2)" "unprognostic (2.37e-1)" "unprognostic (9.48e-2)" "unprognostic (7.66e-2)" 1.1 1.6 3.1 1.4 9.5 1.1 1.2 5.6 10.5 1.1 1.9 0.0 3.9 2.6 4.6 3.0 1.1 19.6 2.0 3.9 1.6 5.5 5.6 1.5 2.5 1.2 1.7 5.4 1.4 2.5 5.1 20.5 1.0 9.7 1.3 1.7 0.8 1.7 2.0 5.3 1.7 3.3 2.3 2.3 1.3 5.8 1.3 2.3 0.0 1.8 0.6 1.3 1.3 0.8 0.2 0.0 1.2 0.0 0.0 0.4 0.0 0.5 1.1 0.4 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 1.1 2.2 0.5 0.7 0.3 0.1 0.9 0.7 0.2 0.0 0.0 0.0 0.1 3.4 0.5 0.1 0.0 0.9 0.1 0.9 0.1 0.0 0.2 0.0 0.6 0.2 3.0 0.0 0.2 0.0 0.5 0.0 1.4 0.1 0.3 0.0 2.1 2.2 0.0 0.3 0.1 0.4 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.8 0.0 0.1 4.5 1.3 0.1 0.0 0.6 0.1 1.2 0.0 0.0 0.3 0.0 0.0 0.2 0.2 0.2 0.0 0.1 0.0 0.1 0.4 0.0 0.0 0.0 0.4 0.0 3.1 9.5 5.6 10.5 1.6 5.5 1.7 5.4 9.7 2.3 0.0 0.6 0.0 0.5 0.1 0.4 0.7 0.0 0.0 0.0 1.8 0.0 0.0 1.7 0.4 0.0 0.0 1.8 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.1 0.0 4.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.0 1.7 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.5 WAS "IMD2, THC, WASP, WASPA" ENSG00000015285 "Wiskott-Aldrich syndrome" P42768 X 48676596-48691427 "Cancer-related genes, Disease related genes, Predicted intracellular proteins" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 30.7;lymphoid tissue: 55.9" "Cell type enhanced" "Detected in many" 8 "B-cells: 72.2;Hofbauer cells: 95.2;Kupffer cells: 94.9;Macrophages: 70.0;T-cells: 87.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 20.3" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 21.7;HEL: 19.1;HMC-1: 46.5;MOLT-4: 19.7;NB-4: 21.5;RPMI-8226: 26.5;THP-1: 19.5;U-266/70: 24.6;U-937: 24.8" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA002022, CAB004290" Enhanced Approved "Plasma membrane,Cytosol" NA NA 320000 "Plasma membrane" Cytosol "CAB004290: AB_628445, HPA002022: AB_1080581" "unprognostic (1.43e-3)" "unprognostic (2.09e-3)" "unprognostic (2.36e-2)" "prognostic favorable (4.95e-4)" "unprognostic (9.89e-2)" "prognostic favorable (3.78e-4)" "unprognostic (5.12e-3)" "unprognostic (7.60e-2)" "unprognostic (1.54e-2)" "unprognostic (2.86e-1)" "unprognostic (7.40e-2)" "unprognostic (3.60e-1)" "prognostic unfavorable (5.58e-6)" "unprognostic (2.24e-1)" "unprognostic (2.37e-2)" "unprognostic (3.55e-2)" "unprognostic (1.71e-1)" 7.6 4.0 4.9 28.9 7.8 30.7 3.3 2.0 5.1 2.7 4.4 5.9 0.5 4.8 2.4 5.6 3.7 4.5 4.4 3.0 4.6 4.1 4.1 5.0 12.6 29.9 7.6 1.3 2.6 2.2 0.7 2.6 5.4 6.0 3.2 3.2 3.5 5.4 1.9 1.4 2.2 14.3 3.7 12.8 55.9 4.1 1.7 7.3 53.2 2.8 1.4 33.2 5.8 2.5 2.1 3.5 20.3 5.3 2.1 3.2 2.0 0.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 21.7 0.1 0.0 0.1 0.7 0.0 0.0 0.0 12.5 0.1 19.1 0.2 0.0 0.2 9.8 46.5 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.2 13.4 0.0 2.2 19.7 21.5 0.1 0.3 0.1 17.3 0.0 26.5 0.0 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.1 19.5 0.1 0.0 0.1 0.3 0.0 24.6 12.0 15.2 0.1 24.8 0.0 1.8 4.6 20.3 3.0 5.0 2.2 1.8 2.3 2.5 3.5 2.1 2.1 2.3 18.1 2.1 5.3 1.8 3.2 2.0 4.9 7.8 2.0 5.1 4.6 4.1 7.6 1.3 6.0 7.3 3.0 21.3 72.2 0.1 2.2 0.0 0.8 0.0 2.7 0.0 0.0 0.0 0.8 1.7 0.1 0.5 0.5 0.0 23.3 0.3 0.9 1.5 0.2 46.2 0.9 95.2 0.0 1.2 5.5 94.9 0.8 0.0 70.0 3.3 45.9 0.0 0.2 0.1 0.0 0.0 1.5 0.0 0.0 0.6 1.4 1.1 1.3 1.1 87.0 0.0 0.1 WASF2 "SCAR2, WAVE2" ENSG00000158195 "WAS protein family member 2" Q9Y6W5 1 27404226-27490158 "Predicted intracellular proteins" "Host-virus interaction" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022632, HPA045288" Enhanced Approved "Plasma membrane,Cytosol" NA NA 470000 "Plasma membrane" Cytosol "CAB022632: , HPA045288: AB_2679287" "unprognostic (9.58e-2)" "unprognostic (8.93e-2)" "unprognostic (6.28e-2)" "unprognostic (1.02e-1)" "unprognostic (4.40e-1)" "unprognostic (2.27e-2)" "prognostic unfavorable (5.29e-8)" "unprognostic (3.94e-2)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.48e-4)" "unprognostic (7.60e-3)" "unprognostic (1.10e-1)" "unprognostic (9.15e-3)" "unprognostic (2.24e-1)" "unprognostic (1.56e-1)" "unprognostic (1.47e-1)" "unprognostic (8.26e-2)" 36.9 23.3 22.0 23.8 30.0 30.0 28.6 13.6 24.0 31.9 28.8 33.2 13.2 15.7 36.9 16.0 55.3 28.8 22.3 20.5 22.8 13.1 20.2 11.6 29.4 31.1 32.5 12.6 38.8 24.0 21.3 14.8 29.7 23.2 26.4 23.3 22.2 25.6 26.1 11.4 35.1 26.7 42.9 31.5 34.0 26.4 20.7 32.7 32.3 21.6 22.2 35.2 39.1 30.3 18.9 21.8 36.9 38.4 8.5 12.9 16.8 24.4 11.7 27.3 24.8 19.9 26.1 15.8 20.0 18.6 22.1 19.9 10.1 26.5 17.0 19.4 31.2 15.0 19.7 21.9 32.8 26.5 23.8 13.8 37.1 20.8 11.9 26.8 29.6 21.4 23.8 35.8 24.0 45.0 24.0 27.6 19.0 29.5 8.9 29.9 8.8 22.0 13.6 21.9 12.5 18.1 46.1 33.5 17.4 15.8 13.9 13.6 15.0 34.9 15.6 26.1 17.3 13.0 18.0 36.2 18.4 19.1 38.0 15.7 18.3 24.1 22.8 21.7 36.8 20.6 14.8 23.3 18.5 12.9 29.1 10.5 14.1 10.2 8.9 14.8 18.9 10.7 8.1 36.9 8.5 38.4 21.8 10.2 16.8 22.0 30.0 13.6 24.0 22.8 13.1 32.5 12.6 23.2 32.7 62.5 51.0 92.0 173.5 131.5 24.5 30.1 86.6 64.3 69.4 85.5 13.7 174.6 53.0 89.1 42.3 188.8 120.0 46.7 88.6 107.9 114.2 242.5 56.7 41.4 133.0 19.1 104.2 120.3 180.2 47.6 152.8 97.4 72.6 162.3 79.4 56.5 119.6 91.2 171.5 37.6 19.4 135.8 119.5 121.8 114.1 170.0 120.0 87.1 89.2 299.4 WDR1 ENSG00000071127 "WD repeat domain 1" O75083 4 10074339-10116949 "Plasma proteins, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Late spermatids: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020804, HPA036434, HPA070293" Approved Supported "Plasma membrane,Cell Junctions" NA NA 280000000 "Plasma membrane, Cell Junctions" "CAB020804: , HPA036434: AB_2675121, HPA070293: AB_2732152" "unprognostic (1.35e-1)" "unprognostic (6.64e-2)" "unprognostic (5.31e-2)" "unprognostic (1.32e-3)" "unprognostic (2.65e-1)" "unprognostic (1.22e-1)" "unprognostic (2.63e-3)" "unprognostic (6.83e-3)" "unprognostic (1.69e-1)" "unprognostic (9.00e-3)" "unprognostic (2.52e-2)" "unprognostic (2.61e-1)" "prognostic favorable (1.73e-5)" "unprognostic (1.11e-1)" "unprognostic (3.56e-1)" "unprognostic (3.46e-2)" "unprognostic (4.83e-3)" 40.2 23.7 19.0 49.4 18.1 33.5 35.0 8.1 22.6 53.5 53.3 25.8 38.4 39.2 80.9 54.2 59.6 54.9 57.6 49.5 19.6 20.5 55.4 41.3 41.7 57.4 22.1 17.1 51.5 22.2 19.5 18.6 40.4 26.8 47.1 38.3 37.6 38.5 49.1 32.1 31.6 54.5 88.0 19.5 46.9 41.1 38.0 16.0 74.5 49.9 36.4 50.2 69.6 41.5 22.9 40.2 54.2 61.2 32.5 55.6 64.1 30.5 30.7 27.5 23.1 20.9 34.7 43.4 77.3 71.4 69.9 55.0 36.7 38.7 21.3 25.2 92.2 76.0 20.0 29.9 56.5 74.8 33.2 10.2 60.7 31.4 26.0 48.9 19.2 70.4 33.3 29.0 70.9 35.5 53.5 75.1 38.0 18.1 35.4 67.7 17.5 84.8 27.1 32.6 24.6 30.8 40.0 25.2 18.0 43.6 48.8 9.3 10.2 33.0 18.3 31.8 37.7 15.3 20.9 112.9 53.9 22.6 44.6 67.6 22.4 35.8 27.9 57.0 29.3 66.8 37.1 29.0 54.2 48.3 51.7 37.4 22.9 40.6 48.2 37.8 16.9 41.7 44.4 54.1 32.5 61.2 40.2 55.6 64.1 19.0 18.1 8.1 22.6 19.6 20.5 22.1 17.1 26.8 16.0 32.8 48.2 70.0 155.9 129.0 22.1 55.6 73.9 62.9 60.3 99.5 39.3 147.9 72.9 294.0 462.5 69.7 206.5 0.0 185.6 249.1 66.7 101.7 80.8 62.3 224.0 31.8 104.6 84.7 141.3 926.6 43.4 122.8 75.9 402.2 113.7 74.5 238.9 137.2 86.7 88.0 24.9 97.0 170.5 94.8 67.2 119.7 193.7 125.0 117.8 177.3 WDR53 "MGC12928, MGC64882" ENSG00000185798 "WD repeat domain 53" Q7Z5U6 3 196554177-196568674 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 48.0" "Group enriched" "Detected in many" 6 "Early spermatids: 232.6;Late spermatids: 86.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA016420 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA016420: AB_1858812" "unprognostic (3.29e-2)" "unprognostic (4.24e-3)" "unprognostic (9.89e-2)" "unprognostic (2.29e-3)" "unprognostic (2.26e-1)" "unprognostic (4.71e-2)" "prognostic unfavorable (1.57e-6)" "unprognostic (4.49e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (2.57e-1)" "unprognostic (2.10e-3)" "unprognostic (4.48e-3)" "unprognostic (8.01e-3)" "unprognostic (1.68e-1)" "unprognostic (1.12e-1)" "unprognostic (5.38e-2)" "unprognostic (1.97e-1)" 4.3 4.3 5.9 6.8 6.9 7.2 5.2 6.4 5.9 4.0 4.2 4.5 7.1 2.1 4.9 6.6 5.1 3.9 3.5 4.0 4.8 3.8 4.0 5.4 3.8 5.5 5.9 4.3 4.3 3.3 7.5 11.9 4.4 6.1 4.1 4.1 4.8 4.0 4.5 6.8 6.7 4.5 4.1 5.0 6.2 4.0 48.0 4.6 7.4 4.2 3.2 6.5 3.9 4.2 7.5 5.9 13.9 6.7 6.5 14.9 4.9 19.1 4.1 7.4 6.6 7.6 6.6 11.9 10.1 7.9 11.5 10.9 11.2 10.2 9.1 34.1 6.1 10.6 11.2 9.3 8.7 14.4 14.3 8.1 9.2 10.1 7.3 9.5 12.9 7.6 5.4 12.8 10.2 11.2 5.7 8.9 11.6 8.9 17.6 8.7 17.8 10.9 13.2 10.1 12.2 12.0 13.1 12.7 19.4 6.3 6.7 7.3 8.0 7.0 10.5 14.8 10.4 27.0 12.1 8.3 9.8 9.2 10.9 19.7 15.0 30.0 27.2 6.5 16.6 9.8 9.6 5.1 13.9 8.6 4.4 14.0 7.5 12.3 8.7 4.1 7.1 10.3 6.2 4.4 6.5 6.7 5.9 14.9 4.9 5.9 6.9 6.4 5.9 4.8 3.8 5.9 4.3 6.1 4.6 0.0 3.2 0.8 2.8 3.8 3.1 2.7 2.5 1.4 4.5 3.5 0.0 4.7 5.0 4.2 232.6 5.2 1.0 0.0 3.7 5.5 2.8 2.3 9.2 2.4 3.9 3.2 0.0 3.1 4.5 86.7 4.6 5.0 5.0 8.2 1.5 3.6 2.6 1.9 3.2 3.5 2.3 19.4 6.2 27.9 13.1 4.1 3.9 5.7 2.3 2.3 WDR6 ENSG00000178252 "WD repeat domain 6" Q9NNW5 3 49007062-49015953 "Predicted intracellular proteins" "Cell cycle" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042622 Approved Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA042622: AB_10966784" "unprognostic (2.41e-2)" "unprognostic (2.03e-1)" "unprognostic (2.14e-1)" "unprognostic (1.26e-2)" "unprognostic (4.80e-2)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.97e-6)" "unprognostic (1.79e-2)" "unprognostic (1.90e-1)" "unprognostic (1.20e-1)" "unprognostic (1.01e-3)" "unprognostic (1.94e-2)" "prognostic favorable (4.52e-5)" "unprognostic (1.13e-1)" "unprognostic (1.51e-1)" "unprognostic (1.87e-1)" "unprognostic (1.61e-2)" 15.8 36.7 21.5 26.1 23.5 14.9 19.7 29.9 29.9 32.7 31.0 30.8 56.4 27.5 39.0 37.0 18.7 33.1 32.6 20.4 20.1 20.4 26.0 22.0 21.1 28.2 22.8 26.9 60.9 46.0 56.7 55.8 24.3 22.1 39.0 22.1 34.3 33.4 54.4 23.9 26.6 28.3 40.8 17.5 29.1 24.7 23.7 22.1 26.9 50.7 20.3 25.1 31.2 24.6 12.3 14.4 10.3 12.9 11.7 18.9 12.0 17.6 24.3 40.2 34.1 27.0 22.1 27.2 26.3 21.7 29.8 24.2 21.5 25.6 28.3 16.8 41.9 22.9 20.1 32.1 36.8 21.3 22.5 21.3 26.8 59.6 28.4 27.4 27.7 12.1 39.6 26.5 27.5 20.8 41.4 21.7 30.2 15.2 30.4 26.9 35.0 32.1 31.6 35.7 16.1 22.6 18.8 17.2 17.8 35.3 52.4 19.6 36.7 19.7 16.2 11.4 30.7 28.2 22.2 28.9 22.2 35.7 21.5 34.9 53.6 22.9 24.6 30.1 35.5 15.9 3.7 9.1 10.3 16.9 12.9 18.9 12.0 12.5 12.9 11.3 12.3 14.7 10.9 3.4 11.7 6.5 14.4 10.5 12.0 21.5 23.5 29.9 29.9 20.1 20.4 22.8 26.9 22.1 22.1 20.8 44.0 22.5 20.1 15.9 23.5 2.0 28.1 22.7 38.7 45.4 45.2 35.1 8.3 25.4 3.7 17.3 21.2 0.0 22.4 17.9 19.9 24.4 27.8 38.0 22.8 35.0 69.4 23.9 14.5 4.2 35.4 16.4 11.8 20.8 31.0 44.4 24.7 21.0 26.5 25.9 45.7 25.8 16.9 22.3 17.6 9.9 47.3 24.1 30.2 15.3 WDR66 "CaM-IP4, MGC33630" ENSG00000158023 "WD repeat domain 66" Q8TBY9 12 121917862-122003927 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 24.6;pituitary gland: 28.4;testis: 35.0" "Cell type enriched" "Detected in many" 5 "Ciliated cells: 228.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in single" 10 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 10 "dendritic cells: 4.9" "Cell line enhanced" "Detected in some" "HBEC3-KT: 21.9;hTCEpi: 20.7;hTERT-HME1: 14.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA039902, HPA040005" Supported Uncertain "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA039902: AB_10795236, HPA040005: AB_10795160" "unprognostic (4.92e-3)" "unprognostic (9.05e-2)" "unprognostic (7.99e-3)" "prognostic favorable (3.11e-4)" "unprognostic (5.58e-3)" "unprognostic (6.89e-3)" "unprognostic (1.44e-2)" "unprognostic (2.45e-1)" "unprognostic (2.89e-1)" "unprognostic (2.34e-1)" "unprognostic (7.72e-2)" "unprognostic (1.55e-1)" "unprognostic (2.43e-2)" "unprognostic (4.29e-2)" "unprognostic (1.37e-1)" "unprognostic (1.79e-2)" "unprognostic (1.35e-1)" 1.3 1.2 6.3 1.0 13.2 0.4 1.7 0.4 4.0 4.4 0.5 4.5 1.5 0.4 2.5 11.3 0.5 24.6 2.0 1.5 6.4 3.7 3.2 1.8 6.4 0.9 0.7 3.2 3.9 2.1 4.7 28.4 1.3 18.0 0.8 0.4 1.3 1.3 2.2 0.5 1.8 0.5 1.0 0.9 2.0 0.8 35.0 2.4 0.0 6.7 0.0 1.2 0.8 1.7 0.2 4.9 0.4 0.0 0.1 0.3 0.0 1.8 0.2 0.3 0.1 0.3 0.3 0.3 0.2 1.7 0.8 2.1 0.2 0.9 0.1 2.5 0.1 0.5 0.6 0.2 21.9 3.1 0.1 0.3 0.1 0.4 0.2 2.6 0.0 6.0 1.2 20.7 1.7 14.0 0.4 0.9 0.3 5.0 0.0 1.3 0.6 0.2 0.4 0.3 0.3 0.1 0.3 0.5 0.0 3.8 0.3 1.7 0.1 0.2 0.0 0.1 0.6 0.5 0.1 0.7 1.8 2.7 0.3 0.3 0.3 0.1 2.6 2.0 0.0 0.4 0.4 0.0 0.0 0.1 0.0 0.1 0.1 0.2 0.2 0.0 0.2 0.1 0.1 0.4 0.1 0.0 4.9 0.3 0.0 6.3 13.2 0.4 4.0 6.4 3.7 0.7 3.2 18.0 2.4 6.0 10.0 1.5 5.9 5.5 5.0 2.2 5.1 228.8 36.4 10.4 29.5 0.2 3.3 3.1 38.6 1.3 0.0 0.0 0.4 0.1 1.9 1.9 8.1 0.8 0.5 7.9 1.7 28.3 2.2 49.3 6.9 1.8 1.7 1.0 0.0 1.8 0.7 0.0 7.1 1.1 16.8 6.5 1.0 34.9 14.4 3.1 0.5 0.8 0.0 2.2 WIPF1 "WASPIP, WIP" ENSG00000115935 "WAS/WASL interacting protein family member 1" O43516 2 174559572-174682916 "Disease related genes, Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 8 "Kupffer cells: 132.4;monocytes: 161.5;T-cells: 221.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 45.4;HMC-1: 37.8;Karpas-707: 65.4;U-266/70: 52.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003739, CAB009737, HPA070706" Enhanced Approved "Plasma membrane,Cytosol" No No 290000 Cytosol "Plasma membrane" "CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300" "unprognostic (4.76e-2)" "unprognostic (4.80e-2)" "unprognostic (1.49e-1)" "unprognostic (9.88e-2)" "unprognostic (1.87e-1)" "unprognostic (2.27e-3)" "unprognostic (2.05e-1)" "unprognostic (1.21e-1)" "unprognostic (7.22e-2)" "unprognostic (1.26e-1)" "unprognostic (3.25e-2)" "unprognostic (1.46e-1)" "prognostic unfavorable (1.14e-4)" "unprognostic (3.65e-2)" "unprognostic (5.43e-2)" "unprognostic (1.58e-1)" "unprognostic (2.50e-2)" 20.6 7.3 10.5 47.0 14.4 23.2 21.6 2.1 9.2 17.1 16.5 20.2 6.6 8.7 14.3 11.4 10.3 9.8 17.2 12.0 14.6 10.5 9.0 7.8 22.6 55.7 21.1 5.6 8.7 4.7 5.7 4.2 15.6 10.9 10.6 10.7 10.5 10.5 11.7 4.0 7.3 21.3 13.8 44.2 55.5 9.9 4.5 14.9 42.9 11.4 8.9 51.7 22.8 15.3 12.3 8.2 52.7 12.9 17.8 25.0 15.3 0.1 1.4 3.5 0.0 8.8 15.7 3.6 6.5 5.6 2.6 4.1 0.4 0.3 45.4 2.0 9.8 3.3 0.1 0.5 0.0 3.4 30.7 0.8 23.9 5.9 0.0 3.4 19.9 37.8 6.6 1.1 6.1 0.5 3.4 5.7 3.9 0.6 65.4 7.7 0.0 22.0 18.3 4.0 0.0 0.2 19.0 1.4 8.5 2.4 0.1 0.5 7.3 0.0 1.8 3.9 6.8 0.0 9.7 4.4 9.0 2.5 6.4 6.2 52.2 31.9 23.7 13.5 13.6 24.7 12.1 10.8 26.2 25.0 11.9 21.0 12.3 16.8 24.5 8.2 10.3 13.8 18.1 52.7 17.8 12.9 3.6 18.7 15.3 10.5 14.4 2.1 9.2 14.6 10.5 21.1 5.6 10.9 14.9 17.9 30.3 74.6 5.1 11.1 0.9 8.9 0.0 0.0 7.9 3.5 23.6 1.3 5.0 1.8 29.6 27.4 0.0 0.0 10.1 70.1 48.8 3.9 65.8 1.3 77.2 0.0 4.7 37.4 132.4 57.3 23.3 101.7 25.3 161.5 1.0 1.2 12.1 0.0 17.0 27.9 3.3 12.9 27.7 3.9 2.0 9.7 3.4 221.6 1.9 2.7 XIRP2 CMYA3 ENSG00000163092 "Xin actin binding repeat containing 2" A4UGR9 2 166888487-167259753 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Actin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "skeletal muscle: 292.8" "Cell type enriched" "Detected in some" 66 "Cardiomyocytes: 1858.5" "Cancer enriched" "Detected in some" 5 "head and neck cancer: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 3.3;HEL: 1.5;HUVEC TERT2: 8.7;U-2197: 6.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA034813, HPA074599" Enhanced Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA034813: AB_10602588, HPA074599: " "unprognostic (5.27e-4)" "unprognostic (5.96e-3)" "unprognostic (7.42e-2)" "unprognostic (2.42e-1)" "unprognostic (1.74e-1)" "unprognostic (2.56e-1)" 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 3.3 0.0 0.0 24.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 4.3 0.0 292.8 0.0 0.0 0.0 0.0 0.1 0.0 0.6 0.0 0.0 2.3 51.0 2.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.1 0.0 0.0 1.5 0.0 0.2 0.2 0.0 0.0 0.9 0.0 0.2 0.7 0.0 8.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 6.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1858.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 28.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 20.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 XPC "RAD4, XPCC" ENSG00000154767 "XPC complex subunit, DNA damage recognition and repair factor" Q01831 3 14145147-14178783 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "DNA damage, DNA repair, Transcription, Transcription regulation" DNA-binding "Cancer-related genes, Disease mutation, Xeroderma pigmentosum" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009932, HPA035707, HPA069673" Supported Enhanced "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "CAB009932: AB_2241587, HPA035707: AB_2674743, HPA069673: AB_2686167" "unprognostic (7.46e-2)" "unprognostic (2.52e-2)" "unprognostic (4.50e-2)" "unprognostic (3.01e-1)" "unprognostic (6.63e-2)" "unprognostic (2.54e-2)" "unprognostic (1.97e-1)" "unprognostic (5.65e-2)" "unprognostic (1.50e-1)" "unprognostic (7.13e-3)" "unprognostic (4.39e-2)" "unprognostic (2.07e-1)" "prognostic favorable (4.14e-7)" "unprognostic (1.59e-1)" "unprognostic (7.88e-2)" "unprognostic (7.62e-2)" "prognostic favorable (2.46e-4)" 20.2 17.1 14.2 24.0 30.2 8.4 21.4 16.1 19.3 22.3 18.9 20.8 27.5 18.0 24.6 18.3 16.9 24.9 25.1 12.4 16.2 14.4 24.6 23.4 19.9 21.1 33.4 15.2 35.0 20.9 35.4 26.7 28.0 22.1 20.9 15.9 16.7 17.6 30.3 22.4 30.5 23.6 17.7 22.6 23.3 15.9 12.9 30.6 18.5 25.7 12.4 20.8 22.4 22.3 10.9 7.0 34.6 8.8 8.8 12.2 6.1 4.5 11.6 13.1 8.4 19.7 13.6 44.5 11.3 32.3 10.9 8.5 4.2 5.4 15.1 5.0 13.7 5.1 5.7 8.6 18.0 9.0 6.1 7.4 8.0 12.3 7.8 17.5 6.0 15.3 19.3 21.4 14.5 29.1 12.8 12.9 6.9 11.0 8.2 12.1 9.5 4.9 5.7 7.8 7.4 7.9 6.3 5.9 12.1 13.8 13.5 2.8 10.2 12.3 10.2 8.1 21.5 10.7 4.9 20.2 4.2 11.5 6.4 5.2 18.9 13.7 8.9 10.1 7.0 15.2 12.0 8.2 9.4 9.8 6.3 9.6 10.7 11.2 9.6 7.0 10.9 12.2 8.7 34.6 8.8 8.8 6.7 9.2 6.1 14.2 30.2 16.1 19.3 16.2 14.4 33.4 15.2 22.1 30.6 56.6 54.6 22.2 18.7 12.2 33.8 11.2 33.1 84.3 73.9 15.7 37.3 34.0 29.9 16.3 1.9 24.9 12.3 46.7 16.9 17.1 16.4 15.5 44.1 30.4 16.2 25.4 15.6 22.1 24.3 1.8 28.4 28.4 8.5 38.7 12.2 29.9 15.2 14.8 26.5 34.1 50.6 25.8 18.0 22.7 57.3 9.7 26.8 34.6 13.3 8.7 XPNPEP2 ENSG00000122121 "X-prolyl aminopeptidase 2" O43895 X 129738974-129769538 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Aminopeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 9 "intestine: 145.6;kidney: 49.7" "Cell type enhanced" "Detected in some" 23 "Enterocytes: 21.3;Hepatocytes: 11.6;Proximal tubular cells: 49.7" "Group enriched" "Detected in many" 6 "colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9" "Not detected" "Not detected" "Group enriched" "Detected in many" 4 "gdT-cell: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2" "Group enriched" "Detected in many" 7 "monocytes: 4.4;T-cells: 7.3" "Cell line enhanced" "Detected in some" "ASC diff: 6.3;ASC TERT1: 33.4;HSkMC: 16.9" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA000339, CAB025136, CAB025269, HPA064568" Enhanced Approved "Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 8900000 "Plasma membrane, Cytosol" "CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: " "unprognostic (7.95e-2)" "unprognostic (5.73e-2)" "unprognostic (2.56e-1)" "unprognostic (6.21e-3)" "unprognostic (3.54e-2)" "unprognostic (1.54e-1)" "unprognostic (4.04e-1)" "unprognostic (3.26e-1)" "unprognostic (3.01e-1)" "unprognostic (2.41e-2)" "unprognostic (3.07e-1)" "unprognostic (9.28e-3)" "unprognostic (2.77e-2)" "unprognostic (6.53e-2)" "unprognostic (3.18e-2)" "unprognostic (1.39e-2)" "unprognostic (3.26e-3)" 4.7 0.5 0.0 1.1 0.1 0.0 3.2 0.0 0.1 1.7 57.4 0.1 0.8 37.0 1.2 1.7 4.2 3.4 1.3 2.6 0.0 0.0 49.7 8.0 1.0 1.2 0.0 0.0 3.5 0.9 0.0 0.0 0.6 0.1 3.6 2.0 0.7 0.7 0.3 1.6 2.1 145.6 2.5 0.1 0.2 1.7 1.2 0.0 0.1 0.9 1.4 0.3 4.0 10.7 0.4 0.8 0.2 4.4 0.0 7.3 1.3 0.0 0.0 0.5 0.0 6.3 33.4 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.8 0.0 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.4 0.0 0.6 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 7.3 2.1 2.2 0.0 2.4 4.8 0.3 0.4 0.7 3.6 0.2 0.0 4.4 0.8 2.2 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 1.6 0.0 0.4 0.0 0.0 0.0 1.8 0.0 0.1 5.0 0.0 0.0 0.0 21.3 0.0 0.0 0.0 4.4 0.0 0.0 11.6 0.7 0.0 1.2 0.6 0.3 0.0 0.0 0.0 1.7 0.0 0.9 0.0 0.0 5.8 0.0 49.7 0.0 0.0 0.2 0.0 0.0 0.9 1.0 0.0 0.2 0.0 XRN1 SEP1 ENSG00000114127 "5'-3' exoribonuclease 1" Q8IZH2 3 142306607-142448062 "Predicted intracellular proteins" "DNA-binding, Exonuclease, Hydrolase, Nuclease, RNA-binding" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in all" 4 "RH-30: 58.4" "Low region specificity" "Detected in all" "HPA035005, HPA035006" Approved Supported "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA035005: AB_10670695, HPA035006: AB_10672750" "unprognostic (3.52e-1)" "unprognostic (2.35e-2)" "unprognostic (2.49e-1)" "unprognostic (1.35e-2)" "unprognostic (2.40e-2)" "unprognostic (1.68e-2)" "unprognostic (1.24e-1)" "unprognostic (2.67e-1)" "unprognostic (1.06e-1)" "unprognostic (2.16e-2)" "prognostic unfavorable (9.43e-4)" "unprognostic (7.68e-2)" "unprognostic (6.16e-2)" "unprognostic (1.23e-1)" "unprognostic (2.41e-1)" "unprognostic (2.43e-2)" "unprognostic (6.32e-2)" 16.5 12.4 9.9 16.2 15.5 24.4 15.9 23.8 15.7 15.7 17.5 7.5 12.4 14.7 15.2 14.2 13.4 11.5 11.0 10.1 8.4 6.8 9.6 21.7 15.9 16.1 11.7 9.0 17.4 13.2 17.4 26.5 23.6 10.7 12.5 13.0 8.2 14.4 13.3 21.2 17.2 25.0 14.4 15.2 16.2 11.7 11.8 10.9 30.8 12.9 10.8 15.3 15.0 15.2 7.4 6.1 18.3 4.7 4.3 8.4 2.5 10.0 1.9 4.6 3.9 5.2 8.6 2.8 4.7 6.3 6.1 7.6 1.7 3.0 4.0 4.9 6.2 4.9 3.9 4.1 2.4 9.4 10.2 3.1 5.9 3.3 1.6 4.5 5.9 6.0 6.7 2.7 4.4 5.8 5.7 5.5 4.5 3.9 9.6 5.5 1.9 5.1 3.1 1.4 1.4 2.1 4.2 58.4 5.0 2.9 5.1 2.7 3.4 8.4 4.6 3.6 2.9 5.6 4.6 7.4 4.3 2.4 4.9 4.0 13.8 7.0 6.4 4.0 3.1 3.7 18.3 4.7 12.2 8.3 4.2 5.8 7.4 6.4 7.4 2.3 6.0 8.4 5.8 17.2 4.3 4.0 6.1 4.6 2.5 9.9 15.5 23.8 15.7 8.4 6.8 11.7 9.0 10.7 10.9 50.6 26.6 34.1 28.0 22.8 31.5 23.0 17.8 26.8 33.0 43.6 47.1 17.6 10.0 12.9 37.7 26.6 30.0 23.3 11.0 6.0 21.8 33.7 19.8 42.4 14.1 25.4 27.1 36.8 30.0 15.1 23.0 23.1 13.5 26.2 18.5 23.2 15.6 24.6 27.3 12.0 57.0 6.5 17.9 55.7 14.9 24.7 44.7 35.5 13.6 42.3 XYLT1 "PXYLT1, XT-I" ENSG00000103489 "Xylosyltransferase 1" Q86Y38 16 17101769-17470881 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" "Glycosyltransferase, Transferase" "Disease mutation, Dwarfism" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 21.6" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 92.3;Peritubular cells: 47.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 19.2;ASC TERT1: 11.9;U-2197: 19.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA007478, HPA007966" Approved Approved "Endoplasmic reticulum,Plasma membrane" "Secreted to blood" NA NA 30000 "Plasma membrane" "Endoplasmic reticulum" "HPA007478: AB_1080616, HPA007966: AB_1080618" "unprognostic (1.82e-1)" "unprognostic (7.17e-2)" "unprognostic (1.63e-1)" "unprognostic (1.38e-2)" "unprognostic (2.83e-1)" "unprognostic (9.12e-2)" "unprognostic (8.13e-2)" "unprognostic (9.40e-2)" "unprognostic (2.41e-3)" "unprognostic (2.82e-2)" "unprognostic (2.11e-1)" "unprognostic (1.01e-1)" "unprognostic (8.66e-3)" "unprognostic (2.49e-1)" "unprognostic (1.76e-1)" "unprognostic (2.95e-1)" "unprognostic (6.05e-2)" 5.7 5.9 6.3 21.6 3.1 5.9 7.0 3.8 6.7 8.0 7.4 1.4 0.9 3.9 7.4 3.0 4.9 3.2 4.4 3.8 6.3 4.2 1.9 0.9 2.9 7.5 4.3 2.2 5.5 2.6 0.2 1.8 5.4 2.6 4.4 4.9 3.4 2.6 4.3 1.3 4.1 4.7 5.1 3.9 6.3 3.2 3.0 2.1 4.6 2.7 6.7 6.6 4.7 4.2 1.2 0.8 1.2 3.6 0.9 0.7 0.5 0.0 0.1 2.7 0.0 19.2 11.9 3.3 8.5 4.3 1.0 0.4 0.2 0.2 2.1 0.0 10.3 0.3 0.2 0.0 1.7 1.5 4.1 0.2 2.6 0.0 0.0 0.2 3.7 3.5 4.4 0.2 5.5 0.8 1.6 0.0 0.2 0.3 8.0 1.0 0.3 0.0 4.0 2.9 1.4 0.0 1.2 0.0 0.4 0.0 3.9 0.7 5.2 0.6 2.6 0.5 2.1 0.7 2.3 0.0 9.0 1.0 19.7 0.0 9.0 0.5 3.9 10.0 4.2 7.6 0.6 0.6 1.2 0.6 2.5 0.7 1.2 0.5 0.3 0.8 1.2 0.5 0.4 0.3 0.9 3.6 0.2 0.7 0.5 6.3 3.1 3.8 5.3 6.3 4.2 4.3 2.2 2.6 2.1 3.0 4.5 7.5 1.5 7.0 13.3 2.7 0.0 0.0 1.2 0.0 92.3 9.8 0.0 1.2 0.4 2.2 5.1 0.0 1.4 16.8 16.2 3.4 2.3 0.0 3.3 0.0 12.1 2.5 8.5 0.4 11.8 8.0 3.3 2.8 3.8 1.3 2.6 7.0 47.0 0.2 4.1 6.5 5.7 0.2 2.5 16.2 11.0 4.4 6.5 4.2 YES1 "c-yes, HsT441, Yes" ENSG00000176105 "YES proto-oncogene 1, Src family tyrosine kinase" P07947 18 721588-812546 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Kinase, Transferase, Tyrosine-protein kinase" "FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 6 "basophil: 14.7" "Lineage enriched" "Detected in many" 6 "granulocytes: 14.7" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004370, HPA026480" Approved Supported "Plasma membrane,Cytosol" NA NA 4300000 "Plasma membrane, Cytosol" "CAB004370: AB_627370, HPA026480: AB_1858921" "unprognostic (3.28e-1)" "unprognostic (1.62e-2)" "unprognostic (5.87e-2)" "unprognostic (2.47e-2)" "unprognostic (6.24e-2)" "unprognostic (4.24e-2)" "unprognostic (6.01e-2)" "unprognostic (1.03e-2)" "unprognostic (1.95e-2)" "unprognostic (1.85e-3)" "prognostic unfavorable (2.46e-4)" "unprognostic (2.14e-1)" "unprognostic (8.12e-2)" "unprognostic (4.65e-2)" "unprognostic (1.81e-1)" "unprognostic (4.79e-2)" "unprognostic (4.11e-1)" 26.2 13.1 17.0 9.4 15.6 2.6 47.2 6.7 12.8 15.8 23.8 8.9 13.7 18.2 13.1 17.4 22.0 10.7 14.9 17.9 14.8 12.4 22.6 43.2 23.6 13.7 15.8 6.6 13.2 21.4 16.7 10.7 31.3 16.8 12.2 17.3 6.5 23.7 21.0 10.6 12.3 24.8 18.8 16.8 34.5 15.5 13.6 12.0 8.1 16.8 15.6 7.1 21.9 17.5 0.1 0.1 14.7 0.0 1.0 2.5 0.6 14.4 7.2 22.8 17.8 13.7 17.0 26.8 9.6 19.7 11.4 15.7 17.1 10.7 0.0 10.3 16.3 14.6 8.5 21.3 17.1 22.4 0.0 7.2 4.3 7.1 11.9 11.1 3.3 7.7 13.0 18.4 17.2 19.2 14.2 38.4 2.4 18.7 6.4 16.2 9.9 2.0 4.3 14.4 8.8 9.2 2.5 17.9 1.2 16.6 17.2 4.6 5.4 19.9 15.1 12.6 15.7 10.4 6.9 33.0 28.1 31.2 21.2 25.9 5.6 2.7 0.8 10.6 4.7 16.6 14.7 0.0 0.9 2.5 0.0 1.6 0.1 0.5 1.4 0.0 0.0 1.2 1.9 0.0 1.0 0.0 0.1 0.1 0.6 17.0 15.6 6.7 12.8 14.8 12.4 15.8 6.6 16.8 12.0 23.8 30.8 1.5 33.5 53.3 6.2 16.5 20.4 26.8 34.2 27.9 5.9 28.2 3.3 25.6 20.2 77.6 27.4 0.0 34.0 20.3 31.2 52.1 12.8 33.4 4.3 3.2 21.9 41.1 5.6 7.9 17.0 5.3 23.6 1.0 35.7 16.3 40.3 21.0 12.0 38.5 8.0 19.4 20.6 12.8 11.7 43.4 38.1 15.2 31.0 58.7 YTHDC1 "KIAA1966, YT521, YT521-B" ENSG00000083896 "YTH domain containing 1" Q96MU7 4 68310387-68350089 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036462 Supported Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA036462: AB_10669793" "unprognostic (1.02e-1)" "unprognostic (8.44e-3)" "unprognostic (5.74e-3)" "unprognostic (1.35e-1)" "unprognostic (7.59e-2)" "unprognostic (1.33e-3)" "unprognostic (1.52e-3)" "unprognostic (8.28e-2)" "unprognostic (1.38e-1)" "unprognostic (1.09e-1)" "unprognostic (2.35e-2)" "unprognostic (1.41e-2)" "unprognostic (6.64e-3)" "unprognostic (1.63e-2)" "unprognostic (1.70e-1)" "unprognostic (4.05e-1)" "prognostic favorable (7.29e-5)" 22.1 16.6 25.1 28.8 33.2 101.8 24.3 38.4 25.8 30.3 20.8 24.4 24.0 16.7 29.2 25.1 25.4 20.2 17.6 18.5 23.5 19.6 19.8 19.5 21.1 26.8 26.1 23.4 39.7 24.2 27.6 32.4 33.2 22.8 25.2 21.3 13.8 22.7 30.2 32.9 26.1 21.2 27.6 25.4 23.6 20.6 17.7 35.1 30.2 23.8 20.2 26.7 34.8 30.3 18.0 15.1 41.6 9.3 7.5 11.1 3.2 17.6 10.6 21.7 13.0 13.1 11.4 18.0 19.5 12.3 12.2 12.9 13.1 16.3 29.0 16.0 9.9 9.9 13.4 20.3 17.1 19.9 21.4 12.3 22.1 15.2 14.5 13.4 23.3 17.1 10.8 18.6 10.9 26.2 15.7 13.2 14.1 20.8 17.1 17.8 13.5 27.1 21.0 16.3 17.3 10.5 23.8 24.6 12.9 19.1 20.5 18.9 14.8 17.0 18.4 14.1 21.2 14.4 16.3 13.9 14.1 14.9 9.7 12.8 17.8 11.9 30.3 9.5 15.2 12.9 20.2 8.3 14.7 9.9 5.0 7.7 12.7 8.0 7.9 4.6 18.0 11.1 9.2 41.6 7.5 9.3 15.1 7.3 3.2 25.1 33.2 38.4 25.8 23.5 19.6 26.1 23.4 22.8 35.1 104.2 120.5 72.4 101.3 106.6 102.8 78.1 73.9 139.2 159.3 69.8 66.8 58.2 44.7 60.9 61.3 76.3 40.0 23.3 49.7 94.0 62.9 98.5 88.2 72.1 37.8 85.8 82.2 47.9 51.2 14.3 69.0 70.8 60.8 45.1 60.5 91.4 65.5 48.7 63.6 32.1 131.7 51.8 97.3 131.7 89.6 117.6 99.5 74.8 54.4 85.9 ZBED3 MGC15435 ENSG00000132846 "Zinc finger BED-type containing 3" Q96IU2 5 77072072-77087323 "Predicted intracellular proteins, Transcription factors" "Wnt signaling pathway" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Hepatocytes: 24.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "AN3-CA: 18.9;JURKAT: 19.6;MOLT-4: 17.8" "Low region specificity" "Detected in all" HPA055995 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA055995: AB_2683000" "unprognostic (3.23e-2)" "unprognostic (1.17e-1)" "unprognostic (2.24e-2)" "unprognostic (1.22e-1)" "unprognostic (3.78e-2)" "unprognostic (4.02e-2)" "unprognostic (2.97e-1)" "unprognostic (1.45e-2)" "unprognostic (6.96e-3)" "unprognostic (1.82e-2)" "unprognostic (8.64e-3)" "unprognostic (3.63e-1)" "prognostic favorable (1.68e-4)" "unprognostic (2.08e-1)" "unprognostic (1.92e-1)" "unprognostic (5.41e-2)" "unprognostic (1.08e-1)" 14.4 5.2 8.0 3.0 16.6 3.4 13.0 6.7 10.8 10.5 6.9 20.5 6.4 5.7 15.8 12.7 3.8 10.6 5.3 6.5 9.5 6.2 18.0 16.2 7.3 3.3 22.7 7.2 12.2 10.9 13.9 9.0 3.6 9.5 7.8 6.5 8.3 8.3 10.3 3.7 3.9 5.0 13.0 10.5 5.0 8.7 4.0 13.7 5.2 16.4 1.6 2.8 5.4 5.8 0.2 1.8 0.3 1.1 0.1 0.8 0.2 3.2 2.6 3.4 18.9 14.5 1.0 0.2 1.1 3.2 1.7 4.5 5.6 1.5 0.0 7.1 2.1 0.7 0.4 1.8 1.1 1.5 1.0 3.5 2.5 5.7 6.4 8.6 3.3 1.0 16.2 4.4 0.8 3.3 2.7 5.3 19.6 0.0 7.0 1.0 3.2 17.8 0.5 2.3 0.8 1.6 7.5 6.6 1.0 7.8 1.2 3.8 8.0 3.8 3.2 5.4 1.4 4.8 2.4 2.1 1.5 2.9 3.3 4.4 5.1 4.8 7.3 2.3 6.5 3.4 0.0 1.1 0.3 0.4 0.4 0.4 0.1 0.3 0.5 0.9 0.2 0.8 0.8 0.3 0.1 0.1 1.8 0.0 0.2 8.0 16.6 6.7 10.8 9.5 6.2 22.7 7.2 9.5 13.7 0.0 3.2 3.0 3.4 1.1 8.3 9.6 10.2 0.0 3.4 12.2 11.8 1.3 14.9 4.1 3.4 9.0 2.0 0.0 5.1 0.2 4.8 4.4 1.1 24.6 8.2 3.2 15.5 9.2 10.2 1.5 16.4 4.6 6.8 0.0 5.1 13.8 3.7 3.5 10.6 16.5 14.4 0.0 3.3 1.4 3.3 1.3 0.2 0.0 6.4 1.4 ZDHHC20 "DHHC20, FLJ25952" ENSG00000180776 "Zinc finger DHHC-type containing 20" Q5W0Z9 13 21372573-21459370 "Enzymes, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 47.4" "Cell type enhanced" "Detected in many" 4 "Early spermatids: 77.2;Kupffer cells: 86.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014483, HPA014702" Approved Supported "Vesicles,Plasma membrane" NA NA "Vesicles, Plasma membrane" "HPA014483: AB_1859000, HPA014702: AB_1859001" "unprognostic (1.31e-1)" "unprognostic (2.16e-3)" "unprognostic (7.31e-3)" "unprognostic (8.89e-2)" "unprognostic (3.37e-2)" "unprognostic (1.03e-1)" "unprognostic (1.06e-3)" "unprognostic (3.77e-1)" "unprognostic (1.24e-2)" "unprognostic (1.26e-2)" "prognostic unfavorable (6.55e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (1.01e-4)" "unprognostic (3.76e-2)" "unprognostic (7.65e-2)" "unprognostic (6.15e-2)" "unprognostic (1.13e-2)" 7.5 7.0 8.3 9.4 33.6 14.9 11.3 6.4 15.3 10.3 10.9 21.0 7.6 10.8 9.3 5.6 18.4 7.1 10.0 5.4 12.7 11.8 3.8 7.6 10.6 12.3 47.4 4.9 6.5 6.1 4.0 5.3 10.8 26.1 9.2 9.6 3.1 10.4 9.9 5.5 12.2 15.4 8.9 45.0 8.6 23.1 22.0 35.8 10.4 10.0 5.1 10.9 16.2 9.6 4.6 7.8 8.8 15.2 10.1 10.2 11.1 13.2 7.7 11.2 7.1 10.5 11.1 27.5 14.6 14.7 9.8 8.7 13.9 40.9 14.2 7.9 17.8 10.3 21.7 12.9 11.2 18.5 15.4 8.2 24.9 4.8 7.7 5.9 16.8 10.8 10.0 7.9 9.6 6.8 12.4 15.1 18.4 6.9 6.0 14.4 11.2 23.5 6.4 9.1 35.2 7.6 18.9 20.2 4.9 11.6 24.9 10.7 4.9 19.1 12.0 7.8 12.0 11.0 8.6 26.2 10.3 9.9 17.3 10.8 6.2 7.6 14.7 7.4 9.7 29.1 8.8 15.2 3.4 10.2 14.2 9.4 4.6 8.8 8.7 7.8 3.7 8.3 8.5 2.7 10.1 12.0 3.9 9.3 11.1 8.3 33.6 6.4 15.3 12.7 11.8 47.4 4.9 26.1 35.8 47.6 26.9 15.8 6.9 0.9 8.3 6.4 17.8 20.1 36.4 10.4 7.9 18.2 0.0 8.6 77.2 15.0 29.0 0.0 10.5 16.6 10.3 19.1 13.9 17.4 19.9 17.5 23.1 19.6 86.8 67.8 14.4 35.8 1.7 7.2 29.0 4.4 18.7 23.0 10.3 6.2 9.6 19.4 6.9 9.7 12.3 1.4 37.3 20.8 23.4 16.9 ZDHHC5 "DHHC5, KIAA1748, ZNF375" ENSG00000156599 "Zinc finger DHHC-type containing 5" Q9C0B5 11 57667747-57701187 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA014670 Approved Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA014670: AB_2257442" "unprognostic (1.34e-1)" "unprognostic (3.47e-2)" "unprognostic (2.51e-1)" "unprognostic (2.29e-1)" "unprognostic (5.32e-2)" "unprognostic (1.70e-2)" "unprognostic (9.82e-3)" "unprognostic (1.74e-3)" "unprognostic (4.36e-2)" "unprognostic (9.78e-2)" "prognostic unfavorable (6.74e-5)" "unprognostic (1.76e-1)" "unprognostic (4.72e-3)" "unprognostic (2.16e-1)" "unprognostic (6.80e-2)" "unprognostic (2.06e-2)" "unprognostic (1.74e-3)" 19.6 18.2 6.9 14.2 16.1 13.0 17.3 12.4 19.2 20.0 18.7 14.1 20.9 14.6 19.8 15.9 45.8 16.0 19.1 18.2 8.2 8.1 27.8 24.8 18.7 18.0 8.5 8.2 16.2 21.3 31.4 13.9 31.4 12.8 15.5 18.2 19.1 29.3 18.4 31.3 33.2 25.9 15.2 8.7 21.5 16.3 35.7 7.8 26.4 25.5 23.9 39.1 23.3 26.0 9.4 13.4 15.5 11.3 6.9 13.1 9.0 28.4 31.6 12.4 12.6 27.5 21.2 23.4 26.8 32.1 22.4 16.8 19.1 35.1 19.2 34.8 31.6 19.3 40.3 19.3 31.7 20.0 23.6 8.7 16.3 14.5 17.0 30.8 30.5 27.7 29.8 28.7 33.1 33.7 18.6 25.2 16.2 21.4 24.3 28.3 17.1 17.1 8.5 15.0 21.1 19.0 17.1 25.1 23.7 25.6 42.2 9.0 11.5 24.9 28.2 26.1 17.5 30.2 17.5 29.5 29.1 15.1 30.5 18.6 17.7 21.9 16.5 21.6 15.8 25.2 15.5 8.1 9.8 11.1 10.1 13.1 9.0 10.9 9.4 8.0 9.4 11.0 11.1 10.2 6.9 11.3 13.4 9.8 9.0 6.9 16.1 12.4 19.2 8.2 8.1 8.5 8.2 12.8 7.8 14.9 10.9 5.3 10.2 14.3 17.5 18.1 12.7 14.7 20.5 12.2 35.3 8.5 3.3 13.1 15.8 11.7 31.9 0.0 15.7 8.4 8.5 14.0 19.6 13.2 11.0 12.7 11.1 13.5 16.1 6.8 10.9 12.0 1.7 9.0 16.2 9.6 19.0 19.3 7.1 10.2 45.0 0.0 9.2 6.5 6.6 17.3 15.6 8.7 15.8 15.9 ZGPAT "dJ583P15.3, FLJ14972, GPATC6, GPATCH6, KIAA1847, MGC44880, ZC3H9, ZC3HDC9, ZIP" ENSG00000197114 "Zinc finger CCCH-type and G-patch domain containing" Q8N5A5 20 63707465-63736142 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 56.1" "Cell type enhanced" "Detected in some" 9 "Alveolar cells type 1: 3.0;Alveolar cells type 2: 4.3;Club cells: 2.3;granulocytes: 2.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056705 Supported "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA056705: AB_2683213" "unprognostic (4.50e-2)" "unprognostic (2.74e-1)" "unprognostic (5.30e-2)" "unprognostic (4.42e-2)" "unprognostic (8.58e-2)" "prognostic favorable (6.17e-5)" "unprognostic (1.06e-1)" "unprognostic (6.97e-2)" "unprognostic (2.52e-1)" "unprognostic (1.54e-1)" "unprognostic (9.31e-3)" "unprognostic (1.60e-2)" "unprognostic (3.43e-3)" "unprognostic (1.37e-1)" "unprognostic (4.11e-2)" "unprognostic (1.24e-1)" "unprognostic (9.86e-3)" 9.3 9.8 9.6 13.6 14.5 14.5 8.0 20.2 13.2 7.6 8.9 12.0 10.8 11.1 12.9 6.1 9.1 8.1 11.2 8.8 10.3 7.1 11.7 56.1 7.2 11.0 16.9 10.7 7.3 12.6 8.3 10.8 9.0 14.2 8.3 3.9 8.0 14.0 8.8 9.2 10.5 10.8 9.4 8.5 11.7 10.3 14.9 15.0 11.3 8.0 5.8 13.5 8.3 9.2 15.6 21.7 19.2 16.4 20.2 23.8 13.0 8.6 11.1 4.4 7.0 3.6 2.5 10.1 9.0 6.0 14.3 6.0 23.8 11.9 9.0 17.2 5.0 13.8 15.8 2.9 10.6 1.8 6.0 7.7 8.4 9.7 24.3 7.1 5.2 14.9 6.4 9.0 5.8 2.3 3.8 7.7 10.9 9.2 8.5 4.7 8.6 12.9 12.5 7.1 12.8 14.0 13.6 3.3 9.1 7.9 8.0 8.3 10.4 12.8 14.5 8.0 2.3 9.9 14.8 8.7 22.3 7.9 8.4 11.4 8.4 13.2 12.3 14.0 5.2 9.9 6.6 16.0 19.2 23.8 16.4 23.1 15.6 20.4 21.5 15.1 14.5 20.3 20.5 17.0 20.2 13.2 21.7 19.8 13.0 9.6 14.5 20.2 13.2 10.3 7.1 16.9 10.7 14.2 15.0 3.0 4.3 0.0 0.0 0.0 0.9 0.2 0.0 0.0 2.3 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.1 0.0 0.2 0.2 0.2 0.0 2.3 1.6 0.2 0.0 1.7 0.6 1.8 0.0 0.0 0.4 1.7 0.0 0.0 0.3 0.3 0.0 0.0 0.4 1.0 0.0 0.3 0.0 0.1 0.3 0.2 0.0 0.0 0.1 ZMYND10 "BLU, CILD22" ENSG00000004838 "Zinc finger MYND-type containing 10" O75800 3 50341110-50346852 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Ciliopathy, Disease mutation, Kartagener syndrome, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 55.7;testis: 99.4" "Group enriched" "Detected in many" 10 "Ciliated cells: 293.1;Early spermatids: 194.4;Late spermatids: 324.6;Spermatocytes: 352.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 12.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 3.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "T-47d: 10.6;U-87 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA035255 Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane" Cytosol "HPA035255: AB_10601928" "unprognostic (2.93e-3)" "unprognostic (2.98e-3)" "unprognostic (1.15e-2)" "unprognostic (3.85e-3)" "unprognostic (4.44e-1)" "unprognostic (7.78e-3)" "unprognostic (4.71e-2)" "unprognostic (6.13e-2)" "unprognostic (1.15e-2)" "unprognostic (1.33e-1)" "unprognostic (3.12e-2)" "unprognostic (6.73e-2)" "prognostic favorable (6.75e-5)" "unprognostic (8.25e-2)" "unprognostic (1.26e-1)" "unprognostic (1.16e-1)" "unprognostic (1.18e-1)" 0.1 0.1 1.9 0.2 4.8 0.3 0.6 0.3 0.8 1.6 0.1 5.5 0.2 0.2 0.9 4.6 0.2 55.7 0.3 0.1 2.6 3.1 0.5 0.2 4.7 0.2 0.2 0.3 4.2 0.2 1.4 1.6 0.1 10.2 0.1 0.1 0.3 0.2 0.2 0.2 0.2 0.1 0.3 0.5 0.2 0.1 99.4 1.2 0.1 0.8 0.1 0.1 0.1 0.0 0.4 1.1 0.8 0.7 3.8 2.5 0.5 2.7 1.0 0.4 0.8 1.0 1.6 0.8 0.4 1.8 3.0 0.9 0.2 1.4 1.0 1.1 1.7 0.3 0.6 2.4 0.1 0.3 1.1 1.1 2.5 3.6 0.1 0.1 0.7 1.2 0.1 0.3 3.8 0.2 2.7 0.2 2.2 0.6 0.6 0.5 1.4 0.5 3.4 0.0 0.4 1.1 1.1 0.1 0.8 3.7 0.1 2.9 1.2 0.3 0.8 0.2 0.1 10.6 0.9 0.0 0.8 0.8 1.8 0.2 1.4 0.6 0.3 7.4 3.4 0.2 0.3 0.4 0.3 2.5 0.4 1.0 0.1 0.2 0.4 1.1 0.4 0.1 0.5 0.8 3.8 0.7 0.4 0.1 0.5 1.9 4.8 0.3 0.8 2.6 3.1 0.2 0.3 10.2 1.2 3.0 6.1 0.0 0.3 0.5 1.2 0.8 0.0 293.1 29.6 1.8 3.9 0.1 0.0 0.7 194.4 0.0 0.0 0.0 0.0 0.2 0.4 0.5 0.0 0.5 0.5 0.0 0.0 1.3 0.0 324.6 8.3 0.2 1.7 0.0 0.4 1.0 0.1 0.0 5.3 0.7 5.7 0.0 0.4 352.7 8.5 0.4 0.1 0.7 0.2 0.1 ZNF20 KOX13 ENSG00000132010 "Zinc finger protein 20" P17024 19 12092843-12140407 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in many" 5 "Ciliated cells: 32.1;Early spermatids: 34.4;Late spermatids: 39.3" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 18.5" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" HPA020887 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020887: AB_2218842" "unprognostic (1.77e-2)" "unprognostic (1.06e-2)" "unprognostic (1.69e-2)" "unprognostic (1.20e-3)" "unprognostic (4.00e-2)" "unprognostic (1.08e-4)" "unprognostic (1.69e-1)" "unprognostic (2.14e-2)" "unprognostic (1.57e-3)" "unprognostic (1.04e-1)" "unprognostic (4.40e-2)" "unprognostic (7.01e-2)" "unprognostic (9.23e-2)" "unprognostic (1.21e-1)" "unprognostic (1.50e-2)" "unprognostic (1.15e-2)" "unprognostic (1.21e-3)" 3.3 4.0 2.7 3.5 4.0 4.9 6.3 3.5 3.7 7.3 4.4 2.3 9.5 1.8 6.3 7.8 4.5 10.3 2.7 2.5 3.0 2.8 5.6 2.6 3.6 4.3 2.8 1.3 6.6 6.1 4.0 9.5 3.8 4.0 9.1 4.4 2.7 4.6 4.0 1.9 6.2 7.5 3.9 2.9 6.0 4.4 14.8 3.8 8.9 9.3 3.9 3.9 5.3 4.5 2.3 2.2 18.5 2.2 6.0 3.3 1.0 3.3 0.1 4.6 9.6 2.1 3.5 3.6 3.0 5.3 2.7 3.8 1.0 1.9 3.2 3.4 3.4 4.0 2.1 2.5 2.1 2.8 2.6 0.7 1.3 3.5 1.6 1.2 0.1 3.0 3.0 4.6 1.1 1.6 3.1 1.6 6.5 2.0 0.5 5.7 1.3 4.1 3.6 7.8 1.6 2.6 3.1 2.6 1.7 3.4 7.3 2.0 4.6 2.7 1.9 3.9 4.7 3.6 5.2 0.0 6.5 2.2 6.3 2.0 5.3 2.9 3.1 0.4 0.0 2.5 9.7 2.2 5.1 1.5 1.1 1.5 1.5 1.3 1.5 1.2 2.3 1.4 1.2 18.5 6.0 2.0 2.2 3.3 1.0 2.7 4.0 3.5 3.7 3.0 2.8 2.8 1.3 4.0 3.8 0.0 0.0 0.0 0.7 0.1 0.5 0.7 2.5 32.1 0.0 1.8 2.0 0.8 1.7 2.0 34.4 0.1 2.3 0.0 2.1 1.0 0.4 1.7 2.3 2.1 1.3 0.0 4.1 0.0 1.0 39.3 0.6 0.2 0.0 1.8 1.3 0.5 1.9 2.5 0.0 1.9 1.3 0.0 0.4 7.6 1.7 0.5 0.9 0.0 1.2 1.4 ZNF229 ENSG00000278318 "Zinc finger protein 229" Q9UJW7 19 44417519-44448578 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 5 "Bipolar cells: 4.8;Cone photoreceptor cells: 3.9;Rod photoreceptor cells: 4.9" "Low cancer specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 4.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 9.1" HPA001494 Uncertain Approved "Vesicles,Plasma membrane" NA NA Vesicles "Plasma membrane" "HPA001494: AB_1080692" "unprognostic (2.59e-1)" "unprognostic (7.41e-4)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (3.90e-1)" "unprognostic (2.17e-1)" "unprognostic (3.34e-2)" "unprognostic (7.18e-3)" "unprognostic (1.17e-2)" "unprognostic (4.66e-2)" "unprognostic (4.18e-2)" "unprognostic (5.04e-3)" "prognostic favorable (8.43e-5)" "unprognostic (3.66e-3)" "unprognostic (2.01e-2)" "unprognostic (2.18e-1)" "unprognostic (4.34e-1)" 1.7 4.1 6.6 0.5 8.2 0.4 2.3 7.7 4.0 2.9 1.2 1.5 1.1 1.7 3.6 2.6 1.9 4.8 1.4 3.1 4.8 2.1 1.7 1.4 0.8 1.8 2.2 6.0 0.9 10.5 8.7 2.5 3.9 2.9 0.4 3.4 2.5 2.2 1.9 0.8 0.6 2.7 4.5 1.2 1.2 2.1 3.8 1.5 6.6 0.0 0.8 2.7 0.9 1.4 0.4 0.5 0.1 4.8 1.1 0.4 0.0 4.8 3.8 0.1 4.1 2.7 0.0 5.9 2.5 3.3 4.2 0.0 0.7 0.0 2.7 3.6 5.3 2.0 0.0 4.4 2.2 0.0 1.7 0.7 1.1 0.3 6.7 0.1 0.0 4.2 0.1 2.8 9.1 3.9 2.9 0.0 0.2 0.0 3.7 0.1 0.0 0.0 3.4 0.0 1.3 0.0 0.0 1.6 3.0 7.5 1.2 1.2 2.7 0.4 0.0 2.8 0.1 0.0 3.0 2.5 0.1 0.8 0.2 5.0 2.8 0.0 0.0 0.0 3.6 0.0 0.1 0.5 0.0 0.0 0.0 0.4 0.0 0.0 0.4 1.4 1.1 0.4 0.0 4.8 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.5 0.1 4.8 3.3 0.0 2.7 0.0 0.0 3.9 0.7 3.3 1.6 0.6 0.6 0.0 0.0 1.1 0.3 0.2 1.6 0.0 0.0 0.6 1.6 0.0 0.0 0.3 0.0 0.9 0.0 0.0 0.0 0.0 3.8 1.7 0.0 1.8 1.2 4.9 0.0 0.5 1.9 2.2 0.0 0.7 0.0 0.5 0.6 ZNF277 "NRIF4, ZNF277P" ENSG00000198839 "Zinc finger protein 277" Q9NRM2 7 112206588-112343096 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA027307 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA027307: AB_1859164" "unprognostic (2.04e-1)" "unprognostic (1.43e-1)" "unprognostic (1.07e-1)" "unprognostic (3.95e-2)" "unprognostic (7.76e-2)" "unprognostic (3.17e-2)" "unprognostic (1.43e-1)" "unprognostic (4.18e-2)" "unprognostic (4.60e-2)" "unprognostic (7.61e-2)" "unprognostic (1.88e-2)" "unprognostic (2.85e-1)" "prognostic favorable (9.47e-4)" "unprognostic (1.05e-1)" "unprognostic (2.64e-2)" "unprognostic (2.46e-1)" "unprognostic (1.06e-1)" 15.2 14.8 11.2 12.9 16.2 10.9 20.1 9.3 13.8 13.6 13.9 8.4 8.8 13.7 14.7 8.8 18.4 12.6 14.3 14.4 11.8 9.1 22.7 30.0 19.2 14.3 11.3 11.9 15.4 23.5 13.5 16.4 8.1 11.6 17.1 14.2 5.5 14.9 12.9 12.7 17.7 13.4 15.9 16.1 13.7 14.6 10.2 14.1 23.9 22.4 11.1 15.6 26.6 13.6 13.3 10.4 9.5 14.3 12.4 17.2 9.1 5.9 6.2 8.3 10.3 13.7 38.1 6.4 5.8 12.8 4.9 10.4 5.7 9.3 13.3 11.6 6.2 11.1 5.0 5.2 10.1 11.6 7.0 8.0 5.4 6.1 12.6 13.4 10.3 7.9 21.9 18.1 9.4 12.4 19.8 16.9 14.7 9.5 14.2 9.2 9.6 14.4 20.1 4.9 7.9 6.4 8.0 9.8 13.8 14.4 6.8 6.3 12.7 7.1 13.7 14.1 13.3 5.5 11.0 10.4 6.8 4.1 17.7 5.5 10.4 8.4 13.2 5.8 10.2 7.6 7.1 11.6 9.5 11.2 14.3 15.9 13.3 15.2 17.2 10.4 11.2 16.3 13.5 9.3 12.4 11.6 10.1 17.0 9.1 11.2 16.2 9.3 13.8 11.8 9.1 11.3 11.9 11.6 14.1 35.7 18.2 13.7 16.1 18.3 10.0 11.8 22.9 10.7 18.2 5.2 2.0 10.4 23.2 20.2 37.5 16.5 11.8 0.0 27.0 13.8 12.7 16.7 7.0 17.3 19.2 30.2 17.7 10.4 39.5 4.4 15.8 26.3 11.8 36.9 21.0 5.8 24.3 21.0 23.7 25.9 11.4 19.4 13.3 20.6 7.8 21.2 11.6 28.4 22.1 18.1 ZNF337 dJ694B14.1 ENSG00000130684 "Zinc finger protein 337" Q9Y3M9 20 25674215-25696841 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Ciliated cells: 22.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "HPA044303, HPA064219" Approved Approved "Nuclear speckles,Plasma membrane" NA NA "Plasma membrane" "Nuclear speckles" "HPA044303: AB_2678890, HPA064219: AB_2685215" "unprognostic (2.14e-1)" "unprognostic (2.19e-2)" "unprognostic (1.65e-2)" "unprognostic (1.80e-1)" "unprognostic (1.30e-1)" "unprognostic (5.81e-3)" "unprognostic (4.54e-3)" "unprognostic (6.99e-2)" "unprognostic (2.34e-1)" "unprognostic (1.34e-2)" "unprognostic (3.15e-2)" "unprognostic (9.36e-4)" "prognostic unfavorable (2.87e-6)" "unprognostic (1.29e-1)" "unprognostic (1.54e-1)" "unprognostic (3.93e-2)" "unprognostic (8.82e-3)" 10.4 9.8 11.7 9.0 14.3 10.8 13.6 49.5 14.8 17.9 14.6 16.1 13.3 7.0 19.8 19.4 9.6 18.0 9.0 8.4 10.9 9.8 9.4 6.9 13.5 12.3 15.1 14.2 23.1 8.4 20.3 19.0 9.3 11.2 16.6 10.9 11.0 8.6 17.2 11.9 12.9 11.1 15.4 9.4 13.4 8.7 7.0 14.9 19.0 12.2 6.0 11.0 14.3 26.1 3.8 3.9 4.8 3.9 5.3 9.6 3.8 7.8 14.4 11.5 8.0 9.4 11.9 9.7 6.8 6.1 5.4 6.7 2.9 7.4 10.0 6.5 6.2 11.1 12.9 7.7 22.2 7.3 3.6 6.1 6.2 9.3 12.5 8.3 5.5 6.7 11.1 19.9 6.2 18.4 13.8 8.3 13.2 5.4 8.9 10.3 8.8 15.0 10.1 3.1 4.4 10.2 9.4 10.8 4.9 5.5 8.7 9.4 10.0 7.0 11.0 9.2 14.8 6.4 7.7 11.0 11.5 6.1 7.6 8.9 12.5 6.7 3.6 5.5 4.7 9.2 0.0 2.4 4.8 7.2 3.9 7.9 3.8 6.0 6.8 3.9 3.2 8.4 9.6 0.1 5.3 2.2 3.9 3.9 3.8 11.7 14.3 49.5 14.8 10.9 9.8 15.1 14.2 11.2 14.9 6.0 12.5 1.5 4.6 1.8 8.8 0.8 5.1 22.7 17.0 3.5 2.0 2.8 3.3 3.3 0.8 4.6 1.1 0.0 2.7 1.9 3.1 3.9 4.7 2.9 2.7 6.4 5.2 3.1 4.8 0.0 6.6 1.6 1.7 2.8 4.3 9.2 2.6 0.0 5.3 1.7 13.0 0.0 3.1 5.6 9.6 2.0 1.9 4.8 2.4 1.5 ZNF407 "FLJ13839, FLJ20307, KIAA1703" ENSG00000215421 "Zinc finger protein 407" Q9C0G0 18 74597870-75065671 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA028255, HPA041673" Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA028255: AB_10603466, HPA041673: AB_2677610" "unprognostic (3.96e-1)" "unprognostic (1.95e-1)" "unprognostic (2.48e-1)" "unprognostic (8.62e-2)" "unprognostic (4.61e-2)" "unprognostic (2.09e-2)" "unprognostic (1.76e-2)" "unprognostic (4.31e-1)" "unprognostic (1.19e-3)" "unprognostic (4.04e-4)" "unprognostic (3.47e-2)" "unprognostic (2.22e-1)" "prognostic favorable (9.79e-5)" "unprognostic (8.87e-2)" "unprognostic (3.07e-1)" "unprognostic (1.24e-1)" "unprognostic (3.11e-2)" 7.7 6.3 8.5 11.7 11.4 12.0 7.6 15.5 10.5 11.8 9.4 5.3 5.8 5.8 11.7 5.2 7.3 9.4 5.5 8.1 7.3 5.2 6.6 6.0 7.4 7.9 7.8 5.7 12.8 6.0 14.9 13.2 10.8 9.0 7.6 6.0 5.9 8.4 7.7 13.3 7.7 10.3 8.7 7.5 11.2 7.5 10.0 7.7 18.1 9.4 8.2 7.6 9.9 9.2 2.4 3.6 6.0 2.6 3.0 3.1 0.9 4.6 4.9 5.6 5.1 4.1 6.1 4.0 6.2 5.5 4.6 5.0 2.0 2.7 6.7 1.9 8.7 3.1 5.5 5.2 6.8 6.9 11.1 3.2 8.6 6.6 3.8 3.7 13.0 7.6 5.5 3.1 7.4 6.5 4.4 6.9 4.8 4.9 10.0 7.0 3.7 6.3 1.8 3.2 1.7 4.4 6.5 7.2 5.3 3.3 8.8 5.3 5.0 5.8 3.7 4.4 4.2 4.2 5.6 9.6 10.5 4.4 2.9 4.9 3.5 7.2 7.1 3.8 5.6 6.2 4.0 1.9 2.3 3.1 2.6 2.9 2.1 2.3 1.7 0.7 2.4 2.6 3.1 6.0 3.0 1.6 3.6 0.6 0.9 8.5 11.4 15.5 10.5 7.3 5.2 7.8 5.7 9.0 7.7 6.0 4.6 6.1 4.7 2.9 10.7 16.5 5.1 8.1 5.7 5.2 5.9 3.4 0.0 3.8 3.2 5.8 5.4 0.0 2.5 2.3 3.8 4.2 1.1 5.1 2.7 4.8 4.1 2.5 5.6 2.2 4.9 4.4 5.0 2.8 4.9 8.1 3.4 3.7 4.2 1.9 13.7 6.5 3.3 9.6 12.2 3.6 4.3 5.1 3.3 3.8 ZNF510 KIAA0972 ENSG00000081386 "Zinc finger protein 510" Q9Y2H8 9 96755865-96778129 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Horizontal cells: 15.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049139 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Nucleoplasm, Plasma membrane" "HPA049139: AB_2680651" "unprognostic (2.70e-2)" "unprognostic (3.44e-1)" "unprognostic (1.07e-1)" "unprognostic (6.92e-2)" "unprognostic (2.01e-2)" "unprognostic (1.43e-2)" "unprognostic (3.78e-1)" "unprognostic (1.21e-2)" "unprognostic (8.50e-3)" "unprognostic (3.90e-2)" "unprognostic (1.06e-1)" "unprognostic (4.34e-2)" "prognostic favorable (5.94e-4)" "unprognostic (1.02e-2)" "unprognostic (1.17e-1)" "unprognostic (5.17e-2)" "unprognostic (2.18e-2)" 9.1 9.2 10.9 6.5 15.7 5.7 12.7 23.0 13.9 14.4 8.8 6.3 11.6 4.6 11.5 8.1 7.9 10.7 6.5 7.4 11.5 10.3 8.9 8.5 8.4 11.4 8.6 12.3 14.9 10.7 13.5 19.8 6.9 10.1 12.6 9.3 5.2 7.5 11.2 9.2 6.2 6.8 11.3 9.2 10.1 6.8 8.2 9.1 14.9 11.2 4.3 13.3 13.9 10.7 5.9 1.3 3.8 2.9 6.4 7.7 2.1 5.1 5.2 11.5 8.5 9.8 9.2 5.9 5.8 11.4 9.7 8.6 4.9 3.8 6.7 3.1 6.1 9.5 11.2 3.3 5.4 8.7 10.7 5.5 9.4 9.7 2.5 5.8 3.6 6.2 7.9 7.2 8.3 10.4 9.1 9.3 12.9 9.6 6.5 9.4 4.6 10.4 4.8 8.1 7.5 5.3 6.8 18.8 3.3 5.1 4.9 11.9 9.5 11.2 5.2 5.7 8.4 3.8 6.8 8.2 6.2 5.9 7.0 6.7 11.4 12.0 4.9 3.5 2.5 6.2 2.3 1.2 3.8 3.8 1.9 7.7 3.6 5.0 3.0 1.0 5.9 5.7 5.2 0.4 6.4 2.9 1.3 7.1 2.1 10.9 15.7 23.0 13.9 11.5 10.3 8.6 12.3 10.1 9.1 3.0 2.7 2.0 1.4 1.4 10.5 4.4 0.0 4.0 3.4 3.5 2.0 2.0 1.7 1.9 5.0 2.7 1.0 0.0 2.3 1.2 1.7 1.4 1.1 1.0 1.7 15.9 1.2 5.5 3.4 5.6 5.5 2.2 5.0 1.0 1.8 3.8 1.3 1.7 3.9 1.5 7.0 6.5 1.4 3.2 4.9 1.3 0.7 3.2 1.4 1.0 ZNF598 "FLJ00086, HEL2" ENSG00000167962 "Zinc finger protein 598" 16 1997654-2009823 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041760, HPA041896" Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041760: AB_10792490, HPA041896: AB_10796464" "unprognostic (9.43e-2)" "unprognostic (1.34e-2)" "unprognostic (8.17e-2)" "unprognostic (6.76e-3)" "unprognostic (3.44e-1)" "unprognostic (1.20e-1)" "unprognostic (2.22e-2)" "unprognostic (7.07e-3)" "unprognostic (1.22e-1)" "unprognostic (4.45e-2)" "unprognostic (1.43e-1)" "unprognostic (5.06e-2)" "unprognostic (4.69e-2)" "unprognostic (1.78e-1)" "unprognostic (1.02e-1)" "unprognostic (1.81e-2)" "unprognostic (7.81e-2)" 8.4 6.1 4.1 9.1 9.4 14.3 13.9 10.6 9.5 8.3 7.7 8.8 4.7 9.9 8.7 4.0 10.0 7.1 4.8 5.6 5.2 4.1 5.9 12.2 7.8 9.1 4.2 7.1 9.8 24.8 6.5 12.9 8.1 6.4 8.9 3.2 6.8 15.6 7.3 12.9 15.3 9.9 9.5 2.9 11.8 12.4 10.1 6.1 10.0 7.7 10.6 12.5 6.8 7.6 1.8 3.2 0.6 0.9 1.2 1.7 0.5 9.9 12.8 3.3 7.9 3.0 4.1 9.5 7.4 3.8 4.9 3.9 13.9 6.0 9.9 9.3 4.8 4.1 11.8 5.4 9.2 1.3 14.1 30.9 7.7 13.7 7.6 13.5 12.3 8.8 4.5 12.6 7.8 15.1 2.8 5.3 12.4 17.3 15.5 2.5 17.1 11.7 19.1 9.6 5.4 15.6 26.7 6.5 23.1 2.4 3.6 15.9 12.9 7.6 9.3 12.0 1.1 6.5 20.6 8.6 10.5 12.5 9.0 13.9 17.4 15.4 13.1 4.5 11.9 9.6 0.6 0.6 0.2 1.2 0.7 1.7 1.1 1.2 0.9 0.7 1.8 1.1 1.6 0.4 1.2 0.9 3.2 0.3 0.5 4.1 9.4 10.6 9.5 5.2 4.1 4.2 7.1 6.4 6.1 6.0 11.5 3.0 10.2 26.4 12.0 0.8 15.3 5.3 6.8 1.8 15.7 8.1 0.0 7.5 4.1 10.0 14.0 23.3 22.5 11.0 12.2 16.3 12.7 17.3 8.2 15.9 10.9 7.4 10.3 7.5 12.4 9.1 1.7 7.2 31.1 7.1 17.5 5.8 7.8 2.7 10.0 0.0 10.5 6.3 13.0 30.5 7.8 6.9 16.5 17.6 ZNF655 "VIK, VIK-1" ENSG00000197343 "Zinc finger protein 655" Q8N720 7 99558406-99576453 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029534, HPA050750" Uncertain Supported "Nucleoplasm,Plasma membrane" NA NA Nucleoplasm "Plasma membrane" "HPA029534: AB_10603008, HPA050750: AB_2681225" "prognostic favorable (7.12e-4)" "unprognostic (3.03e-2)" "unprognostic (9.62e-2)" "unprognostic (5.00e-1)" "unprognostic (1.51e-1)" "unprognostic (5.42e-2)" "unprognostic (3.31e-2)" "unprognostic (3.93e-3)" "prognostic unfavorable (7.24e-4)" "unprognostic (2.01e-1)" "unprognostic (1.49e-2)" "unprognostic (1.18e-1)" "unprognostic (1.42e-2)" "unprognostic (2.16e-1)" "unprognostic (2.11e-1)" "unprognostic (1.62e-2)" "unprognostic (1.12e-1)" 14.6 19.0 17.4 24.1 20.7 10.3 16.9 31.1 20.3 18.8 20.2 19.7 18.0 22.2 15.3 19.0 39.2 15.6 15.1 11.3 14.7 14.4 19.1 21.2 19.9 23.8 21.3 16.1 19.4 30.8 13.9 25.0 21.1 20.4 16.9 16.8 14.1 25.5 19.0 18.2 25.5 19.7 19.8 21.3 22.2 24.1 11.1 19.4 27.8 16.0 14.3 23.1 21.4 20.7 15.0 17.5 44.7 22.2 14.7 25.7 21.4 16.2 15.8 5.8 8.6 6.6 9.9 5.0 9.8 18.5 17.0 16.3 8.7 16.0 11.4 0.1 13.7 22.6 10.3 6.8 11.9 17.2 13.7 9.9 7.9 6.7 11.0 10.1 14.4 15.3 8.5 14.5 15.7 22.2 8.2 7.4 9.7 21.0 15.8 10.6 0.0 20.1 13.2 6.8 0.0 0.0 7.2 5.4 22.4 11.2 17.9 6.7 12.4 9.3 0.3 9.8 9.6 5.3 8.6 5.2 9.5 25.1 15.6 17.6 18.6 27.1 24.8 9.7 7.3 15.3 44.7 18.8 31.2 22.3 19.9 20.5 15.0 20.5 25.6 17.5 13.3 16.5 20.7 21.9 14.7 22.2 10.1 25.7 21.4 17.4 20.7 31.1 20.3 14.7 14.4 21.3 16.1 20.4 19.4 89.3 73.3 45.4 33.6 39.8 46.9 31.5 33.1 26.8 48.9 22.7 39.3 24.8 28.2 24.8 7.8 13.4 38.0 0.0 31.4 35.4 23.7 39.5 17.4 20.8 32.5 47.7 39.9 19.0 58.3 7.1 23.6 52.1 21.9 33.3 34.0 23.0 36.8 49.1 23.7 33.4 45.2 12.9 24.1 30.2 25.1 42.8 61.6 48.4 25.9 52.5 ZNF783 DKFZp667J212 ENSG00000204946 "Zinc finger family member 783" Q6ZMS7 7 149262171-149297302 "Predicted intracellular proteins" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" HPA020375 Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA020375: AB_1859453" "unprognostic (3.17e-3)" "unprognostic (2.54e-1)" "unprognostic (8.40e-3)" "unprognostic (1.16e-1)" "unprognostic (6.13e-2)" "unprognostic (1.08e-3)" "unprognostic (4.28e-3)" "unprognostic (1.05e-1)" "unprognostic (4.24e-3)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "unprognostic (3.29e-2)" "prognostic unfavorable (2.24e-7)" "unprognostic (2.49e-2)" "unprognostic (6.05e-2)" "unprognostic (1.61e-2)" "prognostic favorable (4.11e-4)" 10.1 8.1 11.4 14.4 14.9 6.5 15.1 14.3 15.8 11.5 9.4 15.4 9.9 10.0 13.1 11.2 8.2 13.0 11.0 7.2 11.6 7.7 8.5 4.6 8.6 16.1 13.1 18.4 17.2 11.2 9.4 10.2 7.2 12.5 13.0 9.7 12.2 9.3 13.5 11.6 12.6 12.2 20.1 15.4 17.7 9.1 9.2 12.5 2.9 11.8 6.2 15.0 9.9 16.1 3.8 2.7 0.5 4.5 1.5 3.2 1.1 3.4 3.5 5.7 4.1 3.8 7.3 5.4 2.2 1.1 5.0 2.2 5.5 6.4 11.6 5.6 3.5 1.2 2.3 4.0 4.3 2.2 3.2 3.7 7.5 7.6 1.1 8.7 4.8 9.4 7.6 8.9 4.6 5.6 3.2 3.4 4.1 6.0 6.0 4.1 7.3 7.3 7.5 12.9 7.9 4.7 1.6 0.5 10.1 5.6 5.7 4.6 9.6 8.5 4.0 5.8 3.1 4.4 9.8 5.0 4.0 1.0 2.2 4.8 9.3 5.8 0.1 5.8 1.7 8.7 0.3 1.1 0.5 3.2 2.2 2.5 2.3 2.0 2.0 1.3 3.8 2.7 2.2 0.4 1.5 4.5 2.7 1.2 1.1 11.4 14.9 14.3 15.8 11.6 7.7 13.1 18.4 12.5 12.5 3.0 2.4 7.8 2.4 2.3 14.3 1.4 7.6 4.0 1.2 0.0 9.8 2.5 3.3 2.0 3.9 2.9 2.0 0.0 2.4 1.7 4.5 3.6 0.0 5.0 3.6 6.4 3.5 6.7 8.5 3.5 8.1 2.8 5.0 2.8 5.1 3.4 2.1 0.0 5.3 0.8 8.6 12.9 3.1 14.7 5.9 2.6 0.9 4.1 4.7 2.1 ZNF839 C14orf131 ENSG00000022976 "Zinc finger protein 839" A8K0R7 14 102317377-102342702 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 5 "Erythroid cells: 23.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020434 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA020434: AB_10669862" "unprognostic (7.83e-2)" "unprognostic (1.96e-1)" "unprognostic (2.28e-1)" "unprognostic (8.81e-2)" "unprognostic (1.49e-1)" "unprognostic (2.33e-1)" "unprognostic (6.73e-2)" "unprognostic (5.69e-2)" "unprognostic (1.85e-1)" "unprognostic (7.10e-3)" "prognostic favorable (4.57e-4)" "unprognostic (2.40e-2)" "prognostic favorable (5.00e-4)" "unprognostic (1.32e-1)" "unprognostic (2.17e-2)" "unprognostic (1.08e-1)" "unprognostic (8.21e-2)" 8.9 9.9 10.9 10.6 14.1 11.3 15.7 11.6 16.9 11.1 10.2 14.4 9.0 8.1 15.3 11.2 8.4 19.7 7.8 8.4 11.1 10.1 9.7 13.0 6.8 11.0 8.8 13.4 12.9 15.6 14.3 13.2 9.0 8.9 10.1 9.5 13.0 11.9 13.4 18.6 21.6 10.3 10.6 8.3 15.2 8.7 39.7 7.8 11.3 12.9 8.8 11.8 7.8 9.5 1.9 2.1 3.5 1.9 0.3 2.6 0.4 8.7 8.0 10.4 18.7 4.8 8.3 17.8 6.8 5.6 8.6 7.1 3.0 7.5 9.0 5.6 4.6 3.5 8.6 6.7 17.2 6.6 12.0 12.8 6.3 7.2 5.0 4.3 5.8 5.5 6.6 13.0 16.6 15.5 13.1 11.4 12.8 13.3 11.9 12.0 16.2 8.9 9.4 13.9 4.8 8.0 19.3 6.3 5.7 7.6 7.2 5.6 17.7 5.7 7.2 6.0 10.3 16.3 9.7 4.4 5.5 5.0 7.6 6.0 11.7 8.4 10.3 4.3 7.0 9.1 0.0 0.7 2.3 2.4 1.9 2.6 1.9 1.6 1.5 1.3 1.4 2.6 2.2 3.5 0.3 0.4 2.1 2.1 0.4 10.9 14.1 11.6 16.9 11.1 10.1 8.8 13.4 8.9 7.8 0.0 7.7 0.0 2.3 2.7 6.8 2.0 5.1 6.7 4.5 10.4 7.9 4.6 10.0 3.1 12.3 1.8 3.9 23.3 2.5 2.5 2.1 2.0 3.5 4.7 2.6 3.2 1.2 5.5 2.2 1.4 4.6 2.1 3.3 1.0 5.8 6.0 2.1 0.0 3.9 5.5 9.0 0.0 0.9 12.5 12.7 2.3 4.7 2.5 5.2 1.4 ZSWIM1 "C20orf162, dJ337O18.5" ENSG00000168612 "Zinc finger SWIM-type containing 1" Q9BR11 20 45881227-45885266 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041147, HPA046751" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041147: AB_2677329, HPA046751: AB_2679785" "unprognostic (6.27e-2)" "unprognostic (1.03e-1)" "unprognostic (1.87e-1)" "unprognostic (1.51e-2)" "unprognostic (1.69e-2)" "unprognostic (1.95e-1)" "prognostic unfavorable (5.47e-4)" "unprognostic (9.06e-2)" "unprognostic (1.18e-1)" "unprognostic (1.02e-1)" "prognostic favorable (1.77e-4)" "unprognostic (1.78e-1)" "unprognostic (2.77e-2)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "unprognostic (4.64e-1)" "unprognostic (4.29e-2)" 11.3 13.8 7.3 7.6 11.4 10.2 7.8 17.2 15.7 7.3 8.5 10.4 5.6 8.8 10.1 7.8 9.3 9.3 10.1 9.8 7.5 7.7 12.8 11.3 6.9 9.5 6.9 8.5 12.6 14.1 10.0 11.4 12.2 6.3 10.3 7.7 14.1 10.4 8.1 27.3 12.3 10.6 9.1 8.1 12.2 8.7 9.0 9.5 16.1 11.5 9.8 13.3 9.6 7.0 5.4 4.4 6.9 3.7 1.2 5.3 1.4 6.4 8.1 6.1 7.4 11.1 6.5 6.2 4.4 5.8 10.2 9.4 18.5 7.6 7.7 13.4 6.4 10.7 15.6 9.9 12.6 7.6 2.9 5.9 10.1 10.1 12.6 6.8 8.1 10.4 9.3 10.6 8.4 8.1 7.4 7.9 6.9 8.9 6.2 5.8 19.6 9.1 6.7 3.3 7.3 9.1 7.0 8.9 5.4 6.5 9.6 8.1 5.2 15.4 22.7 5.2 5.7 13.5 6.1 6.4 11.1 7.0 5.9 6.5 6.2 4.4 7.9 8.8 6.4 5.6 3.8 2.9 6.9 1.0 3.7 0.7 5.4 3.7 1.6 1.6 5.1 5.3 4.7 3.1 1.2 3.5 4.4 3.0 1.4 7.3 11.4 17.2 15.7 7.5 7.7 6.9 8.5 6.3 9.5 3.0 2.4 0.5 1.7 1.0 2.4 4.8 0.0 0.0 1.2 0.0 0.0 2.5 3.3 1.8 0.2 1.3 2.6 0.0 3.3 2.3 1.4 1.9 3.5 1.7 1.5 6.4 2.4 2.5 1.6 0.4 3.1 1.2 0.0 1.0 2.6 1.4 2.8 3.2 1.4 1.2 3.2 0.0 1.7 0.6 1.7 1.4 1.9 1.7 2.3 1.6 ZSWIM8 "4832404P21Rik, KIAA0913" ENSG00000214655 "Zinc finger SWIM-type containing 8" A7E2V4 10 73785582-73801797 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 64.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041244 Approved Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA041244: AB_10794269" "unprognostic (8.83e-2)" "unprognostic (2.86e-1)" "unprognostic (2.89e-3)" "unprognostic (1.44e-1)" "unprognostic (4.00e-2)" "prognostic favorable (5.61e-4)" "unprognostic (3.11e-1)" "unprognostic (1.64e-1)" "unprognostic (2.97e-1)" "unprognostic (1.69e-1)" "unprognostic (2.24e-3)" "unprognostic (1.31e-1)" "unprognostic (1.52e-1)" "unprognostic (2.41e-1)" "unprognostic (1.98e-1)" "unprognostic (2.49e-1)" "unprognostic (2.52e-1)" 22.5 30.2 27.1 17.7 27.9 35.3 20.6 29.8 32.4 21.7 27.2 38.1 29.7 25.6 25.5 43.3 33.1 19.9 24.9 19.8 25.9 20.4 28.8 43.1 22.3 20.9 34.0 24.9 26.4 23.3 39.0 50.0 28.1 28.6 29.9 17.8 29.8 30.3 28.9 19.5 48.2 34.8 27.9 20.0 36.8 21.8 29.1 37.0 22.7 30.1 15.9 22.2 21.7 24.0 3.5 6.6 9.0 4.2 1.9 5.7 1.7 5.7 9.9 12.4 20.3 29.6 14.2 7.2 7.4 20.7 10.6 12.8 8.7 4.8 3.3 5.4 12.3 10.5 9.0 4.3 8.7 5.4 5.2 9.1 4.6 10.5 11.4 22.3 3.1 18.1 23.0 15.8 13.2 15.5 29.1 12.5 7.0 6.5 6.4 12.1 8.8 4.8 9.5 3.7 4.7 31.2 5.8 5.8 1.9 15.1 12.5 3.0 13.6 6.1 18.4 10.5 11.2 12.3 6.7 12.5 12.0 7.1 5.3 7.5 16.4 8.8 2.1 13.0 4.7 6.1 4.3 4.1 3.2 5.7 2.7 3.3 3.5 2.6 2.4 3.2 2.7 1.1 3.7 9.0 1.9 4.2 6.6 3.2 1.7 27.1 27.9 29.8 32.4 25.9 20.4 34.0 24.9 28.6 37.0 3.0 8.6 4.8 6.7 11.0 29.7 1.4 25.5 6.7 4.5 19.2 64.8 10.5 1.7 10.6 3.4 15.2 26.1 0.0 12.8 7.3 12.7 15.2 0.0 26.9 15.6 33.4 19.5 38.1 23.2 2.1 20.4 12.0 15.1 15.4 15.5 20.3 15.7 17.5 22.6 10.2 47.4 12.9 10.8 32.1 14.5 12.4 24.0 10.0 9.9 12.2